PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Venkatanarayan, A; Raulji, P; Norton, W; Chakravarti, D; Coarfa, C; Su, XH; Sandur, SK; Ramirez, MS; Lee, J; Kingsley, CV; Sananikone, EF; Rajapakshe, K; Naff, K; Parker-Thornburg, J; Bankson, JA; Tsai, KY; Gunaratne, PH; Flores, ER				Venkatanarayan, Avinashnarayan; Raulji, Payal; Norton, William; Chakravarti, Deepavali; Coarfa, Cristian; Su, Xiaohua; Sandur, Santosh K.; Ramirez, Marc S.; Lee, Jaehuk; Kingsley, Charles V.; Sananikone, Eliot F.; Rajapakshe, Kimal; Naff, Katherine; Parker-Thornburg, Jan; Bankson, James A.; Tsai, Kenneth Y.; Gunaratne, Preethi H.; Flores, Elsa R.			IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo	NATURE			English	Article							P53-INDUCIBLE REGULATOR; P63; P73; ACTIVATION; MUTANT; TAP63; CHEMOTHERAPY; SUPPRESSION; INHIBITION; MUTATIONS	TP53 is commonly altered in human cancer, and Tp53 reactivation suppresses tumoursin vivo inmice(1,2) (TP53 and Tp53 are also known as p53). This strategy has proven difficult to implement therapeutically, and here we examine an alternative strategy by manipulating the p53 family members, Tp63 and Tp73 (also known as p63 and p73, respectively). The acidic transactivation-domain-bearing (TA) isoforms of p63 and p73 structurally and functionally resemble p53, whereas the Delta N isoforms (lacking the acidic transactivation domain) of p63 and p73 are frequently overexpressed in cancer and act primarily in a dominant-negative fashion against p53, TAp63 and TAp73 to inhibit their tumour-suppressive functions(3-8). The p53 family interacts extensively in cellular processes that promote tumour suppression, such as apoptosis and autophagy(9-14), thus a clear understanding of this interplay in cancer is needed to treat tumours with alterations in the p53 pathway. Here we show that deletion of the Delta N isoforms of p63 or p73 leads to metabolic reprogramming and regression of p53-deficient tumours through upregulation of IAPP, the gene that encodes amylin, a 37-amino-acid peptide co-secreted with insulin by the b cells of the pancreas. We found that IAPP is causally involved in this tumour regression and that amylin functions through the calcitonin receptor (CalcR) and receptor activity modifying protein 3 (RAMP3) to inhibit glycolysis and induce reactive oxygen species and apoptosis. Pramlintide, a synthetic analogue of amylin that is currently used to treat type 1 and type 2 diabetes, caused rapid tumour regression in p53-deficient thymic lymphomas, representing a novel strategy to target p53-deficient cancers.	[Venkatanarayan, Avinashnarayan; Raulji, Payal; Chakravarti, Deepavali; Su, Xiaohua; Sandur, Santosh K.; Sananikone, Eliot F.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Venkatanarayan, Avinashnarayan; Raulji, Payal; Chakravarti, Deepavali; Su, Xiaohua; Sandur, Santosh K.; Sananikone, Eliot F.; Tsai, Kenneth Y.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Venkatanarayan, Avinashnarayan; Chakravarti, Deepavali; Sananikone, Eliot F.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Venkatanarayan, Avinashnarayan; Chakravarti, Deepavali; Su, Xiaohua; Sandur, Santosh K.; Sananikone, Eliot F.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Houston, TX 77030 USA; [Norton, William; Naff, Katherine] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Coarfa, Cristian; Rajapakshe, Kimal] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sandur, Santosh K.] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Mumbai 400085, Maharashtra, India; [Ramirez, Marc S.; Lee, Jaehuk; Kingsley, Charles V.; Bankson, James A.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Parker-Thornburg, Jan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Tsai, Kenneth Y.] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Bhabha Atomic Research Center (BARC); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston	Flores, ER (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	elsaflores@mdanderson.org	Rajapakshe, Kimal/P-1592-2015; Bankson, James A./J-9798-2014	Bankson, James A./0000-0002-8574-154X; Tsai, Kenneth/0000-0001-5325-212X	NCI [R01CA160394, R01CA134796]; CPRIT [RP120124, RP101243-P5]; NCI-Cancer Center Core Grant [CA-16672]; Lymphoma SPORE [P50CA136411]; Hildegardo E. and Olga M. Flores Foundation; Mel Klein Foundation; NATIONAL CANCER INSTITUTE [P50CA136411, R01CA134796, P30CA016672, R01CA160394] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CPRIT; NCI-Cancer Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lymphoma SPORE; Hildegardo E. and Olga M. Flores Foundation; Mel Klein Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We than kA. Jain, V. Pant, J. Jackson, A. Marisetty, K. Michel and the Small Animal Imaging Facility (SAIF) for technical advice. This work was supported by grants to E.R.F. from NCI (R01CA160394) and (R01CA134796), CPRIT (RP120124), NCI-Cancer Center Core Grant (CA-16672) (University of Texas M.D. Anderson Cancer Center), a development award from the Lymphoma SPORE (P50CA136411), the Hildegardo E. and Olga M. Flores Foundation, and the Mel Klein Foundation and grant to J.A.B. from CPRIT(RP101243-P5). E.R.F. is a scholar of the Leukemia and Lymphoma Society, the Rita Allen Foundation and the V Foundation for Cancer Research. A.V. is a Schissler Scholar and D.C. is a CPRIT Scholar (RP101502).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Castle AL, 1998, AM J PHYSIOL-ENDOC M, V275, pE531, DOI 10.1152/ajpendo.1998.275.3.E531; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarti D, 2014, P NATL ACAD SCI USA, V111, pE572, DOI 10.1073/pnas.1319743111; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Edelman S, 2008, BIODRUGS, V22, P375, DOI 10.2165/0063030-200822060-00004; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; MATTSON MP, 1995, BRAIN RES, V676, P219, DOI 10.1016/0006-8993(95)00148-J; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Pillay K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826706; Sandulache VC, 2012, MOL CANCER THER, V11, P1373, DOI 10.1158/1535-7163.MCT-12-0041; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vin H, 2013, ELIFE, V2, DOI 10.7554/eLife.00969; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	47	93	96	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					626	U229		10.1038/nature13910	http://dx.doi.org/10.1038/nature13910			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25409149	Green Accepted			2022-12-28	WOS:000348775000046
J	Zuo, W; Zhang, T; Wu, DZ; Guan, SP; Liew, AA; Yamamoto, Y; Wang, X; Lim, SJ; Vincent, M; Lessard, M; Crum, CP; Xian, W; McKeon, F				Zuo, Wei; Zhang, Ting; Wu, Daniel Zheng'An; Guan, Shou Ping; Liew, Audrey-Ann; Yamamoto, Yusuke; Wang, Xia; Lim, Siew Joo; Vincent, Matthew; Lessard, Mark; Crum, Christopher P.; Xian, Wa; McKeon, Frank			p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration	NATURE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INDUCED PULMONARY-FIBROSIS; MEDICAL PROGRESS; INFLUENZA-VIRUS; IN-VITRO; EXPRESSION; PNEUMONIA; INFECTION; CHILDREN; OUTCOMES	Lung diseases such as chronic obstructive pulmonary disease(1) and pulmonary fibrosis(2) involve the progressive and inexorable destruction of oxygen exchange surfaces and airways, and have emerged as a leading cause of death worldwide. Mitigating therapies, aside from impractical organ transplantation, remain limited and the possibility of regenerative medicine has lacked empirical support. However, it is clinically known that patients who survive sudden, massive loss of lung tissue from necrotizing pneumonia(3,4) or acute respiratory distress syndrome(5,6) often recover full pulmonary function within six months. Correspondingly, we recently demonstrated lung regeneration in mice following H1N1 influenza virus infection, and linked distal airway stem cells expressing Trp63 (p63) and keratin 5, called DASC(p63/Krt5), to this process(7). Here we show that pre-existing, intrinsically committed DASC(p63/Krt5) undergo a proliferative expansion in response to influenza-induced lung damage, and assemble into nascent alveoli at sites of interstitial lung inflammation. We also show that the selective ablation of DASC(p63/Krt5) in vivo prevents this regeneration, leading to pre-fibrotic lesions and deficient oxygen exchange. Finally, we demonstrate that single DASC(p63/Krt5)-derived pedigrees differentiate to type I and type II pneumocytes as well as bronchiolar secretory cells following transplantation to infected lung and also minimize the structural consequences of endogenous stem cell loss on this process. The ability to propagate these cells in culture while maintaining their intrinsic lineage commitment suggests their potential in stem cell-based therapies for acute and chronic lung diseases.	[Zuo, Wei; Zhang, Ting; Wu, Daniel Zheng'An; Guan, Shou Ping; Liew, Audrey-Ann; Lim, Siew Joo; Xian, Wa; McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Yamamoto, Yusuke; Wang, Xia; Xian, Wa; McKeon, Frank] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Vincent, Matthew] Adv Cell Technol, Marlborough, MA 01752 USA; [Lessard, Mark] Jackson Lab, Bar Harbor, ME 04609 USA; [Crum, Christopher P.; Xian, Wa] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Xian, Wa; McKeon, Frank] Natl Univ Hlth Syst, Dept Med, Singapore 119228, Singapore; [Xian, Wa] Univ Connecticut, Dept Genet & Dev Biol, Ctr Hlth, Farmington, CT 06030 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Jackson Laboratory; Jackson Laboratory; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National University of Singapore; University of Connecticut	McKeon, F (corresponding author), ASTAR, Genome Inst Singapore, Singapore 138672, Singapore.	waxian@jax.org; mckeon.xian@gmail.com		Lessard, Mark/0000-0002-1927-2204	Joint Council Off ice of the Agency for Science Technology Research Agency (ASTAR), Singapore; Defense Advanced Research Projects Agency (DARPA) [N66001-09-1-2121]; Johnson & Johnson ASTAR Joint Program; Connecticut Innovations	Joint Council Off ice of the Agency for Science Technology Research Agency (ASTAR), Singapore; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Johnson & Johnson ASTAR Joint Program; Connecticut Innovations	This work was supported by grants from the Joint Council Off ice of the Agency for Science Technology Research Agency (ASTAR), Singapore (W.X., F.M.), Defense Advanced Research Projects Agency (DARPA, N66001-09-1-2121 to F.M.), the Johnson & Johnson ASTAR Joint Program (W.X., F.M.) and support from Connecticut Innovations (W.X., F.M.). We thank M. LaLande, B. Lane and H. Hui Ng for support, G. Wright, B. Tennent, B. Knowles and T. McLaughlin for comments on the manuscript, J. Hammer for artwork, P. Kraus for blastocyst injections, and H. Ahmad and K. L. Goh for technical assistance. We thank H. Green for advice and support.	Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BASKERVILLE A, 1974, BRIT J EXP PATHOL, V55, P130; Becker Klaus, 2013, Cold Spring Harb Protoc, V2013, P743, DOI 10.1101/pdb.prot076521; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; KEREM E, 1994, AM J RESP CRIT CARE, V149, P242, DOI 10.1164/ajrccm.149.1.8111589; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Li Y, 2009, ARCH DERMATOL RES, V301, P205, DOI 10.1007/s00403-008-0881-y; Matuschak George M, 2010, Mo Med, V107, P252; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sawicki GS, 2008, EUR RESPIR J, V31, P1285, DOI 10.1183/09031936.00099807; Schmidt D, 1996, TOXICOL LETT, V88, P75, DOI 10.1016/0378-4274(96)03720-4; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUGIHARA H, 1993, AM J PATHOL, V142, P783; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; VYALOV SL, 1993, AM J PATHOL, V143, P1754; Wilcox ME, 2013, CHEST, V143, P920, DOI 10.1378/chest.12-0685; Xian W, 2012, CELL CYCLE, V11, P887, DOI 10.4161/cc.11.5.19328	34	287	306	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					616	U194		10.1038/nature13903	http://dx.doi.org/10.1038/nature13903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25383540	Green Published			2022-12-28	WOS:000348775000044
J	Aanen, DK				Aanen, Duur K.			DEVELOPMENTAL BIOLOGY How a long-lived fungus keeps mutations in check	SCIENCE			English	Editorial Material							STEM-CELLS; CANCER; PLANT		Wageningen Univ, Genet Lab, Dept Plant Sci, NL-6708 PB Wageningen, Netherlands	Wageningen University & Research	Aanen, DK (corresponding author), Wageningen Univ, Genet Lab, Dept Plant Sci, NL-6708 PB Wageningen, Netherlands.	duur.aanen@wur.nl						Anderson JB, 2014, MYCOLOGIA, V106, P642, DOI 10.3852/13-367; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Caulin AF, 2011, TRENDS ECOL EVOL, V26, P175, DOI 10.1016/j.tree.2011.01.002; Elez M, 2010, CURR BIOL, V20, P1432, DOI 10.1016/j.cub.2010.06.071; Frank SA, 2004, BIOESSAYS, V26, P291, DOI 10.1002/bies.20000; Gladfelter A, 2009, NAT REV MICROBIOL, V7, P875, DOI 10.1038/nrmicro2249; Heidstra R, 2014, NAT REV MOL CELL BIO, V15, P301, DOI 10.1038/nrm3790; Lanfear R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2836; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; ROSENBERGER RF, 1968, J BACTERIOL, V96, P1208, DOI 10.1128/JB.96.4.1208-1213.1968; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; van Diepeningen AD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0447	14	11	11	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					922	923		10.1126/science.1261401	http://dx.doi.org/10.1126/science.1261401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414293				2022-12-28	WOS:000345696000021
J	Willyard, C				Willyard, Cassandra			Riddle of the rays	NATURE			English	Editorial Material							MALIGNANT-MELANOMA											BERAL V, 1981, BRIT J CANCER, V44, P886, DOI 10.1038/bjc.1981.288; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Elmwood J. M., 1985, INT J CANCER, V35, P427; Gallagher RP, 2011, INT J CANCER, V128, P1872, DOI 10.1002/ijc.25503; Li WQ, 2014, JAMA INTERN MED, V174, P964, DOI 10.1001/jamainternmed.2014.594; Meyskens FL, 2011, RECENT RESULTS CANC, V188, P65, DOI 10.1007/978-3-642-10858-7_5; VAGERO D, 1990, BRIT J IND MED, V47, P317; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806	8	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S112	S113		10.1038/515S112a	http://dx.doi.org/10.1038/515S112a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407706	Bronze			2022-12-28	WOS:000345770600002
J	Lamberts, M; Lip, GYH; Hansen, ML; Lindhardsen, J; Olesen, JB; Raunso, J; Olsen, AMS; Andersen, PK; Gerds, TA; Fosbol, EL; Torp-Pedersen, C; Gislason, GH				Lamberts, Morten; Lip, Gregory Y. H.; Hansen, Morten Lock; Lindhardsen, Jesper; Olesen, Jonas Bjerring; Raunso, Jakob; Olsen, Anne-Marie Schjerning; Andersen, Per Kragh; Gerds, Thomas Alexander; Fosbol, Emil L.; Torp-Pedersen, Christian; Gislason, Gunnar H.			Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy A Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							MYOCARDIAL-INFARCTION; CORONARY INTERVENTION; ORAL ANTICOAGULANTS; TRIPLE THERAPY; WARFARIN; ASPIRIN; STROKE; METAANALYSIS; DEATH; CLOPIDOGREL	Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are assumed to increase bleeding risk, but their actual relation to serious bleeding in patients with atrial fibrillation (AF) who are receiving antithrombotic medication is unknown. Objective: To investigate the risk for serious bleeding and thromboembolism associated with ongoing NSAID and antithrombotic therapy. Design: Observational cohort study. Setting: Nationwide registries. Patients: Danish patients with AF hospitalized between 1997 and 2011. Measurements: Absolute risk for serious bleeding and thromboembolism with ongoing NSAID and antithrombotic therapy, assessed by using Cox models. Results: Of 150 900 patients with AF (median age, 75 years [interquartile range, 65 to 83 years]; 47% female), 53 732 (35.6%) were prescribed an NSAID during a median follow-up of 6.2 years (interquartile range, 2.1 to 14.0 years). There were 17 187 (11.4%) and 19 561 (13.0%) occurrences of serious bleeding and thromboembolism, respectively. At 3 months, the absolute risk for serious bleeding within 14 days of NSAID exposure was 3.5 events per 1000 patients compared with 1.5 events per 1000 patients without NSAID exposure. The risk difference was 1.9 events per 1000 patients. In patients selected for oral anticoagulant therapy, the absolute risk difference was 2.5 events per 1000 patients. Use of NSAIDs was associated with increased absolute risks for serious bleeding and thromboembolism across all antithrombotic regimens and NSAID types. An NSAID dosage above the recommended minimum was associated with a substantially increased hazard ratio for bleeding. Limitation: Observational design and unmeasured confounders. Conclusion: Use of NSAIDs was associated with an independent risk for serious bleeding and thromboembolism in patients with AF. Short-term NSAID exposure was associated with increased bleeding risk. Physicians should exercise caution with NSAIDs in patients with AF.	Gentofte Univ Hosp, DK-2900 Hellerup, Denmark; Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Natl Inst Publ Hlth, DK-2100 Copenhagen, Denmark; Univ Southern Denmark, Copenhagen, Denmark; Aalborg Univ, Aalborg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Birmingham; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Aalborg University	Lamberts, M (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Post 635,Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	mortenlamberts@gmail.com	Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Fosbol, Emil/0000-0002-2048-4167; Lamberts, Morten/0000-0002-9827-440X; Gerds, Thomas Alexander/0000-0002-5955-816X	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Dr. Gislason is supported by an unrestricted research scholarship from the Novo Nordisk Foundation.	Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Cairns JA, 2011, CAN J CARDIOL, V27, P74, DOI 10.1016/j.cjca.2010.11.007; Camm AJ, 2012, EUR HEART J, V33; Chang CH, 2010, STROKE, V41, P1884, DOI 10.1161/STROKEAHA.110.585828; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Davidson BL, 2014, JAMA INTERN MED, V174, P947, DOI 10.1001/jamainternmed.2014.946; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Fosbol EL, 2014, INT J STROKE, V9, P943, DOI 10.1111/j.1747-4949.2012.00863.x; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Galliard-Grigioni KS, 2009, EUR J PHARMACOL, V609, P96, DOI 10.1016/j.ejphar.2009.02.042; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Gislason GH, 2009, ARCH INTERN MED, V169, P141, DOI 10.1001/archinternmed.2008.525; Gullov AL, 1999, ARCH INTERN MED, V159, P1322, DOI 10.1001/archinte.159.12.1322; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hart RG, 1999, CEREBROVASC DIS, V9, P215, DOI 10.1159/000015958; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Husted S, 2014, THROMB HAEMOSTASIS, V111, P781, DOI 10.1160/TH14-03-0228; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Lamberts M, 2013, INT J CARDIOL, V168, P832, DOI 10.1016/j.ijcard.2012.10.004; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Mason PK, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.09.030; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Olsen AMS, 2012, CIRCULATION, V126, P1955, DOI 10.1161/CIRCULATIONAHA.112.112607; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ruiz-Nodar JM, 2011, REV ESP CARDIOL, V64, P965, DOI [10.1016/j.recesp.2011.04.014, 10.1016/j.rec.2011.04.013]; Schaefer MG, 2003, AM J HEALTH-SYST PH, V60, P1319, DOI 10.1093/ajhp/60.13.1319; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956	39	63	65	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					690	U136		10.7326/M13-1581	http://dx.doi.org/10.7326/M13-1581			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402512				2022-12-28	WOS:000347245600026
J	Pratto, F; Brick, K; Khil, P; Smagulova, F; Petukhova, GV; Camerini-Otero, RD				Pratto, Florencia; Brick, Kevin; Khil, Pavel; Smagulova, Fatima; Petukhova, Galina V.; Camerini-Otero, R. Daniel			Recombination initiation maps of individual human genomes	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; COPY NUMBER VARIATION; MEIOTIC RECOMBINATION; HOT-SPOT; SPERM CELLS; HOTSPOTS; PRDM9; MOUSE; INSTABILITY; RATES	DNA double-strand breaks (DSBs) are introduced in meiosis to initiate recombination and generate crossovers, the reciprocal exchanges of genetic material between parental chromosomes. Here, we present high-resolution maps of meiotic DSBs in individual human genomes. Comparing DSB maps between individuals shows that along with DNA binding by PRDM9, additional factors may dictate the efficiency of DSB formation. We find evidence for both GC-biased gene conversion and mutagenesis around meiotic DSB hotspots, while frequent colocalization of DSB hotspots with chromosome rearrangement breakpoints implicates the aberrant repair of meiotic DSBs in genomic disorders. Furthermore, our data indicate that DSB frequency is a major determinant of crossover rate. These maps provide new insights into the regulation of meiotic recombination and the impact of meiotic recombination on genome function.	[Pratto, Florencia; Brick, Kevin; Khil, Pavel; Camerini-Otero, R. Daniel] NIDDK, NIH, Bethesda, MD 20892 USA; [Smagulova, Fatima; Petukhova, Galina V.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Uniformed Services University of the Health Sciences - USA	Petukhova, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA.	galina.petukhova@usuhs.edu; rdcamerini@mail.nih.gov	Brick, Kevin/N-1156-2019; Smagulova, Fatima/K-5459-2015	Brick, Kevin/0000-0002-9596-6400; Smagulova, Fatima/0000-0001-6883-1968; Pratto, Florencia/0000-0002-9678-8044	NIH from National Institute of General Medical Sciences [1R01GM084104-01A1]; March of Dimes [1-FY13-506]; NIDDK Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084104] Funding Source: NIH RePORTER	NIH from National Institute of General Medical Sciences; March of Dimes(March of Dimes); NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Smith and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Genomics Core for sequencing assistance. We thank M. Lichten and P. Hsieh for critical feedback on the manuscript and also extend our gratitude to A. Jeffreys for providing details of human crossover rates. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, MD (http://biowulf.nih.gov). This research was supported by NIH grant 1R01GM084104-01A1 from National Institute of General Medical Sciences (G.V.P.), March of Dimes grant 1-FY13-506 (G.V.P.) and by the NIDDK Intramural Research Program (R.D.C.O.). The sequencing data reported in this paper are archived at the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) as accession no. GSE59836.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arbel-Eden A, 2013, G3-GENES GENOM GENET, V3, P633, DOI 10.1534/g3.113.005603; Arnheim N, 2003, AM J HUM GENET, V73, P5, DOI 10.1086/376419; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bost B, 2014, BIOESSAYS, V36, P84, DOI 10.1002/bies.201300109; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Clement Y, 2013, MOL BIOL EVOL, V30, P2612, DOI 10.1093/molbev/mst154; Cole F, 2010, MOL CELL, V39, P700, DOI 10.1016/j.molcel.2010.08.017; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dittwald P, 2013, GENOME RES, V23, P1395, DOI 10.1101/gr.152454.112; Dittwald P, 2013, HUM MUTAT, V34, P210, DOI 10.1002/humu.22217; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Fan QQ, 1997, GENETICS, V145, P661; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Khil PP, 2012, GENOME RES, V22, P957, DOI 10.1101/gr.130583.111; Khil PP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000831; KIMURA M, 1973, GENETICS, V75, P199; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Oliver-Bonet M, 2005, MOL HUM REPROD, V11, P517, DOI 10.1093/molehr/gah193; Page J, 2012, CHROMOSOMA, V121, P307, DOI 10.1007/s00412-012-0364-y; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Rocco V, 1996, GENES CELLS, V1, P645, DOI 10.1046/j.1365-2443.1996.00256.x; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; WU TC, 1995, GENETICS, V140, P55; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	62	167	167	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					826	+	1256442	10.1126/science.1256442	http://dx.doi.org/10.1126/science.1256442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6XZ	25395542	Green Accepted			2022-12-28	WOS:000349771600002
J	Alpern, JD; Stauffer, WM; Kesselheim, AS				Alpern, Jonathan D.; Stauffer, William M.; Kesselheim, Aaron S.			High-Cost Generic Drugs - Implications for Patients and Policymakers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Alpern, Jonathan D.; Stauffer, William M.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Alpern, Jonathan D.; Stauffer, William M.] Reg Hosp, Dept Med, St Paul, MN USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Alpern, JD (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.		Liles, Nathan W/C-9819-2018; Kesselheim, Aaron/R-6793-2017	Liles, Nathan W/0000-0002-3710-7296; Kesselheim, Aaron/0000-0002-8867-2666				[Anonymous], MICR 2 0 EL VERS; Choudhry NK, 2009, HEALTH AFFAIR, V28, P827, DOI 10.1377/hlthaff.28.3.827; Colliver V, 2014, PRICES SOAR SOME GEN; Government Accountability Office, 2009, BRANDN PRESCR DRUG P	4	82	82	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1859	1862		10.1056/NEJMp1408376	http://dx.doi.org/10.1056/NEJMp1408376			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT1RB	25390739	Bronze			2022-12-28	WOS:000344709800002
J	Di Saverio, S; Catena, F				Di Saverio, Salomone; Catena, Fausto			Rotation of the Liver in Pneumoperitoneum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Di Saverio, Salomone] CA Pizzardi Maggiore Hosp, Azienda Unit Sanit Locale Bologna, Bologna, Italy; [Catena, Fausto] Maggiore Hosp Parma, Parma, Italy	AUSL di Bologna	Di Saverio, S (corresponding author), CA Pizzardi Maggiore Hosp, Azienda Unit Sanit Locale Bologna, Bologna, Italy.	salo75@inwind.it	Di Saverio, Salomone/G-1437-2012	Di Saverio, Salomone/0000-0001-5685-5022					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					E29	E29		10.1056/NEJMicm1400032	http://dx.doi.org/10.1056/NEJMicm1400032			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25390758				2022-12-28	WOS:000344709800010
J	Hawkes, N				Hawkes, Nigel			Clap along if you feel like happiness is linked to money	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Delhay J, 2012201 SPI; Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5872; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6484; Maruthappu M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6518	4	0	0	8	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2014	349								g6733	10.1136/bmj.g6733	http://dx.doi.org/10.1136/bmj.g6733			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JR	25391839				2022-12-28	WOS:000345445000008
J	Harrison, MJ; Dusheiko, M; Sutton, M; Gravelle, H; Doran, T; Roland, M				Harrison, Mark J.; Dusheiko, Mark; Sutton, Matt; Gravelle, Hugh; Doran, Tim; Roland, Martin			Effect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOR-PERFORMANCE; HEALTH-CARE; FINANCIAL INCENTIVES; HIGHER QUALITY; UK QUALITY; OUTCOMES; PROGRAM; ASSOCIATION; POPULATION; MANAGEMENT	Objective To estimate the impact of a national primary care pay for performance scheme, the Quality and Outcomes Framework in England, on emergency hospital admissions for ambulatory care sensitive conditions (ACSCs). Design Controlled longitudinal study. Setting English National Health Service between 1998/99 and 2010/11. Participants Populations registered with each of 6975 family practices in England. Main outcome measures Year specific differences between trend adjusted emergency hospital admission rates for incentivised ACSCs before and after the introduction of the Quality and Outcomes Framework scheme and two comparators: non-incentivised ACSCs and non-ACSCs. Results Incentivised ACSC admissions showed a relative reduction of 2.7% (95% confidence interval 1.6% to 3.8%) in the first year of the Quality and Outcomes Framework compared with ACSCs that were not incentivised. This increased to a relative reduction of 8.0% (6.9% to 9.1%) in 2010/11. Compared with conditions that are not regarded as being influenced by the quality of ambulatory care (non-ACSCs), incentivised ACSCs also showed a relative reduction in rates of emergency admissions of 2.8% (2.0% to 3.6%) in the first year increasing to 10.9% (10.1% to 11.7%) by 2010/11. Conclusions The introduction of a major national pay for performance scheme for primary care in England was associated with a decrease in emergency admissions for incentivised conditions compared with conditions that were not incentivised. Contemporaneous health service changes seem unlikely to have caused the sharp change in the trajectory of incentivised ACSC admissions immediately after the introduction of the Quality and Outcomes Framework. The decrease seems larger than would be expected from the changes in the process measures that were incentivised, suggesting that the pay for performance scheme may have had impacts on quality of care beyond the directly incentivised activities.	[Harrison, Mark J.; Sutton, Matt] Univ Manchester, Inst Populat Hlth, Manchester Ctr Hlth Econ, Manchester M13 9PL, Lancs, England; [Harrison, Mark J.; Gravelle, Hugh] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Harrison, Mark J.] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada; [Dusheiko, Mark] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Dusheiko, Mark] Univ Lausanne, Inst Hlth Econ & Management, Lausanne, Switzerland; [Roland, Martin] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 0SR, England; [Doran, Tim] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Manchester; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of York - UK; University of Lausanne; University of Cambridge; University of York - UK	Roland, M (corresponding author), Univ Cambridge, Cambridge Ctr Hlth Serv Res, Forvie Site,Robinson Way, Cambridge CB2 0SR, England.	mr108@cam.ac.uk	Harrison, Mark/AFP-1095-2022	Harrison, Mark/0000-0002-2115-2447; Gravelle, Hugh/0000-0002-7753-4233; Sutton, Matt/0000-0002-6635-2127; Roland, Martin/0000-0002-8533-3060	UK Department of Health	UK Department of Health	This study received no direct funding, but it was initiated at a time when the National Primary Care Research and Development Centre at the University of Manchester was receiving core funding from the UK Department of Health. The views expressed are those of the authors and not necessarily those of the Department of Health. The researchers are totally independent of the funders.	Blunt I, 2010, TRENDS EMERGENCY ADM; Bottle A, 2008, J GEN INTERN MED, V23, P135, DOI 10.1007/s11606-007-0390-2; Calderon-Larranaga A, 2011, THORAX, V66, P191, DOI 10.1136/thx.2010.147058; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Chang RE, 2012, HEALTH AFFAIR, V31, P93, DOI 10.1377/hlthaff.2010.0402; Chen JY, 2010, AM J MANAG CARE, V16, pE11; Chen JY, 2011, AM J MED QUAL, V26, P340, DOI 10.1177/1062860611398303; Chernew ME, 2011, HEALTH AFFAIR, V30, P51, DOI 10.1377/hlthaff.2010.0980; Christianson J, 2009, FINANCIAL INCENTIVES; Conrad DA, 2009, ANNU REV PUBL HEALTH, V30, P357, DOI 10.1146/annurev.publhealth.031308.100243; Damberg CL, 2009, HEALTH AFFAIR, V28, P517, DOI 10.1377/hlthaff.28.2.517; Department of Health, 2000, DEP HLTH NAT FRAM CO; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; DUROJAIYE LIA, 1989, PUBLIC HEALTH, V103, P181, DOI 10.1016/S0033-3506(89)80073-3; Dusheiko M, 2011, HEALTH SERV RES, V46, P27, DOI 10.1111/j.1475-6773.2010.01184.x; Emmert M, 2012, EUR J HEALTH ECON, V13, P755, DOI 10.1007/s10198-011-0329-8; Fiorentini G, 2011, EUR J HEALTH ECON, V12, P297, DOI 10.1007/s10198-010-0230-x; Fleetcroft R, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X515359; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Houle SK, 2012, ANN INTERN MED, V157, P889; Kiran T, 2010, J EPIDEMIOL COMMUN H, V64, P927, DOI 10.1136/jech.2009.098806; Kruse GB, 2012, HEALTH SERV RES, V47, P2118, DOI 10.1111/1475-6773.12003; Martin S, 2011, QUALITY IMPROVEMENTS; Mitchell C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572472; National Audit Office, 2013, EM ADM HOSP MAN DEM; Office for National Statistics, 2012, POP EST ENGL WAL MID; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Purdy S, 2009, PUBLIC HEALTH, V123, P169, DOI 10.1016/j.puhe.2008.11.001; Purdy S, 2011, J HEALTH SERV RES PO, V16, P133, DOI 10.1258/jhsrp.2010.010013; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2014, NEW ENGL J MED, V370, P1944, DOI 10.1056/NEJMhpr1316051; Roland M, 2012, ANN INTERN MED, V157, P912, DOI 10.7326/0003-4819-157-12-201212180-00014; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Serumaga B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d108; Simpson CR, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X583407; Soljak M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613142; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; Sutton M, 2010, HEALTH ECON, V19, P1, DOI 10.1002/hec.1440; Tian Y, 2012, EMERGENCY HOSP ADMIS; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Werner RM, 2009, HEALTH AFFAIR, V28, P1498, DOI 10.1377/hlthaff.28.5.1498	46	87	87	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2014	349								g6423	10.1136/bmj.g6423	http://dx.doi.org/10.1136/bmj.g6423			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU2JQ	25389120	Green Published, hybrid			2022-12-28	WOS:000345444900003
J	Sanyaolu, LN; Farmer, SEJ; Cuddihy, PJ				Sanyaolu, Leigh N.; Farmer, Sarah E. J.; Cuddihy, Patrick J.			Nasal septal haematoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT; ABSCESS; DIAGNOSIS; CHILDREN		[Sanyaolu, Leigh N.; Farmer, Sarah E. J.; Cuddihy, Patrick J.] Royal Gwent Hosp, Dept Otolaryngol, Newport, Gwent, Wales	Royal Gwent Hospital	Sanyaolu, LN (corresponding author), Royal Gwent Hosp, Dept Otolaryngol, Newport, Gwent, Wales.	lnsanyaolu@doctors.org.uk		Sanyaolu, Leigh/0000-0002-6762-6986				Agrawal N, 2007, J EVAL CLIN PRACT, V13, P295, DOI 10.1111/j.1365-2753.2006.00700.x; Alshaikh N, 2011, INT J PEDIATR OTORHI, V75, P737, DOI 10.1016/j.ijporl.2011.03.010; Alvarez H, 2000, Auris Nasus Larynx, V27, P339, DOI 10.1016/S0385-8146(00)00071-7; Baring DEC, 2012, OTOLARYNG HEAD NECK, V146, P913, DOI 10.1177/0194599811435892; Canty PA, 1996, ARCH OTOLARYNGOL, V122, P1373; CHUKUEZI AB, 1992, J LARYNGOL OTOL, V106, P396, DOI 10.1017/S0022215100119656; Dispenza C, 2004, INT J PEDIATR OTORHI, V68, P1417, DOI 10.1016/j.ijporl.2004.05.014; Ferlito A, 2005, AM J OTOLARYNG, V26, P181, DOI 10.1016/j.amjoto.2004.11.006; Flint PW., 2015, CUMMINGS OTOLARYNGOL; Huang PH, 2006, OTOLARYNG HEAD NECK, V135, P335, DOI 10.1016/j.otohns.2005.09.015; Lee SJ, 2010, LARYNGOSCOPE, V120, P1931, DOI 10.1002/lary.21072; MATSUBA HM, 1986, ANN PLAS SURG, V16, P161, DOI 10.1097/00000637-198602000-00015; OLSEN KD, 1980, ARCH OTOLARYNGOL, V106, P317; WILSON SW, 1994, INJURY, V25, P685, DOI 10.1016/0020-1383(94)90017-5; Wright RJ, 2011, FACIAL PLAST SURG, V27, P483, DOI 10.1055/s-0031-1288931	15	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2014	349								g6075	10.1136/bmj.g6075	http://dx.doi.org/10.1136/bmj.g6075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CC	25370844				2022-12-28	WOS:000344603600002
J	Garg, AX; Nevis, IF; McArthur, E; Sontrop, JM; Koval, JJ; Lam, NN; Hildebrand, AM; Reese, PP; Storsley, L; Gill, JS; Segev, DL; Habbous, S; Bugeja, A; Knoll, GA; Dipchand, C; Monroy-Cuadros, M; Lentine, KL				Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Reese, Peter P.; Storsley, Leroy; Gill, John S.; Segev, Dorry L.; Habbous, Steven; Bugeja, Ann; Knoll, Greg A.; Dipchand, Christine; Monroy-Cuadros, Mauricio; Lentine, Krista L.		DONOR Network	Gestational Hypertension and Preeclampsia in Living Kidney Donors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL DISCHARGE DATA; MEDICAL OUTCOMES; MATCHED COHORT; CARDIOVASCULAR-DISEASE; ADMINISTRATIVE DATA; PREGNANCY OUTCOMES; RACIAL VARIATION; ORGAN DONORS; DONATION; RISK	Background Young women wishing to become living kidney donors frequently ask whether nephrectomy will affect their future pregnancies. Methods We conducted a retrospective cohort study of living kidney donors involving 85 women (131 pregnancies after cohort entry) who were matched in a 1: 6 ratio with 510 healthy nondonors from the general population (788 pregnancies after cohort entry). Kidney donations occurred between 1992 and 2009 in Ontario, Canada, with follow-up through linked health care databases until March 2013. Donors and nondonors were matched with respect to age, year of cohort entry, residency (urban or rural), income, number of pregnancies before cohort entry, and the time to the first pregnancy after cohort entry. The primary outcome was a hospital diagnosis of gestational hypertension or preeclampsia. Secondary outcomes were each component of the primary outcome examined separately and other maternal and fetal outcomes. Results Gestational hypertension or preeclampsia was more common among living kidney donors than among nondonors (occurring in 15 of 131 pregnancies [11%] vs. 38 of 788 pregnancies [5%]; odds ratio for donors, 2.4; 95% confidence interval, 1.2 to 5.0; P = 0.01). Each component of the primary outcome was also more common among donors (odds ratio, 2.5 for gestational hypertension and 2.4 for preeclampsia). There were no significant differences between donors and nondonors with respect to rates of preterm birth (8% and 7%, respectively) or low birth weight (6% and 4%, respectively). There were no reports of maternal death, stillbirth, or neonatal death among the donors. Most women had uncomplicated pregnancies after donation. Conclusions Gestational hypertension or preeclampsia was more likely to be diagnosed in kidney donors than in matched nondonors with similar indicators of baseline health. (Funded by the Canadian Institutes of Health Research and others.)	[Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Habbous, Steven] Univ Western Ontario, Lawson Hlth Res Inst, London Kidney Clin Res Unit, Inst Clin Evaluat Sci, London, ON, Canada; [Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Habbous, Steven] Univ Western Ontario, Schulich Sch Med & Dent, Div Nephrol, Dept Med, London, ON, Canada; [Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Habbous, Steven] Univ Western Ontario, Schulich Sch Med & Dent, Div Nephrol, Dept Epidemiol, London, ON, Canada; [Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Habbous, Steven] Univ Western Ontario, Schulich Sch Med & Dent, Div Nephrol, Dept Biostat, London, ON, Canada; [Storsley, Leroy] Univ Manitoba, Dept Med, Div Nephrol, Winnipeg, MB, Canada; [Gill, John S.] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC, Canada; [Bugeja, Ann; Knoll, Greg A.] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada; [Dipchand, Christine] Dalhousie Univ, Dept Med, Div Nephrol, Halifax, NS, Canada; [Monroy-Cuadros, Mauricio] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Reese, Peter P.] Univ Penn, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Segev, Dorry L.] Johns Hopkins Univ Sch Med, Dept Surg, Baltimore, MD USA; [Lentine, Krista L.] St Louis Univ, Ctr Outcomes Res, St Louis, MO 63103 USA; [Lentine, Krista L.] St Louis Univ, Div Nephrol, Dept Med, St Louis, MO 63103 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Manitoba; University of British Columbia; University of Ottawa; Dalhousie University; University of Calgary; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Saint Louis University; Saint Louis University	Garg, AX (corresponding author), London Hlth Sci Ctr, London Kidney Clin Res Unit, Rm ELL-101,Westminster Tower, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Garg, Amit X/G-3295-2011; Lam, Ngan/AAX-3472-2020; Lentine, Krista/AAQ-6549-2020; Bugeja, Ann/K-7378-2019	Lam, Ngan/0000-0002-0129-7091; Lentine, Krista/0000-0002-9423-4849; Bugeja, Ann/0000-0002-4106-0451; Sontrop, Jessica M./0000-0001-7784-2028; Boudville, Neil/0000-0002-5884-640X; Habbous, Steven/0000-0002-9650-9105; Knoll, Greg/0000-0001-5442-9310; Storsley, Leroy/0000-0003-1288-4854	Canadian Institutes of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096008] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the Canadian Institutes of Health Research and others.	Ahmadi AR, 2014, KIDNEY INT; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; Doshi MD, 2013, AM J TRANSPLANT, V13, P111, DOI 10.1111/j.1600-6143.2012.04303.x; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Garg AX, 2008, TRANSPLANTATION, V86, P399, DOI 10.1097/TP.0b013e31817ba9e3; Garg AX, 2012, AM J KIDNEY DIS, V59, P770, DOI 10.1053/j.ajkd.2012.01.013; Garg AX, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1203; Geller SE, 2004, AM J OBSTET GYNECOL, V190, P1629, DOI 10.1016/j.ajog.2004.03.061; Gibson KJ, 2006, AM J PHYSIOL-RENAL, V290, pF1153, DOI 10.1152/ajprenal.00241.2005; Hadfield RM, 2008, AUST NZ J OBSTET GYN, V48, P78, DOI 10.1111/j.1479-828X.2007.00818.x; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Ibrahim HN, 2009, AM J TRANSPLANT, V9, P825, DOI 10.1111/j.1600-6143.2009.02548.x; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Josephson MA, 2009, NAT REV NEPHROL, V5, P495, DOI 10.1038/nrneph.2009.129; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Korst LM, 2004, PAEDIATR PERINAT EP, V18, P112, DOI 10.1111/j.1365-3016.2003.00540.x; Lam N, 2012, NEPHROL DIAL TRANSPL, V27, P3291, DOI 10.1093/ndt/gfr802; Lentine KL, 2014, TRANSPLANTATION, V97, P316, DOI 10.1097/01.TP.0000436731.23554.5e; Lentine KL, 2010, NEW ENGL J MED, V363, P724, DOI 10.1056/NEJMoa1000950; Lin J, 2010, NEW ENGL J MED, V363, P797, DOI 10.1056/NEJMc1002100; Nayak-Rao S, 2011, SAUDI J KIDNEY DIS T, V22, P552; Nevis IF, 2009, AM J TRANSPLANT, V9, P661, DOI 10.1111/j.1600-6143.2009.02623.x; Nevis IF, 2011, CLIN J AM SOC NEPHRO, V6, P2587, DOI 10.2215/CJN.10841210; PACKHAM DK, 1992, PATHOLOGY, V24, P164, DOI 10.3109/00313029209063165; Poggio ED, 2009, CLIN J AM SOC NEPHRO, V4, P1677, DOI 10.2215/CJN.02740409; Ray JG, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000337; Reese PP, 2009, AM J TRANSPLANT, V9, P1967, DOI 10.1111/j.1600-6143.2009.02719.x; Reisaeter AV, 2009, AM J TRANSPLANT, V9, P820, DOI 10.1111/j.1600-6143.2008.02427.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sickand M, 2009, AM J TRANSPLANT, V9, P2825, DOI 10.1111/j.1600-6143.2009.02829.x; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Thomas SM, 2013, AM J TRANSPLANT, V13, P2935, DOI 10.1111/ajt.12446; Thomas SM, 2014, CLIN TRANSPLANT, V28, P530, DOI 10.1111/ctr.12344; Tong A, 2012, AM J KIDNEY DIS, V60, P15, DOI 10.1053/j.ajkd.2011.11.043; von Elm E, 2008, ANN INTERN MED, V148, P168, DOI DOI 10.7326/0003-4819-148-2-200801150-00020; Yang RC, 2007, AM J TRANSPLANT, V7, P1542, DOI 10.1111/j.1600-6143.2007.01793.x; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	38	169	181	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					124	133		10.1056/NEJMoa1408932	http://dx.doi.org/10.1056/NEJMoa1408932			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25397608	Green Accepted, Bronze			2022-12-28	WOS:000347443300007
J	Krause, DW; Hoffmann, S; Wible, JR; Kirk, EC; Schultz, JA; von Koenigswald, W; Groenke, JR; Rossie, JB; O'Connor, PM; Seiffert, ER; Dumont, ER; Holloway, WL; Rogers, RR; Rahantarisoa, LJ; Kemp, AD; Andriamialison, H				Krause, David W.; Hoffmann, Simone; Wible, John R.; Kirk, E. Christopher; Schultz, Julia A.; von Koenigswald, Wighart; Groenke, Joseph R.; Rossie, James B.; O'Connor, Patrick M.; Seiffert, Erik R.; Dumont, Elizabeth R.; Holloway, Waymon L.; Rogers, Raymond R.; Rahantarisoa, Lydia J.; Kemp, Addison D.; Andriamialison, Haingoson			First cranial remains of a gondwanatherian mammal reveal remarkable mosaicism	NATURE			English	Article							SOUTH-AMERICA; EYE SIZE; PREDATORY DINOSAUR; ACTIVITY PATTERN; VISUAL-ACUITY; MADAGASCAR; MULTITUBERCULATE; PRIMATES; PALEOCENE; EVOLUTION	Previously known only from isolated teeth and lower jaw fragments recovered from the Cretaceous and Palaeogene of the Southern Hemisphere, the Gondwanatheria constitute the most poorly known of all major maminaliaform radiations. Here we report the discovery of the first skull material of a gondwanatberian, a complete and well-preserved cranium from Upper Cretaceous strata in Madagascar car that we assign to a new genus and species. Phylogenetc analysis strongly supports its placement within Gondwanatheria, which are recognized a monophyletic and closely related to multituber-culates an evolutionarily success clade of Mesozoic mammals known almost exclusively from the Northern Hemisphere. The new taxon is the largest known mammaliaform from the Mesozoic of Gondwana. Its craniofacial anatomy reveals that it was herbivorous, a us in, large-eyed. of and agile, with well-developed high-frequency hearing and a keen sense of smell. The cranium exhibits primitive and derived features, the disparity of which is extreme and probably reflective of a long evolutionary history in geographic isolation.	[Krause, David W.; Hoffmann, Simone; Groenke, Joseph R.; Seiffert, Erik R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Wible, John R.] Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA 15206 USA; [Kirk, E. Christopher; Kemp, Addison D.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Schultz, Julia A.; von Koenigswald, Wighart] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Rossie, James B.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [O'Connor, Patrick M.; Holloway, Waymon L.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [O'Connor, Patrick M.; Holloway, Waymon L.] Ohio Univ, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [Dumont, Elizabeth R.] Univ Massachusetts, Dept Biol, Morrill Sci Ctr 221, Amherst, MA 01003 USA; [Rogers, Raymond R.] Macalester Coll, Dept Geol, St Paul, MN 55105 USA; [Rahantarisoa, Lydia J.] Univ Antananarivo, Dept Geol, Antananarivo 101, Madagascar; [Andriamialison, Haingoson] Univ Antananarivo, Dept Paleontol, Antananarivo 101, Madagascar	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Austin; University of Bonn; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University of Massachusetts System; University of Massachusetts Amherst; Macalester College; University Antananarivo; University Antananarivo	Krause, DW (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	David.Krause@stonybrook.edu	OConnor, Patrick M/I-9383-2012; D, Betsy/ABD-1855-2020	OConnor, Patrick M/0000-0002-6762-3806; Kirk, Chris/0000-0001-9439-3041; Hoffmann, Simone/0000-0001-8984-0601; Groenke, Joseph/0000-0002-9527-1887	National Geographic Society [8597-09]; National Science Foundation [EAR-0446488, EAR-1123642]; Division Of Environmental Biology [0946430] Funding Source: National Science Foundation	National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the Universite d'Antananarivo, the Madagascar Institut pour la Conservation des Ecosystemes Tropicaux, and the villagers of the Lac Kinkony Study Area for logistical support of fieldwork; various ministries of the Republic of Madagascar for permission to conduct field research; members of the 2010 field research team for their efforts; J. Thostenson and M. Hill of the American Museum of Natural History Microscopy & Imaging Facility, New York, New York, and J. Diehm and B. Ruether of Avonix Imaging, Plymouth, Minnesota, and various members of the Department of Radiology at Stony Brook University for providing expert assistance in computed tomography scanning; L. Betti-Nash for artwork; J. Neville for photography; D. Pulaski for reconstructing the cranium and building the finite element models; Z.-X. Luo, G. Rougier and A. Weil for their reviews of the paper; and the National Geographic Society (8597-09) and the National Science Foundation (EAR-0446488, EAR-1123642) for funding.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Berlin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079585; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; CLARK JM, 1985, NATURE, V315, P398, DOI 10.1038/315398a0; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Ekdale EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066624; Evans SE, 2008, P NATL ACAD SCI USA, V105, P2951, DOI 10.1073/pnas.0707599105; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gambaryan Petr P., 1995, Acta Palaeontologica Polonica, V40, P45; Goin FJ, 2012, NATURWISSENSCHAFTEN, V99, P449, DOI 10.1007/s00114-012-0919-z; GUROVICH Y, 2006, THESIS U BUENOS AIRE; Gurovich Y, 2008, PALAEONTOLOGY, V51, P1069, DOI 10.1111/j.1475-4983.2008.00805.x; Gurovich Y, 2009, J MAMM EVOL, V16, P25, DOI 10.1007/s10914-008-9097-3; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Hurum Jorn H., 1998, Journal of Mammalian Evolution, V5, P65, DOI 10.1023/A:1020571003901; Kay RF, 2000, AM J PHYS ANTHROPOL, V113, P235, DOI 10.1002/1096-8644(200010)113:2<235::AID-AJPA7>3.0.CO;2-9; Kemp AD, 2014, ANAT REC, V297, P781, DOI 10.1002/ar.22892; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kirk EC, 2006, J HUM EVOL, V51, P159, DOI 10.1016/j.jhevol.2006.02.004; Koyabu D, 2012, P NATL ACAD SCI USA, V109, P14075, DOI 10.1073/pnas.1208693109; Krause DW, 2013, CAN J EARTH SCI, V50, P324, DOI 10.1139/e2012-074; Krause DW, 1992, J VERTEBR PALEONTOL, V12, P351, DOI 10.1080/02724634.1992.10011465; KRAUSE DW, 1982, PALEOBIOLOGY, V8, P265, DOI 10.1017/S0094837300006989; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; KRAUSE DW, 1993, P NATL ACAD SCI USA, V90, P9379, DOI 10.1073/pnas.90.20.9379; Luo ZX, 2012, ZOOL J LINN SOC-LOND, V166, P433, DOI 10.1111/j.1096-3642.2012.00852.x; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Olson E. C., 1944, SPECIAL PAPERS GEOLO, DOI [10.1130/SPE55-p1, DOI 10.1130/GSAB-55-1]; Pascual R, 1999, J VERTEBR PALEONTOL, V19, P373, DOI 10.1080/02724634.1999.10011148; Pascual Rosendo, 2007, Journal of Mammalian Evolution, V14, P75, DOI 10.1007/s10914-007-9039-5; Rich TH, 2009, ACTA PALAEONTOL POL, V54, P1, DOI 10.4202/app.2009.0101; Ritland S., 1982, THESIS U CHICAGO; Rogers RR, 2013, CRETACEOUS RES, V44, P12, DOI 10.1016/j.cretres.2013.03.008; Ross CF, 2007, J HUM EVOL, V52, P294, DOI 10.1016/j.jhevol.2006.09.006; ROUGIER G. W., 1993, THESIS U BUENOS AIRE; Rougier GW, 2011, NATURE, V479, P98, DOI 10.1038/nature10591; Ruf I, 2013, J VERTEBR PALEONTOL, V33, P382, DOI 10.1080/02724634.2013.722575; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Schultz AH, 1940, AM J PHYS ANTHROPOL, V26, P389, DOI 10.1002/ajpa.1330260138; Scillato-Yane G.J., 1985, Ameghiniana, V21, P173; SCILLATO-YANE G.J., 1984, PECULIAR PARATHERIA, P15; Vidal N, 2010, BIOL LETTERS, V6, P558, DOI 10.1098/rsbl.2010.0220; von Koenigswald W, 1999, ACTA PALAEONTOL POL, V44, P263; Yang AZ, 2007, J NEUROPHYSIOL, V98, P3197, DOI 10.1152/jn.00798.2007	50	80	85	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					512	+		10.1038/nature13922	http://dx.doi.org/10.1038/nature13922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25383528				2022-12-28	WOS:000346247600044
J	Stergachis, AB; Neph, S; Sandstrom, R; Haugen, E; Reynolds, AP; Zhang, MH; Byron, R; Canfield, T; Stelhing-Sun, S; Lee, K; Thurman, RE; Vong, S; Bates, D; Neri, F; Diegel, M; Giste, E; Dunn, D; Vierstra, J; Hansen, RS; Johnson, AK; Sabo, PJ; Wilken, MS; Reh, TA; Treuting, PM; Kaul, R; Groudine, M; Bender, MA; Borenstein, E; Stamatoyannopoulos, JA				Stergachis, Andrew B.; Neph, Shane; Sandstrom, Richard; Haugen, Eric; Reynolds, Alex P.; Zhang, Miaohua; Byron, Rachel; Canfield, Theresa; Stelhing-Sun, Sandra; Lee, Kristen; Thurman, Robert E.; Vong, Shinny; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Giste, Erika; Dunn, Douglas; Vierstra, Jeff; Hansen, R. Scott; Johnson, Audra K.; Sabo, Peter J.; Wilken, Matthew S.; Reh, Thomas A.; Treuting, Piper M.; Kaul, Rajinder; Groudine, Mark; Bender, M. A.; Borenstein, Elhanan; Stamatoyannopoulos, John A.			Conservation of trans-acting circuitry during mammalian regulatory evolution	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; PROTEIN-DNA INTERACTIONS; HUMAN GENOME; NETWORKS; DYNAMICS; DATABASE; MOTIFS; IDENTIFICATION; MECHANISMS; SIMILARITY	The basic body plan and major physiological axes have been highly conserved during mammalian evolution, yet only a small fraction of the human genome sequence appears to be subject to evolutionary constraint. To quantify cis-versus trans-acting contributions to mammalian regulatory evolution, we performed genomic DNase I footprinting of the mouse genome across 25 cell and tissue types, collectively defining similar to 8.6 million transcription factor (TF) occupancy sites at nucleotide resolution. Here we show that mouse TF footprints conjointly encode a regulatory lexicon that is similar to 95% similar with that derived from human TF footprints. However, only similar to 20% of mouse TF footprints have human orthologues. Despite substantial turnover of the cis-regulatory landscape, nearly half of all pairwise regulatory interactions connecting mouse TF genes have been maintained in orthologous human cell types through evolutionary innovation of TF recognition sequences. Furthermore, the higher-level organization of mouse TF-to-TF connections into cellular network architectures is nearly identical with human. Our results indicate that evolutionary selection on mammalian gene regulation is targeted chiefly at the level of trans-regulatory circuitry, enabling and potentiating cis-regulatory plasticity.	[Stergachis, Andrew B.; Neph, Shane; Sandstrom, Richard; Haugen, Eric; Reynolds, Alex P.; Canfield, Theresa; Stelhing-Sun, Sandra; Lee, Kristen; Thurman, Robert E.; Vong, Shinny; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Giste, Erika; Dunn, Douglas; Vierstra, Jeff; Hansen, R. Scott; Johnson, Audra K.; Sabo, Peter J.; Kaul, Rajinder; Borenstein, Elhanan; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Zhang, Miaohua; Byron, Rachel; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Hansen, R. Scott; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Wilken, Matthew S.; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Groudine, Mark] Univ Washington, Div Radiat Oncol, Seattle, WA 98195 USA; [Bender, M. A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98102 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Haugen, Eric/0000-0001-7444-8981; Sandstrom, Richard/0000-0002-3356-1547; Kaul, Rajinder/0000-0002-7895-9284; Vierstra, Jeff/0000-0001-6406-8563	NIH [U54HG004592, U54HG007010, U01ES01156, RC2HG005654, R37 DK44746]; NIDDK [FDK095678A]; NATIONAL EYE INSTITUTE [R01EY021482] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010, U54HG004592, RC2HG005654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our colleagues for their insightful comments and critical readings of the manuscript. We also thank many individuals who provided mouse cell and tissue samples. This work was supported by NIH grants U54HG004592, U54HG007010 and U01ES01156 to J.A.S.; RC2HG005654 to J.A.S. and M. G.; and R37 DK44746 to M. G. and M. A. B. A. B. S. was supported by grant FDK095678A from NIDDK.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; He HH, 2014, NAT METHODS, V11, P73, DOI [10.1038/NEMTH.2762, 10.1038/nmeth.2762]; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lazarovici A., 2013, P NATL ACAD SCI US; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Raff R. A., 1996, SHAPE LIFE GENES DEV; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Sullivan AM, 2014, CELL REP, V8, P2015, DOI 10.1016/j.celrep.2014.08.019; Sung M. H., 2014, MOL CELL; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Vierstra J., SCIENCE IN PRESS; Vierstra J, 2014, NAT METHODS, V11, P66, DOI [10.1038/NMETH.2713, 10.1038/nmeth.2713]; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698	40	151	152	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					365	+		10.1038/nature13972	http://dx.doi.org/10.1038/nature13972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409825	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000345770600035
J	Greenland, P; Peterson, ED; Gaziano, JM				Greenland, Philip; Peterson, Eric D.; Gaziano, J. Michael			Progress Against Cardiovascular Disease Putting the Pieces Together	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION TASK-FORCE; AMERICAN-COLLEGE; GUIDELINES; CHOLESTEROL		[Greenland, Philip] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Durham, NC USA; [Gaziano, J. Michael] Brigham & Womens Hosp, VA Boston, Boston, MA 02115 USA; [Gaziano, J. Michael] Harvard Univ, Sch Med, Boston, MA USA	Northwestern University; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Greenland, P (corresponding author), Northwestern Univ, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	p-greenland@northwestern.edu	Peterson, Eric David/ABF-5033-2021; Greenland, Philip/ABD-5528-2021					Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Krumholz HM, 2014, JAMA-J AM MED ASSOC, V311, P1403, DOI 10.1001/jama.2014.2634; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lund LH, 2014, JAMA-J AM MED ASSOC, V312, P2008, DOI 10.1001/jama.2014.15241; Montori VM, 2014, JAMA-J AM MED ASSOC, V311, P465, DOI 10.1001/jama.2014.110; Reddy VY, 2014, JAMA-J AM MED ASSOC, V312, P1988, DOI 10.1001/jama.2014.15192; Ritchey MD, 2014, JAMA-J AM MED ASSOC, V312, P2037, DOI 10.1001/jama.2014.11344; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; World Health Organization, TOP 10 CAUS DEATH; Zullig LL, 2013, JAMA-J AM MED ASSOC, V310, P2611, DOI 10.1001/jama.2013.282818	13	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1979	1980		10.1001/jama.2014.15554	http://dx.doi.org/10.1001/jama.2014.15554			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399272				2022-12-28	WOS:000345450500011
J	Manning, KD				Manning, Kimberly D.			N of 1	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA	Emory University	Manning, KD (corresponding author), Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA.	kdmanni@emory.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1975	1976		10.1001/jama.2014.12223	http://dx.doi.org/10.1001/jama.2014.12223			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399270				2022-12-28	WOS:000345450500009
J	Ueno, Y				Ueno, Yuichiro			Coping with low ocean sulfate	SCIENCE			English	Editorial Material							SULFUR ISOTOPES; ATMOSPHERE; RECORDS		[Ueno, Yuichiro] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Ueno, Yuichiro] Tokyo Inst Technol, Earth Life Sci Inst WPI ELSI, Meguro Ku, Tokyo 1528551, Japan; [Ueno, Yuichiro] Japan Agcy Marine Earth Sci & Technol, Precambrian Ecosyst Lab, Yokosuka, Kanagawa 2370061, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Ueno, Y (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	ueno.y.ac@m.titech.ac.jp	Yamaichi, Takeshi/A-5595-2010; Ueno, Yuichiro/A-9959-2014	Ueno, Yuichiro/0000-0002-9095-4742	Grants-in-Aid for Scientific Research [26287125] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Crowe SA, 2014, SCIENCE, V346, P735, DOI 10.1126/science.1258966; Danielache SO, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017464; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Johnson JE, 2013, P NATL ACAD SCI USA, V110, P11238, DOI 10.1073/pnas.1305530110; McLoughlin N, 2012, GEOLOGY, V40, P1031, DOI 10.1130/G33313.1; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Paris G, 2014, SCIENCE, V346, P739, DOI 10.1126/science.1258211; Ueno Y, 2008, GEOCHIM COSMOCHIM AC, V72, P5675, DOI 10.1016/j.gca.2008.08.026; Ueno Y, 2009, P NATL ACAD SCI USA, V106, P14784, DOI 10.1073/pnas.0903518106; Zerkle AL, 2012, NAT GEOSCI, V5, P359, DOI [10.1038/NGEO1425, 10.1038/ngeo1425]; Zhelezinskaia I, 2014, SCIENCE, V346, P742, DOI 10.1126/science.1256211	12	13	13	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					703	704		10.1126/science.1261676	http://dx.doi.org/10.1126/science.1261676			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378609				2022-12-28	WOS:000344690100023
J	Parish, E				Parish, Emma			MEDICINE AND THE MEDIA Who should we blame for the death of Baby P?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									The BMJ, London, England		Parish, E (corresponding author), The BMJ, London, England.	eparish@bmj.com						[Anonymous], 2008, DAILY MAIL; BBC, 2014, BBC; Department for Education, 2014, CHILDR SOC WORK WORK; France A., 2009, SUN             0811; Haringey Local Safeguarding Children Board, 2010, SER CAS REV CHILD A; Laming Lord, 2003, VICT CLIMB INQ; Royal College of Paediatrics and Child Health, 2013, CHILD PROT COMP 2013; Sibert J, REV CHILD PROTECTION	8	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2014	349								g6643	10.1136/bmj.g6643	http://dx.doi.org/10.1136/bmj.g6643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CD	25378419				2022-12-28	WOS:000344603700010
J	Ravn, K				Ravn, Karen			The next frontier	NATURE			English	Editorial Material							RICE ORYZA-GLABERRIMA											Keya S. O., 2008, NERICA NEW RICE AFRI; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044	3	3	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S64	S65		10.1038/514S64a	http://dx.doi.org/10.1038/514S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368892	Bronze			2022-12-28	WOS:000343801500008
J	Hwang, SW; Burns, T				Hwang, Stephen W.; Burns, Tom			Health interventions for people who are homeless	LANCET			English	Article							SERIOUS MENTAL-ILLNESS; ASSERTIVE COMMUNITY TREATMENT; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; HOUSING 1ST; CHRONICALLY HOMELESS; CASE-MANAGEMENT; SERVICE USE; SUBSTANCE-ABUSE; PRIMARY-CARE	Homelessness has serious implications for the health of individuals and populations. Primary health-care programmes specifically tailored to homeless individuals might be more effective than standard primary health care. Standard case management, assertive community treatment, and critical time intervention are effective models of mental health-care delivery. Housing First, with immediate provision of housing in independent units with support, improves outcomes for individuals with serious mental illnesses. Many different types of interventions, including case management, are effective in the reduction of substance misuse. Interventions that provide case management and supportive housing have the greatest effect when they target individuals who are the most intensive users of services. Medical respite programmes are an effective intervention for homeless patients leaving the hospital. Although the scientific literature provides guidance on interventions to improve the health of homeless individuals, health-care providers should also seek to address social policies and structural factors that result in homelessness.	[Hwang, Stephen W.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Div Gen Internal Med, Toronto, ON, Canada; [Burns, Tom] Univ Oxford, Dept Psychiat, Warneford Hosp, Oxford, England	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Oxford	Hwang, SW (corresponding author), St Michaels Hosp, Toronto, ON M5B 1W8, Canada.	hwangs@smh.ca	Hwang, Stephen W./GVR-7773-2022					Altena AM, 2010, AM J PREV MED, V38, P637, DOI 10.1016/j.amepre.2010.02.017; Bhui K, 2006, INT J SOC PSYCHIATR, V52, P152, DOI 10.1177/0020764006062096; Bonin E, 2010, ADAPTING YOUR PRACTI; Buchanan David, 2009, Am J Public Health, V99 Suppl 3, pS675, DOI 10.2105/AJPH.2008.137810; Canavan R, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-222; Coldwell CM, 2007, AM J PSYCHIAT, V164, P393, DOI 10.1176/appi.ajp.164.3.393; Coles E, 2012, HEALTH EDUC RES, V27, P624, DOI 10.1093/her/cys065; Collins SE, 2013, AM J PUBLIC HEALTH, V103, pS269, DOI 10.2105/AJPH.2013.301312; Coren E, 2013, COCHRANE DB SYST REV, V2; Darbyshire P, 2006, HEALTH SOC CARE COMM, V14, P553, DOI 10.1111/j.1365-2524.2006.00643.x; de Vet R, 2013, AM J PUBLIC HEALTH, V103, pE13, DOI 10.2105/AJPH.2013.301491; Desai MM, 2005, GEN HOSP PSYCHIAT, V27, P418, DOI 10.1016/j.genhosppsych.2005.06.003; Doran KM, 2013, J HEALTH CARE POOR U, V24, P499, DOI 10.1353/hpu.2013.0053; Drake RE, 1997, J NERV MENT DIS, V185, P298, DOI 10.1097/00005053-199705000-00003; Drake RE, 2007, WORLD PSYCHIATRY, V6, P131; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Fitzpatrick-Lewis D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-638; Gamache G, 2000, PSYCHIATR SERV, V51, P1024, DOI 10.1176/appi.ps.51.8.1024; Gilmer TP, 2010, ARCH GEN PSYCHIAT, V67, P645, DOI 10.1001/archgenpsychiatry.2010.56; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Gonzalez G, 2002, PSYCHIATR SERV, V53, P437, DOI 10.1176/appi.ps.53.4.437; Gordon AJ, 2007, AM J PUBLIC HEALTH, V97, P401, DOI 10.2105/AJPH.2006.094284; Greenwood RM, 2005, AM J COMMUN PSYCHOL, V36, P223, DOI 10.1007/s10464-005-8617-z; Hwang SW, 2005, AM J PREV MED, V29, P311, DOI 10.1016/j.amepre.2005.06.017; Kertesz SG, 2013, AM J PUBLIC HEALTH, V103, pS331, DOI 10.2105/AJPH.2013.301481; Koegel P., 2007, HOMELESSNESS HDB, P245; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; McCormack RP, 2013, AM J PUBLIC HEALTH, V103, pS221, DOI 10.2105/AJPH.2013.301373; McGuire J, 2009, ADM POLICY MENT HLTH, V36, P255, DOI 10.1007/s10488-009-0210-6; McHugo GJ, 2004, SCHIZOPHRENIA BULL, V30, P969, DOI 10.1093/oxfordjournals.schbul.a007146; Montgomery AE, 2013, J COMMUNITY PSYCHOL, V41, P505, DOI 10.1002/jcop.21554; Morrissey JP, 2002, PSYCHIATR SERV, V53, P949, DOI 10.1176/appi.ps.53.8.949; Muckle W, 2012, COCHRANE DB SYST REV, V12; Naranbhai V., 2011, COCHRANE DB SYST REV, V1; Nelson G, 2007, AM J ORTHOPSYCHIAT, V77, P350, DOI 10.1037/0002-9432.77.3.350; North CS, 2005, J DRUG ISSUES, V35, P575, DOI 10.1177/002204260503500309; O'Campo P, 2009, J URBAN HEALTH, V86, P965, DOI 10.1007/s11524-009-9392-1; Palepu A, 2013, AM J PUBLIC HEALTH, V103, pE30, DOI 10.2105/AJPH.2013.301628; Patterson M, 2013, SOC PSYCH PSYCH EPID, V48, P1245, DOI 10.1007/s00127-013-0719-6; Podymow T, 2006, CAN MED ASSOC J, V174, P45, DOI 10.1503/cmaj.1041350; Rosenheck R, 1997, PSYCHIATR SERV, V48, P387; Rosenheck R, 1997, PSYCHIATR SERV, V48, P381; Rosenheck R, 1997, J NERV MENT DIS, V185, P633, DOI 10.1097/00005053-199710000-00007; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Schumacher JE, 2007, J CONSULT CLIN PSYCH, V75, P823, DOI 10.1037/0022-006X.75.5.823; Somers JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072946; Stefancic A, 2013, AM J PUBLIC HEALTH, V103, pS206, DOI 10.2105/AJPH.2013.301606; Susser E, 1997, AM J PUBLIC HEALTH, V87, P256, DOI 10.2105/AJPH.87.2.256; Sznajder-Murray B, 2011, J SOC SERV RES, V37, P457, DOI 10.1080/01488376.2011.585326; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; Tsemberis S, 2000, PSYCHIATR SERV, V51, P487, DOI 10.1176/appi.ps.51.4.487; Tsemberis SJ, 2003, AM J COMMUN PSYCHOL, V32, P305, DOI 10.1023/B:AJCP.0000004750.66957.bf; van Draanen J, 2013, PSYCHIATR REHABIL J, V36, P180, DOI 10.1037/prj0000014; Wolitski RJ, 2010, AIDS BEHAV, V14, P493, DOI 10.1007/s10461-009-9643-x; Wright NMJ, 2006, BRIT J GEN PRACT, V56, P286; Zlotnick C, 2013, AM J PUBLIC HEALTH, V103, pS199, DOI 10.2105/AJPH.2013.301586	56	162	165	3	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1541	1547		10.1016/S0140-6736(14)61133-8	http://dx.doi.org/10.1016/S0140-6736(14)61133-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9MO	25390579				2022-12-28	WOS:000343899600028
J	Weir, MR; Bakris, GL; Bushinsky, DA; Mayo, MR; Garza, D; Stasiv, Y; Wittes, J; Christ-Schmidt, H; Berman, L; Pitt, B				Weir, Matthew R.; Bakris, George L.; Bushinsky, David A.; Mayo, Martha R.; Garza, Dahlia; Stasiv, Yuri; Wittes, Janet; Christ-Schmidt, Heidi; Berman, Lance; Pitt, Bertram		OPAL-HK Investigators	Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SODIUM POLYSTYRENE SULFONATE; MILD PATIENTS HOSPITALIZATION; WORSENING RENAL-FUNCTION; INTESTINAL NECROSIS; MANAGEMENT; RESONIUM; EPLERENONE; SURVIVAL; THERAPY; SAFETY	Background Hyperkalemia increases the risk of death and limits the use of inhibitors of the renin-angiotensin-aldosterone system (RAAS) in high-risk patients. We assessed the safety and efficacy of patiromer, a nonabsorbed potassium binder, in a multicenter, prospective trial. Methods Patients with chronic kidney disease who were receiving RAAS inhibitors and who had serum potassium levels of 5.1 to less than 6.5 mmol per liter received patiromer (at an initial dose of 4.2 g or 8.4 g twice a day) for 4 weeks (initial treatment phase); the primary efficacy end point was the mean change in the serum potassium level from baseline to week 4. Eligible patients at the end of week 4 (those with a baseline potassium level of 5.5 to < 6.5 mmol per liter in whom the level decreased to 3.8 to < 5.1 mmol per liter) entered an 8-week randomized withdrawal phase in which they were randomly assigned to continue patiromer or switch to placebo; the primary efficacy end point was the between-group difference in the median change in the serum potassium level over the first 4 weeks of that phase. Results In the initial treatment phase, among 237 patients receiving patiromer who had at least one potassium measurement at a scheduled visit after day 3, the mean (+/- SE) change in the serum potassium level was -1.01 +/- 0.03 mmol per liter (P<0.001). At week 4, 76% (95% confidence interval, 70 to 81) of the patients had reached the target potassium level (3.8 to < 5.1 mmol per liter). Subsequently, 107 patients were randomly assigned to patiromer (55 patients) or placebo (52 patients) for the randomized withdrawal phase. The median increase in the potassium level from baseline of that phase was greater with placebo than with patiromer (P<0.001); a recurrence of hyperkalemia (potassium level, >= 5.5 mmol per liter) occurred in 60% of the patients in the placebo group as compared with 15% in the patiromer group through week 8 (P<0.001). Mild-to-moderate constipation was the most common adverse event (in 11% of the patients); hypokalemia occurred in 3%. Conclusions In patients with chronic kidney disease who were receiving RAAS inhibitors and who had hyperkalemia, patiromer treatment was associated with a decrease in serum potassium levels and, as compared with placebo, a reduction in the recurrence of hyperkalemia. Copyright (C) 2014 Massachusetts Medical Society.	[Weir, Matthew R.] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Bakris, George L.] Univ Chicago Med, Dept Med, ASH Comprehens Hypertens Ctr, Div Endocrinol Diabet & Metab, Chicago, IL USA; [Bushinsky, David A.] Univ Rochester, Dept Med, Div Nephrol, Rochester, NY USA; [Mayo, Martha R.; Garza, Dahlia; Stasiv, Yuri; Berman, Lance] Relypsa, Redwood City, CA USA; [Wittes, Janet; Christ-Schmidt, Heidi] Stat Collaborat, Washington, DC USA; [Pitt, Bertram] Univ Michigan, Ann Arbor, MI 48109 USA	University System of Maryland; University of Maryland Baltimore; University of Rochester; University of Michigan System; University of Michigan	Weir, MR (corresponding author), Univ Maryland, Med Ctr, Nephrol N3W143, 22 S Greene St, Baltimore, MD 21201 USA.	mweir@medicine.umaryland.edu	Korzh, Oleksii/E-4291-2016; Weir, Matthew R/ABC-3654-2021	Korzh, Oleksii/0000-0001-6838-4360; Weir, Matthew R/0000-0001-8820-5702	Relypsa	Relypsa	Funded by Relypsa; OPAL-HK ClinicalTrials.gov number, NCT01810939.	Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; BERLYNE GM, 1966, LANCET, V1, P167; Buysse JM, 2012, FUTUR CARDIOL, V8, P17, DOI [10.2217/fca.11.71, 10.2217/FCA.11.71]; Chaaban A, 2013, RENAL FAILURE, V35, P185, DOI 10.3109/0886022X.2012.745118; Cheng ES, 2002, BURNS, V28, P189, DOI 10.1016/S0305-4179(01)00099-7; Chernin G, 2012, CLIN CARDIOL, V35, P32, DOI 10.1002/clc.20987; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Eschalier R, 2013, J AM COLL CARDIOL, V62, P1585, DOI 10.1016/j.jacc.2013.04.086; Fordjour KN, 2014, AM J MED SCI, V347, P93, DOI 10.1097/MAJ.0b013e318279b105; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; GERSTMAN BB, 1992, AM J KIDNEY DIS, V20, P159, DOI 10.1016/S0272-6386(12)80544-0; Gruy-Kapral C, 1998, J AM SOC NEPHROL, V9, P1924; Harel Z, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.08.016; HODGES JL, 1962, ANN MATH STAT, V33, P482, DOI 10.1214/aoms/1177704575; Kessler C, 2011, J HOSP MED, V6, P136, DOI 10.1002/jhm.834; Lazich L, 2014, SEMIN NEPHROL, V34, P333, DOI 10.1016/j.semnephrol.2014.04.008; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; McGowan CE, 2009, SOUTH MED J, V102, P493, DOI 10.1097/SMJ.0b013e31819e8978; MIKRUT M, 2004, HOSP PHARM, V39, P765; MINFORD EJ, 1992, POSTGRAD MED J, V68, P302, DOI 10.1136/pgmj.68.798.302; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; O'Brien PC, 2005, STAT MED, V24, P341, DOI 10.1002/sim.1963; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; Rossignol P, 2014, CIRC-HEART FAIL, V7, P51, DOI 10.1161/CIRCHEARTFAILURE.113.000792; Sandal S, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/940320; SCHEER L, 1961, NEW ENGL J MED, V264, P115, DOI 10.1056/NEJM196101192640303; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Weir MR, 2010, CLIN J AM SOC NEPHRO, V5, P531, DOI 10.2215/CJN.07821109; Yildirim T, 2012, RENAL FAILURE, V34, P1095, DOI 10.3109/0886022X.2012.717478	30	396	409	5	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					211	221		10.1056/NEJMoa1410853	http://dx.doi.org/10.1056/NEJMoa1410853			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3HX	25415805	Bronze			2022-12-28	WOS:000348119200005
J	Ma, ZJ; Melville, DS; Liu, JG; Chen, Y; Yang, HY; Ren, WW; Zhang, ZW; Piersma, T; Li, B				Ma, Zhijun; Melville, David S.; Liu, Jianguo; Chen, Ying; Yang, Hongyan; Ren, Wenwei; Zhang, Zhengwang; Piersma, Theunis; Li, Bo			ECOSYSTEMS MANAGEMENT Rethinking China's new great wall	SCIENCE			English	Editorial Material									[Ma, Zhijun; Chen, Ying; Li, Bo] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200438, Peoples R China; [Liu, Jianguo] Michigan State Univ, Ctr Syst Integrat & Sustainabil, Dept Fisheries & Wildlife, E Lansing, MI 48823 USA; [Yang, Hongyan] Beijing Forestry Univ, Coll Nat Reserve, Beijing 100083, Peoples R China; [Yang, Hongyan; Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Chair Global Flyway Ecol, NL-9700 CC Groningen, Netherlands; [Yang, Hongyan; Piersma, Theunis] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Ecol, NL-1790 AB Den Burg, Texel, Netherlands; [Ren, Wenwei] World Wildlife Fund China Shanghai Off, Shanghai 200083, Peoples R China; [Zhang, Zhengwang] Beijing Normal Univ, Coll Life Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Beijing 100875, Peoples R China	Fudan University; Michigan State University; Beijing Forestry University; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Beijing Normal University	Ma, ZJ (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200438, Peoples R China.	zhijunm@fudan.edu.cn	Ma, Zhijun/B-4650-2011; Li, Bo/AAA-8968-2020; Li, Bo/B-8016-2010; Liu, Jianguo/G-5211-2015	Li, Bo/0000-0002-7294-6888; Li, Bo/0000-0002-0439-5666; Piersma, Theunis/0000-0001-9668-466X; Liu, Jianguo/0000-0001-6344-0087				Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; [Anonymous], 2012, IUCN SITUATION ANAL; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Chen Z.X., 2000, CHINESE SCI BULL, V45, P17, DOI DOI 10.1007/BF02886190; China Council for International Cooperation on Environment and Development, 2010, ANN POL REP EC MAN G, P113; [Consultation Group of Academic Division of Earth Science of Chinese Academy of Sciences CAS], 2011, 2011 SCI DEV REP, P344; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Guan D. M., 2013, STUDY NATL MARINE FU; He GZ, 2013, SCIENCE, V341, P133, DOI 10.1126/science.1235000; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Lieberthal Kenneth, 1988, POLICY MAKING CHINA; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035	12	316	361	18	356	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					912	914		10.1126/science.1257258	http://dx.doi.org/10.1126/science.1257258			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6EL	25414287				2022-12-28	WOS:000345696000015
J	Vierstra, J; Rynes, E; Sandstrom, R; Zhang, MH; Canfield, T; Hansen, RS; Stehling-Sun, S; Sabo, PJ; Byron, R; Humbert, R; Thurman, RE; Johnson, AK; Vong, S; Lee, K; Bates, D; Neri, F; Diegel, M; Giste, E; Haugen, E; Dunn, D; Wilken, MS; Josefowicz, S; Samstein, R; Chang, KH; Eichler, EE; De Bruijn, M; Reh, TA; Skoultchi, A; Rudensky, A; Orkin, SH; Papayannopoulou, T; Treuting, PM; Selleri, L; Kaul, R; Groudine, M; Bender, MA; Stamatoyannopoulos, JA				Vierstra, Jeff; Rynes, Eric; Sandstrom, Richard; Zhang, Miaohua; Canfield, Theresa; Hansen, R. Scott; Stehling-Sun, Sandra; Sabo, Peter J.; Byron, Rachel; Humbert, Richard; Thurman, Robert E.; Johnson, Audra K.; Vong, Shinny; Lee, Kristen; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Giste, Erika; Haugen, Eric; Dunn, Douglas; Wilken, Matthew S.; Josefowicz, Steven; Samstein, Robert; Chang, Kai-Hsin; Eichler, Evan E.; De Bruijn, Marella; Reh, Thomas A.; Skoultchi, Arthur; Rudensky, Alexander; Orkin, Stuart H.; Papayannopoulou, Thalia; Treuting, Piper M.; Selleri, Licia; Kaul, Rajinder; Groudine, Mark; Bender, M. A.; Stamatoyannopoulos, John A.			Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution	SCIENCE			English	Article							TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; GENOME; EXPANSION; LINEAGES; ELEMENTS; ENHANCER; REGIONS; SITES	To study the evolutionary dynamics of regulatory DNA, we mapped >1.3 million deoxyribonuclease I-hypersensitive sites (DHSs) in 45 mouse cell and tissue types, and systematically compared these with human DHS maps from orthologous compartments. We found that the mouse and human genomes have undergone extensive cis-regulatory rewiring that combines branch-specific evolutionary innovation and loss with widespread repurposing of conserved DHSs to alternative cell fates, and that this process is mediated by turnover of transcription factor (TF) recognition elements. Despite pervasive evolutionary remodeling of the location and content of individual cis-regulatory regions, within orthologous mouse and human cell types the global fraction of regulatory DNA bases encoding recognition sites for each TF has been strictly conserved. Our findings provide new insights into the evolutionary forces shaping mammalian regulatory DNA landscapes.	[Vierstra, Jeff; Rynes, Eric; Sandstrom, Richard; Canfield, Theresa; Stehling-Sun, Sandra; Sabo, Peter J.; Humbert, Richard; Thurman, Robert E.; Johnson, Audra K.; Vong, Shinny; Lee, Kristen; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Giste, Erika; Haugen, Eric; Dunn, Douglas; Eichler, Evan E.; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Zhang, Miaohua; Byron, Rachel; Groudine, Mark; Bender, M. A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Hansen, R. Scott; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Wilken, Matthew S.; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Josefowicz, Steven; Samstein, Robert; Rudensky, Alexander] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Josefowicz, Steven; Samstein, Robert; Eichler, Evan E.; Rudensky, Alexander; Orkin, Stuart H.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Chang, Kai-Hsin; Papayannopoulou, Thalia] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [De Bruijn, Marella] John Radcliffe Hosp, Weatherall Inst Mol Med, Med Res Council MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Skoultchi, Arthur] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Orkin, Stuart H.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst,Dept Pediat Oncol, Boston, MA 02115 USA; [Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Selleri, Licia] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Groudine, Mark] Univ Washington, Dept Radiat Oncol, Seattle, WA 98109 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Washington; University of Washington Seattle; Cornell University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Samstein, Robert/0000-0001-6860-2401; Vierstra, Jeff/0000-0001-6406-8563; Kaul, Rajinder/0000-0002-7895-9284; Sandstrom, Richard/0000-0002-3356-1547; josefowicz, steven/0000-0001-7453-779X; Haugen, Eric/0000-0001-7444-8981	NIH grants [U54HG007010, 1RC2HG005654, R37DK44746, 2R01HD04399709]; NSF Graduate Research Fellowship [DGE-071824]; Medical Research Council [MC_UU_12009/2] Funding Source: researchfish; MRC [MC_UU_12009/2] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043997] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021482] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010, RC2HG005654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096266, R37DK044746] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants U54HG007010 (J.A.S.), 1RC2HG005654 (J.A.S. and M.G.), R37DK44746 (M.G. and M.A.B.), and 2R01HD04399709 (L.S.) and by NSF Graduate Research Fellowship DGE-071824 (J.V.). E.E.E. is on the scientific advisory boards for Pacific Biosciences Inc., SynapDx Corp., and DNAnexus Inc. J.V. and J.A.S. designed the experiments and analysis; E.R., R.S., and R.E.T. aided in data analysis and management; all other authors participated in data generation and sample collection; and J.V. and J.A.S. wrote the manuscript with help from E.R. We thank H. Wang and E. K. Salinas for help with figures. All sequence data generated in this study can be accessed with GEO accession numbers found within tables S1 and S2.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Garel S, 1999, DEVELOPMENT, V126, P5285; Guenet JL, 2005, GENOME RES, V15, P1729, DOI 10.1101/gr.3728305; Hardouin SN, 2000, CLIN GENET, V57, P237, DOI 10.1034/j.1399-0004.2000.570401.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laperriere D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-23; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Payne JL, 2014, SCIENCE, V343, P875, DOI 10.1126/science.1249046; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P11207, DOI 10.1073/pnas.90.23.11207; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Schachterle W, 2012, DEV BIOL, V361, P439, DOI 10.1016/j.ydbio.2011.10.023; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xiong Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-587; Yue F, 2014, NATURE, V515, P355, DOI [10.1038/nature13992, DOI 10.1038/NATURE13992]	26	167	169	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					1007	1012		10.1126/science.1246426	http://dx.doi.org/10.1126/science.1246426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25411453	Green Accepted, Green Submitted			2022-12-28	WOS:000345696000047
J	Zimmerman, A; Bai, L; Ginty, DD				Zimmerman, Amanda; Bai, Ling; Ginty, David D.			The gentle touch receptors of mammalian skin	SCIENCE			English	Review							RAPIDLY ADAPTING MECHANORECEPTORS; PACINIAN CORPUSCLES; MERKEL-CELL; GLABROUS SKIN; HAIRY SKIN; CUTANEOUS MECHANORECEPTORS; UNMYELINATED AFFERENTS; SENSORY NEURONS; FINE-STRUCTURE; GLANS-PENIS	The skin is our largest sensory organ, transmitting pain, temperature, itch, and touch information to the central nervous system. Touch sensations are conveyed by distinct combinations of mechanosensory end organs and the low-threshold mechanoreceptors (LTMRs) that innervate them. Here we explore the various structures underlying the diverse functions of cutaneous LTMR end organs. Beyond anchoring of LTMRs to the surrounding dermis and epidermis, recent evidence suggests that the non-neuronal components of end organs play an active role in signaling to LTMRs and may physically gate force-sensitive channels in these receptors. Combined with LTMR intrinsic properties, the balance of these factors comprises the response properties of mechanosensory neurons and, thus, the neural encoding of touch.	[Zimmerman, Amanda; Bai, Ling; Ginty, David D.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Bai, Ling] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Bai, Ling] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Ginty, DD (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	david_ginty@hms.harvard.edu			NIH [R01 NS34814, R01 DE022750]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ginty laboratory for helpful discussions and comments on this manuscript. Our research addressing the organization and function of LTMRs and their circuits is supported by NIH grants R01 NS34814 and R01 DE022750 (to D.D.G.). D.D.G. is an investigator of the Howard Hughes Medical Institute.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; BENTIVOGLIO M, 1995, BRAIN RES BULL, V38, P161, DOI 10.1016/0361-9230(95)00083-Q; BIEMESDERFER D, 1978, BRAIN RES, V142, P197, DOI 10.1016/0006-8993(78)90631-5; Blake DT, 1997, J NEUROSCI, V17, P7480; Brisben AJ, 1999, J NEUROPHYSIOL, V81, P1548, DOI 10.1152/jn.1999.81.4.1548; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; CAUNA N, 1958, J ANAT, V92, P1; CAUNA N, 1956, AM J ANAT, V99, P315, DOI 10.1002/aja.1000990206; CAUNA N, 1960, J BIOPHYS BIOCHEM CY, V8, P467, DOI 10.1083/jcb.8.2.467; Fagan BM, 2001, NEUROREPORT, V12, P341, DOI 10.1097/00001756-200102120-00032; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; HALATA Z, 1986, BRAIN RES, V371, P205, DOI 10.1016/0006-8993(86)90357-4; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HARTSCHUH W, 1980, J INVEST DERMATOL, V75, P159, DOI 10.1111/1523-1747.ep12522555; Hu J, 2010, EMBO J, V29, P855, DOI 10.1038/emboj.2009.398; IDE C, 1976, AM J ANAT, V147, P329, DOI 10.1002/aja.1001470307; IGGO A, 1977, J PHYSIOL-LONDON, V266, P275, DOI 10.1113/jphysiol.1977.sp011768; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; JANIG W, 1971, BRAIN RES, V28, P203, DOI 10.1016/0006-8993(71)90655-X; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; KNIBESTO.M, 1973, J PHYSIOL-LONDON, V232, P427, DOI 10.1113/jphysiol.1973.sp010279; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Lechner SG, 2013, PHYSIOLOGY, V28, P142, DOI 10.1152/physiol.00059.2012; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Li LS, 2014, ELIFE, V3, DOI 10.7554/eLife.01901; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; LOEWENSTEIN WR, 1966, J PHYSIOL-LONDON, V182, P346, DOI 10.1113/jphysiol.1966.sp007827; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; MIHARA M, 1979, J INVEST DERMATOL, V73, P325, DOI 10.1111/1523-1747.ep12550322; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Pare M, 2002, J COMP NEUROL, V445, P347, DOI 10.1002/cne.10196; Pawson L, 2000, SOMATOSENS MOT RES, V17, P159; Pawson L, 2007, SOMATOSENS MOT RES, V24, P85, DOI 10.1080/08990220701388364; Pawson L, 2009, J NEUROSCI, V29, P2695, DOI 10.1523/JNEUROSCI.5974-08.2009; PEASE DC, 1957, J BIOPHYS BIOCHEM CY, V3, P331, DOI 10.1083/jcb.3.3.331; RICE FL, 1986, J COMP NEUROL, V252, P186, DOI 10.1002/cne.902520205; SATO M, 1961, J PHYSIOL-LONDON, V159, P391, DOI 10.1113/jphysiol.1961.sp006817; Shih C, 2013, J SEX MED, V10, P1783, DOI 10.1111/jsm.12191; SPENCER PS, 1973, J NEUROCYTOL, V2, P217, DOI 10.1007/BF01474721; Takahashi-Iwanaga H, 2003, J NEUROCYTOL, V32, P363, DOI 10.1023/B:NEUR.0000011330.57530.2f; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; VALLBO A, 1993, BRAIN RES, V628, P301, DOI 10.1016/0006-8993(93)90968-S; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517; Yamamoto T, 1966, J Electron Microsc (Tokyo), V15, P158	50	243	250	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					950	954		10.1126/science.1254229	http://dx.doi.org/10.1126/science.1254229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414303	Green Accepted			2022-12-28	WOS:000345696000033
J	Majzoub, K; Hafirassou, ML; Meignin, C; Goto, A; Marzi, S; Fedorova, A; Verdier, Y; Vinh, J; Hoffmann, JA; Martin, F; Baumert, TF; Schuster, C; Imler, JL				Majzoub, Karim; Hafirassou, Mohamed Lamine; Meignin, Carine; Goto, Akira; Marzi, Stefano; Fedorova, Antonina; Verdier, Yann; Vinh, Joelle; Hoffmann, Jules A.; Martin, Franck; Baumert, Thomas F.; Schuster, Catherine; Imler, Jean-Luc			RACK1 Controls IRES-Mediated Translation of Viruses	CELL			English	Article							HEPATITIS-C-VIRUS; CRICKET PARALYSIS VIRUS; 40S RIBOSOMAL-SUBUNIT; INITIATION-FACTOR 3; EUKARYOTIC TRANSLATION; DEPENDENT TRANSLATION; VERSATILE SCAFFOLD; PROTEIN-SYNTHESIS; DECODING CENTER; 80S RIBOSOME	Fighting viral infections is hampered by the scarcity of viral targets and their variability, resulting in development of resistance. Viruses depend on cellular molecules-which are attractive alternative targets-for their life cycle, provided that they are dispensable for normal cell functions. Using the model organism Drosophila melanogaster, we identify the ribosomal protein RACK1 as a cellular factor required for infection by internal ribosome entry site (IRES)-containing viruses. We further show that RACK1 is an essential determinant for hepatitis C virus translation and infection, indicating that its function is conserved for distantly related human and fly viruses. Inhibition of RACK1 does not affect Drosophila or human cell viability and proliferation, and RACK1-silenced adult flies are viable, indicating that this protein is not essential for general translation. Our findings demonstrate a specific function for RACK1 in selective mRNA translation and uncover a target for the development of broad antiviral intervention.	[Majzoub, Karim; Meignin, Carine; Goto, Akira; Hoffmann, Jules A.; Imler, Jean-Luc] CNRS, UPR9022, Inst Biol Mol & Cellulaire, F-67000 Strasbourg, France; [Hafirassou, Mohamed Lamine; Meignin, Carine; Fedorova, Antonina; Hoffmann, Jules A.; Baumert, Thomas F.; Schuster, Catherine; Imler, Jean-Luc] Univ Strasbourg, F-67000 Strasbourg, France; [Hafirassou, Mohamed Lamine; Fedorova, Antonina; Baumert, Thomas F.; Schuster, Catherine] INSERM, UMR1110, Inst Rech Malad Virales & Hepat, F-67000 Strasbourg, France; [Marzi, Stefano; Martin, Franck] CNRS, UPR9002, Inst Biol Mol & Cellulaire, F-67000 Strasbourg, France; [Verdier, Yann; Vinh, Joelle] ESPCI ParisTech, USR3149, F-75005 Paris, France; [Hoffmann, Jules A.] Univ Strasbourg, Inst Etud Avancees, F-67000 Strasbourg, France; [Baumert, Thomas F.] Hop Univ Strasbourg, IHU, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schuster, C (corresponding author), Univ Strasbourg, F-67000 Strasbourg, France.	catherine.schuster@unistra.fr; jl.imler@unistra.fr	Schuster, Catherine/H-9355-2016; Imler, Jean-Luc/GXH-4323-2022; MARTIN, Franck/D-9042-2015; GOTO, Akira/V-7847-2017; Vinh, Joelle/K-1347-2015; Marzi, Stefano/A-1810-2012; Baumert, Thomas/ABF-4718-2020	Schuster, Catherine/0000-0001-7281-4511; MARTIN, Franck/0000-0001-9724-4025; GOTO, Akira/0000-0003-3395-484X; Vinh, Joelle/0000-0001-7184-2668; Marzi, Stefano/0000-0003-0399-4613; Baumert, Thomas/0000-0002-8864-2168; Meignin, Carine/0000-0002-6588-9045; Verdier, Yann/0000-0002-3319-0053; Majzoub, Karim/0000-0001-7345-6840	CNRS; Inserm; NIH [PO1 AI070167]; Investissement d'Avenir program (HepSys) [ANR-10-LAB-28]; Investissement d'Avenir program (NetRNA) [ANR-10-LABX-36]; Investissement d'Avenir program (I2MC) [ANR-11-EQPX-0022]; Investissement d'Avenir program (IDEX) [W13RATCS]; ANR [ANR-09-MIEN-006-01, ANR-11-SVSE802501]; ARC [IHU201301187]; ANRS [2010-307/2011-415]; FRM; TGE FT-ICR; ESPCI ParisTech; Fonds pour la Recherche et la Technologie of the French Ministry of Research for the LTQ FT acquisition; ANRS; CNRS/Region Alsace; IDEX program from the University of Strasbourg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investissement d'Avenir program (HepSys)(French National Research Agency (ANR)); Investissement d'Avenir program (NetRNA)(French National Research Agency (ANR)); Investissement d'Avenir program (I2MC)(French National Research Agency (ANR)); Investissement d'Avenir program (IDEX)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); ANRS(ANRSFrench National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); TGE FT-ICR; ESPCI ParisTech; Fonds pour la Recherche et la Technologie of the French Ministry of Research for the LTQ FT acquisition; ANRS(ANRSFrench National Research Agency (ANR)); CNRS/Region Alsace(Centre National de la Recherche Scientifique (CNRS)Region Grand-Est); IDEX program from the University of Strasbourg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CNRS, Inserm, and grants from NIH (PO1 AI070167 to J.A.H. and J.-L.I.); Investissement d'Avenir programs (HepSys ANR-10-LAB-28 to T. B. and NetRNA ANR-10-LABX-36; I2MC ANR-11-EQPX-0022, to J.-L.I. and S. M.; IDEX W13RATCS to C. S.); ANR (ANR-09-MIEN-006-01 to J.-L.I. and ANR-11-SVSE802501 to F. M.); ARC (IHU201301187 to T. B.); ANRS (2010-307/2011-415, to C. S.); and FRM (to C. M.). Financial support from the TGE FT-ICR, the ESPCI ParisTech, and the Fonds pour la Recherche et la Technologie of the French Ministry of Research for the LTQ FT acquisition are gratefully acknowledged. M. L. H., K. M., and A. F. were supported by fellowships from ANRS, CNRS/Region Alsace, and the IDEX program from the University of Strasbourg, respectively. We thank S. Pellegrino and M. Yusupov (IGBMC, Strasbourg) for advice and assistance in the preparation of translation competent cell free extracts; R. Bartenschlager (University of Heidelberg, Heidelberg, Germany) for providing Jc1 and Luc-Jc1 expression vectors; F. V. Chisari (TSRI, La Jolla) for Huh7.5.1 cells; M. Beckerle (University of Utah) for providing RACK1 antiserum; S. Thompson (Birmingham) for sharing the plasmid pSRT208; and the transgenic RNAi Project (TRiP) at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks. We also thank E. Santiago, N. Ftaich, and M. Parnot for technical assistance; B. Fischer and D. Dembele (siRNA screening and microarray platforms at IGBMC) for the InCell1000 and the transcriptomic analysis; and E. Westhof and W. Filipowicz for discussions and critical reading of the manuscript.	Belozerov VE, 2014, MOL CELL BIOL, V34, P474, DOI 10.1128/MCB.00824-13; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Bushell M, 2000, EUR J BIOCHEM, V267, P1083, DOI 10.1046/j.1432-1327.2000.01101.x; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choudhuri A, 2013, P NATL ACAD SCI USA, V110, P9818, DOI 10.1073/pnas.1302934110; Chu YD, 2014, CELL CYCLE, V13, P1995, DOI 10.4161/cc.29017; Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fraser CS, 2009, NAT STRUCT MOL BIOL, V16, P397, DOI 10.1038/nsmb.1572; Gibson TJ, 2012, FEBS LETT, V586, P2787, DOI 10.1016/j.febslet.2012.04.048; Hashem Y, 2013, NATURE, V503, P539, DOI 10.1038/nature12658; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jannot G, 2011, EMBO REP, V12, P581, DOI 10.1038/embor.2011.66; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kadrmas JL, 2007, DEV DYNAM, V236, P2207, DOI 10.1002/dvdy.21217; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Koh CS, 2014, P NATL ACAD SCI USA, V111, P9139, DOI 10.1073/pnas.1406335111; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Otsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024359; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Speth C, 2013, PLANT J, V76, P433, DOI 10.1111/tpj.12308; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Topisirovic I, 2011, CELL, V145, P333, DOI 10.1016/j.cell.2011.04.006; Volta V, 2013, CELL MOL LIFE SCI, V70, P1439, DOI 10.1007/s00018-012-1215-y; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wakiyama M, 2006, BIOCHEM BIOPH RES CO, V343, P1067, DOI 10.1016/j.bbrc.2006.03.076; Walsh D, 2014, GENE DEV, V28, P835, DOI 10.1101/gad.236752.113; Xiao F., 2014, GUT; Xiao F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004128; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	64	116	120	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1086	1095		10.1016/j.cell.2014.10.041	http://dx.doi.org/10.1016/j.cell.2014.10.041			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416947	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000345506300020
J	Woodward, C; Shulmeister, J; Larsen, J; Jacobsen, GE; Zawadzki, A				Woodward, C.; Shulmeister, J.; Larsen, J.; Jacobsen, G. E.; Zawadzki, A.			The hydrological legacy of deforestation on global wetlands	SCIENCE			English	Article							WATER YIELD; NEW-ZEALAND; LATE-HOLOCENE; SOUTH ISLAND; VEGETATION CHANGES; ECOSYSTEMS; CATCHMENT; LAKE; AFFORESTATION; SETTLEMENT	Increased catchment erosion and nutrient loading are commonly recognized impacts of deforestation on global wetlands. In contrast, an increase in water availability in deforested catchments is well known in modern studies but is rarely considered when evaluating past human impacts. We used a Budyko water balance approach, a meta-analysis of global wetland response to deforestation, and paleoecological studies from Australasia to explore this issue. After complete deforestation, we demonstrated that water available to wetlands increases by up to 15% of annual precipitation. This can convert ephemeral swamps to permanent lakes or even create new wetlands. This effect is globally significant, with 9 to 12% of wetlands affected, including 20 to 40% of Ramsar wetlands, but is widely unrecognized because human impact studies rarely test for it.	[Woodward, C.; Shulmeister, J.; Larsen, J.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia; [Jacobsen, G. E.; Zawadzki, A.] Australian Nucl Sci & Technol Org, Inst Environm Res, Kirrawee Dc, NSW 2232, Australia	University of Queensland; Australian Nuclear Science & Technology Organisation	Woodward, C (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Chamberlain Bldg,St Lucia Campus, Brisbane, Qld 4072, Australia.	c.woodward1@uq.edu.au	Shulmeister, James/J-2859-2015	Shulmeister, James/0000-0001-5863-9462; Larsen, Joshua/0000-0002-0650-7369; Woodward, Craig/0000-0003-1197-820X	Australian Research Council Discovery Project [DP 110103081]; Australian Institute for Nuclear Science and Engineering [ALNGRA11068, ALNGRA12071]	Australian Research Council Discovery Project(Australian Research Council); Australian Institute for Nuclear Science and Engineering	This research was part of an Australian Research Council Discovery Project (DP 110103081) and was also partly supported by the Australian Institute for Nuclear Science and Engineering (grants ALNGRA11068 and ALNGRA12071). The database used for the meta-analysis of Holocene records of catchment deforestation and wetland change can be downloaded from the Dryad Digital Repository at http://dx.doi.org/10.5061/dryad.m62gj.	Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Brinson MM, 2002, ENVIRON CONSERV, V29, P115, DOI 10.1017/S0376892902000085; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Bruijnzeel L.A, 1988, J TROP FOR SCI, V1, P229; Budyko MI., 1974, CLIMATE LIFE; Cubizolle H, 2012, QUATERN INT, V251, P77, DOI 10.1016/j.quaint.2011.07.001; Farley KA, 2005, GLOBAL CHANGE BIOL, V11, P1565, DOI 10.1111/j.1365-2486.2005.01011.x; GALE SJ, 1995, QUATERNARY SCI REV, V14, P395, DOI 10.1016/0277-3791(95)00033-X; Gergis J, 2012, CLIMATIC CHANGE, V111, P923, DOI 10.1007/s10584-011-0263-x; HORNBECK JW, 1993, J HYDROL, V150, P323, DOI 10.1016/0022-1694(93)90115-P; Macklin MG, 2012, GEOLOGY, V40, P775, DOI 10.1130/G33364.1; McWethy DB, 2010, P NATL ACAD SCI USA, V107, P21343, DOI 10.1073/pnas.1011801107; Page MJ, 2010, MAR GEOL, V270, P30, DOI 10.1016/j.margeo.2009.10.019; Sahin V, 1996, J HYDROL, V178, P293, DOI 10.1016/0022-1694(95)02825-0; Silberstein R., 2003, 0301 MON U COOP RES; Sondergaard M, 2007, J APPL ECOL, V44, P1089, DOI 10.1111/j.1365-2664.2007.01426.x; Sterling SM, 2013, NAT CLIM CHANGE, V3, P385, DOI [10.1038/NCLIMATE1690, 10.1038/nclimate1690]; Stubbs B. J., 1998, Environment and History, V4, P145, DOI 10.3197/096734098779555628; Szesztay K., 2010, HYDROL SCI B, V19, P73; Vance TR, 2013, J CLIMATE, V26, P710, DOI 10.1175/JCLI-D-12-00003.1; Williams PW, 2005, EARTH PLANET SC LETT, V230, P301, DOI 10.1016/j.epsl.2004.10.024; Woodward C, 2014, HOLOCENE, V24, P668, DOI 10.1177/0959683614526935; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325	24	82	83	16	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					844	847		10.1126/science.1260510	http://dx.doi.org/10.1126/science.1260510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395535	Green Submitted			2022-12-28	WOS:000344659900043
J	Kurylo, JC; Schmidt, AH				Kurylo, John C.; Schmidt, Andrew H.			Gas Gangrene of a Prosthetic Hip	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kurylo, John C.; Schmidt, Andrew H.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA	Hennepin County Medical Center	Kurylo, JC (corresponding author), Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA.	john.kurylo.md@gmail.com		Schmidt, Andrew/0000-0002-9740-4049					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1917	1917		10.1056/NEJMicm1400498	http://dx.doi.org/10.1056/NEJMicm1400498			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25390742				2022-12-28	WOS:000344709800009
J	Crowe, SA; Paris, G; Katsev, S; Jones, C; Kim, ST; Zerkle, AL; Nomosatryo, S; Fowle, DA; Adkins, JF; Sessions, AL; Farquhar, J; Canfield, DE				Crowe, Sean A.; Paris, Guillaume; Katsev, Sergei; Jones, CarriAyne; Kim, Sang-Tae; Zerkle, Aubrey L.; Nomosatryo, Sulung; Fowle, David A.; Adkins, Jess F.; Sessions, Alex L.; Farquhar, James; Canfield, Donald E.			Sulfate was a trace constituent of Archean seawater	SCIENCE			English	Article							SULFUR CYCLE; ISOTOPE FRACTIONATION; REDUCTION; OCEAN; RECORDS; MATTER; CARBON; OXYGEN	In the low-oxygen Archean world (>2400 million years ago), seawater sulfate concentrations were much lower than today, yet open questions frustrate the translation of modern measurements of sulfur isotope fractionations into estimates of Archean seawater sulfate concentrations. In the water column of Lake Matano, Indonesia, a low-sulfate analog for the Archean ocean, we find large (>20 per mil) sulfur isotope fractionations between sulfate and sulfide, but the underlying sediment sulfides preserve a muted range of delta S-34 values. Using models informed by sulfur cycling in Lake Matano, we infer Archean seawater sulfate concentrations of less than 2.5 micromolar. At these low concentrations, marine sulfate residence times were likely 10(3) to 10(4) years, and sulfate scarcity would have shaped early global biogeochemical cycles, possibly restricting biological productivity in Archean oceans.	[Crowe, Sean A.; Jones, CarriAyne] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Crowe, Sean A.; Jones, CarriAyne] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Crowe, Sean A.; Jones, CarriAyne; Canfield, Donald E.] Univ Southern Denmark, NordCEE, Odense, Denmark; [Crowe, Sean A.; Jones, CarriAyne; Canfield, Donald E.] Univ Southern Denmark, Dept Biol, Odense, Denmark; [Paris, Guillaume; Adkins, Jess F.; Sessions, Alex L.] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; [Katsev, Sergei] Univ Minnesota, Large Lakes Observ, Minneapolis, MN 55812 USA; [Katsev, Sergei] Univ Minnesota, Dept Phys, Minneapolis, MN 55812 USA; [Kim, Sang-Tae] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada; [Zerkle, Aubrey L.] Univ St Andrews, Dept Earth & Environm Sci, St Andrews, Fife, Scotland; [Nomosatryo, Sulung] Indonesian Inst Sci, Limnol Res Ctr, Cibinong, West Java, Indonesia; [Fowle, David A.] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA; [Farquhar, James] Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University of British Columbia; University of British Columbia; University of Southern Denmark; University of Southern Denmark; California Institute of Technology; University of Minnesota System; University of Minnesota Duluth; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; McMaster University; University of St Andrews; Indonesian Institute of Sciences; University of Kansas; University System of Maryland; University of Maryland College Park	Crowe, SA (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	sacrowe1@gmail.com	Kim, Sang-Tae/C-2768-2013; Adkins, Jess/GYI-8778-2022; Sessions, Alex/ABC-9207-2020; Fowle, David/B-1074-2008; Kim, Sang-Tae/A-1406-2008; Paris, Guillaume/ABA-3266-2020; Canfield, Don/C-1735-2012; Jones, CarriAyne/K-1906-2012	Sessions, Alex/0000-0001-6120-2763; Fowle, David/0000-0001-7765-9047; Kim, Sang-Tae/0000-0002-5639-3750; Canfield, Don/0000-0001-7602-8366; Jones, CarriAyne/0000-0002-7196-5825; Zerkle, Aubrey/0000-0003-2324-1619; Paris, Guillaume/0000-0001-8368-1224	Agouron Institute Geobiology Fellowship; Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship; Danish National Research Foundation [DNRF53]; European Research Council	Agouron Institute Geobiology Fellowship; Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Danish National Research Foundation(Danmarks Grundforskningsfond); European Research Council(European Research Council (ERC)European Commission)	We thank A. Sturm and C. Henny for help with fieldwork. S. Poulton provided sediment delta<SUP>34</SUP>S data. A. Hefford helped compile Archean S-isotope data. Funding to S. A. C. was provided by an Agouron Institute Geobiology Fellowship and a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship. Additional funding was provided by the Danish National Research Foundation (grant no. DNRF53) and the European Research Council. All data are available in the supplementary materials.	Berner RA, 1998, SCIENCE, V282, P1426, DOI 10.1126/science.282.5393.1426; CAMERON EM, 1987, CHEM GEOL, V65, P341, DOI 10.1016/0168-9622(87)90013-3; Canfield DE, 2001, GEOCHIM COSMOCHIM AC, V65, P1117, DOI 10.1016/S0016-7037(00)00584-6; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Canfield DE, 2010, GEOLOGY, V38, P415, DOI 10.1130/G30723.1; Canfield DE, 2009, P NATL ACAD SCI USA, V106, P8123, DOI 10.1073/pnas.0902037106; Chen CTA, 1996, MAR CHEM, V54, P179, DOI 10.1016/0304-4203(96)00021-7; Crowe SA, 2014, GEOBIOLOGY, V12, P322, DOI 10.1111/gbi.12089; Crowe SA, 2008, P NATL ACAD SCI USA, V105, P15938, DOI 10.1073/pnas.0805313105; Farquhar J, 2013, P NATL ACAD SCI USA, V110, P17638, DOI 10.1073/pnas.1218851110; Fischer WW, 2014, P NATL ACAD SCI USA, V111, P5468, DOI 10.1073/pnas.1322577111; GOLDHABER MB, 1980, MAR CHEM, V9, P95, DOI 10.1016/0304-4203(80)90063-8; Gomes ML, 2013, GEOLOGY, V41, P663, DOI 10.1130/G34187.1; Guo QJ, 2009, GEOLOGY, V37, P399, DOI 10.1130/G25423A.1; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Halevy I, 2013, P NATL ACAD SCI USA, V110, P17644, DOI 10.1073/pnas.1213148110; Halevy I, 2010, SCIENCE, V329, P204, DOI 10.1126/science.1190298; Jamieson JW, 2013, NAT GEOSCI, V6, P61, DOI [10.1038/ngeo1647, 10.1038/NGEO1647]; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1979, GEOCHIM COSMOCHIM AC, V43, P363, DOI 10.1016/0016-7037(79)90201-1; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; LAMBERT IB, 1978, NATURE, V276, P808, DOI 10.1038/276808a0; Leavitt WD, 2013, P NATL ACAD SCI USA, V110, P11244, DOI 10.1073/pnas.1218874110; Nakagawa M, 2012, LIMNOL OCEANOGR, V57, P974, DOI 10.4319/lo.2012.57.4.0974; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Paris G, 2013, CHEM GEOL, V345, P50, DOI 10.1016/j.chemgeo.2013.02.022; Petsch ST, 1998, AM J SCI, V298, P246, DOI 10.2475/ajs.298.3.246; Poulton SW, 2011, ELEMENTS, V7, P107, DOI 10.2113/gselements.7.2.107; Roerdink DL, 2012, EARTH PLANET SC LETT, V331, P177, DOI 10.1016/j.epsl.2012.03.020; Sim MS, 2011, GEOCHIM COSMOCHIM AC, V75, P4244, DOI 10.1016/j.gca.2011.05.021; Stueken EE, 2012, NAT GEOSCI, V5, P722, DOI [10.1038/NGEO1585, 10.1038/ngeo1585]	31	189	190	1	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					735	739		10.1126/science.1258966	http://dx.doi.org/10.1126/science.1258966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378621				2022-12-28	WOS:000344690100037
J	Samanta, A; Tuckerman, ME; Yu, TQ; E, WN				Samanta, Amit; Tuckerman, Mark E.; Yu, Tang-Qing; E, Weinan			Microscopic mechanisms of equilibrium melting of a solid	SCIENCE			English	Article							CRYSTAL INSTABILITY; COLLOIDAL CRYSTALS; STABILITY LIMIT; GERM-FORMATION; STRING METHOD; NUCLEATION; ENERGY; TEMPERATURE; LINDEMANN; METALS	The melting of a solid, like other first-order phase transitions, exhibits an intrinsic time-scale disparity: The time spent by the system in metastable states is orders of magnitude longer than the transition times between the states. Using rare-event sampling techniques, we find that melting of representative solids-here, copper and aluminum-occurs via multiple, competing pathways involving the formation and migration of point defects or dislocations. Each path is characterized by multiple barrier-crossing events arising from multiple metastable states within the solid basin. At temperatures approaching superheating, melting becomes a single barrier-crossing process, and at the limit of superheating, the melting mechanism is driven by a vibrational instability. Our findings reveal the importance of nonlocal behavior, suggesting a revision of the perspective of classical nucleation theory.	[Samanta, Amit] Lawrence Livermore Natl Lab, Condensed Matter & Mat Div, Livermore, CA 94550 USA; [Samanta, Amit; E, Weinan] Princeton Univ, Program Appl & Computat Math, Princeton, NJ 08544 USA; [Tuckerman, Mark E.] NYU, Dept Chem, New York, NY 10003 USA; [Tuckerman, Mark E.; Yu, Tang-Qing] NYU, Courant Inst Math Sci, New York, NY 10012 USA; [Tuckerman, Mark E.] NYU East China Normal Univ Ctr Computat Chem, NYU Shanghai, Shanghai 200062, Peoples R China; [E, Weinan] Peking Univ, Beijing Int Ctr Math Res, Beijing 100871, Peoples R China; [E, Weinan] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [E, Weinan] Princeton Univ, Dept Math, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Princeton University; New York University; New York University; NYU Shanghai; Peking University; Peking University; Princeton University	Samanta, A (corresponding author), Lawrence Livermore Natl Lab, Condensed Matter & Mat Div, Livermore, CA 94550 USA.	asamanta@math.princeton.edu; mark.tuckerman@nyu.edu; weinan@math.princeton.edu	Yu, Tang-Qing/C-5437-2011	E, Weinan/0000-0003-0272-9500	U.S. Department of Energy (DOE) [DE-SC0009248]; National Natural Science Foundation of China [9130005]; DOE by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NSF [CHE-1301314]; Division Of Chemistry [1301314] Funding Source: National Science Foundation	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); DOE by Lawrence Livermore National Laboratory; NSF(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Work by W. E and A. S. at Princeton was supported by the U.S. Department of Energy (DOE) (grant DE-SC0009248) and in Beijing by the National Natural Science Foundation of China (9130005). This work was partially performed under the auspices of DOE by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. Work by M. E. T. was supported by NSF grant CHE-1301314.	Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; Bai XM, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.134109; Becker R, 1935, ANN PHYS-BERLIN, V24, P719; Born M, 1939, J CHEM PHYS, V7, P591, DOI 10.1063/1.1750497; CAHN JW, 1957, ACTA METALL MATER, V5, P169, DOI 10.1016/0001-6160(57)90021-4; CAHN RW, 1988, NATURE, V334, P17, DOI 10.1038/334017a0; COTTERILL RMJ, 1980, NATURE, V288, P467, DOI 10.1038/288467a0; COUCHMAN PR, 1976, PHILOS MAG, V34, P327, DOI 10.1080/14786437608221946; FECHT HJ, 1988, NATURE, V334, P50, DOI 10.1038/334050a0; Forsblom M, 2005, NAT MATER, V4, P388, DOI 10.1038/nmat1375; FUKUSHIMA E, 1955, J PHYS SOC JPN, V10, P970, DOI 10.1143/JPSJ.10.970; GILVARRY JJ, 1956, PHYS REV, V102, P308, DOI 10.1103/PhysRev.102.308; Gomez L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLEtt.90.095701; GORECKI T, 1974, Z METALLKD, V65, P426; Jin ZH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.055703; KUHLMANN D, 1965, PHYS REV, V140, P1599, DOI 10.1103/PhysRev.140.A1599; Lindemann FA, 1910, PHYS Z, V11, P609; LYNDENBELL RM, 1993, MOL PHYS, V80, P801, DOI 10.1080/00268979300102661; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Mott NF, 1940, NATURE, V145, P801, DOI 10.1038/145801a0; Rosner H, 2007, PHIL MAG LETT, V87, P341, DOI 10.1080/09500830601182906; Sear RP, 2012, INT MATER REV, V57, P328, DOI 10.1179/1743280411Y.0000000015; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; TALLON JL, 1982, NATURE, V299, P188, DOI 10.1038/299188a0; Volmer M, 1926, Z PHYS CHEM-STOCH VE, V119, P277; Wang ZR, 2012, SCIENCE, V338, P87, DOI 10.1126/science.1224763; Weinan E, 2005, J PHYS CHEM B, V109, P6688, DOI 10.1021/jp0455430; Yu TQ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.015701	29	86	88	8	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					729	732		10.1126/science.1253810	http://dx.doi.org/10.1126/science.1253810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378619	Green Submitted			2022-12-28	WOS:000344690100035
J	Stoopler, ET; Sollecito, TP				Stoopler, Eric T.; Sollecito, Thomas P.			Recurrent Gingival and Oral Mucosal Lesions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LICHEN-PLANUS		[Stoopler, Eric T.; Sollecito, Thomas P.] Univ Penn, Sch Dent Med, Dept Oral Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Stoopler, ET (corresponding author), Univ Penn, Sch Dent Med, 240 S 40th St, Philadelphia, PA 19104 USA.	ets@dental.upenn.edu						Al-Hashimi I, 2007, ORAL SURG ORAL MED O, V103, pS25, DOI 10.1016/j.tripleo.2006.11.001; Au J, 2013, ORAL MAXIL SURG CLIN, V25, P93, DOI 10.1016/j.coms.2012.11.007; Crincoli V, 2011, IMMUNOPHARM IMMUNOT, V33, P11, DOI 10.3109/08923973.2010.498014; DeRossi Scott S, 2005, Dent Clin North Am, V49, P77, DOI 10.1016/j.cden.2004.08.004; Fitzpatrick SG, 2014, J AM DENT ASSOC, V145, P45, DOI 10.14219/jada.2013.10; Le Cleach L, 2012, NEW ENGL J MED, V366, P723, DOI 10.1056/NEJMcp1103641; Lodi G, 2004, BRIT J DERMATOL, V151, P1172, DOI 10.1111/j.1365-2133.2004.06257.x; Lodi G, 2012, BRIT J DERMATOL, V166, P938, DOI 10.1111/j.1365-2133.2012.10821.x; Parashar P, 2011, OTOLARYNG CLIN N AM, V44, P89, DOI 10.1016/j.otc.2010.09.004; Thongprasom K, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001168, 10.1002/14651858.CD001168.pub2]	10	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1794	1795		10.1001/jama.2014.4298	http://dx.doi.org/10.1001/jama.2014.4298			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25369491				2022-12-28	WOS:000344194500018
J	Lonnroth, K; Migliori, GB; Raviglione, M				Loennroth, Knut; Migliori, Giovanni Battista; Raviglione, Mario			Toward Tuberculosis Elimination in Low-Incidence Countries: Reflections From a Global Consultation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									WHO, Global TB Programme, CH-1211 Geneva, Switzerland	World Health Organization	Lonnroth, K (corresponding author), WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland.		Lönnroth, Knut/L-2339-2014; Lonnroth, Knut/H-5470-2017; Migliori, Giovanni Battista/AAB-8589-2020	Lönnroth, Knut/0000-0001-5054-8240; Lonnroth, Knut/0000-0001-6944-0256; Migliori, Giovanni Battista/0000-0002-2597-574X; RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; European Centre for Disease Prevention and Control, 2008, FRAM ACT PLAN FIGHT; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; World Health Organization, 2014, TUB EL LOW COUNTR FR; World Health Organization, 2014, A6711 WHO; World Health Organization (WHO), 2015, GLOBAL TUBERCULOSIS	10	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					670	U91		10.7326/M14-1888	http://dx.doi.org/10.7326/M14-1888			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364889				2022-12-28	WOS:000347244100009
J	Osinusi, A; Kohli, A; Marti, MM; Nelson, A; Zhang, XZ; Meissner, EG; Silk, R; Townsend, K; Pang, PS; Subramanian, GM; McHutchison, JG; Fauci, AS; Masur, H; Kottilil, S				Osinusi, Anu; Kohli, Anita; Marti, Miriam M.; Nelson, Amy; Zhang, Xiaozhen; Meissner, Eric G.; Silk, Rachel; Townsend, Kerry; Pang, Phillip S.; Subramanian, G. Mani; McHutchison, John G.; Fauci, Anthony S.; Masur, Henry; Kottilil, Shyam			Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse An Open-Label Pilot Study	ANNALS OF INTERNAL MEDICINE			English	Article							SOFOSBUVIR PLUS RIBAVIRIN; TREATMENT-NAIVE; IN-VITRO; NS5A INHIBITOR; UNITED-STATES; HCV; RESISTANCE; LEDIPASVIR; POLYMERASE; SYSTEM	Background: The interferon (IFN)-free regimen of sofosbuvir and ribavirin for 24 weeks was recently approved to treat chronic hepatitis C virus (HCV) genotype 1 (GT-1) infection for patients ineligible for IFN. However, sofosbuvir plus ribavirin therapy is associated with relapse in 15% to 30% of patients with HCV GT-1. Neither the mechanism of relapse nor the optimal re-treatment strategy for these patients is defined. Objective: To assess the safety and efficacy of sofosbuvir plus ledipasvir in patients with chronic HCV GT-1 that relapsed after sofosbuvir plus ribavirin therapy. Design: Phase 2a, open-label study. (ClinicalTrials.gov: NCT01805882) Setting: Single U.S site. Patients: 14 patients with HCV GT-1 that relapsed after treatment with sofosbuvir plus ribavirin for 24 weeks were re-treated with sofosbuvir plus ledipasvir for 12 weeks. Measurements: HCV RNA concentration and population sequencing to detect NS5B S282T mutations. Results: All 14 patients treated with sofosbuvir plus ledipasvir for 12 weeks achieved a sustained virologic response, including 7 with advanced liver disease (Knodell Histology Activity Index score of 3 or 4) and 1 with a detectable NS5B S282T mutation after sofosbuvir plus ribavirin therapy. Sofosbuvir plus ledipasvir was well-tolerated with few adverse events. Four grade 3 events (elevated serum creatinine in a patient with baseline renal insufficiency, hypercholesterolemia, and hypophosphatemia) occurred. There were no grade 4 events or treatment discontinuations. Limitation: Small sample size. Conclusion: The fixed-dose combination of sofosbuvir plus ledipasvir was efficacious in a small cohort of patients with HCV GT-1 that relapsed after sofosbuvir plus ribavirin therapy, even in the setting of advanced liver disease. Larger studies are needed to confirm these preliminary efficacy results.	Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; NIAID, Immunoregulat Lab, NIH, Ctr Clin, Bethesda, MD 20892 USA; Leidos Biomed Res, Frederick, MD USA; Frederick Natl Lab Canc Res, Frederick, MD USA; [Osinusi, Anu; Pang, Phillip S.; Subramanian, G. Mani; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gilead Sciences	Kottilil, S (corresponding author), NIH, 10-11N204,9000 Rockville Pike, Bethesda, MD 20892 USA.	skottilil@niaid.nih.gov	Kottilil, Shyam/ABF-7605-2021	Nelson, Amy/0000-0001-9028-1894	National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; Gilead Sciences	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gilead Sciences(Gilead Sciences)	National Institute of Allergy and Infectious Diseases, National Institutes of Health, National Cancer Institute, and Gilead Sciences.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Charlton MR, 2013, HEPATOLOGY, V58, p1378A; Cheng G, 2012, P 47 ANN M EUR ASS S; Curry MP, 2013, HEPATOLOGY, V58, p314A; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Lam AM, 2011, ANTIMICROB AGENTS CH, V55, P2566, DOI 10.1128/AAC.00032-11; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Le Pogam S, 2006, VIROLOGY, V351, P349, DOI 10.1016/j.virol.2006.03.045; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Paolucci S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-355; Pawlotsky JM, 2012, ANTIVIR THER, V17, P411, DOI 10.3851/IMP2088; Sulkowski MS, 2013, HEPATOLOGY, V58, p313A	23	55	55	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					634	U126		10.7326/M14-1211	http://dx.doi.org/10.7326/M14-1211			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364884	Green Accepted			2022-12-28	WOS:000347244100004
J	Harris, M				Harris, Matthew			Research papers should omit their authors' affiliations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COUNTRIES; JOURNALS; GAP		NYU, New York, NY 10021 USA	New York University	Harris, M (corresponding author), NYU, New York, NY 10021 USA.	mjh599@nyu.edu		Harris, Matthew/0000-0002-0005-9710	National Institute for Health Research [CL-2010-21-014] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Crisp Nigel., 2010, TURNING WORLD UPSIDE; Dadwal V, 2013, J PUBLIC SECTOR MANA, V43, P4; Dopson S, 2008, J CHANG MANAG, V8, P213, DOI 10.1080/14697010802133577; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; Kahneman D., 2011, THINKING FAST SLOW; Link AM, 1998, JAMA-J AM MED ASSOC, V280, P246, DOI 10.1001/jama.280.3.246; Mendis S, 2003, LANCET, V361, P2246, DOI 10.1016/S0140-6736(03)13753-1; Norwegian Branch of the Nordic Cochrane Centre, DECIDE FRAM POL MAK; Opthof T, 2002, CARDIOVASC RES, V56, P339, DOI 10.1016/S0008-6363(02)00712-5; Patel V, 2001, BRIT J PSYCHIAT, V178, P406, DOI 10.1192/bjp.178.5.406; PETERS DP, 1982, BEHAV BRAIN SCI, V5, P187, DOI 10.1017/S0140525X00011183; Smits H, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0065-9; YACH D, 1992, INT J EPIDEMIOL, V21, P557, DOI 10.1093/ije/21.3.557	14	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2014	349								g6439	10.1136/bmj.g6439	http://dx.doi.org/10.1136/bmj.g6439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CB	25368392				2022-12-28	WOS:000344603500005
J	Chaisson, MJP; Huddleston, J; Dennis, MY; Sudmant, PH; Malig, M; Hormozdiari, F; Antonacci, F; Surti, U; Sandstrom, R; Boitano, M; Landolin, JM; Stamatoyannopoulos, JA; Hunkapiller, MW; Korlach, J; Eichler, EE				Chaisson, Mark J. P.; Huddleston, John; Dennis, Megan Y.; Sudmant, Peter H.; Malig, Maika; Hormozdiari, Fereydoun; Antonacci, Francesca; Surti, Urvashi; Sandstrom, Richard; Boitano, Matthew; Landolin, Jane M.; Stamatoyannopoulos, John A.; Hunkapiller, Michael W.; Korlach, Jonas; Eichler, Evan E.			Resolving the complexity of the human genome using single-molecule sequencing	NATURE			English	Article							ALIGNMENT; PROGRAM; GAPS; MAP	The human genome is arguably the most complete mammalian reference assembly(1-3), yetmore than 160 euchromatic gaps remain(4-6) and aspects of its structural variation remain poorly understood ten years after its completion(7-9). To identify missing sequence and genetic variation, here we sequence and analyse ahaploid human genome (CHM1) using single-molecule, real-time DNA sequencing(10). We close or extend 55% of the remaining interstitial gaps in the human GRCh37 reference genome-78% of which carried long runs of degenerate short tandem repeats, often several kilobases in length, embedded within (G+C)-rich genomic regions. We resolve the complete sequence of 26,079 euchromatic structural variants at the base-pair level, including inversions, complex insertions and long tracts of tandem repeats. Most have not been previously reported, with the greatest increases in sensitivity occurring for events less than 5 kilobases in size. Compared to the human reference, we find a significant insertional bias (3: 1) in regions corresponding to complex insertions and long short tandem repeats. Our results suggest a greater complexity of the human genome in the form of variation of longer and more complex repetitive DNA that can now be largely resolved with the application of this longer-read sequencing technology.	[Chaisson, Mark J. P.; Huddleston, John; Dennis, Megan Y.; Sudmant, Peter H.; Malig, Maika; Hormozdiari, Fereydoun; Sandstrom, Richard; Stamatoyannopoulos, John A.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Huddleston, John; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Antonacci, Francesca] Univ Bari Aldo Moro, Dipartimento Biol, I-70125 Bari, Italy; [Surti, Urvashi] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Boitano, Matthew; Landolin, Jane M.; Hunkapiller, Michael W.; Korlach, Jonas] Pacific Biosci Calif Inc, Menlo Pk, CA 94025 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Universita degli Studi di Bari Aldo Moro; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Antonacci, Francesca/F-5457-2013	Antonacci, Francesca/0000-0002-5833-6186; Sandstrom, Richard/0000-0002-3356-1547; Hormozdiari, Fereydoun/0000-0003-2703-9274; Sudmant, Peter/0000-0002-9573-8248	US National Institutes of Health (NIH) [HG002385, HG007497]; US National Institute of Neurological Disorders and Stroke [K99NS083627]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007635, R01HG002385, U41HG007497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS083627] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Alexander, D. Church and A. Klammer for discussions, K. Mohajeri and L. Harsh man for technical assistance and T. Brown for assistance in manuscript preparation. This work was supported, in part, by US National Institutes of Health (NIH) grant HG002385 and HG007497 to E.E.E. M.Y.D. is supported by the US National Institute of Neurological Disorders and Stroke (award K99NS083627). E.E.E. is an investigator of the Howard Hughes Medical Institute.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Genovese G, 2013, NAT GENET, V45, P406, DOI 10.1038/ng.2565; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kimelman A, 2012, GENOME RES, V22, P802, DOI 10.1101/gr.133850.111; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kurahashi H, 2007, GENOME RES, V17, P461, DOI 10.1101/gr.5769507; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee H, 2012, BIOINFORMATICS, V28, P2097, DOI 10.1093/bioinformatics/bts330; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Smit A, 1996, REPEATMASKER OPEN 30; Steinberg KM, GENOME RES IN PRESS; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	27	448	466	6	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					608	U163		10.1038/nature13907	http://dx.doi.org/10.1038/nature13907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25383537	Green Submitted, Green Accepted			2022-12-28	WOS:000348775000042
J	Robert, C; Karaszewska, B; Schachter, J; Rutkowski, P; Mackiewicz, A; Stroiakovski, D; Lichinitser, M; Dummer, R; Grange, F; Mortier, L; Chiarion-Sileni, V; Drucis, K; Krajsova, I; Hauschild, A; Lorigan, P; Wolter, P; Long, GV; Flaherty, K; Nathan, P; Ribas, A; Martin, AM; Sun, P; Crist, W; Legos, J; Rubin, SD; Little, SM; Schadendorf, D				Robert, Caroline; Karaszewska, Boguslawa; Schachter, Jacob; Rutkowski, Piotr; Mackiewicz, Andrzej; Stroiakovski, Daniil; Lichinitser, Michael; Dummer, Reinhard; Grange, Florent; Mortier, Laurent; Chiarion-Sileni, Vanna; Drucis, Kamil; Krajsova, Ivana; Hauschild, Axel; Lorigan, Paul; Wolter, Pascal; Long, Georgina V.; Flaherty, Keith; Nathan, Paul; Ribas, Antoni; Martin, Anne-Marie; Sun, Peng; Crist, Wendy; Legos, Jeff; Rubin, Stephen D.; Little, Shonda M.; Schadendorf, Dirk			Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRAF-MUTATED MELANOMA; METASTATIC MELANOMA; ACQUIRED-RESISTANCE; MEK INHIBITION; RAF INHIBITION; V600E MUTATION; VEMURAFENIB; OVERCOME; CRITERIA; TUMORS	BACKGROUND The BRAF inhibitors vemurafenib and dabrafenib have shown efficacy as mono-therapies in patients with previously untreated metastatic melanoma with BRAF V600E or V600K mutations. Combining dabrafenib and the MEK inhibitor trametinib, as compared with dabrafenib alone, enhanced antitumor activity in this population of patients. METHODS In this open-label, phase 3 trial, we randomly assigned 704 patients with metastatic melanoma with a BRAF V600 mutation to receive either a combination of dabrafenib (150 mg twice daily) and trametinib (2 mg once daily) or vemurafenib (960 mg twice daily) orally as first-line therapy. The primary end point was overall survival. RESULTS At the preplanned interim overall survival analysis, which was performed after 77% of the total number of expected events occurred, the overall survival rate at 12 months was 72% (95% confidence interval [CI], 67 to 77) in the combination-therapy group and 65% (95% CI, 59 to 70) in the vemurafenib group (hazard ratio for death in the combination-therapy group, 0.69; 95% CI, 0.53 to 0.89; P = 0.005). The prespecified interim stopping boundary was crossed, and the study was stopped for efficacy in July 2014. Median progression-free survival was 11.4 months in the combination-therapy group and 7.3 months in the vemurafenib group (hazard ratio, 0.56; 95% CI, 0.46 to 0.69; P< 0.001). The objective response rate was 64% in the combination-therapy group and 51% in the vemurafenib group (P< 0.001). Rates of severe adverse events and study-drug discontinuations were similar in the two groups. Cutaneous squamous-cell carcinoma and keratoacanthoma occurred in 1% of patients in the combination-therapy group and 18% of those in the vemurafenib group. CONCLUSIONS Dabrafenib plus trametinib, as compared with vemurafenib monotherapy, significantly improved overall survival in previously untreated patients with metastatic melanoma with BRAF V600E or V600K mutations, without increased overall toxicity. (Funded by GlaxoSmithKline; ClinicalTrials.gov number, NCT01597908.)	[Robert, Caroline] Gustave Roussy, Villejuif, France; [Robert, Caroline] INSERM, U981, Villejuif, France; [Grange, Florent] CHU Reims, Hop Robert Debre, Reims, France; [Mortier, Laurent] CHU Lille, Hop Claude Huriez, F-59037 Lille, France; [Karaszewska, Boguslawa] Przychodnia Lekarska Komed, Konin, Poland; [Rutkowski, Piotr] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Rutkowski, Piotr] Inst Oncol, Warsaw, Poland; [Mackiewicz, Andrzej] Poznan Univ Med Sci, Med Polonia, Poznan, Poland; [Drucis, Kamil] Swissmed Ctr Zdrowia, Gdansk, Poland; [Drucis, Kamil] Med Univ Gdansk, Gdansk, Poland; [Schachter, Jacob] Chaim Sheba Med Ctr, Ramat, Israel; [Stroiakovski, Daniil] Moscow City Oncol Hosp 62, Moscow, Russia; [Lichinitser, Michael] Russian Acad Med Sci, Canc Res Ctr, Moscow, Russia; [Dummer, Reinhard] Univ Zurich, Zurich, Switzerland; [Chiarion-Sileni, Vanna] Ist Ricovero & Cura Carattere Sci, Ist Oncol Veneto, Padua, Italy; [Krajsova, Ivana] Gen Univ Hosp, Dermatooncol Dept, Prague, Czech Republic; [Hauschild, Axel] Univ Klinikum Schleswig Holstein, Kiel, Germany; [Stroiakovski, Daniil] Univ Hosp Essen, Essen, Germany; [Lorigan, Paul] Christie NHS Fdn Trust, Manchester, Lancs, England; [Nathan, Paul] Mt Vernon Canc Ctr, Northwood, Middx, England; [Wolter, Pascal] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium; [Long, Georgina V.] Univ Sydney, Melanoma Inst Australia, Mater Hosp, Sydney, NSW 2006, Australia; [Flaherty, Keith] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Martin, Anne-Marie; Sun, Peng; Crist, Wendy; Legos, Jeff; Rubin, Stephen D.; Little, Shonda M.] GlaxoSmithKline Oncol Res & Dev, Collegeville, PA USA	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU de Reims; Universite de Lille - ISITE; CHU Lille; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Poznan University of Medical Sciences; Fahrenheit Universities; Medical University Gdansk; Chaim Sheba Medical Center; Russian Academy of Medical Sciences; University of Zurich; IRCCS Istituto Oncologico Veneto (IOV); General University Hospital Prague; University of Kiel; Schleswig Holstein University Hospital; University of Duisburg Essen; Christie NHS Foundation Trust; Mount Vernon Cancer Centre; KU Leuven; University Hospital Leuven; Melanoma Institute Australia; University of Sydney; Harvard University; Massachusetts General Hospital; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; GlaxoSmithKline	Robert, C (corresponding author), Gustave Roussy, Serv Dermatol, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	caroline.robert@gustaveroussy.fr	Lorigan, Paul/J-6898-2015; Schadendorf, Dirk/AAE-8206-2019; sileni, vanna chiarion/B-9042-2018; Robert, Caroline/G-6157-2018; Krajsova, Ivana/I-4505-2017; Long, Georgina V/C-1771-2013; Rutkowski, Piotr/B-3907-2013	Lorigan, Paul/0000-0002-8875-2164; sileni, vanna chiarion/0000-0001-9191-9124; Robert, Caroline/0000-0002-9493-0238; Krajsova, Ivana/0000-0002-1599-6424; Long, Georgina V/0000-0001-8894-3545; Rutkowski, Piotr/0000-0002-8920-5429; Nathan, Paul/0000-0002-2327-3250; Stroyakovskiy, Daniil/0000-0003-1973-1092; Drucis, Kamil/0000-0002-7251-3505	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Supported by GlaxoSmithKline.	Boussemart L, 2013, ANN ONCOL, V24, P1691, DOI 10.1093/annonc/mdt015; Carnahan J, 2010, MOL CANCER THER, V9, P2399, DOI 10.1158/1535-7163.MCT-10-0181; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Greger JG, 2012, MOL CANCER THER, V11, P909, DOI 10.1158/1535-7163.MCT-11-0989; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; LONG GV, 2014, J CLIN ONCOL S, V32; Menzies AM, 2014, CLIN CANCER RES, V20, P2035, DOI 10.1158/1078-0432.CCR-13-2054; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Robert C, 2011, CURR OPIN ONCOL, V23, P177, DOI 10.1097/CCO.0b013e3283436e8c; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023	27	1709	1748	8	141	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					30	39		10.1056/NEJMoa1412690	http://dx.doi.org/10.1056/NEJMoa1412690			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25399551	Green Accepted			2022-12-28	WOS:000347100800007
J	Gonsalves, G; Staley, P				Gonsalves, Gregg; Staley, Peter			Panic, Paranoia, and Public Health - The AIDS Epidemic's Lessons for Ebola	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gonsalves, Gregg] Yale Univ, Sch Law, Yale Global Hlth Justice Partnership, New Haven, CT 06520 USA; [Gonsalves, Gregg] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Yale University; Yale University	Gonsalves, G (corresponding author), Yale Univ, Sch Law, Yale Global Hlth Justice Partnership, New Haven, CT 06520 USA.			Gonsalves, Gregg/0000-0002-5789-9841				Berrill K.T., 1990, J INTERPERS VIOLENCE, V5, P274; BRANDT AM, 1988, SCIENCE, V239, P375, DOI 10.1126/science.3276007; Center for HIV Law and Policy, 2010, POS JUST PROJ; Dorf MC, 2014, CONTAINING EBOLE QUA, DOI 10.1056/NEJMp1413425; GOSTIN L O, 1989, Journal of the American Medical Association, V261, P1621, DOI 10.1001/jama.261.11.1621; GOSTIN LO, 1990, JAMA-J AM MED ASSOC, V263, P950	6	54	55	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2348	2349		10.1056/NEJMp1413425	http://dx.doi.org/10.1056/NEJMp1413425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW7DX	25372947				2022-12-28	WOS:000346425800002
J	Chen, X; Grandont, L; Li, HJ; Hauschild, R; Paque, S; Abuzeineh, A; Ralcusova, H; Benkova, E; Perrot-Rechenmann, C; Friml, J				Chen, Xu; Grandont, Laurie; Li, Hongjiang; Hauschild, Robert; Paque, Sebastien; Abuzeineh, Anas; Ralcusova, Hana; Benkova, Eva; Perrot-Rechenmann, Catherine; Friml, Jiri			Inhibition of cell expansion by rapid ABP1-mediated auxin effect on microtubules	NATURE			English	Article							BINDING PROTEIN-1; EPIDERMAL-CELLS; ROOT-GROWTH; ARABIDOPSIS; ENDOCYTOSIS; GRAVITROPISM; PERCEPTION; NUCLEATION; REVEALS; ARRAYS	The prominent and evolutionarily ancient role of the plant hormone auxin is the regulation of cell expansion(1). Cell expansion requires ordered arrangement of the cytoskeleton(2) but molecular mechanisms underlying its regulation by signalling molecules including auxin are unknown. Here we show in the model plant Arabidopsis thaliana that in elongating cells exogenous application of auxin or redistribution of endogenous auxin induces very rapid microtubule re-orientation from transverse to longitudinal, coherent with the inhibition of cell expansion. This fast auxin effect requires auxin binding protein 1 (ABP1) and involves a contribution of downstream signalling components such as ROP6 GTPase, ROP-interactive protein RIC1 and the microtubule-severing protein katanin. These components are required for rapid auxin- and ABP I -mediated re-orientation of microtubules to regulate cell elongation in roots and dark-grown hypocotyls as well as asymmetric growth during gravitropic responses.	[Chen, Xu; Li, Hongjiang; Hauschild, Robert; Ralcusova, Hana; Benkova, Eva; Friml, Jiri] Inst Sci Technol Austria 1ST Austria, A-3400 Klosterneuburg, Austria; [Chen, Xu; Li, Hongjiang; Abuzeineh, Anas; Ralcusova, Hana; Benkova, Eva; Friml, Jiri] Univ Ghent, Vlaams Inst Biotechnol VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Chen, Xu; Li, Hongjiang; Abuzeineh, Anas; Ralcusova, Hana; Benkova, Eva; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Grandont, Laurie; Paque, Sebastien; Perrot-Rechenmann, Catherine] CNRS, Saclay Plant Sci LabEx, Inst Sci Vegetal, UPR2355, F-91198 Gif Sur Yvette, France	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Perrot-Rechenmann, C (corresponding author), CNRS, Saclay Plant Sci LabEx, Inst Sci Vegetal, UPR2355, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	Catherine.Rechenmann@isv.cnrs-gif.fr; jiri.friml@ist.ac.at	Friml, Jiri/D-9511-2012	Friml, Jiri/0000-0002-8302-7596; Chen, Xu/0000-0002-5166-083X; Li, Hongjiang/0000-0001-5039-9660	European Research Council [ERC-2011-StG-20101109-PSDP]; ANR blanc AuxiWall project [ANR-11-BSV5-0007]; Agency for Innovation by Science and Technology (IWT); Conseil General de l'Essonne	European Research Council(European Research Council (ERC)European Commission); ANR blanc AuxiWall project(French National Research Agency (ANR)); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Conseil General de l'Essonne	We thank R. Dixit for performing complementary experiments, D. W. Ehrhardt and T. Hashimoto for providing the seeds of TUB6 RFP and EB1b-GFP respectively, E. Zazimalova, J. Petrasek and M. Fendrych for discussing the manuscript and J. Leung for text optimization. This work was supported by the European Research Council (project ERC-2011-StG-20101109-PSDP, to J.F.), ANR blanc AuxiWall project (ANR-11-BSV5-0007, to C.P.-R. and L.G.) and the Agency for Innovation by Science and Technology (IWT) (to H.R.). This work benefited from the facilities and expertise of the Imagif Cell Biology platform (http://www.imagif.cnrs.fr), which is supported by the Conseil General de l'Essonne.	Blancaflor EB, 2002, J PLANT GROWTH REGUL, V21, P120, DOI 10.1007/s003440010041; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Chan J, 2003, NAT CELL BIOL, V5, P967, DOI 10.1038/ncb1057; Chan J, 2007, NAT CELL BIOL, V9, P171, DOI 10.1038/ncb1533; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Chen X, 2012, CURR BIOL, V22, P1326, DOI 10.1016/j.cub.2012.05.020; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; Lucas J, 2008, CURR OPIN PLANT BIOL, V11, P94, DOI 10.1016/j.pbi.2007.12.001; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; Montagnac G, 2013, NATURE, V502, P567, DOI 10.1038/nature12571; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Sedbrook JC, 2008, TRENDS PLANT SCI, V13, P303, DOI 10.1016/j.tplants.2008.04.002; Shishova M, 2010, J PLANT PHYSIOL, V167, P417, DOI 10.1016/j.jplph.2009.12.014; Simon S, 2013, NEW PHYTOL, V200, P1034, DOI 10.1111/nph.12437; Tromas A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3496; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Ubeda-Tomas S, 2012, TRENDS PLANT SCI, V17, P326, DOI 10.1016/j.tplants.2012.02.002; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003	30	94	100	2	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					90	U206		10.1038/nature13889	http://dx.doi.org/10.1038/nature13889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25409144	Green Accepted			2022-12-28	WOS:000346310800045
J	Mauri, L; Kereiakes, DJ; Yeh, RW; Driscoll-Shempp, P; Cutlip, DE; Steg, PG; Normand, SLT; Braunwald, E; Wiviott, SD; Cohen, DJ; Holmes, DR; Krucoff, MW; Hermiller, J; Dauerman, HL; Simon, DI; Kandzari, DE; Garratt, KN; Lee, DP; Pow, TK; Lee, PV; Rinaldi, MJ; Massaro, JM				Mauri, Laura; Kereiakes, Dean J.; Yeh, Robert W.; Driscoll-Shempp, Priscilla; Cutlip, Donald E.; Steg, P. Gabriel; Normand, Sharon-Lise T.; Braunwald, Eugene; Wiviott, Stephen D.; Cohen, David J.; Holmes, David R., Jr.; Krucoff, Mitchell W.; Hermiller, James; Dauerman, Harold L.; Simon, Daniel I.; Kandzari, David E.; Garratt, Kirk N.; Lee, David P.; Pow, Thomas K.; Lee, Peter Ver; Rinaldi, Michael J.; Massaro, Joseph M.		DAPT Study Investigators	Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CLINICAL-OUTCOMES; CLOPIDOGREL; TRIALS; ASPIRIN; MULTICENTER; TICAGRELOR; PREVENTION; THROMBOSIS; RATIONALE	BACKGROUND Dual antiplatelet therapy is recommended after coronary stenting to prevent thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain. METHODS Patients were enrolled after they had undergone a coronary stent procedure in which a drug-eluting stent was placed. After 12 months of treatment with a thienopyridine drug (clopidogrel or prasugrel) and aspirin, patients were randomly assigned to continue receiving thienopyridine treatment or to receive placebo for another 18 months; all patients continued receiving aspirin. The coprimary efficacy end points were stent thrombosis and major adverse cardiovascular and cerebrovascular events (a composite of death, myocardial infarction, or stroke) during the period from 12 to 30 months. The primary safety end point was moderate or severe bleeding. RESULTS A total of 9961 patients were randomly assigned to continue thienopyridine treatment or to receive placebo. Continued treatment with thienopyridine, as compared with placebo, reduced the rates of stent thrombosis (0.4% vs. 1.4%; hazard ratio, 0.29 [95% confidence interval {CI}, 0.17 to 0.48]; P<0.001) and major adverse cardiovascular and cerebrovascular events (4.3% vs. 5.9%; hazard ratio, 0.71 [95% CI, 0.59 to 0.85]; P<0.001). The rate of myocardial infarction was lower with thienopyridine treatment than with placebo (2.1% vs. 4.1%; hazard ratio, 0.47; P<0.001). The rate of death from any cause was 2.0% in the group that continued thienopyridine therapy and 1.5% in the placebo group (hazard ratio, 1.36 [95% CI, 1.00 to 1.85]; P = 0.05). The rate of moderate or severe bleeding was increased with continued thienopyridine treatment (2.5% vs. 1.6%, P = 0.001). An elevated risk of stent thrombosis and myocardial infarction was observed in both groups during the 3 months after discontinuation of thienopyridine treatment. CONCLUSIONS Dual antiplatelet therapy beyond 1 year after placement of a drug-eluting stent, as compared with aspirin therapy alone, significantly reduced the risks of stent thrombosis and major adverse cardiovascular and cerebrovascular events but was associated with an increased risk of bleeding.	[Mauri, Laura; Yeh, Robert W.; Driscoll-Shempp, Priscilla; Cutlip, Donald E.; Massaro, Joseph M.] Harvard Clin Res Inst, Boston, MA USA; [Mauri, Laura; Braunwald, Eugene; Wiviott, Stephen D.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Mauri, Laura; Yeh, Robert W.; Cutlip, Donald E.; Normand, Sharon-Lise T.; Braunwald, Eugene; Wiviott, Stephen D.] Harvard Univ, Sch Med, Boston, MA USA; [Yeh, Robert W.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Cutlip, Donald E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Massaro, Joseph M.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Kereiakes, Dean J.] Christ Hosp, Heart & Vasc Ctr, Cincinnati, OH 45219 USA; [Kereiakes, Dean J.] Lindner Ctr Res & Educ, Cincinnati, OH USA; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ Fibrosis, INSERM,U1148, F-75877 Paris, France; [Steg, P. Gabriel] Univ Paris Diderot, Paris, France; [Steg, P. Gabriel] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, Inst Cardiovasc Med & Sci, London, England; [Cohen, David J.] Univ Missouri, Sch Med, St Lukes Mid Amer Heart Inst, Kansas City, MO 64108 USA; [Holmes, David R., Jr.] Mayo Clin, Rochester, MN USA; [Krucoff, Mitchell W.] Duke Univ, Med Ctr, Durham, NC USA; [Rinaldi, Michael J.] Carolinas HealthCare Syst, Sanger Heart & Vasc Inst, Charlotte, NC USA; [Hermiller, James] St Vincent Heart Ctr, Indianapolis, IN USA; [Dauerman, Harold L.] Univ Vermont, Burlington, VT USA; [Simon, Daniel I.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Kandzari, David E.] Piedmont Heart Inst, Atlanta, GA USA; [Garratt, Kirk N.] Lenox Hill Hosp, New York, NY 10021 USA; [Lee, David P.] Stanford Univ, Stanford, CA 94305 USA; [Pow, Thomas K.] Great Lakes Heart & Vasc Inst, St Joseph, MI USA; [Lee, Peter Ver] Eastern Maine Med Ctr, Bangor, ME USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Boston University; Christ Hospital - Ohio; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Mayo Clinic; Duke University; Carolinas HealthCare System; University of Vermont; Case Western Reserve University; Case Western Reserve University Hospital; Piedmont Heart Institute; Northwell Health; Stanford University; Eastern Maine Medical Center	Mauri, L (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	lmauri1@partners.org	mauri, laura/GPS-4868-2022; Wiviott, Stephen/HIK-2534-2022; Yeh, Robert/AAJ-3463-2020; STEG, Philippe Gabriel/Z-1567-2019	Normand, Sharon-Lise/0000-0001-7027-4769; STEG, Philippe Gabriel/0000-0001-6896-2941; TEIGER, emmanuel/0000-0001-7515-4344; Wijns, William/0000-0002-7267-4376; Mansouri, Vahid/0000-0001-8472-9058	Abbott; Boston Scientific; Cordis; Medtronic; Bristol-Myers Squibb-Sanofi Pharmaceuticals; Eli Lilly; Daiichi Sankyo; Department of Health and Human Services [1RO1FD003870-01]; FOOD AND DRUG ADMINISTRATION [R01FD003870] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL057506, R01HL057506] Funding Source: NIH RePORTER	Abbott(Abbott Laboratories); Boston Scientific(Boston Scientific); Cordis; Medtronic(Medtronic); Bristol-Myers Squibb-Sanofi Pharmaceuticals(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited); Department of Health and Human Services; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by Abbott, Boston Scientific, Cordis, and Medtronic, Bristol-Myers Squibb-Sanofi Pharmaceuticals Partnership, Eli Lilly, and Daiichi Sankyo, and by a grant (1RO1FD003870-01) from the Department of Health and Human Services.	Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonaca MP, 2014, AM HEART J, V167, P437, DOI 10.1016/j.ahj.2013.12.020; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Garg P, AM HEART J; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Ho PM, 2008, JAMA-J AM MED ASSOC, V299, P532, DOI 10.1001/jama.299.5.532; Ho PM, 2008, JAMA-J AM MED ASSOC, V299, P2390; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Levine GN, 2012, CIRCULATION, V125, P1058, DOI 10.1161/CIR.0b013e3182447787; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Little R. J. A., 1987, STAT ANAL MISSING DA; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Meredith IT, 2012, J AM COLL CARDIOL, V59, P1362, DOI 10.1016/j.jacc.2011.12.016; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Togni M, 2004, EUR HEART J, V25, P1208, DOI 10.1016/j.ehj.2004.04.024; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wijns W, 2014, EUR HEART J, V35, P2812, DOI 10.1093/eurheartj/ehu318; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P1716	35	1343	1392	1	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2155	2166		10.1056/NEJMoa1409312	http://dx.doi.org/10.1056/NEJMoa1409312			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25399658	Green Accepted, Green Published			2022-12-28	WOS:000345976700004
J	Tilman, D; Clark, M				Tilman, David; Clark, Michael			Global diets link environmental sustainability and human health	NATURE			English	Article							MEDITERRANEAN DIET; NUTRITION TRANSITION; MEAT CONSUMPTION; VEGETARIAN DIETS; ADVENTIST HEALTH; CANCER INCIDENCE; HEART-DISEASE; LAND-USE; MORTALITY; SURVIVAL	Diets link environmental and human health. Rising incomes and urbanization are driving a global dietary transition in which traditional diets are replaced by diets higher in refined sugars, refined fats, oils and meats. By 2050 these dietary trends, if unchecked, would be a major contributor to an estimated 80 per cent increase in global agricultural greenhouse gas emissions from food production and to global land clearing. Moreover, these dietary shifts are greatly increasing the incidence of type II diabetes, coronary heart disease and other chronic non-communicable diseases that lower global life expectancies. Alternative diets that offer substantial health benefits could, if widely adopted, reduce global agricultural greenhouse gas emissions, reduce land clearing and resultant species extinctions, and help prevent such diet-related chronic non-communicable diseases. The implementation of dietary solutions to the tightly linked diet-environment-health trilemma is a global challenge, and opportunity, of great environmental and public health importance.	[Tilman, David; Clark, Michael] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Tilman, David] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Tilman, David/ABD-5309-2021	Clark, Michael/0000-0001-7161-7751	LTER programme of the US National Science Foundation; University of Minnesota Foundation	LTER programme of the US National Science Foundation(National Science Foundation (NSF)); University of Minnesota Foundation(University of Minnesota System)	We thank M. Burgess, A. Clark and E. Hallstrom for their comments, K. Thompson for assistance with data collection, editing, and creating figures, and the LTER programme of the US National Science Foundation and the University of Minnesota Foundation for support.	Alexandratos N., 2012, ESA1203 FAO; Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S1368980011002515; Bartley D., 2014, STATE WORLD FISHERIE, P199; Brunner EJ, 2008, AM J CLIN NUTR, V87, P1414, DOI 10.1093/ajcn/87.5.1414; Buckland G, 2012, AM J CLIN NUTR, V96, P142, DOI 10.3945/ajcn.111.024216; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Couto E, 2011, BRIT J CANCER, V104, P1493, DOI 10.1038/bjc.2011.106; Daley CA, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-10; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Eisler MC, 2014, NATURE, V507, P32, DOI 10.1038/507032a; Eshel G, 2006, EARTH INTERACT, V10, DOI 10.1175/EI167.1; FAO, 2013, FISHSTAT; FAO, 2009, ETUDES TRAVAUX LASDE; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Groningen Growth and Development Centre, 2013, TOT EC DAT; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; Havlik P, 2014, P NATL ACAD SCI USA, V111, P3709, DOI 10.1073/pnas.1308044111; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Hoevenaar-Blom MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045458; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huang T, 2012, ANN NUTR METAB, V60, P233, DOI 10.1159/000337301; InterAct Project, 2011, DIABETES CARE, V34, P1913, DOI 10.2337/dc11-0891; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Key TJ, 2009, BRIT J CANCER, V101, P192, DOI 10.1038/sj.bjc.6605098; Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L; Key TJA, 1996, BMJ-BRIT MED J, V313, P775, DOI 10.1136/bmj.313.7060.775; Kuznets S, 1955, AM ECON REV, V45, P1; Lagiou P, 2006, BRIT J NUTR, V96, P384, DOI 10.1079/BJN20061824; Mann JI, 1997, HEART, V78, P450, DOI 10.1136/hrt.78.5.450; Marlow HJ, 2009, AM J CLIN NUTR, V89, pS1699, DOI 10.3945/ajcn.2009.26736Z; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Mathlouthi N, 2002, CAN J ANIM SCI, V82, P193, DOI 10.4141/A01-047; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mitrou PN, 2007, ARCH INTERN MED, V167, P2461, DOI 10.1001/archinte.167.22.2461; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nijdam D, 2012, FOOD POLICY, V37, P760, DOI 10.1016/j.foodpol.2012.08.002; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; O'Kiely P, 2011, IRISH J AGR FOOD RES, V50, P189; Orlich MJ, 2013, JAMA INTERN MED, V173, P1230, DOI 10.1001/jamainternmed.2013.6473; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Popp A, 2010, GLOBAL ENVIRON CHANG, V20, P451, DOI 10.1016/j.gloenvcha.2010.02.001; Schmitz C, 2014, AGR ECON-BLACKWELL, V45, P69, DOI 10.1111/agec.12090; Singh PN, 2003, AM J CLIN NUTR, V78, p526S, DOI 10.1093/ajcn/78.3.526S; Smil V., 2000, FEEDING WORLD CHALLE; Smith J., 2013, Animal Frontiers, V3, P6, DOI 10.2527/af.2013-0002; SNOWDON DA, 1984, PREV MED, V13, P490, DOI 10.1016/0091-7435(84)90017-3; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Sundrum A, 2011, NJAS-WAGEN J LIFE SC, V58, P163, DOI 10.1016/j.njas.2011.09.006; Tantamango-Bartley Y, 2013, CANCER EPIDEM BIOMAR, V22, P286, DOI 10.1158/1055-9965.EPI-12-1060; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tonstad S, 2013, NUTR METAB CARDIOVAS, V23, P292, DOI 10.1016/j.numecd.2011.07.004; Tonstad S, 2009, DIABETES CARE, V32, P791, DOI 10.2337/dc08-1886; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tubielle F. N., 2014, AGR FORESTRY OTHER L; United States Department of Agriculture, 2013, CHOOS MY PLAT; United States Department of Agriculture, 2013, NAT NUTR DAT; Waite R, 2014, WORLDFISH; Westhoek H, 2014, GLOBAL ENVIRON CHANG, V26, P196, DOI 10.1016/j.gloenvcha.2014.02.004; Willett Walter C., 1995, American Journal of Clinical Nutrition, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563	74	1570	1605	86	1359	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					518	+		10.1038/nature13959	http://dx.doi.org/10.1038/nature13959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25383533				2022-12-28	WOS:000346247600045
J	Weil, A				Weil, Anne			MAMMALIAN EVOLUTION A beast of the southern wild	NATURE			English	Editorial Material									Oklahoma State Univ, Ctr Hlth Sci, Dept Anat & Cell Biol, Tulsa, OK 74107 USA	Oklahoma State University System; Oklahoma State University Center for Health Sciences	Weil, A (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Dept Anat & Cell Biol, Tulsa, OK 74107 USA.	anne.weil@okstate.edu						Bi S., 2014, NATURE; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Cifelli RL, 2013, NATURE, V500, P160, DOI 10.1038/500160a; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Krause DW, 2014, NATURE, V515, P512, DOI 10.1038/nature13922; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Marsh O.C., 1880, AM J SCI, V20, P235, DOI 10.2475/ajs.s3-20.117.235; Zheng XT, 2013, NATURE, V500, P199, DOI 10.1038/nature12353; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	10	1	1	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					495	496		10.1038/nature13940	http://dx.doi.org/10.1038/nature13940			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25383538				2022-12-28	WOS:000346247600037
J	Fallon, TR; Weng, JK				Fallon, Timothy R.; Weng, Jing-Ke			A Molecular Gauge for Nitrogen Economy in Plants	CELL			English	Editorial Material							ARABIDOPSIS; KINASE; PII	Understanding nitrogen metabolism in plants holds promise for future agricultural improvements. Chellamuthu et al. now identify a feedback regulation in plant nitrogen metabolism through glutamine sensing. This mechanism appears to be conserved from algae to flowering plants with a few surprising exceptions.	[Fallon, Timothy R.; Weng, Jing-Ke] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Fallon, Timothy R.; Weng, Jing-Ke] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Weng, JK (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	wengj@wi.mit.edu	Weng, Jing-Ke/A-6900-2015; Weng, Jing-Ke/V-5934-2019	Weng, Jing-Ke/0000-0003-3059-0075; Weng, Jing-Ke/0000-0003-3059-0075; Fallon, Timothy R/0000-0002-3048-7679	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beez S, 2009, J MOL BIOL, V389, P748, DOI 10.1016/j.jmb.2009.04.053; Chellamuthu VR, 2014, CELL, V159, P1188, DOI 10.1016/j.cell.2014.10.015; Crookes W, 1898, Science, V8, P561, DOI 10.1126/science.8.200.561; Ferrario-Mery S, 2006, FEBS LETT, V580, P2015, DOI 10.1016/j.febslet.2006.02.075; Forchhammer K, 2007, FRONT BIOSCI-LANDMRK, V12, P358, DOI 10.2741/2069; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; STASWICK PE, 1994, ANNU REV PLANT PHYS, V45, P303, DOI 10.1146/annurev.pp.45.060194.001511	8	0	0	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					977	978		10.1016/j.cell.2014.11.007	http://dx.doi.org/10.1016/j.cell.2014.11.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416938	Bronze, Green Submitted			2022-12-28	WOS:000345506300011
J	Ma, DL; Vano-Galvan, S				Ma, Dong-Lai; Vano-Galvan, Sergio			Annular Secondary Syphilis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ma, Dong-Lai] Peking Union Med Coll Hosp Beijing, Beijing, Peoples R China; [Vano-Galvan, Sergio] Hosp Ramon & Cajal, E-28034 Madrid, Spain	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Hospital Universitario Ramon y Cajal	Ma, DL (corresponding author), Peking Union Med Coll Hosp Beijing, Beijing, Peoples R China.	mdonglai@sohu.com		Vano-Galvan, Sergio/0000-0003-2773-7494					0	3	3	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					2017	2017		10.1056/NEJMicm1315543	http://dx.doi.org/10.1056/NEJMicm1315543			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT5ST	25409374				2022-12-28	WOS:000345002900011
J	Nathwani, AC; Reiss, UM; Tuddenham, EGD; Rosales, C; Chowdary, P; McIntosh, J; Della Peruta, M; Lheriteau, E; Patel, N; Raj, D; Riddell, A; Pie, J; Rangarajan, S; Bevan, D; Recht, M; Shen, YM; Halka, KG; Basner-Tschakarjan, E; Mingozzi, F; High, KA; Allay, J; Kay, MA; Ng, CYC; Zhou, J; Cancio, M; Morton, CL; Gray, JT; Srivastava, D; Nienhuis, AW; Davidoff, AM				Nathwani, A. C.; Reiss, U. M.; Tuddenham, E. G. D.; Rosales, C.; Chowdary, P.; McIntosh, J.; Della Peruta, M.; Lheriteau, E.; Patel, N.; Raj, D.; Riddell, A.; Pie, J.; Rangarajan, S.; Bevan, D.; Recht, M.; Shen, Y. -M.; Halka, K. G.; Basner-Tschakarjan, E.; Mingozzi, F.; High, K. A.; Allay, J.; Kay, M. A.; Ng, C. Y. C.; Zhou, J.; Cancio, M.; Morton, C. L.; Gray, J. T.; Srivastava, D.; Nienhuis, A. W.; Davidoff, A. M.			Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COAGULATION FACTOR-IX; EFFICIENT TRANSDUCTION; HUMAN FIX; VECTOR; LIVER; EXPRESSION	Background In patients with severe hemophilia B, gene therapy that is mediated by a novel self-complementary adeno-associated virus serotype 8 (AAV8) vector has been shown to raise factor IX levels for periods of up to 16 months. We wanted to determine the durability of transgene expression, the vector dose-response relationship, and the level of persistent or late toxicity. Methods We evaluated the stability of transgene expression and long-term safety in 10 patients with severe hemophilia B: 6 patients who had been enrolled in an initial phase 1 dose-escalation trial, with 2 patients each receiving a low, intermediate, or high dose, and 4 additional patients who received the high dose (2x1012 vector genomes per kilogram of body weight). The patients subsequently underwent extensive clinical and laboratory monitoring. Results A single intravenous infusion of vector in all 10 patients with severe hemophilia B resulted in a dose-dependent increase in circulating factor IX to a level that was 1 to 6% of the normal value over a median period of 3.2 years, with observation ongoing. In the high-dose group, a consistent increase in the factor IX level to a mean (+/- SD) of 5.1 +/- 1.7% was observed in all 6 patients, which resulted in a reduction of more than 90% in both bleeding episodes and the use of prophylactic factor IX concentrate. A transient increase in the mean alanine aminotransferase level to 86 IU per liter (range, 36 to 202) occurred between week 7 and week 10 in 4 of the 6 patients in the high-dose group but resolved over a median of 5 days (range, 2 to 35) after prednisolone treatment. Conclusions In 10 patients with severe hemophilia B, the infusion of a single dose of AAV8 vector resulted in long-term therapeutic factor IX expression associated with clinical improvement. With a follow-up period of up to 3 years, no late toxic effects from the therapy were reported.	[Nathwani, A. C.; Tuddenham, E. G. D.; Chowdary, P.; McIntosh, J.; Riddell, A.; Pie, J.] Royal Free NHS Trust, Katharine Dormandy Haemophilia Ctr, London, England; [Nathwani, A. C.; Tuddenham, E. G. D.; Chowdary, P.; McIntosh, J.; Riddell, A.; Pie, J.] Royal Free NHS Trust, Thrombosis Unit, London, England; [Nathwani, A. C.; Tuddenham, E. G. D.; Rosales, C.; McIntosh, J.; Della Peruta, M.; Lheriteau, E.; Patel, N.; Raj, D.] UCL, Inst Canc, Dept Haematol, London, England; [Rangarajan, S.; Bevan, D.] St Thomas Hosp, London, England; [Nathwani, A. C.; Rosales, C.; Raj, D.] NHS Blood & Transplant, Watford, England; [Rangarajan, S.] Basingstoke & North Hampshire Fdn Trust, Basingstoke, Hants, England; [Reiss, U. M.; Gray, J. T.; Nienhuis, A. W.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Ng, C. Y. C.; Zhou, J.; Cancio, M.; Morton, C. L.; Davidoff, A. M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Srivastava, D.] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Allay, J.] Poplar Healthcare, Memphis, TN USA; [Recht, M.] Oregon Hlth & Sci Univ, Hemophilia Ctr, Portland, OR 97201 USA; [Shen, Y. -M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Halka, K. G.] Scott & White Healthcare, Temple Clin, Temple, TX USA; [Basner-Tschakarjan, E.; Mingozzi, F.; High, K. A.] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Kay, M. A.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Kay, M. A.] Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA	University of London; University College London; University of London; University College London; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Stanford University; Stanford University	Nathwani, AC (corresponding author), Royal Free Hosp, Katharine Dormandy Haemophilia Ctr, Pond St, London NW3 2QG, England.	a.nathwani@ucl.ac.uk	Tuddenham, Edward/AAS-6196-2020; Chowdary, P/I-2623-2012; Huang, ZhiXin/H-5123-2017; della peruta, marco/H-8704-2016; Gray, John T/D-2916-2016; High, Katherine A./AAB-9322-2020	Tuddenham, Edward/0000-0001-8955-2909; Chowdary, P/0000-0002-6690-8586; Huang, ZhiXin/0000-0003-0705-1970; Gray, John T/0000-0002-1888-4612; High, Katherine/0000-0002-0805-6223; Kay, Mark/0000-0002-2799-2615; Della Peruta, Marco/0000-0002-5580-1847; Rangarajan, Savita/0000-0001-7367-133X	National Heart, Lung, and Blood Institute [HL094396]; United Kingdom Medical Research Council; Katharine Dormandy Trust; United Kingdom Department of Health; NHS Blood and Transplant; Biomedical Research Centre of the National Institute for Health Research (NIHR); Department of Health; University College London Hospitals NHS Foundation Trust; University College London; Royal Free Hospital Charity, an NIHR Program [RP-PG-0310-1001]; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities; Howard Hughes Medical Institute; Medical Research Council [G0502121] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10071] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094396, R01HL073838] Funding Source: NIH RePORTER; MRC [G0502121] Funding Source: UKRI	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Katharine Dormandy Trust; United Kingdom Department of Health; NHS Blood and Transplant; Biomedical Research Centre of the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Department of Health; University College London Hospitals NHS Foundation Trust; University College London(General Electric); Royal Free Hospital Charity, an NIHR Program; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a grant from the National Heart, Lung, and Blood Institute (HL094396), the United Kingdom Medical Research Council, the Katharine Dormandy Trust, the United Kingdom Department of Health, NHS Blood and Transplant, a grant from the Biomedical Research Centre of the National Institute for Health Research (NIHR), Department of Health, to the University College London Hospitals NHS Foundation Trust and University College London, the Royal Free Hospital Charity, an NIHR Program Grant (RP-PG-0310-1001), the Assisi Foundation of Memphis, the American Lebanese Syrian Associated Charities, and the Howard Hughes Medical Institute.	Allay JA, 2011, HUM GENE THER, V22, P595, DOI 10.1089/hum.2010.202; den Uijl IEM, 2011, HAEMOPHILIA, V17, P41, DOI 10.1111/j.1365-2516.2010.02383.x; Fagone P, 2012, HUM GENE THER METHOD, V23, P1, DOI 10.1089/hgtb.2011.104; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; NATHWANI AC, 1992, BAILLIERE CLIN HAEM, V5, P383, DOI 10.1016/S0950-3536(11)80025-9; Nathwani AC, 2007, BLOOD, V109, P1414, DOI 10.1182/blood-2006-03-010181; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Pipe SW, 2012, AM J HEMATOL, V87, pS33, DOI 10.1002/ajh.23146; Ponder KP, 2008, HAEMOPHILIA, V14, P618, DOI 10.1111/j.1365-2516.2008.01660.x; Snyder RO, 1997, NAT GENET, V16, P270, DOI 10.1038/ng0797-270; Takada Y, 2013, LIVER TRANSPLANT, V19, P896, DOI 10.1002/lt.23679	17	811	860	3	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					1994	2004		10.1056/NEJMoa1407309	http://dx.doi.org/10.1056/NEJMoa1407309			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT5ST	25409372	Green Accepted			2022-12-28	WOS:000345002900008
J	O'Neill, LAJ				O'Neill, Luke A. J.			BIOCHEMISTRY Succinate strikes	NATURE			English	Editorial Material							ISCHEMIA; SIGNAL	The high levels of tissue-damaging reactive oxygen species that arise during a stroke or heart attack have been shown to be generated through the accumulation of the metabolic intermediate succinate. See Letter p. 431	Trinity Coll Dublin, Sch Biochem & Immunol, Trin Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trin Biomed Sci Inst, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; HOCHACHKA PW, 1975, SCIENCE, V187, P613, DOI 10.1126/science.163485; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986	11	12	13	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					350	351		10.1038/nature13941	http://dx.doi.org/10.1038/nature13941			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25383526				2022-12-28	WOS:000345770600031
J	Shelke, SA; Piccirilli, JA				Shelke, Sandip A.; Piccirilli, Joseph A.			ORIGINS OF LIFE RNA made in its own mirror image	NATURE			English	Editorial Material							IN-VITRO; SELECTION; EVOLUTION; POLYMERASE; LIGANDS; DNA	An RNA enzyme has been generated that can assemble a mirror-image version of itself. The finding helps to answer a long-standing conundrum about how RNA molecules could have proliferated on prebiotic Earth. See Letter p. 440	[Shelke, Sandip A.; Piccirilli, Joseph A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Shelke, SA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA.	jpicciri@uchicago.edu	Shelke, Sandip/I-6022-2019; Shelke, Sandip/B-4691-2014	Shelke, Sandip/0000-0002-6119-123X; Shelke, Sandip/0000-0002-6119-123X				ASHLEY GW, 1992, J AM CHEM SOC, V114, P9731, DOI 10.1021/ja00051a001; Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/nchem.1781, 10.1038/NCHEM.1781]; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Eulberg D, 2003, CHEMBIOCHEM, V4, P979, DOI 10.1002/cbic.200300663; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Sczepanski JT, 2014, NATURE, V515, P440, DOI 10.1038/nature13900; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121	11	6	6	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					347	348		10.1038/nature13935	http://dx.doi.org/10.1038/nature13935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25363771				2022-12-28	WOS:000345770600029
J	Stillman, MD				Stillman, Michael D.			The Affordable Care Act, 1 Year Later	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA	University of Louisville	Stillman, MD (corresponding author), Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA.							[Anonymous], 2014, HLTH KENT HLTH INS C; Stephens J., 2014, HLTH COVERAGE CARE S; Stillman M, 2013, NEW ENGL J MED, V369, P1880, DOI 10.1056/NEJMp1312793	3	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					1960	1961		10.1056/NEJMp1410509	http://dx.doi.org/10.1056/NEJMp1410509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT5ST	25409369				2022-12-28	WOS:000345002900004
J	Ali, MK; Bullard, KM; Gregg, EW; del Rio, C				Ali, Mohammed K.; Bullard, Kai McKeever; Gregg, Edward W.; del Rio, Carlos			A Cascade of Care for Diabetes in the United States: Visualizing the Gaps	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-GLUCOSE CONTROL; MULTIFACTORIAL INTERVENTION; COST-EFFECTIVENESS; RISK-FACTORS; HIV CARE; TYPE-2; MANAGEMENT; STRATEGIES; PATIENT; MORTALITY	Background: A "cascade-of-care" concept helped to address implementation gaps in HIV care. Objective: To develop a similar cascade for U.S. diabetes care to visualize gaps in awareness of diagnosis, engagement, and treatment. Design: Nationally representative cross-sectional surveys. Setting: 2007 to 2012 NHANES (National Health and Nutrition Examination Surveys). Participants: Nonpregnant civilians aged 18 years or older. Measurements: Standardized data collection and laboratory procedures. Diabetes care was benchmarked against recent diabetes and cardiovascular risk reduction guidelines. Results: In 2012, an estimated 28.4 million (11.8%) U.S. adults had diabetes, of whom 20.5 million (72.2%) were aware of their diagnosis. Among diagnosed adults, 95.3% had a usual care provider and 91.7% made 2 or more visits in the past year. In contrast, among undiagnosed adults, 84.5% had a usual care provider and 66.5% reported 2 or more visits in the past year. Among diagnosed adults, 63.7%, 65.5%, 56.6%, and 80.6% met individualized hemoglobin A(1c), blood pressure (BP <140/80 mmHg), lipid (low-density lipoprotein [LDL] cholesterol <2.6 mmol/L [<100 mg/dL]), and nonsmoking goals, respectively; 26.7% met combined ABC (hemoglobin A1c, BP, and LDL cholesterol) targets, and 21.3% met combined ABC targets and did not smoke. Among undiagnosed adults, 77.0%, 57.9%, 36.0%, and 77.9% met hemoglobin A1c, BP, lipid, and nonsmoking goals, respectively; 22.1% met combined ABC targets; and 18.8% met combined ABC targets and were nonsmokers. Limitation: Institutionalized and noncivilian persons are not surveyed in NHANES. Conclusion: Three of 10 adults with diabetes remain undiagnosed, which may be related to less access to care. Compared with diagnosed adults, undiagnosed adults have less elevated hemoglobin A1c levels, less lipid treatment and worse control, and similarly poor BP and combined ABC control regardless of smoking status. Addressing these care gaps in both groups would prevent long-term complications.	Emory Univ, Natl Ctr Chron Dis Prevent & Hlth Promot, Rollins Sch Publ Hlth, Ctr Dis Control & Prevent, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; Emory University	Ali, MK (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, 4770 Buford Highway NE, Atlanta, GA 30341 USA.	mkali@emory.edu	del Rio, Carlos/B-3763-2012; Ali, Mohammed K/N-9833-2013	del Rio, Carlos/0000-0002-0153-3517; Ali, Mohammed/0000-0001-7266-2503; Gregg, Edward/0000-0003-2381-6822				Ahmann AJ, 2007, AM J MANAG CARE, V13, pS41; Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; American Diabetes Association, 2014, AR YOU RISK AL; American Heart Association, 2012, KNOW YOUR HLTH NUM; [Anonymous], 1998, BMJ, V317, P720; Barr D, 2013, REVITALIZING US NATL; Bernstein J., 2010, DOES INSURANCE COVER; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP 20; Centers for Disease Control and Prevention National Center for Health Statistics National Health and Nutrition Examination Survey, 2012, UPD ADV NHANES HEM A; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Ettner SL, 2006, HEALTH SERV RES, V41, P1221, DOI 10.1111/j.1475-6773.2006.00533.x; Fryar Cheryl D, 2012, NCHS Data Brief, P1; Gaede P, 2008, DIABETES CARE, V31, P1510, DOI 10.2337/dc07-2452; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gray A, 2000, BMJ-BRIT MED J, V320, P1373, DOI 10.1136/bmj.320.7246.1373; Gregg EW, 2010, MED CARE, V48, P31, DOI 10.1097/MLR.0b013e3181bd4783; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kelly E, 2010, J OCCUP ENVIRON MED, V52, P528, DOI 10.1097/JOM.0b013e3181dbe339; Martin SS, 2014, ANN INTERN MED, V160, P356, DOI 10.7326/M13-2805; MN Community Measurement, 2012, 2012 HLTH CAR QUAL R; Mohiuddin SM, 2007, CHEST, V131, P446, DOI 10.1378/chest.06-1587; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Ofri D, 2014, NY TIMES; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pogach L, 2011, JAMA-J AM MED ASSOC, V305, P709, DOI 10.1001/jama.2011.153; Ratner RE, 2011, DIABETES CARE, V34, P1054, DOI 10.2337/dc10-1987; Renders CM, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD001481]; Rolando L, 2013, J OCCUP ENVIRON MED, V55, P410, DOI 10.1097/JOM.0b013e31827cbaec; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Schmittdiel J, 2008, J GEN INTERN MED, V23, P77, DOI 10.1007/s11606-007-0452-5; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Srikanth S, 2005, CARDIOL CLIN, V23, P193, DOI 10.1016/j.ccl.2004.11.002; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stellefson M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120180; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thorpe KE, 2010, HEALTH AFFAIR, V29, P718, DOI 10.1377/hlthaff.2009.0474; TRIAD Study Grp, 2010, DIABETES CARE, V33, P940, DOI 10.2337/dc09-1802; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; U.S. Census Bureau Population Division, 2010, METH US RES POP EST	55	98	102	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					681	689		10.7326/M14-0019	http://dx.doi.org/10.7326/M14-0019			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402511				2022-12-28	WOS:000347245600025
J	Jubelt, LE; Graham, J; Maeng, DD; Li, HL; Epstein, AJ; Metlay, JP				Jubelt, Lindsay E.; Graham, Jove; Maeng, Daniel D.; Li, Huilin; Epstein, Andrew J.; Metlay, Joshua P.			Patient Ratings of Case Managers in a Medical Home: Associations With Patient Satisfaction and Health Care Utilization	ANNALS OF INTERNAL MEDICINE			English	Article							VOLUNTARY DISENROLLMENT; REPORTED EXPERIENCE; COMMUNICATION; BENEFICIARIES; OUTCOMES; QUALITY; RISK; HOSPITALIZATION; PERCEPTIONS; PREDICTORS	Background: Case managers are employed in medical homes to coordinate care for clinically complex patients. Objective: To measure the association of patient perceptions of case manager performance with overall satisfaction and subsequent health care utilization. Design: Retrospective cohort study. Setting: Integrated health system in Pennsylvania. Patients: Members of the health system-owned health plan who 1) received primary care in the health system's clinics, 2) were exposed to clinic-embedded case managers, and 3) completed a survey of satisfaction with care. Measurements: Survey assessment of case manager performance and overall satisfaction with care and claims-based assessment of case manager performance and subsequent hospitalizations or emergency department visits. Survey measures were dichotomized into very good versus less than very good. Results: A total of 1755 patients (44%) completed the survey and 1415 met study criteria. Survey respondents who reported very good ratings of case manager performance across all items had a higher probability of reporting very good overall satisfaction with care (92.2% vs. 62.5%; P < 0.001) and had a lower incidence of subsequent emergency department visits (incidence rate ratio, 0.79 [95% CI, 0.64 to 0.98]; P = 0.029) but not hospitalizations (incidence rate ratio, 0.92 [CI, 0.75 to 1.11]; P = 0.37) up to 2 years after the survey compared with survey respondents who reported less-than-very good case manager performance on 1 or more questions on the survey. Limitations: Satisfaction data demonstrated substantial ceiling effects. Survey nonresponse may have introduced bias in the results. Conclusion: Patients' favorable perceptions of case managers are associated with higher overall satisfaction with care and may lower risk for future acute care use.	[Epstein, Andrew J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Li, Huilin] NYU, Langone Med Ctr, Dept Populat Hlth, New York, NY 10016 USA; [Graham, Jove] Geisinger Ctr Hlth Res, Danville, PA 17822 USA; [Maeng, Daniel D.] Geisinger Hlth Syst, Danville, PA 17822 USA; [Metlay, Joshua P.] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; New York University; NYU Langone Medical Center; Geisinger Health System; Harvard University; Massachusetts General Hospital	Jubelt, LE (corresponding author), NYU, Sch Med, Dept Populat Hlth, 1 Pk Ave,10th Floor, New York, NY 10016 USA.	lindsay.jubelt@nyumc.org		Epstein, Andrew/0000-0001-5078-6564; Li, Huilin/0000-0002-8288-7068	Robert Wood Johnson Foundation; U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI073957] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Robert Wood Johnson Foundation and the U.S. Department of Veterans Affairs.	Abramowitz S, 1987, QRB Qual Rev Bull, V13, P122; Agency for Healthcare Research and Quality, CAHPS CLIN GROUP SUR; Chang JT, 2006, ANN INTERN MED, V144, P665, DOI 10.7326/0003-4819-144-9-200605020-00010; Chen J, 2000, J OFF STAT, V16, P113; Devoe JE, 2008, J AM BOARD FAM MED, V21, P441, DOI 10.3122/jabfm.2008.05.080054; Elliott MN, 2009, MED CARE, V47, P842, DOI 10.1097/MLR.0b013e318197b22a; Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Gray BM, 2012, HEALTH SERV RES, V47, P4, DOI 10.1111/j.1475-6773.2011.01302.x; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Hargraves JL, 2003, HEALTH SERV RES, V38, P1509; Heller A, 2009, MED CARE, V47, P850, DOI 10.1097/MLR.0b013e318197b661; Hutchinson A, 1999, QUAL HEALTH CARE, V8, P213, DOI 10.1136/qshc.8.4.213; Jackson JL, 2001, SOC SCI MED, V52, P609, DOI 10.1016/S0277-9536(00)00164-7; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Keenan PS, 2009, MED CARE, V47, P882, DOI 10.1097/MLR.0b013e3181a39415; Kellerman R, 2007, AM FAM PHYSICIAN, V76, P774; Kern LM, 2013, AM J MANAG CARE, V19, P403; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Larkins AS, 2013, EUR J GASTROEN HEPAT, V25, P44, DOI 10.1097/MEG.0b013e3283589f80; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lied TR, 2003, HEALTH CARE FINANC R, V25, P55; Lin PJ, 2010, AM J MANAG CARE, V16, P191; Maeng DD, 2013, POPUL HEALTH MANAG, V16, P157, DOI 10.1089/pop.2012.0048; Manary MP, 2013, NEW ENGL J MED, V368, P201, DOI 10.1056/NEJMp1211775; Mitchell SE, 2014, J GEN INTERN MED, V29, P349, DOI 10.1007/s11606-013-2647-2; O'Connor SJ, 2003, HEALTH CARE MANAGE R, V28, P21, DOI 10.1097/00004010-200301000-00003; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Pope GC, 2011, EVALUATION CMS HCC R; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Ruiz-Moral R, 2006, PATIENT EDUC COUNS, V64, P242, DOI 10.1016/j.pec.2006.02.010; Safran DG, 2001, J FAM PRACTICE, V50, P130; Tallman Karen, 2007, Perm J, V11, P19; Williams S, 1998, FAM PRACT, V15, P480, DOI 10.1093/fampra/15.5.480; Wofford MM, 2004, ACAD MED, V79, P134, DOI 10.1097/00001888-200402000-00008; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	36	11	11	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S59	S65		10.7326/M13-3007	http://dx.doi.org/10.7326/M13-3007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402405				2022-12-28	WOS:000364909900009
J	Laskey, WK				Laskey, Warren K.			Drug-Eluting Stents: Boom or Bust?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORONARY-ARTERY STENTS; OUTCOMES; THERAPY; HEALTH		[Laskey, Warren K.] Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Laskey, WK (corresponding author), Univ New Mexico, Dept Internal Med, Div Cardiol, MSC10-5550,1 Univ New Mexico, Albuquerque, NM 87131 USA.	wlaskey@salud.unm.edu						Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Groeneveld PW, 2011, ARCH INTERN MED, V171, P1289, DOI 10.1001/archinternmed.2011.141; Kandzari DE, 2005, AM J CARDIOL, V96, P750, DOI 10.1016/j.amjcard.2005.05.015; Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416; Patel MR, 2009, J AM COLL CARDIOL, V53, P530, DOI 10.1016/j.jacc.2008.10.005; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816	9	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					740	U190		10.7326/M14-0874	http://dx.doi.org/10.7326/M14-0874			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402515				2022-12-28	WOS:000347245600031
J	Lee, JH; Kim, CF				Lee, Joo-Hyeon; Kim, Carla F.			Mesenchymal progenitor panoply	SCIENCE			English	Editorial Material							MOUSE LUNG		[Lee, Joo-Hyeon; Kim, Carla F.] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Lee, JH (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA.	carla.kim@childrens.harvard.edu	Lee, Joo-Hyeon/AAM-2777-2020	Lee, Joo-Hyeon/0000-0002-7364-6422	Wellcome Trust [107633] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; El Agha E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038452; Kumar ME, 2014, SCIENCE, V346, P827, DOI 10.1126/science.1258810; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Peng T, 2013, NATURE, V500, P589, DOI 10.1038/nature12358; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9	9	2	2	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					810	811		10.1126/science.aaa0609	http://dx.doi.org/10.1126/science.aaa0609			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395521				2022-12-28	WOS:000344659900020
J	DeBaun, MR				DeBaun, Michael R.			Thinking beyond survival	NATURE			English	Editorial Material							SICKLE; TRANSFUSIONS		Vanderbilt Univ, Med Ctr, Vanderbilt Meharry Ctr Excellence Sickle Cell Dis, Nashville, TN 37235 USA	Meharry Medical College; Vanderbilt University	DeBaun, MR (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Meharry Ctr Excellence Sickle Cell Dis, Nashville, TN 37235 USA.	m.debaun@vanderbilt.edu						Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; King AA, 2014, AM J HEMATOL, V89, P162, DOI 10.1002/ajh.23604; Yanni E, 2009, J PEDIATR-US, V154, P541, DOI 10.1016/j.jpeds.2008.09.052	4	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S16	S16		10.1038/515S16a	http://dx.doi.org/10.1038/515S16a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390138				2022-12-28	WOS:000344631400010
J	Humphries, C				Humphries, Courtney			A complicated path	NATURE			English	Editorial Material																		Abdulmalik O, 2005, BRIT J HAEMATOL, V128, P552, DOI 10.1111/j.1365-2141.2004.05332.x; Manwani D, 2013, BLOOD, V122, P3892, DOI 10.1182/blood-2013-05-498311	2	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S4	S5		10.1038/515S4a	http://dx.doi.org/10.1038/515S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390140	Bronze			2022-12-28	WOS:000344631400004
J	Choudhry, NK; Liao, JM; Detsky, AS				Choudhry, Niteesh K.; Liao, Joshua M.; Detsky, Allan S.			Selecting a Specialist Adding Evidence to the Clinical Practice of Making Referrals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; CARE; PHYSICIAN		[Choudhry, Niteesh K.; Liao, Joshua M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA; [Choudhry, Niteesh K.; Liao, Joshua M.] Harvard Univ, Sch Med, Boston, MA USA; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dept Med, Toronto, ON M5S 1A1, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Choudhry, NK (corresponding author), Brigham & Womens Hosp, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	nchoudhry@partners.org						Barnett ML, 2012, ARCH INTERN MED, V172, P163, DOI 10.1001/archinternmed.2011.722; Forrest CB, PRIMARY CARE PHYSICI; Kinchen KS, 2004, ANN FAM MED, V2, P245, DOI 10.1370/afm.68; Mehrotra A, 2011, MILBANK Q, V89, P39, DOI 10.1111/j.1468-0009.2011.00619.x; Song ZR, 2014, JAMA-J AM MED ASSOC, V312, P597, DOI 10.1001/jama.2014.7878; Tung YC, 2014, MED CARE, V52, P519, DOI 10.1097/MLR.0000000000000132	6	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1861	1862		10.1001/jama.2014.12963	http://dx.doi.org/10.1001/jama.2014.12963			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387183				2022-12-28	WOS:000344532600012
J	Kharbanda, EO; Vazquez-Benitez, G; Lipkind, HS; Klein, NP; Cheetham, TC; Naleway, A; Omer, SB; Hambidge, SJ; Lee, GM; Jackson, ML; McCarthy, NL; DeStefano, F; Nordin, JD				Kharbanda, Elyse O.; Vazquez-Benitez, Gabriela; Lipkind, Heather S.; Klein, Nicola P.; Cheetham, T. Craig; Naleway, Allison; Omer, Saad B.; Hambidge, Simon J.; Lee, Grace M.; Jackson, Michael L.; McCarthy, Natalie L.; DeStefano, Frank; Nordin, James D.			Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INACTIVATED INFLUENZA VACCINE; ADVISORY-COMMITTEE; TDAP IMMUNIZATION; VIRUS VACCINE; PREGNANCY; SAFETY; DIPHTHERIA; TETANUS; WOMEN; RECOMMENDATIONS	IMPORTANCE In 2010, due to a pertussis outbreak and neonatal deaths, the California Department of Health recommended that the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) be administered during pregnancy. Tdap is now recommended by the Advisory Committee on Immunization Practices for all pregnant women, preferably between 27 and 36 weeks' gestation. Limited data exist on Tdap safety during pregnancy. OBJECTIVE To evaluate whether maternal Tdap vaccination during pregnancy is associated with increased risks of adverse obstetric events or adverse birth outcomes. DESIGN AND SETTING Retrospective, observational cohort study using administrative health care databases from 2 California Vaccine Safety Datalink sites. PARTICIPANTS AND EXPOSURES Of 123 494 women with singleton pregnancies ending in a live birth between January 1, 2010, and November 15, 2012, 26 229 (21%) received Tdap during pregnancy and 97 265 did not. MAIN OUTCOMES AND MEASURES Risks of small-for-gestational-age (SGA) births (<10th percentile), chorioamnionitis, preterm birth (<37 weeks' gestation), and hypertensive disorders of pregnancy were evaluated. Relative risk (RR) estimates were adjusted for site, receipt of another vaccine during pregnancy, and propensity to receive Tdap during pregnancy. Cox regression was used for preterm delivery, and Poisson regression for other outcomes. RESULTS Vaccination was not associated with increased risks of adverse birth outcomes: crude estimates for preterm delivery were 6.3% of vaccinated and 7.8% of unvaccinated women (adjusted RR, 1.03; 95% CI, 0.97-1.09); 8.4% of vaccinated and 8.3% of unvaccinated had an SGA birth (adjusted RR, 1.00; 95% CI, 0.96-1.06). Receipt of Tdap before 20 weeks was not associated with hypertensive disorder of pregnancy (adjusted RR, 1.09; 95% CI, 0.99-1.20); chorioamnionitis was diagnosed in 6.1% of vaccinated and 5.5% of unvaccinated women (adjusted RR, 1.19; 95% CI, 1.13-1.26). CONCLUSIONS AND RELEVANCE In this cohort of women with singleton pregnancies that ended in live birth, receipt of Tdap during pregnancy was not associated with increased risk of hypertensive disorders of pregnancy or preterm or SGA birth, although a small but statistically significant increased risk of chorioamnionitis diagnosis was observed.	[Kharbanda, Elyse O.; Vazquez-Benitez, Gabriela; Nordin, James D.] HealthPartners Inst Educ & Res, Minneapolis, MN 55440 USA; [Lipkind, Heather S.] Yale Univ, New Haven, CT USA; [Klein, Nicola P.] Kaiser Permanente No Calif, Oakland, CA USA; [Cheetham, T. Craig] Kaiser Permanente So Calif, Pasadena, CA 91101 USA; [Naleway, Allison] Kaiser Permanente Northwest, Portland, OR USA; [Omer, Saad B.] Kaiser Permanente Georgia, Atlanta, GA USA; [Hambidge, Simon J.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Hambidge, Simon J.] Denver Hlth, Dept Ambulatory Care Serv, Denver, CO USA; [Lee, Grace M.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Lee, Grace M.] Harvard Univ, Sch Med, Boston, MA USA; [Jackson, Michael L.] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [McCarthy, Natalie L.; DeStefano, Frank] Ctr Dis Control & Prevent, Atlanta, GA USA	Yale University; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Denver Health Medical Center; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Group Health Cooperative; Centers for Disease Control & Prevention - USA	Kharbanda, EO (corresponding author), HealthPartners Inst Educ & Res, POB 1524,MS 21111R, Minneapolis, MN 55440 USA.	elyse.o.kharbanda@healthpartners.com		Kharbanda, Elyse/0000-0003-1806-6502; Nordin, James/0000-0002-3359-5843; Hambidge, Simon/0000-0002-7535-0668	CDC [200-2012-53526]; CDC Vaccine Safety Datalink infrastructure task order [200-2012-53581, 200-2012-53580]	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC Vaccine Safety Datalink infrastructure task order	This study was funded through contract 200-2012-53526 from the CDC. Additional funding for chart reviews came from contracts 200-2012-53581 and 200-2012-53580 from the CDC Vaccine Safety Datalink infrastructure task order.	Abramovici A, 2014, AM J PERINAT, V31, P1009, DOI 10.1055/s-0034-1371357; Andrade SE, 2013, PHARMACOEPIDEM DR S, V22, P7, DOI 10.1002/pds.3319; [Anonymous], 2013, Obstet Gynecol, V121, P1411, DOI 10.1097/01.AOG.0000431054.33593.e3; Baggs J, 2011, PEDIATRICS, V127, pS45, DOI 10.1542/peds.2010-1722H; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P817; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P669; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Christian LM, 2013, AM J REPROD IMMUNOL, V70, P45, DOI 10.1111/aji.12117; Christian LM, 2011, VACCINE, V29, P8982, DOI 10.1016/j.vaccine.2011.09.039; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Donegan K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4219; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Getahun D, 2013, J MED STAT INFORM, V1, P1, DOI DOI 10.7243/2053-7662-1-3; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Healy CM, 2013, CLIN INFECT DIS, V56, P539, DOI 10.1093/cid/cis923; Irving SA, 2013, OBSTET GYNECOL, V121, P159, DOI [10.1097/AOG.0b013e318279f56f, http://10.1097/AOG.0b013e318279f56f]; Jimenez-Truque N, 2014, JAMA-J AM MED ASSOC, V311, P1736, DOI 10.1001/jama.2014.3555; Kharbanda EO, 2014, PREV MED, V67, P316, DOI 10.1016/j.ypmed.2014.05.025; Kharbanda EO, 2012, AM J OBSTET GYNECOL, V207, pS47, DOI 10.1016/j.ajog.2012.06.073; Kharbanda EO, 2013, OBSTET GYNECOL, V122, P659, DOI 10.1097/AOG.0b013e3182a1118a; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1486, DOI 10.2105/AJPH.84.9.1486; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Myatt L, 2013, BJOG-INT J OBSTET GY, V120, P1183, DOI 10.1111/1471-0528.12128; Naleway AL, 2013, VACCINE, V31, P2898, DOI 10.1016/j.vaccine.2013.03.069; Nordin JD, 2014, J PEDIATR-US, V164, P1051, DOI 10.1016/j.jpeds.2014.01.037; Nordin JD, 2013, OBSTET GYNECOL, V121, P519, DOI 10.1097/AOG.0b013e3182831b83; Nordin JD, 2014, J PEDIAT, V164, pe2; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Pasternak Bjorn, 2012, BMJ, V344, pe2794, DOI 10.1136/bmj.e2794; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Shakib JH, 2013, J PEDIATR-US, V163, P1422, DOI 10.1016/j.jpeds.2013.06.021; Sheffield JS, 2012, OBSTET GYNECOL, V120, P532, DOI 10.1097/AOG.0b013e318263a278; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041; Zheteyeva YA, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.006	45	143	145	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1897	1904		10.1001/jama.2014.14825	http://dx.doi.org/10.1001/jama.2014.14825			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS8ZE	25387187	Green Accepted, Bronze			2022-12-28	WOS:000344532600019
J	Burki, T				Burki, Talha			VECTOR BORNE DISEASE India's ambition to eliminate visceral leishmaniasis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BIHAR					talhakburki@gmail.com						Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bhatia B, 2014, TIMES INDIA; Ross R., 1899, REPORT NATURE KALA A; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Sinha PK, 2014, LANCET GLOB HEALTH, V2, pE7, DOI 10.1016/S2214-109X(13)70151-7	6	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2014	349								g6671	10.1136/bmj.g6671	http://dx.doi.org/10.1136/bmj.g6671			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CF	25380595				2022-12-28	WOS:000344603900002
J	Robinson, CM; Pfeiffer, JK				Robinson, Christopher M.; Pfeiffer, Julie K.			Leaping the norovirus hurdle	SCIENCE			English	Editorial Material							ENTERIC VIRUS; MICROBIOTA; INFECTION; DISEASE		[Robinson, Christopher M.; Pfeiffer, Julie K.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Robinson, CM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	julie.pfeiffer@utsouthwestern.edu	Robinson, Christopher/FKL-4907-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074668] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI074668] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Miura T, 2013, J VIROL, V87, P9441, DOI 10.1128/JVI.01060-13; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592	13	7	8	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					700	701		10.1126/science.aaa0607	http://dx.doi.org/10.1126/science.aaa0607			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378607	Green Accepted			2022-12-28	WOS:000344690100021
J	Williams, CC; Jan, CH; Weissman, JS				Williams, Christopher C.; Jan, Calvin H.; Weissman, Jonathan S.			Targeting and plasticity of mitochondrial proteins revealed by proximity-specific ribosome profiling	SCIENCE			English	Article							FUMARATE REDUCTASE; MESSENGER-RNAS; IMPORT; PROTEOME; DATABASE; SITES; GENE	Nearly all mitochondrial proteins are nuclear-encoded and are targeted to their mitochondrial destination from the cytosol. Here, we used proximity-specific ribosome profiling to comprehensively measure translation at the mitochondrial surface in yeast. Most inner-membrane proteins were cotranslationally targeted to mitochondria, reminiscent of proteins entering the endoplasmic reticulum (ER). Comparison between mitochondrial and ER localization demonstrated that the vast majority of proteins were targeted to a specific organelle. A prominent exception was the fumarate reductase Osm1, known to reside in mitochondria. We identified a conserved ER isoform of Osm1, which contributes to the oxidative protein-folding capacity of the organelle. This dual localization was enabled by alternative translation initiation sites encoding distinct targeting signals. These findings highlight the exquisite in vivo specificity of organellar targeting mechanisms.	[Williams, Christopher C.; Jan, Calvin H.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA.	jonathan.weissman@ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	Center for RNA Systems Biology; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER	Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Weissman and P. Walter labs for discussion and E. Costa and V. Okreglak for critical reading of the manuscript. The University of California, San Francisco, Center for Advanced Technology and Nikon Imaging Center provided technical support. We thank C. Policarpi for assistance in strain construction and pilot ribosome profiling experiments, G. Brar for sharing unpublished ribosome profiling data, P. Walter for use of the Su9-TagBFP plasmid, and J. Horst for assistance with anaerobic growth conditions and equipment. This research was supported by the Center for RNA Systems Biology and the Howard Hughes Medical Institute. C. C. W. is an NSF Graduate Research Fellow. C. H. J. is the Rebecca Ridley Kry Fellow of the Damon Runyon Cancer Research Foundation (DRG-2085-11). Data are deposited in Gene Expression Omnibus under accession nos. GSE61011 and GSE61012.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Enomoto K, 2002, FEMS MICROBIOL LETT, V215, P103; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Liu ZH, 2013, APPL ENVIRON MICROB, V79, P2962, DOI 10.1128/AEM.03207-12; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Muratsubaki H, 1998, ARCH BIOCHEM BIOPHYS, V352, P175, DOI 10.1006/abbi.1998.0583; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; SUISSA M, 1982, J BIOL CHEM, V257, P3048; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	27	212	215	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					748	751		10.1126/science.1257522	http://dx.doi.org/10.1126/science.1257522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378625	Green Accepted			2022-12-28	WOS:000344690100041
J	Downer, M; Zgadzaj, R				Downer, Mike; Zgadzaj, Rafal			ACCELERATOR PHYSICS Surf's up at SLAC	NATURE			English	Editorial Material							ELECTRONS	A 'plasma afterburner' just 30 centimetres long accelerates electrons hundreds of times faster than giant conventional accelerators. The result may ultimately open up a low-cost technology for particle colliders. SEE LETTER P 92	[Downer, Mike; Zgadzaj, Rafal] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Downer, M (corresponding author), Univ Texas Austin, Dept Phys, Austin, TX 78712 USA.	downer@physics.utexas.edu			Direct For Mathematical & Physical Scien [1416218] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Blumenfeld I, 2007, NATURE, V445, P741, DOI 10.1038/nature05538; Caldwell A, 2009, NAT PHYS, V5, P363, DOI 10.1038/NPHYS1248; Hogan MJ, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/055030; Lebedev V, 2013, PHYS REV SPEC TOP-AC, V16, DOI 10.1103/PhysRevSTAB.16.108001; Lee S, 2002, PHYS REV SPEC TOP-AC, V5, DOI 10.1103/PhysRevSTAB.5.011001; Litos M, 2014, NATURE, V515, P92, DOI 10.1038/nature13882; Schroeder CB, 2013, PHYS REV SPEC TOP-AC, V16, DOI 10.1103/PhysRevSTAB.16.108002; Schroeder CB, 2012, PHYS REV SPEC TOP-AC, V15, DOI 10.1103/PhysRevSTAB.15.051301; Tzoufras M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.145002; Wang XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2988	10	4	4	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					40	41		10.1038/515040a	http://dx.doi.org/10.1038/515040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373669				2022-12-28	WOS:000344187500022
J	Balachandran, JS; Patel, SR				Balachandran, Jay S.; Patel, Sanjay R.			Obstructive Sleep Apnea	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							POSITIVE AIRWAY PRESSURE; CLINICAL-PRACTICE GUIDELINE; PRACTICE PARAMETERS; DAYTIME SLEEPINESS; BLOOD-PRESSURE; WEIGHT-LOSS; THERAPY; CPAP; RISK; HYPERTENSION	The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including ACP Smart Medicine and MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic from these primary sources in collaboration with the ACP's Medical Education and Publishing divisions and with the assistance of science writers and physician writers. Editorial consultants from ACP Smart Medicine and MKSAP provide expert review of the content. Readers who are interested in these primary resources for more detail can consult http://smartmedicine.acponline.org, http://www.acponline.org/products_services/mksap/15/?pr31, and other resources referenced in each issue of In the Clinic. CME Objective: To review current evidence for the screening and prevention, diagnosis, treatment, and practice improvement of obstructive sleep apnea. The information contained herein should never be used as a substitute for clinical judgment. (C) 2014 American College of Physicians						Patel, Sanjay/0000-0002-9142-5172; Balachandran, Jay/0000-0001-5574-4662				Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; [Anonymous], 2011, CAN RESPIR J, V18, P25, DOI 10.1155/2011/506189; Arias MA, 2006, EUR HEART J, V27, P1106, DOI 10.1093/eurheartj/ehi807; Aurora RN, 2010, SLEEP, V33, P1408, DOI 10.1093/sleep/33.10.1408; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Benbadis SR, 1999, ANN INTERN MED, V130, P289, DOI 10.7326/0003-4819-130-4-199902160-00014; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; Chai CL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005308.pub2; Chai-Coetzer CL, 2013, JAMA-J AM MED ASSOC, V309, P997, DOI 10.1001/jama.2013.1823; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Dixon JB, 2012, JAMA-J AM MED ASSOC, V308, P1142, DOI 10.1001/2012.jama.11580; Duran-Cantolla J, 2010, BMJ-BRIT MED J, V341, pc5991; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Frey WC, 2003, OBES SURG, V13, P676, DOI 10.1381/096089203322509228; Gottlieb DJ, 2014, NEW ENGL J MED, V370, P2276, DOI 10.1056/NEJMoa1306766; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Gross JB, 2014, ANESTHESIOLOGY, V120, P268, DOI 10.1097/ALN.0000000000000053; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; Hallowell PT, 2007, SURGERY, V142, P608, DOI 10.1016/j.surg.2007.08.002; Hallowell PT, 2007, SURGERY, P142; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-20; Johansson K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4609; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1055/s-2002-32318; Kaw R, 2012, CHEST, V141, P436, DOI 10.1378/chest.11-0283; Kuna ST, 2011, AM J RESP CRIT CARE, V183, P1238, DOI 10.1164/rccm.201011-1770OC; Lettieri CJ, 2009, ANN INTERN MED, V151, P696, DOI 10.7326/0003-4819-151-10-200911170-00006; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; Montserrat JM, 2001, AM J RESP CRIT CARE, V164, P608, DOI 10.1164/ajrccm.164.4.2006034; Morgenthaler TI, 2006, SLEEP, V29, P1031; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Newman AB, 2005, ARCH INTERN MED, V165, P2408, DOI 10.1001/archinte.165.20.2408; Pack AI, 2001, AM J RESP CRIT CARE, V164, P1675, DOI 10.1164/ajrccm.164.9.2103032; Parthasarathy S, 2014, J CLIN SLEEP MED, V10, P243, DOI 10.5664/jcsm.3518; Patel SR, 2003, ARCH INTERN MED, V163, P565, DOI 10.1001/archinte.163.5.565; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Phillips CL, 2013, AM J RESP CRIT CARE, V187, P879, DOI 10.1164/rccm.201212-2223OC; Proczko MA, 2014, J ANESTH; Punjabi NM, 2008, AM J RESP CRIT CARE, V177, P1150, DOI 10.1164/rccm.200712-1884OC; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187; Rosen CL, 2012, SLEEP, V35, P757, DOI 10.5665/sleep.1870; Sawyer AM, 2011, SLEEP MED REV, V15, P343, DOI 10.1016/j.smrv.2011.01.003; Schwab RJ, 2013, AM J RESP CRIT CARE, V188, P613, DOI 10.1164/rccm.201307-1282ST; Strohl KP, 2013, AM J RESP CRIT CARE, V187, P1259, DOI 10.1164/rccm.201304-0726ST; Strollo P, 2014, ASSURANCE OBSTRUCTIV; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Tuomilehto HPI, 2009, AM J RESP CRIT CARE, V179, P320, DOI 10.1164/rccm.200805-669OC; Weaver TE, 2012, AM J RESP CRIT CARE, V186, P677, DOI 10.1164/rccm.201202-0200OC; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1996, ARCH INTERN MED, V156, P2445, DOI 10.1001/archinte.156.21.2445	56	15	16	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9							ITC1	10.7326/0003-4819-161-9-201411040-01005	http://dx.doi.org/10.7326/0003-4819-161-9-201411040-01005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364899				2022-12-28	WOS:000347244100001
J	Callaway, E				Callaway, Ewen			The birth of rice	NATURE			English	Editorial Material							DOMESTICATION											Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Gross BL, 2014, P NATL ACAD SCI USA, V111, P6190, DOI 10.1073/pnas.1308942110; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Sang T, 2013, CURR OPIN PLANT BIOL, V16, P139, DOI 10.1016/j.pbi.2013.03.003; Wing R. A., 2014, NAT GENET, V46, P982	6	36	39	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S58	S59		10.1038/514S58a	http://dx.doi.org/10.1038/514S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BW	25368889				2022-12-28	WOS:000343801500005
J	Balogh, ZJ; Lumsdaine, W; Moore, EE; Moore, FA				Balogh, Zsolt J.; Lumsdaine, William; Moore, Ernest E.; Moore, Frederick A.			Postinjury abdominal compartment syndrome: from recognition to prevention	LANCET			English	Article							INCREASED INTRAABDOMINAL PRESSURE; DAMAGE CONTROL RESUSCITATION; RESPIRATORY-DISTRESS-SYNDROME; LINEA ALBA FASCIOTOMY; OPEN ABDOMEN; FASCIAL CLOSURE; TRAUMA PATIENTS; NONOPERATIVE MANAGEMENT; PLANNED REOPERATION; CONTROL LAPAROTOMY	Postinjury abdominal compartment syndrome (ACS) is an example of a deadly clinical occurrence that was eliminated by strategic research and focused preventions. In the 1990s, the syndrome emerged with the widespread use of damage control surgery and aggressive crystalloid-based resuscitation. Patients who previously exsanguinated on the operating table made it to intensive care units, but then developed highly lethal hyperacute respiratory, renal, and cardiac failure due to increased abdominal pressure. Among many factors, delayed haemorrhage control and preload driven excessive use of crystalloid resuscitation were identifi ed as modifi able predictors. The surrogate eff ect of preventive strategies, including the challenge of the 40-year-old standard of large volume crystalloid resuscitation for traumatic shock, greatly reduced cases of ACS. The discoveries were rapidly translated to civilian and military trauma surgical practices and fundamentally changed the way trauma patients are resuscitated today with substantially improved outcomes.	[Balogh, Zsolt J.; Lumsdaine, William] John Hunter Hosp, Dept Traumatol, Newcastle, NSW 2310, Australia; [Balogh, Zsolt J.; Lumsdaine, William] Univ Newcastle, Newcastle, NSW 2310, Australia; [Moore, Ernest E.] Univ Colorado, Dept Surg, Denver, CO 80202 USA; [Moore, Frederick A.] Univ Florida, Dept Surg, Gainesville, FL USA	John Hunter Hospital; University of Newcastle; University of Colorado System; University of Colorado Denver; State University System of Florida; University of Florida	Balogh, ZJ (corresponding author), John Hunter Hosp, Dept Traumatol, Newcastle, NSW 2310, Australia.	zsolt.balogh@hnehealth.nsw.gov.au	Balogh, Zsolt/A-2002-2010; Lumsdaine, William/AAK-2083-2021	Balogh, Zsolt/0000-0002-0277-4822; 				Acosta S, 2011, BRIT J SURG, V98, P735, DOI 10.1002/bjs.7383; Albrecht R, 1999, AM SURGEON, V65, P724; Avery J, 2006, GENERALIZED STURMIANS AND ATOMIC SPECTRA, P1; Balogh Z, 2003, J TRAUMA, V54, P848, DOI 10.1097/01.TA.0000070166.29649.F3; Balogh Z, 2002, AM J SURG, V184, P538, DOI 10.1016/S0002-9610(02)01050-4; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Balogh Z, 2003, AM J SURG, V186, P602, DOI 10.1016/j.amjsurg.2003.09.002; Balogh Z, 2003, SHOCK, V20, P483, DOI 10.1097/01.shk.0000093346.68755.43; Balogh Z, 2007, INJURY, V38, P272, DOI 10.1016/j.injury.2006.02.026; Balogh ZJ, 2011, ARCH SURG-CHICAGO, V146, P938, DOI 10.1001/archsurg.2011.73; Balogh ZJ, 2009, WORLD J SURG, V33, P1134, DOI 10.1007/s00268-009-0002-x; Biffl WL, 2001, AM J SURG, V182, P645, DOI 10.1016/S0002-9610(01)00814-5; BISHOP MH, 1995, J TRAUMA, V38, P780, DOI 10.1097/00005373-199505000-00018; BISHOP MH, 1993, CRIT CARE MED, V21, P56, DOI 10.1097/00003246-199301000-00013; Bjorck M, 2011, AM SURGEON, V77, pS58; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; BOTHA AJ, 1995, J TRAUMA, V39, P411; BRADLEY SE, 1947, FED PROC, V6, P80; BRINSON R, 1989, DIGEST DIS SCI, V34, P97, DOI 10.1007/BF01536161; Burch J, 2002, AM J SURG, V184, P543; BURCH JM, 1992, ANN SURG, V215, P476, DOI 10.1097/00000658-199205000-00010; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P235, DOI 10.1097/TA.0b013e318236b319; BURROWS R, 1995, S AFR MED J, V85, P46; Cheatham M, 2006, ABDOMINAL COMPARTMEN, P89; Cheatham ML, 2013, WORLD J SURG, V37, P2018, DOI 10.1007/s00268-013-2080-z; Cheatham ML, 2010, CRIT CARE MED, V38, P402, DOI 10.1097/CCM.0b013e3181b9e9b1; Chen RJ, 2001, J TRAUMA, V51, P44, DOI 10.1097/00005373-200107000-00007; Ciresi DL, 1999, AM SURGEON, V65, P720; Corcos AC, 2001, J TRAUMA, V51, P1062, DOI 10.1097/00005373-200112000-00006; Cothren CC, 2007, AM J SURG, V194, P804, DOI 10.1016/j.amjsurg.2007.08.023; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; CULLEN DJ, 1989, CRIT CARE MED, V17, P118, DOI 10.1097/00003246-198902000-00002; Dalfino L, 2008, INTENS CARE MED, V34, P707, DOI 10.1007/s00134-007-0969-4; Demetriades D, 2014, SURG CLIN N AM, V94, P131, DOI 10.1016/j.suc.2013.10.010; DIEBEL L, 1992, AM SURGEON, V58, P573; DIEBEL LN, 1992, J TRAUMA, V33, P45, DOI 10.1097/00005373-199207000-00010; DIEBEL LN, 1992, J TRAUMA, V33, P279, DOI 10.1097/00005373-199208000-00019; Duchesne JC, 2010, J TRAUMA, V69, P46, DOI 10.1097/TA.0b013e3181df91fa; Duchesne JC, 2010, AM SURGEON, V76, P312; Eleftheriadis E, 1996, WORLD J SURG, V20, P11, DOI 10.1007/s002689900002; FIETSAM R, 1989, AM SURGEON, V55, P396; Gattinoni L, 1998, AM J RESP CRIT CARE, V158, P3, DOI 10.1164/ajrccm.158.1.9708031; GRANGER DN, 1976, GASTROENTEROLOGY, V71, P1023; Gunter OL, 2008, J TRAUMA, V65, P527, DOI 10.1097/TA.0b013e3181826ddf; HARMAN PK, 1982, ANN SURG, V196, P594, DOI 10.1097/00000658-198211000-00015; HERSHENSON MB, 1985, J PEDIATR SURG, V20, P348, DOI 10.1016/S0022-3468(85)80217-7; Hess JR, 2006, TRANSFUSION, V46, P685, DOI 10.1111/j.1537-2995.2006.00816.x; HIRSHBERG A, 1994, J TRAUMA, V37, P365, DOI 10.1097/00005373-199409000-00005; Holodinsky JK, 2013, CRIT CARE, V17, DOI 10.1186/cc13075; Hong JJ, 2002, BRIT J SURG, V89, P591, DOI 10.1046/j.1365-2168.2002.02072.x; Howdieshell TR, 2004, AM J SURG, V188, P301, DOI 10.1016/j.amjsurg.2004.03.007; Ivatury RR, 1998, J TRAUMA, V44, P1016, DOI 10.1097/00005373-199806000-00014; Kasotakis G, 2013, J TRAUMA ACUTE CARE, V74, P1215, DOI 10.1097/TA.0b013e3182826e13; Kirkpatrick AW, 2007, ACTA CLIN BELG, V62, P60, DOI 10.1179/acb.2007.62.s1.008; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Kirkpatrick AW, 2006, J AM COLL SURGEONS, V202, P668, DOI 10.1016/j.jamcollsurg.2005.11.020; KIRSCH AJ, 1994, UROLOGY, V43, P453, DOI 10.1016/0090-4295(94)90230-5; Kopelman T, 2000, J TRAUMA, V49, P744, DOI 10.1097/00005373-200010000-00025; Kozar RA, 2005, J TRAUMA, V59, P1066, DOI 10.1097/01.ta.0000188937.75879.ab; KRON IL, 1984, ANN SURG, V199, P28, DOI 10.1097/00000658-198401000-00005; Leppaniemi A, 2011, AM SURGEON, V77, P99; Maxwell RA, 1999, J TRAUMA, V47, P995, DOI 10.1097/00005373-199912000-00001; McKinley BA, 2002, J TRAUMA, V53, P825, DOI 10.1097/00005373-200211000-00004; McNelis J, 2002, ARCH SURG-CHICAGO, V137, P133, DOI 10.1001/archsurg.137.2.133; MELDRUM DR, 1995, AM J SURG, V170, P537, DOI 10.1016/S0002-9610(99)80011-7; Meldrum DR, 1997, AM J SURG, V174, P667, DOI 10.1016/S0002-9610(97)00201-8; Mentula P, 2010, ARCH SURG-CHICAGO, V145, P764, DOI 10.1001/archsurg.2010.132; Miller PR, 2004, ANN SURG, V239, P608, DOI 10.1097/01.sla.0000124291.09032.bf; Miller PR, 2002, J TRAUMA, V53, P843, DOI 10.1097/00005373-200211000-00007; Miller PR, 1998, J TRAUMA, V44, P107, DOI 10.1097/00005373-199801000-00013; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; MOORE FA, 1995, SURG CLIN N AM, V75, P257, DOI 10.1016/S0039-6109(16)46587-4; Moore FA, 1996, J TRAUMA, V40, P510; Morris JA, 1997, J TRAUMA, V42, P404; MORRIS JA, 1993, ANN SURG, V217, P576, DOI 10.1097/00000658-199305010-00019; MUTOH T, 1992, J APPL PHYSIOL, V72, P575, DOI 10.1152/jappl.1992.72.2.575; Oda J, 2002, J TRAUMA, V52, P625, DOI 10.1097/00005373-200204000-00003; Offner PJ, 2001, ARCH SURG-CHICAGO, V136, P676, DOI 10.1001/archsurg.136.6.676; Paramore R H, 1913, Proc R Soc Med, V6, P291; Parra MW, 2006, J TRAUMA, V60, P1119, DOI 10.1097/01.ta.0000217274.48792.4d; Raeburn CD, 2001, AM J SURG, V182, P542, DOI 10.1016/S0002-9610(01)00821-2; Ranieri VM, 1997, AM J RESP CRIT CARE, V156, P1082, DOI 10.1164/ajrccm.156.4.97-01052; Rao M, 2007, COLORECTAL DIS, V9, P266, DOI 10.1111/j.1463-1318.2006.01154.x; RASMUSSEN I, 1995, EUR J SURG, V161, P819; Regner JL, 2012, WORLD J SURG, V36, P497, DOI 10.1007/s00268-011-1203-7; Rezende-Neto JB, 2003, SHOCK, V20, P303, DOI 10.1097/01.shk.0000082487.34705.d3; Rezende-Neto JB, 2002, J TRAUMA, V53, P1121, DOI 10.1097/00005373-200212000-00015; RICHARDS WO, 1983, ANN SURG, V197, P183, DOI 10.1097/00000658-198302000-00010; Ridings PC, 1995, J TRAUMA, V39, P1071, DOI 10.1097/00005373-199512000-00010; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Schochl H, 2010, ANAESTHESIA, V65, P199, DOI 10.1111/j.1365-2044.2009.06188.x; Schwartz DA, 2014, J TRAUMA ACUTE CARE, V76, P134, DOI 10.1097/TA.0b013e3182ab0cfc; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; SHELLY MP, 1987, BRIT J ANAESTH, V59, P800, DOI 10.1093/bja/59.6.800; SHIRES T, 1964, ARCH SURG-CHICAGO, V88, P688; SHIRES T, 1965, SURG CLIN N AM, V45, P365; Shires T, 1960, SURG FORUM, V11, P115; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; Simon RJ, 1997, J TRAUMA, V42, P398, DOI 10.1097/00005373-199703000-00006; Smith A, 2013, CAN J SURG, V56, pE154, DOI 10.1503/cjs.020012; STONE HH, 1983, ANN SURG, V197, P532, DOI 10.1097/00000658-198305000-00005; SUGRUE M, 1995, BRIT J SURG, V82, P235, DOI 10.1002/bjs.1800820234; Sugrue M, 1996, WORLD J SURG, V20, P988, DOI 10.1007/s002689900149; van Hensbroek PB, 2009, WORLD J SURG, V33, P199, DOI 10.1007/s00268-008-9867-3; Velmahos GC, 2000, ANN SURG, V232, P409, DOI 10.1097/00000658-200009000-00013; Wendon Julia A, 2006, Hepatology, V44, P504, DOI 10.1002/hep.21311; WESLEY JR, 1981, J PEDIATR SURG, V16, P264, DOI 10.1016/S0022-3468(81)80677-X; Youssef AM, 2012, J TRAUMA ACUTE CARE, V72, P183, DOI 10.1097/TA.0b013e31822a3254	110	51	54	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1466	1475		10.1016/S0140-6736(14)61689-5	http://dx.doi.org/10.1016/S0140-6736(14)61689-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25390328				2022-12-28	WOS:000343107000027
J	Chansakul, T; von Keudell, A; Rohloff, P; Janneck, L; Bustamante, N; Weaver, MJ; Fulwadhva, U				Chansakul, Thanissara; von Keudell, Arvind; Rohloff, Peter; Janneck, Laura; Bustamante, Nirma; Weaver, Michael J.; Fulwadhva, Urvi			Scapular prolapse into the intrathoracic cavity in a lung transplant patient	LANCET			English	Editorial Material							THORACOTOMY		[Chansakul, Thanissara; Fulwadhva, Urvi] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [von Keudell, Arvind; Weaver, Michael J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA; [Rohloff, Peter] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Hosp Med, Boston, MA 02115 USA; [Janneck, Laura; Bustamante, Nirma] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Emergency Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	von Keudell, A (corresponding author), Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02114 USA.	avonkeudell@mgh.harvard.edu	Rohloff, Peter/P-8722-2017	Rohloff, Peter/0000-0001-7274-8315; Janneck, Laura/0000-0001-6228-7383				Eguchi T, 2011, INTERACT CARDIOV TH, V12, P326, DOI 10.1510/icvts.2010.248690; Gilkeson RC, 1998, AM J ROENTGENOL, V171, P1706, DOI 10.2214/ajr.171.6.9843320; GOULD SW, 1994, CAN ASSOC RADIOL J, V45, P145; Lee RS, 2012, ACTA CHIR BELG, V112, P450, DOI 10.1080/00015458.2012.11680873; Murray JG, 1996, AM J ROENTGENOL, V166, P1405, DOI 10.2214/ajr.166.6.8633454; Palissery V, 2009, Int Arch Med, V2, P10, DOI 10.1186/1755-7682-2-10	6	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1476	1476		10.1016/S0140-6736(14)61642-1	http://dx.doi.org/10.1016/S0140-6736(14)61642-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25390329				2022-12-28	WOS:000343107000028
J	Robert, C; Long, GV; Brady, B; Dutriaux, C; Maio, M; Mortier, L; Hassel, JC; Rutkowski, P; McNeil, C; Kalinka-Warzocha, E; Savage, KJ; Hernberg, MM; Lebbe, C; Charles, J; Mihalcioiu, C; Chiarion-Sileni, V; Mauch, C; Cognetti, F; Arance, A; Schmidt, H; Schadendorf, D; Gogas, H; Lundgren-Eriksson, L; Horak, C; Sharkey, B; Waxman, IM; Atkinson, V; Ascierto, PA				Robert, Caroline; Long, Georgina V.; Brady, Benjamin; Dutriaux, Caroline; Maio, Michele; Mortier, Laurent; Hassel, Jessica C.; Rutkowski, Piotr; McNeil, Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J.; Hernberg, Micaela M.; Lebbe, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni, Vanna; Mauch, Cornelia; Cognetti, Francesco; Arance, Ana; Schmidt, Henrik; Schadendorf, Dirk; Gogas, Helen; Lundgren-Eriksson, Lotta; Horak, Christine; Sharkey, Brian; Waxman, Ian M.; Atkinson, Victoria; Ascierto, Paolo A.			Nivolumab in Previously Untreated Melanoma without BRAF Mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC MELANOMA; ANTI-PD-1 ANTIBODY; IMPROVED SURVIVAL; MEK INHIBITION; OPEN-LABEL; VEMURAFENIB; SAFETY; IPILIMUMAB; EFFICACY; PHASE-3	BACKGROUND Nivolumab was associated with higher rates of objective response than chemotherapy in a phase 3 study involving patients with ipilimumab-refractory metastatic melanoma. The use of nivolumab in previously untreated patients with advanced melanoma has not been tested in a phase 3 controlled study. METHODS We randomly assigned 418 previously untreated patients who had metastatic melanoma without a BRAF mutation to receive nivolumab (at a dose of 3 mg per kilogram of body weight every 2 weeks and dacarbazine-matched placebo every 3 weeks) or dacarbazine (at a dose of 1000 mg per square meter of body-surface area every 3 weeks and nivolumab-matched placebo every 2 weeks). The primary end point was overall survival. RESULTS At 1 year, the overall rate of survival was 72.9% (95% confidence interval [CI], 65.5 to 78.9) in the nivolumab group, as compared with 42.1% (95% CI, 33.0 to 50.9) in the dacarbazine group (hazard ratio for death, 0.42; 99.79% CI, 0.25 to 0.73; P < 0.001). The median progression-free survival was 5.1 months in the nivolumab group versus 2.2 months in the dacarbazine group (hazard ratio for death or progression of disease, 0.43; 95% CI, 0.34 to 0.56; P < 0.001). The objective response rate was 40.0% (95% CI, 33.3 to 47.0) in the nivolumab group versus 13.9% (95% CI, 9.5 to 19.4) in the dacarbazine group (odds ratio, 4.06; P < 0.001). The survival benefit with nivolumab versus dacarbazine was observed across prespecified subgroups, including subgroups defined by status regarding the programmed death ligand 1 (PD-L1). Common adverse events associated with nivolumab included fatigue, pruritus, and nausea. Drug-related adverse events of grade 3 or 4 occurred in 11.7% of the patients treated with nivolumab and 17.6% of those treated with dacarbazine. CONCLUSIONS Nivolumab was associated with significant improvements in overall survival and progression-free survival, as compared with dacarbazine, among previously untreated patients who had metastatic melanoma without a BRAF mutation.	[Robert, Caroline] Gustave Roussy, Villejuif, France; [Robert, Caroline] INSERM, U981, Villejuif, France; [Dutriaux, Caroline] Ctr Hosp Univ, Hop St Andre, Bordeaux, France; [Mortier, Laurent] Hop Claude Huriez, Lille, France; [Lebbe, Celeste] Assistance Publ Hop Paris Dermatol, Paris, France; [Lebbe, Celeste] Univ Paris 07, INSERM, Ctr Invest Clin, Hop St Louis,U976, Paris, France; [Charles, Julie] Univ Grenoble 1, Grenoble Univ Hosp, INSERM, U823, Grenoble, France; [Long, Georgina V.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2006, Australia; [Long, Georgina V.] Mater Hosp, Sydney, NSW, Australia; [Brady, Benjamin] Cabrini Hlth, Melbourne, Vic, Australia; [McNeil, Catriona] Melanoma Inst Australia, Camperdown, NSW, Australia; [McNeil, Catriona] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Atkinson, Victoria] Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [Atkinson, Victoria] Greenslopes Private Hosp, Gallipoli Med Res Fdn, Greenslopes, Qld, Australia; [Maio, Michele] Univ Hosp Siena, Siena, Italy; [Chiarion-Sileni, Vanna] Veneto Ist Ricovero & Cura Carattere Sci, Inst Oncol, Padua, Italy; [Cognetti, Francesco] Regina Elena Inst Canc Res, Div Oncol, Rome, Italy; [Ascierto, Paolo A.] Fdn Pascale, Ist Nazl Tumori, Naples, Italy; [Hassel, Jessica C.] Univ Heidelberg Hosp, Heidelberg, Germany; [Hassel, Jessica C.] Natl Ctr Tumor Dis, Heidelberg, Germany; [Mauch, Cornelia] Univ Hosp Cologne, Dept Dermatol, Bonn, Germany; [Mauch, Cornelia] Ctr Integrierte Onkol Koln, Bonn, Germany; [Schadendorf, Dirk] Univ Essen Gesamthsch, Dept Dermatol, Essen, Germany; [Rutkowski, Piotr] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Rutkowski, Piotr] Inst Oncol, Warsaw, Poland; [Kalinka-Warzocha, Ewa] Wojewodzki Szpital Specjalisty M Kopernika, Lodz, Poland; [Savage, Kerry J.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Mihalcioiu, Catalin] Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Hernberg, Micaela M.] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Arance, Ana] Hosp Clin Barcelona, Barcelona, Spain; [Schmidt, Henrik] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; [Gogas, Helen] Univ Athens, Sch Med, Laiko Gen Hosp, GR-10679 Athens, Greece; [Lundgren-Eriksson, Lotta] Lund Univ, Dept Clin Sci, Div Oncol, Lund, Sweden; [Horak, Christine; Waxman, Ian M.] Bristol Myers Squibb Co, Lawrenceville, NJ USA; [Sharkey, Brian] Bristol Myers Squibb Co, Wallingford, CT 06492 USA	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Bordeaux; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Melanoma Institute Australia; University of Sydney; Cabrini Health; Melanoma Institute Australia; University of Sydney; University of Siena; University Hospital of Siena; IRCCS Istituto Oncologico Veneto (IOV); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Fondazione Pascale; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Bonn; University of Cologne; University of Duisburg Essen; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; British Columbia Cancer Agency; McGill University; Royal Victoria Hospital; University of Helsinki; Helsinki University Central Hospital; University of Barcelona; Hospital Clinic de Barcelona; Aarhus University; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Lund University; Bristol-Myers Squibb; Bristol-Myers Squibb	Robert, C (corresponding author), Gustave Roussy, INSERM, Dermatol Serv, U981, Villejuif, France.	caroline.robert@gustaveroussy.fr	Long, Georgina V/C-1771-2013; Cognetti, Francesco/AAC-2637-2019; sileni, vanna chiarion/B-9042-2018; charles, julie/E-8929-2013; Rutkowski, Piotr/B-3907-2013; Ascierto, Paolo A/J-9106-2016; Atkinson, Victoria G/G-2507-2015; Robert, Caroline/G-6157-2018; Savage, Kerry/HCH-5539-2022; Schmidt, Henrik/A-1753-2008; Schadendorf, Dirk/AAE-8206-2019	Long, Georgina V/0000-0001-8894-3545; sileni, vanna chiarion/0000-0001-9191-9124; charles, julie/0000-0003-4667-6009; Rutkowski, Piotr/0000-0002-8920-5429; Ascierto, Paolo A/0000-0002-8322-475X; Robert, Caroline/0000-0002-9493-0238; Maio, Michele/0000-0002-0323-6321; COGNETTI, FRANCESCO/0000-0003-2022-9446; Kalinka, Ewa/0000-0003-4791-8372; coral, sandra/0000-0002-1308-3082; Arance, Ana/0000-0003-2896-1957; Melucci, Maria Teresa/0000-0002-1677-3345	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Supported by Bristol-Myers Squibb.	American Cancer Society, CANC FACTS FIG 2014; [Anonymous], KEYTR PEMBR PRESCR I; [Anonymous], NCI COMM TERM CRIT A; [Anonymous], MEL SKIN CANC; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Espinosa E, 2014, AM J THER; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Grosso J, 2013, J CLIN ONCOL, V31; Hamid O, 2013, ASCO M S, V31, P9010, DOI DOI 10.1200/jco.2013.31.15_suppl.9010; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; McDermott DF, 2014, EUR SOC MED ONC 2014; Ribas AF, 2014, J CLIN ONCOL S, V32, p5s; Ribas Antoni, 2012, Am Soc Clin Oncol Educ Book, P675, DOI 10.14694/EdBook_AM.2012.32.675; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang CY, 2014, CANCER IMMUNOL RES, V2, P846, DOI 10.1158/2326-6066.CIR-14-0040; Weber JS, 2013, J CLIN ONCOL, V31; Weber JS, 2013, J CLIN ONCOL, V31, P4311, DOI 10.1200/JCO.2013.51.4802; Weber JS, 2014, EUR SOC MED ONC 2014; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; World Health Organization, ULTR RAD INTERSUN PR	27	3825	3952	8	295	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					320	330		10.1056/NEJMoa1412082	http://dx.doi.org/10.1056/NEJMoa1412082			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ4PJ	25399552	Green Published			2022-12-28	WOS:000348204500007
J	Xue, SF; Tian, SQ; Fujii, K; Kladwang, W; Das, R; Barna, M				Xue, Shifeng; Tian, Siqi; Fujii, Kotaro; Kladwang, Wipapat; Das, Rhiju; Barna, Maria			RNA regulons in Hox 5 ' UTRs confer ribosome specificity to gene regulation	NATURE			English	Article							LINKED DYSKERATOSIS-CONGENITA; CAP-DEPENDENT TRANSLATION; SECONDARY STRUCTURE; MESSENGER-RNAS; ENTRY SITE; CAPILLARY-ELECTROPHORESIS; SPECIALIZED RIBOSOMES; MEDIATED TRANSLATION; ROBUST ANALYSIS; AXIAL SKELETON	Emerging evidence suggests that the ribosome has a regulatory function in directing how the genome is translated in time and space. However, how this regulation is encoded in the messenger RNA sequence remains largely unknown. Here we uncover unique RNA regulons embedded in homeobox (Hox) 5' untranslated regions (UTRs) that confer ribosome-mediated control of gene expression. These structured RNA elements, resembling viral internal ribosome entry sites (IRESs), are found in subsets of Hox mRNAs. They facilitate ribosome recruitment and require the ribosomal protein RPL38 for their activity. Despite numerous layers of Hox gene regulation, these IRES elements are essential for converting Hox transcripts into proteins to pattern the mammalian body plan. This specialized mode of IRES-dependent translation is enabled by an additional regulatory element that we term the translation inhibitory element (TIE), which blocks cap-dependent translation of transcripts. Together, these data uncover a new paradigm for ribosome-mediated control of gene expression and organismal development.	[Xue, Shifeng; Fujii, Kotaro; Barna, Maria] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Xue, Shifeng; Fujii, Kotaro; Barna, Maria] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Xue, Shifeng] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA; [Tian, Siqi; Kladwang, Wipapat; Das, Rhiju] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; Stanford University; Stanford University	Barna, M (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	mbarna@stanford.edu		Fujii, Kotaro/0000-0002-6028-4776; Das, Rhiju/0000-0001-7497-0972; Xue, Shifeng/0000-0002-4668-5952	Agency of Science, Technology and Research of Singapore; Stanford Graduate Fellowship; Human Frontier Science Program Fellowship [NIH R01 GM102519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102519] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008509] Funding Source: NIH RePORTER	Agency of Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Stanford Graduate Fellowship(Stanford University); Human Frontier Science Program Fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank members of the Barna laboratory and D. Ruggero for discussion and critical reading of the manuscript. We thank E. Sarinay Cenik for advice with RNA pull- down experiments; and Y. Rim, A. Sapiro and A. Mateo for technical assistance. This work was supported by the Agency of Science, Technology and Research of Singapore (S. X.), Stanford Graduate Fellowship (S. T.), Human Frontier Science Program Fellowship (K. F.), NIH R01 GM102519 (R. D.), NIH Director's New InnovatorAward, 7DP2OD00850902(M. B.), Alfred P. SloanResearch Fellowship(M. B.) and Pew Scholars Award (M. B.).	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Boulet AM, 1996, DEV BIOL, V177, P232, DOI 10.1006/dbio.1996.0159; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Coulombe Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010600; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dinman JD, 2009, J BIOL CHEM, V284, P11761, DOI 10.1074/jbc.R800074200; FLETCHER L, 1990, J BIOL CHEM, V265, P19582; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; Harris D. A., 2003, CURR PROTOC NUCL ACI; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Johnston IA, 2006, J EXP BIOL, V209, P2249, DOI 10.1242/jeb.02153; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kim H, 2013, NUCLEIC ACIDS RES, V41, pW492, DOI 10.1093/nar/gkt501; Kim J, 2009, BIOINFORMATICS, V25, P1137, DOI 10.1093/bioinformatics/btp110; Kladwang W., 2014, PREPRINT; Kladwang W, 2014, BIOCHEMISTRY-US, V53, P3063, DOI 10.1021/bi5003426; Kladwang W, 2011, NAT CHEM, V3, P954, DOI [10.1038/nchem.1176, 10.1038/NCHEM.1176]; Kladwang W, 2011, RNA, V17, P522, DOI 10.1261/rna.2516311; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Lukavsky PJ, 2003, NAT STRUCT BIOL, V10, P1033, DOI 10.1038/nsb1004; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; OH SK, 1992, GENE DEV, V6, P1643, DOI 10.1101/gad.6.9.1643; Phinney DG, 2005, BIOCHEM BIOPH RES CO, V338, P1759, DOI 10.1016/j.bbrc.2005.10.140; Plank TDM, 2012, WIRES RNA, V3, P195, DOI 10.1002/wrna.1105; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Riley A, 2010, NUCLEIC ACIDS RES, V38, P4665, DOI 10.1093/nar/gkq241; Seetin MG, 2014, METHODS MOL BIOL, V1086, P95, DOI 10.1007/978-1-62703-667-2_6; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Stupina VA, 2011, J VIROL, V85, P4638, DOI 10.1128/JVI.00005-11; Talkish J, 2014, RNA, V20, P713, DOI 10.1261/rna.042218.113; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Tian SQ, 2014, RNA, V20, P1815, DOI 10.1261/rna.044321.114; Ungureanu NH, 2006, J BIOL CHEM, V281, P15155, DOI 10.1074/jbc.M511319200; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xia XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004136; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Yoon S, 2011, BIOINFORMATICS, V27, P1798, DOI 10.1093/bioinformatics/btr277	59	192	194	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					33	U55		10.1038/nature14010	http://dx.doi.org/10.1038/nature14010			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25409156	Green Accepted			2022-12-28	WOS:000347178400029
J	Budai, JD; Hong, JW; Manley, ME; Specht, ED; Li, CW; Tischler, JZ; Abernathy, DL; Said, AH; Leu, BM; Boatner, LA; McQueeney, RJ; Delaire, O				Budai, John D.; Hong, Jiawang; Manley, Michael E.; Specht, Eliot D.; Li, Chen W.; Tischler, Jonathan Z.; Abernathy, Douglas L.; Said, Ayman H.; Leu, Bogdan M.; Boatner, Lynn A.; McQueeney, Robert J.; Delaire, Olivier			Metallization of vanadium dioxide driven by large phonon entropy	NATURE			English	Article							METAL-INSULATOR-TRANSITION; MOTT-HUBBARD; LATTICE-DYNAMICS; VO2; PEIERLS; RUTILE; VIEW; NBO2	Phase competition underlies many remarkable and technologically important phenomena in transition metal oxides. Vanadium dioxide (VO2) exhibits a first-order metal-insulator transition (MIT) near room temperature, where conductivity is suppressed and the lattice changes from tetragonal to monoclinic on cooling. Ongoing attempts to explain this coupled structural and electronic transition begin with two alternative starting points: a Peierls MIT driven by instabilities in electron-lattice dynamics and a Mott MIT where strong electronelectron correlations drive charge localization'. A key missing piece of the VO2 puzzle is the role of lattice vibrations. Moreover, a comprehensive thermodynamic treatment must integrate both entropic and energetic aspects of the transition. Here we report that the entropy driving the MIT in VO2 is dominated by strongly anharmonic phonons rather than electronic contributions, and provide a direct determination of phonon dispersions. Our ab initio calculations identify softer bonding in the tetragonal phase, relative to the monoclinic phase, as the origin of the large vibrational entropy stabilizing the metallic mtile phase. They further reveal how a balance between higher entropy in the metal and orbital-driven lower energy in the insulator fully describes the thermodynamic forces controlling the MIT. Our study illustrates the critical role of anharmonic lattice dynamics in metal oxide phase competition, and provides guidance for the predictive design of new materials.	[Budai, John D.; Hong, Jiawang; Manley, Michael E.; Specht, Eliot D.; Li, Chen W.; Boatner, Lynn A.; Delaire, Olivier] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; [Tischler, Jonathan Z.; Said, Ayman H.; Leu, Bogdan M.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Abernathy, Douglas L.] Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA; [McQueeney, Robert J.] Oak Ridge Natl Lab, Neutron Sci Directorate, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Budai, JD (corresponding author), Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA.	budaijd@ornl.gov; delaireoa@ornl.gov	Manley, Michael/P-3426-2019; Specht, Eliot D/A-5654-2009; Hong, Jiawang/B-2864-2009; Delaire, Olivier/AAZ-7838-2020; Li, Chen/D-1542-2010; Budai, John/R-9276-2016; Abernathy, Douglas L/A-3038-2012; Li, Chen/AAJ-3933-2021; BL18, ARCS/A-3000-2012; Boatner, Lynn A/I-6428-2013; Manley, Michael/N-4334-2015; McQueeney, Robert J/A-2864-2016; Leu, Bogdan/J-9952-2015	Manley, Michael/0000-0003-4053-9986; Specht, Eliot D/0000-0002-3191-2163; Hong, Jiawang/0000-0002-9915-8072; Li, Chen/0000-0002-0758-5334; Budai, John/0000-0002-7444-1306; Abernathy, Douglas L/0000-0002-3533-003X; Li, Chen/0000-0002-0758-5334; Boatner, Lynn A/0000-0002-0235-7594; McQueeney, Robert J/0000-0003-0718-5602; Delaire, Olivier/0000-0003-1230-2834; Leu, Bogdan/0000-0003-2020-0686	US Department of Energy (DOE), Basic Energy Sciences (BES), Materials Sciences and Engineering Division (MSED); Center for Accelerating Materials Modeling - US DOE, BES, MSED; Laboratory Directed Research and Development Program of ORNL; US DOE, BES, Scientific User Facilities Division; Scientific User Facilities Division, Office of Basic Energy Sciences, US Department of Energy; US DOE [DE-AC02-06CH11357]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]	US Department of Energy (DOE), Basic Energy Sciences (BES), Materials Sciences and Engineering Division (MSED)(United States Department of Energy (DOE)); Center for Accelerating Materials Modeling - US DOE, BES, MSED(United States Department of Energy (DOE)); Laboratory Directed Research and Development Program of ORNL; US DOE, BES, Scientific User Facilities Division(United States Department of Energy (DOE)); Scientific User Facilities Division, Office of Basic Energy Sciences, US Department of Energy(United States Department of Energy (DOE)); US DOE(United States Department of Energy (DOE)); Office of Science of the US Department of Energy(United States Department of Energy (DOE))	Research by J.D.B., O.D., M.E.M., E.D.S., L.A.B. and R.J.M. was supported by the US Department of Energy (DOE), Basic Energy Sciences (BES), Materials Sciences and Engineering Division (MSED). Research by J.H. was supported by the Center for Accelerating Materials Modeling, funded by the US DOE, BES, MSED. Experimental work by C.W.L. was sponsored by the Laboratory Directed Research and Development Program of ORNL (Principal Investigator, O.D.). Research by D.L.A. at the Spallation Neutron Source and J.Z.T., A.H.S. and B.M.L. at the Advanced Photon Source (APS), Argonne National Laboratory (ANL), was supported by the US DOE, BES, Scientific User Facilities Division. We thank A. Tselev, S. Nagler, A. Banerjee, H. Krakauer and V. Cooper for interesting discussions on VO<INF>2</INF>. Inelastic neutron scattering measurements were performed using the ARCS facility at the ORNL Spallation Neutron Source, which is sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, US Department of Energy. We thank J. Niedziela for help with the sample environment at ARCS. IXS measurements were performed using the X-ray Operations and Research (XOR) beamline 30-ID (HERIX) at the APS. Diffuse X-ray scattering measurements were performed using the XOR beamline 33-BM-C at the APS. We thank J. Karapetrova and C. Schleputz for assistance in setting up experiments at UN ICAT. Use of the APS, an Office of Science User Facility operated for the US DOE Office of Science by ANL, was supported by the US DOE under contract no. DE-AC02-06CH11357. Theoretical calculations were performed using resources of the National Energy Research Scientific Computing Center, a DOE Office of Science User Facility supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231. We thank O. Hellman for providing the temperature-dependent effective potential software and assistance.	Abernathy DL, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3680104; Aetukuri NB, 2013, NAT PHYS, V9, P661, DOI 10.1038/NPHYS2733; BERGLUND CN, 1969, PHYS REV, V185, P1022, DOI 10.1103/PhysRev.185.1022; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; COMES R, 1970, ACTA CRYSTALL A-CRYS, VA 26, P244, DOI 10.1107/S056773947000061X; COMES R, 1974, ACTA CRYSTALLOGR A, VA 30, P55, DOI 10.1107/S056773947400009X; Eyert V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016401; Eyert V, 2002, ANN PHYS-BERLIN, V11, P650, DOI 10.1002/1521-3889(200210)11:9<650::AID-ANDP650>3.0.CO;2-K; GERVAIS F, 1985, PHYS REV B, V31, P4809, DOI 10.1103/PhysRevB.31.4809; GOODENOUGH JB, 1971, J SOLID STATE CHEM, V3, P490, DOI 10.1016/0022-4596(71)90091-0; Haverkort MW, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196404; HEARN CJ, 1972, J PHYS PART C SOLID, V5, P1317, DOI 10.1088/0022-3719/5/12/012; Hellman O, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.104111; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Jeong J, 2013, SCIENCE, V339, P1402, DOI 10.1126/science.1230512; Karapetrova E, 2011, NUCL INSTRUM METH A, V649, P52, DOI 10.1016/j.nima.2010.12.159; Khomskii DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.156402; Kim S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195106; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Liebsch A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.085109; LIECHTENSTEIN AI, 1995, PHYS REV B, V52, pR5467, DOI 10.1103/PhysRevB.52.R5467; LONGO JM, 1970, ACTA CHEM SCAND, V24, P420, DOI 10.3891/acta.chem.scand.24-0420; Lovesey S. W., 1985, THEORY NEUTRON SCATT; Manley ME, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144111; Maurer D, 1999, PHYS REV B, V60, P13249, DOI 10.1103/PhysRevB.60.13249; MCWHAN DB, 1974, PHYS REV B, V10, P490, DOI 10.1103/PhysRevB.10.490; Nakano M, 2012, NATURE, V487, P459, DOI 10.1038/nature11296; Park JH, 2013, NATURE, V500, P431, DOI 10.1038/nature12425; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PINTCHOVSKI F, 1978, J PHYS CHEM SOLIDS, V39, P941, DOI 10.1016/0022-3697(78)90108-7; PYNN R, 1978, PHYS REV B, V17, P2196, DOI 10.1103/PhysRevB.17.2196; Qu BY, 2011, J APPL PHYS, V110, DOI 10.1063/1.3665640; RICE TM, 1994, PHYS REV LETT, V73, P3042, DOI 10.1103/PhysRevLett.73.3042; Squires G. L., 1978, INTRO THEORY NEUTRON; SRIVASTAVA R, 1971, PHYS REV LETT, V27, P727, DOI 10.1103/PhysRevLett.27.727; SUGIYAMA K, 1991, Z KRISTALLOGR, V194, P305, DOI 10.1524/zkri.1991.194.3-4.305; TERAUCHI H, 1978, PHYS REV B, V17, P2494, DOI 10.1103/PhysRevB.17.2494; Thouin F, 2019, NAT MATER, V18, P349, DOI [10.1038/s41563-018-0262-7, 10.1016/0022-3093(95)00355-X]; Togo A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134106; Tomczak JM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.115103; TRAYLER JG, 1971, PHYS REV B-SOLID ST, V3, P3457, DOI 10.1103/PhysRevB.3.3457; Weber C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256402; WENTZCOVITCH RM, 1994, PHYS REV LETT, V72, P3389, DOI 10.1103/PhysRevLett.72.3389; Whittaker L, 2011, J PHYS CHEM LETT, V2, P745, DOI 10.1021/jz101640n; Yuan X, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235103; ZYLBERSZTEJN A, 1975, PHYS REV B, V11, P4383, DOI 10.1103/PhysRevB.11.4383	47	208	209	37	476	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					535	+		10.1038/nature13865	http://dx.doi.org/10.1038/nature13865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25383524	Green Submitted			2022-12-28	WOS:000346247600049
J	Stitziel, NO; Won, HH; Morrison, AC; Peloso, GM; Do, R; Lange, LA; Fontanillas, P; Gupta, N; Duga, S; Goel, A; Farrall, M; Saleheen, D; Ferrario, P; Konig, I; Asselta, R; Merlini, PA; Marziliano, N; Notarangelo, MF; Schick, U; Auer, P; Assimes, TL; Reilly, M; Wilensky, R; Rader, DJ; Hovingh, GK; Meitinger, T; Kessler, T; Kastrati, A; Laugwitz, KL; Siscovick, D; Rotter, JI; Hazen, SL; Tracy, R; Cresci, S; Spertus, J; Jackson, R; Schwartz, SM; Natarajan, P; Crosby, J; Muzny, D; Ballantyne, C; Rich, SS; O'Donnell, CJ; Abecasis, G; Sunyaev, S; Nickerson, DA; Buring, JE; Ridker, PM; Chasman, DI; Austin, E; Ye, Z; Kullo, IJ; Weeke, PE; Shaffer, CM; Bastarache, LA; Denny, JC; Roden, DM; Palmer, C; Deloukas, P; Lin, DY; Tang, ZZ; Erdmann, J; Schunkert, H; Danesh, J; Marrugat, J; Elosua, R; Ardissino, D; McPherson, R; Watkins, H; Reiner, AP; Wilson, JG; Altshuler, D; Gibbs, RA; Lander, ES; Boerwinkle, E; Gabriel, S; Kathiresan, S				Stitziel, Nathan O.; Won, Hong-Hee; Morrison, Alanna C.; Peloso, Gina M.; Do, Ron; Lange, Leslie A.; Fontanillas, Pierre; Gupta, Namrata; Duga, Stefano; Goel, Anuj; Farrall, Martin; Saleheen, Danish; Ferrario, Paola; Koenig, Inke; Asselta, Rosanna; Merlini, Piera A.; Marziliano, Nicola; Notarangelo, Maria Francesca; Schick, Ursula; Auer, Paul; Assimes, Themistocles L.; Reilly, Muredach; Wilensky, Robert; Rader, Daniel J.; Hovingh, G. Kees; Meitinger, Thomas; Kessler, Thorsten; Kastrati, Adnan; Laugwitz, Karl-Ludwig; Siscovick, David; Rotter, Jerome I.; Hazen, Stanley L.; Tracy, Russell; Cresci, Sharon; Spertus, John; Jackson, Rebecca; Schwartz, Stephen M.; Natarajan, Pradeep; Crosby, Jacy; Muzny, Donna; Ballantyne, Christie; Rich, Stephen S.; O'Donnell, Christopher J.; Abecasis, Goncalo; Sunyaev, Shamil; Nickerson, Deborah A.; Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.; Austin, Erin; Ye, Zi; Kullo, Iftikhar J.; Weeke, Peter E.; Shaffer, Christian M.; Bastarache, Lisa A.; Denny, Joshua C.; Roden, Dan M.; Palmer, Colin; Deloukas, Panos; Lin, Dan-Yu; Tang, Zheng-zheng; Erdmann, Jeanette; Schunkert, Heribert; Danesh, John; Marrugat, Jaume; Elosua, Roberto; Ardissino, Diego; McPherson, Ruth; Watkins, Hugh; Reiner, Alex P.; Wilson, James G.; Altshuler, David; Gibbs, Richard A.; Lander, Eric S.; Boerwinkle, Eric; Gabriel, Stacey; Kathiresan, Sekar			Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENETIC-VARIANTS; CHOLESTEROL; EZETIMIBE; RISK; LDL; SIMVASTATIN; ABSORPTION; RATIONALE; EFFICACY; DESIGN	BACKGROUND Ezetimibe lowers plasma levels of low-density lipoprotein (LDL) cholesterol by inhibiting the activity of the Niemann-Pick C1-like 1 (NPC1L1) protein. However, whether such inhibition reduces the risk of coronary heart disease is not known. Human mutations that inactivate a gene encoding a drug target can mimic the action of an inhibitory drug and thus can be used to infer potential effects of that drug. METHODS We sequenced the exons of NPC1L1 in 7364 patients with coronary heart disease and in 14,728 controls without such disease who were of European, African, or South Asian ancestry. We identified carriers of inactivating mutations (nonsense, splice-site, or frameshift mutations). In addition, we genotyped a specific inactivating mutation (p.Arg406X) in 22,590 patients with coronary heart disease and in 68,412 controls. We tested the association between the presence of an inactivating mutation and both plasma lipid levels and the risk of coronary heart disease. RESULTS With sequencing, we identified 15 distinct NPC1L1 inactivating mutations; approximately 1 in every 650 persons was a heterozygous carrier for 1 of these mutations. Heterozygous carriers of NPC1L1 inactivating mutations had a mean LDL cholesterol level that was 12 mg per deciliter (0.31 mmol per liter) lower than that in noncarriers (P = 0.04). Carrier status was associated with a relative reduction of 53% in the risk of coronary heart disease (odds ratio for carriers, 0.47; 95% confidence interval, 0.25 to 0.87; P = 0.008). In total, only 11 of 29,954 patients with coronary heart disease had an inactivating mutation (carrier frequency, 0.04%) in contrast to 71 of 83,140 controls (carrier frequency, 0.09%). CONCLUSIONS Naturally occurring mutations that disrupt NPC1L1 function were found to be associated with reduced plasma LDL cholesterol levels and a reduced risk of coronary heart disease.	[Stitziel, Nathan O.; Cresci, Sharon] Washington Univ, Sch Med, Dept Med, Div Cardiovasc, St Louis, MO 63130 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO 63130 USA; [Cresci, Sharon] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Won, Hong-Hee; Peloso, Gina M.; Do, Ron; Natarajan, Pradeep; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Won, Hong-Hee; Peloso, Gina M.; Do, Ron; Natarajan, Pradeep; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [O'Donnell, Christopher J.; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Won, Hong-Hee; Peloso, Gina M.; Do, Ron; Natarajan, Pradeep; O'Donnell, Christopher J.; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Sunyaev, Shamil] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Won, Hong-Hee; Peloso, Gina M.; Do, Ron; Fontanillas, Pierre; Gupta, Namrata; Natarajan, Pradeep; Sunyaev, Shamil; Altshuler, David; Lander, Eric S.; Gabriel, Stacey; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Morrison, Alanna C.; Crosby, Jacy; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Muzny, Donna; Gibbs, Richard A.; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Ballantyne, Christie] Baylor Coll Med, Sect Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Duga, Stefano; Asselta, Rosanna] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy; [Merlini, Piera A.; Marziliano, Nicola; Notarangelo, Maria Francesca; Ardissino, Diego] Azienda Osped Univ Parma, Parma, Italy; [Merlini, Piera A.; Ardissino, Diego] Assoc Studio Trombosi Cardiol, Pavia, Italy; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Danesh, John] Univ Cambridge, Cambridge, England; [Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Palmer, Colin] Univ Dundee, Med Res Inst, Dundee, Scotland; [Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Saleheen, Danish] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Reilly, Muredach; Wilensky, Robert] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Ferrario, Paola; Koenig, Inke] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Buring, Julie E.] Med Univ Lubeck, Inst Integrat & Expt Genom, D-23538 Lubeck, Germany; [Buring, Julie E.] DZHK German Res Ctr Cardiovasc Res Partner Site H, Lubeck, Germany; [Meitinger, Thomas] Helmholtz Zentrum, Inst Humangenet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, D-80290 Munich, Germany; [Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, D-80290 Munich, Germany; [Kessler, Thorsten; Kastrati, Adnan; Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Meitinger, Thomas; Kastrati, Adnan; Laugwitz, Karl-Ludwig; Schunkert, Heribert] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany; [Schick, Ursula; Schwartz, Stephen M.; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Siscovick, David] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Siscovick, David] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98195 USA; [Schwartz, Stephen M.; Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Auer, Paul] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53201 USA; [Assimes, Themistocles L.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Assimes, Themistocles L.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Jackson, Rebecca] Ohio State Univ, Dept Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Tracy, Russell] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Tracy, Russell] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Spertus, John] Univ Missouri Kansas City, St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Austin, Erin; Ye, Zi; Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Weeke, Peter E.; Shaffer, Christian M.; Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Bastarache, Lisa A.; Denny, Joshua C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Tang, Zheng-zheng] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Weeke, Peter E.] Rigshosp, Copenhagen Univ Hosp, Mol Cardiol Lab, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Deloukas, Panos] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Marrugat, Jaume; Elosua, Roberto] Inst Hosp Mar Invest Med IMIM, Grp Epidemiol & Genet Cardiovasc, Barcelona, Spain; [McPherson, Ruth] Univ Ottawa Heart Inst, Div Cardiol, Ottawa, ON, Canada; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Milan; University of Parma; University Hospital of Parma; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; Wellcome Trust Sanger Institute; University of Dundee; University of London; Queen Mary University London; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Lubeck; University of Lubeck; German Centre for Cardiovascular Research; Helmholtz Association; Technical University of Munich; Technical University of Munich; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Milwaukee; Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Amsterdam; Academic Medical Center Amsterdam; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; University of Vermont; University of Vermont; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Virginia; University of Michigan System; University of Michigan; Mayo Clinic; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Rigshospitalet; University of Copenhagen; King Abdulaziz University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Ottawa; University of Ottawa Heart Institute; University of Mississippi; University of Mississippi Medical Center	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan@partners.org	Asselta, Rosanna/AAC-2367-2019; Erdmann, Jeanette/A-4417-2009; Ferrario, Paola G./AAR-8775-2020; Auer, Paul/AAC-5060-2019; Spertus, John/ABD-3075-2021; Won, Hong-Hee/D-2672-2011; Nicola, Marziliano/ABF-9518-2021; Altshuler, David M/A-4476-2009; Ardissino, Diego/AAC-4041-2022; Hazen, Stanley L/ABD-5845-2021; Study, GoDARTS/K-9448-2016; König, Inke R/A-4544-2009; Palmer, Colin NA/C-7053-2008; Assimes, Themistocles Leonard/D-9696-2015; Deloukas, Panos/B-2922-2013; , Kastrati/Y-2389-2019; Stitziel, Nathan/AAL-8413-2021; Erdmann, Jeanette/P-7513-2014; Roden, Dan/ABD-5412-2021; Duga, Stefano/F-8173-2014; Rotter, Jerome/AAY-6598-2021; Kessler, Thorsten/AAI-7292-2021; Kessler, Thorsten/O-7426-2015; Denny, Josh/AAL-3359-2021; Ballantyne, Christie/A-6599-2008; Natarajan, Pradeep/H-9764-2019; Meitinger, Thomas/O-1318-2015; Zi, Ye/GWM-3932-2022	Asselta, Rosanna/0000-0001-5351-0619; Ferrario, Paola G./0000-0003-1769-6799; Won, Hong-Hee/0000-0001-5719-0552; Altshuler, David M/0000-0002-7250-4107; König, Inke R/0000-0003-0504-6465; Palmer, Colin NA/0000-0002-6415-6560; Assimes, Themistocles Leonard/0000-0003-2349-0009; Deloukas, Panos/0000-0001-9251-070X; Stitziel, Nathan/0000-0002-4963-8211; Erdmann, Jeanette/0000-0002-4486-6231; Duga, Stefano/0000-0003-3457-1410; Kessler, Thorsten/0000-0003-3326-1621; Denny, Josh/0000-0002-3049-7332; Natarajan, Pradeep/0000-0001-8402-7435; Marrugat, Jaume/0000-0003-3320-554X; Ballantyne, Christie/0000-0002-6432-1730; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Watkins, Hugh/0000-0002-5287-9016; solinas, emilia/0000-0003-3532-1317; Rich, Stephen/0000-0003-3872-7793; Reilly, Muredach/0000-0002-3035-9386; Morrison, Alanna/0000-0001-6381-4296; ELOSUA, ROBERTO/0000-0001-8235-0095; Meitinger, Thomas/0000-0002-8838-8403; Goel, Anuj/0000-0003-2307-4021	National Institutes of Health; MRC [MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107816, ZIAHL006173, RC2HL102926, T32HL007208, ZIAHL006002, RC2HL102925, ZIAHL006175, K08HL114642] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006378, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG049505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institutes of Health and others.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030; Cannon CP, 2008, AM HEART J, V156, P826, DOI 10.1016/j.ahj.2008.07.023; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2014, CELL METAB, V20, P387, DOI 10.1016/j.cmet.2014.08.007; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Do R, NATURE IN PRESS; Doney ASF, 2004, ARTERIOSCL THROM VAS, V24, P2403, DOI 10.1161/01.ATV.0000147897.57527.e4; Erdmann J, 2013, NATURE, V504, P432, DOI 10.1038/nature12722; Ezzet F, 2001, J CLIN PHARMACOL, V41, P943, DOI 10.1177/00912700122010915; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Hegele Robert A, 2005, Lipids Health Dis, V4, P16, DOI 10.1186/1476-511X-4-16; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; KRAWCZAK M, 1992, HUM GENET, V90, P41; Krumholz HM, 2010, CIRC-CARDIOVASC QUAL, V3, P565, DOI 10.1161/CIRCOUTCOMES.110.959577; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mannucci PM, 2003, CIRCULATION, V107, P1117, DOI 10.1161/01.CIR.0000051465.94572.D0; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Saleheen D, 2009, EUR J EPIDEMIOL, V24, P329, DOI 10.1007/s10654-009-9334-y; Senti M, 2001, ARTERIOSCL THROM VAS, V21, P415, DOI 10.1161/01.ATV.21.3.415; Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC; Taylor HA, 2005, ETHNIC DIS, V15, pS1; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang J, 2005, CLIN GENET, V67, P175, DOI 10.1111/j.1399-0004.2004.00388.x; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Ye Zi, 2013, Glob Cardiol Sci Pract, V2013, P82, DOI 10.5339/gcsp.2013.10; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	38	293	298	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2072	2082		10.1056/NEJMoa1405386	http://dx.doi.org/10.1056/NEJMoa1405386			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25390462	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000345580000006
J	Belkaid, Y; Segre, JA				Belkaid, Yasmine; Segre, Julia A.			Dialogue between skin microbiota and immunity	SCIENCE			English	Review							STAPHYLOCOCCUS-EPIDERMIDIS; ANTIMICROBIAL PEPTIDES; DENDRITIC CELLS; COLONIZATION RESISTANCE; PROPIONIBACTERIUM-ACNES; GENOME SEQUENCE; GUT MICROBIOTA; DIVERSITY; DISEASE; INFLAMMATION	Human skin, the body's largest organ, functions as a physical barrier to bar the entry of foreign pathogens, while concomitantly providing a home to myriad commensals. Over a human's life span, keratinized skin cells, immune cells, and microbes all interact to integrate the processes of maintaining skin's physical and immune barrier under homeostatic healthy conditions and also under multiple stresses, such as wounding or infection. In this Review, we explore the intricate interactions of microbes and immune cells on the skin surface and within associated appendages to regulate this orchestrated maturation in the context of both host physiological changes and environmental challenges.	[Belkaid, Yasmine] NIAID, Program Barrier Immun & Repair, NIH, Bethesda, MD 20892 USA; [Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Segre, Julia A.] NHGRI, Microbial Genom Sect, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Belkaid, Y (corresponding author), NIAID, Program Barrier Immun & Repair, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov; jsegre@nhgri.nih.gov		Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and National Human Genome Research Institute, National Institutes of Health. We thank A. Byrd, V. Ridaura, and T. Hand for discussion about the manuscript and help with the preparation of the figures. We apologize to our colleagues tor riot having cited all papers relevant to this expanding field because of space constraints.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bek-Thomsen M, 2008, J CLIN MICROBIOL, V46, P3355, DOI 10.1128/JCM.00799-08; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Chalmers RJG, 2001, BRIT J DERMATOL, V145, P891, DOI 10.1046/j.1365-2133.2001.04505.x; Chehoud C, 2013, P NATL ACAD SCI USA, V110, P15061, DOI 10.1073/pnas.1307855110; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; James WD, 2005, NEW ENGL J MED, V352, P1463, DOI 10.1056/NEJMcp033487; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Koch R, 1884, Br Med J, V2, P403; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lee DY, 2008, J INVEST DERMATOL, V128, P1863, DOI 10.1038/sj.jid.5701235; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; MARPLES RR, 1971, J INVEST DERMATOL, V56, P127, DOI 10.1111/1523-1747.ep12260695; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nakatsuji T, 2014, J INVEST DERMATOL, V134, P11, DOI 10.1038/jid.2013.379; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Scharschmidt Tiffany C, 2013, Drug Discov Today Dis Mech, V10; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Shen W, 2014, P NATL ACAD SCI USA, V111, pE2977, DOI 10.1073/pnas.1401820111; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Turovskiy Y, 2011, J APPL MICROBIOL, V110, P1105, DOI 10.1111/j.1365-2672.2011.04977.x; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Volz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Watt FM, 2014, SCIENCE, V346, P937, DOI 10.1126/science.1253734; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	67	329	354	17	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					954	959		10.1126/science.1260144	http://dx.doi.org/10.1126/science.1260144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414304				2022-12-28	WOS:000345696000034
J	Lo, JA; Fisher, DE				Lo, Jennifer A.; Fisher, David E.			The melanoma revolution: From UV carcinogenesis to a new era in therapeutics	SCIENCE			English	Review							FREQUENT SOMATIC MUTATIONS; ULTRAVIOLET-RADIATION; METASTATIC MELANOMA; INHIBITOR RESISTANCE; CONFERS RESISTANCE; IMPROVED SURVIVAL; MEK INHIBITION; BRAF; ONCOGENE; VEMURAFENIB	Melanoma, the deadliest form of skin cancer, is an a ressive disease that is rising in incidence. Although melanoma is a historically treatment-resistant malignancy, in recent years unprecedented breakthroughs in targeted therapies and immunotherapies have revolutionized the standard of care for patients with advanced disease. Here, we provide an overview of recent developments in our understanding of melanoma risk factors, genomics, and molecular pathogenesis and how these insights have driven advances in melanoma treatment. In addition, we review benefits and limitations of current therapies and look ahead to continued progress in melanoma prevention and therapy. Remarkable achievements in the field have already produced a paradigm shift in melanoma treatment: Metastatic melanoma, once considered incurable, can now be treated with potentially curative rather than palliative intent.	[Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr,Dept Dermatol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Canc Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Fisher, DE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr,Dept Dermatol, Boston, MA 02114 USA.	dfisher3@partners.org	Fisher, David/AAH-2878-2019	/0000-0002-9520-6874	NIH [T32GM007753, P01CA163222, R01AR043369, R01CA150226]; Melanoma Research Alliance, the U.S.-Israel Binational Science Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE [R01CA150226, P01CA163222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance, the U.S.-Israel Binational Science Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tsao, C.-H. Won, and I. Kim for clinical images and K Robinson and K. Flaherty for useful comments and discussions. We extend our sincere apologies to those colleagues whose studies were not cited due to space constraints. This work was supported by the NIH under award numbers T32GM007753 (J.A.L.), P01CA163222, R01AR043369, and R01CA150226 and by grants tram the Melanoma Research Alliance, the U.S.-Israel Binational Science Foundation, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.E.F.).	Albert MR, 2002, J AM ACAD DERMATOL, V47, P930, DOI 10.1067/mjd.2002.127254; ALBINO AP, 1984, NATURE, V308, P69, DOI 10.1038/308069a0; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Bardeesy N, 2005, MOL CELL BIOL, V25, P4176, DOI 10.1128/MCB.25.10.4176-4188.2005; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; EVERSON TC, 1956, ANN SURG, V144, P366, DOI 10.1097/00000658-195609000-00007; Fell GL, 2014, CELL, V157, P1527, DOI 10.1016/j.cell.2014.04.032; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Furge KA, 2001, P NATL ACAD SCI USA, V98, P10722, DOI 10.1073/pnas.191067898; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Garibyan L, 2010, CURR ONCOL REP, V12, P319, DOI 10.1007/s11912-010-0119-y; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; GREENE MH, 1981, LANCET, V1, P1196, DOI 10.1016/S0140-6736(81)92359-X; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kraehn GM, 2001, BRIT J CANCER, V84, P72, DOI 10.1054/bjoc.2000.1535; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kvam E, 1999, J INVEST DERMATOL, V113, P209, DOI 10.1046/j.1523-1747.1999.00653.x; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Maertens O, 2013, CANCER DISCOV, V3, P338, DOI 10.1158/2159-8290.CD-12-0313; Mayer D, 2012, J AM ACAD DERMATOL, V66, pE9, DOI 10.1016/j.jaad.2010.10.002; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; MORTON DL, 1970, SURGERY, V68, P158; Mosher CE, 2010, ARCH DERMATOL, V146, P412, DOI 10.1001/archdermatol.2009.385; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Smalley KSM, 2008, MOL CANCER THER, V7, P2876, DOI 10.1158/1535-7163.MCT-08-0431; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Viros A, 2014, NATURE, V511, P478, DOI 10.1038/nature13298; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	75	258	271	10	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					945	949		10.1126/science.1253735	http://dx.doi.org/10.1126/science.1253735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414302	Green Accepted			2022-12-28	WOS:000345696000032
J	Navrotsky, A				Navrotsky, Alexandra			NUCLEAR MATERIALS Taking the measure of molten uranium oxide	SCIENCE			English	Editorial Material									[Navrotsky, Alexandra] Univ Calif Davis, Peter A Rock Thermochem Lab, Davis, CA 95616 USA; [Navrotsky, Alexandra] Univ Calif Davis, NEAT ORU, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Navrotsky, A (corresponding author), Univ Calif Davis, Peter A Rock Thermochem Lab, Davis, CA 95616 USA.	anavrotsky@ucdavis.edu						Burakov B. E., 1996, P MRS, V465, P1297; Burns PC, 2012, SCIENCE, V335, P1184, DOI 10.1126/science.1211285; Skinner LB, 2014, SCIENCE, V346, P984, DOI 10.1126/science.1259709; Yakub E, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2764484	4	10	10	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					916	917		10.1126/science.aaa0163	http://dx.doi.org/10.1126/science.aaa0163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414289				2022-12-28	WOS:000345696000017
J	Cramer, P				Cramer, Patrick			A Tale of Chromatin and Transcription in 100 Structures	CELL			English	Review							RNA-POLYMERASE-II; NUCLEOSOME CORE PARTICLE; HISTONE METHYLTRANSFERASE SET7/9; MAINTENANCE DNA METHYLATION; YEAST TFIIA/TBP/DNA COMPLEX; REPRESSOR-OPERATOR COMPLEX; CARBOXY-TERMINAL DOMAIN; 3.3 ANGSTROM RESOLUTION; X-RAY CRYSTALLOGRAPHY; MEDIATOR HEAD MODULE	To celebrate a century of X-ray crystallography, I describe how 100 crystal structures influenced chromatin and transcription research.	Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de						Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Basu RS, 2013, J BIOL CHEM, V288, P3305, DOI 10.1074/jbc.M112.387712; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Baumli S, 2012, STRUCTURE, V20, P1788, DOI 10.1016/j.str.2012.08.011; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Bosken CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4505; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Campagne S, 2014, NAT STRUCT MOL BIOL, V21, P269, DOI 10.1038/nsmb.2777; Chang WH, 2000, CELL, V102, P609, DOI 10.1016/S0092-8674(00)00083-0; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chen Y, 2006, P NATL ACAD SCI USA, V103, P13956, DOI 10.1073/pnas.0606381103; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chittuluru JR, 2011, NAT STRUCT MOL BIOL, V18, P1196, DOI 10.1038/nsmb.2128; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Elsasser SJ, 2012, NATURE, V491, P560, DOI 10.1038/nature11608; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; KONIG P, 1993, J MOL BIOL, V233, P139, DOI 10.1006/jmbi.1993.1490; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Lolli G, 2004, STRUCTURE, V12, P2067, DOI 10.1016/j.str.2004.08.013; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muhlbacher W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5310; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Nguyen VQ, 2013, CELL, V154, P1220, DOI 10.1016/j.cell.2013.08.018; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; Obri A, 2014, NATURE, V505, P648, DOI 10.1038/nature12922; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; Racki LR, 2014, J MOL BIOL, V426, P2034, DOI 10.1016/j.jmb.2014.02.021; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Saravanan M, 2012, P NATL ACAD SCI USA, V109, P20883, DOI 10.1073/pnas.1214735109; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Scheffer MP, 2011, P NATL ACAD SCI USA, V108, P16992, DOI 10.1073/pnas.1108268108; SCHEVITZ RW, 1985, NATURE, V317, P782, DOI 10.1038/317782a0; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Serpa JJ, 2012, EUR J MASS SPECTROM, V18, P251, DOI 10.1255/ejms.1178; SHAKKED Z, 1981, PROC R SOC SER B-BIO, V213, P479, DOI 10.1098/rspb.1981.0076; Shi YG, 2014, CELL, V159, P995, DOI 10.1016/j.cell.2014.10.051; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789a0; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	184	21	21	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					985	994		10.1016/j.cell.2014.10.047	http://dx.doi.org/10.1016/j.cell.2014.10.047			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416940	Green Published, Bronze			2022-12-28	WOS:000345506300013
J	Owens, B				Owens, Brian			MELANOMA	NATURE			English	Editorial Material																			0	40	44	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S109	S109		10.1038/515S109a	http://dx.doi.org/10.1038/515S109a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3PR	25407704	Bronze			2022-12-28	WOS:000349541200001
J	Schmale, J; Shindell, D; von Schneidemesser, E; Chabay, I; Lawrence, M				Schmale, Julia; Shindell, Drew; von Schneidemesser, Erika; Chabay, Ilan; Lawrence, Mark			Clean up our skies	NATURE			English	Editorial Material							CLIMATE-CHANGE; AIR		[Schmale, Julia; von Schneidemesser, Erika; Chabay, Ilan; Lawrence, Mark] Inst Adv Sustainabil Studies, Potsdam, Germany; [Shindell, Drew] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University	Schmale, J (corresponding author), Paul Scherrer Inst, Zurich, Switzerland.	julia.schmale@gmail.com	Schmale, Julia/Q-3942-2019; von Schneidemesser, Erika/AAL-8777-2021; Schmale, Julia/F-8851-2016; Shindell, Drew/D-4636-2012	Schmale, Julia/0000-0002-1048-7962; Schmale, Julia/0000-0002-1048-7962; Shindell, Drew/0000-0003-1552-4715; von Schneidemesser, Erika/0000-0003-1386-285X; Lawrence, Mark/0000-0002-2178-4903; Chabay, Ilan/0000-0002-9776-8803				Bowerman NHA, 2013, NAT CLIM CHANGE, V3, P1021, DOI [10.1038/nclimate2034, 10.1038/NCLIMATE2034]; Harlan SL, 2011, CURR OPIN ENV SUST, V3, P126, DOI 10.1016/j.cosust.2011.01.001; Hu AX, 2013, NAT CLIM CHANGE, V3, P730, DOI [10.1038/nclimate1869, 10.1038/NCLIMATE1869]; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Pierrehumbert RT, 2014, ANNU REV EARTH PL SC, V42, P341, DOI 10.1146/annurev-earth-060313-054843; Schmale J, 2014, ATMOS ENVIRON, V90, P146, DOI 10.1016/j.atmosenv.2014.03.016; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; U. S. Environmental Protection Agency, 2012, RED BLACK CARB EM S; UNEP, 2011, INT ASS BLACK CARB T; Williams M, 2012, CARBON MANAG, V3, P511, DOI 10.4155/CMT.12.49	10	86	86	5	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					335	337		10.1038/515335a	http://dx.doi.org/10.1038/515335a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7HE	25409811	Bronze, Green Published			2022-12-28	WOS:000345770600019
J	Paixao, ARM; de Lemos, JA				Paixao, Andre R. M.; de Lemos, James A.			Acute Troponin Elevation and the Classification of Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EARLY-DIAGNOSIS; ASSOCIATION; ASSAYS		[Paixao, Andre R. M.; de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	de Lemos, JA (corresponding author), Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd,E5-7528, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021		Roche Diagnostics; Abbott Diagnostics; AstraZeneca; Janssen; Diadexus; Amgen; Sanofi/Regeneron	Roche Diagnostics; Abbott Diagnostics(Abbott Laboratories); AstraZeneca(AstraZeneca); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Diadexus; Amgen(Amgen); Sanofi/Regeneron(Regeneron)	Dr de Lemos reports grant support and consulting income from Roche Diagnostics and Abbott Diagnostics; and consulting income from AstraZeneca, Janssen, Diadexus, Amgen, and Sanofi/Regeneron. Dr Paixao reports no disclosures.	Alcalai R, 2007, ARCH INTERN MED, V167, P276, DOI 10.1001/archinte.167.3.276; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Than M, 2012, J AM COLL CARDIOL, V59, P2091, DOI 10.1016/j.jacc.2012.02.035; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	9	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2032	2033		10.1001/jama.2014.5554	http://dx.doi.org/10.1001/jama.2014.5554			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399280				2022-12-28	WOS:000345450500019
J	Reddy, VY; Sievert, H; Halperin, J; Doshi, SK; Buchbinder, M; Neuzil, P; Huber, K; Whisenant, B; Kar, S; Swarup, V; Gordon, N; Holmes, D				Reddy, Vivek Y.; Sievert, Horst; Halperin, Jonathan; Doshi, Shephal K.; Buchbinder, Maurice; Neuzil, Petr; Huber, Kenneth; Whisenant, Brian; Kar, Saibal; Swarup, Vijay; Gordon, Nicole; Holmes, David		PROTECT AF Steering Comm Investiga	Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMBOLIC PROTECTION; STROKE PREVENTION; SYSTEM; THERAPY; RISK	IMPORTANCE While effective in preventing stroke in patients with atrial fibrillation (AF), warfarin is limited by a narrow therapeutic profile, a need for lifelong coagulation monitoring, and multiple drug and diet interactions. OBJECTIVE To determine whether a local strategy of mechanical left atrial appendage (LAA) closure was noninferior to warfarin. DESIGN, SETTING, AND PARTICIPANTS PROTECT AF was a multicenter, randomized (2: 1), unblinded, Bayesian-designed study conducted at 59 hospitals of 707 patients with nonvalvular AF and at least 1 additional stroke risk factor (CHADS(2) score >= 1). Enrollment occurred between February 2005 and June 2008 and included 4-year follow-up through October 2012. Noninferiority required a posterior probability greater than 97.5% and superiority a probability of 95% or greater; the noninferiority margin was a rate ratio of 2.0 comparing event rates between treatment groups. INTERVENTIONS Left atrial appendage closure with the device (n = 463) or warfarin (n = 244; target international normalized ratio, 2-3). MAIN OUTCOMES AND MEASURES A composite efficacy end point including stroke, systemic embolism, and cardiovascular/unexplained death, analyzed by intention-to-treat. RESULTS At a mean (SD) follow-up of 3.8 (1.7) years (2621 patient-years), there were 39 events among 463 patients (8.4%) in the device group for a primary event rate of 2.3 events per 100 patient-years, compared with 34 events among 244 patients (13.9%) for a primary event rate of 3.8 events per 100 patient-years with warfarin (rate ratio, 0.60; 95% credible interval, 0.41-1.05), meeting prespecified criteria for both noninferiority (posterior probability, >99.9%) and superiority (posterior probability, 96.0%). Patients in the device group demonstrated lower rates of both cardiovascular mortality (1.0 events per 100 patient-years for the device group [17/463 patients, 3.7%] vs 2.4 events per 100 patient-years with warfarin [22/244 patients, 9.0%]; hazard ratio [HR], 0.40; 95% CI, 0.21-0.75; P = .005) and all-cause mortality (3.2 events per 100 patient-years for the device group [57/466 patients, 12.3%] vs 4.8 events per 100 patient-years with warfarin [44/244 patients, 18.0%]; HR, 0.66; 95% CI, 0.45-0.98; P = .04). CONCLUSIONS AND RELEVANCE After 3.8 years of follow-up among patients with nonvalvular AF at elevated risk for stroke, percutaneous LAA closure met criteria for both noninferiority and superiority, compared with warfarin, for preventing the combined outcome of stroke, systemic embolism, and cardiovascular death, as well as superiority for cardiovascular and all-cause mortality.	[Reddy, Vivek Y.; Halperin, Jonathan] Mt Sinai Sch Med, New York, NY 10029 USA; [Reddy, Vivek Y.; Doshi, Shephal K.] St Johns Hlth Ctr, Santa Monica, CA USA; [Reddy, Vivek Y.; Neuzil, Petr] Homolka Hosp, Prague, Czech Republic; [Sievert, Horst] Cardiovasc Ctr Frankfurt, Frankfurt, Germany; [Buchbinder, Maurice] Fdn Cardiovasc Med, La Jolla, CA USA; [Huber, Kenneth] St Lukes Hosp, Kansas City, MO USA; [Whisenant, Brian] Intermt Med Ctr, Murray, UT USA; [Kar, Saibal] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Swarup, Vijay] Arizona Heart Rhythm Ctr, Scottsdale, AZ USA; [Gordon, Nicole] Boston Sci, St Paul, MN USA; [Holmes, David] Mayo Clin, Coll Med, Rochester, MN USA	Icahn School of Medicine at Mount Sinai; Na Homolce Hospital; Cardiovascular Center (CVC) Frankfurt; Saint Luke's Hospital - Missouri; Intermountain Healthcare; Intermountain Medical Center; Cedars Sinai Medical Center; Boston Scientific; Mayo Clinic	Reddy, VY (corresponding author), Mt Sinai Sch Med, Helmsley Electrophysiol Ctr, One Gustave L Levy Pl,POB 1030, New York, NY 10029 USA.	vivek.reddy@mountsinai.org	Halperin, Jonathan/AAJ-4721-2020	Halperin, Jonathan/0000-0002-8318-5471; Khasgiwala, Anunita/0000-0002-7037-0416; Douglas, Pamela/0000-0001-9876-4049; Pickett, Robert/0000-0002-7764-3800; Reddy, Vivek/0000-0002-5638-4993	Atritech	Atritech	This study was funded by the manufacturer of the device, Atritech (now owned by Boston Scientific), which provided the LAA closure device used in this trial.	ABERG H, 1969, ACTA MED SCAND, V185, P373; Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Fountain RB, 2006, AM HEART J, V151, P956, DOI 10.1016/j.ahj.2006.02.005; Gangireddy SR, 2012, EUR HEART J, V33, P2700, DOI 10.1093/eurheartj/ehs292; Gelman A., 1995, BAYESIAN DATA ANALYS; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Park JW, 2011, CATHETER CARDIO INTE, V77, P700, DOI 10.1002/ccd.22764; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Reddy VY, 2013, J AM COLL CARDIOL, V61, P2551, DOI 10.1016/j.jacc.2013.03.035; Reddy VY, 2013, CIRCULATION, V127, P720, DOI 10.1161/CIRCULATIONAHA.112.114389; Reddy VY, 2011, CIRCULATION, V123, P417, DOI 10.1161/CIRCULATIONAHA.110.976449; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sick PB, 2007, J AM COLL CARDIOL, V49, P1490, DOI 10.1016/j.jacc.2007.02.035; Sievert H, 2002, CIRCULATION, V105, P1887, DOI 10.1161/01.CIR.0000015698.54752.6D; STODDARD MF, 1995, J AM COLL CARDIOL, V25, P452, DOI 10.1016/0735-1097(94)00396-8; Tagalakis V, 2007, CANCER TREAT REV, V33, P358, DOI 10.1016/j.ctrv.2007.02.004	23	501	520	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1988	1998		10.1001/jama.2014.15192	http://dx.doi.org/10.1001/jama.2014.15192			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399274	Bronze			2022-12-28	WOS:000345450500013
J	Kadri, SS; Danner, RL				Kadri, Sameer S.; Danner, Robert L.			Review: In sepsis, the effect of resuscitation with crystalloid and colloid fluids on mortality varies Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CRITICALLY-ILL ADULTS; KIDNEY INJURY; ASSOCIATION; ALBUMIN; SALINE		[Kadri, Sameer S.; Danner, Robert L.] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Kadri, SS (corresponding author), NIH, Dept Crit Care Med, Bethesda, MD 20892 USA.		Kadri, Sameer/Q-9081-2019		CLINICAL CENTER [ZIACL008060] Funding Source: NIH RePORTER	CLINICAL CENTER		Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Raghunathan K, 2014, CRIT CARE MED, V42, P1585, DOI 10.1097/CCM.0000000000000305; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	6	0	0	2	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC12	10.7326/0003-4819-161-10-201411180-02012	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402533				2022-12-28	WOS:000347245600022
J	Lee, TC; Frenette, C; Jayaraman, D; Green, L; Pilote, L				Lee, Todd C.; Frenette, Charles; Jayaraman, Dev; Green, Laurence; Pilote, Louise			Antibiotic Self-stewardship: Trainee-Led Structured Antibiotic Time-outs to Improve Antimicrobial Use	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; GUIDELINES; KNOWLEDGE; AMERICA	Background: Antibiotic use is an important quality improvement target. Nearly 50% of antibiotic use is unnecessary or inappropriate. To combat overuse, the Centers for Disease Control and Prevention (CDC) proposed "time-outs" to reevaluate antibiotics. Objective: To optimize antibiotic use through trainee-led time-outs. Design: Before-after study. Setting: Internal medicine (2 units, 46 beds) at a university hospital. Patients: Inpatients (n = 679). Intervention: From January 2012 until June 2013, while receiving monthly education on antimicrobial stewardship, resident physicians adjusted patients' antibiotic therapy through twice-weekly time-out audits using a structured electronic checklist. Measurements: Antibiotic costs were standardized and compared in the year before and after the audits. Use was measured as World Health Organization defined daily doses (DDDs) per 1000 patient-days. Total antibiotic use and the use of moxifloxacin, carbapenems, antipseudomonal penicillins, and vancomycin were compared by using interrupted time series. Rates of nosocomial Clostridium difficile infection were compared by using incidence rate ratios. Results: Total costs in the units decreased from $149 743CAD (January 2011 to January 2012) to $80 319 (January 2012 to January 2013), for a savings of $69 424 (46% reduction). Of the savings, $54 150 (78%) was related to carbapenems and $15 274 (22%) was due to other antibiotic classes. Adherence with the auditing process was 80%. In the time-series analyses, the only reliable and statistically significant change was a reduction in the rate of moxifloxicin use, by -1.9 DDDs per 1000 patient-days per month (95% CI, -3.8 to -0.02; P = 0.048). Rates of C. difficile infection decreased from 24.2 to 19.6 per 10 000 patient-days (incidence rate ratio, 0.8 [CI, 0.5 to 1.3]). Limitation: Other temporal factors may confound the findings. Conclusions: An antibiotic self-stewardship bundle to implement the CDC's suggested time-outs seems to have reduced overall costs and targeted antibiotic use.	McGill Univ, Ctr Hlth, Montreal, PQ, Canada; McGill Univ, McGill Ctr Qual Improvement, Montreal, PQ, Canada	McGill University; McGill University	Lee, TC (corresponding author), Royal Victoria Hosp, Div Internal Med, 687 Pine Ave West,Room A4-21, Montreal, PQ H3A 1A1, Canada.	todd.lee@mcgill.ca		Lee, Todd/0000-0002-2267-4239; Pilote, Louise/0000-0002-6159-0628	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This article is part of the Annals supplement "RWJF Clinical Scholars in Pursuit of the Value Proposition: Evaluations of Low-Cost Innovations for Prevention and Management of Conditions." The Robert Wood Johnson Foundation provided funding for publication of this supplement, which is only available online at www.annals.org. Carol M. Mangione, MD, MPH (co-director of the RWJF Clinical Scholars Program at the University of California, Los Angeles); Jaya K. Rao, MD, MHS (Annals Deputy Editor); and Christine Laine, MD, MPH (Annals Editor in Chief), served as editors for this supplement.	Abbo LM, 2013, CLIN INFECT DIS, V57, P631, DOI 10.1093/cid/cit370; Centers for Disease Control and Prevention, COR EL HOSP ANT STEW; Centers for Disease Control and Prevention (CDC), 2012, GET SMART HEALTHC; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Drew RH, 2009, PHARMACOTHERAPY, V29, P593, DOI 10.1592/phco.29.5.593; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Johannsson B, 2011, INFECT CONT HOSP EP, V32, P367, DOI 10.1086/658946; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Polk RE, 2011, CLIN INFECT DIS, V53, P1100, DOI 10.1093/cid/cir672; Srinivasan A, 2004, ARCH INTERN MED, V164, P1451, DOI 10.1001/archinte.164.13.1451; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Weiss CH, 2013, CRIT CARE MED, V41, P2563, DOI 10.1097/CCM.0b013e318298291a; Weiss CH, 2011, AM J RESP CRIT CARE, V184, P680, DOI 10.1164/rccm.201101-0037OC; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	15	60	61	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S53	S58		10.7326/M13-3016	http://dx.doi.org/10.7326/M13-3016			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3RR	25402404				2022-12-28	WOS:000364909900008
J	Kumar, ME; Bogard, PE; Espinoza, FH; Menke, DB; Kingsley, DM; Krasnow, MA				Kumar, Maya E.; Bogard, Patrick E.; Espinoza, F. Hernan; Menke, Douglas B.; Kingsley, David M.; Krasnow, Mark A.			Defining a mesenchymal progenitor niche at single-cell resolution	SCIENCE			English	Article							SMOOTH-MUSCLE; STEM-CELLS; INTESTINAL CRYPT; LUNG DEVELOPMENT; SELF-RENEWAL; POPULATIONS; HOMEOSTASIS; CONTRIBUTE; PROGRAM; GENE	Most vertebrate organs are composed of epithelium surrounded by support and stromal tissues formed from mesenchyme cells, which are not generally thought to form organized progenitor pools. Here, we use clonal cell labeling with multicolor reporters to characterize individual mesenchymal progenitors in the developing mouse lung. We observe a diversity of mesenchymal progenitor populations with different locations, movements, and lineage boundaries. Airway smooth muscle (ASM) progenitors map exclusively to mesenchyme ahead of budding airways. Progenitors recruited from these tip pools differentiate into ASM around airway stalks; flanking stalk mesenchyme can be induced to form an ASM niche by a lateral bud or by an airway tip plus focal Wnt signal. Thus, mesenchymal progenitors can be organized into localized and carefully controlled domains that rival epithelial progenitor niches in regulatory sophistication.	[Kumar, Maya E.; Bogard, Patrick E.; Espinoza, F. Hernan; Menke, Douglas B.; Kingsley, David M.; Krasnow, Mark A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kumar, Maya E.; Bogard, Patrick E.; Espinoza, F. Hernan; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Menke, Douglas B.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Menke, Douglas B.; Kingsley, David M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University System of Georgia; University of Georgia; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	krasnow@stanford.edu	Kumar, Maya/HDM-9018-2022	Menke, Douglas/0000-0002-7109-1451; Bogard, Patrick/0000-0002-7137-7089; Espinoza, Francisco/0000-0002-1855-1914	National Research Service Award (NRSA) [F32HL083645]; NIH [R01HL075769, U01HL099995]; Vera M. Wall Center for Pulmonary Vascular Disease at Stanford University; Damon Runyon and Parker B. Francis postdoctoral fellowships; NRSA postdoctoral fellowship [F32HD048006]; NIH Center of Excellence in Genomic Studies grant [5P50HG2568]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD048006] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075769, U01HL099995, F32HL083645, U01HL099999] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER	National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vera M. Wall Center for Pulmonary Vascular Disease at Stanford University; Damon Runyon and Parker B. Francis postdoctoral fellowships; NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center of Excellence in Genomic Studies grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Research Service Award (NRSA) postdoctoral fellowship F32HL083645 (M.E.K.), NIH grants R01HL075769 and U01HL099995, and the Vera M. Wall Center for Pulmonary Vascular Disease at Stanford University (M.A.K.); Damon Runyon and Parker B. Francis postdoctoral fellowships (F.H.E.); NRSA postdoctoral fellowship F32HD048006 (D.B.M.); and NIH Center of Excellence in Genomic Studies grant 5P50HG2568 (D.M.K.). M.A.K. and D.M.K. are investigators of the Howard Hughes Medical Institute. M.E.K. and M.A.K. designed the experiments, performed data analysis, and wrote the manuscript. M.E.K. performed the experiments. M.E.K. and P.E.B. made the Tbx4LME transgenic mice. F.H.E. analyzed gene expression at branch tips. D.B.M. and D.M.K. isolated the Tbx4 enhancer element. The data reported in this paper are tabulated in the supplementary materials, and expression profiling data sets have been deposited to the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) (GSE62039). The authors thank D. Riordan for help with statistical analysis and L. Luo and I. Weissman for generously sharing mouse lines before publication.	Arey LB., 1965, TXB LAB MANUAL EMBRY, P350; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Berair R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-145; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bogard P., 2012, THESIS; Cano E, 2013, AM J PHYSIOL-LUNG C, V305, pL322, DOI 10.1152/ajplung.00424.2012; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; CRICK FHC, 1975, SCIENCE, V189, P340, DOI 10.1126/science.806966; De Langhe SP, 2006, DEV BIOL, V299, P52, DOI 10.1016/j.ydbio.2006.07.001; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Dixit R, 2013, DEVELOPMENT, V140, P4398, DOI 10.1242/dev.098079; Flint JM, 1906, AM J ANAT, V6, P1; Goss AM, 2011, DEV BIOL, V356, P541, DOI 10.1016/j.ydbio.2011.06.011; Greif DM, 2012, DEV CELL, V23, P482, DOI 10.1016/j.devcel.2012.07.009; GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; MacCord K., 2012, EMBRYO PROJECT ENCYC; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Menke DB, 2008, DEVELOPMENT, V135, P2543, DOI 10.1242/dev.017384; Metzger R., 2007, THESIS; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Pearse RV, 2007, DEV BIOL, V310, P388, DOI 10.1016/j.ydbio.2007.08.002; Prentiss C. W., 1915, LAB MANUAL TXB EMBRY; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; SPOONER BS, 1970, J EXP ZOOL, V175, P445, DOI 10.1002/jez.1401750404; TADERERA JV, 1967, DEV BIOL, V16, P489, DOI 10.1016/0012-1606(67)90061-9; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	40	89	91	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					827	+	1258810	10.1126/science.1258810	http://dx.doi.org/10.1126/science.1258810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6XZ	25395543	Green Accepted			2022-12-28	WOS:000349771600003
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Randomised controlled trials: tests of interaction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Bennewith O, 2002, BRIT MED J, V324, P1254, DOI 10.1136/bmj.324.7348.1254; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4488	3	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 14	2014	349								g6820	10.1136/bmj.g6820	http://dx.doi.org/10.1136/bmj.g6820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JU	25398492				2022-12-28	WOS:000345445300006
J	Klitzman, R; Appelbaum, PS; Chung, WK				Klitzman, Robert; Appelbaum, Paul S.; Chung, Wendy K.			Should Life Insurers Have Access to Genetic Test Results?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSURANCE		[Klitzman, Robert] Columbia Univ, Masters Bioeth Program, Med Ctr, New York, NY 10032 USA; [Appelbaum, Paul S.] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY USA; [Appelbaum, Paul S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Klitzman, R (corresponding author), Columbia Univ, Masters Bioeth Program, 1051 Riverside Dr,Unit 15, New York, NY 10032 USA.	rlk2@columbia.edu	Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042	NHGRI NIH HHS [P50HG007257, RM1 HG007257, P50 HG007257] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007257] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], INS GEN MOR EXT 2017; Joly Y, 2014, EUR J HUM GENET, V22, P575, DOI 10.1038/ejhg.2013.228; Klitzman R., 2012, AM I MY GENES CONFRO; Knoppers BM, 2009, GENETICS LIFE INSURA, P173; National Human Genome Research Institute, GEN STAT LEG DAT; Peikoff Kira, 2014, NY TIMES; Prince A., 2013, BROOKLYN LAW REV, V79, P175; Taylor DH, 2010, HEALTH AFFAIR, V29, P102, DOI 10.1377/hlthaff.2009.0525	8	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1855	1856		10.1001/jama.2014.13301	http://dx.doi.org/10.1001/jama.2014.13301			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387181	Green Accepted, Green Submitted			2022-12-28	WOS:000344532600009
J	Wadden, TA; Butryn, ML; Hong, PS; Tsai, AG				Wadden, Thomas A.; Butryn, Meghan L.; Hong, Patricia S.; Tsai, Adam G.			Behavioral Treatment of Obesity in Patients Encountered in Primary Care Settings A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DIABETES PREVENTION PROGRAM; WEIGHT-LOSS INTERVENTION; LIFE-STYLE INTERVENTION; PRIMARY-HEALTH-CARE; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; METABOLIC SYNDROME; LOSS MAINTENANCE; OVERWEIGHT; MANAGEMENT	IMPORTANCE In 2011, the Centers for Medicare & Medicaid Services (CMS) approved intensive behavioral weight loss counseling for approximately 14 face-to-face, 10- to 15-minute sessions over 6 months for obese beneficiaries in primary care settings, when delivered by physicians and other CMS-defined primary care practitioners. OBJECTIVE To conduct a systematic review of behavioral counseling for overweight and obese patients recruited from primary care, as delivered by primary care practitioners working alone or with trained interventionists (eg, medical assistants, registered dietitians), or by trained interventionists working independently. EVIDENCE REVIEW We searched PubMed, CINAHL, and EMBASE for randomized controlled trials published between January 1980 and June 2014 that recruited overweight and obese patients from primary care; provided behavioral counseling (ie, diet, exercise, and behavioral therapy) for at least 3 months, with at least 6 months of postrandomization follow-up; included at least 15 participants per treatment group and objectively measured weights; and had a comparator, an intention-to-treat analysis, and attrition of less than 30% at 1 year or less than 40% at longer follow-up. FINDINGS Review of 3304 abstracts yielded 12 trials, involving 3893 participants, that met inclusion-exclusion criteria and prespecified quality ratings. No studies were found in which primary care practitioners delivered counseling that followed the CMS guidelines. Mean 6-month weight changes from baseline in the intervention groups ranged from a loss of 0.3 kg to 6.6 kg. In the control group, mean change ranged from a gain of 0.9 kg to a loss of 2.0 kg. Weight loss in both groups generally declined with longer follow-up (12-24 months). Interventions that prescribed both reduced energy intake (eg, >= 500 kcal/d) and increased physical activity (eg, >= 150 minutes a week of walking), with traditional behavioral therapy, generally produced larger weight loss than interventions without all 3 specific components. In the former trials, more treatment sessions, delivered in person or by telephone by trained interventionists, were associated with greater mean weight loss and likelihood of patients losing 5% or more of baseline weight. CONCLUSIONS AND RELEVANCE Intensive behavioral counseling can induce clinically meaningful weight loss, but there is little research on primary care practitioners providing such care. The present findings suggest that a range of trained interventionists, who deliver counseling in person or by telephone, could be considered for treating overweight or obesity in patients encountered in primary care settings. Copyright 2014 American Medical Association. All rights reserved.	[Wadden, Thomas A.; Hong, Patricia S.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Butryn, Meghan L.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Tsai, Adam G.] Univ Colorado, Sch Med, Aurora, CO USA; [Tsai, Adam G.] Kaiser Permanente Colorado, Denver, CO USA	University of Pennsylvania; Pennsylvania Medicine; Drexel University; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente	Wadden, TA (corresponding author), Penn Perelman Sch Med, Ctr Weight & Eating Disorders, 3535 Market St,Ste 3029, Philadelphia, PA 19104 USA.	Wadden@mail.med.upenn.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK-65018]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK065018] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Wadden's work on this project was supported, in part, by grant DK-65018 from the National Institute of Diabetes and Digestive and Kidney Diseases.	Ali MK, 2012, HEALTH AFFAIR, V31, P67, DOI 10.1377/hlthaff.2011.1009; American Medical Association, ANN REF COMM REP; Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Bacigalupo R, 2013, OBES REV, V14, P279, DOI 10.1111/obr.12006; Bennett GG, 2012, ARCH INTERN MED, V172, P565, DOI 10.1001/archinternmed.2012.1; Berg AO, 2003, ANN INTERN MED, V139, P930, DOI 10.7326/0003-4819-139-11-200312020-00012; Centers for Medicare & Medicaid Services, CAG00423N; Centers for Medicare & Medicaid Services, SERV SUPPL INC PHYS; Christian JG, 2008, ARCH INTERN MED, V168, P141, DOI 10.1001/archinternmed.2007.13; Christian JG, 2011, J AM DIET ASSOC, V111, P75, DOI 10.1016/j.jada.2010.10.006; de Vos BC, 2014, EUR J NUTR, V53, P95, DOI 10.1007/s00394-013-0505-y; Donnelly JE, 2013, OBESITY, V21, P1951, DOI 10.1002/oby.20334; Ely AC, 2008, J RURAL HEALTH, V24, P125, DOI 10.1111/j.1748-0361.2008.00148.x; Greaves CJ, 2008, BRIT J GEN PRACT, V58, P535, DOI 10.3399/bjgp08X319648; Hardcastle S, 2008, PATIENT EDUC COUNS, V70, P31, DOI 10.1016/j.pec.2007.09.014; Hardcastle SJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-40; Harvey-Berino J, 2010, PREV MED, V51, P123, DOI 10.1016/j.ypmed.2010.04.018; Haynes RB, 2006, J CLIN EPIDEMIOL, V59, P881, DOI 10.1016/j.jclinepi.2006.06.006; Heshka S, 2003, JAMA-J AM MED ASSOC, V289, P1792, DOI 10.1001/jama.289.14.1792; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Jensen MD, 2014, OBESITY, V22, pS5, DOI 10.1002/oby.20821; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kumanyika SK, 2012, OBESITY, V20, P1249, DOI 10.1038/oby.2011.329; LeBlanc ES, 2011, ANN INTERN MED, V155, P434, DOI 10.7326/0003-4819-155-7-201110040-00006; Logue E, 2005, OBES RES, V13, P917, DOI 10.1038/oby.2005.106; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; Martin PD, 2008, OBESITY, V16, P2462, DOI 10.1038/oby.2008.399; Martin PD, 2006, OBESITY, V14, P1412, DOI 10.1038/oby.2006.160; Miller WR, 2002, MOTIVATIONAL INTERVI; Molenaar EA, 2010, FAM PRACT, V27, P143, DOI 10.1093/fampra/cmp104; Moore H, 2003, BMJ-BRIT MED J, V327, P1; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Munsch S, 2003, SWISS MED WKLY, V133, P148; Nanchahal K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000793; Patient-Centered Outcomes Research Institute, 2014, PCOR INV 20 MILL STU; Perri MG, 2008, ARCH INTERN MED, V168, P2347, DOI 10.1001/archinte.168.21.2347; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pritchard DA, 1999, J EPIDEMIOL COMMUN H, V53, P311, DOI 10.1136/jech.53.5.311; Prochaska JO, 1997, HLTH BEHAV HLTH ED T, P60; Rao G, 2011, CIRCULATION, V124, P1182, DOI 10.1161/CIR.0b013e31822b9543; Ridgeway NA, 1999, SOUTHERN MED J, V92, P667, DOI 10.1097/00007611-199907000-00004; Rock CL, 2010, JAMA-J AM MED ASSOC, V304, P1803, DOI 10.1001/jama.2010.1503; Ross R, 2012, ARCH INTERN MED, V172, P414, DOI 10.1001/archinternmed.2011.1972; Ryan DH, 2010, ARCH INTERN MED, V170, P146, DOI 10.1001/archinternmed.2009.508; Steinberg DM, 2013, OBESITY, V21, P1789, DOI 10.1002/oby.20396; Tsai AG, 2010, OBESITY, V18, P1614, DOI 10.1038/oby.2009.457; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637; Weinstock RS, 2013, J GEN INTERN MED, V28, P1620, DOI 10.1007/s11606-013-2529-7; West DS, 2008, OBESITY, V16, P1413, DOI 10.1038/oby.2008.224; West DS, 2007, DIABETES CARE, V30, P1081, DOI 10.2337/dc06-1966; Whittemore R, 2009, NURS RES, V58, P2, DOI 10.1097/NNR.0b013e31818fcef3; Willaing I, 2004, EUR J CARDIOV PREV R, V11, P513, DOI 10.1097/00149831-200412000-00012; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Xiao L, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.17; Yardley L, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-67; Yoong SL, 2013, PUBLIC HEALTH NUTR, V16, P2083, DOI 10.1017/S1368980012004375	58	162	165	0	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1779	1791		10.1001/jama.2014.14173	http://dx.doi.org/10.1001/jama.2014.14173			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS3QX	25369490	Green Accepted			2022-12-28	WOS:000344194500016
J	Packham, DK; Rasmussen, HS; Lavin, PT; El-Shahawy, MA; Roger, SD; Block, G; Qunibi, W; Pergola, P; Singh, B				Packham, David K.; Rasmussen, Henrik S.; Lavin, Philip T.; El-Shahawy, Mohamed A.; Roger, Simon D.; Block, Geoffrey; Qunibi, Wajeh; Pergola, Pablo; Singh, Bhupinder			Sodium Zirconium Cyclosilicate in Hyperkalemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALDOSTERONE SYSTEM BLOCKADE; CHRONIC KIDNEY-DISEASE; POLYSTYRENE SULFONATE; METABOLIC-ACIDOSIS; PREDICTORS; SPIRONOLACTONE; ASSOCIATION; VEGETABLES; FRUITS	Background Hyperkalemia (serum potassium level, >5.0 mmol per liter) is associated with increased mortality among patients with heart failure, chronic kidney disease, or diabetes. We investigated whether sodium zirconium cyclosilicate (ZS-9), a novel selective cation exchanger, could lower serum potassium levels in patients with hyperkalemia. Methods In this multicenter, two-stage, double-blind, phase 3 trial, we randomly assigned 753 patients with hyperkalemia to receive either ZS-9 (at a dose of 1.25 g, 2.5 g, 5 g, or 10 g) or placebo three times daily for 48 hours. Patients with normokalemia (serum potassium level, 3.5 to 4.9 mmol per liter) at 48 hours were randomly assigned to receive either ZS-9 or placebo once daily on days 3 to 14 (maintenance phase). The primary end point was the exponential rate of change in the mean serum potassium level at 48 hours. Results At 48 hours, the mean serum potassium level had decreased from 5.3 mmol per liter at baseline to 4.9 mmol per liter in the group of patients who received 2.5 g of ZS-9, 4.8 mmol per liter in the 5-g group, and 4.6 mmol per liter in the 10-g group, for mean reductions of 0.5, 0.5, and 0.7 mmol per liter, respectively (P<0.001 for all comparisons) and to 5.1 mmol per liter in the 1.25-g group and the placebo group (mean reduction, 0.3 mmol per liter). In patients who received 5 g of ZS-9 and those who received 10 g of ZS-9, serum potassium levels were maintained at 4.7 mmol per liter and 4.5 mmol per liter, respectively, during the maintenance phase, as compared with a level of more than 5.0 mmol per liter in the placebo group (P<0.01 for all comparisons). Rates of adverse events were similar in the ZS-9 group and the placebo group (12.9% and 10.8%, respectively, in the initial phase; 25.1% and 24.5%, respectively, in the maintenance phase). Diarrhea was the most common complication in the two study groups. Conclusions Patients with hyperkalemia who received ZS-9, as compared with those who received placebo, had a significant reduction in potassium levels at 48 hours, with normokalemia maintained during 12 days of maintenance therapy. Copyright (C) 2014 Massachusetts Medical Society.	[Packham, David K.] Melbourne Renal Res Grp, Reservoir, Vic 3073, Australia; [Packham, David K.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Packham, David K.] Royal Melbourne Hosp, Dept Nephrol, Melbourne, Vic 3050, Australia; [Roger, Simon D.] Renal Res, Gosford, NSW, Australia; [Rasmussen, Henrik S.; Singh, Bhupinder] ZS Pharma, Coppell, TX USA; [Qunibi, Wajeh] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Pergola, Pablo] Renal Associates, San Antonio, TX USA; [Lavin, Philip T.] Boston Biostat Res Fdn, Framingham, MA USA; [El-Shahawy, Mohamed A.] Acad Med Res Inst, Los Angeles, CA USA; [Singh, Bhupinder] Apex Res, Riverside, CA USA; [Block, Geoffrey] Denver Nephrologists, Denver, CO USA	University of Melbourne; Royal Melbourne Hospital; University of Texas System; University of Texas Health San Antonio	Packham, DK (corresponding author), Melbourne Renal Res Grp, 73 Pine St, Reservoir, Vic 3073, Australia.	dmpackham@netspace.net.au			ZS Pharma	ZS Pharma	Funded by ZS Pharma; ClinicalTrials.gov number, NCT01737697.	Aaron KJ, 2013, MAYO CLIN PROC, V88, P987, DOI 10.1016/j.mayocp.2013.06.005; Ahn SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084467; An JN, 2012, CRIT CARE, V16, DOI 10.1186/cc11872; Ash SR., KIDNEY INT IN PRESS; Berl Tomas, 2009, J Renin Angiotensin Aldosterone Syst, V10, P1, DOI 10.1177/1470320309102747; Cejas MDC, 2013, REV ESP ENFERM DIG, V105, P232, DOI 10.4321/s1130-01082013000400010; Dunkler D, 2013, JAMA INTERN MED, V173, P1682, DOI 10.1001/jamainternmed.2013.9051; Estacio RO, 2009, POSTGRAD MED, V121, P33, DOI 10.3810/pgm.2009.05.2000; Goraya N, 2014, KIDNEY INT, V86, P1031, DOI 10.1038/ki.2014.83; Goraya N, 2013, CLIN J AM SOC NEPHRO, V8, P371, DOI 10.2215/CJN.02430312; Goraya N, 2012, CURR OPIN NEPHROL HY, V21, P635, DOI 10.1097/MNH.0b013e328357a69b; Harel Z, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.08.016; Jain N, 2012, AM J CARDIOL, V109, P1510, DOI 10.1016/j.amjcard.2012.01.367; Khanagavi J, 2014, ARCH MED SCI, V10, P251, DOI 10.5114/aoms.2014.42577; McCullough PA, 2014, REV CARDIOVASC MED, V15, P11, DOI 10.3909/ricm0727; Navaneethan SD, 2009, COCHRANE DB SYST REV, V3; Palmer Biff F, 2010, Proc (Bayl Univ Med Cent), V23, P239; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; St Peter WL, 2013, PHARMACOTHERAPY, V33, P496, DOI 10.1002/phar.1232; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Stojiljkovic L, 2007, CURR PHARM DESIGN, V13, P1335, DOI 10.2174/138161207780618768; Svensson M, 2004, J CARD FAIL, V10, P297, DOI 10.1016/j.cardfail.2003.10.012; Tongyoo Assanee, 2013, Journal of the Medical Association of Thailand, V96, P1617; Tylicki L, 2012, J NEPHROL, V25, P900, DOI 10.5301/jn.5000134; Uribarri J, 2012, KIDNEY INT, V81, P7, DOI 10.1038/ki.2011.331; Vardeny O, 2014, CIRC-HEART FAIL, V7, P573, DOI 10.1161/CIRCHEARTFAILURE.114.001104; Watson MA, 2012, AM J KIDNEY DIS, V60, P409, DOI 10.1053/j.ajkd.2012.04.023; Yang A, 2014, ADV CHRONIC KIDNEY D, V21, P247; Yuan CM, 2013, AM J MED, V126, pE12, DOI 10.1016/j.amjmed.2013.02.034	29	293	309	5	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					222	231		10.1056/NEJMoa1411487	http://dx.doi.org/10.1056/NEJMoa1411487			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3HX	25415807				2022-12-28	WOS:000348119200006
J	Marti, MC; Webb, AAR				Marti, Maria C.; Webb, Alex A. R.			PLANT SCIENCE Leaf veins share the time of day	NATURE			English	Editorial Material							CIRCADIAN CLOCK; ARABIDOPSIS; WAVES	Techniques for isolating and analysing leaf cell types have now been developed, leading to the discovery that circadian clocks in the plant vasculature communicate with and regulate clocks in neighbouring cells. See Letter p. 419	[Marti, Maria C.; Webb, Alex A. R.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Marti, MC (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	alex.webb@plantsci.cam.ac.uk	Ruiz, María Carmen Martí/AAB-2564-2019; Marti, Carmen/ABD-8806-2020	Webb, Alex/0000-0003-0261-4375; Marti Ruiz, Maria Carmen/0000-0003-1698-1168				Choi WG, 2014, P NATL ACAD SCI USA, V111, P6497, DOI 10.1073/pnas.1319955111; Endo M, 2014, NATURE, V515, P419, DOI 10.1038/nature13919; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; James AB, 2008, SCIENCE, V322, P1832, DOI 10.1126/science.1161403; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Wenden B, 2012, P NATL ACAD SCI USA, V109, P6757, DOI 10.1073/pnas.1118814109	10	2	2	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					352	353		10.1038/nature13936	http://dx.doi.org/10.1038/nature13936			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25363777				2022-12-28	WOS:000345770600033
J	Ramakrishnan, V				Ramakrishnan, V.			The Ribosome Emerges from a Black Box	CELL			English	Review							AMINOACYL-TRANSFER-RNA; COMPLETE NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI RIBOSOME; PROTEIN CROSS-LINKING; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; BINDING-SITES; PEPTIDYL TRANSFERASE; ELECTRON-MICROSCOPY; SECONDARY STRUCTURE	Although the basic facts about the ribosome were already known 40 years ago, elucidating its atomic structure and molecular mechanisms required sheer persistence and the innovative use of new technology and methods. These advances have transformed our understanding of translation in the cell.	MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk		Ramakrishnan, V/0000-0002-4699-2194	Medical Research Council [MC_U105184332] Funding Source: Medline; Wellcome Trust [096570] Funding Source: Medline; MRC [MC_U105184332] Funding Source: UKRI; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Aqvist J, 2012, CURR OPIN STRUC BIOL, V22, P815, DOI 10.1016/j.sbi.2012.07.008; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BERNABEU C, 1982, P NATL ACAD SCI-BIOL, V79, P3111, DOI 10.1073/pnas.79.10.3111; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; BYERS B, 1966, J CELL BIOL, V30, pC1; CAPEL MS, 1987, SCIENCE, V238, P1403, DOI 10.1126/science.3317832; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; DORING T, 1994, EMBO J, V13, P2677, DOI 10.1002/j.1460-2075.1994.tb06558.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; GLOTZ C, 1980, NUCLEIC ACIDS RES, V8, P2377, DOI 10.1093/nar/8.11.2377; GREUER B, 1987, NUCLEIC ACIDS RES, V15, P3241, DOI 10.1093/nar/15.8.3241; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; GULLE H, 1988, NUCLEIC ACIDS RES, V16, P815, DOI 10.1093/nar/16.3.815; HELD WA, 1973, J BIOL CHEM, V248, P5720; HOPE H, 1988, ACTA CRYSTALLOGR B, V44, P22, DOI 10.1107/S0108768187008632; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; LAKE JA, 1976, J MOL BIOL, V105, P131, DOI 10.1016/0022-2836(76)90200-X; Liu TT, 2014, ELIFE, V3, DOI 10.7554/eLife.03406; MILLIGAN RA, 1986, NATURE, V319, P693, DOI 10.1038/319693a0; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MOORE PB, 1988, NATURE, V331, P223, DOI 10.1038/331223a0; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; NOLLER HF, 1972, P NATL ACAD SCI USA, V69, P3115, DOI 10.1073/pnas.69.11.3115; Nomura M., 1974, RIBOSOMES; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; POWERS T, 1995, RNA, V1, P194; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ramakrishnan V, 1998, TRENDS BIOCHEM SCI, V23, P208, DOI 10.1016/S0968-0004(98)01214-6; RHEINBERGER HJ, 1981, P NATL ACAD SCI-BIOL, V78, P5310, DOI 10.1073/pnas.78.9.5310; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; TRAKHANOV SD, 1987, FEBS LETT, V220, P319, DOI 10.1016/0014-5793(87)80838-4; TRAUB P, 1968, SCIENCE, V160, P198, DOI 10.1126/science.160.3824.198; UNWIN PNT, 1977, NATURE, V269, P118, DOI 10.1038/269118a0; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; VONBOHLEN K, 1991, J MOL BIOL, V222, P11, DOI 10.1016/0022-2836(91)90730-T; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; WETTSTEI.FO, 1965, J MOL BIOL, V11, P35, DOI 10.1016/S0022-2836(65)80169-3; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; YONATH AE, 1980, BIOCHEM INT, V1, P428; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911	68	79	79	1	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					979	984		10.1016/j.cell.2014.10.052	http://dx.doi.org/10.1016/j.cell.2014.10.052			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416939	Bronze			2022-12-28	WOS:000345506300012
J	Morey-Vargas, OL; Shah, P				Morey-Vargas, Oscar L.; Shah, Pankaj			In metformin-treated type 2 diabetes, weekly dulaglutide was noninferior to daily liraglutide for HbA(1c) levels Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Morey-Vargas, Oscar L.; Shah, Pankaj] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Morey-Vargas, OL (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Meneghini LF, 2011, J CLIN ENDOCR METAB, V96, P3337, DOI 10.1210/jc.2011-1074	2	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC9	10.7326/0003-4819-161-10-201411180-02009	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402542				2022-12-28	WOS:000347245600016
J	Rondina, M				Rondina, Matthew			In nonvalvular atrial fibrillation, effects of rivaroxaban compared with warfarin did not differ by patient age Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIAL		Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Rondina, M (corresponding author), Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092161, R01HL126547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048022, R03AG040631] Funding Source: NIH RePORTER; NHLBI NIH HHS [K23 HL092161, R01 HL126547] Funding Source: Medline; NIA NIH HHS [R03 AG040631, R01 AG048022] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Halvorsen S, 2014, EUR HEART J, V35, P1864, DOI 10.1093/eurheartj/ehu046	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC5	10.7326/0003-4819-161-10-201411180-02005	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402538	Green Accepted			2022-12-28	WOS:000347245600008
J	Zhelezinskaia, I; Kaufman, AJ; Farquhar, J; Cliff, J				Zhelezinskaia, Iadviga; Kaufman, Alan J.; Farquhar, James; Cliff, John			Large sulfur isotope fractionations associated with Neoarchean microbial sulfate reduction	SCIENCE			English	Article							WESTERN-AUSTRALIA; HAMERSLEY BASIN; KAAPVAAL CRATON; ATMOSPHERE; EVOLUTION; SEDIMENTS; RECORD; SYSTEMATICS; RESERVOIR; INSIGHTS	The minor extent of sulfur isotope fractionation preserved in many Neoarchean sedimentary successions suggests that sulfate-reducing microorganisms played an insignificant role in ancient marine environments, despite evidence that these organisms evolved much earlier. We present bulk, microdrilled, and ion probe sulfur isotope data from carbonate-associated pyrite in the similar to 2.5-billion-year-old Batatal Formation of Brazil, revealing large mass-dependent fractionations (approaching 50 per mil) associated with microbial sulfate reduction, as well as consistently negative Delta S-33 values (similar to -2 per mil) indicative of atmospheric photochemical reactions. Persistent S-33 depletion through similar to 60 meters of shallow marine carbonate implies long-term stability of seawater sulfate abundance and isotope composition. In contrast, a negative Delta S-33 excursion in lower Batatal strata indicates a response time of similar to 40,000 to 150,000 years, suggesting Neoarchean sulfate concentrations between similar to 1 and 10 mu M.	[Zhelezinskaia, Iadviga; Kaufman, Alan J.; Farquhar, James] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Zhelezinskaia, Iadviga; Kaufman, Alan J.; Farquhar, James] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Cliff, John] Univ Western Australia, ARC Ctr Excellence Core Crust Fluid Syst, Ctr Microscopy Characterizat & Anal, Crawley, WA 6009, Australia	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Western Australia	Zhelezinskaia, I (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	zhelezka@umd.edu	Cliff, John B/C-7696-2011; Zhelezinskaia, Iadviga/ABH-8456-2020	Cliff, John B/0000-0002-7395-5604; Zhelezinskaia, Iadviga/0000-0002-7677-0488	Fulbright Program [15110620]; NASA Astrobiology Institute [NNA09DA81A]; NSF Frontiers of Earth Surface Dynamics program [432129]; Directorate For Geosciences [1338810] Funding Source: National Science Foundation	Fulbright Program; NASA Astrobiology Institute; NSF Frontiers of Earth Surface Dynamics program; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank C. Noce, N. Geboy, and A. Shrestha, as well as the facilities and the scientific and technical assistance of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterization and Analysis at the University of Western Australia, a facility funded by the University, State, and Commonwealth governments. Supported by the Fulbright Program (grantee ID 15110620, I.Z.), NASA Astrobiology Institute grant NNA09DA81A (J.F.), and NSF Frontiers of Earth Surface Dynamics program grant 432129 (A.J.K.). All data are provided in the supplementary materials.	Altermann W, 1998, SEDIMENT GEOL, V120, P225, DOI 10.1016/S0037-0738(98)00034-7; Bontognali TRR, 2012, P NATL ACAD SCI USA, V109, P15146, DOI 10.1073/pnas.1207491109; Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Cheney ES, 1996, PRECAMBRIAN RES, V79, P3, DOI 10.1016/0301-9268(95)00085-2; Condie KC, 2001, PRECAMBRIAN RES, V106, P239, DOI 10.1016/S0301-9268(00)00097-8; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2013, P NATL ACAD SCI USA, V110, P17638, DOI 10.1073/pnas.1218851110; Fischer WW, 2009, PRECAMBRIAN RES, V169, P15, DOI 10.1016/j.precamres.2008.10.010; Gomes ML, 2013, GEOLOGY, V41, P663, DOI 10.1130/G34187.1; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Halevy I, 2013, P NATL ACAD SCI USA, V110, P17644, DOI 10.1073/pnas.1213148110; Halevy I, 2010, SCIENCE, V329, P204, DOI 10.1126/science.1190298; Jamieson JW, 2013, NAT GEOSCI, V6, P61, DOI [10.1038/ngeo1647, 10.1038/NGEO1647]; Johnston DT, 2007, GEOCHIM COSMOCHIM AC, V71, P3929, DOI 10.1016/j.gca.2007.05.008; Johnston DT, 2011, EARTH-SCI REV, V106, P161, DOI 10.1016/j.earscirev.2011.02.003; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Leavitt WD, 2013, P NATL ACAD SCI USA, V110, P11244, DOI 10.1073/pnas.1218874110; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Ono SH, 2009, PRECAMBRIAN RES, V169, P58, DOI 10.1016/j.precamres.2008.10.013; Paris G., 2012, MINERAL MAG, V76, P2204; Partridge MA, 2008, EARTH PLANET SC LETT, V272, P41, DOI 10.1016/j.epsl.2008.03.051; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Reinhard CT, 2013, NATURE, V497, P100, DOI 10.1038/nature12021; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Shen YN, 2009, EARTH PLANET SC LETT, V279, P383, DOI 10.1016/j.epsl.2009.01.018; SIMONSON BM, 1993, PRECAMBRIAN RES, V60, P287, DOI 10.1016/0301-9268(93)90052-4; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238	30	66	66	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					742	744		10.1126/science.1256211	http://dx.doi.org/10.1126/science.1256211			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378623				2022-12-28	WOS:000344690100039
J	Ianchulev, T; Minckler, DS; Hoskins, HD; Packer, M; Stamper, R; Pamnani, RD; Koo, EY				Ianchulev, Tsontcho; Minckler, Donald S.; Hoskins, H. Dunbar; Packer, Mark; Stamper, Robert; Pamnani, Ravinder D.; Koo, Edward Y.			Wearable Technology With Head-Mounted Displays and Visual Function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ianchulev, Tsontcho; Hoskins, H. Dunbar; Stamper, Robert; Koo, Edward Y.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94109 USA; [Minckler, Donald S.] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA USA; [Packer, Mark] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Pamnani, Ravinder D.] Stanford Univ, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California Irvine; Oregon Health & Science University; Stanford University	Ianchulev, T (corresponding author), Univ Calif San Francisco, 909 Hyde St,Ste 530, San Francisco, CA 94109 USA.	sean@ianchulev.com	Packer, Mark/P-8600-2019	Packer, Mark/0000-0003-2681-6641				Steel SE, 1996, OPHTHAL PHYSL OPT, V16, P95, DOI 10.1016/0275-5408(95)00026-7	1	9	9	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1799	1801		10.1001/jama.2014.13754	http://dx.doi.org/10.1001/jama.2014.13754			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25369493	Green Submitted			2022-12-28	WOS:000344194500020
J	Whitson, HE; Lin, FR				Whitson, Heather E.; Lin, Frank R.			Hearing and Vision Care for Older Adults Sensing a Need to Update Medicare Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEMENTIA		[Whitson, Heather E.] Duke Univ, Med Ctr, Dept Med Geriatr, Durham, NC 27710 USA; [Whitson, Heather E.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Whitson, Heather E.] Duke Ctr Study Aging & Human Dev, Durham, NC USA; [Whitson, Heather E.] Durham VA Geriatr Res Educ & Clin Ctr GRECC, Durham, NC USA; [Lin, Frank R.] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Sch Med, Dept Med Geriatr, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Ctr Hlth & Aging, Baltimore, MD USA	Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Whitson, HE (corresponding author), Duke Univ, Med Ctr, POB 3003, Durham, NC 27710 USA.	heather.whitson@duke.edu	Whitson, Heather/K-8941-2019	Whitson, Heather/0000-0002-8417-4846	NATIONAL INSTITUTE ON AGING [R01AG043438, P30AG028716, R24AG045050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC011279] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG028716, R01AG043438, R24AG045050, R01 AG043438, R24 AG045050, P30AG028716] Funding Source: Medline; NIDCD NIH HHS [K23DC011279, K23 DC011279] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Hudson HL, 2006, OPHTHALMOLOGY, V113, P1987, DOI 10.1016/j.ophtha.2006.07.010; International Federation on Ageing, 2013, HIGH COST LOW VIS EV; IOM (Institute of Medicine) and NRC (National Research Council), 2014, HEAR LOSS HLTH AG WO; Lin FR, 2014, AGING MENT HEALTH, V18, P671, DOI 10.1080/13607863.2014.915924; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; National Eye Institute (NEI), LOW VIS; NIH Research Portfolio Online Reporting Tools (RePORT), HEARING AIDS; Rogers MAM, 2010, AM J EPIDEMIOL, V171, P728, DOI 10.1093/aje/kwp453; USPSTF, US PREV SERV TASK FO	9	26	27	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1739	1740		10.1001/jama.2014.13535	http://dx.doi.org/10.1001/jama.2014.13535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25369486	Green Accepted			2022-12-28	WOS:000344194500009
J	Guo, X; Wang, L; Li, J; Ding, ZY; Xiao, JX; Yin, XT; He, S; Shi, P; Dong, LP; Li, GH; Tian, CL; Wang, JW; Cong, Y; Xu, YH				Guo, Xue; Wang, Ling; Li, Jie; Ding, Zhanyu; Xiao, Jianxiong; Yin, Xiaotong; He, Shuang; Shi, Pan; Dong, Liping; Li, Guohong; Tian, Changlin; Wang, Jiawei; Cong, Yao; Xu, Yanhui			Structural insight into autoinhibition and histone H3-induced activation of DNMT3A	NATURE			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; MAMMALIAN DEVELOPMENT; RECOMBINANT HISTONES; HIGH-RESOLUTION; METHYLTRANSFERASE; PATTERNS; EXPRESSION; SOFTWARE; GENOME	DNA methylation is an important epigenetic modification that is essential for various developmental processes through regulating gene expression, genomic imprinting, and epigenetic inheritance(1-5). Mammalian genomic DNA methylation is established during embryogenesis by de novo DNA methyltransferases, DNMT3A and DNMT3B(6-8), and the methylation patterns vary with developmental stages and cell types(9-12). DNAmethyltransferase 3-like protein (DNMT3L) is a catalytically inactive paralogue of DNMT3 enzymes, which stimulates the enzymatic activity of Dnmt3a(13). Recent studies have established a connection between DNA methylation and histone modifications, and revealed a histone-guided mechanism for the establishment of DNA methylation(14). The ATRX-DNMT3-DNMT3L (ADD) domain of Dnmt3a recognizes unmethylated histone H3 (H3K4me0)(15-17). The histone H3 tail stimulates the enzymatic activity of Dnmt3a in vitro(17,18), whereas the molecular mechanism remains elusive. Here we show that DNMT3A exists in an autoinhibitory form and that the histone H3 tail stimulates its activity in a DNMT3L-independent manner. We determine the crystal structures of DNMT3A-DNMT3L (autoinhibitory form) and DNMT3A-DNMT3L-H3 (active form) complexes at 3.82 and 2.90 angstrom resolution, respectively. Structural and biochemical analyses indicate that the ADD domain of DNMT3A interacts with and inhibits enzymatic activity of the catalyticdomain (CD) through blocking its DNA-binding affinity. HistoneH3(but not H3K4me3) disrupts ADD-CD interaction, induces a large movement of the ADD domain, and thus releases the autoinhibition of DNMT3A. The finding adds another layer of regulation of DNA methylation to ensure that the enzyme is mainly activated at proper targeting loci when unmethylated H3K4 is present, and strongly supports a negative correlation between H3K4me3 and DNA methylation across the mammalian genome(9,10,19,20). Our study provides a new insight into an unexpected autoinhibition and histone H3-induced activation of the de novo DNA methyltransferase after its initial genomic positioning.	[Guo, Xue; Wang, Ling; Li, Jie; Xiao, Jianxiong; Yin, Xiaotong; He, Shuang; Xu, Yanhui] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Guo, Xue; Wang, Ling; Xu, Yanhui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Ding, Zhanyu; Cong, Yao] Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Ctr Prot Sci Shanghai, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Shi, Pan; Tian, Changlin] Chinese Acad Sci, High Magnet Field Lab, Hefei 230031, Peoples R China; [Shi, Pan; Tian, Changlin] Univ Sci & Technol China, Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Shi, Pan; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Dong, Liping; Li, Guohong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Dong, Liping] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Jiawei] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University	Xu, YH (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai Canc Ctr, Shanghai 200032, Peoples R China.	xuyh@fudan.edu.cn	Xu, Yanhui/D-5119-2019; Wang, Ling/HGA-0927-2022; Wang, Ling/AAC-9797-2021; Xiao, Jianxiong/ABA-4938-2021; Wang, Jiawei/D-1144-2010	Xiao, Jianxiong/0000-0002-7263-0226; Wang, Jiawei/0000-0001-9893-8539	National Basic Research Program of China [2011CB965300, 2009CB918600, 2013CB910401]; National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China [2014ZX09507-002, 2011ZX09506-001]; National Natural Science Foundation of China [31270779, 91419301, 31030019, U1432242, 31270771, 31222016, 31300685, U1332138]; Basic Research Project of Shanghai Science and Technology Commission [12JC1402700, 13JC1406300]; Fok Ying Tung Education Foundation [20090071220012]; Chinese Academy of Sciences Pilot Strategic Science and Technology Projects B [XDB08030201, XDB08030302]	National Basic Research Program of China(National Basic Research Program of China); National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Chinese Academy of Sciences Pilot Strategic Science and Technology Projects B	We thank staff of beamline BL17U at Shanghai Synchrotron Radiation Facility, China, for their assistance in data collection, and H. Wang for help on electron microscopy analyses. We thank staff of the Biomedical Core Facility, Fudan University, for their help on biochemical analyses, and A. D. Riggs for providing the complementary DNAs of DNMT3A and DNMT3L. This work was supported by grants from the National Basic Research Program of China (2011CB965300, 2009CB918600, 2013CB910401), the National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China (2014ZX09507-002, 2011ZX09506-001), the National Natural Science Foundation of China (31270779, 91419301, 31030019, U1432242, 31270771, 31222016,31300685, U1332138), the Basic Research Project of Shanghai Science and Technology Commission (12JC1402700, 13JC1406300), the Fok Ying Tung Education Foundation (20090071220012), and the Chinese Academy of Sciences Pilot Strategic Science and Technology Projects B (numbers XDB08030201,XDB08030302). Y.C. is a scholar of the Hundred Talents Program of the Chinese Academy of Sciences.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1485, DOI 10.1093/nar/8.7.1485; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cong Y, 2010, METHOD ENZYMOL, V482, P211, DOI 10.1016/S0076-6879(10)82009-9; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; DeLano W.L, PYMOL MOL GRAPHICS S; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guibert S, 2009, EPIGENOMICS-UK, V1, P81, DOI 10.2217/EPI.09.5; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ludtke S. J., 2001, JMB; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1999, METH MOL B, V119, P1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajavelu A, 2012, NUCLEIC ACIDS RES, V40, P569, DOI 10.1093/nar/gkr753; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Shi P, 2011, PROTEIN SCI, V20, P224, DOI 10.1002/pro.545; Shi P, 2010, BIOCHEM BIOPH RES CO, V402, P461, DOI 10.1016/j.bbrc.2010.10.046; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	43	210	221	1	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					640	U281		10.1038/nature13899	http://dx.doi.org/10.1038/nature13899			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25383530				2022-12-28	WOS:000348775000049
J	Schrier, RW; Abebe, KZ; Perrone, RD; Torres, VE; Braun, WE; Steinman, TI; Winklhofer, FT; Brosnahan, G; Czarnecki, PG; Hogan, MC; Miskulin, DC; Rahbari-Oskoui, FF; Grantham, JJ; Harris, PC; Flessner, MF; Bae, KT; Moore, CG; Chapman, AB				Schrier, Robert W.; Abebe, Kaleab Z.; Perrone, Ronald D.; Torres, Vicente E.; Braun, William E.; Steinman, Theodore I.; Winklhofer, Franz T.; Brosnahan, Godela; Czarnecki, Peter G.; Hogan, Marie C.; Miskulin, Dana C.; Rahbari-Oskoui, Frederic F.; Grantham, Jared J.; Harris, Peter C.; Flessner, Michael F.; Bae, Kyongtae T.; Moore, Charity G.; Chapman, Arlene B.		HALT-PKD Trial Investigators	Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VOLUME PROGRESSION; CONVERTING ENZYME; RENAL-DISEASE; OUTCOMES; RENIN; HYPERTENSION; ALDOSTERONE; INHIBITION; TRIALS; RISK	BACKGROUND Hypertension is common in autosomal dominant polycystic kidney disease (ADPKD) and is associated with increased total kidney volume, activation of the renin-angiotensin-aldosterone system, and progression of kidney disease. METHODS In this double-blind, placebo-controlled trial, we randomly assigned 558 hypertensive participants with ADPKD (15 to 49 years of age, with an estimated glomerular filtration rate [GFR] >60 ml per minute per 1.73 m(2) of body-surface area) to either a standard blood-pressure target (120/70 to 130/80 mm Hg) or a low blood-pressure target (95/60 to 110/75 mm Hg) and to either an angiotensin-converting-enzyme inhibitor (lisinopril) plus an angiotensin-receptor blocker (telmisartan) or lisinopril plus placebo. The primary outcome was the annual percentage change in the total kidney volume. RESULTS The annual percentage increase in total kidney volume was significantly lower in the low-blood-pressure group than in the standard-blood-pressure group (5.6% vs. 6.6%, P = 0.006), without significant differences between the lisinopril-telmisartan group and the lisinopril-placebo group. The rate of change in estimated GFR was similar in the two medication groups, with a negative slope difference in the short term in the low-blood-pressure group as compared with the standard-blood-pressure group (P<0.001) and a marginally positive slope difference in the long term (P = 0.05). The left-ventricular-mass index decreased more in the low-blood-pressure group than in the standard-blood-pressure group (-1.17 vs. -0.57 g per square meter per year, P<0.001); urinary albumin excretion was reduced by 3.77% with the low-pressure target and increased by 2.43% with the standard target (P<0.001). Dizziness and light-headedness were more common in the low-blood-pressure group than in the standard-blood-pressure group (80.7% vs. 69.4%, P = 0.002). CONCLUSIONS In early ADPKD, the combination of lisinopril and telmisartan did not significantly alter the rate of increase in total kidney volume. As compared with standard blood-pressure control, rigorous blood-pressure control was associated with a slower increase in total kidney volume, no overall change in the estimated GFR, a greater decline in the left-ventricular-mass index, and greater reduction in urinary albumin excretion.	[Schrier, Robert W.; Brosnahan, Godela] Univ Colorado, Denver, CO 80202 USA; [Abebe, Kaleab Z.; Bae, Kyongtae T.; Moore, Charity G.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Perrone, Ronald D.; Miskulin, Dana C.] Tufts Med Ctr, Boston, MA USA; [Steinman, Theodore I.; Czarnecki, Peter G.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Torres, Vicente E.; Hogan, Marie C.; Harris, Peter C.] Mayo Clin, Coll Med, Rochester, MN USA; [Braun, William E.] Cleveland Clin, Cleveland, OH USA; [Winklhofer, Franz T.; Grantham, Jared J.] Univ Kansas, Med Ctr, Kansas City, MO USA; [Rahbari-Oskoui, Frederic F.; Chapman, Arlene B.] Emory Univ, Sch Med, Atlanta, GA USA; [Flessner, Michael F.] NIH, Bethesda, MD 20892 USA	University of Colorado System; University of Colorado Denver; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Mayo Clinic; Cleveland Clinic Foundation; University of Kansas; Emory University; National Institutes of Health (NIH) - USA	Schrier, RW (corresponding author), Univ Colorado, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.	robert.schrier@ucdenver.edu	Abebe, Kaleab/K-4400-2019; Brosnahan, Godela/AAB-5741-2021	Abebe, Kaleab/0000-0002-3644-8419; Masoumi, Amirali/0000-0002-1079-7258; Rahbari-Oskoui, Frederic/0000-0001-8933-4880; Torres, Vicente/0000-0003-2008-1576; Nurko, Samuel/0000-0003-0936-4807; Patterson, Charity/0000-0002-0060-0124	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102, UL1TR000135, UL1TR001064, UL1TR001082, UL1TR000001, UL1TR000454, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585, UL1RR025780, M01RR023940, UL1RR025008, UL1RR024989, UL1RR024150, UL1RR025758, UL1RR025752, UL1RR033179, M01RR000039, M01RR000054, M01RR001032, M01RR000051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062402, U01DK062411, U01DK062410, P01DK034039, U01DK082230, U01DK062401, U01DK062408] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; HALT-PKD [Study A] ClinicalTrials.gov number, NCT00283686.	Bae KT, 2009, CLIN J AM SOC NEPHRO, V4, P719, DOI 10.2215/CJN.03750708; Balding DJ, 2004, APPL LONGITUDINAL AN; CHAPMAN AB, 1990, NEW ENGL J MED, V323, P1091, DOI 10.1056/NEJM199010183231602; Chapman AB, 2012, CLIN J AM SOC NEPHRO, V7, P479, DOI 10.2215/CJN.09500911; Chapman AB, 2010, CLIN J AM SOC NEPHRO, V5, P102, DOI 10.2215/CJN.04310709; Cook J, 2008, INTRO STAT METHODS C; GABOW PA, 1990, KIDNEY INT, V38, P1177, DOI 10.1038/ki.1990.330; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; GRAHAM PC, 1988, KIDNEY INT, V33, P1084, DOI 10.1038/ki.1988.115; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Jia GF, 2010, PEDIATR NEPHROL, V25, P1139, DOI 10.1007/s00467-010-1477-2; KEITH DS, 1994, AM J KIDNEY DIS, V24, P491, DOI 10.1016/S0272-6386(12)80907-3; KLAHR S, 1995, J AM SOC NEPHROL, V6, P1318; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Orskov B, 2012, NEPHROL DIAL TRANSPL, V27, P1607, DOI 10.1093/ndt/gfr467; Orskov B, 2010, CLIN J AM SOC NEPHRO, V5, P2034, DOI 10.2215/CJN.01460210; Patch C, 2011, AM J KIDNEY DIS, V57, P856, DOI 10.1053/j.ajkd.2011.01.023; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; Reddy NPK, 2014, RENAL FAILURE, V36, P831, DOI 10.3109/0886022X.2014.899432; Schrier R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018407.60002.B9; Schrier RW, 2011, AM J KIDNEY DIS, V57, P811, DOI 10.1053/j.ajkd.2011.02.379; Schrier RW, 2003, KIDNEY INT, V63, P678, DOI 10.1046/j.1523-1755.2003.00776.x; Schrier RW, 2014, J AM SOC NEPHROL; Smith HW., 1943, LECT KIDNEY, P3; Spithoven EM, 2014, KIDNEY INT, V86, P1244, DOI 10.1038/ki.2014.120; Thomas W, 2010, STEROIDS, V75, P550, DOI 10.1016/j.steroids.2009.09.008; TORRES VE, 1992, KIDNEY INT, V42, P364, DOI 10.1038/ki.1992.297; TORRES VE, 1991, MAYO CLIN PROC, V66, P1010, DOI 10.1016/S0025-6196(12)61724-8; Torres VE, 2012, KIDNEY INT, V81, P577, DOI 10.1038/ki.2011.411; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Watanabe G, 1996, J BIOL CHEM, V271, P22570, DOI 10.1074/jbc.271.37.22570; Zafar I, 2007, AM J PHYSIOL-RENAL, V293, pF854, DOI 10.1152/ajprenal.00059.2007	35	294	301	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2255	2266		10.1056/NEJMoa1402685	http://dx.doi.org/10.1056/NEJMoa1402685			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW1KQ	25399733	Bronze, Green Accepted			2022-12-28	WOS:000346048800006
J	Kernbauer, E; Ding, Y; Cadwell, K				Kernbauer, Elisabeth; Ding, Yi; Cadwell, Ken			An enteric virus can replace the beneficial function of commensal bacteria	NATURE			English	Article							AUTOPHAGY GENE ATG16L1; DAY-CARE-CENTER; GUT MICROBIOTA; INFECTION; DISEASE; VIROME; PATHOGENESIS; INFLAMMATION; REPLICATION; RESISTANCE	Intestinal microbial communities have profound effects on host physiology(1). Whereas the symbiotic contribution of commensal bacteria is well established, the role of eukaryotic viruses that are present in the gastrointestinal tract under homeostatic conditions is undefined(2,3). Here we demonstrate that a common enteric RNA virus can replace the beneficial function of commensal bacteria in the intestine. Mmine norovirus (MNV) infection of germ-free or antibiotictreated mice restored intestinal morphology and lymphocyte function without inducing overt inflammation and disease. The presence of MNV also suppressed an expansion of group 2 innate lymphoid cells observed in the absence of bacteria, and induced transcriptional changes in the intestine associated with immune development and type I interferon (IFN) signalling. Consistent with this observation, the IFN-a receptor was essential for the ability of MNV to compensate for bacterial depletion. Importantly, MNV infection offset the deleterious effect of treatment with antibiotics in models of intestinal injury and pathogenic bacterial infection. These data indicate that eukaryotic viruses have the capacity to support intestinal homeostasis and shape mucosal immunity, similarly to commensal bacteria.	[Kernbauer, Elisabeth; Cadwell, Ken] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Kernbauer, Elisabeth; Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ding, Yi] New York Presbyterian Hosp, New York, NY 10065 USA; [Ding, Yi] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; NewYork-Presbyterian Hospital; New York University	Cadwell, K (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA.	ken.cadwell@med.nyu.edu		Cadwell, Ken/0000-0002-5860-0661	Cancer Center Support Grant [P30CA016087]; National Institutes of Health [R01 DK093668]; New York University Whitehead Fellowship; Vilcek Fellowship; Erwin Schrodinger Fellowship from the Austrian Science Foundation; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093668] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [J 3435] Funding Source: researchfish	Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Whitehead Fellowship; Vilcek Fellowship; Erwin Schrodinger Fellowship from the Austrian Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank S. Koralov and P. Loke for advice on the manuscript, E. Venturin i for assistance with deep sequencing, S. Brown and Z. Tang for data analysis, L. Ciriboga for CD3 staining, the flow cytometry and histopathology cores (Cancer Center Support Grant, P30CA016087) for assistance with sample preparation and analyses, M. Alva and D. Littman for assistance with breeding and maintaining GF mice, and H. Moura Silva for sample collection for MNV isolation. This research was supported by National Institutes of Health grant R01 DK093668 (K.C.) and a New York University Whitehead Fellowship (K.C.), Vilcek Fellowship (E.K.) and Erwin Schrodinger Fellowship from the Austrian Science Foundation (E.K.).	Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Gonzalez-Hernandez MB, 2012, JOVE-J VIS EXP, DOI 10.3791/4297; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; GROHMANN G, 1991, J CLIN MICROBIOL, V29, P544, DOI 10.1128/JCM.29.3.544-550.1991; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kim M, 2010, VIRUS RES, V147, P1, DOI 10.1016/j.virusres.2009.08.013; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lipkin WI, 2013, CURR OPIN VIROL, V3, P199, DOI 10.1016/j.coviro.2013.03.010; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; MATSON DO, 1990, PEDIATR INFECT DIS J, V9, P190, DOI 10.1097/00006454-199003000-00009; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Ninomiya M, 2008, J CLIN MICROBIOL, V46, P507, DOI 10.1128/JCM.01703-07; Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Ott C, 2000, J GEN VIROL, V81, P2949, DOI 10.1099/0022-1317-81-12-2949; Popgeorgiev N, 2013, INTERVIROLOGY, V56, P395, DOI 10.1159/000354561; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Tajima M, 2013, EXP ANIM TOKYO, V62, P127, DOI 10.1538/expanim.62.127; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432	38	321	337	4	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					94	U223		10.1038/nature13960	http://dx.doi.org/10.1038/nature13960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25409145	Green Accepted			2022-12-28	WOS:000346310800046
J	Busche, C; Vila-Nadal, L; Yan, J; Miras, HN; Long, DL; Georgiev, VP; Asenov, A; Pedersen, RH; Gadegaard, N; Mirza, MM; Paul, DJ; Poblet, JM; Cronin, L				Busche, Christoph; Vila-Nadal, Laia; Yan, Jun; Miras, Haralampos N.; Long, De-Liang; Georgiev, Vihar P.; Asenov, Asen; Pedersen, Rasmus H.; Gadegaard, Nikolaj; Mirza, Muhammad M.; Paul, Douglas J.; Poblet, Josep M.; Cronin, Leroy			Design and fabrication of memory devices based on nanoscale polyoxometalate clusters	NATURE			English	Article							TRANSISTOR	Flash memory devices that is, non-volatile computer storage media that can be electrically erased and reprogrammed are vital for portable electronics, but the scaling down of metal-oxide-semiconductor (MOS) flash memory to sizes of below ten nanometres per data cell presents challenges. Molecules have been proposed to replace MOS flash memory(1), but they suffer from low electrical conductivity, high resistance, low device yield, and finite thermal stability, limiting their integration into current MOS technologies. Although great advances have been made in the pursuit of molecule-based flash memory(2), there are a number of significant barriers to the realization of devices using conventional MOS technologies(3-7). Here we show that core-shell polyoxometalate (POM) molecules(8) can act as candidate storage nodes for MOS flash memory. Realistic, industry-standard device simulations validate our approach at the nanometre scale, where the device performance is determined mainly by the number of molecules in the storage media and not by their position. To exploit the nature of the core-shell POM clusters, we show, at both the molecular and device level, that embedding [(Se(IV)O-3)(2)](4-) as an oxidizable dopant in the cluster core allows the oxidation of the molecule to a [Se(V)(2)O-6](2-) moiety containing a {Se(v)-Se(v)} bond (where curly brackets indicate a moiety, not a molecule) and reveals a new 5 + oxidation state for selenium. This new oxidation state can be observed at the device level, resulting in a new type of memory, which we call 'write-once-erase'. Taken together, these results show that POMs have the potential to be used as a realistic nanoscale flash memory. Also, the configuration of the doped POM core may lead to new types of electrical behaviour(9-11). This work suggests a route to the practical integration of configurable molecules in MOS technologies as the lithographic scales approach the molecular limit(12).	[Busche, Christoph; Vila-Nadal, Laia; Yan, Jun; Miras, Haralampos N.; Long, De-Liang; Cronin, Leroy] Univ Glasgow, Sch Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland; [Georgiev, Vihar P.; Asenov, Asen; Pedersen, Rasmus H.; Gadegaard, Nikolaj; Mirza, Muhammad M.; Paul, Douglas J.] Univ Glasgow, Sch Engn, Glasgow G12 8LT, Lanark, Scotland; [Poblet, Josep M.] Univ Rovira & Virgili, Dept Quim Fis & Inorgan, E-43007 Tarragona, Spain	University of Glasgow; University of Glasgow; Universitat Rovira i Virgili	Cronin, L (corresponding author), Univ Glasgow, Sch Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland.	lee.cronin@glasgow.ac.uk	Giorgiev, Vihar Petkov/G-8983-2011; Vilà-Nadal, Laia/M-9165-2019; Long, Deliang/C-3500-2011; Gadegaard, Nikolaj/E-9243-2010; Cronin, Leroy/AAW-8067-2020; Miras, Haralampos/C-1691-2008; Miras, Haralampos N./C-6345-2014; Poblet, Josep M./A-2739-2008; Cronin, Leroy/B-7752-2008; Vila-Nadal, Laia/I-9063-2014; Paul, Douglas J/F-7116-2014	Giorgiev, Vihar Petkov/0000-0001-6473-2508; Vilà-Nadal, Laia/0000-0002-7718-7227; Gadegaard, Nikolaj/0000-0002-3396-846X; Cronin, Leroy/0000-0001-8035-5757; Miras, Haralampos/0000-0002-0086-5173; Miras, Haralampos N./0000-0002-0086-5173; Poblet, Josep M./0000-0002-4533-0623; Cronin, Leroy/0000-0001-8035-5757; Vila-Nadal, Laia/0000-0002-7718-7227; Paul, Douglas J/0000-0001-7402-8530; Busche, Christoph/0000-0002-3493-2020	EPSRC [EP/H024107/1, EP/I033459/1, EP/J015156/1]; COST Action [CM1203]; Royal Society Wolfson Foundation for a Merit Award; University of Glasgow; Engineering and Physical Sciences Research Council [EP/J015156/1, EP/H024107/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); COST Action(European Cooperation in Science and Technology (COST)); Royal Society Wolfson Foundation for a Merit Award; University of Glasgow; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We gratefully acknowledge financial support from the EPSRC for funding (grants EP/H024107/1, EP/I033459/1 and EP/J015156/1), the COST Action CM1203 (PoCheMoN), the Royal Society Wolfson Foundation for a Merit Award, and the University of Glasgow. V.P.G. and A.A. thank S. Markov and S. M. Amoroso for discussions.	Bonfiglio V, 2013, SOLID STATE ELECTRON, V84, P127, DOI 10.1016/j.sse.2013.02.029; Chen PC, 2008, IEEE T NANOTECHNOL, V7, P668, DOI 10.1109/TNANO.2008.2006273; Fleming C, 2008, NAT NANOTECHNOL, V3, P229, DOI 10.1038/nnano.2008.66; Fowler RH, 1928, P R SOC LOND A-CONTA, V119, P173, DOI 10.1098/rspa.1928.0091; Gallon C, 2004, IEEE T ELECTRON DEV, V51, P1254, DOI 10.1109/TED.2004.831358; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Lehmann J, 2007, NAT NANOTECHNOL, V2, P312, DOI 10.1038/nnano.2007.110; Li HL, 2011, J AM CHEM SOC, V133, P9423, DOI 10.1021/ja201594k; Long DL, 2006, CHEM-EUR J, V12, P3699, DOI 10.1002/chem.200501002; Seol ML, 2012, ACS NANO, V6, P183, DOI 10.1021/nn204535p; Shaw J, 2012, IEEE T ELECTRON DEV, V59, P1189, DOI 10.1109/TED.2012.2184797; Shaw J, 2011, IEEE T ELECTRON DEV, V58, P826, DOI 10.1109/TED.2010.2097266; SIMMONS JG, 1963, J APPL PHYS, V34, P1793, DOI 10.1063/1.1702682; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Vila-Nadal L, 2013, CHEM-EUR J, V19, P16502, DOI 10.1002/chem.201301631; Vila-Nadal L, 2013, ANGEW CHEM INT EDIT, V52, P9695, DOI 10.1002/anie.201303126; Zhu H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4817009	17	238	239	17	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					545	549		10.1038/nature13951	http://dx.doi.org/10.1038/nature13951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25409147				2022-12-28	WOS:000346247600050
J	Lacro, RV; Dietz, HC; Sleeper, LA; Yetman, AT; Bradley, TJ; Colan, SD; Pearson, GD; Tierney, ESS; Levine, JC; Atz, AM; Benson, DW; Braverman, AC; Chen, S; De Backer, J; Gelb, BD; Grossfeld, PD; Klein, GL; Lai, WW; Liou, A; Loeys, BL; Markham, LW; Olson, AK; Paridon, SM; Pemberton, VL; Pierpont, ME; Pyeritz, RE; Radojewski, E; Roman, MJ; Sharkey, AM; Stylianou, MP; Wechsler, SB; Young, LT; Mahony, L				Lacro, R. V.; Dietz, H. C.; Sleeper, L. A.; Yetman, A. T.; Bradley, T. J.; Colan, S. D.; Pearson, G. D.; Tierney, E. S. Selamet; Levine, J. C.; Atz, A. M.; Benson, D. W.; Braverman, A. C.; Chen, S.; De Backer, J.; Gelb, B. D.; Grossfeld, P. D.; Klein, G. L.; Lai, W. W.; Liou, A.; Loeys, B. L.; Markham, L. W.; Olson, A. K.; Paridon, S. M.; Pemberton, V. L.; Pierpont, M. E.; Pyeritz, R. E.; Radojewski, E.; Roman, M. J.; Sharkey, A. M.; Stylianou, M. P.; Wechsler, S. Burns; Young, L. T.; Mahony, L.		Pediat Heart Network Investigators	Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AORTIC-ROOT DILATION; CLINICAL-TRIAL; DOUBLE-BLIND; BLOCKADE; RECEPTOR; THERAPY; GROWTH; MULTICENTER; PROGRESSION; DILATATION	BACKGROUND Aortic-root dissection is the leading cause of death in Marfan's syndrome. Studies suggest that with regard to slowing aortic-root enlargement, losartan may be more effective than beta-blockers, the current standard therapy in most centers. METHODS We conducted a randomized trial comparing losartan with atenolol in children and young adults with Marfan's syndrome. The primary outcome was the rate of aortic-root enlargement, expressed as the change in the maximum aortic-root-diameter z score indexed to body-surface area (hereafter, aortic-root z score) over a 3-year period. Secondary outcomes included the rate of change in the absolute diameter of the aortic root; the rate of change in aortic regurgitation; the time to aortic dissection, aortic-root surgery, or death; somatic growth; and the incidence of adverse events. RESULTS From January 2007 through February 2011, a total of 21 clinical centers enrolled 608 participants, 6 months to 25 years of age (mean [+/- SD] age, 11.5 +/- 6.5 years in the atenolol group and 11.0 +/- 6.2 years in the losartan group), who had an aorticroot z score greater than 3.0. The baseline-adjusted rate of change (+/- SE) in the aortic-root z score did not differ significantly between the atenolol group and the losartan group (-0.139 +/- 0.013 and -0.107 +/- 0.013 standard-deviation units per year, respectively; P = 0.08). Both slopes were significantly less than zero, indicating a decrease in the degree of aortic-root dilatation relative to body-surface area with either treatment. The 3-year rates of aortic-root surgery, aortic dissection, death, and a composite of these events did not differ significantly between the two treatment groups. CONCLUSIONS Among children and young adults with Marfan's syndrome who were randomly assigned to losartan or atenolol, we found no significant difference in the rate of aorticroot dilatation between the two treatment groups over a 3-year period.	[Lacro, R. V.; Colan, S. D.; Tierney, E. S. Selamet; Levine, J. C.] Boston Childrens Hosp, Boston, MA 02115 USA; [Dietz, H. C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Sleeper, L. A.; Colan, S. D.; Chen, S.; Klein, G. L.] New England Res Inst, Watertown, MA 02172 USA; [Yetman, A. T.] Primary Childrens Med Ctr, Salt Lake City, UT USA; [Yetman, A. T.] Univ Utah, Salt Lake City, UT USA; [Bradley, T. J.; Radojewski, E.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Pearson, G. D.; Pemberton, V. L.; Stylianou, M. P.] NHLBI, NIH, Bethesda, MD 20892 USA; [Atz, A. M.] Med Univ S Carolina, Charleston, SC USA; [Benson, D. W.] Cincinnati Childrens Med Ctr, Cincinnati, OH USA; [Braverman, A. C.; Sharkey, A. M.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [De Backer, J.; Loeys, B. L.] Ghent Univ Hosp, Ghent, Belgium; [Gelb, B. D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Lai, W. W.] Childrens Hosp New York, New York, NY USA; [Roman, M. J.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Grossfeld, P. D.] Univ Calif San Diego, Rady Childrens Hosp, San Diego, CA 92103 USA; [Liou, A.] Texas Childrens Hosp, Houston, TX 77030 USA; [Markham, L. W.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Olson, A. K.] Seattle Childrens Hosp, Seattle, WA USA; [Paridon, S. M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Pyeritz, R. E.] Univ Penn, Philadelphia, PA 19104 USA; [Pierpont, M. E.] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Wechsler, S. Burns] Duke Univ, Med Ctr, Durham, NC USA; [Young, L. T.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Mahony, L.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Harvard University; Boston Children's Hospital; Johns Hopkins University; HealthCore, Inc; Utah System of Higher Education; University of Utah; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Medical University of South Carolina; Cincinnati Children's Hospital Medical Center; Washington University (WUSTL); Ghent University; Ghent University Hospital; Icahn School of Medicine at Mount Sinai; Cornell University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Baylor College of Medicine; Vanderbilt University; Seattle Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Children's Hospitals & Clinics of Minnesota; Duke University; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lacro, RV (corresponding author), Boston Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.	ron.lacro@cardio.chboston.org	Loeys, Bart/B-3236-2017; De Backer, Julie/B-2897-2014; Colan, Steven/ABB-4580-2020; Atz, Andrew/J-9196-2015	Loeys, Bart/0000-0003-3703-9518; De Backer, Julie/0000-0001-8878-1507; Olson, Aaron/0000-0002-5237-400X; Atz, Andrew/0000-0002-4744-3832; Bradley, Timothy/0000-0003-2948-0506	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL068270, U10HL109778, U01HL068281, U01HL085057, U10HL109741, U10HL109743, U01HL068292, U01HL068270, U01HL068290, U01HL068288, U01HL068285, U01HL068279, U01HL068269, U10HL109673] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov number, NCT00429364.	Balding DJ, 2004, APPL LONGITUDINAL AN; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Chiu HH, 2013, MAYO CLIN PROC, V88, P271, DOI 10.1016/j.mayocp.2012.11.005; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; Detaint D, 2010, ARCH CARDIOVASC DIS, V103, P317, DOI 10.1016/j.acvd.2010.04.008; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Erkula G, 2002, AM J MED GENET, V109, P100, DOI 10.1002/ajmg.10312; EVERETT AD, 1994, HYPERTENSION, V23, P587, DOI 10.1161/01.HYP.23.5.587; Forteza A, 2011, REV ESP CARDIOL, V64, P492, DOI [10.1016/j.rec.2011.02.013, 10.1016/j.recesp.2011.02.009]; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Gambarin FI, 2009, J CARDIOVASC MED, V10, P354, DOI 10.2459/JCM.0b013e3283232a45; Greally M.T., 2006, GENEREVIEWS; Groenink M, 2013, EUR HEART J, V34, P3491, DOI 10.1093/eurheartj/eht334; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Lacro RV, 2007, AM HEART J, V154, P624, DOI 10.1016/j.ahj.2007.06.024; Lacro RV, 2013, AM HEART J, V165, P828, DOI 10.1016/j.ahj.2013.02.019; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Milewicz DM, 2005, CIRCULATION, V111, pE150, DOI 10.1161/01.CIR.0000155243.70456.F4; Moberg K, 2012, INT J CARDIOL, V157, P354, DOI 10.1016/j.ijcard.2010.12.070; Mullen MJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-408; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Pees C, 2013, AM J CARDIOL, V112, P1477, DOI 10.1016/j.amjcard.2013.06.019; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Tierney ESS, 2013, J AM SOC ECHOCARDIOG, V26, P657, DOI 10.1016/j.echo.2013.02.018; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	28	309	317	2	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2061	2071		10.1056/NEJMoa1404731	http://dx.doi.org/10.1056/NEJMoa1404731			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25405392	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000345580000005
J	Bakker, OJ; van Brunschot, S; van Santvoort, HC; Besselink, MG; Bollen, TL; Boermeester, MA; Dejong, CH; van Goor, H; Bosscha, K; Ali, UA; Bouwense, S; van Grevenstein, WM; Heisterkamp, J; Houdijk, AP; Jansen, JM; Karsten, TM; Manusama, ER; Nieuwenhuijs, VB; Schaapherder, AF; van der Schelling, GP; Schwartz, MP; Spanier, BWM; Tan, A; Vecht, J; Weusten, BL; Witteman, BJ; Akkermans, LM; Bruno, MJ; Dijkgraaf, MG; van Ramshorst, B; Gooszen, HG				Bakker, O. J.; van Brunschot, S.; van Santvoort, H. C.; Besselink, M. G.; Bollen, T. L.; Boermeester, M. A.; Dejong, C. H.; van Goor, H.; Bosscha, K.; Ali, U. Ahmed; Bouwense, S.; van Grevenstein, W. M.; Heisterkamp, J.; Houdijk, A. P.; Jansen, J. M.; Karsten, T. M.; Manusama, E. R.; Nieuwenhuijs, V. B.; Schaapherder, A. F.; van der Schelling, G. P.; Schwartz, M. P.; Spanier, B. W. M.; Tan, A.; Vecht, J.; Weusten, B. L.; Witteman, B. J.; Akkermans, L. M.; Bruno, M. J.; Dijkgraaf, M. G.; van Ramshorst, B.; Gooszen, H. G.		Dutch Pancreatitis Study Grp	Early versus On-Demand Nasoenteric Tube Feeding in Acute Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY ENTERAL NUTRITION; CRITICALLY-ILL PATIENT; SMALL-BOWEL MOTILITY; NECROTIZING PANCREATITIS; INTERNATIONAL CONSENSUS; BACTERIAL TRANSLOCATION; PRACTICE GUIDELINES; ESPEN GUIDELINES; CONTROLLED-TRIAL; ORGAN FAILURE	BACKGROUND Early enteral feeding through a nasoenteric feeding tube is often used in patients with severe acute pancreatitis to prevent gut-derived infections, but evidence to support this strategy is limited. We conducted a multicenter, randomized trial comparing early nasoenteric tube feeding with an oral diet at 72 hours after presentation to the emergency department in patients with acute pancreatitis. METHODS We enrolled patients with acute pancreatitis who were at high risk for complications on the basis of an Acute Physiology and Chronic Health Evaluation II score of 8 or higher (on a scale of 0 to 71, with higher scores indicating more severe disease), an Imrie or modified Glasgow score of 3 or higher (on a scale of 0 to 8, with higher scores indicating more severe disease), or a serum C-reactive protein level of more than 150 mg per liter. Patients were randomly assigned to nasoenteric tube feeding within 24 hours after randomization (early group) or to an oral diet initiated 72 hours after presentation (on-demand group), with tube feeding provided if the oral diet was not tolerated. The primary end point was a composite of major infection (infected pancreatic necrosis, bacteremia, or pneumonia) or death during 6 months of follow-up. RESULTS A total of 208 patients were enrolled at 19 Dutch hospitals. The primary end point occurred in 30 of 101 patients (30%) in the early group and in 28 of 104 (27%) in the on-demand group (risk ratio, 1.07; 95% confidence interval, 0.79 to 1.44; P = 0.76). There were no significant differences between the early group and the on-demand group in the rate of major infection (25% and 26%, respectively; P = 0.87) or death (11% and 7%, respectively; P = 0.33). In the on-demand group, 72 patients (69%) tolerated an oral diet and did not require tube feeding. CONCLUSIONS This trial did not show the superiority of early nasoenteric tube feeding, as compared with an oral diet after 72 hours, in reducing the rate of infection or death in patients with acute pancreatitis at high risk for complications.	[Bakker, O. J.; van Santvoort, H. C.; Ali, U. Ahmed; van Grevenstein, W. M.; Akkermans, L. M.] Univ Med Ctr Utrecht, Dept Surg, NL-3508 GA Utrecht, Netherlands; [van Brunschot, S.] Amsterdam Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Besselink, M. G.; Boermeester, M. A.] Amsterdam Med Ctr, Dept Surg, Amsterdam, Netherlands; [Dijkgraaf, M. G.] Amsterdam Med Ctr, Clin Res Unit, Amsterdam, Netherlands; [Jansen, J. M.] Onze Lieve Vrouw Hosp, Dept Gastroenterol, Amsterdam, Netherlands; [Bollen, T. L.] St Antonius Hosp, Dept Radiol, Nieuwegein, Netherlands; [Weusten, B. L.] St Antonius Hosp, Dept Gastroenterol, Nieuwegein, Netherlands; [van Ramshorst, B.] St Antonius Hosp, Dept Surg, Nieuwegein, Netherlands; [Dejong, C. H.] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Dejong, C. H.] NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [van Goor, H.; Bouwense, S.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands; [Gooszen, H. G.] Radboud Univ Nijmegen, Med Ctr, Dept Operat Room Evidence Based Surg, NL-6525 ED Nijmegen, Netherlands; [Tan, A.] Canisius Wilhelmina Hosp, Dept Gastroenterol, Nijmegen, Netherlands; [Bosscha, K.] Jeroen Bosch Hosp, Dept Surg, sHertogenbosch, Netherlands; [Heisterkamp, J.] St Elizabeth Hosp, Dept Surg, Tilburg, Netherlands; [Houdijk, A. P.] Med Ctr Alkmaar, Dept Surg, Alkmaar, Netherlands; [Karsten, T. M.] Reinier de Graaf Gasthuis, Dept Surg, Delft, Netherlands; [Manusama, E. R.] Med Ctr Leeuwarden, Dept Surg, Leeuwarden, Netherlands; [Nieuwenhuijs, V. B.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands; [Schaapherder, A. F.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands; [van der Schelling, G. P.] Amphia Hosp, Dept Surg, Breda, Netherlands; [Schwartz, M. P.] Meander Med Ctr, Dept Gastroenterol, Amersfoort, Netherlands; [Spanier, B. W. M.] Rijnstate Hosp, Dept Gastroenterol, Arnhem, Netherlands; [Vecht, J.] Isala Clin, Dept Gastroenterol, Zwolle, Netherlands; [Witteman, B. J.] Hosp Gelderse Vallei Ede, Dept Gastroenterol, Ede, Netherlands; [Bruno, M. J.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Jeroen Bosch Ziekenhuis; Elisabeth-TweeSteden Ziekenhuis (ETZ); Medical Center Of Alkmaar; Reinier de Graaf Hospital; Medical Center Leeuwarden; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Amphia Hospital; Meander Medisch Centrum; Rijnstate Hospital; Isala Clinics; Gelderse Vallei Hospital; Erasmus University Rotterdam; Erasmus MC	Bakker, OJ (corresponding author), Univ Med Ctr Utrecht, POB 85500,HP G04-228, NL-3508 GA Utrecht, Netherlands.		Bosscha, Koop/AAC-3641-2020; Besselink, Marc/H-3294-2019; van Goor, H./H-8035-2014; Besselink, Marc G/R-4268-2019; Gooszen, H.G./H-8036-2014; Bouwense, Stefan/P-6468-2015; bosscha, koop/AAL-2916-2021	van Goor, H./0000-0003-0323-4876; Besselink, Marc G/0000-0003-2650-9350; Bouwense, Stefan/0000-0002-7600-9429; bosscha, koop/0000-0002-7961-3314; Boermeester, Marja/0000-0003-3890-8105	Netherlands Organization for Health Research and Development; ZonMw Health Care Efficiency Research Program [170992902]; Nutricia [08/KR/AB/002]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); ZonMw Health Care Efficiency Research Program; Nutricia(Danone Nutricia)	Supported by grants from the Netherlands Organization for Health Research and Development, the ZonMw Health Care Efficiency Research Program (170992902), and Nutricia (08/KR/AB/002).	Ammori BJ, 1999, J GASTROINTEST SURG, V3, P252, DOI 10.1016/S1091-255X(99)80067-5; Bakker OJ, 2013, GUT, V62, P1475, DOI 10.1136/gutjnl-2012-302870; Bakker OJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-73; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Besselink MG, 2009, BRIT J SURG, V96, P267, DOI 10.1002/bjs.6447; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Besselink MG, 2009, ANN SURG, V250, P712, DOI 10.1097/SLA.0b013e3181bce5bd; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Casaer MP, 2014, NEW ENGL J MED, V370, P1227, DOI 10.1056/NEJMra1304623; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; CORFIELD AP, 1985, LANCET, V2, P403; DICKERSON RN, 1991, CRIT CARE MED, V19, P484, DOI 10.1097/00003246-199104000-00005; Fagenholz PJ, 2007, ANN EPIDEMIOL, V17, P491, DOI 10.1016/j.annepidem.2007.02.002; Fritz S, 2010, AM J SURG, V200, P111, DOI 10.1016/j.amjsurg.2009.08.019; Gupta R, 2003, PANCREATOLOGY, V3, P406, DOI 10.1159/000073657; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; JONES BJM, 1986, GUT, V27, P47, DOI 10.1136/gut.27.Suppl_1.47; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koretz RL, 2014, CLIN NUTR, V33, P240, DOI 10.1016/j.clnu.2013.06.006; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Li JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064926; Marik PE, 2009, CURR OPIN CRIT CARE, V15, P131, DOI 10.1097/MCC.0b013e328319910a; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Marik PE, 2002, CRIT CARE MED, V30, P725; McClave SA, 2009, NUTR CLIN PRACT, V24, P305, DOI 10.1177/0884533609335176; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Meier R, 2006, CLIN NUTR, V25, P275, DOI 10.1016/j.clnu.2006.01.019; Mirtallo JM, 2012, JPEN-PARENTER ENTER, V36, P284, DOI 10.1177/0148607112440823; Mounzer R, 2012, GASTROENTEROLOGY, V142, P1476, DOI 10.1053/j.gastro.2012.03.005; Neoptolemos JP, 2000, LANCET, V355, P1955, DOI 10.1016/S0140-6736(00)02327-8; Nieuwenhuijs VB, 1998, ANN SURG, V228, P188, DOI 10.1097/00000658-199808000-00007; Olah A, 2002, NUTRITION, V18, P259, DOI 10.1016/S0899-9007(01)00755-9; Pan LY, 2010, PANCREAS, V39, P633, DOI 10.1097/MPA.0b013e3181c79654; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Petrov MS, 2006, DIGEST SURG, V23, P336, DOI 10.1159/000097949; Petrov MS, 2009, BRIT J NUTR, V101, P787, DOI 10.1017/S0007114508123443; Rahman SH, 2003, J GASTROINTEST SURG, V7, P26, DOI 10.1016/S1091-255X(02)00090-2; Rahman SH, 2003, GUT, V52, P270, DOI 10.1136/gut.52.2.270; Rodriguez JR, 2008, ANN SURG, V247, P294, DOI 10.1097/SLA.0b013e31815b6976; Singh VK, 2011, CLIN GASTROENTEROL H, V9, P1098, DOI 10.1016/j.cgh.2011.08.026; Singh VK, 2009, CLIN GASTROENTEROL H, V7, P1247, DOI 10.1016/j.cgh.2009.08.012; Spanier BWM, 2013, WORLD J GASTROENTERO, V19, P3018, DOI 10.3748/wjg.v19.i20.3018; Sun JK, 2013, WORLD J GASTROENTERO, V19, P917, DOI 10.3748/wjg.v19.i6.917; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Van Felius ID, 2003, NEUROGASTROENT MOTIL, V15, P267, DOI 10.1046/j.1365-2982.2003.00410.x; van Santvoort HC, 2011, GASTROENTEROLOGY, V141, P1254, DOI 10.1053/j.gastro.2011.06.073; van Santvoort HC, 2010, NEW ENGL J MED, V362, P1491, DOI 10.1056/NEJMoa0908821; Wereszczynska-Siemiatkowska U, 2013, PANCREAS, V42, P640, DOI 10.1097/MPA.0b013e318271bb61; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; Wu BU, 2008, GASTROENTEROLOGY, V135, P816, DOI 10.1053/j.gastro.2008.05.053; Yadav D, 2007, PANCREAS, V34, P174; Ziegler TR, 2009, NEW ENGL J MED, V361, P1088, DOI 10.1056/NEJMct0806956	53	161	188	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					1983	1993		10.1056/NEJMoa1404393	http://dx.doi.org/10.1056/NEJMoa1404393			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT5ST	25409371	Green Published			2022-12-28	WOS:000345002900007
J	Chouchani, ET; Pell, VR; Gaude, E; Aksentijevic, D; Sundier, SY; Robb, EL; Logan, A; Nadtochiy, SM; Ord, ENJ; Smith, AC; Eyassu, F; Shirley, R; Hu, CH; Dare, AJ; James, AM; Rogatti, S; Hartley, RC; Eaton, S; Costa, ASH; Brookes, PS; Davidson, SM; Duchen, MR; Saeb-Parsy, K; Shattock, MJ; Robinson, AJ; Work, LM; Frezza, C; Krieg, T; Murphy, MP				Chouchani, Edward T.; Pell, Victoria R.; Gaude, Edoardo; Aksentijevic, Dunja; Sundier, Stephanie Y.; Robb, Ellen L.; Logan, Angela; Nadtochiy, Sergiy M.; Ord, Emily N. J.; Smith, Anthony C.; Eyassu, Filmon; Shirley, Rachel; Hu, Chou-Hui; Dare, Anna J.; James, Andrew M.; Rogatti, Sebastian; Hartley, Richard C.; Eaton, Simon; Costa, Ana S. H.; Brookes, Paul S.; Davidson, Sean M.; Duchen, Michael R.; Saeb-Parsy, Kourosh; Shattock, Michael J.; Robinson, Alan J.; Work, Lorraine M.; Frezza, Christian; Krieg, Thomas; Murphy, Michael P.			Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS	NATURE			English	Article							PURINE NUCLEOTIDE CYCLE; COMPLEX-I; SUPEROXIDE-PRODUCTION; HYPOXIA-ISCHEMIA; MECHANISM; CARDIOPROTECTION; DEHYDROGENASE; CONSEQUENCES; INHIBITION; PROTECTION	Ischaemia-reperfusion injury occurs when the blood supply to an organ is disrupted and then restored, and underlies many disorders, notably heart attack and stroke. While reperfusion of ischaemic tissue is essential for survival, it also initiates oxidative damage, cell death and aberrant immune responses through the generation of mitochondrial reactive oxygen species (ROS)(1-5). Although mitochondrial ROS production in ischaemia reperfusion is established, it has generally been considered a nonspecific response to reperfusion(1,3). Here we develop a comparative in vivo metabolomic analysis, and unexpectedly identify widely conserved metabolic pathways responsible for mitochondrial ROS production during ischaemia reperfusion. We show that selective accumulation of the citric acid cycle intermediate succinate is a universal metabolic signature of ischaemia in a range of tissues and is responsible for mitochondrial ROS production during reperfusion. Ischaemic succinate accumulation arises from reversal of succinate dehydrogenase, which in turn is driven by fumarate overflow from purine nucleotide breakdown and partial reversal of the malate/aspartate shuttle. After reperfusion, the accumulated succinate is rapidly re-oxidized by succinate dehydrogenase, driving extensive ROS generation by reverse electron transport at mitochondrial complex I. Decreasing ischaemic succinate accumulation by pharmacological inhibition is sufficient to ameliorate in vivo ischaemia-reperfusion injury in murine models of heart attack and stroke. Thus, we have identified a conserved metabolic response of tissues to ischaemia and reperfusion that unifies many hitherto unconnected aspects of ischaemia-reperfusion injury. Furthermore, these findings reveal a new pathway for metabolic control of ROS production in vivo, while demonstrating that inhibition of ischaemic succinate accumulation and its oxidation after subsequent reperfusion is a potential therapeutic target to decrease ischaemia-reperfusion injury in a range of pathologies.	[Chouchani, Edward T.; Robb, Ellen L.; Logan, Angela; Smith, Anthony C.; Eyassu, Filmon; Dare, Anna J.; James, Andrew M.; Rogatti, Sebastian; Robinson, Alan J.; Murphy, Michael P.] MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Chouchani, Edward T.; Pell, Victoria R.; Hu, Chou-Hui; Krieg, Thomas] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; [Gaude, Edoardo; Costa, Ana S. H.; Frezza, Christian] Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge CB2 0XZ, England; [Aksentijevic, Dunja; Shattock, Michael J.] Kings Coll London, Rayne Inst, British Heart Fdn Ctr Res Excellence, St Thomas Hosp, London SE1 7EH, England; [Sundier, Stephanie Y.; Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Sundier, Stephanie Y.; Duchen, Michael R.] UCL, UCL Consortium Mitochondrial Biol, London WC1E 6BT, England; [Nadtochiy, Sergiy M.; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Ord, Emily N. J.; Shirley, Rachel; Work, Lorraine M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Hartley, Richard C.] Univ Glasgow, Sch Chem, Glasgow G12 8QQ, Lanark, Scotland; [Eaton, Simon] UCL Inst Child Hlth, Unit Paediat Surg, London WC1N 1EH, England; [Davidson, Sean M.] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England; [Saeb-Parsy, Kourosh] Addenbrookes Hosp, Univ Dept Surg, Cambridge CB2 0QQ, England; [Saeb-Parsy, Kourosh] Addenbrookes Hosp, Cambridge NIHR Biomed Res Ctr, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; University of London; University College London; University of Rochester; University of Glasgow; University of Glasgow; University of London; University College London; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Frezza, C (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Box 197, Cambridge CB2 0XZ, England.	CF366@mrc-cu.cam.ac.uk; tk382@medschl.cam.ac.uk; mpm@mrc-mbu.cam.ac.uk	Davidson, Sean M/F-5275-2010; Lorkiewicz, Pawel/A-2126-2011; Eaton, Simon/C-4942-2008; duchen, michael/A-2116-2009; Hartley, Richard/E-3489-2010; Costa, Ana/HDL-9297-2022; Hartley, Richard/AAT-7834-2020; Frezza, Christian/G-2174-2010; Smith, Anthony C/B-1891-2009; Costa, Ana SH/H-2852-2012; Murphy, Michael P/C-2120-2009; James, Andrew M/A-2639-2015; Chouchani, Edward T./HCH-3775-2022	Davidson, Sean M/0000-0001-5182-4980; Lorkiewicz, Pawel/0000-0002-1755-9826; Eaton, Simon/0000-0003-0892-9204; duchen, michael/0000-0003-2548-4294; Hartley, Richard/0000-0003-1033-5405; Hartley, Richard/0000-0003-1033-5405; Frezza, Christian/0000-0002-3293-7397; Smith, Anthony C/0000-0003-0141-0434; Costa, Ana SH/0000-0001-8932-6370; Murphy, Michael P/0000-0003-1115-9618; James, Andrew M/0000-0002-0515-9649; Brookes, Paul/0000-0002-8639-8413; Shattock, Michael/0000-0001-6242-7585; Gaude, Edoardo/0000-0001-8523-7792; Aksentijevic, Dunja/0000-0002-8480-6727; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Krieg, Thomas/0000-0002-5192-580X; Work, Lorraine/0000-0002-6462-4109; Ord, Emily/0000-0001-8564-7724	Medical Research Council (UK); Canadian Institutes of Health Research; Gates Cambridge Trust; British Heart Foundation; BBSRC [BB/I012923/1] Funding Source: UKRI; MRC [MC_UP_1101/3, MC_U105674181, MC_U105663142, G1100562, MC_UU_12022/6] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I012923/1] Funding Source: researchfish; British Heart Foundation [PG/07/126/24223, RG/12/4/29426, PG/12/42/29655] Funding Source: researchfish; Medical Research Council [MC_U105674181, G1100562, MC_UP_1101/3, 1095363, MC_UU_12022/6, MC_U105663142] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Gates Cambridge Trust; British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Medical Research Council (UK) and by grants from Canadian Institutes of Health Research and the Gates Cambridge Trust (E.T.C.) and the British Heart Foundation (T.K.,V.R.P., L.M.W.). We thank J. Hirstand G. C. Brown for discussions.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Aksentijevic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109021; Barron JT, 1998, J MOL CELL CARDIOL, V30, P1571, DOI 10.1006/jmcc.1998.0722; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; BUNGER R, 1980, H-S Z PHYSIOL CHEM, V361, P907, DOI 10.1515/bchm2.1980.361.1.907; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Davidson SM, 2006, CARDIOVASC RES, V71, P10, DOI 10.1016/j.cardiores.2006.01.019; Davidson Sean M, 2007, Methods Mol Biol, V372, P421, DOI 10.1007/978-1-59745-365-3_30; DERVARTANIAN DV, 1964, BIOCHIM BIOPHYS ACTA, V92, P233, DOI 10.1016/0926-6569(64)90182-8; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Gaude E, 2013, CURR METABOL, V1, P180, DOI 10.2174/2213235X11301020005; Goodpaster AM, 2010, ANAL BIOCHEM, V401, P134, DOI 10.1016/j.ab.2010.02.005; GUTMAN M, 1978, MOL CELL BIOCHEM, V20, P41; Hamel D, 2014, ARTERIOSCL THROM VAS, V34, P285, DOI 10.1161/ATVBAHA.113.302131; HARMSEN E, 1981, CLIN CHIM ACTA, V115, P73, DOI 10.1016/0009-8981(81)90108-X; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; HOCHACHKA PW, 1975, SCIENCE, V187, P613, DOI 10.1126/science.163485; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Koizumi JYY, 1986, JPN J STROKE, V8, P1, DOI [DOI 10.3995/JSTROKE.8.1, DOI 10.3995/jstroke.8.1]; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Methner C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0337-1; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Ord ENJ, 2013, J CEREBR BLOOD F MET, V33, P1215, DOI 10.1038/jcbfm.2013.70; Ord ENJ, 2012, J NEUROSCI METH, V211, P305, DOI 10.1016/j.jneumeth.2012.09.001; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; OSBORNE KA, 1987, J NEUROL NEUROSUR PS, V50, P402, DOI 10.1136/jnnp.50.4.402; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Romero P, 2005, GENOME BIOL, V6; Schmidt K, 2010, EUR HEART J, V31, P1655, DOI 10.1093/eurheartj/ehp555; Smith AC, 2012, NUCLEIC ACIDS RES, V40, pD1160, DOI 10.1093/nar/gkr1101; Smith AC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-102; Sridharan V, 2008, AM J PHYSIOL-CELL PH, V295, pC29, DOI 10.1152/ajpcell.00466.2007; SWAIN JL, 1984, J CLIN INVEST, V74, P1422, DOI 10.1172/JCI111553; TAEGTMEYER H, 1978, CIRC RES, V43, P808, DOI 10.1161/01.RES.43.5.808; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; VandenBerghe G, 1997, J INHERIT METAB DIS, V20, P193, DOI 10.1023/A:1005304722259; Wojtovich AP, 2013, BBA-BIOENERGETICS, V1827, P598, DOI 10.1016/j.bbabio.2012.12.007; Yellon DM., 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	50	1440	1488	39	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					431	+		10.1038/nature13909	http://dx.doi.org/10.1038/nature13909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25383517	Green Submitted, Green Accepted			2022-12-28	WOS:000345770600050
J	MacBean, N; Peylin, P				MacBean, Natasha; Peylin, Philippe			BIOGEOCHEMISTRY Agriculture and the global carbon cycle	NATURE			English	Editorial Material							ATMOSPHERIC CO2; NORTHERN ECOSYSTEMS; VEGETATION; AMPLITUDE	Evolving agricultural practices dramatically increased crop production in the twentieth century. Two studies now find that this has altered the seasonal flux of atmospheric carbon dioxide. See Letters p. 394 & p. 398	[MacBean, Natasha; Peylin, Philippe] LOrme Merisiers, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	MacBean, N (corresponding author), LOrme Merisiers, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France.	natasha.macbean@lsce.ipsl.fr	MacBean, Natasha/L-2190-2015	MacBean, Natasha/0000-0001-6797-4836; Peylin, Philippe/0000-0001-9335-6994				Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; FAO, 2013, FAO STAT YB 2013; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Gray JM, 2014, NATURE, V515, P398, DOI 10.1038/nature13957; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kohlmaier GH, 1989, TELLUS B, V41, P487, DOI 10.1111/j.1600-0889.1989.tb00137.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; PEARMAN GI, 1981, J GEOPHYS RES-OCEANS, V86, P9839, DOI 10.1029/JC086iC10p09839; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Zeng N, 2014, NATURE, V515, P394, DOI 10.1038/nature13893; Zimov SA, 1999, SCIENCE, V284, P1973, DOI 10.1126/science.284.5422.1973	12	11	15	7	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					351	352		10.1038/515351a	http://dx.doi.org/10.1038/515351a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409823				2022-12-28	WOS:000345770600032
J	Loxterkamp, D				Loxterkamp, David			LETTER FROM NEW ENGLAND What a doctor is good for	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Seaport Community Hlth Ctr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, ME 04915 USA.	david.loxterkamp@gmail.com						Kaiser Family Foundation, STATE HEALTH FACTS T; NCCPA, 2014, 2013 STATISTICAL PRO	2	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2014	349								g6894	10.1136/bmj.g6894	http://dx.doi.org/10.1136/bmj.g6894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JZ	25410322				2022-12-28	WOS:000345445700003
J	DeLoughery, T				DeLoughery, Thomas			Review: In AF with CKD, novel oral anticoagulants reduce stroke or systemic embolism compared with warfarin Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							APIXABAN		Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	DeLoughery, T (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							Chai-Adisaksopha C, 2014, BLOOD, V124, P2450, DOI 10.1182/blood-2014-07-590323; Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274; Hylek EM, 2014, J AM COLL CARDIOL, V63, P2141, DOI 10.1016/j.jacc.2014.02.549; Lansberg MG, 2012, CHEST, V141, pE601S, DOI 10.1378/chest.11-2302; Lega JC, 2014, J THROMB HAEMOST, V12, P337, DOI 10.1111/jth.12486	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC4	10.7326/0003-4819-161-10-201411180-02004	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402537				2022-12-28	WOS:000347245600006
J	Nutt, D				Nutt, David			Help luck along to find psychiatric medicines	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Nutt, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	d.nutt@imperial.ac.uk							0	8	8	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					165	165		10.1038/515165a	http://dx.doi.org/10.1038/515165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391924	Bronze			2022-12-28	WOS:000344631400014
J	Paris, G; Adkins, JF; Sessions, AL; Webb, SM; Fischer, WW				Paris, G.; Adkins, J. F.; Sessions, A. L.; Webb, S. M.; Fischer, W. W.			Neoarchean carbonate-associated sulfate records positive Delta S-33 anomalies	SCIENCE			English	Article							MASS-INDEPENDENT FRACTIONATION; MULTIPLE SULFUR ISOTOPES; TRANSVAAL SUPERGROUP; CONSTRAINTS; PHOTOLYSIS; ATMOSPHERE; REDUCTION; BARITES; ORIGIN; CRATON	Mass-independent fractionation of sulfur isotopes (reported as Delta S-33) recorded in Archean sedimentary rocks helps to constrain the composition of Earth's early atmosphere and the timing of the rise of oxygen similar to 2.4 billion years ago. Although current hypotheses predict uniformly negative Delta S-33 for Archean seawater sulfate, this remains untested through the vast majority of Archean time. We applied x-ray absorption spectroscopy to investigate the low sulfate content of particularly well-preserved Neoarchean carbonates and mass spectrometry to measure their Delta S-33 signatures. We report unexpected, large, widespread positive Delta S-33 values from stratigraphic sections capturing over 70 million years and diverse depositional environments. Combined with the pyrite record, these results show that sulfate does not carry the expected negative Delta S-33 from sulfur mass-independent fractionation in the Neoarchean atmosphere.	[Paris, G.; Adkins, J. F.; Sessions, A. L.; Fischer, W. W.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Webb, S. M.] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA	California Institute of Technology	Paris, G (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	gparis@caltech.edu	Webb, Samuel M/D-4778-2009; Adkins, Jess/GYI-8778-2022; Paris, Guillaume/ABA-3266-2020; Sessions, Alex/ABC-9207-2020	Webb, Samuel M/0000-0003-1188-0464; Sessions, Alex/0000-0001-6120-2763; Paris, Guillaume/0000-0001-8368-1224	NSF Division of Earth Sciences award [EAR-1349858]; Henry and Camille Dreyfus Postdoctoral Program in Environmental Chemistry; David and Lucile Packard Foundation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	NSF Division of Earth Sciences award; Henry and Camille Dreyfus Postdoctoral Program in Environmental Chemistry; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Johnson for help with stratigraphic sample collection and fruitful comments; N. Beukes and I. Halevy for helpful discussions; K. Bergmann for assistance with C and O analyses; and C. Ma, T. Present, and J. Johnson for assistance with scanning electron microscopy. We acknowledge support from NSF Division of Earth Sciences award no. EAR-1349858. Assistance from N. Dalleska and use of IC instrumentation in the Environmental Analysis Center at the California Institute of Technology is gratefully acknowledged. G. P. was funded by the Henry and Camille Dreyfus Postdoctoral Program in Environmental Chemistry. W. W. F. acknowledges support from the David and Lucile Packard Foundation. Drill core GKP01 was sampled with support from the Agouron Institute. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393).	Bao HM, 2007, GEOCHIM COSMOCHIM AC, V71, P4868, DOI 10.1016/j.gca.2007.05.032; Baroni M, 2007, SCIENCE, V315, P84, DOI 10.1126/science.1131754; Bekker A, 2009, SCIENCE, V326, P1086, DOI 10.1126/science.1177742; BEUKES NJ, 1987, SEDIMENT GEOL, V54, P1, DOI 10.1016/0037-0738(87)90002-9; Domagal-Goldman SD, 2008, EARTH PLANET SC LETT, V269, P29, DOI 10.1016/j.epsl.2008.01.040; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2013, P NATL ACAD SCI USA, V110, P17638, DOI 10.1073/pnas.1218851110; Fischer WW, 2009, PRECAMBRIAN RES, V169, P15, DOI 10.1016/j.precamres.2008.10.010; Fischer WW, 2014, P NATL ACAD SCI USA, V111, P5468, DOI 10.1073/pnas.1322577111; GROTZINGER JP, 1993, J GEOL, V101, P235, DOI 10.1086/648218; Guo QJ, 2009, GEOLOGY, V37, P399, DOI 10.1130/G25423A.1; Halevy I, 2010, SCIENCE, V329, P204, DOI 10.1126/science.1190298; Hu GX, 2003, GEOCHIM COSMOCHIM AC, V67, P3101, DOI 10.1016/S0016-7037(02)00929-8; Kah LC, 2001, PRECAMBRIAN RES, V111, P203, DOI 10.1016/S0301-9268(01)00161-9; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Leavitt WD, 2013, P NATL ACAD SCI USA, V110, P11244, DOI 10.1073/pnas.1218874110; Lyons JR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031031; Masterson AL, 2011, EARTH PLANET SC LETT, V306, P253, DOI 10.1016/j.epsl.2011.04.004; Ono SH, 2009, PRECAMBRIAN RES, V169, P48, DOI 10.1016/j.precamres.2008.10.012; Ono SH, 2009, PRECAMBRIAN RES, V169, P58, DOI 10.1016/j.precamres.2008.10.013; Papineau D., 2006, GEOBIOLOGY, V4, P227; Paris G, 2013, CHEM GEOL, V345, P50, DOI 10.1016/j.chemgeo.2013.02.022; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Roerdink DL, 2012, EARTH PLANET SC LETT, V331, P177, DOI 10.1016/j.epsl.2012.03.020; Sumner DY, 1996, J SEDIMENT RES, V66, P419; Ueno Y, 2008, GEOCHIM COSMOCHIM AC, V72, P5675, DOI 10.1016/j.gca.2008.08.026; Ueno Y, 2009, P NATL ACAD SCI USA, V106, P14784, DOI 10.1073/pnas.0903518106; Van Kranendonk MJ, 2006, EARTH-SCI REV, V74, P197, DOI 10.1016/j.earscirev.2005.09.005; Whitehill AR, 2013, P NATL ACAD SCI USA, V110, P17697, DOI 10.1073/pnas.1306979110; Whitehill AR, 2012, GEOCHIM COSMOCHIM AC, V94, P238, DOI 10.1016/j.gca.2012.06.014; Zerkle AL, 2012, NAT GEOSCI, V5, P359, DOI [10.1038/NGEO1425, 10.1038/ngeo1425]	33	56	57	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					739	741		10.1126/science.1258211	http://dx.doi.org/10.1126/science.1258211			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378622				2022-12-28	WOS:000344690100038
J	Qaseem, A; Dallas, P; Forciea, MA; Starkey, M; Denberg, TD				Qaseem, Amir; Dallas, Paul; Forciea, Mary Ann; Starkey, Melissa; Denberg, Thomas D.		Clinical Guidelines Comm American	Dietary and Pharmacologic Management to Prevent Recurrent Nephrolithiasis in Adults: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							CALCIUM-OXALATE UROLITHIASIS; RANDOMIZED CONTROLLED TRIAL; LOW-ANIMAL-PROTEIN; 1ST KIDNEY-STONE; ACETOHYDROXAMIC ACID; SHOCKWAVE LITHOTRIPSY; POTASSIUM CITRATE; PROPHYLAXIS; THIAZIDE; CALCULI	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the comparative effectiveness and safety of preventive dietary and pharmacologic management of recurrent nephrolithiasis in adults. Methods: This guideline is based on published literature on this topic that was identified using MEDLINE, the Cochrane Database of Systematic Reviews (through March 2014), Google Scholar, ClinicalTrials.gov, and Web of Science. Searches were limited to English-language publications. The clinical outcomes evaluated for this guideline include symptomatic stone recurrence, pain, urinary tract obstruction with acute renal impairment, infection, procedure-related illness, emergency department visits, hospitalizations, quality of life, and end-stage renal disease. This guideline grades the quality of evidence and strength of recommendations using ACP's clinical practice guidelines grading system. The target audience for this guideline is all clinicians, and the target patient population is all adults with recurrent nephrolithiasis (>= 1 prior kidney stone episode). Recommendation 1: ACP recommends management with increased fluid intake spread throughout the day to achieve at least 2 L of urine per day to prevent recurrent nephrolithiasis. (Grade: weak recommendation, low-quality evidence) Recommendation 2: ACP recommends pharmacologic monotherapy with a thiazide diuretic, citrate, or allopurinol to prevent recurrent nephrolithiasis in patients with active disease in which increased fluid intake fails to reduce the formation of stones. (Grade: weak recommendation, moderate-quality evidence)	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn Hlth Syst, Philadelphia, PA USA; Virginia Tech, Carilion Sch Med, Roanoke, VA USA; Carilion Clin, Roanoke, VA USA	American College of Physicians; University of Pennsylvania; Virginia Polytechnic Institute & State University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Starkey, Melissa/0000-0002-5818-0265	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Ahlstrand C, 1995, RENAL STONES ASPECTS, P195; ALAOPAS M, 1987, SCAND J UROL NEPHROL, V21, P311, DOI 10.3109/00365598709180789; Attanasio M, 2011, PEDIATR NEPHROL, V26, P337, DOI 10.1007/s00467-010-1562-6; BARCELO P, 1993, J UROLOGY, V150, P1761, DOI 10.1016/S0022-5347(17)35888-3; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; BORGHI L, 1993, J CARDIOVASC PHARM, V22, pS78; Di Silverio F, 2000, EUR UROL, V37, P145, DOI 10.1159/000020131; Dussol B, 2008, NEPHRON CLIN PRACT, V110, pC185, DOI 10.1159/000167271; ETTINGER B, 1988, J UROLOGY, V139, P679, DOI 10.1016/S0022-5347(17)42599-7; ETTINGER B, 1986, NEW ENGL J MED, V315, P1386, DOI 10.1056/NEJM198611273152204; Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2; Fernandez-Rodriguez A, 2006, Actas Urol Esp, V30, P305; Fink HA, 2012, CHRONIC KIDNEY DIS S; Fink HA, 2013, ANN INTERN MED, V158, P535, DOI 10.7326/0003-4819-158-7-201304020-00005; GRIFFITH DP, 1988, J UROLOGY, V140, P318, DOI 10.1016/S0022-5347(17)41592-8; GRIFFITH DP, 1991, EUR UROL, V20, P243; Hiatt RA, 1996, AM J EPIDEMIOL, V144, P25, DOI 10.1093/oxfordjournals.aje.a008851; HOFBAUER J, 1994, BRIT J UROL, V73, P362, DOI 10.1111/j.1464-410X.1994.tb07597.x; Kocvara R, 1999, BJU INT, V84, P393; LAERUM E, 1984, ACTA MED SCAND, V215, P383; Lojanapiwat B, 2011, INT BRAZ J UROL, V37, P611, DOI 10.1590/S1677-55382011000500007; Miano L, 1985, UROLITHIASIS RELATED, P521; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; Premgamone Amorn, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P654; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Robertson WG, 1985, MULTICENTRE TRIAL EV, P545; Sarica K, 2006, UROL RES, V34, P184, DOI 10.1007/s00240-006-0040-x; SCHOLZ D, 1982, J UROLOGY, V128, P903, DOI 10.1016/S0022-5347(17)53269-3; SHUSTER J, 1992, J CLIN EPIDEMIOL, V45, P911, DOI 10.1016/0895-4356(92)90074-W; SMITH MJV, 1977, J UROLOGY, V117, P690, DOI 10.1016/S0022-5347(17)58588-2; Soygur T, 2002, J ENDOUROL, V16, P149, DOI 10.1089/089277902753716098; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; URIBARRI J, 1989, ANN INTERN MED, V111, P1006, DOI 10.7326/0003-4819-111-12-1006; WILLIAMS JJ, 1984, NEW ENGL J MED, V311, P760, DOI 10.1056/NEJM198409203111203	35	76	81	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					659	U85		10.7326/M13-2908	http://dx.doi.org/10.7326/M13-2908			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364887				2022-12-28	WOS:000347244100007
J	Watts, G				Watts, Geoff			Anthony John McMichael Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1498	1498		10.1016/S0140-6736(14)61913-9	http://dx.doi.org/10.1016/S0140-6736(14)61913-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9MO	25390568	Bronze			2022-12-28	WOS:000343899600014
J	Izawa, D; Pines, J				Izawa, Daisuke; Pines, Jonathon			The mitotic checkpoint complex binds a second CDC20 to inhibit active APC/C	NATURE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; BUBR1; MAD2; MITOSIS; DESTRUCTION; APC(CDC20); MECHANISM; TURNOVER; SUPPORTS; ARREST	The spindle assembly checkpoint (SAC) maintains genomic stability by delaying chromosome segregation until the last chromosome has attached to the mitotic spindle. The SAC prevents the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase from recognizing cyclin B and securin by catalysing the incorporation of the APC/C co-activator, CDC20, into a complex called the mitotic checkpoint complex (MCC). The SAC works through unattached kinetochores generating a diffusible 'wait anaphase' signal(1,2) that inhibits the APC/C in the cytoplasm, but the nature of this signal remains a key unsolved problem. Moreover, the SAC and the APC/C are highly responsive to each other: the APC/C quickly targets cyclin B and securin once all the chromosomes attach in metaphase, but is rapidly inhibited should kinetochore attachment be perturbed(3,4). How this is achieved is also unknown. Here, we show that the MCC can inhibit a second CDC20 that has already bound and activated the APC/C. We show how the MCC inhibits active APC/C and that this is essential for the SAC. Moreover, this mechanism can prevent anaphase in the absence of kinetochore signalling. Thus, we propose that the diffusible 'wait anaphase' signal could be the MCC itself, and explain how reactivating the SAC can rapidly inhibit active APC/C.	[Izawa, Daisuke; Pines, Jonathon] Gurdon Inst, Cambridge CB2 1QN, England; [Izawa, Daisuke; Pines, Jonathon] Dept Zool, Cambridge CB2 1QN, England		Pines, J (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	jp103@cam.ac.uk		Pines, Jonathon/0000-0002-5227-6004	Cancer Research UK; Wellcome Trust; CR UK; Cancer Research UK [13959, 13678] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); CR UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We are grateful to T. Matsusaka for developing infrared-dye-conjugated ubiquitylation substrates, to A. Musacchio, W. Earnshaw, T. Kiyomitsu and M. Yanagida for reagents, and to A. Musacchio and members of our laboratory for critical discussions. This work was supported by a project and a programme grant from Cancer Research UK to J.P. J.P. acknowledges core funding to the Gurdon Institute from the Wellcome Trust and CR UK.	Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Izawa D, 2012, J CELL BIOL, V199, P27, DOI 10.1083/jcb.201205170; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; Lau DTC, 2012, CURR BIOL, V22, P180, DOI 10.1016/j.cub.2011.12.029; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Mariani L., 2012, CURR BIOL; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rieder CL, 1997, P NATL ACAD SCI USA, V94, P5107, DOI 10.1073/pnas.94.10.5107; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286	29	124	129	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					631	U245		10.1038/nature13911	http://dx.doi.org/10.1038/nature13911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25383541	Green Accepted			2022-12-28	WOS:000348775000047
J	Rohatgi, A; Khera, A; Berry, JD; Givens, EG; Ayers, CR; Wedin, KE; Neeland, IJ; Yuhanna, IS; Rader, DR; de Lemos, JA; Shaul, PW				Rohatgi, Anand; Khera, Amit; Berry, Jarett D.; Givens, Edward G.; Ayers, Colby R.; Wedin, Kyle E.; Neeland, Ian J.; Yuhanna, Ivan S.; Rader, Daniel R.; de Lemos, James A.; Shaul, Philip W.			HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ATHEROSCLEROSIS; ABILITY	BACKGROUND It is unclear whether high-density lipoprotein (HDL) cholesterol concentration plays a causal role in atherosclerosis. A more important factor may be HDL cholesterol efflux capacity, the ability of HDL to accept cholesterol from macrophages, which is a key step in reverse cholesterol transport. We investigated the epidemiology of cholesterol efflux capacity and its association with incident atherosclerotic cardiovascular disease outcomes in a large, multiethnic population cohort. METHODS We measured HDL cholesterol level, HDL particle concentration, and cholesterol efflux capacity at baseline in 2924 adults free from cardiovascular disease who were participants in the Dallas Heart Study, a probability-based population sample. The primary end point was atherosclerotic cardiovascular disease, defined as a first nonfatal myocardial infarction, nonfatal stroke, or coronary revascularization or death from cardiovascular causes. The median follow-up period was 9.4 years. RESULTS In contrast to HDL cholesterol level, which was associated with multiple traditional risk factors and metabolic variables, cholesterol efflux capacity had minimal association with these factors. Baseline HDL cholesterol level was not associated with cardiovascular events in an adjusted analysis (hazard ratio, 1.08; 95% confidence interval [CI], 0.59 to 1.99). In a fully adjusted model that included traditional risk factors, HDL cholesterol level, and HDL particle concentration, there was a 67% reduction in cardiovascular risk in the highest quartile of cholesterol efflux capacity versus the lowest quartile (hazard ratio, 0.33; 95% CI, 0.19 to 0.55). Adding cholesterol efflux capacity to traditional risk factors was associated with improvement in discrimination and reclassification indexes. CONCLUSIONS Cholesterol efflux capacity, a new biomarker that characterizes a key step in reverse cholesterol transport, was inversely associated with the incidence of cardiovascular events in a population-based cohort.	[Rohatgi, Anand; Khera, Amit; Berry, Jarett D.; Givens, Edward G.; Ayers, Colby R.; Neeland, Ian J.; de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Yuhanna, Ivan S.; Shaul, Philip W.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Ctr Pulm & Vasc Biol, Dallas, TX 75390 USA; [Wedin, Kyle E.] Emory Univ, Dept Internal Med, Atlanta, GA 30322 USA; [Rader, Daniel R.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Rader, Daniel R.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Rohatgi, A (corresponding author), Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	rohatgi@utsouthwestern.edu	de Lemos, James/ABD-6669-2021		Donald W. Reynolds Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL118131] Funding Source: NIH RePORTER	Donald W. Reynolds Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the Donald W. Reynolds Foundation and others.	Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boden WE, 2012, NEW ENGL J MED, V367, P189; Calkin AC, 2009, CIRCULATION, V120, P2095, DOI 10.1161/CIRCULATIONAHA.109.870709; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Jain T, 2004, J AM COLL CARDIOL, V44, P1011, DOI 10.1016/j.jacc.2004.05.069; Khera AV, 2013, ARTERIOSCL THROM VAS, V33, P1449, DOI 10.1161/ATVBAHA.113.301519; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Maroules CD, 2013, RADIOLOGY, V269, P84, DOI 10.1148/radiol.13122707; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Saddar S, 2013, CIRC RES, V112, P140, DOI 10.1161/CIRCRESAHA.112.280081; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Voight BF, 2012, LANCET, V380, P564; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	29	910	935	7	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2383	2393		10.1056/NEJMoa1409065	http://dx.doi.org/10.1056/NEJMoa1409065			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25404125	Green Accepted, Bronze			2022-12-28	WOS:000346425800007
J	Whipple, KX				Whipple, Kelin X.			GEOGRAPHY Can erosion drive tectonics?	SCIENCE			English	Editorial Material							HIMALAYAN DENUDATION; CLIMATE; THRUST; RIVER		Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Whipple, KX (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	kxw@asu.edu						Coutand I, 2014, J GEOPHYS RES-SOL EA, V119, P1446, DOI 10.1002/2013JB010891; Godard V, 2014, GEOLOGY, V42, P243, DOI 10.1130/G35342.1; Herman F, 2013, NATURE, V504, P423, DOI 10.1038/nature12877; Hirschmiller J, 2014, GEOLOGY, V42, P247, DOI 10.1130/G35057.1; Humphrey NF, 2000, GEOLOGY, V28, P43, DOI 10.1130/0091-7613(2000)28<43:RIODIR>2.0.CO;2; Lang KA, 2014, EARTH PLANET SC LETT, V397, P145, DOI 10.1016/j.epsl.2014.04.026; Scherler D, 2014, J GEOPHYS RES-EARTH, V119, P83, DOI 10.1002/2013JF002955; Thiede RC, 2013, EARTH PLANET SC LETT, V371, P278, DOI 10.1016/j.epsl.2013.03.004; Wang P, 2014, SCIENCE, V346, P978, DOI 10.1126/science.1259041; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413; Zeitler P.K., 2014, SPEC PAP GEOL SOC AM, V507, P23	11	21	27	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					918	919		10.1126/science.aaa0887	http://dx.doi.org/10.1126/science.aaa0887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414290				2022-12-28	WOS:000345696000018
J	Endo, M; Shimizu, H; Nohales, MA; Araki, T; Kay, SA				Endo, Motomu; Shimizu, Hanako; Nohales, Maria A.; Araki, Takashi; Kay, Steve A.			Tissue-specific clocks in Arabidopsis show asymmetric coupling	NATURE			English	Article							CIRCADIAN CLOCK; EXPRESSION; PROMOTER; NETWORK; ROLES; TIME	Many organisms rely on a circadian clock system to adapt to daily and seasonal environmental changes. The mammalian circadian clock consists of a central clock in the suprachiasmatic nucleus that has tightly coupled neurons and synchronizes other clocks in peripheral tissues(1,2). Plants also have a circadian clock, but plant circadian clock function has long been assumed to be uncoupled(3). Only a few studies have been able to show weak, local coupling among cells'. Here, by implementing two novel techniques, we have performed a comprehensive tissue-specific analysis of leaf tissues, and show that the vasculature and mesophyll clocks asymmetrically regulate each other in Arabidopsis. The circadian clock in the vasculature has characteristics distinct from other tissues, cycles robustly without environmental cues, and affects circadian clock regulation in other tissues. Furthermore, we found that vasculature-enriched genes that are rhythmically expressed are preferentially expressed in the evening, whereas rhythmic mesophyll-enriched genes tend to be expressed in the morning. Our results set the stage for a deeper understanding of how the vasculature circadian clock in plants regulates key physiological responses such as flowering time.	[Endo, Motomu; Shimizu, Hanako; Araki, Takashi] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068501, Japan; [Endo, Motomu] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Nohales, Maria A.; Kay, Steve A.] Univ So Calif Mol & Computat Biol, Dept Biol, Dana & David Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA	Kyoto University; Japan Science & Technology Agency (JST)	Endo, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068501, Japan.	moendo@lif.kyoto-u.ac.jp	Araki, Takashi/G-1760-2013; Kay, Steve A/F-6025-2011; Nohales, Maria A./AAA-8319-2019	Araki, Takashi/0000-0002-3616-1493; Kay, Steve A/0000-0002-0402-2878; Nohales, Maria A./0000-0002-7874-4021	HFSP long-term Fellowship [LT00017/2008-L]; JST PRESTO [11103346]; JSPS KAKENHI [22770036, 25650097]; Sumitomo Foundation; Nakatani Foundation; National Institutes of Health (NIH) [R01 GM056006, GM067837];  [19060012];  [19060016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067837, R01GM056006] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25113005] Funding Source: KAKEN	HFSP long-term Fellowship; JST PRESTO(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation; Nakatani Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Fukuda and Y. Sugisawa for processing raw microarray data; S. Yonehara for providing c-Jun and A-Fos plasmids; G. Breton, K. Hitomi, T. Oyama, T. Muranaka and Y. Kondo for advice; T. Koto, K. Katayama and B. Y. Chow for technical assistance; J. A. Hejna and T. R. Endo for English proofreading. This work was supported by an HFSP long-term Fellowship LT00017/2008-L (to M.E.), a JST PRESTO 11103346 (to M.E), JSPS KAKENHI grants 22770036 and 25650097 (to M.E.), a Sumitomo Foundation and Nakatani Foundation (to M.E.), Grants-in-Aid for Scientific Research on Priority Areas 19060012 and 19060016 (to T.A.), and National Institutes of Health (NIH) Grants R01 GM056006 and GM067837 (to S.A.K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barclay JL, 2012, PROG BRAIN RES, V199, P163, DOI 10.1016/B978-0-444-59427-3.00030-7; Cano-Delgado A, 2010, ANNU REV CELL DEV BI, V26, P605, DOI 10.1146/annurev-cellbio-100109-104107; Endo M, 2005, PLANT CELL, V17, P1941, DOI 10.1105/tpc.105.032342; Endo M, 2007, PLANT CELL, V19, P84, DOI 10.1105/tpc.106.048157; Fukuda H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098102; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Herrero E, 2012, PLANT CELL, V24, P428, DOI 10.1105/tpc.111.093807; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; James AB, 2008, SCIENCE, V322, P1832, DOI 10.1126/science.1161403; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kerk NM, 2003, PLANT PHYSIOL, V132, P27, DOI 10.1104/pp.102.018127; Khan JA, 2007, PLANT PHYSIOL, V143, P1576, DOI 10.1104/pp.106.092296; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kozuka T, 2011, PLANT CELL, V23, P3684, DOI 10.1105/tpc.111.085852; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nagel DH, 2012, CURR BIOL, V22, pR648, DOI 10.1016/j.cub.2012.07.025; Nishimura T, 2003, PLANT CELL PHYSIOL, V44, P1131, DOI 10.1093/pcp/pcg158; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Pokhilko A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-23; Ranjan A, 2011, DEVELOPMENT, V138, P1851, DOI 10.1242/dev.061036; Sawchuk MG, 2008, PLANT PHYSIOL, V148, P1908, DOI 10.1104/pp.108.126946; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Takahashi H, 2000, PLANT J, V23, P171, DOI 10.1046/j.1365-313x.2000.00768.x; Thain SC, 2000, CURR BIOL, V10, P951, DOI 10.1016/S0960-9822(00)00630-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wenden B, 2012, P NATL ACAD SCI USA, V109, P6757, DOI 10.1073/pnas.1118814109; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	36	162	165	7	108	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					419	+		10.1038/nature13919	http://dx.doi.org/10.1038/nature13919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25363766	Green Accepted, Green Published			2022-12-28	WOS:000345770600047
J	Gupta, S				Gupta, Sujata			No hiding in the dark	NATURE			English	Editorial Material							SKIN-CANCER RISK; MELANOMA; COLOR; GENES											Abe Y, 2013, J DERMATOL SCI, V69, P167, DOI 10.1016/j.jdermsci.2012.10.016; Agbai ON, 2014, J AM ACAD DERMATOL, V70, P748, DOI 10.1016/j.jaad.2013.11.038; ARMSTRONG BK, 1993, MELANOMA RES, V3, P395, DOI 10.1097/00008390-199311000-00002; Brose MS, 2002, CANCER RES, V62, P6997; Hu SS, 2006, ARCH DERMATOL, V142, P704, DOI 10.1001/archderm.142.6.704; Kabigting Filamer D, 2009, Dermatol Online J, V15, P3; Lange JR, 2007, J CLIN ONCOL, V25, P1363, DOI 10.1200/JCO.2006.08.8310; Lee HY, 2012, ANN ACAD MED SINGAP, V41, P17; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Wu SW, 2014, CANCER EPIDEM BIOMAR, V23, P1080, DOI 10.1158/1055-9965.EPI-13-0821; Yoshizawa J, 2014, J DERMATOL, V41, P296, DOI 10.1111/1346-8138.12432	11	5	5	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S121	S123		10.1038/515S121a	http://dx.doi.org/10.1038/515S121a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407710	Bronze			2022-12-28	WOS:000345770600006
J	Kaul, P; Federspiel, JJ; Dai, XM; Stearns, SC; Smith, SC; Yeung, M; Beyhaghi, H; Zhou, L; Stouffer, GA				Kaul, Prashant; Federspiel, Jerome J.; Dai, Xuming; Stearns, Sally C.; Smith, Sidney C., Jr.; Yeung, Michael; Beyhaghi, Hadi; Zhou, Lei; Stouffer, George A.			Association of Inpatient vs Outpatient Onset of ST-Elevation Myocardial Infarction With Treatment and Clinical Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOOR-TO-BALLOON; TIME; MORTALITY; QUALITY; SYSTEM	IMPORTANCE Reperfusion times for ST-elevation myocardial infarction (STEMI) occurring in outpatients have improved significantly, but quality improvement efforts have largely ignored STEMI occurring in hospitalized patients (inpatient-onset STEMI). OBJECTIVE To define the incidence and variables associated with treatment and outcomes of patients who develop STEMI during hospitalization for conditions other than acute coronary syndromes (ACS). DESIGN, SETTING, AND PARTICIPANTS Retrospective observational analysis of STEMIs occurring between 2008 and 2011 as identified in the California State Inpatient Database. EXPOSURES STEMIs were classified as inpatient onset or outpatient onset based on present-on-admission codes. Patients who had a STEMI after being hospitalized for ACS were excluded from the analysis. MAIN OUTCOMES AND MEASURES Regression models were used to evaluate associations among location of onset of STEMI, resource utilization, and outcomes. Adjustments were made for patient age, sex, comorbidities, and hospital characteristics. The analysis allowed for the location of inpatient STEMI to have a multiplicative rather than an additive effect for resource utilization since these measures were highly skewed. RESULTS A total of 62 021 STEMIs were identified in 303 hospitals, of which 3068 (4.9%) occurred in patients hospitalized for non-ACS indications. Patients with inpatient-onset STEMI were older (mean, 71.5 [SD, 13.5] years vs 64.9 [SD, 14.1] years; P < .001) and more frequently female (47.4% vs 32%; P < .001) than those with outpatient-onset STEMI. Patients with inpatient-onset STEMI had higher in-hospital mortality (33.6% vs 9.2%; adjusted odds ratio (AOR), 3.05; 95% CI, 2.76-3.38; P < .001), were less likely to be discharged home (33.7% vs 69.4%; AOR, 0.38; 95% CI, 0.34-0.42; P < .001), and were less likely to undergo cardiac catheterization (33.8% vs 77.8%; AOR, 0.19; 95% CI, 0.16-0.21; P < .001) or percutaneous coronary intervention (21.6% vs 65%; AOR, 0.23; 95% CI, 0.21-0.26; P < .001). Length of stay and inpatient charges were higher for inpatient-onset STEMI (mean length of stay, 13.4 days [95% CI, 12.8-14.0 days] vs 4.7 days [95% CI, 4.6-4.8 days]; adjusted multiplicative effect, 2.51; 95% CI, 2.35-2.69; P < .001; mean inpatient charges, $245 000 [95% CI, $235 300-$ 254 800] vs $129 000 [95% CI, $127 900-$130 100]; adjusted multiplicative effect, 2.09; 95% CI, 1.93-2.28; P < .001). CONCLUSIONS AND RELEVANCE Patients who had a STEMI while hospitalized for a non-ACS condition, compared with those with onset of STEMI as an outpatient, were less likely to undergo invasive testing or intervention and had a higher in-hospital mortality rate.	[Kaul, Prashant; Dai, Xuming; Smith, Sidney C., Jr.; Yeung, Michael; Stouffer, George A.] Univ N Carolina, Div Cardiol, Chapel Hill, NC 27599 USA; [Federspiel, Jerome J.; Stearns, Sally C.; Beyhaghi, Hadi; Zhou, Lei] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA; [Federspiel, Jerome J.; Stearns, Sally C.] Univ N Carolina, Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stouffer, GA (corresponding author), Univ N Carolina, Div Cardiol, Chapel Hill, NC 27599 USA.	rstouff@med.unc.edu	Stouffer, George/AAK-4763-2021; Federspiel, Jerome/C-7519-2009	Federspiel, Jerome/0000-0003-0321-6280; Beyhaghi, Hadi/0000-0003-2862-9663	National Heart, Lung, and Blood Institute [F30-HL110483]; National Institute of General Medical Sciences [T32-GM008719]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL110483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data acquisition and Dr Federspiel's effort were supported by grants F30-HL110483 from the National Heart, Lung, and Blood Institute and T32-GM008719 from the National Institute of General Medical Sciences. The CA-SID is a product of the Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality, in partnership with the California Office of Statewide Health Planning and Development.	Dai XM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000004; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Garberich RF, 2014, CIRCULATION, V129, P1225, DOI 10.1161/CIRCULATIONAHA.113.005568; Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Jollis JG, 2007, JAMA-J AM MED ASSOC, V298, P2371, DOI 10.1001/jama.298.20.joc70124; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2011, CIRCULATION, V124, P1038, DOI 10.1161/CIRCULATIONAHA.111.044107; Maynard C, 2006, ARCH INTERN MED, V166, P1410, DOI 10.1001/archinte.166.13.1410; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Peterson ED, 2009, CIRC-CARDIOVASC QUAL, V2, P491, DOI 10.1161/CIRCOUTCOMES.108.847145; State Inpatient Database, 2015, HEALTHC COST UT PROJ; Zahn R, 2000, J AM COLL CARDIOL, V35, P1820, DOI 10.1016/S0735-1097(00)00629-X	15	34	34	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1999	2007		10.1001/jama.2014.15236	http://dx.doi.org/10.1001/jama.2014.15236			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399275	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000345450500014
J	Farzadfard, F; Lu, TK				Farzadfard, Fahim; Lu, Timothy K.			Genomically encoded analog memory with precise in vivo DNA writing in living cell populations	SCIENCE			English	Article							SINGLE-STRANDED-DNA; REVERSE-TRANSCRIPTASE; INFORMATION-STORAGE; ESCHERICHIA-COLI; RECOMBINATION; LOGIC; REPLICATION; EFFICIENT; SYSTEM; INVOLVEMENT	Cellular memory is crucial to many natural biological processes and sophisticated synthetic biology applications. Existing cellular memories rely on epigenetic switches or recombinases, which are limited in scalability and recording capacity. In this work, we use the DNA of living cell populations as genomic "tape recorders" for the analog and distributed recording of long-term event histories. We describe a platform for generating single-stranded DNA (ssDNA) in vivo in response to arbitrary transcriptional signals. When coexpressed with a recombinase, these intracellularly expressed ssDNAs target specific genomic DNA addresses, resulting in precise mutations that accumulate in cell populations as a function of the magnitude and duration of the inputs. This platform could enable long-term cellular recorders for environmental and biomedical applications, biological state machines, and enhanced genome engineering strategies.	[Farzadfard, Fahim; Lu, Timothy K.] MIT, Synthet Biol Grp, Elect Res Lab, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Farzadfard, Fahim; Lu, Timothy K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Farzadfard, Fahim; Lu, Timothy K.] MIT Synthet Biol Ctr, Cambridge, MA 02139 USA; [Farzadfard, Fahim; Lu, Timothy K.] MIT Microbiol Program, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lu, TK (corresponding author), MIT, Synthet Biol Grp, Elect Res Lab, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	timlu@mit.edu		/0000-0003-1389-8203	NIH New Innovator Award [1DP2OD008435]; NIH National Centers for Systems Biology [1P50GM098792]; U.S. Office of Naval Research [N000141310424]; Defense Advanced Research Projects Agency; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435] Funding Source: NIH RePORTER	NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Centers for Systems Biology; U.S. Office of Naval Research(Office of Naval Research); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH New Innovator Award (1DP2OD008435), NIH National Centers for Systems Biology (1P50GM098792), the U.S. Office of Naval Research (N000141310424), and the Defense Advanced Research Projects Agency. Sequencing data have been deposited in GenBank with accession numbers KM923743 to KM923754.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/nnano.2014.58, 10.1038/NNANO.2014.58]; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; BEBENEK K, 1993, J BIOL CHEM, V268, P10324; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Brakmann S, 2001, CHEMBIOCHEM, V2, P212, DOI 10.1002/1439-7633(20010302)2:3<212::AID-CBIC212>3.3.CO;2-I; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Burrill DR, 2012, GENE DEV, V26, P1486, DOI 10.1101/gad.189035.112; Chirieleison SM, 2013, NAT CHEM, V5, P1000, DOI [10.1038/NCHEM.1764, 10.1038/nchem.1764]; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Huen MSY, 2006, NUCLEIC ACIDS RES, V34, P6183, DOI 10.1093/nar/gkl852; Inniss MC, 2013, CURR BIOL, V23, pR812, DOI 10.1016/j.cub.2013.06.047; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Lampson BC, 2005, CYTOGENET GENOME RES, V110, P491, DOI 10.1159/000084982; LIM D, 1989, CELL, V56, P891, DOI 10.1016/0092-8674(89)90693-4; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MAO JR, 1995, J BIOL CHEM, V270, P19684, DOI 10.1074/jbc.270.34.19684; MIROCHNITCHENKO O, 1994, J BIOL CHEM, V269, P2380; MIYATA S, 1992, P NATL ACAD SCI USA, V89, P5735, DOI 10.1073/pnas.89.13.5735; Mosberg JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044638; Ohlendorf R, 2012, J MOL BIOL, V416, P534, DOI 10.1016/j.jmb.2012.01.001; Olson EJ, 2014, NAT METHODS, V11, P449, DOI 10.1038/nmeth.2884; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; Poteete AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067440; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Sharma Prem L., 2005, Antiviral Chemistry & Chemotherapy, V16, P169; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; YEE T, 1984, CELL, V38, P203, DOI 10.1016/0092-8674(84)90541-5; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	51	180	207	3	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					825	+	1256272	10.1126/science.1256272	http://dx.doi.org/10.1126/science.1256272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6XZ	25395541	Green Accepted, Green Submitted			2022-12-28	WOS:000349771600001
J	Manz, C; Ross, JS; Grande, D				Manz, Christopher; Ross, Joseph S.; Grande, David			Marketing to Physicians in a Digital World	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Manz, Christopher] Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Grande, David] Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Grande, David] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Fdn,Clin Scholars Program, New Haven, CT 06510 USA; [Ross, Joseph S.] Yale Univ, Dept Hlth Policy & Management, Sch Publ Hlth, New Haven, CT USA; [Ross, Joseph S.] Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Ross, Joseph S.] Yale New Haven Med Ctr, New Haven, CT 06504 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University	Manz, C (corresponding author), Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA.		Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735; Ross, Joseph/0000-0002-9218-3320				[Anonymous], PHARM PARTN SOL; McBride R., 2013, 10 STARTUPS FUELING; Physicians Interactive, DIG MARK ECOUPON; Wilson D., 2011, NY TIMES, pB1	4	6	7	3	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1857	1859		10.1056/NEJMp1408974	http://dx.doi.org/10.1056/NEJMp1408974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT1RB	25390738				2022-12-28	WOS:000344709800001
J	Schulte, J; Rothaus, CS; Adler, JN; Phimister, EG				Schulte, Joann; Rothaus, Carla S.; Adler, Jonathan N.; Phimister, Elizabeth G.			Screening an Asymptomatic Person for Genetic Risk - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2014, NEW ENGL J MED, V370, P2442, DOI 10.1056/NEJMclde1311959	1	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20							e30	10.1056/NEJMclde1411151	http://dx.doi.org/10.1056/NEJMclde1411151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT1RB	25390759				2022-12-28	WOS:000344709800015
J	Simon, A				Simon, Anna			Cholesterol Metabolism and Immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							25-HYDROXYCHOLESTEROL; INTERFERON		Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Simon, A (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands.		Simon, Anna/D-3757-2009	Simon, Anna/0000-0002-6141-7921				Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681	5	34	35	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1933	1935		10.1056/NEJMcibr1412016	http://dx.doi.org/10.1056/NEJMcibr1412016			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25390746	Green Published			2022-12-28	WOS:000344709800017
J	Clement, ME; Hicks, CB				Clement, Meredith E.; Hicks, Charles B.			RPR and the Serologic Diagnosis of Syphilis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TESTS		[Clement, Meredith E.; Hicks, Charles B.] Duke Univ, Div Infect Dis, Dept Med, Durham, NC 27710 USA	Duke University	Hicks, CB (corresponding author), Duke Univ, Div Infect Dis, Dept Med, Med Ctr, POB 3360,Hanes House Rm 254, Durham, NC 27710 USA.	charles.hicks@dm.duke.edu		Clement, Meredith/0000-0002-0283-6368	NIAID NIH HHS [T32 AI007392] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Association of Public Health Laboratories, LABORATORY DIAGNOSTI; Centers for Disease Control and Prevention, NATIONAL NOTIFIABLE; Centers for Disease Control and Prevention, SYPHILIS CDC FACT SH; Centers for Disease Control and Prevention, 2010, 2010 STD TREATMENT G; Centers for Disease Control and Prevention, RECENT CHANGES TO GO; Centers for Medicare & Medicaid Services, 2014, FEE SCHEDULE 14CLAB; Golden MR, 2003, JAMA-J AM MED ASSOC, V290, P1510, DOI 10.1001/jama.290.11.1510; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Marra CM, 2004, J INFECT DIS, V189, P369, DOI 10.1086/381227; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832	10	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1922	1923		10.1001/jama.2014.2087	http://dx.doi.org/10.1001/jama.2014.2087			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387191	Green Accepted, Green Published			2022-12-28	WOS:000344532600023
J	van der Meer, AJ; Wedemeyer, H; Feld, JJ; Dufour, JF; Zeuzem, S; Hansen, BE; Janssen, HLA				van der Meer, Adriaan J.; Wedemeyer, Heiner; Feld, Jordan J.; Dufour, Jean-Francois; Zeuzem, Stefan; Hansen, Bettina E.; Janssen, Harry L. A.			Life Expectancy in Patients With Chronic HCV Infection and Cirrhosis Compared With a General Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CHRONIC HEPATITIS-C; VIRUS-INFECTION; MORTALITY		[van der Meer, Adriaan J.; Hansen, Bettina E.; Janssen, Harry L. A.] Erasmus MC Univ, Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands; [Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Feld, Jordan J.] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada; [Dufour, Jean-Francois] Univ Bern, Dept Clin Res, Bern, Switzerland; [Zeuzem, Stefan] Klinikum Johann Wolfgang Goethe Univ, Med Klin 1, Frankfurt, Germany	Erasmus University Rotterdam; Erasmus MC; Hannover Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Bern; Goethe University Frankfurt; Goethe University Frankfurt Hospital	van der Meer, AJ (corresponding author), Erasmus MC Univ, Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	a.vandermeer@erasmusmc.nl	Zeuzem, Stefan/AAE-7435-2019; Feld, Jordan/AAH-5628-2020; Dufour, Jean Francois Jacques/AAL-9866-2020; Hansen, Bettina E/P-5468-2014	Feld, Jordan/0000-0003-2640-2211; Dufour, Jean Francois Jacques/0000-0002-8062-1346; Hansen, Bettina E/0000-0001-8307-3341				Akamatsu M, 2006, LIVER INT, V26, P536, DOI 10.1111/j.1478-3231.2006.01260.x; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; van der Meer AJ, 2014, J HEPATOL, V60, P191, DOI 10.1016/j.jhep.2013.07.043; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878	6	72	74	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1927	1928		10.1001/jama.2014.12627	http://dx.doi.org/10.1001/jama.2014.12627			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387192	Bronze			2022-12-28	WOS:000344532600024
J	Shao, SC; Hegde, RS				Shao, Sichen; Hegde, Ramanujan S.			Local synthesis and disposal	SCIENCE			English	Editorial Material							SUBSTRATE-SPECIFICITY; QUALITY-CONTROL; IN-VIVO; BIOTINYLATION; PROTEINS; DEGRADATION		[Shao, Sichen; Hegde, Ramanujan S.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Shao, SC (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk		Shao, Sichen/0000-0003-2679-5537; Hegde, Ramanujan/0000-0001-8338-852X	Medical Research Council [MC_UP_A022_1007] Funding Source: Medline; MRC [MC_UP_A022_1007] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Lu WC, 2014, BIOTECHNOL BIOENG, V111, P1071, DOI 10.1002/bit.25176; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522	13	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					701	702		10.1126/science.1261602	http://dx.doi.org/10.1126/science.1261602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378608				2022-12-28	WOS:000344690100022
J	Butt, CA				Butt, Carrie A.			The Lady in Mauve Lyonel Feininger	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1722	1723		10.1001/jama.2013.279811	http://dx.doi.org/10.1001/jama.2013.279811			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25369477				2022-12-28	WOS:000344194500001
J	Mann, J; McLean, R; Skeaff, M; Morenga, LT				Mann, Jim; McLean, Rachael; Skeaff, Murray; Morenga, Lisa Te			Low carbohydrate diets: going against the grain	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; WEIGHT-LOSS; FAT; RISK; DISEASE		[Mann, Jim] Univ Otago, Dept Human Nutr, Dunedin 9054, New Zealand; Univ Otago, Edgar Ctr Diabet & Obes Res, Dunedin 9054, New Zealand	University of Otago; University of Otago	Mann, J (corresponding author), Univ Otago, Dept Human Nutr, POB 56, Dunedin 9054, New Zealand.	jim.mann@otago.ac.nz	McLean, Rachael/AAF-7596-2019; Te Morenga, Lisa/C-4459-2011	McLean, Rachael/0000-0002-0005-328X; Te Morenga, Lisa/0000-0003-3526-0091				Bueno NB, 2013, BRIT J NUTR, V110, P1178, DOI 10.1017/S0007114513000548; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hession M, 2009, OBES REV, V10, P36, DOI 10.1111/j.1467-789X.2008.00518.x; Hooper L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7666; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Johansson I, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-40; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Mann J, 2007, EUR J CLIN NUTR, V61, pS132, DOI 10.1038/sj.ejcn.1602943; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Nordic Council of Ministers, 2014, NORD NUTR REC 2012 I; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Scientific Advisory Committee on Nutrition, 2014, CARB HLTH R IN PRESS; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; US Department of Agriculture US Department of Health and Human Services, 2020, DIET GUID AM 2020 20; USDA, 2014, SER SYST REV REL DIE; WHO, 2014, GUID FREE S IN PRESS	19	14	14	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1479	1480		10.1016/S0140-6736(14)61413-6	http://dx.doi.org/10.1016/S0140-6736(14)61413-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9MO	25390561				2022-12-28	WOS:000343899600004
J	Barretto, RPJ; Gillis-Smith, S; Chandrashekar, J; Yarmolinsky, DA; Schnitzer, MJ; Ryba, NJP; Zuker, CS				Barretto, Robert P. J.; Gillis-Smith, Sarah; Chandrashekar, Jayaram; Yarmolinsky, David A.; Schnitzer, Mark J.; Ryba, Nicholas J. P.; Zuker, Charles S.			The neural representation of taste quality at the periphery	NATURE			English	Article							FLUORESCENCE MICROENDOSCOPY; MAMMALIAN BRAIN; CHORDA TYMPANI; UMAMI TASTE; RECEPTORS; STIMULI; SWEET; CELLS; MICE; BUDS	The mammalian taste system is responsible for sensing and responding to the five basic taste qualities: sweet, sour, bitter, salty and umami. Previously, we showed that each taste is detected by dedicated taste receptor cells (TRCs) on the tongue and palate epithelium(1). To understand how TRCs transmit information to higher neural centres, we examined the tuning properties of large ensembles of neurons in the first neural station of the gustatory system. Here, we generated and characterized a collection of transgenic mice expressing a genetically encoded calcium indicator' in central and peripheral neurons, and used a gradient refractive index microendoscope combined with high-resolution two-photon microscopy to image taste responses from ganglion neurons buried deep at the base of the brain. Our results reveal fine selectivity in the taste preference of ganglion neurons; demonstrate a strong match between TRCs in the tongue and the principal neural afferents relaying taste information to the brain; and expose the highly specific transfer of taste information between taste cells and the central nervous system.	[Barretto, Robert P. J.; Gillis-Smith, Sarah; Yarmolinsky, David A.; Zuker, Charles S.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Barretto, Robert P. J.; Gillis-Smith, Sarah; Yarmolinsky, David A.; Zuker, Charles S.] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Barretto, Robert P. J.; Gillis-Smith, Sarah; Yarmolinsky, David A.; Zuker, Charles S.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Chandrashekar, Jayaram; Zuker, Charles S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA.	nick.ryba@nih.gov; cz2195@columbia.edu		Chandrashekar, jayaram/0000-0001-6412-0114; Ryba, Nicholas/0000-0002-2060-8393	NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the National Institute of Dental and Craniofacial Research (NIDCR) transgenic-core and C. Guo at Janelia Farms for help in generating the Thy1-GCaMP3 mouse lines, B. Shields for histology support, and Y. Oka and M. Butnaru for nerve recording and pharmacological advice. We also thank members of the Zuker laboratory for helpful comments. This research was supported in part by the intramural research program of NIDCR (N.J.P.R.). C.S.Z. is an investigator of the Howard Hughes Medical Institute and a Senior Fellow at Janelia Farms.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FRANK M, 1969, SCIENCE, V164, P1183, DOI 10.1126/science.164.3884.1183; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; GRILL HJ, 1978, BRAIN RES, V143, P281, DOI 10.1016/0006-8993(78)90569-3; Heyer BR, 2003, CHEM SENSES, V28, P631, DOI 10.1093/chemse/bjg056; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; HYMAN AM, 1980, J GEN PHYSIOL, V76, P125, DOI 10.1085/jgp.76.2.125; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Simon SA, 2006, NAT REV NEUROSCI, V7, P890, DOI 10.1038/nrn2006; Sollars SI, 2005, J PHYSIOL-LONDON, V564, P877, DOI 10.1113/jphysiol.2005.083741; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zaidi FN, 2006, J NEUROSCI, V26, P8243, DOI 10.1523/JNEUROSCI.5142-05.2006; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	30	87	88	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					373	U511		10.1038/nature13873	http://dx.doi.org/10.1038/nature13873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25383521	Green Accepted			2022-12-28	WOS:000347810300047
J	Garg, AX; Kurz, A; Sessler, DI; Cuerden, M; Robinson, A; Mrkobrada, M; Parikh, CR; Mizera, R; Jones, PM; Tiboni, M; Font, A; Cegarra, V; Gomez, MFR; Meyhoff, CS; VanHelder, T; Chan, MTV; Torres, D; Parlow, J; Clanchet, MD; Amir, M; Bidgoli, SJ; Pasin, L; Martinsen, K; Malaga, G; Myles, P; Acedillo, R; Roshanov, PS; Walsh, M; Dresser, G; Kumar, P; Fleischmann, E; Villar, JC; Painter, T; Biccard, B; Bergese, S; Srinathan, S; Cata, JP; Chan, V; Mehra, B; Wijeysundera, DN; Leslie, K; Forget, P; Whitlock, R; Yusuf, S; Devereaux, PJ				Garg, Amit X.; Kurz, Andrea; Sessler, Daniel I.; Cuerden, Meaghan; Robinson, Andrea; Mrkobrada, Marko; Parikh, Chirag R.; Mizera, Richard; Jones, Philip M.; Tiboni, Maria; Font, Adria; Cegarra, Virginia; Rojas Gomez, Maria Fernanda; Meyhoff, Christian S.; VanHelder, Tomas; Chan, Matthew T. V.; Torres, David; Parlow, Joel; de Nadal Clanchet, Miriam; Amir, Mohammed; Bidgoli, Seyed Javad; Pasin, Laura; Martinsen, Kristian; Malaga, German; Myles, Paul; Acedillo, Rey; Roshanov, Pavel S.; Walsh, Michael; Dresser, George; Kumar, Priya; Fleischmann, Edith; Carlos Villar, Juan; Painter, Thomas; Biccard, Bruce; Bergese, Sergio; Srinathan, Sadeesh; Cata, Juan P.; Chan, Vincent; Mehra, Bhupendra; Wijeysundera, Duminda N.; Leslie, Kate; Forget, Patrice; Whitlock, Richard; Yusuf, Salim; Devereaux, P. J.		POISE-2 Investigators	Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; OMEGA-3-DERIVED MEDIATORS; TRANEXAMIC ACID; AGONISTS; DISEASE; NEUROPROTECTINS; DOCOSATRIENES; TRANSFUSION; RATIONALE	IMPORTANCE Acute kidney injury, a common complication of surgery, is associated with poor outcomes and high health care costs. Some studies suggest aspirin or clonidine administered during the perioperative period reduces the risk of acute kidney injury; however, these effects are uncertain and each intervention has the potential for harm. OBJECTIVE To determine whether aspirin compared with placebo, and clonidine compared with placebo, alters the risk of perioperative acute kidney injury. DESIGN, SETTING, AND PARTICIPANTS A 2 x 2 factorial randomized, blinded, clinical trial of 6905 patients undergoing noncardiac surgery from 88 centers in 22 countries with consecutive patients enrolled between January 2011 and December 2013. INTERVENTIONS Patients were assigned to take aspirin (200 mg) or placebo 2 to 4 hours before surgery and then aspirin (100 mg) or placebo daily up to 30 days after surgery, and were assigned to take oral clonidine (0.2 mg) or placebo 2 to 4 hours before surgery, and then a transdermal clonidine patch (which provided clonidine at 0.2 mg/d) or placebo patch that remained until 72 hours after surgery. MAIN OUTCOMES AND MEASURES Acute kidney injury was primarily defined as an increase in serum creatinine concentration from the preoperative concentration by either an increase of 0.3 mg/dL or greater (>= 26.5 mu mol/L) within 48 hours of surgery or an increase of 50% or greater within 7 days of surgery. RESULTS Aspirin (n = 3443) vs placebo (n = 3462) did not alter the risk of acute kidney injury (13.4% vs 12.3%, respectively; adjusted relative risk, 1.10; 95% CI, 0.96-1.25). Clonidine (n = 3453) vs placebo (n = 3452) did not alter the risk of acute kidney injury (13.0% vs 12.7%, respectively; adjusted relative risk, 1.03; 95% CI, 0.90-1.18). Aspirin increased the risk of major bleeding. In a post hoc analysis, major bleeding was associated with a greater risk of subsequent acute kidney injury (23.3% when bleeding was present vs 12.3% when bleeding was absent; adjusted hazard ratio, 2.20; 95% CI, 1.72-2.83). Similarly, clonidine increased the risk of clinically important hypotension. In a post hoc analysis, clinically important hypotension was associated with a greater risk of subsequent acute kidney injury (14.3% when hypotension was present vs 11.8% when hypotension was absent; adjusted hazard ratio, 1.34; 95% CI, 1.14-1.58). CONCLUSIONS AND RELEVANCE Among patients undergoing major noncardiac surgery, neither aspirin nor clonidine administered perioperatively reduced the risk of acute kidney injury.	[Garg, Amit X.; Cuerden, Meaghan; Mrkobrada, Marko; Jones, Philip M.; Acedillo, Rey; Roshanov, Pavel S.; Dresser, George] London Hlth Sci Ctr, London, ON N6A 4G5, Canada; [Garg, Amit X.; Cuerden, Meaghan; Mrkobrada, Marko; Jones, Philip M.; Acedillo, Rey; Roshanov, Pavel S.; Dresser, George] Univ Western Ontario, London, ON, Canada; [Kurz, Andrea; Sessler, Daniel I.] Cleveland Clin, Cleveland, OH 44106 USA; [Robinson, Andrea; Mizera, Richard; Tiboni, Maria; VanHelder, Tomas; Walsh, Michael; Whitlock, Richard; Yusuf, Salim; Devereaux, P. J.] McMaster Univ, Hamilton Hlth Sci Ctr, St Josephs Healthcare & Populat Hlth Res Inst, Hamilton, ON, Canada; [Parikh, Chirag R.] Yale Univ, Sch Med, New Haven, CT USA; [Font, Adria; Cegarra, Virginia] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Rojas Gomez, Maria Fernanda] Fdn Oftalmol Santander, Bucaramanga, Colombia; [Meyhoff, Christian S.] Herlev Hosp, Copenhagen, Denmark; [Meyhoff, Christian S.] Univ Copenhagen, Copenhagen, Denmark; [Chan, Matthew T. V.] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Torres, David] Univ Los Andes, Clin Santa Maria, Santiago, Chile; [Parlow, Joel] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; [de Nadal Clanchet, Miriam] Hosp Valle De Hebron, Barcelona, Spain; [Amir, Mohammed] Shifa Int Hosp Ltd, Islamabad, Pakistan; [Bidgoli, Seyed Javad] CHU Brugmann, Brussels, Belgium; [Pasin, Laura] Ist Sci San Raffaele, I-20132 Milan, Italy; [Martinsen, Kristian] Vejle Hosp, Vejle, Denmark; [Malaga, German] Hosp Nacl Cayetano Heredia, Lima, Peru; [Myles, Paul] Monash Univ, Melbourne, Vic 3004, Australia; [Kumar, Priya] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Fleischmann, Edith] Vienna Gen Hosp, Vienna, Austria; [Fleischmann, Edith] Med Univ Vienna, Vienna, Austria; [Carlos Villar, Juan] Fdn Cardioinfantil, Bogota, Colombia; [Carlos Villar, Juan] Univ Autonoma Bucaramanga, Bogota, Colombia; [Painter, Thomas] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Biccard, Bruce] Nelson R Mandela Sch Med, Durban, South Africa; [Bergese, Sergio] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Srinathan, Sadeesh] Univ Manitoba, Winnipeg, MB, Canada; [Cata, Juan P.] Univ Texas Houston, Houston, TX USA; [Cata, Juan P.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Chan, Vincent; Wijeysundera, Duminda N.] Univ Hlth Network, Toronto, ON, Canada; [Chan, Vincent; Wijeysundera, Duminda N.] Univ Toronto, Toronto, ON, Canada; [Mehra, Bhupendra] Mahatma Gandhi Inst Med Sci, Wardha, India; [Leslie, Kate] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Forget, Patrice] Clin Univ St Luc, B-1200 Brussels, Belgium; [Forget, Patrice] Catholic Univ Louvain, B-1200 Brussels, Belgium	London Health Sciences Centre; Western University (University of Western Ontario); Cleveland Clinic Foundation; McMaster University; Yale University; Hospital of Santa Creu i Sant Pau; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Chinese University of Hong Kong; Universidad de los Andes - Chile; Queens University - Canada; Hospital Universitari Vall d'Hebron; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Southern Denmark; Lillebaelt Hospital; Monash University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Medical University of Vienna; Fundacion Cardioinfantil - Instituto de Cardiologia; Royal Adelaide Hospital; University of Kwazulu Natal; University System of Ohio; Ohio State University; University of Manitoba; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Mahatma Gandhi Institute of Medical Sciences, Sevagram; Royal Melbourne Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Garg, AX (corresponding author), London Hlth Sci Ctr, 800 Commissioners Rd E, London, ON N6A 4G5, Canada.	garg@lhsc.on.ca	Dresser, George/G-3291-2011; GIN, Tony/J-2521-2013; Sessler, Daniel/D-3504-2011; Jones, Philip/AAI-5640-2020; Painter, Thomas/K-6311-2017; de Nadal, Miriam/J-8127-2017; Chan, Matthew/J-2884-2013; Mrkobrada, Marko/G-3336-2011; Garg, Amit X/G-3295-2011; Meyhoff, Christian S./B-4777-2009; Wijeysundera, Duminda/L-3350-2018; Chan, Vincent/AAY-3553-2020; del Valle, Santiago Garcia/H-5388-2018; Walsh, Michael/ABE-1278-2021; Devereaux, PJ/AAF-2862-2019; Forget, Patrice/AAO-6918-2020; Myles, Paul/AAU-9524-2020; Amir, Mohammed/AAI-8792-2020; Álvarez-García, Jesús/N-9426-2016; Salmasi, Vafi/O-9908-2019; Painter, Thomas/K-3899-2019; Whitlock, Richard/AAQ-1593-2021; Meyer-Treschan, Tanja A./S-6624-2017; Devereaux, PJ/AAY-1757-2021; Pasin, Laura/AAA-8188-2020; Villar Centeno, Juan Carlos/AAX-5401-2021; Vizcaychipi, Marcela/H-5487-2011	GIN, Tony/0000-0001-7283-6761; Sessler, Daniel/0000-0001-9932-3077; Jones, Philip/0000-0003-2296-6327; Painter, Thomas/0000-0003-2216-2046; de Nadal, Miriam/0000-0002-4559-2463; Chan, Matthew/0000-0002-3574-7855; Meyhoff, Christian S./0000-0002-4885-4609; Wijeysundera, Duminda/0000-0002-5897-8605; del Valle, Santiago Garcia/0000-0002-6216-8226; Walsh, Michael/0000-0001-8292-2014; Forget, Patrice/0000-0001-5772-8439; Myles, Paul/0000-0002-3324-5456; Álvarez-García, Jesús/0000-0002-2015-6446; Painter, Thomas/0000-0003-2216-2046; Whitlock, Richard/0000-0002-6863-5884; Meyer-Treschan, Tanja A./0000-0001-9363-1028; Gonzalez-Suarez, Susana/0000-0001-7119-1092; Amir, Mohammed/0000-0003-4726-5674; Roshanov, Pavel/0000-0003-3908-1955; Kurz, Andrea/0000-0001-5887-3099; Yusuf, Salim/0000-0003-4776-5601; piriou, vincent/0000-0001-6900-1480; Devereaux, PJ/0000-0003-2935-637X; Uribe, Alberto/0000-0001-7897-8322; Sabate, Sergi/0000-0001-7582-2832; Malaga, German/0000-0002-7828-300X; Villar, Juan Carlos/0000-0002-7047-7299; Parikh, Chirag/0000-0001-9051-7385; Leslie, Kate/0000-0001-8512-3517; ALVAREZ PINZON, ANDRES/0000-0003-3488-8020; Cortes, Olga L/0000-0002-9023-7479; Tena, Beatriz/0000-0001-9325-0858; Pasin, Laura/0000-0001-5757-4791; Vizcaychipi, Marcela/0000-0001-7894-873X; Torres, David/0000-0003-2908-6365; Salmasi, Vafi/0000-0002-1288-4531; Caballero-Alvarado, Jose/0000-0001-8297-6901	Canadian Institutes of Health Research; Australian National Health and Medical Research Council; Spanish Ministry of Health and Social Policy; Boehringer Ingelheim	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Health and Social Policy(Spanish Government); Boehringer Ingelheim(Boehringer Ingelheim)	The Perioperative Ischemic Evaluation-2 (POISE-2) Trial and this acute kidney injury substudy were financially supported by grants from the Canadian Institutes of Health Research. Financial support for POISE-2 was also provided by the Australian National Health and Medical Research Council and the Spanish Ministry of Health and Social Policy. Boehringer Ingelheim provided the clonidine study drug and some funding. Bayer Pharma AG provided the aspirin study drug.	Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Acedillo RR, 2013, ANN SURG, V258, P901, DOI 10.1097/SLA.0000000000000244; Allison PD, 2005, SUGI 30 P, P113; Billings FT, 2008, AM J PHYSIOL-RENAL, V295, pF741, DOI 10.1152/ajprenal.90244.2008; Blaudszun G, 2012, ANESTHESIOLOGY, V116, P1312, DOI 10.1097/ALN.0b013e31825681cb; Cao LH, 2012, ANN SURG, V255, P399, DOI 10.1097/SLA.0b013e318234313b; Carpenter JR, MISSING DATA CLIN TR; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1504, DOI 10.1056/NEJMoa1401106; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Devereaux PJ, 2014, AM HEART J, V167, P804, DOI 10.1016/j.ahj.2014.01.007; Doutremepuich C, 2013, AM J CARDIOVASC DRUG, V13, P377, DOI 10.1007/s40256-013-0044-1; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; EKNOYAN G, 1983, J LAB CLIN MED, V102, P699; ELLIS JE, 1994, ANESTH ANALG, V79, P1133; Garg AX, 2014, JAMA-J AM MED ASSOC, V311, P2191, DOI 10.1001/jama.2014.4952; Garg AX, 2014, BMJ OPEN, V4, DOI DOI 10.1136/BMJOPEN-2014-004886; Gerrah R, 2004, J CARDIOVASC SURG, V45, P545; Gerrah Rabin, 2003, Asian Cardiovasc Thorac Ann, V11, P304; Hiralal R, 2010, CLIN INVEST MED, V33, pE375; IDEURA T, 1980, AM J PATHOL, V98, P123; Karkouti K, 2012, BRIT J ANAESTH, V109, pI29, DOI 10.1093/bja/aes422; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082289; Korte W, 2011, THROMB HAEMOSTASIS, V105, P743, DOI 10.1160/TH10-04-0217; Kulka PJ, 1996, CRIT CARE MED, V24, P947, DOI 10.1097/00003246-199606000-00012; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Myles PS, 2008, AM HEART J, V155, P224, DOI 10.1016/j.ahj.2007.10.003; Myles PS, 1999, ANAESTH INTENS CARE, V27, P137, DOI 10.1177/0310057X9902700202; Quintin L, 1996, ANESTH ANALG, V83, P687, DOI 10.1097/00000539-199610000-00005; SAS, SAS STAT R 9 2  US G; Serhan CN, 2004, LIPIDS, V39, P1125, DOI 10.1007/s11745-004-1339-7; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; SOLEZ K, 1981, AM J PATHOL, V103, P163; Walsh M, 2013, ANESTH ANALG, V117, P924, DOI 10.1213/ANE.0b013e3182a1ec84; Walsh M, 2013, ANESTHESIOLOGY, V119, P507, DOI 10.1097/ALN.0b013e3182a10e26; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wu CT, 2004, ANESTH ANALG, V99, P502, DOI 10.1213/01.ANE.0000117146.46373.51; Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	44	71	73	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2254	2264		10.1001/jama.2014.15284	http://dx.doi.org/10.1001/jama.2014.15284			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25399007	Bronze			2022-12-28	WOS:000345684800020
J	Fu, RR; Weiss, BP; Lima, EA; Harrison, RJ; Bai, XN; Desch, SJ; Ebel, DS; Suavet, C; Wang, HP; Glenn, D; Le Sage, D; Kasama, T; Walsworth, RL; Kuan, AT				Fu, Roger R.; Weiss, Benjamin P.; Lima, Eduardo A.; Harrison, Richard J.; Bai, Xue-Ning; Desch, Steven J.; Ebel, Denton S.; Suavet, Clement; Wang, Huapei; Glenn, David; Le Sage, David; Kasama, Takeshi; Walsworth, Ronald L.; Kuan, Aaron T.			Solar nebula magnetic fields recorded in the Semarkona meteorite	SCIENCE			English	Article							PROTOPLANETARY DISKS; ORDINARY CHONDRITES; DUSTY OLIVINES; CHONDRULES; PARTICLES; ACCRETION; ORIGIN; MODEL; STAR	Magnetic fields are proposed to have played a critical role in some of the most enigmatic processes of planetary formation by mediating the rapid accretion of disk material onto the central star and the formation of the first solids. However, there have been no experimental constraints on the intensity of these fields. Here we show that dusty olivine-bearing chondrules from the Semarkona meteorite were magnetized in a nebular field of 54 21 microteslas. This intensity supports chondrule formation by nebular shocks or planetesimal collisions rather than by electric currents, the x-wind, or other mechanisms near the Sun. This implies that background magnetic fields in the terrestrial planet-forming region were likely 5 to 54 microteslas, which is sufficient to account for measured rates of mass and angular momentum transport in protoplanetary disks.	[Fu, Roger R.; Weiss, Benjamin P.; Lima, Eduardo A.; Suavet, Clement; Wang, Huapei] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Harrison, Richard J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Bai, Xue-Ning; Glenn, David; Walsworth, Ronald L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Desch, Steven J.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Ebel, Denton S.] Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; [Le Sage, David; Walsworth, Ronald L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kasama, Takeshi] Tech Univ Denmark, Ctr Electron Nanoscopy, DK-2800 Lyngby, Denmark; [Kuan, Aaron T.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); University of Cambridge; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Arizona State University; Arizona State University-Tempe; American Museum of Natural History (AMNH); Harvard University; Technical University of Denmark; Harvard University	Fu, RR (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	rogerfu@mit.edu	Harrison, Richard J/B-3609-2010; Harrison, Richard/R-8802-2019; Bai, Xue-Ning/AGO-2685-2022; Kasama, Takeshi/K-5383-2012; Bai, Xue-Ning/AAK-7772-2021; Bai, Xuening/H-7346-2017	Harrison, Richard J/0000-0003-3469-762X; Harrison, Richard/0000-0003-3469-762X; Kasama, Takeshi/0000-0003-3312-781X; Bai, Xue-Ning/0000-0001-6906-9549; Bai, Xuening/0000-0001-6906-9549; Bai, Xuening/0000-0003-1172-3039; Le Sage, David/0000-0003-1678-9491; /0000-0003-3635-2676; Lima, Eduardo/0000-0002-5667-0033	NASA Lunar Science Institute; NASA Solar System Exploration and Research Virtual Institute; European Research Council under the European Union; NASA through the Hubble Fellowship; Defense Advanced Research Projects Agency QuASAR program; NSF; U.S. Rosetta Project, Jet Propulsion Laboratory; Leverhulme Trust	NASA Lunar Science Institute; NASA Solar System Exploration and Research Virtual Institute; European Research Council under the European Union(European Research Council (ERC)); NASA through the Hubble Fellowship; Defense Advanced Research Projects Agency QuASAR program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); U.S. Rosetta Project, Jet Propulsion Laboratory; Leverhulme Trust(Leverhulme Trust)	We thank S. A. Balbus, A. J. Brearley, H. C. Connolly, A. M. Hughes, B. C. Johnson, J. L. Kirschvink, M. Mac Low, G. J. MacPherson, M. I. Petaev, D. D. Sasselov, H. E. Schlichting, J. B. Simon, N. Turner, and B. Zanda for discussions that improved the manuscript. We also thank J. Gross, S. Wallace, and Z. I. Balogh for help with SEM and STEM sample analyses and acknowledge S.-C. L. L. Lappe, N. S. Church, S. Russell, M. Uehara, and N. Nakamura for pioneering work on the magnetism of dusty olivines. We thank T. F. Peterson for supporting critical instrumentation and analysis costs. R. R. F., B. P. W., E. A. L., S. J. D., and C. S. thank the NASA Origins Program, while R. R. F. and B. P. W. thank the U.S. Rosetta Project, Jet Propulsion Laboratory for support. R. R. F. thanks the NSF Graduate Research Fellowship Program, and C. S. thanks the NASA Lunar Science Institute and the NASA Solar System Exploration and Research Virtual Institute for support. R. J. H. and T. K. thank the European Research Council under the European Union's Seventh Framework Programme and the Leverhulme Trust for support. X. N. B. acknowledges support from NASA through the Hubble Fellowship. D. G., D. L. S., and R. L. W. thank the Defense Advanced Research Projects Agency QuASAR program and the NSF for support.	ALEXANDER CMO, 1989, GEOCHIM COSMOCHIM AC, V53, P3045, DOI 10.1016/0016-7037(89)90180-4; Bai XN, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/50; Bai XN, 2009, ASTROPHYS J, V701, P737, DOI 10.1088/0004-637X/701/1/737; Bus SJ, 2002, ICARUS, V158, P146, DOI 10.1006/icar.2002.6856; Cody GD, 2008, EARTH PLANET SC LETT, V272, P446, DOI 10.1016/j.epsl.2008.05.008; Crutcher RM, 2012, ANNU REV ASTRON ASTR, V50, P29, DOI 10.1146/annurev-astro-081811-125514; Cuzzi JN, 2008, ASTROPHYS J, V687, P1432, DOI 10.1086/591239; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; Desch SJ, 2001, ASTROPHYS J, V550, P314, DOI 10.1086/319703; Fu RR, 2014, EARTH PLANET SC LETT, V404, P54, DOI 10.1016/j.epsl.2014.07.014; Fu RR, 2012, SCIENCE, V338, P238, DOI 10.1126/science.1225648; Garrick-Bethell I, 2010, EARTH PLANET SC LETT, V294, P1, DOI 10.1016/j.epsl.2010.02.013; Gattacceca J, 2014, METEORIT PLANET SCI, V49, P652, DOI 10.1111/maps.12268; Haisch Jr K. E., 2001, ASTROPHYS J LETT, V553, pL153; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; Lappe SCLL, 2013, GEOCHEM GEOPHY GEOSY, V14, P2143, DOI 10.1002/ggge.20141; Lappe SCLL, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003811; Leroux H, 2003, METEORIT PLANET SCI, V38, P81, DOI 10.1111/j.1945-5100.2003.tb01047.x; LEVY EH, 1989, ICARUS, V81, P74, DOI 10.1016/0019-1035(89)90126-7; Lima E. A., 2013, AGU FALL M SAN FRANC, VGP43B-07; McNally CP, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L2; Miura H, 2008, ICARUS, V197, P269, DOI 10.1016/j.icarus.2008.04.019; Mostefaoui S, 2002, METEORIT PLANET SCI, V37, P421, DOI 10.1111/j.1945-5100.2002.tb00825.x; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Reisener R. J., 1999, LUN PLAN SCI C 30; Stephens IW, 2014, NATURE, V514, P597, DOI 10.1038/nature13850; STOFFLER D, 1991, GEOCHIM COSMOCHIM AC, V55, P3845, DOI 10.1016/0016-7037(91)90078-J; Suavet C, 2011, GEOLOGY, V39, P123, DOI 10.1130/G31655.1; Sugiura N., 1985, P LUN PLAN SCI C 15, pC729; Turner N.J., 2014, PROTOSTARS PLANETS, P411; Uehara M, 2006, EARTH PLANET SC LETT, V250, P292, DOI 10.1016/j.epsl.2006.07.042; Wardle M, 2007, ASTROPHYS SPACE SCI, V311, P35, DOI 10.1007/s10509-007-9575-8; Watson G.S., 1956, MON NOT R ASTRON SOC, V7, P160, DOI DOI 10.1111/J.1365-246X.1956.TB05561.X; Weiss BP, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004940; Winklhofer M, 1997, J GEOPHYS RES-SOL EA, V102, P22695, DOI 10.1029/97JB01730	36	110	111	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1089	1092		10.1126/science.1258022	http://dx.doi.org/10.1126/science.1258022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25394792	Green Submitted			2022-12-28	WOS:000345763400036
J	Stehfest, E				Stehfest, Elke			DIET Food choices for health and planet	NATURE			English	Editorial Material							CLIMATE-CHANGE		PBL Netherlands Environm Assessment Agcy, Dept Climate Air & Energy, NL-3720 AH Bilthoven, Netherlands		Stehfest, E (corresponding author), PBL Netherlands Environm Assessment Agcy, Dept Climate Air & Energy, NL-3720 AH Bilthoven, Netherlands.	elke.stehfest@pbl.nl	Stehfest, Elke/AAZ-4121-2020	Stehfest, Elke/0000-0003-3016-2679				Havlik P, 2014, P NATL ACAD SCI USA, V111, P3709, DOI 10.1073/pnas.1308044111; Nijdam D, 2012, FOOD POLICY, V37, P760, DOI 10.1016/j.foodpol.2012.08.002; Stehfest E, 2013, AGR SYST, V114, P38, DOI 10.1016/j.agsy.2012.07.002; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; von Lampe M, 2014, AGR ECON-BLACKWELL, V45, P3, DOI 10.1111/agec.12086	8	29	31	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					501	502		10.1038/nature13943	http://dx.doi.org/10.1038/nature13943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25383535				2022-12-28	WOS:000346247600041
J	Hodaei, H; Miri, MA; Heinrich, M; Christodoulides, DN; Khajavikhan, M				Hodaei, Hossein; Miri, Mohammad-Ali; Heinrich, Matthias; Christodoulides, Demetrios N.; Khajavikhan, Mercedeh			Parity-time-symmetric microring lasers	SCIENCE			English	Article							SEMICONDUCTOR-LASERS; MICROCAVITIES	The ability to control the modes oscillating within a laser resonator is of fundamental importance. In general, the presence of competing modes can be detrimental to beam quality and spectral purity, thus leading to spatial as well as temporal fluctuations in the emitted radiation. We show that by harnessing notions from parity-time (PT) symmetry, stable single-longitudinal mode operation can be readily achieved in a system of coupled microring lasers. The selective breaking of PT symmetry can be used to systematically enhance the maximum attainable output power in the desired mode. This versatile concept is inherently self-adapting and facilitates mode selectivity over a broad bandwidth without the need for other additional intricate components. Our experimental findings provide the possibility to develop synthetic optical devices and structures with enhanced functionality.	[Hodaei, Hossein; Miri, Mohammad-Ali; Heinrich, Matthias; Christodoulides, Demetrios N.; Khajavikhan, Mercedeh] Univ Cent Florida, CREOL, Coll Opt & Photon, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Khajavikhan, M (corresponding author), Univ Cent Florida, CREOL, Coll Opt & Photon, Orlando, FL 32816 USA.	merce-deh@creol.ucf.edu	Heinrich, Matthias/F-3111-2011	Heinrich, Matthias/0000-0003-3552-0789; Khajavikhan, Mercedeh/0000-0002-7091-1470	Army Research Office [W911NF-14-1-0543]; NSF [ECCS-1128520]; Air Force Office of Scientific Research [FA9550-12-1-0148, FA9550-14-1-0037]; German National Academy of Sciences Leopoldina [LPDS 2012-01]	Army Research Office; NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); German National Academy of Sciences Leopoldina	We gratefully acknowledge the nancial support from Army Research Office (grant W911NF-14-1-0543), NSF (grant ECCS-1128520), and Air Force Office of Scientific Research (grants FA9550-12-1-0148 and FA9550-14-1-0037). M.H. was supported by the German National Academy of Sciences Leopoldina (grants LPDS 2012-01). We thank M. Mills for helpful discussions.	ASADA M, 1984, IEEE J QUANTUM ELECT, V20, P745, DOI 10.1109/JQE.1984.1072464; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Brandstetter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5034; Chang L, 2014, NAT PHOTONICS, V8, P524, DOI [10.1038/nphoton.2014.133, 10.1038/NPHOTON.2014.133]; Chong YD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.093902; El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632; Feng L, 2013, NAT MATER, V12, P108, DOI [10.1038/NMAT3495, 10.1038/nmat3495]; FLEMING MW, 1981, IEEE J QUANTUM ELECT, V17, P44, DOI 10.1109/JQE.1981.1070634; Graefe EM, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.013818; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; IGA K, 1988, IEEE J QUANTUM ELECT, V24, P1845, DOI 10.1109/3.7126; Khajavikhan M, 2012, NATURE, V482, P204, DOI 10.1038/nature10840; Klaiman S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080402; KOGELNIK H, 1972, J APPL PHYS, V43, P2327, DOI 10.1063/1.1661499; Kottos T, 2010, NAT PHYS, V6, P166, DOI 10.1038/nphys1612; Liew SF, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4883637; Longhi S, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.031801; Lumer Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.263901; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; MCCALL SL, 1992, APPL PHYS LETT, V60, P289, DOI 10.1063/1.106688; Miri MA, 2012, OPT LETT, V37, P764, DOI 10.1364/OL.37.000764; Miroshnichenko AE, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012123; NAKAMURA M, 1975, APPL PHYS LETT, V27, P403, DOI 10.1063/1.88492; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; SCHAWLOW AL, 1958, PHYS REV, V112, P1940, DOI 10.1103/PhysRev.112.1940; Schindler J, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.040101; Scott DD, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.050102; Szameit A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.021806; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Wiersig J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.203901	35	1006	1019	44	377	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					975	978		10.1126/science.1258480	http://dx.doi.org/10.1126/science.1258480			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414308				2022-12-28	WOS:000345696000038
J	in 't Veld, PJH; Herzog, F; Ladurner, R; Davidson, IF; Piric, S; Kreidl, E; Bhaskara, V; Aebersold, R; Peters, JM				in 't Veld, Pim J. Huis; Herzog, Franz; Ladurner, Rene; Davidson, Iain F.; Piric, Sabina; Kreidl, Emanuel; Bhaskara, Venugopal; Aebersold, Ruedi; Peters, Jan-Michael			Characterization of a DNA exit gate in the human cohesin ring	SCIENCE			English	Article							ATP HYDROLYSIS; CHROMOSOMES; CHROMATIN; WAPL; REPLICATION; COMPLEX; BINDING; SCC2; ACETYLATION; ASSOCIATION	Chromosome segregation depends on sister chromatid cohesion mediated by cohesin. The cohesin subunits Smc1, Smc3, and Scc1 form tripartite rings that are thought to open at distinct sites to allow entry and exit of DNA. However, direct evidence for the existence of open forms of cohesin is lacking. We found that cohesin's proposed DNA exit gate is formed by interactions between Scc1 and the coiled-coil region of Smc3. Mutation of this interface abolished cohesin's ability to stably associate with chromatin and to mediate cohesion. Electron microscopy revealed that weakening of the Smc3-Scc1 interface resulted in opening of cohesin rings, as did proteolytic cleavage of Scc1. These open forms may resemble intermediate states of cohesin normally generated by the release factor Wapl and the protease separase, respectively.	[in 't Veld, Pim J. Huis; Ladurner, Rene; Davidson, Iain F.; Piric, Sabina; Kreidl, Emanuel; Bhaskara, Venugopal; Peters, Jan-Michael] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Herzog, Franz; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Herzog, Franz] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich	Peters, JM (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.	peters@imp.ac.at	Herzog, Franz/G-4832-2012; Veld, Pim J. Huis in 't/AAJ-9030-2020	Herzog, Franz/0000-0001-8270-1449; Veld, Pim J. Huis in 't/0000-0003-0234-6390; Ladurner, Rene/0000-0001-9261-7304; /0000-0002-8002-9967; Kreidl, Emanuel/0000-0002-4037-5881; Bhaskara, Venugopal/0000-0002-8807-3292	Austrian Science Fund [W1221, SFB-F34]; European Community [227764, 241548]; Boehringer Ingelheim; Austrian Research Promotion Agency (FFG Laura Bass); Vienna Science and Technology Fund [WWTF LS09-13]	Austrian Science Fund(Austrian Science Fund (FWF)); European Community(European Commission); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Research Promotion Agency (FFG Laura Bass); Vienna Science and Technology Fund	We thank O. Hudecz, K. Mechtler, G. Schmauss, K. Uzunova, M. Brandstetter, H. Kotisch, G. Resch, and A. Schleiffer for excellent technical support and I. Berger for an introduction to MultiBac. P.J.H. was supported by the Austrian Science Fund (W1221) and received funding from the European Community (FP7/2007-2013, no. 227764). Research in the laboratory of J.-M.P. is supported by Boehringer Ingelheim, the Austrian Science Fund (SFB-F34 and Wittgenstein award), the Austrian Research Promotion Agency (FFG Laura Bass), the Vienna Science and Technology Fund (WWTF LS09-13), and the European Community (FP7/2007-2013, no. 241548, MitoSys).	Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Arumugam P, 2006, CURR BIOL, V16, P1998, DOI 10.1016/j.cub.2006.09.002; Burmann F, 2013, NAT STRUCT MOL BIOL, V20, P371, DOI 10.1038/nsmb.2488; Buheitel J, 2013, EMBO J, V32, P666, DOI 10.1038/emboj.2013.7; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Eichinger CS, 2013, EMBO J, V32, P656, DOI 10.1038/emboj.2012.346; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; Ouyang ZQ, 2013, P NATL ACAD SCI USA, V110, P11355, DOI 10.1073/pnas.1304594110; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Zhang NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069458	28	123	123	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					968	972		10.1126/science.1256904	http://dx.doi.org/10.1126/science.1256904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414306				2022-12-28	WOS:000345696000036
J	Root, CM; Denny, CA; Hen, R; Axel, R				Root, Cory M.; Denny, Christine A.; Hen, Rene; Axel, Richard			The participation of cortical amygdala in innate, odour-driven behaviour	NATURE			English	Article							OLFACTORY-BULB; PIRIFORM CORTEX; REPRESENTATIONS; MOUSE; DROSOPHILA; GENE; INFORMATION; CIRCUITS; NEURONS; PATHWAY	Innate behaviours are observed in naive animals without prior learning or experience, suggesting that the neural circuits that mediate these behaviours are genetically determined and stereotyped. The neural circuits that convey olfactory information from the sense organ to the cortical and subcortical olfactory centres have been anatomically defined(1-3), but the specific pathways responsible for innate responses to volatile odours have not been identified. Here we devise genetic strategies that demonstrate that a stereotyped neural circuit that transmits information from the olfactory bulb to cortical amygdala is necessary for innate aversive and appetitive behaviours. Moreover, we use the promoter of the activity-dependent gene arcto express the photosensitive ion channel, channelrhodopsin, in neurons of the cortical amygdala activated by odours that elicit innate behaviours. Optical activation of these neurons leads to appropriate behaviours that recapitulate the responses to innate odours. These data indicate that the cortical amygdala plays a critical role in generating innate odour-driven behaviours but do not preclude its participation in learned olfactory behaviours.	[Root, Cory M.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Root, Cory M.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Denny, Christine A.] New York State Psychiat Inst & Hosp, Dept Biol Sci, New York, NY 10032 USA; [Denny, Christine A.; Hen, Rene] New York State Psychiat Inst & Hosp, Dept Neurosci & Psychiat, New York, NY 10032 USA; [Denny, Christine A.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, New York State Psychiat Inst, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu	Denny, Christine Ann A/I-5235-2015	Denny, Christine Ann A/0000-0002-6926-2020; Axel, Richard/0000-0002-3141-4076	Howard Hughes Medical Institute; Mathers Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017908] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mathers Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Abbott, T. Jessell and D. Costantini for comments and reading the manuscript; B. Bader for assistance with experiments; M. Mendelsohn and N. Zabello for help with mice; P. Kisloff for assistance in preparation of the manuscript; and A. Nemes and M. Gutierrez for laboratory support. This work was supported by the Howard Hughes Medical Institute and the Mathers Foundation.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Louise E. M., 1983, PHYSIOL ENTOMOL, V8, P97; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schwabe K, 2004, NEUROSCIENCE, V126, P727, DOI 10.1016/j.neuroscience.2004.04.022; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P274, DOI 10.1016/j.conb.2010.02.013; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tonegawa S, 2008, NEURON, V57, P175, DOI 10.1016/j.neuron.2008.01.005; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vo-Dinh T., 2003, BIOMEDICAL PHOTONICS, P37; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	34	172	175	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					269	U274		10.1038/nature13897	http://dx.doi.org/10.1038/nature13897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25383519	Green Accepted			2022-12-28	WOS:000344631400051
J	Obermeyer, Z; Makar, M; Abujaber, S; Dominici, F; Block, S; Cutler, DM				Obermeyer, Ziad; Makar, Maggie; Abujaber, Samer; Dominici, Francesca; Block, Susan; Cutler, David M.			Association Between the Medicare Hospice Benefit and Health Care Utilization and Costs for Patients With Poor-Prognosis Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; NEAR-DEATH; END; CHEMOTHERAPY; BENEFICIARIES; INTENSITY; CLAIMS; BREAST; PLACE	IMPORTANCE More patients with cancer use hospice currently than ever before, but there are indications that care intensity outside of hospice is increasing, and length of hospice stay decreasing. Uncertainties regarding how hospice affects health care utilization and costs have hampered efforts to promote it. OBJECTIVE To compare utilization and costs of health care for patients with poor-prognosis cancers enrolled in hospice vs similar patients without hospice care. DESIGN, SETTING, AND PARTICIPANTS Matched cohort study of patients in hospice and nonhospice care using a nationally representative 20% sample of Medicare fee-for-service beneficiaries who died in 2011. Patients with poor-prognosis cancers (eg, brain, pancreatic, metastatic malignancies) enrolled in hospice before death were matched to similar patients who died without hospice care. EXPOSURES Period between hospice enrollment and death for hospice beneficiaries, and the equivalent period of nonhospice care before death for matched nonhospice patients. MAIN OUTCOMES AND MEASURES Health care utilization including hospitalizations and procedures, place of death, cost trajectories before and after hospice start, and cumulative costs, all during the last year of life. RESULTS Among 86 851 patients with poor-prognosis cancers, median time from first poor-prognosis diagnosis to death was 13 months (interquartile range [IQR], 3-34), and 51 924 (60%) entered hospice before death. Matching yielded a cohort balanced on age, sex, region, time from poor-prognosis diagnosis to death, and baseline care utilization, with 18 165 patients in the hospice group and 18 165 in the nonhospice group. [GRAPHICS] After matching, 11% of nonhospice and 1% of hospice beneficiaries who had cancer-directed therapy after exposure were excluded. Median hospice duration was 11 days. Nonhospice beneficiaries had significantly greater health care utilization, largely for acute conditions not directly related to cancer and higher overall costs. CONCLUSIONS AND RELEVANCE In this sample of Medicare fee-for-service beneficiaries with poor-prognosis cancer, those receiving hospice care vs not (control), had significantly lower rates of hospitalization, intensive care unit admission, and invasive procedures at the end of life, along with significantly lower total costs during the last year of life.	[Obermeyer, Ziad] Harvard Univ, Sch Med, Dept Emergency Med, Boston, MA USA; [Obermeyer, Ziad] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Obermeyer, Ziad; Makar, Maggie; Abujaber, Samer] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Obermeyer, Ziad; Block, Susan] Brigham & Womens Hosp, Ariadne Labs, Boston, MA 02115 USA; [Obermeyer, Ziad; Block, Susan] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Dominici, Francesca] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Block, Susan] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; [Block, Susan] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Block, Susan] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Cutler, David M.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Cutler, David M.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; National Bureau of Economic Research	Obermeyer, Z (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, Neville House,75 Francis St, Boston, MA 02115 USA.	zobermeyer@partners.org		Cutler, David/0000-0002-4949-8917; /0000-0002-1224-4657	National Institutes of Health [DP5 OD012161]; National Cancer Institute [P01 CA134294]; Agency for Healthcare Research and Quality [K18 HS021991]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K18HS021991] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA134294] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant DP5 OD012161 (Dr Obermeyer), National Cancer Institute grant P01 CA134294 (Dr Dominici), and Agency for Healthcare Research and Quality grant K18 HS021991 (Dr Dominici).	Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Bogasky S, 2014, MED MED RES REV, V4, P1; Casarett DJ, 2011, JAMA-J AM MED ASSOC, V305, P1031, DOI 10.1001/jama.2011.271; Du XLL, 2006, MED CARE, V44, P124, DOI 10.1097/01.mlr.0000196978.34283.a6; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Glare P, 2008, PROGNOSIS ADV CANC; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Huskamp HA, 2001, HEALTH AFFAIR, V20, P204, DOI 10.1377/hlthaff.20.3.204; Iacus SM, 2011, J AM STAT ASSOC, V106, P345, DOI 10.1198/jasa.2011.tm09599; Institute of Medicine, 2014, DYING AM IMPR QUAL H; Institute of Medicine of the National Academies, 2013, GEOGR VAR HLTH CAR S; Kelley AS, 2013, HEALTH AFFAIR, V32, P552, DOI 10.1377/hlthaff.2012.0851; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Meier DE, 2011, MILBANK Q, V89, P343, DOI 10.1111/j.1468-0009.2011.00632.x; National Hospice and Palliative Care Organization, 2012, NHPCO FACTS FIG HOSP; Research Data Assistance Center, CMMI PAYM BUNDL IN; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P915, DOI 10.1001/jama.2012.229; Warren JL, 2002, MED CARE, V40, P55; Wennberg JE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f549; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	25	81	81	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1888	1896		10.1001/jama.2014.14950	http://dx.doi.org/10.1001/jama.2014.14950			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS8ZE	25387186	Green Submitted, Green Accepted			2022-12-28	WOS:000344532600018
J	Starmer, AJ; Spector, ND; Srivastava, R; West, DC; Rosenbluth, G; Allen, AD; Noble, EL; Tse, LL; Dalal, AK; Keohane, CA; Lipsitz, SR; Rothschild, JM; Wien, MF; Yoon, CS; Zigmont, KR; Wilson, KM; O'Toole, JK; Solan, LG; Aylor, M; Bismilla, Z; Coffey, M; Mahant, S; Blankenburg, RL; Destino, LA; Everhart, JL; Patel, SJ; Bale, JF; Spackman, JB; Stevenson, AT; Calaman, S; Cole, FS; Balmer, DF; Hepps, JH; Lopreiato, JO; Yu, CE; Sectish, TC; Landrigan, CP				Starmer, A. J.; Spector, N. D.; Srivastava, R.; West, D. C.; Rosenbluth, G.; Allen, A. D.; Noble, E. L.; Tse, L. L.; Dalal, A. K.; Keohane, C. A.; Lipsitz, S. R.; Rothschild, J. M.; Wien, M. F.; Yoon, C. S.; Zigmont, K. R.; Wilson, K. M.; O'Toole, J. K.; Solan, L. G.; Aylor, M.; Bismilla, Z.; Coffey, M.; Mahant, S.; Blankenburg, R. L.; Destino, L. A.; Everhart, J. L.; Patel, S. J.; Bale, J. F., Jr.; Spackman, J. B.; Stevenson, A. T.; Calaman, S.; Cole, F. S.; Balmer, D. F.; Hepps, J. H.; Lopreiato, J. O.; Yu, C. E.; Sectish, T. C.; Landrigan, C. P.		I-PASS Study Grp	Changes in Medical Errors after Implementation of a Handoff Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVERSE DRUG EVENTS; I-PASS HANDOFF; INTENSIVE-CARE; DUTY HOURS; WORK HOURS; POPULATION; EDUCATION; SAFETY; INTERVENTION; RESIDENTS	BACKGROUND Miscommunications are a leading cause of serious medical errors. Data from multicenter studies assessing programs designed to improve handoff of information about patient care are lacking. METHODS We conducted a prospective intervention study of a resident handoff-improvement program in nine hospitals, measuring rates of medical errors, preventable adverse events, and miscommunications, as well as resident workflow. The intervention included a mnemonic to standardize oral and written handoffs, handoff and communication training, a faculty development and observation program, and a sustainability campaign. Error rates were measured through active surveillance. Handoffs were assessed by means of evaluation of printed handoff documents and audio recordings. Workflow was assessed through time-motion observations. The primary outcome had two components: medical errors and preventable adverse events. RESULTS In 10,740 patient admissions, the medical-error rate decreased by 23% from the preintervention period to the postintervention period (24.5 vs. 18.8 per 100 admissions, P<0.001), and the rate of preventable adverse events decreased by 30% (4.7 vs. 3.3 events per 100 admissions, P<0.001). The rate of nonpreventable adverse events did not change significantly (3.0 and 2.8 events per 100 admissions, P = 0.79). Site-level analyses showed significant error reductions at six of nine sites. Across sites, significant increases were observed in the inclusion of all prespecified key elements in written documents and oral communication during handoff (nine written and five oral elements; P<0.001 for all 14 comparisons). There were no significant changes from the preintervention period to the postintervention period in the duration of oral handoffs (2.4 and 2.5 minutes per patient, respectively; P = 0.55) or in resident workflow, including patient-family contact and computer time. CONCLUSIONS Implementation of the handoff program was associated with reductions in medical errors and in preventable adverse events and with improvements in communication, without a negative effect on workflow.	[Starmer, A. J.; Allen, A. D.; Noble, E. L.; Tse, L. L.; Sectish, T. C.; Landrigan, C. P.] Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA 02115 USA; [Starmer, A. J.; Dalal, A. K.; Lipsitz, S. R.; Rothschild, J. M.; Sectish, T. C.; Landrigan, C. P.] Harvard Univ, Sch Med, Boston, MA USA; [Dalal, A. K.; Keohane, C. A.; Lipsitz, S. R.; Rothschild, J. M.; Sectish, T. C.; Landrigan, C. P.] Brigham & Womens Hosp, Ctr Patient Safety Res, Div Gen Med, Boston, MA 02115 USA; [Landrigan, C. P.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Keohane, C. A.] CRICO Risk Management Fdn, Boston, MA USA; [Starmer, A. J.; Aylor, M.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Dept Pediat, Portland, OR 97201 USA; [Spector, N. D.] Drexel Univ, Coll Med, St Christophers Hosp Children, Dept Pediat,Sect Gen Pediat, Philadelphia, PA 19104 USA; [Calaman, S.] Drexel Univ, Coll Med, St Christophers Hosp Children, Sect Crit Care, Philadelphia, PA 19104 USA; [Srivastava, R.; Spackman, J. B.; Stevenson, A. T.] Univ Utah, Sch Med, Dept Pediat, Primary Childrens Hosp, Salt Lake City, UT USA; [Bale, J. F., Jr.] Univ Utah, Sch Med, Dept Neurol, Primary Childrens Hosp, Salt Lake City, UT USA; [Srivastava, R.] Intermt Healthcare, Inst Hlth Care Delivery Res, Salt Lake City, UT USA; [West, D. C.; Rosenbluth, G.] Univ Calif San Francisco, Benioff Childrens Hosp, Dept Pediat, San Francisco, CA 94143 USA; [Blankenburg, R. L.; Destino, L. A.; Everhart, J. L.; Patel, S. J.] Stanford Univ, Sch Med, Lucile Packard Childrens Hosp Stanford, Dept Pediat,Div Gen Pediat, Palo Alto, CA 94304 USA; [Wilson, K. M.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA; [O'Toole, J. K.; Solan, L. G.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Bismilla, Z.; Coffey, M.; Mahant, S.] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Coffey, M.] Hosp Sick Children, Ctr Qual Improvement & Patient Safety, Toronto, ON M5G 1X8, Canada; [Mahant, S.] Hosp Sick Children, Inst Hlth Policy Management & Evaluat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada; [Patel, S. J.] Kapiolani Med Ctr Women & Children, Dept Pediat, Div Gen Pediat, Honolulu, HI USA; [Patel, S. J.] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Cole, F. S.] St Louis Childrens Hosp, Edward Mallinckrodt Dept Pediat, St Louis, MO USA; [Cole, F. S.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Balmer, D. F.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Balmer, D. F.] Baylor Coll Med, Houston, TX 77030 USA; [Hepps, J. H.; Lopreiato, J. O.; Yu, C. E.] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Dept Pediat, Bethesda, MD 20814 USA; [Lopreiato, J. O.] Uniformed Serv Univ Hlth Sci, Val G Hemming Simulat Ctr, Bethesda, MD 20814 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Oregon Health & Science University; Drexel University; Drexel University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; University of California System; University of California San Francisco; Lucile Packard Children's Hospital (LPCH); Stanford University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Centre for Quality Improvement & Patient Safety; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Hawaii System; St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA	Starmer, AJ (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	amy.starmer@childrens.harvard.edu	Hefner, Jennifer/P-5962-2014; Satterwhite, Shannon/K-5004-2015; West, Daniel/AAW-3111-2020; Balmer, Dorene/AAY-1185-2021; Ramotar, Matt W/K-2193-2019	Hefner, Jennifer/0000-0001-8083-8038; Satterwhite, Shannon/0000-0002-6351-2287; West, Daniel/0000-0002-0909-4213; Landrigan, Christopher/0000-0001-8386-4100; Hobson, Wendy/0000-0002-1918-1417; Balmer, Dorene/0000-0001-6805-4062; Blankenburg, Rebecca/0000-0002-1938-6113	Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019456] Funding Source: NIH RePORTER	Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funded by the Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, and others.	[Anonymous], 2014, SENT EV DAT ROOT CAU; Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Berry JG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001158; Berry JG, 2011, JAMA-J AM MED ASSOC, V305, P682, DOI 10.1001/jama.2011.122; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Calaman S., 2013, I PASS HANDOFF CURRI; Cohen E, 2011, PEDIATRICS, V127, P529, DOI 10.1542/peds.2010-0910; DeRienzo CM, 2012, ACAD MED, V87, P403, DOI 10.1097/ACM.0b013e318248e5c2; Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Feudtner C, 2000, PEDIATRICS, V106, P205; Gordon M, 2011, MED EDUC, V45, P1081, DOI 10.1111/j.1365-2923.2011.04049.x; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Kaushal R, 2002, AM J HEALTH-SYST PH, V59, P2323, DOI 10.1093/ajhp/59.23.2323; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Levine AC, 2010, SLEEP, V33, P1043, DOI 10.1093/sleep/33.8.1043; Lipsitz SR, 2000, BIOMETRICS, V56, P528, DOI 10.1111/j.0006-341X.2000.00528.x; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; O'Toole J. K., 2013, I PASS HANDOFF CURRI; O'Toole JK, 2014, ACAD PEDIATR, V14, P221, DOI 10.1016/j.acap.2014.02.013; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Riesenberg LA, 2009, ACAD MED, V84, P1775, DOI 10.1097/ACM.0b013e3181bf51a6; Rosenbluth G., MEDEDPORTAL, V9, P9397, DOI [10.15766/mep_2374-8265.9397, DOI 10.15766/MEP_2374-8265.9397]; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Sectish TC, 2010, PEDIATRICS, V126, P619, DOI 10.1542/peds.2010-1793; Spector N, 2013, I PASS HAND CURR COR; Starmer A. J., 2013, I PASS HANDOFF CURRI; Starmer AJ, 2014, ACAD MED, V89, P876, DOI 10.1097/ACM.0000000000000264; Starmer AJ, 2013, JAMA-J AM MED ASSOC, V310, P2262, DOI 10.1001/jama.2013.281961; Starmer AJ, 2012, PEDIATRICS, V129, P201, DOI 10.1542/peds.2011-2966; TeamSTEPPS, NAT IMPL; The Joint Commission, 2007, IMPR AM HOSP JOINT C; Wang Y, 2014, NEW ENGL J MED, V370, P341, DOI 10.1056/NEJMsa1300991; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	37	453	459	2	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1803	1812		10.1056/NEJMsa1405556	http://dx.doi.org/10.1056/NEJMsa1405556			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372088	Bronze			2022-12-28	WOS:000344170300009
J	Fazel, S; Geddes, JR; Kushel, M				Fazel, Seena; Geddes, John R.; Kushel, Margot			The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations	LANCET			English	Article							TRAUMATIC BRAIN-INJURY; ADVERSE CHILDHOOD EXPERIENCES; CARE UTILIZATION PATTERNS; NEW-YORK-CITY; MENTAL-HEALTH; RISK-FACTORS; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; SMOKING-CESSATION; SUBSTANCE-USE	In the European Union, more than 400 000 individuals are homeless on any one night and more than 600 000 are homeless in the USA. The causes of homelessness are an interaction between individual and structural factors. Individual factors include poverty, family problems, and mental health and substance misuse problems. The availability of low-cost housing is thought to be the most important structural determinant for homelessness. Homeless people have higher rates of premature mortality than the rest of the population, especially from suicide and unintentional injuries, and an increased prevalence of a range of infectious diseases, mental disorders, and substance misuse. High rates of non-communicable diseases have also been described with evidence of accelerated ageing. Although engagement with health services and adherence to treatments is often compromised, homeless people typically attend the emergency department more often than non-homeless people. We discuss several recommendations to improve the surveillance of morbidity and mortality in homeless people. Programmes focused on high-risk groups, such as individuals leaving prisons, psychiatric hospitals, and the child welfare system, and the introduction of national and state-wide plans that target homeless people are likely to improve outcomes.	[Fazel, Seena; Geddes, John R.] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Kushel, Margot] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA	University of Oxford; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Fazel, S (corresponding author), Univ Oxford, Dept Psychiat, Warneford Hosp, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Lorente, Rosa/AAL-5850-2021; Fazel, Seena/B-5307-2008; Geddes, John/B-8240-2011	Fazel, Seena/0000-0002-5383-5365; Geddes, John/0000-0002-5281-5960; Kushel, Margot/0000-0002-1361-6889	Wellcome Trust; National Institute for Health Research [NF-SI-0611-10150] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	SF is supported by a Wellcome Trust Senior Research Fellowship in clinical science. JRG is an NIHR Senior Investigator. We are grateful to Achim Wolf for assistance with the literature searches.	Adams J, 2007, J HEALTH CARE POOR U, V18, P173, DOI 10.1353/hpu.2007.0000; Apollonio DE, 2005, TOB CONTROL, V14, P409, DOI 10.1136/tc.2005.011890; Arangua L, 2007, TOB CONTROL, V16, P143, DOI 10.1136/tc.2006.018697; Argintaru N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-577; Arnaud A, 2010, EUR J PUBLIC HEALTH, V20, P601, DOI 10.1093/eurpub/ckp197; Arnsten JH, 2004, ADDICT BEHAV, V29, P1155, DOI 10.1016/j.addbeh.2004.03.010; Badiaga S, 2008, EMERG INFECT DIS, V14, P1353, DOI 10.3201/eid1409.080204; Baggett TP, 2013, ADDICTION, V108, P2009, DOI 10.1111/add.12292; Baggett TP, 2013, NEW ENGL J MED, V369, P201, DOI 10.1056/NEJMp1301935; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Baggett TP, 2011, J GEN INTERN MED, V26, P627, DOI 10.1007/s11606-011-1638-4; Baggett TP, 2010, AM J PREV MED, V39, P164, DOI 10.1016/j.amepre.2010.03.024; Baggett TP, 2010, AM J PUBLIC HEALTH, V100, P1326, DOI 10.2105/AJPH.2009.180109; Beijer U, 2009, THESIS, P1; Beijer U, 2012, LANCET INFECT DIS, V12, P859, DOI 10.1016/S1473-3099(12)70177-9; Beijer U, 2011, SCAND J PUBLIC HEALT, V39, P121, DOI 10.1177/1403494810393554; Beijer U, 2010, EUR J PUBLIC HEALTH, V20, P511, DOI 10.1093/eurpub/ckq033; Bharel M, 2013, AM J PUBLIC HEALTH, V103, pS311, DOI 10.2105/AJPH.2013.301421; Brown RT, 2013, JAMA INTERN MED, V173, P1831, DOI 10.1001/jamainternmed.2013.6627; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; Busch-Geertsema V., 2010, EUROPEAN CONSENSUS C; Canavan R, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-222; Capp R, 2013, AM J EMERG MED, V31, P1333, DOI 10.1016/j.ajem.2013.05.050; Caton CLM, 2013, AIDS BEHAV, V17, P856, DOI 10.1007/s10461-012-0198-x; Caton CLM, 2005, AM J PUBLIC HEALTH, V95, P1753, DOI 10.2105/AJPH.2005.063321; Centers for Disease Control and Prevention, 2013, TRAUMATIC BRAIN INJU; Chambers C, 2014, COMMUNITY MENT HLT J, V50, P553, DOI 10.1007/s10597-013-9605-7; Cheung AM, 2004, CAN MED ASSOC J, V170, P1243, DOI 10.1503/cmaj.1031167; Coe AB, 2015, RES SOC ADMIN PHARM, V11, pE110, DOI 10.1016/j.sapharm.2012.11.004; Corliss HL, 2011, AM J PUBLIC HEALTH, V101, P1683, DOI 10.2105/AJPH.2011.300155; Crane M, 2005, J GERONTOL B-PSYCHOL, V60, pS152, DOI 10.1093/geronb/60.3.S152; Culhane DP, 2010, PENN SCHOOL OF SOCIA; Dworsky A, 2013, AM J PUBLIC HEALTH, V103, pS318, DOI 10.2105/AJPH.2013.301455; Dworsky A, 2009, CHILD WELFARE, V88, P23; Edens EL, 2011, WOMEN HEALTH ISS, V21, P383, DOI 10.1016/j.whi.2011.03.004; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; European Comission, 2013, COMMISSION STAFF WOR; Fazel S., 2012, British Journal of Psychiatry, V200, P364, DOI 10.1192/bjp.bp.111.096370; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Federation of National Organisations Working with the Homeless, 2012, ON THE WAY HOME FEAN; Fichter MM, 2005, EUR ARCH PSY CLIN N, V255, P111, DOI 10.1007/s00406-004-0543-9; Frances Pierre, 2013, Rev Prat, V63, P29; Frencher SK, 2010, J TRAUMA, V69, pS191, DOI 10.1097/TA.0b013e3181f1d31e; Garibaldi B, 2005, J GEN INTERN MED, V20, P726, DOI 10.1111/j.1525-1497.2005.0142.x; Garner L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-951; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gilchrist G, 2005, EUR J PUBLIC HEALTH, V15, P587, DOI 10.1093/eurpub/cki036; Greenberg GA, 2008, PSYCHIAT SERV, V59, P170, DOI 10.1176/ps.2008.59.2.170; Greenberg GA, 2010, J HEALTH CARE POOR U, V21, P1234, DOI 10.1353/hpu.2010.0926; Guyavarch E, 2010, CHANGING FACES HOMEL; Henry M, 2013, THE 2013 ANNUAL HOME; Homelessness Taskforce Department of Families Housing Community Services and Indigenous Affairs Commonwealth of Australia, 2008, THE ROAD HOME A NATI; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2014, LANCET, V384, P1541, DOI 10.1016/S0140-6736(14)61133-8; Hwang SW, 2013, AM J PUBLIC HEALTH, V103, pS294, DOI 10.2105/AJPH.2013.301369; Hwang SW, 2011, MED CARE, V49, P350, DOI 10.1097/MLR.0b013e318206c50d; Hwang SW, 2010, AM J PUBLIC HEALTH, V100, P1454, DOI 10.2105/AJPH.2009.182022; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Jones CA, 2009, CURR CARDIOL REV, V5, P69, DOI 10.2174/157340309787048086; Kaba M, 2010, EMERG INFECT DIS, V16, P1761, DOI 10.3201/eid1611.091890; Kerker BD, 2011, AM J PUBLIC HEALTH, V101, P546, DOI 10.2105/AJPH.2010.193102; Kidder DP, 2007, AM J PUBLIC HEALTH, V97, P2238, DOI 10.2105/AJPH.2006.090209; Kim DH, 2008, FAM COMMUNITY HEALTH, V31, P269, DOI 10.1097/01.FCH.0000336090.37280.2e; Kramer CB, 2008, J BURN CARE RES, V29, P461, DOI 10.1097/BCR.0b013e31817112b0; Ku BS, 2010, PUBLIC HEALTH REP, V125, P398, DOI 10.1177/003335491012500308; Kubisova D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-51; Kuhn R, 1998, AM J COMMUN PSYCHOL, V26, P207, DOI 10.1023/A:1022176402357; Kushel MB, 2007, ARCH PEDIAT ADOL MED, V161, P986, DOI 10.1001/archpedi.161.10.986; Kushel MB, 2003, ARCH INTERN MED, V163, P2492, DOI 10.1001/archinte.163.20.2492; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Laporte A, 2010, LA LETTRE DE LOBSERV, V5, P1; Larney S, 2009, AUST NZ J PUBL HEAL, V33, P347, DOI 10.1111/j.1753-6405.2009.00406.x; Lebrun-Harris LA, 2013, HEALTH SERV RES, V48, P992, DOI 10.1111/1475-6773.12009; Lee CH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-720; Lee Edgar., 2001, HELPING AMERICAS HOM; Lee TC, 2005, CIRCULATION, V111, P2629, DOI 10.1161/CIRCULATIONAHA.104.510826; Lindamer LA, 2012, ADM POLICY MENT HLTH, V39, P200, DOI 10.1007/s10488-011-0350-3; Lyles CR, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120301; Mackelprang JL, 2014, INT J INJ CONTROL SA, V21, P289, DOI 10.1080/17457300.2013.825631; McDonald L, 2007, J GERONTOL SOC WORK, V49, P19, DOI 10.1300/J083v49n01_02; Meinbresse M, 2014, VIOLENCE VICTIMS, V29, P122, DOI 10.1891/0886-6708.VV-D-12-00069; Milloy MJ, 2012, AIDS PATIENT CARE ST, V26, P60, DOI 10.1089/apc.2011.0169; Minnery J, 2007, J SOC ISSUES, V63, P641, DOI 10.1111/j.1540-4560.2007.00528.x; Moniruzzaman, 2012, MENTAL HLTH SUBSTANC, V5, P85, DOI [10.1080/17523281.2011.618143, DOI 10.1080/17523281.2011.618143]; Montgomery AE, 2013, AM J PUBLIC HEALTH, V103, pS262, DOI 10.2105/AJPH.2013.301474; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; Newburn T, 2005, LIVING IN FEAR VIOLE; NICE, 2012, TUBERCULOSIS HARD TO; Nielsen SF, 2011, LANCET, V377, P2205, DOI 10.1016/S0140-6736(11)60747-2; Nordentoft M, 2003, BRIT MED J, V327, P81, DOI 10.1136/bmj.327.7406.81; Nusselder WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073979; O'Carroll A, 2008, EUR J PUBLIC HEALTH, V18, P448, DOI 10.1093/eurpub/ckn038; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Ohsaka Takako, 2003, Nihon Koshu Eisei Zasshi, V50, P686; Okuyemi KS, 2006, NICOTINE TOB RES, V8, P689, DOI 10.1080/14622200600789841; Okuyemi KS, 2006, NICOTINE TOB RES, V8, P287, DOI 10.1080/14622200500494971; Okuyemi KS, 2013, NICOTINE TOB RES, V15, P22, DOI 10.1093/ntr/nts030; Oliveira LD, 2012, CAD SAUDE PUBLICA, V28, P1517, DOI 10.1590/S0102-311X2012000800010; Pascual JC, 2008, GEN HOSP PSYCHIAT, V30, P14, DOI 10.1016/j.genhosppsych.2007.08.006; Pleace N, 2000, HOUSING STUD, V15, P581, DOI 10.1080/02673030050081113; Porter J, 2011, HEALTH PROMOT PRACT, V12, p144S, DOI 10.1177/1524839911414412; Raoult D, 2001, Lancet Infect Dis, V1, P77, DOI 10.1016/S1473-3099(01)00062-7; Riley AJ, 2003, BRIT J GEN PRACT, V53, P473; Romaszko J, 2013, CENT EUR J MED, V8, P283, DOI 10.2478/s11536-012-0114-9; Roos LE, 2013, AM J PUBLIC HEALTH, V103, pS275, DOI 10.2105/AJPH.2013.301323; Rosario M, 2012, CHILD YOUTH SERV REV, V34, P186, DOI 10.1016/j.childyouth.2011.09.016; Roy E, 2004, JAMA-J AM MED ASSOC, V292, P569, DOI 10.1001/jama.292.5.569; Schanzer B, 2007, AM J PUBLIC HEALTH, V97, P464, DOI 10.2105/AJPH.2005.076190; Scott J, 2013, QJM-INT J MED, V106, P547, DOI 10.1093/qjmed/hct063; Shelley D, 2010, AM J HEALTH BEHAV, V34, P544; Shinn M, 2007, J HEALTH PSYCHOL, V12, P696, DOI 10.1177/1359105307080581; Shinn M, 2007, J SOC ISSUES, V63, P657, DOI 10.1111/j.1540-4560.2007.00529.x; Snyder LD, 2004, CHEST, V125, P1719, DOI 10.1378/chest.125.5.1719; Song J, 2008, J GEN INTERN MED, V23, P2031, DOI 10.1007/s11606-008-0771-1; Sprake EF, 2014, J HUM NUTR DIET, V27, P242, DOI 10.1111/jhn.12130; Strehlau V, 2012, J PSYCHIATR PRACT, V18, P349, DOI 10.1097/01.pra.0000419819.60505.dc; Sun S, 2012, SCAND J PUBLIC HEALT, V40, P115, DOI 10.1177/1403494811435493; Thompson RG, 2013, AM J PUBLIC HEALTH, V103, pS282, DOI 10.2105/AJPH.2013.301302; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Torchalla I, 2012, CHILD MALTREATMENT, V17, P132, DOI 10.1177/1077559512439350; Torchalla I, 2011, DRUG ALCOHOL DEPEN, V118, P173, DOI 10.1016/j.drugalcdep.2011.03.016; Torchalla I, 2011, NICOTINE TOB RES, V13, P934, DOI 10.1093/ntr/ntr101; Tsai J, 2013, AM J PUBLIC HEALTH, V103, pS225, DOI 10.2105/AJPH.2013.301307; Tsai J, 2013, AM J EMERG MED, V31, P855, DOI 10.1016/j.ajem.2013.02.046; Tyler KA, 2010, VIOLENCE VICTIMS, V25, P101, DOI 10.1891/0886-6708.25.1.101; United Kingdom Department for Communities and Local Government, 2013, STATISTICAL DATA SET; United Kingdom Department for Communities and Local Government, 2013, ROUGH SLEEPING STATI; United States Interagency Council on Homelessness, 2010, OPENING DOORS FEDERA; van den Bree MBM, 2009, J ADOLESCENT HEALTH, V45, P571, DOI 10.1016/j.jadohealth.2009.03.027; Vargas CM, 1997, PREV MED, V26, P678, DOI 10.1006/pmed.1997.0190; Verlinde E, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-242	132	753	758	10	204	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1529	1540		10.1016/S0140-6736(14)61132-6	http://dx.doi.org/10.1016/S0140-6736(14)61132-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9MO	25390578	Green Accepted			2022-12-28	WOS:000343899600027
J	Holmes, D				Holmes, David			John Geddes: design for life Profile	LANCET			English	Biographical-Item																		GEDDES J, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1495	1495		10.1016/S0140-6736(14)61911-5	http://dx.doi.org/10.1016/S0140-6736(14)61911-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9MO	25390566				2022-12-28	WOS:000343899600012
J	Hudson, KL; Collins, FS				Hudson, Kathy L.; Collins, Francis S.			Sharing and Reporting the Results of Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hudson, Kathy L.; Collins, Francis S.] NIH, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA	Hudson, KL (corresponding author), NIH, 1 Ctr Dr,Bldg 1,Room 109, Bethesda, MD 20814 USA.	kathy.hudson@nih.gov						European Federation of Psychologists' Associations, 2013, EUROPSY THE EUROPEAN; European Medicines Agency, 2013, DRAFT POLICY ON PUBL; Executive Office of the President; Office of Science and Technology Policy, 2013, INCREASING ACCESS RE; National Institute of Mental Health, DATA SHARING EXPECTA; National Institutes of Health, DRAFT NIH POLICY ON; Saito H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101826	6	78	78	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					355	356		10.1001/jama.2014.10716	http://dx.doi.org/10.1001/jama.2014.10716			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25408371	Green Published, Bronze			2022-12-28	WOS:000349072600012
J	Banks, AS; McAllister, FE; Camporez, JPG; Zushin, PJH; Jurczak, MJ; Laznik-Bogoslavski, D; Shulman, GI; Gygi, SP; Spiegelman, BM				Banks, Alexander S.; McAllister, Fiona E.; Camporez, Joao Paulo G.; Zushin, Peter-James H.; Jurczak, Michael J.; Laznik-Bogoslavski, Dina; Shulman, Gerald I.; Gygi, Steven P.; Spiegelman, Bruce M.			An ERK/Cdk5 axis controls the diabetogenic actions of PPAR gamma	NATURE			English	Article							CYCLIN-DEPENDENT KINASE-5; ACTIVATED PROTEIN-KINASE; INSULIN SENSITIVITY; MASS-SPECTROMETRY; MEK INHIBITION; PHOSPHORYLATION; MODULATION; GLUCOSE; OBESE; CDK5	Obesity-linked insulin resistance is a major precursor to the development of type 2 diabetes. Previous work has shown that phosphorylation of PPAR gamma (peroxisome proliferator-activated receptor gamma) at serine 273 by cydin-dependent kinase 5 (Cdk5) stimulates diabetogenic gene expression in adipose tissues(1). Inhibition of this modification is a key therapeutic mechanism for anti-diabetic drugs that bind PPAR gamma, such as the thiazolidinediones and PPAR gamma partial agonists or non-agonists(2). For a better understanding of the importance of this obesity-linked PPAR gamma phosphorylation, we created mice that ablated Cdk5 specifically in adipose tissues. These mice have both a paradoxical increase in PPAR gamma phosphorylation at serine 273 and worsened insulin resistance. Unbiased proteomic studies show that extracellular signal-regulated kinase (ERK) kinases are activated in these knockout animals. Here we show that ERK directly phosphorylates serine 273 of PPAR gamma in a robust manner and that Cdk5 suppresses ERKs through direct action on a novel site in MAP kinase/ ERK kinase (MEK). Importantly, pharmacological inhibition of MEK and ERK markedly improves insulin resistance in both obese wildtype and ob/ob mice, and also completely reverses the deleterious effects of the Cdk5 ablation. These data show that an ERK/Cdk5 axis controls PPAR gamma function and suggest that MEK/ERK inhibitors may hold promise for the treatment of type 2 diabetes.	[Banks, Alexander S.; Zushin, Peter-James H.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Banks, Alexander S.; Zushin, Peter-James H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [McAllister, Fiona E.; Gygi, Steven P.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Camporez, Joao Paulo G.; Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Yale Mouse Metab Phenotyping Ctr, New Haven, CT 06510 USA; [Camporez, Joao Paulo G.; Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Camporez, Joao Paulo G.; Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Laznik-Bogoslavski, Dina; Spiegelman, Bruce M.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Yale University; Yale University; Yale University; Harvard University; Dana-Farber Cancer Institute	Banks, AS (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 75 Francis St, Boston, MA 02115 USA.	abanks@research.bwh.harvard.edu; bruce_spiegelman@dfci.harvard.edu	Banks, Alexander/B-4832-2012; Camporez, Joao Paulo G/B-9122-2015; Shulman, Gerald I./P-7176-2019	Banks, Alexander/0000-0003-1787-6925; Shulman, Gerald I./0000-0003-1529-5668; Jurczak, Michael/0000-0002-6335-6915; Camporez, Joao Paulo/0000-0003-3486-4301	National Institutes of Health (NIH) [DK31405, DK93638]; Harvard University Milton Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031405, K01DK093638, R37DK031405, P30DK034854] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Milton Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Rosen for providing us with the adiponectin Cre mice before their initial publication; members of the Spiegelman laboratory (Dana-Farber Cancer Institute) and D. Cohen (Brigham and Women's Hospital) for discussions; and C. Palmer and K. LeClair for reading the manuscript. B.M.S. acknowledges National Institutes of Health (NIH) grant DK31405. A.B. acknowledges NIH grant DK93638, the Harvard University Milton Fund, and the Harvard Digestive Disease Center, Core D.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Banks AS, 2011, CELL METAB, V14, P587, DOI 10.1016/j.cmet.2011.09.012; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hawasli AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005808; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jager J, 2011, DIABETOLOGIA, V54, P180, DOI 10.1007/s00125-010-1944-0; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Kettenbach AN, 2011, ANAL CHEM, V83, P7635, DOI 10.1021/ac201894j; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Lau KS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001338; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; McAllister FE, 2013, ANAL CHEM, V85, P4666, DOI 10.1021/ac303478g; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sun KH, 2008, J NEUROCHEM, V107, P265, DOI 10.1111/j.1471-4159.2008.05616.x; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181	44	199	202	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					391	U581		10.1038/nature13887	http://dx.doi.org/10.1038/nature13887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25409143	Green Submitted, Green Accepted			2022-12-28	WOS:000347810300051
J	Sedgwick, P				Sedgwick, Philip			One way analysis of variance: post hoc testing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				McCowan LME, 2009, BMJ-BRIT MED J, V338, pb108; Sedgwick P., 2010, BMJ, V340, pc2673, DOI [10.1136/bmj.c2673, DOI 10.1136/BMJ.C2673]; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6284; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5310; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2427	6	2	2	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 21	2014	349								g7067	10.1136/bmj.g7067	http://dx.doi.org/10.1136/bmj.g7067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2KB	25416414				2022-12-28	WOS:000345446000005
J	Palmer, T				Palmer, Tim			Build high-resolution global climate models	NATURE			English	Editorial Material									Univ Oxford, Oxford Martin Programme Modelling & Predicting Cl, Oxford OX1 2JD, England	University of Oxford	Palmer, T (corresponding author), Univ Oxford, Oxford Martin Programme Modelling & Predicting Cl, Oxford OX1 2JD, England.	t.n.palmer@atm.ox.ac.uk		Palmer, Tim/0000-0002-7121-2196				IPCC, 2013, CLIMATE CHANGE 2022; Jakob C, 2010, B AM METEOROL SOC, V91, P869, DOI 10.1175/2009BAMS2898.1; Palmer TN, 2012, Q J ROY METEOR SOC, V138, P841, DOI 10.1002/qj.1923; Palmer T, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0118; Palmer T, 2011, PHYS WORLD, V24, P14; Rauser F., B AM METEIR IN PRESS; Rodwell MJ, 2007, Q J ROY METEOR SOC, V133, P129, DOI 10.1002/qj.23; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Shukla J, 2010, B AM METEOROL SOC, V91, P1407, DOI 10.1175/2010BAMS2900.1; Stevens B, 2013, SCIENCE, V340, P1053, DOI 10.1126/science.1237554	10	63	65	2	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					338	339		10.1038/515338a	http://dx.doi.org/10.1038/515338a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7HE	25409812	Bronze			2022-12-28	WOS:000345770600020
J	Neal, RD; Hamilton, W; Rogers, TK				Neal, Richard D.; Hamilton, William; Rogers, Trevor K.			Lung cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; DIAGNOSTIC INTERVALS; CLINICAL-FEATURES; RESEARCH DATABASE; GENERAL-PRACTICE; COMMON		[Neal, Richard D.] Bangor Univ, North Wales Ctr Primary Care Res, Wrexham LL13 7YP, Wales; [Hamilton, William] Univ Exeter, Dept Primary Care Diagnost, Sch Med, Exeter, Devon, England; [Rogers, Trevor K.] Doncaster & Bassetlaw NHS Fdn Trust, Doncaster Royal Infirm, Doncaster, England	Bangor University; University of Exeter	Neal, RD (corresponding author), Bangor Univ, North Wales Ctr Primary Care Res, Wrexham LL13 7YP, Wales.	r.neal@bangor.ac.uk		Hamilton, William/0000-0003-1611-1373	Cancer Research UK [12199] Funding Source: Medline; Department of Health Funding Source: Medline	Cancer Research UK(Cancer Research UK); Department of Health		Cancer Research UK, 2014, LUNG CANC INC STAT; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hamilton W, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660751; Hippisley-Cox J, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606627; Iyen-Omofoman B, 2013, THORAX, V68, P451, DOI 10.1136/thoraxjnl-2012-202348; Kiri VA, 2010, PRIM CARE RESP J, V19, P57, DOI 10.4104/pcrj.2009.00048; Lyratzopoulos G, 2013, BRIT J CANCER, V108, P686, DOI 10.1038/bjc.2013.1; Mitchell ED, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660760; National Institute for Health and Care Excellence, 2005, REF SUSP CANC; National Institute for Health and Care Excellence, 2011, DIAGN TREATM LUNG CA; Neal RD, 2014, BRIT J CANCER, V110, P584, DOI 10.1038/bjc.2013.791; Neal RD, PRIMARY HLT IN PRESS; Shim J, 2014, FAM PRACT, V31, P137, DOI 10.1093/fampra/cmt076; Stapley S, 2006, BRIT J GEN PRACT, V56, P570; Torring ML, 2013, EUR J CANCER, V49, P2187, DOI 10.1016/j.ejca.2013.01.025; Treasure T, 2012, THORAX, V67, P759, DOI 10.1136/thoraxjnl-2012-202006	17	21	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2014	349								g6560	10.1136/bmj.g6560	http://dx.doi.org/10.1136/bmj.g6560			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CE	25376443				2022-12-28	WOS:000344603800002
J	Seifter, JL				Seifter, Julian L.			Integration of Acid-Base and Electrolyte Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ANION GAP; METABOLIC-ACIDOSIS; ALKALOSIS; DISTURBANCES; CHLORIDE; STEWART; SODIUM		[Seifter, Julian L.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02482 USA; [Seifter, Julian L.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Seifter, JL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Renal, 75 Francis St, Boston, MA 02482 USA.	jseifter@partners.org						Adrogue HJ, 2009, KIDNEY INT, V76, P1239, DOI 10.1038/ki.2009.359; [Anonymous], 1968, N ENGL J MED, V278, P1004; BATLLE DC, 1988, NEW ENGL J MED, V318, P594, DOI 10.1056/NEJM198803103181002; Berend K, 2014, NEW ENGL J MED, V371, P1434, DOI 10.1056/NEJMra1003327; CARLISLE EJF, 1991, J AM SOC NEPHROL, V1, P1019; Chadha V, 2009, SEMIN NEPHROL, V29, P399, DOI 10.1016/j.semnephrol.2009.03.013; Constable PD, 1997, J APPL PHYSIOL, V83, P297, DOI 10.1152/jappl.1997.83.1.297; Corey HE, 2003, KIDNEY INT, V64, P777, DOI 10.1046/j.1523-1755.2003.00177.x; EMMETT M, 1977, MEDICINE, V56, P38, DOI 10.1097/00005792-197756010-00002; FENCL V, 1989, ANNU REV MED, V40, P17; FORDTRAN JS, 1971, NEW ENGL J MED, V284, P329, DOI 10.1056/NEJM197102112840612; GAMBLE JL, 1960, B JOHNS HOPKINS HOSP, V107, P247; Gennari FJ, 2008, CLIN J AM SOC NEPHRO, V3, P1861, DOI 10.2215/CJN.02450508; Gennari FJ, 2011, AM J KIDNEY DIS, V58, P626, DOI 10.1053/j.ajkd.2011.06.004; GOODKIN DA, 1984, CLIN ENDOCRINOL META, V13, P333, DOI 10.1016/S0300-595X(84)80025-0; KAHN AM, 1985, AM J PHYSIOL, V248, pF212, DOI 10.1152/ajprenal.1985.248.2.F212; Koeppen BM, 2009, ADV PHYSIOL EDUC, V33, P275, DOI 10.1152/advan.00054.2009; Kurtz I, 2008, AM J PHYSIOL-RENAL, V294, pF1009, DOI 10.1152/ajprenal.00475.2007; Luke RG, 2012, J AM SOC NEPHROL, V23, P204, DOI 10.1681/ASN.2011070720; MADIAS NE, 1984, J LAB CLIN MED, V104, P15; MCAULIFFE JJ, 1986, AM J MED, V81, P86, DOI 10.1016/0002-9343(86)90187-7; Medarov BI, 2009, MAYO CLIN PROC, V84, P261, DOI 10.1016/S0025-6196(11)61144-0; OH MS, 1977, NEW ENGL J MED, V297, P814, DOI 10.1056/NEJM197710132971507; Omron Edward M, 2010, J Intensive Care Med, V25, P271, DOI 10.1177/0885066610371633; Peters J P, 1939, QUANTITATIVE CLIN CH, P868; RELMAN AS, 1952, YALE J BIOL MED, V24, P540; SELDIN DW, 1972, KIDNEY INT, V1, P306, DOI 10.1038/ki.1972.43; Selk N, 2011, SEMIN DIALYSIS, V24, P85, DOI 10.1111/j.1525-139X.2011.00848.x; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Wang XY, 2001, J CLIN INVEST, V108, P215, DOI 10.1172/JCI200110366; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004	31	53	56	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1821	1831		10.1056/NEJMra1215672	http://dx.doi.org/10.1056/NEJMra1215672			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372090				2022-12-28	WOS:000344170300011
J	Shen, H				Shen, Helen			INTERACTIVE NOTEBOOKS: SHARING THE CODE	NATURE			English	Editorial Material																			0	129	130	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					151	152		10.1038/515151a	http://dx.doi.org/10.1038/515151a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS3OE	25373681	Bronze			2022-12-28	WOS:000344187500048
J	Watson, JEM; Dudley, N; Segan, DB; Hockings, M				Watson, James E. M.; Dudley, Nigel; Segan, Daniel B.; Hockings, Marc			The performance and potential of protected areas	NATURE			English	Review							ECOSYSTEM SERVICES; DEGAZETTEMENT PADDD; CONSERVATION; BIODIVERSITY; POVERTY; AFRICA; STRATEGIES; RESERVES; NETWORK; SUCCESS	Originally conceived to conserve iconic landscapes and wildlife, protected areas are now expected to achieve an increasingly diverse set of conservation, social and economic objectives. The amount of land and sea designated as formally protected has markedly increased over the past century, but there is still a major shortfall in political commitments to enhance the coverage and effectiveness of protected areas. Financial support for protected areas is dwarfed by the benefits that they provide, but these returns depend on effective management. A step change involving increased recognition, funding, planning and enforcement is urgently needed if protected areas are going to fulfil their potential.	[Watson, James E. M.; Dudley, Nigel; Hockings, Marc] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld 4072, Australia; [Watson, James E. M.; Segan, Daniel B.] Global Conservat Program, Wildlife Conservat Soc, Bronx, NY 10460 USA; [Watson, James E. M.; Segan, Daniel B.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Dudley, Nigel] Equilibrium Res, Bristol BS1 6UQ, Avon, England; [Hockings, Marc] UNEP World Conservat Monitoring Ctr, Cambridge CD3 0DL, England	University of Queensland; Wildlife Conservation Society; University of Queensland	Watson, JEM (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld 4072, Australia.	jwatson@wcs.org	Watson, James Edward Maxwell/D-8779-2013; Hockings, Marc/A-1283-2007	Watson, James Edward Maxwell/0000-0003-4942-1984; Hockings, Marc/0000-0003-4419-8963				Agrawal A., 2009, CONSERV SOC, V7, P1, DOI 10.4103/0972-4923.54790; Ardron J, 2008, MAR POLICY, V32, P832, DOI 10.1016/j.marpol.2008.03.018; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Blom A, 2004, BIOL CONSERV, V118, P479, DOI 10.1016/j.biocon.2003.09.023; Borrini-Feyerabend G., 2013, GOVERNANCE PROTECTED; Bovarnick A, 2010, FINANCIAL SUSTAINABI; Brockington D, 2006, CONSERV BIOL, V20, P250, DOI 10.1111/j.1523-1739.2006.00335.x; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Bucaram SJ, 2013, OCEAN COAST MANAGE, V78, P88, DOI 10.1016/j.ocecoaman.2013.03.001; Burke L, 2012, REEFS RISK REVISITED; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Canadian Parks and Wilderness Society, 2012, STAT CAN PARKS 2012; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Clark NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065298; Comay L. B., 2013, NATL PARK SERVICE RE; Convention on Biodiversity, 2003, PROT AR SYNTH INF TH; Convention on Biological Diversity, 2011, COP 10 DEC X 2 STRAT; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Devillers R, 2015, AQUAT CONSERV, V25, P480, DOI 10.1002/aqc.2445; Dudley N., 2003, RUNNING PURE IMPORTA; Dudley N., 1999, PARTNERSHIPS PROTECT, P3; Duran AP, 2013, BIOL CONSERV, V160, P272, DOI 10.1016/j.biocon.2013.02.003; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Edwards DP, 2014, CONSERV LETT, V7, P302, DOI 10.1111/conl.12076; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Emslie R., 1999, AFRICAN RHINO STATUS; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Ferraro PJ, 2011, ENVIRON RESOUR ECON, V48, P269, DOI 10.1007/s10640-010-9408-z; Frey BS, 2011, INT J CULT POLICY, V17, P555, DOI 10.1080/10286632.2010.541906; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Great Barrier Reef Marine Park Authority, 2014, GREAT BARR REEF REG; Green JMH, 2012, BIOL CONSERV, V150, P5, DOI 10.1016/j.biocon.2012.02.023; Gross-Camp ND, 2012, ORYX, V46, P24, DOI 10.1017/S0030605311001372; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; International Union for Conservation of Nature, 1980, WORLD CONS STRAT LIV; International Union for the Conservation of Nature and Natural Resources, 2008, GUIDELINES APPL PROT; Irland L. C., 2008, Journal of Sustainable Forestry, V27, P189, DOI 10.1080/10549810802219963; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Knicley JE, 2012, HARVARD ENVIRON LAW, V36, P79; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Lubchenco J, 2003, ECOL APPL, V13, pS3; Maekawa M, 2013, NAT RESOUR FORUM, V37, P127, DOI 10.1111/1477-8947.12020; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Mascia MB, 2014, BIOL CONSERV, V169, P355, DOI 10.1016/j.biocon.2013.11.021; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Micheli F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05799-180419; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Noss RF, 2012, CONSERV BIOL, V26, P1, DOI 10.1111/j.1523-1739.2011.01738.x; Osti M, 2011, BIODIVERS CONSERV, V20, P1863, DOI 10.1007/s10531-011-0056-6; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Phillips A., 2004, PARKS, V14, P4; Postel SL, 2005, NAT RESOUR FORUM, V29, P98, DOI 10.1111/j.1477-8947.2005.00119.x; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Prieur M., 2012, NONREGRESSION ENV LA; Rastogi A, 2012, J ENVIRON MANAGE, V113, P328, DOI 10.1016/j.jenvman.2012.10.003; Republic of Uganda, 2008, NAT OIL GAS POL UG; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ritchie EG, 2013, CONSERV BIOL, V27, P1133, DOI 10.1111/cobi.12189; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Runte A., 1977, Journal of Forest History, V21, P64, DOI 10.2307/3983461; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scharlemann JPW, 2010, ORYX, V44, P352, DOI 10.1017/S0030605310000542; Sciberras M, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-4; Shahabuddin G, 2010, BIOL CONSERV, V143, P2926, DOI 10.1016/j.biocon.2010.04.040; Sheehan EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083883; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Spalding M., 2008, WORLDS PROTECTED ARE, P146; Steinberg PF, 2009, GLOBAL ENVIRON POLIT, V9, P61, DOI 10.1162/glep.2009.9.3.61; Stockholm International Peace Research Institute, 2014, MIL EXP; Stolton S, 2010, ARGUMENTS FOR PROTECTED AREAS: MULTIPLE BENEFITS FOR CONSERVATION AND USE, P1; Sukumar R., 2006, International Zoo Yearbook, V40, P1, DOI 10.1111/j.1748-1090.2006.00001.x; Swaisgood RR, 2010, BIOSCIENCE, V60, P626, DOI 10.1525/bio.2010.60.8.8; Taylor MFJ, 2011, BIODIVERS CONSERV, V20, P767, DOI 10.1007/s10531-010-9977-8; Tulloch AIT, 2013, DIVERS DISTRIB, V19, P465, DOI 10.1111/j.1472-4642.2012.00947.x; UNEP-WCMC, 2014, WORLD DAT PROT AR; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Watkins H., 2014, HS2 CASE GREENER VIS; Watson J, 2010, ORYX, V44, P79, DOI 10.1017/S0030605309990226; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/NCLIMATE2007, 10.1038/nclimate2007]; Watson JEM, 2009, DIVERS DISTRIB, V15, P1028, DOI 10.1111/j.1472-4642.2009.00601.x; White C, 2012, P NATL ACAD SCI USA, V109, P4696, DOI 10.1073/pnas.1114215109; Willemen L, 2013, ECOSYST SERV, V4, P95, DOI 10.1016/j.ecoser.2013.02.004; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X; Zafir AWA, 2011, ORYX, V45, P225, DOI 10.1017/S0030605310000864; Zeiger J. B., 1992, Parks & Recreation (Arlington), V27, P74	99	1043	1086	79	875	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					67	73		10.1038/nature13947	http://dx.doi.org/10.1038/nature13947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373676				2022-12-28	WOS:000344187500030
J	Valgimigli, M; Sabate, M; Kaiser, C; Brugaletta, S; Hernandez, JMD; Galatius, S; Cequier, A; Eberli, F; de Belder, A; Serruys, PW; Ferrante, G				Valgimigli, Marco; Sabate, Manel; Kaiser, Christoph; Brugaletta, Salvatore; de la Torre Hernandez, Jose Maria; Galatius, Soeren; Cequier, Angel; Eberli, Franz; de Belder, Adam; Serruys, Patrick W.; Ferrante, Giuseppe			Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDUCED INTIMAL HYPERPLASIA; DUAL-ANTIPLATELET TREATMENT; ALL-COMER PATIENTS; MYOCARDIAL-INFARCTION; CLINICAL-EVALUATION; CORONARY; THROMBOSIS; IMPLANTATION; THERAPY; DESIGN	Objectives To examine the safety and effectiveness of cobalt-chromium everolimus eluting stents compared with bare metal stents. Design Individual patient data meta-analysis of randomised controlled trials. Cox proportional regression models stratified by trial, containing random effects, were used to assess the impact of stent type on outcomes. Hazard ratios with 95% confidence interval for outcomes were reported. Data sources and study selection Medline, Embase, the Cochrane Central Register of Controlled Trials. Randomised controlled trials that compared cobalt-chromium everolimus eluting stents with bare metal stents were selected. The principal investigators whose trials met the inclusion criteria provided data for individual patients. Primary outcomes The primary outcome was cardiac mortality. Secondary endpoints were myocardial infarction, definite stent thrombosis, definite or probable stent thrombosis, target vessel revascularisation, and all cause death. Results The search yielded five randomised controlled trials, comprising 4896 participants. Compared with patients receiving bare metal stents, participants receiving cobalt-chromium everolimus eluting stents had a significant reduction of cardiac mortality (hazard ratio 0.67, 95% confidence interval 0.49 to 0.91; P=0.01), myocardial infarction (0.71, 0.55 to 0.92; P=0.01), definite stent thrombosis (0.41, 0.22 to 0.76; P=0.005), definite or probable stent thrombosis (0.48, 0.31 to 0.73; P<0.001), and target vessel revascularisation (0.29, 0.20 to 0.41; P<0.001) at a median follow-up of 720 days. There was no significant difference in all cause death between groups (0.83, 0.65 to 1.06; P=0.14). Findings remained unchanged at multivariable regression after adjustment for the acuity of clinical syndrome (for instance, acute coronary syndrome v stable coronary artery disease), diabetes mellitus, female sex, use of glycoprotein IIb/IIIa inhibitors, and up to one year v longer duration treatment with dual antiplatelets. Conclusions This meta-analysis offers evidence that compared with bare metal stents the use of cobalt-chromium everolimus eluting stents improves global cardiovascular outcomes including cardiac survival, myocardial infarction, and overall stent thrombosis.	[Valgimigli, Marco; Serruys, Patrick W.] Erasmus MC, Thoraxctr, NL-3015 CE Rotterdam, Netherlands; [Sabate, Manel; Brugaletta, Salvatore] Univ Hosp Clin, Dept Cardiol, IDIBAPS, Barcelona 08036, Spain; [Kaiser, Christoph] Univ Basel Hosp, CH-4003 Basel, Switzerland; [de la Torre Hernandez, Jose Maria] Hosp Marques de Valdecilla, Santander 39008, Spain; [Galatius, Soeren] Gentofte Univ Hosp, DK-2900 Hellerup, Denmark; [Cequier, Angel] Univ Hosp Bellvitge, Barcelona 08907, Spain; [Eberli, Franz] Stadtspital Triemli, CH-8063 Zurich, Switzerland; [de Belder, Adam] Brighton & Sussex Univ Hosp NHS Trust, Brighton BN1 6AG, E Sussex, England; [Ferrante, Giuseppe] Humanitas Clin & Res Inst IRCCS, I-20089 Milan, Italy	Erasmus University Rotterdam; Erasmus MC; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Basel; Hospital Universitario Marques de Valdecilla (HUMV); University of Copenhagen; Herlev & Gentofte Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Triemli Hospital; Brighton and Sussex University Hospitals NHS Trust; University of Brighton	Valgimigli, M (corresponding author), Erasmus MC, Thoraxctr, NL-3015 CE Rotterdam, Netherlands.	m.valgimigli@erasmusmc.nl	Ferrante, Giuseppe/AAN-7122-2020; Brugaletta, Salvatore/AAJ-2090-2020; Kaiser, Christoph/AAA-9284-2022; Ferrante, Giuseppe/K-5384-2016; Valgimigli, Marco/AAE-9103-2019; Sabate, Manel/AAX-7245-2021	Ferrante, Giuseppe/0000-0001-9175-1464; Ferrante, Giuseppe/0000-0001-9175-1464; Valgimigli, Marco/0000-0002-4353-7110; Sabate Tenas, Manel/0000-0002-2316-3705	Abbott Vascular	Abbott Vascular(Abbott Laboratories)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare that MV has received honorariums for lectures/advisory board from Abbott Vascular and that MS, AC, and SG have received honorariums for lectures/advisory board and research grant from Abbott Vascular.	Beijk Marcel A, 2007, EuroIntervention, V3, P206, DOI 10.4244/EIJV3I2A36; Brener SJ, 2013, AM HEART J, V166, P1035, DOI 10.1016/j.ahj.2013.08.030; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; de Belder A, 2014, J AM COLL CARDIOL, V63, P1371, DOI 10.1016/j.jacc.2013.10.053; de la Torre-Hernandez JM, 2008, J AM COLL CARDIOL, V51, P986, DOI 10.1016/j.jacc.2007.10.057; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gada H, 2013, JACC-CARDIOVASC INTE, V6, P1263, DOI 10.1016/j.jcin.2013.07.009; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Kalesan B, 2012, EUR HEART J, V33, P977, DOI 10.1093/eurheartj/ehs036; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Raber L, 2011, J AM COLL CARDIOL, V57, P2143, DOI 10.1016/j.jacc.2011.01.023; ROGERS C, 1995, CIRCULATION, V91, P2995, DOI 10.1161/01.CIR.91.12.2995; Sabate M, 2014, JACC-CARDIOVASC INTE, V7, P64, DOI 10.1016/j.jcin.2013.09.006; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; Valgimigli M, 2008, JAMA-J AM MED ASSOC, V299, P1788, DOI 10.1001/jama.299.15.joc80026; Valgimigli M, 2014, JACC-CARDIOVASC INTE, V7, P20, DOI 10.1016/j.jcin.2013.09.008; Valgimigli M, 2013, EUR HEART J, V34, P909, DOI 10.1093/eurheartj/ehs460; Valgimigli M, 2010, AM HEART J, V160, P804, DOI 10.1016/j.ahj.2010.07.034; Xie XY, 2010, J BIOMED MATER RES B, V93B, P497, DOI 10.1002/jbm.b.31609	39	72	74	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2014	349								g6427	10.1136/bmj.g6427	http://dx.doi.org/10.1136/bmj.g6427			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CC	25378023	Green Published, hybrid			2022-12-28	WOS:000344603600004
J	Dinman, JD				Dinman, Jonathan D.			MOLECULAR BIOLOGY Entry signals control development	NATURE			English	Editorial Material							RIBOSOME; TRANSLATION		Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu		Dinman, Jonathan/0000-0002-2402-9698	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL119439] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; MIRSKY AE, 1951, J GEN PHYSIOL, V34, P451, DOI 10.1085/jgp.34.4.451; Mokrejs M, 2010, NUCLEIC ACIDS RES, V38, pD131, DOI 10.1093/nar/gkp981; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010	10	0	0	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					24	25		10.1038/nature14069	http://dx.doi.org/10.1038/nature14069			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25409148	Green Accepted			2022-12-28	WOS:000347178400023
J	Lantos, JD; Spertus, JA				Lantos, John D.; Spertus, John A.			The Concept of Risk in Comparative-Effectiveness Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Lantos, John D.] Univ Missouri, Childrens Mercy Hosp, Kansas City, MO 64110 USA; [Spertus, John A.] Univ Missouri, St Lukes Hosp, Kansas City, MO USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Saint Luke's Hospital - Missouri; University of Missouri System; University of Missouri Kansas City	Lantos, JD (corresponding author), Univ Missouri, Childrens Mercy Hosp, Kansas City, MO 64110 USA.		Spertus, John/ABD-3075-2021					Department of Health and Human Services, 2014, FED REG, p[79, 63629]; hhs, 1979, BELM REP ETH PRINC G	2	19	19	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2129	2130		10.1056/NEJMhle1413301	http://dx.doi.org/10.1056/NEJMhle1413301			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25390458	Bronze			2022-12-28	WOS:000345580000016
J	Lessler, J				Lessler, Justin			IMMUNOLOGY Charting the life-course epidemiology of influenza	SCIENCE			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	justin@jhu.edu		Lessler, Justin/0000-0002-9741-8109				Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Horsfall FL, 1941, J EXP MED, V74, P433, DOI 10.1084/jem.74.5.433; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211	6	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					919	920		10.1126/science.aaa0613	http://dx.doi.org/10.1126/science.aaa0613			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414291				2022-12-28	WOS:000345696000019
J	Carninci, P				Carninci, Piero			GENOMICS Mice in the ENCODE spotlight	NATURE			English	Editorial Material							LANDSCAPE; ELEMENTS	Following on from affiliated projects in humans and model invertebrates, the Mouse ENCODE Project presents comprehensive data sets on genome regulation in this key mammalian model. See Articles p. 355, p. 365, p. 371 & LETTER p. 402	RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan	RIKEN	Carninci, P (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, RIKEN Yokohama Campus, Yokohama, Kanagawa 2300045, Japan.	carninci@riken.jp	Carninci, Piero/K-1568-2014	Carninci, Piero/0000-0001-7202-7243				Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	11	9	9	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					346	347		10.1038/515346a	http://dx.doi.org/10.1038/515346a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409821				2022-12-28	WOS:000345770600028
J	Swerdloff, R; Anawalt, BD				Swerdloff, Ronald; Anawalt, Bradley D.			Testosterone-Replacement Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIOVASCULAR-DISEASE; MEN		[Swerdloff, Ronald] Harbor UCLA Med Ctr, Los Angeles, CA 90502 USA; [Anawalt, Bradley D.] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Washington; University of Washington Seattle	Swerdloff, R (corresponding author), Harbor UCLA Med Ctr, Los Angeles, CA 90502 USA.		Anawalt, Bradley D./AAW-3316-2020	Anawalt, Bradley D./0000-0003-2652-4032				Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168; Layton JB, 2014, J CLIN ENDOCR METAB, V99, P835, DOI 10.1210/jc.2013-3570; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Page ST, 2014, LANCET DIABETES ENDO, V2, P609, DOI 10.1016/S2213-8587(14)70082-8; Wang C, 2011, DIABETES CARE, V34, P1669, DOI 10.2337/dc10-2339; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101	7	14	14	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					2032	2034		10.1056/NEJMclde1406595	http://dx.doi.org/10.1056/NEJMclde1406595			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT5ST	25409377				2022-12-28	WOS:000345002900016
J	Green, MS; Badgett, RG				Green, Michael S.; Badgett, Robert G.			Review: Fiber supplementation improves symptoms in the irritable bowel syndrome Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Green, Michael S.; Badgett, Robert G.] Univ Kansas, Sch Med, Wichita, KS 67214 USA	University of Kansas; University of Kansas Medical Center	Green, MS (corresponding author), Univ Kansas, Sch Med, Wichita, KS 67214 USA.		Badgett, Robert/AAD-3429-2021	Badgett, Robert/0000-0003-2888-3303				Bijkerk CJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3154; Halmos EP, 2014, GASTROENTEROLOGY, V146, P67, DOI [10.1053/j.gastro.2013.09.046, 10.1053/j.gastro.2014.04.034]; Ruepert L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003460.pub3, 10.1002/14651858.CD003460]	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC10	10.7326/0003-4819-161-10-201411180-02010	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402531				2022-12-28	WOS:000347245600018
J	Laing, BY; Mangione, CM; Tseng, CH; Leng, M; Vaisberg, E; Mahida, M; Bholat, M; Glazier, E; Morisky, DE; Bell, DS				Laing, Brian Yoshio; Mangione, Carol M.; Tseng, Chi-Hong; Leng, Mei; Vaisberg, Ekaterina; Mahida, Megha; Bholat, Michelle; Glazier, Eve; Morisky, Donald E.; Bell, Douglas S.			Effectiveness of a Smartphone Application for Weight Loss Compared With Usual Care in Overweight Primary Care Patients A Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							OBESITY	Background: Many smartphone applications (apps) for weight loss are available, but little is known about their effectiveness. Objective: To evaluate the effect of introducing primary care patients to a free smartphone app for weight loss. Design: Randomized, controlled trial. (ClinicalTrials.gov: NCT01650337) Setting: 2 academic primary care clinics. Patients: 212 primary care patients with body mass index of 25 kg/m(2) or greater. Intervention: 6 months of usual care without (n = 107) or with (n = 105) assistance in downloading the MyFitnessPal app (MyFitnessPal). Measurements: Weight loss at 6 months (primary outcome) and changes in systolic blood pressure and behaviors, frequency of app use, and satisfaction (secondary outcomes). Results: After 6 months, weight change was minimal, with no difference between groups (mean between-group difference, -0.30 kg [95% CI, -1.50 to 0.95 kg]; P = 0.63). Change in systolic blood pressure also did not differ between groups (mean between-group difference, -1.7 mm Hg [CI, -7.1 to 3.8 mm Hg]; P = 0.55). Compared with patients in the control group, those in the intervention group increased use of a personal calorie goal (mean between-group difference, 2.0 d/wk [CI, 1.1 to 2.9 d/wk]; P < 0.001), although other self-reported behaviors did not differ between groups. Most users reported high satisfaction with MyFitnessPal, but logins decreased sharply after the first month. Limitations: Despite being blinded to the name of the app, 14 control group participants (13%) used MyFitnessPal. In addition, 32% of intervention group participants and 19% of control group participants were lost to follow-up at 6 months. The app was given to patients by research assistants, not by physicians. Conclusion: Smartphone apps for weight loss may be useful for persons who are ready to self-monitor calories, but introducing a smartphone app is unlikely to produce substantial weight change for most patients.	Univ Calif Los Angeles, Robert Wood Johnson Clin Scholars Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Morisky, Donald E.] Univ Calif Los Angeles, Dept Community Hlth Sci, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; RAND Corp, Santa Monica, CA 90406 USA; Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; RAND Corporation; University of California System; University of California Los Angeles	Laing, BY (corresponding author), Martin Luther King Outpatient Ctr, 1670 East 120th St, Los Angeles, CA 90059 USA.	blaing@stanfordalumni.org	Bell, Douglas S/G-6702-2013; Morisky, Donald/AAU-4679-2021	Bell, Douglas S/0000-0002-5063-8294; 	Robert Wood Johnson Foundation; National Institutes of Health/National Center for Advancing Translational Sciences; Resource Centers for Minority Aging Research Center for Health Improvement of Minority Elderly under the National Institutes of Health/National Institute on Aging; NATIONAL CANCER INSTITUTE [R43CA094404] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021684] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institutes of Health/National Center for Advancing Translational Sciences; Resource Centers for Minority Aging Research Center for Health Improvement of Minority Elderly under the National Institutes of Health/National Institute on Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Robert Wood Johnson Foundation Clinical Scholars Program, National Institutes of Health/National Center for Advancing Translational Sciences for the UCLA Clinical and Translational Science Institute, and the Resource Centers for Minority Aging Research Center for Health Improvement of Minority Elderly under the National Institutes of Health/National Institute on Aging.	Allison PD., 2002, MISSING DATA QUANTIT, P79; Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739; Azar KMJ, 2013, AM J PREV MED, V45, P583, DOI 10.1016/j.amepre.2013.07.005; Bandura A., 1977, COGNITIVE THER RES, V1, P177, DOI [10.1007/BF01186792, DOI 10.1007/BF01186792]; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Carter MC, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2283; Cohn M., 2012, BALTIMORE SUN; Curb JD, 2002, DIABETES CARE, V25, P386; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heath C, 1993, Fam Med, V25, P401; Kullgren JT, 2013, ANN INTERN MED, V158, P505, DOI 10.7326/0003-4819-158-7-201304020-00002; McLean N, 2003, INT J OBESITY, V27, P987, DOI 10.1038/sj.ijo.0802383; Patrick K, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1100; Smith A., 2013, SMARTPHONE OWNERSHIP; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220	19	206	213	4	61	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S5	S12		10.7326/M13-3005	http://dx.doi.org/10.7326/M13-3005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3RR	25402403	Green Accepted, Green Published			2022-12-28	WOS:000364909900003
J	Slovick, A; Durham, SR; Till, SJ				Slovick, Anna; Durham, Stephen R.; Till, Stephen J.			Grass pollen immunotherapy for treatment of allergic rhinitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUBLINGUAL IMMUNOTHERAPY; EFFICACY; SAFETY; CHILDREN; TABLETS		[Slovick, Anna; Till, Stephen J.] Kings Coll London, Guys Hosp, Sch Med, Div Asthma Allergy & Lung Biol, London SE1 9RT, England; [Durham, Stephen R.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Sect Allergy & Clin Immunol, London SW3 6LY, England; [Till, Stephen J.] Guys & St Thomas NHS Fdn Trust, Dept Allergy, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust	Till, SJ (corresponding author), Kings Coll London, Guys Hosp, Sch Med, Div Asthma Allergy & Lung Biol, London SE1 9RT, England.	stephen.till@kcl.ac.uk		Till, Stephen/0000-0003-4518-3093				[Anonymous], 1986, Br Med J (Clin Res Ed), V293, P948; Blaiss M, 2011, J ALLERGY CLIN IMMUN, V127, P64, DOI 10.1016/j.jaci.2010.11.034; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Calderon MA, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001936.PUB2; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Dahl R, 2008, J ALLERGY CLIN IMMUN, V121, P512, DOI 10.1016/j.jaci.2007.10.039; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; de Groot H, 2009, ALLERGY, V64, P963, DOI 10.1111/j.1398-9995.2009.01998.x; Devillier P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-71; Durham SR, 2007, ALLERGY, V62, P954, DOI 10.1111/j.1398-9995.2007.01402.x; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Eifan AO, 2007, ALLERGY, V62, P567, DOI 10.1111/j.1398-9995.2006.01301.x; Francis JN, 2008, J ALLERGY CLIN IMMUN, V121, P1120, DOI 10.1016/j.jaci.2008.01.072; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; Javeed N, 1996, CATHETER CARDIO DIAG, V39, P383, DOI 10.1002/(SICI)1097-0304(199612)39:4<383::AID-CCD13>3.3.CO;2-G; Kiel MA, 2013, J ALLERGY CLIN IMMUN, V132, P353, DOI 10.1016/j.jaci.2013.03.013; LANG DM, 1991, ANN INTERN MED, V115, P270, DOI 10.7326/0003-4819-115-4-270; Matricardi PM, 2011, J ALLERGY CLIN IMMUN, V128, P791, DOI 10.1016/j.jaci.2011.03.049; Meadows A, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17270; National Institute for Health and Care Excellence, 2013, GUIDE TO THE METHODS; Nelson HS, 2011, J ALLERGY CLIN IMMUN, V127, P72, DOI 10.1016/j.jaci.2010.11.035; NOON L, 1955, Ann Allergy, V13, P713; Radulovic S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002893.pub2; REID MJ, 1993, J ALLERGY CLIN IMMUN, V92, P6, DOI 10.1016/0091-6749(93)90030-J; Walker SM, 2011, CLIN EXP ALLERGY, V41, P1177, DOI 10.1111/j.1365-2222.2011.03794.x	26	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2014	349								g6586	10.1136/bmj.g6586	http://dx.doi.org/10.1136/bmj.g6586			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JX	25403477				2022-12-28	WOS:000345445500002
J	Romps, DM; Seeley, JT; Vollaro, D; Molinari, J				Romps, David M.; Seeley, Jacob T.; Vollaro, David; Molinari, John			Projected increase in lightning strikes in the United States due to global warming	SCIENCE			English	Article							CLIMATE-CHANGE; PRECIPITATION; PARAMETERIZATION; DISTRIBUTIONS; FREQUENCY; RADAR; FIRE	Lightning plays an important role in atmospheric chemistry and in the initiation of wildfires, but the impact of global warming on lightning rates is poorly constrained. Here we propose that the lightning flash rate is proportional to the convective available potential energy (CAPE) times the precipitation rate. Using observations, the product of CAPE and precipitation explains 77% of the variance in the time series of total cloud-toground lightning flashes over the contiguous United States (CONUS). Storms convert CAPE times precipitated water mass to discharged lightning energy with an efficiency of 1%. When this proxy is applied to 11 climate models, CONUS lightning strikes are predicted to increase 12 +/- 5% per degree Celsius of global warming and about 50% over this century.	[Romps, David M.; Seeley, Jacob T.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Romps, David M.; Seeley, Jacob T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Vollaro, David; Molinari, John] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Romps, DM (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	romps@berkeley.edu	Romps, David/F-8285-2011	Romps, David/0000-0001-7649-5175; Seeley, Jacob/0000-0003-0769-292X	Scientific Discovery through Advanced Computing (SciDAC) program - U.S. Department of Energy Office of Advanced Scientific Computing Research and Office of Biological and Environmental Research; U.S. Department of Energy's Earth System Modeling, an Office of Science, Office of Biological and Environmental Research program [DE-AC02-05CH11231]; National Science Foundation (NSF) Graduate Research Fellowship [DGE1106400]; NSF [AGS1132576]	Scientific Discovery through Advanced Computing (SciDAC) program - U.S. Department of Energy Office of Advanced Scientific Computing Research and Office of Biological and Environmental Research; U.S. Department of Energy's Earth System Modeling, an Office of Science, Office of Biological and Environmental Research program(United States Department of Energy (DOE)); National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	D.M.R. acknowledges support from the Scientific Discovery through Advanced Computing (SciDAC) program funded by the U.S. Department of Energy Office of Advanced Scientific Computing Research and Office of Biological and Environmental Research, and by the U.S. Department of Energy's Earth System Modeling, an Office of Science, Office of Biological and Environmental Research program under contract no. DE-AC02-05CH11231. J.T.S. acknowledges support from the National Science Foundation (NSF) Graduate Research Fellowship under grant no. DGE1106400. D.V. and J.M. acknowledge support from NSF under grant no. AGS1132576. Thanks are due to the SPARC data center for archiving the high-resolution radiosonde data and making them publicly available. The authors are also grateful to J. Paul, B. Lawrence, K. Sugioka, and N. Jeevanjee for their help with the precipitation data. Thanks also to three anonymous reviewers. Data sources are described in the online supplementary materials.	Banerjee A, 2014, ATMOS CHEM PHYS, V14, P9871, DOI 10.5194/acp-14-9871-2014; BATTAN LJ, 1965, J ATMOS SCI, V22, P79, DOI 10.1175/1520-0469(1965)022<0079:SFGPAL>2.0.CO;2; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; Diffenbaugh NS, 2013, P NATL ACAD SCI USA, V110, P16361, DOI 10.1073/pnas.1307758110; Grewe V, 2007, SCI TOTAL ENVIRON, V374, P167, DOI 10.1016/j.scitotenv.2007.01.032; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Holle RL, 2014, MON WEATHER REV, V142, P1037, DOI 10.1175/MWR-D-13-00121.1; Kitzmiller D, 2013, J HYDROL ENG, V18, P133, DOI 10.1061/(ASCE)HE.1943-5584.0000523; Krause A, 2014, J GEOPHYS RES-BIOGEO, V119, P312, DOI 10.1002/2013JG002502; Levy H, 1996, J GEOPHYS RES-ATMOS, V101, P22911, DOI 10.1029/96JD02341; Meijer EW, 2001, PHYS CHEM EARTH PT C, V26, P577, DOI 10.1016/S1464-1917(01)00050-2; Michalon N, 1999, GEOPHYS RES LETT, V26, P3097, DOI 10.1029/1999GL010837; Muller CJ, 2011, J CLIMATE, V24, P2784, DOI 10.1175/2011JCLI3876.1; Murugavel P, 2014, INT J CLIMATOL, V34, P3179, DOI 10.1002/joc.3901; Orville RE, 2001, MON WEATHER REV, V129, P1179, DOI 10.1175/1520-0493(2001)129<1179:CTGLIT>2.0.CO;2; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pawar SD, 2012, ATMOS RES, V106, P44, DOI 10.1016/j.atmosres.2011.11.007; Petersen WA, 1998, J GEOPHYS RES-ATMOS, V103, P14025, DOI 10.1029/97JD02064; PRICE C, 1992, J GEOPHYS RES-ATMOS, V97, P9919, DOI 10.1029/92JD00719; PRICE C, 1994, J GEOPHYS RES-ATMOS, V99, P10823, DOI 10.1029/94JD00019; PRICE C, 1994, MON WEATHER REV, V122, P1930, DOI 10.1175/1520-0493(1994)122<1930:MGLDIA>2.0.CO;2; Reeve N, 1999, Q J ROY METEOR SOC, V125, P893, DOI 10.1002/qj.49712555507; Romps DM, 2011, J ATMOS SCI, V68, P123, DOI 10.1175/2010JAS3542.1; Schumann U, 2007, ATMOS CHEM PHYS, V7, P3823, DOI 10.5194/acp-7-3823-2007; Singh MS, 2013, GEOPHYS RES LETT, V40, P4398, DOI 10.1002/grl.50796; Sobel AH, 2011, J CLIMATE, V24, P473, DOI 10.1175/2010JCLI3748.1; SPARC, 2013, US HIGH VERT RES RAD; Tapia A, 1998, J APPL METEOROL, V37, P1497, DOI 10.1175/1520-0450(1998)037<1497:EOCRFL>2.0.CO;2; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trapp RJ, 2007, P NATL ACAD SCI USA, V104, P19719, DOI 10.1073/pnas.0705494104; Trapp RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036203; Wacker RS, 1999, J GEOPHYS RES-ATMOS, V104, P2151, DOI 10.1029/1998JD200060; Williams E, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000380; WILLIAMS ER, 1992, SCIENCE, V256, P1184, DOI 10.1126/science.256.5060.1184; WILLIAMS ER, 1992, J ATMOS SCI, V49, P1386, DOI 10.1175/1520-0469(1992)049<1386:ARAESO>2.0.CO;2; WILLIAMS ER, 1994, MON WEATHER REV, V122, P1917, DOI 10.1175/1520-0493(1994)122<1917:GCRTSV>2.0.CO;2; Ye B, 1998, J CLIMATE, V11, P1997, DOI 10.1175/1520-0442-11.8.1997	38	303	313	14	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					851	854		10.1126/science.1259100	http://dx.doi.org/10.1126/science.1259100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395536	Green Submitted			2022-12-28	WOS:000344659900045
J	Gulden, FO; Sestan, N				Gulden, Forrest O.; Sestan, Nenad			Building a bigger brain	NATURE			English	Editorial Material							TRANSCRIPTOME; NEOCORTEX; EVOLUTION		[Gulden, Forrest O.; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Gulden, Forrest O.; Sestan, Nenad] Yale Univ, Sch Med, Dept Psychiat, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Gulden, Forrest O.; Sestan, Nenad] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Gulden, FO (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, 333 Cedar St, New Haven, CT 06510 USA.	forrest.gulden@yale.edu; nenad.sestan@yale.edu						Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Breunig JJ, 2011, NEURON, V70, P614, DOI 10.1016/j.neuron.2011.05.005; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dixon-Salazar TJ, 2010, ANN NY ACAD SCI, V1214, P156, DOI 10.1111/j.1749-6632.2010.05819.x; Evsyukova I, 2013, ANNU REV CELL DEV BI, V29, P299, DOI 10.1146/annurev-cellbio-101512-122400; Herculano-Houzel S, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00077; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	15	5	5	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					206	207		10.1038/515206a	http://dx.doi.org/10.1038/515206a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391958				2022-12-28	WOS:000344631400036
J	Marx, V				Marx, Vivien			A DEEP LOOK AT SYNAPTIC DYNAMICS	NATURE			English	Editorial Material							PROTEINS											Denker A, 2011, P NATL ACAD SCI USA, V108, P17177, DOI 10.1073/pnas.1112688108; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Revelo NH, 2014, J CELL BIOL, V205, P591, DOI 10.1083/jcb.201402066; Watanabe S, 2014, NATURE; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884	8	5	5	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					293	297		10.1038/515293a	http://dx.doi.org/10.1038/515293a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391965				2022-12-28	WOS:000344631400056
J	Piel, FB; Weatherall, DJ				Piel, Frederic B.; Weatherall, David J.			The alpha-Thalassemias	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COST-BENEFIT-ANALYSIS; HEMOGLOBIN-H DISEASE; NEGATIVE EPISTASIS; HYDROPS-FETALIS; GLOBAL BURDEN; HEALTH; GENE; DISORDERS; EPIDEMIOLOGY; FREQUENCIES		[Piel, Frederic B.] Univ Oxford, Dept Zool, Evolutionary Ecol Infect Dis Grp, Oxford OX1 3PS, England; [Weatherall, David J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX1 3PS, England	University of Oxford; University of Oxford	Piel, FB (corresponding author), Univ Oxford, Dept Zool, Tinbergen Bldg,South Parks Rd, Oxford OX1 3PS, England.	fred.piel@zoo.ox.ac.uk		Piel, Frederic B./0000-0001-8131-7728	Medical Research Council [MC_UU_12009/13] Funding Source: researchfish; MRC [MC_UU_12009/13] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmadnezhad E, 2012, INT J PREVENTIVE MED, V3, P687; Benz EJ, 2011, NEW ENGL J MED, V364, P770, DOI 10.1056/NEJMe1013338; Chong SS, 2000, BLOOD, V95, P360; Chui DHK, 2005, ANN HUM BIOL, V32, P123, DOI 10.1080/03014460500075084; Chui DHK, 2003, BLOOD, V101, P791, DOI 10.1182/blood-2002-07-1975; Chui DHK, 1998, BLOOD, V91, P2213, DOI 10.1182/blood.V91.7.2213.2213_2213_2222; de Silva S, 2000, LANCET, V355, P786, DOI 10.1016/S0140-6736(99)08246-X; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Fucharoen Suthat, 2009, Hematology Am Soc Hematol Educ Program, P26, DOI 10.1182/asheducation-2009.1.26; Galanello R, 2011, GENET MED, V13, P83, DOI 10.1097/GIM.0b013e3181fcb468; GANCZAKOWSKI M, 1995, BRIT J HAEMATOL, V89, P485, DOI 10.1111/j.1365-2141.1995.tb08353.x; Giardine B, 2014, NUCLEIC ACIDS RES, V42, pD1063, DOI 10.1093/nar/gkt911; Ginsberg G, 1998, J MED SCREEN, V5, P120, DOI 10.1136/jms.5.3.120; Giordano PC, 2009, HEMOGLOBIN, V33, P124, DOI 10.1080/03630260902827684; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Higgs DR, 2009, CELL MOL LIFE SCI, V66, P1154, DOI 10.1007/s00018-008-8529-9; Higgs DR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011718; HIGGS DR, 1993, BAILLIERE CLIN HAEM, V6, P117, DOI 10.1016/S0950-3536(05)80068-X; Kassebaum NJ, 2013, LANCET, V381, P73; Koren A, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.012; Lal A, 2011, NEW ENGL J MED, V364, P710, DOI 10.1056/NEJMoa1010174; Leung KY, 2004, PRENATAL DIAG, V24, P899, DOI 10.1002/pd.1035; Ma SK, 2001, INT J MOL MED, V8, P171; Mills A, 2014, NEW ENGL J MED, V370, P552, DOI 10.1056/NEJMra1110897; MODELL B, 1993, TRENDS GENET, V9, P46, DOI 10.1016/0168-9525(93)90186-L; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; MODIANO G, 1991, AM J HUM GENET, V48, P390; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; OSTROWSKY JT, 1985, AM J PUBLIC HEALTH, V75, P732, DOI 10.2105/AJPH.75.7.732; Padilla CD, 2007, J INHERIT METAB DIS, V30, P490, DOI 10.1007/s10545-007-0687-7; Padilla Carmencita D., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P215; Pasvol G, 2006, PLOS MED, V3, P591, DOI 10.1371/journal.pmed.0030235; Penman BS, 2011, EVOLUTION, V65, P3625, DOI 10.1111/j.1558-5646.2011.01408.x; Penman BS, 2009, P NATL ACAD SCI USA, V106, P21242, DOI 10.1073/pnas.0910840106; PETROU M, 1992, BRIT J OBSTET GYNAEC, V99, P985, DOI 10.1111/j.1471-0528.1992.tb13703.x; Thein SL, 2005, HAEMATOLOGICA, V90, P649; Vichinsky EP, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011742; Vichinsky Elliott P, 2009, Hematology Am Soc Hematol Educ Program, P35, DOI 10.1182/asheducation-2009.1.35; Vichinsky EP, 2005, ANN NY ACAD SCI, V1054, P18, DOI 10.1196/annals.1345.003; Weatherall D, 2004, AM J HUM GENET, V74, P385, DOI 10.1086/381402; Weatherall DJ, 2010, ANN NY ACAD SCI, V1202, P17, DOI 10.1111/j.1749-6632.2010.05546.x; Weatherall D, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P663; Weatherall David, 2011, Indian J Med Res, V134, P493; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ, 2010, BRIT J HAEMATOL, V149, P635, DOI 10.1111/j.1365-2141.2010.08118.x; Weatherall DJ, 1996, NAT MED, V2, P847, DOI 10.1038/nm0896-847; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; Weatherall DJ, 1997, BRIT MED J, V314, P1675, DOI 10.1136/bmj.314.7095.1675; Weatherall DJ., 2001, THALASSAEMIA SYNDROM, V4th ed; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Wonke B, 2007, SCAND J CLIN LAB INV, V67, P87, DOI 10.1080/00365510601046474; Zeuner D, 1999, HEALTH TECHNOL ASSES, V3, P1	56	168	179	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1908	1916		10.1056/NEJMra1404415	http://dx.doi.org/10.1056/NEJMra1404415			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25390741	Green Published			2022-12-28	WOS:000344709800008
J	Jones, MK; Watanabe, M; Zhu, S; Graves, CL; Keyes, LR; Grau, KR; Gonzalez-Hernandez, MB; Iovine, NM; Wobus, CE; Vinje, J; Tibbetts, SA; Wallet, SM; Karst, SM				Jones, Melissa K.; Watanabe, Makiko; Zhu, Shu; Graves, Christina L.; Keyes, Lisa R.; Grau, Katrina R.; Gonzalez-Hernandez, Mariam B.; Iovine, Nicole M.; Wobus, Christiane E.; Vinje, Jan; Tibbetts, Scott A.; Wallet, Shannon M.; Karst, Stephanie M.			Enteric bacteria promote human and mouse norovirus infection of B cells	SCIENCE			English	Article							BLOOD-GROUP ANTIGEN; INTESTINAL EPITHELIAL-CELLS; MURINE NOROVIRUSES; NORWALK VIRUS; GASTROENTERITIS; MICROBIOTA; REPLICATION; LEWIS	The cell tropism of human noroviruses and the development of an in vitro infection model remain elusive. Although susceptibility to individual human norovirus strains correlates with an individual's histo-blood group antigen (HBGA) profile, the biological basis of this restriction is unknown. We demonstrate that human and mouse noroviruses infected B cells in vitro and likely in vivo. Human norovirus infection of B cells required the presence of HBGA-expressing enteric bacteria. Furthermore, mouse norovirus replication was reduced in vivo when the intestinal microbiota was depleted by means of oral antibiotic administration. Thus, we have identified B cells as a cellular target of noroviruses and enteric bacteria as a stimulatory factor for norovirus infection, leading to the development of an in vitro infection model for human noroviruses.	[Jones, Melissa K.; Watanabe, Makiko; Zhu, Shu; Keyes, Lisa R.; Grau, Katrina R.; Tibbetts, Scott A.; Karst, Stephanie M.] Univ Florida, Coll Med, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Graves, Christina L.; Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Graves, Christina L.; Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Gonzalez-Hernandez, Mariam B.; Wobus, Christiane E.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Iovine, Nicole M.] Univ Florida, Dept Med, Div Infect Dis, Gainesville, FL USA; [Vinje, Jan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; Centers for Disease Control & Prevention - USA	Karst, SM (corresponding author), Univ Florida, Coll Med, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.	skarst@ufl.edu	Vinje, Jan/ABE-6336-2020	Vinje, Jan/0000-0002-1530-3675; Graves, Christina/0000-0002-7387-2462; Wobus, Christiane/0000-0001-5286-0924	NIH [R01 AI080611, R21 AI103961]; National Institute of Food and Agriculture [2011-68003-30395]; NIH/National Institute of Dental and Craniofacial Research [T90 DE021990-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103961, T32AI007110, R01AI080611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NIH/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank R. Condit, G. McFadden, and H. Virgin for critical discussions and reading of the manuscript. We thank R. Renne and F. Zhu for providing cell lines and J. Pfeiffer for mouse antibiotic depletion protocols. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This work was funded by NIH R01 AI080611 and R21 AI103961 for C. E. W; and National Institute of Food and Agriculture 2011-68003-30395 for J.V. C. L. G. was supported in part by NIH/National Institute of Dental and Craniofacial Research T90 DE021990-02 (Burne). A patent application pertinent to this work has been filed (U.S. patent application no. 61/992,040: Methods and Compositions for Caliciviridae, M.J. and S. K. as inventors).	Arias A, 2012, J GEN VIROL, V93, P1432, DOI 10.1099/vir.0.042176-0; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Herbst-Kralovetz MM, 2013, EMERG INFECT DIS, V19, P431, DOI 10.3201/eid1903.121029; Hsu CC, 2006, COMPARATIVE MED, V56, P247; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Kahan SM, 2011, VIROLOGY, V421, P202, DOI 10.1016/j.virol.2011.09.030; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Koo HL, 2010, DISCOV MED, V10, P61; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; May J, 2013, VIROLOGY, V444, P218, DOI 10.1016/j.virol.2013.06.013; Miura T, 2013, J VIROL, V87, P9441, DOI 10.1128/JVI.01060-13; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Papafragkou E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063485; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Rasko DA, 2000, EUR J BIOCHEM, V267, P6059, DOI 10.1046/j.1432-1327.2000.01683.x; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; SPRINGER GF, 1961, J EXP MED, V113, P1077, DOI 10.1084/jem.113.6.1077; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Takanashi S, 2014, ARCH VIROL, V159, P257, DOI 10.1007/s00705-013-1806-4; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; van Beek J., 2013, EUROSURVEILLANCE; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592	32	544	571	14	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					755	759		10.1126/science.1257147	http://dx.doi.org/10.1126/science.1257147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378626	Green Accepted			2022-12-28	WOS:000344690100043
J	Ahn, HS; Kim, HJ; Welch, HG				Ahn, Hyeong Sik; Kim, Hyun Jung; Welch, H. Gilbert			Korea's Thyroid-Cancer "Epidemic" - Screening and Overdiagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ahn, Hyeong Sik; Kim, Hyun Jung] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Welch, H. Gilbert] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	Korea University; Korea University Medicine (KU Medicine); Dartmouth College	Ahn, HS (corresponding author), Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea.							HARACH HR, 1985, CANCER, V56, P531, DOI DOI 10.1002/1097-0142(19850801)56:3!; Is thyroid cancer overdiagnosed?, 2014, KOREA TIMES     0323; 이승훈, 2008, Endocrinology and Metabolism, V23, P35; National Evidence-based Healthcare Collaborating Agency, 2013, RES EV THYR SCREEN S; VANDERLAAN WP, 1947, NEW ENGL J MED, V237, P221, DOI [10.1056/NEJM194708142370703, 10.1056/NEJM194702132360702]	5	704	746	4	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1765	1767		10.1056/NEJMp1409841	http://dx.doi.org/10.1056/NEJMp1409841			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372084				2022-12-28	WOS:000344170300004
J	Venkataramaiah, S; Sriganesh, K				Venkataramaiah, Sudhir; Sriganesh, Kamath			Carotid Cavernous Fistula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Venkataramaiah, Sudhir; Sriganesh, Kamath] Natl Inst Mental Hlth & Neurosci, Bangalore 560029, Karnataka, India	National Institute of Mental Health & Neurosciences - India	Venkataramaiah, S (corresponding author), Natl Inst Mental Hlth & Neurosci, Bangalore 560029, Karnataka, India.	vsudhir77@gmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1832	1832		10.1056/NEJMicm1311966	http://dx.doi.org/10.1056/NEJMicm1311966			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372091				2022-12-28	WOS:000344170300012
J	Crystal, AS; Shaw, AT; Sequist, LV; Friboulet, L; Niederst, MJ; Lockerman, EL; Frias, RL; Gainor, JF; Amzallag, A; Greninger, P; Lee, D; Kalsy, A; Gomez-Caraballo, M; Elamine, L; Howe, E; Hur, W; Lifshits, E; Robinson, HE; Katayama, R; Faber, AC; Awad, MM; Ramaswamy, S; Mino-Kenudson, M; Iafrate, AJ; Benes, CH; Engelman, JA				Crystal, Adam S.; Shaw, Alice T.; Sequist, Lecia V.; Friboulet, Luc; Niederst, Matthew J.; Lockerman, Elizabeth L.; Frias, Rosa L.; Gainor, Justin F.; Amzallag, Arnaud; Greninger, Patricia; Lee, Dana; Kalsy, Anuj; Gomez-Caraballo, Maria; Elamine, Leila; Howe, Emily; Hur, Wooyoung; Lifshits, Eugene; Robinson, Hayley E.; Katayama, Ryohei; Faber, Anthony C.; Awad, Mark M.; Ramaswamy, Sridhar; Mino-Kenudson, Mari; Iafrate, A. John; Benes, Cyril H.; Engelman, Jeffrey A.			Patient-derived models of acquired resistance can identify effective drug combinations for cancer	SCIENCE			English	Article							CELL LUNG-CANCER; KINASE INHIBITION; BYPASS MECHANISMS; ALK; CRIZOTINIB; MUTATIONS; GEFITINIB; CHEMOTHERAPY; ACTIVATION; CERITINIB	Targeted cancer therapies have produced substantial clinical responses, but most tumors develop resistance to these drugs. Here, we describe a pharmacogenomic platform that facilitates rapid discovery of drug combinations that can overcome resistance. We established cell culture models derived from biopsy samples of lung cancer patients whose disease had progressed while on treatment with epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors and then subjected these cells to genetic analyses and a pharmacological screen. Multiple effective drug combinations were identified. For example, the combination of ALK and MAPK kinase (MEK) inhibitors was active in an ALK-positive resistant tumor that had developed a MAP2K1 activating mutation, and the combination of EGFR and fibroblast growth factor receptor (FGFR) inhibitors was active in an EGFR mutant resistant cancer with a mutation in FGFR3. Combined ALK and SRC (pp60c-src) inhibition was effective in several ALK-driven patient-derived models, a result not predicted by genetic analysis alone. With further refinements, this strategy could help direct therapeutic choices for individual patients.	[Crystal, Adam S.; Shaw, Alice T.; Sequist, Lecia V.; Friboulet, Luc; Niederst, Matthew J.; Lockerman, Elizabeth L.; Frias, Rosa L.; Gainor, Justin F.; Amzallag, Arnaud; Greninger, Patricia; Lee, Dana; Kalsy, Anuj; Gomez-Caraballo, Maria; Elamine, Leila; Howe, Emily; Lifshits, Eugene; Katayama, Ryohei; Faber, Anthony C.; Awad, Mark M.; Ramaswamy, Sridhar; Benes, Cyril H.; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA; [Crystal, Adam S.; Shaw, Alice T.; Sequist, Lecia V.; Friboulet, Luc; Niederst, Matthew J.; Lockerman, Elizabeth L.; Frias, Rosa L.; Gainor, Justin F.; Amzallag, Arnaud; Greninger, Patricia; Lee, Dana; Kalsy, Anuj; Gomez-Caraballo, Maria; Elamine, Leila; Howe, Emily; Lifshits, Eugene; Robinson, Hayley E.; Katayama, Ryohei; Faber, Anthony C.; Awad, Mark M.; Ramaswamy, Sridhar; Mino-Kenudson, Mari; Iafrate, A. John; Benes, Cyril H.; Engelman, Jeffrey A.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Robinson, Hayley E.; Mino-Kenudson, Mari; Iafrate, A. John] Massachusetts Gen Hosp, Ctr Canc, Dept Pathol, Boston, MA 02114 USA; [Hur, Wooyoung] Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Hur, Wooyoung] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hur, Wooyoung] Korea Inst Sci & Technol, Chem Kin Res Ctr, Seoul 136791, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Korea Institute of Science & Technology (KIST)	Engelman, JA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA.	cbenes@partners.org; jengelman@partners.org	Gainor, Justin/T-5411-2019; Frias, Rosa L./AAT-3133-2021; Katayama, Ryohei/K-8537-2014; friboulet, luc/N-7276-2015; Amzallag, Arnaud/Y-5802-2019	Katayama, Ryohei/0000-0001-7394-895X; friboulet, luc/0000-0002-1129-4978; Amzallag, Arnaud/0000-0001-7467-1227; Crystal, Adam/0000-0002-2302-2654	NIH [R01CA137008, R01CA164273, 1U54HG006097-01]; Wellcome Trust [086357, 102696]; National Cancer Institute Lung SPORE [P50CA090578]; Department of Defense; Conquer Cancer Foundation Young Investigator Award; Uniting Against Lung Cancer; Free to Breathe; Lungevity; National Foundation for Cancer Research; Be a Piece of the Solution; Novartis; Sanofi-Aventis; AstraZeneca; Chugai; Amgen; Genentech; GSK; Merck; Pfizer; Boehringer Ingelheim; Ariad; Roche; Ignyta; NATIONAL CANCER INSTITUTE [R01CA137008, P50CA090578, R01CA164273] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Cancer Institute Lung SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Conquer Cancer Foundation Young Investigator Award; Uniting Against Lung Cancer; Free to Breathe; Lungevity; National Foundation for Cancer Research; Be a Piece of the Solution; Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Chugai; Amgen(Amgen); Genentech(Roche HoldingGenentech); GSK(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Ariad; Roche(Roche Holding); Ignyta; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. H. Park for direction, redirection, and support; S. R. Vora for continual critical discussion and support; W. Michaud for providing feeder cells and training for the development of patient-derived cell lines; and N. Gray for providing several kinase inhibitors. This study was funded by support from the NIH R01CA137008 (J.A.E.), R01CA164273 (A.T.S. and J.A.E.), 1U54HG006097-01 (C.H.B.), the Wellcome Trust (086357 and 102696, C.H.B.), the National Cancer Institute Lung SPORE P50CA090578 (A.S.C., A.J.I., and J.A.E.), the Department of Defense (L.V.S. and J.A.E.), Conquer Cancer Foundation Young Investigator Award (A.S.C.), Uniting Against Lung Cancer (A.S.C. and A.T.S.), Free to Breathe (A.S.C.), Lungevity (L.V.S. and J.A.E.), National Foundation for Cancer Research (A.T.S.), and Be a Piece of the Solution. J.A.E. is a paid consultant for Novartis, Sanofi-Aventis, AstraZeneca, Chugai, Amgen, Genentech, GSK, Merck, and Pfizer, and he holds equity in Gatekeeper Pharmaceuticals, which has a potential equity interest in T790M inhibitors. J.A.E. also receives research support from Novartis. J.F.G. is a paid consultant for Boehringer Ingelheim. A.T.S. is a paid consultant for Pfizer, Novartis, Ariad, Chugai, Genentech, Roche, and Ignyta. A.J.I. is a Senior Advisory Board member and holds equity in Enzymatics Inc. For gene expression analyses, the raw data are deposited in ArrayExpress (accession number is E-MTAB-783). The normalized data are available at www.cancerrxgene.org/downloads.	BAGRODIA S, 1991, NATURE, V349, P172, DOI 10.1038/349172a0; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Marks JL, 2008, CANCER RES, V68, P5524, DOI 10.1158/0008-5472.CAN-08-0099; Marsilje TH, 2013, J MED CHEM, V56, P5675, DOI 10.1021/jm400402q; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Tanizaki J, 2012, CLIN CANCER RES, V18, P6219, DOI 10.1158/1078-0432.CCR-12-0392; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Yamaguchi N, 2014, LUNG CANCER, V83, P37, DOI 10.1016/j.lungcan.2013.09.019	27	508	530	2	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1480	1486		10.1126/science.1254721	http://dx.doi.org/10.1126/science.1254721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25394791	Green Accepted			2022-12-28	WOS:000346536500056
J	McCracken, KW; Cata, EM; Crawford, CM; Sinagoga, KL; Schumacher, M; Rockich, BE; Tsai, YH; Mayhew, CN; Spence, JR; Zavros, Y; Wells, JM				McCracken, Kyle W.; Cata, Emily M.; Crawford, Calyn M.; Sinagoga, Katie L.; Schumacher, Michael; Rockich, Briana E.; Tsai, Yu-Hwai; Mayhew, Christopher N.; Spence, Jason R.; Zavros, Yana; Wells, James M.			Modelling human development and disease in pluripotent stem-cell-derived gastric organoids	NATURE			English	Article							HELICOBACTER-PYLORI INFECTION; EPIDERMAL GROWTH-FACTOR; IN-VITRO; DEFINITIVE ENDODERM; DUODENAL-ULCER; SPECIFICATION; MORPHOGENESIS; INTEGRATION; EPITHELIUM; MESODERM	Gastric diseases, including peptic ulcer disease and gastric cancer, affect 10% of the world's population and are largely due to chronic Helicobacter pylori infection(1-3). Species differences in embryonic development and architecture of the adult stomach make animal models suboptimal for studying human stomach organogenesis and pathogenesis(4), and there is no experimental model of normal human gastric mucosa. Here we report the de novo generation of three-dimensional human gastric tissue in vitro through the directed differentiation of human pluripotent stem cells. We show that temporal manipulation of the FGF, WNT, BMP, retinoic acid and EGF signalling pathways and three-dimensional growth are sufficient to generate human gastric organoids (hGOs). Developing hGOs progressed through molecular and morphogenetic stages that were nearly identical to the developing antrum of the mouse stomach. Organoids formed primitive gastric gland-and pit-like domains, proliferative zones containing LGR5-expressing cells, surface and antral mucous cells, and a diversity of gastric endocrine cells. We used hGO cultures to identify novel signalling mechanisms that regulate early endoderm patterning and gastric endocrine cell differentiation upstream of the transcription factor NEUROG3. UsinghGOs to model pathogenesis of human disease, we found that H. pylori infection resulted in rapid association of the virulence factor CagA with the c-Met receptor, activation of signalling and induction of epithelial proliferation. Together, these studies describe a new and robust in vitro system for elucidating the mechanisms underlying human stomach development and disease.	[McCracken, Kyle W.; Cata, Emily M.; Crawford, Calyn M.; Sinagoga, Katie L.; Mayhew, Christopher N.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Schumacher, Michael; Zavros, Yana] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Rockich, Briana E.; Spence, Jason R.] Univ Michigan, Dept Cell & Dev Biol, Sch Med, Ann Arbor, MI 48109 USA; [Tsai, Yu-Hwai; Spence, Jason R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center	Wells, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	zavrosya@ucmail.uc.edu; james.wells@cchmc.org	Mayhew, Christopher N/AGB-4929-2022	Mayhew, Chris/0000-0002-7408-1726; Schumacher, Michael/0000-0003-3353-0414; McCracken, Kyle/0000-0001-7650-5513	National Institutes of Health [R01DK080823, R01DK092456, K01DK091415]; NIGMS Medical Scientist Training Program [T32 GM063483]; American Gastroenterological Association: Robert and Sally Funderburg Research Award in Gastric Cancer; Cincinnati Digestive Disease Center Award [P30 DK0789392]; Clinical Translational Science Award [U54 RR025216]; Michigan Gastrointestinal Peptide Research Center (MGPRC) [NIDDK 5P30DK034933]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI116491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK080823, R01DK083402, P30DK034933, R01DK098350, R01DK092456, K01DK091415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483, R01GM072915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Medical Scientist Training Program; American Gastroenterological Association: Robert and Sally Funderburg Research Award in Gastric Cancer; Cincinnati Digestive Disease Center Award; Clinical Translational Science Award; Michigan Gastrointestinal Peptide Research Center (MGPRC); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Zorn, J. Whitsett, N. Shroyer, the Pluripotent Stem Cell Facility and members of the Wells and Zorn laboratories for reagents and feedback. We also thank M. Kofron for assistance with confocal imaging and T. Westbrook for providing the pInducer20 vector. We thank R. Peek for assistance with analysing electron micrograph images. This work was supported by National Institutes of Health grants R01DK080823, R01DK092456 and K01DK091415, NIGMS Medical Scientist Training Program T32 GM063483, and the American Gastroenterological Association: Robert and Sally Funderburg Research Award in Gastric Cancer. We also acknowledge core support from the Cincinnati Digestive Disease Center Award (P30 DK0789392), Clinical Translational Science Award (U54 RR025216), the Michigan Gastrointestinal Peptide Research Center (MGPRC; NIDDK 5P30DK034933), and technical support from CCHMC Confocal Imaging Core, CCHMC Pathology Core, and CCHMC Viral Vector Core.	Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Choi E., 2014, GUT; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; JOHNSON LR, 1980, AM J PHYSIOL, V238, pG45, DOI 10.1152/ajpgi.1980.238.1.G45; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; MAJUMDAR APN, 1984, J PEDIATR GASTR NUTR, V3, P618, DOI 10.1097/00005176-198409000-00024; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Olbe L, 1996, GASTROENTEROLOGY, V110, P1386, DOI 10.1053/gast.1996.v110.pm8613042; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peek RM, 2008, DIS MODEL MECH, V1, P50, DOI 10.1242/dmm.000364; Peek RM, 1997, JNCI-J NATL CANCER I, V89, P863, DOI 10.1093/jnci/89.12.863; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Teo AKK, 2012, STEM CELLS, V30, P631, DOI 10.1002/stem.1022; Tiso N, 2002, MECH DEVELOP, V118, P29, DOI 10.1016/S0925-4773(02)00252-6; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Verzi MP, 2009, GASTROENTEROLOGY, V136, P1701, DOI 10.1053/j.gastro.2009.01.009; Wang ZX, 2006, DEV BIOL, V297, P433, DOI 10.1016/j.ydbio.2006.05.019; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Xia HHX, 2000, AM J GASTROENTEROL, V95, P114, DOI 10.1111/j.1572-0241.2000.01609.x; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Yuan YH, 2006, NAT CLIN PRACT GASTR, V3, P80, DOI 10.1038/ncpgasthep0393	42	573	603	13	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					400	+		10.1038/nature13863	http://dx.doi.org/10.1038/nature13863			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25363776	Green Accepted			2022-12-28	WOS:000346484800048
J	Tepass, U				Tepass, Ulrich			DEVELOPMENTAL BIOLOGY Polarize to elongate	NATURE			English	Editorial Material							PLANAR POLARITY; CELL POLARITY; CONVERGENT EXTENSION; RHO-GTPASE; DROSOPHILA; MORPHOGENESIS; DYNAMICS; GERMBAND; RHOGEF2; PATHWAY		Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada	University of Toronto	Tepass, U (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada.	u.tepass@utoronto.ca						Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Collinet C, 2013, PROG MOL BIOL TRANSL, V116, P25, DOI 10.1016/B978-0-12-394311-8.00002-9; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Kolesnikov T, 2007, DEV BIOL, V307, P53, DOI 10.1016/j.ydbio.2007.04.014; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Pare AC, 2014, NATURE, V515, P523, DOI 10.1038/nature13953; Simoes SD, 2014, J CELL BIOL, V204, P575, DOI 10.1083/jcb.201307070; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Vichas A, 2011, SEMIN CELL DEV BIOL, V22, P858, DOI 10.1016/j.semcdb.2011.09.013; Walck-Shannon E, 2014, NAT REV MOL CELL BIO, V15, P34, DOI 10.1038/nrm3723; Warrington SJ, 2013, DEVELOPMENT, V140, P1045, DOI 10.1242/dev.088724; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	18	4	4	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					499	501		10.1038/nature13937	http://dx.doi.org/10.1038/nature13937			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25363775				2022-12-28	WOS:000346247600040
J	Frisch, S				Frisch, Suzy			Medical cannabis: US researchers battle for access to the plant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												suzyfrisch@yahoo.com						Abrams DI, 2007, CLIN PHARMACOL THER, V82, P572, DOI 10.1038/sj.clpt.6100200; Aggarwal Sunil K, 2009, J Opioid Manag, V5, P153; Borgelt LM, 2013, PHARMACOTHERAPY, V33, P195, DOI 10.1002/phar.1187; Charuvastra A, 2005, J ADDICT DIS, V24, P87, DOI 10.1300/J069v24n03_07; Drug Enforcement Administration, 2011, DEA POS MAR; Drug Enforcement Administration, DRUG SCHED; Drug Policy Alliance, DEA 4 DEC IMP REJ SC; FRISCH S, MED CANNABIS US RES; Grant I, 2010, REPORT LEGISLATURE G; Hotakeinen R, 2014, FEDS ACCUSED STEERIN; ProCon, 2014, SUMM CHART 23 STAT D; ProConorg, 2014, NUMB LEG MED MAR PAT; Rappold RS, 2014, WEBMD HLTH NEWS 0402	13	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 21	2014	349								g6997	10.1136/bmj.g6997	http://dx.doi.org/10.1136/bmj.g6997			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2KB	25416312				2022-12-28	WOS:000345446000003
J	Pope, BD; Ryba, T; Dileep, V; Yue, F; Wu, WS; Denas, O; Vera, DL; Wang, YL; Hansen, RS; Canfield, TK; Thurman, RE; Cheng, Y; Gulsoy, G; Dennis, JH; Snyder, MP; Stamatoyannopoulos, JA; Taylor, J; Hardison, RC; Kahveci, T; Ren, B; Gilbert, DM				Pope, Benjamin D.; Ryba, Tyrone; Dileep, Vishnu; Yue, Feng; Wu, Weisheng; Denas, Olgert; Vera, Daniel L.; Wang, Yanli; Hansen, R. Scott; Canfield, Theresa K.; Thurman, Robert E.; Cheng, Yong; Guelsoy, Guenhan; Dennis, Jonathan H.; Snyder, Michael P.; Stamatoyannopoulos, John A.; Taylor, James; Hardison, Ross C.; Kahveci, Tamer; Ren, Bing; Gilbert, David M.			Topologically associating domains are stable units of replication-timing regulation	NATURE			English	Article							H3 LYSINE 27; REVEALS; ORGANIZATION; METHYLATION; CHROMOSOME; DYNAMICS; GENOMES; SWITCH; EZH2	Eukaryotic chromosomes replicate in a temporal order known as the replication-timing program(1). In mammals, replication timing is cell-type-specific with at least half the genome switching replication timing during development, primarily in units of 400-800 kilobases (replication domains'), whose positions are preserved in different cell types, conserved between species, and appear to confine long-range effects of chromosome rearrangements(2-7). Early and late replication correlate, respectively, with open and closed three-dimensional chromatin compartments identified by high-resolution chromosome conformation capture (Hi-C), and, to a lesser extent, late replication correlates with lamina-associated domains (LADs)(4,5,8,9). Recent Hi-C mapping has unveiled substructure within chromatin compartments called topologically associating domains (TADs) that are largely conserved in their positions between cell types and are similar in size to replication domains(8,10). However, TADs can be further sub-stratified into smaller domains, challenging the significance of structures at any particular scale(11,12). Moreover, attempts to reconcile TADs and LADs to replication-timing data have not revealed a common, underlying domain structure(8,9,13). Here we localize boundaries of replication domains to the early-replicating border of replication-timing transitions and map their positions in 18 human and 13 mouse cell types. We demonstrate that, collectively, replication domain boundaries share a near one-to-one correlation with TAD boundaries, whereas within a cell type, adjacent TADs that replicate at similar times obscure replication domain boundaries, largely accounting for the previously reported lack of alignment. Moreover, cell-type-specific replication timing of TADs partitions the genome into two large-scale sub-nuclear compartments revealing that replication-timing transitions are indistinguishable from late-replicating regions in chromatin composition and lamina association and accounting for the reduced correlation of replication timing to LADs and heterochromatin. Our results reconcile cell-type-specific sub-nuclear compartmentalization and replication timing with developmentally stable structural domains and offer a unified model for large-scale chromosome structure and function.	[Pope, Benjamin D.; Dileep, Vishnu; Vera, Daniel L.; Dennis, Jonathan H.; Gilbert, David M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Ryba, Tyrone] New Coll Florida, Div Nat Sci, Sarasota, FL 34243 USA; [Yue, Feng] Penn State Univ, Sch Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Yue, Feng; Wang, Yanli; Snyder, Michael P.] Penn State Univ, Huck Inst Life Sci, Bioinformat & Genom Program, University Pk, PA 16802 USA; [Wu, Weisheng; Hardison, Ross C.] Penn State Univ, Huck Inst Life Sci, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Denas, Olgert; Taylor, James] Emory Univ, O WayneRollins Res Ctr, Dept Biol, Atlanta, GA 30322 USA; [Denas, Olgert; Taylor, James] Emory Univ, O WayneRollins Res Ctr, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Hansen, R. Scott] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Canfield, Theresa K.; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Cheng, Yong] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Guelsoy, Guenhan; Kahveci, Tamer] Univ Florida, Gainesville, FL 32611 USA; [Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	State University System of Florida; Florida State University; State University System of Florida; New College Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Emory University; Emory University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; State University System of Florida; University of Florida; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Gilbert, DM (corresponding author), Florida State Univ, Dept Biol Sci, 319 Stadium Dr, Tallahassee, FL 32306 USA.	gilbert@bio.fsu.edu	Dileep, Vishnu/S-1328-2018; Taylor, James/F-1026-2011; Pope, Ben/Y-4326-2019; cheng, yong/I-4270-2012; Hardison, Ross C/G-1142-2010	Dileep, Vishnu/0000-0001-9181-2191; Taylor, James/0000-0001-5079-840X; Pope, Ben/0000-0003-1847-9163; Hardison, Ross C/0000-0003-4084-7516; Vera, Daniel/0000-0003-2202-7397; Snyder, Michael/0000-0003-0784-7987	NIH [GM083337, GM085354, HG005602, HG005573, DK065806, HG003991]; National Cancer Institute of the National Institutes of Health [F31CA165863]; NATIONAL CANCER INSTITUTE [F31CA165863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997, R01HG003991, RC2HG005573, RC2HG005602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065806, R56DK065806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083337, P01GM085354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Laugesen, G. Andersen and K. Helm for providing Suz12 control and knockout naive mESC lines. We thank F.Ay, M. Libbrecht,W. S. Noble, E. Besnard, J. M. LeMaitre, C. Cayrou, M. Mechali and J. Dekker for helpful discussions. This research was supported by NIH grants GM083337 and GM085354 to D.M.G., HG005602 to M.P.S., HG005573 and DK065806 to R.C.H., and HG003991 to B.R. B.D.P. is supported by the National Cancer Institute of the National Institutes of Health under award number F31CA165863.	Audit B, 2009, NUCLEIC ACIDS RES, V37, P6064, DOI 10.1093/nar/gkp631; Baker A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002443; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farkash-Amar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048986; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Filippova D, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-14; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Julienne H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003233; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Lu JJ, 2010, J CELL BIOL, V189, P967, DOI 10.1083/jcb.201002002; McGuffee SR, 2013, MOL CELL, V50, P123, DOI 10.1016/j.molcel.2013.03.004; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pope BD, 2012, HUM MOL GENET, V21, P4162, DOI 10.1093/hmg/dds232; Rhind N, 2010, CHROMOSOME RES, V18, P35, DOI 10.1007/s10577-009-9093-3; Ryba T, 2012, GENOME RES, V22, P1833, DOI 10.1101/gr.138511.112; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Takebayashi S, 2012, P NATL ACAD SCI USA, V109, P12574, DOI 10.1073/pnas.1207185109; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; Wright M. L., 2011, DNA REPLICATION CURR; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	36	506	524	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					402	+		10.1038/nature13986	http://dx.doi.org/10.1038/nature13986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409831	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000345770600043
J	Xing, Z; Lin, AF; Li, CL; Liang, K; Wang, SY; Liu, Y; Park, PK; Qin, L; Wei, YK; Hawke, DH; Hung, MC; Lin, CR; Yang, LQ				Xing, Zhen; Lin, Aifu; Li, Chunlai; Liang, Ke; Wang, Shouyu; Liu, Yang; Park, Peter K.; Qin, Li; Wei, Yongkun; Hawke, David H.; Hung, Mien-Chie; Lin, Chunru; Yang, Liuqing			IncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals	CELL			English	Article							BREAST-CANCER METASTASIS; RNA-BINDING PROTEINS; NONCODING RNAS; POLYMERASE-II; CITRON KINASE; FHA DOMAIN; HEDGEHOG; MECHANISMS; GENES; SNIP1	IncRNAs are known to regulate a number of different developmental and tumorigenic processes. Here, we report a role for lncRNA BCAR4 in breast cancer metastasis that is mediated by chemokine-induced binding of BCAR4 to two transcription factors with extended regulatory consequences. BCAR4 binding of SNIP1 and PNUTS in response to CCL21 releases the SNIP1's inhibition of p300-dependent histone acetylation, which in turn enables the BCAR4-recruited PNUTS to bind H3K18ac and relieve inhibition of RNA Pol II via activation of the PP1 phosphatase. This mechanism activates a noncanonical Hedgehog/GLI2 transcriptional program that promotes cell migration. BCAR4 expression correlates with advanced breast cancers, and therapeutic delivery of locked nucleic acids (LNAs) targeting BCAR4 strongly suppresses breast cancer metastasis in mouse models. The findings reveal a disease-relevant lncRNA mechanism consisting of both direct coordinated protein recruitment and indirect regulation of transcription factors.	[Xing, Zhen; Lin, Aifu; Li, Chunlai; Liang, Ke; Wang, Shouyu; Liu, Yang; Park, Peter K.; Wei, Yongkun; Hung, Mien-Chie; Lin, Chunru; Yang, Liuqing] Univ Texas, Grad Sch Biomed Sci, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, Mien-Chie; Lin, Chunru; Yang, Liuqing] Univ Texas, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX USA; [Yang, Liuqing] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Hawke, David H.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Qin, Li] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan	University of Texas System; University of Texas System; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; China Medical University Taiwan; China Medical University Taiwan	Lin, CR (corresponding author), Univ Texas, Grad Sch Biomed Sci, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	clin2@mdanderson.org; lyang7@mdanderson.org	Li, Chunlai/AAI-8839-2021; Hung, Mien-Chie/ABD-5911-2021	Li, Chunlai/0000-0003-1897-9889; Hung, Mien-Chie/0000-0003-4317-4740; Hawke, David/0000-0002-6102-7843; Qin, Li/0000-0003-0099-4992	NIH [4R00DK094981-02, 5R00CA166527-03]; UT Startup grant; UT STARS grant; CPRIT award [R1218]; NATIONAL CANCER INSTITUTE [P30CA016672, R00CA166527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK094981] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012304] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Startup grant; UT STARS grant; CPRIT award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Dr. Joan Massague and Dr. Jianming Xu for providing the MDA-MB-231 LM2 cell line and D. Aten for assistance with figure presentation. We thank the Small Animal Imaging Facility at the MD Anderson Cancer Center for assistance in mice imaging. This work was supported by an NIH K99/R00 award (4R00DK094981-02), UT Startup and UT STARS grants (to C. Lin.), and an NIH K99/R00 award (5R00CA166527-03), CPRIT award (R1218), and UT Startup and UT STARS grants (to L.Y.).	Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Ciurciu A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003885; Dias N, 2002, MOL CANCER THER, V1, P347; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Favoni RE, 2000, PHARMACOL REV, V52, P179; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Fujii M, 2006, MOL CELL, V24, P771, DOI 10.1016/j.molcel.2006.11.006; Gai M, 2011, MOL BIOL CELL, V22, P3768, DOI 10.1091/mbc.E10-12-0952; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Godinho M, 2011, J CELL PHYSIOL, V226, P1741, DOI 10.1002/jcp.22503; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hui M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3401; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kim RH, 2001, J BIOL CHEM, V276, P46297, DOI 10.1074/jbc.M103819200; Kim RH, 2000, GENE DEV, V14, P1605; Kim YM, 2003, J BIOL CHEM, V278, P13819, DOI 10.1074/jbc.M209621200; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Meijer D, 2006, MOL CANCER RES, V4, P379, DOI 10.1158/1541-7786.MCR-05-0156; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Thelie A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-125; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang X, 2012, ONCOGENE, V31, P187, DOI 10.1038/onc.2011.232; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105	38	333	346	3	103	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1110	1125		10.1016/j.cell.2014.10.013	http://dx.doi.org/10.1016/j.cell.2014.10.013			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416949	Bronze, Green Accepted			2022-12-28	WOS:000345506300022
J	Aggarwal, H; Brott, BC				Aggarwal, Himanshu; Brott, Brigitta C.			Review: Statins before coronary catheterization reduce contrast-induced acute kidney injury Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Aggarwal, Himanshu; Brott, Brigitta C.] Univ Alabama Birmingham, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham	Aggarwal, H (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35233 USA.			Brott, Brigitta/0000-0002-9707-7500				Abe M, 2014, AM J CARDIOL, V114, P362, DOI 10.1016/j.amjcard.2014.05.009	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC7	10.7326/0003-4819-161-10-201411180-02007	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402540				2022-12-28	WOS:000347245600012
J	Hodgkinson, JA; Tucker, KL; Crawford, C; Greenfield, SM; Heneghan, C; Hinton, L; Khan, K; Locock, L; Mackillop, L; McCourt, C; Selwood, M; McManus, RJ				Hodgkinson, James A.; Tucker, Katherine L.; Crawford, Carole; Greenfield, Sheila M.; Heneghan, Carl; Hinton, Lisa; Khan, Khalid; Locock, Louise; Mackillop, Lucy; McCourt, Christine; Selwood, Mary; McManus, Richard J.			Is self monitoring of blood pressure in pregnancy safe and effective?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; PREECLAMPSIA; HOME; HYPERTENSION; WOMEN; OSCILLOMETRY; INFLATIONARY; VALIDATION; DIAGNOSIS; ECLAMPSIA	Guidelines encourage the use of self monitoring of blood pressure in pregnancy, and research suggests that women prefer it. But Hodgkinson and colleagues explain that our enthusiasm may run ahead of the evidence and call for more research before it is routinely adopted	[Hodgkinson, James A.; Greenfield, Sheila M.] Univ Birmingham, Birmingham, W Midlands, England; [Tucker, Katherine L.; Crawford, Carole; Heneghan, Carl; Hinton, Lisa; Locock, Louise; Selwood, Mary; McManus, Richard J.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX3 6GG, England; [Khan, Khalid] Blizard Inst, Ctr Primary Care & Publ Hlth, Womens Hlth Res Unit, London, England; [Locock, Louise] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Mackillop, Lucy] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Womens Ctr, Oxford, England; [McCourt, Christine] City Univ London, London EC1V 0HB, England	University of Birmingham; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; City University London	McManus, RJ (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX3 6GG, England.	richard.mcmanus@phc.ox.ac.uk	Hinton, Lisa/AAA-2266-2019; Khan, Khalid S/AAT-8824-2020; Hodgkinson, James/AAY-3410-2020	Khan, Khalid S/0000-0001-5084-7312; Hodgkinson, James/0000-0002-7583-5278; Hinton, Lisa/0000-0002-6082-3151; McCourt, Christine/0000-0003-4765-5795; Tucker, Katherine/0000-0001-6544-8066; Mackillop, Lucy/0000-0002-1927-1594	National Institute for Health Research [PB-PG-1207-15042, NIHR-RP-02-12-015, CDF/01/017, RP-PG-1209-10051] Funding Source: researchfish; Department of Health [CDF/01/017, NIHR-RP-02-12-015, RP-PG-1209-10051, PB-PG-1207-15042] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Aberg A, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P72; American College of Obstetricians and gynecologists ibI, 2013, HYP PREGN IND PRACT; [Anonymous], 2004, 7 RPEP JOINT NAT COM; Ayala DE, 1997, HYPERTENSION, V30, P611, DOI 10.1161/01.HYP.30.3.611; Baral-Grant S, 2012, INT J HYPERTENS, V58, P2068; Bellomo G, 1999, JAMA-J AM MED ASSOC, V282, P1447, DOI 10.1001/jama.282.15.1447; Bodnar LM, 2005, ANN EPIDEMIOL, V15, P475, DOI 10.1016/j.annepidem.2004.12.008; CARTWRIGHT W, 1992, BRIT J OBSTET GYNAEC, V99, P182, DOI 10.1111/j.1471-0528.1992.tb14495.x; Cartwright W, 1993, PROFESSIONAL CARE MO, V3, P8; Chung Y, 2009, HYPERTENS PREGNANCY, V28, P348, DOI 10.1080/10641950802601286; De Greeff A, 2006, J HYPERTENS       S4, V24, pS279; de Greeff A, 2009, BLOOD PRESS MONIT, V14, P37, DOI 10.1097/MBP.0b013e32831e305d; Dehaeck U, 2010, J OBSTET GYNAECOL CA, V32, P328, DOI 10.1016/S1701-2163(16)34476-0; Denolle T, 2008, HYPERTENS PREGNANCY, V27, P305, DOI 10.1080/10641950802000950; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Golara M, 2002, BJOG-INT J OBSTET GY, V109, P1143; Hermida RC, 2005, BLOOD PRESS MONIT, V10, P33, DOI 10.1097/00126097-200502000-00007; Hermida RC, 1997, HYPERTENSION, V30, P1531, DOI 10.1161/01.HYP.30.6.1531; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kitagawa M, 2000, J Obstet Gynaecol Res, V26, P427; Lamminpaa R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-47; LINDHEIMER MD, 2000, HYPERTENSION COMPANI, P688; Magee LA, 2007, HYPERTENS PREGNANCY, V26, P371, DOI 10.1080/10641950701547549; Maternal and Child Health Research Consortium, 2001, CONF ENQ STILLB DEAT; Meads CA, 2008, HLTH TECHNOL ASSESS, V12; Naef R W 3rd, 1998, J Perinatol, V18, P226; Natarajan P, 1999, AM J OBSTET GYNECOL, V181, P1203, DOI 10.1016/S0002-9378(99)70109-2; National Collaborating Centre for Women's and Children's Health, 2008, ANT CAR ROUT CAR HLT; National Institute for Health and Care Excellence, 2008, NICE CLIN GUID CG62; National Institute for Health and Clinical Excellence, 2010, NIC CLIN GUID CG107; National Institutes of Health, 2000, WORK GROUP REP HIGH; NICE, 2011, NICE GUID CG127; Office for National Statistics, 2014, STAT B CONC ENGL WAL; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; RAYBURN WF, 1984, AM J OBSTET GYNECOL, V148, P159, DOI 10.1016/S0002-9378(84)80168-4; RAYBURN WF, 1985, CLIN EXP HYPERTENS B, V4, P63, DOI 10.3109/10641958509031656; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reinders A, 2003, BJOG-INT J OBSTET GY, V110, P134, DOI 10.1016/S1470-0328(02)02538-7; Reinders A, 2005, BJOG, V112, P1; Ross-McGill H, 2000, BRIT J OBSTET GYNAEC, V107, P217, DOI 10.1111/j.1471-0528.2000.tb11692.x; Schwartz WJ, 1996, J REPROD MED, V41, P581; Swindells HE, 1990, MIDWIFE HLTH VISITOR, V26, P88; Taylor RS, 2001, HYPERTENS PREGNANCY, V20, P25, DOI 10.1081/PRG-100104169; Thornton JG, 2000, BRIT J OBSTET GYNAEC, V107, P1181, DOI 10.1111/j.1471-0528.2000.tb11129.x; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Waugh J, 2003, HYPERTENS PREGNANCY, V22, P93, DOI 10.1081/PRG-120017007	51	23	24	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2014	349								g6616	10.1136/bmj.g6616	http://dx.doi.org/10.1136/bmj.g6616			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JY	25406132	Green Accepted, Green Published			2022-12-28	WOS:000345445600004
J	Venkatesh, A; Goodrich, K; Conway, PH				Venkatesh, Arjun; Goodrich, Kate; Conway, Patrick H.			Opportunities for Quality Measurement to Improve the Value of Care for Patients With Multiple Chronic Conditions	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH OUTCOMES; GUIDELINES	Quality measurement efforts have not historically focused on patients with multiple chronic conditions (MCCs), despite them comprising one quarter of the population and two thirds of health care spending. The Patient Protection and Affordable Care Act (ACA) creates several mechanisms for the Centers for Medicare & Medicaid Services (CMS) to transform quality measurement into an organized enterprise designed to support clinicians caring for this vulnerable population. This article highlights 3 emerging policy opportunities for CMS to guide public and private quality measurement efforts for patients with MCCs. First, it discusses infusing an MCC framework into measure development to promote patient-centered, as opposed to single-disease-specific, performance measurement. Second, it describes the importance of using common performance measures for individual clinicians, hospitals, and communities to accelerate meaningful improvement in the prevention and management of chronic conditions across local populations. Finally, the need for longitudinal measurement as a foundation for sustained quality improvement is presented. The ACA's expansion of insurance access and portability necessitates collaborative alignment of chronic condition quality measurement efforts between public and private programs to develop a high-value lifelong health system.	[Venkatesh, Arjun] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06519 USA; [Goodrich, Kate; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Ctr Clin Stand & Qual, Baltimore, MD 21244 USA; George Washington Univ, Sch Med, Washington, DC USA; Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Yale University; Centers for Medicare & Medicaid Services; George Washington University; Cincinnati Children's Hospital Medical Center	Venkatesh, A (corresponding author), Yale Univ, Sch Med, Dept Emergency Med, 464 Congress St,Suite 260, New Haven, CT 06519 USA.	arjun.venkatesh@yale.edu			Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	By the Robert Wood Johnson Foundation Clinical Scholars Program (Dr. Venkatesh).	Agency for Healthcare Research and Quality, 2006, AHRQ QUAL IND PREV Q; Ashman JJ, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120308; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barr Victoria J, 2003, Hosp Q, V7, P73; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Chan CL, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-405; Conway PH, 2013, JAMA-J AM MED ASSOC, V309, P2215, DOI 10.1001/jama.2013.4929; Conway PH, 2013, EHEALTH ALIGNING QUA; Dunn L., 2011, BECKERS HOSP RE 1004; Eddy DM, 2012, HEALTH AFFAIR, V31, P2441, DOI 10.1377/hlthaff.2011.1274; Ford ES, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.130244, 10.5888/pcd10.120316e, 10.5888/pcd10.120316]; Goodman RA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120239; Halfon N, 2013, NEW ENGL J MED, V368, P1569, DOI 10.1056/NEJMp1215897; National Quality Forum, MEAS APPL PARTN; National Quality Forum, 2012, MCC MEAS FRAM FIN RE; Owens DK, 2013, ANN INTERN MED, V159, P223, DOI 10.7326/0003-4819-159-3-201308060-00014; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Robert Wood Johnson Foundation, 2010, CHRONIC CONDITIONS M; Taksler GB, 2013, ANN INTERN MED, V159, P161, DOI 10.7326/0003-4819-159-3-201308060-00005; Tinetti ME, 2011, J AM GERIATR SOC, V59, P1686, DOI 10.1111/j.1532-5415.2011.03573.x; Tinetti ME, 2011, NEW ENGL J MED, V364, P2478, DOI 10.1056/NEJMp1100535; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; US Department of Health and Human Services, 2011, 2011 REP C NAT STRAT; Vitry AI, 2008, MED J AUSTRALIA, V189, P360, DOI 10.5694/j.1326-5377.2008.tb02079.x; Wagner E H, 1998, Eff Clin Pract, V1, P2; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203	26	15	15	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S76	S80		10.7326/M13-3014	http://dx.doi.org/10.7326/M13-3014			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402407				2022-12-28	WOS:000364909900011
J	Crepp, JR				Crepp, Justin R.			Improving planet-finding spectrometers	SCIENCE			English	Editorial Material									Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	University of Notre Dame	Crepp, JR (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	jcrepp@nd.edu						Bonfils X, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201014704; Davies R, 2012, ANNU REV ASTRON ASTR, V50, P305, DOI 10.1146/annurev-astro-081811-125447; Johnson JA, 2014, PHYS TODAY, V67, P31, DOI 10.1063/PT.3.2309; Johnson JA, 2010, PUBL ASTRON SOC PAC, V122, P905, DOI 10.1086/655775; Jovanovic N., 2014, P SOC PHOTO-OPT INS, V9147, P287; Lovis C., 2011, EXOPLANETS, P526; Mahadevan S, 2012, PROC SPIE, V8446, DOI 10.1117/12.926102; Quirrenbach A, 2012, PROC SPIE, V8446, DOI 10.1117/12.925164; Redman S., 2011, THESIS PENNSYLVANIA; Takami H, 2008, P SOC PHOTO-OPT INS, V7014, P1404, DOI 10.1117/12.788254	11	24	24	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					809	810		10.1126/science.1262071	http://dx.doi.org/10.1126/science.1262071			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395520	Green Submitted			2022-12-28	WOS:000344659900019
J	Martinez-Martinez, AJ; Kennedy, AR; Mulvey, RE; O'Hara, CT				Martinez-Martinez, Antonio J.; Kennedy, Alan R.; Mulvey, Robert E.; O'Hara, Charles T.			Directed ortho-meta'- and meta-meta'-dimetalations: A template base approach to deprotonation	SCIENCE			English	Article							ORTHO-LITHIATION; ORTHO-METALATION; POLYSUBSTITUTED AROMATICS; ARYL; AMIDE; TETRAHYDROFURAN; METHODOLOGY; ACTIVATION; REAGENTS; LITHIUM	The regioselectivity of deprotonation reactions between arene substrates and basic metalating agents is usually governed by the electronic and/or coordinative characteristics of a directing group attached to the benzene ring. Generally, the reaction takes place in the ortho position, adjacent to the substituent. Here, we introduce a protocol by which the metalating agent, a disodium-monomagnesium alkyl-amide, forms a template that extends regioselectivity to more distant arene sites. Depending on the nature of the directing group, ortho-meta' or meta-meta' dimetalation is observed, in the latter case breaking the dogma of ortho metalation. This concept is elaborated through the characterization of both organometallic intermediates and electrophilically quenched products.	[Martinez-Martinez, Antonio J.; Kennedy, Alan R.; Mulvey, Robert E.; O'Hara, Charles T.] Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow G1 1XL, Lanark, Scotland	University of Strathclyde	Mulvey, RE (corresponding author), Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow G1 1XL, Lanark, Scotland.	r.e.mulvey@strath.ac.uk; charlie.ohara@strath.ac.uk	Mulvey, Robert E/M-4106-2014; O'Hara, Charles T/M-5204-2014; Martinez-Martinez, Antonio/T-3110-2017	Mulvey, Robert E/0000-0002-1015-2564; O'Hara, Charles T/0000-0002-1691-1568; Martinez-Martinez, Antonio/0000-0002-0684-1244	Royal Society (Wolfson research merit award); Engineering and Physical Sciences Research Council (EPSRC) (Career Acceleration Fellowship) [EP/J001872/1, EP/L001497/1]; EPSRC [EP/L001497/1, EP/J001872/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L001497/1, EP/J001872/1] Funding Source: researchfish	Royal Society (Wolfson research merit award)(Royal Society of London); Engineering and Physical Sciences Research Council (EPSRC) (Career Acceleration Fellowship); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We gratefully acknowledge financial support from the Royal Society (Wolfson research merit award to R.E.M.) and the Engineering and Physical Sciences Research Council (EPSRC) (Career Acceleration Fellowship, EP/J001872/1 and EP/L001497/1 to C.T.O.H.). E. Hevia and B. J. Fleming are also thanked for insightful discussions. We are also grateful to the EPSRC UK National Mass Spectrometry Facility (NMSF), Swansea for collecting our mass spectral data. Metrical data for 5a and 8a are freely available from the Cambridge Crystallographic Database Centre (CCDC-1017351 and CCDC-1017352, respectively).	Albores P, 2009, ANGEW CHEM INT EDIT, V48, P3317, DOI 10.1002/anie.200805566; BAUER W, 1989, J AM CHEM SOC, V111, P7191, DOI 10.1021/ja00200a044; BAUER W, 1984, HELV CHIM ACTA, V67, P1972, DOI 10.1002/hlca.19840670736; BEAK P, 1982, ACCOUNTS CHEM RES, V15, P306, DOI 10.1021/ar00082a002; BEAK P, 1977, J ORG CHEM, V42, P1823, DOI 10.1021/jo00430a042; Blair VL, 2008, ANGEW CHEM INT EDIT, V47, P6208, DOI 10.1002/anie.200801158; Chadwick ST, 2000, J AM CHEM SOC, V122, P8640, DOI 10.1021/ja001471o; Flick K., 1972, US Pat., Patent No. 3652589; Fyfe AA, 2011, ANGEW CHEM INT EDIT, V50, P7776, DOI 10.1002/anie.201103027; Gilman H, 1939, J AM CHEM SOC, V61, P109, DOI 10.1021/ja01870a037; Haag B, 2011, ANGEW CHEM INT EDIT, V50, P9794, DOI 10.1002/anie.201101960; HARDER S, 1988, J ORGANOMET CHEM, V339, P7, DOI 10.1016/0022-328X(88)80519-9; Hickey MR, 2005, ORG PROCESS RES DEV, V9, P764, DOI 10.1021/op0501444; Kauch M, 2006, SYNTHESIS-STUTTGART, P1578, DOI 10.1055/s-2006-926462; Kauch M, 2006, SYNTHESIS-STUTTGART, P1575, DOI 10.1055/s-2006-926461; Kennedy AR, 2014, CHEM COMMUN, V50, P10588, DOI 10.1039/c4cc04959d; Krasovskiy A, 2006, ANGEW CHEM INT EDIT, V45, P2958, DOI 10.1002/anie.200504024; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Macklin T. K., 2005, HDB C H TRANSFORMATI, V1, P106; Macklin TK, 2005, ORG LETT, V7, P2519, DOI 10.1021/ol050393c; Martinez-Martinez AJ, 2014, CHEM SCI, V5, P771, DOI 10.1039/c3sc52816b; Metallinos C, 1999, ORG LETT, V1, P1183, DOI 10.1021/ol990846b; MORTIER J, 1994, J ORG CHEM, V59, P4042, DOI 10.1021/jo00094a007; Mulvey RE, 2009, ACCOUNTS CHEM RES, V42, P743, DOI 10.1021/ar800254y; PROTIVA M, 1991, Drugs of the Future, V16, P911; SAA JM, 1992, J AM CHEM SOC, V114, P9093, DOI 10.1021/ja00049a048; SCHADE C, 1985, J ORGANOMET CHEM, V295, pC25, DOI 10.1016/0022-328X(85)80326-0; Schlosser M, 2013, ORGANOMETALLICS SYNT; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; Tang RY, 2014, NATURE, V507, P215, DOI 10.1038/nature12963; Whisler MC, 2004, ANGEW CHEM INT EDIT, V43, P2206, DOI 10.1002/anie.200300590; Wittig G, 1938, BER DTSCH CHEM GES, V71, P1903, DOI 10.1002/cber.19380710922	32	142	141	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					834	837		10.1126/science.1259662	http://dx.doi.org/10.1126/science.1259662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395533	Green Accepted			2022-12-28	WOS:000344659900040
J	Bangalore, S; Toklu, B; Kotwal, A; Volodarskiy, A; Sharma, S; Kirtane, AJ; Feit, F				Bangalore, Sripal; Toklu, Bora; Kotwal, Anupam; Volodarskiy, Alexander; Sharma, Sahil; Kirtane, Ajay J.; Feit, Frederick			Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y(12) inhibitors	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNFRACTIONATED HEPARIN; BIVALIRUDIN; INCONSISTENCY; FONDAPARINUX; CONSISTENCY; ENOXAPARIN	Objectives To investigate the relative benefits of unfractionated heparin, low molecular weight heparin(LMWH), fondaparinux, and bivalirudin as treatment options for patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention (PCI). Design Mixed treatment comparison and direct comparison meta-analysis of randomized trials in the era of stents and P2Y(12) inhibitors. Data sources and study selection A search of Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL) for randomized trials comparing unfractionated heparin plus glycoprotein IIb/IIIa inhibitor(GpIIb/IIIa inhibitor), unfractionated heparin, bivalirudin, fondaparinux, or LMWH plus GpIIb/IIIa inhibitor for patients undergoing primary PCI. Outcomes The primary efficacy outcome was short term (in hospital or within 30 days) major adverse cardiovascular event; the primary safety outcome was short term major bleeding. Results We identified 22 randomized trials that enrolled 22 434 patients. In the mixed treatment comparison models, when compared with unfractionated heparin plus GpIIb/IIIa inhibitor, unfractionated heparin was associated with a higher risk of major adverse cardiovascular events (relative risk 1.49 (95% confidence interval 1.21 to 1.84), as were bivalirudin (relative risk 1.34 (1.01 to 1.78)) and fondaparinux (1.78 (1.01 to 3.14)). LMWH plus GpIIb/IIIa inhibitor showed highest treatment efficacy, followed (in order) by unfractionated heparin plus GpIIb/IIIa inhibitor, bivalirudin, unfractionated heparin, and fondaparinux. Bivalirudin was associated with lower major bleeding risk compared with unfractionated heparin plus GpIIb/IIIa inhibitor (relative risk 0.47 (0.30 to 0.74)) or unfractionated heparin (0.58 (0.37 to 0.90)). Bivalirudin, followed by unfractionated heparin, LMWH plus GpIIb/IIIa inhibitor, unfractionated heparin plus GpIIb/IIIa inhibitor, and fondaparinux were the hierarchy for treatment safety. Results were similar in direct comparison meta-analyses: bivalirudin was associated with a 39%, 44%, and 65% higher risk of myocardial infarction, urgent revascularization, and stent thrombosis respectively when compared with unfractionated heparin with or without GpIIb/IIIa inhibitor. However, bivalirudin was associated with a 48% lower risk of major bleeding compared with unfractionated heparin plus GpIIb/IIIa inhibitor and 32% lower compared with unfractionated heparin alone. Conclusions In patients undergoing primary PCI, unfractionated heparin plus GpIIb/IIIa inhibitor and LMWH plus GpIIb/IIIa inhibitor were most efficacious, with the lowest rate of major adverse cardiovascular events, whereas bivalirudin was safest, with the lowest bleeding. These relationships should be considered in selecting anticoagulant therapies in patients undergoing primary PCI.	[Bangalore, Sripal; Toklu, Bora; Volodarskiy, Alexander; Feit, Frederick] NYU, Sch Med, New York, NY 10016 USA; [Kotwal, Anupam] Univ Massachusetts, Worcester, MA 01605 USA; [Sharma, Sahil] Lincoln Med Ctr, Bronx, NY USA; [Kirtane, Ajay J.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA	New York University; University of Massachusetts System; University of Massachusetts Worcester; Columbia University; NewYork-Presbyterian Hospital	Bangalore, S (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	sripalbangalore@gmail.com		Bangalore, Sripal/0000-0001-9485-0652				Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Li WM, 2011, CHINESE MED J-PEKING, V124, P3275, DOI 10.3760/cma.j.issn.0366-6999.2011.20.012; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Montalescot G, 2011, LANCET, V378, P693, DOI 10.1016/S0140-6736(11)60876-3; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Schulz S, 2014, EUR HEART J, V35, P2285, DOI 10.1093/eurheartj/ehu182; Shahzad A, 2014, LANCET, V6736, P1, DOI [10.1016/S0140-6736(14)60924-7, DOI 10.1016/S0140-6736(14)60924-7]; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; White IR, 2009, STATA J, V9, P40, DOI 10.1177/1536867X0900900103; Winchester DE, 2012, CLIN CARDIOL, V35, P93, DOI 10.1002/clc.20974; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	22	38	44	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2014	349								g6419	10.1136/bmj.g6419	http://dx.doi.org/10.1136/bmj.g6419			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JQ	25389143	Green Published, hybrid			2022-12-28	WOS:000345444900002
J	Ghosh, I; Ghosh, T; Bardagi, JI; Konig, B				Ghosh, Indrajit; Ghosh, Tamal; Bardagi, Javier I.; Koenig, Burkhard			Reduction of aryl halides by consecutive visible light-induced electron transfer processes	SCIENCE			English	Article							HOMOLYTIC AROMATIC-SUBSTITUTION; C-H-ARYLATION; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; DIAZONIUM SALTS; TRANSFORMATIONS; HETEROARENES; ACTIVATION; TRANSITION; ALDEHYDES	Biological photosynthesis uses the energy of several visible light photons for the challenging oxidation of water, whereas chemical photocatalysis typically involves only single-photon excitation. Perylene bisimide is reduced by visible light photoinduced electron transfer (PET) to its stable and colored radical anion. We report here that subsequent excitation of the radical anion accumulates sufficient energy for the reduction of stable aryl chlorides giving aryl radicals, which were trapped by hydrogen atom donors or used in carbon-carbon bond formation. This consecutive PET (conPET) overcomes the current energetic limitation of visible light photoredox catalysis and allows the photocatalytic conversion of less reactive chemical bonds in organic synthesis.	[Ghosh, Indrajit; Ghosh, Tamal; Bardagi, Javier I.; Koenig, Burkhard] Univ Regensburg, Inst Organ Chem, D-93040 Regensburg, Germany	University of Regensburg	Konig, B (corresponding author), Univ Regensburg, Inst Organ Chem, D-93040 Regensburg, Germany.	burkhard.koenig@ur.de	Ghosh, Indrajit/Z-3421-2019; Koenig, Burkhard/A-1362-2009; Koenig, Burkhard/GRX-2026-2022; Ghosh, Indrajit/D-2302-2010; Koenig, Burkhard/O-8172-2019	Ghosh, Indrajit/0000-0002-5127-2271; Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850; Ghosh, Indrajit/0000-0002-5127-2271; Koenig, Burkhard/0000-0002-6131-4850	Deutsche Forschungsgemeinschaft [GRK 1626]; Alexander von Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank the Deutsche Forschungsgemeinschaft (GRK 1626) for financial support. J.I.B. thanks the Alexander von Humboldt Foundation for a scholarship. We thank R. Vasold for his assistance in GC-MS measurements.	Buden ME, 2013, ORG LETT, V15, P1174, DOI 10.1021/ol3034687; Cahard E, 2012, ANGEW CHEM INT EDIT, V51, P3673, DOI 10.1002/anie.201200084; CHAMI Z, 1991, J ORG CHEM, V56, P586, DOI 10.1021/jo00002a020; Cheng YN, 2013, ORG LETT, V15, P2664, DOI 10.1021/ol400946k; Concepcion JJ, 2012, P NATL ACAD SCI USA, V109, P15560, DOI 10.1073/pnas.1212254109; Costentin C, 2004, J AM CHEM SOC, V126, P16051, DOI 10.1021/ja045989u; Furst L, 2010, ORG LETT, V12, P3104, DOI 10.1021/ol101146f; Gosztola D, 2000, J PHYS CHEM A, V104, P6545, DOI 10.1021/jp000706f; Hari DP, 2014, ANGEW CHEM INT EDIT, V53, P725, DOI 10.1002/anie.201307051; Hari DP, 2013, ANGEW CHEM INT EDIT, V52, P4734, DOI 10.1002/anie.201210276; Hari DP, 2012, J AM CHEM SOC, V134, P2958, DOI 10.1021/ja212099r; Harkins SB, 2005, J AM CHEM SOC, V127, P2030, DOI 10.1021/ja043092r; Kim H, 2012, ANGEW CHEM INT EDIT, V51, P12303, DOI 10.1002/anie.201203599; Liu YX, 2013, SYNLETT, V24, P507, DOI 10.1055/s-0032-1318155; Narayanam JMR, 2009, J AM CHEM SOC, V131, P8756, DOI 10.1021/ja9033582; Newcomb M., 2012, ENCY RADICALS CHEM B, P107; Nguyen JD, 2012, NAT CHEM, V4, P854, DOI 10.1038/NCHEM.1452; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Pause L, 1999, J AM CHEM SOC, V121, P7158, DOI 10.1021/ja991365q; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Ramanan C, 2012, J AM CHEM SOC, V134, P386, DOI 10.1021/ja2080482; Ravelli D, 2009, CHEM SOC REV, V38, P1999, DOI 10.1039/b714786b; REHM D, 1970, ISRAEL J CHEM, V8, P259; Rossi RA, 2003, CHEM REV, V103, P71, DOI 10.1021/cr960134o; Sasaki Y, 2013, J AM CHEM SOC, V135, P5441, DOI 10.1021/ja400238r; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Shirman E, 2008, J PHYS CHEM B, V112, P8855, DOI 10.1021/jp8029743; Tauber MJ, 2006, J AM CHEM SOC, V128, P1782, DOI 10.1021/ja057031k; Teply F, 2011, COLLECT CZECH CHEM C, V76, P859, DOI 10.1135/cccc2011078; Wurthner F, 2004, CHEM COMMUN, P1564, DOI 10.1039/b401630k; Xuan J, 2012, ANGEW CHEM INT EDIT, V51, P6828, DOI 10.1002/anie.201200223	32	611	613	34	694	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					725	728		10.1126/science.1258232	http://dx.doi.org/10.1126/science.1258232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378618				2022-12-28	WOS:000344690100034
J	Ulrich, CM				Ulrich, Connie M.			PERSONAL VIEW Ebola is causing moral distress among African healthcare workers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ETHICAL CLIMATE; NURSES; STRESS		[Ulrich, Connie M.] Univ Penn, Sch Nursing, Dept Med Eth & Hlth Policy, Philadelphia, PA 19106 USA; [Ulrich, Connie M.] Univ Penn, New Courtland Ctr Transit & Hlth, Philadelphia, PA 19106 USA	University of Pennsylvania; University of Pennsylvania	Ulrich, CM (corresponding author), Univ Penn, Sch Nursing, Dept Med Eth & Hlth Policy, Philadelphia, PA 19106 USA.							Bradley I., 2009, CLIN CORRELATIO 0528; Camus A., 1991, PLAGUE; Hamric AB, 2007, CRIT CARE MED, V35, P422, DOI 10.1097/01.CCM.0000254722.50608.2D; Harrowing JN, 2010, INT J NURS STUD, V47, P723, DOI 10.1016/j.ijnurstu.2009.11.010; Jameton A., 1984, NURSING PRACTICE ETH, DOI 10.1002/chp.4760040110; Malik K., 2014 HUM DEV REP SUS; Piers RD, 2011, JAMA-J AM MED ASSOC, V306, P2694, DOI 10.1001/jama.2011.1888; Ulrich C, 2007, SOC SCI MED, V65, P1708, DOI 10.1016/j.socscimed.2007.05.050; Ulrich CM, 2010, J ADV NURS, V66, P2510, DOI 10.1111/j.1365-2648.2010.05425.x; World Health Organization, 2014, EB RESP ROADM SIT RE	10	30	31	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2014	349								g6672	10.1136/bmj.g6672	http://dx.doi.org/10.1136/bmj.g6672			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT0CF	25380700	Green Published, Bronze			2022-12-28	WOS:000344603900003
J	Jutkowitz, E; Choi, HK; Pizzi, LT; Kuntz, KM				Jutkowitz, Eric; Choi, Hyon K.; Pizzi, Laura T.; Kuntz, Karen M.			Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM URATE; HYPERURICEMIA; HEALTH; CARE; RECOMMENDATIONS; RHEUMATOLOGY; POPULATION; FREQUENCY; EFFICACY; FLARES	Background: Gout is the most common inflammatory arthritis in the United States. Objective: To evaluate the cost-effectiveness of urate-lowering treatment strategies for the management of gout. Design: Markov model. Data Sources: Published literature and expert opinion. Target Population: Patients for whom allopurinol or febuxostat is a suitable initial urate-lowering treatment. Time Horizon: Lifetime. Perspective: Health care payer. Intervention: 5 urate-lowering treatment strategies were evaluated: no treatment; allopurinol-or febuxostat-only therapy; allopurinol-febuxostat sequential therapy; and febuxostat-allopurinol sequential therapy. Two dosing scenarios were investigated: fixed dose (80 mg of febuxostat daily, 0.80 success rate; 300 mg of allopurinol daily, 0.39 success rate) and dose escalation (<= 120 mg of febuxostat daily, 0.82 success rate; <= 800 mg of allopurinol daily, 0.78 success rate). Outcome Measures: Discounted costs, discounted quality-adjusted life-years, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: In both dosing scenarios, allopurinol-only therapy was cost-saving. Dose-escalation allopurinol-febuxostat sequential therapy was more costly but more effective than dose-escalation allopurinol therapy, with an incremental cost-effectiveness ratio of $39 400 per quality-adjusted life-year. Results of Sensitivity Analysis: The relative rankings of treatments did not change. Our results were relatively sensitive to several potential variations of model assumptions; however, the cost-effectiveness ratios of dose escalation with allopurinol-febuxostat sequential therapy remained lower than the willingness-to-pay threshold of $109 000 per quality-adjusted life-year. Limitation: Long-term outcome data for patients with gout, including medication adherence, are limited. Conclusion: Allopurinol single therapy is cost-saving compared with no treatment. Dose-escalation allopurinol-febuxostat sequential therapy is cost-effective compared with accepted willingness-to-pay thresholds.	Univ Minnesota, Minneapolis, MN 55455 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Jefferson Sch Pharm, Philadelphia, PA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School	Jutkowitz, E (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, MMC 729,420 Delaware St SE, Minneapolis, MN 55455 USA.	Jutko001@umn.edu			Agency for Healthcare Research and Quality; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065944, R01AR056291, R21AR056042, P60AR047785] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Agency for Healthcare Research and Quality.	Sanchez JLA, 2007, ARCH SURG-CHICAGO, V142, P50, DOI 10.1001/archsurg.142.1.50; [Anonymous], 2010, 2010 RED BOOK PHARM; ARELLANO F, 1993, ANN PHARMACOTHER, V27, P337, DOI 10.1177/106002809302700317; Beard SM, 2014, EUR J HEALTH ECON, V15, P453, DOI 10.1007/s10198-013-0486-z; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Becker MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2978; Becker MA, 2009, J RHEUMATOL, V36, P1273, DOI 10.3899/jrheum.080814; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Briggs A, 2006, DECISION MODELLING H; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Dong D, 2012, NEUROLOGY, V79, P1259, DOI 10.1212/WNL.0b013e31826aac73; FERRAZ MB, 1995, J RHEUMATOL, V22, P908; Gold MR, 1996, COST EFFECTIVENESS H; Hamburger M, 2011, PHYSICIAN SPORTSMED, V39, P98, DOI 10.3810/psm.2011.11.1946; Henry J. Kaiser Family Foundation, 2010, MED ENROLLMENT PERCE; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Khanna PP, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-117; MCINNES GT, 1981, ANN RHEUM DIS, V40, P245, DOI 10.1136/ard.40.3.245; Meltzer Michele, 2012, Evid Based Med, V17, P105, DOI 10.1136/ebmed-2011-100065; Moreland LW, 2005, NEW ENGL J MED, V353, P2505, DOI 10.1056/NEJMe058247; National Institute for Health and Care Excellence, 2008, FEB MAN HYP PEOPL CO; Neogi T, 2006, J RHEUMATOL, V33, P104; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Rees F, 2013, ANN RHEUM DIS, V72, P826, DOI 10.1136/annrheumdis-2012-201676; Reinders MK, 2010, CLIN INTERV AGING, V5, P7; Rothenbacher D, 2011, RHEUMATOLOGY, V50, P973, DOI 10.1093/rheumatology/keq363; RUNDLES RW, 1966, ANN INTERN MED, V64, P229, DOI 10.7326/0003-4819-64-2-229; Sarawate CA, 2006, MAYO CLIN PROC, V81, P925, DOI 10.4065/81.7.925; Sarawate CA, 2006, JCR-J CLIN RHEUMATOL, V12, P61, DOI 10.1097/01.rhu.0000209882.50228.9f; Schumacher HR, 2009, RHEUMATOLOGY, V48, P188, DOI 10.1093/rheumatology/ken457; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Sheils J., 2009, HARMONIZING OBAMA BA; Stamp LK, 2011, ARTHRITIS RHEUM-US, V63, P412, DOI 10.1002/art.30119; Stevenson M, 2011, PHARMACOECONOMICS, V29, P133, DOI 10.2165/11535770-000000000-00000; Wu EQ, 2008, J MANAGE CARE PHARM, V14, P164, DOI 10.18553/jmcp.2008.14.2.164; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	39	38	44	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					617	U112		10.7326/M14-0227	http://dx.doi.org/10.7326/M14-0227			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364883				2022-12-28	WOS:000347244100002
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Just enough medicine for all	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Richards T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5765	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2014	349								g6421	10.1136/bmj.g6421	http://dx.doi.org/10.1136/bmj.g6421			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CB	25366144	Bronze, Green Published			2022-12-28	WOS:000344603500004
J	Ferry, G				Ferry, Georgina			The art of medicine Dorothy Hodgkin: on proteins and patterns	LANCET			English	Editorial Material												mgf@georginaferry.com							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1496	1497		10.1016/S0140-6736(14)61912-7	http://dx.doi.org/10.1016/S0140-6736(14)61912-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9MO	25390567				2022-12-28	WOS:000343899600013
J	Torres, VE; Abebe, KZ; Chapman, AB; Schrier, RW; Braun, WE; Steinman, TI; Winklhofer, FT; Brosnahan, G; Czarnecki, PG; Hogan, MC; Miskulin, DC; Rahbari-Oskoui, FF; Grantham, JJ; Harris, PC; Flessner, MF; Moore, CG; Perrone, RD				Torres, Vicente E.; Abebe, Kaleab Z.; Chapman, Arlene B.; Schrier, Robert W.; Braun, William E.; Steinman, Theodore I.; Winklhofer, Franz T.; Brosnahan, Godela; Czarnecki, Peter G.; Hogan, Marie C.; Miskulin, Dana C.; Rahbari-Oskoui, Frederic F.; Grantham, Jared J.; Harris, Peter C.; Flessner, Michael F.; Moore, Charity G.; Perrone, Ronald D.		HALT-PKD Trial Investigators	Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE CONTROL; COMBINATION THERAPY; ALDOSTERONE SYSTEM; CONVERTING-ENZYME; RECEPTOR BLOCKER; ACE-INHIBITOR; RENIN; PROGRESSION; RAMIPRIL; PROTEINURIA	BACKGROUND Hypertension develops early in patients with autosomal dominant polycystic kidney disease (ADPKD) and is associated with disease progression. The renin-angiotensin-aldosterone system (RAAS) is implicated in the pathogenesis of hypertension in patients with ADPKD. Dual blockade of the RAAS may circumvent compensatory mechanisms that limit the efficacy of monotherapy with an angiotensin-converting- enzyme (ACE) inhibitor or angiotensin II-receptor blocker (ARB). METHODS In this double-blind, placebo-controlled trial, we randomly assigned 486 patients, 18 to 64 years of age, with ADPKD (estimated glomerular filtration rate [GFR], 25 to 60 ml per minute per 1.73 m(2) of body-surface area) to receive an ACE inhibitor (lisinopril) and placebo or lisinopril and an ARB (telmisartan), with the doses adjusted to achieve a blood pressure of 110/70 to 130/80 mm Hg. The composite primary outcome was the time to death, end-stage renal disease, or a 50% reduction from the baseline estimated GFR. Secondary outcomes included the rates of change in urinary aldosterone and albumin excretion, frequency of hospitalizations for any cause and for cardiovascular causes, incidence of pain, frequency of ADPKD-related symptoms, quality of life, and adverse study-medication effects. Patients were followed for 5 to 8 years. RESULTS There was no significant difference between the study groups in the incidence of the composite primary outcome (hazard ratio with lisinopril-telmisartan, 1.08; 95% confidence interval, 0.82 to 1.42). The two treatments controlled blood pressure and lowered urinary aldosterone excretion similarly. The rates of decline in the estimated GFR, urinary albumin excretion, and other secondary outcomes and adverse events, including hyperkalemia and acute kidney injury, were also similar in the two groups. CONCLUSIONS Monotherapy with an ACE inhibitor was associated with blood-pressure control in most patients with ADPKD and stage 3 chronic kidney disease. The addition of an ARB did not alter the decline in the estimated GFR.	[Torres, Vicente E.; Hogan, Marie C.; Harris, Peter C.] Mayo Clin, Coll Med, Rochester, MN 55901 USA; [Abebe, Kaleab Z.; Moore, Charity G.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Chapman, Arlene B.; Rahbari-Oskoui, Frederic F.] Emory Univ, Sch Med, Atlanta, GA USA; [Schrier, Robert W.; Brosnahan, Godela] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Braun, William E.] Cleveland Clin, Cleveland, OH USA; [Steinman, Theodore I.; Czarnecki, Peter G.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Miskulin, Dana C.; Perrone, Ronald D.] Tufts Med Ctr, Boston, MA USA; [Winklhofer, Franz T.; Grantham, Jared J.] Univ Kansas, Med Ctr, Kansas City, MO USA; [Flessner, Michael F.] NIH, Bethesda, MD 20892 USA	Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Cleveland Clinic Foundation; Harvard University; Beth Israel Deaconess Medical Center; Tufts Medical Center; University of Kansas; National Institutes of Health (NIH) - USA	Torres, VE (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55901 USA.	torres.vicente@mayo.edu	Brosnahan, Godela/AAB-5741-2021; Abebe, Kaleab/K-4400-2019	Abebe, Kaleab/0000-0002-3644-8419; Masoumi, Amirali/0000-0002-1079-7258; Patterson, Charity/0000-0002-0060-0124; Rahbari-Oskoui, Frederic/0000-0001-8933-4880; Torres, Vicente/0000-0003-2008-1576; Nurko, Samuel/0000-0003-0936-4807	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001064, UL1TR001082, UL1TR000454, UL1TR000001, UL1TR000439, UL1TR001102, UL1TR000135] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000054, UL1RR033179, M01RR023940, UL1RR024150, UL1RR025780, M01RR000585, M01RR000039, M01RR000051, UL1RR025758, M01RR001032, UL1RR025008, UL1RR024989, UL1RR025752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062408, U01DK062402, P30DK090728, U01DK062401, U01DK062410, U01DK062411, U01DK082230] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; HALT-PKD [Study B] ClinicalTrials.gov number, NCT01885559.	CHAPMAN AB, 1990, NEW ENGL J MED, V323, P1091, DOI 10.1056/NEJM199010183231602; Chapman AB, 2010, CLIN J AM SOC NEPHRO, V5, P102, DOI 10.2215/CJN.04310709; Ecder T, 2000, AM J KIDNEY DIS, V35, P427, DOI 10.1016/S0272-6386(00)70195-8; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; GRAHAM PC, 1988, KIDNEY INT, V33, P1084, DOI 10.1038/ki.1988.115; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jennings DL, 2007, DIABETIC MED, V24, P486, DOI 10.1111/j.1464-5491.2007.02097.x; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT S, V5, P337, DOI DOI 10.1038/KISUP.2012.46; KLAHR S, 1995, J AM SOC NEPHROL, V5, P2037; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; LAN KKG, 1989, STAT MED, V8, P1191, DOI 10.1002/sim.4780081003; Laverman GD, 2002, KIDNEY INT, V62, P1020, DOI 10.1046/j.1523-1755.2002.00536.x; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; Loghman-Adham M, 2004, AM J PHYSIOL-RENAL, V287, pF775, DOI 10.1152/ajprenal.00370.2003; MacKinnon M, 2006, AM J KIDNEY DIS, V48, P8, DOI 10.1053/j.ajkd.2006.04.077; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Schrier RW, 2009, J AM SOC NEPHROL, V20, P1888, DOI 10.1681/ASN.2008080882; Seber G., 1989, NONLINEAR REGRESSION; Susantitaphong P, 2013, AM J HYPERTENS, V26, P424, DOI 10.1093/ajh/hps038; TORRES VE, 1992, KIDNEY INT, V42, P364, DOI 10.1038/ki.1992.297; TORRES VE, 1991, MAYO CLIN PROC, V66, P1010, DOI 10.1016/S0025-6196(12)61724-8; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Torres VE, 2012, KIDNEY INT, V81, P577, DOI 10.1038/ki.2011.411; van Dijk MA, 2003, NEPHROL DIAL TRANSPL, V18, P2314, DOI 10.1093/ndt/gfg417; Vonesh EF, 2006, STAT MED, V25, P143, DOI 10.1002/sim.2249; Walz G, 2010, NEW ENGL J MED, V363, P1977; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zeltner R, 2008, NEPHROL DIAL TRANSPL, V23, P573, DOI 10.1093/ndt/gfm731	36	177	180	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2267	2276		10.1056/NEJMoa1402686	http://dx.doi.org/10.1056/NEJMoa1402686			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW1KQ	25399731	Green Accepted			2022-12-28	WOS:000346048800007
J	Schratt, G				Schratt, Gerhard			NEUROBIOLOGY A molecular knife to dice depression	NATURE			English	Editorial Material							BETA-CATENIN; MICRORNAS; MECHANISMS; MODEL		Univ Marburg, Inst Physiol Chem, Biochemisch Pharmakol Centrum, D-35032 Marburg, Germany	Philipps University Marburg	Schratt, G (corresponding author), Univ Marburg, Inst Physiol Chem, Biochemisch Pharmakol Centrum, D-35032 Marburg, Germany.	schratt@staff.uni-marburg.de						Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Dias C, 2014, NATURE, V516, P51, DOI 10.1038/nature13976; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Foulkes WD, 2014, NAT REV CANCER, V14, P662, DOI 10.1038/nrc3802; Garmezy N, 1973, SCHIZOPHRENIA 1 10 D, P163; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Maguschak KA, 2012, NEUROPHARMACOLOGY, V62, P78, DOI 10.1016/j.neuropharm.2011.08.032; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Trew JL, 2011, CLIN PSYCHOL REV, V31, P1156, DOI 10.1016/j.cpr.2011.07.007; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011	15	3	5	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					45	46		10.1038/nature13942	http://dx.doi.org/10.1038/nature13942			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25383532				2022-12-28	WOS:000346310800032
J	Smith, PK; Puskas, JD; Ascheim, DD; Voisine, P; Gelijns, AC; Moskowitz, AJ; Hung, JW; Parides, MK; Ailawadi, G; Perrault, LP; Acker, MA; Argenziano, M; Thourani, V; Gammie, JS; Miller, MA; Page, P; Overbey, JR; Bagiella, E; Dagenais, F; Blackstone, EH; Kron, IL; Rose, EA; Moquete, EG; Jeffries, N; Gardner, TJ; O'Gara, PT; Alexander, JH; Michler, RE				Smith, P. K.; Puskas, J. D.; Ascheim, D. D.; Voisine, P.; Gelijns, A. C.; Moskowitz, A. J.; Hung, J. W.; Parides, M. K.; Ailawadi, G.; Perrault, L. P.; Acker, M. A.; Argenziano, M.; Thourani, V.; Gammie, J. S.; Miller, M. A.; Page, P.; Overbey, J. R.; Bagiella, E.; Dagenais, F.; Blackstone, E. H.; Kron, I. L.; Rose, E. A.; Moquete, E. G.; Jeffries, N.; Gardner, T. J.; O'Gara, P. T.; Alexander, J. H.; Michler, R. E.		Cardiothoracic Surg Trials Network	Surgical Treatment of Moderate Ischemic Mitral Regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-FAILURE; MYOCARDIAL-INFARCTION; SURVIVAL; SURGERY; REVASCULARIZATION; DETERMINANT; MECHANISM; SOCIETY; TRENDS; TIME	BACKGROUND Ischemic mitral regurgitation is associated with increased mortality and morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitralvalve repair to coronary-artery bypass grafting (CABG) are uncertain. METHODS We randomly assigned 301 patients with moderate ischemic mitral regurgitation to CABG alone or CABG plus mitral-valve repair (combined procedure). The primary end point was the left ventricular end-systolic volume index (LVESVI), a measure of left ventricular remodeling, at 1 year. This end point was assessed with the use of a Wilcoxon rank-sum test in which deaths were categorized as the lowest LVESVI rank. RESULTS At 1 year, the mean LVESVI among surviving patients was 46.1+/-22.4 ml per square meter of body-surface area in the CABG-alone group and 49.6+/-31.5 ml per square meter in the combined-procedure group (mean change from baseline, -9.4 and -9.3 ml per square meter, respectively). The rate of death was 6.7% in the combined-procedure group and 7.3% in the CABG-alone group (hazard ratio with mitral-valve repair, 0.90; 95% confidence interval, 0.38 to 2.12; P = 0.81). The rank-based assessment of LVESVI at 1 year (incorporating deaths) showed no significant between-group difference (z score, 0.50; P = 0.61). The addition of mitral-valve repair was associated with a longer bypass time (P<0.001), a longer hospital stay after surgery (P = 0.002), and more neurologic events (P = 0.03). Moderate or severe mitral regurgitation was less common in the combined-procedure group than in the CABG-alone group (11.2% vs. 31.0%, P<0.001). There were no significant between-group differences in major adverse cardiac or cerebrovascular events, deaths, readmissions, functional status, or quality of life at 1 year. CONCLUSIONS In patients with moderate ischemic mitral regurgitation, the addition of mitral-valve repair to CABG did not result in a higher degree of left ventricular reverse remodeling. Mitral-valve repair was associated with a reduced prevalence of moderate or severe mitral regurgitation but an increased number of untoward events. Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow-up may determine whether the lower prevalence of mitral regurgitation translates into a net clinical benefit.	[Smith, P. K.] Duke Univ, Med Ctr, Dept Surg, Div Cardiovasc & Thorac Surg, Durham, NC 27710 USA; [Alexander, J. H.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Puskas, J. D.; Rose, E. A.] Icahn Sch Med Mt Sinai, Mt Sinai Hlth Syst, Dept Cardiac Surg, New York, NY 10029 USA; [Ascheim, D. D.; Gelijns, A. C.; Moskowitz, A. J.; Parides, M. K.; Overbey, J. R.; Bagiella, E.; Moquete, E. G.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Int Ctr Hlth Outcomes & Innovat Res, New York, NY 10029 USA; [Argenziano, M.] Columbia Univ, Coll Phys & Surg, Dept Surg, Dept Cardiothorac Surg, New York, NY USA; [Michler, R. E.] Albert Einstein Coll Med, Monash Med Ctr, Dept Cardiothorac & Vasc Surg, New York, NY USA; [Voisine, P.; Dagenais, F.] Hop Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Perrault, L. P.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Page, P.] Hop Sacre Coeur, Dept Surg, Montreal, PQ H4J 1C5, Canada; [Hung, J. W.] Massachusetts Gen Hosp, Echocardiog Core Lab, Boston, MA 02114 USA; [O'Gara, P. T.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Ailawadi, G.; Kron, I. L.] Univ Virginia, Sch Med, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA; [Acker, M. A.] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Thourani, V.] Emory Univ, Sch Med, Div Cardiothorac Surg, Clin Res Unit, Atlanta, GA 30322 USA; [Gammie, J. S.] Univ Maryland, Baltimore, MD 21201 USA; [Miller, M. A.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Jeffries, N.] NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; [Blackstone, E. H.] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH USA; [Gardner, T. J.] Christiana Care Hlth Syst, Ctr Heart & Vasc Hlth, Newark, DE USA	Duke University; Duke University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Yeshiva University; Laval University; Universite de Montreal; Universite de Montreal; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Virginia; University of Pennsylvania; Emory University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cleveland Clinic Foundation; Christiana Care Health System	Gelijns, AC (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, 1 Gustave L Levy Pl,Box 1077, New York, NY 10029 USA.	annetine.gelijns@mssm.edu	Stevens, Louis-Mathieu/E-6453-2016; Rose, Eric/AAJ-2281-2020; thourani, vinod/AAP-5968-2020; Alexander, John/GVS-7271-2022; Parides, Michael/GON-8474-2022	Stevens, Louis-Mathieu/0000-0003-3372-3419; Overbey, Jessica/0000-0001-7283-1661; Moskowitz, Alan/0000-0002-4412-9450; Alexander, John/0000-0002-1444-2462; Browndyke, Jeffrey/0000-0002-8573-7073; Holubkov, Richard/0000-0003-0431-3381; Douglas, Pamela/0000-0001-9876-4049	National Heart, Lung, and Blood Institute [U01 HL088942]; National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; Thoratec and HeartWare; Edwards Lifesciences; St. Jude Medical; Sorin Medical; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL088925, UM1HL088953, UM1HL088955, U01HL088942] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Thoratec and HeartWare; Edwards Lifesciences; St. Jude Medical(St. Jude Medical); Sorin Medical; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a cooperative agreement (U01 HL088942) with the National Heart, Lung, and Blood Institute, including funding by the National Institute of Neurological Disorders and Stroke and the Canadian Institutes of Health Research.; Dr. Acker reports receiving consulting fees from Thoratec and HeartWare. Dr. Gelijns reports holding equity in MERS International. Dr. Thourani reports receiving grant support from Edwards Lifesciences, St. Jude Medical, and Sorin Medical. No other potential conflict of interest relevant to this article was reported.	Aklog L, 2001, CIRCULATION, V104, pI68; Bax JJ, 2004, CIRCULATION, V110, pII103, DOI 10.1161/01.CIR-0000138196.06772.4e; Bursi F, 2005, CIRCULATION, V111, P295, DOI 10.1161/01.CIR.0000151097.30779.04; Carson P, 2003, J CARD FAIL, V9, P164, DOI 10.1054/jcaf.2003.22; Castleberry AW, 2014, CIRCULATION, V129, P2547, DOI 10.1161/CIRCULATIONAHA.113.005223; Chan KMJ, 2012, CIRCULATION, V126, P2502, DOI 10.1161/CIRCULATIONAHA.112.143818; Christenson J T, 1995, J Heart Valve Dis, V4, P484; Deja MA, 2012, CIRCULATION, V125, P2639, DOI 10.1161/CIRCULATIONAHA.111.072256; ElBardissi AW, 2012, J THORAC CARDIOV SUR, V143, P273, DOI 10.1016/j.jtcvs.2011.10.029; Fattouch K, 2010, ANN THORAC SURG, V90, P1187, DOI 10.1016/j.athoracsur.2010.03.103; Fattouch K, 2009, J THORAC CARDIOV SUR, V138, P278, DOI 10.1016/j.jtcvs.2008.11.010; Flynn M, 2009, J THORAC CARDIOV SUR, V137, P1063, DOI 10.1016/j.jtcvs.2008.12.023; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grigioni F, 2005, J AM COLL CARDIOL, V45, P260, DOI 10.1016/j.jacc.2004.10.030; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; IZUMI S, 1987, CIRCULATION, V76, P777, DOI 10.1161/01.CIR.76.4.777; Kang DH, 2006, CIRCULATION, V114, pI499, DOI 10.1161/CIRCULATIONAHA.105.000398; Kim YH, 2005, ANN THORAC SURG, V79, P1895, DOI 10.1016/j.athoracsur.2004.11.005; KONO T, 1992, J AM COLL CARDIOL, V20, P1594, DOI 10.1016/0735-1097(92)90455-V; Konstam MA, 2003, J CARD FAIL, V9, P350, DOI 10.1054/j.cardfail.2003.09.001; Kumanohoso T, 2003, J THORAC CARDIOV SUR, V125, P135, DOI 10.1067/mtc.2003.78; Lam BK, 2005, ANN THORAC SURG, V79, P462, DOI 10.1016/j.athoracsur.2004.07.040; Lamas GA, 1997, CIRCULATION, V96, P827; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lee R, 2011, ANN THORAC SURG, V91, P677, DOI 10.1016/j.athoracsur.2010.11.009; Mallidi HR, 2004, J THORAC CARDIOV SUR, V127, P636, DOI 10.1016/j.jtcvs.2003.09.010; Michler RE, 2013, J THORAC CARDIOV SUR, V146, P1139, DOI 10.1016/j.jtcvs.2012.09.007; Milano CA, 2008, ANN THORAC SURG, V86, P735, DOI 10.1016/j.athoracsur.2008.05.017; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Penicka M, 2009, CIRCULATION, V120, P1474, DOI 10.1161/CIRCULATIONAHA.108.842104; Perez de Isla L, 2007, EUR HEART J, V28, P2866, DOI 10.1093/eurheartj/ehm469; Roshanali F, 2006, ECHOCARDIOGR-J CARD, V23, P31, DOI 10.1111/j.1540-8175.2006.00163.x; Ryden T, 2001, EUR J CARDIO-THORAC, V20, P276, DOI 10.1016/S1010-7940(01)00770-9; Schroder JN, 2005, CIRCULATION, V112, pI293, DOI 10.1161/CIRCULATIONAHA.104.523472; Smith PK, 2012, J THORAC CARDIOV SUR, V143, P111, DOI 10.1016/j.jtcvs.2011.05.006; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Wong DR, 2005, ANN THORAC SURG, V80, P570, DOI 10.1016/j.athoracsur.2005.03.034; Yiu SF, 2000, CIRCULATION, V102, P1400, DOI 10.1161/01.CIR.102.12.1400; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	42	276	295	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2178	2188		10.1056/NEJMoa1410490	http://dx.doi.org/10.1056/NEJMoa1410490			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25405390	Bronze, Green Accepted			2022-12-28	WOS:000345976700006
J	Harbauer, AB; Opalinska, M; Gerbeth, C; Herman, JS; Rao, S; Schonfisch, B; Guiard, B; Schmidt, O; Pfanner, N; Meisinger, C				Harbauer, Angelika B.; Opalinska, Magdalena; Gerbeth, Carolin; Herman, Josip S.; Rao, Sanjana; Schoenfisch, Birgit; Guiard, Bernard; Schmidt, Oliver; Pfanner, Nikolaus; Meisinger, Chris			Cell cycle-dependent regulation of mitochondrial preprotein translocase	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; OUTER-MEMBRANE; MORPHOLOGY; DYNAMICS; KINASES; FUSION; SPECIFICITY; PHOSPHATASE; PROGRESSION	Mitochondria play central roles in cellular energy conversion, metabolism, and apoptosis. Mitochondria import more than 1000 different proteins from the cytosol. It is unknown if the mitochondrial protein import machinery is connected to the cell division cycle. We found that the cyclin-dependent kinase Cdk1 stimulated assembly of the main mitochondrial entry gate, the translocase of the outer membrane (TOM), in mitosis. The molecular mechanism involved phosphorylation of the cytosolic precursor of Tom6 by cyclin Clb3-activated Cdk1, leading to enhanced import of Tom6 into mitochondria. Tom6 phosphorylation promoted assembly of the protein import channel Tom40 and import of fusion proteins, thus stimulating the respiratory activity of mitochondria in mitosis. Tom6 phosphorylation provides a direct means for regulating mitochondrial biogenesis and activity in a cell cycle-specific manner.	[Harbauer, Angelika B.; Opalinska, Magdalena; Gerbeth, Carolin; Herman, Josip S.; Rao, Sanjana; Schoenfisch, Birgit; Schmidt, Oliver; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Harbauer, Angelika B.; Gerbeth, Carolin] Univ Freiburg, Trinat Graduiertenkolleg 1478, D-79104 Freiburg, Germany; [Harbauer, Angelika B.; Gerbeth, Carolin; Rao, Sanjana] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Harbauer, Angelika B.; Schmidt, Oliver; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Rao, Sanjana] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de; chris.meisinger@biochemie.uni-freiburg.de	Meisinger, Chris/J-1110-2014; Pfanner, Nikolaus/AAV-7878-2021	Meisinger, Chris/0000-0002-8326-3548; Schmidt, Oliver/0000-0002-7921-4663; Harbauer, Angelika/0000-0002-4568-9003; Opalinska, Magdalena/0000-0003-1449-4243	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School); Bundesministerium fur Bildung und Forschung (Dynamo) [Sonderforschungsbereich 746]; Trinationales Graduiertenkolleg GRK [1478]	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School); Bundesministerium fur Bildung und Forschung (Dynamo)(Federal Ministry of Education & Research (BMBF)); Trinationales Graduiertenkolleg GRK	We thank M. Bohnert, N. Wiedemann, M. van der Laan, T. Becker, L. Ellenrieder, D. Mikropoulou, and W. Stroukov for discussion, materials, and basic characterization of yeast mutants. This work was supported by the Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School), Bundesministerium fur Bildung und Forschung (Dynamo), Sonderforschungsbereich 746, and Trinationales Graduiertenkolleg GRK 1478. Work included in this study has also been performed in partial fulfillment of the requirements for the doctoral theses of A. B. H. and O.S. at the University of Freiburg. The data presented in this paper are tabulated in the main paper and the supplementary materials.	Amon A, 2002, METHOD ENZYMOL, V351, P457; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dukanovic J, 2009, MOL CELL BIOL, V29, P5975, DOI 10.1128/MCB.00069-09; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Fajas L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00004; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gerbeth C, 2013, CELL METAB, V18, P578, DOI 10.1016/j.cmet.2013.09.006; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Radulovic M, 2010, MOL CELL PROTEOMICS, V9, P145, DOI 10.1074/mcp.M900078-MCP200; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Vevea JD, 2014, TRENDS CELL BIOL, V24, P53, DOI 10.1016/j.tcb.2013.07.003; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753	35	86	89	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1109	1113		10.1126/science.1261253	http://dx.doi.org/10.1126/science.1261253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25378463				2022-12-28	WOS:000345763400042
J	Yarborough, M				Yarborough, Mark			Openness in science is key to keeping public trust	NATURE			English	Editorial Material									Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Davis	Yarborough, M (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.	mark.yarborough@ucdmc.ucdavis.edu	Yarborough, Mark/L-4098-2019	Yarborough, Mark/0000-0001-8188-4968					0	14	14	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					313	313		10.1038/515313a	http://dx.doi.org/10.1038/515313a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7HE	25409791	Green Submitted, Bronze			2022-12-28	WOS:000345770600010
J	Mega, JL; Sabatine, MS; Antman, EM				Mega, Jessica L.; Sabatine, Marc S.; Antman, Elliott M.			Population and Personalized Medicine in the Modern Era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STRATEGY; DISEASE; RISK		[Mega, Jessica L.; Sabatine, Marc S.; Antman, Elliott M.] Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Boston, MA 02115 USA; [Mega, Jessica L.; Sabatine, Marc S.; Antman, Elliott M.] Harvard Univ, Sch Med, Boston, MA USA; [Antman, Elliott M.] Amer Heart Assoc, Dallas, TX USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Mega, JL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	jmega@partners.org	Sabatine, Marc/AAJ-6751-2020	Sabatine, Marc/0000-0002-0691-3359				Castellano JM, 2014, J AM COLL CARDIOL, V64, P613, DOI 10.1016/j.jacc.2014.06.009; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Sugarman J, 2014, JAMA-J AM MED ASSOC, V311, P2381, DOI 10.1001/jama.2014.4164; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P918, DOI 10.1001/jama.2013.277064; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228	8	24	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1969	1970		10.1001/jama.2014.15224	http://dx.doi.org/10.1001/jama.2014.15224			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399267				2022-12-28	WOS:000345450500006
J	Varvarigou, V; Farioli, A; Korre, M; Sato, S; Dahabreh, IJ; Kales, SN				Varvarigou, Vasileia; Farioli, Andrea; Korre, Maria; Sato, Sho; Dahabreh, Issa J.; Kales, Stefanos N.			Law enforcement duties and sudden cardiac death among police officers in United States: case distribution study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; FIREFIGHTERS; EVENTS; STRESS; EXERTION; ANGER; RISK	Objective To assess the association between risk of sudden cardiac death and stressful law enforcement duties compared with routine/non-emergency duties. Design Case distribution study (case series with survey information on referent exposures). Setting United States law enforcement. Participants Summaries of deaths of over 4500 US police officers provided by the National Law Enforcement Officers Memorial Fund and the Officer Down Memorial Page from 1984 to 2010. Main outcome measures Observed and expected sudden cardiac death counts and relative risks for sudden cardiac death events during specific strenuous duties versus routine/non-emergency activities. Independent estimates of the proportion of time that police officers spend across various law enforcement duties obtained from surveys of police chiefs and front line officers. Impact of varying exposure assessments, covariates, and missing cases in sensitivity and stability analyses. Results 441 sudden cardiac deaths were observed during the study period. Sudden cardiac death was associated with restraints/altercations (25%, n=108), physical training (20%, n=88), pursuits of suspects (12%, n=53), medical/rescue operations (8%, n=34), routine duties (23%, n=101), and other activities (11%, n=57). Compared with routine/non-emergency activities, the risk of sudden cardiac death was 34-69 times higher during restraints/altercations, 32-51 times higher during pursuits, 20-23 times higher during physical training, and 6-9 times higher during medical/rescue operations. Results were robust to all sensitivity and stability analyses. Conclusions Stressful law enforcement duties are associated with a risk of sudden cardiac death that is markedly higher than the risk during routine/non-emergency duties. Restraints/altercations and pursuits are associated with the greatest risk. Our findings have public health implications and suggest that primary and secondary cardiovascular prevention efforts are needed among law enforcement officers.	[Varvarigou, Vasileia; Farioli, Andrea; Korre, Maria; Kales, Stefanos N.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Varvarigou, Vasileia] Tufts Med Sch, St Elizabeths Med Ctr, Dept Internal Med, Brighton, MA USA; [Farioli, Andrea; Korre, Maria; Sato, Sho; Kales, Stefanos N.] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Cambridge, MA 02138 USA; [Farioli, Andrea] Univ Bologna, DIMEC, Dept Med & Surg Sci, Bologna, Italy; [Dahabreh, Issa J.] Brown Univ, Sch Publ Hlth, Ctr Evidence Based Med, Providence, RI 02912 USA; [Dahabreh, Issa J.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA	Harvard University; Harvard T.H. Chan School of Public Health; St. Elizabeth's Medical Center; Tufts University; Harvard University; Cambridge Health Alliance; University of Bologna; Brown University; Brown University	Kales, SN (corresponding author), Cambridge Hosp, Dept Environm Hlth, Macht Bldg 427,1493 Cambridge St, Cambridge, MA 02139 USA.	skales@hsph.harvard.edu	Farioli, Andrea/K-9256-2016	Farioli, Andrea/0000-0003-2001-2140	Harvard-NIOSH Education and Research Center [2 T42 OH008416-08]; Monica Odening '06 Internship and Research Fund in Mathematics (Hamilton College); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008416] Funding Source: NIH RePORTER	Harvard-NIOSH Education and Research Center(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Monica Odening '06 Internship and Research Fund in Mathematics (Hamilton College); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	Research support was provided by a pilot project grant awarded by the Harvard-NIOSH Education and Research Center Grant No 2 T42 OH008416-08 and the Monica Odening '06 Internship and Research Fund in Mathematics (Hamilton College).	Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Anderson GS, 2002, POLICING, V25, P399, DOI 10.1108/13639510210429437; [Anonymous], 2012, PROT HUM SUBJ; [Anonymous], 2012, OCC EMPL STAT; [Anonymous], CURR POP SURV; Braunwald E., 2012, BRAUNWALDS HEART DIS; Collins PA, 2003, OCCUP MED-OXFORD, V53, P256, DOI 10.1093/occmed/kqg061; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P1225, DOI 10.1001/jama.2011.336; Farioli A, 2014, OCCUP MED LOND; Geibe JR, 2008, AM J CARDIOL, V101, P585, DOI 10.1016/j.amjcard.2007.10.017; Greenland S, 1999, STAT MED, V18, P1, DOI 10.1002/(SICI)1097-0258(19990115)18:1<1::AID-SIM961>3.0.CO;2-L; Hickman MJ, 2011, POLICE Q, V14, P227, DOI 10.1177/1098611111413991; Holder JD, 2006, J OCCUP ENVIRON MED, V48, P1047, DOI 10.1097/01.jom.0000235909.31632.46; Johnson Kevin, 2013, US TODAY; Kales SN, 2007, NEW ENGL J MED, V356, P1207, DOI 10.1056/NEJMoa060357; Kales Stefanos N, 2003, Environ Health, V2, P14, DOI 10.1186/1476-069X-2-14; Kales SN, 2009, AM J HYPERTENS, V22, P11, DOI 10.1038/ajh.2008.296; Korre M, 2014, POLIC-J POLICY PRACT, V8, P109, DOI 10.1093/police/pau001; Lash T.L., 2014, INT J EPIDEMIOL; Lipovetzky N, 2007, ISR MED ASSOC J, V9, P310; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; National Occuparional Research Agenda. CDC, 2014, CDC; Ramey SL, 2008, AAOHN J, V56, P54; Smith DL, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-6; Soteriades ES, 2011, CARDIOL REV, V19, P202, DOI 10.1097/CRD.0b013e318215c105; Tiesman HM, 2013, AM J IND MED, V56, P693, DOI 10.1002/ajim.22182; U.S Department of Labor BLS, 2012, ED DESK RISK POL WOR; VIOLANTI JM, 1994, PSYCHOL REP, V75, P824, DOI 10.2466/pr0.1994.75.2.824; Yang J, 2013, AM J CARDIOL, V112, P1962, DOI 10.1016/j.amjcard.2013.08.029; Zimmerman FH, 2012, CARDIOL REV, V20, P159, DOI 10.1097/CRD.0b013e318248d631	31	34	35	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2014	349								g6534	10.1136/bmj.g6534	http://dx.doi.org/10.1136/bmj.g6534			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JY	25406189	Green Published, hybrid			2022-12-28	WOS:000345445600002
J	de Massy, B				de Massy, Bernard			Hidden features of human hotspots	SCIENCE			English	Editorial Material							MEIOTIC RECOMBINATION; PRDM9; MICE; GENE		Inst Human Genet, F-34396 Montpellier, France	Universite de Montpellier	de Massy, B (corresponding author), Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier, France.	bernard.de-massy@igh.cnrs.fr						Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Odenthal-Hesse L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004106; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869	12	1	1	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					808	809		10.1126/science.aaa0612	http://dx.doi.org/10.1126/science.aaa0612			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395519				2022-12-28	WOS:000344659900018
J	Gammon, K				Gammon, Katharine			Editorial control	NATURE			English	Editorial Material							DISEASE											Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Romero Z, 2013, J CLIN INVEST, V123, P3317, DOI 10.1172/JCI67930; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016	3	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S11	S13		10.1038/515S11a	http://dx.doi.org/10.1038/515S11a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390136				2022-12-28	WOS:000344631400008
J	Monteggia, LM				Monteggia, Lisa M.			Put therapies first	NATURE			English	Editorial Material									Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Monteggia, LM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	lisa.monteggia@utsouthwestern.edu							0	48	53	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					200	200		10.1038/515200a	http://dx.doi.org/10.1038/515200a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391955				2022-12-28	WOS:000344631400031
J	Tallis, H; Lubchenco, J				Tallis, Heather; Lubchenco, Jane			A call for inclusive conservation	NATURE			English	Editorial Material							SCIENCE		[Tallis, Heather] Nature Conservancy, Santa Cruz, CA 94954 USA; [Lubchenco, Jane] Oregon State Univ, Corvallis, OR 97331 USA	Nature Conservancy; Oregon State University	Tallis, H (corresponding author), Nature Conservancy, Santa Cruz, CA 94954 USA.	htallis@tnc.org	Guerrero Gonzalez, Angela/L-2554-2014; Acuña, Vicenç/L-6608-2014; Biggs, Reinette/A-5155-2010; Nicholas, Kimberly A./W-7096-2019; Watson, James Edward Maxwell/D-8779-2013; Kark, Salit/C-6795-2016; Klein, Alexandra-Maria/J-5871-2016; Clerici, Nicola/H-7758-2019; Clerici, Nicola/C-8994-2012; Pufal, Gesine/K-7872-2016; Mills, Morena/C-6546-2013; Posada, Juan/G-3616-2016; Wood, Spencer/A-3603-2009; klein, carissa/F-1632-2011; Adams, Vanessa/A-3834-2012	Guerrero Gonzalez, Angela/0000-0002-1556-9860; Acuña, Vicenç/0000-0002-4485-6703; Biggs, Reinette/0000-0003-0300-4149; Nicholas, Kimberly A./0000-0002-4756-7851; Watson, James Edward Maxwell/0000-0003-4942-1984; Kark, Salit/0000-0002-7183-3988; Klein, Alexandra-Maria/0000-0003-2139-8575; Clerici, Nicola/0000-0003-4547-7606; Clerici, Nicola/0000-0003-4547-7606; Pufal, Gesine/0000-0002-2513-254X; Mills, Morena/0000-0001-9865-0770; Posada, Juan/0000-0001-7794-9300; klein, carissa/0000-0002-6299-6451; Giakoumi, Sylvaine/0000-0002-3301-5538; Griffin, Robert/0000-0002-6271-5613; Adams, Vanessa/0000-0002-3509-7901; Gerber, Leah/0000-0002-6763-6842; Maggini, Ramona/0000-0001-7031-0096	Direct For Biological Sciences [1026415] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Alagona Peter, 2013, GRIZZLY ENDANGERED S, DOI DOI 10.1525/9780520954410; Carson Rachel, 1994, SILENT SPRING; Chapin FS, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00166.1; Gudynas E., 2011, NATURALEZA CONDERECH, P239; Kareiva P, 2012, BIOSCIENCE, V62, P962, DOI 10.1525/bio.2012.62.11.5; Max D. T., 2014, NEW YORKER; Reid WV, 2006, NATURE, V443, P749, DOI 10.1038/443749a; Soule M, 2013, CONSERV BIOL, V27, P895, DOI 10.1111/cobi.12147; Toledo Victor, 2014, MEMORIA BIOCULTURAL; UNESCO Institute for Statistics, 2012, WOM SCI UIS FACT SHE	10	203	207	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					27	28		10.1038/515027a	http://dx.doi.org/10.1038/515027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS3OE	25373659	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000344187500013
J	Tran, TH; Hsiao, YS; Jo, J; Chou, CY; Dietrich, LEP; Walz, T; Tong, L				Tran, Timothy H.; Hsiao, Yu-Shan; Jo, Jeanyoung; Chou, Chi-Yuan; Dietrich, Lars E. P.; Walz, Thomas; Tong, Liang			Structure and function of a single-chain, multi-domain long-chain acyl-CoA carboxylase	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA PAO1; COMPLETE GENOME SEQUENCE; PYRUVATE-CARBOXYLASE; CRYSTAL-STRUCTURE; CARBOXYLTRANSFERASE DOMAIN; MYCOBACTERIUM-TUBERCULOSIS; 3-DIMENSIONAL STRUCTURE; ACETYL-COENZYME; BIOTIN; SOFTWARE	Biotin-dependent carboxylases are widely distributed in nature and have important functions in the metabolism of fatty acids, amino acids, carbohydrates, cholesterol and other compounds(1-6). Defective mutations in several of these enzymes have been linked to serious metabolic diseases in humans, and acetyl-CoA carboxylase is a target for drug discovery in the treatment of diabetes, cancer and other diseases(7-9). Here we report the identification and biochemical, structural and functional characterizations of a novel single-chain (120 kDa), multi-domain biotin-dependent carboxylase in bacteria. It has preference for long-chain acyl-CoA substrates, although it is also active towards short-chain and medium-chainacyl-CoAs, and we have named it long-chain acyl-CoA carboxylase. The holoenzyme is a homo-hexamer with molecular mass of 720 kDa. The 3.0 angstrom crystal structure of the long-chain acyl-CoA carboxylase holoenzyme from Mycobacterium avium subspecies paratuberculosis revealed an architecture that is strikingly different from those of related biotin-dependent carboxylases(10,11). In addition, the domains of each monomer have no direct contact with each other. They are instead extensively swapped in the holoenzyme, such that one cycle of catalysis involves the participation of four monomers. Functional studies in Pseudomonas aeruginosa suggest that the enzyme is involved in the utilization of selected carbon and nitrogen sources.	[Tran, Timothy H.; Jo, Jeanyoung; Chou, Chi-Yuan; Dietrich, Lars E. P.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Hsiao, Yu-Shan; Walz, Thomas] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Columbia University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Walz, Thomas/0000-0003-2606-2835; Tong, Liang/0000-0002-0563-6468; Dietrich, Lars/0000-0003-2049-1137; Chou, Chi-Yuan/0000-0002-3400-171X	National Institutes of Health (NIH) [S10OD012018]; NIH [R01DK067238, R01AI103369, NCRR 1S10RR028832-01]; Protein Structure Initiative of the NIH [U54GM094597]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580, T32GM008798, U54GM094597] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012018] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Structure Initiative of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Huang for carrying out some initial studies in this project; A. Price-Whelan for discussions on P. aeruginosa physiology; R. Jackimowicz, N. Whalen and H. Robinson for access to the X29A beamline; Z. Li for EM support; P. Penczek for help with SPARX. The in-house instrument for X-ray diffraction was purchased with a National Institutes of Health (NIH) grant to L.T. (S10OD012018). This research is supported by grants from the NIH (R01DK067238 to L.T. and R01AI103369 to L.E.P.D.) and from the Protein Structure Initiative of the NIH (U54GM094597 to L.T.). The Orchestra High Performance Compute Cluster at Harvard Medical School is a shared facility partly supported by NIH grant NCRR 1S10RR028832-01. T.W. is an investigator with the Howard Hughes Medical Institute.	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Aguilar JA, 2008, J BACTERIOL, V190, P4888, DOI 10.1128/JB.00454-08; Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan C, 2012, J BIOL CHEM, V287, P9389, DOI 10.1074/jbc.M111.319475; Forster-Fromme K, 2010, APPL MICROBIOL BIOT, V87, P859, DOI 10.1007/s00253-010-2644-x; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grande R., 2007, J BACTERIOL, V189, P5257; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huang CS, 2012, NATURE, V481, P219, DOI 10.1038/nature10691; Huang CS, 2010, NATURE, V466, P1001, DOI 10.1038/nature09302; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Lai HF, 2006, APPL ENVIRON MICROB, V72, P7785, DOI 10.1128/AEM.01564-06; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polyak SW, 2012, APPL MICROBIOL BIOT, V93, P983, DOI 10.1007/s00253-011-3796-z; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Shea April, 2012, Methods Mol Biol, V881, P331, DOI 10.1007/978-1-61779-827-6_12; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Waldrop GL, 2012, PROTEIN SCI, V21, P1597, DOI 10.1002/pro.2156; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	45	20	22	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					120	+		10.1038/nature13912	http://dx.doi.org/10.1038/nature13912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25383525	Green Accepted, Green Submitted			2022-12-28	WOS:000349098000044
J	Faller, WJ; Jackson, TJ; Knight, JRP; Ridgway, RA; Jamieson, T; Karim, SA; Jones, C; Radulescu, S; Huels, DJ; Myant, KB; Dudek, KM; Casey, HA; Scopelliti, A; Cordero, JB; Vidal, M; Pende, M; Ryazanov, AG; Sonenberg, N; Meyuhas, O; Hall, MN; Bushell, M; Willis, AE; Sansom, OJ				Faller, William J.; Jackson, Thomas J.; Knight, John R. P.; Ridgway, Rachel A.; Jamieson, Thomas; Karim, Saadia A.; Jones, Carolyn; Radulescu, Sorina; Huels, David J.; Myant, Kevin B.; Dudek, Kate M.; Casey, Helen A.; Scopelliti, Alessandro; Cordero, Julia B.; Vidal, Marcos; Pende, Mario; Ryazanov, Alexey G.; Sonenberg, Nahum; Meyuhas, Oded; Hall, Michael N.; Bushell, Martin; Willis, Anne E.; Sansom, Owen J.			mTORC1-mediated translational elongation limits intestinal tumour initiation and growth	NATURE			English	Article							COLORECTAL-CANCER; STEM-CELLS; MAMMALIAN TARGET; BETA-CATENIN; IN-VITRO; C-MYC; KINASE; GENE; MTOR; INHIBITION	Inactivation of APC is a strongly predisposing event in the development of colorectal cancer(1,2), prompting the search for vulnerabilities specific to cells that have lost APC function. Signalling through the mTOR pathway is known to be required for epithelial cell proliferation and tumour growth(3,5), and the current paradigm suggests that a critical function of mTOR activity is to upregulate translational initiation through phosphorylation of 4EBP 1 (refs 6, 7). This model predicts that the mTOR inhibitor rapamycin, which does not efficiently inhibit 4EBP 1 (ref. 8), would be ineffective in limiting cancer progression in APC-deficient lesions. Here we show in mice that mTOR complex 1 (mTORC1) activity is absolutely required for the proliferation of Apc-deficient (but not wild-type) enterocytes, revealing an unexpected opportunity for therapeutic intervention. Although APC-deficient cells show the expected increases in protein synthesis, our study reveals that it is translation elongation, and not initiation, which is the rate-limiting component. Mechanistically, mTORC1-mediated inhibition of eEF2 kinase is required for the proliferation of APC-deficient cells. Importantly, treatment of established APC-deficient adenomas with rapamycin (which can target eEF2 through the mTORCI-56K-eEF2K axis) causes tumour cells to undergo growth arrest and differentiation. Taken together, our data suggest that inhibition of translation elongation using existing, clinically approved drugs, such as the rapalogs, would provide clear therapeutic benefit for patients at high risk of developing colorectal cancer.	[Faller, William J.; Ridgway, Rachel A.; Jamieson, Thomas; Karim, Saadia A.; Radulescu, Sorina; Huels, David J.; Myant, Kevin B.; Casey, Helen A.; Scopelliti, Alessandro; Cordero, Julia B.; Vidal, Marcos; Sansom, Owen J.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Jackson, Thomas J.; Knight, John R. P.; Jones, Carolyn; Dudek, Kate M.; Bushell, Martin; Willis, Anne E.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Pende, Mario] Inst Necker Enfants Malad, CS 61431, Paris, France; [Pende, Mario] INSERM, U1151, F-75014 Paris, France; [Pende, Mario] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Ryazanov, Alexey G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Meyuhas, Oded] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Beatson Institute; University of Leicester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rutgers State University New Brunswick; Rutgers State University Medical Center; McGill University; McGill University; Hebrew University of Jerusalem; University of Basel	Sansom, OJ (corresponding author), Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Pende, Mario/AFR-1348-2022; Knight, John/GSE-3183-2022; ryazanov, alexey/J-8081-2017; Jackson, Thomas/GQI-2752-2022; Knight, John/V-2922-2019	Pende, Mario/0000-0002-7864-8937; Jackson, Thomas/0000-0003-1669-6666; Knight, John/0000-0002-8771-5484; myant, kevin/0000-0001-8017-1093; Huels, David/0000-0001-6154-1183; Cordero, Julia/0000-0003-1701-9480; Faller, William James/0000-0002-0738-2254; Willis, Anne/0000-0002-1470-8531; Hall, Michael N/0000-0002-2998-0757; Sansom, Owen J./0000-0001-9540-3010; Scopelliti, Alessandro/0000-0002-7541-8108	AICR; Cancer Research UK; European Research Council; European Union Seventh Framework Programme [278568]; BBSRC [BB/F018738/2, BB/F02326X/2, BB/H024980/1] Funding Source: UKRI; MRC [MC_UP_A600_1023, MC_UP_A600_1024, MC_EX_G0902052] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F018738/2, BB/H024980/1, BB/F02326X/2] Funding Source: researchfish; Cancer Research UK [11594] Funding Source: researchfish; Medical Research Council [MC_EX_G0902052, MC_UP_A600_1023, MC_UP_A600_1024] Funding Source: researchfish; Versus Arthritis [20409, 21139] Funding Source: researchfish; National Centre for the Replacement [G1000078/1] Funding Source: researchfish	AICR; Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); European Union Seventh Framework Programme(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); National Centre for the Replacement	W.J.F. is funded by AICR. O.J.S. is funded by Cancer Research UK, European Research Council Investigator Grant (COLONCAN) and the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement number 278568. M.B. is a Medical Research Council Senior Fellow. The authors acknowledge P. Cammareri, J. Morton and C. Murgia for proofreading of the manuscript.	Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Baan B, 2012, GUT, V61, P1708, DOI 10.1136/gutjnl-2011-301626; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bernal NP, 2005, J PEDIATR SURG, V40, P1025, DOI 10.1016/j.jpedsurg.2005.03.021; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Firczuk H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.73; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gorshtein A, 2009, ENDOCR-RELAT CANCER, V16, P1017, DOI 10.1677/ERC-08-0269; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Gutzkow KB, 2003, CELL SIGNAL, V15, P871, DOI 10.1016/S0898-6568(03)00038-X; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jiang YP, 2001, J BIOL CHEM, V276, P10943, DOI 10.1074/jbc.M007758200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Martineau Y, 2014, ONCOGENE, V33, P1367, DOI 10.1038/onc.2013.100; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Pourdehnada M, 2013, P NATL ACAD SCI USA, V110, P11988, DOI 10.1073/pnas.1310230110; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	194	201	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					497	+		10.1038/nature13896	http://dx.doi.org/10.1038/nature13896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25383520	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000348196500037
J	Ortega, MA; Hao, Y; Zhang, Q; Walker, MC; van der Donk, WA; Nair, SK				Ortega, Manuel A.; Hao, Yue; Zhang, Qi; Walker, Mark C.; van der Donk, Wilfred A.; Nair, Satish K.			Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PRECURSOR LIPID II; IN-VITRO; BIOSYNTHESIS; PEPTIDE; PROTEIN; GENERATION; PRENISIN	Lantibiotics are a class of peptide antibiotics that contain one or more thioether bonds. The lantibiotic nisin is an antimicrobial peptide that is widely used as a food preservative to combat food-borne pathogens(1). Nisin contains dehydroalanine and dehydrobutyrine residues that are formed by the dehydration of Ser/Thr by the lantibiotic dehydratase NisB (ref. 2). Recent biochemical studies revealed that NisB glutamylates Ser/Thr side chains as part of the dehydration process'. However, the molecular mechanism by which NisB uses glutamate to catalyse dehydration remains unresolved. Here we show that this process involves Outamyl-tRNA(Glu) to activate Ser/Thr residues. In addition, the 2.9-angstrom crystal structure of NisB in complex with its substrate peptide NisA reveals the presence of two separate domains that catalyse the Ser/Thr glutamylation and glutamate elimination steps. The co-crystal structure also provides insights into substrate recognition by lantibiotic dehydratases. Our findings demonstrate an unexpected role for aminoacyl-tRNA in the formation of dehydroamino acids in lantibiotics, and serve as a basis for the functional characterization of the many lantibiotic-like dehydratases involved in the biosynthesis of other classes of natural products. [GRAPHICS] .	[Ortega, Manuel A.; Hao, Yue; van der Donk, Wilfred A.; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Zhang, Qi; Walker, Mark C.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Zhang, Qi; Walker, Mark C.; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, 600 South Mathews Ave, Urbana, IL 61801 USA.	vddonk@illinois.edu; s-nair@life.uiuc.edu	Hao, Yue/O-6107-2019; van der Donk, Wilfred/K-2961-2015; Hao, Yue/AAA-3530-2022; Nair, Satish/AAY-2510-2021	van der Donk, Wilfred/0000-0002-5467-7071; Hao, Yue/0000-0003-0943-0499; Walker, Mark/0000-0003-3942-003X	National Institutes of Health (NIH) [R01 GM 058822, R01 GM079038]; National Institute of General Medical Sciences (NIGMS) NIH Chemistry Biology Interface Training Grant [5T32-GM070421]; Ford Foundation; Lowell P. Hager fellowship from the Department of Biochemistry; NIH [S10 RR027109 A]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058822, T32GM070421, R01GM079038, F32GM112284] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS) NIH Chemistry Biology Interface Training Grant; Ford Foundation; Lowell P. Hager fellowship from the Department of Biochemistry; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Brister and colleagues for facilitating data collection at LS-CAT (Argonne National Labs, Illinois). This work was supported by grants from the National Institutes of Health (NIH) (R01 GM 058822 to W.A.v.d.D., and R01 GM079038 to S.K.N.). M.A.O. was supported partly by a National Institute of General Medical Sciences (NIGMS) NIH Chemistry Biology Interface Training Grant (5T32-GM070421) and by the Ford Foundation. Y.H. was supported partly by a Lowell P. Hager fellowship from the Department of Biochemistry. The Bruker UltrafleXtreme MALDI-TOF/TOF mass spectrometer was purchased in part with a grant from the NIH (S10 RR027109 A). The content of this work is solely the responsibility of the authors and do not necessarily represent the official views of the NIH or Ford Foundation.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bougioukou DJ, 2013, P NATL ACAD SCI USA, V110, P10952, DOI 10.1073/pnas.1303568110; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francklyn CS, 2010, FEBS LETT, V584, P366, DOI 10.1016/j.febslet.2009.11.045; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garg N, 2013, P NATL ACAD SCI USA, V110, P7258, DOI 10.1073/pnas.1222488110; Garg RP, 2008, P NATL ACAD SCI USA, V105, P6543, DOI 10.1073/pnas.0708957105; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Janssen Brian D, 2012, Methods Mol Biol, V905, P291, DOI 10.1007/978-1-61779-949-5_19; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KALETTA C, 1989, J BACTERIOL, V171, P1597, DOI 10.1128/jb.171.3.1597-1601.1989; Khusainov R, 2011, MOL MICROBIOL, V82, P706, DOI 10.1111/j.1365-2958.2011.07846.x; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; Koehnke J, 2013, ANGEW CHEM INT EDIT, V52, P13991, DOI 10.1002/anie.201306302; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li B, 2009, METHOD ENZYMOL, V458, P533, DOI 10.1016/S0076-6879(09)04821-6; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044453; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2008, APPL ENVIRON MICROB, V74, P4680, DOI 10.1128/AEM.00112-08; Lubelski J, 2009, J BIOL CHEM, V284, P25962, DOI 10.1074/jbc.M109.026690; Marques JC, 2011, J BIOL CHEM, V286, P18331, DOI 10.1074/jbc.M111.230227; Mavaro A, 2011, J BIOL CHEM, V286, P30552, DOI 10.1074/jbc.M111.263210; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Plat A, 2011, APPL ENVIRON MICROB, V77, P604, DOI 10.1128/AEM.01503-10; Rio D. C., 2011, RNA LAB MANUAL, P216; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sardar D., 2014, ACS SYNTH BIOL; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Sen AK, 1999, EUR J BIOCHEM, V261, P524, DOI 10.1046/j.1432-1327.1999.00303.x; Shazman S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000146; Sherlin LD, 2001, RNA, V7, P1671; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Thorn A, 2013, ACTA CRYSTALLOGR D, V69, P2251, DOI 10.1107/S0907444913027534; VANDERMEER JR, 1993, J BACTERIOL, V175, P2578, DOI 10.1128/JB.175.9.2578-2588.1993; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Zhang Q, 2014, P NATL ACAD SCI USA, V111, P12031, DOI 10.1073/pnas.1406418111; Zhang WJ, 2011, P NATL ACAD SCI USA, V108, P12249, DOI 10.1073/pnas.1109539108	49	195	199	1	148	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					509	+		10.1038/nature13888	http://dx.doi.org/10.1038/nature13888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25363770	Green Accepted			2022-12-28	WOS:000348196500040
J	Kim, JM; Wu, SP; Tomasiak, TM; Mergel, C; Winter, MB; Stiller, SB; Robles-Colmanares, Y; Stroud, RM; Tampe, R; Craik, CS; Cheng, YF				Kim, JungMin; Wu, Shenping; Tomasiak, Thomas M.; Mergel, Claudia; Winter, Michael B.; Stiller, Sebastian B.; Robles-Colmanares, Yaneth; Stroud, Robert M.; Tampe, Robert; Craik, Charles S.; Cheng, Yifan			Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC exporter	NATURE			English	Article							P-GLYCOPROTEIN; MULTIDRUG TRANSPORTER; CRYSTAL-STRUCTURE; MICROSCOPY; VISUALIZATION; CONFORMATION; FLEXIBILITY; PROTEINS; CHANNEL; REVEAL	ATP-binding cassette (ABC) transporters translocate substrates across cell membranes, using energy harnessed from ATP binding and hydrolysis at their nucleotide-binding domains(1,2). ABC exporters are present both in prokaryotes and eukaryotes, with examples implicated in multidrug resistance of pathogens and cancer cells, as well as in many human diseases(3,4). TmrAB is a heterodimeric ABC exporter from the thermophilic Gram-negative eubacterium Therm us thermophilus; it is homologous to various multidrug transporters and contains one degenerate site with a non-catalytic residue next to the Walker B motif. Here we report a subnanometre-resolution structure of detergent-solubilized TmrAB in a nucleotide-free, inward-facing conformation by single-particle electron cryomicroscopy. The reconstructions clearly resolve characteristic features of ABC transporters, including helices in the transmembrane domain and nucleotide-binding domains. A cavity in the transmembrane domain is accessible laterally from the cytoplasmic side of the membrane as well as from the cytoplasm, indicating that the transporter lies in an inward-facing open conformation. The two nucleotide-binding domains remain in contact via their carboxy-terminal helices. Furthermore, comparison between our structure and the crystal structures of other ABC transporters suggests a possible trajectory of conformational changes that involves a sliding and rotating motion between the two nucleotide-binding domains during the transition from the inward-facing to outward-facing conformations.	[Kim, JungMin; Winter, Michael B.; Stroud, Robert M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wu, Shenping; Tomasiak, Thomas M.; Robles-Colmanares, Yaneth; Stroud, Robert M.; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Mergel, Claudia; Stiller, Sebastian B.; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Goethe University Frankfurt; Goethe University Frankfurt	Stroud, RM (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany.	stroud@msg.ucsf.edu; tampe@em.uni-frankfurt.de; Charles.Craik@ucsf.edu; ycheng@ucsf.edu	Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R01GM098672, S10RR026814, P50GM082250, 1 P41CA196276-01, P50GM073210, R37GM024485]; University of California San Francisco Program for Breakthrough Biomedical Research; German Research Foundation [SFB 807, SFB 902, TA157/7]; European Drug Initiative on Channels and Transporters (EDICT) - European Commission Seventh Framework Program; NATIONAL CANCER INSTITUTE [P41CA196276] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250, R01GM098672, P50GM073210, R37GM024485, P01GM111126, R01GM024485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Program for Breakthrough Biomedical Research; German Research Foundation(German Research Foundation (DFG)); European Drug Initiative on Channels and Transporters (EDICT) - European Commission Seventh Framework Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01GM098672, S10RR026814 and P50GM082250 to Y.C., 1 P41CA196276-01 to C.S.C., P50GM073210 to R.M.S. and C.S.C., and R37GM024485 to R.M.S.), the University of California San Francisco Program for Breakthrough Biomedical Research (to Y.C.), and the German Research Foundation (SFB 807, SFB 902 and TA157/7 to R.T.) as well as the European Drug Initiative on Channels and Transporters (EDICT to R.T.) funded by the European Commission Seventh Framework Program.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kim J, 2011, METHODS, V55, P303, DOI 10.1016/j.ymeth.2011.09.012; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Zutz A, 2011, J BIOL CHEM, V286, P7104, DOI 10.1074/jbc.M110.201178	40	94	94	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					396	U598		10.1038/nature13872	http://dx.doi.org/10.1038/nature13872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363761	Green Accepted			2022-12-28	WOS:000347810300052
J	Lyon, GM; Mehta, AK; Varkey, JB; Brantly, K; Plyler, L; McElroy, AK; Kraft, CS; Towner, JS; Spiropoulou, C; Stroher, U; Uyeki, TM; Ribner, BS				Lyon, G. Marshall; Mehta, Aneesh K.; Varkey, Jay B.; Brantly, Kent; Plyler, Lance; McElroy, Anita K.; Kraft, Colleen S.; Towner, Jonathan S.; Spiropoulou, Christina; Stroeher, Ute; Uyeki, Timothy M.; Ribner, Bruce S.		Emory Serious Communicable Dis	Clinical Care of Two Patients with Ebola Virus Disease in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMORRHAGIC-FEVER; INFECTION; FEATURES; KIKWIT; UGANDA; CONGO	West Africa is currently experiencing the largest outbreak of Ebola virus disease (EVD) in history. Two patients with EVD were transferred from Liberia to our hospital in the United States for ongoing care. Malaria had also been diagnosed in one patient, who was treated for it early in the course of EVD. The two patients had substantial intravascular volume depletion and marked electrolyte abnormalities. We undertook aggressive supportive measures of hydration (typically, 3 to 5 liters of intravenous fluids per day early in the course of care) and electrolyte correction. As the patients' condition improved clinically, there was a concomitant decline in the amount of virus detected in plasma.	[Lyon, G. Marshall; Mehta, Aneesh K.; Varkey, Jay B.; Kraft, Colleen S.; Ribner, Bruce S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Kraft, Colleen S.] Emory Univ, Sch Med, Dept Pathol, Div Infect Dis, Atlanta, GA 30322 USA; [McElroy, Anita K.] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA USA; [McElroy, Anita K.; Towner, Jonathan S.; Spiropoulou, Christina; Stroeher, Ute; Uyeki, Timothy M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Brantly, Kent; Plyler, Lance] Samaritans Purse, Boone, NC USA	Emory University; Emory University; Emory University; Centers for Disease Control & Prevention - USA	Lyon, GM (corresponding author), 101 Woodruff Cir,WMB 2101, Atlanta, GA 30322 USA.	gmlyon@emory.edu	Mehta, Aneesh/B-8054-2012; Kraft, Colleen S/M-2347-2013; Towner, Jonathan/ABC-3780-2020	Mehta, Aneesh/0000-0002-6552-9162; Kraft, Colleen S/0000-0003-1757-8477; McElroy, Anita/0000-0001-6764-7536	CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the CDC.	Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Del Rio C, 2014, ANN INTERN MED; Feldmann H., 2013, FIELDS VIROLOGY, V1, P923; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; MacNeil A, 2010, EMERG INFECT DIS, V16, P1969, DOI 10.3201/eid1612.100627; McElroy AK, 2014, J INFECT DIS, V210, P558, DOI 10.1093/infdis/jiu088; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298; Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x; Peters C.J., 2010, MANDELL DOUGLAS BENN, P2259; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Rao SSC, 2006, JPEN-PARENTER ENTER, V30, P433, DOI 10.1177/0148607106030005433; Rollin PE, 2007, J INFECT DIS, V196, pS364, DOI 10.1086/520613; Seas C, 2010, MANDELL DOUGLAS BENN, P2777; Sobarzo A, 2013, NEW ENGL J MED, V369, P492, DOI 10.1056/NEJMc1300266; WHO, 2014, GLOB AL RESP EB VIR; WHO Blood Regulators Network, 2014, POS PAP COLL US CONV; Wong G, 2014, TRENDS MICROBIOL, V22, P456, DOI 10.1016/j.tim.2014.04.002; World Health Organization, 2014, EB RESP ROADM SIT RE	21	254	277	0	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2402	2409		10.1056/NEJMoa1409838	http://dx.doi.org/10.1056/NEJMoa1409838			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25390460	Bronze			2022-12-28	WOS:000346425800009
J	Reich, S; Guilligay, D; Pflug, A; Malet, H; Berger, I; Crepin, T; Hart, D; Lunardi, T; Nanao, M; Ruigrok, RWH; Cusack, S				Reich, Stefan; Guilligay, Delphine; Pflug, Alexander; Malet, Helene; Berger, Imre; Crepin, Thibaut; Hart, Darren; Lunardi, Thomas; Nanao, Max; Ruigrok, Rob W. H.; Cusack, Stephen			Structural insight into cap-snatching and RNA synthesis by influenza polymerase	NATURE			English	Article							VIRUS VIRION RNA; MESSENGER-RNAS; IN-VITRO; MAXIMUM-LIKELIHOOD; ACTIVE-SITE; P-PROTEINS; TRANSCRIPTION; SUBUNIT; ENDONUCLEASE; REPLICATION	Influenza virus polymerase uses a capped primer, derived by 'cap-snatching' from host pre-messenger RNA, to transcribe its RNA genome into mRNA and a stuttering mechanism to generate the poly(A) tail. By contrast, genome replication is unprimed and generates exact full-length copies of the template. Here we use crystal structures of bat influenza A and human influenza B polymerases (FluA and FluB), bound to the viral RNA promoter, to give mechanistic insight into these distinct processes. In the FluA structure, a loop analogous to the priming loop of flavivirus polymerases suggests that influenza could initiate unprimed template replication by a similar mechanism. Comparing the FluA and FluB structures suggests that cap-snatching involves in situ rotation of the PB2 cap-binding domain to direct the capped primer first towards the endonuclease and then into the polymerase active site. The polymerase probably undergoes considerable conformational changes to convert the observed pre-initiation state into the active initiation and elongation states.	[Reich, Stefan; Guilligay, Delphine; Pflug, Alexander; Malet, Helene; Berger, Imre; Hart, Darren; Lunardi, Thomas; Nanao, Max; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Reich, Stefan; Guilligay, Delphine; Pflug, Alexander; Malet, Helene; Berger, Imre; Crepin, Thibaut; Hart, Darren; Lunardi, Thomas; Nanao, Max; Ruigrok, Rob W. H.; Cusack, Stephen] Univ Grenoble Alpes, Ctr Natl Rech Sci, EMBL Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France.	cusack@embl.fr	Nanao, Max/ABA-9292-2021; Hart, Darren/C-4858-2015	Nanao, Max/0000-0002-6340-1376; Cusack, Stephen/0000-0002-9324-0796; Pflug, Alexander/0000-0002-4680-1298; Hart, Darren/0000-0002-3502-2002; MALET, Helene/0000-0002-2834-7386; Berger, Imre/0000-0001-7518-9045; Reich, Stefan/0000-0001-8822-2908; CREPIN, Thibaut/0000-0003-2663-1794; Reich, Stefan/0000-0001-6817-753X	ERC V-RNA [322586]; EU FLU-PHARM [259751]; Roche	ERC V-RNA; EU FLU-PHARM; Roche(Roche Holding)	We thank the staff of the European Molecular Biology Laboratory (EMBL) eukaryotic expression and high-throughput crystallization facilities within the Partnership for Structural Biology (PSB) and members of the ESRF-EMBL Joint Structural Biology Group for help on European Synchrotron Radiation Facility (ESRF) beamlines. The work was supported by ERC Advanced Grant V-RNA (322586) and EU Grant FLU-PHARM (259751) to S.C. and partially by a Roche Postdoc Fellowship to S.R.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Bier K, 2011, J GEN VIROL, V92, P1627, DOI 10.1099/vir.0.029231-0; BRAAM J, 1983, CELL, V34, P609; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Datta K., 2013, NUCLEIC ACIDS RES, V441, P349; De la Pena M, 2007, EMBO J, V26, P4913, DOI 10.1038/sj.emboj.7601912; DeLano W.L, PYMOL MOL GRAPHICS S; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Flick R, 1996, RNA, V2, P1046; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P17, DOI 10.1016/j.virol.2010.09.003; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P27, DOI 10.1016/j.virol.2010.09.006; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HAGEN M, 1995, J GEN VIROL, V76, P603, DOI 10.1099/0022-1317-76-3-603; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kuechler E., 1982, NUCLEIC ACIDS RES, V10, P4803; Lee YS, 1998, J GEN VIROL, V79, P673, DOI 10.1099/0022-1317-79-4-673; Lescar J, 2009, CURR OPIN STRUC BIOL, V19, P759, DOI 10.1016/j.sbi.2009.10.011; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Lim K, 2014, INT J BIOCHEM CELL B, V53, P237, DOI 10.1016/j.biocel.2014.05.022; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Ng AKL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036415; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nie Y, 2014, METHODS MOL BIOL, V1091, P131, DOI 10.1007/978-1-62703-691-7_8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflug A., NATURE; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Pritlove DC, 1998, J VIROL, V72, P1280, DOI 10.1128/JVI.72.2.1280-1286.1998; Pritlove DC, 1999, J VIROL, V73, P2109, DOI 10.1128/JVI.73.3.2109-2114.1999; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Shih SR, 1996, VIROLOGY, V226, P430, DOI 10.1006/viro.1996.0673; Siebert X, 2009, ACTA CRYSTALLOGR D, V65, P651, DOI 10.1107/S0907444909008671; Sikora D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06181; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; Wakai C, 2011, J VIROL, V85, P7504, DOI 10.1128/JVI.02375-10; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	54	289	298	5	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					361	+		10.1038/nature14009	http://dx.doi.org/10.1038/nature14009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25409151				2022-12-28	WOS:000346484800039
J	Settembre, C; Ballabio, A				Settembre, Carmine; Ballabio, Andrea			CELL METABOLISM Autophagy transcribed	NATURE			English	Editorial Material							LIPID-METABOLISM; TFEB		[Settembre, Carmine; Ballabio, Andrea] Telethon Inst Genet & Med, I-80078 Naples, Italy; [Settembre, Carmine; Ballabio, Andrea] Univ Naples Federico II, Dept Translat Med, Naples, Italy; [Settembre, Carmine; Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Baylor College of Medicine	Settembre, C (corresponding author), Telethon Inst Genet & Med, I-80078 Naples, Italy.		Settembre, Carmine/AIA-9170-2022; BALLABIO, Andrea/AAL-2672-2020	BALLABIO, Andrea/0000-0003-1381-4604; SETTEMBRE, Carmine/0000-0002-5829-8589	Fondazione Telethon Funding Source: Custom; Telethon [TGM11CB6] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976	10	22	23	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					40	41		10.1038/nature13939	http://dx.doi.org/10.1038/nature13939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25383529				2022-12-28	WOS:000346310800028
J	Knoll, GA; Humar, A; Fergusson, D; Johnston, O; House, AA; Kim, SJ; Ramsay, T; Chasse, M; Pang, XL; Zaltzman, J; Cockfield, S; Cantarovich, M; Karpinski, M; Lebel, L; Gill, JS				Knoll, Greg A.; Humar, Atul; Fergusson, Dean; Johnston, Olwyn; House, Andrew A.; Kim, S. Joseph; Ramsay, Tim; Chasse, Michael; Pang, Xiaoli; Zaltzman, Jeff; Cockfield, Sandra; Cantarovich, Marcelo; Karpinski, Martin; Lebel, Louise; Gill, John S.			Levofloxacin for BK Virus Prophylaxis Following Kidney Transplantation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYOMAVIRUS BK; VIREMIC PATIENTS; IMMUNOSUPPRESSION; RECIPIENTS; NEPHROPATHY; REDUCTION; CYTOMEGALOVIRUS; PREVENTION; IMPACT; FLUOROQUINOLONES	IMPORTANCE BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Viral reactivation occurs first in the urine (BK viruria) and is associated with a high risk of transplant failure. There are currently no therapies to prevent or treat BK virus infection. Quinolone antibiotics have antiviral properties against BK virus but efficacy at preventing this infection has not been shown in prospective controlled studies. OBJECTIVE To determine if levofloxacin can prevent BK viruria in kidney transplant recipients. DESIGN, SETTING, AND PARTICIPANTS Double-blind, placebo-controlled randomized trial involving 154 patients who received a living or deceased donor kidney-only transplant in 7 Canadian transplant centers between December 2011 and June 2013. INTERVENTIONS Participants were randomly assigned to receive a 3-month course of levofloxacin (500mg/d; n = 76) or placebo (n = 78) starting within 5 days after transplantation. MAIN OUTCOMES AND MEASURES The primary outcomewas time to occurrence of BK viruria (detected using quantitative real-time polymerase chain reaction) within the first year after transplantation. Secondary outcomes included BK viremia, peak viral load, rejection, and patient and allograft survival. RESULTS The mean follow-up time was 46.5 weeks in the levofloxacin group and 46.3 weeks in the placebo group (27 patients had follow-up terminated before the end of the planned follow-up period or development of viruria because the trial was stopped early owing to lack of funding). BK viruria occurred in 22 patients (29%) in the levofloxacin group and in 26 patients (33.3%) in the placebo group (hazard ratio, 0.91; 95% CI, 0.51-1.63; P = .58). There was no significant difference between the 2 groups in regard to any of the secondary end points. There was an increased risk of resistant infection among isolates usually sensitive to quinolones in the levofloxacin group vs placebo (14/24 [58.3%] vs 15/45 [33.3%], respectively; risk ratio, 1.75; 95% CI, 1.01-2.98) as well as a nonsignificant increased risk of suspected tendinitis (6/76 [7.9%] vs 1/78 [1.3%]; risk ratio, 6.16; 95% CI, 0.76-49.95). CONCLUSIONS AND RELEVANCE Among kidney transplant recipients, a 3-month course of levofloxacin initiated early following transplantation did not prevent BK viruria. Levofloxacin was associated with an increased risk of adverse events such as bacterial resistance. These findings do not support the use of levofloxacin to prevent posttransplant BK virus infection.	[Knoll, Greg A.] Univ Ottawa, Dept Med, Kidney Res Ctr, Div Nephrol, Ottawa, ON, Canada; [Knoll, Greg A.; Fergusson, Dean; Ramsay, Tim; Chasse, Michael; Lebel, Louise] Univ Ottawa, Res Inst, Ottawa Hosp, Clin Epidemiol Program, Ottawa, ON, Canada; [Knoll, Greg A.; Fergusson, Dean; Ramsay, Tim; Chasse, Michael; Lebel, Louise] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Humar, Atul; Kim, S. Joseph] Univ Toronto, Toronto Gen Hosp, Dept Med, Toronto, ON M5S 1A1, Canada; [Johnston, Olwyn] Vancouver Gen Hosp, Dept Med, Vancouver, BC, Canada; [House, Andrew A.] Univ Western Ontario, Dept Med, London, ON, Canada; [Johnston, Olwyn] London Hlth Sci Ctr, London, ON, Canada; [Pang, Xiaoli] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Zaltzman, Jeff] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Cockfield, Sandra] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Cantarovich, Marcelo] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; [Karpinski, Martin] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Gill, John S.] St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Gill, John S.] Univ British Columbia, Ctr Hlth Evaluat & Outcomes Sci, Vancouver, BC V5Z 1M9, Canada; [Gill, John S.] Tufts Univ New England Med Ctr, Boston, MA USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of British Columbia; Western University (University of Western Ontario); London Health Sciences Centre; University of Alberta; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Alberta; McGill University; University of Manitoba; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Tufts Medical Center	Gill, JS (corresponding author), St Pauls Hosp, Providence Bldg,Ward 6a,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jgill@providencehealth.bc.ca	House, Andrew/G-3304-2011; Chassé, Michaël/Y-7820-2019; Chassé, Michaël/L-7906-2017	Chassé, Michaël/0000-0001-7075-1924; Fergusson, Dean/0000-0002-3389-2485; Knoll, Greg/0000-0001-5442-9310; Ramsay, Tim/0000-0001-8478-8170	Canadian Institutes of Health Research (CIHR) [222493]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This project was funded by the Canadian Institutes of Health Research (CIHR) protocol 222493.	Ali SH, 2007, ANTIVIR THER, V12, P1; Almeras C, 2011, TRANSPL INFECT DIS, V13, P101, DOI 10.1111/j.1399-3062.2011.00619.x; Almeras C, 2008, TRANSPLANTATION, V85, P1099, DOI 10.1097/TP.0b013e31816a33d4; [Anonymous], 2004, AM J TRANSPLANT, V4, P135; [Anonymous], 2004, AM J TRANSPLANT, V4, P89; [Anonymous], 2013, USRDS ANN DAT REP AT; Bohl DL, 2007, CLIN J AM SOC NEPHRO, V2, pS36, DOI 10.2215/CJN.00920207; Brennan DC, 2005, AM J TRANSPLANT, V5, P582, DOI 10.1111/j.1600-6143.2005.00742.x; De Paolis P, 2009, TRANSPL P, V41, P1207, DOI 10.1016/j.transproceed.2009.03.091; Gabardi S, 2010, CLIN J AM SOC NEPHRO, V5, P1298, DOI 10.2215/CJN.08261109; Hardinger KL, 2010, AM J TRANSPLANT, V10, P407, DOI 10.1111/j.1600-6143.2009.02952.x; Hirsch HH, 2013, AM J TRANSPLANT, V13, P179, DOI 10.1111/ajt.12110; Hirsch HH, 2005, TRANSPLANTATION, V79, P1277, DOI 10.1097/01.TP.0000156165.83160.09; Humar A, 2006, AM J TRANSPLANT, V6, P262, DOI 10.1111/j.1600-6143.2005.01207.x; Humar A, 2009, AM J TRANSPLANT, V9, pS78, DOI 10.1111/j.1600-6143.2009.02897.x; Humar A, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-185; Hymes LC, 2006, PEDIATR TRANSPLANT, V10, P920, DOI 10.1111/j.1399-3046.2006.00575.x; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Lee BT, 2014, CLIN J AM SOC NEPHRO, V9, P583, DOI 10.2215/CJN.04230413; Leung AYH, 2005, CLIN INFECT DIS, V40, P528, DOI 10.1086/427291; Martin SI, 2009, AM J TRANSPLANT, V9, pS227, DOI 10.1111/j.1600-6143.2009.02914.x; Pang XLL, 2007, J CLIN MICROBIOL, V45, P3568, DOI 10.1128/JCM.00655-07; Paya C, 2004, AM J TRANSPLANT, V4, P611, DOI 10.1111/j.1600-6143.2004.00382.x; Rafat C, 2011, TRANSPL INFECT DIS, V13, P344, DOI 10.1111/j.1399-3062.2011.00602.x; Repchinsky C., 2007, COMPENDIUM PHARM SPE; Ryan JD, 2007, AM J TRANSPLANT, V7, P537; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sharma BN, 2011, ANTIVIR RES, V92, P115, DOI 10.1016/j.antiviral.2011.07.012; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Wagenlehner FME, 2006, INT J ANTIMICROB AG, V28, P551, DOI 10.1016/j.ijantimicag.2006.07.026; Wojciechowski D, 2012, TRANSPLANTATION, V94, P1117, DOI 10.1097/TP.0b013e31826ec74e; Zeidan S, 2013, TRANSPL INFECT DIS, V15, pE268, DOI 10.1111/tid.12141	32	78	79	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2106	2114		10.1001/jama.2014.14721	http://dx.doi.org/10.1001/jama.2014.14721			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25399012	Bronze			2022-12-28	WOS:000345626800014
J	Gligoris, TG; Scheinost, JC; Burmann, F; Petela, N; Chan, KL; Uluocak, P; Beckouet, F; Gruber, S; Nasmyth, K; Lowe, J				Gligoris, Thomas G.; Scheinost, Johanna C.; Buermann, Frank; Petela, Naomi; Chan, Kok-Lung; Uluocak, Pelin; Beckouet, Frederic; Gruber, Stephan; Nasmyth, Kim; Loewe, Jan			Closing the cohesin ring: Structure and function of its Smc3-kleisin interface	SCIENCE			English	Article							SISTER-CHROMATID COHESION; ACETYLATION; COMPLEXES; PROTEIN; CHROMOSOMES; CLEAVAGE; PROPHASE; PROMOTES; SUBUNIT; WAPL	Through their association with a kleisin subunit (Scc1), cohesin's Smc1 and Smc3 subunits are thought to form tripartite rings that mediate sister chromatid cohesion. Unlike the structure of Smc1/Smc3 and Smc1/Scc1 interfaces, that of Smc3/Scc1 is not known. Disconnection of this interface is thought to release cohesin from chromosomes in a process regulated by acetylation. We show here that the N-terminal domain of yeast Sccl contains two alpha helices, forming a four-helix bundle with the coiled coil emerging from Smc3's adenosine triphosphatase head. Mutations affecting this interaction compromise cohesin's association with chromosomes. The interface is far from Smc3 residues, whose acetylation prevents cohesin's dissociation from chromosomes. Cohesin complexes holding chromatids together in vivo do indeed have the configuration of hetero-trimeric rings, and sister DNAs are entrapped within these.	[Gligoris, Thomas G.; Scheinost, Johanna C.; Petela, Naomi; Chan, Kok-Lung; Uluocak, Pelin; Beckouet, Frederic; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Buermann, Frank; Gruber, Stephan] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Chan, Kok-Lung] Univ Sussex, MRC, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Uluocak, Pelin] Univ Oxford, Dunn Sch Pathol, Oxford OX1 3RF, England; [Loewe, Jan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of Oxford; Max Planck Society; University of Sussex; University of Oxford; MRC Laboratory Molecular Biology	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk; jyl@mrc-lmb.cam.ac.uk	Löwe, Jan/X-6998-2019; Gligoris, Thomas/AAO-7594-2020; Beckouet, Frederic/P-5389-2016; Gruber, Stephan/AFC-4848-2022	Beckouet, Frederic/0000-0002-9009-1852; Gruber, Stephan/0000-0002-0150-0395; chan, kok-lung/0000-0002-8796-8385; Burmann, Frank/0000-0002-9428-0933; Nasmyth, Kim/0000-0001-7030-4403; Lowe, Jan/0000-0002-5218-6615	European Molecular Biology Organization long-term fellowship [ALTF 2008-127]; John Fell Fund [132/108]; Medical Research Council [U10518432, C573/A11625]; Wellcome Trust [095514/Z/11/Z, 091859/Z/10/Z]; Cancer Research UK [C573/A 12386]; MitoSys project [241548]; MRC [MC_U105184326] Funding Source: UKRI; Cancer Research UK [12386] Funding Source: researchfish; Medical Research Council [MC_U105184326] Funding Source: researchfish	European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); John Fell Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); MitoSys project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	T.G.G. is supported by a European Molecular Biology Organization long-term fellowship (ALTF 2008-127) and the John Fell Fund (132/108). The work was funded by the Medical Research Council (U10518432 to J.L, C573/A11625 to J.C.S.), the Wellcome Trust (095514/Z/11/Z to J.L., 091859/Z/10/Z to K.N.), Cancer Research UK (C573/A 12386 to K.N.), and the MitoSys project (FP7/2007-2013 under grant agreement 241548 to K.N.).	Arumugam P, 2006, CURR BIOL, V16, P1998, DOI 10.1016/j.cub.2006.09.002; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Burmann F, 2013, NAT STRUCT MOL BIOL, V20, P371, DOI 10.1038/nsmb.2488; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Chan KL, 2013, P NATL ACAD SCI USA, V110, P13020, DOI 10.1073/pnas.1306900110; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Ivanov D, 2007, MOL CELL, V27, P300, DOI 10.1016/j.molcel.2007.07.002; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Roig MB, 2014, FEBS LETT, V588, P3692, DOI 10.1016/j.febslet.2014.08.015; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880	28	170	172	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					963	967		10.1126/science.1256917	http://dx.doi.org/10.1126/science.1256917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414305	Green Accepted			2022-12-28	WOS:000345696000035
J	Stine, NW; Chokshi, DA				Stine, Nicholas W.; Chokshi, Dave A.			Elimination of Lipid Levels From Quality Measures Implications and Alternatives	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GUIDELINES		[Stine, Nicholas W.; Chokshi, Dave A.] New York City Hlth & Hosp Corp, New York, NY USA; [Stine, Nicholas W.; Chokshi, Dave A.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10013 USA	New York University	Stine, NW (corresponding author), NYU, Sch Med, New York City Hlth & Hosp Corp, Dept Populat Hlth, 125 Worth St,Ste 401, New York, NY 10013 USA.	nicholas.stine@nychhc.org		Chokshi, Dave/0000-0001-7467-4591; Stine, Nicholas/0000-0001-8811-259X				[Anonymous], STAT ASP CHOIC DEC A; Centers for Medicare & Medicaid Services (CMS), MED PROGR REV PAYM P; Department of Veterans Affairs (VA), 2014, REV PERF MEAS LIP MA; Eddy DM, 2012, HEALTH AFFAIR, V31, P2441, DOI 10.1377/hlthaff.2011.1274; Fuster, 2010, PROMOTING CARDIOVASC; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Montori VM, 2014, JAMA-J AM MED ASSOC, V311, P465, DOI 10.1001/jama.2014.110; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	9	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1971	1972		10.1001/jama.2014.15600	http://dx.doi.org/10.1001/jama.2014.15600			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399268				2022-12-28	WOS:000345450500007
J	Afzal, S; Brondum-Jacobsen, P; Bojesen, SE; Nordestgaard, BG				Afzal, Shoaib; Brondum-Jacobsen, Peter; Bojesen, Stig E.; Nordestgaard, Borge G.			Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; 25-HYDROXYVITAMIN D; HDL CHOLESTEROL; RISK; CANCER; RECEPTOR; ASSOCIATIONS; DISEASE; PROTEIN; DIFFERENTIATION	Objective To test the hypothesis that genetically low 25-hydroxyvitamin D concentrations are associated with increased mortality. Design Mendelian randomisation analysis. Setting Copenhagen City Heart Study, Copenhagen General Population Study, and Copenhagen Ischemic Heart Disease Study. Participants 95 766 white participants of Danish descent from three cohorts, with median follow-up times of 19.1, 5.8, and 7.9 years, genotyped for genetic variants in DHCR7 and CYP2R1 affecting plasma 25-hydroxyvitamin D concentrations; 35 334 also had plasma 25-hydroxyvitamin D measurements. Participants were followed from study entry through 2013, during which time 10 349 died. Main outcome measures All cause mortality and cause specific mortality, adjusted for common risk factors for all cause mortality based on the World Health Organization's global health status. Results The multivariable adjusted hazard ratios for a 20 nmol/L lower plasma 25-hydroxyvitamin D concentration were 1.19 (95% confidence interval 1.14 to 1.25) for all cause mortality, 1.18 (1.09 to 1.28) for cardiovascular mortality, 1.12 (1.03 to 1.22) for cancer mortality, and 1.27 (1.15 to 1.40) for other mortality. Each increase in DHCR7/CYP2R1 allele score was associated with a 1.9 nmol/L lower plasma 25-hydroxyvitamin D concentration and with increased all cause, cancer, and other mortality but not with cardiovascular mortality. The odds ratio for a genetically determined 20 nmol/L lower plasma 25-hydroxyvitamin D concentration was 1.30 (1.05 to 1.61) for all cause mortality, with a corresponding observational multivariable adjusted odds ratio of 1.21 (1.11 to 1.31). Corresponding genetic and observational odds ratios were 0.77 (0.55 to 1.08) and 1.13 (1.03 to 1.24) for cardiovascular mortality, 1.43 (1.02 to 1.99) and 1.10 (1.02 to 1.19) for cancer mortality, and 1.44 (1.01 to 2.04) and 1.17 (1.06 to 1.29) for other mortality. The results were robust in sensitivity analyses. Conclusions Genetically low 25-hydroxyvitamin D concentrations were associated with increased all cause mortality, cancer mortality, and other mortality but not with increased cardiovascular mortality. These findings are compatible with the notion that genetically low 25-hydroxyvitamin D concentrations may be causally associated with cancer and other mortality but also suggest that the observational association with cardiovascular mortality could be the result of confounding.	[Afzal, Shoaib; Brondum-Jacobsen, Peter; Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Afzal, Shoaib; Brondum-Jacobsen, Peter; Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Afzal, Shoaib; Brondum-Jacobsen, Peter; Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark.	Boerge.Nordestgaard@regionh.dk	Afzal, Shoaib/B-6763-2012; Nordestgaard, Borge Gronne/ABF-1310-2020	Afzal, Shoaib/0000-0002-1442-4694; Nordestgaard, Borge/0000-0002-1954-7220; Bojesen, Stig/0000-0002-4061-4133	Danish Heart Foundation; Danish Medical Research Council; Copenhagen County Foundation; Herlev Hospital, Copenhagen University Hospital	Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Copenhagen County Foundation; Herlev Hospital, Copenhagen University Hospital	The Copenhagen General Population Study and Copenhagen City Heart Study are supported by the Danish Heart Foundation, Danish Medical Research Council, Copenhagen County Foundation, and Herlev Hospital, Copenhagen University Hospital. All researchers operate independently of the funding bodies.	Afzal S, 2014, LANCET DIABETES ENDO, V2, P298, DOI 10.1016/S2213-8587(13)70200-6; Afzal S, 2013, J INVEST DERMATOL, V133, P629, DOI 10.1038/jid.2012.395; Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Andersen RV, 2003, J AM COLL CARDIOL, V41, P1972, DOI 10.1016/S0735-1097(03)00407-8; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Berry DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037465; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Didelez V, 2010, STAT SCI, V25, P22, DOI 10.1214/09-STS316; EISMAN JA, 1987, CANCER RES, V47, P21; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Ooi EM, 2014, CIRC CARDIOVASC GENE; Ordonez-Moran P, 2005, FRONT BIOSCI-LANDMRK, V10, P2723, DOI 10.2741/1731; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rode L, 2014, INT J EPIDEMIOL, V43, P1473, DOI 10.1093/ije/dyu119; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SHABAHANG M, 1993, CANCER RES, V53, P3712; SimboliCampbell M, 1996, J STEROID BIOCHEM, V58, P367, DOI 10.1016/0960-0760(96)00055-6; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Tetens I, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.7153; The Human Protein Atlas, 2013, CYP2R1; The Human Protein Atlas, 2013, VDR; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Thomas DC, 2007, ANN EPIDEMIOL, V17, P511, DOI 10.1016/j.annepidem.2006.12.005; Trummer O, 2013, CLIN CHEM, V59, P793, DOI 10.1373/clinchem.2012.193185; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	55	197	199	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2014	349								g6330	10.1136/bmj.g6330	http://dx.doi.org/10.1136/bmj.g6330			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JY	25406188	Green Published, hybrid			2022-12-28	WOS:000345445600001
J	McKay, R				McKay, Robert			Did Antarctica initiate the ice age cycles?	SCIENCE			English	Editorial Material							SOUTHERN-OCEAN; SHEET; STRATIFICATION; GLACIATION		Victoria Univ Wellington, Antarctic Res Ctr, Wellington, New Zealand	Victoria University Wellington	McKay, R (corresponding author), Victoria Univ Wellington, Antarctic Res Ctr, Wellington, New Zealand.	robert.mckay@vuw.ac.nz	McKay, Robert/N-2449-2015	McKay, Robert/0000-0002-5602-6985				Bailey I, 2013, QUATERNARY SCI REV, V75, P181, DOI 10.1016/j.quascirev.2013.06.004; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Hillenbrand CD, 2006, PALAEOGEOGR PALAEOCL, V242, P240, DOI 10.1016/j.palaeo.2006.06.001; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; McKay R, 2012, P NATL ACAD SCI USA, V109, P6423, DOI 10.1073/pnas.1112248109; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Woodard SC, 2014, SCIENCE, V346, P847, DOI 10.1126/science.1255586	12	0	0	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					812	813		10.1126/science.1262048	http://dx.doi.org/10.1126/science.1262048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395522				2022-12-28	WOS:000344659900021
J	Hyman, S				Hyman, Steven			Depression needs large human-genetics studies	NATURE			English	Editorial Material							GENOME-WIDE ASSOCIATION; DISORDER		Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hyman, S (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	seh@harvard.edu						Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013, NATURE GENET, V45, P984; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Hyman SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003142; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Levinson DF, 2014, BIOL PSYCHIAT, V76, P510, DOI 10.1016/j.biopsych.2014.07.029; Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, 2013, MOL PSYCHIAT, V18, P497; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Wood A. R., 2014, NATURE GENET	10	31	32	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					189	191		10.1038/515189a	http://dx.doi.org/10.1038/515189a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT0MZ	25391945	Bronze			2022-12-28	WOS:000344631400023
J	Levander, A; Bezada, MJ; Niu, F; Humphreys, ED; Palomeras, I; Thurner, SM; Masy, J; Schmitz, M; Gallart, J; Carbonell, R; Miller, MS				Levander, A.; Bezada, M. J.; Niu, F.; Humphreys, E. D.; Palomeras, I.; Thurner, S. M.; Masy, J.; Schmitz, M.; Gallart, J.; Carbonell, R.; Miller, M. S.			Subduction-driven recycling of continental margin lithosphere	NATURE			English	Article							GULF-OF-MEXICO; TECTONIC EVOLUTION; ATLAS MOUNTAINS; ALBORAN REGION; MOROCCAN ATLAS; SOUTH-AMERICA; BENEATH; DELAMINATION; CONSTRAINTS; TOMOGRAPHY	Whereas subduction recycling of oceanic lithosphere is one of the central themes of plate tectonics, the recycling of continental lithosphere appears to be far more complicated and less well understood(1). Delamination and convective downwelling are two widely recognized processes invoked to explain the removal of lithospheric mantle under or adjacent to orogenic belts(2-5). Here we relate oceanic plate subduction to removal of adjacent continental lithosphere in certain plate tectonic settings. We have developed teleseismic body wave images from dense broadband seismic experiments that show higher than expected volumes of anomalously fast mantle associated with the subducted Atlantic slab under northeastern South America and the Alboran slab beneath the Gibraltar arc region(6,7); the anomalies are under, and are aligned with, the continental margins at depths greater than 200 kilometres. Rayleigh wave analysis(8,9) finds that the lithospheric mantle under the continental margins is significantly thinner than expected, and that thin lithosphere extends from the orogens adjacent to the subduction zones inland to the edges of nearby cratonic cores. Taking these data together, here we describe a process that can lead to the loss of continental lithosphere adjacent to a subduction zone. Subducting oceanic plates can viscously entrain and remove the bottom of the continental thermal boundary layer lithosphere from adjacent continental margins. This drives surface tectonics and pre-conditions the margins for further deformation by creating topography along the lithosphere-asthenosphere boundary. This can lead to development of secondary downwellings under the continental interior, probably under both South America and the Gibraltar arc(8,10), and to delamination of the entire lithospheric mantle, as around the Gibraltar arc(11). This process reconciles numerous, sometimes mutually exclusive, geodynamic models proposed to explain the complex oceanic-continental tectonics of these subduction zones(12-17).	[Levander, A.; Niu, F.; Palomeras, I.; Thurner, S. M.; Masy, J.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Bezada, M. J.; Humphreys, E. D.] Univ Oregon, Dept Geol Sci, Eugene, OR 97043 USA; [Bezada, M. J.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Niu, F.] Univ Petr, State Key Lab Petr Resources & Prospecting, Beijing 102249, Peoples R China; [Niu, F.] Univ Petr, Unconvent Nat Gas Inst, Beijing 102249, Peoples R China; [Schmitz, M.] Fdn Venezolana Invest Sismol, Caracas 1073, Venezuela; [Gallart, J.; Carbonell, R.] CSIC, Inst Ciencias Terra Jaume Almera, E-08028 Barcelona, Spain; [Miller, M. S.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	Rice University; University of Oregon; University of Minnesota System; University of Minnesota Twin Cities; China University of Petroleum; China University of Petroleum; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Geociencias Barcelona (GEO3BCN); University of Southern California	Levander, A (corresponding author), Rice Univ, Dept Earth Sci, Houston, TX 77005 USA.	alan@rice.edu	Carbonell, Ramon/C-7847-2014; Miller, Meghan S/A-2688-2011; Gallart, Josep/A-8469-2008; gallart, josep/ABB-5863-2021; Palomeras, Imma/I-6712-2017; Schmitz, Michael/A-9597-2017	Carbonell, Ramon/0000-0003-2019-1214; Miller, Meghan S/0000-0001-5494-2296; Gallart, Josep/0000-0003-3833-9571; Palomeras, Imma/0000-0003-4809-0925; Schmitz, Michael/0000-0003-4543-2352	US National Science Foundation [EAR 0003572, 0607801, 0808939, EAR 0808931, EAR 0809023, 1054638]; Venezuelan National Fund for Science, Technology and Innovation grant [G-2002000478]; PDVSA-INTEVEP-FUNVISIS [2004-141]; Spanish Ministry of Science and Innovation [CSD2006-00041, CGL2009-09727, CGL2010-15146]; A. v. Humboldt Foundation Research Prize; Directorate For Geosciences [0808939] Funding Source: National Science Foundation; Division Of Earth Sciences [0809023] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Venezuelan National Fund for Science, Technology and Innovation grant; PDVSA-INTEVEP-FUNVISIS; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); A. v. Humboldt Foundation Research Prize; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank R. Govers for suggestions that improved the clarity and quality of the manuscript, and E. Engquist for aid in using the Rice DAVinCI Visualization Laboratory. We especially thank M. Harnafi and the Scientific Institute of Rabat for their contributions to the project. This research was supported by US National Science Foundation grants EAR 0003572, 0607801 and 0808939 (A.L.), EAR 0808931 (E.D.H.), EAR 0809023 and 1054638 (M.S.M.), the Venezuelan National Fund for Science, Technology and Innovation grant G-2002000478 and PDVSA-INTEVEP-FUNVISIS cooperative agreement 2004-141 (M.S.), the Spanish Ministry of Science and Innovation grants CSD2006-00041, CGL2009-09727 and CGL2010-15146 (J.G. and R.C.), and by an A. v. Humboldt Foundation Research Prize (A.L.).	[Anonymous], 1999, SED BAS WOR; Ayarza P, 2014, GEOCHEM GEOPHY GEOSY, V15, P1698, DOI 10.1002/2013GC005164; Bezada MJ, 2014, GEOCHEM GEOPHY GEOSY, V15, P975, DOI 10.1002/2013GC005059; Bezada MJ, 2013, EARTH PLANET SC LETT, V368, P51, DOI 10.1016/j.epsl.2013.02.024; Bezada MJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007682; BURKE K, 1988, ANNU REV EARTH PL SC, V16, P201, DOI 10.1146/annurev.ea.16.050188.001221; Calvert A, 2000, J GEOPHYS RES-SOL EA, V105, P10871, DOI 10.1029/2000JB900024; Clark SA, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002084; Mancilla FD, 2013, GEOLOGY, V41, P307, DOI 10.1130/G33733.1; Dueker KG, 1997, J GEOPHYS RES-SOL EA, V102, P8313, DOI 10.1029/96JB03857; Duggen S, 2004, EARTH PLANET SC LETT, V218, P91, DOI 10.1016/S0012-821X(03)00632-0; Forsyth DW, 2005, GEOPHYS MONOGR SER, V157, P81, DOI 10.1029/156GM06; Gao S, 2008, EARTH PLANET SC LETT, V270, P41, DOI 10.1016/j.epsl.2008.03.008; Govers R, 2005, EARTH PLANET SC LETT, V236, P505, DOI 10.1016/j.epsl.2005.03.022; Gutscher MA, 2002, GEOLOGY, V30, P1071, DOI 10.1130/0091-7613(2002)030<1071:EFASBG>2.0.CO;2; Houseman G, 2001, GEOL SOC SPEC PUBL, V184, P13, DOI 10.1144/GSL.SP.2001.184.01.02; Kaislaniemi L, 2014, GEOCHEM GEOPHY GEOSY, V15, P3175, DOI 10.1002/2014GC005414; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; Levander A, 2011, NATURE, V472, P461, DOI 10.1038/nature10001; Levander A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004056; Lonergan L, 1997, TECTONICS, V16, P504, DOI 10.1029/96TC03937; Masy J., EARTH PLANE IN PRESS; Palomeras I, 2014, GEOCHEM GEOPHY GEOSY, V15, P140, DOI 10.1002/2013GC004861; Perouse E, 2010, GEOLOGY, V38, P823, DOI 10.1130/G30963.1; Pindell J, 2006, GEOL ACTA, V4, P303; Pindell JL, 2009, GEOL SOC SPEC PUBL, V328, P1, DOI 10.1144/SP328.1; PLATT JP, 1989, GEOLOGY, V17, P540, DOI 10.1130/0091-7613(1989)017<0540:ECOTCL>2.3.CO;2; Rondenay S, 2009, SURV GEOPHYS, V30, P377, DOI 10.1007/s10712-009-9071-5; Rosenbaum G., 2003, THESIS MONASH U; ROYDEN LH, 1993, TECTONICS, V12, P629, DOI 10.1029/92TC02641; SCLATER JG, 1981, J GEOPHYS RES, V86, P1535, DOI 10.1029/JB086iB12p11535; Seber D, 1996, NATURE, V379, P785, DOI 10.1038/379785a0; SLEEP NH, 1971, GEOPHYS J ROY ASTR S, V24, P325, DOI 10.1111/j.1365-246X.1971.tb02182.x; TAO WC, 1992, J GEOPHYS RES-SOL EA, V97, P8877, DOI 10.1029/91JB02422; Thurner S, 2014, GEOCHEM GEOPHY GEOSY, V15, P1113, DOI 10.1002/2013GC005124; VanDecar JC, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000884; Yang Y, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004180; Zandt G, 2004, NATURE, V431, P41, DOI 10.1038/nature02847	38	52	53	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					253	U219		10.1038/nature13878	http://dx.doi.org/10.1038/nature13878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391963				2022-12-28	WOS:000344631400047
J	Nogrady, B				Nogrady, Bianca			Life beyond the pain	NATURE			English	Editorial Material							SICKLE-CELL-DISEASE											Ballas SK, 2010, BLOOD, V116, P311, DOI 10.1182/blood-2010-04-276386; Brandow AM, 2013, AM J HEMATOL, V88, P37, DOI 10.1002/ajh.23341; Kohli DR, 2010, BLOOD, V116, P456, DOI 10.1182/blood-2010-01-260372; Molokie RE, 2014, EUR J PHARMACOL, V723, P419, DOI 10.1016/j.ejphar.2013.10.062; Wilkie DJ, 2010, J NATL MED ASSOC, V102, P18, DOI 10.1016/S0027-9684(15)30471-5	5	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S8	S9		10.1038/515S8a	http://dx.doi.org/10.1038/515S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390148	Bronze			2022-12-28	WOS:000344631400006
J	Ferreira, J; Aragao, LEOC; Barlow, J; Barreto, P; Berenguer, E; Bustamante, M; Gardner, TA; Lees, AC; Lima, A; Louzada, J; Pardini, R; Parry, L; Peres, CA; Pompeu, PS; Tabarelli, M; Zuanon, J				Ferreira, J.; Aragao, L. E. O. C.; Barlow, J.; Barreto, P.; Berenguer, E.; Bustamante, M.; Gardner, T. A.; Lees, A. C.; Lima, A.; Louzada, J.; Pardini, R.; Parry, L.; Peres, C. A.; Pompeu, P. S.; Tabarelli, M.; Zuanon, J.			Brazil's environmental leadership at risk	SCIENCE			English	Editorial Material												joice.ferreira@embrapa.br	Parry, Luke/ABD-4194-2021; Louzada, Julio/F-1265-2010; Pardini, Renata/C-4095-2012; Peres, Carlos A./B-1276-2013; Zuanon, Jansen A. S./E-5791-2013; Lees, Alexander Charles/S-2443-2019; Barlow, Jos/HGE-9486-2022; Bustamante, Mercedes/GQZ-8625-2022; Peres, Carlos Augusto/N-8275-2019; Barlow, Jos/E-7861-2014; Santos Pompeu, Paulo/F-6696-2012; aragao, luiz eoc/G-8387-2012; Peres, Carlos A./ABE-8361-2020; Bustamante, Mercedes/AAQ-7231-2020; Bustamante, Mercedes MC/H-7597-2015; Tabarelli, Marcelo/F-1088-2010	Parry, Luke/0000-0003-0330-9516; Louzada, Julio/0000-0002-1481-3112; Pardini, Renata/0000-0002-3769-8401; Peres, Carlos A./0000-0002-1588-8765; Zuanon, Jansen A. S./0000-0001-8354-2750; Lees, Alexander Charles/0000-0001-7603-9081; Santos Pompeu, Paulo/0000-0002-7938-1517; aragao, luiz eoc/0000-0002-4134-6708; Peres, Carlos A./0000-0002-1588-8765; Bustamante, Mercedes/0000-0003-1008-452X; Bustamante, Mercedes MC/0000-0003-1008-452X; Tabarelli, Marcelo/0000-0001-7573-7216	ESRC [ES/K010018/1] Funding Source: UKRI; NERC [NE/K016431/1] Funding Source: UKRI; Economic and Social Research Council [ES/K010018/1] Funding Source: researchfish; Natural Environment Research Council [NE/K016431/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ANDE, 2021, ADM NAC EN PLAN MAES; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Brasil Ministerio de Minas e Energia (MME), 2010, PLAN NAC MIN 2030; Business and Biodiversity Offsets Programme (BBOP), 2012, GUID NOT STAND BIOD; Fearnside PM, 2014, ENVIRON SCI POLICY, V38, P164, DOI 10.1016/j.envsci.2013.11.004; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Pilgrim JD, 2013, CONSERV LETT, V6, P376, DOI 10.1111/conl.12002; Ricketts TH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000331; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; Verissimo A., 2011, PROTECTED AREAS BRAZ; Villarroya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107144; WDPA, 2012, DATABASE	14	187	193	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					706	707		10.1126/science.1260194	http://dx.doi.org/10.1126/science.1260194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT1JT	25378611				2022-12-28	WOS:000344690100025
J	Hammerschmidt, K; Rose, CJ; Kerr, B; Rainey, PB				Hammerschmidt, Katrin; Rose, Caroline J.; Kerr, Benjamin; Rainey, Paul B.			Life cycles, fitness decoupling and the evolution of multicellularity	NATURE			English	Article							PSEUDOMONAS-FLUORESCENS; EXPERIMENTAL POPULATIONS; ADAPTIVE DIVERGENCE; COOPERATION; SELECTION; INDIVIDUALITY; CONSTRUCTION; COMPETITION; TRANSITION; CONFLICT	Cooperation is central to the emergence of multicellular life; however, the means by which the earliest collectives (groups of cells) maintained integrity in the face of destructive cheating types is unclear. One idea posits cheats as a primitive germ line in a life cycle that facilitates collective reproduction. Here we describe an experiment in which simple cooperating lineages of bacteria were propagated under a selective regime that rewarded collective-level persistence. Collectives reproduced via life cycles that either embraced, or purged, cheating types. When embraced, the life cycle alternated between phenotypic states. Selection fostered inception of a developmental switch that underpinned the emergence of collectives whose fitness, during the course of evolution, became decoupled from the fitness of constituent cells. Such development and decoupling did not occur when groups reproduced via a cheat-purging regime. Our findings capture key events in the evolution of Darwinian individuality during the transition from single cells to multicellularity.	[Hammerschmidt, Katrin; Rose, Caroline J.; Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, Auckland 0745, New Zealand; [Hammerschmidt, Katrin; Rose, Caroline J.; Rainey, Paul B.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 0745, New Zealand; [Kerr, Benjamin] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Kerr, Benjamin] Univ Washington, BEACON Ctr Study Evolut Act, Seattle, WA 98195 USA; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, D-24306 Plon, Germany	Massey University; Massey University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Max Planck Society	Rainey, PB (corresponding author), Massey Univ, New Zealand Inst Adv Study, Auckland 0745, New Zealand.	p.b.rainey@massey.ac.nz	Rainey, Paul/A-3207-2008; Hammerschmidt, Katrin/J-5180-2014; Hammerschmidt, Katrin/CAF-4889-2022	Rainey, Paul/0000-0003-0879-5795; Hammerschmidt, Katrin/0000-0003-0172-8995; Hammerschmidt, Katrin/0000-0003-0172-8995; Rose, Caroline/0000-0001-7133-0355	French State; Ile-de-France; Marsden Fund Council; Foundational Questions in Evolutionary Biology Fund [RFP-12-20]; National Science Foundation [DBI-0939454]; NSF CAREER Award [DEB0952825]	French State; Ile-de-France; Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); Foundational Questions in Evolutionary Biology Fund; National Science Foundation(National Science Foundation (NSF)); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank S. Nestmann for assistance with molecular aspects of the work and for guiding construction of the mutS deletion mutant. We thank E. Libby and Y. Pichugin for discussion, and S. DeMonte and P. G. Smith for comments on drafts of the manuscript. We are indebted to PacBio and particularly J. Korlach and Y. Song for genome sequencing. P. B. R. currently holds an International Blaise Pascal Research Chair funded by the French State and the Ile-de-France, managed by the Fondation de l'Ecole Normale Superieure. The work was directly supported by the Marsden Fund Council from government funding administered by the Royal Society of New Zealand, and in part by grant RFP-12-20 from the Foundational Questions in Evolutionary Biology Fund, by the National Science Foundation under Cooperative Agreement Number DBI-0939454, and by an NSF CAREER Award Grant (DEB0952825).	Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; Bonner John Tyler, 1998, Integrative Biology, V1, P27; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI DOI 10.1515/9781400858712; DAMUTH J, 1988, BIOL PHILOS, V3, P407, DOI 10.1007/BF00647962; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Godfrey-Smith Peter, 2009, DARWINIAN POPULATION; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Griesemer J., 2000, SELECTION, V1, P67, DOI DOI 10.1556/SELECT.1.2000.1-3.7; Heilbron K, 2014, GENETICS, V197, P981, DOI 10.1534/genetics.114.163147; LEIGH EG, 1977, P NATL ACAD SCI USA, V74, P4542, DOI 10.1073/pnas.74.10.4542; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lewontin R. C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; Libby E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082274; Libby E, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/3/035001; Maynard Smith J., 1988, EVOLUTIONARY PROGR, P219; McDonald MJ, 2009, GENETICS, V183, P1041, DOI 10.1534/genetics.109.107110; Michod RE, 1996, P ROY SOC B-BIOL SCI, V263, P813, DOI 10.1098/rspb.1996.0121; Michod Richard E., 1999, Lectures on Mathematics in the Life Sciences, V26, P47; Michod Richard E., 1999, DARWINIAN DYNAMICS E; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; NUNNEY L, 1985, AM NAT, V126, P212, DOI 10.1086/284410; Nunney L, 1999, P ROY SOC B-BIOL SCI, V266, P493, DOI 10.1098/rspb.1999.0664; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Okasha S, 2012, INTERFACE FOCUS, V2, P49, DOI 10.1098/rsfs.2011.0046; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; Rainey PB, 2007, NATURE, V446, P616, DOI 10.1038/446616a; Rainey PB, 2014, ANNU REV ECOL EVOL S, V45, P599, DOI 10.1146/annurev-ecolsys-120213-091740; Rainey PB, 2010, BIOESSAYS, V32, P872, DOI 10.1002/bies.201000039; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Sober Elliott, 1998, OTHERS EVOLUTION PSY; Spiers AJ, 2002, GENETICS, V161, P33; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tarnita CE, 2013, J THEOR BIOL, V320, P10, DOI 10.1016/j.jtbi.2012.11.022; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; WADE MJ, 1980, BEHAV ECOL SOCIOBIOL, V7, P167, DOI 10.1007/BF00299360; WOLPERT L, 1990, BIOL J LINN SOC, V39, P109, DOI 10.1111/j.1095-8312.1990.tb00506.x; Wolpert L, 2002, NATURE, V420, P745, DOI 10.1038/420745a; Zhang XX, 2007, J MICROBIOL METH, V71, P78, DOI 10.1016/j.mimet.2007.07.001	47	104	108	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					75	+		10.1038/nature13884	http://dx.doi.org/10.1038/nature13884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373677				2022-12-28	WOS:000344187500031
J	Wedzicha, W				Wedzicha, Wisia			Ombudsman's report on the letter by Manduca and others	LANCET			English	Editorial Material							PEOPLE; GAZA		Univ London Imperial Coll Sci Technol & Med, Airways Dis Sect, Natl Heart & Lung Inst, London SW3 6LR, England	Imperial College London	Wedzicha, W (corresponding author), Univ London Imperial Coll Sci Technol & Med, Airways Dis Sect, Natl Heart & Lung Inst, London SW3 6LR, England.	ombudsman@lancet.com						Horton R, 2014, LANCET, V384, P1332, DOI 10.1016/S0140-6736(14)61782-7; Manduca P, 2014, LANCET, V384, P746, DOI 10.1016/S0140-6736(14)61316-7; Manduca P, 2014, LANCET, V384, P397, DOI 10.1016/S0140-6736(14)61044-8; United Nations Office for the Coordination of Humanitarian Affairs, 2014, OCC PAL TERR GAZ EM	4	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1486	1487		10.1016/S0140-6736(14)61897-3	http://dx.doi.org/10.1016/S0140-6736(14)61897-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9MO	25390562				2022-12-28	WOS:000343899600008
J	Villeval, MC				Villeval, Marie Claire			BEHAVIOURAL ECONOMICS Professional identity can increase dishonesty	NATURE			English	Editorial Material									[Villeval, Marie Claire] GATE, F-69007 Lyon, France; [Villeval, Marie Claire] CNRS, F-69007 Lyon, France; [Villeval, Marie Claire] Univ Lyon, F-69007 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Lyon 2; Centre National de la Recherche Scientifique (CNRS)	Villeval, MC (corresponding author), GATE, F-69007 Lyon, France.	villeval@gate.cnrs.fr	Villeval, Marie Claire/H-7773-2017	Villeval, Marie Claire/0000-0001-8578-5449				Akerlof GA, 2010, IDENTITY ECONOMICS: HOW OUR IDENTITIES SHAPE OUR WORK, WAGES, AND WELL-BEING, P1; Ariely D., 2012, HONEST TRUTH DISHONE; Benjamin DJ, 2010, AM ECON REV, V100, P1913, DOI 10.1257/aer.100.4.1913; Chen Y., 2006, AM ECON REV, V99, P431; Cohn A, 2014, NATURE, V516, P86, DOI 10.1038/nature13977; Fischbacher U, 2013, J EUR ECON ASSOC, V11, P525, DOI 10.1111/jeea.12014; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Lefebvre M., 2014, INT TAX PUBLIC FINAN; Reicher S.D., 1995, EUR REV SOC PSYCHOL, V6, P161, DOI [10.1080/14792779443000049, DOI 10.1080/14792779443000049]	10	6	6	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					48	49		10.1038/nature14068	http://dx.doi.org/10.1038/nature14068			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW5JD	25409155	Green Submitted			2022-12-28	WOS:000346310800034
J	Kosiborod, M; Rasmussen, HS; Lavin, P; Qunibi, WY; Spinowitz, B; Packham, D; Roger, SD; Yang, A; Lerma, E; Singh, B				Kosiborod, Mikhail; Rasmussen, Henrik S.; Lavin, Philip; Qunibi, Wajeh Y.; Spinowitz, Bruce; Packham, David; Roger, Simon D.; Yang, Alex; Lerma, Edgar; Singh, Bhupinder			Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia The HARMONIZE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC KIDNEY-DISEASE; POLYSTYRENE SULFONATE; MANAGEMENT; ASSOCIATION; BICARBONATE; PREDICTORS; RISK; HOSPITALIZATION; SPIRONOLACTONE; SORBITOL	IMPORTANCE Hyperkalemia is a common electrolyte abnormality that may be difficult to manage because of a lack of effective therapies. Sodium zirconium cyclosilicate is a nonabsorbed cation exchanger that selectively binds potassium in the intestine. OBJECTIVE To evaluate the efficacy and safety of zirconium cyclosilicate for 28 days in patients with hyperkalemia. DESIGN, SETTING, AND PARTICIPANTS HARMONIZE was a phase 3, multicenter, randomized, double-blind, placebo-controlled trial evaluating zirconium cyclosilicate in outpatients with hyperkalemia (serum potassium >= 5.1 mEq/L) recruited from 44 sites in the United States, Australia, and South Africa (March-August 2014). INTERVENTIONS Patients (n = 258) received 10 g of zirconium cyclosilicate 3 times daily in the initial 48-hour open-label phase. Patients (n = 237) achieving normokalemia (3.5-5.0 mEq/L) were then randomized to receive zirconium cyclosilicate, 5 g (n = 45 patients), 10 g (n = 51), or 15 g (n = 56), or placebo (n = 85) daily for 28 days. MAIN OUTCOMES AND MEASURES The primary end point was mean serum potassium level in each zirconium cyclosilicate group vs placebo during days 8-29 of the randomized phase. RESULTS In the open-label phase, serum potassium levels declined from 5.6 mEq/L at baseline to 4.5 mEq/L at 48 hours. Median time to normalization was 2.2 hours, with 84% of patients (95% CI, 79%-88%) achieving normokalemia by 24 hours and 98%(95% CI, 96%-99%) by 48 hours. In the randomized phase, serum potassium was significantly lower during days 8-29 with all 3 zirconium cyclosilicate doses vs placebo (4.8 mEq/L [95% CI, 4.6-4.9], 4.5 mEq/L [95% CI, 4.4-4.6], and 4.4 mEq/L [95% CI, 4.3-4.5] for 5 g, 10 g, and 15 g; 5.1 mEq/L [95% CI, 5.0-5.2] for placebo; P < .001 for all comparisons). The proportion of patients with mean potassium < 5.1 mEq/L during days 8-29 was significantly higher in all zirconium cyclosilicate groups vs placebo (36/45 [80%], 45/50 [90%], and 51/54 [94%] for the 5-g, 10-g, and 15-g groups, vs 38/82 [46%] with placebo; P < .001 for each dose vs placebo). Adverse events were comparable between zirconium cyclosilicate and placebo, although edema was more commonin the 15-g group (edema incidence: 2/85 [2%], 1/45 [2%], 3/51 [6%], and 8/56 [14%] patients in the placebo, 5-g, 10-g, and 15-g groups). Hypokalemia developed in 5/51 (10%) and 6/56 patients (11%) in the 10-g and 15-g zirconium cyclosilicate groups, vs none in the 5-g or placebo groups. CONCLUSIONS AND RELEVANCE Among outpatients with hyperkalemia, open-label sodium zirconium cyclosilicate reduced serum potassium to normal levels within 48 hours; compared with placebo, all 3 doses of zirconium cyclosilicate resulted in lower potassium levels and a higher proportion of patients with normal potassium levels for up to 28 days. Further studies are needed to evaluate the efficacy and safety of zirconium cyclosilicate beyond 4 weeks and to assess long-term clinical outcomes.	[Kosiborod, Mikhail] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Kosiborod, Mikhail] Univ Missouri, Kansas City, MO USA; [Rasmussen, Henrik S.; Singh, Bhupinder] ZS Pharma, Coppell, TX USA; [Lavin, Philip] Boston Biostat Res Fdn, Framingham, MA USA; [Qunibi, Wajeh Y.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Spinowitz, Bruce] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Packham, David] Univ Melbourne, Melbourne Renal Res Grp, Melbourne, Vic, Australia; [Packham, David] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Roger, Simon D.] Renal Res, Gosford, Australia; [Yang, Alex] Xelay Acumen, Belmont, CA USA; [Lerma, Edgar] Univ Illinois, Coll Med, Chicago, IL USA; [Lerma, Edgar] Advocate Christ Med Ctr, Oak Lawn, IL USA	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Texas System; University of Texas Health San Antonio; Cornell University; University of Melbourne; University of Melbourne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kosiborod, M (corresponding author), St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	mkosiborod@saint-lukes.org	Kosiborod, Mikhail/HDO-1541-2022; Lerma, Edgar/K-5970-2014	Kosiborod, Mikhail/0000-0002-3750-9789; Lerma, Edgar/0000-0002-0976-5478	ZS Pharma	ZS Pharma	The study was sponsored and funded by ZS Pharma.	Aaron KJ, 2013, MAYO CLIN PROC, V88, P987, DOI 10.1016/j.mayocp.2013.06.005; Abramowitz MK, 2013, CLIN J AM SOC NEPHRO, V8, P714, DOI 10.2215/CJN.08340812; Ahn SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084467; An JN, 2012, CRIT CARE, V16, DOI 10.1186/cc11872; Ash SR, 2013, J AM SOC NEPHROL, V24, p2B; BLUMBERG A, 1992, KIDNEY INT, V41, P369, DOI 10.1038/ki.1992.51; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Cejas MDC, 2013, REV ESP ENFERM DIG, V105, P232, DOI 10.4321/s1130-01082013000400010; Cohn JN, 2007, ADV THER, V24, P1290, DOI 10.1007/BF02877776; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; El Shahawy M, 51 EUR REN ASS EUR D; FLINN RB, 1961, NEW ENGL J MED, V264, P111, DOI 10.1056/NEJM196101192640302; Fordjour KN, 2014, AM J MED SCI, V347, P93, DOI 10.1097/MAJ.0b013e318279b105; Goraya N, 2012, CURR OPIN NEPHROL HY, V21, P635, DOI 10.1097/MNH.0b013e328357a69b; Goyal A, 2012, JAMA-J AM MED ASSOC, V307, P157, DOI 10.1001/jama.2011.1967; Harel Z, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.08.016; Jain N, 2012, AM J CARDIOL, V109, P1510, DOI 10.1016/j.amjcard.2012.01.367; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kessler C, 2011, J HOSP MED, V6, P136, DOI 10.1002/jhm.834; Khanagavi J, 2014, ARCH MED SCI, V10, P251, DOI 10.5114/aoms.2014.42577; Kuijvenhoven MA, 2013, INT J CLIN PHARM-NET, V35, P1099, DOI 10.1007/s11096-013-9830-8; Loniewski I, 2014, KIDNEY INT, V85, P529, DOI 10.1038/ki.2013.401; McMahon GM, 2012, INTENS CARE MED, V38, P1834, DOI 10.1007/s00134-012-2636-7; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P542, DOI 10.2215/CJN.04750908; Palmer Biff F, 2010, Proc (Bayl Univ Med Cent), V23, P239; Rossignol P, 2014, CIRC-HEART FAIL, V7, P51, DOI 10.1161/CIRCHEARTFAILURE.113.000792; SCHEER L, 1961, NEW ENGL J MED, V264, P115, DOI 10.1056/NEJM196101192640303; St Peter WL, 2013, PHARMACOTHERAPY, V33, P496, DOI 10.1002/phar.1232; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Svensson M, 2004, J CARD FAIL, V10, P297, DOI 10.1016/j.cardfail.2003.10.012; Tongyoo Assanee, 2013, Journal of the Medical Association of Thailand, V96, P1617; Vardeny O, 2014, CIRC-HEART FAIL, V7, P573, DOI 10.1161/CIRCHEARTFAILURE.114.001104; Vardeny O, 2013, CIRC-HEART FAIL, V6, P970, DOI 10.1161/CIRCHEARTFAILURE.113.000530; Watson M, 2010, CLIN J AM SOC NEPHRO, V5, P1723, DOI 10.2215/CJN.03700410; Watson MA, 2012, AM J KIDNEY DIS, V60, P409, DOI 10.1053/j.ajkd.2012.04.023; Weinberg JM, 2009, ARCH INTERN MED, V169, P1587, DOI 10.1001/archinternmed.2009.284; Yang A, 2014, AM J KIDNEY DIS, V63, pA115; Yuan CM, 2013, AM J MED, V126, pE12, DOI 10.1016/j.amjmed.2013.02.034	38	242	256	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2223	2233		10.1001/jama.2014.15688	http://dx.doi.org/10.1001/jama.2014.15688			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25402495				2022-12-28	WOS:000345684800017
J	Rowland, AA; Chitwood, PJ; Phillips, MJ; Voeltz, GK				Rowland, Ashley A.; Chitwood, Patrick J.; Phillips, Melissa J.; Voeltz, Gia K.			ER Contact Sites Define the Position and Timing of Endosome Fission	CELL			English	Article							ENDOPLASMIC-RETICULUM; WASH COMPLEX; RETROMER; PROTEINS; CA2+; CHOLESTEROL; REGULATORS; INHIBITOR; DYNASORE; DOMAINS	Endocytic cargo and Rab GTPases are segregated to distinct domains of an endosome. These domains maintain their identity until they undergo fission to traffic cargo. It is not fully understood how segregation of cargo or Rab proteins is maintained along the continuous endosomal membrane or what machinery is required for fission. Endosomes form contact sites with the endoplasmic reticulum (ER) that are maintained during trafficking. Here, we show that stable contacts form between the ER and endosome at constricted sorting domains, and free diffusion of cargo is limited at these positions. We demonstrate that the site of constriction and fission for early and late endosomes is spatially and temporally linked to contact sites with the ER. Lastly, we show that altering ER structure and dynamics reduces the efficiency of endosome fission. Together, these data reveal a surprising role for ER contact in defining the timing and position of endosome fission.	[Rowland, Ashley A.; Chitwood, Patrick J.; Phillips, Melissa J.; Voeltz, Gia K.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Voeltz, GK (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	gia.voeltz@colorado.edu		CHITWOOD, PATRICK/0000-0003-4350-8720; Hoyer, Melissa/0000-0003-0858-4998	NIH [GM07135, T32 GM08759, GM083977]; NSF Graduate Research Fellowship [DGE 1144083]; American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083977, T32GM008759, T32GM007135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Nunnari, J. Friedman, and L. Greene for helpful discussions. We also thank C. Merrifield, L. Greene, and G. Hajnoczky for generating plasmids used here and D. Billadeau for the FAM21 containing plasmid and the WASH1 antibody. A. A. R. is a Gordon Stone Fellow and was supported by a pre-doctoral training grant from the NIH (GM07135). M. J. P. is supported by an NSF Graduate Research Fellowship DGE 1144083 and was supported by a pre-doctoral training grant from the NIH (T32 GM08759). This work is also supported by a Research Scholar grant from the American Cancer Society and by a grant from the NIH (GM083977) to G. K. V.	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gautreau A., 2014, COLD SPRING HARB PER, V6, P1; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Hunt SD, 2013, J CELL SCI, V126, P2493, DOI 10.1242/jcs.122317; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Lopez-Sanjurjo CI, 2013, J CELL SCI, V126, P289, DOI 10.1242/jcs.116103; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mesaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019764; Morgan AJ, 2013, J CELL BIOL, V200, P789, DOI 10.1083/jcb.201204078; Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Seaman MNJ, 2013, TRENDS CELL BIOL, V23, P522, DOI 10.1016/j.tcb.2013.04.010; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Trischler M, 1999, J CELL SCI, V112, P4773; van der Kant R, 2014, J CELL SCI, V127, P929, DOI 10.1242/jcs.137539; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Zajac AL, 2013, CURR BIOL, V23, P1173, DOI 10.1016/j.cub.2013.05.015; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	45	252	254	6	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1027	1041		10.1016/j.cell.2014.10.023	http://dx.doi.org/10.1016/j.cell.2014.10.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416943	Green Accepted, Bronze			2022-12-28	WOS:000345506300016
J	Yue, F; Cheng, Y; Breschi, A; Vierstra, J; Wu, WS; Ryba, T; Sandstrom, R; Ma, ZH; Davis, C; Pope, BD; Shen, Y; Pervouchine, DD; Djebali, S; Thurman, RE; Kaul, R; Rynes, E; Kirilusha, A; Marinov, GK; Williams, BA; Trout, D; Amrhein, H; Fisher-Aylor, K; Antoshechkin, I; DeSalvo, G; See, LH; Fastuca, M; Drenkow, J; Zaleski, C; Dobin, A; Prieto, P; Lagarde, J; Bussotti, G; Tanzer, A; Denas, O; Li, KW; Bender, MA; Zhang, MH; Byron, R; Groudine, MT; McCleary, D; Pham, L; Ye, Z; Kuan, S; Edsall, L; Wu, YC; Rasmussen, MD; Bansal, MS; Kellis, M; Keller, CA; Morrissey, CS; Mishra, T; Jain, D; Dogan, N; Harris, RS; Cayting, P; Kawli, T; Boyle, AP; Euskirchen, G; Kundaje, A; Lin, S; Lin, Y; Jansen, C; Malladi, VS; Cline, MS; Erickson, DT; Kirkup, VM; Learned, K; Sloan, CA; Rosenbloom, KR; De Sousa, BL; Beal, K; Pignatelli, M; Flicek, P; Lian, J; Kahveci, T; Lee, D; Kent, WJ; Santos, MR; Herrero, J; Notredame, C; Johnson, A; Vong, S; Lee, K; Bates, D; Neri, F; Diegel, M; Canfield, T; Sabo, PJ; Wilken, MS; Reh, TA; Giste, E; Shafer, A; Kutyavin, T; Haugen, E; Dunn, D; Reynolds, AP; Neph, S; Humbert, R; Hansen, RS; De Bruijn, M; Selleri, L; Rudensky, A; Josefowicz, S; Samstein, R; Eichler, EE; Orkin, SH; Levasseur, D; Papayannopoulou, T; Chang, KH; Skoultchi, A; Gosh, S; Disteche, C; Treuting, P; Wang, Y; Weiss, MJ; Blobel, GA; Cao, X; Zhong, S; Wang, T; Good, PJ; Lowdon, RF; Adams, LB; Zhou, XQ; Pazin, MJ; Feingold, EA; Wold, B; Taylor, J; Mortazavi, A; Weissman, SM; Stamatoyannopoulos, JA; Snyder, MP; Guigo, R; Gingeras, TR; Gilbert, DM; Hardison, RC; Beer, MA; Ren, B				Yue, Feng; Cheng, Yong; Breschi, Alessandra; Vierstra, Jeff; Wu, Weisheng; Ryba, Tyrone; Sandstrom, Richard; Ma, Zhihai; Davis, Carrie; Pope, Benjamin D.; Shen, Yin; Pervouchine, Dmitri D.; Djebali, Sarah; Thurman, Robert E.; Kaul, Rajinder; Rynes, Eric; Kirilusha, Anthony; Marinov, Georgi K.; Williams, Brian A.; Trout, Diane; Amrhein, Henry; Fisher-Aylor, Katherine; Antoshechkin, Igor; DeSalvo, Gilberto; See, Lei-Hoon; Fastuca, Meagan; Drenkow, Jorg; Zaleski, Chris; Dobin, Alex; Prieto, Pablo; Lagarde, Julien; Bussotti, Giovanni; Tanzer, Andrea; Denas, Olgert; Li, Kanwei; Bender, M. A.; Zhang, Miaohua; Byron, Rachel; Groudine, Mark T.; McCleary, David; Pham, Long; Ye, Zhen; Kuan, Samantha; Edsall, Lee; Wu, Yi-Chieh; Rasmussen, Matthew D.; Bansal, Mukul S.; Kellis, Manolis; Keller, Cheryl A.; Morrissey, Christapher S.; Mishra, Tejaswini; Jain, Deepti; Dogan, Nergiz; Harris, Robert S.; Cayting, Philip; Kawli, Trupti; Boyle, Alan P.; Euskirchen, Ghia; Kundaje, Anshul; Lin, Shin; Lin, Yiing; Jansen, Camden; Malladi, Venkat S.; Cline, Melissa S.; Erickson, Drew T.; Kirkup, Vanessa M.; Learned, Katrina; Sloan, Cricket A.; Rosenbloom, Kate R.; De Sousa, Beatriz Lacerda; Beal, Kathryn; Pignatelli, Miguel; Flicek, Paul; Lian, Jin; Kahveci, Tamer; Lee, Dongwon; Kent, W. James; Santos, Miguel Ramalho; Herrero, Javier; Notredame, Cedric; Johnson, Audra; Vong, Shinny; Lee, Kristen; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Canfield, Theresa; Sabo, Peter J.; Wilken, Matthew S.; Reh, Thomas A.; Giste, Erika; Shafer, Anthony; Kutyavin, Tanya; Haugen, Eric; Dunn, Douglas; Reynolds, Alex P.; Neph, Shane; Humbert, Richard; Hansen, R. Scott; De Bruijn, Marella; Selleri, Licia; Rudensky, Alexander; Josefowicz, Steven; Samstein, Robert; Eichler, Evan E.; Orkin, Stuart H.; Levasseur, Dana; Papayannopoulou, Thalia; Chang, Kai-Hsin; Skoultchi, Arthur; Gosh, Srikanta; Disteche, Christine; Treuting, Piper; Wang, Yanli; Weiss, Mitchell J.; Blobel, Gerd A.; Cao, Xiaoyi; Zhong, Sheng; Wang, Ting; Good, Peter J.; Lowdon, Rebecca F.; Adams, Leslie B.; Zhou, Xiao-Qiao; Pazin, Michael J.; Feingold, Elise A.; Wold, Barbara; Taylor, James; Mortazavi, Ali; Weissman, Sherman M.; Stamatoyannopoulos, John A.; Snyder, Michael P.; Guigo, Roderic; Gingeras, Thomas R.; Gilbert, David M.; Hardison, Ross C.; Beer, Michael A.; Ren, Bing		Mouse ENCODE Consortium	A comparative encyclopedia of DNA elements in the mouse genome	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; EMBRYONIC STEM-CELLS; PERVASIVE TRANSCRIPTION; CHROMATIN INTERACTIONS; EVOLUTIONARY DYNAMICS; TRANSPOSABLE ELEMENTS; ENCODE DATA; LANDSCAPE; GENE; EXPRESSION	The laboratory mouse shares the majority of its protein-coding genes with humans, making it the premier model organism in biomedical research, yet the two mammals differ in significant ways. To gain greater insights into both shared and species-specific transcriptional and cellular regulatory programs in the mouse, the Mouse ENCODE Consortium has mapped transcription, DNase I hypersensitivity, transcription factor binding, chromatin modifications and replication domains throughout the mouse genome in diverse cell and tissue types. By comparing with the human genome, we not only confirm substantial conservation in the newly annotated potential functional sequences, but also find a large degree of divergence of sequences involved in transcriptional regulation, chromatin state and higher order chromatin organization. Our results illuminate the wide range of evolutionary forces acting on genes and their regulatory regions, and provide a general resource for research into mammalian biology and mechanisms of human diseases.	[Yue, Feng; Shen, Yin; McCleary, David; Pham, Long; Ye, Zhen; Kuan, Samantha; Edsall, Lee; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Yue, Feng; Shen, Yin; McCleary, David; Pham, Long; Ye, Zhen; Kuan, Samantha; Edsall, Lee; Ren, Bing] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Yue, Feng] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Cheng, Yong; Ma, Zhihai; Cayting, Philip; Kawli, Trupti; Boyle, Alan P.; Euskirchen, Ghia; Kundaje, Anshul; Lin, Shin; Lin, Yiing; Malladi, Venkat S.; Erickson, Drew T.; Sloan, Cricket A.; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Breschi, Alessandra; Pervouchine, Dmitri D.; Djebali, Sarah; Prieto, Pablo; Lagarde, Julien; Bussotti, Giovanni; Tanzer, Andrea; Notredame, Cedric; Guigo, Roderic] Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; [Breschi, Alessandra; Pervouchine, Dmitri D.; Djebali, Sarah; Prieto, Pablo; Lagarde, Julien; Bussotti, Giovanni; Tanzer, Andrea; Notredame, Cedric; Guigo, Roderic] UPF, Barcelona 08003, Catalonia, Spain; [Vierstra, Jeff; Sandstrom, Richard; Thurman, Robert E.; Kaul, Rajinder; Rynes, Eric; Johnson, Audra; Vong, Shinny; Lee, Kristen; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Canfield, Theresa; Sabo, Peter J.; Giste, Erika; Shafer, Anthony; Kutyavin, Tanya; Haugen, Eric; Dunn, Douglas; Reynolds, Alex P.; Neph, Shane; Humbert, Richard; Hansen, R. Scott; Eichler, Evan E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wu, Weisheng; Keller, Cheryl A.; Morrissey, Christapher S.; Mishra, Tejaswini; Jain, Deepti; Dogan, Nergiz; Harris, Robert S.; Hardison, Ross C.] Penn State Univ, Huck Inst,Life Sci, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Ryba, Tyrone; Pope, Benjamin D.; Gilbert, David M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Davis, Carrie; See, Lei-Hoon; Fastuca, Meagan; Drenkow, Jorg; Zaleski, Chris; Dobin, Alex; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kirilusha, Anthony; Marinov, Georgi K.; Williams, Brian A.; Trout, Diane; Amrhein, Henry; Fisher-Aylor, Katherine; Antoshechkin, Igor; DeSalvo, Gilberto; Wold, Barbara] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Tanzer, Andrea] Univ Vienna, Fac Chem, Dept Theoret Chem, A-1090 Vienna, Austria; [Denas, Olgert; Li, Kanwei; Taylor, James] Emory Univ, O Wayne Rollins Res Ctr, Dept Biol, Atlanta, GA 30322 USA; [Denas, Olgert; Li, Kanwei; Taylor, James] Emory Univ, O Wayne Rollins Res Ctr, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Bender, M. A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Zhang, Miaohua; Byron, Rachel; Groudine, Mark T.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Groudine, Mark T.] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA; [Wu, Yi-Chieh; Rasmussen, Matthew D.; Bansal, Mukul S.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Jansen, Camden; Mortazavi, Ali] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Cline, Melissa S.; Kirkup, Vanessa M.; Learned, Katrina; Rosenbloom, Kate R.; Kent, W. James] Univ Calif Santa Cruz, Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [De Sousa, Beatriz Lacerda; Santos, Miguel Ramalho] Univ Calif San Francisco, Dept Obstet Gynecol, San Francisco, CA 94143 USA; [De Sousa, Beatriz Lacerda; Santos, Miguel Ramalho] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [De Sousa, Beatriz Lacerda; Santos, Miguel Ramalho] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Beal, Kathryn; Pignatelli, Miguel; Flicek, Paul; Herrero, Javier; Levasseur, Dana] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Lian, Jin; Weissman, Sherman M.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Kahveci, Tamer] Univ Florida, Gainesville, FL 32611 USA; [Lee, Dongwon; Beer, Michael A.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Lee, Dongwon; Beer, Michael A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Herrero, Javier] UCL, UCL Canc Inst, Bill Lyons Informat Ctr, London WC1E 6DD, England; [Wilken, Matthew S.; Reh, Thomas A.; Wang, Yanli] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [De Bruijn, Marella] Univ Oxford, MRC Mol Haemotol Unit, Oxford OX3 9DS, England; [Selleri, Licia] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Rudensky, Alexander; Josefowicz, Steven; Samstein, Robert] Mem Sloan Kettering Canc Ctr, Program Immunol, HHMI & Ludwig Ctr, New York, NY 10065 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Cambridge, MA 02138 USA; [Levasseur, Dana] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Papayannopoulou, Thalia; Chang, Kai-Hsin] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Skoultchi, Arthur; Gosh, Srikanta] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Disteche, Christine] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Treuting, Piper] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Wang, Yanli] Penn State Univ, Bioinformat & Genom Program, University Pk, PA 16802 USA; [Weiss, Mitchell J.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cao, Xiaoyi; Zhong, Sheng] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Wang, Ting] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, Dept Genet, St Louis, MO 63108 USA; [Good, Peter J.; Lowdon, Rebecca F.; Adams, Leslie B.; Zhou, Xiao-Qiao; Pazin, Michael J.; Feingold, Elise A.] NHGRI, NIH, Bethesda, MD 20892 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Stanford University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University System of Florida; Florida State University; Cold Spring Harbor Laboratory; California Institute of Technology; University of Vienna; Emory University; Emory University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Irvine; University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; European Molecular Biology Laboratory (EMBL); Yale University; State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins University; University of London; University College London; University of Washington; University of Washington Seattle; University of Oxford; Cornell University; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; University of Iowa; University of Washington; University of Washington Seattle; Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Ren, B (corresponding author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jstam@u.washington.edu; mpsnyder@stanford.edu; roderic.guigo@crg.cat; gingeras@cshl.edu; gilbert@bio.fsu.edu; ross@bx.psu.edu; mbeer@jhu.edu; biren@ucsd.edu	Pervouchine, Dmitri/AAU-5399-2021; Pervouchine, Dmitri/H-5252-2015; Kundaje, Anshul/Y-2598-2019; Tanzer, Andrea/AAY-5431-2021; Kellis, Manolis/ABE-7385-2020; cheng, yong/I-4270-2012; Taylor, James/F-1026-2011; Treuting, Piper M./AAB-2721-2019; Fisher, Andrew/A-1113-2016; Tanzer, Andrea/L-3147-2015; Hardison, Ross C/G-1142-2010; Beer, Michael/AFV-4282-2022; Ramalho-Santos, Miguel/L-9092-2018; Mishra, Tejaswini/D-3528-2018; Kundaje, Anshul/Y-2739-2019; Djebali, Sarah/O-9817-2014; Pervouchine, Dmitri/AAE-2178-2020; Lagarde, Julien/AAI-1686-2020; Cao, Xiaoyi/Q-4157-2019; Dogan-Artun, Nergiz/AAG-2681-2021; Weiss, Mitchell J/W-9814-2018; Kumar, Swathi/I-7941-2015; Herrero, Javier/H-6971-2019; Ma, Zhihai/E-7130-2015; Pope, Ben/Y-4326-2019; Cao, Xiaoyi/D-4646-2017; Boyle, Alan/I-1848-2014; Adams, Leslie/AAZ-9323-2020; Guigo, Roderic/D-1303-2010; Prieto Barja, Pablo/H-2035-2015; notredame, cedric/G-3868-2010; Bussotti, Giovanni/C-3082-2019	Pervouchine, Dmitri/0000-0003-0543-9760; Pervouchine, Dmitri/0000-0003-0543-9760; Kundaje, Anshul/0000-0003-3084-2287; Tanzer, Andrea/0000-0003-2873-4236; Kellis, Manolis/0000-0001-7113-9630; Taylor, James/0000-0001-5079-840X; Treuting, Piper M./0000-0002-1812-1519; Tanzer, Andrea/0000-0003-2873-4236; Hardison, Ross C/0000-0003-4084-7516; Ramalho-Santos, Miguel/0000-0003-0177-5556; Mishra, Tejaswini/0000-0001-9931-1260; Kundaje, Anshul/0000-0003-3084-2287; Djebali, Sarah/0000-0002-0599-1267; Lagarde, Julien/0000-0002-0290-7445; Cao, Xiaoyi/0000-0001-7222-5450; Weiss, Mitchell J/0000-0003-2460-3036; Kumar, Swathi/0000-0002-2770-5145; Herrero, Javier/0000-0001-7313-717X; Pope, Ben/0000-0003-1847-9163; Cao, Xiaoyi/0000-0001-7222-5450; Boyle, Alan/0000-0002-2081-1105; Adams, Leslie/0000-0003-4956-271X; Guigo, Roderic/0000-0002-5738-4477; Prieto Barja, Pablo/0000-0002-1615-3998; Zhou, Xiao-Qiao/0000-0002-0724-5153; notredame, cedric/0000-0003-1461-0988; Fisher-Aylor, Katherine/0000-0003-3371-2947; Sandstrom, Richard/0000-0002-3356-1547; Beer, Michael A/0000-0001-9955-3809; Dobin, Alexander/0000-0002-4115-9128; Kaul, Rajinder/0000-0002-7895-9284; Samstein, Robert/0000-0001-6860-2401; Edsall, Lee Elizabeth/0000-0002-0326-2829; Dogan-Artun, Nergiz/0000-0002-5922-4194; Lee, Dongwon/0000-0002-1568-2249; Haugen, Eric/0000-0001-7444-8981; Vierstra, Jeff/0000-0001-6406-8563; Bussotti, Giovanni/0000-0002-4078-7413; Lin, Yiing/0000-0002-0317-7608; josefowicz, steven/0000-0001-7453-779X; Flicek, Paul/0000-0002-3897-7955; Pazin, Michael/0000-0002-7561-3640; Snyder, Michael/0000-0003-0784-7987; Lin, Shin/0000-0003-0118-0413	National Institutes of Health [R01HG003991, 1U54HG007004, 3RC2HG005602, GM083337, GM085354, F31CA165863, RC2HG005573, R01DK065806]; Spanish Plan Nacional [BIO2011-26205]; ERC [BIO2011-26205, 294653]; National Science Foundation Graduate Research Fellowship [DGE-071824]; Wellcome Trust [095908]; NHGRI [U01HG004695];  [R01HD043997-09];  [F32HL110473];  [K99HL119617]; MRC [MC_UU_12009/2] Funding Source: UKRI; Medical Research Council [MC_UU_12009/2] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043997] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F31CA165863, P30CA008748, P30CA045508] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021482] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL064190, U01HL099656, F32HL110473, P01HL110860, U01HL099993, K99HL119617] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007348, U54HG006997, R01HG007175, RC2HG005602, R01HG003991, R01HG004037, U54HG006998, R01HG007354, K99HG007356, U01HG004695, U54HG007004, RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065806, R01DK065806, R01DK096266, R37DK044746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354, T32GM081739, R01GM083337] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Plan Nacional(Spanish Government); ERC(European Research Council (ERC)European Commission); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is funded by grants R01HG003991 (B. R.), 1U54HG007004 (T. R. G.), 3RC2HG005602 (M. P. S.), GM083337 and GM085354 (D. M. G.), F31CA165863 (B. D. P.), RC2HG005573 and R01DK065806 (R. C. H.) from the National Institutes of Health, and BIO2011-26205 from the Spanish Plan Nacional and ERC 294653 (to R. G.). J.V. is supported by a National Science Foundation Graduate Research Fellowship under grant no. DGE-071824. K. B., M. P., J.H. and P. F. acknowledge the Wellcome Trust (grant number 095908), the NHGRI (grant number U01HG004695) and the European Molecular Biology Laboratory. We thank G. Hon for helping the analysis of high-throughput enhancer validation. L. S. is supported by R01HD043997-09. S. L. was supported by grants F32HL110473 and K99HL119617.	Baker A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002443; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Denas O., 2014, BIORXIV; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Fraser HB, 2013, GENOME RES, V23, P1089, DOI 10.1101/gr.152710.112; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Jacques PE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003504; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; King DC, 2007, GENOME RES, V17, P775, DOI 10.1101/gr.5592107; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lande-Diner L, 2009, MOL CELL, V34, P767, DOI 10.1016/j.molcel.2009.05.027; Lin S., P NATL ACAD IN PRESS; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Maston GA, 2012, ANNU REV GENOM HUM G, V13, P29, DOI 10.1146/annurev-genom-090711-163723; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Moindrot B, 2012, NUCLEIC ACIDS RES, V40, P9470, DOI 10.1093/nar/gks736; Mortazavi A, 2013, GENOME RES, V23, P2136, DOI 10.1101/gr.158261.113; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Paigen K, 2003, GENETICS, V163, P1; Pervouchine D., 2014, BIORXIV; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Ryba T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002225; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Sundaram V., 2014, GENOME RES; Takebayashi S, 2012, P NATL ACAD SCI USA, V109, P12574, DOI 10.1073/pnas.1207185109; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vierstra J., SCIENCE IN PRESS; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; Wilson MD, 2009, CURR OPIN GENET DEV, V19, P579, DOI 10.1016/j.gde.2009.10.003; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Wu Y. -C., 2014, BIORXIV; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011; Zheng W, 2011, ANNU REV GENOM HUM G, V12, P327, DOI 10.1146/annurev-genom-082908-150139	71	979	1000	8	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					355	+		10.1038/nature13992	http://dx.doi.org/10.1038/nature13992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409824	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000345770600034
J	Zeng, N; Zhao, F; Collatz, GJ; Kalnay, E; Salawitch, RJ; West, TO; Guanter, L				Zeng, Ning; Zhao, Fang; Collatz, George J.; Kalnay, Eugenia; Salawitch, Ross J.; West, Tristram O.; Guanter, Luis			Agricultural Green Revolution as a driver of increasing atmospheric CO2 seasonal amplitude	NATURE			English	Article							MAUNA-LOA; CARBON-DIOXIDE; CHLOROPHYLL FLUORESCENCE; HUMAN APPROPRIATION; CYCLE; VEGETATION; 20TH-CENTURY; VARIABILITY; BIOSPHERE; ECOSYSTEM	The atmospheric carbon dioxide (CO2) record displays a prominent seasonal cycle that arises mainly from changes in vegetation growth and the corresponding CO2 uptake during the boreal spring and summer growing seasons and CO2 release during the autumn and winter seasons(1). The CO2 seasonal amplitude has increased over the past five decades, suggesting an increase in Northern Hemisphere biospheric activity(2,5,6). It has been proposed that vegetation growth may have been stimulated by higher concentrations of CO2 as well as by warming in recent decades, but such mechanisms have been unable to explain the full range and magnitude of the observed increase in CO2 seasonal amplitude(2,6-13). Here we suggest that the intensification of agriculture (the Green Revolution, in which much greater crop yield per unit area was achieved by hybridization, irrigation and fertilization) during the past five decades is a driver of changes in the seasonal characteristics of the global carbon cycle. Our analysis of CO2 data and atmospheric inversions shows a robust 15 per cent long-term increase in CO2 seasonal amplitude from 1961 to 2010, punctuated by large decadal and interannual variations. Using a terrestrial carbon cycle model that takes into account high-yield cultivars, fertilizer use and irrigation, we find that the long-term increase in CO2 seasonal amplitude arises from two major regions: the midlatitude cropland between 25 degrees N and 60 degrees N and the high-latitude natural vegetation between 50 degrees N and 70 degrees N. The long-term trend of seasonal amplitude increase is 0.311 +/- 0.027 per cent per year, of which sensitivity experiments attribute 45,29 and 26 per cent to land-use change, climate variability and change, and increased productivity due to CO2 fertilization, respectively. Vegetation growth was earlier by one to two weeks, as measured by the mid-point of vegetation carbon uptake, and took up 0.5 petagrams more carbon in July, the height of the growing season, during 2001-2010 than in 1961-1970, suggesting that human land use and management contribute to seasonal changes in the CO2 exchange between the biosphere and the atmosphere.	[Zeng, Ning; Zhao, Fang; Kalnay, Eugenia; Salawitch, Ross J.] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Zeng, Ning; Zhao, Fang; Kalnay, Eugenia; Salawitch, Ross J.] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Collatz, George J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [West, Tristram O.] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Guanter, Luis] Free Univ Berlin, Inst Space Sci, D-12165 Berlin, Germany	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Free University of Berlin	Zeng, N (corresponding author), Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA.	zeng@atmos.umd.edu	collatz, george j/D-5381-2012; Zeng, Ning/A-3130-2008; Salawitch, Ross/B-4605-2009; Guanter, Luis/I-1588-2015	Zeng, Ning/0000-0002-7489-7629; Salawitch, Ross/0000-0001-8597-5832; Guanter, Luis/0000-0002-8389-5764; Kalnay, Eugenia/0000-0002-9984-9906	NOM [NA100AR4310248, NAO9NE54400006]; NSF [AGS-1129088]; NASA [NNH12AU351]	NOM; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	We thank all data providers, especially the NOAA CO<INF>2</INF> and Carbon Tracker team, and the Jena inversion team. M. Heimann suggested the flux data site comparison. This research was supported by NOM (NA100AR4310248 and NAO9NE54400006), the NSF (AGS-1129088), and NASA (NNH12AU351).	BACASTOW RB, 1985, J GEOPHYS RES-ATMOS, V90, P10529, DOI 10.1029/JD090iD06p10529; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Buermann W, 2007, P NATL ACAD SCI USA, V104, P4249, DOI 10.1073/pnas.0611224104; Cadule P, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003556; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Griffiths A. D., 2013, ATMOS MEAS TECH, V6, P207, DOI [10.5194/amt-6-207-2013, DOI 10.5194/AMT-6-2803-2013, DOI 10.5194/AMT-6-207-2013]; Guanter L, 2014, P NATL ACAD SCI USA, V111, pE1327, DOI 10.1073/pnas.1320008111; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; HEIMANN M, 1986, P16; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Jain HK, 2010, GREEN REVOLUTION: HISTORY, IMPACT AND FUTURE, P1; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kohlmaier GH, 1989, TELLUS B, V41, P487, DOI 10.1111/j.1600-0889.1989.tb00137.x; Kucharik CJ, 2003, J ENVIRON QUAL, V32, P247, DOI 10.2134/jeq2003.0247; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; MASARIE KA, 1995, J GEOPHYS RES-ATMOS, V100, P11593, DOI 10.1029/95JD00859; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Parazoo NC, 2013, GEOPHYS RES LETT, V40, P2829, DOI 10.1002/grl.50452; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Sinclair TR, 1998, CROP SCI, V38, P638, DOI 10.2135/cropsci1998.0011183X003800030002x; Tans P., 2013, TRENDS IN ATMOSPHERI; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; TUCKER CJ, 1986, NATURE, V319, P195, DOI 10.1038/319195a0; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Zeng N, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2005GL024607, 10.1029/2005gl024607]; Zeng N, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002273; Zeng N, 2003, ADV ATMOS SCI, V20, P677, DOI 10.1007/BF02915395	33	121	131	10	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					394	+		10.1038/nature13893	http://dx.doi.org/10.1038/nature13893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409829				2022-12-28	WOS:000345770600041
J	Kullgren, JT; Dicks, TN; Fu, XY; Richardson, D; Tzanis, GL; Tobi, M; Marcus, SC				Kullgren, Jeffrey T.; Dicks, Tanisha N.; Fu, Xiaoying; Richardson, Diane; Tzanis, George L.; Tobi, Martin; Marcus, Steven C.			Financial Incentives for Completion of Fecal Occult Blood Tests Among Veterans A 2-Stage, Pragmatic, Cluster, Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							COLORECTAL-CANCER; LONGITUDINAL ADHERENCE; WEIGHT-LOSS; DECISION; IMPACT; COLON; CARE	Background: Rates of patient completion of fecal occult blood tests (FOBTs) are often low. Objective: To examine whether financial incentives increase rates of FOBT completion. Design: A 2-stage, parallel-design, pragmatic, cluster, randomized, controlled trial with clustering by clinic day (ClinicalTrials.gov: NCT01516489). Setting: Primary care clinic of the Philadelphia Veterans Affairs Medical Center. Patients: 1549 patients who were prescribed an FOBT (unique samples of 713 patients for stage 1 and 836 patients for stage 2). Intervention: In stage 1, patients were assigned to usual care or receipt of $5, $10, or $20 for FOBT completion. In stage 2, different patients were assigned to usual care or receipt of $5, a 1 in 10 chance of $50, or entry into a $500 raffle for FOBT completion. Measurements: Primary outcome was FOBT completion within 30 days. Preplanned subgroup analyses examined 30-day FOBT completion by previous nonadherence to a prescribed FOBT. Results: In stage 1, none of the incentives increased rates of FOBT completion. In stage 2, a 1 in 10 chance of $50 increased FOBT completion compared with usual care (between-group difference, 19.6% [95% CI, 10.7% to 28.6%]; P < 0.001) but a $5 fixed payment and entry into a raffle for $500 did not. None of the incentives were more effective among patients who had previously been nonadherent to an FOBT than among patients who had previously completed an FOBT. Limitations: Single Veterans Affairs medical center setting, short follow-up, use of 3-sample rather than 1-sample immunochemical FOBTs, limited power to detect small effects of incentives, inability to evaluate cost-effectiveness. Conclusion: A 1 in 10 chance of receiving $50 was effective at increasing rates of FOBT completion, but 5 other tested incentives were not.	[Kullgren, Jeffrey T.] Vet Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48113 USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; [Dicks, Tanisha N.; Fu, Xiaoying; Richardson, Diane; Tzanis, George L.; Tobi, Martin] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Marcus, Steven C.] Univ Penn, Sch Social Policy & Practice, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Kullgren, JT (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, POB 130170, Ann Arbor, MI 48113 USA.	jkullgre@med.umich.edu			Veterans Affairs Center for Health Equity Research and Promotion	Veterans Affairs Center for Health Equity Research and Promotion	Veterans Affairs Center for Health Equity Research and Promotion.	BeLue R, 2011, PSYCHO-ONCOLOGY, V20, P1151, DOI 10.1002/pon.1838; Bond JH, 1997, GASTROENTEROL CLIN N, V26, P57, DOI 10.1016/S0889-8553(05)70283-1; Davis T, 2013, CANCER-AM CANCER SOC, V119, P3879, DOI 10.1002/cncr.28272; El-Serag HB, 2006, ARCH INTERN MED, V166, P2202, DOI 10.1001/archinte.166.20.2202; Fenton JJ, 2010, ANN FAM MED, V8, P397, DOI 10.1370/afm.1133; Gellad ZF, 2011, AM J GASTROENTEROL, V106, P1125, DOI 10.1038/ajg.2011.11; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Green BB, 2013, ANN INTERN MED, V158, P301, DOI 10.7326/0003-4819-158-5-201303050-00002; Greiner KA, 2005, PREV MED, V41, P676, DOI 10.1016/j.ypmed.2004.12.010; Hade Erinn M., 2010, Journal of the National Cancer Institute Monographs, P97, DOI 10.1093/jncimonographs/lgq011; Jackson GL, 2010, J GEN INTERN MED, V25, P38, DOI 10.1007/s11606-009-1155-x; Javadzade Seyed Homamodin, 2012, J Educ Health Promot, V1, P18, DOI 10.4103/2277-9531.99218; John LK, 2011, J GEN INTERN MED, V26, P621, DOI 10.1007/s11606-010-1628-y; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kullgren JT, 2013, ANN INTERN MED, V158, P505, DOI 10.7326/0003-4819-158-7-201304020-00002; Kullgren JT, 2013, HEALTHCARE; Lee JK, 2009, J GEN INTERN MED, V24, P1192, DOI 10.1007/s11606-009-1087-5; Liles EG, 2012, AM J MANAG CARE, V18, P588; Liss DT, 2013, J COMMUN HEALTH, V38, P829, DOI 10.1007/s10900-013-9685-x; Little R. J. A., 2002, STAT ANAL MISSING DA; Long JA, 2005, AM J PUBLIC HEALTH, V95, P2246, DOI 10.2105/AJPH.2004.061127; Long MD, 2012, DIGEST DIS SCI, V57, P288, DOI 10.1007/s10620-011-1895-4; Miller DP, 2005, J GEN INTERN MED, V20, P984, DOI 10.1111/j.1525-1497.2005.0081.x; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Mosen DM, 2010, MED CARE, V48, P604, DOI 10.1097/MLR.0b013e3181dbdce7; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Oliver A, 2012, J HEALTH POLIT POLIC, V37, P201, DOI 10.1215/03616878-1538602; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Rubin DB, 1987, MULTIPLE IMPUTATION; Sabatino SA, 2012, AM J PREV MED, V43, P97, DOI 10.1016/j.amepre.2012.04.009; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Singh H, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-49; Singh H, 2009, AM J GASTROENTEROL, V104, P2543, DOI 10.1038/ajg.2009.324; Stokamer CL, 2005, J GEN INTERN MED, V20, P278, DOI 10.1111/j.1525-1497.2005.40023.x; Sutherland K, 2008, MED CARE RES REV, V65, p36S, DOI 10.1177/1077558708324235; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Tu SP, 2006, CANCER-AM CANCER SOC, V107, P959, DOI 10.1002/cncr.22091; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Volpp KG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-272; Volpp KG, 2009, HEALTH AFFAIR, V28, P206, DOI 10.1377/hlthaff.28.1.206; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Volpp KG, 2006, CANCER EPIDEM BIOMAR, V15, P12, DOI 10.1158/1055-9965.EPI-05-0314; Walsh JME, 2010, AM J PREV MED, V39, P1, DOI 10.1016/j.amepre.2010.02.020; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	44	34	35	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S35	S43		10.7326/M13-3015	http://dx.doi.org/10.7326/M13-3015			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402401				2022-12-28	WOS:000364909900006
J	Leening, MJG; Ferket, BS; Steyerberg, EW; Kavousi, M; Deckers, JW; Nieboer, D; Heeringa, J; Portegies, MLP; Hofman, A; Ikram, MA; Hunink, MGM; Franco, OH; Stricker, BH; Witteman, JCM; Roos-Hesselink, JW				Leening, Maarten J. G.; Ferket, Bart S.; Steyerberg, Ewout W.; Kavousi, Maryam; Deckers, Jaap W.; Nieboer, Daan; Heeringa, Jan; Portegies, Marileen L. P.; Hofman, Albert; Ikram, M. Arfan; Hunink, M. G. Myriam; Franco, Oscar H.; Stricker, Bruno H.; Witteman, Jacqueline C. M.; Roos-Hesselink, Jolien W.			Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; STROKE INCIDENCE; COMPETING RISKS; PREDICTION; FRAMINGHAM; HEALTH; ASSOCIATION; PREVENTION; ROTTERDAM; US	Objective To evaluate differences in first manifestations of cardiovascular disease between men and women in a competing risks framework. Design Prospective population based cohort study. Setting People living in the community in Rotterdam, the Netherlands. Participants 8419 participants (60.9% women) aged >= 55 and free from cardiovascular disease at baseline. Main outcome measures First diagnosis of coronary heart disease (myocardial infarction, revascularisation, and coronary death), cerebrovascular disease (stroke, transient ischaemic attack, and carotid revascularisation), heart failure, or other cardiovascular death; or death from non-cardiovascular causes. Data were used to calculate lifetime risks of cardiovascular disease and its first incident manifestations adjusted for competing non-cardiovascular death. Results During follow-up of up to 20.1 years, 2888 participants developed cardiovascular disease (826 coronary heart disease, 1198 cerebrovascular disease, 762 heart failure, and 102 other cardiovascular death). At age 55, overall lifetime risks of cardiovascular disease were 67.1% (95% confidence interval 64.7% to 69.5%) for men and 66.4% (64.2% to 68.7%) for women. Lifetime risks of first incident manifestations of cardiovascular disease in men were 27.2% (24.1% to 30.3%) for coronary heart disease, 22.8% (20.4% to 25.1%) for cerebrovascular disease, 14.9% (13.3% to 16.6%) for heart failure, and 2.3% (1.6% to 2.9%) for other deaths from cardiovascular disease. For women the figures were 16.9% (13.5% to 20.4%), 29.8% (27.7% to 31.9%), 17.5% (15.9% to 19.2%), and 2.1% (1.6% to 2.7%), respectively. Differences in the number of events that developed over the lifespan in women compared with men (per 1000) were -7 for any cardiovascular disease, -102 for coronary heart disease, 70 for cerebrovascular disease, 26 for heart failure, and -1 for other cardiovascular death; all outcomes manifested at a higher age in women. Patterns were similar when analyses were restricted to hard atherosclerotic cardiovascular disease outcomes, but absolute risk differences between men and women were attenuated for both coronary heart disease and stroke. Conclusions At age 55, though men and women have similar lifetime risks of cardiovascular disease, there are considerable differences in the first manifestation. Men are more likely to develop coronary heart disease as a first event, while women are more likely to have cerebrovascular disease or heart failure as their first event, although these manifestations appear most often at older ages.	[Leening, Maarten J. G.; Ferket, Bart S.; Kavousi, Maryam; Heeringa, Jan; Portegies, Marileen L. P.; Hofman, Albert; Ikram, M. Arfan; Hunink, M. G. Myriam; Franco, Oscar H.; Stricker, Bruno H.; Witteman, Jacqueline C. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Leening, Maarten J. G.; Deckers, Jaap W.; Roos-Hesselink, Jolien W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Cardiol, NL-3000 CA Rotterdam, Netherlands; [Leening, Maarten J. G.; Hofman, Albert] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ferket, Bart S.; Ikram, M. Arfan; Hunink, M. G. Myriam] Univ Med Ctr Rotterdam, Erasmus MC, Dept Radiol, NL-3000 CA Rotterdam, Netherlands; [Ferket, Bart S.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Inst Healthcare Delivery Sci, New York, NY 10029 USA; [Steyerberg, Ewout W.; Nieboer, Daan] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Portegies, Marileen L. P.; Ikram, M. Arfan] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Stricker, Bruno H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Stricker, Bruno H.] Inspectorate Hlth Care, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Icahn School of Medicine at Mount Sinai; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC	Stricker, BH (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol NA 2818, POB 2040, NL-3000 CA Rotterdam, Netherlands.	b.stricker@erasmusmc.nl	Ikram, M. Arfan/AAM-5225-2021; Kavousi, Maryam/F-1174-2018; Franco, Óscar H/ABE-2305-2020	Kavousi, Maryam/0000-0001-5976-6519; Franco, Óscar H/0000-0002-4606-4929; Ferket, Bart/0000-0003-2754-545X	Erasmus MC Thorax Foundation [A1]; Physico Foundation; De Drie Lichten Foundation [04/14]; Netherlands Organisation for Health Research and Development (ZonMw); Netherlands Organisation for Scientific Research (NWO) (ZonMw HTA) [80-82500-98-10208]; Netherlands Organisation for Scientific Research (NWO) (Vici) [918-76-619]; Prins Bernhard Cultuurfonds Fellowship award [30140588]; AXA Research Fund; Netherlands Heart Foundation (NHF) [2012T008]; Erasmus University Trustfonds; Erasmus MC; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science; Ministry of Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam	Erasmus MC Thorax Foundation; Physico Foundation; De Drie Lichten Foundation; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research (NWO) (ZonMw HTA); Netherlands Organisation for Scientific Research (NWO) (Vici)(Netherlands Organization for Scientific Research (NWO)); Prins Bernhard Cultuurfonds Fellowship award; AXA Research Fund(AXA Research Fund); Netherlands Heart Foundation (NHF)(Netherlands Heart Foundation); Erasmus University Trustfonds; Erasmus MC; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam	This work was supported by grants from the Erasmus MC Thorax Foundation (project grant A1 to JWR-H); the Physico Foundation; the De Drie Lichten Foundation (project grant 04/14 to MJGL); the Netherlands Organisation for Health Research and Development (ZonMw) and the Netherlands Organisation for Scientific Research (NWO) (ZonMw HTA grant 80-82500-98-10208 to BHS; and Vici grant 918-76-619 to JCMW). MJGL is supported by a Prins Bernhard Cultuurfonds Fellowship award (grant 30140588 to MJGL); MK is supported by the AXA Research Fund; MAI is supported by the Netherlands Heart Foundation (NHF grant 2012T008 to MAI); additional funding was obtained from the Erasmus University Trustfonds. The Rotterdam Study is supported by the Erasmus MC and Erasmus University Rotterdam; the Netherlands Organisation for Scientific Research (NWO); the Netherlands Organisation for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Genomics Initiative (NGI); the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. None of the funders had any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Bos MJ, 2007, JAMA-J AM MED ASSOC, V298, P2877, DOI 10.1001/jama.298.24.2877; Bos MJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001634; Butler J, 2011, HEART, V97, P1304, DOI 10.1136/hrt.2011.225482; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Feinstein M, 2012, CIRCULATION, V126, P50, DOI 10.1161/CIRCULATIONAHA.111.057232; Ferket BS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001361; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 1995, Ned Tijdschr Geneeskd, V139, P1975; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Huffman MD, 2013, J AM COLL CARDIOL, V61, P1510, DOI 10.1016/j.jacc.2013.01.022; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Lee SJ, 2013, JAMA-J AM MED ASSOC, V310, P2609, DOI 10.1001/jama.2013.282612; Leening MJG, 2014, EPIDEMIOLOGY, V25, P470, DOI 10.1097/EDE.0000000000000091; Leening MJG, 2012, EUR J EPIDEMIOL, V27, P173, DOI 10.1007/s10654-012-9668-8; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Lloyd-Jones DM, 2007, AM J CARDIOL, V99, P535, DOI 10.1016/j.amjcard.2006.09.099; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Marma AK, 2009, CIRCULATION, V120, P384, DOI 10.1161/CIRCULATIONAHA.108.835470; Meister R, 2008, REPROD TOXICOL, V26, P31, DOI 10.1016/j.reprotox.2008.06.006; Michos ED, 2012, CIRCULATION, V125, P1723, DOI 10.1161/CIRCULATIONAHA.112.099929; Nichols M., 2012, EUROPEAN CARDIOVASCU; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stork S, 2006, AM J MED, V119, P519, DOI 10.1016/j.amjmed.2005.10.062; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312	42	172	176	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2014	349								g5992	10.1136/bmj.g5992	http://dx.doi.org/10.1136/bmj.g5992			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JX	25403476	Green Published, hybrid			2022-12-28	WOS:000345445500001
J	Lukas, D; Huchard, E				Lukas, Dieter; Huchard, Elise			The evolution of infanticide by males in mammalian societies	SCIENCE			English	Article							SOCIAL MONOGAMY; PRIMATES; RISK; STRATEGIES; FEMALES	Male mammals often kill conspecific offspring. The benefits of such infanticide to males, and its costs to females, probably vary across mammalian social and mating systems. We used comparative analyses to show that infanticide primarily evolves in social mammals in which reproduction is monopolized by a minority of males. It has not promoted social counterstrategies such as female gregariousness, pair living, or changes in group size and sex ratio, but is successfully prevented by female sexual promiscuity, a paternity dilution strategy. These findings indicate that infanticide is a consequence, rather than a cause, of contrasts in mammalian social systems affecting the intensity of sexual conflict.	[Lukas, Dieter; Huchard, Elise] Univ Cambridge, Dept Zool, Large Anim Res Grp, Cambridge CB2 3EJ, England; [Huchard, Elise] Univ Montpellier, Ctr Ecol Fonct & Evolut, CNRS, UMR 5175, F-34293 Montpellier 5, France	University of Cambridge; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Lukas, D (corresponding author), Univ Cambridge, Dept Zool, Large Anim Res Grp, Downing St, Cambridge CB2 3EJ, England.	dl384@cam.ac.uk	Huchard, Elise/G-9072-2011	Huchard, Elise/0000-0002-6944-449X; Lukas, Dieter/0000-0002-7141-3545	European Research Council [294494-THCB2011]; Natural Environment Research Council [NE/RG53472]	European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful to T. Clutton-Brock, P. Kappeler, G. Cowlishaw, D. Blumstein, and an anonymous reviewer for helpful comments on an earlier draft of this manuscript, and to the Large Animal Research Group for insightful discussions. D.L. received funding from the European Research Council (grant no. 294494-THCB2011) and E.H. from the Natural Environment Research Council (grant no. NE/RG53472). Data supporting this study are available in the supplementary materials.	Beaulieu JM, 2012, EVOLUTION, V66, P2369, DOI 10.1111/j.1558-5646.2012.01619.x; Blumstein Daniel T., 2000, P178, DOI 10.1017/CBO9780511542312.010; Borries C, 2011, BEHAV ECOL SOCIOBIOL, V65, P685, DOI 10.1007/s00265-010-1070-5; Crockett Carolyn M., 2000, P75, DOI 10.1017/CBO9780511542312.006; Ebensperger LA, 1998, BIOL REV, V73, P321, DOI 10.1017/S0006323198005209; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; HRDY SB, 1974, FOLIA PRIMATOL, V22, P19; Janson Charles H., 2000, P469, DOI 10.1017/CBO9780511542312.021; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Lukas D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0418; Lupicki D, 2010, MAMMALIA, V74, P339, DOI 10.1515/MAMM.2010.031; Nunn Charles L., 2000, P388, DOI 10.1017/CBO9780511542312.018; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; Palombit Ryne A., 2012, P432; Pradhan GR, 2008, BEHAVIOUR, V145, P251, DOI 10.1163/156853907783244710; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Teichroeb JA, 2012, BEHAV ECOL, V23, P1348, DOI 10.1093/beheco/ars128; van Noordwijk Maria A., 2000, P322, DOI 10.1017/CBO9780511542312.016; van Schaik Carel P., 2000, P61, DOI 10.1017/CBO9780511542312.005; VanSchaik CP, 1997, P ROY SOC B-BIOL SCI, V264, P1687, DOI 10.1098/rspb.1997.0234; VANSCHAIK CP, 1990, BEHAVIOUR, V115, P30, DOI 10.1163/156853990X00284; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009	24	99	102	2	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					841	844		10.1126/science.1257226	http://dx.doi.org/10.1126/science.1257226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395534	Green Submitted			2022-12-28	WOS:000344659900042
J	Cumming, GS; Buerkert, A; Hoffmann, EM; Schlecht, E; von Cramon-Taubadel, S; Tscharntke, T				Cumming, Graeme S.; Buerkert, Andreas; Hoffmann, Ellen M.; Schlecht, Eva; von Cramon-Taubadel, Stephan; Tscharntke, Teja			Implications of agricultural transitions and urbanization for ecosystem services	NATURE			English	Review							SOCIAL-ECOLOGICAL SYSTEMS; TROPICAL FORESTS; CLIMATE-CHANGE; GLOBAL CHANGE; WEST-AFRICA; BIODIVERSITY; CONSERVATION; SUSTAINABILITY; LANDSCAPE; COLLAPSE	Historically, farmers and hunter-gatherers relied directly on ecosystem services, which they both exploited and enjoyed. Urban populations still rely on ecosystems, but prioritize non-ecosystem services (socioeconomic). Population growth and densification increase the scale and change the nature of both ecosystem-and non-ecosystem-service supply and demand, weakening direct feedbacks between ecosystems and societies and potentially pushing social-ecological systems into traps that can lead to collapse. The interacting and mutually reinforcing processes of technological change, population growth and urbanization contribute to over-exploitation of ecosystems through complex feedbacks that have important implications for sustainable resource use.	[Cumming, Graeme S.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7701 Cape Town, South Africa; [Buerkert, Andreas; Hoffmann, Ellen M.; Schlecht, Eva] Univ Kassel, D-37213 Witzenhausen, Germany; [Schlecht, Eva] Univ Gottingen, D-37213 Witzenhausen, Germany; [von Cramon-Taubadel, Stephan] Univ Gottingen, Dept Agr Econ & Rural Dev, D-37073 Gottingen, Germany; [Tscharntke, Teja] Univ Gottingen, D-37077 Gottingen, Germany	National Research Foundation - South Africa; University of Cape Town; Universitat Kassel; University of Gottingen; University of Gottingen; University of Gottingen	Cumming, GS (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7701 Cape Town, South Africa.	gscumming@gmail.com	Tscharntke, Teja/N-5123-2014; Cumming, Graeme S./B-6551-2008; Hoffmann, Ellen/AAP-4442-2020	Cumming, Graeme S./0000-0002-3678-1326; Hoffmann, Ellen/0000-0003-1953-9383	Universitat Kassel; Georg-August-Universitat Gottingen; James S. McDonnell Foundation [BU1308/5-3, SCHL587/4-3]; UrbanFood project - Volkswagen Foundation [I/82 189, RTG 1644]	Universitat Kassel; Georg-August-Universitat Gottingen; James S. McDonnell Foundation; UrbanFood project - Volkswagen Foundation	G.S.C. thanks the Universitat Kassel (http://www.icdd.unikassel.de) and Georg-August-Universitat Gottingen for travel funding. This research was partially supported by a James S. McDonnell Foundation grant to G. S. C. and benefitted from discussions between A. B. and E. S. in BU1308/5-3, SCHL587/4-3 and the UrbanFood project, funded by the Volkswagen Foundation (No. I/82 189); between S. v. C-T. and T. T. within the RTG 1644 (Scaling Problems in Statistics); and the discussions of T. T. within the CRC 990 (EFForTS).	Angelstam P, 2011, SILVA FENN, V45, P1111, DOI 10.14214/sf.90; Bationo A, 1998, AGR ECOSYST ENVIRON, V71, P19, DOI 10.1016/S0167-8809(98)00129-7; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Berkes F., 2018, SACRED ECOLOGY; Bjorklund J, 1999, ECOL ECON, V29, P269, DOI 10.1016/S0921-8009(99)00014-2; Boserup E., 1981, POPULATION AND TECHN; Brinkmann K, 2012, LANDSCAPE URBAN PLAN, V105, P94, DOI 10.1016/j.landurbplan.2011.12.003; Buerkert Andreas, 2013, Secheresse (Montrouge), V24, P322, DOI 10.1684/sec.2013.0402; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Carpenter SR, 2000, ECOSYSTEMS, V3, P495, DOI 10.1007/s100210000043; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chapin FS, 2006, AM NAT, V168, pS36, DOI 10.1086/509047; Child MF, 2009, BIOL CONSERV, V142, P2593, DOI 10.1016/j.biocon.2009.06.007; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Costanza R, 2007, AMBIO, V36, P522, DOI 10.1579/0044-7447(2007)36[522:SOCWCW]2.0.CO;2; Cramer W, 2004, PHILOS T R SOC B, V359, P331, DOI 10.1098/rstb.2003.1428; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Cumming GS, 2006, ECOL SOC, V11; Daily GC, 1996, ECOL APPL, V6, P991, DOI 10.2307/2269582; Dasgupta S, 2002, J ECON PERSPECT, V16, P147, DOI 10.1257/0895330027157; DeFries R, 2010, LAND USE POLICY, V27, P130, DOI 10.1016/j.landusepol.2009.07.003; Deutscher Bauernverband (German Farmers' Union), 2013, SITUATIONSBERICHT 20; Einhorn ES, 1989, MODERN WELFARE STATE; FAOSTAT, 2013, CROPS PRIMARY PRODUC; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Genske D., 2006, PROC 10TH IAEG INT C, P82; Getter KL, 2006, HORTSCIENCE, V41, P1276, DOI 10.21273/HORTSCI.41.5.1276; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Hofsten Erland, 1976, SWEDISH POPULATION H, P152; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Huang J, 2012, J CLEAN PROD, V21, P45, DOI 10.1016/j.jclepro.2011.09.014; ISEAL, 2012, STD CONTR HUM WELL B; Ishii HT, 2010, LANDSC ECOL ENG, V6, P307, DOI 10.1007/s11355-010-0104-5; Jansson A, 1999, ECOSYSTEMS, V2, P351, DOI 10.1007/s100219900085; Johnson Todd M., 1997, CLEAR WATER BLUE SKI; Jose Martinez-Harms Maria, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P17, DOI 10.1080/21513732.2012.663792; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuznets S, 1955, AM ECON REV, V45, P1; Leamer EE, 1999, J DEV ECON, V59, P3, DOI 10.1016/S0304-3878(99)00004-8; Lebel L, 2002, AMBIO, V31, P311, DOI 10.1639/0044-7447(2002)031[0311:ITASAI]2.0.CO;2; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Livi-Bacci M., 2012, CONCISE HIST WORLD P; Lobell H, 2008, SCAND ECON HIST REV, V56, P142, DOI 10.1080/03585520802191282; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Luck MA, 2001, ECOSYSTEMS, V4, P782, DOI 10.1007/s10021-001-0046-8; MATSUYAMA K, 1992, J ECON THEORY, V58, P317, DOI 10.1016/0022-0531(92)90057-O; McGinnis MD, 2011, POLICY STUD J, V39, P169, DOI 10.1111/j.1541-0072.2010.00401.x; MCINTOSH RJ, 1981, J AFR HIST, V22, P1, DOI 10.1017/S0021853700018983; Millennium Assessment, 2005, ECOSYSTEMS AND HUMAN; Mooney HA, 2013, P NATL ACAD SCI USA, V110, P3665, DOI 10.1073/pnas.1107484110; Mortimore M, 2005, J ARID ENVIRON, V63, P567, DOI 10.1016/j.jaridenv.2005.03.005; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nevens F, 2013, J CLEAN PROD, V50, P111, DOI 10.1016/j.jclepro.2012.12.001; Norberg J., 2008, COMPLEXITY THEORY FO; O'Brien KL, 2000, GLOBAL ENVIRON CHANG, V10, P221, DOI 10.1016/S0959-3780(00)00021-2; Ocampo J., 2009, J LBERIAN LATIN AM E, V28, P11; Ostrom E, 2003, J THEOR POLIT, V15, P239, DOI 10.1177/0951692803015003002; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Popp A, 2014, CLIMATIC CHANGE, V123, P495, DOI 10.1007/s10584-013-0926-x; Rabotyagov SS, 2014, REV ENV ECON POLICY, V8, P58, DOI 10.1093/reep/ret024; Rasmussen LV, 2012, ECOL SOC, V17, DOI 10.5751/ES-04614-170114; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Revilla E, 2014, J BUS RES, V67, P1123, DOI 10.1016/j.jbusres.2013.05.021; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rodriguez J. P., 2005, MILLENNIUM ECOSYSTEM, V2; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Scheffer M, 2007, ECOL SOC, V12; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schon L., 1997, SCANDINAVIAN EC HIST, V45, P209, DOI DOI 10.1080/03585522.1997.10414668; Shen JL, 2009, ENVIRON POLLUT, V157, P3106, DOI 10.1016/j.envpol.2009.05.016; Smith A., 1845, AN INQUIRY INTO THE; Smith EA, 2000, ANNU REV ANTHROPOL, V29, P493, DOI 10.1146/annurev.anthro.29.1.493; Soma T, 2012, INT J INTANG HERIT, V7, P103; State Environmental Protection Administration of China, 2004, SEPA REPORT; Stern DI, 2004, WORLD DEV, V32, P1419, DOI 10.1016/j.worlddev.2004.03.004; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Tainter J. A., 1988, THE COLLAPSE OF COMP; Tappan G, 2007, AGR SYST, V94, P38, DOI 10.1016/j.agsy.2005.07.011; Tengo M., 2004, THESIS; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POPULATION PRO, VI; van Beers C, 2001, ECOL ECON, V36, P475, DOI 10.1016/S0921-8009(00)00245-7; Wu JG, 2014, LANDSCAPE URBAN PLAN, V125, P209, DOI 10.1016/j.landurbplan.2014.01.018; Xiuqin Y., 2010, BEIJING STATISTICAL; Young H, 2013, DEV CHANGE, V44, P125, DOI 10.1111/dech.12003; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zhang S., 2007, STUDY ON WATER TARIF; Zhuang GS, 2001, CHINESE SCI BULL, V46, P895, DOI 10.1007/BF02900460; Zimmerman B, 2001, ENVIRON CONSERV, V28, P10, DOI 10.1017/S0376892901000029	99	274	295	45	612	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					50	57		10.1038/nature13945	http://dx.doi.org/10.1038/nature13945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS3OE	25373674				2022-12-28	WOS:000344187500028
J	Woolston, C				Woolston, Chris			RICE	NATURE			English	Editorial Material																			0	19	19	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S49	S49		10.1038/514S49a	http://dx.doi.org/10.1038/514S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BW	25368885	Bronze			2022-12-28	WOS:000343801500001
J	Ikeda, Y; Shimada, K; Teramoto, T; Uchiyama, S; Yamazaki, T; Oikawa, S; Sugawara, M; Ando, K; Murata, M; Yokoyama, K; Ishizuka, N				Ikeda, Yasuo; Shimada, Kazuyuki; Teramoto, Tamio; Uchiyama, Shinichiro; Yamazaki, Tsutomu; Oikawa, Shinichi; Sugawara, Masahiro; Ando, Katsuyuki; Murata, Mitsuru; Yokoyama, Kenji; Ishizuka, Naoki			Low-Dose Aspirin for Primary Prevention of Cardiovascular Everts in Japanese Patients 60 Years or Older Vuith Atherosclerotic Risk Factors A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; BASE-LINE DATA; FOLLOW-UP; EVENTS; MORTALITY; PROGRESSION; PREVALENCE	IMPORTANCE Prevention of atherosclerotic cardiovascular diseases is an important public health priority in Japan due to an aging population. OBJECTIVE To determine whether daily, low-dose aspirin reduces the incidence of cardiovascular events in older Japanese patients with multiple atherosclerotic risk factors. DESIGN, SETTING, AND PARTICIPANTS The Japanese Primary Prevention Project (JPPP) was a multicenter, open-label, randomized, parallel-group trial. Patients (N = 14 464) were aged 60 to 85 years, presenting with hypertension, dyslipidemia, or diabetes mellitus recruited by primary care physicians at 1007 clinics in Japan between March 2005 and June 2007, and were followed up for up to 6.5 years, with last follow-up in May 2012. A multidisciplinary expert panel (blinded to treatment assignments) adjudicated study outcomes. INTERVENTIONS Patients were randomized 1:1 to enteric-coated aspirin 100 mg/d or no aspirin in addition to ongoing medications. MAIN OUTCOMES AND MEASURES Composite primary outcome was death from cardiovascular causes (myocardial infarction, stroke, and other cardiovascular causes), nonfatal stroke (ischemic or hemorrhagic, including undefined cerebrovascular events), and nonfatal myocardial infarction. Secondary outcomes included individual end points. RESULTS The study was terminated early by the data monitoring committee after a median follow-up of 5.02 years (interquartile range, 4.55-533) based on likely futility. In both the aspirin and no aspirin groups, 56 fatal events occurred. Patients with an occurrence of nonfatal stroke totaled 114 in the aspirin group and 108 in the no aspirin group; of nonfatal myocardial infarction, 20 in the aspirin group and 38 in the no aspirin group; of undefined cerebrovascular events, 3 in the aspirin group and Sin the no aspirin group. The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% Cl, 2.40%-3.20%] for aspirin vs 2.96% [95% Cl, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% Cl, 0.77-1.15]; P = .54). Aspirin significantly reduced incidence of nonfatal myocardial infarction (0.30 [95% Cl, 0.19-0.47] for aspirin vs 0.58 [95% Cl, 0.42-0.81] for no aspirin; HR, 0.53 [95% Cl, 0.31-0.91]; P = .02) and transient ischemic attack (0.26 [95% Cl, 0.16-0.42] for aspirin vs 0.49 [95% Cl, 0.35-0.69] for no aspirin; HR, 0.57 [95% Cl, 0.32-0.99]; P =.04), and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization (0.86 [95% Cl, 0.67-1.11] for aspirin vs 0.51 [95% Cl, 0.37-0.72] for no aspirin; HR, 1.85 [95% Cl, 1.22-2.81]; P = .004). CONCLUSIONS AND RELEVANCE Once-daily, low-dose aspirin did not significantly reduce the risk of the composite outcome of cardiovascular death, nonfatal stroke, and nonfatal myocardial infarction among Japanese patients 60 years or older with atherosclerotic risk factors.	[Ikeda, Yasuo] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo 1628480, Japan; [Shimada, Kazuyuki] Shinoyama City Hosp, Dept Cardiol, Shinoyama City, Tochigi, Japan; [Teramoto, Tamio] Teikyo Univ, Teikyo Acad Res Ctr, Tokyo 173, Japan; [Teramoto, Tamio] Int Univ Hlth & Welf, Clin Res Ctr Med, Tokyo, Japan; [Yamazaki, Tsutomu] Tokyo Univ Hosp, Clin Res Support Ctr, Ctr Epidemiol & Prevent Med, Tokyo, Japan; [Oikawa, Shinichi] Fukujuji Hosp, Diabet & Lifestyle Dis Ctr, Tokyo, Japan; [Sugawara, Masahiro] Sugawara Med Clin, Dept Internal Med, Tokyo, Japan; [Ando, Katsuyuki] Kitamura Mem Clin, Dept Internal Med, Tokyo, Japan; [Murata, Mitsuru] Keio Univ, Sch Med, Dept Lab Med, Tokyo, Japan; [Yokoyama, Kenji] Tokai Univ, Hachioji Hosp, Dept Hematol, Tokyo 151, Japan; [Ishizuka, Naoki] Canc Inst Hosp, Clin Trial Dept, Tokyo, Japan	Waseda University; Teikyo University; International University of Health & Welfare; University of Tokyo; Fukujuji Hospital; Keio University; Tokai University; Japanese Foundation for Cancer Research	Ikeda, Y (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, TWIns Bldg,2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	yikeda@aoni.waseda.jp			Japanese Ministry of Health, Labor, and Welfare; Waksman Foundation of Japan	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Waksman Foundation of Japan(Waksman Foundation of Japan Inc.)	The Japanese Primary Prevention Project (JPPP) was sponsored by the Japanese Ministry of Health, Labor, and Welfare and the Waksman Foundation of Japan. Enteric-coated 100 mg aspirin tablets were provided free of charge by Bayer Yakuhin.	[Anonymous], 2000, J Atheroscler Thromb, V7, P110; [Anonymous], 1995, Hypertens Res, V18, P235; [Anonymous], 2006, HYPERTENS RES, V29, pS1; Baba S, 2001, DIABETES RES CLIN PR, V54, P191, DOI 10.1016/S0168-8227(01)00288-1; Bartolucci AA, 2011, AM J CARDIOL, V107, P1796, DOI 10.1016/j.amjcard.2011.02.325; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Ishii M, 2004, JUNKANKIKA, V55, P471; Ishikawa H, 2014, GUT, V63, P1755, DOI 10.1136/gutjnl-2013-305827; ISRCTN Register, ASP SIMV COMB CARD E; Japan Atherosclerosis Society, JAP ATH SOC JAS GUID; Kuramoto K, 1999, HYPERTENSION, V34, P1129; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Matsumoto M, MERSENNE TWISTER 623; Matsuzaki M, 2002, CIRC J, V66, P1087, DOI 10.1253/circj.66.1087; Ministry of Health Labour and Welfare Japan, 2014, MIN HLTH LAB WELF RE; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Ogihara T, 2000, AM J HYPERTENS, V13, P461, DOI 10.1016/S0895-7061(99)00215-0; Raju N, 2011, AM J MED, V124, P621, DOI 10.1016/j.amjmed.2011.01.018; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Takishita S, 2000, RINSHOU IYAKU, V16, P1363; Teramoto T, 2010, AM HEART J, V159, P361, DOI 10.1016/j.ahj.2009.11.030; The Japan Diabetes Society, 2004, EV BAS PRACT GUID TR; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; WHO (World Health Organization), ATLAS HEART DIS STRO; Yamazaki T, 2007, CIRC J, V71, P995, DOI 10.1253/circj.71.995; Yasue H, 1999, AM J CARDIOL, V83, P1308, DOI 10.1016/S0002-9149(99)00091-0; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	36	221	247	0	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2510	2520		10.1001/jama.2014.15690	http://dx.doi.org/10.1001/jama.2014.15690			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25401325	Bronze			2022-12-28	WOS:000346346900014
J	Mansour, MR; Abraham, BJ; Anders, L; Berezovskaya, A; Gutierrez, A; Durbin, AD; Etchin, J; Lawton, L; Sallan, SE; Silverman, LB; Loh, ML; Hunger, SP; Sanda, T; Young, RA; Look, AT				Mansour, Marc R.; Abraham, Brian J.; Anders, Lars; Berezovskaya, Alla; Gutierrez, Alejandro; Durbin, Adam D.; Etchin, Julia; Lawton, Lee; Sallan, Stephen E.; Silverman, Lewis B.; Loh, Mignon L.; Hunger, Stephen P.; Sanda, Takaomi; Young, Richard A.; Look, A. Thomas			An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MONOALLELIC EXPRESSION; TRANSCRIPTION FACTORS; SELECTIVE-INHIBITION; CELL IDENTITY; TAL1 COMPLEX; GENES; DISRUPTION; DISEASE; LINEAGE	In certain human cancers, the expression of critical oncogenes is driven from large regulatory elements, called super-enhancers, that recruit much of the cell's transcriptional apparatus and are defined by extensive acetylation of histone H3 lysine 27 (H3K27ac). In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene. MYB binds to this new site and recruits its H3K27 acetylase-binding partner CBP, as well as core components of a major leukemogenic transcriptional complex that contains RUNX1, GATA-3, and TAL1 itself. Additionally, most endogenous super-enhancers found in T-ALL cells are occupied by MYB and CBP, which suggests a general role for MYB in super-enhancer initiation. Thus, this study identifies a genetic mechanism responsible for the generation of oncogenic super-enhancers in malignant cells.	[Mansour, Marc R.; Berezovskaya, Alla; Gutierrez, Alejandro; Durbin, Adam D.; Etchin, Julia; Sallan, Stephen E.; Silverman, Lewis B.; Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Mansour, Marc R.] UCL, UCL Canc Inst, Dept Haematol, London WC1E 6BT, England; [Abraham, Brian J.; Anders, Lars; Lawton, Lee; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gutierrez, Alejandro; Sallan, Stephen E.; Silverman, Lewis B.; Look, A. Thomas] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Loh, Mignon L.] Univ Calif San Francisco, Benioff Childrens Hosp, Dept Pediat, San Francisco, CA 94143 USA; [Hunger, Stephen P.] Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Hunger, Stephen P.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Sanda, Takaomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Sanda, Takaomi] Yong Loo Lin Sch Med, Dept Med, Singapore 117599, Singapore; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of London; University College London; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT)	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA.	young@wi.mit.edu; thomas_look@dfci.harvard.edu	Young, Richard A/F-6495-2012; Abraham, Brian/C-2230-2019	Young, Richard A/0000-0001-8855-8647; Abraham, Brian/0000-0001-8085-3027; Durbin, Adam/0000-0002-5472-9847; Loh, Mignon/0000-0003-4099-4700; Mansour, Marc/0000-0001-6835-3791	Claudia Adams Barr Innovative Basic Science Research Program; Kay Kendall Leukaemia Trust; Leukaemia and Lymphoma Research, UK; National Cancer Institute, NIH [CA167124]; Department of Defense [CA120215]; William Lawrence and Blanche Hughes Foundation; National Research Foundation (NRF), Prime Minister's Office, Singapore under its NRF Fellowship Program [NRF-NRFF2013-02]; NIH [1R01CA176746-01, 5P01CA109901-08, 5P01CA68484, CA98543, CA114766, CA98413, CA30969, CA29139]; NATIONAL CANCER INSTITUTE [U10CA098543, P01CA068484, R01CA120215, U24CA114766, U10CA029139, R21CA167124, U10CA098413, U10CA030969, P01CA109901, P30CA014051, R01CA176746] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	Claudia Adams Barr Innovative Basic Science Research Program; Kay Kendall Leukaemia Trust; Leukaemia and Lymphoma Research, UK; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); William Lawrence and Blanche Hughes Foundation; National Research Foundation (NRF), Prime Minister's Office, Singapore under its NRF Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. Gilbert for helpful editorial comments on the manuscript, J. Reddy for sharing data, and F. Alt and F. Meng for helpful advice on the design of the CRISPR experiments. We would like to dedicate this paper to the memory of Michael Fayngersh. We gratefully acknowledge the children with T-ALL and their families for the samples analyzed in these studies. M.R.M. was supported by the Claudia Adams Barr Innovative Basic Science Research Program, the Kay Kendall Leukaemia Trust, and a Bennett Fellowship from Leukaemia and Lymphoma Research, UK. A.G. is a Research Fellow of the Gabrielle's Angel Foundation for Cancer Research, a Clinical Investigator of the Damon Runyon Cancer Research Foundation, and is supported by grants National Cancer Institute, NIH, CA167124, Department of Defense, CA120215 and an award from the William Lawrence and Blanche Hughes Foundation. T.S. is supported by a grant from the National Research Foundation (NRF), Prime Minister's Office, Singapore under its NRF Fellowship Program (award no. NRF-NRFF2013-02). This work was funded by NIH grants 1R01CA176746-01 and 5P01CA109901-08 (A.T.L.), and 5P01CA68484 (S.E.S. and A.T.L.). Children's Oncology Group cell banking and sample distribution were supported by grants CA98543, CA114766, CA98413, CA30969, and CA29139 from the NIH. S.P.H. is the Ergen Family Chair in Pediatric Cancer. R.A.Y. is a founder and member of the Board of Directors of Syros Pharmaceuticals, a company developing therapies that target gene regulatory elements including super-enhancers.	APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; BREIT TM, 1993, J EXP MED, V177, P965, DOI 10.1084/jem.177.4.965; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Ferrando AA, 2004, BLOOD, V103, P1909, DOI 10.1182/blood-2003-07-2577; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jirtle RL, 1999, EXP CELL RES, V248, P18, DOI 10.1006/excr.1999.4453; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; LEROYVIARD K, 1994, BLOOD, V84, P3819, DOI 10.1182/blood.V84.11.3819.bloodjournal84113819; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mansour MR, 2013, J EXP MED, V210, P1545, DOI 10.1084/jem.20122516; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Tie F, 2014, DEVELOPMENT, V141, P1129, DOI 10.1242/dev.102392; Walker EJ, 2012, CANCER RES, V72, P636, DOI 10.1158/0008-5472.CAN-11-2266; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhou Y, 2013, BLOOD, V122, P4199, DOI 10.1182/blood-2013-02-483875	24	475	496	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1373	1377		10.1126/science.1259037	http://dx.doi.org/10.1126/science.1259037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25394790	Green Submitted, Green Accepted			2022-12-28	WOS:000346189600053
J	Mukherjee, R				Mukherjee, Ranjan			The winding road	SCIENCE			English	Editorial Material																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					1026	1026		10.1126/science.346.6212.1026	http://dx.doi.org/10.1126/science.346.6212.1026			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6EL	25414316				2022-12-28	WOS:000345696000049
J	Bloomfield, HE				Bloomfield, Hanna E.			Adding niacin plus laropiprant to statins did not reduce vascular events and increased serious adverse events Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bloomfield, Hanna E.] VA Med Ctr, Minneapolis, MN 55417 USA; [Bloomfield, Hanna E.] Univ Minnesota, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Bloomfield, HE (corresponding author), VA Med Ctr, Minneapolis, MN 55417 USA.			bloomfield, hanna/0000-0002-0756-7064				Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	3	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC8	10.7326/0003-4819-161-10-201411180-02008	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402541				2022-12-28	WOS:000347245600014
J	Patel, MS; Day, S; Small, DS; Howell, JT; Lautenbach, GL; Nierman, EH; Volpp, KG				Patel, Mitesh S.; Day, Susan; Small, Dylan S.; Howell, John T., III; Lautenbach, Gillian L.; Nierman, Eliot H.; Volpp, Kevin G.			Using Default Options Within the Electronic Health Record to Increase the Prescribing of Generic-Equivalent Medications A Quasi-experimental Study	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIANS; POWER	Background: Low-value services, such as prescribing brand-name medications that have existing generic equivalents, contribute to unnecessary health care spending. Objective: To evaluate the association of an intervention by using the electronic health record with provider prescription of generic-equivalent medications. Design: Quasi-experimental study. Setting: General internal medicine (IM) (n = 2) and family medicine (FM) (n = 2) clinics at the University of Pennsylvania from June 2011 to September 2012. Participants: Attending physicians (IM, n = 38; FM, n = 17) and residents (IM, n = 166; FM, n = 34). Intervention: In January 2012, the default in the electronic health record was changed for IM providers from displaying brand and generic medications to displaying initially only generics, with the ability to opt out. Measurements: Monthly prescriptions of brand-name and generic-equivalent beta-blockers, statins, and proton-pump inhibitors. Results: During the preintervention period, FM providers had slightly higher rates of generic medication prescribing (range, 80.8% to 85.5%) than did IM providers (range, 75.4% to 79.6%), but both groups had similar trends. In the postintervention period relative to the preintervention period, IM providers had an increase in generic prescribing compared with FM providers for all 3 medications combined (5.4 percentage points [95% CI, 2.2 to 8.7 percentage points]; P < 0.001), beta-blockers (10.5 percentage points [CI, 5.8 to 15.2 percentage points]; P < 0.001), and statins (4.0 percentage points [CI, 0.4 to 7.6 percentage points]; P = 0.002). Results for proton-pump inhibitors (2.1 percentage points [CI, -3.7 to 8.0 percentage points]; P = 0.47) were not significant. Subset analyses revealed similar findings for attending physicians. Among residents, however, results were imprecise, with wide CIs. Limitation: Observational single-center evaluation, comparison groups that represented different specialties, and a small subset of medication classes studied. Conclusion: The use of default options was an effective method to increase the odds of prescribing generic medication equivalents for beta-blockers and statins.	[Patel, Mitesh S.; Day, Susan; Lautenbach, Gillian L.; Nierman, Eliot H.; Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Small, Dylan S.] Univ Penn, Dept Stat, Wharton Sch, Philadelphia, PA 19104 USA; [Howell, John T., III] Univ Penn, Off Chief Med Informat Officer, Philadelphia, PA 19104 USA; Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Patel, MS (corresponding author), Univ Penn, Perelman Sch Med, Div Gen Internal Med, 423 Guardian Dr,12th Floor,Blockley Hall, Philadelphia, PA 19104 USA.	mpatel@upenn.edu		Volpp, Kevin/0000-0003-1423-4599	U.S. Department of Veterans Affairs; Robert Wood Johnson Foundation	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	U.S. Department of Veterans Affairs and Robert Wood Johnson Foundation.	Agresti A, 2007, INTRO CATEGORICAL DA, P108; American College of Physicians, HIGH VAL CAR IN; Avery Anthony J, 2005, Inform Prim Care, V13, P3; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Boltri JM, 2002, FAM MED, V34, P729; Brill A, 2011, OVERSPENDING MULTISO; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Centers for Medicare & Medicaid, NAT HLTH EXP PROJ 20; Charlson ME, 2005, J GEN INTERN MED, V20, P497, DOI 10.1111/j.1525-1497.2005.0085.x; Choi J.J., 2002, TAX POLICY EC, V16, P67, DOI DOI 10.1162/089286402760173467; Gellad WF, 2013, ANN INTERN MED, V159, P105, DOI 10.7326/0003-4819-159-2-201307160-00664; Gimbel Ronald W, 2003, Prog Transplant, V13, P17; Halpern SD, 2007, NEW ENGL J MED, V357, P1340, DOI 10.1056/NEJMsb071595; Halpern SD, 2013, HEALTH AFFAIR, V32, P408, DOI 10.1377/hlthaff.2012.0895; Johnson EJ, 2004, TRANSPLANTATION, V78, P1713, DOI 10.1097/01.TP.0000149788.10382.B2; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Karlinsky JB, 2000, AM J MED QUAL, V15, P26, DOI 10.1177/106286060001500105; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; Mazer JS, 2011, GENERIC SUBSTITUTION; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; NEWMAN S. C., 2001, WILEY S PRO STAT BIO; Patel MS, 2012, J GEN INTERN MED, V27, P1544, DOI 10.1007/s11606-012-2050-4; Penn Medicine Division of General Internal Medicine, 2013, FAC STAFF; Penn Medicine Family Medicine, 2013, PHYS TEAM; Penn Medicine Family Medicine, RES PLAC; Penn Medicine Family Medicine, CURR RES; Rogers WH., 1993, STATA TECHNICAL B RE, V13, P19; Schweitzer M, 1996, MED CARE, V34, P583, DOI 10.1097/00005650-199606000-00008; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Van der Sijs H, 2006, J AM MED INFORM ASSN, V13, P138, DOI 10.1197/jamia.M1809; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P1635, DOI 10.1001/jama.2012.13616; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	35	55	55	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S44	S52		10.7326/M13-3001	http://dx.doi.org/10.7326/M13-3001			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402402				2022-12-28	WOS:000364909900007
J	Tu, B; Rich, B; Labos, C; Brophy, JM				Tu, Benny; Rich, Ben; Labos, Christopher; Brophy, James M.			Coronary Revascularization in Diabetic Patients A Systematic Review and Bayesian Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							DRUG-ELUTING STENTS; ARTERY-BYPASS SURGERY; BARE-METAL STENTS; MULTIVESSEL DISEASE; RANDOMIZED-TRIALS; FOLLOW-UP; GRAFT-SURGERY; CLINICAL-OUTCOMES; VASCULAR-DISEASE; CARDIAC-SURGERY	Background: The optimal revascularization technique in diabetic patients is an important unresolved question. Purpose: To compare long-term outcomes between the revascularization techniques of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Data Sources: English-language publications in PubMed, the Cochrane Central Register of Controlled Trials, Ovid, and EMBASE between 1 January 1990 and 1 June 2014. Study Selection: Two investigators independently reviewed randomized, controlled trials comparing PCI (with drug-eluting or baremetal stents) with CABG in adults with diabetes with multivessel or left main coronary artery disease. Data Extraction: Study design, quality, patient characteristics, length of follow-up, and outcomes were extracted. For duplicate publications, outcomes were obtained from the publication with the longest follow-up. Data Synthesis: 40 studies were combined using a Bayesian network meta-analysis that accounted for the variation in stent choice. The primary outcome, a composite of all-cause mortality, nonfatal myocardial infarction, and stroke, increased with PCI (odds ratio [OR], 1.33 [95% credible interval {CrI}, 1.01 to 1.65]). Percutaneous coronary intervention resulted in increased mortality (OR, 1.44 [CrI, 1.05 to 1.91]), no change in the number of myocardial infarctions (OR, 1.33 [CrI, 0.86 to 1.95]), and fewer strokes (OR, 0.56 [CrI, 0.36 to 0.88]). Limitations: Study design and length of follow-up were heterogeneous, and results were driven primarily by a single study. Costs and nonvascular complications of the interventions were not examined. Conclusion: Coronary artery bypass grafting seems to be the preferred revascularization technique in diabetics, especially if longterm survival is anticipated. However, because of residual uncertainties and increased risk for stroke with CABG, clinical judgment is required when choosing a revascularization technique in patients with diabetes.	Univ Queensland, Brisbane, Qld, Australia; McGill Univ, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada	University of Queensland; McGill University; McGill University	Brophy, JM (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, 687 Pine Ave West,Ross 4-12, Montreal, PQ H3A 1A1, Canada.	james.brophy@mcgill.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875; Tu, Benny Yat-Shan/0000-0001-5268-7041	Fonds de recherche du Quebec-Sante	Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	Dr. Brophy receives a salary and operating support from the Fonds de recherche du Quebec-Sante, a nonprofit provincial funding agency.	Alderman E, 1997, CIRCULATION, V96, P1761, DOI 10.1161/01.CIR.96.6.1761; [Anonymous], 1999, Int J Cardiovasc Intervent, V2, P41; [Anonymous], 2013, R PROJECT STAT COMPU; Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057; Bansilal S, 2012, AM HEART J, V164, P591, DOI 10.1016/j.ahj.2012.06.012; Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B; Booth J, 2008, CIRCULATION, V118, P381, DOI 10.1161/CIRCULATIONAHA.107.739144; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Caixeta A, 2009, J AM COLL CARDIOL, V54, P894, DOI 10.1016/j.jacc.2009.04.077; Cao C, 2013, J THORAC CARDIOV SUR, V145, P738, DOI 10.1016/j.jtcvs.2012.02.004; Chan C, 2008, CATHETER CARDIO INTE, V72, P591, DOI 10.1002/ccd.21719; Daemen J, 2008, J AM COLL CARDIOL, V52, P1957, DOI 10.1016/j.jacc.2008.09.010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Eagle KA, 1999, CIRCULATION, V100, P1464, DOI 10.1161/01.CIR.100.13.1464; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; From AM, 2010, EUROINTERVENTION, V6, P269, DOI 10.4244/; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; HENDERSON RA, 1992, EUR HEART J, V13, P781, DOI 10.1093/oxfordjournals.eurheartj.a060256; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Jimenez-Quevedo P, 2007, EUR HEART J, V28, P1946, DOI 10.1093/eurheartj/ehm197; Kamalesh M, 2013, J AM COLL CARDIOL, V61, P808, DOI 10.1016/j.jacc.2012.11.044; Kappetein AP, 2013, EUR J CARDIO-THORAC, V43, P1006, DOI 10.1093/ejcts/ezt017; Kapur A, 2005, AM HEART J, V149, P13, DOI 10.1016/j.ahj.2004.07.001; Kapur A, 2009, ANN SCI C BRIT CARD; Kapur A, 2008, EUR SOC CARD 2008 MU; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Kelbaek H, 2008, J AM COLL CARDIOL, V51, P2011, DOI 10.1016/j.jacc.2008.01.056; Kirtane AJ, 2008, J AM COLL CARDIOL, V51, P708, DOI 10.1016/j.jacc.2007.10.035; Kissel CK, 2011, INTERVENTIONAL CARDI, V3, P461, DOI [10.2217/ica.11.44, DOI 10.2217/ICA.11.44]; Klein LW, 2006, J AM COLL CARDIOL, V47, P22, DOI 10.1016/j.jacc.2005.08.057; Lima EG, 2013, AM HEART J, V166, P250, DOI 10.1016/j.ahj.2013.04.017; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Macaya Carlos, 2006, EuroIntervention, V2, P69; Mack MJ, 2011, ANN THORAC SURG, V92, P2140, DOI 10.1016/j.athoracsur.2011.06.028; Maresta A, 2008, AM J CARDIOL, V101, P1560, DOI 10.1016/j.amjcard.2008.01.040; Mauri L., 2007, TRANSC CARD THER 200; Mauri L, 2010, JACC-CARDIOVASC INTE, V3, P1240, DOI 10.1016/j.jcin.2010.08.021; Meliga Emanuele, 2008, EuroIntervention, V4, P77, DOI 10.4244/EIJV4I1A14; Meredith IT, 2008, PRESENTED AT EUROPCR; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; Onuma Y, 2011, JACC-CARDIOVASC INTE, V4, P317, DOI 10.1016/j.jcin.2010.12.004; Pache J, 2005, EUR HEART J, V26, P1262, DOI 10.1093/eurheartj/ehi098; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Plummer M., 2013, JAGS JUST ANOTHER GI; Rodriguez A, 2007, C SOL 2007 BUEN AIR; Rodriguez AE, 2007, EUR HEART J, V28, P2118, DOI 10.1093/eurheartj/ehm297; Rodriguez Alfredo E, 2006, EuroIntervention, V2, P53; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sedlis SP, 2002, J AM COLL CARDIOL, V40, P1555, DOI 10.1016/S0735-1097(02)02346-X; Sinning JM, 2012, AM HEART J, V163, P446, DOI 10.1016/j.ahj.2011.12.010; Sipahi I, 2014, JAMA INTERN MED, V174, P223, DOI 10.1001/jamainternmed.2013.12844; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Suttorp MJ, 2006, CIRCULATION, V114, P921, DOI 10.1161/CIRCULATIONAHA.106.613588; Verma S, 2013, LANCET DIABETES ENDO, V1, P317, DOI 10.1016/S2213-8587(13)70089-5; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	61	18	18	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					724	U179		10.7326/M14-0808	http://dx.doi.org/10.7326/M14-0808			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402514				2022-12-28	WOS:000347245600029
J	Fowlie, M; Goulder, L; Kotchen, M; Borenstein, S; Bushnell, J; Davis, L; Greenstone, M; Kolstad, C; Knittel, C; Stavins, R; Wara, M; Wolak, F; Wolfram, C				Fowlie, Meredith; Goulder, Lawrence; Kotchen, Matthew; Borenstein, Severin; Bushnell, James; Davis, Lucas; Greenstone, Michael; Kolstad, Charles; Knittel, Christopher; Stavins, Robert; Wara, Michael; Wolak, Frank; Wolfram, Catherine			An economic perspective on the EPA's Clean Power Plan	SCIENCE			English	Editorial Material									[Fowlie, Meredith; Borenstein, Severin; Davis, Lucas; Wolfram, Catherine] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Goulder, Lawrence; Kolstad, Charles; Wara, Michael; Wolak, Frank] Stanford Univ, Palo Alto, CA 94305 USA; [Kotchen, Matthew] Yale Univ, New Haven, CT 06511 USA; [Bushnell, James] Univ Calif Davis, Davis, CA 95616 USA; [Greenstone, Michael] Univ Chicago, Chicago, IL 60637 USA; [Knittel, Christopher] MIT, Cambridge, MA 02412 USA; [Stavins, Robert] Harvard Univ, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; Stanford University; Yale University; University of California System; University of California Davis; University of Chicago; Massachusetts Institute of Technology (MIT); Harvard University	Fowlie, M (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	fowlie@berkeley.edu						Allcott H, 2012, J ECON PERSPECT, V26, P3, DOI 10.1257/jep.26.1.3; Holland SP, 2009, AM ECON J-ECON POLIC, V1, P106, DOI 10.1257/pol.1.1.106; Schmalensee R, 2013, J ECON PERSPECT, V27, P103, DOI 10.1257/jep.27.1.103; U.S. EPA, 2014, REGULATORY IMPACT AN	4	21	21	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					815	816		10.1126/science.1261349	http://dx.doi.org/10.1126/science.1261349			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT0YL	25395524				2022-12-28	WOS:000344659900023
J	Zhang, BY; Chassaing, B; Shi, ZD; Uchiyama, R; Zhang, Z; Denning, TL; Crawford, SE; Pruijssers, AJ; Iskarpatyoti, JA; Estes, MK; Dermody, TS; Ouyang, WJ; Williams, IR; Vijay-Kumar, M; Gewirtz, AT				Zhang, Benyue; Chassaing, Benoit; Shi, Zhenda; Uchiyama, Robin; Zhang, Zhan; Denning, Timothy L.; Crawford, Sue E.; Pruijssers, Andrea J.; Iskarpatyoti, Jason A.; Estes, Mary K.; Dermody, Terence S.; Ouyang, Wenjun; Williams, Ifor R.; Vijay-Kumar, Matam; Gewirtz, Andrew T.			Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18	SCIENCE			English	Article							DENDRITIC CELLS; BACTERIAL FLAGELLIN; T-CELLS; NLRC4; PROTECTS; MUCOSAL; TLR5; MICE	Activators of innate immunity may have the potential to combat a broad range of infectious agents. We report that treatment with bacterial flagellin prevented rotavirus (RV) infection in mice and cured chronically RV-infected mice. Protection was independent of adaptive immunity and interferon (IFN, type I and II) and required flagellin receptors Toll-like receptor 5 (TLR5) and NOD-like receptor C4 (NLRC4). Flagellin-induced activation of TLR5 on dendritic cells elicited production of the cytokine interleukin-22 (IL-22), which induced a protective gene expression program in intestinal epithelial cells. Flagellin also induced NLRC4-dependent production of IL-18 and immediate elimination of RV-infected cells. Administration of IL-22 and IL-18 to mice fully recapitulated the capacity of flagellin to prevent or eliminate RV infection and thus holds promise as a broad-spectrum antiviral agent.	[Zhang, Benyue; Chassaing, Benoit; Shi, Zhenda; Uchiyama, Robin; Zhang, Zhan; Denning, Timothy L.; Gewirtz, Andrew T.] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Uchiyama, Robin; Denning, Timothy L.; Williams, Ifor R.; Gewirtz, Andrew T.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Crawford, Sue E.; Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Pruijssers, Andrea J.; Iskarpatyoti, Jason A.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37212 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Microbiol, Nashville, TN 37212 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Immunol, Nashville, TN 37212 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Vijay-Kumar, Matam] Penn State Univ, Dept Nutr Sci & Med, University Pk, PA 16802 USA	University System of Georgia; Georgia State University; Emory University; Baylor College of Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Roche Holding; Genentech; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gewirtz, AT (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	agewirtz@gsu.edu	Williams, Ifor R/D-3648-2011; Pruijssers, Andrea J/S-5725-2018; Vijay-Kumar, Matam/Q-8988-2019; Ouyang, Wenjun/ABA-8763-2020; Chassaing, Benoit/R-3819-2017	Williams, Ifor R/0000-0002-8810-2911; Pruijssers, Andrea J/0000-0001-7910-626X; Denning, Timothy/0000-0002-1072-7444; Chassaing, Benoit/0000-0002-4285-769X; Ouyang, Wenjun/0000-0002-1811-5864	NIH [DK061417]; American Reinvestment and Recovery Act [AI107943, DK064730, DK56338, AI038296, AI080656]; Crohn's and Colitis Foundation of America; Elizabeth B. Lamb Center for Pediatric Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080656, R21AI107943, R01AI038296, R01AI080656, R37AI038296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061417, R01DK064730, P30DK056338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Reinvestment and Recovery Act; Crohn's and Colitis Foundation of America; Elizabeth B. Lamb Center for Pediatric Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Virgin, T. Nice, A.-U. Rasheed, R. Ahmed, G. Silvestri, B. Rouse, B. Pulendran, A. Lukacher, S-M. Kang, and D. Kalman for helpful discussions. We thank D. Moore and K. Yu for technical support. This work was supported by NIH grants DK061417-and an accompanying award from the American Reinvestment and Recovery Act-AI107943, DK064730, DK56338, AI038296, and AI080656. B.C. is supported by a fellowship from the Crohn's and Colitis Foundation of America. T.S.D. is supported by Elizabeth B. Lamb Center for Pediatric Research. Recombinant IL-22, antibodies to IL-17 and IL-22, and Il22<SUP>-/-</SUP> mice were provided under a materials transfer agreement by Genentech (South San Francisco, CA). Patents for use of flagellin and IL-22/IL-18 to treat or prevent viral infection have been applied for under application nos. PCT/US2011/052301 (Emory University) and 61/888/439 (Georgia State University, provisional). RNA-sequencing data are deposited in Gene Expression Omnibus with accession no. GSE62479.	Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Chassaing B., 2014, GASTROENTEROLOGY; Feng NG, 1997, ADV EXP MED BIOL, V412, P233; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Jiang JQ, 2008, J VIROL, V82, P6812, DOI 10.1128/JVI.00450-08; Jones RM, 2011, GUT, V60, P648, DOI 10.1136/gut.2010.223891; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Nordlander S, 2014, MUCOSAL IMMUNOL, V7, P775, DOI 10.1038/mi.2013.95; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Sen A, 2009, J VIROL, V83, P10322, DOI 10.1128/JVI.01186-09; UHNOO I, 1990, J VIROL, V64, P361, DOI 10.1128/JVI.64.1.361-368.1990; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Vijay-Kumar M, 2005, J IMMUNOL, V174, P6322, DOI 10.4049/jimmunol.174.10.6322; Vijay-Kumar M, 2009, MUCOSAL IMMUNOL, V2, P197, DOI 10.1038/mi.2009.9; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	25	155	170	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					861	865		10.1126/science.1256999	http://dx.doi.org/10.1126/science.1256999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395539	Green Accepted			2022-12-28	WOS:000344659900048
J	Iossifov, I; O'Roak, BJ; Sanders, SJ; Ronemus, M; Krumm, N; Levy, D; Stessman, HA; Witherspoon, KT; Vives, L; Patterson, KE; Smith, JD; Paeper, B; Nickerson, DA; Dea, J; Dong, S; Gonzalez, LE; Mandell, JD; Mane, SM; Murtha, MT; Sullivan, CA; Walker, MF; Waqar, Z; Wei, LP; Willsey, AJ; Yamrom, B; Lee, YH; Grabowska, E; Dalkic, E; Wang, ZH; Marks, S; Andrews, P; Leotta, A; Kendall, J; Hakker, I; Rosenbaum, J; Ma, BC; Rodgers, L; Troge, J; Narzisi, G; Yoon, S; Schatz, MC; Ye, K; McCombie, WR; Shendure, J; Eichler, EE; State, MW; Wigler, M				Iossifov, Ivan; O'Roak, Brian J.; Sanders, Stephan J.; Ronemus, Michael; Krumm, Niklas; Levy, Dan; Stessman, Holly A.; Witherspoon, Kali T.; Vives, Laura; Patterson, Karynne E.; Smith, Joshua D.; Paeper, Bryan; Nickerson, Deborah A.; Dea, Jeanselle; Dong, Shan; Gonzalez, Luis E.; Mandell, Jeffrey D.; Mane, Shrikant M.; Murtha, Michael T.; Sullivan, Catherine A.; Walker, Michael F.; Waqar, Zainulabedin; Wei, Liping; Willsey, A. Jeremy; Yamrom, Boris; Lee, Yoon-ha; Grabowska, Ewa; Dalkic, Ertugrul; Wang, Zihua; Marks, Steven; Andrews, Peter; Leotta, Anthony; Kendall, Jude; Hakker, Inessa; Rosenbaum, Julie; Ma, Beicong; Rodgers, Linda; Troge, Jennifer; Narzisi, Giuseppe; Yoon, Seungtai; Schatz, Michael C.; Ye, Kenny; McCombie, W. Richard; Shendure, Jay; Eichler, Evan E.; State, Matthew W.; Wigler, Michael			The contribution of de novo coding mutations to autism spectrum disorder	NATURE			English	Article							COPY-NUMBER VARIATION; INTELLECTUAL DISABILITY; STRUCTURAL VARIATION; INHERITED DISEASE; PATERNAL AGE; SCHIZOPHRENIA; NETWORK; RISK; EVOLUTION; RESOURCE	Whole exome sequencing has proven to be a powerful tool for understanding the genetic architecture of human disease. Here we apply it to more than 2,500 simplex families, each having a child with an autistic spectrum disorder. By comparing affected to unaffected siblings, we show that 13% of de novo missense mutations and 43% of de novo likely gene-disrupting (LGD) mutations contribute to 12% and 9% of diagnoses, respectively. Including copy number variants, coding de novo mutations contribute to about 30% of all simplex and 45% of female diagnoses. Almost all LGD mutations occur opposite wild-type alleles. LGD targets in affected females significantly overlap the targets in males of lower intelligence quotient (IQ), but neither overlaps significantly with targets in males of higher IQ. We estimate that LGD mutation in about 400 genes can contribute to the joint class of affected females and males of lower IQ, with an overlapping and similar number of genes vulnerable to contributory missense mutation. LGD targets in the joint class overlap with published targets for intellectual disability and schizophrenia, and are enriched for chromatin modifiers, FMRP-associated genes and embryonically expressed genes. Most of the significance for the latter comes from affected females.	[Iossifov, Ivan; Ronemus, Michael; Levy, Dan; Yamrom, Boris; Lee, Yoon-ha; Grabowska, Ewa; Dalkic, Ertugrul; Wang, Zihua; Marks, Steven; Andrews, Peter; Leotta, Anthony; Kendall, Jude; Hakker, Inessa; Rosenbaum, Julie; Ma, Beicong; Rodgers, Linda; Troge, Jennifer; Narzisi, Giuseppe; Yoon, Seungtai; Schatz, Michael C.; McCombie, W. Richard; Wigler, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [O'Roak, Brian J.; Krumm, Niklas; Stessman, Holly A.; Witherspoon, Kali T.; Vives, Laura; Patterson, Karynne E.; Smith, Joshua D.; Paeper, Bryan; Nickerson, Deborah A.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [O'Roak, Brian J.] Oregon Hlth & Sci Univ, Portland, OR 97208 USA; [Sanders, Stephan J.; Dea, Jeanselle; Mandell, Jeffrey D.; Walker, Michael F.; Willsey, A. Jeremy; State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Sanders, Stephan J.; Dong, Shan; Willsey, A. Jeremy; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Dong, Shan; Wei, Liping] Peking Univ, Sch Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Gonzalez, Luis E.; Murtha, Michael T.; Sullivan, Catherine A.; Waqar, Zainulabedin; State, Matthew W.] Yale Univ, Ctr Child Study, Sch Med, New Haven, CT 06520 USA; [Mane, Shrikant M.] Yale Univ, Ctr Child Study, Yale Ctr Genom Anal, New Haven, CT 06520 USA; [Wei, Liping] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Grabowska, Ewa; Narzisi, Giuseppe] New York Genome Ctr, New York, NY 10013 USA; [Dalkic, Ertugrul] Bulent Ecevit Univ, Sch Med, Dept Med Biol, TR-67600 Zonguldak, Turkey; [Ye, Kenny] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [State, Matthew W.] Yale Univ, Dept Psychiat, Sch Med, New Haven, CT 06520 USA	Cold Spring Harbor Laboratory; University of Washington; University of Washington Seattle; Oregon Health & Science University; University of California System; University of California San Francisco; Yale University; Peking University; Yale University; Yale University; National Institute of Biological Sciences, Beijing; Bulent Ecevit University; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Yale University	Shendure, J (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu; eee@gs.washington.edu; matthew.state@ucsf.edu; wigler@cshl.edu	State, Matthew/W-2256-2019; Sanders, Stephan/S-8645-2019; Schatz, Michael/L-2690-2019; Wang, Zhiquan/HHS-6768-2022; Shendure, Jay/AAU-3684-2021; DONG, Shan/GVS-5706-2022; Ye, Kenny/U-2341-2019; Ye, Kenny/GSM-7731-2022	Schatz, Michael/0000-0002-4118-4446; Ye, Kenny/0000-0002-1466-855X; State, Matthew/0000-0003-1624-8302; Dong, Shan/0000-0001-9130-0225; Stessman, Holly/0000-0002-0764-3493; Sanders, Stephan/0000-0001-9112-5148; Shendure, Jay/0000-0002-1516-1865; O'Roak, Brian/0000-0002-4141-0095; Mandell, Jeffrey/0000-0002-3839-2543	Simons Foundation Autism Research Initiative grants [SF191889, M144095 R11154, SF235988]; Howard Hughes Medical Institute (International Student Research Fellowship); Canadian Institutes of Health Research (Doctoral Foreign Study Award); NHLBI [HL-102923, HL-102924, HL-102925, HL-102926, HL-103010]	Simons Foundation Autism Research Initiative grants; Howard Hughes Medical Institute (International Student Research Fellowship)(Howard Hughes Medical Institute); Canadian Institutes of Health Research (Doctoral Foreign Study Award); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Simons Foundation Autism Research Initiative grants to E.E.E. (SF191889), M.W.S. (M144095 R11154) and M.W. (SF235988) supported this work. Additional support was provided by the Howard Hughes Medical Institute (International Student Research Fellowship to S.J.S.) and the Canadian Institutes of Health Research (Doctoral Foreign Study Award to A.J.W.). E.E.E. is an Investigator of the Howard Hughes Medical Institute. We thank all the families at the participating SSC sites, as well as the principal investigators (A. L. Beaudet, R. Bernier, J. Constantino, E. H. Cook Jr, E. Fombonne, D. Geschwind, D. E. Grice, A. Klin, D. H. Ledbetter, C. Lord, C. L. Martin, D. M. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M. W. State, W. Stone, J. S. Sutcliffe, C. A. Walsh and E. Wijsman) and the coordinators and staff at the SSC sites for the recruitment and comprehensive assessment of simplex families; the SFARI staff for facilitating access to the SSC; and the Rutgers University Cell and DNA Repository (RUCDR) for accessing biomaterials. We would also like to thank the CSHL Woodbury Sequencing Center, the Genome Institute at the Washington University School of Medicine, and Yale Center for Genomic Analysis (in particular J. Overton) for generating sequencing data; E. Antoniou and E. Ghiban for their assistance in data production at CSHL; and T. Brooks-Boone, N. Wright-Davis and M. Wojciechowski for their help in administering the project at Yale. The NHLBI GO Exome Sequencing Project and its ongoing studies produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Darnell JC, 2011, CURR OPIN GENET DEV, V21, P465, DOI 10.1016/j.gde.2011.05.002; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Eckersiey-Maslin MA, 2014, TRENDS GENET, V30, P237, DOI 10.1016/j.tig.2014.03.003; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jeffries AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085093; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Narzisi G, 2014, NAT METHODS, V11, P1033, DOI [10.1038/NMETH.3069, 10.1038/nmeth.3069]; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Veitia RA, 2013, TRENDS GENET, V29, P385, DOI 10.1016/j.tig.2013.04.004; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	49	1438	1469	2	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					216	U136		10.1038/nature13908	http://dx.doi.org/10.1038/nature13908			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25363768	Green Accepted			2022-12-28	WOS:000344631400039
J	Einav, L; Levin, J				Einav, Liran; Levin, Jonathan			Economics in the age of big data	SCIENCE			English	Review							TEACHERS; BEHAVIOR; IMPACTS	The quality and quantity of data on economic activity are expanding rapidly. Empirical research increasingly relies on newly available large-scale administrative data or private sector data that often is obtained through collaboration with private firms. Here we highlight some challenges in accessing and using these new data. We also discuss how new data sets may change the statistical methods used by economists and the types of questions posed in empirical research.	[Einav, Liran; Levin, Jonathan] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Einav, Liran; Levin, Jonathan] NBER, Cambridge, MA 02138 USA	Stanford University; National Bureau of Economic Research	Einav, L (corresponding author), Stanford Univ, Dept Econ, Stanford, CA 94305 USA.	leinav@stanford.edu			NSF; Alfred P. Sloan Foundation; Toulouse Network on Information Technology	NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Toulouse Network on Information Technology	Parts of this Review draw on an earlier article (46). We have benefited from discussions with S. Athey, P. McAfee, and H. Varian. We acknowledge research support from the NSF, the Alfred P. Sloan Foundation, and the Toulouse Network on Information Technology.	Abowd JM, 1999, ECONOMETRICA, V67, P251, DOI 10.1111/1468-0262.00020; AKERMAN A, 2013, 7762 IZA; ALBERGOTTI R, 2014, WALL STREET J; Antenucci D., 2014, 20010 NBER; Baker S.R., 2013, 1302 CHIC BOOTH; BELLONI A, 2012, CEMMAP WORKING PAPER; BLAKE T, 20171 NBER; CARD D, 2010, 112 NSF SBE ID; CAVALLO A, 2012, MASSACHUSETTS INSTIT; Cavallo A, 2013, J MONETARY ECON, V60, P152, DOI 10.1016/j.jmoneco.2012.10.002; CHETTY R, 2012, TIME TRENDS USE ADM; Chetty R, 2014, Q J ECON, V129, P1553, DOI 10.1093/qje/qju022; Chetty R, 2014, AM ECON REV, V104, P2593, DOI 10.1257/aer.104.9.2593; Chetty R, 2014, AM ECON REV, V104, P2633, DOI 10.1257/aer.104.9.2633; Chetty R, 2011, Q J ECON, V126, P1593, DOI 10.1093/qje/qjr041; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Einav L., 2014, INNOVATION POLICY EC, V14, P1, DOI [10.1086/674019, DOI 10.1086/674019]; EINAV L, 17385 NBER; EINAV L, 2013, 19021 NBER; Einav L, 2014, AM ECON REV, V104, P1, DOI 10.1257/aer.104.1.1; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Hamermesh DS, 2013, J ECON LIT, V51, P162, DOI 10.1257/jel.51.1.162; Hastie T., 2009, UNSUPERVISED LEARNIN; Horton J. J., 2013, EFFECTS SUBSIDIZING; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Kohavi R, 2009, DATA MIN KNOWL DISC, V18, P140, DOI 10.1007/s10618-008-0114-1; Kum HC, 2011, SCIENCE, V332, P1263, DOI 10.1126/science.332.6035.1263-a; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lewis R.A., 2014, WORKING PAPER; Lewis RA, 2014, QME-QUANT MARK ECON, V12, P235, DOI 10.1007/s11129-014-9146-6; Ostrovsky M, 2009, 2054 STANF U GRAD SC; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Rajaraman A., 2011, MINING MASSIVE DATAS; Rivkin SG, 2005, ECONOMETRICA, V73, P417, DOI 10.1111/j.1468-0262.2005.00584.x; Scott S.L., 2014, INT J MATH MODELLING, V5, P4, DOI [DOI 10.1504/IJMMNO.2014.059942, 10.1504/IJMMNO.2014.059942]; Syverson C, 2011, J ECON LIT, V49, P326, DOI 10.1257/jel.49.2.326; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183; VARIAN H, 2013, NAT ASS BUS EC ANN M; Varian HR, 2014, J ECON PERSPECT, V28, P3, DOI 10.1257/jep.28.2.3; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990	42	217	228	18	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					715	+	1243089	10.1126/science.1243089	http://dx.doi.org/10.1126/science.1243089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT1JT	25378629				2022-12-28	WOS:000344690100029
J	Pintilie, H; Petchey, W; Dhatariya, K; Karim, M				Pintilie, Hannah; Petchey, William; Dhatariya, Ketan; Karim, Mahzuz			A collapse with hypertension and hypokalaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pintilie, Hannah; Petchey, William; Karim, Mahzuz] Norfolk & Norwich Univ Hosp, Dept Renal Med, Norwich NR4 7UY, Norfolk, England; [Pintilie, Hannah; Dhatariya, Ketan] Norfolk & Norwich Univ Hosp, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Karim, M (corresponding author), Norfolk & Norwich Univ Hosp, Dept Renal Med, Norwich NR4 7UY, Norfolk, England.	mkarim@doctors.org.uk	Karim, Mahzuz/H-3138-2019					Nieman L.K., UPTODATE	1	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2014	349								g6582	10.1136/bmj.g6582	http://dx.doi.org/10.1136/bmj.g6582			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CC	25370845				2022-12-28	WOS:000344603600013
J	Westcott, PMK; Halliwill, KD; To, MD; Rashid, M; Rust, AG; Keane, TM; Delrosario, R; Jen, KY; Gurley, KE; Kemp, CJ; Fredlund, E; Quigley, DA; Adams, DJ; Balmain, A				Westcott, Peter M. K.; Halliwill, Kyle D.; To, Minh D.; Rashid, Mamunur; Rust, Alistair G.; Keane, Thomas M.; Delrosario, Reyno; Jen, Kuang-Yu; Gurley, Kay E.; Kemp, Christopher J.; Fredlund, Erik; Quigley, David A.; Adams, David J.; Balmain, Allan			The mutational landscapes of genetic and chemical models of Kras-driven lung cancer	NATURE			English	Article							SEQUENCING DATA; K-RAS; POINT MUTATIONS; EXPRESSION; GENOME; MOUSE; SIGNATURES; CARCINOMA; MTUS1; CELL	Next-generation sequencing of human tumours has refined our understanding of the mutational processes operative in cancer initiation and progression, yet major questions remain regarding the factors that induce driver mutations and the processes that shape mutation selection during tumorigenesis. Here we performed whole-exome sequencing on adenomas from three mouse models of non-small-cell lung cancer, which were induced either by exposure to carcinogens (methyl-nitrosourea (MNU) and urethane) or by genetic activation of Kras (Kras(LA2)). Although the MNU-induced tumours carried exactly the same initiating mutation in Kras as seen in the Kras(LA2) model (G12D), MNU tumours had an average of 192 non-synonymous, somatic single-nucleotide variants, compared with only six in tumours from the Kras(LA2) model. By contrast, the Kras(LA2) tumours exhibited a significantly higher level of aneuploidy and copy number alterations compared with the carcinogen-induced tumours, suggesting that carcinogen-induced and genetically engineered models lead to tumour development through different routes. The wild-type allele of Kras has been shown to act as a tumour suppressor inmouse models of non-small-cell lung cancer. We demonstrate that urethane-induced tumours from wild-type mice carry mostly (94%) Kras Q61R mutations, whereas those from Kras heterozygous animals carry mostly (92%) KrasQ61L mutations, indicating a major role for germ-line Kras status in mutation selection during initiation. The exome wide mutation spectra incarcinogen-induced tumours overwhelmingly display signatures of the initiating carcinogen, while adenocarcinomas acquire additional C > T mutations at CpG sites. These data provide a basis for understanding results from human tumour genome sequencing, which has identified two broad categories of tumours based on the relative frequency of single-nucleotide variations and copy number alterations(1), and underline the importance of carcinogen models for understanding the complex mutation spectra seen in human cancers.	[Westcott, Peter M. K.; Halliwill, Kyle D.; To, Minh D.; Delrosario, Reyno; Quigley, David A.; Balmain, Allan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Westcott, Peter M. K.; Halliwill, Kyle D.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Rashid, Mamunur; Rust, Alistair G.; Keane, Thomas M.; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Jen, Kuang-Yu] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Gurley, Kay E.; Kemp, Christopher J.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Fredlund, Erik] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, S-17121 Stockholm, Sweden; [Balmain, Allan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Wellcome Trust Sanger Institute; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Karolinska Institutet; University of California System; University of California San Francisco	Balmain, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.	abalmain@cc.ucsf.edu	Jen, Kuang-Yu/AAM-5722-2020; Jen, Kuang-Yu/AAM-5429-2020	Adams, David/0000-0001-9490-0306; Rust, Alistair/0000-0001-7287-192X; Keane, Thomas/0000-0001-7532-6898; Jen, Kuang-Yu/0000-0003-2815-5912	National Cancer Institute (NCI) [R01 CA111834, U01 CA84244, U01 CA141455, U01 CA176287]; Bonnie Addario Foundation; National Institutes of Health (NIH) [T32 GM007175]; National Science Foundation GRFP award; NCI F31 NRSA award; NIH [T32 GM007175]; Cancer Research UK; Wellcome Trust; Cancer Research UK [13031] Funding Source: researchfish	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bonnie Addario Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation GRFP award; NCI F31 NRSA award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was supported by National Cancer Institute (NCI) grants R01 CA111834, U01 CA84244, U01 CA141455 and U01 CA176287 (to A.B.), and partly funded by the Bonnie Addario Foundation. P.M.K.W. was supported by the National Institutes of Health (NIH) training grant T32 GM007175 and a National Science Foundation GRFP award, and is currently supported by an NCI F31 NRSA award. K.D.H. was supported by the NIH training grant T32 GM007175, and is currently supported by an NCI F31 NRSA award. D.J.A. is supported by Cancer Research UK and the Wellcome Trust. We are appreciative of help and comments from our colleagues in refining this study and manuscript. We would also like to thank S. Busch for assistance with animal studies, and S. Green, T. Yuan and M. McMahon for providing the K493.1 cell line.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Berndt A, 2011, CANCER RES, V71, P5779, DOI 10.1158/0008-5472.CAN-11-1418; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Benedetto M, 2006, MOL CELL ENDOCRINOL, V252, P207, DOI 10.1016/j.mce.2006.03.014; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; Fawdar S, 2013, P NATL ACAD SCI USA, V110, P12426, DOI 10.1073/pnas.1305207110; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forkert PG, 2010, DRUG METAB REV, V42, P355, DOI 10.3109/03602531003611915; Frank B, 2007, CARCINOGENESIS, V28, P1442, DOI 10.1093/carcin/bgm033; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kurowska M, 2012, MUTAT RES-FUND MOL M, V738, P52, DOI 10.1016/j.mrfmmm.2012.08.008; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; NUZUM EO, 1990, MOL CARCINOGEN, V3, P287, DOI 10.1002/mc.2940030509; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; To MD, 2008, NAT GENET, V40, P1240, DOI 10.1038/ng.211; To MD, 2011, MOL CANCER RES, V9, P1339, DOI 10.1158/1541-7786.MCR-11-0219; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Xiao J, 2012, ONCOL LETT, V4, P113, DOI 10.3892/ol.2012.673; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zuern C, 2010, ONCOL REP, V23, P183, DOI 10.3892/or_00000621	42	224	229	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					489	+		10.1038/nature13898	http://dx.doi.org/10.1038/nature13898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25363767	Green Accepted, Green Submitted			2022-12-28	WOS:000348196500035
J	Huang, YH; Zhu, C; Kondo, Y; Anderson, AC; Gandhi, A; Russell, A; Dougan, SK; Petersen, BS; Melum, E; Pertel, T; Clayton, KL; Raab, M; Chen, Q; Beauchemin, N; Yazaki, PJ; Pyzik, M; Ostrowski, MA; Glickman, JN; Rudd, CE; Ploegh, HL; Franke, A; Petsko, GA; Kuchroo, VK; Blumberg, RS				Huang, Yu-Hwa; Zhu, Chen; Kondo, Yasuyuki; Anderson, Ana C.; Gandhi, Amit; Russell, Andrew; Dougan, Stephanie K.; Petersen, Britt-Sabina; Melum, Espen; Pertel, Thomas; Clayton, Kiera L.; Raab, Monika; Chen, Qiang; Beauchemin, Nicole; Yazaki, Paul J.; Pyzik, Michal; Ostrowski, Mario A.; Glickman, Jonathan N.; Rudd, Christopher E.; Ploegh, Hidde L.; Franke, Andre; Petsko, Gregory A.; Kuchroo, Vijay K.; Blumberg, Richard S.			CEACAM1 regulates TIM-3-mediated tolerance and exhaustion	NATURE			English	Article							CD4(+) T-CELLS; CRYSTAL-STRUCTURE; MURINE; TIM-3; RECEPTOR; ADHESION; PROTEIN; ANTIGEN; BINDING; INDUCTION	T-cell immunoglobulin domain and mucin domain-3 (TIM-3, also known as HAVCR2) is an activation-induced inhibitory molecule involved in tolerance and shown to induce T-cell exhaustion in chronic viral infection and cancers'. Under some conditions, TIM-3 expression has also been shown to be stimulatory. Considering that TIM-3, like cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death 1 (PD-1), is being targeted for cancer immunotherapy, it is important to identify the circumstances under which TIM-3 can inhibit and activate T-cell responses. Here we show that TIM-3 is co-expressed and forms a heterodimer with carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1), another well-known molecule expressed on activated T cells and involved in T-cell inhibition(6-10). Biochemical, biophysical and X-ray crystallography studies show that the membranedistal immunoglobulin-variable (IgV) -like amino-terminal domain of each is crucial to these interactions. The presence of CEACAM 1 endows TIM-3 with inhibitory function. CEACAM1 facilitates the maturation and cell surface expression of TIM-3 by forming a heterodimeric interaction in cis through the highly related membranedistal N-terminal domains of each molecule. CEACAM 1 and TIM-3 also bind in trans through their N-terminal domains. Both cis and trans interactions between CEACAM1 and TIM-3 determine the tolerance-inducing function of TIM-3. In a mouse adoptive transfer colitis model, CEACAM 1 -deficient T cells are hyper-inflammatory with reduced cell surface expression of TIM-3 and regulatory cytokines, and this is restored by T-cell-specific CEACAM 1 expression. During chronic viral infection and in a tumour environment, CEACAM1 and TIM-3 mark exhausted T cells. Co-blockade of CEACAM1 and TIM-3 leads to enhancement of anti-tumour immune responses with improved elimination of tumours in mouse colorectal cancer models. Thus, CEACAM 1 serves as a heterophilic ligand for TIM-3 that is required for its ability to mediate T-cell inhibition, and this interaction has a crucial role in regulating autoimmunity and anti-tumour immunity.	[Huang, Yu-Hwa; Kondo, Yasuyuki; Gandhi, Amit; Melum, Espen; Pyzik, Michal; Blumberg, Richard S.] Harvard Univ, Sch Med, Dept Med, Div Gastroenterol,Brigham & Womens Hosp, Boston, MA 02115 USA; [Zhu, Chen; Anderson, Ana C.; Pertel, Thomas; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Zhu, Chen; Anderson, Ana C.; Pertel, Thomas; Kuchroo, Vijay K.] Brigham & Womens Hosp, Harvard Inst Med, Boston, MA 02115 USA; [Russell, Andrew; Petsko, Gregory A.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Dougan, Stephanie K.; Ploegh, Hidde L.] MIT, Whitehead Inst, Cambridge, MA 02142 USA; [Petersen, Britt-Sabina; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Melum, Espen] Oslo Univ Hosp, Norwegian PSC Res Ctr, Div Canc Med Surg & Transplantat, N-0424 Oslo, Norway; [Clayton, Kiera L.; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Raab, Monika; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Cell Signalling Sect, Cambridge CB2 1QP, England; [Chen, Qiang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Beauchemin, Nicole] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Yazaki, Paul J.] City Hope Natl Med Ctr, Beckman Inst, Duarte, CA 91010 USA; [Ostrowski, Mario A.] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5S 1A8, Canada; [Glickman, Jonathan N.] Miraca Life Sci, GI Pathol, Newton, MA 02464 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brandeis University; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Kiel; University of Oslo; University of Toronto; University of Cambridge; Sichuan University; McGill University; City of Hope; Beckman Research Institute of City of Hope; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Blumberg, RS (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Gastroenterol,Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	rblumberg@partners.org	Franke, Andre/B-2151-2010; chen, qiang/M-1630-2016; Rudd, Christopher E/GOH-2021-2022; Pyzik, Michal/AAC-7220-2019; Petsko, Gregory/AAO-7962-2020; Anderson, Ana C/ABD-6829-2021; Rudd, Christopher E/ABF-7259-2021; Löscher, Britt-Sabina/I-1671-2012	Franke, Andre/0000-0003-1530-5811; chen, qiang/0000-0002-2398-4482; Rudd, Christopher E/0000-0001-5295-9019; Anderson, Ana C/0000-0002-0877-2932; Löscher, Britt-Sabina/0000-0001-9022-9017; Pertel, Thomas/0000-0002-2286-6011; Pyzik, Michal/0000-0003-2591-6202	American Cancer Society [RSG-11-057-01-LIB]; Norwegian PSC research center; Unger Vetlesen Medical Fund; Crohn's & Colitis Foundation of America fellowship grant; Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces' Award; Harvard Clinical Translational Science Center [UL1 TR001102]; National Basic Research Program of China [2010CB529906]; Canadian Institute of Health Research [MOP-93787]; AACR-Pancreatic Cancer Action Network; National Institutes of Health (NIH) [GM32415, AI073748, NS045937, AI039671, AI056299, DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center (HDDC) [DK0034854]; High Point Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748, P01AI039671, P01AI056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R37DK044319, R01DK088199, R01DK051362, R56DK053056, R01DK044319, R01DK053056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, R01GM026788, P41GM111244, R01GM032415, R37GM032415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Norwegian PSC research center; Unger Vetlesen Medical Fund; Crohn's & Colitis Foundation of America fellowship grant; Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces' Award(German Research Foundation (DFG)); Harvard Clinical Translational Science Center; National Basic Research Program of China(National Basic Research Program of China); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); AACR-Pancreatic Cancer Action Network; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center (HDDC); High Point Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Gallagher, M. Yoshida and K. Holmes for essential reagents, R. Gali for statistical assistance, C. Chen, T. Wesse, S. Sabet,S. Greve, T. Henke, D. Tan, K. Sakuishi and J. Sullivan for technical assistance, E. Greenfield and C. Bencsics for core services, and J. H. Wang, E. Reinherz, R. Grenha, H. lijima, J. Shively, A. Kaser, T. E. Adolph, K. Baker, D. Ringe and S. Zeissig for discussions. We thank the staff of the Dana Farber/Harvard Cancer Center monoclonal antibody core for purification of proteins used in X-ray crystallography and beam line X25 and X6A of the National Synchrotron Light Source (NSLS), Brookhaven National Laboratory, USA. The NSLS is supported by the US Department of Energy. This work was supported by the American Cancer Society grant RSG-11-057-01-LIB (A.C.A); the Norwegian PSC research center and the Unger Vetlesen Medical Fund (EM.); Crohn's & Colitis Foundation of America fellowship grant (Y.-H.H.); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces' Award (A.F. and B.-S.P.); Harvard Clinical Translational Science Center, UL1 TR001102 (R. Gali); the National Basic Research Program of China No. 2010CB529906 (Q.C.); Canadian Institute of Health Research (K.L.C. and N.B.); Canadian Institute of Health Research grant MOP-93787 (M.A.O.); AACR-Pancreatic Cancer Action Network (H.L.P. and S.K.D.); National Institutes of Health (NIH) grant GM32415 (GAP.); NIH grants AI073748, NS045937, AI039671 and AI056299 (V.K.K.); NIH grants DK044319, DK051362, DK053056, DK088199, the Harvard Digestive Diseases Center (HDDC) DK0034854 and High Point Foundation (R.S.B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Bansal-Pakala P, 2001, NAT MED, V7, P907, DOI 10.1038/90942; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Chen LF, 2012, IMMUNITY, V37, P930, DOI 10.1016/j.immuni.2012.07.016; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gallagher TM, 1997, J VIROL, V71, P3129, DOI 10.1128/JVI.71.4.3129-3137.1997; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; MIZUGUCHI K, 1995, CURR OPIN STRUC BIOL, V5, P377, DOI 10.1016/0959-440X(95)80100-6; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Morales VM, 1999, J IMMUNOL, V163, P1363; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Patel PC, 2013, J BIOL CHEM, V288, P29654, DOI 10.1074/jbc.M113.504639; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; SMITH AL, 1991, J INFECT DIS, V163, P879, DOI 10.1093/infdis/163.4.879; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; TRUELOVE SC, 1976, GUT, V17, P192, DOI 10.1136/gut.17.3.192; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Zhang XW, 2002, PROTEIN EXPRES PURIF, V25, P105, DOI 10.1006/prep.2002.1616; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	56	361	405	3	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					386	U566		10.1038/nature13848	http://dx.doi.org/10.1038/nature13848			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363763	Green Submitted, Green Accepted			2022-12-28	WOS:000347810300050
J	Barrington-Trimis, JL; Samet, JM; McConnell, R				Barrington-Trimis, Jessica L.; Samet, Jonathan M.; McConnell, Rob			Flavorings in Electronic Cigarettes An Unrecognized Respiratory Health Hazard?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Barrington-Trimis, Jessica L.; Samet, Jonathan M.; McConnell, Rob] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California	Barrington-Trimis, JL (corresponding author), Univ So Calif, Dept Prevent Med, 2001 N Soto St,230-D, Los Angeles, CA 90089 USA.	jtrimis@usc.edu	Barrington-Trimis, Jessica/ABE-7311-2020		NCI NIH HHS [P50CA180905, P50 CA180905] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA180905] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrams DB, 2014, JAMA-J AM MED ASSOC, V311, P135, DOI 10.1001/jama.2013.285347; [Anonymous], 2012, RESPIRATORY HEALTH A; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Farsalinos KE, 2015, NICOTINE TOB RES, V17, P168, DOI 10.1093/ntr/ntu176; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Hallagan J., 2014, THE SAFETY ASSESSMEN; Kreiss K, 2014, AM J IND MED, V57, P129, DOI 10.1002/ajim.22282; Potera C, 2012, ENVIRON HEALTH PERSP, V120, pA457, DOI 10.1289/ehp.120-a457; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	9	157	159	0	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2493	2494		10.1001/jama.2014.14830	http://dx.doi.org/10.1001/jama.2014.14830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25383564	Green Accepted			2022-12-28	WOS:000346346900006
J	Tomas, NM; Beck, LH; Meyer-Schwesinger, C; Seitz-Polski, B; Ma, H; Zahner, G; Dolla, G; Hoxha, E; Helmchen, U; Dabert-Gay, AS; Debayle, D; Merchant, M; Klein, J; Salant, DJ; Stahl, RAK; Lambeau, G				Tomas, Nicola M.; Beck, Laurence H., Jr.; Meyer-Schwesinger, Catherine; Seitz-Polski, Barbara; Ma, Hong; Zahner, Gunther; Dolla, Guillaume; Hoxha, Elion; Helmchen, Udo; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Merchant, Michael; Klein, Jon; Salant, David J.; Stahl, Rolf A. K.; Lambeau, Gerard			Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHOSPHOLIPASE-A2 RECEPTOR; AUTOANTIBODIES; ANTIBODIES; DIAGNOSIS	BACKGROUND Idiopathic membranous nephropathy is an autoimmune disease. In approximately 70% of patients, it is associated with autoantibodies against the phospholipase A2 receptor 1 (PLA2R1). Antigenic targets in the remaining patients are unknown. METHODS Using Western blotting, we screened serum samples from patients with idiopathic membranous nephropathy, patients with other glomerular diseases, and healthy controls for antibodies against human native glomerular proteins. We partially purified a putative new antigen, identified this protein by means of mass spectrometry of digested peptides, and validated the results by analysis of recombinant protein expression, immunoprecipitation, and immunohistochemical analysis. RESULTS Serum samples from 6 of 44 patients in a European cohort and 9 of 110 patients in a Boston cohort with anti-PLA2R1-negative idiopathic membranous nephropathy recognized a glomerular protein that was 250 kD in size. None of the serum samples from the 74 patients with idiopathic membranous nephropathy who were seropositive for anti-PLA2R1 antibodies, from the 76 patients with other glomerular diseases, and from the 44 healthy controls reacted against this antigen. Although this newly identified antigen is clearly different from PLA2R1, it shares some biochemical features, such as N-glycosylation, membranous location, and reactivity with serum only under nonreducing conditions. Mass spectrometry identified this antigen as thrombospondin type-1 domain-containing 7A (THSD7A). All reactive serum samples recognized recombinant THSD7A and immunoprecipitated THSD7A from glomerular lysates. Moreover, immunohistochemical analyses of biopsy samples from patients revealed localization of THSD7A to podocytes, and IgG eluted from one of these samples was specific for THSD7A. CONCLUSIONS In our cohort, 15 of 154 patients with idiopathic membranous nephropathy had circulating autoantibodies to THSD7A but not to PLA2R1, a finding that suggests a distinct subgroup of patients with this condition.	[Tomas, Nicola M.; Seitz-Polski, Barbara; Dolla, Guillaume; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Lambeau, Gerard] CNRS, Inst Pharmacol Mol & Cellulaire, UMR7275, F-06560 Valbonne, France; [Tomas, Nicola M.; Seitz-Polski, Barbara; Dolla, Guillaume; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Lambeau, Gerard] Univ Nice Sophia Antipolis, Valbonne, France; [Tomas, Nicola M.; Meyer-Schwesinger, Catherine; Zahner, Gunther; Hoxha, Elion; Helmchen, Udo; Stahl, Rolf A. K.] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Beck, Laurence H., Jr.; Ma, Hong; Salant, David J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Merchant, Michael; Klein, Jon] Univ Louisville, Louisville, KY 40292 USA; [Klein, Jon] Robley Rex Vet Affairs Med Ctr, Louisville, KY USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Hamburg; University Medical Center Hamburg-Eppendorf; Boston University; University of Louisville	Lambeau, G (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, 660 Rte Lucioles, F-06560 Valbonne, France.	lambeau@ipmc.cnrs.fr	Seitz-Polski, Barbara/ADS-4852-2022; Hoxha, Elion/ABB-2981-2021; Lambeau, Gerard/GRJ-5624-2022; Merchant, Michael/F-7109-2013; Merchant, Michael/N-7444-2013	Seitz-Polski, Barbara/0000-0002-8913-5969; Salant, David/0000-0002-3866-3120; Lambeau, Gerard/0000-0002-9239-518X; Merchant, Michael/0000-0003-4128-4057	French National Center for Scientific Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090029, T32DK007053, R01DK097053] Funding Source: NIH RePORTER	French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the French National Center for Scientific Research and others.	Beck LH, 2010, SEMIN NEPHROL, V30, P635, DOI 10.1016/j.semnephrol.2010.09.011; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Dahnrich C, 2013, CLIN CHIM ACTA, V421, P213, DOI 10.1016/j.cca.2013.03.015; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Deegens JKJ, 2007, DRUG AGING, V24, P717, DOI 10.2165/00002512-200724090-00002; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Ju WJ, 2013, GENOME RES, V23, P1862, DOI 10.1101/gr.155697.113; Larsen C, 2013, FORTUNE, V167, P26; Seitz-Polski B, 2014, NEPHROL DIAL TRANSPL; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Wang CH, 2010, J CELL PHYSIOL, V222, P685, DOI 10.1002/jcp.21990	19	509	563	4	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2277	2287		10.1056/NEJMoa1409354	http://dx.doi.org/10.1056/NEJMoa1409354			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW1KQ	25394321	Green Accepted			2022-12-28	WOS:000346048800008
J	Watt, FM				Watt, Fiona M.			Mammalian skin cell biology: At the interface between laboratory and clinic	SCIENCE			English	Review							STEM-CELL; TOUCH RECEPTORS; GENE-EXPRESSION; EPIDERMAL-CELLS; DIFFERENTIATION; GROWTH; REGENERATION; MIGRATION; DYNAMICS; INTEGRIN	Mammalian skin research represents the convergence of three complementary disciplines: cell biology, mouse genetics, and dermatology. The skin provides a paradigm for current research in cell adhesion, inflammation, and tissue stem cells. Here, I discuss recent insights into the cell biology of skin. Single-cell analysis has revealed that human epidermal stem cells are heterogeneous and differentiate in response to multiple extrinsic signals. Live-cell imaging, optogenetics, and cell ablation experiments show skin cells to be remarkably dynamic. High-throughput, genome-wide approaches have yielded unprecedented insights into the circuitry that controls epidermal stem cell fate. Last, integrative biological analysis of human skin disorders has revealed unexpected functions for elements of the skin that were previously considered purely structural.	Kings Coll London, Guys Hosp, Ctr Stem Cells & Regenerat Med, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Watt, FM (corresponding author), Kings Coll London, Guys Hosp, Ctr Stem Cells & Regenerat Med, 28th Floor,Tower Wing, London SE1 9RT, England.	fiona.watt@kcl.ac.uk	Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154	Medical Research Council; Wellcome Trust; Medical Research Council [MR/K026666/1] Funding Source: researchfish; MRC [MR/K026666/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	I am most grateful to the Medical Research Council and the Wellcome Trust tor funding, and to all members of my laboratory, collaborators, and colleagues for their input.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Arwert EN, 2010, P NATL ACAD SCI USA, V107, P19903, DOI 10.1073/pnas.1007404107; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cipolat S, 2014, ELIFE, V3, DOI 10.7554/eLife.01888; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Donati G, 2014, P NATL ACAD SCI USA, V111, pE1501, DOI 10.1073/pnas.1312880111; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Gautrot JE, 2012, BIOMATERIALS, V33, P5221, DOI 10.1016/j.biomaterials.2012.04.009; Godsel LM, 2010, MOL BIOL CELL, V21, P2844, DOI 10.1091/mbc.E10-02-0131; Green H, 2008, BIOESSAYS, V30, P897, DOI 10.1002/bies.20797; Guinea-Viniegra J, 2012, J CLIN INVEST, V122, P2898, DOI 10.1172/JCI63103; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Itoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077673; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kim JS, 2012, BIOPHYS J, V103, P1828, DOI 10.1016/j.bpj.2012.09.016; Klein AM, 2011, J R SOC INTERFACE, V8, P1815, DOI 10.1098/rsif.2011.0240; Koetsier JL, 2014, J INVEST DERMATOL, V134, P112, DOI 10.1038/jid.2013.266; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kretzschmar K, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013631; Krishna Vedula Sri Ram, 2014, Nature Materials, V13, P87, DOI 10.1038/NMAT3814; Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Liakath-Ali K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4540; Livshits G, 2012, P NATL ACAD SCI USA, V109, P4886, DOI 10.1073/pnas.1202120109; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Maalouf SW, 2012, J DERMATOL SCI, V66, P108, DOI 10.1016/j.jdermsci.2012.02.009; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Mertz AF, 2013, P NATL ACAD SCI USA, V110, P842, DOI 10.1073/pnas.1217279110; Mulder KW, 2012, NAT CELL BIOL, V14, P753, DOI 10.1038/ncb2520; Nekrasova O, 2013, TRENDS CELL BIOL, V23, P537, DOI 10.1016/j.tcb.2013.06.004; Oates AC, 2011, DEVELOPMENT, V138, P601, DOI 10.1242/dev.059923; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Patel DM, 2014, J CELL BIOL, V206, P779, DOI 10.1083/jcb.201312110; Perera GK, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007217; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Sasaki T, 2013, J ALLERGY CLIN IMMUN, V132, P1111, DOI 10.1016/j.jaci.2013.08.027; Schepeler T, 2014, DEVELOPMENT, V141, P2559, DOI 10.1242/dev.104588; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; Schumacher M, 2014, J INVEST DERMATOL, V134, P1332, DOI 10.1038/jid.2013.535; Sevilla LM, 2008, J CELL SCI, V121, P3561, DOI 10.1242/jcs.029538; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Tan DWM, 2013, DEVELOPMENT, V140, P1433, DOI 10.1242/dev.087551; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Uitto J, 2012, J INVEST DERMATOL, V132, P820, DOI [10.1038/jid.2011.389, 10.1038/skinbio.2012.6]; Watt FM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005124; Zimmerman A, 2014, SCIENCE, V346, P950, DOI 10.1126/science.1254229	60	122	125	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					937	940		10.1126/science.1253734	http://dx.doi.org/10.1126/science.1253734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414300				2022-12-28	WOS:000345696000030
J	Aylor, M; Anderson, JM; Vanderford, P; Halsey, M; Lai, S; Braner, DAV				Aylor, Megan; Anderson, JoDee M.; Vanderford, Paula; Halsey, Matthew; Lai, Susanna; Braner, Dana A. V.			Reduction of Pulled Elbow	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NURSEMAIDS ELBOW		[Aylor, Megan; Anderson, JoDee M.; Vanderford, Paula; Halsey, Matthew; Lai, Susanna; Braner, Dana A. V.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA	Oregon Health & Science University	Braner, DAV (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, CDRC P, 707 SW Gaines Rd, Portland, OR 97239 USA.	branerd@ohsu.edu	Braner, Dana/Q-4919-2019					Brown D, 2009, ORTHOP NURS, V28, P161, DOI 10.1097/NOR.0b013e3181ada779; Brown M, 2013, ANN EMERG MED, V61, P291, DOI 10.1016/j.annemergmed.2012.10.024; ILLINGWORTH CM, 1975, BRIT MED J, V2, P672, DOI 10.1136/bmj.2.5972.672; Kaplan RE, 2002, PEDIATRICS, V110, P171, DOI 10.1542/peds.110.1.171; Krul M, 2012, COCHRANE DB SYST REV, V1; Macias CG, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e10; McDonald J, 1999, ACAD EMERG MED, V6, P715, DOI 10.1111/j.1553-2712.1999.tb00440.x; Rudloe TF, 2012, PEDIATR EMERG CARE, V28, P771, DOI 10.1097/PEC.0b013e3182624906	8	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21							e32	10.1056/NEJMvcm1211809	http://dx.doi.org/10.1056/NEJMvcm1211809			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT5ST	25409393				2022-12-28	WOS:000345002900010
J	Espin-Palazon, R; Stachura, DL; Campbell, CA; Garcia-Moreno, D; Del Cid, N; Kim, AD; Candel, S; Meseguer, J; Mulero, V; Traver, D				Espin-Palazon, Raquel; Stachura, David L.; Campbell, Clyde A.; Garcia-Moreno, Diana; Del Cid, Natasha; Kim, Albert D.; Candel, Sergio; Meseguer, Jose; Mulero, Victoriano; Traver, David			Proinflammatory Signaling Regulates Hematopoietic Stem Cell Emergence	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS; AORTIC ENDOTHELIUM; DEFINITIVE HEMATOPOIESIS; EARLY MACROPHAGES; ZEBRAFISH EMBRYO; MOUSE EMBRYO; FACTOR-ALPHA; TNF-ALPHA	Hematopoietic stemcells (HSCs) underlie the production of blood and immune cells for the lifetime of an organism. In vertebrate embryos, HSCs arise from the unique transdifferentiation of hemogenic endothelium comprising the floor of the dorsal aorta during a brief developmental window. To date, this process has not been replicated in vitro from pluripotent precursors, partly because the full complement of required signaling inputs remains to be determined. Here, we show that TNFR2 via TNF alpha activates the Notch and NF-kappa B signaling pathways to establish HSC fate, indicating a requirement for inflammatory signaling in HSC generation. We determine that primitive neutrophils are the major source of TNF alpha, assigning a role for transient innate immune cells in establishing the HSC program. These results demonstrate that proinflammatory signaling, in the absence of infection, is utilized by the developing embryo to generate the lineal precursors of the adult hematopoietic system.	[Espin-Palazon, Raquel; Stachura, David L.; Campbell, Clyde A.; Del Cid, Natasha; Kim, Albert D.; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Espin-Palazon, Raquel; Garcia-Moreno, Diana; Candel, Sergio; Meseguer, Jose; Mulero, Victoriano] Univ Murcia, IMIB Arrixaca, Fac Biol, Dept Biol Celular & Histol, E-30100 Murcia, Spain; [Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of California System; University of California San Diego	Mulero, V (corresponding author), Univ Murcia, IMIB Arrixaca, Fac Biol, Dept Biol Celular & Histol, Campus Univ Espinardo, E-30100 Murcia, Spain.	vmulero@um.es; dtraver@ucsd.edu	Garcia-Moreno, Diana/ABG-2131-2020	Mulero, Victoriano/0000-0001-9527-0211; Garcia, Diana/0000-0002-1521-2327; Candel Camacho, Sergio/0000-0001-7919-6584	Spanish Ministry of Science and Innovation [BIO2011-23400, CSD2007-00002]; Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia de la Region de Murcia [04538/GERM/06]; NIH [K01-DK087814-01A1, R01-DK074482]; CIRM New Faculty Award [RN1-00575-1]; AHA Innovative Science Award [12PILT12860010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK087814, R01DK074482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia de la Region de Murcia(Fundacion Seneca); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM New Faculty Award; AHA Innovative Science Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Spanish Ministry of Science and Innovation (grants BIO2011-23400, and CSD2007-00002 to V. M.), the Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia de la Region de Murcia (grant 04538/GERM/06 to V. M. and predoctoral and postdoctoral fellowships to R. E.-P.), the NIH (K01-DK087814-01A1; D. L. S.), a CIRM New Faculty Award RN1-00575-1 (D. T.), AHA Innovative Science Award 12PILT12860010 (D. T.), and NIH R01-DK074482 (D. T.). We thank Inmaculada Fuentes, Pedro Martinez, Efren Reyes, Chase Melick, and Karen Ong for technical assistance; Nadia Mercader for ideas and discussion; Francisco Juan Martinez-Navarro and Liangdao Li for help with WISH; and Kylie Price and SAI staff for flow cytometry.	Abbas S, 2003, J BIOL CHEM, V278, P20077, DOI 10.1074/jbc.M208619200; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Ang HL, 2007, BIOESSAYS, V29, P1039, DOI 10.1002/bies.20647; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2010, BLOOD, V115, P2777, DOI 10.1182/blood-2009-09-244590; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bigas A, 2013, BLOOD CELL MOL DIS, V51, P264, DOI 10.1016/j.bcmd.2013.07.005; Bigas A, 2012, BLOOD, V119, P3226, DOI 10.1182/blood-2011-10-355826; Bigas A, 2010, INT J DEV BIOL, V54, P1175, DOI 10.1387/ijdb.093049ab; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cao Q, 2011, NEUROSCIENCE, V192, P140, DOI 10.1016/j.neuroscience.2011.06.060; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Espin R, 2013, DIS MODEL MECH, V6, P383, DOI 10.1242/dmm.010249; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Fernandez L, 2008, EXP HEMATOL, V36, P545, DOI 10.1016/j.exphem.2007.12.012; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Gerondakis S, 2012, IMMUNOL REV, V246, P272, DOI 10.1111/j.1600-065X.2011.01090.x; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Johnston DA, 2009, GENE, V435, P36, DOI 10.1016/j.gene.2009.01.003; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Kim AD, 2014, EMBO J, V33, P2363, DOI 10.15252/embj.201488784; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kobayashi I, 2014, NATURE, V512, P319, DOI 10.1038/nature13623; KOHCHI C, 1994, INT J BIOCHEM, V26, P111, DOI 10.1016/0020-711X(94)90203-8; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kortschak RD, 2001, DEV GENES EVOL, V211, P350; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kyba M, 2003, EXP HEMATOL, V31, P994, DOI 10.1016/j.exphem.2003.08.002; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Mizrahi K, 2014, BLOOD, V124, P176, DOI 10.1182/blood-2014-03-559641; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Quillien A, 2014, DEVELOPMENT, V141, P1544, DOI 10.1242/dev.099986; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Roca FJ, 2008, J IMMUNOL, V181, P5071, DOI 10.4049/jimmunol.181.7.5071; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; SHALABY MR, 1990, J EXP MED, V172, P1517, DOI 10.1084/jem.172.5.1517; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; THISSE C, 1993, DEVELOPMENT, V119, P1203; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; Wang H, 2013, J BIOL CHEM, V288, P16761, DOI 10.1074/jbc.M112.446633; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wiens GD, 2011, DEV COMP IMMUNOL, V35, P1324, DOI 10.1016/j.dci.2011.03.031; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhao C, 2012, STEM CELLS, V30, P709, DOI 10.1002/stem.1050; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007	67	196	199	0	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1070	1085		10.1016/j.cell.2014.10.031	http://dx.doi.org/10.1016/j.cell.2014.10.031			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416946	Bronze, Green Accepted			2022-12-28	WOS:000345506300019
J	Koren, A; Handsaker, RE; Kamitaki, N; Karlic, R; Ghosh, S; Polak, P; Eggan, K; McCarroll, SA				Koren, Amnon; Handsaker, Robert E.; Kamitaki, Nolan; Karlic, Rosa; Ghosh, Sulagna; Polak, Paz; Eggan, Kevin; McCarroll, Steven A.			Genetic Variation in Human DNA Replication Timing	CELL			English	Article							JAK2 HAPLOTYPE; HUMAN MUTATION; INITIATION; CANCER; WAVES; DYNAMICS; SNP	Genomic DNA replicates in a choreographed temporal order that impacts the distribution of mutations along the genome. We show here that DNA replication timing is shaped by genetic polymorphisms that act in cis upon megabase-scale DNA segments. In genome sequences from proliferating cells, read depth along chromosomes reflected DNA replication activity in those cells. We used this relationship to analyze variation in replication timing among 161 individuals sequenced by the 1000 Genomes Project. Genome-wide association of replication timing with genetic variation identified 16 loci at which inherited alleles associate with replication timing. We call these "replication timing quantitative trait loci" (rtQTLs). rtQTLs involved the differential use of replication origins, exhibited allele-specific effects on replication timing, and associated with gene expression variation at megabase scales. Our results show replication timing to be shaped by genetic polymorphism and identify a means by which inherited polymorphism regulates the mutability of nearby sequences.	[Koren, Amnon; Handsaker, Robert E.; Kamitaki, Nolan; Ghosh, Sulagna; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Koren, Amnon; Handsaker, Robert E.; Kamitaki, Nolan; Ghosh, Sulagna; McCarroll, Steven A.] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Koren, Amnon; Handsaker, Robert E.; Kamitaki, Nolan; Ghosh, Sulagna; Polak, Paz; Eggan, Kevin; McCarroll, Steven A.] Harvard, Cambridge, MA 02142 USA; [Handsaker, Robert E.; Kamitaki, Nolan; Ghosh, Sulagna; Eggan, Kevin; McCarroll, Steven A.] MIT, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Karlic, Rosa] Univ Zagreb, Fac Sci, Div Biol, Bioinformat Grp, Zagreb 10000, Croatia; [Ghosh, Sulagna; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Polak, Paz] MIT, Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Polak, Paz] Harvard Univ, Sch Med, Dept Med, Ctr Canc, Boston, MA 02114 USA; [Polak, Paz] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Zagreb; Harvard University; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021; Eggan, Kevin/P-7119-2018; Polak, Paz/AAH-9380-2020	Handsaker, Bob/0000-0002-3128-3547; Kamitaki, Nolan/0000-0003-0614-0189; McCarroll, Steven/0000-0002-6954-8184; Karlic, Rosa/0000-0002-1291-2897	National Human Genome Research Institute [R01 HG 006855]; Integra-Life Seventh Framework Programme [315997]; Stanley Center for Psychiatric Research; Howard Hughes Medical Institute; Harvard Stem Cell Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Integra-Life Seventh Framework Programme; Stanley Center for Psychiatric Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Stem Cell Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Vanessa Van Doren for technical assistance and David Altshuler, Chris Patil, Giulio Genovese, Sam Rose, and Itamar Simon for discussions and comments on the manuscript. This work was supported by the National Human Genome Research Institute (R01 HG 006855 to S. A. M.), the Integra-Life Seventh Framework Programme (grant 315997 to R. K.), the Stanley Center for Psychiatric Research, the Howard Hughes Medical Institute, and the Harvard Stem Cell Institute.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dimitriadou E, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-46; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hawkins M, 2013, CELL REP, V5, P1132, DOI 10.1016/j.celrep.2013.10.014; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lepretre F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1215; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Manukjan G, 2013, BIOTECHNIQUES, V55, P231, DOI 10.2144/000114097; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Martincorena I, 2013, BIOESSAYS, V35, P123, DOI 10.1002/bies.201200150; Mukhopadhyay R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004319; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pedersen BS, 2013, NUCLEIC ACIDS RES, V41, P7615, DOI 10.1093/nar/gkt552; Pope BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027413; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Ryba T, 2012, GENOME RES, V22, P1833, DOI 10.1101/gr.138511.112; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; SHARP PM, 1989, SCIENCE, V246, P808, DOI 10.1126/science.2683084; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; van de Wiel MA, 2009, BIOINFORMATICS, V25, P1099, DOI 10.1093/bioinformatics/btp132; van Heesch S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r33; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101	43	97	98	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1015	1026		10.1016/j.cell.2014.10.025	http://dx.doi.org/10.1016/j.cell.2014.10.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416942	Green Accepted, Bronze			2022-12-28	WOS:000345506300015
J	Huffman, MD; de Cates, AN; Ebrahim, S				Huffman, Mark D.; de Cates, Angharad N.; Ebrahim, Shah			Fixed-Dose Combination Therapy (Polypill) for the Prevention of Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Is fixed-dose combination therapy (polypill) that combines antiplatelet, blood;pressure-lowering, and cholesterol-lowering medications into a single pill associated with improved cardiovascular disease (CVD) risk factors or reduced all-cause mortality or fatal ancl nonfatal CVD events? Is the polypill associated with an increase in adverse events? BOTTOM LINE Polypills are associated with greater reductions in systolic blood pressure and total cholesterol compared with usual care, placebo, or active comparators, but also with a 19% higher risk of any adverse event. Due to limited power from available evidence, the association of polypills with all-cause mortality or fatal and nonfatal CVD events is uncertain,	[Huffman, Mark D.] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [de Cates, Angharad N.] Univ Warwick, Div Hlth Sci, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Camden, England	Northwestern University; University of Warwick; University of London; London School of Hygiene & Tropical Medicine	Huffman, MD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Cochrane Heart Grp US Satellite, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	m-huffman@northwestern.edu	de Cates, Angharad/N-6550-2013	de Cates, Angharad/0000-0001-7848-1295; Huffman, Mark/0000-0001-7412-2519	National Institute for Health Research [ACF-2011-08-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; de Cates AN, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009868.pub2; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Huffman MD, 2014, J AM COLL CARDIOL, V63, P1368, DOI 10.1016/j.jacc.2013.08.1665; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P1507; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P918, DOI 10.1001/jama.2013.277064	7	10	11	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2030	2031		10.1001/jama.2014.13616	http://dx.doi.org/10.1001/jama.2014.13616			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399279	Green Accepted			2022-12-28	WOS:000345450500018
J	King, D				King, David			Marketing wearable home baby monitors: real peace of mind?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFANT-DEATH-SYNDROME; APNEA; SIDS		Univ Sheffield, Acad Unit Child Hlth, Sheffield S10 2TH, S Yorkshire, England	University of Sheffield	King, D (corresponding author), Univ Sheffield, Acad Unit Child Hlth, Sheffield S10 2TH, S Yorkshire, England.	d.a.king@sheffield.ac.uk						[Anonymous], 2014, TIME; Blackmon LR, 2003, PEDIATRICS, V111, P914; HODGMAN JE, 1988, ANN NY ACAD SCI, V533, P164, DOI 10.1111/j.1749-6632.1988.tb37246.x; Moon RY, 2011, PEDIATRICS, V128, pE1341, DOI 10.1542/peds.2011-2285; Owlet, INTRO OWLET SMART SO; Owlet Care, OWL VIT MON YOUR CHI; Peck S., 2014, TELEGRAPH; Ramanathan R, 2001, JAMA-J AM MED ASSOC, V285, P2199, DOI 10.1001/jama.285.17.2199; Rest Devices, STAY CONN MIM BAB MO; Rollins Center for Entrepreneurship and Technology, 2013, IBMC 2013 TEAM OWL 1; Sproutling, SMART BAB MON; Startup Bootcamp, D MADDEN REST DEV; WARD SLD, 1986, PEDIATRICS, V77, P451	13	5	5	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2014	349								g6639	10.1136/bmj.g6639	http://dx.doi.org/10.1136/bmj.g6639			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JY	25406191	Green Accepted			2022-12-28	WOS:000345445600005
J	Hole, B; Whittlestone, T; Tomson, C				Hole, Barnaby; Whittlestone, Tim; Tomson, Charles			Investigating asymptomatic invisible haematuria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NONDIABETIC RENAL-DISEASE; MICROSCOPIC HEMATURIA; FOLLOW-UP; RISK; ADULTS; MICROHEMATURIA; PROGRESSION; PATIENT		[Hole, Barnaby; Tomson, Charles] Southmead Gen Hosp, Dept Renal Med, Bristol BS10 5NB, Avon, England; [Whittlestone, Tim] Southmead Gen Hosp, Dept Urol, Bristol BS10 5NB, Avon, England	Southmead Hospital; Southmead Hospital	Tomson, C (corresponding author), Southmead Gen Hosp, Dept Renal Med, Bristol BS10 5NB, Avon, England.	charles.tomson@nhs.net		Tomson, Charles/0000-0002-0224-8726	National Institute for Health Research [ACF-2014-25-005] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Banks J, 2014, LANCET ONCOL, V15, P232, DOI 10.1016/S1470-2045(13)70588-6; CULCLASURE TF, 1994, ARCH INTERN MED, V154, P649, DOI 10.1001/archinte.154.6.649; Davis R, 2012, J UROLOGY, V188, P2473, DOI 10.1016/j.juro.2012.09.078; Edwards TJ, 2011, BJU INT, V107, P247, DOI 10.1111/j.1464-410X.2010.09521.x; Giatras I, 1997, ANN INTERN MED, V127, P337, DOI 10.7326/0003-4819-127-5-199709010-00001; Hemstreet GP, 2001, JNCI-J NATL CANCER I, V93, P427, DOI 10.1093/jnci/93.6.427; HIATT RA, 1994, CANCER EPIDEM BIOMAR, V3, P439; Jafar TH, 2001, KIDNEY INT, V60, P1131, DOI 10.1046/j.1523-1755.2001.0600031131.x; Khadra MH, 2000, J UROLOGY, V163, P524, DOI 10.1016/S0022-5347(05)67916-5; Loo RK, 2013, MAYO CLIN PROC, V88, P129, DOI 10.1016/j.mayocp.2012.10.004; MESSING EM, 1995, J UROLOGY, V154, P57, DOI 10.1016/S0022-5347(01)67224-0; National Institute for Health and Care Excellence, 2014, CHRON KIDN DIS NAT C; Price S, 2014, BR J GEN PRACT, V64, P464; Renal Association and British Association of Urological Surgeons, 2008, JOINT CONS STAT IN A; Rodgers M, 2006, HLTH TECHNOL ASSESS, V10, piii; Tomson C, 2002, BJU INT, V90, P185, DOI 10.1046/j.1464-410X.2002.02841.x; Tomson CRV, 2003, CLIN MED, V3, P513, DOI 10.7861/clinmedicine.3-6-513; Vivante A, 2011, JAMA-J AM MED ASSOC, V306, P729, DOI 10.1001/jama.2011.1141; Yanagihara T, 2007, PEDIATR INT, V49, P570, DOI 10.1111/j.1442-200X.2007.02426.x	19	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2014	349								g6768	10.1136/bmj.g6768	http://dx.doi.org/10.1136/bmj.g6768			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JX	25404006				2022-12-28	WOS:000345445500007
J	Yang, JH; Hahn, JY; Bin Song, Y; Choi, SH; Choi, JH; Lee, SH; Jeong, MH; Choi, DJ; Park, JS; Park, HS; Gwon, HC				Yang, Jeong Hoon; Hahn, Joo-Yong; Bin Song, Young; Choi, Seung-Hyuk; Choi, Jin-Ho; Lee, Sang Hoon; Jeong, Myung-Ho; Choi, Dong-Joo; Park, Jong Seon; Park, Hun Sik; Gwon, Hyeon-Cheol			Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONVERTING ENZYME-INHIBITORS; HIGH-RISK; TELMISARTAN; CAPTOPRIL; METAANALYSIS; DYSFUNCTION; MANAGEMENT; MORTALITY; TRIAL	Objective To investigate the association between treatment with an angiotensin receptor blocker and clinical outcomes in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function. Design A prospective cohort study using data from a nationwide large scale registry. Setting 53 hospitals involved in treatment of acute myocardial infarction in Korea. Participants Between November 2005 and September 2010, we studied 6698 patients with ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention and had a left ventricular ejection fraction >= 40%. Main outcome measures Cardiac death or myocardial infarction. Patients were divided into an angiotensin receptor blocker group (n=1185), an angiotensin converting enzyme (ACE) inhibitor group (n=4564), and a group who did not receive any renin angiotensin system blocker (n=949). Propensity score matching analysis was also performed. Results Cardiac death or myocardial infarction occurred in 21 patients (1.8%) in the angiotensin receptor blocker group, 77 patients (1.7%) in the ACE inhibitor group, and 33 patients (3.5%) in the no renin angiotensin system blocker group. After propensity score matching (1175 pairs), there was no significant difference in the rate of cardiac death or myocardial infarction between the angiotensin receptor blocker group and ACE inhibitor group (21 (1.8%) v 23 (2.0%), adjusted hazard ratio 0.65, 95% confidence interval 0.30 to 1.38; P=0.65). The angiotensin receptor blocker group had a lower rate of cardiac death or myocardial infarction than the no renin angiotensin system blocker group in matched populations (803 pairs) (14 (1.7%) v 25 (3.1%), 0.35, 0.14 to 0.90; P=0.03). Conclusion Angiotensin receptor blocker showed beneficial effects comparable with ACE inhibitors in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function. Angiotensin receptor blockers could be used as an alternative to ACE inhibitors in such patients.	[Yang, Jeong Hoon; Hahn, Joo-Yong; Bin Song, Young; Choi, Seung-Hyuk; Choi, Jin-Ho; Lee, Sang Hoon; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Jeong, Myung-Ho] Chonnam Natl Univ Hosp, Dept Med, Div Cardiol, Kwangju, South Korea; [Choi, Dong-Joo] Seoul Natl Univ, Bundang Hosp, Dept Med, Div Cardiol, Songnam, South Korea; [Park, Jong Seon] Yeungnam Univ Hosp, Dept Med, Taegu, South Korea; [Park, Hun Sik] Kyungpook Natl Univ Hosp, Dept Med, Taegu, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Chonnam National University; Chonnam National University Hospital; Seoul National University (SNU); Yeungnam University; Yeungnam University Hospital; Kyungpook National University; Kyungpook National University Hospital	Hahn, JY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea.	jyhahn@skku.edu	Hahn, Joo-Yong/AAU-7250-2020	Hahn, Joo-Yong/0000-0002-4412-377X	Korean Society of Cardiology	Korean Society of Cardiology	This study was supported by the Korean Society of Cardiology.	[Anonymous], 1994, LANCET, V19, P343; COLLINS R, 1995, LANCET, V345, P669; Das SR, 2011, J AM COLL CARDIOL, V58, P2642, DOI 10.1016/j.jacc.2011.09.030; Hong YJ, 2013, INT J CARDIOL, V163, P1, DOI 10.1016/j.ijcard.2012.02.003; Kang SH, 2012, AM J CARDIOL, V109, P787, DOI 10.1016/j.amjcard.2011.11.006; Kim HK, 2011, AM J CARDIOL, V107, P965, DOI 10.1016/j.amjcard.2010.11.018; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057; McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Rubin DB, 2000, J AM STAT ASSOC, V95, P573, DOI 10.2307/2669400; Savarese G, 2013, J AM COLL CARDIOL, V61, P131, DOI 10.1016/j.jacc.2012.10.011; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	18	23	23	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 14	2014	349								g6650	10.1136/bmj.g6650	http://dx.doi.org/10.1136/bmj.g6650			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JU	25398372	Green Published, hybrid			2022-12-28	WOS:000345445300003
J	Odame, I				Odame, Isaac			We need a global solution	NATURE			English	Editorial Material							SICKLE-CELL-DISEASE		[Odame, Isaac] Hosp Sick Children, Global Sickle Cell Dis Network, Toronto, ON M5G 1X8, Canada; [Odame, Isaac] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Odame, Isaac] Univ Toronto, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Odame, I (corresponding author), Hosp Sick Children, Global Sickle Cell Dis Network, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	isaac.odame@sickkids.ca						Aygun B, 2012, PEDIATR BLOOD CANCER, V59, P386, DOI 10.1002/pbc.24175; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Weatherall D, 2005, BLOOD, V105, P921, DOI 10.1182/blood-2004-06-2404	3	19	19	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S10	S10		10.1038/515S10a	http://dx.doi.org/10.1038/515S10a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390135	Bronze			2022-12-28	WOS:000344631400007
J	Roushan, P; Neill, C; Chen, Y; Kolodrubetz, M; Quintana, C; Leung, N; Fang, M; Barends, R; Campbell, B; Chen, Z; Chiaro, B; Dunsworth, A; Jeffrey, E; Kelly, J; Megrant, A; Mutus, J; O'Malley, PJJ; Sank, D; Vainsencher, A; Wenner, J; White, T; Polkovnikov, A; Cleland, AN; Martinis, JM				Roushan, P.; Neill, C.; Chen, Yu; Kolodrubetz, M.; Quintana, C.; Leung, N.; Fang, M.; Barends, R.; Campbell, B.; Chen, Z.; Chiaro, B.; Dunsworth, A.; Jeffrey, E.; Kelly, J.; Megrant, A.; Mutus, J.; O'Malley, P. J. J.; Sank, D.; Vainsencher, A.; Wenner, J.; White, T.; Polkovnikov, A.; Cleland, A. N.; Martinis, J. M.			Observation of topological transitions in interacting quantum circuits	NATURE			English	Article							SUPERCONDUCTING CIRCUITS; PHASE; INSULATORS; SPIN	Topology, with its abstract mathematical constructs, often manifests itself in physics and has a pivotal role in our understanding of natural phenomena. Notably, the discovery of topological phases in condensed-matter systems has changed the modern conception of phases of matter(1-5). The global nature of topological ordering, however, makes direct experimental probing an outstanding challenge. Present experimental tools are mainly indirect and, as a result, are inadequate for studying the topology of physical systems at a fundamental level. Here we employ the exquisite control afforded by state-of-the-art superconducting quantum circuits to investigate topological properties of various quantum systems. The essence of our approach is to infer geometric curvature by measuring the deflection of quantum trajectories in the curved space of the Hamiltonian(6). Topological properties are then revealed by integrating the curvature over closed surfaces, a quantum analogue of the Gauss-Bonnet theorem. We benchmark our technique by investigating basic topological concepts of the historically important Haldane model(7) after mapping the momentum space of this condensed-matter model to the parameter space of a single-qubit Hamiltonian. In addition to constructing the topological phase diagram, we are able to visualize the microscopic spin texture of the associated states and their evolution across a topological phase transition. Going beyond non-interacting systems, we demonstrate the power of our method by studying topology in an interacting quantum system. This required anew qubit architecture(8,9) that allows for simultaneous control over every term in a two-qubit Hamiltonian. By exploring the parameter space of this Hamiltonian, we discover the emergence of an interaction-induced topological phase. Our work establishes a powerful, generalizable experimental platform to study topological phenomena in quantum systems.	[Roushan, P.; Neill, C.; Chen, Yu; Quintana, C.; Leung, N.; Fang, M.; Barends, R.; Campbell, B.; Chen, Z.; Chiaro, B.; Dunsworth, A.; Jeffrey, E.; Kelly, J.; Megrant, A.; Mutus, J.; O'Malley, P. J. J.; Sank, D.; Vainsencher, A.; Wenner, J.; White, T.; Cleland, A. N.; Martinis, J. M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Kolodrubetz, M.; Polkovnikov, A.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Martinis, J. M.] Google Inc, Santa Barbara, CA 93117 USA	University of California System; University of California Santa Barbara; Boston University; Google Incorporated	Martinis, JM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	martinis@physics.ucsb.edu	Polkovnikov, Anatoli/HDM-9329-2022; Wenner, James/G-3777-2014; Cleland, Andrew/AAG-7581-2019; Kolodrubetz, Michael/B-2438-2018	Wenner, James/0000-0001-7107-4734; Kolodrubetz, Michael/0000-0001-5628-3300	NSF [DMR-0907039, DMR-1029764]; AFOSR [FA9550-10-1-0110]; ODNI, IARPA, through ARO grant [W911NF-10-1-0334]; NSF	NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ODNI, IARPA, through ARO grant; NSF(National Science Foundation (NSF))	We acknowledge discussions with J. Moore, C. Nayak, M. Niu, A. Rahmani, T. Souza, M. Vavilov, D. Weld and A. Yazdani. This work was supported by the NSF (grants DMR-0907039 and DMR-1029764), the AFOSR (FA9550-10-1-0110), and the ODNI, IARPA, through ARO grant W911NF-10-1-0334. Devices were made at the UCSB Nanofab Facility, part of the NSF-funded NNIN, and the NanoStructures Cleanroom Facility.	Atala M, 2013, NAT PHYS, V9, P795, DOI [10.1038/nphys2790, 10.1038/NPHYS2790]; Barends R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.080502; Bernevig B.A., 2013, TOPOLOGICAL INSULATO; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Buluta I, 2009, SCIENCE, V326, P108, DOI 10.1126/science.1177838; CHEN Y., 2014, PREPRINT; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Geller M. R., 2014, PREPRINT; Gritsev V, 2012, P NATL ACAD SCI USA, V109, P6457, DOI 10.1073/pnas.1116693109; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Houck AA, 2012, NAT PHYS, V8, P292, DOI [10.1038/nphys2251, 10.1038/NPHYS2251]; Klitzing K. V., 1980, PHYS REV LETT, V45, P494, DOI [10.1103/PhysRevLett.45.494, DOI 10.1103/PHYSREVLETT.45.494]; Leek PJ, 2007, SCIENCE, V318, P1889, DOI 10.1126/science.1149858; Mariantoni M, 2011, SCIENCE, V334, P61, DOI 10.1126/science.1208517; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Neeley M, 2009, SCIENCE, V325, P722, DOI 10.1126/science.1173440; Schroer MD, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.050402; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Wen X.G., 2004, QUANTUM FIELD THEORY; Wilczek F., 1989, GEOMETRIC PHASES PHY, V5; Xu CR, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.052102	24	146	147	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					241	244		10.1038/nature13891	http://dx.doi.org/10.1038/nature13891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391961	Green Submitted			2022-12-28	WOS:000344631400044
J	Guillevin, L; Pagnoux, C; Karras, A; Khouatra, C; Aumaitre, O; Cohen, P; Maurier, F; Decaux, O; Ninet, J; Gobert, P; Quemeneur, T; Blanchard-Delaunay, C; Godmer, P; Puechal, X; Carron, PL; Hatron, PY; Limal, N; Hamidou, M; Ducret, M; Daugas, E; Papo, T; Bonnotte, B; Mahr, A; Ravaud, P; Mouthon, L				Guillevin, L.; Pagnoux, C.; Karras, A.; Khouatra, C.; Aumaitre, O.; Cohen, P.; Maurier, F.; Decaux, O.; Ninet, J.; Gobert, P.; Quemeneur, T.; Blanchard-Delaunay, C.; Godmer, P.; Puechal, X.; Carron, P. -L.; Hatron, P. -Y.; Limal, N.; Hamidou, M.; Ducret, M.; Daugas, E.; Papo, T.; Bonnotte, B.; Mahr, A.; Ravaud, P.; Mouthon, L.		French Vasculitis Study Grp	Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; LOW-DOSE RITUXIMAB; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; RANDOMIZED-TRIAL; WEGENERS-GRANULOMATOSIS; ORAL CYCLOPHOSPHAMIDE; REMISSION-INDUCTION; THERAPY; POLYANGIITIS; METHOTREXATE	BACKGROUND The combination of cyclophosphamide and glucocorticoids leads to remission in most patients with antineutrophil cytoplasm antibody (ANCA)-associated vasculitides. However, even when patients receive maintenance treatment with azathioprine or methotrexate, the relapse rate remains high. Rituximab may help to maintain remission. METHODS Patients with newly diagnosed or relapsing granulomatosis with polyangiitis, microscopic polyangiitis, or renal-limited ANCA-associated vasculitis in complete remission after a cyclophosphamide-glucocorticoid regimen were randomly assigned to receive either 500 mg of rituximab on days 0 and 14 and at months 6, 12, and 18 after study entry or daily azathioprine until month 22. The primary end point at month 28 was the rate of major relapse (the reappearance of disease activity or worsening, with a Birmingham Vasculitis Activity Score >0, and involvement of one or more major organs, disease-related life-threatening events, or both). RESULTS The 115 enrolled patients (87 with granulomatosis with polyangiitis, 23 with microscopic polyangiitis, and 5 with renal-limited ANCA-associated vasculitis) received azathioprine (58 patients) or rituximab (57 patients). At month 28, major relapse had occurred in 17 patients in the azathioprine group (29%) and in 3 patients in the rituximab group (5%) (hazard ratio for relapse, 6.61; 95% confidence interval, 1.56 to 27.96; P = 0.002). The frequencies of severe adverse events were similar in the two groups. Twenty-five patients in each group (P = 0.92) had severe adverse events; there were 44 events in the azathioprine group and 45 in the rituximab group. Eight patients in the azathioprine group and 11 in the rituximab group had severe infections, and cancer developed in 2 patients in the azathioprine group and 1 in the rituximab group. Two patients in the azathioprine group died (1 from sepsis and 1 from pancreatic cancer). CONCLUSIONS More patients with ANCA-associated vasculitides had sustained remission at month 28 with rituximab than with azathioprine.	[Guillevin, L.; Pagnoux, C.; Cohen, P.; Puechal, X.; Mahr, A.; Mouthon, L.] Univ Paris 05, Hop Cochin, Sorbonne Paris Cite,Dept Med Interne, Ctr Reference Malad Autoimmunes Rares,INSERM,U101, Paris, France; [Karras, A.] Univ Paris 05, Hop Europeen Georges Pompidou, Nephrol Unit, Paris, France; [Daugas, E.] Univ Paris 05, Hop Bichat, Serv Nephrol, Dept Hospitalo Univ FIRE,INSERM,U699, Paris, France; [Papo, T.] Hop Cochin, Dept Med Interne, F-75674 Paris, France; [Ravaud, P.] Univ Paris 05, Hop Hotel Dieu, Ctr Epidemiol Clin, INSERM,U738, Paris, France; [Khouatra, C.] Hop Univ Louis Pradel, Ctr Reference Malad Pulm Rares, Serv Pneumol, Lyon, France; [Ninet, J.] Hop Edouard Herriot, Serv Med Interne, Lyon, France; [Aumaitre, O.] Hop Gabriel Montpied, Ctr Hosp Univ, Clermont Ferrand, France; [Maurier, F.] Hop Prives Metz, Serv Med Interne, Metz, France; [Decaux, O.] Univ Rennes 1, Hop Sud, Hop Univ Rennes, Dept Med Interne,IGDR UMR 6290, Rennes, France; [Gobert, P.] Hop Gen Henri Duffaut, Serv Med Interne & Nephrol, Avignon, France; [Quemeneur, T.] Ctr Hosp Valenciennes, Dept Nephrol, Valenciennes, France; [Quemeneur, T.] Ctr Hosp Valenciennes, Dept Med Interne, Valenciennes, France; [Blanchard-Delaunay, C.] Ctr Hosp Gen Niort, Serv Med Interne, Niort, France; [Godmer, P.] Ctr Hosp Bretagne Atlantique Vannes, Dept Med Interne, Vannes, France; [Carron, P. -L.] CHU Grenoble, Serv Nephrol Dialyse & Transplantat, F-38043 Grenoble, France; [Hatron, P. -Y.] Univ Lille Nord France, CHU Lille, Ctr Natl Reference Sclerodermie Syst, Hop Claude Huriez,Serv Med Interne, Lille, France; [Limal, N.] Hop Henri Mondor, AP HP, Ctr Reference Labellise Prise Charge Cytopenies A, Serv Med Interne, F-94010 Creteil, France; [Hamidou, M.] Hop Hotel Dieu, Ctr Hosp Univ, Dept Med Interne, Nantes, France; [Ducret, M.] Hop Annecy, Dept Nephrol, Annecy, France; [Bonnotte, B.] Univ Bourgogne, Ctr Hosp Univ Dijon, Serv Med Interne & Immunol Clin, IFR100, Dijon, France; [Bonnotte, B.] INSERM, UMR 1098, Besancon, France; [Pagnoux, C.] Mt Sinai Hosp, Dept Rheumatol, Toronto, ON M5G 1X5, Canada; [Khouatra, C.] AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; CHU Lyon; CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Rennes; Universite de Rennes; CH de Valenciennes; CH de Valenciennes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Nantes Universite; CHU de Nantes; Centre Hospitalier Annecy Genevois; CHU Dijon Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Assistance Publique Hopitaux Paris (APHP)	Guillevin, L (corresponding author), Hop Cochin, Dept Med Interne, 27 Rue Faubourg St Jacques, F-75679 Paris 14, France.	loic.guillevin@cch.aphp.fr	Launay, David/A-5270-2018; Launay, David/H-1674-2016; Puéchal, Xavier/P-1555-2017; Bonnotte, Bernard/ABA-2525-2021; ravaud, philippe/C-1694-2009; SEROR, Raphaele/E-2283-2017; Pagnoux, Christian/C-4612-2015; Lambert, Blandine S/O-6002-2016	Launay, David/0000-0003-1840-1817; Launay, David/0000-0003-1840-1817; Puéchal, Xavier/0000-0003-3573-9203; Bonnotte, Bernard/0000-0002-1098-4598; SEROR, Raphaele/0000-0002-5523-1856; Lambert, Blandine S/0000-0002-8429-2404; Frimat, Marie/0000-0002-7461-8298; Mahr, Alfred/0000-0002-1564-9115; DAUGAS, Eric/0000-0001-7256-7979; Ravaud, Philippe/0000-0001-8264-9206	French Ministry of Health	French Ministry of Health	Funded by the French Ministry of Health; MAINRITSAN ClinicalTrials.gov number, NCT00748644; EudraCT number, 2008-002846-51.	Barcellini W, 2013, EUR J HAEMATOL, V91, P546, DOI 10.1111/ejh.12199; Besada E, 2014, RHEUMATOLOGY, V53, P1818, DOI 10.1093/rheumatology/keu194; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Cartin-Ceba R, 2012, ARTHRITIS RHEUM-US, V64, P3770, DOI 10.1002/art.34584; Clain JM, 2013, PRESSE MED, V42, P530, DOI 10.1016/j.lpm.2013.01.048; Common Terminology Criteria for Adverse Events v3.0 (CTCAE), 2006, COMMON TERMINOLOGY C; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; FAUCI AS, 1979, NEW ENGL J MED, V301, P235, DOI 10.1056/NEJM197908023010503; Flossmann O, 2008, POSTGRAD MED J, V84, P143, DOI 10.1136/ard.2005.051078; Guillevin L, 1997, ARTHRITIS RHEUM, V40, P2187, DOI 10.1002/art.1780401213; Hoffman GS, 2013, PRESSE MED, V42, P643, DOI 10.1016/j.lpm.2013.01.047; Hogan J, 2014, CLIN J AM SOC NEPHRO, V9, P1657, DOI 10.2215/CJN.01600214; Holle JU, 2011, ARTHRITIS RHEUM-US, V63, P257, DOI 10.1002/art.27763; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; Jones RB, 2009, ARTHRITIS RHEUM, V60, P2156, DOI 10.1002/art.24637; Mariette X, 2014, ANN RHEUM DIS, V73, P1508, DOI 10.1136/annrheumdis-2013-203480; McGregor JG, 2012, CLIN J AM SOC NEPHRO, V7, P240, DOI 10.2215/CJN.05610611; Pagnoux C, 2008, NEW ENGL J MED, V359, P2790, DOI 10.1056/NEJMoa0802311; Pequeno-Luevano M, 2013, HEMATOLOGY, V18, P233, DOI 10.1179/1607845412Y.0000000073; Ringelstein M, 2013, MULT SCLER J, V19, P1544, DOI 10.1177/1352458513498125; Roubaud-Baudron C, 2012, J RHEUMATOL, V39, P125, DOI 10.3899/jrheum.110143; Sanders JF, 2003, NEW ENGL J MED, V349, P2072; Specks U, 2013, NEW ENGL J MED, V369, P417, DOI 10.1056/NEJMoa1213277; Springer J, 2014, MEDICINE, V93, P82, DOI 10.1097/MD.0000000000000020; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; van Vollenhoven RF, 2013, ANN RHEUM DIS, V72, P1496, DOI 10.1136/annrheumdis-2012-201956; Walsh M, 2010, ARTHRIT CARE RES, V62, P1166, DOI 10.1002/acr.20176	30	598	638	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1771	1780		10.1056/NEJMoa1404231	http://dx.doi.org/10.1056/NEJMoa1404231			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372085				2022-12-28	WOS:000344170300006
J	Carlat, D				Carlat, Danny			DOCTORS AND INDUSTRY Exploring the link between industry payments to doctors and prescribing habits	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Tufts Univ, Boston, MA 02111 USA	Tufts University	Carlat, D (corresponding author), Tufts Univ, Boston, MA 02111 USA.	Daniel.carlat@gmail.com						Jarvies D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6003	1	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2014	349								g6651	10.1136/bmj.g6651	http://dx.doi.org/10.1136/bmj.g6651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CD	25378357				2022-12-28	WOS:000344603700011
J	Corbett, A; Burns, A; Ballard, C				Corbett, Anne; Burns, Alistair; Ballard, Clive			Don't use antipsychotics routinely to treat agitation and aggression in people with dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO; RISPERIDONE; METAANALYSIS; PSYCHOSIS; SYMPTOMS; DISEASE; TRIAL; DRUGS		[Corbett, Anne; Ballard, Clive] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Burns, Alistair] Univ Manchester, Manchester M13 9NT, Lancs, England	University of London; King's College London; University of Manchester	Ballard, C (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	clive.ballard@kcl.ac.uk	Corbett, Anne/B-3223-2014	Corbett, Anne/0000-0003-2015-0316; Ballard, Clive/0000-0003-0022-5632; Burns, Alistair/0000-0002-9837-0645				APA Work Group on Alzheimer's Disease and other Dementias, 2007, Am J Psychiatry, V164, P5; Ballard C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003476.pub2; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Ballard C, 2008, PLOS MED, V5, P587, DOI 10.1371/journal.pmed.0050076; Ballard C, 2006, NAT REV NEUROSCI, V7, P492, DOI 10.1038/nrn1926; Ballard C, 2013, CURR OPIN PSYCHIATR, V26, P252, DOI 10.1097/YCO.0b013e32835f414b; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Barnes TRE, 2012, BRIT J PSYCHIAT, V201, P221, DOI 10.1192/bjp.bp.111.107631; Brodaty H, 2003, J CLIN PSYCHIAT, V64, P134, DOI 10.4088/JCP.v64n0205; Corbett A, 2012, NAT REV NEUROL, V8, P264, DOI 10.1038/nrneurol.2012.53; De Deyn PP, 1999, NEUROLOGY, V53, P946, DOI 10.1212/WNL.53.5.946; Declercq T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007726.pub2; Devanand DP, 2011, INT J GERIATR PSYCH, V26, P937, DOI 10.1002/gps.2630; Katz IR, 1999, J CLIN PSYCHIAT, V60, P107, DOI 10.4088/JCP.v60n0207; Medicines and Healthcare Regulatory Agency, ANT DRUGS; National Institute for Health and Care Excellence, 2006, DEM SUPP PEOPL DEM T; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Testad I, 2014, INT PSYCHOGERIATR, V26, P1083, DOI 10.1017/S1041610214000131; US Federal Drugs Agency, 2005, PUBL HLTH ADV DEATHS	22	52	52	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2014	349								g6420	10.1136/bmj.g6420	http://dx.doi.org/10.1136/bmj.g6420			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CB	25368388				2022-12-28	WOS:000344603500003
J	Motani, R; Jiang, DY; Chen, GB; Tintori, A; Rieppel, O; Ji, C; Huang, JD				Motani, Ryosuke; Jiang, Da-Yong; Chen, Guan-Bao; Tintori, Andrea; Rieppel, Olivier; Ji, Cheng; Huang, Jian-Dong			A basal ichthyosauriform with a short snout from the Lower Triassic of China	NATURE			English	Article							LETHALLY HOT TEMPERATURES; GREENHOUSE; REPTILIA; AMNIOTES; CHAOHU	The incompleteness of the fossil record obscures the origin of many of the more derived clades of vertebrates. One such group is the Ichthyopterygia, a clade of obligatory marine reptiles that appeared in the Early Triassic epoch, without any known intermediates(1). Here we describe a basal ichthyosauriform from the upper Lower Triassic (about 248 million years ago) of China, whose primitive skeleton indicates possible amphibious habits. It is smaller than ichthyopterygians and had unusually large flippers that probably allowed limited terrestrial locomotion. It also retained characteristics of terrestrial diapsid reptiles, including a short snout and body trunk(2). Unlike more-derived ichthyosauriforms(3), it was probably a suction feeder. The new species supports the sister-group relationships between ichthyosauriforms and Hupehsuchia(4), the two forming the Ichthyosauromorpha. Basal ichthyosauromorphs are known exclusively from south China, suggesting that the clade originated in the region, which formed a warm(5,6) and humid(7) tropical archipelago(8) in the Early Triassic. The oldest unequivocal record of a sauropterygian is also from the same stratigraphic unit of the region(9).	[Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-Yong] Peking Univ, Minist Educ, Lab Orogen Belt & Crustal Evolut, Beijing 100871, Peoples R China; [Jiang, Da-Yong] Peking Univ, Dept Geol, Beijing 100871, Peoples R China; [Jiang, Da-Yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Jiang, Da-Yong] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Guan-Bao; Huang, Jian-Dong] Anhui Geol Museum, Dept Res, Hefei 230031, Anhui, Peoples R China; [Tintori, Andrea] Univ Milan, Dipartimento Sci Terra, I-20133 Milan, Italy; [Rieppel, Olivier] Field Museum, Ctr Integrat Res, Chicago, IL 60605 USA; [Ji, Cheng] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Key Lab Econ Stratig & Palaeogeog, Nanjing 210008, Jiangsu, Peoples R China	University of California System; University of California Davis; Peking University; Peking University; Peking University; Chinese Academy of Sciences; University of Milan; Field Museum of Natural History (Chicago); Chinese Academy of Sciences	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, One Shields Ave, Davis, CA 95616 USA.	rmotani@ucdavis.edu; djiang@pku.edu.cn	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	National Geographic Society Committee for Research and Exploration [8669-09]; National Natural Science Foundation of China [40920124002, 41372016]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [123102]; Research Fund for the Doctoral Program of Higher Education [20120001110072]; Project of Protection for Geological Heritage from Department of Land and Resource of Anhui Province	National Geographic Society Committee for Research and Exploration(National Geographic Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Project of Protection for Geological Heritage from Department of Land and Resource of Anhui Province	We thank T. Sato for the excellent preparation of the holotype. The study was enabled by grants from the National Geographic Society Committee for Research and Exploration (8669-09) to R.M., Project 40920124002 and 41372016 from the National Natural Science Foundation of China to D.-Y.J., Project 123102 from State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) to D.-Y.J., Project 20120001110072 from the Research Fund for the Doctoral Program of Higher Education to D.-Y.J., and a Project of Protection for Geological Heritage from Department of Land and Resource of Anhui Province to G.-B.C.	Boettcher, 1990, STUTTGARTER BEITRA B, V164, P1; Caldwell Michael W., 1994, Journal of Vertebrate Paleontology, V14, p19A; CALLAWAY JM, 1989, CAN J EARTH SCI, V26, P1491, DOI 10.1139/e89-126; CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; CARROLL RL, 1985, SPEC PAP PALAEONTOL, P145; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; COX CB, 1973, GEOL MAG, V110, P405, DOI 10.1017/S0016756800036190; Goudemand N, 2013, SCIENCE, V339, DOI 10.1126/science.1232924; Harland W.B., 1997, GEOLOGICAL SOC MEMOI, V17, P1, DOI [DOI 10.1144/gsl.mem.1997.017.01.16, 10.1144/GSL.MEM.1997.017.01.26, DOI 10.1144/GSL.MEM.1997.017.01.26]; Hoffstetter R., 1969, P201; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Jiang DY, 2014, J VERTEBR PALEONTOL, V34, P1044, DOI 10.1080/02724634.2014.846264; MARSH H, 1984, AUST J ZOOL, V32, P767, DOI 10.1071/ZO9840767; Mazouchova N, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026007; McGOWAN C., 2003, ICHTHYOPTERYGIA, V8; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; Motani R., J VERTEBR P IN PRESS; Motani R., 2014, PLOS ONE, V9; Motani R., 1972, J VERTEBR P IN PRESS; Motani R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066075; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Nicholls Elizabeth L., 1995, P521; Peron S, 2005, GEODIN ACTA, V18, P431, DOI 10.3166/ga.18.431-446; RIEPPEL O, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V208, P123; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Sun ZM, 2009, EARTH PLANET SC LETT, V279, P350, DOI 10.1016/j.epsl.2009.01.009; Talevi M, 2012, NATURWISSENSCHAFTEN, V99, P241, DOI 10.1007/s00114-012-0886-4; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Xiao WJ, 2005, GEOL SOC AM BULL, V117, P945, DOI 10.1130/B25417.1	29	77	85	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					485	+		10.1038/nature13866	http://dx.doi.org/10.1038/nature13866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25383536				2022-12-28	WOS:000348196500034
J	Seok, S; Fu, T; Choi, SE; Li, Y; Zhu, R; Kumar, S; Sun, XX; Yoon, G; Kang, Y; Zhong, WX; Ma, J; Kemper, B; Kemper, JK				Seok, Sunmi; Fu, Ting; Choi, Sung-E; Li, Yang; Zhu, Rong; Kumar, Subodh; Sun, Xiaoxiao; Yoon, Gyesoon; Kang, Yup; Zhong, Wenxuan; Ma, Jian; Kemper, Byron; Kemper, Jongsook Kim			Transcriptional regulation of autophagy by an FXR-CREB axis	NATURE			English	Article							FARNESOID X RECEPTOR; COACTIVATOR CRTC2; LIPID-METABOLISM; GENOMIC ANALYSIS; ER STRESS; PHOSPHORYLATION; DISEASE; BINDING; OBESITY; LIVER	Lysosomal degradation of cytoplasmic components by autophagy is essential for cellular survival and homeostasis under nutrient-deprived conditions(1-4). Acute regulation of autophagy by nutrient-sensing kinases is well defined(3,5-7), but longer-term transcriptional regulation is relatively unknown. Here we show that the fed-state sensing nuclear receptor farnesoid X receptor (FXR)(8,9) and the fasting transcriptional activator cAMP response element-binding protein (CREB)(10,11) coordinately regulate the hepatic autophagy gene network. Pharmacological activation of FXR repressed many autophagy genes and inhibited autophagy even in fasted mice, and feeding-mediated inhibition of macroautophagy was attenuated in FXR-knockout mice. From mouse liver chromatin immunoprecipitation and high-throughput sequencing data(12,15), FXR and CREB binding peaks were detected at 178 and 112 genes, respectively, out of 230 autophagy-related genes, and 78 genes showed shared binding, mostly in their promoter regions. CREB promoted autophagic degradation of lipids, or lipophagy(16), under nutrient-deprived conditions, and FXR inhibited this response. Mechanistically, CREB upregulated autophagy genes, including A tg7, Ulkl and Tfeb, by recruiting the coactivator CRTC2. After feeding or pharmacological activation, FXR trans-repressed these genes by disrupting the functional CREB-CRTC2 complex. This study identifies the new FXR-CREB axis as a key physiological switch regulating autophagy, resulting in sustained nutrient regulation of autophagy during feeding/fasting cycles.	[Seok, Sunmi; Fu, Ting; Choi, Sung-E; Kumar, Subodh; Kemper, Byron; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Choi, Sung-E; Yoon, Gyesoon; Kang, Yup] Ajou Univ, Sch Med, Inst Med Sci, Suwon 442749, South Korea; [Li, Yang; Ma, Jian] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Li, Yang; Ma, Jian] Univ Illinois, Inst Genome Biol, Urbana, IL 61801 USA; [Zhu, Rong; Sun, Xiaoxiao; Zhong, Wenxuan] Univ Georgia, Dept Stat, Athens, GA 30602 USA	University of Illinois System; University of Illinois Urbana-Champaign; Ajou University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; University of Georgia	Kemper, JK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	jongsook@illinois.edu	Fu, Shirley Ting/B-7632-2018; Li, Yang/F-4020-2012; Ma, Jian/A-9838-2008	Li, Yang/0000-0001-5464-4328; Ma, Jian/0000-0002-4202-5834	National Institutes of Health [DK62777, DK95842]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062777, R01DK095842, R01DK062777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Ryerson and D. Tkac for constructing the pGEX4T-FXR clones. We thank M. Montminy for providing Ad-CRTC2 and Ad-CRTC2(S171A), S.-H. Koo for the CREB and CRTC2 plasmids, G. Hotamisligil for Ad-GFP-LC3, and R. Puertollano for the Flag-TFEB plasmid. This study was supported by grants from the National Institutes of Health (DK62777 and DK95842) to J.K.K.	Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Everett LJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-337; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee J, 2012, HEPATOLOGY, V56, P108, DOI 10.1002/hep.25609; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Luo Q, 2012, P NATL ACAD SCI USA, V109, P20865, DOI 10.1073/pnas.1219028109; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sachdeva UM, 2008, AUTOPHAGY, V4, P581, DOI 10.4161/auto.6141; Seok S, 2013, J BIOL CHEM, V288, P23252, DOI 10.1074/jbc.M113.452037; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	26	280	291	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					108	U274		10.1038/nature13949	http://dx.doi.org/10.1038/nature13949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25383523	Green Published, Green Accepted			2022-12-28	WOS:000346310800049
J	Pare, AC; Vichas, A; Fincher, CT; Mirman, Z; Farrell, DL; Mainieri, A; Zallen, JA				Pare, Adam C.; Vichas, Athea; Fincher, Christopher T.; Mirman, Zachary; Farrell, Dene L.; Mainieri, Avantika; Zallen, Jennifer A.			A positional Toll receptor code directs convergent extension in Drosophila	NATURE			English	Article							PLANAR CELL POLARITY; INNATE IMMUNE RECOGNITION; DORSAL-VENTRAL PATTERN; TISSUE MORPHOGENESIS; NEGATIVE REGULATOR; AXIS ELONGATION; EXPRESSION; FORCES; GENE; INTERCALATION	Elongation of the head-to-tail body axis by convergent extension is a conserved developmental process throughout metazoans. In Drosophila, patterns of transcription factor expression provide spatial cues that induce systematically oriented cell movements and promote tissue elongation. However, the mechanisms by which patterned transcriptional inputs control cell polarity and behaviour have long been elusive. We demonstrate that three Toll family receptors, Toll-2, Toll-6 and Toll-8, are expressed in overlapping transverse stripes along the anterior-posterior axis and act in combination to direct planar polarity and polarized cell rearrangements during convergent extension. Simultaneous disruption of all three receptors strongly reduces actomyosin -driven junctional remodelling and axis elongation, and an ectopic stripe of Toll receptor expression is sufficient to induce planar polarized actomyosin contractility. These results demonstrate that tissue-level patterns of Toll receptor expression provide spatial signals that link positional information from the anterior-posterior patterning system to the essential cell behaviours that drive convergent extension.	[Pare, Adam C.; Vichas, Athea; Fincher, Christopher T.; Mirman, Zachary; Farrell, Dene L.; Mainieri, Avantika; Zallen, Jennifer A.] Howard Hughes Med Inst, New York, NY 10065 USA; [Pare, Adam C.; Vichas, Athea; Fincher, Christopher T.; Mirman, Zachary; Farrell, Dene L.; Mainieri, Avantika; Zallen, Jennifer A.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Zallen, JA (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	zallenj@mskcc.org		Vichas, Athea/0000-0001-6328-6200	NIH/NIGMS [GM079340, GM102803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079340, R01GM102803] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Anderson, K. Kasza, W. Razzell, G. Sabio, M. Shirasu-Hiza, A. Spencer, M. Tamada and R. Zallen for comments on the manuscript, B. Glick for the fast-folding YFP, M. Buszczak for pUASp-w-attB, and the BAC-Recombineering Core Facility at the University of Chicago for Toll-8-YFP. This work was funded by NIH/NIGMS grants GM079340 and GM102803 to JA.Z. J.A.Z. is an Early Career Scientist of the Howard Hughes Medical Institute.	Ballard SL, 2014, J CELL BIOL, V204, P1157, DOI 10.1083/jcb.201308115; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; CHIANG C, 1994, MECH DEVELOP, V47, P225; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; DUFFY JB, 1991, GENE DEV, V5, P2176, DOI 10.1101/gad.5.12a.2176; ELDON E, 1994, DEVELOPMENT, V120, P885; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; GERTTULA S, 1988, GENETICS, V119, P123; Grote K, 2011, THESCIENTIFICWORLDJO, V11, P981, DOI 10.1100/tsw.2011.92; Huebener P, 2013, BBA-MOL BASIS DIS, V1832, P1005, DOI 10.1016/j.bbadis.2012.11.017; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Kasza KE, 2014, P NATL ACAD SCI USA, V111, P11732, DOI 10.1073/pnas.1400520111; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KEITH FJ, 1990, EMBO J, V9, P4299, DOI 10.1002/j.1460-2075.1990.tb07878.x; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kim S, 2006, GENESIS, V44, P541, DOI 10.1002/dvg.20245; Kleve CD, 2006, DEV DYNAM, V235, P1953, DOI 10.1002/dvdy.20820; Kolesnikov T, 2007, DEV BIOL, V307, P53, DOI 10.1016/j.ydbio.2007.04.014; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Ludwig MZ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002364; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Mahaffey JP, 2013, DEVELOPMENT, V140, P1262, DOI 10.1242/dev.085316; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; McIlroy G, 2013, NAT NEUROSCI, V16, P1248, DOI 10.1038/nn.3474; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Rose D, 1997, DEVELOPMENT, V124, P1561; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shindo A, 2014, SCIENCE, V343, P649, DOI 10.1126/science.1243126; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; STJOHNSTON D, 1992, CELL, V68, P201; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Walck-Shannon E, 2014, NAT REV MOL CELL BIO, V15, P34, DOI 10.1038/nrm3723; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wieschaus E., 1992, GASTRULATION, P213; Williams M, 2014, DEV CELL, V29, P34, DOI 10.1016/j.devcel.2014.02.007; Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	62	148	150	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					523	+		10.1038/nature13953	http://dx.doi.org/10.1038/nature13953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25363762	Green Accepted			2022-12-28	WOS:000346247600046
J	Hoag, H				Hoag, Hannah			A chance of survival	NATURE			English	Editorial Material							METASTATIC MELANOMA; CANCER; BRAF; VEMURAFENIB; RESISTANCE; IPILIMUMAB; ANTIBODY; SAFETY											Boussemart L, 2014, NATURE, V513, P105, DOI 10.1038/nature13572; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lipson EJ, 2011, CLIN CANCER RES, V17, P6958, DOI 10.1158/1078-0432.CCR-11-1595; Ribas A, 2014, LANCET ONCOL, V15, P954, DOI 10.1016/S1470-2045(14)70301-8; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Trunzer K, 2013, J CLIN ONCOL, V31, P1767, DOI 10.1200/JCO.2012.44.7888	14	5	5	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S118	S120		10.1038/515S118a	http://dx.doi.org/10.1038/515S118a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407709	Bronze			2022-12-28	WOS:000345770600005
J	Insel, TR; Landis, S				Insel, Thomas R.; Landis, Story			Allison Doupe (1954-2014) OBITUARY	NATURE			English	Biographical-Item									[Insel, Thomas R.] NIMH, Bethesda, MD 20892 USA; [Landis, Story] US Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Insel, TR (corresponding author), NIMH, Bethesda, MD 20892 USA.	tinsel@mail.nih.gov; landiss@ninds.nih.gov							0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					344	344		10.1038/515344a	http://dx.doi.org/10.1038/515344a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409820	Bronze			2022-12-28	WOS:000345770600027
J	Venkateshvaran, D; Nikolka, M; Sadhanala, A; Lemaur, V; Zelazny, M; Kepa, M; Hurhangee, M; Kronemeijer, AJ; Pecunia, V; Nasrallah, I; Romanov, I; Broch, K; McCulloch, I; Emin, D; Olivier, Y; Cornil, J; Beljonne, D; Sirringhaus, H				Venkateshvaran, Deepak; Nikolka, Mark; Sadhanala, Aditya; Lemaur, Vincent; Zelazny, Mateusz; Kepa, Michal; Hurhangee, Michael; Kronemeijer, Auke Jisk; Pecunia, Vincenzo; Nasrallah, Iyad; Romanov, Igor; Broch, Katharina; McCulloch, Iain; Emin, David; Olivier, Yoann; Cornil, Jerome; Beljonne, David; Sirringhaus, Henning			Approaching disorder-free transport in high-mobility conjugated polymers	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; HIGH-PERFORMANCE; ELECTRONIC TRANSPORT; SEEBECK COEFFICIENT; LOCALIZED STATES; AMBIPOLAR; HOLE	Conjugated polymers enable the production of flexible semiconductor devices that can be processed from solution at low temperatures. Over the past 25 years, device performance has improved greatly as a wide variety of molecular structures have been studied(1). However, one major limitation has not been overcome; transport properties in polymer films are still limited by pervasive conformational and energetic disorder(2-5). This not only limits the rational design of materials with higher performance, but also prevents the study of physical phenomena associated with an extended pi-electron delocalization along the polymer backbone. Here we report a comparative transport study of several high-mobility conjugated polymers by field-effect-modulated Seebeck, transistor and sub-bandgap optical absorption measurements. We show that in several of these polymers, most notably in a recently reported, indacenodithiophene-based donor-acceptor copolymer with a near-amorphous microstructure(6), the charge transport properties approach intrinsic disorder-free limits at which all molecular sites are thermally accessible. Molecular dynamics simulations identify the origin of this long sought-after regime as a planar, torsion-free backbone conformation that is surprisingly resilient to side-chain disorder. Our results provide molecular-design guidelines for 'disorder-free' conjugated polymers.	[Venkateshvaran, Deepak; Nikolka, Mark; Sadhanala, Aditya; Zelazny, Mateusz; Kronemeijer, Auke Jisk; Pecunia, Vincenzo; Nasrallah, Iyad; Romanov, Igor; Broch, Katharina; Sirringhaus, Henning] Univ Cambridge, Cavendish Lab, Optoelect Grp, JJ Thomson Ave, Cambridge CB3 0HE, England; [Lemaur, Vincent; Olivier, Yoann; Cornil, Jerome; Beljonne, David] Univ Mons, Lab Chem Novel Mat, B-7000 Mons, Belgium; [Kepa, Michal] Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland; [Hurhangee, Michael; McCulloch, Iain] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; [Hurhangee, Michael; McCulloch, Iain] Univ London Imperial Coll Sci Technol & Med, Ctr Plast Elect, London SW7 2AZ, England; [Emin, David] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA	University of Cambridge; University of Mons; University of Edinburgh; Imperial College London; Imperial College London; University of New Mexico	Sirringhaus, H (corresponding author), Univ Cambridge, Cavendish Lab, Optoelect Grp, JJ Thomson Ave, Cambridge CB3 0HE, England.	hs220@cam.ac.uk	Pecunia, Vincenzo/D-2588-2016; Pecunia, Vincenzo/GVU-3822-2022; Sirringhaus, Henning/ABD-1555-2021; McCulloch, Iain/G-1486-2015; Sadhanala, Aditya/J-1212-2017; Pecunia, Vincenzo/W-1390-2019; Olivier, Yoann/P-9176-2017	Pecunia, Vincenzo/0000-0003-3244-1620; Sirringhaus, Henning/0000-0001-9827-6061; McCulloch, Iain/0000-0002-6340-7217; Sadhanala, Aditya/0000-0003-2832-4894; Pecunia, Vincenzo/0000-0003-3244-1620; Olivier, Yoann/0000-0003-2193-1536; /0000-0002-7099-7323; Broch, Katharina/0000-0002-9354-292X; Lemaur, Vincent/0000-0001-8601-286X	Engineering and Physical Sciences Research Council [EP/G060738/1]; Technology Strategy Board (PORSCHED project); Cambridge Commonwealth Trust through Cambridge International Scholarship; German Research Foundation; NanoDTC in Cambridge; European Commission/Region Wallonne (FEDER - Smartfilm RF project); Interuniversity Attraction Pole programme of the Belgian Federal Science Policy Office [PAI 7/05]; Programme d'Excellence de la Region Wallonne (OPTI2MAT project); FNRS-FRFC; EPSRC [EP/G060738/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1108202] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Technology Strategy Board (PORSCHED project); Cambridge Commonwealth Trust through Cambridge International Scholarship; German Research Foundation(German Research Foundation (DFG)); NanoDTC in Cambridge; European Commission/Region Wallonne (FEDER - Smartfilm RF project); Interuniversity Attraction Pole programme of the Belgian Federal Science Policy Office; Programme d'Excellence de la Region Wallonne (OPTI2MAT project)(French National Research Agency (ANR)); FNRS-FRFC(Fonds de la Recherche Scientifique - FNRS); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We gratefully acknowledge financial support from the Engineering and Physical Sciences Research Council through a programme grant (EP/G060738/1) and the Technology Strategy Board (PORSCHED project). D.V. acknowledges financial support from the Cambridge Commonwealth Trust through a Cambridge International Scholarship. K.B. acknowledges post-doctoral fellowship support from the German Research Foundation. M.Z. acknowledges funding from NanoDTC in Cambridge. The work in Mons was supported by the European Commission/Region Wallonne (FEDER - Smartfilm RF project), the Interuniversity Attraction Pole programme of the Belgian Federal Science Policy Office (PAI 7/05), Programme d'Excellence de la Region Wallonne (OPTI2MAT project) and FNRS-FRFC. D.B. and J.C. are FNRS Research Fellows.	Aselage TL, 1998, PHYS REV LETT, V81, P2316, DOI 10.1103/PhysRevLett.81.2316; BASSLER H, 1981, PHYS STATUS SOLIDI B, V107, P9, DOI 10.1002/pssb.2221070102; Brondijk JJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.056601; Bruetting W., 2005, PHYS ORGANIC SEMICON; Callen H. B., 1960, THERMODYNAMICS, V17; Chen ZY, 2012, ADV MATER, V24, P647, DOI 10.1002/adma.201102786; Cho E, 2012, J AM CHEM SOC, V134, P6177, DOI 10.1021/ja210272z; DeLongchamp DM, 2007, ADV MATER, V19, P833, DOI 10.1002/adma.200602651; Emin D, 1999, PHYS REV B, V59, P6205, DOI 10.1103/PhysRevB.59.6205; Emin D, 2013, POLARONS, P1; Emin D., 2013, WILEY ENCYCLOPEDIA O; Germs WC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.016601; Jacobson MA, 2001, J CRYST GROWTH, V230, P459, DOI 10.1016/S0022-0248(01)01246-5; Kim G, 2014, J AM CHEM SOC, V136, P9477, DOI 10.1021/ja504537v; Kim NK, 2014, ACS APPL MATER INTER, V6, P9614, DOI 10.1021/am502007j; Kronemeijer AJ, 2014, ADV MATER, V26, P728, DOI 10.1002/adma.201303060; Kronemeijer AJ, 2012, ADV MATER, V24, P1558, DOI 10.1002/adma.201104522; Li J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00754; Nielsen CB, 2013, ADV MATER, V25, P1859, DOI 10.1002/adma.201201795; Noriega R, 2013, NAT MATER, V12, P1038, DOI [10.1038/nmat3722, 10.1038/NMAT3722]; Olivier Y, 2014, ADV MATER, V26, P2119, DOI 10.1002/adma.201305809; OVERHOF H, 1981, PHILOS MAG B, V43, P433, DOI 10.1080/01418638108222108; Pernstich KP, 2008, NAT MATER, V7, P321, DOI 10.1038/nmat2120; Rivnay J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.121306; Schmidtke JP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.167401; Sirringhaus H, 2005, ADV MATER, V17, P2411, DOI 10.1002/adma.200501152; Sirringhaus H, 2014, ADV MATER, V26, P1319, DOI 10.1002/adma.201304346; Tseng HR, 2014, ADV MATER, V26, P2993, DOI 10.1002/adma.201305084; Venkateshvaran D, 2014, APL MATER, V2, DOI 10.1063/1.4867224; von Muhlenen A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115338; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Zhang WM, 2010, J AM CHEM SOC, V132, P11437, DOI 10.1021/ja1049324; Zhang XR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3238	33	705	710	30	779	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					384	388		10.1038/nature13854	http://dx.doi.org/10.1038/nature13854			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25383522	Green Accepted			2022-12-28	WOS:000345770600039
J	Kessler, R				Kessler, Rodger			Review: In primary care, screening with the GAD-7 detected anxiety disorder; the PHQ detected panic disorder Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Vermont, Coll Med, Burlington, VT 05405 USA	University of Vermont	Kessler, R (corresponding author), Univ Vermont, Coll Med, Burlington, VT 05405 USA.							Kessler R, 2009, J CLIN PSYCHOL, V65, P253, DOI 10.1002/jclp.20546; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041	3	0	0	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC13	10.7326/0003-4819-161-10-201411180-02013	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402534				2022-12-28	WOS:000347245600024
J	Mangione, CM; Goldman, L				Mangione, Carol M.; Goldman, Lee			40 Years of Training Physician-Scientists: A Journey From Clinical Pearls to Evidence-Based Practice and Policies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEALTH-CARE; COST		[Mangione, Carol M.] Univ Calif Los Angeles, David Geffen Sch Med, Med, Los Angeles, CA 90095 USA; [Mangione, Carol M.] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Hlth Policy & Management, Los Angeles, CA 90095 USA; [Goldman, Lee] Columbia Univ, Med Ctr, Fac Hlth Sci, New York, NY 10032 USA; [Goldman, Lee] Columbia Univ, Med Ctr, Fac Med, New York, NY 10032 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Columbia University; Columbia University	Mangione, CM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Med, 10940 Wilshire Blvd,Suite 700, Los Angeles, CA 90095 USA.				NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021684] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000124, UL1TR000124] Funding Source: Medline; NIA NIH HHS [P30 AG021684] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andersen R, 1968, DECADE HLTH SERVICES; BARRY MJ, 1988, JAMA-J AM MED ASSOC, V259, P3010, DOI 10.1001/jama.259.20.3010; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; Brook RH, 2012, J GEN INTERN MED, V27, P890, DOI 10.1007/s11606-012-2078-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung BW, 2014, ANN INTERN MED, V161, pS23, DOI 10.7326/M13-3011; Cook T.C., 1979, QUASIEXPERIMENTATION; ENTHOVEN AC, 1994, SOC SCI MED, V39, P1413, DOI 10.1016/0277-9536(94)90236-4; Feinstein AR, 1987, CLINIMETRICS; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Heisler M, 2014, ANN INTERN MED, V161, pS13, DOI 10.7326/M13-3012; Horwitz LI, 2014, ANN INTERN MED, V161, pS66, DOI 10.7326/M13-3000; Institute of Medicine, 2013, CTSA PROGR NIH OPP A; Jubelt LE, 2014, ANN INTERN MED, V161, pS59, DOI 10.7326/M13-3007; Kullgren JT, 2014, ANN INTERN MED, V161, pS35, DOI 10.7326/M13-3015; Laing BY, 2014, ANN INTERN MED, V161, pS5, DOI 10.7326/M13-3005; Lee TC, 2014, ANN INTERN MED, V161, pS53, DOI 10.7326/M13-3016; Newhouse JP, 1993, FREE ALL LESSONS RAN; 'NIH Roadmap for Medical Research' Released, 2002, NIH ROADM MED RES RE; Patel MS, 2014, ANN INTERN MED, V161, pS44, DOI 10.7326/M13-3001; Patient-Centered Outcomes Research Institute, 2013, PCORI METH REP APP A; PAUKER SG, 1975, NEW ENGL J MED, V293, P229, DOI 10.1056/NEJM197507312930505; Pauker SG, 1977, P ANN S COMP APPL ME, P53; Robert Wood Johnson Foundation, 2014, 2014 PRES MESS; Sackett DL, 1985, CLIN EPIDEMIOLOGY BA; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Venkatesh A, 2014, ANN INTERN MED, V161, pS76, DOI 10.7326/M13-3014; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805	31	0	1	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S2	S4		10.7326/M14-2387	http://dx.doi.org/10.7326/M14-2387			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402399	Green Accepted, Green Published			2022-12-28	WOS:000364909900002
J	Oda, T; Yanagisawa, H; Kamiya, R; Kikkawa, M				Oda, Toshiyuki; Yanagisawa, Haruaki; Kamiya, Ritsu; Kikkawa, Masahide			A molecular ruler determines the repeat length in eukaryotic cilia and flagella	SCIENCE			English	Article							DYNEIN REGULATORY COMPLEX; CHLAMYDOMONAS FLAGELLA; NEBULIN; MICROTUBULES; LINK	Existence of cellular structures with specific size raises a fundamental question in biology: How do cells measure length? One conceptual answer to this question is by a molecular ruler, but examples of such rulers in eukaryotes are lacking. In this work, we identified a molecular ruler in eukaryotic cilia and flagella. Using cryo-electron tomography, we found that FAP59 and FAP172 form a 96-nanometer (nm)-long complex in Chlamydomonas flagella and that the absence of the complex disrupted 96-nm repeats of axonemes. Furthermore, lengthening of the FAP59/172 complex by domain duplication resulted in extension of the repeats up to 128 nm, as well as duplication of specific axonemal components. Thus, the FAP59/172 complex is the molecular ruler that determines the 96-nm repeat length and arrangements of components in cilia and flagella.	[Oda, Toshiyuki; Yanagisawa, Haruaki; Kikkawa, Masahide] Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kamiya, Ritsu] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kamiya, Ritsu] Gakushuin Univ, Dept Life Sci, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	University of Tokyo; University of Tokyo; Gakushuin University	Kikkawa, M (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mkikkawa@m.u-tokyo.ac.jp	Oda, Toshiyuki/GLR-2321-2022; Kikkawa, Masahide/A-6692-2010	Oda, Toshiyuki/0000-0001-8090-2159; Kikkawa, Masahide/0000-0001-7656-8194; Yanagisawa, Haruaki/0000-0003-0313-2343	CREST, Japan Science and Technology Agency; Takeda Science Foundation; Kazato Research Foundation; Japan Society for the Promotion of Science KAKENHI grant [20770119]	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kazato Research Foundation(Kazato Research Foundation); Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Hirono (University of Tokyo) and T. Yagi (Prefectural University of Hiroshima) for technical assistance and valuable advice. This work was supported by CREST, Japan Science and Technology Agency (to M. K.), the Takeda Science Foundation (to M. K. and T. O.), the Kazato Research Foundation (to T. O.), and Japan Society for the Promotion of Science KAKENHI grant 20770119 (to H.Y.). We declare no competing financial interests. The electron microscopy maps of averaged DMT are available in the EM Data Bank (www.emdatabank.org) under accession numbers EMD-6108 to EMD-6117.	Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Boesger Jens, 2012, Int J Plant Genomics, V2012, P581460, DOI 10.1155/2012/581460; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; Cornelis GR, 2006, CURR OPIN MICROBIOL, V9, P201, DOI 10.1016/j.mib.2006.01.002; Fernandes I, 2014, J CELL BIOL, V206, P559, DOI 10.1083/jcb.201401094; Greaser ML, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00035; HAIMO LT, 1981, J CELL BIOL, V91, pS125, DOI 10.1083/jcb.91.3.125s; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; King SM, 2006, CELL MOTIL CYTOSKEL, V63, P245, DOI 10.1002/cm.20129; KRUGER M, 1991, J CELL BIOL, V115, P97, DOI 10.1083/jcb.115.1.97; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Merveille AC, 2014, J VET INTERN MED, V28, P771, DOI 10.1111/jvim.12336; Norrander JM, 1996, J MOL BIOL, V257, P385, DOI 10.1006/jmbi.1996.0170; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; Oda T, 2013, J STRUCT BIOL, V183, P305, DOI 10.1016/j.jsb.2013.07.003; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; TRINICK J, 1994, TRENDS BIOCHEM SCI, V19, P405, DOI 10.1016/0968-0004(94)90088-4	24	97	99	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					857	860		10.1126/science.1260214	http://dx.doi.org/10.1126/science.1260214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395538				2022-12-28	WOS:000344659900047
J	Sanchez-Bayo, F				Sanchez-Bayo, Francisco			The trouble with neonicotinoids	SCIENCE			English	Editorial Material									Univ Sydney, Fac Agr & Environm, Eveleigh, NSW 2015, Australia	University of Sydney	Sanchez-Bayo, F (corresponding author), Univ Sydney, Fac Agr & Environm, Eveleigh, NSW 2015, Australia.	sanchezbayo@mac.com	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216				Beketov MA, 2008, ENVIRON TOXICOL CHEM, V27, P461, DOI 10.1897/07-322R.1; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Decourtye A., 2009, INSECT NICOTINIC ACE, P85; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Moncharmont FXD, 2003, ENVIRON TOXICOL CHEM, V22, P3088, DOI 10.1897/02-578; Nyman AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062472; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	15	121	126	12	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					806	807		10.1126/science.1259159	http://dx.doi.org/10.1126/science.1259159			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395518				2022-12-28	WOS:000344659900017
J	Whitty, CJM; Farrar, J; Ferguson, N; Edmunds, WJ; Piot, P; Leach, M; Davies, SC				Whitty, Christopher J. M.; Farrar, Jeremy; Ferguson, Neil; Edmunds, W. John; Piot, Peter; Leach, Melissa; Davies, Sally C.			Tough choices to reduce Ebola transmission	NATURE			English	Editorial Material							VIRUS TRANSMISSION; HEMORRHAGIC-FEVER; OUTBREAK		[Whitty, Christopher J. M.] UK Dept Int Dev, London, England; [Farrar, Jeremy] Wellcome Trust Res Labs, London, England; [Ferguson, Neil] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Edmunds, W. John; Piot, Peter] London Sch Hyg & Trop Med, London, England; [Leach, Melissa] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; [Davies, Sally C.] UK Dept Hlth, London, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Sussex	Whitty, CJM (corresponding author), UK Dept Int Dev, London, England.	c-whitty@dfid.gov.uk	Ferguson, Neil/B-8578-2008; Farrar, Jeremy J./HGA-7610-2022	Ferguson, Neil/0000-0002-1154-8093; Whitty, Christopher/0000-0002-6076-5027; Farrar, Jeremy/0000-0002-2700-623X	Medical Research Council [MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080, NF-SI-0508-10252, NF-SI-0513-10125] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357; Hewlett B S, 2005, Bull Soc Pathol Exot, V98, P230; Heymann DL, 2014, NATURE, V514, P299, DOI 10.1038/514299a; Kerstiens B, 1999, J INFECT DIS, V179, pS263, DOI 10.1086/514320; World Health Organization, 2014, EB RESP ROADM SIT RE	7	43	44	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					192	194		10.1038/515192a	http://dx.doi.org/10.1038/515192a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT0MZ	25391946	Bronze			2022-12-28	WOS:000344631400024
J	Reiling, J				Reiling, Jennifer			The Etiology of Syphilis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1905, THE JOURNAL A M A, Vxxxi, P77; [Anonymous], 1905, THE JOURNAL A M A, Vxxxi, p[1790, 1870]	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1935	1935		10.1001/jama.2013.279832	http://dx.doi.org/10.1001/jama.2013.279832			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387204				2022-12-28	WOS:000344532600035
J	Zemcov, M; Smidt, J; Arai, T; Bock, J; Cooray, A; Gong, Y; Kim, MG; Korngut, P; Lam, A; Lee, DH; Matsumoto, T; Matsuura, S; Nam, UW; Roudier, G; Tsumura, K; Wada, T				Zemcov, Michael; Smidt, Joseph; Arai, Toshiaki; Bock, James; Cooray, Asantha; Gong, Yan; Kim, Min Gyu; Korngut, Phillip; Lam, Anson; Lee, Dae Hee; Matsumoto, Toshio; Matsuura, Shuji; Nam, Uk Won; Roudier, Gael; Tsumura, Kohji; Wada, Takehiko			On the origin of near-infrared extragalactic background light anisotropy	SCIENCE			English	Article							EXPERIMENT CIBER; POPULATION-III; FLUCTUATIONS; SKY; SPECTRUM	Extragalactic background light (EBL) anisotropy traces variations in the total production of photons over cosmic history and may contain faint, extended components missed in galaxy point-source surveys. Infrared EBL fluctuations have been attributed to primordial galaxies and black holes at the epoch of reionization (EOR) or, alternately, intrahalo light (IHL) from stars tidally stripped from their parent galaxies at low redshift. We report new EBL anisotropy measurements from a specialized sounding rocket experiment at 1.1 and 1.6 micrometers. The observed fluctuations exceed the amplitude from known galaxy populations, are inconsistent with EOR galaxies and black holes, and are largely explained by IHL emission. The measured fluctuations are associated with an EBL intensity that is comparable to the background from known galaxies measured through number counts and therefore a substantial contribution to the energy contained in photons in the cosmos.	[Zemcov, Michael; Bock, James; Korngut, Phillip; Lam, Anson] CALTECH, Dept Phys Math & Astron, Pasadena, CA 91125 USA; [Zemcov, Michael; Bock, James; Korngut, Phillip; Roudier, Gael] NASA, JPL, Pasadena, CA 91109 USA; [Smidt, Joseph] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Smidt, Joseph; Cooray, Asantha; Gong, Yan] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Arai, Toshiaki; Matsumoto, Toshio; Matsuura, Shuji; Wada, Takehiko] Japan Aerosp Explorat Agcy JAXA, ISAS, Dept Space Astron & Astrophys, Sagamihara, Kanagawa 2525210, Japan; [Arai, Toshiaki] Univ Tokyo, Grad Sch Sci, Dept Phys, Tokyo 1130033, Japan; [Kim, Min Gyu] Seoul Natl Univ, Dept Phys & Astron, Seoul 151742, South Korea; [Lam, Anson] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Lee, Dae Hee; Nam, Uk Won] Korea Astron & Space Sci Inst KASI, Taejon 305348, South Korea; [Matsumoto, Toshio] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Tsumura, Kohji] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Irvine; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; Seoul National University (SNU); University of California System; University of California Los Angeles; Korea Astronomy & Space Science Institute (KASI); Academia Sinica - Taiwan; Tohoku University	Bock, J (corresponding author), CALTECH, Dept Phys Math & Astron, Pasadena, CA 91125 USA.	jjb@astro.caltech.edu	Wada, Takehiko/ACR-9959-2022; Matsuura, Shuji/B-5658-2016; Tsumura, Kohji/AAK-2603-2021	Matsuura, Shuji/0000-0002-5698-9634; Tsumura, Kohji/0000-0001-7143-6520; Lam, Anson/0000-0001-8729-415X	NASA APRA [NNX07AI54G, NNG05WC18G, NNX07AG43G, NNX07AJ24G, NNX10AE12G]; Jet Propulsion Laboratory's Director's Research and Development Fund; KAKENHI from Japan Society for the Promotion of Science (JSPS) [20.34, 18204018, 19540250, 21340047, 21111004]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Pioneer Project from Korea Astronomy and Space Science Institute (KASI); NASA Postdoctoral Program; NSF CAREER [AST-0645427]; NSF [AST-1313319]; JSPS Research Fellowship for Young Scientists; National Aeronautics and Space Administration; National Science Foundation; Grants-in-Aid for Scientific Research [13J10283] Funding Source: KAKEN; Direct For Mathematical & Physical Scien [1313319] Funding Source: National Science Foundation	NASA APRA(National Aeronautics & Space Administration (NASA)); Jet Propulsion Laboratory's Director's Research and Development Fund; KAKENHI from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pioneer Project from Korea Astronomy and Space Science Institute (KASI); NASA Postdoctoral Program(National Aeronautics & Space Administration (NASA)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Our thanks to O. Dore, J. Filippini, and K. Ganga for useful conversations and comments throughout the course of this work and K. Helgason for kindly providing models of the statistics of the near-infrared CIB. The authors acknowledge the excellent support from the NASA sounding rockets program that was essential in developing, testing, qualifying, launching, and recovering our payloads. The CIBER auto-and cross-power spectra are available for public download at http://ciber.caltech.edu/zemcovetal. This work was supported by NASA APRA research grants NNX07AI54G, NNG05WC18G, NNX07AG43G, NNX07AJ24G, and NNX10AE12G. Initial support was provided by an award to J. B. from the Jet Propulsion Laboratory's Director's Research and Development Fund. Japanese participation in CIBER was supported by KAKENHI (20.34, 18204018, 19540250, 21340047, and 21111004) from Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT). Korean participation in CIBER was supported by the Pioneer Project from Korea Astronomy and Space Science Institute (KASI). M.Z. and P. K. acknowledge support from NASA Postdoctoral Program fellowships, A. C. acknowledges support from an NSF CAREER award AST-0645427 and NSF AST-1313319, and K. T. acknowledges support from the JSPS Research Fellowship for Young Scientists. This publication makes use of data products from the Two Micron All Sky Survey (2MASS), which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by the National Aeronautics and Space Administration and the National Science Foundation. This work made use of images and/or data products provided by the National Optical Astronomy Observatory (NOAO) Deep Wide-Field Survey (NDWFS), which is supported by NOAO, operated by AURA, Inc., under a cooperative agreement with the National Science Foundation.	Abramowski A, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220355; Bock J, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/32; Brandt TD, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/129; Cappelluti N, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/68; Cooray A, 2004, ASTROPHYS J, V606, P611, DOI 10.1086/383137; Cooray A, 2012, NATURE, V490, P514, DOI 10.1038/nature11474; Cooray A, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/92; Fernandez ER, 2006, ASTROPHYS J, V646, P703, DOI 10.1086/505126; Fernandez ER, 2010, ASTROPHYS J, V710, P1089, DOI 10.1088/0004-637X/710/2/1089; Franceschini A, 2008, ASTRON ASTROPHYS, V487, P837, DOI 10.1051/0004-6361:200809691; Fukugita M, 1998, ASTROPHYS J, V503, P518, DOI 10.1086/306025; Helgason K, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/113; Kashlinsky A, 2007, ASTROPHYS J, V654, pL5, DOI 10.1086/510483; Kashlinsky A, 2004, ASTROPHYS J, V608, P1, DOI 10.1086/386365; Kashlinsky A, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/63; Kashlinsky A, 2005, NATURE, V438, P45, DOI 10.1038/nature04143; Kollmeier JA, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/2/L32; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Levenson LR, 2007, ASTROPHYS J, V666, P34, DOI 10.1086/520112; Madau P, 2005, MON NOT R ASTRON SOC, V359, pL37, DOI 10.1111/j.1745-3933.2005.00031.x; Matsumoto T, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/124; Pyo J, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/102; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Thompson RI, 2007, ASTROPHYS J, V666, P658, DOI 10.1086/520634; Tsumura K., 2003, P ASTRON SOC JAPAN, V65, P120; Tsumura K, 2013, PUBL ASTRON SOC JPN, V65, DOI 10.1093/pasj/65.6.119; Yue B, 2013, MON NOT R ASTRON SOC, V433, P1556, DOI 10.1093/mnras/stt826; Zemcov M, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/31	28	80	80	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					732	735		10.1126/science.1258168	http://dx.doi.org/10.1126/science.1258168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378620	Green Accepted, Green Submitted			2022-12-28	WOS:000344690100036
J	Watts, G				Watts, Geoff			Clare Marx: new President of the Royal College of Surgeons	LANCET			English	Biographical-Item																		MARX C, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1418	1418		10.1016/S0140-6736(14)61852-3	http://dx.doi.org/10.1016/S0140-6736(14)61852-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25390314				2022-12-28	WOS:000343107000013
J	Zhou, Y; Liu, X; Engstrom, EM; Nimchuk, ZL; Pruneda-Paz, JL; Tarr, PT; Yan, A; Kay, SA; Meyerowitz, EM				Zhou, Yun; Liu, Xing; Engstrom, Eric M.; Nimchuk, Zachary L.; Pruneda-Paz, Jose L.; Tarr, Paul T.; Yan, An; Kay, Steve A.; Meyerowitz, Elliot M.			Control of plant stem cell function by conserved interacting transcriptional regulators	NATURE			English	Article							ARABIDOPSIS SHOOT MERISTEMS; GENE-EXPRESSION; PROTEIN; WUSCHEL; PATTERNS; MAINTENANCE; HOMEOSTASIS; NICHES; FATE; APEX	Plant stem cells in the shoot apical meristem (SAM) and root apical meristem are necessary for postembryonic development of above-ground tissues and roots, respectively, while secondary vascular stem cells sustain vascular development(1-4). WUSCHEL (WUS), a homeodomain transcription factor expressed in the rib meristem of the Arabidopsis SAM, is a key regulatory factor controlling SAM stem cell populations(5,6), and is thought to establish the shoot stem cell niche through a feedback circuit involving the CLAVATA3 (CLV3) peptide signalling pathway(7). WUSCHEL-RELATED HOMEOBOX 5 (WOX5), which is specifically expressed in the root quiescent centre, defines quiescent centre identity and functions interchangeably with WUS in the control of shoot and root stem cell niches(8). WOX4, expressed in Arabidopsisprocambial cells, defines the vascular stem cell niche(9-11). WUS/WOX family proteins are evolutionarily and functionally conserved throughout the plant kingdom(1,2) and emerge as key actors in the specification and maintenance of stem cells within all meristems13. However, the nature of the genetic regime in stem cell niches that centre on WOX gene function has been elusive, and molecular links underlying conserved WUS/WOX function in stem cell niches remain unknown. Here we demonstrate that the Arabidopsis HAIRY MERISTEM (HAM) family of transcription regulators act as conserved interacting cofactors with WUS/WOX proteins. HAM and WUS share common targets in vivo and their physical interaction is important in driving downstream transcriptional programs and in promoting shoot stem cell proliferation. Differences in the overlapping expression patterns of WOX and HAM family members underlie the formation of diverse stem cell niche locations, and the HAM family is essential for all of these stem cell niches. These findings establish a new framework for the control of stem cell production during plant development.	[Zhou, Yun; Liu, Xing; Nimchuk, Zachary L.; Tarr, Paul T.; Yan, An; Meyerowitz, Elliot M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Engstrom, Eric M.] Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; [Nimchuk, Zachary L.; Meyerowitz, Elliot M.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Pruneda-Paz, Jose L.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Kay, Steve A.] Univ So Calif, Dept Biol Sci, Dana & David Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA	California Institute of Technology; William & Mary; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Southern California	Meyerowitz, EM (corresponding author), CALTECH, Div Biol, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	meyerow@caltech.edu	Kay, Steve A/F-6025-2011; Zhou, Yun/B-5542-2013; Meyerowitz, Elliot M/A-7118-2009	Kay, Steve A/0000-0002-0402-2878; Zhou, Yun/0000-0003-4105-5174; Liu, Xing/0000-0001-9677-4470	National Institutes of Health (NIH) [R01 GM104244]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3406]; NIH [GM094212, GM056006, GM067837]; Jane Coffin Childs (JCC) Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104244, R01GM067837, R37GM067837, RC2GM092412, R01GM056006, R00GM094212] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs (JCC) Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to R. Deshaies for his support with the protein purification and pull-down experiments, to D. Rees for sharing the 96-well format luminometer, to T. Laux, T. Greb and X. Deng for sharing published reagents, to K. Sugimoto and A. Roeder for help with the histology experiments and critical reading of the manuscript, to A. Sampathkumar for the suggestion of confocal imaging, and to A. Garda and L. Wang for technical support. Scanning electron microscopy was performed at the Applied Research Center of the College of William and Mary with technical assistance from B. Robertson. This work was funded by National Institutes of Health (NIH) grant R01 GM104244 and by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (through grant GBMF3406) to E.M.M., by a Caltech Gosney Postdoctoral Fellowship to Y.Z., by NIH grants GM094212,GM056006 and GM067837 to S.A.K., and was aided by a grant from The Jane Coffin Childs (JCC) Memorial Fund for Medical Research to X.L., a JCC fellow.	Barrell PJ, 2006, BIOTECHNIQUES, V41, P708, DOI 10.2144/000112306; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dinneny JR, 2008, CELL, V132, P553, DOI 10.1016/j.cell.2008.02.001; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Graf P, 2010, PLANT CELL, V22, P716, DOI 10.1105/tpc.109.068296; Harper S., 2008, CURR PROTOC PROTEIN, P661; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Huang X, 2012, PLANT CELL, V24, P4590, DOI 10.1105/tpc.112.103994; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Laux T, 1996, DEVELOPMENT, V122, P87; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Miyashima S, 2013, EMBO J, V32, P178, DOI 10.1038/emboj.2012.301; Nardmann J, 2009, MOL BIOL EVOL, V26, P1745, DOI 10.1093/molbev/msp084; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Roeder AHK, 2003, CURR BIOL, V13, P1630, DOI 10.1016/j.cub.2003.08.027; Sablowski R, 2007, CURR OPIN PLANT BIOL, V10, P639, DOI 10.1016/j.pbi.2007.07.001; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schulze S, 2010, PLANT J, V64, P668, DOI 10.1111/j.1365-313X.2010.04359.x; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Suer S, 2011, PLANT CELL, V23, P3247, DOI 10.1105/tpc.111.087874; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511	41	148	162	14	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					377	U528		10.1038/nature13853	http://dx.doi.org/10.1038/nature13853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363783	Green Accepted, Green Published			2022-12-28	WOS:000347810300048
J	Brunner, JD; Lim, NK; Schenck, S; Duerst, A; Dutzler, R				Brunner, Janine D.; Lim, Novandy K.; Schenck, Stephan; Duerst, Alessia; Dutzler, Raimund			X-ray structure of a calcium-activated TMEM16 lipid scramblase	NATURE			English	Article							CA2+-ACTIVATED CL-CHANNEL; CHLORIDE CHANNEL; PROTEIN; FAMILY; IDENTIFICATION; SUBSTRUCTURE; PURIFICATION; TRANSPORTER; PRECURSORS; SOFTWARE	The TMEM16 family of proteins, also known as anoctamins, features a remarkable functional diversity. This family contains the long sought-after Ca2+-activated chloride channels as well as lipid scramblases and cation channels. Here we present the crystal structure of a TMEM16 family member from the fungus Nectria haematococca that operates as a Ca2+-activated lipid scramblase. Each subunit of the homodimeric protein contains ten transmembrane helices and a hydrophilic membrane-traversing cavity that is exposed to the lipid bilayer as a potential site of catalysis. This cavity harbours a conserved Ca2+-binding site located within the hydrophobic core of the membrane. Mutations of residues involved in Ca2+ coordination affect both lipid scrambling in N. haematococca TMEM16 and ion conduction in the Cl- channel TMEM16A. The structure reveals the general architecture of the family and its mode of Ca2+ activation. It also provides insight into potential scrambling mechanisms and serves as a framework to unravel the conduction of ions in certain TMEM16 proteins.	[Brunner, Janine D.; Lim, Novandy K.; Schenck, Stephan; Duerst, Alessia; Dutzler, Raimund] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Dutzler, R (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	dutzler@bioc.uzh.ch	Brunner, Janine/AAJ-5628-2020; Brunner, Janine/AAL-5584-2021	Brunner, Janine/0000-0003-4237-9322	European Research Council (AnoBest) [339116]; Swiss National Science Foundation through the National Centre of Competence in Research TransCure	European Research Council (AnoBest); Swiss National Science Foundation through the National Centre of Competence in Research TransCure	This research was supported by a grant from the European Research Council (no. 339116, AnoBest) and by the Swiss National Science Foundation through the National Centre of Competence in Research TransCure. We thank the staff of the X06SA beamline for support during data collection, B. Blattman and C. Stutz-Ducommun of the Protein Crystallization Center at UZH, for their support with crystallization, B. Dreier for help with MALS experiments, A. Szydelko for providing ecClC as negative control in the scramblase assay and D. Drew for the FGY217 yeast strain. All members of the Dutzler laboratory are acknowledged for help in all stages of the project.	Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dekkers DWC, 2002, BIOCHEM J, V362, P741, DOI 10.1042/0264-6021:3620741; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Ferrera L, 2011, COMPR PHYSIOL, V1, P2155, DOI 10.1002/cphy.c110017; Garcia-Celma J, 2013, J GEN PHYSIOL, V141, P479, DOI 10.1085/jgp.201210927; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Milenkovic VM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-319; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ni YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086734; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pifferi S, 2012, EXP PHYSIOL, V97, P193, DOI 10.1113/expphysiol.2011.058230; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Sanyal S, 2010, P NATL ACAD SCI USA, V107, P11289, DOI 10.1073/pnas.1002408107; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki T, 2014, J BIOL CHEM, V289, P7438, DOI 10.1074/jbc.M113.542324; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2014, J GEN PHYSIOL, V143, P253, DOI 10.1085/jgp.201311047; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	67	292	294	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					207	+		10.1038/nature13984	http://dx.doi.org/10.1038/nature13984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25383531				2022-12-28	WOS:000346383500036
J	Fowler, RA; Mittmann, N; Geerts, W; Heels-Ansdell, D; Gould, MK; Guyatt, G; Krahn, M; Finfer, S; Pinto, R; Chan, B; Ormanidhi, O; Arabi, Y; Qushmaq, I; Rocha, MG; Dodek, P; McIntyre, L; Hall, R; Ferguson, ND; Mehta, S; Marshall, JC; Doig, CJ; Muscedere, J; Jacka, MJ; Klinger, JR; Vlahakis, N; Orford, N; Seppelt, I; Skrobik, YK; Sud, S; Cade, JF; Cooper, J; Cook, D				Fowler, Robert A.; Mittmann, Nicole; Geerts, William; Heels-Ansdell, Diane; Gould, Michael K.; Guyatt, Gordon; Krahn, Murray; Finfer, Simon; Pinto, Ruxandra; Chan, Brian; Ormanidhi, Orges; Arabi, Yaseen; Qushmaq, Ismael; Rocha, Marcelo G.; Dodek, Peter; McIntyre, Lauralyn; Hall, Richard; Ferguson, Niall D.; Mehta, Sangeeta; Marshall, John C.; Doig, Christopher James; Muscedere, John; Jacka, Michael J.; Klinger, James R.; Vlahakis, Nicholas; Orford, Neil; Seppelt, Ian; Skrobik, Yoanna K.; Sud, Sachin; Cade, John F.; Cooper, Jamie; Cook, Deborah		Canadian Critical Care Trials Grp; Australia New Zealand Intensive Ca	Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOLECULAR-WEIGHT HEPARIN; DIRECT MEDICAL COSTS; INTENSIVE-CARE-UNIT; HOSPITALIZED-PATIENTS; CONFIDENCE-INTERVALS; ECONOMIC-EVALUATION; PROPHYLAXIS; VARIABILITY; THROMBOSIS; OUTCOMES	IMPORTANCE Venous thromboembolism (VTE) is a common complication of acute illness, and its prevention is a ubiquitous aspect of inpatient care. A multicenter blinded, randomized trial compared the effectiveness of the most common pharmocoprevention strategies, unfractionated heparin (UFH) and the low-molecular-weight heparin (LMWH) dalteparin, finding no difference in the primary end point of leg deep-vein thrombosis but a reduced rate of pulmonary embolus and heparin-induced thrombocytopenia among critically ill medical-surgical patients who received dalteparin. OBJECTIVE To evaluate the comparative cost-effectiveness of LMWH vs UFH for prophylaxis against VTE in critically ill patients. DESIGN, SETTING, AND PARTICIPANTS Prospective economic evaluation concurrent with the Prophylaxis for Thromboembolism in Critical Care Randomized Trial (May 2006 to June 2010). The economic evaluation adopted a health care payer perspective and in-hospital time horizon; derived baseline characteristics and probabilities of intensive care unit and in-hospital events; and measured costs among 2344 patients in 23 centers in 5 countries and applied these costs to measured resource use and effects of all enrolled patients. MAIN OUTCOMES AND MEASURES Costs, effects, incremental cost-effectiveness of LMWH vs UFH during the period of hospitalization, and sensitivity analyses across cost ranges. RESULTS Hospital costs per patient were $39 508 (interquartile range [IQR], $24 676 to $71 431) for 1862 patients who received LMWH compared with $40 805 (IQR, $24 393 to $76 139) for 1862 patients who received UFH (incremental cost, -$1297 [IQR, -$4398 to $1404]; P =.41). In 78% of simulations, a strategy using LMWH was most effective and least costly. In sensitivity analyses, a strategy using LMWH remained least costly unless the drug acquisition cost of dalteparin increased from $8 to $179 per dose and was consistent among higher-and lower-spending health care systems. There was no threshold at which lowering the acquisition cost of UFH favored prophylaxis with UFH. CONCLUSIONS AND RELEVANCE From a health care payer perspective, the use of the LMWH dalteparin for VTE prophylaxis among critically ill medical-surgical patients was more effective and had similar or lower costs than the use of UFH. These findings were driven by lower rates of pulmonary embolus and heparin-induced thrombocytopenia and corresponding lower overall use of resources with LMWH.	[Fowler, Robert A.; Pinto, Ruxandra] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Mittmann, Nicole] Sunnybrook Hlth Sci Ctr, Hlth Outcomes & PharmacoEcon HOPE Res Ctr, Toronto, ON M4N 3M5, Canada; [Mittmann, Nicole] Univ Toronto, Dept Pharmacol, Toronto, ON M4N 3M5, Canada; [Geerts, William; Krahn, Murray] Univ Toronto, Dept Med, Toronto, ON M4N 3M5, Canada; [Heels-Ansdell, Diane; Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Gould, Michael K.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Finfer, Simon] Univ Sydney, Royal N Shore Hosp, George Inst Global Hlth, St Leonards, NSW 2065, Australia; [Chan, Brian] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M4N 3M5, Canada; [Ormanidhi, Orges] Univ Toronto, THETA Collaborat, Toronto, ON M4N 3M5, Canada; [Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Qushmaq, Ismael] King Faisal Specialist Hosp & Res Centre Gen Org, Dept Med, Jeddah, Saudi Arabia; [Rocha, Marcelo G.] Hosp Santa Casa, Dept Intens Care, Porto Alegre, RS, Brazil; [Dodek, Peter] St Pauls Hosp, Div Crit Care Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada; [Dodek, Peter] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [McIntyre, Lauralyn] Ottawa Hosp, Dept Med Crit Care, Ctr Transfus & Crit Care Res, Res Inst, Ottawa, ON, Canada; [Hall, Richard] Dalhousie Univ, Dept Anesthesiol, Halifax, NS, Canada; [Hall, Richard] Capital Dist Hlth Author, Halifax, NS, Canada; [Hall, Richard] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Hall, Richard] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada; [Hall, Richard] Dalhousie Univ, Dept Surg, Halifax, NS B3H 4H2, Canada; [Ferguson, Niall D.; Mehta, Sangeeta] Univ Toronto, Dept Med, Interdept Div Crit Care Med, Toronto, ON M4N 3M5, Canada; [Ferguson, Niall D.] Univ Toronto, Dept Physiol, Interdept Div Crit Care Med, Toronto, ON M4N 3M5, Canada; [Ferguson, Niall D.] Univ Hlth Network, Div Respirol, Dept Med, Toronto, ON, Canada; [Ferguson, Niall D.; Mehta, Sangeeta] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Marshall, John C.] Univ Toronto, Dept Surg, Toronto, ON M4N 3M5, Canada; [Marshall, John C.] Univ Toronto, St Michaels Coll, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Doig, Christopher James] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Doig, Christopher James] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Doig, Christopher James] Univ Calgary, Dept Med, Calgary, AB, Canada; [Doig, Christopher James] Alberta Hlth Serv, Multisyst Intens Care Unit, Foothills Med Ctr, Edmonton, AB, Canada; [Muscedere, John] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Jacka, Michael J.] Univ Alberta Hosp, Dept Anesthesiol & Crit Care, Edmonton, AB T6G 2B7, Canada; [Klinger, James R.] Brown Univ, Rhode Isl Hosp, Albert Med Sch, Div Pulm Sleep & Crit Care Med, Providence, RI 02903 USA; [Vlahakis, Nicholas] Mayo Clin, Dept Pulm & Crit Care Med, Rochester, MN USA; [Orford, Neil] Deakin Univ, Australian & New Zealand Intens Care Res Ctr, Intens Care Barwon Hlth, Monash Univ,Sch Med, Melbourne, Vic, Australia; [Seppelt, Ian] Nepean Hosp, Penrith, NSW, Australia; [Skrobik, Yoanna K.] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Sud, Sachin] Trillium Hosp, Dept Med, Mississauga, ON, Canada; [Cade, John F.] Royal Melbourne Hosp, Intens Care Unit, Parkville, Vic 3050, Australia; [Cooper, Jamie] Monash Univ, ANZIC RC Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Cook, Deborah] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Cook, Deborah] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; McMaster University; Kaiser Permanente; George Institute for Global Health; Royal North Shore Hospital; University of Sydney; University of Toronto; University of Toronto; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Ottawa; Ottawa Hospital Research Institute; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; Queens University - Canada; University of Alberta; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Mayo Clinic; Deakin University; Monash University; Nepean Hospital; University of Sydney; Universite de Montreal; Royal Melbourne Hospital; Monash University; McMaster University; McMaster University	Fowler, RA (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,Room D478, Toronto, ON M4N 3M5, Canada.	rob.fowler@sunnybrook.ca	Mehta, Sangeeta/C-4623-2015; Skrobik, Yoanna/J-6393-2013; Ferguson, Niall/D-7619-2019; Skrobik, Yoanna/K-8165-2014; McIntyre, Lauralyn/AAR-7710-2021; Doig, Christopher/AAC-7949-2020; Muscedere, John/AAH-9291-2021; Arabi, Yaseen/ABF-3316-2020; Cooper, D. James/G-7961-2013; Chan, Brian/AAF-3874-2021	Ferguson, Niall/0000-0002-6213-5264; Skrobik, Yoanna/0000-0002-5315-6020; McIntyre, Lauralyn/0000-0001-7421-1407; Doig, Christopher/0000-0002-8576-9139; Arabi, Yaseen/0000-0001-5735-6241; Cooper, D. James/0000-0002-5872-9051; Chan, Brian/0000-0001-5037-0446; Herridge, Margaret/0000-0002-2903-1631; Orford, Neil/0000-0002-2285-9233; Finfer, Simon/0000-0002-2785-5864; Krahn, Murray/0000-0001-5836-397X; Friedrich, Jan/0000-0001-7248-2350	Heart and Stroke Foundation (Ontario, Canada); University of Toronto; Canadian Intensive Care Foundation; Canadian Institutes of Health Research; Heart and Stroke Foundation (Canada); Australian and New Zealand College of Anesthetists Research Foundation	Heart and Stroke Foundation (Ontario, Canada)(Heart & Stroke Foundation of Canada); University of Toronto(University of Toronto); Canadian Intensive Care Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (Canada)(Heart & Stroke Foundation of Canada); Australian and New Zealand College of Anesthetists Research Foundation	E-PROTECT was funded by the Heart and Stroke Foundation (Ontario, Canada), the University of Toronto, and the Canadian Intensive Care Foundation. PROTECT was funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation (Canada), and the Australian and New Zealand College of Anesthetists Research Foundation.	Angus DC, 2002, AM J RESP CRIT CARE, V165, P540; [Anonymous], 10 YEAR CURR CONV; [Anonymous], VEN THROMB RED RISK; Arnold DM, 2013, THROMB RES, V131, P204, DOI 10.1016/j.thromres.2012.12.005; Callum J, 2011, BLOODY EASY 3 BLOOD; Campbell MK, 1999, QJM-INT J MED, V92, P177, DOI 10.1093/qjmed/92.3.177; Canadian Agency for Drugs and Technologies in Health (CADTH), GUID EC EV HLTH TECH; Chiasson TC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000098; Cook D, 2014, J CRIT CARE, V29; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Douketis J, 2008, ARCH INTERN MED, V168, P1805, DOI 10.1001/archinte.168.16.1805; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Fowler R, 2007, CRIT CARE MED, V35, pA158; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Gold MR, 1996, COST EFFECTIVENESS H; Grant-in-Aid (GIA) and Career Investigator, GRANT AID GIA CAR IN; Guyatt GH, 2012, CHEST, V141, P1129; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; Kucher N, 2008, J THROMB HAEMOST, V6, P2082, DOI 10.1111/j.1538-7836.2008.03172.x; Lauzier F, 2014, CRIT CARE, V18, DOI 10.1186/cc13844; Nanwa N, 2011, PHARMACOECONOMICS, V29, P511, DOI 10.2165/11584330-000000000-00000; RAPOPORT J, 1990, MED CARE, V28, P338, DOI 10.1097/00005650-199004000-00005; Sarosiek S, 2013, JAMA INTERN MED, V173, P513, DOI 10.1001/jamainternmed.2013.343; Shermock KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066311; Stinnett AA, 1996, HEALTH ECON, V5, P470, DOI 10.1002/(SICI)1099-1050(199609)5:5<470::AID-HEC224>3.0.CO;2-5; Sud S, 2011, AM J RESP CRIT CARE, V184, P1289, DOI 10.1164/rccm.201106-1059OC; The Joint Commission, VEN THROMB; Thirugnanam S, 2012, CRIT CARE, V16, DOI 10.1186/cc11241; Tilleul P, 2006, J CRIT CARE, V21, P173, DOI 10.1016/j.jcrc.2005.12.013; World Bank, OFF EXCH RAT; Zeidan AM, 2013, AM J HEMATOL, V88, P545, DOI 10.1002/ajh.23450	33	41	41	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2135	2145		10.1001/jama.2014.15101	http://dx.doi.org/10.1001/jama.2014.15101			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25362228	Bronze, Green Published			2022-12-28	WOS:000345626800017
J	Biba, E				Biba, Erin			The sunscreen pill	NATURE			English	Editorial Material							HUMAN SKIN; EXTRACT; DAMAGE											Gonzalez S, 1997, PHOTODERMATOL PHOTO, V13, P50, DOI 10.1111/j.1600-0781.1997.tb00108.x; Middelkamp-Hup MA, 2004, J AM ACAD DERMATOL, V51, P910, DOI 10.1016/j.jaad.2004.06.027; Middelkamp-Hup MA, 2004, J AM ACAD DERMATOL, V50, P41, DOI 10.1016/S0190-9622(03)02732-4; Palombo P, 2007, SKIN PHARMACOL PHYS, V20, P199, DOI 10.1159/000101807; Zattra E, 2009, AM J PATHOL, V175, P1952, DOI 10.2353/ajpath.2009.090351	5	12	12	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S124	S125		10.1038/515S124a	http://dx.doi.org/10.1038/515S124a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407711				2022-12-28	WOS:000345770600007
J	Hause, RJ; Shendure, J				Hause, Ronald J.; Shendure, Jay			Genetic Variation Meets Replication Origins	CELL			English	Editorial Material							HUMAN MUTATION		[Hause, Ronald J.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865; Hause, Ronald/0000-0002-5229-7366	NCCDPHP CDC HHS [DP1HG007811] Funding Source: Medline	NCCDPHP CDC HHS		Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Mechali M, 2013, CURR OPIN GENET DEV, V23, P124, DOI 10.1016/j.gde.2013.02.010; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Van der Aa N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1352	7	1	1	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					973	974		10.1016/j.cell.2014.11.009	http://dx.doi.org/10.1016/j.cell.2014.11.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416936	Bronze			2022-12-28	WOS:000345506300009
J	Cole, TB				Cole, Thomas B.			Pictorial Quilt Harriet Powers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1952	1953		10.1001/jama.2013.279853	http://dx.doi.org/10.1001/jama.2013.279853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399258				2022-12-28	WOS:000345450500001
J	Ritchey, MD; Loustalot, F; Bowman, BA; Hong, YL				Ritchey, Matthew D.; Loustalot, Fleetwood; Bowman, Barbara A.; Hong, Yuling			Trends in Mortality Rates by Subtypes of Heart Disease in the United States, 2000-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ritchey, Matthew D.; Loustalot, Fleetwood; Bowman, Barbara A.; Hong, Yuling] US Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Ritchey, MD (corresponding author), US Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE, Atlanta, GA 30341 USA.	hha7@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Coady SA, 2001, J CLIN EPIDEMIOL, V54, P40, DOI 10.1016/S0895-4356(00)00272-9; Georgiopoulou VV, 2010, CARDIOL CLIN, V28, P675, DOI 10.1016/j.ccl.2010.07.005; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; US Centers for Disease Control and Prevention, UND CAUS DEATH 1999; WHO, 2010, INT STAT CLASS DIS R	6	21	21	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2037	2039		10.1001/jama.2014.11344	http://dx.doi.org/10.1001/jama.2014.11344			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399281	Bronze, Green Accepted			2022-12-28	WOS:000345450500020
J	Goel, SS; Aksoy, O; Gupta, S; Houghtaling, PL; Tuzcu, EM; Marwick, T; Mihaljevic, T; Svensson, L; Blackstone, EH; Griffin, BP; Stewart, WJ; Barzilai, B; Menon, V; Kapadia, SR				Goel, Sachin S.; Aksoy, Olcay; Gupta, Supriya; Houghtaling, Penny L.; Tuzcu, E. Murat; Marwick, Thomas; Mihaljevic, Tomislav; Svensson, Lars; Blackstone, Eugene H.; Griffin, Brian P.; Stewart, William J.; Barzilai, Benico; Menon, Venu; Kapadia, Samir R.			Renin-Angiotensin System Blockade Therapy After Surgical Aortic Valve Replacement for Severe Aortic Stenosis A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR MASS; CONVERTING-ENZYME-INHIBITORS; HEART-FAILURE; MYOCARDIAL FIBROSIS; DYSFUNCTION; REGRESSION; HYPERTROPHY; ECHOCARDIOGRAPHY; CANDESARTAN; INFARCTION	Background: Data are lacking on the effect of renin-angiotensin system (RAS) blockade therapy with angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers after surgical aortic valve replacement (SAVR) for severe aortic stenosis (AS). Objective: To investigate the association between RAS blockade therapy and outcomes after SAVR for severe AS. Design: Retrospective study. Setting: Single tertiary referral care center. Patients: Patients who were prescribed angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers after SAVR for severe AS between 1991 and 2010 who had at least 2 refills 90 days apart and at least a 6-month follow-up constituted the RAS blockade group (n = 741). Patients who did not receive these prescriptions were in the untreated group (n = 1011). Unadjusted and propensity-matched analyses (594 matched pairs of treated and untreated patients) were performed. Measurements: The primary outcome was survival rates after SAVR. Secondary end points were changes in left ventricular mass index, left ventricular ejection fraction, and left atrial size. Results: Overall unadjusted estimated survival rates at 1, 5, and 10 years were significantly greater in the RAS blockade group than in the non-RAS blockade group (99%, 90%, and 60% vs. 99%, 81%, and 53%, respectively; P < 0.001). Among propensity-matched patients, estimated survival rates at 1, 5, and 10 years remained significantly greater in the RAS blockade group than in the non-RAS blockade group (99%, 90%, and 71% vs. 96%, 78%, and 49%, respectively; P < 0.001). For the matched cohorts, the groups did not significantly differ in the change in left ventricular mass index (P = 0.37), left ventricular ejection fraction (P = 0.67), or left atrial size (P = 0.43) after SAVR on echocardiographic analysis. Limitation: Retrospective, single-center analysis. Conclusion: Renin-angiotensin system blockade therapy is associated with increased survival rates in patients after SAVR for severe AS. A randomized trial of RAS blockade therapy after SAVR should be considered.	[Kapadia, Samir R.] Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	Cleveland Clinic Foundation; University of Tasmania; Menzies Institute for Medical Research	Kapadia, SR (corresponding author), Cleveland Clin Fdn, J2-3,9500 Euclid Ave, Cleveland, OH 44195 USA.	kapadis@ccf.org	Menon, Venu/AAF-1871-2019; Goel, Sachin/AAD-4137-2019; Marwick, Thomas/AAK-3869-2021	Marwick, Thomas/0000-0001-9065-0899				Abramov D, 2010, ECHOCARDIOGR-J CARD, V27, P223, DOI 10.1111/j.1540-8175.2009.01004.x; Azevedo CF, 2010, J AM COLL CARDIOL, V56, P278, DOI 10.1016/j.jacc.2009.12.074; BERGSTRALH EJ, 1995, 56 MAY FDN; BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2002.120329; Blackstone EH, 2001, J THORAC CARDIOV SUR, V122, P430, DOI 10.1067/mtc.2001.117536; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Breitenbach I, 2012, J THORAC CARDIOV SUR, V144, P640, DOI 10.1016/j.jtcvs.2011.11.017; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Cleveland Clinic, THE HAZ PACK; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Dahl JS, 2010, AM J CARDIOL, V106, P713, DOI 10.1016/j.amjcard.2010.04.028; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P598, DOI 10.1016/S0735-1097(98)00609-3; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Gjertsson P, 2005, J THORAC CARDIOV SUR, V129, P890, DOI 10.1016/j.jtcvs.2004.09.004; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; KRAYENBUEHL HP, 1989, CIRCULATION, V79, P744, DOI 10.1161/01.CIR.79.4.744; Lim E, 2008, ANN THORAC SURG, V85, P2026, DOI 10.1016/j.athoracsur.2008.02.023; LONN EM, 1994, CIRCULATION, V90, P2056, DOI 10.1161/01.CIR.90.4.2056; Lund O, 2004, J HEART VALVE DIS, V13, P357; Mason DP, 2008, ANN THORAC SURG, V85, P1193, DOI 10.1016/j.athoracsur.2007.12.023; Mitra R, 2012, STAT METHODS MED RES; Nadir MA, 2011, J AM COLL CARDIOL, V58, P570, DOI 10.1016/j.jacc.2011.01.063; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Rajeswaran J, 2014, STAT METHODS MED RES; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P145	39	25	25	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					699	U149		10.7326/M13-1505	http://dx.doi.org/10.7326/M13-1505			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402513				2022-12-28	WOS:000347245600027
J	Auslander, S; Fussenegger, M				Auslaender, Simon; Fussenegger, Martin			Dynamic genome engineering in living cells	SCIENCE			English	Editorial Material							MAMMALIAN-CELLS; LOGIC; CIRCUIT; BIOLOGY; SWITCH		[Auslaender, Simon; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland	ETH Zurich	Auslander, S (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.	fussenegger@bsse.ethz.ch						Auslander D, 2014, MOL CELL, V55, P397, DOI 10.1016/j.molcel.2014.06.007; Auslander D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5408; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; MIROCHNITCHENKO O, 1994, J BIOL CHEM, V269, P2380; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	14	4	5	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					813	814		10.1126/science.aaa1246	http://dx.doi.org/10.1126/science.aaa1246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395523				2022-12-28	WOS:000344659900022
J	Sheldon, MT; van de Groep, J; Brown, AM; Polman, A; Atwater, HA				Sheldon, Matthew T.; van de Groep, Jorik; Brown, Ana M.; Polman, Albert; Atwater, Harry A.			Plasmoelectric potentials in metal nanostructures	SCIENCE			English	Article							ANTENNAS; LIGHT	The conversion of optical power to an electric potential is of general interest for energy applications and is typically obtained via optical excitation of semiconductor materials. We developed a method for achieving electric potential that uses an all-metal geometry based on the plasmon resonance inmetal nanostructures. In arrays of gold nanoparticles on an indium tin oxide substrate and arrays of 100-nanometer-diameter holes in 20-nanometer-thick gold films on a glass substrate, we detected negative and positive surface potentials during monochromatic irradiation at wavelengths belowor above the plasmon resonance, respectively. We observed plasmoelectric surface potentials as large as 100 millivolts under illumination of 100 milliwatts per square centimeter. Plasmoelectric devices may enable the development of all-metal optoelectronic devices that can convert light into electrical energy.	[Sheldon, Matthew T.; Brown, Ana M.; Atwater, Harry A.] CALTECH, Thomas J Watson Labs Appl Phys, Pasadena, CA 91125 USA; [van de Groep, Jorik; Polman, Albert] FOM Inst AMOLF, Ctr Nanophoton, NL-1098 XG Amsterdam, Netherlands	California Institute of Technology; AMOLF	Atwater, HA (corresponding author), CALTECH, Thomas J Watson Labs Appl Phys, MC 128-95, Pasadena, CA 91125 USA.	haa@caltech.edu	Sheldon, Matthew/P-7949-2019; Polman, Albert/D-1490-2011; Atwater, Harry A/H-2823-2014; Sheldon, Matthew T/O-4433-2014; van de Groep, Jorik/AAH-4056-2021	Sheldon, Matthew/0000-0002-4940-7966; Polman, Albert/0000-0002-0685-3886; Atwater, Harry A/0000-0001-9435-0201; Sheldon, Matthew T/0000-0002-4940-7966; van de Groep, Jorik/0000-0003-3033-8005	U.S. Department of Energy (DOE) Office of Science [DE-FG02-07ER46405]; NSF Graduate Research Fellowship; DOE "Light-Material Interactions in Energy Conversion" Energy Frontier Research Center [DE-SC0001293]; Netherlands Organization for Scientific Research (NWO); European Research Council	U.S. Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); DOE "Light-Material Interactions in Energy Conversion" Energy Frontier Research Center(United States Department of Energy (DOE)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	Supported by U.S. Department of Energy (DOE) Office of Science grant DE-FG02-07ER46405 (M.S. and H.A.A.), an NSF Graduate Research Fellowship (A.B.), and experimental facilities of the DOE "Light-Material Interactions in Energy Conversion" Energy Frontier Research Center grant DE-SC0001293. Work at AMOLF is part of the research program of the Foundation for Fundamental Research on Matter [which is financially supported by the Netherlands Organization for Scientific Research (NWO)] and by the European Research Council. The data are archived in the laboratory of H. A. A. and A. P. We thank E. Kosten, V. Brar, D. Callahan, M. Deceglie, A. Leenheer, J. Fakonas, R. van Roij, B. M. Mulder, and H. J. Bakker for helpful discussions.	Ashcroft N.W., 1976, SOLID STATE PHYS; Barnes WL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107401; Cerruti MG, 2006, ANAL CHEM, V78, P3282, DOI 10.1021/ac0600555; Figarova S.R., 2010, THERMODYNAMICS GIBBS; Foiles C.L., 1976, THERMOELECTRIC POWER; Knight MW, 2011, SCIENCE, V332, P702, DOI 10.1126/science.1203056; Noginova N, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035447; NONNENMACHER M, 1991, APPL PHYS LETT, V58, P2921, DOI 10.1063/1.105227; Novo C, 2009, J AM CHEM SOC, V131, P14664, DOI 10.1021/ja905216h; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI [10.1038/nphoton.2010.237, 10.1038/NPHOTON.2010.237]; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]	11	178	178	8	317	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					828	831		10.1126/science.1258405	http://dx.doi.org/10.1126/science.1258405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395532				2022-12-28	WOS:000344659900038
J	Jotzu, G; Messer, M; Desbuquois, R; Lebrat, M; Uehlinger, T; Greif, D; Esslinger, T				Jotzu, Gregor; Messer, Michael; Desbuquois, Remi; Lebrat, Martin; Uehlinger, Thomas; Greif, Daniel; Esslinger, Tilman			Experimental realization of the topological Haldane model with ultracold fermions	NATURE			English	Article							INSULATOR; LATTICE; PHASE	The Haldane model on a honeycomb lattice is a paradigmatic example of a Hamiltonian featuring topologically distinct phases of matter(1). It describes a mechanism through which a quantum Hall effect can appear as an intrinsic property of a band structure, rather than being caused by an external magnetic field(2). Although physical implementation has been considered unlikely, the Haldane model has provided the conceptual basis for theoretical and experimental research exploring topological insulators and superconductors(2-6). Here we report the experimental realization of the Haldane model and the characterization of its topological band structure, using ultracold fermionic atoms in a periodically modulated optical honeycomb lattice. The Haldane model is based on breaking both time-reversal symmetry and inversion symmetry. To break time-reversal symmetry, we introduce complex next-nearest-neighbour tunnelling terms, which we induce through circular modulation of the lattice position(7). To break inversion symmetry, we create an energy offset between neighbouring sites(8). Breaking either of these symmetries opens a gap in the band structure, which we probe using momentum-resolved interband transitions. We explore the resulting Berry curvatures, which characterize the topology of the lowest band, by applying a constant force to the atoms and find orthogonal drifts analogous to a Hall current. The competition between the two broken symmetries gives rise to a transition between topologically distinct regimes. By identifying the vanishing gap at a single Dirac point, we map out this transition line experimentally and quantitatively compare it to calculations using Floquet theory without free parameters. We verify that our approach, which allows us to tune the topological properties dynamically, is suitable even for interacting fermionic systems. Furthermore, we propose a direct extension to realize spin-dependent topological Hamiltonians.	[Jotzu, Gregor; Messer, Michael; Desbuquois, Remi; Lebrat, Martin; Uehlinger, Thomas; Greif, Daniel; Esslinger, Tilman] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Esslinger, T (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Greif, Daniel/M-4480-2017; Desbuquois, Rémi/A-2256-2017; Esslinger, Tilman/M-9022-2016	Greif, Daniel/0000-0002-0721-7726; Desbuquois, Rémi/0000-0003-3726-0538; Esslinger, Tilman/0000-0002-8333-107X; Jotzu, Gregor/0000-0003-4421-5874; Lebrat, Martin/0000-0002-2123-6026	SNF; NCCR-QSIT; SQMS (ERC advanced grant)	SNF; NCCR-QSIT; SQMS (ERC advanced grant)	We thank H. Aoki for drawing our attention to the relevance of their proposal for optical lattices and N. Cooper, S. Huber, L. Tarruell, L. Wang and A. Zenesini for discussions. We acknowledge the SNF, the NCCR-QSIT and the SQMS (ERC advanced grant) for funding.	Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; Aidelsburger M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.255301; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; CHANG MC, 1995, PHYS REV LETT, V75, P1348, DOI 10.1103/PhysRevLett.75.1348; Dauphin A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.135302; Dudarev AM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.153005; DUNLAP DH, 1986, PHYS REV B, V34, P3625, DOI 10.1103/PhysRevB.34.3625; Grushin AG, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.156801; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Jimenez-Garcia K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225303; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Lignier H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220403; Lim LK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.175303; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Neupert T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.236804; Oka T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.081406; Parker CV, 2013, NAT PHYS, V9, P769, DOI [10.1038/nphys2789, 10.1038/NPHYS2789]; Price HM, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.033620; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Struck J, 2013, NAT PHYS, V9, P738, DOI [10.1038/nphys2750, 10.1038/NPHYS2750]; Struck J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225304; Struck J, 2011, SCIENCE, V333, P996, DOI 10.1126/science.1207239; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871; Uehlinger T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185307; Varney CN, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115125; Williams RA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.050404; Zenesini A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100403	30	1395	1401	11	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					237	U191		10.1038/nature13915	http://dx.doi.org/10.1038/nature13915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391960	Green Submitted			2022-12-28	WOS:000344631400043
J	Wakeman, SE; Ghoshhajra, BB; Dudzinski, DM; Wilens, T; Slavin, PL				Wakeman, Sarah E.; Ghoshhajra, Brian B.; Dudzinski, David M.; Wilens, Timothy; Slavin, Peter L.			Case 35-2014: A 31-Year-Old Woman with Fevers, Chest Pain, and a History of HCV Infection and Substance-Use Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RHEUMATIC MANIFESTATIONS; DRUG-USERS; ASSOCIATION; METHADONE; CRITERIA; ADDICTS; ABUSERS; DEATH		[Wakeman, Sarah E.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Ghoshhajra, Brian B.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Dudzinski, David M.] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Wilens, Timothy] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Slavin, Peter L.] Massachusetts Gen Hosp, Dept Adm, Boston, MA 02114 USA; [Wakeman, Sarah E.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Ghoshhajra, Brian B.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Dudzinski, David M.] Harvard Univ, Sch Med, Dept Cardiol, Boston, MA USA; [Wilens, Timothy] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Slavin, Peter L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wakeman, SE (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Ghoshhajra, Brian/J-2114-2016	Ghoshhajra, Brian/0000-0002-3865-3432	Siemens Healthcare; Sanofi; AdvantageHealthCare; Pfizer; Euthymics/Neurovance; Theravance; Tris; Guilford Press; U.S. National Football League (ERM Associates); U.S. Minor/Major League Baseball; Bay Cove Human Services (Clinical Services)	Siemens Healthcare(Siemens AG); Sanofi; AdvantageHealthCare; Pfizer(Pfizer); Euthymics/Neurovance; Theravance; Tris; Guilford Press; U.S. National Football League (ERM Associates); U.S. Minor/Major League Baseball; Bay Cove Human Services (Clinical Services)	Dr. Ghoshhajra reports receiving lecture fees from Siemens Healthcare; Dr. Dudzinski, consulting fees from Sanofi and AdvantageHealthCare; and Dr. Wilens, grant support from Pfizer and consulting fees from Euthymics/Neurovance, Theravance, Tris, Guilford Press, U.S. National Football League (ERM Associates), U.S. Minor/Major League Baseball, and Bay Cove Human Services (Clinical Services). No other potential conflict of interest relevant to this article was reported.	Alfandre DJ, 2009, MAYO CLIN PROC, V84, P255, DOI 10.1016/S0025-6196(11)61143-9; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Carrieri MP, 2006, CLIN INFECT DIS, V43, pS197, DOI 10.1086/508184; Chan ACH, 2004, JAIDS-J ACQ IMM DEF, V35, P56, DOI 10.1097/00126334-200401010-00008; Choi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024459; Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Gonzalez-Juanatey C, 2001, MEDICINE, V80, P9, DOI 10.1097/00005792-200101000-00002; Han DH, 2003, RADIOGRAPHICS, V23, P1521, DOI 10.1148/rg.1103035043; HUANG RM, 1989, AM J ROENTGENOL, V153, P41, DOI 10.2214/ajr.153.1.41; KLATT EC, 1990, J FORENSIC SCI, V35, P1143; LEVIN MH, 1984, J CLIN MICROBIOL, V20, P758, DOI 10.1128/JCM.20.4.758-762.1984; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Mattick RP, 2003, COCHRANE DB SYST REV, V2; Mertz D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-42; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; PODZAMCZER D, 1986, EUR J CLIN MICROBIOL, V5, P477, DOI 10.1007/BF02075717; ROBERTSTHOMSON PJ, 1992, RHEUMATOL INT, V12, P61, DOI 10.1007/BF00300978; Rodriguez G, 2011, AM J EMERG MED, V29, P816, DOI 10.1016/j.ajem.2011.03.009; SCHEIDEGGER C, 1989, REV INFECT DIS, V11, P486; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; Sigmon SC, 2013, JAMA PSYCHIAT, V70, P1347, DOI 10.1001/jamapsychiatry.2013.2216; Southern WN, 2012, AM J MED, V125, P594, DOI 10.1016/j.amjmed.2011.12.017; Substance Abuse and Mental Health Services Association, RES 2012 NAT SURV DR; SWISHER LA, 1994, AM J EMERG MED, V12, P343, DOI 10.1016/0735-6757(94)90156-2; Wakeman SE, 2014, AM J MED, V127, P465, DOI 10.1016/j.amjmed.2013.12.018; WEISSE AB, 1993, AM J MED, V94, P274, DOI 10.1016/0002-9343(93)90059-X	27	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1918	1926		10.1056/NEJMcpc1407131	http://dx.doi.org/10.1056/NEJMcpc1407131			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25390743				2022-12-28	WOS:000344709800011
J	Smith, JM				Smith, Jeanette M.			Liberty Loan Parade Arthur Clifton Goodwin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1840	1841		10.1001/jama.2013.279825	http://dx.doi.org/10.1001/jama.2013.279825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387171				2022-12-28	WOS:000344532600001
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Fat doctors are patients too	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OBESITY; POPULATION					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Amani R, 2013, ASIA PAC J CLIN NUTR, V22, P505, DOI 10.6133/apjcn.2013.22.4.11; Booth HP, 2014, FAM PRACT, V31, P643, DOI 10.1093/fampra/cmu064; Brown I, 2006, BRIT J GEN PRACT, V56, P666; Donnelly L, 2014, NHS HOSPITAL CAFES A; Flint E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4887; Furber CM, 2011, MIDWIFERY, V27, P437, DOI 10.1016/j.midw.2010.04.001; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Helm T, 2014, GUARDIAN; Henegan C, 2013, THE MEN WHO MADE US; Jackson EJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003567; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Millett D., 2014, GP 23; Puhl RM, 2013, INT J OBESITY, V37, P1415, DOI 10.1038/ijo.2013.33; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636	14	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2014	349								g6464	10.1136/bmj.g6464	http://dx.doi.org/10.1136/bmj.g6464			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JP	25385743	Green Published, Bronze			2022-12-28	WOS:000345444800004
J	van de Walle, A				van de Walle, Axel			Simulations provide a rare look at real melting	SCIENCE			English	Editorial Material									Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University	van de Walle, A (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	avdw@brown.edu	van de Walle, Axel/L-5676-2013; van de Walle, Axel/GNM-9324-2022	van de Walle, Axel/0000-0002-3415-1494; van de Walle, Axel/0000-0002-3415-1494				Alfe D, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3605601; Alfe D, 1999, NATURE, V401, P462, DOI 10.1038/46758; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Henkelman G, 2001, J CHEM PHYS, V115, P9657, DOI 10.1063/1.1415500; Hong QJ, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4819792; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Perez D, 2009, ANN REP COMP CHEM, V5, P79, DOI 10.1016/S1574-1400(09)00504-0; Samanta A, 2014, SCIENCE, V346, P729, DOI 10.1126/science.1253810; Tiwary P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230602; Tiwary P, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094304; Yip S., 2005, HANDBOOK OF MATERIAL	12	6	6	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					704	705		10.1126/science.1259685	http://dx.doi.org/10.1126/science.1259685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378610				2022-12-28	WOS:000344690100024
J	Griebeler, ML; Morey-Vargas, OL; Brito, JP; Tsapas, A; Wang, Z; Leon, BGC; Phung, OJ; Montori, VM; Murad, MH				Griebeler, Marcio L.; Morey-Vargas, Oscar L.; Brito, Juan P.; Tsapas, Apostolos; Wang, Zhen; Leon, Barbara G. Carranza; Phung, Olivia J.; Montori, Victor M.; Murad, M. Hassan			Pharmacologic Interventions for Painful Diabetic Neuropathy An Umbrella Systematic Review and Comparative Effectiveness Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ALDOSE-REDUCTASE INHIBITOR; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED-RELEASE OXYCODONE; DOUBLE-BLIND; PERIPHERAL NEUROPATHY; SYMPTOMATIC TREATMENT; IMIPRAMINE TREATMENT; MULTICENTER TRIAL; TOPICAL CAPSAICIN; SODIUM VALPROATE	Background: Multiple treatments for painful diabetic peripheral neuropathy are available. Purpose: To evaluate the comparative effectiveness of oral and topical analgesics for diabetic neuropathy. Data Sources: Multiple electronic databases between January 2007 and April 2014, without language restriction. Study Selection: Parallel or crossover randomized, controlled trials that evaluated pharmacologic treatments for adults with painful diabetic peripheral neuropathy. Data Extraction: Duplicate extraction of study data and assessment of risk of bias. Data Synthesis: 65 randomized, controlled trials involving 12 632 patients evaluated 27 pharmacologic interventions. Approximately one half of these studies had high or unclear risk of bias. Nine head-to-head trials showed greater pain reduction associated with serotonin-norepinephrine reuptake inhibitors (SNRIs) than anticonvulsants (standardized mean difference [SMD], -0.34 [95% credible interval {CrI}, -0.63 to -0.05]) and with tricyclic antidepressants (TCAs) than topical capsaicin 0.075%. Network meta-analysis showed that SNRIs (SMD, -1.36 [CrI, -1.77 to -0.95]), topical capsaicin (SMD, -0.91 [CrI, -1.18 to -0.08]), TCAs (SMD, -0.78 [CrI, -1.24 to -0.33]), and anticonvulsants (SMD, -0.67 [CrI, -0.97 to -0.37]) were better than placebo for short-term pain control. Specifically, carbamazepine (SMD, -1.57 [CrI, -2.83 to -0.31]), venlafaxine (SMD, -1.53 [CrI, -2.41 to -0.65]), duloxetine (SMD, -1.33 [CrI, -1.82 to -0.86]), and amitriptyline (SMD, -0.72 [CrI, -1.35 to -0.08]) were more effective than placebo. Adverse effects included somnolence and dizziness with TCAs, SNRIs, and anticonvulsants; xerostomia with TCAs; and peripheral edema and burning sensation with pregabalin and capsaicin. Limitation: Confidence in findings was limited because most evidence came from indirect comparisons of trials with short (-3 months) follow-up and unclear or high risk of bias. Conclusion: Several medications may be effective for short-term management of painful diabetic neuropathy, although their comparative effectiveness is unclear.	Mayo Clin, Rochester, MN 55905 USA; Aristotle Univ Thessaloniki, Thessaloniki, Greece; [Phung, Olivia J.] Western Univ Hlth Sci, Coll Pharm, Pomona 91766, CA USA; [Phung, Olivia J.] Western Univ Hlth Sci, Western Diabet Inst, Pomona, CA 91766 USA	Mayo Clinic; Aristotle University of Thessaloniki; Western University of Health Sciences; Western University of Health Sciences	Murad, MH (corresponding author), Mayo Clin, Div Prevent Med, Dept Med, 200 First St SW, Rochester, MN 55905 USA.	murad.mohammad@mayo.edu	Murad, M. Hassan/AAW-4367-2020; Tsapas, Apostolos/P-5593-2019; Griebeler, Marcio/AAN-9987-2021; Griebeler, Marcio/M-1385-2016	Tsapas, Apostolos/0000-0003-0221-4072; Griebeler, Marcio/0000-0001-5723-1182; Murad, Mohammad Hassan/0000-0001-5502-5975; Montori, Victor/0000-0003-0595-2898	Mayo Foundation for Medical Education and Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	Mayo Foundation for Medical Education and Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Mayo Foundation for Medical Education and Research.	Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Backonja M, 1998, JAMA-J AM MED ASSOC, V280, P1831, DOI 10.1001/jama.280.21.1831; Bansal D, 2009, DIABETIC MED, V26, P1019, DOI 10.1111/j.1464-5491.2009.02806.x; Beydoun A, 2006, ACTA NEUROL SCAND, V113, P395, DOI 10.1111/j.1600-0404.2006.00631.x; BIESBROECK R, 1995, ADV THER, V12, P111; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton Andrew J M, 2008, Curr Diab Rep, V8, P429, DOI 10.1007/s11892-008-0074-2; Boyle J, 2012, DIABETES CARE, V35, P2451, DOI 10.2337/dc12-0656; Bril V, 2011, PM&R, V3, P345, DOI [10.1016/j.pmrj.2011.03.008, 10.1212/WNL.0b013e3182166ebe]; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Chou R, 2009, J GEN INTERN MED, V24, P178, DOI 10.1007/s11606-008-0877-5; DEJGARD A, 1988, LANCET, V1, P9; Dogra S, 2005, EUR J PAIN, V9, P543, DOI 10.1016/j.ejpain.2004.11.006; Domecq JP, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-44; DONOFRIO P, 1991, ARCH INTERN MED, V151, P2225; Eisenberg E, 2001, NEUROLOGY, V57, P505, DOI 10.1212/WNL.57.3.505; Freeman R, 2007, CURR MED RES OPIN, V23, P147, DOI 10.1185/030079906X162674; Freynhagen R, 2005, PAIN, V115, P254, DOI 10.1016/j.pain.2005.02.032; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Gao Y, 2010, CHINESE MED J-PEKING, V123, P3184, DOI 10.3760/cma.j.issn.0366-6999.2010.22.003; GILL JS, 1990, DIABETES METAB, V16, P296; Gimbel JS, 2003, NEUROLOGY, V60, P927, DOI 10.1212/01.WNL.0000057720.36503.2C; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Gorson KC, 1999, J NEUROL NEUROSUR PS, V66, P251, DOI 10.1136/jnnp.66.2.251; Griebeler ML, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-61; Grosskopf J, 2006, ACTA NEUROL SCAND, V114, P177, DOI 10.1111/j.1600-0404.2005.00559.x; Hotta N, 2001, DIABETES CARE, V24, P1776, DOI 10.2337/diacare.24.10.1776; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Jensen MP, 2006, CLIN J PAIN, V22, P97, DOI 10.1097/01.ajp.0000173018.64741.62; [JIA Haiyan 贾海燕], 2006, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V6, P321; Jose VM, 2007, DIABETIC MED, V24, P377, DOI 10.1111/j.1464-5491.2007.02093.x; Kadiroglu AK, 2008, J DIABETES COMPLICAT, V22, P241, DOI 10.1016/j.jdiacomp.2007.03.010; Kochar DK, 2004, QJM-INT J MED, V97, P33, DOI 10.1093/qjmed/hch007; Kochar DK, 2002, ACTA NEUROL SCAND, V106, P248, DOI 10.1034/j.1600-0404.2002.01229.x; KVINESDAL B, 1984, JAMA-J AM MED ASSOC, V251, P1727, DOI 10.1001/jama.251.13.1727; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Lesser H., 2004, Neurology, V63, P2104; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lindsay TJ, 2010, AM FAM PHYSICIAN, V82, P151; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MACLEOD AF, 1992, DIABETES METAB, V18, P14; Matsuoka K., 1997, Diabetologia, V40, pA559; Max M B, 1987, Anesth Prog, V34, P123; MAX MB, 1991, PAIN, V45, P3, DOI 10.1016/0304-3959(91)90157-S; MAX MB, 1992, NEW ENGL J MED, V326, P1250, DOI 10.1056/NEJM199205073261904; McCleane G, 1999, PAIN, V83, P105, DOI 10.1016/S0304-3959(99)00095-0; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Morello CM, 1999, ARCH INTERN MED, V159, P1931, DOI 10.1001/archinte.159.16.1931; Nelson KA, 1997, NEUROLOGY, V48, P1212, DOI 10.1212/WNL.48.5.1212; OHARE JP, 1988, DIABETIC MED, V5, P537, DOI 10.1111/j.1464-5491.1988.tb01047.x; Oskarsson P, 1997, DIABETES CARE, V20, P1594, DOI 10.2337/diacare.20.10.1594; Quilici S, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-6; Raskin J, 2005, PAIN MED, V6, P346, DOI 10.1111/j.1526-4637.2005.00061.x; Raskin P, 2004, NEUROLOGY, V63, P865, DOI 10.1212/01.WNL.0000137341.89781.14; Rauck RL, 2007, CLIN J PAIN, V23, P150, DOI 10.1097/01.ajp.0000210957.39621.b2; Richter RW, 2005, J PAIN, V6, P253, DOI 10.1016/j.jpain.2004.12.007; Rosenstock J, 2004, PAIN, V110, P628, DOI 10.1016/j.pain.2004.05.001; Rowbotham MC, 2004, PAIN, V110, P697, DOI 10.1016/j.pain.2004.05.010; Sang CN, 2002, ANESTHESIOLOGY, V96, P1053, DOI 10.1097/00000542-200205000-00005; Satoh J, 2011, DIABETIC MED, V28, P109, DOI 10.1111/j.1464-5491.2010.03152.x; SCHEFFLER NM, 1991, J AM PODIAT MED ASSN, V81, P288, DOI 10.7547/87507315-81-6-288; Schwartz S, 2011, CURR MED RES OPIN, V27, P151, DOI 10.1185/03007995.2010.537589; Shaibani A, 2009, J PAIN, V10, P818, DOI 10.1016/j.jpain.2009.01.322; Simpson D A, 2001, J Clin Neuromuscul Dis, V3, P53; SINDRUP SH, 1990, PAIN, V42, P135, DOI 10.1016/0304-3959(90)91157-E; SINDRUP SH, 1989, EUR J CLIN PHARMACOL, V37, P151, DOI 10.1007/BF00558223; Snedecor SJ, 2014, PAIN PRACT, V14, P167, DOI 10.1111/papr.12054; STRACKE H, 1992, DIABETES CARE, V15, P1550, DOI 10.2337/diacare.15.11.1550; TANDAN R, 1992, DIABETES CARE, V15, P8, DOI 10.2337/diacare.15.1.8; Tesfaye S, 2011, DIABETES-METAB RES, V27, P629, DOI 10.1002/dmrr.1225; Thienel U, 2004, ACTA NEUROL SCAND, V110, P221, DOI 10.1111/j.1600-0404.2004.00338.x; Tolle T, 2008, EUR J PAIN, V12, P203, DOI 10.1016/j.ejpain.2007.05.003; Vinik AI, 2007, PAIN, V128, P169, DOI 10.1016/j.pain.2006.09.040; Vrethem M, 1997, CLIN J PAIN, V13, P313, DOI 10.1097/00002508-199712000-00009; Watson CPN, 2003, PAIN, V105, P71, DOI 10.1016/S0304-3959(03)00160-X; Wernicke JF, 2006, NEUROLOGY, V67, P1411, DOI 10.1212/01.wnl.0000240225.04000.1a; WILTON TD, 1974, S AFR MED J, V48, P869; Wong MC, 2007, BMJ-BRIT MED J, V335, P87, DOI 10.1136/bmj.39213.565972.AE; Wright JM, 1997, ANN PHARMACOTHER, V31, P29, DOI 10.1177/106002809703100103; Wymer JP, 2009, CLIN J PAIN, V25, P376, DOI 10.1097/AJP.0b013e318196d2b6; Yasuda H, 2011, J DIABETES INVEST, V2, P132, DOI 10.1111/j.2040-1124.2010.00073.x; YOUNG RJ, 1983, DIABETES, V32, P938, DOI 10.2337/diabetes.32.10.938; ZIEGLER D, 1991, DIABETES RES CLIN PR, V14, P63, DOI 10.1016/0168-8227(91)90054-H; Ziegler D, 2010, DIABETES CARE, V33, P839, DOI 10.2337/dc09-1578	85	87	100	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					639	U138		10.7326/M14-0511	http://dx.doi.org/10.7326/M14-0511			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364885				2022-12-28	WOS:000347244100005
J	Siriwardena, AK; Siriwardena, AM				Siriwardena, Ajith K.; Siriwardena, Alison M.			Pancreatic cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADENOCARCINOMA; TUMOR		[Siriwardena, Ajith K.] Manchester Royal Infirm, Reg Hepatopancreatobiliary Unit, Manchester M13 9WL, Lancs, England; [Siriwardena, Ajith K.] Univ Manchester, Manchester, Lancs, England; [Siriwardena, Alison M.] Bramhall Pk Med Ctr, Stockport, Lancs, England	University of Manchester; University of Manchester	Siriwardena, AK (corresponding author), Manchester Royal Infirm, Reg Hepatopancreatobiliary Unit, Oxford Rd, Manchester M13 9WL, Lancs, England.	ajith.siriwardena@cmft.nhs.uk						Bond-Smith G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2476; Brennan MF, 1996, ANN SURG, V223, P506, DOI 10.1097/00000658-199605000-00006; Cancer Research UK, CANC INC MORT UK; Cancer Research UK, PANCR CANC SYMPT; Cancer Research UK, TYP PANCR CANC; Cancer Research UK, PANCR CANC SURV STAT; Hippisley-Cox J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616355; Johnson CD, 2005, GUT, V54, DOI 10.1136/gut.2004.057059; Karlson BM, 1999, RADIOLOGY, V213, P107, DOI 10.1148/radiology.213.1.r99oc25107; National Cancer Intelligence Network, 2013, ROUT DIAGN EXPL EM P; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Sah RP, 2013, NAT REV GASTRO HEPAT, V10, P423, DOI 10.1038/nrgastro.2013.49; Shrikhande SV, 2012, HPB, V14, P658, DOI 10.1111/j.1477-2574.2012.00508.x; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Stapley S, 2012, BRIT J CANCER, V106, P1940, DOI 10.1038/bjc.2012.190; Watanabe I, 2004, PANCREAS, V28, P160, DOI 10.1097/00006676-200403000-00007	17	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2014	349								g6385	10.1136/bmj.g6385	http://dx.doi.org/10.1136/bmj.g6385			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DM	25361852				2022-12-28	WOS:000344156600002
J	Villar, L; Dayan, GH; Arredondo-Garcia, JL; Rivera, DM; Cunha, R; Deseda, C; Reynales, H; Costa, MS; Morales-Ramirez, JO; Carrasquilla, G; Rey, LC; Dietze, R; Luz, K; Rivas, E; Montoya, MCM; Supelano, MC; Zambrano, B; Langevin, E; Boaz, M; Tornieporth, N; Saville, M; Noriega, F				Villar, Luis; Dayan, Gustavo Horacio; Luis Arredondo-Garcia, Jose; Maribel Rivera, Doris; Cunha, Rivaldo; Deseda, Carmen; Reynales, Humberto; Costa, Maria Selma; Morales-Ramirez, Javier Osvaldo; Carrasquilla, Gabriel; Rey, Luis Carlos; Dietze, Reynaldo; Luz, Kleber; Rivas, Enrique; Miranda Montoya, Maria Consuelo; Cortes Supelano, Margarita; Zambrano, Betzana; Langevin, Edith; Boaz, Mark; Tornieporth, Nadia; Saville, Melanie; Noriega, Fernando		CYD15 Study Grp	Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II; IMMUNOGENICITY; SAFETY; RECOMBINANT; TRIAL; CHALLENGES; GUIDELINES; BRAZIL; VIRUS	Background In light of the increasing rate of dengue infections throughout the world despite vector-control measures, several dengue vaccine candidates are in development. Methods In a phase 3 efficacy trial of a tetravalent dengue vaccine in five Latin American countries where dengue is endemic, we randomly assigned healthy children between the ages of 9 and 16 years in a 2: 1 ratio to receive three injections of recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV) or placebo at months 0, 6, and 12 under blinded conditions. The children were then followed for 25 months. The primary outcome was vaccine efficacy against symptomatic, virologically confirmed dengue (VCD), regardless of disease severity or serotype, occurring more than 28 days after the third injection. Results A total of 20,869 healthy children received either vaccine or placebo. At baseline, 79.4% of an immunogenicity subgroup of 1944 children had seropositive status for one or more dengue serotypes. In the per-protocol population, there were 176 VCD cases (with 11,793 person-years at risk) in the vaccine group and 221 VCD cases (with 5809 person-years at risk) in the control group, for a vaccine efficacy of 60.8% (95% confidence interval [CI], 52.0 to 68.0). In the intention-to-treat population (those who received at least one injection), vaccine efficacy was 64.7% (95% CI, 58.7 to 69.8). Serotype-specific vaccine efficacy was 50.3% for serotype 1, 42.3% for serotype 2, 74.0% for serotype 3, and 77.7% for serotype 4. Among the severe VCD cases, 1 of 12 was in the vaccine group, for an intention-to-treat vaccine efficacy of 95.5%. Vaccine efficacy against hospitalization for dengue was 80.3%. The safety profile for the CYD-TDV vaccine was similar to that for placebo, with no marked difference in rates of adverse events. Conclusions The CYD-TDV dengue vaccine was efficacious against VCD and severe VCD and led to fewer hospitalizations for VCD in five Latin American countries where dengue is endemic. (Funded by Sanofi Pasteur; ClinicalTrials.gov number, NCT01374516.)	[Villar, Luis] Univ Ind Santander, Sch Med, Clin Epidemiol Unit, Bucaramanga, Colombia; [Reynales, Humberto] Ctr Estudios & Invest Salud, Ctr Atenc & Invest Med, Bogota, Colombia; [Carrasquilla, Gabriel] Fdn Santa Fe Bogota, Bogota, Colombia; [Miranda Montoya, Maria Consuelo; Cortes Supelano, Margarita] Sanofi Pasteur, Bogota, Colombia; [Dayan, Gustavo Horacio; Boaz, Mark; Noriega, Fernando] Sanofi Pasteur, Swiftwater, PA 18370 USA; [Luis Arredondo-Garcia, Jose] Inst Nacl Pediat, Mexico City, DF, Mexico; [Rivas, Enrique] Sanofi Pasteur, Mexico City, DF, Mexico; [Maribel Rivera, Doris] ODISH, Tegucigalpa, Honduras; [Cunha, Rivaldo] Fed Univ State Mato Grosso do Sul UFMS, Campo Grande, Brazil; [Costa, Maria Selma] S Leste Univ, Univ Fed Goias, Hosp Clin, Goiania, Go, Brazil; [Rey, Luis Carlos] Univ Fed Ceara, Inst Biomed, Fortaleza, Ceara, Brazil; [Dietze, Reynaldo] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, Vitoria, Brazil; [Luz, Kleber] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil; [Deseda, Carmen] Caribbean Travel Med Clin, San Juan, PR USA; [Morales-Ramirez, Javier Osvaldo] Clin Res Puerto Rico, San Juan, PR USA; [Zambrano, Betzana] Sanofi Pasteur, Montevideo, Uruguay; [Langevin, Edith; Tornieporth, Nadia] Sanofi Pasteur, Marcy Letoile, France; [Saville, Melanie] Sanofi Pasteur, Lyon, France	Universidad Industrial de Santander; Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Goias; Universidade Federal do Ceara; Universidade Federal do Espirito Santo; Universidade Federal do Rio Grande do Norte; Sanofi-Aventis	Dayan, GH (corresponding author), Sanofi Pasteur, Discovery Dr, Swiftwater, PA 18370 USA.	gustavo.dayan@sanofipasteur.com	Paniago, Anamaria M M/B-7747-2012; de Matos, Vanessa Terezinha Gubert/A-9484-2013	Paniago, Anamaria M M/0000-0002-8925-7712; de Matos, Vanessa Terezinha Gubert/0000-0002-9361-2780; L'Azou Jackson, Maina/0000-0001-7753-0630; Kalayanarooj, Siripen/0000-0002-3568-0929; Dietze, Reynaldo/0000-0002-6995-8001; Arredondo-Garcia, Jose Luis/0000-0001-6560-046X; Miranda Montoya, Maria Consuelo/0000-0001-5730-0723	Sanofi Pasteur	Sanofi Pasteur	Funded by Sanofi Pasteur; ClinicalTrials.gov number, NCT01374516.	Boaz M., 2014, Trials in Vaccinology, V3, P127, DOI 10.1016/j.trivac.2014.07.002; BRESLOW NE, 1987, STAT METHODS CANC RE, V2, P94; Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; da Costa VG, 2014, VACCINE, V32, P4885, DOI 10.1016/j.vaccine.2014.07.008; Dayan GH, 2013, AM J TROP MED HYG, V89, P1058, DOI 10.4269/ajtmh.13-0304; Dayan GH, 2013, VACCINE, V31, P5047, DOI 10.1016/j.vaccine.2013.08.088; Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Hombach J, 2009, J CLIN VIROL, V46, pS7, DOI 10.1016/S1386-6532(09)70287-2; Lam SK, 2013, EXPERT REV VACCINES, V12, P995, DOI 10.1586/14760584.2013.824712; Lanata CF, 2012, VACCINE, V30, P5935, DOI 10.1016/j.vaccine.2012.07.043; Leo YS, 2012, HUM VACC IMMUNOTHER, V8, P1259, DOI 10.4161/hv.21224; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; McArthur MA, 2013, EXPERT REV VACCINES, V12, P933, DOI 10.1586/14760584.2013.815412; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Poo J, 2010, PEDIAT INFECT DIS J, DOI 10.1097/INF.0b013e3181fe05af; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461; Tran NH, 2012, J VACCINES VACCIN, V3, P162, DOI [10.4172/2157-7560.1000162, DOI 10.4172/2157-7560.1000162]; Van der Vliet D, 2013, P AM SOC TROP MED HY; Machado AAV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003104; Villar LA, 2013, PEDIATR INFECT DIS J, V32, P1102, DOI 10.1097/INF.0b013e31829b8022; WHO, 1997, DENG HAEM FEV DIAGN; Zambrano B, 2014, J PEDIATR INFECT DIS, V3, P181, DOI 10.1093/jpids/piu071	31	626	648	0	129	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					113	123		10.1056/NEJMoa1411037	http://dx.doi.org/10.1056/NEJMoa1411037			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25365753				2022-12-28	WOS:000347443300006
J	Lonfat, N; Montavon, T; Darbellay, F; Gitto, S; Duboule, D				Lonfat, Nicolas; Montavon, Thomas; Darbellay, Fabrice; Gitto, Sandra; Duboule, Denis			Convergent evolution of complex regulatory landscapes and pleiotropy at Hox loci	SCIENCE			English	Article							EXTERNAL GENITALIA; TRANSGENIC ANALYSIS; GENE-REGULATION; DOMAINS; MORPHOGENESIS; EXPRESSION; APPENDAGE; ENHANCERS; CLUSTERS; HOXA-13	Hox genes are required during the morphogenesis of both vertebrate digits and external genitals. We investigated whether transcription in such distinct contexts involves a shared enhancer-containing landscape. We show that the same regulatory topology is used, yet with some tissue-specific enhancer-promoter interactions, suggesting the hijacking of a regulatory backbone from one context to the other. In addition, comparable organizations are observed at both HoxA and HoxD clusters, which separated through genome duplication in an ancestral invertebrate animal. We propose that this convergent regulatory evolution was triggered by the preexistence of some chromatin architecture, thus facilitating the subsequent recruitment of the appropriate transcription factors. Such regulatory topologies may have both favored and constrained the evolution of pleiotropic developmental loci in vertebrates.	[Lonfat, Nicolas; Montavon, Thomas; Darbellay, Fabrice; Duboule, Denis] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Gitto, Sandra; Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Duboule, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	denis.duboule@epfl.ch		duboule, denis/0000-0001-9961-2960; Lonfat, Nicolas/0000-0001-7078-3301; Darbellay, Fabrice/0000-0001-6942-3325; Montavon, Thomas/0000-0001-8247-1399	Federal Institute of Technology (EPFL); University of Geneva; Swiss National Research Foundation [310030B_138662]; European Research Council [232790]	Federal Institute of Technology (EPFL); University of Geneva; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission)	We thank D. Noordermeer, P. Fabre, G. Andrey, A. Necsulea, and all colleagues from the Duboule laboratories for their help and for reagents and discussions. We thank M. Docquier and the Geneva Genomics Platform, S. Verp and S. Offner for help with transgenic animals, and M. Leleu from the Bioinformatics and Biostatistics Core Facility (BBCF) of the Ecole Polytechnique Federale (EPFL). Computations were performed at Vital-IT center for high-performance computing of the Swiss Institute of Bioinformatics, using tools developed by the BBCF. This work was supported by funds from the Federal Institute of Technology (EPFL), the University of Geneva, the Swiss National Research Foundation (no. 310030B_138662), and European Research Council grant SystemsHox.ch (no. 232790). Data sets presented in this study are available with accession no. GSE62269.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Cohn MJ, 2011, DEV DYNAM, V240, P1108, DOI 10.1002/dvdy.22631; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; Duboule D, 1998, TRENDS GENET, V14, P54, DOI 10.1016/S0168-9525(97)01358-9; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gonzalez F, 2007, DEV BIOL, V306, P847, DOI 10.1016/j.ydbio.2007.03.020; HAACK H, 1993, DEV BIOL, V157, P410, DOI 10.1006/dbio.1993.1145; HOLLAND PWH, 1994, DEVELOPMENT, P125; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Lehoczky JA, 2008, EVOL DEV, V10, P421, DOI 10.1111/j.1525-142X.2008.00253.x; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ohno S., 1970, EVOLUTION GENE DUPLI; Ravi V, 2009, P NATL ACAD SCI USA, V106, P16327, DOI 10.1073/pnas.0907914106; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Suzuki K, 2003, DEVELOPMENT, V130, P6209, DOI 10.1242/dev.00846; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Warot X, 1997, DEVELOPMENT, V124, P4781; Woltering JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001773	27	92	93	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					1004	1006		10.1126/science.1257493	http://dx.doi.org/10.1126/science.1257493			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414315				2022-12-28	WOS:000345696000046
J	Barouch, DH; Michael, NL				Barouch, Dan H.; Michael, Nelson L.			Accelerating HIV-1 Vaccine Efficacy Trials	CELL			English	Editorial Material							DOUBLE-BLIND; GAG/POL/NEF VACCINE; HVTN 503/PHAMBILI; RHESUS-MONKEYS; SOUTH-AFRICA; PHASE 2H; INFECTION; CHALLENGES		[Barouch, Dan H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Barouch, Dan H.] Harvard, Cambridge, MA 02139 USA; [Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu; nmichael@hivresearch.org	Barouch, Dan/Y-3918-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096040, U19AI095985, R01AI084794, U19AI078526] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI095985, U19 AI096040, U19 AI078526, R01 AI084794] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baden LR, 2014, J INFECT DIS; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Reynolds MR, 2012, VACCINE, V30, P4465, DOI 10.1016/j.vaccine.2012.04.082; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519	13	15	15	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					969	972		10.1016/j.cell.2014.10.046	http://dx.doi.org/10.1016/j.cell.2014.10.046			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416935	Green Accepted, Bronze			2022-12-28	WOS:000345506300008
J	Cullen, BR				Cullen, Bryan R.			HIV-1 Packing to Leave	CELL			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; GAG MEMBRANE-BINDING; RNA; REGION; SITES		[Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Cullen, Bryan R.] Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA	Duke University; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	bryan.cullen@duke.edu						Chukkapalli V, 2013, J VIROL, V87, P7155, DOI 10.1128/JVI.00075-13; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; CLEVER J, 1995, J VIROL, V69, P2101, DOI 10.1128/JVI.69.4.2101-2109.1995; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; RICHARDSON JH, 1993, J VIROL, V67, P3997, DOI 10.1128/JVI.67.7.3997-4005.1993; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924	10	0	0	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					975	976		10.1016/j.cell.2014.11.008	http://dx.doi.org/10.1016/j.cell.2014.11.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416937	Bronze			2022-12-28	WOS:000345506300010
J	Joachimiak, LA; Walzthoeni, T; Liu, CW; Aebersold, R; Frydman, J				Joachimiak, Lukasz A.; Walzthoeni, Thomas; Liu, Corey W.; Aebersold, Ruedi; Frydman, Judith			The Structural Basis of Substrate Recognition by the Eukaryotic Chaperonin TRiC/CCT	CELL			English	Article							GROEL APICAL DOMAIN; CYTOSOLIC CHAPERONIN; BINDING-SITES; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; COMPLEX; PROTEINS; SUBUNIT; PROTEOSTASIS	The eukaryotic chaperonin TRiC (also called CCT) is the obligate chaperone for many essential proteins. TRiC is hetero-oligomeric, comprising two stacked rings of eight different subunits each. Subunit diversification from simpler archaeal chaperonins appears linked to proteome expansion. Here, we integrate structural, biophysical, and modeling approaches to identify the hitherto unknown substrate-binding site in TRiC and uncover the basis of substrate recognition. NMR and modeling provided a structural model of a chaperonin-substrate complex. Mutagenesis and crosslinking-mass spectrometry validated the identified substrate-binding interface and demonstrate that TRiC contacts full-length substrates combinatorially in a subunit-specific manner. The binding site of each subunit has a distinct, evolutionarily conserved pattern of polar and hydrophobic residues specifying recognition of discrete substrate motifs. The combinatorial recognition of polypeptides broadens the specificity of TRiC and may direct the topology of bound polypeptides along a productive folding trajectory, contributing to TRiC's unique ability to fold obligate substrates.	[Joachimiak, Lukasz A.; Frydman, Judith] Stanford Univ, Dept Biol & Genet, Stanford, CA 94305 USA; [Liu, Corey W.] Stanford Univ, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA; [Walzthoeni, Thomas; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Walzthoeni, Thomas] Univ Zurich, ETH Zurich, Ph D Program Mol Life Sci, CH-8057 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland	Stanford University; Stanford University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Joachimiak, LA (corresponding author), Pacific Biosci, 1380 Willow St, Menlo Pk, CA 94025 USA.	lajoachi@gmail.com; jfrydman@stanford.edu		, judith/0000-0003-2302-6943	NIH fellowship; NIH grants; ERC grant [AdG-233226]; ETH Zurich; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074074, U01GM098254] Funding Source: NIH RePORTER	NIH fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC grant; ETH Zurich(ETH Zurich); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. R. Andino, A. Joachimiak, D. Gestaut, and K. Dalton for comments on the manuscript and Drs. L. Gierasch and D. Agard for advice. We thank Dr. M. Eckart from the PAN facility for help with the SPR experiments. This work was supported by an NIH fellowship to L.A.J., NIH grants to J.F., ERC grant to R. A. (Proteomics v3.0; AdG-233226 to R. A.), and funds from ETH Zurich to R. A. and T. W.	Ashcroft AE, 2002, J BIOL CHEM, V277, P33115, DOI 10.1074/jbc.M203398200; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bigotti MG, 2008, ARCH BIOCHEM BIOPHYS, V474, P331, DOI 10.1016/j.abb.2008.03.015; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heller M, 2004, J MOL BIOL, V336, P717, DOI 10.1016/j.jmb.2003.12.035; Hong S, 2001, J VIROL, V75, P2526, DOI 10.1128/JVI.75.6.2526-2534.2001; Hua QX, 2001, J MOL BIOL, V306, P513, DOI 10.1006/jmbi.2000.4405; Hynes GM, 2000, J BIOL CHEM, V275, P18985, DOI 10.1074/jbc.M910297199; Inoue Y, 2011, VIROLOGY, V410, P38, DOI 10.1016/j.virol.2010.10.026; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kasembeli M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001844; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Mao BC, 2014, J AM CHEM SOC, V136, P1893, DOI 10.1021/ja409845w; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Pappenberger G, 2002, J MOL BIOL, V318, P1367, DOI 10.1016/S0022-2836(02)00190-0; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Ritco-Vonsovici M, 2000, J MOL BIOL, V304, P81, DOI 10.1006/jmbi.2000.4177; Rommelaere H, 1999, BIOCHEMISTRY-US, V38, P3246, DOI 10.1021/bi9815905; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Salgado GF, 2009, BIOCHEMISTRY-US, V48, P2355, DOI 10.1021/bi801794v; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tian GL, 2013, METHOD CELL BIOL, V115, P155, DOI 10.1016/B978-0-12-407757-7.00011-6; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; van der Schot G, 2013, J BIOMOL NMR, V57, P27, DOI 10.1007/s10858-013-9762-6; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; You L, 2004, J MOL BIOL, V341, P1343, DOI 10.1016/j.jmb.2004.06.081; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	53	95	95	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1042	1055		10.1016/j.cell.2014.10.042	http://dx.doi.org/10.1016/j.cell.2014.10.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416944	Bronze, Green Accepted			2022-12-28	WOS:000345506300017
J	Swetter, SM; Geller, AC				Swetter, Susan M.; Geller, Alan C.			Catch melanoma early	NATURE			English	Editorial Material									[Swetter, Susan M.] Stanford Univ, Med Ctr, Pigmented Lesion & Melanoma Program, Palo Alto, CA 94304 USA; [Swetter, Susan M.] Inst Canc Res, Palo Alto, CA USA; [Geller, Alan C.] Harvard Univ, Sch Publ Hlth, Boston, MA USA; [Geller, Alan C.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Swetter, SM (corresponding author), Stanford Univ, Med Ctr, Pigmented Lesion & Melanoma Program, Palo Alto, CA 94304 USA.	sswetter@stanford.edu; ageller@hsph.harvard.edu						Aitken JF, 2010, INT J CANCER, V126, P450, DOI 10.1002/ijc.24747; Katalinic A, 2012, CANCER-AM CANCER SOC, V118, P5395, DOI 10.1002/cncr.27566; Schneider JS, 2008, J AM ACAD DERMATOL, V58, P741, DOI 10.1016/j.jaad.2007.10.648; Swetter SM, 2012, CANCER-AM CANCER SOC, V118, P3725, DOI 10.1002/cncr.26707	4	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S117	S117		10.1038/515S117a	http://dx.doi.org/10.1038/515S117a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407708	Bronze			2022-12-28	WOS:000345770600004
J	McCarthy, L				McCarthy, Lucas			Ambulatory ECG monitoring for 30 d increased AF detection more than 24 h of ECG monitoring after cryptogenic stroke Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	McCarthy, L (corresponding author), Univ Washington, Seattle, WA 98195 USA.							Kamel H, 2014, NEW ENGL J MED, V370, P2532, DOI 10.1056/NEJMe1405046; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kishore A, 2014, STROKE, V45, P520, DOI 10.1161/STROKEAHA.113.003433	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC2	10.7326/0003-4819-161-10-201411180-02002	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402535				2022-12-28	WOS:000347245600003
J	Gravitz, L; Pincock, S				Gravitz, Lauren; Pincock, Stephen			SICKLE-CELL DISEASE	NATURE			English	Editorial Material														Pincock, Stephen/0000-0003-1655-2902					0	22	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S1	S1		10.1038/515S1a	http://dx.doi.org/10.1038/515S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390134	Bronze			2022-12-28	WOS:000344631400001
J	Scott, AR				Scott, Andrew R.			Creating a cure-all	NATURE			English	Editorial Material							SICKLE-CELL-DISEASE; TRANSPLANTATION											Bolanos-Meade J, 2012, BLOOD, V120, P4285, DOI 10.1182/blood-2012-07-438408; Hsieh MM, 2014, JAMA-J AM MED ASSOC, V312, P48, DOI 10.1001/jama.2014.7192; Kanter J, 2013, BLOOD REV, V27, P279, DOI 10.1016/j.blre.2013.09.001; Vrecenak J. D., 2014, BLOOD	4	0	0	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S14	S15		10.1038/515S14a	http://dx.doi.org/10.1038/515S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390137	Bronze			2022-12-28	WOS:000344631400009
J	von Gottberg, A; de Gouveia, L; Tempia, S; Quan, V; Meiring, S; von Mollendorf, C; Madhi, SA; Zell, ER; Verani, JR; O'Brien, KL; Whitney, CG; Klugman, KP; Cohen, C				von Gottberg, Anne; de Gouveia, Linda; Tempia, Stefano; Quan, Vanessa; Meiring, Susan; von Mollendorf, Claire; Madhi, Shabir A.; Zell, Elizabeth R.; Verani, Jennifer R.; O'Brien, Katherine L.; Whitney, Cynthia G.; Klugman, Keith P.; Cohen, Cheryl		GERMS-SA Investigators	Effects of Vaccination on Invasive Pneumococcal Disease in South Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIV-INFECTED ADULTS; CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; CHILDREN; ERA; IMMUNIZATION; EPIDEMIOLOGY; SURVEILLANCE; PREVENTION; EFFICACY	BACKGROUND In South Africa, a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 with a three-dose schedule for infants at 6, 14, and 36 weeks of age; a 13-valent vaccine (PCV13) replaced PCV7 in 2011. In 2012, it was estimated that 81% of 12-month-old children had received three doses of vaccine. We assessed the effect of vaccination on invasive pneumococcal disease. METHODS We conducted national, active, laboratory-based surveillance for invasive pneumococcal disease. We calculated the change in the incidence of the disease from a prevaccine (baseline) period (2005 through 2008) to postvaccine years 2011 and 2012, with a focus on high-risk age groups. RESULTS Surveillance identified 35,192 cases of invasive pneumococcal disease. The rates among children younger than 2 years of age declined from 54.8 to 17.0 cases per 100,000 person-years from the baseline period to 2012, including a decline from 32.1 to 3.4 cases per 100,000 person-years in disease caused by PCV7 serotypes (-89%; 95% confidence interval [CI], -92 to -86). Among children not infected with the human immunodeficiency virus (HIV), the estimated incidence of invasive pneumococcal disease caused by PCV7 serotypes decreased by 85% (95% CI, -89 to -79), whereas disease caused by nonvaccine serotypes increased by 33% (95% CI, 15 to 48). Among adults 25 to 44 years of age, the rate of PCV7-serotype disease declined by 57% (95% CI, -63 to -50), from 3.7 to 1.6 cases per 100,000 person-years. CONCLUSIONS Rates of invasive pneumococcal disease among children in South Africa fell substantially by 2012. Reductions in the rates of disease caused by PCV7 serotypes among both children and adults most likely reflect the direct and indirect effects of vaccination.	[von Gottberg, Anne; de Gouveia, Linda; Quan, Vanessa; Meiring, Susan; von Mollendorf, Claire; Madhi, Shabir A.; Cohen, Cheryl] Univ Witwatersrand, Ctr Resp Dis & Meningitis, Natl Inst Communicable Dis NICD, Natl Hlth Lab Serv NHLS, Johannesburg, South Africa; [von Gottberg, Anne; de Gouveia, Linda; Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Zell, Elizabeth R.; Verani, Jennifer R.; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA; [Klugman, Keith P.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [O'Brien, Katherine L.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	von Gottberg, A (corresponding author), Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Private Bag X4, ZA-2131 Johannesburg, Gauteng, South Africa.	annev@nicd.ac.za	Meiring, Susan/M-1463-2019; Moore, David/AAU-7186-2020; Mlisana, Koleka/N-6204-2013	Meiring, Susan/0000-0003-4508-5469; Moore, David/0000-0001-6091-1605; von Gottberg, Anne/0000-0002-0243-7455; Cohen, Cheryl/0000-0003-0376-2302; O'Brien, Katherine/0000-0002-0164-4030; Malope-Kgokong, Babatyi/0000-0001-7446-7664; Mlisana, Koleka/0000-0002-8436-3268	National Institute for Communicable Diseases of the National Health Laboratory Service; President's Emergency Plan for AIDS Relief; U.S. Agency for International Development's Antimicrobial Resistance Initiative; Centers for Disease Control and Prevention [U62/CCU022901, 5U2GPS001328, U60/CCU022088]; Pfizer; Global Alliance for Vaccines and Immunization through the Program for Appropriate Technology in Health; GlaxoSmithKline; Sanofi Pasteur; Novartis	National Institute for Communicable Diseases of the National Health Laboratory Service; President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Agency for International Development's Antimicrobial Resistance Initiative(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pfizer(Pfizer); Global Alliance for Vaccines and Immunization through the Program for Appropriate Technology in Health; GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur; Novartis(Novartis)	Supported by the National Institute for Communicable Diseases of the National Health Laboratory Service, the President's Emergency Plan for AIDS Relief, the U.S. Agency for International Development's Antimicrobial Resistance Initiative, and the Centers for Disease Control and Prevention (cooperative agreements U62/CCU022901, 5U2GPS001328, and U60/CCU022088).; Dr. von Gottberg reports receiving grant support through her institution from Pfizer; Dr. von Mollendorf, receiving honoraria for presentations from Pfizer and salary support from the Global Alliance for Vaccines and Immunization through the Program for Appropriate Technology in Health; Dr. Madhi, receiving fees from GlaxoSmithKline and Pfizer for serving on advisory boards, lecture fees from GlaxoSmithKline, Pfizer, and Sanofi Pasteur, and grant support through his institution from GlaxoSmithKline, Pfizer, and Novartis; Dr. O'Brien, receiving grant support from GlaxoSmithKline and Pfizer; and Dr. Klugman, receiving fees from Pfizer and GlaxoSmithKline for serving on advisory boards and grant support from Pfizer. No other potential conflict of interest relevant to this article was reported.	Andrews N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028435; [Anonymous], WHO VACC PREV DIS MO; Barron P, 2013, B WORLD HEALTH ORGAN, V91, P70, DOI 10.2471/BLT.12.106807; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Clinical and Laboratory Standards Institute (CLSI), 2008, AUSTRALIA; Cohen AL, 2010, AIDS, V24, P2253, DOI 10.1097/QAD.0b013e32833d46fd; Cohen C, 2014, CLIN INFECT DIS, V59, P808, DOI 10.1093/cid/ciu431; Crowther-Gibson P, 2012, ANTIMICROB AGENTS CH, V56, P5088, DOI 10.1128/AAC.06463-11; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Department of Health, 2011 NAT ANT SENT HI; du Plessis M, 2008, INT J ANTIMICROB AG, V32, pS66, DOI 10.1016/j.ijantimicag.2008.06.002; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Hampton LM, 2012, J INFECT DIS, V205, P401, DOI 10.1093/infdis/jir755; Huebner RE, 1999, S AFR MED J, V89, P924; Johnson LF, 2012, S AFR J HIV MED, P22; Johnson LF, THEMBISA VERSION 1 0; Karstaedt AS, 2001, CLIN INFECT DIS, V33, P610, DOI 10.1086/322589; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Knoll MD, 2014, PEDIATR INFECT DIS J, V33, pS119, DOI 10.1097/INF.0000000000000079; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; Madhi SA, 2012, VACCINE, V30, pC21, DOI 10.1016/j.vaccine.2012.05.055; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Public Health England, 2014, RES AN PNEUM DIS CAS; Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008; Scott P, 2011, VACCINE, V29, P9711, DOI 10.1016/j.vaccine.2011.07.042; Statistics South Africa, 2013, STATSONLINE P0302 MI; Stephens DS, 2005, LANCET, V365, P855, DOI 10.1016/S0140-6736(05)71043-6; von Gottberg A, 2013, VACCINE, V31, P4200, DOI 10.1016/j.vaccine.2013.04.077; von Mollendorf C, 2014, ANTIMICROB AGENTS CH, V58, P3293, DOI 10.1128/AAC.02580-13; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; World Health Organization, WHO UNICEF EST PCV3; World Health Organization, WHO PROGR IMM VACC B; World Health Organization/UNAIDS, 2001, AFR HEALTH SCI, V1, P30	41	243	246	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1889	1899		10.1056/NEJMoa1401914	http://dx.doi.org/10.1056/NEJMoa1401914			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25386897				2022-12-28	WOS:000344709800006
J	Zaanen, J				Zaanen, Jan			Electron mirages in an iron salt	NATURE			English	Editorial Material							SUPERCONDUCTIVITY		Leiden Univ, Inst Lorentz Theoret Phys, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Zaanen, J (corresponding author), Leiden Univ, Inst Lorentz Theoret Phys, NL-2300 RA Leiden, Netherlands.	jan@lorentz.leidenuniv.nl						BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Ge J. Q., 2014, PREPRINT; Keimer B., 2014, PREPRINT; Lee JJ, 2014, NATURE, V515, P245, DOI 10.1038/nature13894; Liu DF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1946; Stewart GR, 2011, REV MOD PHYS, V83, P1589, DOI 10.1103/RevModPhys.83.1589; Turner D. W., 1970, MOL PHOTOELECTRON SP; Wang QY, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/037402; Zaanen J, 2011, 100 YEARS SUPERCONDU, P92	9	1	1	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					205	206		10.1038/515205a	http://dx.doi.org/10.1038/515205a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391957	Green Published			2022-12-28	WOS:000344631400035
J	Corcoran, AJ; Conner, WE				Corcoran, Aaron J.; Conner, William E.			Bats jamming bats: Food competition through sonar interference	SCIENCE			English	Article							FREE-TAILED BAT; BIG BROWN BATS; CONSPECIFICS	Communication signals are susceptible to interference ("jamming") from conspecifics and other sources. Many active sensing animals, including bats and electric fish, alter the frequency of their emissions to avoid inadvertent jamming from conspecifics. We demonstrated that echolocating bats adaptively jam conspecifics during competitions for food. Three-dimensional flight path reconstructions and audio-video field recordings of foraging bats (Tadarida brasiliensis) revealed extended interactions in which bats emitted sinusoidal frequency-modulated ultrasonic signals that interfered with the echolocation of conspecifics attacking insect prey. Playbacks of the jamming call, but not of control sounds, caused bats to miss insect targets. This study demonstrates intraspecific food competition through active disruption of a competitor's sensing during food acquisition.	[Corcoran, Aaron J.; Conner, William E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27106 USA; [Corcoran, Aaron J.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Wake Forest University; University System of Maryland; University of Maryland College Park	Corcoran, AJ (corresponding author), Wake Forest Univ, Dept Biol, 030 Winston Hall, Winston Salem, NC 27106 USA.	aaron.j.corcoran@gmail.com			Wake Forest University Summer Fellowship Program; American Museum of Natural History (Theodore Roosevelt Grant); National Institute of Deafness and Communicative Disorders of the National Institutes of Health [UMD T32 DC-00046]; National Science Foundation [IOS-1257248]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000046] Funding Source: NIH RePORTER	Wake Forest University Summer Fellowship Program; American Museum of Natural History (Theodore Roosevelt Grant); National Institute of Deafness and Communicative Disorders of the National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Z. Walker, K. Roman, D. Margius, N. Dowdy, and K. Irvin for field assistance; the Southwestern Research Station staff for coordination of activities; and C. Moss for thoughtful review of the manuscript. Funding was provided by the Wake Forest University Summer Fellowship Program, the American Museum of Natural History (Theodore Roosevelt Grant), an institutional training grant (UMD T32 DC-00046) from the National Institute of Deafness and Communicative Disorders of the National Institutes of Health, and the National Science Foundation (grant number IOS-1257248). Data are available in the supplementary materials.	Barlow KE, 1997, ANIM BEHAV, V53, P991, DOI 10.1006/anbe.1996.0398; BATES DL, 1990, CAN J ZOOL, V68, P49, DOI 10.1139/z90-009; Betke M, 2008, J MAMMAL, V89, P18, DOI 10.1644/07-MAMM-A-011.1; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Corcoran AJ, 2011, J EXP BIOL, V214, P2416, DOI 10.1242/jeb.054783; Corcoran AJ, 2009, SCIENCE, V325, P325, DOI 10.1126/science.1174096; Fuzessery ZM, 2006, J NEUROPHYSIOL, V96, P1320, DOI 10.1152/jn.00021.2006; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; Gillam Erin H, 2007, Proc Biol Sci, V274, P651, DOI 10.1098/rspb.2006.0047; Heiligenberg W., 1991, NEURAL NETS ELECT FI; Masters WM, 1996, J COMP PHYSIOL A, V179, P703, DOI 10.1007/BF00216134; Nelson ME, 2006, J COMP PHYSIOL A, V192, P573, DOI 10.1007/s00359-006-0099-4; Ratcliffe JM, 2004, CAN J ZOOL, V82, P966, DOI 10.1139/Z04-074; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; Wilkinson GS, 1998, ANIM BEHAV, V55, P337, DOI 10.1006/anbe.1997.0557; Wright GS, 2014, CURR BIOL, V24, P885, DOI 10.1016/j.cub.2014.02.058	16	45	46	2	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					745	747		10.1126/science.1259512	http://dx.doi.org/10.1126/science.1259512			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378624				2022-12-28	WOS:000344690100040
J	Gould, MK				Gould, Michael K.			Lung-Cancer Screening with Low-Dose Computed Tomography	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SELECTION CRITERIA; SMOKING-CESSATION; ACTION PROJECT; CT; RISK; PREVALENCE; TRIAL; ASSOCIATION; POPULATION; PREDICTION	A 60-year-old woman comes for follow-up regarding essential hypertension. She has no symptoms other than mild, long-standing dyspnea on exertion; she specifically reports that she has no cough or chest pain and that her weight has not changed. There is no personal history of cancer or family history of lung cancer. She reports smoking one pack of cigarettes per day since 16 years of age. On prior visits, she declined assistance with smoking cessation, citing her stressful life situation as the primary caretaker for her disabled husband. Should you advise lung-cancer screening with low-dose computed tomography (CT)?	[Gould, Michael K.] Kaiser Permanente, Dept Res & Evaluat, Pasadena, CA USA	Kaiser Permanente	Gould, MK (corresponding author), Kaiser Permanente So Calif, Dept Res & Evaluat, 100 S Los Robles Ave,Suite 304, Pasadena, CA 91101 USA.	michael.k.gould@kp.org			Archimedes	Archimedes	Dr. Gould reports receiving salary support from Archimedes to help develop computer models of lung-cancer screening, serving as a guest member of the Medicare Evidence Development and Coverage Advisory Committee for lung-cancer screening, and participating in the development of Lung-RADS for the American College of Radiology. No other potential conflict of interest relevant to this article was reported.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; American Academy of Family Physicians, 2014, CLIN PREV SERV REC L; American College of Radiology, 2014, LUNG CT SCREEN REP D; American Lung Association, 2012, PROV GUID LUNG CANC; Anderson CM, 2009, CANCER EPIDEM BIOMAR, V18, P3476, DOI 10.1158/1055-9965.EPI-09-0176; [Anonymous], 2009, Ann Intern Med, V151, pI, DOI 10.7326/0003-4819-151-9-200911030-00002; Arenberg D, 2012, J NATL COMPR CANC NE, V10, P277, DOI 10.6004/jnccn.2012.0024; Ashraf H, 2009, THORAX, V64, P388, DOI 10.1136/thx.2008.102475; Bach PB, 2013, JAMA-J AM MED ASSOC, V309, P2212, DOI 10.1001/jama.2013.4449; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2012, ANN INTERN MED, V157, P571, DOI 10.7326/0003-4819-157-8-201210160-00524; BERLIN NI, 1984, AM REV RESPIR DIS, V130, P545; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Calonge N, 2010, ANN INTERN MED, V152, P199, DOI 10.7326/0003-4819-152-3-201002020-00025; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Cassidy A, 2007, INT J CANCER, V120, P1, DOI 10.1002/ijc.22331; deKoning HJ, 2013, BENEFITS HARMS COMPU; Diederich S, 2002, RADIOLOGY, V222, P773, DOI 10.1148/radiol.2223010490; FLEHINGER BJ, 1993, CANCER, V72, P1573, DOI 10.1002/1097-0142(19930901)72:5<1573::AID-CNCR2820720514>3.0.CO;2-9; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; FONTANA RS, 1984, AM REV RESPIR DIS, V130, P561; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Hendrick RE, 2012, AM J ROENTGENOL, V198, P723, DOI 10.2214/AJR.11.7146; Henschke CI, 2008, NEW ENGL J MED, V359, P877; Henschke CI, 2008, NEW ENGL J MED, V358, P1875; Henschke CI, 2001, CANCER, V92, P153, DOI 10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke C, 2008, NEW ENGL J MED, V358, P1862, DOI 10.1056/NEJMc086128; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Humphrey LL, 2014, ANN INTERN MED, V160, P212, DOI 10.7326/L14-5003-3; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Kozower BD, 2010, ANN THORAC SURG, V90, P875, DOI 10.1016/j.athoracsur.2010.03.115; Mckee BJ, 2013, J AM COLL RADIOL, V10, P586, DOI 10.1016/j.jacr.2013.02.015; Medicare Evidence Development and Coverage Advisory Committee, 2014, LUNG CANC SCREEN LOW; Memorial Sloan Kettering Cancer Center, 2014, LUNG CANC SCREEN DEC; NAIDICH DP, 1990, RADIOLOGY, V175, P729, DOI 10.1148/radiology.175.3.2343122; National Lung Screening Trial Research Team, 2011, JNCI-J NATL CANCER I, V103, P1560; NCCN Clinical Practice Guidelines in Oncology, 2014, LUNG CANC SCREEN VER; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Pastorino U, 2012, EUR J CANCER PREV, V21, P308, DOI 10.1097/CEJ.0b013e328351e1b6; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Preventive Services Task Force, 2010, ANN INTERN MED, V152, P688; Preventive Services Task Force, 2013, SCREEN LUNG CANC; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.2002.20.4.911; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Tammemagi MC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju084; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Townsend CO, 2005, CANCER-AM CANCER SOC, V103, P2154, DOI 10.1002/cncr.21045; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003	57	40	43	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1813	1820		10.1056/NEJMcp1404071	http://dx.doi.org/10.1056/NEJMcp1404071			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372089				2022-12-28	WOS:000344170300010
J	Gostin, LO; Waxman, HA; Foege, W				Gostin, Lawrence O.; Waxman, Henry A.; Foege, William			The President's National Security Agenda Curtailing Ebola, Safeguarding the Future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Waxman, Henry A.] US House Representat, Washington, DC USA; [Foege, William] Emory Univ, Sch Publ Hlth, Atlanta, GA USA	Georgetown University; Emory University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu						[Anonymous], BUDGET CUTS CONTINUE; Barry M, 2014, LOS ANGELES TIMES; Gostin LO, 2014, LANCET, V384, pE49, DOI 10.1016/S0140-6736(14)61345-3; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186	4	14	14	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					27	28		10.1001/jama.2014.16572	http://dx.doi.org/10.1001/jama.2014.16572			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25412348				2022-12-28	WOS:000347478000008
J	Muoio, DM; Newgard, CB				Muoio, Deborah M.; Newgard, Christopher B.			DIABETES The good in fat	NATURE			English	Editorial Material							ADIPOSE-TISSUE; METABOLISM		[Muoio, Deborah M.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27701 USA; [Muoio, Deborah M.; Newgard, Christopher B.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Muoio, Deborah M.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27701 USA; [Muoio, Deborah M.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27701 USA	Duke University; Duke University; Duke University; Duke University	Muoio, DM (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27701 USA.	chris.newgard@duke.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, R01DK089312] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK058398, R01 DK089312] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	6	11	12	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					49	50		10.1038/nature14070	http://dx.doi.org/10.1038/nature14070			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25409152	Green Accepted			2022-12-28	WOS:000346310800035
J	Fowler, BJ; Gelfand, BD; Kim, Y; Kerur, N; Tarallo, V; Hirano, Y; Amarnath, S; Fowler, DH; Radwan, M; Young, MT; Pittman, K; Kubes, P; Agarwal, HK; Parang, K; Hinton, DR; Bastos-Carvalho, A; Li, SJ; Yasuma, T; Mizutani, T; Yasuma, R; Wright, C; Ambati, J				Fowler, Benjamin J.; Gelfand, Bradley D.; Kim, Younghee; Kerur, Nagaraj; Tarallo, Valeria; Hirano, Yoshio; Amarnath, Shoba; Fowler, Daniel H.; Radwan, Marta; Young, Mark T.; Pittman, Keir; Kubes, Paul; Agarwal, Hitesh K.; Parang, Keykavous; Hinton, David R.; Bastos-Carvalho, Ana; Li, Shengjian; Yasuma, Tetsuhiro; Mizutani, Takeshi; Yasuma, Reo; Wright, Charles; Ambati, Jayakrishna			Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity	SCIENCE			English	Article							VERSUS-HOST-DISEASE; P2X(7) RECEPTOR; MACULAR DEGENERATION; INFLAMMASOME ACTIVATION; CASPASE-1 ACTIVATION; NLRP3 INFLAMMASOME; P2X7 RECEPTOR; ATP RELEASE; INTERLEUKIN-18; PATHOGENESIS	Nucleoside reverse transcriptase inhibitors (NRTIs) are mainstay therapeutics for HIV that block retrovirus replication. Alu (an endogenous retroelement that also requires reverse transcriptase for its life cycle)-derived RNAs activate P2X7 and the NLRP3 inflammasome to cause cell death of the retinal pigment epithelium in geographic atrophy, a type of age-related macular degeneration. We found that NRTIs inhibit P2X7-mediated NLRP3 inflammasome activation independent of reverse transcriptase inhibition. Multiple approved and clinically relevant NRTIs prevented caspase-1 activation, the effector of the NLRP3 inflammasome, induced by Alu RNA. NRTIs were efficacious in mouse models of geographic atrophy, choroidal neovascularization, graft-versus-host disease, and sterile liver inflammation. Our findings suggest that NRTIs are ripe for drug repurposing in P2X7-driven diseases.	[Fowler, Benjamin J.; Gelfand, Bradley D.; Kim, Younghee; Kerur, Nagaraj; Tarallo, Valeria; Hirano, Yoshio; Bastos-Carvalho, Ana; Li, Shengjian; Yasuma, Tetsuhiro; Mizutani, Takeshi; Yasuma, Reo; Wright, Charles; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA; [Fowler, Benjamin J.; Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Gelfand, Bradley D.] Univ Kentucky, Dept Microbiol Immunol & Human Genet, Lexington, KY 40536 USA; [Gelfand, Bradley D.] Univ Kentucky, Dept Biomed Engn, Lexington, KY 40536 USA; [Tarallo, Valeria] CNR, Inst Genet & Biophys, Angiogenesis Lab, I-80125 Naples, Italy; [Amarnath, Shoba; Fowler, Daniel H.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Radwan, Marta; Young, Mark T.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Pittman, Keir; Kubes, Paul] Univ Calgary, Immunol Res Grp, Calgary, AB T2N 4N1, Canada; [Agarwal, Hitesh K.; Parang, Keykavous] Chapman Univ, Sch Pharm, Irvine, CA 92618 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cardiff University; University of Calgary; Chapman University System; Chapman University; University of Southern California; University of Southern California	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA.	jamba2@email.uky.edu	Gelfand, Brad/L-3926-2019; Young, Mark T/E-8928-2010; Parang, Keykavous/ABC-1584-2021; amarnath, shoba/AAP-4391-2020	Young, Mark T/0000-0002-9615-9002; Parang, Keykavous/0000-0001-8600-0893; Tarallo, Valeria/0000-0002-6920-4402; Hirano, Yoshio/0000-0002-9173-0839	NIH [DP1GM114862, R01EY018350, R01EY018836, R01EY020672, R01EY022238, R01EY024068, T32HL091812, UL1RR033173, K99EY024336]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; Ellison Medical Foundation Senior Scholar in Aging Award; Foundation Fighting Blindness Individual Investigator Research Award; Harrington Discovery Institute Scholar-Innovator Award; Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness departmental unrestricted grant; Programme for Advanced Medical Education - Fundacao Calouste Gulbenkian; Programme for Advanced Medical Education - Fundacao Champalimaud; Programme for Advanced Medical Education - Ministerio da Saude; Programme for Advanced Medical Education - Fundacao para a Ciencia e Tecnologia, Portugal; Bayer Global Ophthalmology Research Award; Alcon Japan Research award; Beckman Initiative for Macular Research; American Heart Association; International Retinal Research Foundation (IRRF); Fight for Sight postdoctoral award; Loris and David Rich Postdoctoral Scholar Award (IRRF); Center for Cancer Research, National Cancer Institute; Biotechnology and Biological Sciences Research Council (BBSRC) grant [BB/J017345/1]; NIH grants [P30EY003040, R01EY001545]; Arnold and Mabel Beckman Foundation; Alberta Innovates Health Solutions Graduate Studentship; BBSRC; BBSRC [BB/J017345/1] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000115, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR033172, UL1RR033173] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024068, R01EY022238, R01EY018836, K99EY024336, P30EY003040, R01EY018350, R01EY020672, R01EY001545] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM114862] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J017345/1] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Ellison Medical Foundation Senior Scholar in Aging Award(Lawrence Ellison Foundation); Foundation Fighting Blindness Individual Investigator Research Award; Harrington Discovery Institute Scholar-Innovator Award; Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness departmental unrestricted grant(Research to Prevent Blindness (RPB)); Programme for Advanced Medical Education - Fundacao Calouste Gulbenkian; Programme for Advanced Medical Education - Fundacao Champalimaud; Programme for Advanced Medical Education - Ministerio da Saude; Programme for Advanced Medical Education - Fundacao para a Ciencia e Tecnologia, Portugal; Bayer Global Ophthalmology Research Award; Alcon Japan Research award; Beckman Initiative for Macular Research; American Heart Association(American Heart Association); International Retinal Research Foundation (IRRF); Fight for Sight postdoctoral award; Loris and David Rich Postdoctoral Scholar Award (IRRF); Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council (BBSRC) grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; Alberta Innovates Health Solutions Graduate Studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank B. K. Ambati, K. Ambati, A. M. Adams, A. M. Rao, and G. S. Rao for discussions; L. Toll, G. R. Pattison R. King, L. Xu, M. McConnell, C. Payne, D. Robertson, G. Botzet, and J. May for technical assistance; G. Dubyak for discussions and providing the HEK293-P2X7 cell line; and the University of Kentucky Viral Core (COBRE) for providing lentivirus-GFP. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. J.A. and B.J.F. are listed as inventors on a patent application for the therapeutic use of NRTIs and chemical derivatives filed by their employer, the University of Kentucky. J.A. is a cofounder of iVeena, Inc., which has licensed the technology described in this work. J.A. was supported by NIH grants (DP1GM114862, R01EY018350, R01EY018836, R01EY020672, R01EY022238, and R01EY024068), Doris Duke Distinguished Clinical Scientist Award, Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, Ellison Medical Foundation Senior Scholar in Aging Award, Foundation Fighting Blindness Individual Investigator Research Award, Harrington Discovery Institute Scholar-Innovator Award, Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair, and Research to Prevent Blindness departmental unrestricted grant; B. J. F. by NIH T32HL091812 and UL1RR033173; A. B. C. by the Programme for Advanced Medical Education (sponsored by Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude and Fundacao para a Ciencia e Tecnologia, Portugal) and Bayer Global Ophthalmology Research Award; Y.H. by Alcon Japan Research award; N.K. by Beckman Initiative for Macular Research and NIH K99EY024336; B. D. G. by American Heart Association and International Retinal Research Foundation (IRRF); T.Y. by Fight for Sight postdoctoral award; and C. W. by The Loris and David Rich Postdoctoral Scholar Award (IRRF). D. H. F and S. A. are supported by the Center for Cancer Research, National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. M. T.Y. and M. R. are supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/J017345/1. D. R. H. is supported by NIH grants P30EY003040 and R01EY001545 and by the Arnold and Mabel Beckman Foundation. K.P. is supported by an Alberta Innovates Health Solutions Graduate Studentship, and M.R. by the BBSRC. me-d4T is available from the University of Kentucky via a Materials Transfer Agreement.	Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Agarwal HK, 2011, BIOORG MED CHEM LETT, V21, P1917, DOI 10.1016/j.bmcl.2011.02.070; Ahmad R, 2002, J VIROL, V76, P12448, DOI 10.1128/JVI.76.24.12448-12456.2002; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; [Anonymous], 2014, GUID US ANT AG HIV 1; BALZARINI J, 1989, J BIOL CHEM, V264, P6127; Baroja-Mazo A, 2013, BBA-BIOMEMBRANES, V1828, P79, DOI 10.1016/j.bbamem.2012.01.002; Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2002, EST SAF START DOS CL; Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Gourine AV, 2005, BRIT J PHARMACOL, V146, P139, DOI 10.1038/sj.bjp.0706287; Hu HZ, 1999, IMMUNOLOGY, V98, P379, DOI 10.1046/j.1365-2567.1999.00881.x; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; Salas E, 2013, J PHARMACOL EXP THER, V347, P802, DOI 10.1124/jpet.113.209452; Schmaltz C, 2003, BLOOD, V101, P2440, DOI 10.1182/blood-2002-07-2109; Solini A, 1999, J CELL SCI, V112, P297; Stylianou E, 2003, CLIN EXP IMMUNOL, V132, P462, DOI 10.1046/j.1365-2249.2003.02179.x; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273	40	145	154	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					1000	1003		10.1126/science.1261754	http://dx.doi.org/10.1126/science.1261754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414314	Green Accepted, Green Submitted			2022-12-28	WOS:000345696000045
J	Sun, BK; Siprashvili, Z; Khavari, PA				Sun, Bryan K.; Siprashvili, Zurab; Khavari, Paul A.			Advances in skin grafting and treatment of cutaneous wounds	SCIENCE			English	Review							STEM-CELLS; EPIDERMOLYSIS-BULLOSA; GENE-THERAPY; T-CELLS; REPAIR; TRANSPLANTATION; PATHWAY; SIGNALS; BURNS; GAMMA	The ability of the skin to repair itself after injury is vital to human survival and is disrupted in a spectrum of disorders. The process of cutaneous wound healing is complex, requiring a coordinated response by immune cells, hematopoietic cells, and resident cells of the skin. We review the classic paradigms of wound healing and evaluate how recent discoveries have enriched our understanding of this process. We evaluate current and experimental approaches to treating cutaneous wounds, with an emphasis on cell-based therapies and skin transplantation.	[Sun, Bryan K.; Siprashvili, Zurab; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu		Sun, Bryan/0000-0002-0740-0125	U.S. Department of Veterans Affairs Office of Research and Development Merit Award [BX001409]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR055914, R01 AR045192]; NIAMS [F32 ARO63508]; Epidermolysis Bullosa Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055914, R01AR045192] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs Office of Research and Development Merit Award; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Epidermolysis Bullosa Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by U.S. Department of Veterans Affairs Office of Research and Development Merit Award BX001409 (P.A.K.), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grants R01 AR055914 and R01 AR045192 (P.A.K.) NIAMS training grant F32 ARO63508 (B.K.S.), and the Epidermolysis Bullosa Research Foundation.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Andreassi A, 2005, CLIN DERMATOL, V23, P332, DOI 10.1016/j.clindermatol.2004.07.024; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Branski LK, 2009, BURNS, V35, P171, DOI 10.1016/j.burns.2008.03.009; Butler KL, 2010, J BURN CARE RES, V31, P874, DOI 10.1097/BCR.0b013e3181f9353a; Chester AL, 2004, J BURN CARE REHABIL, V25, P266, DOI 10.1097/01.BCR.0000124749.85552.CD; Clark RAF, 2001, ANN NY ACAD SCI, V936, P355; Cordeiro JV, 2013, NAT REV MOL CELL BIO, V14, P249, DOI 10.1038/nrm3541; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Davis J S, 1941, Ann Surg, V113, P641, DOI 10.1097/00000658-194105000-00001; De Rosa L, 2014, STEM CELL REP, V2, P1, DOI 10.1016/j.stemcr.2013.11.001; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eaglstein WH, 2001, DERMATOL SURG, V27, P175, DOI 10.1046/j.1524-4725.2001.00299.x; Ferrari S, 2006, EXPERT OPIN BIOL TH, V6, P367, DOI 10.1517/14712598.6.4.367; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jackson WM, 2012, STEM CELL TRANSL MED, V1, P44, DOI 10.5966/sctm.2011-0024; Jones J. E., 2012, COCHRANE DB SYST REV, V1; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781; LEVENSON SM, 1965, ANN SURG, V161, P293, DOI 10.1097/00000658-196502000-00019; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Morimoto N, 2005, J SURG RES, V125, P56, DOI 10.1016/j.jss.2004.11.012; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ogawa R, 2010, PLAST RECONSTR SURG, V125, P557, DOI 10.1097/PRS.0b013e3181c82dd5; Oh JW, 2013, J INVEST DERMATOL, V133, pE14, DOI 10.1038/jid.2013.387; Peck MD, 2011, BURNS, V37, P1087, DOI 10.1016/j.burns.2011.06.005; Petkar KS, 2011, BURNS, V37, P925, DOI 10.1016/j.burns.2011.05.013; Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058; ROSS R, 1968, J CELL BIOL, V39, P152, DOI 10.1083/jcb.39.1.152; Seland H, 2011, BURNS, V37, P99, DOI 10.1016/j.burns.2010.03.014; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Siprashvili Z, 2010, HUM GENE THER, V21, P1299, DOI 10.1089/hum.2010.023; Steed DL, 2006, PLAST RECONSTR SURG, V117, p143S, DOI 10.1097/01.prs.0000222526.21512.4c; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Tolar J, 2011, J INVEST DERMATOL, V131, P848, DOI 10.1038/jid.2010.346; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Xu SH, 2011, CURR BIOL, V21, P1960, DOI 10.1016/j.cub.2011.10.050; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	52	406	422	59	424	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					941	945		10.1126/science.1253836	http://dx.doi.org/10.1126/science.1253836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414301				2022-12-28	WOS:000345696000031
J	Ghosez, P; Triscone, JM				Ghosez, Philippe; Triscone, Jean-Marc			MATERIALS PHYSICS Reactive walls	NATURE			English	Editorial Material							DOMAIN-WALLS; MULTIFERROICS; CONDUCTION	Domain walls are natural borders in ferromagnetic, ferroelectric or ferroelastic materials. It seems that they can also be reactive areas that produce crystallographic phases never before observed in bulk materials. See Letter p.379	[Ghosez, Philippe] Univ Liege, Unit Theoret Mat Phys, B-4000 Sart Tilman Par Liege, Belgium; [Triscone, Jean-Marc] Univ Geneva, Dept Condensed Matter Phys, CH-1211 Geneva, Switzerland	University of Liege; University of Geneva	Ghosez, P (corresponding author), Univ Liege, Unit Theoret Mat Phys, B-4000 Sart Tilman Par Liege, Belgium.	jean-marc.triscone@unige.ch	Ghosez, Philippe/F-1954-2014					Benedek NA, 2013, J PHYS CHEM C, V117, P13339, DOI 10.1021/jp402046t; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Farokhipoor S, 2014, NATURE, V515, P379, DOI 10.1038/nature13918; Ghosez P, 2011, NAT MATER, V10, P269, DOI 10.1038/nmat3003; GLAZER AM, 1972, ACTA CRYSTALLOGR B, VB 28, P3384, DOI 10.1107/S0567740872007976; Guyonnet J, 2011, ADV MATER, V23, P5377, DOI 10.1002/adma.201102254; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Malashevich A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037210; Schroder M, 2012, ADV FUNCT MATER, V22, P3936, DOI 10.1002/adfm.201201174; Seidel J, 2009, NAT MATER, V8, P229, DOI [10.1038/NMAT2373, 10.1038/nmat2373]; Zubko P, 2011, ANNU REV CONDEN MA P, V2, P141, DOI 10.1146/annurev-conmatphys-062910-140445	11	1	1	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					348	350		10.1038/515348a	http://dx.doi.org/10.1038/515348a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409822				2022-12-28	WOS:000345770600030
J	Conte, G; de Asmundis, C; Ciconte, G; Julia, J; Sieira, J; Chierchia, GB; Brugada, P				Conte, Giulio; de Asmundis, Carlo; Ciconte, Giuseppe; Julia, Justo; Sieira, Juan; Chierchia, Gian-Battista; Brugada, Pedro			Follow-up From Childhood to Adulthood of Individuals With Family History of Brugada Syndrome and Normal Electrocardiograms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; CHILDREN		[Conte, Giulio; de Asmundis, Carlo; Ciconte, Giuseppe; Julia, Justo; Sieira, Juan; Chierchia, Gian-Battista; Brugada, Pedro] UZ Brussel VUB, Heart Rhythm Management Ctr, B-1090 Brussels, Belgium	Vrije Universiteit Brussel	Conte, G (corresponding author), UZ Brussel VUB, Heart Rhythm Management Ctr, Laarbeeklaan 101, B-1090 Brussels, Belgium.	giulioconte.cardio@gmail.com	Ciconte, Giuseppe/J-9938-2016; Santinelli, Vincenzo/J-9927-2016	Ciconte, Giuseppe/0000-0001-7886-5467; Conte, Giulio/0000-0003-2248-3456; de Asmundis, Carlo/0000-0001-9351-0760; Santinelli, Vincenzo/0000-0003-4169-3619				Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Conte G, 2014, J AM COLL CARDIOL, V63, P2272, DOI 10.1016/j.jacc.2014.02.574; Makita N, 2007, HEART RHYTHM, V4, P516, DOI 10.1016/j.hrthm.2006.10.028; Matsuo K, 2003, PACE, V26, P1551, DOI 10.1046/j.1460-9592.2003.t01-1-00227.x; Yamakawa Y, 2004, CIRC J, V68, P275, DOI 10.1253/circj.68.275	6	43	44	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2039	2041		10.1001/jama.2014.13752	http://dx.doi.org/10.1001/jama.2014.13752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399282	Bronze			2022-12-28	WOS:000345450500021
J	Hartog, CS; Natanson, C; Sun, JF; Klein, HG; Reinhart, K				Hartog, Christiane S.; Natanson, Charles; Sun, Junfeng; Klein, Harvey G.; Reinhart, Konrad			Concerns over use of hydroxyethyl starch solutions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RENAL-FUNCTION; VOLUME RESUSCITATION; FLUID RESUSCITATION; METAANALYSIS; MORTALITY; SURGERY; THERAPY; SAFETY		[Hartog, Christiane S.; Reinhart, Konrad] Jena Univ Hosp, Ctr Sepsis Care & Control, Dept Anaesthesiol & Intens Care Med, D-07747 Jena, Germany; [Natanson, Charles; Sun, Junfeng] NIH, Crit Care Med Dept, Bethesda, MD 20892 USA; [Klein, Harvey G.] NIH, Dept Transfus Med, Bethesda, MD 20892 USA	Friedrich Schiller University of Jena; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Reinhart, K (corresponding author), Jena Univ Hosp, Ctr Sepsis Care & Control, Dept Anaesthesiol & Intens Care Med, D-07747 Jena, Germany.	konrad.reinhart@med.uni-jena.de		Hartog, Christiane/0000-0003-1098-9775				ALEXANDER B, 1975, FED PROC, V34, P1429; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; [Anonymous], 2013, COCHRANE DATABASE SY; Bellmann R, 2012, CLIN PHARMACOKINET, V51, P225, DOI 10.2165/11594700-000000000-00000; Bion JF, 2013, BR J ANAESTH; Brun-Buisson C, 2014, JAMA-J AM MED ASSOC, V311, P1068, DOI 10.1001/jama.2014.836; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; EMA, 2013, ASS REP SOL INF CONT; FDA, 2013, SAF COMM BOX WARN IN; Hartog CS, 2012, INTENS CARE MED, V38, P1258, DOI 10.1007/s00134-012-2614-0; Hartog CS, 2011, ANESTH ANALG, V112, P635, DOI 10.1213/ANE.0b013e31820ad607; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; James MF, 2012, BRIT J ANAESTH, V108, P60; Jonville-Bera A, 2001, NEW ENGL J MED, V345, P622, DOI 10.1056/NEJM200108233450818; Kozek-Langenecker SA, 2008, ANESTH ANALG, V107, P382, DOI 10.1213/ane.0b013e31817e6eac; LEGENDRE C, 1993, LANCET, V342, P248, DOI 10.1016/0140-6736(93)92345-T; MRHA, 2013, CLASS 2 DRUG AL ACT; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Navickis RJ, 2012, J THORAC CARDIOV SUR, V144, P223, DOI 10.1016/j.jtcvs.2012.04.009; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Takala J, 2013, ANESTH ANALG, V117, P527, DOI 10.1213/ANE.0b013e318296913f; US Department of Health and Human Services Public Health Service Food and Drug Administration (FDA), 2007, NDA REV MEM MID CYCL; Wiedermann CJ, 2014, WIEN KLIN WOCHENSCHR, V126, P189, DOI 10.1007/s00508-014-0503-y; Wilkes MM, 2014, NETH J CRIT CARE, V18, P4; Wise J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1738; Wittstock M, 2013, B ARZNEIMITTELSICHER, P13; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	30	43	43	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2014	349								g5981	10.1136/bmj.g5981	http://dx.doi.org/10.1136/bmj.g5981			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JP	25385352	Green Published			2022-12-28	WOS:000345444800003
J	Woyke, T; Rubin, EM				Woyke, Tanja; Rubin, Edward M.			Searching for new branches on the tree of life	SCIENCE			English	Editorial Material							LINEAGES; HYDROGEN		[Woyke, Tanja] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Woyke, T (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov						Baker BJ, 2006, SCIENCE, V314, P1933, DOI 10.1126/science.1132690; Claverie Jean-Michel, 2013, Commun Integr Biol, V6, pe25685, DOI 10.4161/cib.25685; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ivanova NN, 2014, SCIENCE, V344, P909, DOI 10.1126/science.1250691; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Martin WF, 2012, FEBS LETT, V586, P485, DOI 10.1016/j.febslet.2011.09.031; Nasir A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00194; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schneider GF, 2012, NAT BIOTECHNOL, V30, P326, DOI 10.1038/nbt.2181; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011	15	13	15	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					698	699		10.1126/science.1258871	http://dx.doi.org/10.1126/science.1258871			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378606				2022-12-28	WOS:000344690100020
J	Barzel, A; Paulk, NK; Shi, Y; Huang, Y; Chu, K; Zhang, F; Valdmanis, PN; Spector, LP; Porteus, MH; Gaensler, KM; Kay, MA				Barzel, A.; Paulk, N. K.; Shi, Y.; Huang, Y.; Chu, K.; Zhang, F.; Valdmanis, P. N.; Spector, L. P.; Porteus, M. H.; Gaensler, K. M.; Kay, M. A.			Promoter less gene targeting without nucleases ameliorates haemophilia B in mice	NATURE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; IN-VIVO; LIVER TRANSDUCTION; MOUSE MODEL; THERAPY; INTEGRATION; VECTORS	Site-specific gene addition can allow stable transgene expression for gene therapy. When possible, this is preferred over the use of promiscuously integrating vectors, which are sometimes associated with clonal expansion(1) and oncogenesis(2). Site-specific endonudeases that can induce high rates of targeted genome editing are finding increasing applications in biological discovery and gene therapy(3). However, two safety concerns persist: endonudease-associated adverse effects, both on-target(4) and off-target(5,6); and oncogene activation caused by promoter integration, even without nucleases(7). Here we perform recombinant adeno-associated virus (rAAV)-mediated promoterless gene targeting without nucleases and demonstrate amelioration of the bleeding diathesis in haemophilia B mice. In particular, we target a promoterless human coagulation factor IX (F9) gene to the liver-expressed mouse albumin (Alb) locus. F9 is targeted, along with a preceding 2A-peptide coding sequence, to be integrated just upstream to the Alb stop codon. While F9 is fused to Alb at the DNA and RNA levels, two separate proteins are synthesized by way of ribosomal skipping. Thus, F9 expression is linked to robust hepatic albumin expression without disrupting it. We injected an AAV8-F9 vector into neonatal and adult mice and achieved on-target integration into similar to 0.5% of the albumin alleles in hepatocytes. We established that F9 was produced only from on-target integration, and ribosomal skipping was highly efficient. Stable F9 plasma levels at 7-20% of normal were obtained, and treated F9-deficient mice had normal coagulation times. In conclusion, transgene integration as a 2A-fusion to a highly expressed endogenous gene may obviate the requirement for nucleases and/or vector-borne promoters. This method may allow for safe and efficacious gene targeting in both infants and adults by greatly diminishing off-target effects while still providing therapeutic levels of expression from integration.	[Barzel, A.; Paulk, N. K.; Huang, Y.; Chu, K.; Zhang, F.; Valdmanis, P. N.; Spector, L. P.; Porteus, M. H.; Kay, M. A.] Dept Pediat, Stanford, CA 94305 USA; [Barzel, A.; Paulk, N. K.; Huang, Y.; Chu, K.; Zhang, F.; Valdmanis, P. N.; Spector, L. P.; Kay, M. A.] Dept Genet, Stanford, CA 94305 USA; [Shi, Y.; Gaensler, K. M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kay, MA (corresponding author), Dept Pediat, 269 Campus Dr,CCSR Bldg,Room 2105, Stanford, CA 94305 USA.	markay@stanford.edu	Huang, ZhiXin/H-5123-2017; Barzel, Adi/ABD-2981-2021; Wilson, Matthew H/K-3193-2013	Huang, ZhiXin/0000-0003-0705-1970; Valdmanis, Paul/0000-0001-8840-6969; Paulk, Nicole/0000-0002-5557-6280; Kay, Mark/0000-0002-2799-2615	National Heart Lung & Blood Institute [R01-HL064274, F32-HL119059]; Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA [UL1 TR001085]; Child Health Research Institute of Stanford University; American Liver Foundation; Stanford Dean's Fellowship; Laurie Krauss Lacob Faculty Scholar Fund in Pediatric Translational Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL119059, R01HL064274] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	National Heart Lung & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA; Child Health Research Institute of Stanford University; American Liver Foundation; Stanford Dean's Fellowship; Laurie Krauss Lacob Faculty Scholar Fund in Pediatric Translational Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant to M.A.K. from the National Heart Lung & Blood Institute (R01-HL064274). A.B. was supported by a fellowship from the Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA UL1 TR001085 and Child Health Research Institute of Stanford University. N.K.P. was supported by a fellowship from the National Heart Lung & Blood Institute (F32-HL119059), the Hans Popper Memorial Fellowship from the American Liver Foundation, and the Stanford Dean's Fellowship. M.H.P. was supported by the Laurie Krauss Lacob Faculty Scholar Fund in Pediatric Translational Medicine. The funding organizations played no role in experimental design, data analysis or manuscript preparation.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Anguela XM, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.720.720; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Li CW, 2012, J VIROL, V86, P7752, DOI 10.1128/JVI.00675-12; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Lisowski L, 2012, MOL THER, V20, P1912, DOI 10.1038/mt.2012.164; Lu JM, 2013, MOL THER, V21, P954, DOI 10.1038/mt.2013.33; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Miller DG, 2006, NAT BIOTECHNOL, V24, P1022, DOI 10.1038/nbt1231; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Paulk NK, 2012, HUM GENE THER, V23, P658, DOI 10.1089/hum.2012.038; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Rogers G. L., 2012, J GENET SYNDR GEN S1, P012; Shi Y, 2013, GENE THER, V20, P987, DOI 10.1038/gt.2013.22; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Yew NS, 2013, PEDIATR ENDOCR REV P, V11, P99	35	156	175	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					360	U476		10.1038/nature13864	http://dx.doi.org/10.1038/nature13864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363772	Green Accepted			2022-12-28	WOS:000347810300044
J	Sheffield, MEJ; Dombeck, DA				Sheffield, Mark E. J.; Dombeck, Daniel A.			Calcium transient prevalence across the dendritic arbour predicts place field properties	NATURE			English	Article							NEURONS IN-VIVO; CA1 PYRAMIDAL NEURONS; CELLULAR RESOLUTION; BASAL DENDRITES; NEURAL ACTIVITY; VIRTUAL NAVIGATION; SPIKES; DYNAMICS; SPINES; CELLS	Establishing the hippocampal cellular ensemble that represents an animal's environment involves the emergence and disappearance of place fields in specific CA1 pyramidal neurons(1-4), and the acquisition of different spatial firing properties across the active population(5). While such firing flexibility and diversity have been linked to spatial memory, attention and task performance(6,7), the cellular and network origin of these place cell features is unknown. Basic integrate-and-fire models of place firing propose that such features result solely from varying inputs to place cells(8,9), but recent studies(3,10) suggest instead that place cells themselves may play an active role through regenerative dendritic events. However, owing to the difficulty of performing functional recordings from place cell dendrites, no direct evidence of regenerative dendritic events exists, leaving any possible connection to place coding unknown. Using multi-plane two-photon calcium imaging of CA1 place cell somata, axons and dendrites in mice navigating a virtual environment, here we show that regenerative dendritic events do exist in place cells of behaving mice, and, surprisingly, their prevalence throughout the arbour is highly spatiotemporally variable. Furthermore, we show that the prevalence of such events predicts the spatial precision and persistence or disappearance of place fields. This suggests that the dynamics of spiking throughout the dendritic arbour may play a key role in forming the hippocampal representation of space.	[Sheffield, Mark E. J.; Dombeck, Daniel A.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	Dombeck, DA (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	d-dombeck@northwestern.edu		Dombeck, Daniel/0000-0003-2576-5918; Sheffield, Mark/0000-0003-0969-7820	Klingenstein Foundation; Whitehall Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Northwestern University; National Institutes of Health [1R01MH101297]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101297] Funding Source: NIH RePORTER	Klingenstein Foundation(Klingenstein Philanthropies); Whitehall Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Northwestern University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to B. Mensh for discussions on data conceptualization, interpretation and presentation. We thank C. Harvey, B. Mensh, N. Spruston, C. Woolley, W. Kath and L. Looger for comments on the manuscript, E. Han and P. Boueri for technical assistance, and V. Jayaraman, R. Kerr, D. Kim, L. Looger, K. Svoboda from the GENIE Project (Janelia Farm, Howard Hughes Medical Institute) for GCaMP6. This work was supported by The Klingenstein Foundation, The Whitehall Foundation, The Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust, Northwestern University, The National Institutes of Health (1R01MH101297), and M.S. is an Ellison Medical Foundation Fellow of the Life Sciences Research Foundation.	Ariav G, 2003, J NEUROSCI, V23, P7750; Barry C, 2007, HIPPOCAMPUS, V17, P786, DOI 10.1002/hipo.20324; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grewe BF, 2011, BIOMED OPT EXPRESS, V2, P2035, DOI 10.1364/BOE.2.002035; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Higley MJ, 2008, NEURON, V59, P902, DOI 10.1016/j.neuron.2008.08.020; Hill DN, 2013, P NATL ACAD SCI USA, V110, P13618, DOI 10.1073/pnas.1312599110; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Miri A, 2011, J NEUROPHYSIOL, V105, P964, DOI 10.1152/jn.00702.2010; Mittmann W, 2011, NAT NEUROSCI, V14, P1089, DOI 10.1038/nn.2879; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Palmer LM, 2014, NAT NEUROSCI, V17, P383, DOI 10.1038/nn.3646; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wu XE, 2009, NEURON, V62, P31, DOI 10.1016/j.neuron.2009.02.021; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhou WL, 2008, EUR J NEUROSCI, V27, P923, DOI 10.1111/j.1460-9568.2008.06075.x; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	48	138	138	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					200	U191		10.1038/nature13871	http://dx.doi.org/10.1038/nature13871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25363782	Green Accepted			2022-12-28	WOS:000347477600036
J	McKethan, A; Jha, AK				McKethan, Aaron; Jha, Ashish K.			Designing Smarter Pay-for-Performance Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[McKethan, Aaron] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Kresge 408,677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu						Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Institute of Medicine, 2001, CROSSING THE QUALITY; Jha AK, 2014, JAMA-J AM MED ASSOC, V312, P225, DOI 10.1001/jama.2014.7204; Jha AK, 2013, JAMA-J AM MED ASSOC, V309, P347, DOI 10.1001/jama.2012.196646; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788	6	13	14	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2617	2618		10.1001/jama.2014.15398	http://dx.doi.org/10.1001/jama.2014.15398			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25375310				2022-12-28	WOS:000346966100009
J	Fine, C				Fine, Cordelia			NEUROSCIENCE His brain, her brain?	SCIENCE			English	Editorial Material							SEX-DIFFERENCES; GENDER; CONNECTOME		[Fine, Cordelia] Univ Melbourne, Melbourne Business Sch, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Fine, Cordelia] Univ Melbourne, Ctr Eth Leadership, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne	Fine, C (corresponding author), Univ Melbourne, Melbourne Business Sch, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	cfine@unimelb.edu.au						Fine C., 2010, DELUSIONS GENDER OUR; Fine C, 2013, NEUROETHICS-NETH, V6, P369, DOI 10.1007/s12152-012-9169-1; Halpern DF, 2011, SCIENCE, V333, P1706, DOI 10.1126/science.1205031; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Joel D, 2014, BRIT J PHARMACOL, V171, P4620, DOI 10.1111/bph.12732; Joel D, 2014, P NATL ACAD SCI USA, V111, pE637, DOI 10.1073/pnas.1323319111; Joel D, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-27; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; MILLER DI, 2014, SCI ENG ETHICS, V18, P37, DOI DOI 10.1016/J.TICS.2013.10.011; O'Connor C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110830; Rippon G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00650; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; SPENCE JT, 1993, J PERS SOC PSYCHOL, V64, P624, DOI 10.1037/0022-3514.64.4.624	15	18	18	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					915	916		10.1126/science.1262061	http://dx.doi.org/10.1126/science.1262061			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6EL	25414288				2022-12-28	WOS:000345696000016
J	[Anonymous]				[Anonymous]			Editors' Introduction: Annals Supplement From the Robert Wood Johnson Foundation Clinical Scholars Program	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S1	S1		10.7326/M14-2407	http://dx.doi.org/10.7326/M14-2407			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3RR	25402397				2022-12-28	WOS:000364909900001
J	Cifu, AS; Davis, AM				Cifu, Adam S.; Davis, Andrew M.			Use of HPV Vaccine in Males and Females	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HUMAN-PAPILLOMAVIRUS VACCINATION		[Cifu, Adam S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Davis, Andrew M.] Univ Chicago, Gen Internal Med Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P630; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Bednarczyk RA, 2012, PEDIATRICS, V130, P798, DOI 10.1542/peds.2012-1516; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1705; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741	10	6	8	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1920	1921		10.1001/jama.2014.12274	http://dx.doi.org/10.1001/jama.2014.12274			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387190				2022-12-28	WOS:000344532600022
J	Clement, ME; Okeke, NL; Hicks, CB				Clement, Meredith E.; Okeke, N. Lance; Hicks, Charles B.			Treatment of Syphilis A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; CEREBROSPINAL-FLUID ABNORMALITIES; SEROLOGICAL TREATMENT RESPONSE; BENZATHINE PENICILLIN-G; CD4 CELL COUNTS; TREPONEMA-PALLIDUM; SECONDARY SYPHILIS; CEFTRIAXONE THERAPY; UNITED-STATES	IMPORTANCE The incidence of syphilis in the United States is increasing; it is estimated that more than 55 000 new infections will occur in 2014. Treatment regimens are controversial, especially in specific populations, and assessing treatment response based on serology remains a challenge. OBJECTIVE To review evidence regarding penicillin and nonpenicillin regimens, implications of the "serofast state," and treatment of specific populations including those with neurosyphilis or human immunodeficiency virus (HIV) infection and pregnant women. EVIDENCE REVIEW We searched MEDLINE for English-language human treatment studies dating from January 1965 until July 2014. The American Heart Association classification system was used to rate quality of evidence. FINDINGS We included 102 articles in our review, consisting of randomized trials, meta-analyses, and cohort studies. Case reports and small series were excluded unless they were the only studies providing evidence for a specific treatment strategy. We included 11 randomized trials. Evidence regarding penicillin and nonpenicillin regimens was reviewed from studies involving 11 102 patients. Data on the treatment of early syphilis support the use of a single intramuscular injection of 2.4 million U of benzathine penicillin G, with studies reporting 90% to 100% treatment success rates. The value of multiple-dose treatment of early syphilis is uncertain, especially in HIV-infected individuals. Less evidence is available regarding therapy for late and late latent syphilis. Following treatment, nontreponemal serologic titers should decline in a stable pattern, but a significant proportion of patients may remain seropositive (the "serofast state"). Serologic response to treatment should be evident by 6 months in early syphilis but is generally slower (12-24 months) for latent syphilis. Evidence defining treatment for HIV-infected persons and for pregnant women is limited, but available data support penicillin as first-line therapy. CONCLUSIONS AND RELEVANCE The mainstay of syphilis treatment is parenteral penicillin G despite the relatively modest clinical trial data that support its use.	[Clement, Meredith E.; Okeke, N. Lance] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; [Hicks, Charles B.] Univ Calif San Diego, Div Gen Internal Med, San Diego, CA 92103 USA; [Hicks, Charles B.] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA	Duke University; University of California System; University of California San Diego; University of California System; University of California San Diego	Hicks, CB (corresponding author), Univ Calif San Diego, Div Gen Internal Med, 200 W Arbor Dr,Mail Stop 8681, San Diego, CA 92103 USA.	cbhicks@ucsd.edu			NIAID NIH HHS [T32 AI007392] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agmon-Levin N, 2010, INT J STD AIDS, V21, P249, DOI 10.1258/ijsa.2009.009011; Alexander JM, 1999, OBSTET GYNECOL, V93, P5, DOI 10.1016/S0029-7844(98)00338-X; Association of Public Health Laboratories, 2009, LABORATORY DIAGNOSTI; Bai ZG, 2012, COCHRANE DB SYST REV, V6; Bai ZG, 2008, INT J STD AIDS, V19, P217, DOI 10.1258/ijsa.2007.007245; Berman SM, 2004, COCHRANE DB SYST REV, V82, P433; Blank LJ, 2011, SEX TRANSM INFECT, V87, P9, DOI 10.1136/sti.2010.043893; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Centers for Disease Control and Prevention, SYPHILIS FACT SHEET; Centers for Disease Control and Prevention, STD SURVEILLANCE CAS; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P197; Cernadas JR, 2010, ALLERGY, V65, P1357, DOI 10.1111/j.1398-9995.2010.02441.x; Chanem KG, 2008, AIDS, V22, P1145, DOI 10.1097/QAD.0b013e32830184df; Cohen SE, 2013, INFECT DIS CLIN N AM, V27, P705, DOI 10.1016/j.idc.2013.08.005; Dionne-Odom J, 2013, CLIN INFECT DIS, V56, P1829, DOI 10.1093/cid/cit146; DOWELL ME, 1992, AM J MED, V93, P481, DOI 10.1016/0002-9343(92)90574-U; DUNLOP EMC, 1981, BRIT MED J, V283, P646, DOI 10.1136/bmj.283.6292.646; DURST RD, 1973, ARCH DERMATOL, V108, P663, DOI 10.1001/archderm.108.5.663; FIUMARA NJ, 1986, J AM ACAD DERMATOL, V14, P487, DOI 10.1016/S0190-9622(86)70063-7; Flood JM, 1998, J INFECT DIS, V177, P931, DOI 10.1086/515245; Gentile JH, 1998, CLIN INFECT DIS, V26, P528, DOI 10.1086/517112; Ghanem KG, 2007, SEX TRANSM INFECT, V83, P97, DOI 10.1136/sti.2006.021402; Ghanem KG, 2006, CLIN INFECT DIS, V42, pE45, DOI 10.1086/500406; Ghanem KG, 2008, CLIN INFECT DIS, V47, P258, DOI 10.1086/589295; Ghanem KG, 2011, CLIN INFECT DIS, V53, pS110, DOI 10.1093/cid/cir701; Gibbons RJ, 2003, CIRCULATION, V107, P2979, DOI 10.1161/01.CIR.0000063682.20730.A5; GOEMAN J, 1995, GENITOURIN MED, V71, P275; Golden MR, 2003, JAMA-J AM MED ASSOC, V290, P1510, DOI 10.1001/jama.290.11.1510; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Gonzalez-Lopez JJ, 2009, CLIN INFECT DIS, V49, P1505, DOI 10.1086/644618; GORDON SM, 1994, NEW ENGL J MED, V331, P1469, DOI 10.1056/NEJM199412013312201; Harshan V, 1982, Indian J Dermatol, V27, P119; Hawkes SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056713; HELLERSTROM S, 1962, ACTA DERM-VENEREOL, V42, P179; Holman KM, 2012, SEX TRANSM DIS, V39, P645, DOI 10.1097/OLQ.0b013e3182536574; Hook EW, 2010, J INFECT DIS, V201, P1729, DOI 10.1086/652239; HOOK EW, 1986, SEX TRANSM DIS, V13, P185, DOI 10.1097/00007435-198607000-00018; HOOK EW, 1988, J INFECT DIS, V158, P881, DOI 10.1093/infdis/158.4.881; Hook EW, 2002, SEX TRANSM DIS, V29, P486, DOI 10.1097/00007435-200208000-00010; Idsoe O, 1972, Bull World Health Organ, V47 Suppl, P1; INGRAHAM N R Jr, 1950, Acta Derm Venereol Suppl (Stockh), V31, P60; JEFFERISS FJG, 1963, BRIT J VENER DIS, V39, P143; Jinno S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-605; Kiddugavu MG, 2005, SEX TRANSM DIS, V32, P1, DOI 10.1097/01.olq.0000148297.48590.d8; Klausner JD, 2006, NEW ENGL J MED, V354, P204; Knaute DF, 2012, CLIN INFECT DIS, V55, P1615, DOI 10.1093/cid/cis757; Kofoed K, 2006, SEX TRANSM DIS, V33, P143, DOI 10.1097/01.olq.0000187262.56820.c0; Lewis DA, 2011, SEX TRANSM INFECT, V87, pII39, DOI 10.1136/sti.2010.047712; Li J, 2014, J INFECT DEV COUNTR, V8, P228, DOI 10.3855/jidc.3013; Long CM, 2006, SEX TRANSM DIS, V33, P151, DOI 10.1097/01.olq.0000204506.06551.5f; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; MALONE JL, 1995, AM J MED, V99, P55, DOI 10.1016/S0002-9343(99)80105-3; Manavi K, 2007, INT J STD AIDS, V18, P814, DOI 10.1258/095646207782717018; Marra CM, 2006, J INFECT DIS, V194, P1771, DOI 10.1086/509512; Marra CM, 2004, CLIN INFECT DIS, V38, P1001, DOI 10.1086/382532; Marra CM, 2000, CLIN INFECT DIS, V30, P540, DOI 10.1086/313725; Marra CM, 1996, SEX TRANSM DIS, V23, P184, DOI 10.1097/00007435-199605000-00005; MOHR JA, 1976, JAMA-J AM MED ASSOC, V236, P2208, DOI 10.1001/jama.236.19.2208; MOORTHY TT, 1987, SEX TRANSM DIS, V14, P116, DOI 10.1097/00007435-198704000-00013; MUSHER DM, 1991, J INFECT DIS, V163, P1201, DOI 10.1093/infdis/163.6.1201; MUSHER DM, 1990, ANN INTERN MED, V113, P872, DOI 10.7326/0003-4819-113-11-872; National Library of Medicine, PENICILLIN G PROCAIN; National Library of Medicine, BICILLIN L A PENICIL; National Library of Medicine, PENICILLIN G SODIUM; NELL E. E., 1954, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V38, P92; NORRIS SJ, 1988, ANTIMICROB AGENTS CH, V32, P68, DOI 10.1128/AAC.32.1.68; Onoda Y, 1980, Jpn J Antibiot, V33, P18; Palacios R, 2007, JAIDS-J ACQ IMM DEF, V44, P356, DOI 10.1097/QAI.0b013e31802ea4c6; Parkes R, 2004, INT J STD AIDS, V15, P73, DOI 10.1258/095646204322764253; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Pialoux G, 2008, AIDS REV, V10, P85; Pichichero ME, 2007, OTOLARYNG HEAD NECK, V136, P340, DOI 10.1016/j.otohns.2006.10.007; Pound MW, 2005, J CLIN PHARM THER, V30, P291, DOI 10.1111/j.1365-2710.2005.00631.x; Psomas KC, 2012, MED MALADIES INFECT, V42, P15, DOI 10.1016/j.medmal.2011.10.003; Qin JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102203; Riedner G, 2005, NEW ENGL J MED, V353, P1236, DOI 10.1056/NEJMoa044284; Rolfs RT, 1997, NEW ENGL J MED, V337, P307, DOI 10.1056/NEJM199707313370504; ROLFS RT, 1995, CLIN INFECT DIS, V20, pS23, DOI 10.1093/clinids/20.Supplement_1.S23; Schofer H, 1996, GENITOURIN MED, V72, P176; SCHROETER AL, 1972, J AMER MED ASSOC, V221, P471, DOI 10.1001/jama.221.5.471; SCOFER H, 1989, CHEMOTHERAPY, V35, P140, DOI 10.1159/000238661; Sena AC, 2013, CLIN INFECT DIS, V56, P420, DOI 10.1093/cid/cis918; Sena AC, 2011, CLIN INFECT DIS, V53, P1092, DOI 10.1093/cid/cir671; Shann S, 2003, SEX TRANSM INFECT, V79, P415, DOI 10.1136/sti.79.5.415; SMITH C A, 1956, Bull World Health Organ, V15, P1087; Smith NH, 2004, INT J STD AIDS, V15, P328, DOI 10.1258/095646204323012823; Spornraft-Ragaller P, 2011, EUR J MED RES, V16, P47, DOI 10.1186/2047-783X-16-2-47; STERNBERG TH, 1947, JAMA-J AM MED ASSOC, V133, P1; Su J, 2011, PROCEEDINGS OF THE 2; Su JR, 2012, SEX TRANSM DIS, V39, P794, DOI 10.1097/OLQ.0b013e31826f36de; TALWAR S, 1992, GENITOURIN MED, V68, P120; Tittes J, 2013, INT J STD AIDS, V24, P703, DOI 10.1177/0956462413480721; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; Tong ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070102; Van Damme K, 2009, SEX TRANSM DIS, V36, P775, DOI 10.1097/OLQ.0b013e3181bd11dd; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; Wong T, 2008, AM J MED, V121, P903, DOI 10.1016/j.amjmed.2008.04.042; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yang CJ, 2010, CLIN INFECT DIS, V51, P976, DOI 10.1086/656419; Zhou PY, 2005, SEX TRANSM DIS, V32, P495, DOI 10.1097/01.olq.0000170443.70739.cd	101	121	137	1	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1905	1917		10.1001/jama.2014.13259	http://dx.doi.org/10.1001/jama.2014.13259			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387188	Green Accepted			2022-12-28	WOS:000344532600020
J	Moseley, SH				Moseley, S. H.			The other half of the universe?	SCIENCE			English	Editorial Material							BACKGROUND ANISOTROPIES; FLUCTUATIONS; GALAXIES; LIGHT		NASA, Goddard Space Flight Ctr, Lab Observat Cosmol, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Moseley, SH (corresponding author), NASA, Goddard Space Flight Ctr, Lab Observat Cosmol, Greenbelt, MD 20771 USA.	harvey.moseley@nasa.gov						Cooray A, 2007, ASTROPHYS J, V659, pL91, DOI 10.1086/517969; Cooray A, 2012, NATURE, V490, P514, DOI 10.1038/nature11474; Hauser MG, 1998, ASTROPHYS J, V508, P25, DOI 10.1086/306379; Kashlinsky A, 2007, ASTROPHYS J, V654, pL5, DOI 10.1086/510483; Kashlinsky A, 2005, NATURE, V438, P45, DOI 10.1038/nature04143; Matsumoto T, 2005, ASTROPHYS J, V626, P31, DOI 10.1086/429383; Zemcov M, 2014, SCIENCE, V346, P732, DOI 10.1126/science.1258168	7	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					696	697		10.1126/science.aaa1077	http://dx.doi.org/10.1126/science.aaa1077			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378605				2022-12-28	WOS:000344690100019
J	Emery, P; Hammoudeh, M; FitzGerald, O; Combe, B; Martin-Mola, E; Buch, MH; Krogulec, M; Williams, T; Gaylord, S; Pedersen, R; Bukowski, J; Vlahos, B				Emery, Paul; Hammoudeh, Mohammed; FitzGerald, Oliver; Combe, Bernard; Martin-Mola, Emilio; Buch, Maya H.; Krogulec, Marek; Williams, Theresa; Gaylord, Stefanie; Pedersen, Ronald; Bukowski, Jack; Vlahos, Bonnie			Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADALIMUMAB PLUS METHOTREXATE; LOW DISEASE-ACTIVITY; MODIFYING ANTIRHEUMATIC DRUGS; DOUBLE-BLIND; RADIOGRAPHIC PROGRESSION; COMBINATION ETANERCEPT; CONTROLLED OPTIMA; CONTROLLED-TRIAL; INFLIXIMAB; THERAPY	BACKGROUND We assessed the effects of reduction and withdrawal of treatment in patients with rheumatoid arthritis who had a remission while receiving etanercept-plus-methotrexate therapy. METHODS Patients with early active disease who had not previously received methotrexate or biologic therapy received 50 mg of etanercept plus methotrexate weekly for 52 weeks (open-label phase). We then randomly assigned patients who had qualifying responses at weeks 39 and 52 to receive 25 mg of etanercept plus methotrexate (combination-therapy group), methotrexate alone, or placebo for 39 weeks (double-blind phase). Patients who had qualifying responses at week 39 of the double-blind phase had all treatment withdrawn at that time and were followed to week 65 (treatment-withdrawal phase). The primary end point was the proportion of patients with sustained remission in the double-blind phase. RESULTS Of 306 patients enrolled, 193 underwent randomization in the double-blind phase; 131 qualified for the treatment-withdrawal phase. More patients in the combination-therapy group than in the methotrexate-alone group or the placebo group met the criterion for the primary end point (40 of 63 [63%] vs. 26 of 65 [40%] and 15 of 65 [23%], respectively; P = 0.009 for combination therapy vs. methotrexate alone; P<0.001 for combination therapy vs. placebo). At 65 weeks, 28 patients (44%) who had received combination therapy, 19 (29%) who had received methotrexate alone, and 15 (23%) who had received placebo were in remission (P = 0.10 for combination therapy vs. methotrexate alone; P = 0.02 for combination therapy vs. placebo; P = 0.55 for methotrexate alone vs. placebo). No significant between-group differences were observed in radiographic progression of disease. Serious adverse events were reported in 3 patients (5%) in the combination-therapy group, 2 (3%) in the methotrexate-alone group, and 2 (3%) in the placebo group. CONCLUSIONS In patients with early rheumatoid arthritis who had a remission while receiving full-dose etanercept-plus-methotrexate therapy, continuing combination therapy at a reduced dose resulted in better disease control than switching to methotrexate alone or placebo, but no significant difference was observed in radiographic progression.	[Emery, Paul; Buch, Maya H.] Univ Leeds, Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Emery, Paul; Buch, Maya H.] Leeds Teaching Hosp NHS Trust, Natl Inst Hlth Res, Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Hammoudeh, Mohammed] Hamad Med, Doha, Qatar; [FitzGerald, Oliver] St Vincents Univ Hosp, Dublin 4, Ireland; [Combe, Bernard] Univ Montpellier I, Lapeyronie Hosp, Dept Rheumatol, Montpellier, France; [Martin-Mola, Emilio] La Paz Univ Hosp, IdiPaz, Madrid, Spain; [Krogulec, Marek] Hosp Hlth Ctr West Mazovia, Rheumatol Dept, Zyrardow, Poland; [Williams, Theresa; Gaylord, Stefanie; Pedersen, Ronald; Bukowski, Jack; Vlahos, Bonnie] Pfizer, Collegeville, PA USA	Chapel Allerton Hospital; University of Leeds; University of Leeds; Hamad Medical Corporation; University College Dublin; Saint Vincent's University Hospital; Universite de Montpellier; CHU de Montpellier; Hospital Universitario La Paz; Pfizer	Emery, P (corresponding author), Chapel Allerton Hosp, Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England.	p.emery@leeds.ac.uk	emery, paul/B-3560-2013	Buch, Maya/0000-0002-8962-5642; FitzGerald, Oliver/0000-0002-6607-6070	Pfizer; National Institute for Health Research [NF-SI-0513-10139] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish	Pfizer(Pfizer); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	Funded by Pfizer; ClinicalTrials.gov number, NCT00913458.	Aletaha D, 2009, ARTHRITIS RHEUM, V60, P1242, DOI 10.1002/art.24433; Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bejarano V, 2010, RHEUMATOLOGY, V49, P1971, DOI 10.1093/rheumatology/keq194; Bosello S, 2011, ANN RHEUM DIS, V70, P1292, DOI 10.1136/ard.2010.142729; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Brocq O, 2009, JOINT BONE SPINE, V76, P350, DOI 10.1016/j.jbspin.2008.11.009; Buch MH, 2005, ARTHRITIS RHEUM-US, V52, P42, DOI 10.1002/art.20711; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2012, ANN RHEUM DIS, V71, P989, DOI 10.1136/annrheumdis-2011-201066; Emery P, 2010, ARTHRITIS RHEUM-US, V62, P674, DOI 10.1002/art.27268; Emery P, 2009, J RHEUMATOL, V36, P1429, DOI 10.3899/jrheum.081018; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P64, DOI 10.1136/annrheumdis-2011-201247; Kavanaugh A, 2011, ARTHRITIS RHEUM-US, V63, pS665; Kekow J, 2010, ANN RHEUM DIS, V69, P222, DOI 10.1136/ard.2008.102509; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P315, DOI 10.1136/ard.2010.136556; Makinen H, 2007, J RHEUMATOL, V34, P316; Nawata M, 2008, MOD RHEUMATOL, V18, P460, DOI 10.1007/s10165-008-0089-1; Plant MJ, 1998, J RHEUMATOL, V25, P417; Puolakka K, 2005, ARTHRITIS RHEUM, V52, P36, DOI 10.1002/art.20716; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Rantalaiho V, 2009, ARTHRITIS RHEUM-US, V60, P1222, DOI 10.1002/art.24447; Saleem B, 2010, ANN RHEUM DIS, V69, P1636, DOI 10.1136/ard.2009.117341; Schoels M, 2012, ANN RHEUM DIS, V71, P1303, DOI 10.1136/annrheumdis-2011-200490; Smolen JS, 2009, ANN RHEUM DIS, V68, P823, DOI 10.1136/ard.2008.090019; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Tanaka Y, 2013, CLIN EXP RHEUMATOL, V31, pS22; Tanaka Y, 2010, ANN RHEUM DIS, V69, P1286, DOI 10.1136/ard.2009.121491; Tanaka Y, 2009, ANN RHEUM DIS     S3, V68, P120; Tanaka Y, 2012, CURR OPIN RHEUMATOL, V24, P319, DOI 10.1097/BOR.0b013e3283524e4c; Tanaka Y, 2011, ARTHRITIS RHEUM-US, V63, pS962; van der Bijl AE, 2007, ARTHRITIS RHEUM-US, V56, P2129, DOI 10.1002/art.22718; van der Kooij SM, 2009, ANN RHEUM DIS, V68, P1153, DOI 10.1136/ard.2008.093294; VANDERHEIJDE DMFM, 1991, J RHEUMATOL, V18, P1285; Villeneuve E, 2011, ARTHRITIS RHEUM-US, V63, pS960; Welsing PMJ, 2001, ARTHRITIS RHEUM, V44, P2009, DOI 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L	38	147	156	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1781	1792		10.1056/NEJMoa1316133	http://dx.doi.org/10.1056/NEJMoa1316133			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372086				2022-12-28	WOS:000344170300007
J	Huo, HH; Shen, XD; Wang, CY; Zhang, LL; Rose, P; Chen, LA; Harms, K; Marsch, M; Hilt, G; Meggers, E				Huo, Haohua; Shen, Xiaodong; Wang, Chuanyong; Zhang, Lilu; Roese, Philipp; Chen, Liang-An; Harms, Klaus; Marsch, Michael; Hilt, Gerhard; Meggers, Eric			Asymmetric photoredox transition-metal catalysis activated by visible light	NATURE			English	Article							DUAL-CATALYSIS; COMPLEXES; ALKYLATION; ELECTRON; TRIFLUOROMETHYLATION; ALDEHYDES; DRIVEN; ACID	Asymmetric catalysis is seen as one of the most economical strategies to satisfy the growing demand for enantiomerically pure small molecules in the fine chemical and pharmaceutical industries(1). And visible light has been recognized as an environmentally friendly and sustainable form of energy for triggering chemical transformations and catalytic chemical processes(2-5). For these reasons, visible-light-driven catalytic asymmetric chemistry is a subject of enormous current interest(2-5). Photoredox catalysis provides the opportunity to generate highly reactive radical ion intermediates with often unusual or unconventional reactivities under surprisingly mild reaction conditions(6). In such systems, photoactivated sensitizers initiate a single electron transfer from(or to) a closed-shell organic molecule to produce radical cations or radical anions whose reactivities are then exploited for interesting or unusual chemical transformations. However, the high reactivity of photoexcited substrates, intermediate radical ions or radicals, and the low activation barriers for follow-up reactions provide significant hurdles for the development of efficient catalytic photochemical processes that work under stereochemical control and provide chiral molecules in an asymmetric fashion(7). Here we report a highly efficient asymmetric catalyst that uses visible light for the necessary molecular activation, thereby combining asymmetric catalysis and photocatalysis. We show that a chiral iridium complex can serve as a sensitizer for photoredox catalysis and at the same time provide very effective asymmetric induction for the enantioselective alkylation of 2-acyl imidazoles. This new asymmetric photoredox catalyst, in which the metal centre simultaneously serves as the exclusive source of chirality, the catalytically active Lewis acid centre, and the photoredox centre, offers new opportunities for the 'green' synthesis of non-racemic chiral molecules.	[Huo, Haohua; Shen, Xiaodong; Wang, Chuanyong; Zhang, Lilu; Roese, Philipp; Harms, Klaus; Marsch, Michael; Hilt, Gerhard; Meggers, Eric] Univ Marburg, Fachbereich Chem, D-35043 Marburg, Germany; [Chen, Liang-An; Meggers, Eric] Xiamen Univ, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China	Philipps University Marburg; Xiamen University	Meggers, E (corresponding author), Univ Marburg, Fachbereich Chem, Hans Meerwein Str, D-35043 Marburg, Germany.	meggers@chemie.uni-marburg.de	Röse, Philipp/AAJ-4297-2021; Shen, Xiaodong/ABI-1910-2020; Meggers, Eric/B-8541-2014	Röse, Philipp/0000-0001-6591-7133; Meggers, Eric/0000-0002-8851-7623; Huo, Haohua/0000-0003-1785-4128; Wang, Chuanyong/0000-0001-9576-8589; Chen, Liang-An/0000-0003-3423-3390	German Research Foundation [ME 1805/4-1]; China Scholarship Council	German Research Foundation(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council)	We acknowledge funding from the German Research Foundation (ME 1805/4-1). H. H. thanks the China Scholarship Council for a stipend.	Alonso R, 2014, ANGEW CHEM INT EDIT, V53, P4368, DOI 10.1002/anie.201310997; ANDRIEUX CP, 1992, J AM CHEM SOC, V114, P6892, DOI 10.1021/ja00043a039; Arceo E, 2013, NAT CHEM, V5, P750, DOI [10.1038/NCHEM.1727, 10.1038/nchem.1727]; Bauer A, 2005, NATURE, V436, P1139, DOI 10.1038/nature03955; Bauer EB, 2012, CHEM SOC REV, V41, P3153, DOI 10.1039/c2cs15234g; Bergonzini G, 2014, CHEM SCI, V5, P112, DOI [10.1039/C3SC52265B, 10.1039/c3sc52265b]; Brimioulle R, 2013, SCIENCE, V342, P840, DOI 10.1126/science.1244809; Cherevatskaya M, 2012, ANGEW CHEM INT EDIT, V51, P4062, DOI 10.1002/anie.201108721; Curran D. P., 1996, STEREOCHEMISTRY RADI; DiRocco DA, 2012, J AM CHEM SOC, V134, P8094, DOI 10.1021/ja3030164; Du JN, 2014, SCIENCE, V344, P392, DOI 10.1126/science.1251511; Evans DA, 2003, J AM CHEM SOC, V125, P8706, DOI 10.1021/ja035509j; Fontecave M, 2005, TOP ORGANOMETAL CHEM, V15, P271; Herrmann AT, 2012, J AM CHEM SOC, V134, P6976, DOI 10.1021/ja302552e; Hopkinson MN, 2014, CHEM-EUR J, V20, P3874, DOI 10.1002/chem.201304823; Huo HH, 2014, J AM CHEM SOC, V136, P2990, DOI 10.1021/ja4132505; Muller C, 2009, ANGEW CHEM INT EDIT, V48, P6640, DOI 10.1002/anie.200901603; Nagib DA, 2009, J AM CHEM SOC, V131, P10875, DOI 10.1021/ja9053338; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Neumann M, 2011, ANGEW CHEM INT EDIT, V50, P951, DOI 10.1002/anie.201002992; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Sato H, 2007, J PHOTOCH PHOTOBIO C, V8, P67, DOI 10.1016/j.jphotochemrev.2007.04.001; Schmittel M, 1997, ANGEW CHEM INT EDIT, V36, P2550, DOI 10.1002/anie.199725501; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Shih HW, 2010, J AM CHEM SOC, V132, P13600, DOI 10.1021/ja106593m; Studer A, 2014, NAT CHEM, V6, P765, DOI 10.1038/nchem.2031; Tarantino KT, 2013, J AM CHEM SOC, V135, P10022, DOI 10.1021/ja404342j; Walsh PJ., 2009, FUNDAMENTALS ASYMMET; Zeitler K, 2009, ANGEW CHEM INT EDIT, V48, P9785, DOI 10.1002/anie.200904056	30	414	418	23	904	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					100	103		10.1038/nature13892	http://dx.doi.org/10.1038/nature13892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373679				2022-12-28	WOS:000344187500037
J	Lally, DR; Monsonego, J				Lally, David R.; Monsonego, Julia			Ectopia Lentis in Marfan's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lally, David R.; Monsonego, Julia] Thomas Jefferson Univ, Wills Eye Hosp, Philadelphia, PA 19107 USA	Jefferson University	Lally, DR (corresponding author), Thomas Jefferson Univ, Wills Eye Hosp, Philadelphia, PA 19107 USA.	david.lally@gmail.com							0	3	4	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					E28	E28		10.1056/NEJMicm1314140	http://dx.doi.org/10.1056/NEJMicm1314140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372113				2022-12-28	WOS:000344170300001
J	Mahieu, E; Chipperfield, MP; Notholt, J; Reddmann, T; Anderson, J; Bernath, PF; Blumenstock, T; Coffey, MT; Dhomse, SS; Feng, W; Franco, B; Froidevaux, L; Griffith, DWT; Hannigan, JW; Hase, F; Hossaini, R; Jones, NB; Morino, I; Murata, I; Nakajima, H; Palm, M; Paton-Walsh, C; Russell, JM; Schneider, M; Servais, C; Smale, D; Walker, KA				Mahieu, E.; Chipperfield, M. P.; Notholt, J.; Reddmann, T.; Anderson, J.; Bernath, P. F.; Blumenstock, T.; Coffey, M. T.; Dhomse, S. S.; Feng, W.; Franco, B.; Froidevaux, L.; Griffith, D. W. T.; Hannigan, J. W.; Hase, F.; Hossaini, R.; Jones, N. B.; Morino, I.; Murata, I.; Nakajima, H.; Palm, M.; Paton-Walsh, C.; Russell, J. M., III; Schneider, M.; Servais, C.; Smale, D.; Walker, K. A.			Recent Northern Hemisphere stratospheric HCl increase due to atmospheric circulation changes	NATURE			English	Article							INORGANIC CHLORINE; OZONE; EVOLUTION; SYSTEM; AIR; AGE	The abundance of chlorine in the Earth's atmosphere increased considerably during the 1970s to 1990s, following large emissions of anthropogenic long-lived chlorine-containing source gases, notably the chlorofluorocarbons. The chemical inertness of chlorofluorocarbons allows their transport and mixing throughout the troposphere on a global scale(1), before they reach the stratosphere where they release chlorine atoms that cause ozone depletion(2). The large ozone loss over Antarctica(3) was the key observation that stimulated the definition and signing in 1987 of the Montreal Protocol, an international treaty establishing a schedule to reduce the production of the major chlorine-and bromine-containing halocarbons. Owing to its implementation, the near-surface total chlorine concentration showed a maximum in 1993, followed by a decrease of half a per cent to one per cent per year(4), in line with expectations. Remote-sensing data have revealed a peak in stratospheric chlorine after 1996(5), then a decrease of close to one per cent per year(6,7), in agreement with the surface observations of the chlorine source gases and model calculations(7). Here we present ground-based and satellite data that show a recent and significant increase, at the 2 sigma level, in hydrogen chloride (HCl), the main stratospheric chlorine reservoir, starting around 2007 in the lower stratosphere of the Northern Hemisphere, in contrast with the ongoing monotonic decrease of near-surface source gases. Using model simulations, we attribute this trend anomaly to a slow down in the Northern Hemisphere atmospheric circulation, occurring over several consecutive years, transporting more aged air to the lower stratosphere, and characterized by a larger relative conversion of source gases to HCl. This short-term dynamical variability will also affect other stratospheric tracers and needs to be accounted for when studying the evolution of the stratospheric ozone layer.	[Mahieu, E.; Franco, B.; Servais, C.] Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; [Chipperfield, M. P.; Dhomse, S. S.; Feng, W.; Hossaini, R.] Univ Leeds, Sch Earth & Environm, Natl Ctr Atmospher Sci, Leeds LS2 9JT, W Yorkshire, England; [Notholt, J.; Palm, M.] Univ Bremen, Dept Phys, D-28334 Bremen, Germany; [Reddmann, T.; Blumenstock, T.; Hase, F.; Schneider, M.] Karlsruhe Inst Technol KIT, Inst Meteorol & Climate Res IMK ASF, D-76021 Karlsruhe, Germany; [Anderson, J.; Russell, J. M., III] Hampton Univ, Dept Atmospher & Planetary Sci, Hampton, VA 23668 USA; [Bernath, P. F.] Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA 23529 USA; [Bernath, P. F.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Bernath, P. F.; Walker, K. A.] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Coffey, M. T.; Hannigan, J. W.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Froidevaux, L.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Griffith, D. W. T.; Jones, N. B.; Paton-Walsh, C.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Morino, I.; Nakajima, H.] Natl Inst Environm Studies NIES, Tsukuba, Ibaraki 3058506, Japan; [Murata, I.] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808578, Japan; [Smale, D.] Natl Inst Water & Atmospher Res NIWA, Lauder 9352, New Zealand; [Walker, K. A.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	University of Liege; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Leeds; University of Bremen; Helmholtz Association; Karlsruhe Institute of Technology; Hampton University; Old Dominion University; University of York - UK; University of Waterloo; National Center Atmospheric Research (NCAR) - USA; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Wollongong; National Institute for Environmental Studies - Japan; Tohoku University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Toronto	Mahieu, E (corresponding author), Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium.	emmanuel.mahieu@ulg.ac.be	Jones, Nicholas B/G-5575-2011; Jones, Nicholas/AFU-3135-2022; FENG, WUHU/B-8327-2008; Nakajima, Hideaki/A-4309-2012; Schneider, Matthias/B-1441-2013; Paton-Walsh, Clare/B-2774-2009; Blumenstock, Thomas/K-2263-2012; Notholt, Justus/P-4520-2016; Nakajima, Hideaki/M-8845-2019; Franco, Bruno/O-5853-2019; Dhomse, Sandip/C-8198-2011; Morino, Isamu/K-1033-2014; Franco, Bruno/F-9595-2017; Dhomse, Sandip/AAM-1119-2021; Bernath, Peter F/B-6567-2012; Hossaini, Ryan/F-7134-2015; Chipperfield, Martyn/H-6359-2013; Palm, Mathias/D-9173-2017	Jones, Nicholas B/0000-0002-0111-2368; Jones, Nicholas/0000-0002-0111-2368; FENG, WUHU/0000-0002-9907-9120; Nakajima, Hideaki/0000-0002-2742-1230; Paton-Walsh, Clare/0000-0003-1156-4138; Blumenstock, Thomas/0000-0003-4005-900X; Notholt, Justus/0000-0002-3324-885X; Nakajima, Hideaki/0000-0002-2742-1230; Franco, Bruno/0000-0003-0736-458X; Dhomse, Sandip/0000-0003-3854-5383; Morino, Isamu/0000-0003-2720-1569; Franco, Bruno/0000-0003-0736-458X; Bernath, Peter F/0000-0002-1255-396X; Chipperfield, Martyn/0000-0002-6803-4149; Palm, Mathias/0000-0001-7191-6911; Hossaini, Ryan/0000-0003-2395-6657; Mahieu, Emmanuel/0000-0002-5251-0286; Hannigan, James/0000-0002-4269-1677	Belgian Science Policy Office (BELSPO), Brussels; Fonds de la Recherche Scientifique-FNRS, Brussels; MeteoSwiss (Global Atmospheric Watch); Federation Wallonie-Bruxelles; International Foundation High Altitude Research Stations Jungfraujoch and Gornergrat (HFSJG, Bern); NASA MEASURE's GOZCARDS programme; National Oceanic and Atmospheric Administration's Educational Partnership Program Cooperative Remote Sensing Science and Technology Center (NOAA EPP CREST); Canadian Space Agency; National Science Foundation; National Aeronautics and Space Administration (NASA); NSF Office of Polar Programs; Danish Meteorological Institute; Australian Research Council [DP110101948]; New Zealand's Ministry of Business, Innovation and Employment; Natural Environment Research Council [ncas10009, NE/J02449X/1, nceo020005] Funding Source: researchfish; NERC [NE/J02449X/1, nceo020005] Funding Source: UKRI	Belgian Science Policy Office (BELSPO), Brussels(Belgian Federal Science Policy Office); Fonds de la Recherche Scientifique-FNRS, Brussels(Fonds de la Recherche Scientifique - FNRS); MeteoSwiss (Global Atmospheric Watch); Federation Wallonie-Bruxelles; International Foundation High Altitude Research Stations Jungfraujoch and Gornergrat (HFSJG, Bern); NASA MEASURE's GOZCARDS programme; National Oceanic and Atmospheric Administration's Educational Partnership Program Cooperative Remote Sensing Science and Technology Center (NOAA EPP CREST); Canadian Space Agency(Canadian Space Agency); National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NSF Office of Polar Programs(National Science Foundation (NSF)); Danish Meteorological Institute; Australian Research Council(Australian Research Council); New Zealand's Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The University of Liege contribution was mainly supported by the Belgian Science Policy Office (BELSPO) and the Fonds de la Recherche Scientifique-FNRS, both in Brussels. Additional support was provided by MeteoSwiss (Global Atmospheric Watch) and the Federation Wallonie-Bruxelles. We thank the International Foundation High Altitude Research Stations Jungfraujoch and Gornergrat (HFSJG, Bern). We thank O. Flock and D. Zander (University of Liege). The SLIMCAT modelling work was supported by the UK Natural Environment Research Council (NCAS and NCEO). The FTIR measurements at Ny-Alesund, Spitsbergen, are supported by the AWI Bremerhaven. The work from Hampton University was partially funded under the NASA MEASURE's GOZCARDS programme and the National Oceanic and Atmospheric Administration's Educational Partnership Program Cooperative Remote Sensing Science and Technology Center (NOAA EPP CREST). The ACE mission is supported primarily by the Canadian Space Agency. We thank U. Raffalski and P. Voelger for technical support at IRF Kiruna. The National Center for Atmospheric Research is supported by the National Science Foundation. The observation programme at Thule, Greenland, is supported under contract by the National Aeronautics and Space Administration (NASA) and the site is also supported by the NSF Office of Polar Programs. We thank the Danish Meteorological Institute for support at Thule. Work at the Jet Propulsion Laboratory, California Institute of Technology, was performed under contract with NASA; we thank R. Fuller for help in producing the GOZCARDS data set, and work by many ACE-FTS, HALOE and MLS team members who helped to produce data towards the GOZCARDS data set is also acknowledged. We thank O. E. Garcia, E. Sepulveda, and the State Meteorological Agency (AEMET) of Spain for scientific and technical support at Izana. The Australian Research Council has provided notable support over the years for the NDACC site at Wollongong, most recently as part of project DP110101948. Measurements at Lauder are core funded through New Zealand's Ministry of Business, Innovation and Employment. We are grateful to all colleagues who have contributed to FTIR data acquisition. We thank ECMWF for providing the ERA-Interim reanalyses.	Bernath PF, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022386; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Engel A, 2009, NAT GEOSCI, V2, P28, DOI 10.1038/NGEO388; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Froidevaux L, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027600; Froidevaux L., GOZCARDS MERGED DATA; Gardiner T, 2008, ATMOS CHEM PHYS, V8, P6719, DOI 10.5194/acp-8-6719-2008; Kohlhepp R, 2012, ATMOS CHEM PHYS, V12, P3527, DOI 10.5194/acp-12-3527-2012; Laube JC, 2014, NAT GEOSCI, V7, P266, DOI 10.1038/ngeo2109; LOVELOCK JE, 1973, NATURE, V241, P194, DOI 10.1038/241194a0; McLandress C, 2009, J CLIMATE, V22, P1516, DOI 10.1175/2008JCLI2679.1; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; Nassar R, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007073; Rinsland CP, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003001; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; RUSSELL JM, 1993, J GEOPHYS RES-ATMOS, V98, P10777, DOI 10.1029/93JD00799; Stiller GP, 2012, ATMOS CHEM PHYS, V12, P3311, DOI 10.5194/acp-12-3311-2012; Waters JW, 2006, IEEE T GEOSCI REMOTE, V44, P1075, DOI 10.1109/TGRS.2006.873771; Waugh DW, 2007, ATMOS CHEM PHYS, V7, P4935, DOI 10.5194/acp-7-4935-2007; World Meteorological Organization, 2011, 52 WMO; ZANDER R, 1992, J ATMOS CHEM, V15, P171, DOI 10.1007/BF00053758	21	81	82	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					104	107		10.1038/nature13857	http://dx.doi.org/10.1038/nature13857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373680	Green Submitted			2022-12-28	WOS:000344187500038
J	Zhuravleva, I; Churazov, E; Schekochihin, AA; Allen, SW; Arevalo, P; Fabian, AC; Forman, WR; Sanders, JS; Simionescu, A; Sunyaev, R; Vikhlinin, A; Werner, N				Zhuravleva, I.; Churazov, E.; Schekochihin, A. A.; Allen, S. W.; Arevalo, P.; Fabian, A. C.; Forman, W. R.; Sanders, J. S.; Simionescu, A.; Sunyaev, R.; Vikhlinin, A.; Werner, N.			Turbulent heating in galaxy clusters brightest in X-rays	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; VELOCITY POWER SPECTRA; INTERNAL GRAVITY-WAVES; COOLING FLOWS; GAS-DENSITY; SURFACE BRIGHTNESS; PERSEUS CLUSTER; EVOLUTION; FEEDBACK; MODELS	The hot (10(7) to 10(8) kelvin), X-ray-emitting intracluster medium (ICM) is the dominant baryonic constituent of clusters of galaxies. In the cores of many clusters, radiative energy losses from the ICM occur on timescalesmuch shorter than the age of the system(1-3). Unchecked, this cooling would lead to massive accumulations of cold gas and vigorous star formation(4), in contradiction to observations(5). Various sources of energy capable of compensating for these cooling losses have been proposed, themost promising being heating by the super-massive black holes in the central galaxies, through inflation of bubbles of relativistic plasma(6-9). Regardless of the original source of energy, the question of how this energy is transferred to the ICM remains open. Here we present a plausible solution to this question based on deep X-ray data and a new data analysis method that enable us to evaluate directly the ICM heating rate from the dissipation of turbulence. We find that turbulent heating is sufficient to offset radiative cooling and indeed appears to balance it locally at each radius-it may therefore be the key element in resolving the gas cooling problem in cluster cores and, more universally, in the atmospheres of X-ray emitting, gas-rich systems on scales from galaxy clusters to groups and elliptical galaxies.	[Zhuravleva, I.; Allen, S. W.; Werner, N.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Zhuravleva, I.; Allen, S. W.; Werner, N.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Churazov, E.; Sunyaev, R.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Churazov, E.; Sunyaev, R.] Space Res Inst IKI, Moscow 117997, Russia; [Schekochihin, A. A.] Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England; [Schekochihin, A. A.] Univ Oxford, Merton Coll, Oxford OX1 4JD, England; [Allen, S. W.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Arevalo, P.] Univ Valparaiso, Fac Ciencias, Inst Fis & Astron, Valparaiso, Chile; [Arevalo, P.] Pontificia Univ Catolica Chile, Fac Fis, Inst Astrofis, Santiago 22, Chile; [Fabian, A. C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Forman, W. R.; Vikhlinin, A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Sanders, J. S.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Simionescu, A.] Japan Aerosp Explorat Agcy, Sagamihara, Kanagawa 2525210, Japan	Stanford University; Stanford University; Max Planck Society; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Oxford; University of Oxford; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Universidad de Valparaiso; Pontificia Universidad Catolica de Chile; University of Cambridge; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Max Planck Society; Japan Aerospace Exploration Agency (JAXA)	Zhuravleva, I (corresponding author), Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, 452 Lomita Mall, Stanford, CA 94305 USA.	zhur@stanford.edu	Werner, Norbert/AAW-2434-2021; Churazov, Eugene/A-7783-2013; Werner, Norbert/G-2832-2019	Werner, Norbert/0000-0003-0392-0120; Churazov, Eugene/0000-0002-0322-884X; Werner, Norbert/0000-0003-0392-0120; Sanders, Jeremy/0000-0003-2189-4501; Schekochihin, Alexander/0000-0003-4421-1128; Forman, William/0000-0002-9478-1682; Simionescu, Aurora/0000-0002-9714-3862; Allen, Steven/0000-0003-0667-5941	NASA through Chandra award by the Chandra X-ray Observatory Center [AR4-15013X]; NASA [NAS8-03060]; US Department of Energy [DE-AC02-76SF00515]; Suzaku grants [NNX12AE05G, NNX13AI49G]; Fondecyt [1140304]; European Commission [PIRSES-GA -2010-2692 64]; Russian Scientific Foundation [14-22-00271]; STFC [ST/F002505/2, ST/K000985/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K000985/1] Funding Source: researchfish; Russian Science Foundation [14-22-00271] Funding Source: Russian Science Foundation	NASA through Chandra award by the Chandra X-ray Observatory Center; NASA(National Aeronautics & Space Administration (NASA)); US Department of Energy(United States Department of Energy (DOE)); Suzaku grants; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); European Commission(European CommissionEuropean Commission Joint Research Centre); Russian Scientific Foundation(Russian Science Foundation (RSF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Russian Science Foundation(Russian Science Foundation (RSF))	Support for this work was provided by the NASA through Chandra award number AR4-15013X issued by the Chandra X-ray Observatory Center, which is operated by the Smithsonian Astrophysical Observatory for and on behalf of the NASA under contract NAS8-03060. S. W. A. acknowledges support from the US Department of Energy under contract number DE-AC02-76SF00515. I.Z. and N.W. are partially supported from Suzaku grants NNX12AE05G and NNX13AI49G. P. A. acknowledges financial support from Fondecyt 1140304 and European Commission's Framework Programme 7, through the Marie Curie International Research Staff Exchange Scheme LACEGAL (PIRSES-GA -2010-2692 64). E. C. and R. S. are partially supported by grant no. 14-22-00271 from the Russian Scientific Foundation.	ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Arevalo P, 2012, MON NOT R ASTRON SOC, V426, P1793, DOI 10.1111/j.1365-2966.2012.21789.x; BALBUS SA, 1990, ASTROPHYS J, V357, P353, DOI 10.1086/168926; Banerjee N, 2014, MON NOT R ASTRON SOC, V443, P687, DOI 10.1093/mnras/stu1179; Beresnyak A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.075001; Birzan L, 2012, MON NOT R ASTRON SOC, V427, P3468, DOI 10.1111/j.1365-2966.2012.22083.x; Brethouwer G, 2007, J FLUID MECH, V585, P343, DOI 10.1017/S0022112007006854; Chandran BD, 2006, ASTROPHYS J, V642, P140, DOI 10.1086/499229; Cho J, 2003, ASTROPHYS J, V589, pL77, DOI 10.1086/376492; Churazov E, 2000, ASTRON ASTROPHYS, V356, P788; Churazov E, 2012, MON NOT R ASTRON SOC, V421, P1123, DOI 10.1111/j.1365-2966.2011.20372.x; Churazov E, 2003, ASTROPHYS J, V590, P225, DOI 10.1086/374923; Churazov E, 2002, MON NOT R ASTRON SOC, V332, P729, DOI 10.1046/j.1365-8711.2002.05332.x; Churazov E, 2001, ASTROPHYS J, V554, P261, DOI 10.1086/321357; Ciotti L, 2001, ASTROPHYS J, V551, P131, DOI 10.1086/320053; COWIE LL, 1977, ASTROPHYS J, V215, P723, DOI 10.1086/155406; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Fabian AC, 2006, MON NOT R ASTRON SOC, V366, P417, DOI 10.1111/j.1365-2966.2005.09896.x; FABIAN AC, 1977, MON NOT R ASTRON SOC, V180, P479, DOI 10.1093/mnras/180.3.479; FABIAN AC, 1994, ANNU REV ASTRON ASTR, V32, P277, DOI 10.1146/annurev.aa.32.090194.001425; Foster AR, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/128; Fujita Y, 2004, ASTROPHYS J, V612, pL9, DOI 10.1086/424483; Gaspari M, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424043; Hillel S., HEATING COLD CLUMPS; Kaneda Y, 2003, PHYS FLUIDS, V15, pL21, DOI 10.1063/1.1539855; Kim WT, 2003, ASTROPHYS J, V596, pL139, DOI 10.1086/379342; Kolmogoroff A, 1941, CR ACAD SCI URSS, V30, P301, DOI 10.1098/rspa.1991.0075; LEA SM, 1976, ASTROPHYS J, V203, P569, DOI 10.1086/154113; Leontovich M., 1965, REV PLASMA PHYS; LUFKIN EA, 1995, ASTROPHYS J, V446, P529, DOI 10.1086/175811; Markevitch M, 2007, PHYS REP, V443, P1, DOI 10.1016/j.physrep.2007.01.001; McCourt M, 2012, MON NOT R ASTRON SOC, V419, P3319, DOI 10.1111/j.1365-2966.2011.19972.x; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; Norman ML, 1999, LECT NOTES PHYS, V530, P106; Nulsen PEJ, 2000, MON NOT R ASTRON SOC, V311, P346, DOI 10.1046/j.1365-8711.2000.03038.x; Omma H, 2004, MON NOT R ASTRON SOC, V348, P1105, DOI 10.1111/j.1365-2966.2004.07382.x; Ossenkopf V, 2008, ASTRON ASTROPHYS, V485, P917, DOI 10.1051/0004-6361:20079106; Ozmidov R. V., 1992, Oceanology, V32, P259; Peterson JR, 2006, PHYS REP, V427, P1, DOI 10.1016/j.physrep.2005.12.007; Pfrommer C, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/10; Randall SW, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/86; Ruszkowski M, 2011, MON NOT R ASTRON SOC, V414, P1493, DOI 10.1111/j.1365-2966.2011.18482.x; Sanders JS, 2012, MON NOT R ASTRON SOC, V421, P726, DOI 10.1111/j.1365-2966.2011.20348.x; Schekochihin AA, 2009, ASTROPHYS J SUPPL S, V182, P310, DOI 10.1088/0067-0049/182/1/310; Smith RK, 2001, ASTROPHYS J, V556, pL91, DOI 10.1086/322992; SREENIVASAN KR, 1995, PHYS FLUIDS, V7, P2778, DOI 10.1063/1.868656; Sternberg A, 2009, MON NOT R ASTRON SOC, V395, P228, DOI 10.1111/j.1365-2966.2009.14566.x; Subramanian K, 2006, MON NOT R ASTRON SOC, V366, P1437, DOI 10.1111/j.1365-2966.2006.09918.x; SUTHERLAND RS, 1993, ASTROPHYS J SUPPL S, V88, P253, DOI 10.1086/191823; Vikhlinin A, 2005, ASTROPHYS J, V628, P655, DOI 10.1086/431142; Werner N, 2006, ASTRON ASTROPHYS, V459, P353, DOI 10.1051/0004-6361:20065678; Zakamska NL, 2003, ASTROPHYS J, V582, P162, DOI 10.1086/344641; Zhuravleva I, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/1/L13	54	208	209	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					85	+		10.1038/nature13830	http://dx.doi.org/10.1038/nature13830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25363764	Green Submitted			2022-12-28	WOS:000344187500033
J	Farh, KKH; Marson, A; Zhu, J; Kleinewietfeld, M; Housley, WJ; Beik, S; Shoresh, N; Whitton, H; Ryan, RJH; Shishkin, AA; Hatan, M; Carrasco-Alfonso, MJ; Mayer, D; Luckey, CJ; Patsopoulos, NA; De Jager, PL; Kuchroo, VK; Epstein, CB; Daly, MJ; Hafler, DA; Bernstein, BE				Farh, Kyle Kai-How; Marson, Alexander; Zhu, Jiang; Kleinewietfeld, Markus; Housley, William J.; Beik, Samantha; Shoresh, Noam; Whitton, Holly; Ryan, Russell J. H.; Shishkin, Alexander A.; Hatan, Meital; Carrasco-Alfonso, Marlene J.; Mayer, Dita; Luckey, C. John; Patsopoulos, Nikolaos A.; De Jager, Philip L.; Kuchroo, Vijay K.; Epstein, Charles B.; Daly, Mark J.; Hafler, David A.; Bernstein, Bradley E.			Genetic and epigenetic fine mapping of causal autoimmune disease variants	NATURE			English	Article							GENOME-WIDE ASSOCIATION; REGULATORY T-CELLS; SUSCEPTIBILITY LOCI; TRANSCRIPTION FACTORS; ENHANCER LANDSCAPE; FOXP3 OCCUPANCY; READ ALIGNMENT; CROHNS-DISEASE; RISK LOCI; B-CELLS	Genome-wide association studies have identified loci underlying human diseases, but the causal nucleotide changes and mechanisms remain largely unknown. Here we developed a fine-mapping algorithm to identify candidate causal variants for 21 autoimmune diseases from genotyping data. We integrated these predictions with transcription and cis-regulatory element annotations, derived by mapping RNA and chromatin in primary immune cells, including resting and stimulated CD4(+) T-cell subsets, regulatory T cells, CD8(+) T cells, B cells, and monocytes. We find that similar to 90% of causal variants are non-coding, with similar to 60% mapping to immune-cell enhancers, many of which gain histone acetylation and transcribe enhancer-associated RNA upon immune stimulation. Causal variants tend to occur near binding sites for master regulators of immune differentiation and stimulus-dependent gene activation, but only 10-20% directly alter recognizable transcription factor binding motifs. Rather, mostnon-coding risk variants, including those that alter gene expression, affect non-canonical sequence determinants not well-explained by current gene regulatory models.	[Farh, Kyle Kai-How; Zhu, Jiang; Kleinewietfeld, Markus; Beik, Samantha; Shoresh, Noam; Whitton, Holly; Ryan, Russell J. H.; Shishkin, Alexander A.; Hatan, Meital; Patsopoulos, Nikolaos A.; De Jager, Philip L.; Epstein, Charles B.; Daly, Mark J.; Hafler, David A.; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Farh, Kyle Kai-How; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Marson, Alexander] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94143 USA; [Zhu, Jiang; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Zhu, Jiang; Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zhu, Jiang; Ryan, Russell J. H.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Zhu, Jiang; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Zhu, Jiang; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Kleinewietfeld, Markus; Housley, William J.; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06511 USA; [Kleinewietfeld, Markus; Housley, William J.; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA; [Shishkin, Alexander A.] CALTECH, Pasadena, CA 91125 USA; [Carrasco-Alfonso, Marlene J.; Mayer, Dita; Luckey, C. John] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Carrasco-Alfonso, Marlene J.; Mayer, Dita; Luckey, C. John] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Patsopoulos, Nikolaos A.; De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02142 USA; [Patsopoulos, Nikolaos A.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02142 USA; [Patsopoulos, Nikolaos A.; De Jager, Philip L.] Harvard Univ, Div Genet, Dept Med, Brigham & Womens Hosp,Med Sch, Boston, MA 02142 USA; [Kuchroo, Vijay K.] Harvard Univ, Ctr Neurol Dis, Brigham & Womens Hosp, Sch Med, Boston, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Yale University; Yale University; California Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Marson, A (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	alexander.marson@ucsf.edu	Kleinewietfeld, Markus/AAI-4497-2021; Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Patsopoulos, Nikolaos/0000-0003-3757-8941; Ryan, Russell/0000-0001-8174-3962; Epstein, Charles B./0000-0001-8358-8345; Kleinewietfeld, Markus/0000-0002-2832-3149; Luckey, Chance John/0000-0002-0787-9121	NIH Common Fund [ES017155]; National Human Genome Research Institute [HG004570]; National Institute of Allergy and Infectious Disease [AI045757, AI046130, AI070352, AI039671]; National Institute of Neurological Disorders and Stroke [NS24247, NS067305]; National Institute of General Medical Sciences [GM093080]; National Multiple Sclerosis Society [CA1061-A-18]; UCSF Sandler Fellowship; Penates Foundation; Nancy Taylor Foundation; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570, U54HG006991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, T32AI007019, U19AI070352, U19AI046130, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748, RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024247, R37NS024247, R01NS067305] Funding Source: NIH RePORTER; Worldwide Cancer Research [12-0089] Funding Source: researchfish	NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); UCSF Sandler Fellowship; Penates Foundation; Nancy Taylor Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Worldwide Cancer Research	We thank members of the NIH Epigenomics Consortium, M. Greenberg, H. Chang and G. Haliburton for constructive comments. We also thank IIBDGC and P. Sullivan for sharing data pre-publication, and G. Cvetanovich, S. Bhela, C. Hartnick, F. Preffer, D. Dombkowski and the Brigham and Women's Hospital PhenoGenetic Project for assistance with data collection. This research was supported by the NIH Common Fund (ES017155), the National Human Genome Research Institute (HG004570), the National Institute of Allergy and Infectious Disease (AI045757, AI046130, AI070352, AI039671), the National Institute of Neurological Disorders and Stroke (NS24247, NS067305), the National Institute of General Medical Sciences (GM093080), the National Multiple Sclerosis Society (CA1061-A-18), the UCSF Sandler Fellowship, a gift from Jake Aronov, the Penates Foundation, the Nancy Taylor Foundation, and the Howard Hughes Medical Institute.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Browning JL, 2006, NAT REV DRUG DISCOV, V5, P564, DOI 10.1038/nrd2085; Brucklacher-Waldert V, 2009, J IMMUNOL, V183, P5494, DOI 10.4049/jimmunol.0901000; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Caron G, 2009, J IMMUNOL, V182, P7595, DOI 10.4049/jimmunol.0804272; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Johnston A., 2009, CURRENT PROTOC IMMUN; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; West LC, 2013, CURR OPIN IMMUNOL, V25, P103, DOI 10.1016/j.coi.2012.11.006; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	67	1089	1109	5	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					337	343		10.1038/nature13835	http://dx.doi.org/10.1038/nature13835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25363779	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000349547400030
J	Chertow, DS; Kleine, C; Edwards, JK; Scaini, R; Giuliani, R; Sprecher, A				Chertow, Daniel S.; Kleine, Christian; Edwards, Jeffrey K.; Scaini, Roberto; Giuliani, Ruggero; Sprecher, Armand			Ebola Virus Disease in West Africa - Clinical Manifestations and Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chertow, Daniel S.; Kleine, Christian; Edwards, Jeffrey K.; Scaini, Roberto; Giuliani, Ruggero; Sprecher, Armand] Liberia Mission, Med Sans Frontieres, Brussels, Belgium; [Chertow, Daniel S.] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA; [Kleine, Christian] JW Goethe Univ Hosp, Dept Infect Dis & Trop Med, Frankfurt, Germany	Doctors Without Borders; National Institutes of Health (NIH) - USA; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Chertow, DS (corresponding author), Liberia Mission, Med Sans Frontieres, Brussels, Belgium.							Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Tattevin P, 2014, INTENS CARE MED, V40, P1738, DOI 10.1007/s00134-014-3473-7	4	240	254	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2054	2057		10.1056/NEJMp1413084	http://dx.doi.org/10.1056/NEJMp1413084			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU4KP	25372854	Bronze			2022-12-28	WOS:000345580000003
J	Feng, L; Wong, ZJ; Ma, RM; Wang, Y; Zhang, X				Feng, Liang; Wong, Zi Jing; Ma, Ren-Min; Wang, Yuan; Zhang, Xiang			Single-mode laser by parity-time symmetry breaking	SCIENCE			English	Article							SPECTRA	Effective manipulation of cavity resonant modes is crucial for emission control in laser physics and applications. Using the concept of parity-time symmetry to exploit the interplay between gain and loss (i.e., light amplification and absorption), we demonstrate a parity-time symmetry-breaking laser with resonant modes that can be controlled at will. In contrast to conventional ring cavity lasers with multiple competing modes, our parity-time microring laser exhibits intrinsic single-mode lasing regardless of the gain spectral bandwidth. Thresholdless parity-time symmetry breaking due to the rotationally symmetric structure leads to stable single-mode operation with the selective whispering-gallery mode order. Exploration of parity-time symmetry in laser physics may open a door to next-generation optoelectronic devices for optical communications and computing.	[Feng, Liang; Wong, Zi Jing; Ma, Ren-Min; Wang, Yuan; Zhang, Xiang] Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Wang, Yuan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	National Science Foundation (NSF); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Zhang, Xiang/F-6905-2011; Wong, Zi Jing/AGP-9517-2022; Wang, Yuan/F-7211-2011	Wang, Yuan/0000-0001-7892-2812; Zhang, Xiang/0000-0002-3272-894X; Wong, Zi Jing/0000-0003-0746-3473	Office of Naval Research Multidisciplinary University Research Initiative program [N00014-13-1-0649]	Office of Naval Research Multidisciplinary University Research Initiative program	Supported by Office of Naval Research Multidisciplinary University Research Initiative program grant N00014-13-1-0649. We thank Y.-L. Xu and K. O'Brien for helpful discussions.	Arbabi A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3633111; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Brandstetter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5034; Chong YD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.093902; Chong YD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053901; Feng L, 2013, NAT MATER, V12, P108, DOI [10.1038/NMAT3495, 10.1038/nmat3495]; Ghafouri-Shiraz H., 2003, DISTRIBUTED FEEDBACK, DOI [10.1002/0470856238, DOI 10.1002/0470856238]; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; HANNA DC, 1972, ELECTRON LETT, V8, P369, DOI 10.1049/el:19720269; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; Klaiman S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080402; Korbl M, 2002, J APPL PHYS, V92, P2942, DOI 10.1063/1.1497448; Liew SF, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4883637; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; Longhi S, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.031801; Lumer Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.263901; Ma RM, 2011, NAT MATER, V10, P110, DOI 10.1038/nmat2919; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Miri MA, 2012, OPT LETT, V37, P764, DOI 10.1364/OL.37.000764; Miroshnichenko AE, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012123; Mizrahi A, 2008, OPT LETT, V33, P1261, DOI 10.1364/OL.33.001261; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Schomerus H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233601; Shang L, 2008, OPT LETT, V33, P1150, DOI 10.1364/OL.33.001150; Wan WJ, 2011, SCIENCE, V331, P889, DOI 10.1126/science.1200735; Wiersig J, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.053809; Yoo G, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063833	30	1024	1035	44	462	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					972	975		10.1126/science.1258479	http://dx.doi.org/10.1126/science.1258479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414307				2022-12-28	WOS:000345696000037
J	Cheng, Y; Ma, ZH; Kim, BH; Wu, WS; Cayting, P; Boyle, AP; Sundaram, V; Xing, XY; Dogan, N; Li, JJ; Euskirchen, G; Lin, S; Lin, Y; Visel, A; Kawli, T; Yang, XQ; Patacsil, D; Keller, CA; Giardine, B; Kundaje, A; Wang, T; Pennacchio, LA; Weng, ZP; Hardison, RC; Snyder, MP				Cheng, Yong; Ma, Zhihai; Kim, Bong-Hyun; Wu, Weisheng; Cayting, Philip; Boyle, Alan P.; Sundaram, Vasavi; Xing, Xiaoyun; Dogan, Nergiz; Li, Jingjing; Euskirchen, Ghia; Lin, Shin; Lin, Yiing; Visel, Axel; Kawli, Trupti; Yang, Xinqiong; Patacsil, Dorrelyn; Keller, Cheryl A.; Giardine, Belinda; Kundaje, Anshul; Wang, Ting; Pennacchio, Len A.; Weng, Zhiping; Hardison, Ross C.; Snyder, Michael P.		Mouse ENCODE Consortium	Principles of regulatory information conservation between mouse and human	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHROMATIN; ENHANCERS; GENOME; SEQUENCES; ELEMENTS; SITES; CTCF	To broaden our understanding of the evolution of gene regulation mechanisms, we generated occupancy profiles for 34 orthologous transcription factors (TFs) in human-mouse erythroid progenitor, lymphoblast and embryonic stem-cell lines. By combining the genome-wide transcription factor occupancy repertoires, associated epigenetic signals, and co-association patterns, here we deduce several evolutionary principles of gene regulatory features operating since the mouse and human lineages diverged. The genomic distribution profiles, primary binding motifs, chromatin states, and DNA methylation preferences are well conserved for TF-occupied sequences. However, the extent to which orthologous DNA segments are bound by orthologous TFs varies both among TFs and with genomic location: binding at promoters is more highly conserved than binding at distal elements. Notably, occupancy-conserved TF-occupied sequences tend to be pleiotropic; they function in several tissues and also co-associate with many TFs. Single nucleotide variants at sites with potential regulatory functions are enriched in occupancy-conserved TF-occupied sequences.	[Cheng, Yong; Ma, Zhihai; Cayting, Philip; Boyle, Alan P.; Li, Jingjing; Euskirchen, Ghia; Lin, Shin; Lin, Yiing; Kawli, Trupti; Yang, Xinqiong; Patacsil, Dorrelyn; Kundaje, Anshul; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kim, Bong-Hyun; Weng, Zhiping] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Wu, Weisheng; Dogan, Nergiz; Keller, Cheryl A.; Giardine, Belinda; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, Huck Inst Life Sci, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Wu, Weisheng] Univ Michigan, BRCF Bioinformat Core, Ann Arbor, MI 48105 USA; [Sundaram, Vasavi; Xing, Xiaoyun; Wang, Ting] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, Dept Genet, St Louis, MO 63108 USA; [Lin, Shin] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94304 USA; [Lin, Yiing] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94701 USA; [Visel, Axel; Pennacchio, Len A.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	Stanford University; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; Washington University (WUSTL); Stanford University; Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Merced	Snyder, MP (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	rch8@psu.edu; mpsnyder@stanford.edu	Dogan-Artun, Nergiz/AAG-2681-2021; Li, Jingjing/B-5136-2016; Lagarde, Julien/AAI-1686-2020; Pervouchine, Dmitri/H-5252-2015; Kundaje, Anshul/Y-2598-2019; Kumar, Swathi/I-7941-2015; Hardison, Ross C/G-1142-2010; Herrero, Javier/H-6971-2019; Tanzer, Andrea/AAY-5431-2021; cheng, yong/I-4270-2012; Kundaje, Anshul/Y-2739-2019; Visel, Axel/A-9398-2009; Ma, Zhihai/E-7130-2015; Pervouchine, Dmitri/AAU-5399-2021; Boyle, Alan/I-1848-2014; Tanzer, Andrea/L-3147-2015; Mishra, Tejaswini/D-3528-2018; Bussotti, Giovanni/C-3082-2019	Li, Jingjing/0000-0001-6025-9522; Lagarde, Julien/0000-0002-0290-7445; Pervouchine, Dmitri/0000-0003-0543-9760; Kundaje, Anshul/0000-0003-3084-2287; Kumar, Swathi/0000-0002-2770-5145; Hardison, Ross C/0000-0003-4084-7516; Herrero, Javier/0000-0001-7313-717X; Tanzer, Andrea/0000-0003-2873-4236; Kundaje, Anshul/0000-0003-3084-2287; Visel, Axel/0000-0002-4130-7784; Pervouchine, Dmitri/0000-0003-0543-9760; Boyle, Alan/0000-0002-2081-1105; Tanzer, Andrea/0000-0003-2873-4236; Mishra, Tejaswini/0000-0001-9931-1260; Edsall, Lee Elizabeth/0000-0002-0326-2829; josefowicz, steven/0000-0001-7453-779X; Cheng, Yong/0000-0002-9314-0971; Dogan-Artun, Nergiz/0000-0002-5922-4194; Zhou, Xiao-Qiao/0000-0002-0724-5153; Sundaram, Vasavi/0000-0001-6571-7027; Lin, Shin/0000-0003-0118-0413; Bussotti, Giovanni/0000-0002-4078-7413; Pennacchio, Len/0000-0002-8748-3732; Kaul, Rajinder/0000-0002-7895-9284; Lin, Yiing/0000-0002-0317-7608; Snyder, Michael/0000-0003-0784-7987; Dobin, Alexander/0000-0002-4115-9128; Samstein, Robert/0000-0001-6860-2401; Pope, Benjamin/0000-0003-1847-9163	National Human Genome Research Institute (NHGRI) [R01HG003988, U54HG006997]; American Recovery and Reinvestment Act; Department of Energy, University of California [DE-AC02-05CH11231];  [3RC2HG005602];  [5U54HG006996];  [1U54HG00699];  [R01DK065806];  [RC2HG005573]; NATIONAL CANCER INSTITUTE [T32CA113275] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021482] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006998, R01HG004037, R01HG003988, R01HG007354, R01HG007175, R01HG007348, RC2HG005602, RC2HG005573, U54HG006997, U54HG006996, U41HG007234, K99HG007356, U54HG007004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE024427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096266, R37DK044746, R01DK065806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083337] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Recovery and Reinvestment Act; Department of Energy, University of California(United States Department of Energy (DOE)University of California System); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is funded by grants 3RC2HG005602, 5U54HG006996 and 1U54HG00699 (M. P. S.), and R01DK065806 and RC2HG005573 (R. C. H.). A. V. and L. A. P. were supported by National Human Genome Research Institute (NHGRI) grant R01HG003988, U54HG006997 and supplementary funds provided by the American Recovery and Reinvestment Act. The in vivo enhancer activity assays were conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California. We acknowledge R. M. Myers for providing access to ChIP-seq data in human embryonic cells. Illumina sequencing services were performed by the Stanford Center for Genomics and Personalized Medicine.	Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Sundaram V., 2014, GENOME RES; Tokugawa Y, 1997, MOL IMMUNOL, V34, P1263, DOI 10.1016/S0161-5890(98)00010-8; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649	29	180	182	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					371	+		10.1038/nature13985	http://dx.doi.org/10.1038/nature13985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409826	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000345770600036
J	Lind, M; Svensson, AM; Kosiborod, M; Gudbjornsdottir, S; Pivodic, A; Wedel, H; Dahlqvist, S; Clements, M; Rosengren, A				Lind, Marcus; Svensson, Ann-Marie; Kosiborod, Mikhail; Gudbjornsdottir, Soffia; Pivodic, Aldina; Wedel, Hans; Dahlqvist, Sofia; Clements, Mark; Rosengren, Annika			Glycemic Control and Excess Mortality in Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALL-CAUSE MORTALITY; POPULATION-BASED COHORT; CARDIOVASCULAR-DISEASE; TRENDS; COMPLICATIONS; RISK; ASSOCIATION; HEMOGLOBIN; REGISTER; HBA1C	BACKGROUND The excess risk of death from any cause and of death from cardiovascular causes is unknown among patients with type 1 diabetes and various levels of glycemic control. We conducted a registry-based observational study to determine the excess risk of death according to the level of glycemic control in a Swedish population of patients with diabetes. METHODS We included in our study patients with type 1 diabetes registered in the Swedish National Diabetes Register after January 1, 1998. For each patient, five controls were randomly selected from the general population and matched according to age, sex, and county. Patients and controls were followed until December 31, 2011, through the Swedish Register for Cause-Specific Mortality. RESULTS The mean age of the patients with diabetes and the controls at baseline was 35.8 and 35.7 years, respectively, and 45.1% of the participants in each group were women. The mean follow-up in the diabetes and control groups was 8.0 and 8.3 years, respectively. Overall, 2701 of 33,915 patients with diabetes (8.0%) died, as compared with 4835 of 169,249 controls (2.9%) (adjusted hazard ratio, 3.52; 95% confidence interval [CI], 3.06 to 4.04); the corresponding rates of death from cardiovascular causes were 2.7% and 0.9% (adjusted hazard ratio, 4.60; 95% CI, 3.47 to 6.10). The multivariable-adjusted hazard ratios for death from any cause according to the glycated hemoglobin level for patients with diabetes as compared with controls were 2.36 (95% CI, 1.97 to 2.83) for a glycated hemoglobin level of 6.9% or lower (<= 52 mmol per mole), 2.38 (95% CI, 2.02 to 2.80) for a level of 7.0 to 7.8% (53 to 62 mmol per mole), 3.11 (95% CI, 2.66 to 3.62) for a level of 7.9 to 8.7% (63 to 72 mmol per mole), 3.65 (95% CI, 3.11 to 4.30) for a level of 8.8 to 9.6% (73 to 82 mmol per mole), and 8.51 (95% CI, 7.24 to 10.01) for a level of 9.7% or higher (>= 83 mmol per mole). Corresponding hazard ratios for death from cardiovascular causes were 2.92 (95% CI, 2.07 to 4.13), 3.39 (95% CI, 2.49 to 4.61), 4.44 (95% CI, 3.32 to 5.96), 5.35 (95% CI, 3.94 to 7.26), and 10.46 (95% CI, 7.62 to 14.37). CONCLUSIONS In our registry-based observational study, patients with type 1 diabetes and a glycated hemoglobin level of 6.9% or lower had a risk of death from any cause or from cardiovascular causes that was twice as high as the risk for matched controls.	[Lind, Marcus; Dahlqvist, Sofia] NU Hosp Org, Dept Med, Uddevalla, Sweden; [Lind, Marcus; Gudbjornsdottir, Soffia; Rosengren, Annika] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Svensson, Ann-Marie] Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden; [Pivodic, Aldina] Stat Konsultgrp, Gothenburg, Sweden; [Wedel, Hans] Nord Sch Publ Hlth, Gothenburg, Sweden; [Rosengren, Annika] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Kosiborod, Mikhail] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Kosiborod, Mikhail; Clements, Mark] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Clements, Mark] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Clements, Mark] Univ Kansas, Sch Med, Kansas City, KS USA	NU Hospital Group; Voestalpine AG; University of Gothenburg; Sahlgrenska University Hospital; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; University of Kansas; University of Kansas Medical Center	Lind, M (corresponding author), Uddevalla Cent Hosp, Dept Med, S-45180 Uddevalla, Sweden.	lind.marcus@telia.com	Kosiborod, Mikhail/HDO-1541-2022; Lind, Marcus/AAI-6733-2021; Lind, Marcus/GRJ-4946-2022	Kosiborod, Mikhail/0000-0002-3750-9789; Lind, Marcus/0000-0002-3796-9283; Clements, Mark/0000-0002-2368-0331; Rosengren, Annika/0000-0002-5409-6605	Swedish government (under the Avtal om Lakarutbildning och medicinsk Forskning; Swedish Society of Medicine; Health and Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland, Sweden; Swedish Heart and Lung Foundation, Diabetes Wellness; Swedish Research Council [2013-5187, 2013-4236]	Swedish government (under the Avtal om Lakarutbildning och medicinsk Forskning; Swedish Society of Medicine; Health and Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland, Sweden; Swedish Heart and Lung Foundation, Diabetes Wellness; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Supported by grants from the Swedish government (under the Avtal om Lakarutbildning och medicinsk Forskning [agreement for medical education and research]), the Swedish Society of Medicine, the Health and Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland, Sweden, the Swedish Heart and Lung Foundation, Diabetes Wellness, and the Swedish Research Council (2013-5187 and 2013-4236).	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Cheng AYY, 2013, CAN J DIABETES, V37, pS1, DOI 10.1016/j.jcjd.2013.01.009; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; Emilsson L, 2011, EUR HEART J, V32, P2430, DOI 10.1093/eurheartj/ehr167; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Hanas R, 2008, TYPE 1 DIABETES CHIL; Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Jeffcoate SL, 2004, DIABETIC MED, V21, P657, DOI 10.1046/j.1464-5491.2003.01065.x; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lind M, 2013, DIABETOLOGIA, V56, P2601, DOI 10.1007/s00125-013-3063-1; Lind M, 2011, LANCET, V378, P140, DOI 10.1016/S0140-6736(11)60471-6; Lind M, 2008, DIABETES METAB SYND, V2, P282, DOI 10.1016/j.dsx.2008.04.006; Lind M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004412; Livingstone SJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001321; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; National Institute for Health and Care Excellence, TYP 1 DIAB DIAGN MAN; Olen O, 2012, DIGEST LIVER DIS, V44, P471, DOI 10.1016/j.dld.2012.01.006; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161; Parving H., 2004, BRENNER RECTORS KIDN, P1777; Secrest AM, 2010, DIABETES, V59, P3216, DOI 10.2337/db10-0862; Secrest AM, 2010, DIABETES CARE, V33, P2573, DOI 10.2337/dc10-1170; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shankar A, 2007, AM J EPIDEMIOL, V166, P393, DOI 10.1093/aje/kwm096; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6; Soedamah-Muthu SS, 2008, DIABETES CARE, V31, P1360, DOI 10.2337/dc08-0107; Soedamah-Muthu SS, 2006, DIABETOLOGIA, V49, P660, DOI 10.1007/s00125-005-0120-4; Swedish National Diabetes Register, 2012, ANN REPORT; Weis U, 2001, QJM-INT J MED, V94, P623, DOI 10.1093/qjmed/94.11.623; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	32	518	527	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					1972	1982		10.1056/NEJMoa1408214	http://dx.doi.org/10.1056/NEJMoa1408214			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT5ST	25409370	Bronze			2022-12-28	WOS:000345002900006
J	Park, DW; Clare, RM; Schulte, PJ; Pieper, KS; Shaw, LK; Califf, RM; Ohman, EM; Van de Werf, F; Hirji, S; Harrington, RA; Armstrong, PW; Granger, CB; Jeong, MH; Patel, MR				Park, Duk-Woo; Clare, Robert M.; Schulte, Phillip J.; Pieper, Karen S.; Shaw, Linda K.; Califf, Robert M.; Ohman, E. Magnus; Van de Werf, Frans; Hirji, Sameer; Harrington, Robert A.; Armstrong, Paul W.; Granger, Christopher B.; Jeong, Myung-Ho; Patel, Manesh R.			Extent, Location, and Clinical Significance ? of Non-Infarct-Related Coronary Artery Disease Among Patimts With ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPERFUSION THERAPY; INTERVENTION; SURVIVAL; MULTIVESSEL; ASSOCIATION; PLAQUE	IMPORTANCE Little information exists about the anatomical characteristics and clinical relevance of non-infarct-related artery (IRA) disease among patients with ST-segment elevation myocardial infarction (STEM1). OBJECTIVES To investigate the incidence, extent, and location of obstructive non-IRA disease and compare 30-day mortality according to the presence of non-IRA disease in patients with STEMI. DESIGN, SETTING, AND PARTICIPANTS Retrospective study of patients pooled from a convenience sample of 8 independent, international, randomized STEMI clinical trials published between 1993 and 2007. Follow-up varied from 1 month to 1year. Among 68 765 patients enrolled in the trials, 28 282 patients with valid angiographic information were included in this analysis. Obstructive coronary artery disease was defined as stenosis of 50% or more of the diameter of a major epicardial artery. To assess the generalizability of trial-based results, external validation was performed using observational data for patients with STEMI from the Korea Acute Myocardial Infarction Registry (KAMIR) (between November 1, 2005, and December 31, 2013; n = 18 217) and the Duke Cardiovascular Databank (between January 1, 2005, and December 31, 2012; n = 1812). MAIN OUTCOMES AND MEASURES Thirty-day mortality following STEMI. RESULTS Overall, 52.8% (14 929 patients) had obstructive non-IRA disease; 29.6% involved 1 vessel and 18.8% involved 2 vessels. There was no substantial difference in the extent and distribution of non-IRA disease according to the IRA territory. Unadjusted and adjusted rates of 30-day mortality were significantly higher in patients with non-IRA disease than in those without non-IRA disease (unadjusted, 4.3% vs 1.7%, respectively; risk difference, 2.7% [95% Cl, 2.3% to 3.0%], P < .001; and adjusted, 3.3% vs 1.9%, respectively; risk difference, 1.4% [95% Cl, 1.0% to 1.8%], P < .001). The overall prevalence and association of non-IRA disease with 30-day mortality was consistent with findings from the KAMIR registry (adjusted, 3.6% for patients with non-IRA disease vs 2.5% in those without it; risk difference, 1.1% [95% Cl, 0.6% to 1.7%]; P < .001), but not with the Duke database (adjusted, 4.7% with non-IRA disease vs 4.3% without it; risk difference, 0.4% [95% Cl, -1.4% to 2.2%], P =.65). CONCLUSIONS AND RELEVANCE In a retrospective pooled analysis of 8 clinical trials, obstructive non-IRA disease was common among patients presenting with STEMI, and was associated with a modest statistically significant increase in 30-day mortality. These findings require confirmation in prospectively designed studies, but raise questions about the appropriateness and timing of non-IRA revascularization in patients with STEMI.	[Park, Duk-Woo] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Seoul, South Korea; [Park, Duk-Woo; Clare, Robert M.; Schulte, Phillip J.; Pieper, Karen S.; Shaw, Linda K.; Ohman, E. Magnus; Hirji, Sameer; Granger, Christopher B.; Patel, Manesh R.] Duke Clin Res Inst, Durham, NC USA; [Califf, Robert M.] Duke Translat Med Inst, Durham, NC USA; [Van de Werf, Frans] Univ Hosp, Leuven, Belgium; [Harrington, Robert A.] Stanford Univ, Stanford, CA 94305 USA; [Armstrong, Paul W.] Univ Alberta, Edmonton, AB, Canada; [Jeong, Myung-Ho] Chonnam Natl Univ, Kwangju, South Korea	University of Ulsan; Asan Medical Center; Duke University; Duke University; Stanford University; University of Alberta; Chonnam National University	Patel, MR (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27715 USA.	manesh.patel@duke.edu	hirji, sameer/AAF-7691-2019; Patel, Manesh/AAC-5385-2019	hirji, sameer/0000-0002-5032-675X; 	John Bush Simson Fund; Duke Clinical Research Institute	John Bush Simson Fund; Duke Clinical Research Institute	This study was supported in part by the John Bush Simson Fund (awarded to Dr Patel). The statistical portion of the manuscript was funded by the Duke Clinical Research Institute.	Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Bar FW, 2006, EUR HEART J, V27, P2516, DOI 10.1093/eurheartj/ehl304; Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016; Chen KY, 2009, CIRCULATION, V119, P3207, DOI 10.1161/CIRCULATIONAHA.108.822791; Corpus RA, 2004, AM HEART J, V148, P493, DOI 10.1016/j.ahj.2004.03.051; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Gibson CM, 2003, J THROMB THROMBOLYS, V15, P189, DOI 10.1023/B:THRO.0000011374.60110.bc; Giugliano RP, 2003, J AM COLL CARDIOL, V41, P1251, DOI 10.1016/S0735-1097(03)00123-2; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Keeley EC, 2004, JAMA-J AM MED ASSOC, V291, P736, DOI 10.1001/jama.291.6.736; Kim DH, 2006, AM HEART J, V151, P668, DOI 10.1016/j.ahj.2005.05.006; Kotani J, 2003, CIRCULATION, V107, P2889, DOI 10.1161/01.CIR.0000072768.80031.74; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Ohman EM, 1997, CIRCULATION, V95, P846; Puymirat E, 2012, JAMA-J AM MED ASSOC, V308, P998, DOI 10.1001/2012.jama.11348; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Thomas L, 2012, JAMA-J AM MED ASSOC, V308, P773, DOI 10.1001/jama.2012.9502; Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Topol EJ, 2001, LANCET, V357, P1905; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Wang JC, 2004, CIRCULATION, V110, P278, DOI 10.1161/01.CIR.0000135468.67850.F4; Widimsky P, 2011, EUR HEART J, V32, P396, DOI 10.1093/eurheartj/ehq410	29	84	90	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2019	2027		10.1001/jama.2014.15095	http://dx.doi.org/10.1001/jama.2014.15095			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399277	Bronze			2022-12-28	WOS:000345450500016
J	Chretien, JP				Chretien, Jean-Paul			Expectation Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DECISION		Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA		Chretien, JP (corresponding author), Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA.							Bingel U, 2014, JAMA-J AM MED ASSOC, V312, P693, DOI 10.1001/jama.2014.8342; DeWitt BS, 1970, PHYS TODAY, V23, P155; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Metrik J, 2012, PSYCHOPHARMACOLOGY, V223, P489, DOI 10.1007/s00213-012-2740-y; Prescott B, 2014, HARVARD MED SCH 0108; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Volkow ND, 2006, NEUROIMAGE, V32, P1782, DOI 10.1016/j.neuroimage.2006.04.192	9	2	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1936	1939		10.1056/NEJMms1406844	http://dx.doi.org/10.1056/NEJMms1406844			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT1RB	25390747				2022-12-28	WOS:000344709800018
J	Skubi, KL; Yoon, TP				Skubi, Kazimer L.; Yoon, Tehshik P.			ORGANIC CHEMISTRY Shape control in reactions with light	NATURE			English	Editorial Material							ASYMMETRIC CATALYSIS; COMPLEX	The report of a light-activated catalyst that dictates the three-dimensional shape - the stereochemistry - of molecules formed in an organic reaction suggests a new strategy for controlling such reactions using visible light. See Letter p. 100	[Skubi, Kazimer L.; Yoon, Tehshik P.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Skubi, KL (corresponding author), Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.		Yoon, Tehshik/Z-1772-2019	Yoon, Tehshik/0000-0002-3934-4973; Skubi, Kazimer/0000-0002-9689-1842				Chen LA, 2013, J AM CHEM SOC, V135, P10598, DOI 10.1021/ja403777k; Du JN, 2014, SCIENCE, V344, P392, DOI 10.1126/science.1251511; Gong L, 2013, ACCOUNTS CHEM RES, V46, P2635, DOI 10.1021/ar400083u; Huo HH, 2014, NATURE, V515, P100, DOI 10.1038/nature13892; Huo HH, 2014, J AM CHEM SOC, V136, P2990, DOI 10.1021/ja4132505; INOUE Y, 1992, CHEM REV, V92, P741, DOI 10.1021/cr00013a001; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176	8	33	33	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					45	46		10.1038/515045a	http://dx.doi.org/10.1038/515045a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373672				2022-12-28	WOS:000344187500026
J	Dayton, L				Dayton, Leigh			Blue-sky rice	NATURE			English	Editorial Material							C-4 PHOTOSYNTHESIS; NITROGEN											Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; Covshoff S, 2012, CURR OPIN BIOTECH, V23, P209, DOI 10.1016/j.copbio.2011.12.011; Hatch MD, 2002, PHOTOSYNTH RES, V73, P251, DOI 10.1023/A:1020471718805; Krishnan SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098843; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044	6	14	14	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S52	S54		10.1038/514S52a	http://dx.doi.org/10.1038/514S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368887	Bronze			2022-12-28	WOS:000343801500003
J	Liu, ZH; Zhang, HT; Liu, ZS; Xing, CY; Fu, P; Ni, ZH; Chen, JH; Lin, HL; Liu, FY; He, YC; He, YN; Miao, LN; Chen, N; Li, Y; Gu, Y; Shi, W; Hu, WX; Liu, ZZ; Bao, H; Zeng, CH; Zhou, ML				Liu, Zhihong; Zhang, Haitao; Liu, Zhangsuo; Xing, Changying; Fu, Ping; Ni, Zhaohui; Chen, Jianghua; Lin, Hongli; Liu, Fuyou; He, Yongcheng; He, Yani; Miao, Lining; Chen, Nan; Li, Ying; Gu, Yong; Shi, Wei; Hu, Weixin; Liu, Zhengzhao; Bao, Hao; Zeng, Caihong; Zhou, Minlin			Multitarget Therapy for Induction Treatment of Lupus Nephritis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							MYCOPHENOLATE-MOFETIL; INTRAVENOUS CYCLOPHOSPHAMIDE; PROSPECTIVE MULTICENTER; RENAL-TRANSPLANTATION; CLINICAL-TRIALS; HISTOLOGIC DATA; MISSING DATA; TACROLIMUS; ERYTHEMATOSUS; CYCLOSPORINE	Background: Treatment of lupus nephritis (LN) remains challenging. Objective: To assess the efficacy and safety of a multitarget therapy consisting of tacrolimus, mycophenolate mofetil, and steroid compared with intravenous cyclophosphamide and steroid as induction therapy for LN. Design: 24-week randomized, open-label, multicenter study. (ClinicalTrials.gov: NCT00876616) Setting: 26 renal centers in China. Patients: Adults (aged 18 to 65 years) with biopsy-proven LN. Intervention: Tacrolimus, 4 mg/d, and mycophenolate mofetil, 1.0 g/d, versus intravenous cyclophosphamide with a starting dose of 0.75 (adjusted to 0.5 to 1.0) g/m(2) of body surface area every 4 weeks for 6 months. Both groups received 3 days of pulse methylprednisolone followed by a tapering course of oral prednisone therapy. Measurements: The primary end point was complete remission at 24 weeks. Secondary end points included overall response (complete and partial remission), time to overall response, and adverse events. Results: After 24 weeks of therapy, more patients in the multitarget group (45.9%) than in the intravenous cyclophosphamide group (25.6%) showed complete remission (difference, 20.3 percentage points [95% CI, 10.0 to 30.6 percentage points]; P < 0.001). The overall response incidence was higher in the multitarget group than in the intravenous cyclophosphamide group (83.5% vs. 63.0%; difference, 20.4 percentage points [CI, 10.3 to 30.6 percentage points]; P < 0.001), and the median time to overall response was shorter in the multitarget group (difference, -4.1 weeks [CI, -7.9 to -2.1 weeks]). Incidence of adverse events did not differ between the multitarget and intravenous cyclophosphamide groups (50.3% [91 of 181] vs. 52.5% [95 of 181]). Limitation: The study was limited to 24 weeks of follow-up. Conclusion: Multitarget therapy provides superior efficacy compared with intravenous cyclophosphamide as induction therapy for LN.	Nanjing Univ, Jinling Hosp, Sch Med, Nanjing 210016, Jiangsu, Peoples R China; [Xing, Changying] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Liu, Zhangsuo; Xing, Changying] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Fu, Ping] West China Hosp, Chengdu, Peoples R China; Ruijin Hosp, Renji Hosp, Shanghai, Peoples R China; Huashan Hosp, Shanghai, Peoples R China; Zhejiang Univ, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Hongli] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China; [Liu, Fuyou] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [He, Yongcheng] Shenzhen Second Peoples Hosp, Shenzhen, Peoples R China; Daping Hosp, Chongqing, Peoples R China; Jilin Univ, Affiliated Hosp 2, Changchun, Peoples R China; Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China; Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China	Nanjing University; Nanjing Medical University; Zhengzhou University; Shanghai Jiao Tong University; Fudan University; Zhejiang University; Dalian Medical University; Central South University; Second People's Hospital of Shenzhen; Army Medical University; Jilin University; Hebei Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Liu, ZH (corresponding author), Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, 305 East Zhongshan Rd, Nanjing 210016, Jiangsu, Peoples R China.	liuzhihong@nju.edu.cn	Liu, Zhihong/ABB-6918-2021	Liu, Zhihong/0000-0001-6093-0726	National Basic Research Program of China, National Key Technology RD Program	National Basic Research Program of China, National Key Technology RD Program	National Basic Research Program of China, National Key Technology R&D Program.	[Anonymous], 2007, MATH STAT METASTATIS; Appel GB, 2009, J AM SOC NEPHROL, V20, P1103, DOI 10.1681/ASN.2008101028; AUSTIN HA, 1994, KIDNEY INT, V45, P544, DOI 10.1038/ki.1994.70; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; AUSTIN HA, 1983, AM J MED, V75, P382, DOI 10.1016/0002-9343(83)90338-8; Austin HA, 2009, J AM SOC NEPHROL, V20, P901, DOI 10.1681/ASN.2008060665; Bao H, 2008, J AM SOC NEPHROL, V19, P2001, DOI 10.1681/ASN.2007121272; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Chan TM, 2000, NEW ENGL J MED, V343, P1156, DOI 10.1056/NEJM200010193431604; Chen W, 2011, AM J KIDNEY DIS, V57, P235, DOI 10.1053/j.ajkd.2010.08.036; Chen YE, 2008, CLIN J AM SOC NEPHRO, V3, P46, DOI 10.2215/CJN.03280807; Daleboudt GMN, 2009, NEPHROL DIAL TRANSPL, V24, P3712, DOI 10.1093/ndt/gfp359; Dall'Era M, 2011, CURR OPIN RHEUMATOL, V23, P454, DOI 10.1097/BOR.0b013e328349a1e5; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Ekberg H, 2011, TRANSPLANTATION, V92, P82, DOI 10.1097/TP.0b013e31821fad06; Ekberg H, 2010, NEPHROL DIAL TRANSPL, V25, P2004, DOI 10.1093/ndt/gfp778; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Ginzler EM, 2005, NEW ENGL J MED, V353, P2219, DOI 10.1056/NEJMoa043731; Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64; Hougaard P, 1995, Lifetime Data Anal, V1, P255; Isenberg D, 2010, RHEUMATOLOGY, V49, P128, DOI 10.1093/rheumatology/kep346; Korbet SM, 2007, J AM SOC NEPHROL, V18, P244, DOI 10.1681/ASN.2006090992; Kulkarni OP, 2012, CURR OPIN RHEUMATOL, V24, P457, DOI 10.1097/BOR.0b013e328354c877; Lee YH, 2011, LUPUS, V20, P636, DOI 10.1177/0961203310389486; Li X, 2012, NEPHROL DIAL TRANSPL, V27, P1467, DOI 10.1093/ndt/gfr484; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Lu F, 2008, LUPUS, V17, P622, DOI 10.1177/0961203308089428; MacFarlane GD, 1999, CLIN CHEM, V45, P1449; Moroni G, 2007, NEPHROL DIAL TRANSPL, V22, P2531, DOI 10.1093/ndt/gfm245; Ong LM, 2005, NEPHROLOGY, V10, P504, DOI 10.1111/j.1440-1797.2005.00444.x; PICKLES A, 1995, STAT MED, V14, P1447, DOI 10.1002/sim.4780141305; Shaw LM, 1998, CLIN BIOCHEM, V31, P317, DOI 10.1016/S0009-9120(98)00040-X; Szeto CC, 2008, RHEUMATOLOGY, V47, P1678, DOI 10.1093/rheumatology/ken335; Uchino A, 2010, CLIN EXP RHEUMATOL, V28, P6; Wang HY, 2008, LUPUS, V17, P638, DOI 10.1177/0961203308089408; Wang LM, 2011, MOL ENDOCRINOL, V25, P1376, DOI 10.1210/me.2011-0029; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Weng MY, 2010, CLIN RHEUMATOL, V29, P771, DOI 10.1007/s10067-010-1403-9; Yap DYH, 2012, NEPHROLOGY, V17, P352, DOI 10.1111/j.1440-1797.2012.01574.x	41	210	236	5	65	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					18	U154		10.7326/M14-1030	http://dx.doi.org/10.7326/M14-1030			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25383558				2022-12-28	WOS:000350103000003
J	Muhlestein, JB; Lappe, DL; Lima, JAC; Rosen, BD; May, HT; Knight, S; Bluemke, DA; Towner, SR; Le, V; Bair, TL; Vavere, AL; Anderson, JL				Muhlestein, Joseph B.; Lappe, Donald L.; Lima, Joao A. C.; Rosen, Boaz D.; May, Heidi T.; Knight, Stacey; Bluemke, David A.; Towner, Steven R.; Viet Le; Bair, Tami L.; Vavere, Andrea L.; Anderson, Jeffrey L.			Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High-Risk Patients With Diabetes The FACTOR-64 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPUTED-TOMOGRAPHY; HEART-DISEASE	IMPORTANCE Coronary artery disease (CAD) is a major cause of cardiovascular morbidity and mortality in patients with diabetes mellitus, yet CAD often is asymptomatic prior to myocardial infarction (MI) and coronary death. OBJECTIVE To assess whether routine screening for CAD by coronary computed tomography angiography (CCTA) in patients with type 1 or type 2 diabetes deemed to be at high cardiac risk followed by CCTA-directed therapy would reduce the risk of death and nonfatal coronary outcomes. DESIGN, SETTING, AND PARTICIPANTS The FACTOR-64 study was a randomized clinical trial in which 900 patients with type 1 or type 2 diabetes of at least 3 to 5 years' duration and without symptoms of CAD were recruited from 45 clinics and practices of a single health system (Intermountain Healthcare, Utah), enrolled at a single-site coordinating center, and randomly assigned to CAD screening with CCTA (n = 452) or to standard national guidelines-based optimal diabetes care (n = 448) (targets: glycated hemoglobin level <7.0%, low-density lipoprotein cholesterol level <100 mg/dL, systolic blood pressure <130 mmHg). All CCTA imaging was performed at the coordinating center. Standard therapy or aggressive therapy (targets: glycated hemoglobin level <6.0%, low-density lipoprotein cholesterol level <70 mg/dL, high-density lipoprotein cholesterol level >50 mg/dL [women] or >40 mg/dL [men], triglycerides level <150 mg/dL, systolic blood pressure <120 mmHg), or aggressive therapy with invasive coronary angiography, was recommended based on CCTA findings. Enrollment occurred between July 2007 and May 2013, and follow-up extended to August 2014. MAIN OUTCOMES AND MEASURES The primary outcome was a composite of all-cause mortality, nonfatal MI, or unstable angina requiring hospitalization; the secondary outcome was ischemic major adverse cardiovascular events (composite of CAD death, nonfatal MI, or unstable angina). RESULTS At a mean follow-up time of 4.0 (SD, 1.7) years, the primary outcome event rates were not significantly different between the CCTA and the control groups (6.2%[28 events] vs 7.6%[34 events]; hazard ratio, 0.80 [95% CI, 0.49-1.32]; P = .38). The incidence of the composite secondary end point of ischemic major adverse cardiovascular events also did not differ between groups (4.4%[20 events] vs 3.8% [17 events]; hazard ratio, 1.15 [95% CI, 0.60-2.19]; P = .68). CONCLUSIONS AND RELEVANCE Among asymptomatic patients with type 1 or type 2 diabetes, use of CCTA to screen for CAD did not reduce the composite rate of all-cause mortality, nonfatal MI, or unstable angina requiring hospitalization at 4 years. These findings do not support CCTA screening in this population.	[Muhlestein, Joseph B.; Lappe, Donald L.; May, Heidi T.; Knight, Stacey; Towner, Steven R.; Viet Le; Bair, Tami L.; Anderson, Jeffrey L.] Intermt Med Ctr Heart Inst, Murray, UT 84107 USA; [Muhlestein, Joseph B.; Lappe, Donald L.; Knight, Stacey; Anderson, Jeffrey L.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Lima, Joao A. C.; Rosen, Boaz D.; Vavere, Andrea L.] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD USA; [Bluemke, David A.] NIH, Dept Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA	Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Muhlestein, JB (corresponding author), Intermt Med Ctr Heart Inst, 5121 S Cottonwood St, Murray, UT 84107 USA.	brent.muhlestein@imail.org	Le, Viet/ABF-2394-2021; Rosen, Boaz D/B-2528-2008; Le, Viet/F-2830-2015; Bluemke, David/GYU-8169-2022	Le, Viet/0000-0001-6659-5332; Le, Viet/0000-0001-6659-5332; Bluemke, David/0000-0002-8323-8086; Knight, Stacey/0000-0003-0092-7327; May, Heidi/0000-0002-7524-5905	Intermountain Research and Medical Foundation; Intermountain Healthcare Urban Central Region, Salt Lake City, Utah; Intermountain Heart Institute Department of Cardiovascular Research; Toshiba Corporation; Bracco Corporation; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	Intermountain Research and Medical Foundation; Intermountain Healthcare Urban Central Region, Salt Lake City, Utah; Intermountain Heart Institute Department of Cardiovascular Research; Toshiba Corporation; Bracco Corporation; CLINICAL CENTER	This study was performed with the support of the Intermountain Research and Medical Foundation, Intermountain Healthcare Urban Central Region, Salt Lake City, Utah, and the Intermountain Heart Institute Department of Cardiovascular Research. In addition, the FACTOR-64 study was supported by grants from Toshiba Corporation and Bracco Corporation.	Am Diabetes Assoc, 1999, CIRCULATION, V100, P1132, DOI 10.1161/01.cir.100.10.1132; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Bax JJ, 2007, DIABETES CARE, V30, P2729, DOI 10.2337/dc07-9927; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Faglia E, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.07.027; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gibbons RJ, 2006, J NUCL CARDIOL, V13, P616, DOI 10.1016/j.nuclcard.2006.06.130; Giri S, 2002, CIRCULATION, V105, P32, DOI 10.1161/hc5001.100528; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Kwan AC, 2014, RADIOLOGY, V272, P690, DOI 10.1148/radiol.14140611; Mark DB, 2010, J AM COLL CARDIOL, V55, P1029, DOI [10.1016/j.jacc.2009.11.048, 10.1016/j.jacc.2009.11.013]; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Rajagopalan N, 2005, J AM COLL CARDIOL, V45, P43, DOI 10.1016/j.jacc.2004.06.078; Tsujimoto T, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000139; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolk MJ, 2014, J AM COLL CARDIOL, V63, P380, DOI 10.1016/j.jacc.2013.11.009; Young LH, 2009, JAMA-J AM MED ASSOC, V301, P1547, DOI 10.1001/jama.2009.476	20	244	250	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2234	2243		10.1001/jama.2014.15825	http://dx.doi.org/10.1001/jama.2014.15825			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25402757				2022-12-28	WOS:000345684800018
J	Seguin-Orlando, A; Korneliussen, TS; Sikora, M; Malaspinas, AS; Manica, A; Moltke, I; Albrechtsen, A; Ko, A; Margaryan, A; Moiseyev, V; Goebel, T; Westaway, M; Lambert, D; Khartanovich, V; Wall, JD; Nigst, PR; Foley, RA; Lahr, MM; Nielsen, R; Orlando, L; Willerslev, E				Seguin-Orlando, Andaine; Korneliussen, Thorfinn S.; Sikora, Martin; Malaspinas, Anna-Sapfo; Manica, Andrea; Moltke, Ida; Albrechtsen, Anders; Ko, Amy; Margaryan, Ashot; Moiseyev, Vyacheslav; Goebel, Ted; Westaway, Michael; Lambert, David; Khartanovich, Valeri; Wall, Jeffrey D.; Nigst, Philip R.; Foley, Robert A.; Lahr, Marta Mirazon; Nielsen, Rasmus; Orlando, Ludovic; Willerslev, Eske			Genomic structure in Europeans dating back at least 36,200 years	SCIENCE			English	Article							MODERN HUMANS; ANCIENT DNA; NEANDERTHAL; DISPERSAL; EVOLUTION; SEQUENCE; CAVE; POPULATIONS; ANCESTRY; BEHAVIOR	The origin of contemporary Europeans remains contentious. We obtained a genome sequence from Kostenki 14 in European Russia dating from 38,700 to 36,200 years ago, one of the oldest fossils of anatomically modern humans from Europe. We find that Kostenki 14 shares a close ancestry with the 24,000-year-old Mal'ta boy from central Siberia, European Mesolithic hunter-gatherers, some contemporary western Siberians, and many Europeans, but not eastern Asians. Additionally, the Kostenki 14 genome shows evidence of shared ancestry with a population basal to all Eurasians that also relates to later European Neolithic farmers. We find that Kostenki 14 contains more Neandertal DNA that is contained in longer tracts than present Europeans. Our findings reveal the timing of divergence of western Eurasians and East Asians to be more than 36,200 years ago and that European genomic structure today dates back to the Upper Paleolithic and derives from a metapopulation that at times stretched from Europe to central Asia.	[Seguin-Orlando, Andaine; Korneliussen, Thorfinn S.; Sikora, Martin; Malaspinas, Anna-Sapfo; Margaryan, Ashot; Foley, Robert A.; Lahr, Marta Mirazon; Orlando, Ludovic; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark; [Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Moltke, Ida] Univ Chicago, Dept Human Genet, Cummings Life Sci Ctr, Chicago, IL 60637 USA; [Moltke, Ida; Albrechtsen, Anders] Univ Copenhagen, Bioinformat Ctr, DK-2200 Copenhagen N, Denmark; [Ko, Amy; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Moiseyev, Vyacheslav; Khartanovich, Valeri] Russian Acad Sci, Peter Great Museum Anthropol & Ethnog, Dept Phys Anthropol, Kunstkamera, St Petersburg 196140, Russia; [Goebel, Ted] Texas A&M Univ, Ctr Study Amer 1, College Stn, TX 77845 USA; [Goebel, Ted] Texas A&M Univ, Dept Anthropol, College Stn, TX 77845 USA; [Westaway, Michael; Lambert, David] Griffith Univ, Environm Futures Res Inst, Brisbane, Qld 4111, Australia; [Wall, Jeffrey D.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Nigst, Philip R.] Univ Cambridge, Div Archaeol, Cambridge CB2 3DZ, England; [Nigst, Philip R.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Foley, Robert A.; Lahr, Marta Mirazon] Univ Cambridge, Dept Archaeol & Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England	University of Copenhagen; University of Cambridge; University of Chicago; University of Copenhagen; University of California System; University of California Berkeley; Russian Academy of Sciences; The Kunstkamera; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Griffith University; University of California System; University of California San Francisco; University of Cambridge; Max Planck Society; University of Cambridge	Lahr, MM (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.	mbml1@cam.ac.uk; rasmus_nielsen@berkeley.edu; ewillerslev@snm.ku.dk	Moltke, Ida/C-6158-2011; Orlando, Ludovic/A-8932-2013; Manica, Andrea/B-5497-2008; Willerslev, Eske/A-9619-2011; Albrechtsen, Anders/K-4281-2013; Sikora, Martin/C-8609-2015; Khartanovich, Valeri I/H-1872-2017; Korneliussen, Thorfinn Sand/F-6421-2014; Korneliussen, Thorfinn Sand/ABB-7656-2021; Manica, Andrea/N-9013-2019; Moiseyev, Vyacheslav/AAD-2659-2019; Willerslev, Eske/AAA-5686-2019; Nielsen, Rasmus/D-4405-2009	Moltke, Ida/0000-0001-7052-8554; Orlando, Ludovic/0000-0003-3936-1850; Manica, Andrea/0000-0003-1895-450X; Willerslev, Eske/0000-0002-7081-6748; Albrechtsen, Anders/0000-0001-7306-031X; Sikora, Martin/0000-0003-2818-8319; Khartanovich, Valeri I/0000-0002-5533-0686; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Manica, Andrea/0000-0003-1895-450X; Nigst, Philip R/0000-0001-7330-8768; Margaryan, Ashot/0000-0002-2576-2429; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; Mirazon Lahr, Marta/0000-0001-5752-5770; Nielsen, Rasmus/0000-0003-0513-6591; Lambert, David/0000-0002-5821-3637	Lundbeck Foundation; Danish National Research Foundation [DNRF94]; Swiss National Science Foundation [PBSKP3_143529]; Marie Curie Career Integration Grant [322261]; Australian Research Council; Villum Fonden [00007171] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Career Integration Grant; Australian Research Council(Australian Research Council); Villum Fonden(Villum Fonden)	We thank J. F. Hoffecker for help and discussion and the Danish National Sequencing Centre, especially C. Mortensen and K. Magnussen, for technical assistance. We also thank D. Poznik for providing the chromosome Y mask file and table of informative SNPs. GeoGenetics members were supported by the Lundbeck Foundation and the Danish National Research Foundation (DNRF94). A.-S.M. was supported by the Swiss National Science Foundation (PBSKP3_143529). Research on the archaeological background by P.R.N. was supported by a Marie Curie Career Integration Grant (322261). M. W. and D. L. thank the Australian Research Council for support. Data for this study are available under accession no. PRJEB7618 from the European Nucleotide Archive (www.ebi.ac.uk/ena). Source code for the main analyses in this study is available at GitHub (https://github.com/martinsikora).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bailey SE, 2009, J HUM EVOL, V57, P11, DOI 10.1016/j.jhevol.2009.02.003; Bar-Yosef O, 2006, ANTHROPOL-INT J HUM, V44, P49; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Formicola V., 1989, RIV ANTROPOL, V67, P287; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gibbons A, 2014, SCIENCE, V343, P1417, DOI 10.1126/science.343.6178.1417; Henry-Gambier D, 2013, BULL SOC PREHIST FR, V110, P645, DOI 10.3406/bspf.2013.14318; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Holliday VT, 2007, GEOARCHAEOLOGY, V22, P181, DOI 10.1002/gea.20163; Howells W. W., 1989, SKULL SHAPES MAP CRA; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P13471, DOI 10.1073/pnas.1211082109; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Kuhn SL, 2009, J HUM EVOL, V56, P87, DOI 10.1016/j.jhevol.2008.07.014; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Marks A. E., 1983, PREHISTORY PALEOENVI, pIX; Marom A, 2012, P NATL ACAD SCI USA, V109, P6878, DOI 10.1073/pnas.1116328109; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Nigst PR, 2014, P NATL ACAD SCI USA, V111, P14394, DOI 10.1073/pnas.1412201111; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N. J., 2012, GENETICS, V112; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Pyle DM, 2006, QUATERNARY SCI REV, V25, P2713, DOI 10.1016/j.quascirev.2006.06.008; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rebollo NR, 2011, J ARCHAEOL SCI, V38, P2424, DOI 10.1016/j.jas.2011.05.010; Rogachev A. N, 1955, ALEKSANDROVSKOE POSE; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sinitsyn AA, 2006, QUATERN INT, V152, P164, DOI 10.1016/j.quaint.2005.12.007; Sirakov N., 2007, PALEO REV ARCHEOL PR, V19, P131; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Stringer C., 1989, PALEORIENT, V15, P99, DOI DOI 10.3406/paleo.1989.4512; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Vishnyatsky LB, 2004, EARLY UPPER PALEOLITHIC BEYOND WESTERN EUROPE, P80; Yazbeck C., 2004, PALEORIENT, V30, P111, DOI [DOI 10.3406/paleo.2004.1015, 10.3406/paleo.2004.1015]	46	195	200	4	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1113	1118		10.1126/science.aaa0114	http://dx.doi.org/10.1126/science.aaa0114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25378462				2022-12-28	WOS:000345763400043
J	Pandey, A; Atkins, KE; Medlock, J; Wenzel, N; Townsend, JP; Childs, JE; Nyenswah, TG; Ndeffo-Mbah, ML; Galvani, AP				Pandey, Abhishek; Atkins, Katherine E.; Medlock, Jan; Wenzel, Natasha; Townsend, Jeffrey P.; Childs, James E.; Nyenswah, Tolbert G.; Ndeffo-Mbah, Martial L.; Galvani, Alison P.			Strategies for containing Ebola in West Africa	SCIENCE			English	Article							REPRODUCTIVE NUMBER; HEMORRHAGIC-FEVER; VIRUS; CONGO; DYNAMICS; KIKWIT	The ongoing Ebola outbreak poses an alarming risk to the countries of West Africa and beyond. To assess the effectiveness of containment strategies, we developed a stochastic model of Ebola transmission between and within the general community, hospitals, and funerals, calibrated to incidence data from Liberia. We find that a combined approach of case isolation, contact-tracing with quarantine, and sanitary funeral practices must be implemented with utmost urgency in order to reverse the growth of the outbreak. As of 19 September, under status quo, our model predicts that the epidemic will continue to spread, generating a predicted 224 (134 to 358) daily cases by 1 December, 280 (184 to 441) by 15 December, and 348 (249 to 545) by 30 December.	[Pandey, Abhishek; Atkins, Katherine E.; Wenzel, Natasha; Ndeffo-Mbah, Martial L.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA; [Atkins, Katherine E.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Medlock, Jan] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Townsend, Jeffrey P.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Childs, James E.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Nyenswah, Tolbert G.] Minist Hlth & Social Welf, Monrovia, Liberia	Yale University; University of London; London School of Hygiene & Tropical Medicine; Oregon State University; Yale University; Yale University	Galvani, AP (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.	alison.galvani@yale.edu	Townsend, Jeffrey/H-2747-2019; Pandey, Abhishek/K-2865-2019	Townsend, Jeffrey/0000-0002-9890-3907; Pandey, Abhishek/0000-0003-4578-7487; Ndeffo Mbah, Martial/0000-0003-4158-7613	National Institutes of Health [NIH 2 U01 GM087719, 5 U01 GM105627]; Notsew Orm Sands Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM105627, U01GM087719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notsew Orm Sands Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by the National Institutes of Health (NIH 2 U01 GM087719 and 5 U01 GM105627) and the Notsew Orm Sands Foundation. The data reported in this paper are tabulated in the supplementary materials. We thank S. G. Gaffney, A. Hofmann, and M. Traina for helpful feedback on the manuscript. All model code and data are available via https://github.com/abhiganit/EbolaCodes/tree/master/Science_Code.	Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; ANDERSON R M, 1991; [Anonymous], 2014, MIN FOR AFF REP LIB; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Fisman D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0114548, 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571]; Galvani AP, 2014, ANN INTERN MED, V161, P749, DOI 10.7326/M14-1904; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; Heymann D., 2008, CONTR COMM DIS MAN, P204; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Liberia Institute of Statistics and Geo-Information Services, 2008, 2008 NAT POP HOUS CE; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Ministry of Health & Social Welfare, 2014, 149 MIN HLTH SOC WEL; Ministry of Health & Social Welfare, 2014, 135 MIN HLTH SOC WEL; Ministry of Health & Social Welfare, 2014, 136 MIN HLTH SOC WEL; Ministry of Health & Social Welfare, 2014, 10130 MIN HLTH SOC W; Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894; Roels TH, 1999, J INFECT DIS, V179, pS92, DOI 10.1086/514286; The Bureau of Public Affairs, 2014, MIN FOR AFF REP LIB; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2014, WHY EB OUTBR HAS BEE; World Health Organization, 2014, WHO STAT M INT HLTH	30	184	187	2	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					991	995		10.1126/science.1260612	http://dx.doi.org/10.1126/science.1260612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414312	Green Accepted			2022-12-28	WOS:000345696000043
J	van der Horst, C				van der Horst, Charles			Civil Disobedience and Physicians - Protesting the Blockade of Medicaid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	van der Horst, C (corresponding author), Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27514 USA.							[Anonymous], 2014, COV GAP UN POOR AD S; Edwards-Levy Ariel, 2013, HUFFINGTON POST; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; United Health Foundation, AM HLTH RANK	4	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					1958	1960		10.1056/NEJMp1410288	http://dx.doi.org/10.1056/NEJMp1410288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT5ST	25409368				2022-12-28	WOS:000345002900003
J	Wall, HK; Hannan, JA; Wright, JS				Wall, Hilary K.; Hannan, Judy A.; Wright, Janet S.			Patients With Undiagnosed Hypertension Hiding in Plain Sight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wall, Hilary K.; Hannan, Judy A.; Wright, Janet S.] Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Wall, HK (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Hwy NE,MS F72, Atlanta, GA 30341 USA.	hwall@cdc.gov		Mihailidis, Alex/0000-0003-2233-0919; Wall, Hilary/0000-0001-6088-0706	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Banerjee D, 2012, AM J HYPERTENS, V25, P97, DOI 10.1038/ajh.2011.179; Baus Adam, 2012, Perspect Health Inf Manag, V9, p1e; Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Nwankwo T, 2011, HYPERTENSION ADULTS; Rakotz MK, 2014, ANN FAM MED, V12, P352, DOI 10.1370/afm.1665; Shah NR, 2009, AHRQ COMP EFF RES ME; Weber MA, 2014, J CLIN HYPERTENS, V16, P14, DOI 10.1111/jch.12237; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981	10	56	56	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1973	1974		10.1001/jama.2014.15388	http://dx.doi.org/10.1001/jama.2014.15388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399269	Green Accepted			2022-12-28	WOS:000345450500008
J	Heisler, M; Choi, H; Palmisano, G; Mase, R; Richardson, C; Fagerlin, A; Montori, VM; Spencer, M; An, LC				Heisler, Michele; Choi, Hwajung; Palmisano, Gloria; Mase, Rebecca; Richardson, Caroline; Fagerlin, Angela; Montori, Victor M.; Spencer, Michael; An, Laurence C.			Comparison of Community Health Worker-Led Diabetes Medication Decision-Making Support for Low-Income Latino and African American Adults With Diabetes Using E-Health Tools Versus Print Materials A Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PARTICIPATORY RESEARCH; PRIMARY-CARE; RACE; MELLITUS; AID; INTERVENTIONS; DISPARITIES; MANAGEMENT; ETHNICITY; ADHERENCE	Background: Health care centers serving low-income communities have scarce resources to support medication decision making among patients with poorly controlled diabetes. Objective: To compare outcomes between community health worker use of a tailored, interactive, Web-based, tablet computer-delivered tool (iDecide) and use of print educational materials. Design: Randomized, 2-group trial conducted from 2011 to 2013 (ClinicalTrials.gov: NCT01427660). Setting: Community health center in Detroit, Michigan, serving a Latino and African American low-income population. Participants: 188 adults with a hemoglobin A(1c) value greater than 7.5% (55%) or those who reported questions, concerns, or difficulty taking diabetes medications. Intervention: Participants were randomly assigned to receive a 1- to 2-hour session with a community health worker who used iDecide or printed educational materials and 2 follow-up calls. Measurements: Primary outcomes were changes in knowledge about antihyperglycemic medications, patient-reported medication decisional conflict, and satisfaction with antihyperglycemic medication information. Also examined were changes in diabetes distress, self-efficacy, medication adherence, and hemoglobin A(1c) values. Results: Ninety-four percent of participants completed 3-month follow-up. Both groups improved across most measures. iDecide participants reported greater improvements in satisfaction with medication information (helpfulness, P = 0.007; clarity, P = 0.03) and in diabetes distress compared with the print materials group (P < 0.001). The other outcomes did not differ between the groups. Limitations: The study was conducted at 1 health center during a short period. The community health workers were experienced in behavioral counseling, thereby possibly mitigating the need for additional support tools. Conclusion: Most outcomes were similarly improved among participants receiving both types of decision-making support for diabetes medication. Longer-term evaluations are necessary to determine whether the greater improvements in satisfaction with medication information and diabetes distress achieved in the iDecide group at 3 months translate into better longer-term diabetes outcomes.	[Heisler, Michele; Choi, Hwajung; Mase, Rebecca; Richardson, Caroline; Fagerlin, Angela] Univ Michigan, Sch Med, Vet Affairs Ann Arbor Hlth Syst, Ann Arbor, MI 48113 USA; Ann Arbor Vet Affairs Hlth Care Syst, Ann Arbor, MI USA; Community Hlth & Social Serv Ctr, Detroit, MI USA; [Montori, Victor M.] Mayo Clin, Rochester, MN 55905 USA; [An, Laurence C.] Univ Michigan, Ctr Hlth Commun Res, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Mayo Clinic; University of Michigan System; University of Michigan	Heisler, M (corresponding author), Univ Michigan, Sch Med, Vet Affairs Ann Arbor Hlth Syst, POB 130170,MS 152, Ann Arbor, MI 48113 USA.	mheisler@umich.edu	Heisler, Michele/B-5774-2015; Albertin, Paloma C/X-1093-2018	Heisler, Michele/0000-0002-6889-2063; Richardson, Caroline/0000-0002-1945-6046; Spencer, Michael/0000-0002-6182-5706; Choi, Hwajung/0000-0001-6497-7679; Montori, Victor/0000-0003-0595-2898	Agency for Healthcare Research and Quality; National Institute of Diabetes and Digestive and Kidney Diseases; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS019256] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, R18DK078558] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Agency for Healthcare Research and Quality and National Institute of Diabetes and Digestive and Kidney Diseases.	Arsie MP, 2000, ACTA DIABETOL, V37, P1, DOI 10.1007/s005920070028; Barbosa CD, 2012, PATIENT PREFER ADHER, V6, P39, DOI 10.2147/PPA.S24752; Blomkvist S., 2005, HUMAN CTR SOFTWARE E, P219; Breslin M, 2008, PATIENT EDUC COUNS, V73, P465, DOI 10.1016/j.pec.2008.07.024; Cegala DJ, 2009, PATIENT EDUC COUNS, V77, P202, DOI 10.1016/j.pec.2009.03.025; Clancy DE, 2007, J GEN INTERN MED, V22, P620, DOI 10.1007/s11606-007-0150-3; Cooper LA, 2006, J GEN INTERN MED, V21, pS21, DOI 10.1111/j.1525-1497.2006.00305.x; Cooper LA, 2012, AM J PUBLIC HEALTH, V102, P979, DOI 10.2105/AJPH.2011.300558; Cooper LA, 2011, J GEN INTERN MED, V26, P1297, DOI 10.1007/s11606-011-1794-6; Dale J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006903.pub2; Doull M, 2005, PEER SUPPORT STRATEG; Fagerlin A, 2004, ANN INTERN MED, V140, P721, DOI 10.7326/0003-4819-140-9-200405040-00012; Feathers JT, 2005, AM J PUBLIC HEALTH, V95, P1552, DOI 10.2105/AJPH.2005.066134; Gibbons MC, 2009, EVIDENCE REPORT TECH; Ginossar T, 2010, J COMPUT-MEDIAT COMM, V15, P530, DOI 10.1111/j.1083-6101.2009.01513.x; Goei M, 2009, PREMIXED INSULIN TYP; Hawkins RP, 2008, HEALTH EDUC RES, V23, P454, DOI 10.1093/her/cyn004; Heisler M, 2008, CLIN DIABETES, V26, P161, DOI DOI 10.2337/diaclin.26.4.161; Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853; Henderson VA, 2013, PROG COMM HLTH PARTN, V7, P171, DOI 10.1353/cpr.2013.0024; Hibbard JH, 2008, HEALTH AFFAIR, V27, P1442, DOI 10.1377/hlthaff.27.5.1442; Israel B. A., 2005, METHODS COMMUNITY BA; Kieffer EC, 2006, HEALTH PROMOT PRACT, V7, p256S, DOI 10.1177/1524839906289353; Kok PE, 2011, J CLIN NURS, V20, P2997, DOI 10.1111/j.1365-2702.2011.03743.x; Krebs P, 2010, PREV MED, V51, P214, DOI 10.1016/j.ypmed.2010.06.004; Lewin S A, 2005, Cochrane Database Syst Rev, pCD004015; Lorig A., 1996, OUTCOME MEASURES HLT; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006; Machin D, 1997, SAMPLE SIZE TABLE CL; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293; Neville LM, 2009, HEALTH EDUC RES, V24, P699, DOI 10.1093/her/cyp006; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; OConnor AM, 2004, DECISION AIDS PEOPLE; Peek ME, 2008, PATIENT EDUC COUNS, V72, P450, DOI 10.1016/j.pec.2008.05.018; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; Raghunathan T.E., 2001, SURV METHODOL, V27, P85; Robinson S, 2007, PILLS TYPE 2 DIABETE; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Smedley BD, 2012, AM J PUBLIC HEALTH, V102, P933, DOI 10.2105/AJPH.2011.300643; Spencer MS, 2011, AM J PUBLIC HEALTH, V101, P2253, DOI 10.2105/AJPH.2010.300106; Spencer MS, 2009, P AM PUBL HLTH ASS A; Stacey D, 2012, 2012 UPDATE IPDAS CO; Tiedje K, 2013, PATIENT EDUC COUNS, V93, P86, DOI 10.1016/j.pec.2013.03.013; Tortolero-Luna G, 2006, J WOMENS HEALTH, V15, P774, DOI 10.1089/jwh.2006.15.774; Trento M, 2008, J ENDOCRINOL INVEST, V31, P1038, DOI 10.1007/BF03345645; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076; White I, 2001, STAT MED, V20, P3441, DOI 10.1002/sim.908; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilkinson MJ, 2013, CURR DIABETES REP, V13, P205, DOI 10.1007/s11892-012-0348-6; Zarcadoolas C, 2006, ADV HLTH LITERACY FR	56	67	68	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S13	S22		10.7326/M13-3012	http://dx.doi.org/10.7326/M13-3012			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402398	Green Accepted			2022-12-28	WOS:000364909900004
J	Roberts, MJ; Campbell, JL; Abel, GA; Davey, AF; Elmore, NL; Maramba, I; Carter, M; Elliott, MN; Roland, MO; Burt, JA				Roberts, Martin J.; Campbell, John L.; Abel, Gary A.; Davey, Antoinette F.; Elmore, Natasha L.; Maramba, Inocencio; Carter, Mary; Elliott, Marc N.; Roland, Martin O.; Burt, Jenni A.			Understanding high and low patient experience scores in primary care: analysis of patients' survey data for general practices and individual doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; SATISFACTION	Objectives To determine the extent to which practice level scores mask variation in individual performance between doctors within a practice. Design Analysis of postal survey of patients' experience of face-to-face consultations with individual general practitioners in a stratified quota sample of primary care practices. Setting Twenty five English general practices, selected to include a range of practice scores on doctor-patient communication items in the English national GP Patient Survey. Participants 7721 of 15 172 patients (response rate 50.9%) who consulted with 105 general practitioners in 25 practices between October 2011 and June 2013. Main outcome measure Score on doctor-patient communication items from post-consultation surveys of patients for each participating general practitioner. The amount of variance in each of six outcomes that was attributable to the practices, to the doctors, and to the patients and other residual sources of variation was calculated using hierarchical linear models. Results After control for differences in patients' age, sex, ethnicity, and health status, the proportion of variance in communication scores that was due to differences between doctors (6.4%) was considerably more than that due to practices (1.8%). The findings also suggest that higher performing practices usually contain only higher performing doctors. However, lower performing practices may contain doctors with a wide range of communication scores. Conclusions Aggregating patients' ratings of doctors' communication skills at practice level can mask considerable variation in the performance of individual doctors, particularly in lower performing practices. Practice level surveys may be better used to "screen" for concerns about performance that require an individual level survey. Higher scoring practices are unlikely to include lower scoring doctors. However, lower scoring practices require further investigation at the level of the individual doctor to distinguish higher and lower scoring general practitioners.	[Roberts, Martin J.; Campbell, John L.; Davey, Antoinette F.; Maramba, Inocencio; Carter, Mary] Univ Exeter, Sch Med, Exeter EX1 2LU, Devon, England; [Abel, Gary A.; Elmore, Natasha L.; Roland, Martin O.; Burt, Jenni A.] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Cambridge Ctr Hlth Serv Res, Cambridge CB2 0SR, England; [Elliott, Marc N.] RAND Corp, Santa Monica, CA 90407 USA	University of Exeter; University of Cambridge; RAND Corporation	Campbell, JL (corresponding author), Univ Exeter, Sch Med, St Lukes Campus, Exeter EX1 2LU, Devon, England.	john.campbell@exeter.ac.uk	Maramba, Inocencio/AHD-1395-2022; Abel, Gary/ABE-1765-2021; Campbell, John/A-5792-2011; Roberts, Martin John/C-3305-2013; Burt, Jenni/L-2951-2013	Maramba, Inocencio/0000-0002-5464-6021; Abel, Gary/0000-0003-2231-5161; Campbell, John/0000-0002-6752-3493; Roberts, Martin John/0000-0002-8010-1068; Davey, Antoinette/0000-0002-5118-6912; Burt, Jenni/0000-0002-0037-274X; Roland, Martin/0000-0002-8533-3060	National Institute for Health Research Programme Grant for Applied Research (NIHR PGfAR) programme [RP-PG-0608-10050]; National Institute for Health Research [RP-PG-0608-10050] Funding Source: researchfish	National Institute for Health Research Programme Grant for Applied Research (NIHR PGfAR) programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a National Institute for Health Research Programme Grant for Applied Research (NIHR PGfAR) programme (RP-PG-0608-10050). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.	[Anonymous], 2014, PAT OP; Berwick DM, 2003, MED CARE, V41, pI30; CBC, 2013, RAT YOUR HOSP ONL TO; Contandriopoulos D, 2014, MED CARE RES REV, V71, P3, DOI 10.1177/1077558713496320; Department of Health, 2014, HARD TRUTHS JOURN PU; Department of Health, 2012, NHS OUTC FRAM 2013 1; Downing SM, 2004, MED EDUC, V38, P1006, DOI 10.1111/j.1365-2929.2004.01932.x; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gelman A., 2007, DATA ANAL USING REGR; Haggerty JL, 2008, ANN FAM MED, V6, P116, DOI 10.1370/afm.802; Health Research Institute, 2013, SCOR HEALTHC NAV CUS; Howie JGR, 2000, FAM PRACT, V17, P455, DOI 10.1093/fampra/17.6.455; Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1941; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Lockyer Jocelyn, 2003, J Contin Educ Health Prof, V23, P4, DOI 10.1002/chp.1340230103; Lyratzopoulos G, 2012, BMJ QUAL SAF, V21, P21, DOI 10.1136/bmjqs-2011-000088; Lyratzopoulos G, 2011, MED CARE, V49, P724, DOI 10.1097/MLR.0b013e31821b3482; Martino SC, 2013, HEALTH SERV RES, V48, P417, DOI 10.1111/j.1475-6773.2012.01452.x; Mazor KM, 2002, HEALTH SERV RES, V37, P1403, DOI 10.1111/1475-6773.11194; NHS England, 2013, IMPR GEN PRACT CALL; NHS England, 2013, NHS CHOIC; NHS England, 2013, GP PAT SURV; NHS Local, 2013, WHAT IS COMP; Paddison CAM, 2013, HLTH EXPECT; Paddison C, 2012, BMJ QUAL SAF, V21, P634, DOI 10.1136/bmjqs-2011-000737; Postgraduate Medical Education and Training Board, 2007, DEV MAINT ASS SYST P; Robert Wood Johnson Foundation, 2013, DEV PUBL REP CAHPS C; Robinson G.K., 1991, STAT SCI, P15, DOI DOI 10.1214/SS/1177011926; Rodriguez HP, 2009, MED CARE, V47, P835, DOI 10.1097/MLR.0b013e318197b1e1; Roland M, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-160; Rozenblum R, 2013, BMJ QUAL SAF, V22, P183, DOI 10.1136/bmjqs-2012-001744; Safran DG, 2006, J GEN INTERN MED, V21, P13, DOI 10.1111/j.1525-1497.2005.00311.x; Salisbury C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5004; Sixma HJ, 1998, MED CARE, V36, P212, DOI 10.1097/00005650-199802000-00010; The Leapfrog Group, 2014, COMP HOSP NOW; University Hospital of South Manchester, 2013, UHSM LAUNCH PION TRA; Wright C, 2012, ACAD MED, V87, P1668, DOI 10.1097/ACM.0b013e3182724cc0	37	33	33	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2014	349								g6034	10.1136/bmj.g6034	http://dx.doi.org/10.1136/bmj.g6034			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU2JQ	25389136	Green Published, hybrid			2022-12-28	WOS:000345444900001
J	Barbier, EB				Barbier, Edward B.			Account for depreciation of natural capital	NATURE			English	Editorial Material									Univ Wyoming, Laramie, WY 82071 USA	University of Wyoming	Barbier, EB (corresponding author), Univ Wyoming, Laramie, WY 82071 USA.	ebarbier@uwyo.edu						[Anonymous], 2013, CAPITAL 21 CENTURY; Barbier EB, 2013, RESOURCES-BASEL, V2, P213, DOI 10.3390/resources2030213; Barbier EB, 2013, ENVIRON DEV ECON, V18, P133, DOI 10.1017/S1355770X12000551; UNU-IHDP and UNEP, 2012, INCL WEALTH REP 2012	4	30	32	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					32	33		10.1038/515032a	http://dx.doi.org/10.1038/515032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS3OE	25373661	Bronze			2022-12-28	WOS:000344187500015
J	Maddox, TM; Stanislawski, MA; Grunwald, GK; Bradley, SM; Ho, PM; Tsai, TT; Patel, MR; Sandhu, A; Valle, J; Magid, DJ; Leon, B; Bhatt, DL; Fihn, SD; Rumsfeld, JS				Maddox, Thomas M.; Stanislawski, Maggie A.; Grunwald, Gary K.; Bradley, Steven M.; Ho, P. Michael; Tsai, Thomas T.; Patel, Manesh R.; Sandhu, Amneet; Valle, Javier; Magid, David J.; Leon, Benjamin; Bhatt, Deepak L.; Fihn, Stephan D.; Rumsfeld, John S.			Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; SECONDARY PREVENTION THERAPIES; CLINICAL-ASSESSMENT; MORTALITY RISK; CART PROGRAM; INSIGHTS; OUTCOMES; ANGINA; STRATIFICATION; IMPLEMENTATION	IMPORTANCE Little is known about cardiac adverse events among patients with nonobstructive coronary artery disease (CAD). OBJECTIVE To compare myocardial infarction (MI) and mortality rates between patients with nonobstructive CAD, obstructive CAD, and no apparent CAD in a national cohort. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of all US veterans undergoing elective coronary angiography for CAD between October 2007 and September 2012 in the Veterans Affairs health care system. Patients with prior CAD events were excluded. EXPOSURES Angiographic CAD extent, defined by degree (no apparent CAD: no stenosis >20%; nonobstructive CAD: >= 1 stenosis >= 20% but no stenosis >= 70%; obstructive CAD: any stenosis >= 70% or left main [LM] stenosis >= 50%) and distribution (1, 2, or 3 vessel). MAIN OUTCOMES AND MEASURES The primary outcome was 1-year hospitalization for nonfatal MI after the index angiography. Secondary outcomes included 1-year all-cause mortality and combined 1-year MI and mortality. RESULTS Among 37 674 patients, 8384 patients (22.3%) had nonobstructive CAD and 20 899 patients (55.4%) had obstructive CAD. Within 1 year, 845 patients died and 385 were rehospitalized for MI. Among patients with no apparent CAD, the 1-year MI rate was 0.11% (n = 8, 95% CI, 0.10%-0.20%) and increased progressively by 1-vessel nonobstructive CAD, 0.24%(n = 10, 95% CI, 0.10%-0.40%); 2-vessel nonobstructive CAD, 0.56%(n = 13, 95% CI, 0.30%-1.00%); 3-vessel nonobstructive CAD, 0.59% (n = 6, 95% CI, 0.30%-1.30%); 1-vessel obstructive CAD, 1.18%(n = 101, 95% CI, 1.00%-1.40%); 2-vessel obstructive CAD, 2.18% (n = 110, 95% CI, 1.80%-2.60%); and 3-vessel or LM obstructive CAD, 2.47%(n = 137, 95% CI, 2.10%-2.90%). After adjustment, 1-year MI rates increased with increasing CAD extent. Relative to patients with no apparent CAD, patients with 1-vessel nonobstructive CAD had a hazard ratio (HR) for 1-year MI of 2.0 (95% CI, 0.8-5.1); 2-vessel nonobstructive HR, 4.6 (95% CI, 2.0-10.5); 3-vessel nonobstructive HR, 4.5 (95% CI, 1.6-12.5); 1-vessel obstructive HR, 9.0 (95% CI, 4.2-19.0); 2-vessel obstructive HR, 16.5 (95% CI, 8.1-33.7); and 3-vessel or LM obstructive HR, 19.5 (95% CI, 9.9-38.2). One-year mortality rates were associated with increasing CAD extent, ranging from 1.38% among patients without apparent CAD to 4.30% with 3-vessel or LM obstructive CAD. After risk adjustment, there was no significant association between 1-or 2-vessel nonobstructive CAD and mortality, but there were significant associations with mortality for 3-vessel nonobstructive CAD (HR, 1.6; 95% CI, 1.1-2.5), 1-vessel obstructive CAD (HR, 1.9; 95% CI, 1.4-2.6), 2-vessel obstructive CAD (HR, 2.8; 95% CI, 2.1-3.7), and 3-vessel or LM obstructive CAD (HR, 3.4; 95% CI, 2.6-4.4). Similar associations were noted with the combined outcome. CONCLUSIONS AND RELEVANCE In this cohort of patients undergoing elective coronary angiography, nonobstructive CAD, compared with no apparent CAD, was associated with a significantly greater 1-year risk of MI and all-cause mortality. These findings suggest clinical importance of nonobstructive CAD and warrant further investigation of interventions to improve outcomes among these patients. Copyright 2014 American Medical Association. All rights reserved.	[Maddox, Thomas M.; Stanislawski, Maggie A.; Grunwald, Gary K.; Bradley, Steven M.; Ho, P. Michael; Rumsfeld, John S.] VA Eastern Colorado Hlth Care Syst, Denver, CO USA; [Maddox, Thomas M.; Grunwald, Gary K.; Bradley, Steven M.; Ho, P. Michael; Sandhu, Amneet; Valle, Javier; Leon, Benjamin; Rumsfeld, John S.] Univ Colorado, Sch Med, Aurora, CO USA; [Grunwald, Gary K.; Magid, David J.] Colorado Sch Publ Hlth, Aurora, CO USA; [Tsai, Thomas T.; Magid, David J.] Kaiser Permanente Colorado, Denver, CO USA; [Patel, Manesh R.] Duke Univ, Durham, NC USA; [Magid, David J.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Fihn, Stephan D.] US Dept Vet Affairs, Off Analyt & Business Intelligence, Washington, DC USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Kaiser Permanente; Duke University; Kaiser Permanente; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs	Maddox, TM (corresponding author), Denver VA Med Ctr, Div Cardiol, Cardiol Sect 111B, 1055 Clermont St, Denver, CO 80220 USA.	thomas.maddox@va.gov	Fihn, Stephan/ABA-1040-2020; Bradley, Steven/AID-7839-2022; Patel, Manesh/AAC-5385-2019	Stanislawski, Maggie/0000-0001-7768-8868	VA Health Services Research and Development career development awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007822] Funding Source: NIH RePORTER	VA Health Services Research and Development career development awards(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The CART program is an operational program of the Department of Veterans Affairs Office of Information and Analytics. Drs Maddox and Bradley are supported with VA Health Services Research and Development career development awards.	Ahmadi N, 2011, AM J CARDIOL, V107, P10, DOI 10.1016/j.amjcard.2010.08.034; AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; [Anonymous], ASS RAC ETHNC; Bigi R, 2003, HEART, V89, P1009, DOI 10.1136/heart.89.9.1009; Box TL, 2010, J GEN INTERN MED, V25, P72, DOI 10.1007/s11606-009-1130-6; Bradley SM, 2014, J AM COLL CARDIOL, V63, P417, DOI 10.1016/j.jacc.2013.09.055; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Bugiardini R, 2006, ARCH INTERN MED, V166, P1391, DOI 10.1001/archinte.166.13.1391; Byrd JB, 2013, AM HEART J, V165, P434, DOI 10.1016/j.ahj.2012.12.009; De Ferrari GM, 2014, EUR HEART J-ACUTE CA, V3, P37, DOI 10.1177/2048872613489315; Dwyer JP, 2008, INT J CARDIOL, V129, P394, DOI 10.1016/j.ijcard.2007.12.023; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; FUSTER V, 1994, CIRCULATION, V90, P2126, DOI 10.1161/01.CIR.90.4.2126; GIROUD D, 1992, AM J CARDIOL, V69, P729, DOI 10.1016/0002-9149(92)90495-K; Hung MJ, 2003, AM J CARDIOL, V91, P1339, DOI 10.1016/S0002-9149(03)00325-4; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lin FY, 2011, J AM COLL CARDIOL, V58, P510, DOI 10.1016/j.jacc.2010.11.078; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; Maddox TM, 2010, CIRC-CARDIOVASC QUAL, V3, P632, DOI 10.1161/CIRCOUTCOMES.109.906214; Mancini GBJ, 2014, JACC-CARDIOVASC INTE, V7, P195, DOI 10.1016/j.jcin.2013.10.017; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Newby LK, 2006, CIRCULATION, V113, P203, DOI 10.1161/CIRCULATIONAHA.105.505636; Otaki Y, 2012, J NUCL CARDIOL, V19, P787, DOI 10.1007/s12350-012-9582-1; Patel MR, 2006, AM HEART J, V152, P641, DOI 10.1016/j.ahj.2006.02.035; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Roe MT, 2000, CIRCULATION, V102, P1101, DOI 10.1161/01.CIR.102.10.1101; Segev A, 2012, EUR HEART J-CARD IMG, V13, P169, DOI 10.1093/ejechocard/jer189; Shah PK, 2007, CURR OPIN LIPIDOL, V18, P492, DOI 10.1097/MOL.0b013e3282efa326; Steg PG, 2014, JAMA INTERN MED, V174, P1651, DOI 10.1001/jamainternmed.2014.3773; SULLIVAN DR, 1990, AM HEART J, V119, P1262, DOI 10.1016/S0002-8703(05)80173-5; Tian J, 2014, J AM COLL CARDIOL, V64, P672, DOI 10.1016/j.jacc.2014.05.052; Wang CH, 2002, AM HEART J, V144, P275, DOI 10.1067/mhj.2002.123843; WILSON RF, 1987, CIRCULATION, V75, P723, DOI 10.1161/01.CIR.75.4.723	40	336	338	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1754	1763		10.1001/jama.2014.14681	http://dx.doi.org/10.1001/jama.2014.14681			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25369489	Green Accepted, Bronze			2022-12-28	WOS:000344194500013
J	Scott, S; Davenport, R				Scott, Shona; Davenport, Richard			PRACTICE POINTER Low pressure headaches caused by spontaneous intracranial hypotension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Scott, Shona; Davenport, Richard] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Davenport, R (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	rjd@skull.dcn.ed.ac.uk						Amoozegar F, 2013, CAN J NEUROL SCI, V40, P144, DOI 10.1017/S0317167100013664; Balkan II, 2012, SCAND J INFECT DIS, V44, P481, DOI 10.3109/00365548.2012.664776; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; DAVENPORT RJ, 1995, J NEUROL NEUROSUR PS, V59, P516, DOI 10.1136/jnnp.59.5.516; Ghavanini AA, 2013, CEPHALALGIA, V33, P43, DOI 10.1177/0333102412466963; Graff-Radford SB, 2014, HEADACHE, V54, P394, DOI 10.1111/head.12283; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; Mokri B, 2013, HEADACHE, V53, P1034, DOI 10.1111/head.12149; Park ES, 2009, J KOREAN NEUROSURG S, V45, P1, DOI 10.3340/jkns.2009.45.1.1; Patrick A, 2007, HEADACHE, V47, P611, DOI 10.1111/j.1526-4610.2007.00763_1.x; Rahman M, 2011, NEUROSURGERY, V69, P4, DOI 10.1227/NEU.0b013e3182134399; Schievink W I, 2000, Neurosurg Focus, V9, pe8, DOI 10.3171/foc.2000.9.1.8; Schievink Wouter I, 2007, J Headache Pain, V8, P325, DOI 10.1007/s10194-007-0421-8; Schievink WI, 2011, HEADACHE, V51, P1442, DOI 10.1111/j.1526-4610.2011.01911.x; Sencakova D, 2001, NEUROLOGY, V57, P1921, DOI 10.1212/WNL.57.10.1921	15	5	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2014	349								g6219	10.1136/bmj.g6219	http://dx.doi.org/10.1136/bmj.g6219			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CD	25378383				2022-12-28	WOS:000344603700001
J	Sohn, E				Sohn, Emily			The toxic side of rice	NATURE			English	Editorial Material																		Castrillo G, 2013, PLANT CELL, V25, P2944, DOI 10.1105/tpc.113.114009; Lorenz A.J., 2009, CROP SCI; Meng XY, 2011, NEW PHYTOL, V191, P49, DOI 10.1111/j.1469-8137.2011.03743.x; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Zhu YG, 2014, ANNU REV EARTH PL SC, V42, P443, DOI 10.1146/annurev-earth-060313-054942	6	67	70	6	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S62	S63		10.1038/514S62a	http://dx.doi.org/10.1038/514S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368891	Bronze			2022-12-28	WOS:000343801500007
J	Juric, D; Castel, P; Griffith, M; Griffith, OL; Won, HH; Ellis, H; Ebbesen, SH; Ainscough, BJ; Ramu, A; Iyer, G; Shah, RH; Huynh, T; Mino-Kenudson, M; Sgroi, D; Isakoff, S; Thabet, A; Elamine, L; Solit, DB; Lowe, S; Quadt, C; Peters, M; Derti, A; Schegel, R; Huang, A; Mardis, ER; Berger, MF; Baselga, J; Scaltriti, M				Juric, Dejan; Castel, Pau; Griffith, Malachi; Griffith, Obi L.; Won, Helen H.; Ellis, Haley; Ebbesen, Saya H.; Ainscough, Benjamin J.; Ramu, Avinash; Iyer, Gopa; Shah, Ronak H.; Huynh, Tiffany; Mino-Kenudson, Mari; Sgroi, Dennis; Isakoff, Steven; Thabet, Ashraf; Elamine, Leila; Solit, David B.; Lowe, ScottW.; Quadt, Cornelia; Peters, Malte; Derti, Adnan; Schegel, Robert; Huang, Alan; Mardis, Elaine R.; Berger, Michael F.; Baselga, Jose; Scaltriti, Maurizio			Convergent loss of PTEN leads to clinical resistance to a PI(3)K alpha inhibitor	NATURE			English	Article							INTRATUMOR HETEROGENEITY; DOMAIN MUTATIONS; EVOLUTION; CANCERS; GROWTH	Broad and deep tumour genome sequencing has shed new light on tumour heterogeneity and provided important insights into the evolution of metastases arising from different clones(1,2). There is an additional layer of complexity, in that tumour evolution may be influenced by selective pressure provided by therapy, in a similar fashion to that occurring in infectious diseases. Here we studied tumour genomic evolution in a patient (index patient) with metastatic breast cancer bearing an activating PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, PI(3)K alpha) mutation. The patient was treated with the PI(3)K alpha inhibitor BYL719, which achieved a lasting clinical response, but the patient eventually became resistant to this drug (emergence of lung metastases) and died shortly thereafter. A rapid autopsy was performed and material from a total of 14 metastatic sites was collected and sequenced. All metastatic lesions, when compared to the pre-treatment tumour, had a copy loss of PTEN (phosphatase and tensin homolog) and those lesions that became refractory to BYL719 had additional and different PTEN genetic alterations, resulting in the loss of PTEN expression. To put these results in context, we examined six other patients also treated with BYL719. Acquired bi-allelic loss of PTEN was found in one of these patients, whereas in two others PIK3CA mutations present in the primary tumour were no longer detected at the time of progression. To characterize our findings functionally, we examined the effects of PTEN knockdown in several preclinical models (both in cell lines intrinsically sensitive to BYL719 and in PTEN-null xenografts derived from our index patient), which we found resulted in resistance to BYL719, whereas simultaneous PI(3) K p110 beta blockade reverted this resistance phenotype. We conclude that parallel genetic evolution of separate metastatic sites with different PTEN genomic alterations leads to a convergent PTEN-null phenotype resistant to PI(3)K alpha inhibition.	[Juric, Dejan; Huynh, Tiffany; Mino-Kenudson, Mari; Sgroi, Dennis; Isakoff, Steven; Thabet, Ashraf; Elamine, Leila] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Castel, Pau; Won, Helen H.; Ellis, Haley; Iyer, Gopa; Shah, Ronak H.; Solit, David B.; Berger, Michael F.; Baselga, Jose; Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program HOPP, New York, NY 10065 USA; [Griffith, Malachi; Mardis, Elaine R.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Griffith, Malachi; Griffith, Obi L.; Mardis, Elaine R.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; [Griffith, Malachi; Griffith, Obi L.; Ainscough, Benjamin J.; Ramu, Avinash; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Griffith, Obi L.; Mardis, Elaine R.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Won, Helen H.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Ebbesen, Saya H.; Lowe, ScottW.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Iyer, Gopa; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Genitourinary Oncol, New York, NY 10065 USA; [Lowe, ScottW.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Canc Biol & Genet Program, New York, NY 10065 USA; [Quadt, Cornelia; Peters, Malte] Novartis Pharma AG, CH-4056 Basel, Switzerland; [Derti, Adnan; Schegel, Robert; Huang, Alan] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Baselga, Jose] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Med Serv, New York, NY 10065 USA	Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Novartis; Novartis; Memorial Sloan Kettering Cancer Center	Scaltriti, M (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program HOPP, 1275 York Ave,Box 20, New York, NY 10065 USA.	bergerm1@mskcc.org; baselgaj@mskcc.org; scaltrim@mskcc.org	Shah, Ronak H/H-9726-2017; Solit, David B./AAC-5309-2019; Isakoff, Steven/ABE-3566-2020; Griffith, Malachi/P-1285-2014; Mardis, Elaine/W-2202-2019; Castel, Pau/AAL-5791-2020; Sgroi, Dennis/AAV-2487-2021; Griffith, Obi/P-1286-2014	Shah, Ronak H/0000-0001-9042-6213; Griffith, Malachi/0000-0002-6388-446X; Castel, Pau/0000-0002-4972-4347; Solit, David/0000-0002-6614-802X; Ainscough, Benjamin/0000-0001-8340-514X; Griffith, Obi/0000-0002-0843-4271; Ramu, Avinash/0000-0003-3799-809X	"Stand Up to Cancer" Dream Team Translational Research Grant; Entertainment Industry Foundation [SU2C-AACR-DT0209]; Breast Cancer Research Foundation; Geoffrey Beene Cancer Research Center; Starr Cancer Consortium; MMHCC [CA105388]; National Institutes of Health [T32 CA-71345-15]; NATIONAL CANCER INSTITUTE [R01CA190642, T32CA113275, U01CA105388, U01CA168409, T32CA071345, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065094] Funding Source: NIH RePORTER	"Stand Up to Cancer" Dream Team Translational Research Grant; Entertainment Industry Foundation; Breast Cancer Research Foundation; Geoffrey Beene Cancer Research Center; Starr Cancer Consortium; MMHCC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the MSKCC Diagnostic Molecular Pathology Laboratory and the MSK Maria-Josee and Henry Kravis Center for Molecular Oncology for assistance with sequencing. We thank M. Asher and U. Bhanot from the MSKCC Pathology Core for assistance with tissue staining. This work was funded by a "Stand Up to Cancer" Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0209), the Breast Cancer Research Foundation, the Geoffrey Beene Cancer Research Center, the Starr Cancer Consortium and an MMHCC grant (CA105388). D.J. is also funded by a National Institutes of Health Training Grant (T32 CA-71345-15) and by philanthropic support from Stephen and Kathleen Chubb.	Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Juric D, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P8-10-07; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Lemey P, 2005, J VIROL, V79, P11981, DOI 10.1128/JVI.79.18.11981-11989.2005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710; Yang ZQ, 2010, CANCER RES, V70, P8487, DOI 10.1158/0008-5472.CAN-10-1013; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	27	365	380	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					240	U230		10.1038/nature13948	http://dx.doi.org/10.1038/nature13948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25409150	Green Accepted			2022-12-28	WOS:000349190300040
J	Strait, RT; Posgai, MT; Mahler, A; Barasa, N; Jacob, CO; Kohl, J; Ehlers, M; Stringer, K; Shanmukhappa, SK; Witte, D; Hossain, MM; Khodoun, M; Herr, AB; Finkelman, FD				Strait, Richard T.; Posgai, Monica T.; Mahler, Ashley; Barasa, Nathaniel; Jacob, Chaim O.; Koehl, Joerg; Ehlers, Marc; Stringer, Keith; Shanmukhappa, Shiva Kumar; Witte, David; Hossain, Md Monir; Khodoun, Marat; Herr, Andrew B.; Finkelman, Fred D.			IgG1 protects against renal disease in a mouse model of cryoglobulinaemia	NATURE			English	Article							FC-GAMMA-RIIB; CLASS SWITCH RECOMBINATION; ANTIINFLAMMATORY ACTIVITY; MONOCLONAL-ANTIBODIES; SEGMENTAL FLEXIBILITY; IMMUNE-RESPONSES; IN-VIVO; COMPLEMENT; INFLAMMATION; RECEPTORS	Immunoglobulins protect against disease to a considerable extent by activating complement and stimulatory immunoglobulin crystallizable fragment receptors (Ig FcRs), and aggregating microbial pathogens(1,2). Yet IgGI, the predominant murine serum Ig isotype, cannot activate complement by the classical pathway, binds more avidly to an inhibitory than to stimulatory FcRs, and has limited ability to aggregate pathogens(1-3). In these regards, it resembles human IgG4 (ref. 4). We hypothesized that limited ability to activate effector mechanisms might protect against immune complex immunopathology. Here we show that IgG 1 -deficient (gamma 1(-)) mice(5), immunized with a potent antigen, develop lethal renal disease soon after they begin to produce antigen-specific antibody, whereas similarly immunized wildtype mice remain healthy. Surprisingly, renal disease in this model is complement and FcR independent and results from immune complex precipitation in glomerular capillaries, as in some cryoglobulinaemic humans(6). IgG3, which self-associates to form large immune complexes(7,8), accounts for more than 97% of the mouse Ig in this cryoglobulin; furthermore, glomerular disease develops when mice are injected with IgG3 anti-trinitrophenyl (TNP) monoclonal antibody followed by a TNP-labelled protein. Renal disease is prevented in both active and passive immunization models by antigen-specific IgGI; other isotypes are less potent at preventing disease. These observations demonstrate the adaptive significance of Ig isotypes that poorly activate effector mechanisms, reveal an immune-complex-dependent, complement- and FcR-independent nephrotoxic mechanism, and suggest that isotypes that poorly activate effector mechanisms may be useful for inhibiting immune complex immunopathology.	[Strait, Richard T.; Mahler, Ashley; Barasa, Nathaniel] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Strait, Richard T.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Posgai, Monica T.; Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Jacob, Chaim O.] Univ So Calif, Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Koehl, Joerg; Herr, Andrew B.; Finkelman, Fred D.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Koehl, Joerg; Ehlers, Marc] Med Univ Lubeck, Inst Syst Inflammat Res, D-23538 Lubeck, Germany; [Stringer, Keith; Shanmukhappa, Shiva Kumar; Witte, David] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Hossain, Md Monir] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Khodoun, Marat; Finkelman, Fred D.] Univ Cincinnati, Coll Med, Dept Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45267 USA; [Finkelman, Fred D.] Cincinnati Vet Affairs Med Ctr, Med Serv, Cincinnati, OH 45220 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Southern California; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Lubeck; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Finkelman, FD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.	finkelfd@UCMAIL.UC.EDU	Ehlers, Marc/C-9441-2011; Koehl, Joerg/C-8531-2011; Hossain, Md/N-5360-2015; Herr, Andrew/R-3049-2019	Ehlers, Marc/0000-0002-5383-8603; Koehl, Joerg/0000-0003-1121-3178; Herr, Andrew/0000-0002-3598-3399	US Department of Veterans Affairs Merit Award; National Institutes of Health [R01 AI072040]; Cincinnati Children's Hospital; University of Cincinnati; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072040] Funding Source: NIH RePORTER	US Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Hospital; University of Cincinnati; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Wills-Karp for C3-deficient mice, D. Metzger for J-chain-deficient mice, M. Muramatsu for AID-deficient mice, S. Izui for a hybridoma that secretes mouse IgG1 anti-TNP monoclonal antibody, M. Robson and L. Aarden for switch variant hybridomas that secrete mouse IgG1, IgG2a and IgG2b anti-TNP monoclonal antibodies, B. DiPasquale for histological staining, and J. Lambris for C5aR antagonist. Research was supported by a US Department of Veterans Affairs Merit Award, National Institutes of Health R01 AI072040, and the University of Cincinnati and Cincinnati Children's Hospital, all to F.D.F.	ABDELMOULA M, 1989, J IMMUNOL, V143, P526; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Barrington R, 2001, IMMUNOL REV, V180, P5, DOI 10.1034/j.1600-065X.2001.1800101.x; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; BOOT JHA, 1988, J IMMUNOL METHODS, V106, P195, DOI 10.1016/0022-1759(88)90197-4; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Chu SY, 2012, J ALLERGY CLIN IMMUN, V129, P1102, DOI 10.1016/j.jaci.2011.11.029; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; Erlandsson L, 1998, EUR J IMMUNOL, V28, P2355, DOI 10.1002/(SICI)1521-4141(199808)28:08&lt;2355::AID-IMMU2355&gt;3.0.CO;2-L; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; FINKELMAN FD, 1982, J IMMUNOL, V129, P638; FULPIUS T, 1994, KIDNEY INT, V45, P962, DOI 10.1038/ki.1994.130; Giorgini A, 2008, J IMMUNOL, V181, P8745, DOI 10.4049/jimmunol.181.12.8745; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; NISHIMURA Y, 1984, J BIOCHEM-TOKYO, V95, P255, DOI 10.1093/oxfordjournals.jbchem.a134592; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Roccatello D, 2007, AM J KIDNEY DIS, V49, P69, DOI 10.1053/j.ajkd.2006.09.015; SCHNEIDER WP, 1988, P NATL ACAD SCI USA, V85, P2509, DOI 10.1073/pnas.85.8.2509; Sheerin NS, 2001, EUR J IMMUNOL, V31, P1255, DOI 10.1002/1521-4141(200104)31:4<1255::AID-IMMU1255>3.0.CO;2-W; Snapper C., 1999, FUNDAMENTAL IMMUNOLO, P837; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575	26	45	47	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					501	+		10.1038/nature13868	http://dx.doi.org/10.1038/nature13868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25363774	Green Accepted, Bronze			2022-12-28	WOS:000348196500038
J	Lee, JM; Wagner, M; Xiao, R; Kim, KH; Feng, D; Lazar, MA; Moore, DD				Lee, Jae Man; Wagner, Martin; Xiao, Rui; Kim, Kang Ho; Feng, Dan; Lazar, Mitchell A.; Moore, David D.			Nutrient-sensing nuclear receptors coordinate autophagy	NATURE			English	Article							FARNESOID-X-RECEPTOR; NEGATIVE FEEDBACK-REGULATION; ACTIVATED RECEPTOR; BILE-ACID; TARGETED DISRUPTION; FATTY-ACIDS; IDENTIFICATION; MTOR; AMPK; METABOLISM	Autophagy is an evolutionarily conserved catabolic process that recycles nutrients upon starvation and maintains cellular energy homeostasis(1-3). Its acute regulation by nutrient-sensing signalling pathways is well described, but its longer-term transcriptional regulation is not. The nuclear receptors peroxisome proliferator-activated receptor-alpha (PPAR alpha) and farnesoid X receptor (FXR) are activated in the fasted and fed liver, respectively(4,5). Here we show that both PPARa and FXR regulate hepatic autophagy in mice. Pharmacological activation of PPARa reverses the normal suppression of autophagy in the fed state, inducing autophagic lipid degradation, or lipophagy. This response is lost in PPARa knockout (Ppara(-/-), also known as Nr1c1(-/-) mice, which are partially defective in the induction of autophagy by fasting. Pharmacological activation of the bile acid receptor FXR strongly suppresses the induction of autophagy in the fasting state, and this response is absent in FXR knockout (Fxr(-/-), also known as Nr1h4(-/-)) mice, which show a partial defect in suppression of hepatic autophagy in the fed state. PPARa and FXR compete for binding to shared sites in autophagic gene promoters, with opposite transcriptional outputs. These results reveal complementary, interlocking mechanisms for regulation of autophagy by nutrient status.	[Lee, Jae Man; Wagner, Martin; Xiao, Rui; Kim, Kang Ho; Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Feng, Dan; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19014 USA; [Feng, Dan; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19014 USA	Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	moore@bcm.edu	Lazar, Mitchell A/AAF-3738-2019	Feng, Dan/0000-0001-5926-8894	Alkek Foundation; Robert R.P. Doherty Jr-Welch Chair in Science [R01 DK49780, DK43806];  [U54 HD-07495-39];  [P30 DX56338-05A2];  [P39 CA125123-04];  [S10RR027783-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049780, P30DK056338, R01DK043806, R37DK043806, P30DK019525] Funding Source: NIH RePORTER	Alkek Foundation; Robert R.P. Doherty Jr-Welch Chair in Science; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Mizushima for the GFP-LC3<SUP>Tg/+</SUP> mice; T. Yoshimori for the mRFP-GFP-LC3 plasmid; M. Komatsu for the Atg7<SUP>F/F</SUP> mice; D. Townley and M. Mancini for transmission electron microscopy and confocal microscopy; the members of the Moore laboratory for comments and additional support. Core facilities supported by grants U54 HD-07495-39, P30 DX56338-05A2, P39 CA125123-04 and S10RR027783-01A1. Next-generation sequencing was performed by the Functional Genomics Core of the Penn Diabetes Research Center (DK19525). This work was supported by funding from the Alkek Foundation and the Robert R.P. Doherty Jr-Welch Chair in Science to D.D.M., and R01 DK49780 and DK43806 to M.A.L.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Brown PJ, 2001, BIOORG MED CHEM LETT, V11, P1225, DOI 10.1016/S0960-894X(01)00188-3; Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0; Chennamsetty I, 2011, J CLIN INVEST, V121, P3724, DOI 10.1172/JCI45277; Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Glauert A. M., 1975, PRACTICAL METHODS EL, P143; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; McKnight NC, 2012, EMBO J, V31, P1931, DOI 10.1038/emboj.2012.36; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Settembre C, 2014, TRENDS CELL BIOL; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	335	351	6	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					112	U291		10.1038/nature13961	http://dx.doi.org/10.1038/nature13961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25383539	Green Submitted, Green Accepted			2022-12-28	WOS:000346310800050
J	Gray, JM; Frolking, S; Kort, EA; Ray, DK; Kucharik, CJ; Ramankutty, N; Friedl, MA				Gray, Josh M.; Frolking, Steve; Kort, Eric A.; Ray, Deepak K.; Kucharik, Christopher J.; Ramankutty, Navin; Friedl, Mark A.			Direct human influence on atmospheric CO2 seasonality from increased cropland productivity	NATURE			English	Article							NET PRIMARY PRODUCTION; CARBON SEQUESTRATION; HARVEST INDEX; NORTHERN ECOSYSTEMS; USE EFFICIENCY; GRAIN-YIELD; MAUNA-LOA; AGRICULTURE; CLIMATE; TRENDS	Ground- and aircraft-based measurements show that the seasonal amplitude of Northern Hemisphere atmospheric carbon dioxide (CO2) concentrations has increased by as much as 50 per cent over the past 50 years(1-3). This increase has been linked to changes in temperate, boreal and arctic ecosystem properties and processes such as enhanced photosynthesis, increased heterotrophic respiration, and expansion of woody vegetation(4-6). However, the precise causal mechanisms behind the observed changes in atmospheric CO2 seasonality remain unclear(2-4). Here we use production statistics and a carbon accounting model to show that increases in agricultural productivity, which have been largely overlooked in previous investigations, explain as much as a quarter of the observed changes in atmospheric CO2 seasonality. Specifically, Northern Hemisphere extratropical maize, wheat, rice, and soybean production grew by 240 per cent between 1961 and 2008, thereby increasing the amount of net carbon uptake by croplands during the Northern Hemisphere growing season by 0.33 petagrams. Maize alone accounts for two-thirds of this change, owing mostly to agricultural intensification within concentrated production zones in the midwestern United States and northern China. Maize, wheat, rice, and soybeans account for about 68 per cent of extratropical dry biomass production, so it is likely that the total impact of increased agricultural production exceeds the amount quantified here.	[Gray, Josh M.; Friedl, Mark A.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Frolking, Steve] Univ New Hampshire, Earth Syst Res Ctr, Durham, NH 03824 USA; [Kort, Eric A.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Ray, Deepak K.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Kucharik, Christopher J.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Kucharik, Christopher J.] Univ Wisconsin, Nelson Inst Ctr Sustainabil & Global Environm, Madison, WI 53706 USA; [Ramankutty, Navin] McGill Univ, Dept Geog, Montreal, PQ H3A 0B9, Canada	Boston University; University System Of New Hampshire; University of New Hampshire; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; McGill University	Gray, JM (corresponding author), Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA.	joshgray@bu.edu	Frolking, Steve/ABF-9046-2021; Friedl, Mark A/A-3570-2012; Ray, Deepak K/F-7720-2012; Kort, Eric A/F-9942-2012; Ramankutty, Navin/AAM-6074-2020	Frolking, Steve/0000-0001-6414-5004; Kort, Eric A/0000-0003-4940-7541; Ramankutty, Navin/0000-0002-3737-5717; Kucharik, Christopher/0000-0002-0400-758X; Gray, Josh/0000-0003-4341-4353; Ray, Deepak/0000-0002-2856-9608	CFCAS; NSERC; BIOCAP; Environment Canada; NRCan; CarboEuropelP; FAO-GTOS-TCO; iLEAPS; Max Planck Institute for Biogeochemistry; National Science Foundation; University of Tuscia; Universite Laval; US Department of Energy; NASA [NNX11AE75G]; NSF [EF-1064614, EAR-1038818]; Gordon and Betty Moore Foundation; Institute on Environment at the University of Minnesota; Emerging Frontiers [1065029] Funding Source: National Science Foundation	CFCAS; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BIOCAP; Environment Canada(CGIAR); NRCan(Natural Resources Canada); CarboEuropelP; FAO-GTOS-TCO; iLEAPS; Max Planck Institute for Biogeochemistry; National Science Foundation(National Science Foundation (NSF)); University of Tuscia; Universite Laval; US Department of Energy(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Institute on Environment at the University of Minnesota; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work used eddy covariance data acquired by the FLUXNET community and in particular by the following networks: AmeriFlux (US Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program (DE-FG02-04ER63917 and DE-FG02-04ER63911)), AfriFlux, AsiaFlux, CarboAfrica, CarboEuropelP, Carboltaly, CarboMont, ChinaFlux, Fluxnet-Canada (supported by CFCAS, NSERC, BIOCAP, Environment Canada, and NRCan), GreenGrass, KoFlux, LBA, NECC, OzFlux, TCOS-Siberia, USCCC. We acknowledge the financial support to the eddy covariance data harmonization provided by CarboEuropelP, FAO-GTOS-TCO, iLEAPS, Max Planck Institute for Biogeochemistry, National Science Foundation, University of Tuscia, Universite Laval and Environment Canada and US Department of Energy and the database development and technical support from Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California - Berkeley, University of Virginia. This work was supported by NASA grant number NNX11AE75G and NSF grant numbers EF-1064614 and NSF EAR-1038818. Research support to D.K.R. was primarily provided by the Gordon and Betty Moore Foundation and the Institute on Environment at the University of Minnesota. We also acknowledge input and data provided by H. Graven and P. Patra.	Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Arai-Sanoh Y, 2010, PLANT PROD SCI, V13, P235, DOI 10.1626/pps.13.235; Aubinet M, 2009, AGR FOREST METEOROL, V149, P407, DOI 10.1016/j.agrformet.2008.09.003; BACASTOW RB, 1985, J GEOPHYS RES-ATMOS, V90, P10529, DOI 10.1029/JD090iD06p10529; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Barichivich J, 2013, GLOBAL CHANGE BIOL, V19, P3167, DOI 10.1111/gcb.12283; Bonifas KD, 2005, WEED SCI, V53, P670, DOI 10.1614/WS-05-002R.1; Buermann W, 2007, P NATL ACAD SCI USA, V104, P4249, DOI 10.1073/pnas.0611224104; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Dawe D, 2004, FIELD CROP RES, V87, P89, DOI 10.1016/j.fcr.2003.08.008; DeFries RS, 1999, GLOBAL BIOGEOCHEM CY, V13, P803, DOI 10.1029/1999GB900037; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; FAO, 2013, FAOST DAT; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Frolking S, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001425; Gehring C, 2013, EUR J AGRON, V46, P25, DOI 10.1016/j.eja.2012.11.006; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Gower ST, 1999, REMOTE SENS ENVIRON, V70, P29, DOI 10.1016/S0034-4257(99)00056-5; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Guanter L, 2014, P NATL ACAD SCI USA, V111, pE1327, DOI 10.1073/pnas.1320008111; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; HAY RKM, 1995, ANN APPL BIOL, V126, P197, DOI 10.1111/j.1744-7348.1995.tb05015.x; Insalud N, 2006, ANN BOT-LONDON, V98, P995, DOI 10.1093/aob/mcl194; Johnson JMF, 2006, AGRON J, V98, P622, DOI 10.2134/agronj2005.0179; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Keppel-Aleks G, 2013, J CLIMATE, V26, P4447, DOI 10.1175/JCLI-D-12-00589.1; Kucharik CJ, 2008, AGRON J, V100, P328, DOI 10.2134/agronj2007.0145; Kumudini S, 2001, CROP SCI, V41, P391, DOI 10.2135/cropsci2001.412391x; Le Quere C, 2012, EARTH SYST SCI DATA, V5, P1107, DOI [10.5194/ESSDD-5-1107-2012, DOI 10.5194/ESSDD-5-1107-2012]; Lobell DB, 2002, GLOBAL CHANGE BIOL, V8, P722, DOI 10.1046/j.1365-2486.2002.00503.x; Lorenz AJ, 2010, CROP SCI, V50, P1, DOI 10.2135/cropsci2009.02.0086; Ma SC, 2010, FIELD CROP RES, V115, P158, DOI 10.1016/j.fcr.2009.10.017; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; PEARMAN GI, 1981, J GEOPHYS RES-OCEANS, V86, P9839, DOI 10.1029/JC086iC10p09839; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Prince SD, 2001, ECOL APPL, V11, P1194, DOI 10.1890/1051-0761(2001)011[1194:NPPOUS]2.0.CO;2; Qiu J., 2003, GEOCARTO INT, V18, P3, DOI [10.1080/10106040308542268, DOI 10.1080/10106040308542268]; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; SCHNYDER H, 1993, NEW PHYTOL, V123, P233, DOI 10.1111/j.1469-8137.1993.tb03731.x; Shearman VJ, 2005, CROP SCI, V45, P175; Sinclair TR, 1998, CROP SCI, V38, P638, DOI 10.2135/cropsci1998.0011183X003800030002x; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; West TO, 2011, BIOGEOSCIENCES, V8, P2037, DOI 10.5194/bg-8-2037-2011; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; West TO, 2003, BIOGEOCHEMISTRY, V63, P73, DOI 10.1023/A:1023394024790; Williams JD, 2013, J SOIL WATER CONSERV, V68, P349, DOI 10.2489/jswc.68.5.349; Wirsenius S, 2003, AGR SYST, V77, P219, DOI 10.1016/S0308-521X(02)00188-9; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112	57	94	97	5	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					398	+		10.1038/nature13957	http://dx.doi.org/10.1038/nature13957			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409830				2022-12-28	WOS:000345770600042
J	Carter, M				Carter, Meg			MEDICINE AND THE MEDIA How Twitter may have helped Nigeria contain Ebola	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												meg@megcarter.com						[Anonymous], 2014, SOCIAL MEDIA WEEK; [Anonymous], 2014, ECONOMIST; [Anonymous], SIERRA LEONE TELECOM; BBC, 2014, BBC; Gleit N, 2014, COMING TOGETHER TO F; Neporent L., 2014, ABC NEWS; OCarroll Lisa, 2014, GUARDIAN SEP, V24; Wall M, 2014, BBC NEWS; Wallis W., 2014, FINANCIAL TIMES; World Health Organization (WHO), 2014, EBOLA RESPONSE ROADM	10	26	26	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2014	349								g6946	10.1136/bmj.g6946	http://dx.doi.org/10.1136/bmj.g6946			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JZ	25410185	Bronze, Green Published			2022-12-28	WOS:000345445700005
J	Daaleman, TP				Daaleman, Timothy P.			The Quality of Mercy Will You Be My Doctor?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Daaleman, TP (corresponding author), Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA.	tim_daaleman@med.unc.edu		Daaleman, Timothy/0000-0002-1649-4266				Green LA, 2001, KEYSTONE 3 ROLE FAMI; Keenan JF, 2007, WORKS MERCY; Long, 2012, NATL FINDINGS ACCESS; Pellegrino ED, 2001, J MED PHILOS, V26, P559, DOI 10.1076/jmep.26.6.559.2998; Shartzer Adele., 2013, ACCESS PHYS SERVICES	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1863	1864		10.1001/jama.2014.12933	http://dx.doi.org/10.1001/jama.2014.12933			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387184				2022-12-28	WOS:000344532600013
J	Deverka, PA; Kaufman, D; McGuire, AL				Deverka, Patricia A.; Kaufman, David; McGuire, Amy L.			Overcoming the Reimbursement Barriers for Clinical Sequencing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Deverka, Patricia A.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Kaufman, David] NIH, Rockville, MD USA; [McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; Baylor College of Medicine	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, 1 Baylor Plaza, Houston, TX 77030 USA.	amcguire@bcm.edu			NHGRI NIH HHS [R01-HG006460-02, R01 HG006460] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006460] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BlueCross BlueShield of North Carolina, 2013, CORP MED POL WHOL EX; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Elenitoba-Johnson KSJ, 2014, ASCO DAILY NEWS 0601; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Veenstra DL, 2013, GENET MED, V15, P14, DOI 10.1038/gim.2012.106; Walsh JME, 2013, PRENATAL DIAG, V33, P514, DOI 10.1002/pd.4109	7	29	29	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1857	1858		10.1001/jama.2014.14915	http://dx.doi.org/10.1001/jama.2014.14915			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387182	Green Accepted			2022-12-28	WOS:000344532600010
J	Elert, E				Elert, Emily			A GOOD GRAIN	NATURE			English	Editorial Material																			0	100	111	4	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S50	S51		10.1038/514S50a	http://dx.doi.org/10.1038/514S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BW	25368886	Bronze			2022-12-28	WOS:000343801500002
J	Bourron, O; Caron-Debarle, M; Hie, M; Amoura, Z; Andreelli, F; Halbron, M; Fonfrede, M; Leroux, G; Vigouroux, C; Hartemann, A				Bourron, Olivier; Caron-Debarle, Martine; Hie, Miguel; Amoura, Zahir; Andreelli, Fabrizio; Halbron, Marine; Fonfrede, Michelle; Leroux, Galle; Vigouroux, Corinne; Hartemann, Agnes			Type B Insulin-resistance syndrome: a cause of reversible autoimmune hypoglycaemia	LANCET			English	Editorial Material							RECEPTOR AUTOANTIBODIES		[Bourron, Olivier; Andreelli, Fabrizio; Halbron, Marine; Hartemann, Agnes] Hop La Pitie Salpetriere, AP HP, Dept Endocrinol Nutr & Diabet, Paris, France; [Hie, Miguel; Amoura, Zahir; Leroux, Galle] Hop La Pitie Salpetriere, Dept Internal Med, Paris, France; [Fonfrede, Michelle] Hop La Pitie Salpetriere, Dept Biochem, Paris, France; [Vigouroux, Corinne] St Antoine Hosp, Dept Mol Biol, Paris, France; [Bourron, Olivier; Caron-Debarle, Martine; Hie, Miguel; Amoura, Zahir; Andreelli, Fabrizio; Vigouroux, Corinne; Hartemann, Agnes] Univ Paris 04, Paris, France; [Caron-Debarle, Martine; Vigouroux, Corinne] St Antoine Res Ctr, INSERM, UMR S 938, Paris, France; [Bourron, Olivier; Hartemann, Agnes] Ctr Rech Cordeliers, INSERM, UMR S 1138, Paris, France; [Bourron, Olivier; Caron-Debarle, Martine; Andreelli, Fabrizio; Halbron, Marine; Vigouroux, Corinne; Hartemann, Agnes] Inst Cardiometab & Nutr, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Bourron, O (corresponding author), Hop La Pitie Salpetriere, Serv Diabetol, F-75013 Paris, France.	olivier.bourron@psl.aphp.fr	AMOURA, Zahir/P-5324-2017; Amoura, Zahir/P-5325-2017	AMOURA, Zahir/0000-0003-0292-9043; Hie, Miguel/0000-0002-8036-9312; Bourron, Olivier/0000-0001-7348-7161				Arioglu E, 2002, MEDICINE, V81, P87, DOI 10.1097/00005792-200203000-00001; Auclair M, 1999, J CLIN ENDOCR METAB, V84, P3197, DOI 10.1210/jc.84.9.3197; Coll AP, 2004, NEW ENGL J MED, V350, P310, DOI 10.1056/NEJM200401153500324; DONS RF, 1983, J CLIN INVEST, V72, P1072, DOI 10.1172/JCI111032; Malek R, 2010, J CLIN ENDOCR METAB, V95, P3641, DOI 10.1210/jc.2010-0167	5	14	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1548	1548		10.1016/S0140-6736(14)61833-X	http://dx.doi.org/10.1016/S0140-6736(14)61833-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9MO	25390580				2022-12-28	WOS:000343899600029
J	Plata, G; Henry, CS; Vitkup, D				Plata, German; Henry, Christopher S.; Vitkup, Dennis			Long-term phenotypic evolution of bacteria	NATURE			English	Article							GENETIC INTERACTION NETWORKS; GENERATION; CONSERVATION; STRAINS	For many decades comparative analyses of protein sequences and structures have been used to investigate fundamental principles of molecular evolution(1,2). In contrast, relatively little is known about the long-term evolution of species' phenotypic and genetic properties. This represents an important gap in our understanding of evolution, as exactly these proprieties play key roles in natural selection and adaptation to diverse environments. Here we perform a comparative analysis of bacterial growth and gene deletion phenotypes using hundreds of genome-scale metabolic models. Overall, bacterial phenotypic evolution can be described by a two-stage process with a rapid initial phenotypic diversification followed by a slow long-term exponential divergence. The observed average divergence trend, with approximately similar fractions of phenotypic properties changing per unit time, continues for billions of years. We experimentally confirm the predicted divergence trend using the phenotypic profiles of 40 diverse bacterial species across more than 60 growth conditions. Our analysis suggests that, at long evolutionary distances, gene essentiality is significantly more conserved than the ability to utilize different nutrients, while synthetic lethality is significantly less conserved. We also find that although a rapid phenotypic evolution is sometimes observed within the same species, a transition from high to low phenotypic similarity occurs primarily at the genus level.	[Plata, German; Vitkup, Dennis] Columbia Univ, Dept Syst Biol, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Plata, German] Columbia Univ, Integrated Program Cellular Mol Struct & Genet St, New York, NY 10032 USA; [Henry, Christopher S.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Vitkup, Dennis] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA	Columbia University; Columbia University; United States Department of Energy (DOE); Argonne National Laboratory; Columbia University	Vitkup, D (corresponding author), Columbia Univ, Dept Syst Biol, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA.	dv2121@columbia.edu		Plata, German/0000-0002-6470-7748	National Institute of General Medical Sciences [GM079759, U54CA121852]; Department of Energy, as part of the SB Knowledgebase [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079759] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy, as part of the SB Knowledgebase(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Bochner and Biolog for providing the experimental phenotypic growth data. We also thank members of the Vitkup laboratory for discussions. This work was supported in part by the National Institute of General Medical Sciences GM079759 grant to D.V. and the U54CA121852 grant to Columbia University. The work by C.S.H. was supported by the Department of Energy contract DE-AC02-06CH11357, as part of the SB Knowledgebase.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barve A, 2013, NATURE, V500, P203, DOI 10.1038/nature12301; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Darwin C, 2009, ON THE ORIGIN OF SPECIES, P1, DOI 10.1017/CBO9780511694295.004; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Monk JM, 2013, P NATL ACAD SCI USA, V110, P20338, DOI 10.1073/pnas.1307797110; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Plata G, 2012, NAT CHEM BIOL, V8, P848, DOI 10.1038/NCHEMBIO.1063; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sabarly V, 2011, J EVOLUTION BIOL, V24, P1559, DOI 10.1111/j.1420-9101.2011.02287.x; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; ZUCKERKANDL EMILE, 1965, P97	30	49	50	3	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					369	U498		10.1038/nature13827	http://dx.doi.org/10.1038/nature13827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363780				2022-12-28	WOS:000347810300046
J	Pflug, A; Guilligay, D; Reich, S; Cusack, S				Pflug, Alexander; Guilligay, Delphine; Reich, Stefan; Cusack, Stephen			Structure of influenza A polymerase bound to the viral RNA promoter	NATURE			English	Article							VIRUS PB1 PROTEIN; HEPATITIS-C VIRUS; CRYSTAL-STRUCTURE; MESSENGER-RNA; VIRION RNA; MUTATIONAL ANALYSIS; ENDONUCLEASE ACTIVITY; TERMINAL DOMAIN; ACTIVE-SITE; CAPPED RNAS	The influenza virus polymerase transcribes or replicates the segmented RNA genome (viral RNA) into viral messenger RNA or full-length copies. To initiate RNA synthesis, the polymerase binds to the conserved 39 and 59 extremities of the viral RNA. Here we present the crystal structure of the heterotrimeric bat influenza A polymerase, comprising subunits PA, PB1 and PB2, bound to its viral RNA promoter. PB1 contains a canonical RNA polymerase fold that is stabilized by large interfaces with PA and PB2. The PA endonuclease and the PB2 cap-binding domain, involved in transcription by cap-snatching, form protrusions facing each other across a solvent channel. The 59 extremity of the promoter folds into a compact hook that is bound in a pocket formed by PB1 and PA close to the polymerase active site. This structure lays the basis for an atomic-level mechanistic understanding of the many functions of influenza polymerase, and opens new opportunities for anti-influenza drug design.	[Pflug, Alexander; Guilligay, Delphine; Reich, Stefan; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Pflug, Alexander; Guilligay, Delphine; Reich, Stefan; Cusack, Stephen] Univ Grenoble Alpes, Ctr Natl Rech Sci, EMBL Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France.	cusack@embl.fr		Reich, Stefan/0000-0001-6817-753X; Reich, Stefan/0000-0001-8822-2908; Cusack, Stephen/0000-0002-9324-0796; Pflug, Alexander/0000-0002-4680-1298	ERC [322586]	ERC(European Research Council (ERC)European Commission)	We thank members of the ESRF-EMBL Joint Structural Biology Group for access to European Synchrotron Radiation Facility (ESRF) beamlines, staff of the European Molecular Biology Laboratory (EMBL) eukaryotic expression and high-throughput crystallization facilities within the Partnership for Structural Biology (PSB), D. Hart for help with construct design, and H. Malet for electron microscopy. This work was supported by ERC Advanced Grant V-RNA (322586) to S.C.	BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Briese T, 2014, J VIROL, V88, P5298, DOI 10.1128/JVI.03391-13; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006; Cauldwell AV, 2014, J GEN VIROL, V95, P1193, DOI 10.1099/vir.0.062836-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark MP, 2014, J MED CHEM, V57, P6668, DOI 10.1021/jm5007275; De la Pena M, 2007, EMBO J, V26, P4913, DOI 10.1038/sj.emboj.7601912; DeLano W.L, PYMOL MOL GRAPHICS S; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Flick R, 1996, RNA, V2, P1046; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; FODOR E, 1995, J VIROL, V69, P4012, DOI 10.1128/JVI.69.7.4012-4019.1995; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Gonzalez S, 1999, J VIROL, V73, P631; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Hutchinson EC, 2011, J GEN VIROL, V92, P1859, DOI 10.1099/vir.0.032813-0; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kerry PS, 2008, VIROLOGY, V373, P202, DOI 10.1016/j.virol.2007.11.030; Kim HJ, 1997, J GEN VIROL, V78, P353, DOI 10.1099/0022-1317-78-2-353; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Leahy MB, 2001, J VIROL, V75, P134, DOI 10.1128/JVI.75.1.134-142.2001; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li ML, 1998, EMBO J, V17, P5844, DOI 10.1093/emboj/17.19.5844; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEUMANN G, 1995, J GEN VIROL, V76, P1709, DOI 10.1099/0022-1317-76-7-1709; Nie Y, 2014, METHODS MOL BIOL, V1091, P131, DOI 10.1007/978-1-62703-691-7_8; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Pautus S, 2013, J MED CHEM, V56, P8915, DOI 10.1021/jm401369y; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Poole DS, 2014, J VIROL, V88, P12572, DOI 10.1128/JVI.01857-14; Poole EL, 2007, FEBS LETT, V581, P5300, DOI 10.1016/j.febslet.2007.10.025; Poon LLM, 1998, J VIROL, V72, P8214, DOI 10.1128/JVI.72.10.8214-8219.1998; Pritlove DC, 1999, J VIROL, V73, P2109, DOI 10.1128/JVI.73.3.2109-2114.1999; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Reich S., NATURE; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Tefsen B, 2014, J VIROL, V88, P1935, DOI 10.1128/JVI.03270-13; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Turrell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2589; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	57	316	323	5	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					355	+		10.1038/nature14008	http://dx.doi.org/10.1038/nature14008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25409142				2022-12-28	WOS:000346484800038
J	Tschopp, P; Sherratt, E; Sanger, TJ; Groner, AC; Aspiras, AC; Hu, JK; Pourquie, O; Gros, J; Tabin, CJ				Tschopp, Patrick; Sherratt, Emma; Sanger, Thomas J.; Groner, Anna C.; Aspiras, Ariel C.; Hu, Jimmy K.; Pourquie, Olivier; Gros, Jerome; Tabin, Clifford J.			A relative shift in cloacal location repositions external genitalia in amniote evolution	NATURE			English	Article							GENE-EXPRESSION; MESENCHYMAL TRANSITION; VERTEBRATE EMBRYOS; HOMOLOGY; PACKAGE; LIMB; ONTOLOGY; PROGRAM; BIOLOGY; TISSUES	The move of vertebrates to a terrestrial lifestyle required major adaptations in their locomotory apparatus and reproductive organs. While the fin-to-limb transition has received considerable attention(1,2), little is known about the developmental and evolutionary origins of external genitalia. Similarities in gene expression have been interpreted as a potential evolutionary link between the limb and genitals(3-6); however, no underlying developmental mechanism has been identified. We re-examined this question using micro-computed tomography, lineage tracing in three amniote clades, and RNA-sequencing-based transcriptional profiling. Here we show that the developmental origin of external genitalia has shifted through evolution, and in some taxa limbs and genitals share a common primordium. In squamates, the genitalia develop directly from the budding hindlimbs, or the remnants thereof, whereas in mice the genital tubercle originates from the ventral and tail bud mesenchyme. The recruitment of different cell populations for genital outgrowth follows a change in the relative position of the cloaca, the genitalia organizing centre. Ectopic grafting of the cloaca demonstrates the conserved ability of different mesenchymal cells to respond to these genitalia-inducing signals. Our results support a limb-like developmental origin of external genitalia as the ancestral condition. Moreover, they suggest that a change in the relative position of the cloacal signalling centre during evolution has led to an altered developmental route for external genitalia in mammals, while preserving parts of the ancestral limb molecular circuitry owing to a common evolutionary origin.	[Tschopp, Patrick; Aspiras, Ariel C.; Hu, Jimmy K.; Pourquie, Olivier; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sherratt, Emma; Sanger, Thomas J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Groner, Anna C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Pourquie, Olivier] IGBMC, F-67400 Illkirch Graffenstaden, France; [Pourquie, Olivier] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gros, Jerome] Inst Pasteur, Dev & Stem Cell Biol Dept, F-75724 Paris 15, France	Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Brigham & Women's Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	jgros@pasteur.fr; tabin@genetics.med.harvard.edu	Pourquié, Olivier/CAJ-5443-2022; Sherratt, Emma/A-9931-2011	Pourquié, Olivier/0000-0001-5189-1227; Sherratt, Emma/0000-0003-2164-7877; Gros, Jerome/0000-0002-2264-2851; Hu, Jimmy/0000-0003-1035-0779	National Science Foundation [ECS-0335765]; Swiss National Science Foundation; EMBO; Human Frontiers Science Program; National Institutes of Health [R37-HD032443]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank D. Duboule, H. Kaessmann, A. Necsulea, B. Okaty, G. Rey and G. P. Wagner for discussions, M. A. de Bakker for the snake Tbx5 probe and A. M. Herrera and M. J. Cohn for discussing and sharing unpublished results. mu CT scans were performed at the Center for Nanoscale Systems, Harvard University (supported by National Science Foundation award ECS-0335765) and at the Museum of Comparative Zoology. Next-generation sequencing was performed at the HMS Biopolymers Facility and computational analyses were run on the Orchestra Cluster, HMS Research Computing. P.T. was supported by post-doctoral fellowships from the Swiss National Science Foundation, EMBO and the Human Frontiers Science Program. A.C.G. was supported by a post-doctoral fellowship from the Swiss National Science Foundation. This work was supported by National Institutes of Health grant R37-HD032443 to C.J.T.	Arendt D, 2005, THEOR BIOSCI, V124, P185, DOI 10.1016/j.thbio.2005.08.002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barde I., 2001, PRODUCTION TITRATION; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Buchtova M, 2008, DEV BIOL, V319, P132, DOI 10.1016/j.ydbio.2008.03.004; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cohn MJ, 2011, DEV DYNAM, V240, P1108, DOI 10.1002/dvdy.22631; COPE ED, 1896, P ACAD NAT SCI PHILA, V48, P461; De Barros MA, 2013, MICROSC RES TECHNIQ, V76, P388, DOI 10.1002/jemt.22178; Eckalbar WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-49; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; GREER AE, 1991, J HERPETOL, V25, P166, DOI 10.2307/1564644; Griffiths M., 1978, BIOL MONOTREMES; Gros J, 2014, SCIENCE, V343, P1253, DOI 10.1126/science.1248228; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Herrera AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06896; Jurberg AD, 2013, DEV CELL, V25, P451, DOI 10.1016/j.devcel.2013.05.009; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Larkins C. E., 2014, SEX DEV; Lin CX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003231; Matsumaru D, 2014, EUR J HUM GENET, V22, P350, DOI 10.1038/ejhg.2013.160; McGlinn E, 2011, METHODS MOL BIOL, V770, P259, DOI 10.1007/978-1-61779-210-6_10; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; Raynaud A., 1985, Biology of Reptilia, V15, P149; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Suzuki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043453; Suzuki K, 2009, CURR OPIN GENET DEV, V19, P491, DOI 10.1016/j.gde.2009.08.004; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Wagner GR, 2001, J EXP ZOOL, V291, P226, DOI 10.1002/jez.1100; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang Z, 2011, NATURE, V477, P583, DOI 10.1038/nature10391; Yamada G, 2006, DEV DYNAM, V235, P1738, DOI 10.1002/dvdy.20807; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	48	52	52	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					391	+		10.1038/nature13819	http://dx.doi.org/10.1038/nature13819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25383527	Green Accepted, Green Submitted			2022-12-28	WOS:000346484800046
J	Brunken, S; Sipila, O; Chambers, ET; Harju, J; Caselli, P; Asvany, O; Honingh, CE; Kaminski, T; Menten, KM; Stutzki, J; Schlemmer, S				Bruenken, Sandra; Sipilae, Olli; Chambers, Edward T.; Harju, Jorma; Caselli, Paola; Asvany, Oskar; Honingh, Cornelia E.; Kaminski, Tomasz; Menten, Karl M.; Stutzki, Juergen; Schlemmer, Stephan			H2D+ observations give an age of at least one million years for a cloud core forming Sun-like stars	NATURE			English	Article							HETERODYNE INSTRUMENT; CHEMISTRY; H-3(+); ORTHO-H-2; RATIO; APEX; CONSTRAINTS; DEPLETION; SOFIA; WATER	The age of dense interstellar cloud cores, where stars and planets form, is a crucial parameter in star formation and difficult to measure. Some models predict rapid collapse(1,2), whereas others predict timescales of more than one million years (ref. 3). One possible approach to determining the age is through chemical changes as cloud contraction occurs, in particular through indirect measurements of the ratio of the two spin isomers (ortho/para) of molecular hydrogen, H-2, which decreases monotonically with age(4-6). This has beendone for the dense cloud core L183, for which the deuterium fractionation of diazenylium(N2H+) was used as a chemical clock to infer(7) that the core has contracted rapidly (on a timescale of less than 700,000 years). Among astronomically observable molecules, the spin isomers of the deuterated trihydrogen cation, ortho-H2D+ and para-H2D+, have the most direct chemical connections to H-2 (refs 8-12) and their abundance ratio provides a chemical clock that is sensitive to greater cloud core ages. So far this ratio has not been determined because para-H2D+ is very difficult to observe. The detection of its rotational ground-state line has only now become possible thanks to accurate measurements of its transition frequency in the laboratory(13), and recent progress in instrumentation technology(14,15). Here we report observations of ortho-and para-H2D+ emission and absorption, respectively, from the dense cloud core hosting IRAS 16293-2422 A/B, a group of nascent solar-type stars (with ages of less than 100,000 years). Using the ortho/para ratio in conjunction with chemical models, we find that the dense core has been chemically processed for at least one million years. The apparent discrepancy with the earlier N2H+ work(7) arises because that chemical clock turns off sooner than the H2D+ clock, but both results imply that star-forming dense cores have ages of about one million years, rather than 100,000 years.	[Bruenken, Sandra; Chambers, Edward T.; Asvany, Oskar; Honingh, Cornelia E.; Stutzki, Juergen; Schlemmer, Stephan] Univ Cologne, Inst Phys, D-50937 Cologne, Germany; [Sipilae, Olli; Harju, Jorma] Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; [Sipilae, Olli; Caselli, Paola] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Caselli, Paola] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Kaminski, Tomasz; Menten, Karl M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany	University of Cologne; University of Helsinki; Max Planck Society; University of Leeds; Max Planck Society	Brunken, S (corresponding author), Univ Cologne, Inst Phys, Zulpicher Str 77, D-50937 Cologne, Germany.	bruenken@phl.uni-koeln.de; schlemmer@ph1.uni-koeln.de	Brünken, Sandra/B-1880-2010; Kaminski, Tomasz/N-8550-2018; Schlemmer, Stephan/E-2903-2015; Harju, Jorma/H-4180-2014	Brünken, Sandra/0000-0001-7175-4828; Kaminski, Tomasz/0000-0001-8541-8024; Schlemmer, Stephan/0000-0002-1421-7281; Chambers, Edward/0000-0003-4195-1032; Harju, Jorma/0000-0002-1189-9790; Caselli, Paola/0000-0003-1481-7911	NASA [NAS2-97001]; DLR [50 OK0901]; Collaborative Research Centre 956 - Deutsche Forschungsgemeinschaft (DFG); Academy of Finland [132291, 250741]; European Research Council (ERC) [PALs 320620]	NASA(National Aeronautics & Space Administration (NASA)); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Collaborative Research Centre 956 - Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Academy of Finland(Academy of Finland); European Research Council (ERC)(European Research Council (ERC)European Commission)	GREAT is a development by the MPI fur Radioastronomie and the KOSMA/Universitat zu Koln, in cooperation with the MPI fur Sonnensystemforschung and the DLR Institut fur Planetenforschung. SOFIA is jointly operated by the Universities Space Research Association, Inc. (USRA), under NASA contract NAS2-97001, and the Deutsches SOFIA Institut (DSI) under DLR contract 50 OK0901 to the University of Stuttgart. APEX, the Atacama Pathfinder Experiment, is a collaboration between the Max Planck Institut fur Radioastronomie (MPIfR), the Onsala Space Observatory (OSO), and the European Southern Observatory (ESO). This work has been supported by the Collaborative Research Centre 956, funded by the Deutsche Forschungsgemeinschaft (DFG). O.S. and J.H. acknowledge support from the Academy of Finland grants 132291 and 250741. P.C. acknowledges the financial support of the European Research Council (ERC; project PALs 320620).	Albertsson T, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/44; Amano T, 2005, J MOL SPECTROSC, V233, P7, DOI 10.1016/j.jms.2005.05.008; Andre P., 2000, Protostars and planets 4, P59; Andre P, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014666; Asvany O, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.233004; BOREIKO RT, 1993, ASTROPHYS J, V405, pL39, DOI 10.1086/186760; Caselli P, 2003, ASTRON ASTROPHYS, V403, pL37, DOI 10.1051/0004-6361:20030526; Caselli P, 2008, ASTRON ASTROPHYS, V492, P703, DOI 10.1051/0004-6361:20079009; Coutens A, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220967; Crabtree KN, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/15; Crimier N, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/200913112; De Graauw T, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014698; FLOWER DR, 1984, MON NOT R ASTRON SOC, V209, P25, DOI 10.1093/mnras/209.1.25; Flower DR, 2006, ASTRON ASTROPHYS, V449, P621, DOI 10.1051/0004-6361:20054246; Gerlich D, 2002, PLANET SPACE SCI, V50, P1275, DOI 10.1016/S0032-0633(02)00094-6; Girart JM, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/1/L11; Grussie F, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/21; Guan X, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218925; Gusten R, 2006, ASTRON ASTROPHYS, V454, pL13, DOI 10.1051/0004-6361:20065420; Hartmann L, 2012, MON NOT R ASTRON SOC, V420, P1457, DOI 10.1111/j.1365-2966.2011.20131.x; Heyminck S, 2006, ASTRON ASTROPHYS, V454, pL21, DOI 10.1051/0004-6361:20065413; Heyminck S, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218811; Honvault P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.023201; Hugo E., 2007, MOL SPACE LAB, P119; Hugo E, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3089422; Juvela M, 1997, ASTRON ASTROPHYS, V322, P943; Keto E, 2010, MON NOT R ASTRON SOC, V402, P1625, DOI 10.1111/j.1365-2966.2009.16033.x; Klein B, 2006, ASTRON ASTROPHYS, V454, pL29, DOI 10.1051/0004-6361:20065415; Klein B, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218864; Le Gal R, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322386; Lombardi M, 2008, ASTRON ASTROPHYS, V480, P785, DOI 10.1051/0004-6361:20079110; Mouschovias TC, 2006, ASTROPHYS J, V646, P1043, DOI 10.1086/500125; Pagani L, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201117161; PAGANI L, 1992, ASTRON ASTROPHYS, V258, P479; Pagani L, 2009, ASTRON ASTROPHYS, V494, P623, DOI 10.1051/0004-6361:200810587; Pagani L, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L35; Semenov D, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201015149; Sipila O, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201220922; Sipila O, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200913350; Stark R, 2004, ASTROPHYS J, V608, P341, DOI 10.1086/392492; Ward-Thompson D., 2007, PROTOSTARS PLANETS, P33; WOOTTEN A, 1989, ASTROPHYS J, V337, P858, DOI 10.1086/167156; Young ET, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/2/L17	44	94	94	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					219	+		10.1038/nature13924	http://dx.doi.org/10.1038/nature13924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25409140				2022-12-28	WOS:000346383500038
J	Naik, RP; Derebail, VK; Grams, ME; Franceschini, N; Auer, PL; Peloso, GM; Young, BA; Lettre, G; Peralta, CA; Katz, R; Hyacinth, HI; Quarells, RC; Grove, ML; Bick, AG; Fontanillas, P; Rich, SS; Smith, JD; Boerwinkle, E; Rosamond, WD; Ito, K; Lanzkron, S; Coresh, J; Correa, A; Sarto, GE; Key, NS; Jacobs, DR; Kathiresan, S; Bibbins-Domingo, K; Kshirsagar, AV; Wilson, JG; Reiner, AP				Naik, Rakhi P.; Derebail, Vimal K.; Grams, Morgan E.; Franceschini, Nora; Auer, Paul L.; Peloso, Gina M.; Young, Bessie A.; Lettre, Guillaume; Peralta, Carmen A.; Katz, Ronit; Hyacinth, Hyacinth I.; Quarells, Rakale C.; Grove, Megan L.; Bick, Alexander G.; Fontanillas, Pierre; Rich, Stephen S.; Smith, Joshua D.; Boerwinkle, Eric; Rosamond, Wayne D.; Ito, Kaoru; Lanzkron, Sophie; Coresh, Josef; Correa, Adolfo; Sarto, Gloria E.; Key, Nigel S.; Jacobs, David R.; Kathiresan, Sekar; Bibbins-Domingo, Kirsten; Kshirsagar, Abhijit V.; Wilson, James G.; Reiner, Alexander P.			Association of Sickle Cell Trait With Chronic Kidney Disease and Albuminuria in African Americans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; RACIAL-DIFFERENCES; PREVALENCE; VARIANTS; DESIGN	IMPORTANCE The association between sickle cell trait (SCT) and chronic kidney disease (CKD) is uncertain. OBJECTIVE To describe the relationship between SCT and CKD and albuminuria in self-identified African Americans. DESIGN, SETTING, AND PARTICIPANTS Using 5 large, prospective, US population-based studies (the Atherosclerosis Risk in Communities Study [ARIC, 1987-2013; n = 3402], Jackson Heart Study [JHS, 2000-2012; n = 2105], Coronary Artery Risk Development in Young Adults [CARDIA, 1985-2006; n = 848], Multi-Ethnic Study of Atherosclerosis [MESA, 2000-2012; n = 1620], and Women's Health Initiative [WHI, 1993-2012; n = 8000]), we evaluated 15 975 self-identified African Americans (1248 participants with SCT [SCT carriers] and 14 727 participants without SCT [noncarriers]). MAIN OUTCOMES AND MEASURES Primary outcomes were CKD (defined as an estimated glomerular filtration rate [eGFR] of <60 mL/min/1.73m(2) at baseline or follow-up), incident CKD, albuminuria (defined as a spot urine albumin: creatinine ratio of >30mg/g or albumin excretion rate >30mg/24 hours), and decline in eGFR (defined as a decrease of >3 mL/min/1.73m2 per year). Effect sizes were calculated separately for each cohort and were subsequently meta-analyzed using a random-effects model. RESULTS A total of 2233 individuals (239 of 1247 SCT carriers [19.2%] vs 1994 of 14 722 noncarriers [13.5%]) had CKD, 1298 (140 of 675 SCT carriers [20.7%] vs 1158 of 8481 noncarriers [13.7%]) experienced incident CKD, 1719 (150 of 665 SCT carriers [22.6%] vs 1569 of 8249 noncarriers [19.0%]) experienced decline in eGFR, and 1322 (154 of 485 SCT carriers [31.8%] vs 1168 of 5947 noncarriers [19.6%]) had albuminuria during the study period. Individuals with SCT had an increased risk of CKD (odds ratio [OR], 1.57 [95% CI, 1.34-1.84]; absolute risk difference [ARD], 7.6%[95% CI, 4.7%-10.8%]), incident CKD (OR, 1.79 [95% CI, 1.45-2.20]; ARD, 8.5%[95% CI, 5.1%-12.3%]), and decline in eGFR (OR, 1.32 [95% CI, 1.07-1.61]; ARD, 6.1%[95% CI, 1.4%-13.0%]) compared with noncarriers. Sickle cell trait was also associated with albuminuria (OR, 1.86 [95% CI, 1.49-2.31]; ARD, 12.6%[95% CI, 7.7%-17.7%]). CONCLUSIONS AND RELEVANCE Among African Americans in these cohorts, the presence of SCT was associated with an increased risk of CKD, decline in eGFR, and albuminuria, compared with noncarriers. These findings suggest that SCT may be associated with the higher risk of kidney disease in African Americans.	[Naik, Rakhi P.; Lanzkron, Sophie] Johns Hopkins Univ, Div Hematol, Dept Med, Baltimore, MD 21287 USA; [Derebail, Vimal K.; Kshirsagar, Abhijit V.] Univ N Carolina, Dept Med, Kidney Ctr, Div Nephrol & Hypertens, Chapel Hill, NC USA; [Grams, Morgan E.] Johns Hopkins Univ, Dept Med, Div Nephrol, Baltimore, MD USA; [Franceschini, Nora; Rosamond, Wayne D.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Auer, Paul L.] Univ Wisconsin Milwaukee, Zilber Sch Publ Hlth, Dept Biostat, Milwaukee, WI USA; [Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Program Med & Populat Genet, Boston & Broad Inst, Ctr Human Genet, Cambridge, MA USA; [Young, Bessie A.] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Montreal, PQ, Canada; [Peralta, Carmen A.] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA USA; [Katz, Ronit] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Hyacinth, Hyacinth I.] Med Univ S Carolina, Dept Neurosci, Stroke Ctr, Charleston, SC USA; [Quarells, Rakale C.] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Grove, Megan L.; Boerwinkle, Eric] Univ Texas Sch, Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Bick, Alexander G.; Fontanillas, Pierre; Ito, Kaoru] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Smith, Joshua D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Correa, Adolfo] Univ Mississippi, Med Ctr, Dept Med & Pediat, Jackson, MS USA; [Sarto, Gloria E.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Key, Nigel S.] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC USA; [Jacobs, David R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS USA; [Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Milwaukee; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Universite de Montreal; Universite de Montreal; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Medical University of South Carolina; Morehouse School of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Virginia; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Mississippi; University of Mississippi Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of Mississippi; University of Mississippi Medical Center; University of Washington; University of Washington Seattle	Naik, RP (corresponding author), Johns Hopkins Univ, Div Hematol, Dept Med, 1830 E Monument St,Ste 7300, Baltimore, MD 21287 USA.	rakhi@jhmi.edu	Ito, Kaoru/AAZ-3440-2021; Auer, Paul/AAC-5060-2019; Lanzkron, Sophie/AFU-9516-2022; Lanzkron, Sophie/AAD-7584-2022; Hyacinth, Hyacinth/U-5722-2017; Katz, Ronit/ABA-1880-2021; Young, Lucky\\1234/GNH-2046-2022	Lanzkron, Sophie/0000-0002-2878-0251; Lanzkron, Sophie/0000-0002-2878-0251; Hyacinth, Hyacinth/0000-0002-1991-7463; Grams, Morgan/0000-0002-4430-6023; Bick, Alexander/0000-0001-5824-9595; Jacobs, David/0000-0002-7232-0543; Rich, Stephen/0000-0003-3872-7793; Derebail, Vimal/0000-0002-7662-7497	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367]; National Human Genome Research Institute (NHGRI) [U01HG004402]; National Institutes of Health (NIH) [HHSN268200625226C]; NIH through the American Recovery and Reinvestment Act (ARRA) [5RC2HL102419]; Baylor Genome Center [U54 HG003273]; Duke University Medical Center [5K12 HL087097-0]; University of North Carolina Clinical Hematology Research Career Development Program; NHLBI [AG0005, N01-HC-95159, 01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167]; National Institute on Minority Health and Health Disparities [HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C, RC4MD005964]; University of Alabama at Birmingham [HHSN268201300025C, HSN268201300026C]; Northwestern University [HHSN268201300027C]; University of Minnesota [HHSN268201300028C]; Kaiser Foundation Research Institute [HHSN268201300029C]; Johns Hopkins University School of Medicine [HHSN268200900041C]; Intramural Research Program of the National Institute on Aging (NIA); NIA [AG0005]; National Center for Research Resources [UL1-TR-000040, UL1-RR-025005]; NIH [R01 DK089174, R01 DK076770-01, 1R01DK102134-01]; US Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK085501, DK085524, DK085526, DK085545, DK085584]; NHGRI [5u54HG003067, U54 HG003067]; NIDDK [R01 DK089174, R01 DK076770-01]; NHLBI. [R01HL086694, N01-HC-95168, N01-HC-95169, RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926, R01HL107816, HL080494-05, 2K12HL087169-06, T32HL007208, 1UO1HL117659, R01HL071862]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095165, N01HC095161, N01HC095169, N01HC095167, N01HC095159, N01HC095168, N01HC095160, N01HC095164, N01HC095162, N01HC095163, N01HC095166] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC4MD005964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080494, K08HL125100, RC2HL103010, R43HL095169, R13HL095166, R01HL087641, U01HL117659, R01HL071862, R44HL095169, R43HL095161, K12HL087097, R01HL095163, RC2HL102924, RC2HL102926, R43HL095160, RC2HL102419, R21HL123677, R21HL095165, K12HL087169, R01HL107816, RC2HL102923, RC2HL102925, R01HL059367, T32HL007208, R01HL086694, R43HL095167] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U01HG004402, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085501, U01DK085526, R01DK089174, R01DK076770, U01DK085545, R01DK102134, U01DK085584, U01DK085524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH through the American Recovery and Reinvestment Act (ARRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Genome Center; Duke University Medical Center; University of North Carolina Clinical Hematology Research Career Development Program; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); University of Alabama at Birmingham; Northwestern University; University of Minnesota(University of Minnesota System); Kaiser Foundation Research Institute; Johns Hopkins University School of Medicine(Johns Hopkins University); Intramural Research Program of the National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Atherosclerosis Risk in Communities Study (ARIC) is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI; contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C and grants R01HL087641, R01HL59367, and R01HL086694); National Human Genome Research Institute (NHGRI; contract U01HG004402); and the National Institutes of Health (NIH; contract HHSN268200625226C). Funding for "Building on Genome Wide Association Studies for NHLBI-diseases: the US CHARGE Consortium" was provided by grant 5RC2HL102419 from the NIH through the American Recovery and Reinvestment Act of 2009 (ARRA). Sequencing was funded by grant U54 HG003273 from the Baylor Genome Center. This ancillary study was supported by grant 5K12 HL087097-0 from the Duke University Medical Center and University of North Carolina Clinical Hematology Research Career Development Program (Dr. Derebail). The Jackson Heart Study (JHS) is supported by the NHLBI and the National Institute on Minority Health and Health Disparities (contracts HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C). The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by NHLBI in collaboration with the University of Alabama at Birmingham (contracts HHSN268201300025C and HSN268201300026C), Northwestern University (contract HHSN268201300027C), University of Minnesota (contract HHSN268201300028C), Kaiser Foundation Research Institute (contract HHSN268201300029C), and Johns Hopkins University School of Medicine (contract HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and intra-agency agreement AG0005 between NIA and NHLBI. The Multi-Ethnic Study of Atherosclerosis (MESA) was supported by the NHLBI (contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169) and by grants UL1-TR-000040 and UL1-RR-025005 from National Center for Research Resources. The Women's Health Initiative (WHI) program is funded by NHLBI, NIH, and the US Department of Health and Human Services (contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C). Funding for the Grand Opportunity Exome Sequencing Project (GO ESP) was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO), and RC2 HL-102924 (WHISP). The exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). Exome sequencing was also performed through the Type 2 Diabetes Genetic Exploration by Next Generation Sequencing (T2D-GENES) consortium, with support from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; contracts DK085501, DK085524, DK085526, DK085545, and DK085584). Additional exome sequencing was performed through the Minority Health Genomics and Translational Research Bio-repository Database (MH-GRID) with support from grant RC4MD005964 from the National Institute on Minority Health and Health Disparities. The MH-GRID investigators (Rakale C. Quarells, Donna K. Arnett, Gary H. Gibbons, Robert L. Davis, Suzanne M. Leal, Deborah A. Nickerson, James Perkins, Charles N. Rotimi, Joel H. Saltz, and Herman A. Taylor, James G. Wilson) collected and provided data for this study.; Chip genotyping and exome sequencing in JHS was also supported by grant R01HL107816 from NHLBI (Dr Kathiresan) and NHGRI (contract 5u54HG003067) (Drs Gabriel and Lander). Support for targeted sequencing was provided by grants U54 HG003067 from the NHGRI (Medical Sequencing Program) and HL080494-05 from NHLBI. Funding for cystatin C and APOL1 in ARIC was provided by grants R01 DK089174 for cystatin C (Dr Selvin) and R01 DK076770-01 for APOL1 from the NIH and NIDDK. Funding for this work was also provided by grant 1R01DK102134-01 from the NIH and NIDDK. This material is the result of work supported by resources from the Veterans Affairs Puget Sound Health Care System (Dr Young), Seattle, Washington. Funding was also provided in part by grant 2K12HL087169-06 (Dr Naik), by grant T32HL007208 (Dr Peloso), by grant 1UO1HL117659 (Dr Key), and by grant R01HL071862 (Dr Reiner) from NHLBI. Some of the data reported here have been supplied by the United States Renal Data System.	Alves TP, 2010, CLIN NEPHROL, V74, pS72; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Becton LJ, 2010, PEDIATR NEPHROL, V25, P1505, DOI 10.1007/s00467-010-1536-8; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Derebail VK, 2010, J AM SOC NEPHROL, V21, P413, DOI 10.1681/ASN.2009070705; FALK RJ, 1992, NEW ENGL J MED, V326, P910, DOI 10.1056/NEJM199204023261402; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Goldsmith JC, 2012, AM J HEMATOL, V87, P340, DOI 10.1002/ajh.22271; Grant AM, 2011, AM J PREV MED, V41, pS435, DOI 10.1016/j.amepre.2011.09.012; GUPTA AK, 1991, J CLIN INVEST, V88, P1963, DOI 10.1172/JCI115521; HELLER P, 1979, NEW ENGL J MED, V300, P1001, DOI 10.1056/NEJM197905033001801; Hicks PJ, 2011, KIDNEY INT, V80, P1339, DOI 10.1038/ki.2011.286; Hostetter TH, 2003, SEMIN NEPHROL, V23, P194, DOI 10.1053/snep.2003.50017; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Ito K, 2014, CIRC RES, V114, P845, DOI 10.1161/CIRCRESAHA.114.302347; KEITEL HG, 1956, J CLIN INVEST, V35, P998, DOI 10.1172/JCI103360; Key NS, 2010, HEMATOL-AM SOC HEMAT, P418, DOI 10.1182/asheducation-2010.1.418; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Muntner P, 2012, CLIN J AM SOC NEPHRO, V7, P101, DOI 10.2215/CJN.06450611; Nath KA, 2012, J AM SOC NEPHROL, V23, P781, DOI 10.1681/ASN.2011101019; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; PETRAKIS NL, 1970, NEW ENGL J MED, V282, P767, DOI 10.1056/NEJM197004022821402; Pritchard JK, 2000, GENETICS, V155, P945; Reese PP, 2008, TRANSPL INT, V21, P328, DOI 10.1111/j.1432-2277.2007.00611.x; SCHNEIDER RG, 1976, BLOOD, V48, P629; STATIUSVANEPS LW, 1970, LANCET, V1, P450; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Taylor HA, 2005, ETHNIC DIS, V15, pS1; Tsaras G, 2009, AM J MED, V122, P507, DOI 10.1016/j.amjmed.2008.12.020; US Renal Data System, 2013, USRDS 2013 ANN DAT R; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	33	126	128	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2115	2125		10.1001/jama.2014.15063	http://dx.doi.org/10.1001/jama.2014.15063			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25393378	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000345626800015
J	Corbyn, Z				Corbyn, Zoe			Lessons from a sunburnt country	NATURE			English	Editorial Material							SKIN-CANCER PREVENTION; TRENDS											Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Fell GL, 2014, CELL, V157, P1527, DOI 10.1016/j.cell.2014.04.032; George PM, 1996, J AM ACAD DERMATOL, V34, P424, DOI 10.1016/S0190-9622(96)90433-8; Goulart JM, 2010, PHOTOCH PHOTOBIO SCI, V9, P432, DOI 10.1039/b9pp00122k; Hillhouse J, 2008, CANCER-AM CANCER SOC, V113, P3257, DOI 10.1002/cncr.23922; Iannacone MR, 2014, MELANOMA MANAG, V1, P75, DOI [10.2217/MMT.14.6, 10.2217/mmt.14.6]; Iannacone MR, 2014, INT J CANC; Lazovich D, 2012, CANCER EPIDEM BIOMAR, V21, P1893, DOI 10.1158/1055-9965.EPI-12-0327; Linos E, 2011, CANCER CAUSE CONTROL, V22, P1067, DOI 10.1007/s10552-011-9780-1; Shih STF, 2009, PREV MED, V49, P449, DOI 10.1016/j.ypmed.2009.09.008; Sinclair C, 2009, BRIT J DERMATOL, V161, P116, DOI 10.1111/j.1365-2133.2009.09459.x; Volkov A, 2013, AUST NZ J PUBL HEAL, V37, P63, DOI 10.1111/1753-6405.12012; Wallingford SC, 2013, BRIT J DERMATOL, V169, P880, DOI 10.1111/bjd.12460	13	15	15	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S114	S116		10.1038/515S114a	http://dx.doi.org/10.1038/515S114a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407707	Bronze			2022-12-28	WOS:000345770600003
J	Ghisellini, G; Tavecchio, F; Maraschi, L; Celotti, A; Sbarrato, T				Ghisellini, G.; Tavecchio, F.; Maraschi, L.; Celotti, A.; Sbarrato, T.			The power of relativistic jets is larger than the luminosity of their accretion disks	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; LARGE-AREA TELESCOPE; SUPERMASSIVE BLACK-HOLES; DIGITAL SKY SURVEY; MINIMUM POWER; FERMI BLAZARS; GALAXIES; CATALOG; QUASAR; ENERGY	Theoretical models for the production of relativistic jets from active galactic nuclei predict that jet power arises from the spin and mass of the central supermassive black hole, as well as from the magnetic field near the event horizon(1). The physical mechanism underlying the contribution from the magnetic field is the torque exerted on the rotating black hole by the field amplified by the accreting material. If the squared magnetic field is proportional to the accretion rate, then there will be a correlation between jet power and accretion luminosity. There is evidence for such a correlation(2-8), but inadequate knowledge of the accretion luminosity of the limited and inhomogeneous samples used prevented a firm conclusion. Here we report an analysis of archival observations of a sample of blazars (quasars whose jets point towards Earth) that overcomes previous limitations. We find a clear correlation between jet power, as measured through the gamma-ray luminosity, and accretion luminosity, as measured by the broad emission lines, with the jet power dominating the disk luminosity, in agreement with numerical simulations(9). This implies that the magnetic field threading the black hole horizon reaches the maximum value sustainable by the accreting matter(10).	[Ghisellini, G.; Tavecchio, F.; Maraschi, L.; Celotti, A.; Sbarrato, T.] Ist Nazl Astrofis, Osservatorio Astron Brera, I-23807 Merate, Italy; [Maraschi, L.] Ist Nazl Astrofis, Osservatorio Astron Brera, I-20121 Milan, Italy; [Celotti, A.] Scuola Int Super Studi Avanzati, I-34135 Trieste, Italy; [Celotti, A.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Sbarrato, T.] Univ Insubria, Dipartimento Fis & Matemat, I-22100 Como, Italy; [Sbarrato, T.] European So Observ, D-8578 Garching, Germany	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); International School for Advanced Studies (SISSA); Istituto Nazionale di Fisica Nucleare (INFN); University of Insubria; European Southern Observatory	Ghisellini, G (corresponding author), Ist Nazl Astrofis, Osservatorio Astron Brera, Via E Bianchi 46, I-23807 Merate, Italy.	gabriele.ghisellini@brera.inaf.it	Sbarrato, Tullia/ABD-8760-2020	Ghisellini, Gabriele/0000-0002-0037-1974; Tavecchio, Fabrizio/0000-0003-0256-0995; Sbarrato, Tullia/0000-0002-3069-9399; Celotti, Anna Lisa/0000-0002-8106-2777	PRIN-INAF grant	PRIN-INAF grant(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	F.T. and L. M. acknowledge partial funding through a PRIN-INAF 2011 grant.	Abdo AA, 2010, ASTROPHYS J, V715, P429, DOI 10.1088/0004-637X/715/1/429; Ackermann M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/171; Bentz MC, 2006, ASTROPHYS J, V644, P133, DOI 10.1086/503537; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; Bottcher M, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/54; Bonnoli G, 2011, MON NOT R ASTRON SOC, V410, P368, DOI 10.1111/j.1365-2966.2010.17450.x; Calderone G, 2013, MON NOT R ASTRON SOC, V431, P210, DOI 10.1093/mnras/stt157; Celotti A, 1997, MON NOT R ASTRON SOC, V286, P415, DOI 10.1093/mnras/286.2.415; CELOTTI A, 1993, MON NOT R ASTRON SOC, V264, P228, DOI 10.1093/mnras/264.1.228; Celotti A, 2008, MON NOT R ASTRON SOC, V385, P283, DOI 10.1111/j.1365-2966.2007.12758.x; DERMER CD, 1995, ASTROPHYS J, V446, pL63, DOI 10.1086/187931; Donato D, 2001, ASTRON ASTROPHYS, V375, P739, DOI 10.1051/0004-6361:20010675; Francis J., 1991, ASTROPHYS J, V373, P465; Ghirlanda G, 2011, MON NOT R ASTRON SOC, V413, P852, DOI 10.1111/j.1365-2966.2010.18173.x; Ghisellini G, 1996, MON NOT R ASTRON SOC, V280, P67, DOI 10.1093/mnras/280.1.67; Ghisellini G, 2012, MON NOT R ASTRON SOC, V424, pL26, DOI 10.1111/j.1745-3933.2012.01280.x; Ghisellini G, 2010, MON NOT R ASTRON SOC, V409, pL79, DOI 10.1111/j.1745-3933.2010.00952.x; Ghisellini G, 2010, MON NOT R ASTRON SOC, V402, P497, DOI 10.1111/j.1365-2966.2009.15898.x; Ghisellini G, 2009, MON NOT R ASTRON SOC, V397, P985, DOI 10.1111/j.1365-2966.2009.15007.x; Ghisellini G, 2001, MON NOT R ASTRON SOC, V327, P739, DOI 10.1046/j.1365-8711.2001.04700.x; Ghisellini G, 2011, AIP CONF PROC, V1381, DOI 10.1063/1.3635832; Koshida S, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/159; Livio M, 1999, ASTROPHYS J, V512, P100, DOI 10.1086/306777; Maraschi L, 2003, ASTROPHYS J, V593, P667, DOI 10.1086/342118; McLure RJ, 2004, MON NOT R ASTRON SOC, V352, P1390, DOI 10.1111/j.1365-2966.2004.08034.x; Meier DL, 2002, NEW ASTRON REV, V46, P247, DOI 10.1016/S1387-6473(01)00189-0; Nalewajko K, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/161; Nemmen RS, 2012, SCIENCE, V338, P1445, DOI 10.1126/science.1227416; Nolan PL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/31; Peterson BM, 2000, ASTROPHYS J, V540, pL13, DOI 10.1086/312862; Punsly B, 2006, ASTROPHYS J, V640, pL21, DOI 10.1086/503277; RAWLINGS S, 1991, NATURE, V349, P138, DOI 10.1038/349138a0; Sbarrato T, 2013, MON NOT R ASTRON SOC, V433, P2182, DOI 10.1093/mnras/stt882; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Shaw MS, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/135; Shaw MS, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/49; Shen Y, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/45; Sikora M, 2000, ASTROPHYS J, V534, P109, DOI 10.1086/308756; Sikora M, 2007, ASTROPHYS J, V658, P815, DOI 10.1086/511972; Tavecchio F, 1998, ASTROPHYS J, V509, P608, DOI 10.1086/306526; Tchekhovskoy A, 2014, MON NOT R ASTRON SOC, V437, P2744, DOI 10.1093/mnras/stt2085; Tchekhovskoy A, 2012, J PHYS CONF SER, V372, DOI 10.1088/1742-6596/372/1/012040; Tchekhovskoy A, 2011, MON NOT R ASTRON SOC, V418, pL79, DOI 10.1111/j.1745-3933.2011.01147.x; THORNE KS, 1974, ASTROPHYS J, V191, P507, DOI 10.1086/152991; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; Vestergaard M, 2006, ASTROPHYS J, V641, P689, DOI 10.1086/500572; Zamaninasab M, 2014, NATURE, V510, P126, DOI 10.1038/nature13399	48	262	268	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					376	+		10.1038/nature13856	http://dx.doi.org/10.1038/nature13856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409827	Green Submitted			2022-12-28	WOS:000345770600037
J	Hanna, NH; Einhorn, LH				Hanna, Nasser H.; Einhorn, Lawrence H.			Testicular Cancer - Discoveries and Updates	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GERM-CELL TUMORS; HIGH-DOSE CHEMOTHERAPY; RANDOMIZED PHASE-III; GENOME-WIDE ASSOCIATION; LYMPH-NODE DISSECTION; LONG-TERM SURVIVORS; CARCINOMA IN-SITU; COMBINATION CHEMOTHERAPY; CISPLATIN CHEMOTHERAPY; SALVAGE TREATMENT		[Hanna, Nasser H.; Einhorn, Lawrence H.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Hanna, NH (corresponding author), 535 Barnhill Dr,Room 473, Indianapolis, IN 46202 USA.	nhanna@iu.edu						Abouassaly R, 2011, EUR UROL, V60, P516, DOI 10.1016/j.eururo.2011.05.055; Albers P, 2008, J CLIN ONCOL, V26, P2966, DOI 10.1200/JCO.2007.12.0899; Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; BOSL GJ, 1988, J CLIN ONCOL, V6, P1231, DOI 10.1200/JCO.1988.6.8.1231; Chieffi P, 2013, J CELL PHYSIOL, V228, P1641, DOI 10.1002/jcp.24328; Culine S, 2007, ANN ONCOL, V18, P917, DOI 10.1093/annonc/mdm062; Dalgaard MD, 2012, J MED GENET, V49, P58, DOI 10.1136/jmedgenet-2011-100174; Daugaard G, 2011, ANN ONCOL, V22, P1054, DOI 10.1093/annonc/mdq575; De Santis M, 2004, J CLIN ONCOL, V22, P1034, DOI 10.1200/JCO.2004.07.188; de Wit R, 2001, J CLIN ONCOL, V19, P1629, DOI 10.1200/JCO.2001.19.6.1629; de Wit R, 2013, J CLIN ONCOL, V31, P3477, DOI 10.1200/JCO.2013.51.0479; de Wit R, 2012, J CLIN ONCOL, V30, P792, DOI 10.1200/JCO.2011.37.0171; Domont J, 2013, UROL ONCOL-SEMIN ORI, V31, P697, DOI 10.1016/j.urolonc.2011.04.004; DONOHUE JP, 1995, J UROLOGY, V153, P85, DOI 10.1097/00005392-199501000-00030; Droz JP, 2007, EUR UROL, V51, P739, DOI 10.1016/j.eururo.2006.10.035; Ehrlich Y, 2010, J CLIN ONCOL, V28, P531, DOI 10.1200/JCO.2009.23.0714; Einhorn LH, 2007, NEW ENGL J MED, V357, P340, DOI 10.1056/NEJMoa067749; EINHORN LH, 1977, ANN INTERN MED, V87, P293, DOI 10.7326/0003-4819-87-3-293; Einhorn LH, 2006, AM J CLIN ONCOL-CANC, V29, P12, DOI 10.1097/01.coc.0000195086.47548.ef; EINHORN LH, 1989, J CLIN ONCOL, V7, P387, DOI 10.1200/JCO.1989.7.3.387; Feldman DR, 2010, INVEST NEW DRUG, V28, P523, DOI 10.1007/s10637-009-9280-2; Feldman DR, 2010, J CLIN ONCOL, V28, P1706, DOI 10.1200/JCO.2009.25.1561; Feldman DR, 2013, J CLIN ONCOL S, V31; Feldman DR, 2012, J CLIN ONCOL S, V30; Fizazi K, 2013, J CLIN ONCOL S, V31; Fung C, 2013, J CLIN ONCOL, V31, P3807, DOI 10.1200/JCO.2013.50.3409; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Haugnes HS, 2010, J CLIN ONCOL, V28, P4649, DOI 10.1200/JCO.2010.29.9362; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Horwich A, 2010, J CLIN ONCOL S, V28, p15s; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kollmannsberger C, 1999, ANN ONCOL, V10, P1393, DOI 10.1023/A:1008365216323; Kollmannsberger C, 2014, J CLIN ONCOL; Kondagunta GV, 2005, J CLIN ONCOL, V23, P6549, DOI 10.1200/JCO.2005.19.638; Koul Sanjay, 2002, Mol Cancer, V1, P8, DOI 10.1186/1476-4598-1-8; Kratz CP, 2011, J MED GENET, V48, P473, DOI 10.1136/jmedgenet-2011-100001; Lip SZL, 2013, ARCH DIS CHILD, V98, P20, DOI 10.1136/archdischild-2012-302051; Loehrer PJ, 1998, J CLIN ONCOL, V16, P2500, DOI 10.1200/JCO.1998.16.7.2500; LOEHRER PJ, 1988, ANN INTERN MED, V109, P540, DOI 10.7326/0003-4819-109-7-540; Lorch A, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4507; Lorch A, 2011, J CLIN ONCOL, V29, P2178, DOI 10.1200/JCO.2010.32.6678; Mead GM, 1997, J CLIN ONCOL, V15, P594; Mortensen MS, 2013, J CLIN ONCOL S, V31; Motzer RJ, 2007, J CLIN ONCOL, V25, P247, DOI 10.1200/JCO.2005.05.4528; Nichols CR, 1998, J CLIN ONCOL, V16, P1287, DOI 10.1200/JCO.1998.16.4.1287; NICHOLS CR, 1989, J CLIN ONCOL, V7, P932, DOI 10.1200/JCO.1989.7.7.932; Nichols CR, 2013, J CLIN ONCOL, V31, P3490, DOI 10.1200/JCO.2012.47.6010; Nigam M, 2014, WORLD J UROL; O'Donnell E, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.6_suppl.324; Oldenburg J, 2013, ANN ONCOL, V24, P125, DOI 10.1093/annonc/mdt304; Oldenburg J, 2003, J CLIN ONCOL, V21, P3310, DOI 10.1200/JCO.2003.03.184; Oliver RTD, 2011, J CLIN ONCOL, V29, P957, DOI 10.1200/JCO.2009.26.4655; Pant-Purohit M, 2013, J BONE MARROW RES, V1, P118; Pettersson A, 2007, NEW ENGL J MED, V356, P1835, DOI 10.1056/NEJMoa067588; Pico JL, 2005, ANN ONCOL, V16, P1152, DOI 10.1093/annonc/mdi228; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rick O, 2006, EUR J CANCER, V42, P1775, DOI 10.1016/j.ejca.2006.03.013; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Schmoll HJ, 2009, ANN ONCOL, V20, P89, DOI 10.1093/annonc/mdp139; Sheikine Y, 2012, AM J CANCER RES, V2, P153; Shinn EH, 2010, J CLIN ONCOL, V28, P2274, DOI 10.1200/JCO.2009.23.9608; Soper MS, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4596; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Sprauten M, 2014, J CLIN ONCOL, V32, P571, DOI 10.1200/JCO.2013.51.2715; Tandstad T, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.4508; Tandstad T, 2009, J CLIN ONCOL, V27, P2122, DOI 10.1200/JCO.2008.18.8953; Travis LB, 2010, JNCI-J NATL CANCER I, V102, P1114, DOI 10.1093/jnci/djq216; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; van Walraven C, 2011, J CLIN ONCOL, V29, P2883, DOI 10.1200/JCO.2011.34.6379; Westermann DH, 2009, WORLD J UROL, V27, P455, DOI 10.1007/s00345-009-0456-3; Willemse PM, 2013, BRIT J CANCER, V109, P60, DOI 10.1038/bjc.2013.226; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302	73	200	204	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					2005	2016		10.1056/NEJMra1407550	http://dx.doi.org/10.1056/NEJMra1407550			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT5ST	25409373				2022-12-28	WOS:000345002900009
J	Schwartz, JL; Mahmoud, A				Schwartz, Jason L.; Mahmoud, Adel			HISTORY OF MEDICINE A Half-Century of Prevention - The Advisory Committee on Immunization Practices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schwartz, Jason L.] Princeton Univ, Univ Ctr Human Values, Princeton, NJ 08544 USA; [Mahmoud, Adel] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Mahmoud, Adel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Schwartz, JL (corresponding author), Princeton Univ, Univ Ctr Human Values, Princeton, NJ 08544 USA.		Schwartz, Jason L./ABA-8718-2020					[Anonymous], 1969, POL GUID PROC PUBL A; Duclos P, 2013, VACCINE, V31, P5314, DOI 10.1016/j.vaccine.2013.08.084; Schwartz JL, 2012, MILBANK Q, V90, P278, DOI 10.1111/j.1468-0009.2012.00664.x; Smith JK, 2010, PSYCHOL AESTHET CREA, V4, P1, DOI 10.1037/a0018727	4	7	7	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					1953	1956		10.1056/NEJMp1410049	http://dx.doi.org/10.1056/NEJMp1410049			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT5ST	25409366				2022-12-28	WOS:000345002900001
J	Shi, YG				Shi, Yigong			A Glimpse of Structural Biology through X-Ray Crystallography	CELL			English	Review							3-DIMENSIONAL FOURIER SYNTHESIS; EPIDERMAL-GROWTH-FACTOR; PROTEIN-COUPLED RECEPTOR; BUSHY STUNT VIRUS; SERIAL FEMTOSECOND CRYSTALLOGRAPHY; REPRESSOR-OPERATOR COMPLEX; NUCLEOSOME CORE PARTICLE; 2.4 ANGSTROM RESOLUTION; LARGE RIBOSOMAL-SUBUNIT; DEPENDENT KINASE CDK6	Since determination of the myoglobin structure in 1957, X-ray crystallography, as the anchoring tool of structural biology, has played an instrumental role in deciphering the secrets of life. Knowledge gained through X-ray crystallography has fundamentally advanced our views on cellular processes and greatly facilitated development of modern medicine. In this brief narrative, I describe my personal understanding of the evolution of structural biology through X-ray crystallography-using as examples mechanistic understanding of protein kinases and integral membrane proteins-and comment on the impact of technological development and outlook of X-ray crystallography.	[Shi, Yigong] Tsinghua Univ, Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn		Shi, Yigong/0000-0003-2030-168X				Abate AA, 2013, EXPERT OPIN INV DRUG, V22, P895, DOI 10.1517/13543784.2013.798641; ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agah Sayeh, 2012, Methods Mol Biol, V914, P3, DOI 10.1007/978-1-62703-023-6_1; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Alattia JR, 2013, BIOTECHNOL BIOENG, V110, P1995, DOI 10.1002/bit.24851; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; Arndt U. W., 1977, ROTATION METHOD CRYS; Assenberg R, 2013, CURR OPIN STRUC BIOL, V23, P393, DOI 10.1016/j.sbi.2013.03.008; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Barends TRM, 2014, NATURE, V505, P244, DOI 10.1038/nature12773; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; BLOOMER AC, 1978, NATURE, V276, P362, DOI 10.1038/276362a0; Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bostick DL, 2007, P NATL ACAD SCI USA, V104, P9260, DOI 10.1073/pnas.0700554104; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Bragg WL, 1914, P CAMB PHILOS SOC, V17, P43; Brotherton DH, 1998, NATURE, V395, P244, DOI 10.1038/26164; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger A., 1990, XPLOR MANUAL V 2 1; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2010, METHODS MOL BIOL, V654, P141, DOI 10.1007/978-1-60761-762-4_8; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Cramer P, 2014, CELL, V159, P985, DOI 10.1016/j.cell.2014.10.047; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Dauter Z, 2005, CR CHIM, V8, P1808, DOI 10.1016/j.crci.2005.02.032; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; DRENTH J, 1968, NATURE, V218, P929, DOI 10.1038/218929a0; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; FISCHER EH, 1955, J BIOL CHEM, V216, P121; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; HARRISON SC, 1969, J MOL BIOL, V42, P457, DOI 10.1016/0022-2836(69)90236-8; HARRISON SC, 1975, J MOL BIOL, V97, P173, DOI 10.1016/S0022-2836(75)80033-7; Hattne J, 2014, NAT METHODS, V11, P545, DOI [10.1038/NMETH.2887, 10.1038/nmeth.2887]; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Joachimiak A, 2009, CURR OPIN STRUC BIOL, V19, P573, DOI 10.1016/j.sbi.2009.08.002; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; KARTHA G, 1967, NATURE, V213, P862, DOI 10.1038/213862a0; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Knapp JE, 2006, P NATL ACAD SCI USA, V103, P7649, DOI 10.1073/pnas.0509411103; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; Kraft P, 2009, J SYNCHROTRON RADIAT, V16, P368, DOI 10.1107/S0909049509009911; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; LIPSCOMB WN, 1969, P NATL ACAD SCI USA, V64, P28, DOI 10.1073/pnas.64.1.28; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LUO M, 1987, SCIENCE, V235, P182, DOI 10.1126/science.3026048; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; MATTHEWS BW, 1967, NATURE, V214, P652, DOI 10.1038/214652a0; MATTHEWS BW, 1974, P NATL ACAD SCI USA, V71, P4178, DOI 10.1073/pnas.71.10.4178; McPherson A, 2014, ACTA CRYSTALLOGR F, V70, P2, DOI 10.1107/S2053230X13033141; Montemayor EJ, 2014, NAT STRUCT MOL BIOL, V21, P544, DOI 10.1038/nsmb.2832; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Morth JP, 2006, ACTA CRYSTALLOGR D, V62, P877, DOI 10.1107/S0907444906023547; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Nagar B, 2002, CANCER RES, V62, P4236; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Neutze R, 2012, CURR OPIN STRUC BIOL, V22, P651, DOI 10.1016/j.sbi.2012.08.006; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAULING L, 1951, P NATL ACAD SCI USA, V37, P282, DOI 10.1073/pnas.37.5.282; PAULING L, 1951, P NATL ACAD SCI USA, V37, P235, DOI 10.1073/pnas.37.5.235; PAULING L, 1951, NATURE, V168, P550, DOI 10.1038/168550a0; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; PERUTZ MF, 1968, NATURE, V219, P29, DOI 10.1038/219029a0; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; PERUTZ MF, 1968, NATURE, V219, P131, DOI 10.1038/219131a0; PHILLIPS JC, 1980, ACTA CRYSTALLOGR A, V36, P856, DOI 10.1107/S0567739480001817; PHILLIPS WC, 1993, NUCL INSTRUM METH A, V334, P621, DOI 10.1016/0168-9002(93)90830-B; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Recondo G, 2014, WORLD J CLIN ONCOL, V5, P440, DOI 10.5306/wjco.v5.i3.440; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; RODGERS DW, 1994, STRUCTURE, V2, P1135, DOI 10.1016/S0969-2126(94)00116-2; ROSENBAU.G, 1971, NATURE, V230, P434, DOI 10.1038/230434a0; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Seibert MM, 2011, NATURE, V470, P78, DOI 10.1038/nature09748; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Subramaniam S, 2002, PHILOS T ROY SOC A, V360, P859, DOI 10.1098/rsta.2001.0971; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; SUTHERLAND EW, 1955, NATURE, V175, P169, DOI 10.1038/175169a0; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Wang TL, 2013, NATURE, V497, P272, DOI 10.1038/nature12045; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789a0; WRIGHT CS, 1969, NATURE, V221, P235, DOI 10.1038/221235a0; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; WYCKOFF HW, 1967, J BIOL CHEM, V242, P3984; Xie T, 2014, P NATL ACAD SCI USA, V111, P13349, DOI 10.1073/pnas.1414837111; Xu K, 2013, NATURE, V497, P268, DOI 10.1038/nature12046; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhou LJ, 2014, NATURE, V506, P116, DOI 10.1038/nature12803; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	220	153	163	5	220	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					995	1014		10.1016/j.cell.2014.10.051	http://dx.doi.org/10.1016/j.cell.2014.10.051			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416941	Bronze			2022-12-28	WOS:000345506300014
J	De Rubeis, S; He, X; Goldberg, AP; Poultney, CS; Samocha, K; Cicek, AE; Kou, Y; Liu, L; Fromer, M; Walker, S; Singh, T; Klei, L; Kosmicki, J; Fu, SC; Aleksic, B; Biscaldi, M; Bolton, PF; Brownfeld, JM; Cai, JL; Campbell, NG; Carracedo, A; Chahrour, MH; Chiocchetti, AG; Coon, H; Crawford, EL; Crooks, L; Curran, SR; Dawson, G; Duketis, E; Fernandez, BA; Gallagher, L; Geller, E; Guter, SJ; Hill, RS; Ionita-Laza, I; Gonzalez, PJ; Kilpinen, H; Klauck, SM; Kolevzon, A; Lee, I; Lei, J; Lehtimaki, T; Lin, CF; Ma'ayan, A; Marshall, CR; McInnes, AL; Neale, B; Owen, MJ; Ozaki, N; Parellada, M; Parr, JR; Purcell, S; Puura, K; Rajagopalan, D; Rehnstrom, K; Reichenberg, A; Sabo, A; Sachse, M; Sanders, SJ; Schafer, C; Schulte-Ruther, M; Skuse, D; Stevens, C; Szatmari, P; Tammimies, K; Valladares, O; Voran, A; Wang, LS; Weiss, LA; Willsey, AJ; Yu, TW; Yuen, RKC; Cook, EH; Freitag, CM; Gill, M; Hultman, CM; Lehner, T; Palotie, A; Schellenberg, GD; Skiar, P; State, MW; Sutcliffe, JS; Walsh, CA; Scherer, SW; Zwick, ME; Barrett, JC; Cutler, DJ; Roeder, K; Devlin, B; Daly, MJ; Buxbaum, JD				De Rubeis, Silvia; He, Xin; Goldberg, Arthur P.; Poultney, Christopher S.; Samocha, Kaitlin; Cicek, A. Ercument; Kou, Yan; Liu, Li; Fromer, Menachem; Walker, Susan; Singh, Tarjinder; Klei, Lambertus; Kosmicki, Jack; Fu, Shih-Chen; Aleksic, Branko; Biscaldi, Monica; Bolton, Patrick F.; Brownfeld, Jessica M.; Cai, Jinlu; Campbell, Nicholas G.; Carracedo, Angel; Chahrour, Maria H.; Chiocchetti, Andreas G.; Coon, Hilary; Crawford, Emily L.; Crooks, Lucy; Curran, Sarah R.; Dawson, Geraldine; Duketis, Eftichia; Fernandez, Bridget A.; Gallagher, Louise; Geller, Evan; Guter, Stephen J.; Hill, R. Sean; Ionita-Laza, Iuliana; Gonzalez, Patricia Jimenez; Kilpinen, Helena; Klauck, Sabine M.; Kolevzon, Alexander; Lee, Irene; Lei, Jing; Lehtimaeki, Terho; Lin, Chiao-Feng; Ma'ayan, Avi; Marshall, Christian R.; McInnes, Alison L.; Neale, Benjamin; Owen, Michael J.; Ozaki, Norio; Parellada, Mara; Parr, Jeremy R.; Purcell, Shaun; Puura, Kaija; Rajagopalan, Deepthi; Rehnstrom, Karola; Reichenberg, Abraham; Sabo, Aniko; Sachse, Michael; Sanders, Stephan J.; Schafer, Chad; Schulte-Ruether, Martin; Skuse, David; Stevens, Christine; Szatmari, Peter; Tammimies, Kristiina; Valladares, Otto; Voran, Annette; Wang, Li-San; Weiss, Lauren A.; Willsey, A. Jeremy; Yu, Timothy W.; Yuen, Ryan K. C.; Cook, Edwin H.; Freitag, Christine M.; Gill, Michael; Hultman, Christina M.; Lehner, Thomas; Palotie, Aarno; Schellenberg, Gerard D.; Skiar, Pamela; State, Matthew W.; Sutcliffe, James S.; Walsh, Christopher A.; Scherer, Stephen W.; Zwick, Michael E.; Barrett, Jeffrey C.; Cutler, David J.; Roeder, Kathryn; Devlin, Bernie; Daly, Mark J.; Buxbaum, Joseph D.		DDD Study; Homozygosity Mapping Collaborative; UK10K Consortium; Autism Sequencing Consortium	Synaptic, transcriptional and chromatin genes disrupted in autism	NATURE			English	Article							DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; SPECTRUM DISORDERS; NEURODEVELOPMENTAL DISORDERS; FRAMEWORK; NETWORK; RISK; SCHIZOPHRENIA; EXPRESSION; DISCOVERY	The genetic architecture of autism spectrum disorder involves the interplay of common and rare variants and their impact on hundreds of genes. Using exome sequencing, here we show that analysis of rare coding variation in 3,871 autism cases and 9,937 ancestry-matched or parental controls implicates 22 autosomal genes at a false discovery rate (FDR) < 0.05, plus a set of 107 autosomal genes strongly enriched for those likely to affect risk (FDR < 0.30). These 107 genes, which show unusual evolutionary constraint against mutations, incur de novo loss-of-function mutations in over 5% of autistic subjects. Many of the genes implicated encode proteins for synaptic formation, transcriptional regulation and chromatin-remodelling pathways. These include voltage-gated ion channels regulating the propagation of action potentials, pacemaking and excitability-transcription coupling, as well as histone-modifying enzymes and chromatin remodellers-most prominently those that mediate post-translational lysine methylation/demethylation modifications of histones.	[De Rubeis, Silvia; Goldberg, Arthur P.; Poultney, Christopher S.; Kou, Yan; Fu, Shih-Chen; Brownfeld, Jessica M.; Cai, Jinlu; Kolevzon, Alexander; Reichenberg, Abraham; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [De Rubeis, Silvia; Goldberg, Arthur P.; Poultney, Christopher S.; Kou, Yan; Fromer, Menachem; Fu, Shih-Chen; Brownfeld, Jessica M.; Cai, Jinlu; Kolevzon, Alexander; Purcell, Shaun; Reichenberg, Abraham; Skiar, Pamela; Buxbaum, Joseph D.] Mt Sinai Med Ctr, Dept Psychiat, New York, NY 10029 USA; [He, Xin; Cicek, A. Ercument; Roeder, Kathryn] Carnegie Mellon Univ, Ray & Stephanie Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Goldberg, Arthur P.; Fromer, Menachem; Skiar, Pamela; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Samocha, Kaitlin; Fromer, Menachem; Kosmicki, Jack; Palotie, Aarno] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Liu, Li; Lei, Jing; Schafer, Chad; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Walker, Susan; Marshall, Christian R.; Rajagopalan, Deepthi; Tammimies, Kristiina; Yuen, Ryan K. C.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Singh, Tarjinder; Crooks, Lucy; Rehnstrom, Karola; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Aleksic, Branko; Ozaki, Norio; UK10K Consortium] Nagoya Univ, Sch Med, Dept Psychiat, Nagoya, Aichi 4668550, Japan; [Biscaldi, Monica] Univ Med Ctr Freiburg, Dept Child & Adolescent Psychiat Psychotherapy &, D-79106 Freiburg, Germany; [Biscaldi, Monica] Ctr Mental Disorders, D-79106 Freiburg, Germany; [Bolton, Patrick F.; Curran, Sarah R.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child Psychiat, London SE5 8AF, England; [Bolton, Patrick F.; Curran, Sarah R.] Kings Coll London, Inst Psychiat Psychol & Neurosci, SGDP Ctr, London SE5 8AF, England; [Campbell, Nicholas G.; Crawford, Emily L.; Sutcliffe, James S.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA; [Campbell, Nicholas G.; Crawford, Emily L.; Sutcliffe, James S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Carracedo, Angel] Univ Santiago de Compostela, CIBERER, Genom Med Grp, Santiago De Compostela 15706, Spain; [Carracedo, Angel] Galician Fdn Genom Med SERGAS, Santiago De Compostela 15706, Spain; [Carracedo, Angel] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia; [Chahrour, Maria H.; Hill, R. Sean; Yu, Timothy W.; Walsh, Christopher A.; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chahrour, Maria H.; Hill, R. Sean; Yu, Timothy W.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Chiocchetti, Andreas G.; Duketis, Eftichia; Sachse, Michael; Freitag, Christine M.] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-60528 Frankfurt, Germany; [Coon, Hilary] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA; [Coon, Hilary] Univ Utah, Dept Psychiat, Salt Lake City, UT 84108 USA; [Dawson, Geraldine] Duke Univ, Duke Inst Brain Sci, Durham, NC 27708 USA; [Fernandez, Bridget A.] Mem Univ Newfoundland, Disciplines Genet & Med, St John, NF A1B 3V6, Canada; [Gallagher, Louise; Gill, Michael] Trin Coll Dublin, Sch Med, Dept Psychiat, Dublin 8, Ireland; [Geller, Evan; Lin, Chiao-Feng; Valladares, Otto; Wang, Li-San; Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Guter, Stephen J.; Cook, Edwin H.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60608 USA; [Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Gonzalez, Patricia Jimenez] Hosp Nacl de Ninos Dr Saenz Herrera, CCSS, Child Dev & Behav Unit, San Jose, Costa Rica; [Kilpinen, Helena] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Klauck, Sabine M.] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Kolevzon, Alexander] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Lee, Irene; Skuse, David] UCL, Inst Child Hlth, London WC1N 1EH, England; [Lehtimaeki, Terho] Fimlab Labs, Dept Clin Chem, SF-33100 Tampere, Finland; [Ma'ayan, Avi] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [McInnes, Alison L.] Kaiser Permanente, Dept Psychiat, San Francisco, CA 94118 USA; [Neale, Benjamin; Stevens, Christine; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Owen, Michael J.] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF24 4HQ, S Glam, Wales; [Owen, Michael J.] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF24 4HQ, S Glam, Wales; [Parellada, Mara] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Child & Adolescent Psychiat Dept, IiSGM,CIBERSAM, E-28040 Madrid, Spain; [Parr, Jeremy R.] Newcastle Univ, Sch Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Puura, Kaija] Tampere Univ, Dept Child Psychiat, Tampere 33521, Finland; [Puura, Kaija] Tampere Univ Hosp, Tampere 33521, Finland; [Reichenberg, Abraham] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Sabo, Aniko] Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA; [Sanders, Stephan J.; Weiss, Lauren A.; Willsey, A. Jeremy; State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Schulte-Ruether, Martin] Univ Hosp RWTH Aachen, JARA Brain Translat Med, Translat Brain Med Psychiat & Neurol, Dept Child & Adolescent Psychiat Psychosomat Psyc, D-52056 Aachen, Germany; [Skuse, David] Great Ormond St Hosp Sick Children, Natl Hlth Serv Fdn Trust, Dept Child & Adolescent Mental Hlth, London WC1N 3JH, England; [Szatmari, Peter] McMaster Univ, Dept Psychiat & Behav Neurosci, Offord Ctr Child Studies, Hamilton, ON L8S 4K1, Canada; [Voran, Annette] Saarland Univ Hosp, Dept Child & Adolescent Psychiat, D-66424 Homburg, Germany; [Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Lehner, Thomas] NIMH, NIH, Bethesda, MD 20892 USA; [Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland, FI-00014 Helsinki, Finland; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Skiar, Pamela; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5S 1A1, Canada; [Zwick, Michael E.; Cutler, David J.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Carnegie Mellon University; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Carnegie Mellon University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Wellcome Trust Sanger Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nagoya University; University of Freiburg; University of London; King's College London; University of London; King's College London; Vanderbilt University; Vanderbilt University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; King Abdulaziz University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Goethe University Frankfurt; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Duke University; Memorial University Newfoundland; Trinity College Dublin; University of Pennsylvania; Pennsylvania Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Icahn School of Medicine at Mount Sinai; University of London; University College London; Icahn School of Medicine at Mount Sinai; Kaiser Permanente; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cardiff University; Cardiff University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Complutense University of Madrid; General University Gregorio Maranon Hospital; Newcastle University - UK; Tampere University; Tampere University; Tampere University Hospital; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; University of California System; University of California San Francisco; RWTH Aachen University; RWTH Aachen University Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; McMaster University; Universitatsklinikum des Saarlandes; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; University of Toronto; Emory University; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Buxbaum, JD (corresponding author), Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA.	mjdaly@broadinstitute.org; joseph.buxbaum@mssm.edu	Yuen, Ryan K. C./J-4876-2012; Ma'ayan, Avi/AAG-3131-2019; De Rubeis, Silvia/E-9852-2013; Ozaki, Norio/M-8908-2014; Lehtimäki, Terho/AAD-1094-2022; Collier, David A/D-1649-2011; Buxbaum, Joseph D/G-6001-2010; Yu, Timothy W./AAF-5738-2019; Parellada, Mara/GQH-7619-2022; Aleksic, Branko/G-1540-2011; Puura, Kaija/ADG-7880-2022; Parellada, Mara/AAQ-1272-2021; Breen, Gerome D/A-5540-2010; Sanders, Stephan/S-8645-2019; Carracedo, Angel/D-4257-2012; Liu, Li/G-1897-2015; Breen, Gerome/Y-2706-2019; Scherer, Stephen W./B-3785-2013; Sifrim, Alejandro/AAY-2019-2021; Sutcliffe, James S/C-1348-2012; State, Matthew/W-2256-2019; Sala, Carlo/A-2493-2009; Daly, Mark J/B-2453-2017; Aleksic, Branko/L-7851-2019; Reichenberg, Abraham/GQB-1227-2022; , Martin/F-4784-2013; Morrow, Eric/J-2767-2013; Eapen, Valsamma/N-9608-2017	Yuen, Ryan K. C./0000-0001-7273-4968; Ma'ayan, Avi/0000-0002-6904-1017; De Rubeis, Silvia/0000-0001-9383-6883; Ozaki, Norio/0000-0002-7360-4898; Lehtimäki, Terho/0000-0002-2555-4427; Collier, David A/0000-0003-4087-1559; Yu, Timothy W./0000-0003-2988-7701; Aleksic, Branko/0000-0001-8982-4580; Parellada, Mara/0000-0001-7977-3601; Breen, Gerome D/0000-0003-2053-1792; Carracedo, Angel/0000-0003-1085-8986; Breen, Gerome/0000-0003-2053-1792; Scherer, Stephen W./0000-0002-8326-1999; Sifrim, Alejandro/0000-0001-8247-4020; Sutcliffe, James S/0000-0001-5200-6007; Sala, Carlo/0000-0003-0662-9523; Daly, Mark J/0000-0002-0949-8752; Aleksic, Branko/0000-0001-8982-4580; , Martin/0000-0002-7198-9923; Geller, Evan/0000-0002-8035-8736; Chiocchetti, Andreas G/0000-0002-7329-9985; Kilpinen, Helena/0000-0001-6692-6154; Roeder, Kathryn/0000-0002-8869-6254; Gill, Michael/0000-0003-0206-5337; Lim, Teng Ting/0000-0003-3651-0654; Green, Jonathan/0000-0002-0143-181X; Morrow, Eric/0000-0003-3430-3520; Lee, Irene O./0000-0003-0004-6802; Tammimies, Kristiina/0000-0002-8324-4697; Guter, Stephen/0000-0002-4476-2045; Singh, Tarjinder/0000-0003-0601-6815; Lin, Chiao-Feng/0000-0002-6177-8807; State, Matthew/0000-0003-1624-8302; Kelly, Kirsten/0000-0003-4234-543X; Stevens, Christine/0000-0002-2621-2234; Cicek, A. Ercument/0000-0001-8613-6619; Gallagher, Louise/0000-0001-9462-2836; Sanders, Stephan/0000-0001-9112-5148; Lei, Jing/0000-0003-3104-9387; Palotie, Aarno/0000-0002-2527-5874; Anney, Richard/0000-0002-6083-407X; Dawson, Geraldine/0000-0003-1410-2764; Chahrour, Maria/0000-0002-3174-1480; Buxbaum, Joseph/0000-0001-8898-8313; Eapen, Valsamma/0000-0001-6296-8306; Samocha, Kaitlin/0000-0002-1704-3352; Freitag, Christine Margarete/0000-0001-9676-4782	National Institutes of Health (NIH) [U01MH100233, U01MH100209, U01MH100229, U01MH100239]; NIH grants [R01MH089208, U54 HG003067]; NIH [R01 MH089482, R37 MH057881, R01 MH061009, UL1TR000445, P50 HD055751, MH089482, NIH RO1 MH083565, RC2MH089952, NIMH MH095034, MH077139, 5UL1 RR024975, P30 HD15052]; Charles and Ann Schlaifer Memorial Fund; UK National Institute for Health Research (NIHR) Senior Investigator award; NIHR Biomedical Research Centre in Mental Health at the South London&Maudsley Hospital; Maria Jose Jove Foundation; Strategic Action from Health Carlos III Institute (FEDER) [FIS PI13/01136];  [HICF-1009-003];  [WT098051];  [WT091310]; Medical Research Council [MR/L010305/1, G9817803B, G0500870] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; MRC [G0500870] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094400, R01MH097849, R01MH095797, RC2MH089952, R37MH057881, U01MH100233, U01MH100239, R01MH095034, R01MH089482, R01MH089208, R01MH061009, U01MH100229, R01MH077139, U01MH100209, R01MH083565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073601] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Ann Schlaifer Memorial Fund; UK National Institute for Health Research (NIHR) Senior Investigator award; NIHR Biomedical Research Centre in Mental Health at the South London&Maudsley Hospital; Maria Jose Jove Foundation; Strategic Action from Health Carlos III Institute (FEDER); ; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants U01MH100233, U01MH100209, U01MH100229 and U01MH100239 to the Autism Sequencing Consortium. Sequencing at Broad Institute was supported by NIH grants R01MH089208 (M.J.D.) and new sequencing by U54 HG003067 (S. Gabriel, E. Lander). Other funding includes NIH R01 MH089482, R37 MH057881 (B. D. and K. R.), R01 MH061009 (J.S.S.), UL1TR000445 (NCAT to VUMC); P50 HD055751 (E. H. C.); MH089482 (J.S.S.), NIH RO1 MH083565 and RC2MH089952 (C. A. W.), NIMH MH095034 (P. S), MH077139 (P.F. Sullivan); 5UL1 RR024975 and P30 HD15052. The DDD Study is funded by HICF-1009-003 and WT098051. UK10K is funded by WT091310. We also acknowledge The National Children's Research Foundation, Our Lady's Children's Hospital, Crumlin; The Meath Foundation; AMNCH, Tallaght; The Health Research Board, Ireland and Autism Speaks, U. S. A. C. A. W. is an Investigator of the Howard Hughes Medical Institute. S.D.R., A.P.G., C.S.P., Y.K. and S.-C.F. are Seaver fellows, supported by the Seaver foundation. A. P. G. is also supported by the Charles and Ann Schlaifer Memorial Fund. P. F. B. is supported by a UK National Institute for Health Research (NIHR) Senior Investigator award and the NIHR Biomedical Research Centre in Mental Health at the South London&Maudsley Hospital. A. C. is supported by Maria Jose Jove Foundation and the grant FIS PI13/01136 of the Strategic Action from Health Carlos III Institute (FEDER). This work was supported in part through the computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. We acknowledge the assistance of D. Hall and his team at National Database for Autism Research. We thank Jian Feng for providing a list of targets of both RBFOX1 and H3K4me3. We thank M. Potter for data coordination; K. Moore and J. Reichert for technical assistance; and, S. Lindsay for helping with molecular validation. We acknowledge the clinicians and organizations that contributed to samples used in this study. Finally, we are grateful to the many families whose participation made this study possible.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Feng J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r65; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Khare SP, 2012, NUCLEIC ACIDS RES, V40, pD337, DOI 10.1093/nar/gkr1125; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Liu L, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-22; Long H, 2013, CEREB CORTEX, V23, P71, DOI 10.1093/cercor/bhr378; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Poultney CS, 2013, AM J HUM GENET, V93, P607, DOI 10.1016/j.ajhg.2013.09.001; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Tan CM, 2013, BIOINFORMATICS, V29, P1872, DOI 10.1093/bioinformatics/btt319; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Volkers L, 2011, EUR J NEUROSCI, V34, P1268, DOI 10.1111/j.1460-9568.2011.07826.x; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	47	1537	1550	10	254	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					209	U119		10.1038/nature13772	http://dx.doi.org/10.1038/nature13772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25363760	Green Accepted, Green Submitted			2022-12-28	WOS:000344631400038
J	van Hasselt, PM; Ferdinandusse, S; Monroe, GR; Ruiter, JPN; Turkenburg, M; Geerlings, MJ; Duran, K; Harakalova, M; van der Zwaag, B; Monavari, AA; Okur, I; Sharrard, MJ; Cleary, M; O'Connell, N; Walker, V; Rubio-Gozalbo, ME; de Vries, MC; Visser, G; Houwen, RHJ; van der Smagt, JJ; Verhoeven-Duif, NM; Wanders, RJA; van Haaften, G				van Hasselt, Peter M.; Ferdinandusse, Sacha; Monroe, Glen R.; Ruiter, Jos P. N.; Turkenburg, Marjolein; Geerlings, Maartje J.; Duran, Karen; Harakalova, Magdalena; van der Zwaag, Bert; Monavari, Ardeshir A.; Okur, Ilyas; Sharrard, Mark J.; Cleary, Maureen; O'Connell, Nuala; Walker, Valerie; Rubio-Gozalbo, M. Estela; de Vries, Maaike C.; Visser, Gepke; Houwen, Roderick H. J.; van der Smagt, Jasper J.; Verhoeven-Duif, Nanda M.; Wanders, Ronald J. A.; van Haaften, Gijs			Monocarboxylate Transporter 1 Deficiency and Ketone Utilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOMIC ENRICHMENT; ANCILLARY PROTEIN; EXPRESSION; HYPOGLYCEMIA; BASIGIN; DISEASE; FAMILY; CD147; MCT1	Ketoacidosis is a potentially lethal condition caused by the imbalance between hepatic production and extrahepatic utilization of ketone bodies. We performed exome sequencing in a patient with recurrent, severe ketoacidosis and identified a homozygous frameshift mutation in the gene encoding monocarboxylate transporter 1 (SLC16A1, also called MCT1). Genetic analysis in 96 patients suspected of having ketolytic defects yielded seven additional inactivating mutations in MCT1, both homozygous and heterozygous. Mutational status was found to be correlated with ketoacidosis severity, MCT1 protein levels, and transport capacity. Thus, MCT1 deficiency is a novel cause of profound ketoacidosis; the present work suggests that MCT1-mediated ketone-body transport is needed to maintain acid-base balance.	[van Hasselt, Peter M.; Visser, Gepke] Wilhelmina Childrens Hosp, Div Pediat, Dept Metab Dis, Utrecht, Netherlands; [Houwen, Roderick H. J.] Wilhelmina Childrens Hosp, Div Pediat, Dept Pediat Gastroenterol, Utrecht, Netherlands; [Monroe, Glen R.; Geerlings, Maartje J.; Duran, Karen; Harakalova, Magdalena; van der Zwaag, Bert; van der Smagt, Jasper J.; Verhoeven-Duif, Nanda M.; van Haaften, Gijs] Univ Med Ctr Utrecht, Dept Med Genet, Ctr Mol Med, Utrecht, Netherlands; [Ferdinandusse, Sacha; Ruiter, Jos P. N.; Turkenburg, Marjolein; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; [Ferdinandusse, Sacha; Ruiter, Jos P. N.; Turkenburg, Marjolein; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Div Pediat, Dept Metab Dis, Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Lab Genet Metab Dis, Maastricht, Netherlands; [de Vries, Maaike C.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6525 ED Nijmegen, Netherlands; [Monavari, Ardeshir A.] Childrens Univ Hosp, Natl Ctr Inherited Metab Disorders, Dublin, Ireland; [Okur, Ilyas] Gazi Univ, Sch Med, Dept Pediat Metab & Nutr, Ankara, Turkey; [Sharrard, Mark J.] Sheffield Childrens Hosp, Dept Paediat Metab Med, Sheffield, S Yorkshire, England; [Cleary, Maureen] Great Ormond St Hosp NHS Fdn Trust, Dept Metab Med, London, England; [O'Connell, Nuala] Dept Lab, Salisbury, Wilts, England; [Walker, Valerie] Southampton Gen Hosp, Dept Clin Biochem, Southampton SO9 4XY, Hants, England	Wilhelmina Kinderziekenhuis; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University; Radboud University Nijmegen; Childrens University Hospital - Temple Street; Gazi University; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Southampton	van Hasselt, PM (corresponding author), UMC Utrecht, Dept Metab Dis, Wilhelmina Childrens Hosp, KE 04-133-1,POB 85090, NL-3508 AB Utrecht, Netherlands.	p.vanhasselt@umcutrecht.nl; g.vanhaaften@umcutrecht.nl	de Vries, M.C./L-4735-2015; Geerlings, Maartje/P-3338-2019; Okur, Ilyas/AAM-2081-2021; Rubio-Gozalbo, M Estela/H-1833-2011; Geerlings, Maartje/P-8309-2015; van Haaften, Gijs/G-7832-2012	Geerlings, Maartje/0000-0003-1164-3573; Okur, Ilyas/0000-0002-8772-0689; Geerlings, Maartje/0000-0003-1164-3573; van Haaften, Gijs/0000-0003-3033-0329; Ferdinandusse, Sacha/0000-0002-7738-5709; Monroe, Glen/0000-0002-8653-2643	Child Health program of the University Medical Center Utrecht	Child Health program of the University Medical Center Utrecht	Supported by the Child Health program of the University Medical Center Utrecht.	FISHBEIN WN, 1986, SCIENCE, V234, P1254, DOI 10.1126/science.3775384; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lengacher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082505; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; Marquard J, 2013, DIABETOLOGIA, V56, P31, DOI 10.1007/s00125-012-2750-7; Merezhinskaya N, 2000, MUSCLE NERVE, V23, P90, DOI 10.1002/(SICI)1097-4598(200001)23:1<90::AID-MUS12>3.0.CO;2-M; Merezhinskaya N, 2009, HISTOL HISTOPATHOL, V24, P243, DOI 10.14670/HH-24.243; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Nijman IJ, 2010, NAT METHODS, V7, P913, DOI 10.1038/nmeth.1516; Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960; Sass JO, 2012, J INHERIT METAB DIS, V35, P23, DOI 10.1007/s10545-011-9324-6; van Veen MR, 2011, PEDIATRICS, V127, pE1021, DOI 10.1542/peds.2010-1706; Westerberg DP, 2013, AM FAM PHYSICIAN, V87, P337; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200	19	56	59	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1900	1907		10.1056/NEJMoa1407778	http://dx.doi.org/10.1056/NEJMoa1407778			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25390740	Green Published			2022-12-28	WOS:000344709800007
J	Grow, HM; Schwartz, MB				Grow, H. Mollie; Schwartz, Marlene B.			Food Marketing to Youth Serious Business	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TELEVISION ADVERTISEMENTS		[Grow, H. Mollie] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98145 USA; [Schwartz, Marlene B.] Yale Univ, New Haven, CT USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Yale University	Grow, HM (corresponding author), Univ Washington, Seattle Childrens Hosp, POB 5371,M-S OC-7-830, Seattle, WA 98145 USA.	mollie.grow@seattlechildrens.org		Schwartz, Marlene/0000-0002-8939-1954				Bernhardt AM, 2014, JAMA PEDIATR, V168, P422, DOI 10.1001/jamapediatrics.2014.140; Bernhardt AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072479; Federal Trade Commission, REV FOOD MARK CHILDR; Harris JL, 2013, AM J PREV MED, V44, P358, DOI 10.1016/j.amepre.2012.11.039; Harris JL, 2014, OLDER STILL VULNERAB; Kelly B, 2010, AM J PUBLIC HEALTH, V100, P1730, DOI 10.2105/AJPH.2009.179267; Powell LM, 2013, CHILD OBES, V9, P524, DOI 10.1089/chi.2013.0072; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960	8	4	4	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1918	+		10.1001/jama.2014.8951	http://dx.doi.org/10.1001/jama.2014.8951			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS8ZE	25387189				2022-12-28	WOS:000344532600021
J	Figer, DF				Figer, Donald F.			ASTROPHYSICS Monster star found hiding in plain sight	NATURE			English	Editorial Material							DISCOVERY; CLUSTER; OBJECT; NEBULA; MASSES; LIMIT; W49A	Massive stars are rare, but they are sources of some of the most energetic phenomena seen in the Universe today. A high-mass candidate has now been found in a star- forming region that has been observed for more than 50 years.	Rochester Inst Technol, Ctr Detectors, Rochester, NY 14623 USA	Rochester Institute of Technology	Figer, DF (corresponding author), Rochester Inst Technol, Ctr Detectors, Rochester, NY 14623 USA.	figer@cfd.rit.edu						Alves J, 2003, ASTROPHYS J, V589, pL45, DOI 10.1086/375801; CASSINELLI JP, 1981, SCIENCE, V212, P1497, DOI 10.1126/science.212.4502.1497; Chene A.-N., 2010, IAU S, V272, P497; Conti PS, 2002, ASTROPHYS J, V564, P827, DOI 10.1086/324283; Crowther PA, 2010, MON NOT R ASTRON SOC, V408, P731, DOI 10.1111/j.1365-2966.2010.17167.x; de Koter A, 1998, ASTROPHYS J, V509, P879, DOI 10.1086/306503; FEITZINGER JV, 1980, ASTRON ASTROPHYS, V84, P50; Figer DF, 2005, NATURE, V434, P192, DOI 10.1038/nature03293; Westerhout G., 1958, B ASTRON I NETH, V14, P215; Wu SW, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201424154; Zhang B, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/79	11	1	1	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					42	44		10.1038/515042a	http://dx.doi.org/10.1038/515042a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373670				2022-12-28	WOS:000344187500024
J	Middleton, SD; Anakwe, RE				Middleton, Scott D.; Anakwe, Raymond E.			Carpal tunnel syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORTICOSTEROID INJECTION; OUTCOMES; RELEASE; SURGERY; AGE		[Middleton, Scott D.] Royal Infirm Edinburgh NHS Trust, Dept Trauma & Orthopaed Surg, Edinburgh, Midlothian, Scotland; [Anakwe, Raymond E.] Imperial Coll NHS Trust, Dept Trauma & Orthopaed Surg, St Marys Hosp, London W1 2NY, England	Royal Infirmary of Edinburgh; University of Edinburgh; Imperial College London	Anakwe, RE (corresponding author), Imperial Coll NHS Trust, Dept Trauma & Orthopaed Surg, St Marys Hosp, London W1 2NY, England.	raymundus@doctors.org.uk		Middleton, Scott/0000-0002-2808-4459				Atroshi I, 2006, BRIT MED J, V332, P1473, DOI 10.1136/bmj.38863.632789.1F; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Atroshi I, 2013, ANN INTERN MED, V159, P309, DOI 10.7326/0003-4819-159-5-201309030-00004; Bagatur AE, 2001, J BONE JOINT SURG BR, V83B, P655, DOI 10.1302/0301-620X.83B5.11350; Becker SJE, 2014, J HAND SURG-EUR VOL, V39, P187, DOI 10.1177/1753193413497903; Bland JDP, 2007, BMJ-BRIT MED J, V335, P343, DOI 10.1136/bmj.39282.623553.AD; Bongers FJM, 2007, BRIT J GEN PRACT, V57, P36; Boya H, 2008, MUSCLE NERVE, V38, P1443, DOI 10.1002/mus.21068; Boyer MI, 2008, J HAND SURG-AM, V33A, P1414, DOI 10.1016/j.jhsa.2008.06.023; British Orthopaedic Association British Society for Surgery of the Hand Royal College of Surgeons., 2013, COMM GUID TREATM PAI; Bruske J, 2002, Acta Orthop Belg, V68, P141; Celiker R, 2002, AM J PHYS MED REHAB, V81, P182, DOI 10.1097/00002060-200203000-00005; de Rijk MC, 2007, J NEUROL NEUROSUR PS, V78, P635, DOI 10.1136/jnnp.2006.102145; Dickson DR, 2014, J HAND SURG-EUR VOL, V39, P627, DOI 10.1177/1753193413509938; Ebenbichler GR, 1998, BRIT MED J, V316, P731, DOI 10.1136/bmj.316.7133.731; Geoghegan JM, 2004, J HAND SURG-BRIT EUR, V29B, P315, DOI 10.1016/j.jhsb.2004.02.009; Gerritsen AAM, 2002, JAMA-J AM MED ASSOC, V288, P1245, DOI 10.1001/jama.288.10.1245; Hakim AJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P275, DOI 10.1002/art.10395; Hobby JL, 2005, J HAND SURG-BRIT EUR, V30B, P599, DOI 10.1016/j.jhsb.2005.07.005; Hoogstins Charlotte E S, 2013, Hand (N Y), V8, P434, DOI 10.1007/s11552-013-9532-7; Keith MW, 2009, J BONE JOINT SURG AM, V91A, P2478, DOI [10.2106/JBJS.1.00643, 10.2106/JBJS.I.00643]; Leit ME, 2004, J HAND SURG-AM, V29A, P379, DOI 10.1016/j.jhsa.2004.02.003; Louie DL, 2013, J BONE JOINT SURG AM, V95A, P1067, DOI 10.2106/JBJS.L.00903; Lozano-Calderon S, 2008, J HAND SURG-AM, V33A, P525, DOI 10.1016/j.jhsa.2008.01.004; Marshall S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001554.pub2; O'Connor D, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003219, DOI 10.1002/14651858.CD003219]; Padua L, 2001, NEUROLOGY, V56, P1459, DOI 10.1212/WNL.56.11.1459; Page MJ, 2012, COCHRANE DB SYST REV, V7, DOI [10.1002/14651858.CD010003, DOI 10.1002/14651858.CD010003.PMID:22786532]; Scholten RJ, 2007, COCHRANE DB SYST REV, V4; Stone OD, 2014, BONE JOINT J, V96B, P1234, DOI 10.1302/0301-620X.96B9.34279; Thomsen JF, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-134; Turner A, 2010, ANZ J SURG, V80, P50, DOI 10.1111/j.1445-2197.2009.05175.x; Van Meir Nathalie, 2003, Acta Orthop Belg, V69, P387	33	72	75	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2014	349								g6437	10.1136/bmj.g6437	http://dx.doi.org/10.1136/bmj.g6437			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CE	25378457				2022-12-28	WOS:000344603800001
J	Schooler, JW				Schooler, Jonathan W.			Metascience could rescue the 'replication crisis'	NATURE			English	Editorial Material									Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Schooler, JW (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	jonathanwschooler@gmail.com	Schooler, Jonathan/AAZ-3977-2020; Schooler, Jonathan/ABE-6434-2020					SCHOOLER JW, 1990, COGNITIVE PSYCHOL, V22, P36, DOI 10.1016/0010-0285(90)90003-M	1	92	94	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					9	9		10.1038/515009a	http://dx.doi.org/10.1038/515009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373639	Bronze			2022-12-28	WOS:000344187500004
J	Castanon, A; Landy, R; Brocklehurst, P; Evans, H; Peebles, D; Singh, N; Walker, P; Patnick, J; Sasieni, P				Castanon, Alejandra; Landy, Rebecca; Brocklehurst, Peter; Evans, Heather; Peebles, Donald; Singh, Naveena; Walker, Patrick; Patnick, Julietta; Sasieni, Peter		PaCt Study Grp	Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREGNANCY; CONIZATION; COLPOSCOPY; PATHOLOGY; OUTCOMES; LESIONS; VOLUME; BIRTH; LASER; WOMEN	Objective To determine the association between depth of excision of cervical intraepithelial neoplasia and risk of preterm birth. Design Case-control study nested in record linkage cohort study. Setting 12 hospitals in England. Participants From a cohort of 11 471 women with at least one histological sample taken at colposcopy and a live singleton birth (before or after colposcopy), 1313 women with a preterm birth (20-36 weeks) were identified and frequency matched on maternal age at delivery, parity, and study site to 1313 women with term births (38-42 weeks). Main outcome measures Risk of preterm birth and very/extreme preterm birth by depth of excisional treatment of the cervical transformation zone. Results After exclusions, 768 preterm births (cases) and 830 term births after colposcopy remained. The risk of preterm birth was no greater in women with a previous small (<10 mm) excision (absolute risk 7.5%, 95% confidence interval 6.0% to 8.9%) than in women with a diagnostic punch biopsy (7.2%, 5.9% to 8.5%). Women with a medium (10-14 mm) (absolute risk 9.6%; relative risk 1.28, 0.98 to 1.68), large (15-19 mm) (15.3%; 2.04, 1.41 to 2.96), or very large (>= 20 mm) excision (18.0%; 2.40, 1.53 to 3.75) had a higher risk of preterm delivery than those with small excision. The same pattern was seen in 161 women with very/extremely preterm births (20-31 weeks) and with increasing volume excised. Most births were conceived more than three years after colposcopy, and the risk of preterm delivery did not seem to depend on time from excision to conception. Conclusions The risk of preterm birth is at most minimally affected by a small excision. Larger excisions, particularly over 15 mm or 2.66 cm(3), are associated with a doubling of the risk of both preterm and very preterm births. The risk does not decrease with increasing time from excision to conception. Efforts should be made to excise the entire lesion while preserving as much healthy cervical tissue as possible. Close obstetric monitoring is warranted for women who have large excisions of the cervical transformation zone.	[Castanon, Alejandra; Landy, Rebecca; Sasieni, Peter] Queen Mary Univ London, Ctr Canc Prevent, Wolfson Inst Prevent Med, Barts & London Sch Med, London EC1M 6BQ, England; [Brocklehurst, Peter; Peebles, Donald] UCL, Inst Womens Hlth, London, England; [Evans, Heather; Walker, Patrick] Royal Free Hampstead NHS Trust, Dept Gynaecol, London, England; [Singh, Naveena] Barts Hlth, Div Cellular Pathol, London, England; [Patnick, Julietta] Publ Hlth England, NHS Canc Screening Programmes, Sheffield, S Yorkshire, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Barts Health NHS Trust; Public Health England	Sasieni, P (corresponding author), Queen Mary Univ London, Ctr Canc Prevent, Wolfson Inst Prevent Med, Barts & London Sch Med, London EC1M 6BQ, England.	p.sasieni@qmul.ac.uk	Singh, Naveena/AAH-2651-2020; Wood, Nicholas/E-7124-2018; Castanon, Alejandra/G-1506-2013	Wood, Nicholas/0000-0002-5909-7885; Sasieni, Peter/0000-0003-1509-8744; Landy, Rebecca/0000-0003-4042-4820; Castanon, Alejandra/0000-0002-1101-6548; Ghaem-Maghami, Sadaf/0000-0002-7369-5080	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme [PB-PG-1208-16187]; Cancer Research UK [16892] Funding Source: researchfish; National Institute for Health Research [PB-PG-1208-16187] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (grant reference number PB-PG-1208-16187). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The funder had no input in the design or conduct of the study; the collation, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Bornstein J, 2012, OBSTET GYNECOL, V120, P166, DOI 10.1097/AOG.0b013e318254f90c; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; Castanon A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5174; Health and Social Care Information Centre, 2012, CERV SCREEN PROGR EN; Health & Social Care Information Centre, 2013, HOSP EP STAT; Jakobsson M, 2009, OBSTET GYNECOL, V114, P504, DOI 10.1097/AOG.0b013e3181b052de; Khalid S, 2012, BJOG-INT J OBSTET GY, V119, P685, DOI 10.1111/j.1471-0528.2011.03252.x; KITCHENER HC, 1995, BRIT J OBSTET GYNAEC, V102, P549, DOI 10.1111/j.1471-0528.1995.tb11359.x; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Noehr B, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.004; Ortoft G, 2010, BJOG-INT J OBSTET GY, V117, P258, DOI 10.1111/j.1471-0528.2009.02438.x; Papoutsis D, 2013, GYNECOL OBSTET INVES, V75, P163, DOI 10.1159/000345864; Phadnis SV, 2010, BJOG-INT J OBSTET GY, V117, P615, DOI 10.1111/j.1471-0528.2010.02501.x; Raio L, 1997, OBSTET GYNECOL, V90, P978, DOI 10.1016/S0029-7844(97)00489-4; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Samson SLA, 2005, OBSTET GYNECOL, V105, P325, DOI 10.1097/01.AOG.0000151991.09124.bb; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Simoens C, 2012, BJOG-INT J OBSTET GY, V119, P1247, DOI 10.1111/j.1471-0528.2012.03429.x; The Health and Social Care Information Centre, 2009, NHS MAT STAT ENGL 20	21	56	61	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2014	349								g6223	10.1136/bmj.g6223	http://dx.doi.org/10.1136/bmj.g6223			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CD	25378384	Green Published, hybrid			2022-12-28	WOS:000344603700002
J	Ecclestone, K; Robinson, BL; Wheeler, S				Ecclestone, Kathryn; Robinson, Ben L.; Wheeler, Sarah			MAUDSLEY DEBATE Is emotional restraint a healthy response to adversity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BEHAVIOR; THERAPY; SYMPTOMS		[Ecclestone, Kathryn] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Robinson, Ben L.] South London & Maudsley NHS Fdn Trust, Natl Psychosis Unit Bethlem Royal Hosp, Beckenham BR3 3BX, Kent, England; [Wheeler, Sarah] Dragon Cafe, Mental Fight Club, London, England	University of Sheffield; South London & Maudsley NHS Trust	Ecclestone, K (corresponding author), Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England.	k.ecclestone@sheffield.ac.uk; benjamin.robinson@slam.nhs.uk						Bosely S., 2014, GUARDIAN; Brown G.W., 1985, EXPRESSED EMOTION FA, P7; Challen A., 2011, UK RESILIENCE PROGRA; Crean HF, 2013, AM J COMMUN PSYCHOL, V52, P56, DOI 10.1007/s10464-013-9576-4; Curtis C, 2007, EDUC PSYCHOL PRACT, V23, P33, DOI 10.1080/02667360601154717; Department for Education and Skills, 2005, SOC EM ASP LEARN STR; Durham RC, 2005, HEALTH TECHNOL ASSES, V9, P1; Ecclestone K., 2009, DANGEROUS RISE THERA, DOI DOI 10.4324/9780203870563; Gillies V, 2011, BRIT J SOCIOL EDUC, V32, P185, DOI 10.1080/01425692.2011.547305; Hallam S, 2009, OXFORD REV EDUC, V35, P313, DOI 10.1080/03054980902934597; Jauhar S, 2014, BRIT J PSYCHIAT, V204, P20, DOI 10.1192/bjp.bp.112.116285; Kissane DW, 2004, PSYCHO-ONCOL, V13, P755, DOI 10.1002/pon.798; Leader D, 2008, GUARDIAN; McGrath P, 2004, SUPPORT CARE CANCER, V12, P25, DOI 10.1007/s00520-003-0547-4; Mustafa M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004253.pub4; Nagano J, 2014, BIOPSYCHOSOC MED, V8, DOI 10.1186/1751-0759-8-8; Nakatani Y, 2014, JPN J CLIN ONCOL, V44, P818, DOI 10.1093/jjco/hyu089; Procter L., 2013, THESIS U SHEFFIELD S; Reback R, 2010, J POLICY ANAL MANAG, V29, P698, DOI 10.1002/pam.20528; Robinson BL, 2013, REGISTRAT        SUM, P4; Rogers C, 1967, BECOMING PERSON; Roter DL, 2006, J GEN INTERN MED, V21, pS28, DOI 10.1111/j.1525-1497.2006.00306.x; Sharples J., 2007, WELL BEING CLASSROOM; Siddique H., 2014, GUARDIAN; Sodha S., 2009, STITCH TIME TACKLING; SPIEGEL D, 1989, LANCET, V2, P888; Stone L, 2014, AUST FAM PHYSICIAN, V43, P191; Wessely S., 2000, COCHRANE DB SYST REV, V2; Yalom I.D., 1980, EXISTENTIAL PSYCHOTH	29	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2014	349								g6607	10.1136/bmj.g6607	http://dx.doi.org/10.1136/bmj.g6607			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT0CD	25378024				2022-12-28	WOS:000344603700006
J	[Anonymous]				[Anonymous]			Probiotics Revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		[Anonymous], 2007, Med Lett Drugs Ther, V49, P66; Doron Shira, 2006, Expert Rev Anti Infect Ther, V4, P261, DOI 10.1586/14787210.4.2.261; Floch MH, 2005, GASTROENTEROL CLIN N, V34, P547, DOI 10.1016/j.gtc.2005.05.004; Im E, 2010, GASTROEN CLIN BIOL, V34, pS62, DOI 10.1016/S0399-8320(10)70023-3; Johnston BC, 2012, ANN INTERN MED, V157, P878, DOI 10.7326/0003-4819-157-12-201212180-00563; Snydman DR, 2008, CLIN INFECT DIS, V46, pS104, DOI 10.1086/523331	6	1	1	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1796	1796		10.1001/jama.2014.14389	http://dx.doi.org/10.1001/jama.2014.14389			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25369492				2022-12-28	WOS:000344194500019
J	Lord, JM; Midwinter, MJ; Chen, YF; Belli, A; Brohi, K; Kovacs, EJ; Koenderman, L; Kubes, P; Lilford, RJ				Lord, Janet M.; Midwinter, Mark J.; Chen, Yen-Fu; Belli, Antonio; Brohi, Karim; Kovacs, Elizabeth J.; Koenderman, Leo; Kubes, Paul; Lilford, Richard J.			The systemic immune response to trauma: an overview of pathophysiology and treatment	LANCET			English	Article							CRITICALLY-ILL PATIENTS; MULTIPLE TRAUMA; HEMORRHAGIC-SHOCK; CONTROLLED-TRIAL; ANTIBIOTIC-PROPHYLAXIS; ENDOTHELIAL-CELLS; ENTERAL NUTRITION; TRANEXAMIC ACID; ADULT PATIENTS; ORGAN FAILURE	Improvements in the control of haemorrhage after trauma have resulted in the survival of many people who would otherwise have died from the initial loss of blood. However, the danger is not over once bleeding has been arrested and blood pressure restored. Two-thirds of patients who die following major trauma now do so as a result of causes other than exsanguination. Trauma evokes a systemic reaction that includes an acute, non-specific, immune response associated, paradoxically, with reduced resistance to infection. The result is damage to multiple organs caused by the initial cascade of inflammation aggravated by subsequent sepsis to which the body has become susceptible. This Series examines the biological mechanisms and clinical implications of the cascade of events caused by large-scale trauma that leads to multiorgan failure and death, despite the stemming of blood loss. Furthermore, the stark and robust epidemiological finding-namely, that age has a profound influence on the chances of surviving trauma irrespective of the nature and severity of the injury-will be explored. Advances in our understanding of the inflammatory response to trauma, the impact of ageing on this response, and how this information has led to new and emerging treatments aimed at combating immune dysregulation and reduced immunity after injury will also be discussed.	[Lord, Janet M.] Univ Birmingham, Sch Immun & Infect, MRC ARUK Ctr Musculoskeletal Ageing Res, Birmingham, W Midlands, England; [Lord, Janet M.; Midwinter, Mark J.; Chen, Yen-Fu; Belli, Antonio] Univ Birmingham, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Midwinter, Mark J.; Chen, Yen-Fu; Lilford, Richard J.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Belli, Antonio] Univ Birmingham, Neurotrauma & Neurodegenerat Sect, Birmingham, W Midlands, England; [Chen, Yen-Fu; Lilford, Richard J.] Univ Warwick, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Brohi, Karim] Queen Mary Univ London, Blizard Inst, Ctr Trauma Sci, London, England; [Kovacs, Elizabeth J.] Loyola Univ, Stritch Sch Med, Dept Surg, Burn & Shock Trauma Inst, Maywood, IL 60153 USA; [Koenderman, Leo] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Warwick; University of London; Queen Mary University London; Loyola University Chicago; Utrecht University; Utrecht University Medical Center; University of Calgary	Lilford, RJ (corresponding author), Univ Warwick, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England.	R.J.Lilford@warwick.ac.uk	Midwinter, Mark J/P-6264-2015; Chen, Yen-Fu/AAD-2825-2019; Koenderman, Leo/AAE-7870-2020; Belli, Antonio/I-3799-2015; Midwinter, Mark/AAB-6527-2019	Midwinter, Mark J/0000-0003-1836-7137; Koenderman, Leo/0000-0002-5636-6453; Belli, Antonio/0000-0002-3211-9933; Midwinter, Mark/0000-0003-1836-7137; Chen, Yen-Fu/0000-0002-9446-2761; Lilford, Richard/0000-0002-0634-984X; Lord, Janet/0000-0003-1030-6786	Medical Research Council; UK National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC); National Institute for Health and Care Excellence (NICE); NIHR SRMRC; National Institute on Ageing [NIH AG018859]; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10008] Funding Source: researchfish; Alberta Innovates [201200844] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG018859] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health and Care Excellence (NICE); NIHR SRMRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alberta Innovates; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Medical Research Council provided funding (see above) for a series of workshops related to trauma research, which led to the development of this paper. The views expressed in this paper are those of the authors. The Medical Research Council was not involved in the preparation of the manuscript or the decision to submit it. Y-FC is funded by the UK National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC) and the National Institute for Health and Care Excellence (NICE). AB's salary is partially funded by the NIHR SRMRC. EK is supported by a National Institute on Ageing grant (NIH AG018859). Julian Bion helped in the identification of trials in intensive care of special relevance to the prevention of multiorgan failure in trauma. We thank Pamela Nayyar for her administrative support and Zulian Liu for her help in searching for ongoing trials.	Afshari A, 2011, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007871.PUB2; Afshari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005370.pub2; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Barraud D, 2013, CHEST, V143, P646, DOI 10.1378/chest.12-1745; Bauer M, 2001, INTENS CARE MED, V27, P376, DOI 10.1007/s001340000824; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bo LL, 2011, CRIT CARE, V15, DOI 10.1186/cc10031; Bowater RJ, 2009, ANN SURG, V249, P551, DOI 10.1097/SLA.0b013e318199f202; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROWDER W, 1990, ANN SURG, V211, P605; Bruijns SR, 2013, J TRAUMA ACUTE CARE, V74, P1432, DOI 10.1097/TA.0b013e31829246c7; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Butcher SK, 2005, AGING CELL, V4, P319, DOI 10.1111/j.1474-9726.2005.00178.x; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Choudhry Mashkoor A., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P127; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Czaikoski PG, 2013, SHOCK, V39, P389, DOI 10.1097/SHK.0b013e31828bbcf9; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; David AS, 2001, BRIT MED J, V323, P1462, DOI 10.1136/bmj.323.7327.1462; DAVIS JM, 1991, J TRAUMA, V31, P725, DOI 10.1097/00005373-199106000-00001; DEFELIPPE J, 1993, SURG GYNECOL OBSTET, V177, P383; Doran CM, 2012, J TRAUMA ACUTE CARE, V72, P835, DOI 10.1097/TA.0b013e318248347b; Douzinas EE, 2000, CRIT CARE MED, V28, P8, DOI 10.1097/00003246-200001000-00002; Drifte G, 2013, CRIT CARE MED, V41, P820, DOI 10.1097/CCM.0b013e318274647d; Duggal NA, 2013, AGING CELL, V12, P873, DOI 10.1111/acel.12114; Edwards P, 2005, LANCET, V365, P1957; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; GLINZ W, 1985, INTENS CARE MED, V11, P288, DOI 10.1007/BF00273538; Gosselin RA, 2004, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.CD003764.pub2, DOI 10.1002/14651858.CD003764.PUB2]; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Gu WJ, 2013, JPEN-PARENTER ENTER, V37, P310, DOI 10.1177/0148607112463245; Gu WJ, 2012, CHEST, V142, P859, DOI 10.1378/chest.12-0679; Hall S, 2014, BRIT J NEUROSURG, V28, P181, DOI 10.3109/02688697.2013.835373; Heeres M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-223; Hemming K, 2012, STAT MED, V31, P201, DOI 10.1002/sim.4372; Hietbrink F, 2009, INJURY, V40, P851, DOI 10.1016/j.injury.2008.11.002; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hodgetts T, 2006, DEFENCE MED ED TRAIN, V570; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Huber-Lang M, 2013, SEMIN IMMUNOL, V25, P73, DOI 10.1016/j.smim.2013.05.006; Jackson PC, 2014, ANN SURG, V259, P979, DOI 10.1097/SLA.0b013e31829160ca; Jansen JO, 2013, CRIT CARE, V17, DOI 10.1186/cc12499; Jenne CN, 2013, INT J LAB HEMATOL, V35, P254, DOI 10.1111/ijlh.12084; Jones JM, 2014, ACTA ANAESTH SCAND, V58, P303, DOI 10.1111/aas.12256; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Lilford R, 2002, BRIT J SURG, V89, P129; Liu Ming-Hua, 2013, Med Sci Monit, V19, P194, DOI 10.12659/MSM.883833; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Marik PE, 2008, INTENS CARE MED, V34, P1980, DOI 10.1007/s00134-008-1213-6; MARZI I, 1993, J TRAUMA, V35, P110, DOI 10.1097/00005373-199307000-00018; Mizock BA, 2010, NUTRITION, V26, P701, DOI 10.1016/j.nut.2009.11.010; Mogilner A, 2012, SCIENCE, V336, P175, DOI 10.1126/science.1216380; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Nathens AB, 2006, SHOCK, V26, P342, DOI 10.1097/01.shk.0000228171.32587.a1; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; Nelson RL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001181.pub3; NICE, 2004, TECHN APPR GUID; Nomellini V, 2009, SHOCK, V31, P11, DOI 10.1097/SHK.0b013e318180f508; Patil S, 2009, J ORTHOP RES, V27, P281, DOI 10.1002/jor.20572; Perel P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5166; Perera AM, 2002, TRAUMA, V4, P189; Perez-Barcena J, 2010, CRIT CARE, V14, DOI 10.1186/cc9388; Probst C, 2010, INJURY, V41, P499, DOI 10.1016/j.injury.2009.06.018; Pugin J, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-27; Reino DC, 2012, SHOCK, V38, P107, DOI 10.1097/SHK.0b013e318257123a; Rhee P, 2000, J TRAUMA, V49, P611, DOI 10.1097/00005373-200010000-00007; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/hta17100, 10.3310/HTA17100]; Roberts I, 2011, LANCET, V377, P1071, DOI 10.1016/S0140-6736(11)60317-6; Roberts I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub3; Rochwerg B, 2014, ANN INTERN MED, V161, P347, DOI 10.7326/M14-0178; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmitz D, 2010, J SURG RES, V163, pE73, DOI 10.1016/j.jss.2010.05.017; Seekamp A, 2004, CRIT CARE MED, V32, P2021, DOI 10.1097/01.CCM.0000142396.59236.F3; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Spruijt NE, 2010, CRIT CARE, V14, DOI 10.1186/cc9218; Stead M, 2011, BRIT J CANCER, V104, P1529, DOI 10.1038/bjc.2011.69; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; The NHS Confederation, IMPL TRAUM SYST KEY; Timar CI, 2013, BLOOD, V121, P510, DOI 10.1182/blood-2012-05-431114; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub5, 10.1002/14651858.MR000013.pub4]; van Gils JM, 2009, J LEUKOCYTE BIOL, V85, P195, DOI 10.1189/jlb.0708400; van Zanten ARH, 2014, JAMA-J AM MED ASSOC, V312, P514, DOI 10.1001/jama.2014.7698; VASSAR MJ, 1991, PROSTAG LEUKOTR ESS, V44, P223, DOI 10.1016/0952-3278(91)90021-V; WADE CE, 1988, J CLIN ENDOCR METAB, V67, P223, DOI 10.1210/jcem-67-2-223; Wafaisade A, 2011, CRIT CARE MED, V39, P621, DOI 10.1097/CCM.0b013e318206d3df; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; WHO, 2010, VIOL INJ FACTS; World Health Organization, GLOB HLTH EST 2014 S; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	104	377	398	11	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1455	1465		10.1016/S0140-6736(14)60687-5	http://dx.doi.org/10.1016/S0140-6736(14)60687-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25390327	Green Accepted			2022-12-28	WOS:000343107000026
J	Kaufman, RM; Djulbegovic, B; Gernsheimer, T; Kleinman, S; Tinmouth, AT; Capocelli, KE; Cipolle, MD; Cohn, CS; Fung, MK; Grossman, BJ; Mintz, PD; O'Malley, BA; Sesok-Pizzini, DA; Shander, A; Stack, GE; Webert, KE; Weinstein, R; Welch, BG; Whitman, GJ; Wong, EC; Tobian, AAR				Kaufman, Richard M.; Djulbegovic, Benjamin; Gernsheimer, Terry; Kleinman, Steven; Tinmouth, Alan T.; Capocelli, Kelley E.; Cipolle, Mark D.; Cohn, Claudia S.; Fung, Mark K.; Grossman, Brenda J.; Mintz, Paul D.; O'Malley, Barbara A.; Sesok-Pizzini, Deborah A.; Shander, Aryeh; Stack, Gary E.; Webert, Kathryn E.; Weinstein, Robert; Welch, Babu G.; Whitman, Glenn J.; Wong, Edward C.; Tobian, Aaron A. R.			Platelet Transfusion: A Clinical Practice Guideline From the AABB	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC INTRACRANIAL HEMORRHAGE; PROGENITOR-CELL TRANSPLANT; VENOUS CATHETER PLACEMENT; BRAIN-INJURY PATIENTS; ACUTE LUNG INJURY; ACUTE-LEUKEMIA; LUMBAR PUNCTURE; ANTIPLATELET THERAPY; BLEEDING DIATHESES	Background: The AABB (formerly, the American Association of Blood Banks) developed this guideline on appropriate use of platelet transfusion in adult patients. Methods: These guidelines are based on a systematic review of randomized, clinical trials and observational studies (1900 to September 2014) that reported clinical outcomes on patients receiving prophylactic or therapeutic platelet transfusions. An expert panel reviewed the data and developed recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Recommendation 1: The AABB recommends that platelets should be transfused prophylactically to reduce the risk for spontaneous bleeding in hospitalized adult patients with therapyinduced hypoproliferative thrombocytopenia. The AABB recommends transfusing hospitalized adult patients with a platelet count of 10 x 10(9) cells/L or less to reduce the risk for spontaneous bleeding. The AABB recommends transfusing up to a single apheresis unit or equivalent. Greater doses are not more effective, and lower doses equal to one half of a standard apheresis unit are equally effective. (Grade: strong recommendation; moderate-quality evidence) Recommendation 2: The AABB suggests prophylactic platelet transfusion for patients having elective central venous catheter placement with a platelet count less than 20 x 10(9) cells/L. (Grade: weak recommendation; low-quality evidence) Recommendation 3: The AABB suggests prophylactic platelet transfusion for patients having elective diagnostic lumbar puncture with a platelet count less than 50 x 10(9) cells/L. (Grade: weak recommendation; very-low-quality evidence) Recommendation 4: The AABB suggests prophylactic platelet transfusion for patients having major elective nonneuraxial surgery with a platelet count less than 50 x 10(9) cells/L. (Grade: weak recommendation; very-low-quality evidence) Recommendation 5: The AABB recommends against routine prophylactic platelet transfusion for patients who are nonthrombocytopenic and have cardiac surgery with cardiopulmonary bypass. The AABB suggests platelet transfusion for patients having bypass who exhibit perioperative bleeding with thrombocytopenia and/or evidence of platelet dysfunction. (Grade: weak recommendation; very-low-quality evidence) Recommendation 6: The AABB cannot recommend for or against platelet transfusion for patients receiving antiplatelet therapy who have intracranial hemorrhage (traumatic or spontaneous). (Grade: uncertain recommendation; very-low-quality evidence)	Brigham & Womens Hosp, Boston, MA 02115 USA; [Djulbegovic, Benjamin] Univ S Florida, Tampa, FL 33612 USA; [Gernsheimer, Terry] Univ Washington, Seattle, WA 98195 USA; [Kleinman, Steven] Univ British Columbia, Victoria, BC V9A 4W4, Canada; Ottawa Hosp Res Inst, Ottawa, ON, Canada; Childrens Hosp Colorado, Aurora, CO 80045 USA; Christiana Care Hlth Syst, Wilmington, DE USA; Univ Minnesota, Minneapolis, MN USA; Univ Vermont, Burlington, VT USA; Washington Univ, Sch Med, St Louis, MO USA; US FDA, Silver Spring, MD USA; Wayne State Univ, Detroit, MI USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Englewood Hosp & Med Ctr, Englewood, NJ USA; Yale Univ, Sch Med, West Haven, CT 06516 USA; McMaster Univ, Hamilton, ON, Canada; [Weinstein, Robert] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Welch, Babu G.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Johns Hopkins Univ, Baltimore, MD USA; Childrens Natl Med Ctr, Washington, DC 20010 USA	Harvard University; Brigham & Women's Hospital; State University System of Florida; University of South Florida; University of Washington; University of Washington Seattle; University of British Columbia; University of Ottawa; Ottawa Hospital Research Institute; Children's Hospital Colorado; Christiana Care Health System; University of Minnesota System; University of Minnesota Twin Cities; University of Vermont; Washington University (WUSTL); US Food & Drug Administration (FDA); Wayne State University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Englewood Hospital & Medical Center; Yale University; McMaster University; University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Children's National Health System	Kaufman, RM (corresponding author), Brigham & Womens Hosp, Dept Pathol, Blood Bank, Amory 260,75 Francis St, Boston, MA 02115 USA.	rmkaufman@partners.org	Djulbegovic, Benjamin/I-3661-2012; Kaufman, Richard M/E-8890-2018; Stack, Gary/E-9646-2014	Djulbegovic, Benjamin/0000-0003-0671-1447; Kaufman, Richard M/0000-0003-1520-4535; Stack, Gary/0000-0002-6501-7255; Grossman, Brenda/0000-0002-1500-8211; Fung, Mark/0000-0001-6081-4151				Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Barrera R, 1996, CANCER, V78, P2025, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2025::AID-CNCR26>3.3.CO;2-T; BISHOP JF, 1987, AM J HEMATOL, V26, P147, DOI 10.1002/ajh.2830260205; BREUER AC, 1982, CANCER-AM CANCER SOC, V49, P2168, DOI 10.1002/1097-0142(19820515)49:10<2168::AID-CNCR2820491031>3.0.CO;2-O; Choi S, 2009, ANESTH ANALG, V109, P648, DOI 10.1213/ane.0b013e3181ac13d1; Creutzfeldt CJ, 2009, J STROKE CEREBROVASC, V18, P221, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.007; Diedrich B, 2005, TRANSFUSION, V45, P1064, DOI 10.1111/j.1537-2995.2005.04157.x; Doerfler ME, 1996, CHEST, V110, P185, DOI 10.1378/chest.110.1.185; Downey DM, 2009, AM SURGEON, V75, P1100; Duffy SM, 2013, J CLIN APHERESIS, V28, P356, DOI 10.1002/jca.21279; Eder AF, 2013, TRANSFUSION, V53, P1442, DOI 10.1111/j.1537-2995.2012.03935.x; Estcourt L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004269.pub3; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Feusner J, 2004, PEDIATR BLOOD CANCER, V43, P793, DOI 10.1002/pbc.20201; Fisher NC, 1999, INTENS CARE MED, V25, P481, DOI 10.1007/s001340050884; FRITZ RD, 1959, NEW ENGL J MED, V261, P59, DOI 10.1056/NEJM195907092610202; Fuller AK, 2011, TRANSFUSION, V51, P1469, DOI 10.1111/j.1537-2995.2010.03039.x; Greeno E, 2007, TRANSFUSION, V47, P201, DOI 10.1111/j.1537-2995.2007.01089.x; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haas B, 2010, J VASC INTERV RADIOL, V21, P212, DOI 10.1016/j.jvir.2009.10.032; Haas FJ, 2011, BLOOD TRANSFUSION GU; HAN T, 1966, CANCER, V19, P1937, DOI 10.1002/1097-0142(196612)19:12<1937::AID-CNCR2820191221>3.0.CO;2-G; Heckman KD, 1997, J CLIN ONCOL, V15, P1143, DOI 10.1200/JCO.1997.15.3.1143; Heddle NM, 2009, BLOOD, V113, P1564, DOI 10.1182/blood-2008-09-178236; Heddle NM, 2002, TRANSFUSION, V42, P556, DOI 10.1046/j.1537-2995.2002.00094.x; Heddle NM, 1999, TRANSFUSION, V39, P231, DOI 10.1046/j.1537-2995.1999.39399219278.x; Howard SC, 2000, JAMA-J AM MED ASSOC, V284, P2222, DOI 10.1001/jama.284.17.2222; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; JPAC - Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee, 2013, TRANSF HDB TRANSF SU; Kelsey P, 2003, BRIT J HAEMATOL, V122, P10; Kitanovski L, 2008, ZDR VESTN, V77, pI111; Kumar A, 2015, TRANSFUSION, V55, P1116, DOI 10.1111/trf.12943; Lozano M, 2014, VOX SANG, V106, P330, DOI 10.1111/vox.12110; Malloy PC, 2009, J VASC INTERV RADIOL, V20, pS240, DOI 10.1016/j.jvir.2008.11.027; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Mumtaz H, 2000, AM J SURG, V180, P503, DOI 10.1016/S0002-9610(00)00552-3; MURPHY S, 1982, AM J HEMATOL, V12, P347, DOI 10.1002/ajh.2830120406; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Patel IJ, 2012, J VASC INTERV RADIOL, V23, P727, DOI 10.1016/j.jvir.2012.02.012; Qureshi HY, 2008, ANAL BIOCHEM, V382, P138, DOI 10.1016/j.ab.2008.07.027; Ray CE, 1997, RADIOLOGY, V204, P97, DOI 10.1148/radiology.204.1.9205228; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; Riley W, 2012, TRANSFUSION, V52, P1957, DOI 10.1111/j.1537-2995.2011.03539.x; ROY AJ, 1973, TRANSFUSION, V13, P283, DOI 10.1111/j.1537-2995.1973.tb05490.x; Ruell J, 2007, BRIT J HAEMATOL, V136, P347, DOI 10.1111/j.1365-2141.2006.06433.x; Samama CM, 2006, MINERVA ANESTESIOL, V72, P447; Samama CM, 2005, CAN J ANAESTH, V52, P30, DOI 10.1007/BF03018577; Schiffer CA, 2001, J CLIN ONCOL, V19, P1519, DOI 10.1200/JCO.2001.19.5.1519; Segal HC, 2005, BRIT J HAEMATOL, V128, P520, DOI 10.1111/j.1365-2141.2004.05352.x; Sensebe L, 2005, BLOOD, V105, P862, DOI 10.1182/blood-2004-05-1841; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; SLICHTER SJ, 1978, CLIN HAEMATOL, V7, P523; SOLOMON J, 1978, LANCET, V1, P267; Spiess BD, 2004, TRANSFUSION, V44, P1143, DOI 10.1111/j.1537-2995.2004.03322.x; Stanworth SJ, 2014, TRANSFUSION, V54, P2385, DOI 10.1111/trf.12646; Stanworth SJ, 2013, NEW ENGL J MED, V368, P1771, DOI 10.1056/NEJMoa1212772; Stramer SL, 2007, ARCH PATHOL LAB MED, V131, P702; Tinmouth A, 2004, TRANSFUSION, V44, P1711, DOI 10.1111/j.0041-1132.2004.04118.x; Tosetto A, 2009, THROMB RES, V124, pE13, DOI 10.1016/j.thromres.2009.06.009; Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932; van Veen JJ, 2004, BRIT J HAEMATOL, V127, P233, DOI 10.1111/j.1365-2141.2004.05178.x; van Veen JJ, 2010, BRIT J HAEMATOL, V148, P15, DOI 10.1111/j.1365-2141.2009.07899.x; Vavricka SR, 2003, ANN HEMATOL, V82, P570, DOI 10.1007/s00277-003-0707-0; Wandt H, 2012, LANCET, V380, P1309, DOI 10.1016/S0140-6736(12)60689-8; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Whitaker BI, 2013, 2011 NATL BLOOD COLL; Whitlock R, 2005, CRIT CARE CLIN, V21, P589, DOI 10.1016/j.ccc.2005.04.003; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Zeidler K, 2011, TRANSFUSION, V51, P2269, DOI 10.1111/j.1537-2995.2011.03147.x; Zumberg MS, 2002, BIOL BLOOD MARROW TR, V8, P569, DOI 10.1053/bbmt.2002.v8.pm12434952	72	475	501	2	40	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					205	U118		10.7326/M14-1589	http://dx.doi.org/10.7326/M14-1589			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25383671				2022-12-28	WOS:000350108100006
J	Bah, EI; Lamah, MC; Fletcher, T; Jacob, ST; Brett-Major, DM; Sall, AA; Shindo, N; Fischer, WA; Lamontagne, F; Saliou, SM; Bausch, DG; Moumie, B; Jagatic, T; Sprecher, A; Lawler, JV; Mayet, T; Jacquerioz, FA; Baggi, MFM; Vallenas, C; Clement, C; Mardel, S; Faye, O; Faye, O; Soropogui, B; Magassouba, N; Koivogui, L; Pinto, R; Fowler, RA				Bah, Elhadj Ibrahima; Lamah, Marie-Claire; Fletcher, Tom; Jacob, Shevin T.; Brett-Major, David M.; Sall, Amadou Alpha; Shindo, Nahoko; Fischer, William A., II; Lamontagne, Francois; Saliou, Sow Mamadou; Bausch, Daniel G.; Moumie, Barry; Jagatic, Tim; Sprecher, Armand; Lawler, James V.; Mayet, Thierry; Jacquerioz, Frederique A.; Baggi, Maria F. Mendez; Vallenas, Constanza; Clement, Christophe; Mardel, Simon; Faye, Ousmane; Faye, Oumar; Soropogui, Bare; Magassouba, Nfaly; Koivogui, Lamine; Pinto, Ruxandra; Fowler, Robert A.			Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMORRHAGIC-FEVER; REGRESSION; INFECTION; OUTBREAK; UGANDA	BACKGROUND In March 2014, the World Health Organization was notified of an outbreak of Zaire ebolavirus in a remote area of Guinea. The outbreak then spread to the capital, Conakry, and to neighboring countries and has subsequently become the largest epidemic of Ebola virus disease (EVD) to date. METHODS From March 25 to April 26, 2014, we performed a study of all patients with laboratory-confirmed EVD in Conakry. Mortality was the primary outcome. Secondary outcomes included patient characteristics, complications, treatments, and comparisons between survivors and nonsurvivors. RESULTS Of 80 patients who presented with symptoms, 37 had laboratory-confirmed EVD. Among confirmed cases, the median age was 38 years (interquartile range, 28 to 46), 24 patients (65%) were men, and 14 (38%) were health care workers; among the health care workers, nosocomial transmission was implicated in 12 patients (32%). Patients with confirmed EVD presented to the hospital a median of 5 days (interquartile range, 3 to 7) after the onset of symptoms, most commonly with fever (in 84% of the patients; mean temperature, 38.6 degrees C), fatigue (in 65%), diarrhea (in 62%), and tachycardia (mean heart rate, >93 beats per minute). Of these patients, 28 (76%) were treated with intravenous fluids and 37 (100%) with antibiotics. Sixteen patients (43%) died, with a median time from symptom onset to death of 8 days (interquartile range, 7 to 11). Patients who were 40 years of age or older, as compared with those under the age of 40 years, had a relative risk of death of 3.49 (95% confidence interval, 1.42 to 8.59; P = 0.007). CONCLUSIONS Patients with EVD presented with evidence of dehydration associated with vomiting and severe diarrhea. Despite attempts at volume repletion, antimicrobial therapy, and limited laboratory services, the rate of death was 43%.	[Bah, Elhadj Ibrahima; Lamah, Marie-Claire; Saliou, Sow Mamadou; Moumie, Barry] Donka Hosp, Conakry, Guinea; [Soropogui, Bare; Magassouba, Nfaly] Univ Gamal Abdel Nasser, Projet Fievre Hemorrag Guinee, Conakry, Guinea; [Koivogui, Lamine] Inst Natl Sante Conakry, Conakry, Guinea; [Fletcher, Tom] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Mardel, Simon] Univ S Manchester Hosp, Emergency Dept, Manchester M20 8LR, Lancs, England; [Jacob, Shevin T.] Hosp Mulago, Masaka, Uganda; [Jacob, Shevin T.] Univ Washington, Dept Med, Seattle, WA USA; [Brett-Major, David M.] WHO, Preparedness & Mass Gatherings, Global Preparedness Surveillance & Response Opera, Global Capac Alert & Response,Hlth Secur Environm, Geneva, Switzerland; [Shindo, Nahoko; Vallenas, Constanza] WHO, Dept Pandem & Epidem Dis, Geneva, Switzerland; [Sall, Amadou Alpha; Faye, Ousmane; Faye, Oumar] Inst Pasteur, Dakar, Senegal; [Fischer, William A., II] Univ N Carolina, Sch Med, Div Pulm & Crit Care Med, Chapel Hill, NC USA; [Lamontagne, Francois] Univ Sherbrooke, Ctr Rech, CHU Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Pinto, Ruxandra] Sunnybrook Hlth Sci Ctr, Trauma Emergency & Crit Care Program, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; Univ Toronto, Toronto, ON, Canada; [Bausch, Daniel G.] US Naval Med Res Unit 6, Virol & Emerging Infect Dept, Lima, Peru; [Bausch, Daniel G.; Jacquerioz, Frederique A.; Baggi, Maria F. Mendez] Tulane Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA; [Jagatic, Tim; Sprecher, Armand] Med Sans Frontieres, Brussels, Belgium; [Lawler, James V.] Naval Med Res Ctr Frederick, Frederick, MD USA; [Mayet, Thierry] Ctr Hosp Dax, Serv Reanimat Polyvalente, Dax, France; [Clement, Christophe] Private Hosp Polyclin Bordeaux Nord Aquitaine, Intens Care Unit, Bordeaux, France	University of Liverpool; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Mulago National Referral Hospital; University of Washington; University of Washington Seattle; World Health Organization; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Sherbrooke; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Tulane University; Doctors Without Borders; Naval Medical Research Center (NMRC)	Fowler, RA (corresponding author), Univ Toronto, Dept Med & Crit Care Med, Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	rob.fowler@sunnybrook.ca	faye, Ousmane/GMW-6500-2022; Jacob, Shevin/CAF-0449-2022; Faye, Oumar/T-7168-2019	Faye, Oumar/0000-0002-3478-1322; Jacob, Shevin/0000-0003-2425-9394; Lawler, James/0000-0003-3736-8485; Fletcher, Tom/0000-0002-3712-415X; Lamontagne, Francois/0000-0002-0360-3427	NATIONAL INSTITUTE ON AGING [R03AG045088] Funding Source: NIH RePORTER; NIA NIH HHS [R03 AG045088] Funding Source: Medline; Wellcome Trust [100890] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Beeching NJ, 2010, INT J ANTIMICROB AG, V36, pS26, DOI 10.1016/j.ijantimicag.2010.06.017; Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357; Brearley MB, 2013, PREHOSP DISASTER MED, V28, P139, DOI 10.1017/S1049023X12001847; Centers for Disease Control and Prevention, OUTBR CHRON EB VIR D; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; MacNeil A, 2010, EMERG INFECT DIS, V16, P1969, DOI 10.3201/eid1612.100627; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Sterk E., 2008, MED SANS FRONTIERES; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004; World Health Organization, 2014, PRIS CHARG CLIN FIEV; World Health Organization, EB RESP ROADM UPD; World Health Organization, 2014, EB VIR DIS GUIN; World Health Organization, EB VIR DIS OUTBR W A; World Health Organization, IND LEAD KEY PARTN D; World Health Organization, GUIN STAT; World Health Organization (WHO), EB VIR DIS FACT SHEE; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	21	281	297	0	99	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					40	47		10.1056/NEJMoa1411249	http://dx.doi.org/10.1056/NEJMoa1411249			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25372658	Green Published, Bronze			2022-12-28	WOS:000347100800008
J	McAfee, T; Babb, S; McNabb, S; Fiore, MC				McAfee, Tim; Babb, Stephen; McNabb, Simon; Fiore, Michael C.			Helping Smokers Quit - Opportunities Created by the Affordable Care Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TOBACCO-DEPENDENCE TREATMENT; MEDICAID COVERAGE; IMPACT		[McAfee, Tim; Babb, Stephen; McNabb, Simon] Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA 30333 USA; [Fiore, Michael C.] Univ Wisconsin, Sch Med & Publ Hlth, Ctr Tobacco Res & Intervent, Madison, WI 53706 USA	Centers for Disease Control & Prevention - USA; University of Wisconsin System; University of Wisconsin Madison	McAfee, T (corresponding author), Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA 30333 USA.		McAfee, Tim/GXG-1246-2022		NCI NIH HHS [P01 CA180945] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA180945] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Fiore MC, 2008, CLIN PRACTICE GUIDEL; Greene J, 2014, AM J PREV MED, V46, P331, DOI 10.1016/j.amepre.2013.11.019; Kofman M., 2012, IMPLEMENTATION TOBAC; Land T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009770; McMenamin SB, 2012, AM J PREV MED, V43, pE27, DOI 10.1016/j.amepre.2012.06.012	5	76	76	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					5	7		10.1056/NEJMp1411437	http://dx.doi.org/10.1056/NEJMp1411437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX7MU	25409263	Bronze, Green Accepted			2022-12-28	WOS:000347100800003
J	Kwo, PY; Mantry, PS; Coakley, E; Te, HS; Vargas, HE; Brown, R; Gordon, F; Levitsky, J; Terrault, NA; Burton, JR; Xie, WG; Setze, C; Badri, P; Pilot-Matias, T; Vilchez, RA; Forns, X				Kwo, Paul Y.; Mantry, Parvez S.; Coakley, Eoin; Te, Helen S.; Vargas, Hugo E.; Brown, Robert, Jr.; Gordon, Fredric; Levitsky, Josh; Terrault, Norah A.; Burton, James R., Jr.; Xie, Wangang; Setze, Carolyn; Badri, Prajakta; Pilot-Matias, Tami; Vilchez, Regis A.; Forns, Xavier			An Interferon-free Antiviral Regimen for HCV after Liver Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C RECURRENCE; VIRUS-INFECTION; RIBAVIRIN; DASABUVIR; ABT-450/R-OMBITASVIR; MULTICENTER; TELAPREVIR; THERAPY; GRAFT; PEGINTERFERON-ALPHA-2B	BACKGROUND Hepatitis C virus (HCV) infection is the leading indication for liver transplantation worldwide, and interferon-containing regimens are associated with low response rates owing to treatment-limiting toxic effects in immunosuppressed liver-transplant recipients. We evaluated the interferon-free regimen of the NS5A inhibitor ombitasvir coformulated with the ritonavir-boosted protease inhibitor ABT-450 (ABT-450/r), the nonnucleoside NS5B polymerase inhibitor dasabuvir, and ribavirin in liver-transplant recipients with recurrent HCV genotype 1 infection. METHODS We enrolled 34 liver-transplant recipients with no fibrosis or mild fibrosis, who received ombitasvir-ABT-450/r (at a once-daily dose of 25 mg of ombitasvir, 150 mg of ABT-450, and 100 mg of ritonavir), dasabuvir (250 mg twice daily), and ribavirin for 24 weeks. Selection of the initial ribavirin dose and subsequent dose modifications for anemia were at the investigator's discretion. The primary efficacy end point was a sustained virologic response 12 weeks after the end of treatment. RESULTS Of the 34 study participants, 33 had a sustained virologic response at post-treatment weeks 12 and 24, for a rate of 97% (95% confidence interval, 85 to 100). The most common adverse events were fatigue, headache, and cough. Five patients (15%) required erythropoietin; no patient required blood transfusion. One patient discontinued the study drugs owing to adverse events after week 18 but had a sustained virologic response. Blood levels of calcineurin inhibitors were monitored, and dosages were modified to maintain therapeutic levels; no episode of graft rejection was observed during the study. CONCLUSIONS Treatment with the multitargeted regimen of ombitasvir-ABT-450/r and dasabuvir with ribavirin was associated with a low rate of serious adverse events and a high rate of sustained virologic response among liver-transplant recipients with recurrent HCV genotype 1 infection, a historically difficult-to-treat population.	[Kwo, Paul Y.] Indiana Univ, Indianapolis, IN 46204 USA; [Mantry, Parvez S.] Liver Inst Methodist Dallas, Dallas, TX USA; [Coakley, Eoin; Xie, Wangang; Setze, Carolyn; Badri, Prajakta; Pilot-Matias, Tami; Vilchez, Regis A.] AbbVie, N Chicago, IL USA; [Te, Helen S.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Levitsky, Josh] Northwestern Univ, Comprehens Transplant Ctr, Chicago, IL 60611 USA; [Vargas, Hugo E.] Mayo Clin, Phoenix, AZ USA; [Brown, Robert, Jr.] Columbia Univ, Med Ctr, Ctr Liver Dis & Transplantat, New York, NY USA; [Gordon, Fredric] Lahey Hosp & Med Ctr, Burlington, MA USA; [Terrault, Norah A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Burton, James R., Jr.] Univ Colorado Denver, Aurora, CO USA; [Forns, Xavier] Univ Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Barcelona, Spain; [Forns, Xavier] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Indiana University System; Indiana University-Purdue University Indianapolis; AbbVie; University of Chicago; University of Chicago Medical Center; Northwestern University; Mayo Clinic; Mayo Clinic Phoenix; Columbia University; Lahey Hospital & Medical Center; University of California System; University of California San Francisco; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona	Kwo, PY (corresponding author), Indiana Univ Sch Med, Gastroenterol Hepatol Div, 975 W Walnut,IB 327, Indianapolis, IN 46202 USA.	pkwo@iu.edu	Levitsky, Josh/AAF-8662-2019; Mantry, Parvez/AAY-2891-2021; Vargas, Hugo E./K-1562-2019	Levitsky, Josh/0000-0001-7527-6093; Vargas, Hugo E./0000-0002-7802-688X; Forns, Xavier/0000-0002-8188-1764	AbbVie; CORAL-I [NCT01782495]	AbbVie(AbbVie); CORAL-I	Funded by AbbVie; CORAL-I ClinicalTrials.gov number, NCT01782495.	Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; [Anonymous], 2012, SCI REG TRASNPL REC; [Anonymous], 2014, GLOB AL RESP GAR HEP; Berenguer M, 2008, AM J TRANSPLANT, V8, P679, DOI 10.1111/j.1600-6143.2007.02126.x; Berenguer M, 2000, HEPATOLOGY, V32, P852, DOI 10.1053/jhep.2000.17924; Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7; Biggins SW, 2012, LIVER TRANSPLANT, V18, P1471, DOI 10.1002/lt.23551; Burton JR, 2014, J HEPATOL, V61, P508, DOI 10.1016/j.jhep.2014.04.037; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Charlton M, 2011, HEPATOLOGY, V54, P3, DOI 10.1002/hep.24470; Coilly A, 2014, J HEPATOL, V60, P78, DOI 10.1016/j.jhep.2013.08.018; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2006, J HEPATOL, V44, P275, DOI 10.1016/j.jhep.2005.09.015; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gane EJ, 2014, AM J TRANSPLANT, V14, P994, DOI 10.1111/ajt.12714; Garg V, 2011, HEPATOLOGY, V54, P20, DOI 10.1002/hep.24443; Gordon FD, 2012, J CLIN GASTROENTEROL, V46, P700, DOI 10.1097/MCG.0b013e31825833be; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lawitz E, 2012, J HEPATOL, V56, pS469, DOI 10.1016/S0168-8278(12)61198-2; Lens S, 2014, SEMIN LIVER DIS, V34, P58, DOI 10.1055/s-0034-1371011; Levitsky J, 2012, GASTROENTEROLOGY, V142, P1132, DOI 10.1053/j.gastro.2012.01.030; Menon RM, 2009, GLOBAL ANTIVIRAL J, V5, P53; Omrane M, 2014, J HEPATOL, V60, pS20, DOI 10.1016/S0168-8278(14)60051-9; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Prieto M, 1999, HEPATOLOGY, V29, P250, DOI 10.1002/hep.510290122; Pungpapong S, 2013, LIVER TRANSPLANT, V19, P690, DOI 10.1002/lt.23669; Saab S, 2014, LIVER INT; Samuel D, 1999, J HEPATOL, V31, P217, DOI 10.1016/S0168-8278(99)80405-X; Selzner N, 2011, J HEPATOL, V55, P207, DOI 10.1016/j.jhep.2010.11.012; Terrault NA, 2006, LIVER TRANSPLANT, V12, P1192, DOI 10.1002/lt.20865; World Health Organization, 2012, GLOB OBS DON TRANSPL; WRIGHT TL, 1992, GASTROENTEROLOGY, V103, P317, DOI 10.1016/0016-5085(92)91129-R; Xiao N, 2010, HEPATIC MED-EVID RES, V2, P99; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	35	319	329	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2375	2382		10.1056/NEJMoa1408921	http://dx.doi.org/10.1056/NEJMoa1408921			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25386767	Green Submitted, Green Published			2022-12-28	WOS:000346425800006
J	Snyder, A; Makarov, V; Merghoub, T; Yuan, J; Zaretsky, JM; Desrichard, A; Walsh, LA; Postow, MA; Wong, P; Ho, TS; Hollmann, TJ; Bruggeman, C; Kannan, K; Li, YY; Elipenahli, C; Liu, CL; Harbison, CT; Wang, LS; Ribas, A; Wolchok, JD; Chan, TA				Snyder, Alexandra; Makarov, Vladimir; Merghoub, Taha; Yuan, Jianda; Zaretsky, Jesse M.; Desrichard, Alexis; Walsh, Logan A.; Postow, Michael A.; Wong, Phillip; Ho, Teresa S.; Hollmann, Travis J.; Bruggeman, Cameron; Kannan, Kasthuri; Li, Yanyun; Elipenahli, Ceyhan; Liu, Cailian; Harbison, Christopher T.; Wang, Lisu; Ribas, Antoni; Wolchok, Jedd D.; Chan, Timothy A.			Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXOME ANALYSIS REVEALS; T-CELL RECOGNITION; CANCER-IMMUNOTHERAPY; TUMOR; ANTIGEN; PEPTIDE; IPILIMUMAB; PROTEIN; EPITOPE; IDENTIFICATION	BACKGROUND Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs overall survival in patients with melanoma. CTLA-4 blockade activates T cells and enables them to destroy tumor cells. METHODS We obtained tumor tissue from patients with melanoma who were treated with ipilimumab or tremelimumab. Whole-exome sequencing was performed on tumors and matched blood samples. Somatic mutations and candidate neoantigens generated from these mutations were characterized. Neoantigen peptides were tested for the ability to activate lymphocytes from ipilimumab-treated patients. RESULTS Malignant melanoma exomes from 64 patients treated with CTLA-4 blockade were characterized with the use of massively parallel sequencing. A discovery set consisted of 11 patients who derived a long-term clinical benefit and 14 patients who derived a minimal benefit or no benefit. Mutational load was associated with the degree of clinical benefit (P = 0.01) but alone was not sufficient to predict benefit. Using genomewide somatic neoepitope analysis and patient-specific HLA typing, we identified candidate tumor neoantigens for each patient. We elucidated a neoantigen landscape that is specifically present in tumors with a strong response to CTLA-4 blockade. We validated this signature in a second set of 39 patients with melanoma who were treated with anti-CTLA-4 antibodies. Predicted neoantigens activated T cells from the patients treated with ipilimumab. CONCLUSIONS These findings define a genetic basis for benefit from CTLA-4 blockade in melanoma and provide a rationale for examining exomes of patients for whom anti-CTLA-4 agents are being considered.	[Snyder, Alexandra; Merghoub, Taha; Postow, Michael A.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Snyder, Alexandra; Makarov, Vladimir; Desrichard, Alexis; Walsh, Logan A.; Kannan, Kasthuri; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Merghoub, Taha; Li, Yanyun; Elipenahli, Ceyhan; Liu, Cailian; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Swim Amer Ludwig Collaborat Res Lab, New York, NY 10065 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Hollmann, Travis J.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Yuan, Jianda; Wong, Phillip; Ho, Teresa S.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr Canc Immunotherapy, New York, NY 10065 USA; [Snyder, Alexandra; Postow, Michael A.; Wolchok, Jedd D.; Chan, Timothy A.] Weill Cornell Med Coll, New York, NY USA; [Bruggeman, Cameron] Columbia Univ, Dept Math, New York, NY 10027 USA; [Zaretsky, Jesse M.; Ribas, Antoni] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Harbison, Christopher T.; Wang, Lisu] Bristol Myers Squibb Co, Princeton, NJ USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Columbia University; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Bristol-Myers Squibb	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave,Box 20, New York, NY 10065 USA.	wolchokj@mskcc.org; chant@mskcc.org	Merghoub, Taha/ABD-8362-2021; Chan, Timothy A/ABD-5850-2021; wang, edwin/G-5372-2010	Walsh, Logan/0000-0001-8771-2577; Desrichard, Alexis/0000-0002-1335-7813; Kannan, Kasthuri/0000-0002-8479-0657; Hollmann, Travis/0000-0003-1599-0433; Wong, Phillip/0000-0002-6360-849X; Snyder Charen, Alexandra/0000-0002-2606-3523	Frederick Adler Fund; National Institutes of Health; Swim across America; Ludwig Trust; Melanoma Research Alliance; Stand Up to Cancer-Cancer Research Institute Immunotherapy Dream Team; Hazen Polsky Foundation; STARR Cancer Consortium; Ruth L. Kirschstein National Research Service Award [T32CA009512]; NATIONAL CANCER INSTITUTE [T32CA009512, P30CA008748] Funding Source: NIH RePORTER	Frederick Adler Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swim across America; Ludwig Trust; Melanoma Research Alliance; Stand Up to Cancer-Cancer Research Institute Immunotherapy Dream Team; Hazen Polsky Foundation; STARR Cancer Consortium; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Frederick Adler Fund, the National Institutes of Health, Swim across America, the Ludwig Trust, the Melanoma Research Alliance, the Stand Up to Cancer-Cancer Research Institute Immunotherapy Dream Team, the Hazen Polsky Foundation, and the STARR Cancer Consortium and by a Ruth L. Kirschstein National Research Service Award (T32CA009512, to Dr. Snyder). Bristol-Myers Squibb, the employer of two authors, did not provide funding for this study.	Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; ALLEN PM, 1987, NATURE, V327, P713, DOI 10.1038/327713a0; Anderson MW, 2003, J IMMUNOL, V171, P5683, DOI 10.4049/jimmunol.171.11.5683; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Insaidoo FK, 2011, J BIOL CHEM, V286, P40163, DOI 10.1074/jbc.M111.283564; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Ku GY, 2010, CANCER-AM CANCER SOC, V116, P1767, DOI 10.1002/cncr.24951; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Li YL, 2010, J MOL BIOL, V399, P596, DOI 10.1016/j.jmb.2010.04.037; Lim JB, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-72; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Morita D, 2013, J VIROL, V87, P482, DOI 10.1128/JVI.02142-12; NOGUCHI Y, 1994, P NATL ACAD SCI USA, V91, P3171, DOI 10.1073/pnas.91.8.3171; Park YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044225; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; POISSON F, 1993, J CLIN MICROBIOL, V31, P2343, DOI 10.1128/JCM.31.9.2343-2349.1993; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Srivastava N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006094; Srivastava PK, 2013, CANCER IMMUNOL IMMUN, V62, P967, DOI 10.1007/s00262-013-1422-x; Stuart GW, 2002, MOL BIOL EVOL, V19, P554, DOI 10.1093/oxfordjournals.molbev.a004111; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok Jedd D, 2010, Cancer Immun, V10, P9; Wong R, 2004, CLIN CANCER RES, V10, P5004, DOI 10.1158/1078-0432.CCR-04-0241	36	2848	2964	17	330	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2189	2199		10.1056/NEJMoa1406498	http://dx.doi.org/10.1056/NEJMoa1406498			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25409260	Bronze, Green Accepted			2022-12-28	WOS:000345976700007
J	Wang, Y; Pfeiffer, JK				Wang, Yao; Pfeiffer, Julie K.			MICROBIOLOGY A backup for bacteria	NATURE			English	Editorial Material							IMMUNE-SYSTEM; VIRUSES; INFECTION; VIROME		[Wang, Yao; Pfeiffer, Julie K.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	julie.pfeiffer@utsouthwestern.edu			NIAID NIH HHS [R01 AI074668] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074668] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Roossinck MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/nrmicro2491; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032	10	0	0	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					42	43		10.1038/nature13938	http://dx.doi.org/10.1038/nature13938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25409141				2022-12-28	WOS:000346310800030
J	Aleksic, J; Ansoldi, S; Antonelli, LA; Antoranz, P; Babic, A; Bangale, P; Barrio, JA; Gonzalez, JB; Bednarek, W; Bernardini, E; Biasuzzi, B; Biland, A; Blanch, O; Bonnefoy, S; Bonnoli, G; Borracci, F; Bretz, T; Carmona, E; Carosi, A; Colin, P; Colombo, E; Contreras, JL; Cortina, J; Covino, S; Da Vela, P; Dazzi, F; De Angelis, A; De Caneva, G; De Lotto, B; Wilhelmi, ED; Mendez, CD; Prester, DD; Dorner, D; Doro, M; Einecke, S; Eisenacher, D; Elsaesser, D; Fonseca, MV; Font, L; Frantzen, K; Fruck, C; Galindo, D; Lopez, RJG; Garczarczyk, M; Terrats, DG; Gaug, M; Godinovic, N; Munoz, AG; Gozzini, SR; Hadasch, D; Hanabata, Y; Hayashida, M; Herrera, J; Hildebrand, D; Hose, J; Hrupec, D; Idec, W; Kadenius, V; Kellermann, H; Kodani, K; Konno, Y; Krause, J; Kubo, H; Kushida, J; La Barbera, A; Lelas, D; Lewandowska, N; Lindfors, E; Lombardi, S; Longo, F; Lopez, M; Lopez-Coto, R; Lopez-Oramas, A; Lorenz, E; Lozano, I; Makariev, M; Mallot, K; Maneva, G; Mankuzhiyil, N; Mannheim, K; Maraschi, L; Marcote, B; Mariotti, M; Martinez, M; Mazin, D; Menzel, U; Miranda, JM; Mirzoyan, R; Moralejo, A; Munar-Adrover, P; Nakajima, D; Niedzwiecki, A; Nilsson, K; Nishijima, K; Noda, K; Orito, R; Overkemping, A; Paiano, S; Palatiello, M; Paneque, D; Paoletti, R; Paredes, JM; Paredes-Fortuny, X; Persic, M; Poutanen, J; Moroni, PGP; Prandini, E; Puljak, I; Reinthal, R; Rhode, W; Ribo, M; Rico, J; Garcia, JR; Rugamer, S; Saito, T; Saito, K; Satalecka, K; Scalzotto, V; Scapin, V; Schultz, C; Schweizer, T; Shore, SN; Sillanpaa, A; Sitarek, J; Snidaric, I; Sobczynska, D; Spanier, F; Stamatescu, V; Stamerra, A; Steinbring, T; Storz, J; Strzys, M; Takalo, L; Takami, H; Tavecchio, F; Temnikov, P; Terzic, T; Tescaro, D; Teshima, M; Thaele, J; Tibolla, O; Torres, DF; Toyama, T; Treves, A; Uellenbeck, M; Vogler, P; Zanin, R; Kadler, M; Schulz, R; Ros, E; Bach, U; Krauss, F; Wilms, J				Aleksic, J.; Ansoldi, S.; Antonelli, L. A.; Antoranz, P.; Babic, A.; Bangale, P.; Barrio, J. A.; Becerra Gonzalez, J.; Bednarek, W.; Bernardini, E.; Biasuzzi, B.; Biland, A.; Blanch, O.; Bonnefoy, S.; Bonnoli, G.; Borracci, F.; Bretz, T.; Carmona, E.; Carosi, A.; Colin, P.; Colombo, E.; Contreras, J. L.; Cortina, J.; Covino, S.; Da Vela, P.; Dazzi, F.; De Angelis, A.; De Caneva, G.; De Lotto, B.; de Ona Wilhelmi, E.; Delgado Mendez, C.; Dominis Prester, D.; Dorner, D.; Doro, M.; Einecke, S.; Eisenacher, D.; Elsaesser, D.; Fonseca, M. V.; Font, L.; Frantzen, K.; Fruck, C.; Galindo, D.; Garcia Lopez, R. J.; Garczarczyk, M.; Garrido Terrats, D.; Gaug, M.; Godinovic, N.; Gonzalez Munoz, A.; Gozzini, S. R.; Hadasch, D.; Hanabata, Y.; Hayashida, M.; Herrera, J.; Hildebrand, D.; Hose, J.; Hrupec, D.; Idec, W.; Kadenius, V.; Kellermann, H.; Kodani, K.; Konno, Y.; Krause, J.; Kubo, H.; Kushida, J.; La Barbera, A.; Lelas, D.; Lewandowska, N.; Lindfors, E.; Lombardi, S.; Longo, F.; Lopez, M.; Lopez-Coto, R.; Lopez-Oramas, A.; Lorenz, E.; Lozano, I.; Makariev, M.; Mallot, K.; Maneva, G.; Mankuzhiyil, N.; Mannheim, K.; Maraschi, L.; Marcote, B.; Mariotti, M.; Martinez, M.; Mazin, D.; Menzel, U.; Miranda, J. M.; Mirzoyan, R.; Moralejo, A.; Munar-Adrover, P.; Nakajima, D.; Niedzwiecki, A.; Nilsson, K.; Nishijima, K.; Noda, K.; Orito, R.; Overkemping, A.; Paiano, S.; Palatiello, M.; Paneque, D.; Paoletti, R.; Paredes, J. M.; Paredes-Fortuny, X.; Persic, M.; Poutanen, J.; Prada Moroni, P. G.; Prandini, E.; Puljak, I.; Reinthal, R.; Rhode, W.; Ribo, M.; Rico, J.; Rodriguez Garcia, J.; Ruegamer, S.; Saito, T.; Saito, K.; Satalecka, K.; Scalzotto, V.; Scapin, V.; Schultz, C.; Schweizer, T.; Shore, S. N.; Sillanpaa, A.; Sitarek, J.; Snidaric, I.; Sobczynska, D.; Spanier, F.; Stamatescu, V.; Stamerra, A.; Steinbring, T.; Storz, J.; Strzys, M.; Takalo, L.; Takami, H.; Tavecchio, F.; Temnikov, P.; Terzic, T.; Tescaro, D.; Teshima, M.; Thaele, J.; Tibolla, O.; Torres, D. F.; Toyama, T.; Treves, A.; Uellenbeck, M.; Vogler, P.; Zanin, R.; Kadler, M.; Schulz, R.; Ros, E.; Bach, U.; Krauss, F.; Wilms, J.			Black hole lightning due to particle acceleration at subhorizon scales	SCIENCE			English	Article							GAMMA-RAY EMISSION; FAST TEV VARIABILITY; RELATIVISTIC JETS; ENERGY; BLAZARS; FLARE; NUCLEUS; MODEL; M87	Supermassive black holes with masses of millions to billions of solar masses are commonly found in the centers of galaxies. Astronomers seek to image jet formation using radio interferometry but still suffer from insufficient angular resolution. An alternative method to resolve small structures is to measure the time variability of their emission. Here we report on gamma-ray observations of the radio galaxy IC 310 obtained with the MAGIC (Major Atmospheric Gamma-ray Imaging Cherenkov) telescopes, revealing variability with doubling time scales faster than 4.8 min. Causality constrains the size of the emission region to be smaller than 20% of the gravitational radius of its central black hole. We suggest that the emission is associated with pulsar-like particle acceleration by the electric field across a magnetospheric gap at the base of the radio jet.	[Aleksic, J.; Blanch, O.; Cortina, J.; Gonzalez Munoz, A.; Lopez-Coto, R.; Lopez-Oramas, A.; Martinez, M.; Moralejo, A.; Rico, J.; Sitarek, J.; Stamatescu, V.] Inst Fis Altes Energies, E-08193 Bellaterra, Spain; [Ansoldi, S.; Biasuzzi, B.; De Angelis, A.; De Lotto, B.; Longo, F.; Mankuzhiyil, N.; Palatiello, M.; Persic, M.] Univ Udine, I-33100 Udine, Italy; [Ansoldi, S.; Biasuzzi, B.; De Angelis, A.; De Lotto, B.; Longo, F.; Mankuzhiyil, N.; Palatiello, M.; Persic, M.] Ist Nazl Fis Nucl INFN Trieste, I-33100 Udine, Italy; [Ansoldi, S.; Biasuzzi, B.; De Angelis, A.; De Lotto, B.; Longo, F.; Mankuzhiyil, N.; Palatiello, M.; Persic, M.] Ist Nazl Astrofis INAF Trieste, I-34127 Trieste, Italy; [Antonelli, L. A.; Bonnoli, G.; Carosi, A.; Covino, S.; La Barbera, A.; Lombardi, S.; Maraschi, L.; Stamerra, A.; Tavecchio, F.] INAF Natl Inst Astrophys, I-00136 Rome, Italy; [Antoranz, P.; Da Vela, P.; Miranda, J. M.; Paoletti, R.] Univ Siena, I-53100 Siena, Italy; [Antoranz, P.; Da Vela, P.; Miranda, J. M.; Paoletti, R.] INFN Pisa, I-53100 Siena, Italy; [Babic, A.; Dominis Prester, D.; Godinovic, N.; Hrupec, D.; Lelas, D.; Puljak, I.; Snidaric, I.; Terzic, T.] Univ Rijeka, Rudjer Boskovic Inst, Croatian MAGIC Consortium, HR-10000 Zagreb, Croatia; [Babic, A.; Dominis Prester, D.; Godinovic, N.; Hrupec, D.; Lelas, D.; Puljak, I.; Snidaric, I.; Terzic, T.] Univ Split, HR-10000 Zagreb, Croatia; [Bangale, P.; Borracci, F.; Colin, P.; Dazzi, F.; Fruck, C.; Hose, J.; Kellermann, H.; Krause, J.; Mazin, D.; Menzel, U.; Mirzoyan, R.; Noda, K.; Paneque, D.; Rodriguez Garcia, J.; Schweizer, T.; Strzys, M.; Teshima, M.; Toyama, T.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Barrio, J. A.; Bonnefoy, S.; Contreras, J. L.; Fonseca, M. V.; Lopez, M.; Lozano, I.; Satalecka, K.; Scapin, V.] Univ Complutense, E-28040 Madrid, Spain; [Becerra Gonzalez, J.; Colombo, E.; Garcia Lopez, R. J.; Herrera, J.; Tescaro, D.] Inst Astrofis Canarias, E-38200 Tenerife, Spain; [Bednarek, W.; Idec, W.; Niedzwiecki, A.; Sobczynska, D.] Univ Lodz, PL-90236 Lodz, Poland; [Bernardini, E.; De Caneva, G.; Garczarczyk, M.; Gozzini, S. R.; Mallot, K.] DESY, D-15738 Zeuthen, Germany; [Biland, A.; Hildebrand, D.; Prandini, E.; Vogler, P.] ETH, CH-8093 Zurich, Switzerland; [Bretz, T.; Dorner, D.; Eisenacher, D.; Elsaesser, D.; Lewandowska, N.; Mannheim, K.; Ruegamer, S.; Spanier, F.; Steinbring, T.; Storz, J.; Tibolla, O.; Kadler, M.; Schulz, R.; Krauss, F.] Univ Wurzburg, D-97074 Wurzburg, Germany; [Carmona, E.; Delgado Mendez, C.] Ctr Invest Energet Medioambientales & Tecnol, E-28040 Madrid, Spain; [de Ona Wilhelmi, E.; Hadasch, D.; Torres, D. F.] Inst Space Sci, E-08193 Barcelona, Spain; [Doro, M.; Mariotti, M.; Paiano, S.; Scalzotto, V.; Schultz, C.] Univ Padua, I-35131 Padua, Italy; [Doro, M.; Mariotti, M.; Paiano, S.; Scalzotto, V.; Schultz, C.] Ist Nazl Fis Nucl, I-35131 Padua, Italy; [Einecke, S.; Frantzen, K.; Overkemping, A.; Rhode, W.; Thaele, J.; Uellenbeck, M.] Tech Univ Dortmund, D-44221 Dortmund, Germany; [Font, L.; Garrido Terrats, D.; Gaug, M.] Univ Autonoma Barcelona, Dept Fis, Unitat Fis Radiac, E-08193 Bellaterra, Spain; [Font, L.; Garrido Terrats, D.; Gaug, M.] Univ Autonoma Barcelona, Inst Estudis Espacials Catalunya, Ctr Estudios Invest Espaciales, E-08193 Bellaterra, Spain; [Galindo, D.; Marcote, B.; Munar-Adrover, P.; Paredes, J. M.; Paredes-Fortuny, X.; Ribo, M.; Zanin, R.] Univ Barcelona, Inst Estudis Espacials Catalunya, Inst Ciencies Cosmos, E-08028 Barcelona, Spain; [Hanabata, Y.; Hayashida, M.; Kodani, K.; Konno, Y.; Kubo, H.; Kushida, J.; Nakajima, D.; Nishijima, K.; Orito, R.; Saito, T.; Saito, K.; Takami, H.; Teshima, M.] Kyoto Univ, Div Phys & Astron, Japanese MAGIC Consortium, Kyoto 6068501, Japan; [Kadenius, V.; Lindfors, E.; Nilsson, K.; Poutanen, J.; Reinthal, R.; Sillanpaa, A.; Takalo, L.] Univ Turku, Tuorla Observ, Finnish MAGIC Consortium, SF-20500 Turku, Finland; [Kadenius, V.; Lindfors, E.; Nilsson, K.; Poutanen, J.; Reinthal, R.; Sillanpaa, A.; Takalo, L.] Univ Oulu, Dept Phys, SF-90100 Oulu, Finland; [Makariev, M.; Maneva, G.; Temnikov, P.] Inst Nucl Energy Res, BG-1784 Sofia, Bulgaria; [Prada Moroni, P. G.; Shore, S. N.] Univ Pisa, I-56126 Pisa, Italy; [Prada Moroni, P. G.; Shore, S. N.] Ist Nazl Fis Nucl, I-56126 Pisa, Italy; [Torres, D. F.] ICREA, E-08193 Barcelona, Spain; [Treves, A.] Univ Insubria, I-22100 Como, Italy; [Treves, A.] INFN Milano Bicocca, I-22100 Como, Italy; [Schulz, R.; Krauss, F.; Wilms, J.] Univ Erlangen Nurnberg, ECAP, Astron Inst, Dr Remeis Sternwarte Bamberg, D-96049 Bamberg, Germany; [Ros, E.; Bach, U.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Ros, E.] Univ Valencia, Astron Observ, E-46980 Valencia, Spain; [Ros, E.] Univ Valencia, Dept Astron & Astrofis, E-46100 Valencia, Spain	Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Siena; Istituto Nazionale di Fisica Nucleare (INFN); Rudjer Boskovic Institute; University of Rijeka; University of Split; Max Planck Society; Complutense University of Madrid; Instituto de Astrofisica de Canarias; University of Lodz; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Wurzburg; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); Dortmund University of Technology; Autonomous University of Barcelona; Autonomous University of Barcelona; Institut d'Estudis Espacials de Catalunya (IEEC); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Kyoto University; University of Turku; University of Oulu; Bulgarian Academy of Sciences; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); ICREA; University of Insubria; Istituto Nazionale di Fisica Nucleare (INFN); University of Erlangen Nuremberg; Max Planck Society; University of Valencia; University of Valencia	Eisenacher, D (corresponding author), Univ Wurzburg, D-97074 Wurzburg, Germany.	deisenacher@astro.uni-wuerzburg.de; mannheim@astro.uni-wuerzburg.de; jsitarek@ifae.es	Lewandowska, Natalia/ADA-6225-2022; Munar-Adrover, Pere/G-1618-2019; Delgado, Carlos/K-7587-2014; Colombo, Eduardo H./I-1323-2015; Maneva, Galina M/L-7120-2016; Covino, Stefano/AAQ-5188-2021; Torres, Diego F./AAF-7931-2019; Doro, Michele/F-9458-2012; Ribó, Marc/B-3579-2015; Zanin, Roberta/B-2316-2018; González, María Victoria Fonseca/E-8093-2019; Lopez, Ramon J. Garcia/AAA-1407-2019; Wilms, Joern/C-8116-2013; Temnikov, Petar P./L-6999-2016; Miranda, Jose/HCI-6099-2022; Font, Lluís/L-4197-2014; de Ona Wilhelmi, Emma/U-5587-2017; Bretz, Thomas/AAK-8726-2020; Cortina, Juan/C-2783-2017; Poutanen, Juri/P-3010-2019; Poutanen, Juri/H-6651-2016; Hadasch, Daniela/N-7819-2016; Gaug, Markus/L-2340-2014; Prester, Dijana Dominis/O-5014-2018; Torres, Diego F/ABD-7940-2020; Rodríguez, Manel Martínez/C-2539-2017; Rico, Javier/K-8004-2014; Lopez-Coto, Ruben/ABG-6191-2020; López-Moya, Marcos/L-2304-2014; Miranda, Jose Miguel/F-2913-2013; Puljak, Ivica/D-8917-2017; Ros, Eduardo/B-1014-2015; Gonzalez, Josefa Becerra/AAH-6071-2019; Hrupec, Dario/AAE-5317-2021; Satalecka, Konstancja/AAT-1309-2020; Antoranz, Pedro/H-5095-2015; González, Jose Luis Contreras/K-7255-2014; Barrio, Juan A/L-3227-2014; Olaizola, Abelardo Moralejo/M-2916-2014; Stamatescu, Victor/C-9945-2016; Terzić, Tomislav/O-4835-2018; Gonzalez, María Victoria Fonseca MV Fonseca/I-2004-2015; Bernardini, Elisa/AAA-4810-2020; Torres, Diego F./O-9422-2016; Makariev, Martin/M-2122-2016; Mazin, Daniel/N-8038-2016; Blanch, Oscar/N-7147-2016; Kadler, Matthias/R-2099-2016; Lombardi, Saverio/Q-2818-2018	Lewandowska, Natalia/0000-0003-0771-6581; Munar-Adrover, Pere/0000-0002-1942-7376; Delgado, Carlos/0000-0002-7014-4101; Colombo, Eduardo H./0000-0002-3700-3745; Maneva, Galina M/0000-0002-5959-4179; Covino, Stefano/0000-0001-9078-5507; Torres, Diego F./0000-0002-1522-9065; Doro, Michele/0000-0001-9104-3214; Ribó, Marc/0000-0002-9931-4557; Zanin, Roberta/0000-0001-6320-1801; González, María Victoria Fonseca/0000-0003-2235-0725; Lopez, Ramon J. Garcia/0000-0002-8204-6832; Wilms, Joern/0000-0003-2065-5410; Temnikov, Petar P./0000-0002-9559-3384; Font, Lluís/0000-0003-2109-5961; de Ona Wilhelmi, Emma/0000-0002-5401-0744; Bretz, Thomas/0000-0002-3800-5531; Cortina, Juan/0000-0003-4576-0452; Poutanen, Juri/0000-0002-0983-0049; Poutanen, Juri/0000-0002-0983-0049; Hadasch, Daniela/0000-0001-8663-6461; Gaug, Markus/0000-0001-8442-7877; Prester, Dijana Dominis/0000-0002-9880-5039; Rodríguez, Manel Martínez/0000-0002-9763-9155; Rico, Javier/0000-0003-4137-1134; López-Moya, Marcos/0000-0002-8791-7908; Miranda, Jose Miguel/0000-0002-1472-9690; Puljak, Ivica/0000-0001-7387-3812; Ros, Eduardo/0000-0001-9503-4892; Gonzalez, Josefa Becerra/0000-0002-6729-9022; Hrupec, Dario/0000-0002-7027-5021; Satalecka, Konstancja/0000-0002-7669-266X; Antoranz, Pedro/0000-0002-3015-3601; González, Jose Luis Contreras/0000-0001-7282-2394; Barrio, Juan A/0000-0002-0965-0259; Olaizola, Abelardo Moralejo/0000-0002-1344-9080; Stamatescu, Victor/0000-0001-9030-7513; Terzić, Tomislav/0000-0002-4209-3407; Gonzalez, María Victoria Fonseca MV Fonseca/0000-0003-2235-0725; Bernardini, Elisa/0000-0003-3108-1141; Torres, Diego F./0000-0002-1522-9065; Makariev, Martin/0000-0002-1622-3116; Mazin, Daniel/0000-0002-2010-4005; Blanch, Oscar/0000-0002-8380-1633; Dazzi, Francesco/0000-0001-5409-6544; Kadler, Matthias/0000-0001-5606-6154; De Lotto, Barbara/0000-0003-3624-4480; Bach, Uwe/0000-0002-7722-8412; Sobczynska, Dorota/0000-0003-4973-7903; Tavecchio, Fabrizio/0000-0003-0256-0995; Niedzwiecki, Andrzej/0000-0002-8541-8849; Noda, Koji/0000-0003-1397-6478; Biasuzzi, Barbara/0000-0003-0322-7449; Fruck, Christian/0000-0001-5880-7518; Paoletti, Riccardo/0000-0003-0158-2826; Prandini, Elisa/0000-0003-4502-9053; Da Vela, Paolo/0000-0003-0604-4517; Lombardi, Saverio/0000-0002-6336-865X; LA BARBERA, ANTONINO/0000-0002-5880-8913; Tibolla, Omar/0000-0002-9074-0584; Bednarek, Wlodek/0000-0003-0605-108X; Marcote, Benito/0000-0001-9814-2354; Bonnoli, Giacomo/0000-0003-2464-9077; McBride, Felicia/0000-0001-6191-1244; Persic, Massimo/0000-0003-1853-4900; Lopez Oramas, Alicia/0000-0003-4603-1884; Antonelli, Lucio Angelo/0000-0002-5037-9034; Bangale, Priyadarshini/0000-0002-3886-3739; Paredes, Josep M./0000-0002-1566-9044; Rhode, Wolfgang/0000-0003-2636-5000; Sitarek, Julian/0000-0002-1659-5374; Stamerra, Antonio/0000-0002-9430-5264; Lopez-Coto, Ruben/0000-0002-3882-9477; Einecke, Sabrina/0000-0001-9687-8237	German BMBF; German MPG; Italian INFN; Swiss National Fund SNF; Spanish MICINN; Spanish Consolider-Ingenio [CPAN CSD2007-00042, MultiDark CSD2009-00064]; Academy of Finland [127740]; DFG; Croatian Science Foundation (HrZZ) [09/176]; University of Rijeka [13.12.1.3.02]; DFG Collaborative Research Centers [SFB823/C4, SFB876/C3]; Polish MNiSzW grant [745/N-HESS-MAGIC/2010/0]; DFG [WI 1860/10-1]; ERDF; Spanish MINECO [FPA2012-39502, JCI-2011-10019, AYA2009-13036-C02-02, AYA2012-38491-C02-01]; Generalitat Valenciana [PROMETEO/2009/104]; COST [MP0905]; national research councils; European Commission [283393]; ICREA Funding Source: Custom; Grants-in-Aid for Scientific Research [12J09375] Funding Source: KAKEN	German BMBF(Federal Ministry of Education & Research (BMBF)); German MPG; Italian INFN(Istituto Nazionale di Fisica Nucleare (INFN)); Swiss National Fund SNF(Swiss National Science Foundation (SNSF)); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Academy of Finland(Academy of Finland); DFG(German Research Foundation (DFG)); Croatian Science Foundation (HrZZ); University of Rijeka; DFG Collaborative Research Centers(German Research Foundation (DFG)); Polish MNiSzW grant; DFG(German Research Foundation (DFG)); ERDF(European Commission); Spanish MINECO(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); COST(European Cooperation in Science and Technology (COST)); national research councils; European Commission(European CommissionEuropean Commission Joint Research Centre); ICREA(ICREA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Instituto de Astrofisica de Canarias for the excellent working conditions at the Observatorio del Roque de los Muchachos in La Palma. The support of the German BMBF and MPG, the Italian INFN, the Swiss National Fund SNF, and the Spanish MICINN is gratefully acknowledged. This work was also supported by the CPAN CSD2007-00042 and MultiDark CSD2009-00064 projects of the Spanish Consolider-Ingenio 2010 program, by grant 127740 of the Academy of Finland, by the DFG Cluster of Excellence "Origin and Structure of the Universe", by the Croatian Science Foundation (HrZZ) Projects 09/176, by the University of Rijeka Project 13.12.1.3.02, by the DFG Collaborative Research Centers SFB823/C4 and SFB876/C3, and by the Polish MNiSzW grant 745/N-HESS-MAGIC/2010/0. We thank also the support by DFG WI 1860/10-1. J. S. was supported by ERDF and the Spanish MINECO through FPA2012-39502 and JCI-2011-10019 grants. E. R. was partially supported by the Spanish MINECO projects AYA2009-13036-C02-02 and AYA2012-38491-C02-01 and by the Generalitat Valenciana project PROMETEO/2009/104, as well as by the COST MP0905 action 'Black Holes in a Violent Universe.' The European VLBI Network is a joint facility of European, Chinese, South African and other radio astronomy institutes funded by their national research councils. The research leading to these results has received funding from the European Commission Seventh Framework Programme (FP/2007-2013) under grant agreement No. 283393 (RadioNet3). The MAGIC data are archived in the data center at the Port dInformacio Cientfica (PIC) in Barcelona. The EVN data are available at the Data Archive at the Joint Institute for VLBI in Europe (JIVE).	Abramowski A, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/151; Acciari VA, 2009, SCIENCE, V325, P444, DOI 10.1126/science.1175406; Aharonian F, 2007, ASTROPHYS J, V664, pL71, DOI 10.1086/520635; Albert J, 2007, ASTROPHYS J, V669, P862, DOI 10.1086/521382; Albert J, 2008, ASTROPHYS J LETT, V685, pL23, DOI 10.1086/592348; Aleksic J, 2012, ASTROPART PHYS, V35, P435, DOI 10.1016/j.astropartphys.2011.11.007; Aleksic J, 2010, ASTROPHYS J LETT, V723, pL207, DOI 10.1088/2041-8205/723/2/L207; Aleksie J, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201321938; Barkov MV, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/170; Barkov MV, 2010, ASTROPHYS J, V724, P1517, DOI 10.1088/0004-637X/724/2/1517; Bednarek W, 1997, MON NOT R ASTRON SOC, V287, pL9, DOI 10.1093/mnras/287.3.L9; Begelman MC, 2008, MON NOT R ASTRON SOC, V384, pL19, DOI 10.1111/j.1745-3933.2007.00413.x; Beskin V. S., 1992, Soviet Astronomy, V36, P642; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; BLANDFORD RD, 1979, ASTROPHYS J, V232, P34, DOI 10.1086/157262; DERMER CD, 1993, ASTROPHYS J, V416, P458, DOI 10.1086/173251; Doeleman SS, 2012, SCIENCE, V338, P355, DOI 10.1126/science.1224768; Gebhardt K, 2009, ASTROPHYS J, V700, P1690, DOI 10.1088/0004-637X/700/2/1690; Ghisellini G, 2008, MON NOT R ASTRON SOC, V386, pL28, DOI 10.1111/j.1745-3933.2008.00454.x; Giannios D, 2010, MON NOT R ASTRON SOC, V402, P1649, DOI 10.1111/j.1365-2966.2009.16045.x; Giannios D, 2009, MON NOT R ASTRON SOC, V395, pL29, DOI 10.1111/j.1745-3933.2009.00635.x; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Kadler M, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118212; Kirk JG, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/104; Levinson A, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/123; Lister ML, 2009, ASTRON J, V138, P1874, DOI 10.1088/0004-6256/138/6/1874; Lyutikov M, 2010, ASTROPHYS J, V722, P197, DOI 10.1088/0004-637X/722/1/197; Lyutikov M, 2009, MON NOT R ASTRON SOC, V396, P1545, DOI 10.1111/j.1365-2966.2009.14811.x; MARASCHI L, 1992, ASTROPHYS J, V397, pL5, DOI 10.1086/186531; MCELROY DB, 1995, ASTROPHYS J SUPPL S, V100, P105, DOI 10.1086/192209; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; MICHEL FC, 1969, PHYS REV LETT, V23, P247, DOI 10.1103/PhysRevLett.23.247; Neronov A, 2007, ASTROPHYS J, V671, P85, DOI 10.1086/522199; Neronov A, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/201014499; Neronov AY, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/065015; Rieger FM, 2000, ASTRON ASTROPHYS, V353, P473; URRY CM, 1991, ASTROPHYS J, V382, P501, DOI 10.1086/170736; van Velzen S, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201322127; Vovk I, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/103	40	100	100	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1080	1084		10.1126/science.1256183	http://dx.doi.org/10.1126/science.1256183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25378461	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000345763400034
J	Farokhipoor, S; Magen, C; Venkatesan, S; Iniguez, J; Daumont, CJM; Rubi, D; Snoeck, E; Mostovoy, M; de Graaf, C; Muller, A; Doblinger, M; Scheu, C; Noheda, B				Farokhipoor, S.; Magen, C.; Venkatesan, S.; Iniguez, J.; Daumont, C. J. M.; Rubi, D.; Snoeck, E.; Mostovoy, M.; de Graaf, C.; Mueller, A.; Doeblinger, M.; Scheu, C.; Noheda, B.			Artificial chemical and magnetic structure at the domain walls of an epitaxial oxide	NATURE			English	Article							SQUARE-PLANAR; PERTURBATION-THEORY; FERROELECTRICITY; COMPLEXES; MANGANESE(II); DISTORTION; OCTAHEDRA; OXIDATION	Progress in nanotechnology requires new approaches to materials synthesis that make it possible to control material functionality down to the smallest scales. An objective of materials research is to achieve enhanced control over the physical properties of materials such as ferromagnets(1), ferroelectrics(2) and superconductors(3). In this context, complex oxides and inorganic perovskites are attractive because slight adjustments of their atomic structures can produce large physical responses and result in multiple functionalities(4,5). In addition, these materials often contain ferroelastic domains(6). The intrinsic symmetry breaking that takes place at the domain walls can induce properties absent from the domains themselves(7), such as magnetic or ferroelectric order and other functionalities, as well as coupling between them. Moreover, large domain wall densities create intense strain gradients, which can also affect the material's properties(8,9). Here we show that, owing to large local stresses, domain walls can promote the formation of unusual phases. In this sense, the domain walls can function as nanoscale chemical reactors. We synthesize a two-dimensional ferromagnetic phase at the domain walls of the orthorhombic perovskite terbium manganite (TbMnO3), which was grown in thin layer sunder epitaxial strain on strontium titanate (SrTiO3) substrates. This phase is yet to be created by standard chemical routes. The density of the two-dimensional sheets can be tuned by changing the film thickness or the substrate lattice parameter (that is, the epitaxial strain), and the distance between sheets can be made as small as 5 nanometres in ultrathin films(10,) such that the new phase at domain walls represents up to 25 per cent of the film volume. The general concept of using domain walls of epitaxial oxides to promote the formation of unusual phases may be applicable to other materials systems, thus giving access to new classes of nanoscale materials for applications in nanoelectronics and spintronics.	[Farokhipoor, S.; Daumont, C. J. M.; Rubi, D.; Mostovoy, M.; de Graaf, C.; Noheda, B.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Magen, C.] Univ Zaragoza, INA, ARAID, LMA, Zaragoza 50018, Spain; [Magen, C.] Univ Zaragoza, Dept Fis Mat Condensada, Zaragoza 50018, Spain; [Magen, C.; Snoeck, E.] Univ Zaragoza, CNRS, INA, TALEM,CEMES, F-30155 Toulouse, France; [Venkatesan, S.; Mueller, A.; Doeblinger, M.; Scheu, C.] Univ Munich, Dept Chem, D-81377 Munich, Germany; [Venkatesan, S.; Mueller, A.; Doeblinger, M.; Scheu, C.] Univ Munich, CENS, D-81377 Munich, Germany; [Iniguez, J.] CSIC, ICMAB, Bellaterra 08193, Spain; [Snoeck, E.] CNRS, CEMES, F-30155 Toulouse, France; [de Graaf, C.] Univ Rovira & Virgili, E-43007 Tarragona, Spain; [de Graaf, C.] ICREA, Barcelona 08010, Spain	University of Groningen; University of Zaragoza; University of Zaragoza; Centre National de la Recherche Scientifique (CNRS); University of Munich; University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB); Centre National de la Recherche Scientifique (CNRS); Universitat Rovira i Virgili; ICREA	Noheda, B (corresponding author), Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.	cmagend@unizar.es; b.noheda@rug.nl	Daumont, Christophe JM/E-7959-2018; Venkatesan, Sriram/B-1899-2009; Íñiguez, Jorge/K-3828-2019; Íñiguez, Jorge/B-6856-2009; Institute, Zernike/W-7033-2019; Materials, Zernike Institute for Advanced/S-4812-2019; de Graaf, Coen/A-5677-2008; Magen, Cesar/A-2825-2013; Rubi, Diego/D-4912-2011	Daumont, Christophe JM/0000-0001-7351-2021; Venkatesan, Sriram/0000-0003-2389-2761; Íñiguez, Jorge/0000-0001-6435-3604; Íñiguez, Jorge/0000-0001-6435-3604; Materials, Zernike Institute for Advanced/0000-0001-8456-2286; de Graaf, Coen/0000-0001-8114-6658; Rubi, Diego/0000-0002-8502-8680; Magen Dominguez, Cesar/0000-0002-6761-6171	NanoNextNL; micro- and nanotechnology consortium of the Government of the Netherlands; Foundation for Fundamental Research on Matter (FOM); Netherlands Organization for Scientific Research (NWO); European Union [312483-ESTEEM2]; Spanish Administration [CTQ2011-23140]; Generalitat de Catalunya [20095GR462]; MINECO-Spain [MAT2010-18113, C5D2007-00041]; German Science Foundation (DFG) via the Cluster of Excellence NIM; ICREA Funding Source: Custom	NanoNextNL; micro- and nanotechnology consortium of the Government of the Netherlands; Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Spanish Administration(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); MINECO-Spain(Spanish Government); German Science Foundation (DFG) via the Cluster of Excellence NIM(German Research Foundation (DFG)); ICREA(ICREA)	We are grateful to B. Kooi, T. Palstra, J. Fontcuberta, E. Canadell and the members of the Leverhulme Trust network 'International Network on Nanoscale Ferroelectrics', in particularJ. F. Scott and F. Morrison, for discussions. This work is supported by NanoNextNL, a micro- and nanotechnology consortium of the Government of the Netherlands and 130 partners. It is also part of the research program NWO-Nano and is funded by the Foundation for Fundamental Research on Matter (FOM), which is financially supported by the Netherlands Organization for Scientific Research (NWO). C.M. and ES. acknowledge the Laboratorio de Microscopias Avanzadas at Instituto de Nanociencia de Aragon, Universidad de Zaragoza, where the aberration-corrected TEM studies were conducted, and the support of the European Union under the Seventh Framework Programme under a contract for an Integrated Infrastructure Initiative Reference 312483-ESTEEM2. C.d.G. obtained financial support from the Spanish Administration (project CTQ2011-23140) and the Generalitat de Catalunya (project 20095GR462). J.I. received financial support from MINECO-Spain (grants nos MAT2010-18113 and C5D2007-00041). D.R. is a fellow of CONICET. S.V., A.M., M.D. and C.S. acknowledge financial support from the German Science Foundation (DFG) via the Cluster of Excellence NIM. We made used of the facilities provided by the CESGA supercomputing centre.	Albright T. A., 1985, ORBITAL INTERACTIONS, p[295, 304]; Alonso JA, 2000, INORG CHEM, V39, P917, DOI 10.1021/ic990921e; ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; BARANDIARAN Z, 1988, J CHEM PHYS, V89, P5739, DOI 10.1063/1.455549; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Catalan G, 2011, NAT MATER, V10, P963, DOI [10.1038/NMAT3141, 10.1038/nmat3141]; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Cui YM, 2005, SOLID STATE COMMUN, V133, P641, DOI 10.1016/j.ssc.2005.01.002; Daraktchiev M, 2008, FERROELECTRICS, V375, P122, DOI 10.1080/00150190802437969; Daumont CJM, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.144115; Daumont CJM, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/18/182001; de Graaf C, 2001, J PHYS CHEM A, V105, P11371, DOI 10.1021/jp013554c; Farokhipoor S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.127601; GLAZER AM, 1972, ACTA CRYSTALLOGR B, VB 28, P3384, DOI 10.1107/S0567740872007976; Goto T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257201; Haeni JH, 2004, NATURE, V430, P758, DOI 10.1038/nature02773; HENKEL G, 1985, ANGEW CHEM INT EDIT, V24, P117, DOI 10.1002/anie.198501171; Hytch MJ, 1998, ULTRAMICROSCOPY, V74, P131, DOI 10.1016/S0304-3991(98)00035-7; Jimenez-Villacorta F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.024420; Johnston KE, 2010, J AM CHEM SOC, V132, P8732, DOI 10.1021/ja101860r; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kirby BJ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072076; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lee D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.057602; Lee JH, 2010, NATURE, V466, P954, DOI 10.1038/nature09331; LIECHTENSTEIN AI, 1995, PHYS REV B, V52, pR5467, DOI 10.1103/PhysRevB.52.R5467; Llordes A, 2012, NAT MATER, V11, P329, DOI [10.1038/NMAT3247, 10.1038/nmat3247]; Malrieu JP, 2014, CHEM REV, V114, P429, DOI 10.1021/cr300500z; Marti X, 2010, J APPL PHYS, V108, DOI 10.1063/1.3514575; Marti X, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3443714; Mochizuki M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134416; MORRIS RJ, 1988, POLYHEDRON, V7, P2001, DOI 10.1016/S0277-5387(00)80715-9; Mostovoy M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067601; Moussa F, 1996, PHYS REV B, V54, P15149, DOI 10.1103/PhysRevB.54.15149; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Prosandeev S, 2013, ADV FUNCT MATER, V23, P234, DOI 10.1002/adfm.201201467; ROITBURD AL, 1976, PHYS STATUS SOLIDI A, V37, P329, DOI 10.1002/pssa.2210370141; Roos BO, 2005, J PHYS CHEM A, V109, P6575, DOI 10.1021/jp0581126; Rubi D, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014416; Salavati-Niasari M, 2007, J MOL CATAL A-CHEM, V274, P58, DOI 10.1016/j.molcata.2007.04.031; Salje EKH, 2012, ANNU REV MATER RES, V42, P265, DOI 10.1146/annurev-matsci-070511-155022; Salje EKH, 2010, CHEMPHYSCHEM, V11, P940, DOI 10.1002/cphc.200900943; Schmid HK, 2006, MICRON, V37, P426, DOI 10.1016/j.micron.2005.12.004; Seidel J, 2009, NAT MATER, V8, P229, DOI [10.1038/NMAT2373, 10.1038/nmat2373]; Sellers SP, 1998, J AM CHEM SOC, V120, P4662, DOI 10.1021/ja973787a; Tagantsev AK, 2010, DOMAINS IN FERROIC CRYSTALS AND THIN FILMS, P521, DOI 10.1007/978-1-4419-1417-0_9; Varela M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085117; Venkatesan S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.214111; Wang DW, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.134107; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Watanabe M., 2009, MICROSC ANAL, V23, P5; White JS, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.037201; Zubko P, 2011, ANNU REV CONDEN MA P, V2, P141, DOI 10.1146/annurev-conmatphys-062910-140445	56	129	132	11	400	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					379	+		10.1038/nature13918	http://dx.doi.org/10.1038/nature13918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409828				2022-12-28	WOS:000345770600038
J	Kutluay, SB; Zang, T; Blanco-Melo, D; Powell, C; Jannain, D; Errando, M; Bieniasz, PD				Kutluay, Sebla B.; Zang, Trinity; Blanco-Melo, Daniel; Powell, Chelsea; Jannain, David; Errando, Manel; Bieniasz, Paul D.			Global Changes in the RNA Binding Specificity of HIV-1 Gag Regulate Virion Genesis	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CIS-ACTING SEQUENCES; TYPE-1 RNA; NUCLEOCAPSID PROTEIN; MEMBRANE ASSOCIATION; SECONDARY STRUCTURE; PACKAGING SIGNAL; VIRAL PARTICLES; CELLULAR RNAS; MATRIX DOMAIN	The HIV-1 Gag protein orchestrates all steps of virion genesis, including membrane targeting and RNA recruitment into virions. Using crosslinking-immunoprecipitation (CLIP) sequencing, we uncover several dramatic changes in the RNA-binding properties of Gag that occur during virion genesis, coincident with membrane binding, multimerization, and proteolytic maturation. Prior to assembly, and after virion assembly and maturation, the nucleocapsid domain of Gag preferentially binds to psi and Rev Response elements in the viral genome, and GU-rich mRNA sequences. However, during virion genesis, this specificity transiently changes in a manner that facilitates genome packaging; nucleocapsid binds to many sites on the HIV-1 genome and to mRNA sequences with a HIV-1-like, A-rich nucleotide composition. Additionally, we find that the matrix domain of Gag binds almost exclusively to specific tRNAs in the cytosol, and this association regulates Gag binding to cellular membranes.	[Kutluay, Sebla B.; Zang, Trinity; Blanco-Melo, Daniel; Powell, Chelsea; Jannain, David; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Lab Retrovirol, New York, NY 10016 USA; [Zang, Trinity; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Howard Hughes Med Inst, New York, NY 10016 USA; [Errando, Manel] Columbia Univ, Barnard Coll, Dept Phys & Astron, New York, NY 10027 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Columbia University	Bieniasz, PD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Lab Retrovirol, 455 First Ave, New York, NY 10016 USA.	pbienias@adarc.org	Blanco-Melo, Daniel/AAG-3682-2020	Blanco-Melo, Daniel/0000-0002-0256-5019; Errando, Manel/0000-0002-1853-863X	AmFAR Mathilde Krim Postdoctoral Fellowship; NIH grants [R01AI501111, P50GM103297]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI116258, R01AI050111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103297] Funding Source: NIH RePORTER	AmFAR Mathilde Krim Postdoctoral Fellowship; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Markus Hafner and members of the Darnell and Tuschl labs for advice and helpful discussions. We thank Michael Summers for the diagram of the Psi and RRE sequences in Figure 2. S.B.K. was supported in part by an AmFAR Mathilde Krim Postdoctoral Fellowship. This work was supported by NIH grants R01AI501111 and P50GM103297.	ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; Alfadhli A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00253; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Berglund JA, 1997, NUCLEIC ACIDS RES, V25, P1042, DOI 10.1093/nar/25.5.1042; BERKHOUT B, 1994, NUCLEIC ACIDS RES, V22, P1705, DOI 10.1093/nar/22.9.1705; BERKOWITZ RD, 1995, VIROLOGY, V212, P718, DOI 10.1006/viro.1995.1530; BERKOWITZ RD, 1993, J VIROL, V67, P7190, DOI 10.1128/JVI.67.12.7190-7200.1993; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Chamanian M, 2013, CELL HOST MICROBE, V13, P181, DOI 10.1016/j.chom.2013.01.007; Chukkapalli V, 2013, J VIROL, V87, P7155, DOI 10.1128/JVI.00075-13; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Cimarelli A, 1999, J VIROL, V73, P5388, DOI 10.1128/JVI.73.7.5388-5401.1999; CLAVEL F, 1990, J VIROL, V64, P5230, DOI 10.1128/JVI.64.10.5230-5234.1990; CLEVER J, 1995, J VIROL, V69, P2101, DOI 10.1128/JVI.69.4.2101-2109.1995; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Das AT, 1997, J VIROL, V71, P2346, DOI 10.1128/JVI.71.3.2346-2356.1997; Dick RA, 2013, J VIROL, V87, P13598, DOI 10.1128/JVI.01659-13; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; GORELICK RJ, 1990, J VIROL, V64, P3207, DOI 10.1128/JVI.64.7.3207-3211.1990; GRANTHAM R, 1986, NATURE, V319, P727, DOI 10.1038/319727b0; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HARRISON GP, 1992, J VIROL, V66, P4144, DOI 10.1128/JVI.66.7.4144-4153.1992; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; KAYE JF, 1995, J VIROL, V69, P6588, DOI 10.1128/JVI.69.10.6588-6592.1995; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; Kuzembayeva M, 2014, VIROLOGY, V454, P362, DOI 10.1016/j.virol.2014.01.019; KYPR J, 1987, NATURE, V327, P20, DOI 10.1038/327020a0; Laham-Karam N, 2007, J VIROL, V81, P10687, DOI 10.1128/JVI.00653-07; LEVER A, 1989, J VIROL, V63, P4085, DOI 10.1128/JVI.63.9.4085-4087.1989; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; LUBAN J, 1994, J VIROL, V68, P3784, DOI 10.1128/JVI.68.6.3784-3793.1994; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; McBride MS, 1997, J VIROL, V71, P2050, DOI 10.1128/JVI.71.3.2050-2058.1997; McBride MS, 1996, J VIROL, V70, P2963, DOI 10.1128/JVI.70.5.2963-2973.1996; McBride MS, 1997, J VIROL, V71, P4544, DOI 10.1128/JVI.71.6.4544-4554.1997; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; Ott DE, 2005, J VIROL, V79, P13839, DOI 10.1128/JVI.79.22.13839-13847.2005; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; Rein A, 2011, TRENDS BIOCHEM SCI, V36, P373, DOI 10.1016/j.tibs.2011.04.001; RICHARDSON JH, 1993, J VIROL, V67, P3997, DOI 10.1128/JVI.67.7.3997-4005.1993; Rulli SJ, 2007, J VIROL, V81, P6623, DOI 10.1128/JVI.02833-06; Russell RS, 2003, J VIROL, V77, P84, DOI 10.1128/JVI.77.1.84-96.2003; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; SHARP PM, 1986, NATURE, V324, P114, DOI 10.1038/324114a0; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664	56	142	144	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1096	1109		10.1016/j.cell.2014.09.057	http://dx.doi.org/10.1016/j.cell.2014.09.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416948	Bronze, Green Accepted			2022-12-28	WOS:000345506300021
J	Werner, MJ				Werner, Michael J.			Protect the USA from UVA	NATURE			English	Editorial Material									[Werner, Michael J.] Holland & Knight, Washington, DC 20006 USA; [Werner, Michael J.] Sunscreens Coalit, Publ Access, Washington, DC USA		Werner, MJ (corresponding author), Holland & Knight, Washington, DC 20006 USA.	michael.werner@hklaw.com							0	7	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S126	S126		10.1038/515S126a	http://dx.doi.org/10.1038/515S126a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407712	Bronze			2022-12-28	WOS:000345770600008
J	Schulz-Schupke, S; Heide, S; Gewalt, S; Ibrahim, T; Linhardt, M; Haas, K; Hoppe, K; Bottiger, C; Groha, P; Bradaric, C; Schmidt, R; Bott-Flugel, L; Ott, I; Goedel, J; Byrne, RA; Schneider, S; Burgdorf, C; Morath, T; Kufner, S; Joner, M; Cassese, S; Hoppmann, P; Hengstenberg, C; Pache, J; Fusaro, M; Massberg, S; Mehilli, J; Schunkert, H; Laugwitz, KL; Kastrati, A				Schulz-Schuepke, Stefanie; Heide, Sandra; Gewalt, Senta; Ibrahim, Tareq; Linhardt, Maryam; Haas, Katharina; Hoppe, Katharina; Boettiger, Corinna; Groha, Philip; Bradaric, Christian; Schmidt, Roland; Bott-Fluegel, Lorenz; Ott, Ilka; Goedel, Julia; Byrne, Robert A.; Schneider, Simon; Burgdorf, Christof; Morath, Tanja; Kufner, Sebastian; Joner, Michael; Cassese, Salvatore; Hoppmann, Petra; Hengstenberg, Christian; Pache, Juergen; Fusaro, Massimiliano; Massberg, Steffen; Mehilli, Julinda; Schunkert, Heribert; Laugwitz, Karl-Ludwig; Kastrati, Adnan		Instrumental Sealing Arterial Punc	Comparison of Vascular Closure Devices vs Manual Compression After Femoral Artery Puncture The ISAR-CLOSURE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ANGIOGRAPHY; METAANALYSIS; EFFICACY; ACCESS	IMPORTANCE The role of vascular closure devices (VCD) for the achievement of hemostasis in patients undergoing transfemoral coronary angiography remains controversial. OBJECTIVE To compare outcomes with the use of 2 hemostasis strategies after diagnostic coronary angiography performed via transfemoral access-a VCD-based strategy with 2 types of devices, an intravascular device and an extravascular device, vs standard manual compression. The primary hypothesis to be tested was that femoral hemostasis achieved through VCD is noninferior to manual compression in terms of vascular access-site complications. A secondary objective was the comparison of the 2 types of VCD. DESIGN, SETTING, AND PARTICIPANTS Randomized, large-scale, multicenter, open-label clinical trial. We enrolled 4524 patients undergoing coronary angiography with a 6 French sheath via the common femoral artery from April 2011 through May 2014 in 4 centers in Germany. Last 30-day follow-up was performed in July 2014. INTERVENTIONS After angiography of the access site, patients were randomized to hemostasis with an intravascular VCD, extravascular VCD, or manual compression in a 1: 1: 1 ratio. MAIN OUTCOMES AND MEASURES Primary end point: the composite of access site-related vascular complications at 30 days after randomization with a 2% noninferiority margin. Secondary end points: time to hemostasis, repeat manual compression, and VCD failure. An a-level of .025 was chosen for primary and secondary comparisons. RESULTS Of the 4524 enrolled patients, 3015 were randomly assigned to a VCD group (1509 received intravascular VCD and 1506 received extravascular VCD) and 1509 patients were randomly assigned to the manual compression group. Before hospital discharge, duplex sonography of the access site was performed in 4231 (94%) patients. The primary end point was observed in 208 patients (6.9%) assigned to receive a VCD and 119 patients (7.9%) assigned to manual compression (difference, -1.0% [1-sided 97.5% CI, 0.7%]; P for noninferiority <.001). Time to hemostasis was significantly shorter in patients with VCD (1 minute [interquartile range {IQR}, 0.5-2.0]), vs manual compression (10 minutes [IQR, 10-15]; P <.001). Time to hemostasis was significantly shorter among patients with intravascular VCD (0.5 minute [IQR, 0.2-1.0]), vs extravascular VCD (2.0 minutes [IQR, 1.0-2.0]; P <.001) and closure device failure was also significantly lower among those with intravascular vs extravascular VCD (80 patients [5.3%], vs 184 patients [12.2%]; P <.001). CONCLUSIONS AND RELEVANCE In patients undergoing transfemoral coronary angiography, VCDs were noninferior to manual compression in terms of vascular access-site complications and reduced time to hemostasis.	[Schulz-Schuepke, Stefanie; Heide, Sandra; Gewalt, Senta; Linhardt, Maryam; Haas, Katharina; Groha, Philip; Ott, Ilka; Goedel, Julia; Byrne, Robert A.; Burgdorf, Christof; Morath, Tanja; Kufner, Sebastian; Cassese, Salvatore; Hengstenberg, Christian; Fusaro, Massimiliano; Schunkert, Heribert; Kastrati, Adnan] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Schulz-Schuepke, Stefanie; Hengstenberg, Christian; Massberg, Steffen; Mehilli, Julinda; Schunkert, Heribert; Laugwitz, Karl-Ludwig; Kastrati, Adnan] Partner Site Munich Heart Alliance, DZHK, Munich, Germany; [Ibrahim, Tareq; Bradaric, Christian; Schneider, Simon; Hoppmann, Petra; Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-80290 Munich, Germany; [Hoppe, Katharina; Boettiger, Corinna; Pache, Juergen] Schon Klin Starnberger See, Berg, Germany; [Schmidt, Roland] Krankenhaus Barmherzigen Bruder, Munich, Germany; [Bott-Fluegel, Lorenz] Klinikum Landkreis Erding, Abt Kardiol & Pneumol, Erding, Germany; [Joner, Michael] CVPath Inst Inc, Gaithersburg, MD USA; [Massberg, Steffen; Mehilli, Julinda] Klinikum LMU, Med Klin & Poliklin 1, Munich, Germany	German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Technical University of Munich; CVPath Institute; University of Munich	Schulz-Schupke, S (corresponding author), Deutsch Herzzentrum Munich, ISARes Ctr, Lazarettstr 36, D-80636 Munich, Germany.	schulzs@dhm.mhn.de	, Kastrati/Y-2389-2019; Massberg, Steffen/AAN-6054-2021; Mehilli, Julinda/F-2629-2016; Joner, Michael/AAR-1229-2021; Hengstenberg, Christian/U-5485-2019; Byrne, Robert/C-3902-2016; Schupke, Stefanie/G-8382-2016	Bott-Flugel, Lorenz/0000-0003-0932-1241; Byrne, Robert/0000-0001-5224-6393; Schupke, Stefanie/0000-0002-0294-2283; Kufner, Sebastian/0000-0002-8091-4552	Deutsches Herzzentrum Munchen, Munich, Germany	Deutsches Herzzentrum Munchen, Munich, Germany	The study was funded by the Deutsches Herzzentrum Munchen, Munich, Germany.	Biancari F, 2010, AM HEART J, V159, P518, DOI 10.1016/j.ahj.2009.12.027; Byrne RA, 2013, NAT REV CARDIOL, V10, P27, DOI 10.1038/nrcardio.2012.160; Dauerman HL, 2007, J AM COLL CARDIOL, V50, P1617, DOI 10.1016/j.jacc.2007.07.028; Holm NR, 2014, EUROINTERVENTION, V10, P183, DOI 10.4244/EIJV10I2A31; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350; Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P1200, DOI 10.1016/j.jacc.2004.06.048; Tavris Dale R, 2004, J Invasive Cardiol, V16, P459; Xhepa E, 2014, EUROINTERVENTION, V10, P198, DOI 10.4244/EIJV10I2A33	10	127	132	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1981	1987		10.1001/jama.2014.15305	http://dx.doi.org/10.1001/jama.2014.15305			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399273	Bronze			2022-12-28	WOS:000345450500012
J	Chung, BW; Ong, M; Ettner, SL; Jones, F; Gilmore, J; McCreary, M; Sherbourne, C; Ngo, V; Koegel, P; Tang, LQ; Dixon, E; Miranda, J; Belin, TR; Wells, KB				Chung, Bowen; Ong, Michael; Ettner, Susan L.; Jones, Felica; Gilmore, James; McCreary, Michael; Sherbourne, Cathy; Ngo, Victoria; Koegel, Paul; Tang, Lingqi; Dixon, Elizabeth; Miranda, Jeanne; Belin, Thomas R.; Wells, Kenneth B.			12-Month Outcomes of Community Engagement Versus Technical Assistance to Implement Depression Collaborative Care A Partnered, Cluster, Randomized, Comparative Effectiveness Trial	ANNALS OF INTERNAL MEDICINE			English	Article							MANAGED PRIMARY-CARE; MENTAL-HEALTH; QUALITY IMPROVEMENT; UNITED-STATES; TREATING DEPRESSION; ADDRESS DEPRESSION; DSM-IV; WELLNESS; PREVALENCE; DISORDERS	Background: Depression collaborative care implementation using community engagement and planning (CEP) across programs improves 6-month client outcomes in minority communities, compared with technical assistance to individual programs (resources for services [RS]). However, 12-month outcomes are unknown. Objective: To compare effects of CEP and RS on mental health-related quality of life (MHRQL) and use of services among depressed clients at 12 months. Design: Matched health and community programs (n = 93) in 2 communities randomly assigned to receive CEP or RS. (ClinicalTrials.gov: NCT01699789). Measurements: Self-reported MHRQL and services use at baseline, 6 months, and 12 months. Setting: Los Angeles, California. Patients: 1018 adults with depressive symptoms (8-item Patient Health Questionnaire score >= 10), 88% of whom were an ethnic minority. Intervention: CEP and RS to implement depression collaborative care. Measurements: The primary outcome was poor MHRQL (12-item mental health composite score <= 40) at baseline, 6 months, and 12 months; the secondary outcome was use of services at 12 months. Results: At 6 months, the finding that CEP outperformed RS to reduce poor MHRQL was significant but sensitive to underlying statistical assumptions. At 12 months, some analyses suggested that CEP was advantageous to MHRQL, whereas others did not confirm a significant difference favoring CEP. The finding that CEP reduced behavioral health hospitalizations at 6 months was less evident at 12 months and was sensitive to underlying statistical assumptions. Other services use did not significantly differ between interventions at 12 months. Limitation: Data are self-reported, and findings are sensitive to modeling assumptions. Conclusion: In contrast to 6-month results, no consistent effects of CEP on reducing the likelihood of poor MHRQL and behavioral health hospitalizations were found at 12 months. Still, given the needs of underresourced communities, the favorable profile of CEP, and the lack of evidence-based alternatives, CEP remains a viable strategy for policymakers and communities to consider.	[Chung, Bowen] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [McCreary, Michael; Tang, Lingqi; Miranda, Jeanne; Wells, Kenneth B.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Hlth Serv & Soc, Los Angeles, CA 90095 USA; Greater Los Angeles Vet Affiars Healthcare Syst, Los Angeles, CA USA; Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Hlth African Amer Families 2, Los Angeles, CA 90095 USA; [Dixon, Elizabeth] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90095 USA; [Sherbourne, Cathy; Ngo, Victoria; Koegel, Paul] RAND Corp, Santa Monica, CA 90407 USA; [Gilmore, James] Behav Hlth Serv, Gardena, CA 90249 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RAND Corporation	Chung, BW (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat, 1000 West Carson St,Box 498, Torrance, CA 90509 USA.	bchung@mednet.ucla.edu	Ong, Michael/AAR-3310-2020; Ong, Michael K/F-7397-2013	Ong, Michael/0000-0001-8530-7754; Ngo, Victoria/0000-0001-8564-7695	National Institute of Mental Health; Robert Wood Johnson Foundation; California Community Foundation; National Library of Medicine; National Institutes of Health/National Center for Advancing Translational Science; NATIONAL CANCER INSTITUTE [R01CA090249] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078853, P30MH068639, P30MH082760] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G08LM011058] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); California Community Foundation; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health/National Center for Advancing Translational Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Institute of Mental Health, Robert Wood Johnson Foundation, California Community Foundation, National Library of Medicine, and National Institutes of Health/National Center for Advancing Translational Science for the UCLA Clinical and Translational Science Institute.	Agency for Toxic Substances and Disease Registry, 2011, PRINC COMM ENG; Asarnow JR, 2005, JAMA-J AM MED ASSOC, V293, P311, DOI 10.1001/jama.293.3.311; Belin TR, 1999, STAT MED, V18, P3123, DOI 10.1002/(SICI)1097-0258(19991130)18:22<3123::AID-SIM277>3.0.CO;2-2; Belin TR, 2010, P AM STAT ASS HLTH P; Bentham W, 2011, ETHN DIS S1, V21; Bluthenthal RN, 2006, ETHNIC DIS, V16, P18; California Pan-Ethnic Health Network, 2012, LOS ANG COUNT MULT H; Chang ET, 2014, PSYCHIAT SE IN PRESS; Chung B, 2010, ETHN DIS S2, V20; Chung Bowen, 2006, Ethn Dis, V16, pS67; Chung BW, 2010, J HEALTH CARE POOR U, V21, P780, DOI 10.1353/hpu.0.0345; Chung BW, 2009, AM J PUBLIC HEALTH, V99, P237, DOI 10.2105/AJPH.2008.141408; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Ell K, 2008, J CLIN ONCOL, V26, P4488, DOI 10.1200/JCO.2008.16.6371; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Gonzalez HM, 2010, ARCH GEN PSYCHIAT, V67, P37, DOI 10.1001/archgenpsychiatry.2009.168; Insel TR, 2003, JAMA-J AM MED ASSOC, V289, P3167, DOI 10.1001/jama.289.23.3167; Institute of Medicine, 2013, CTSA PROGR NIH OPP A; Israel B. A., 2005, METHODS COMMUNITY BA; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jacob V, 2012, AM J PREV MED, V42, P539, DOI 10.1016/j.amepre.2012.01.011; Jones D, 2006, ETHNIC DIS, V16, P54; Jones L, 2009, ETHN DIS S6, V19; Jones L, 2009, ETHN DIS S6, V19; Jones L, 2007, JAMA-J AM MED ASSOC, V297, P407, DOI 10.1001/jama.297.4.407; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Khodyakov Dmitry, 2009, Int J Divers Organ Communities Nations, V9, P167; Kish L, 1965, SURVEY SAMPLING; Korn E, 1999, HHS POV GUID REM 201; Korn EL., 1999, ANAL HLTH SURVEYS; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Los Angeles County Department of Public Health, 2009, KEY IND HLTH SERV AR; McGuive TG, 2008, HEALTH AFFAIR, V27, P393, DOI 10.1377/hlthaff.27.2.393; Mendel P, 2011, ETHN DIS S1, V21; Miranda J, 2006, J CONSULT CLIN PSYCH, V74, P99, DOI 10.1037/0022-006X.74.1.99; Miranda J, 2003, JAMA-J AM MED ASSOC, V290, P57, DOI 10.1001/jama.290.1.57; Miranda J, 2008, AM J PSYCHIAT, V165, P1102, DOI 10.1176/appi.ajp.2008.08030333; Miranda J, 2013, J GEN INTERN MED, V28, P1279, DOI 10.1007/s11606-013-2480-7; Mrazek DA, 2014, PSYCHIAT SERV, V65, P977, DOI 10.1176/appi.ps.201300059; Murray DM, 1998, DESIGN ANAL GROUP RA; National Association of Community Health Centers; Robert Graham Center, 2007, ACC GRANT PRIM CAR P; National Research Council, 2000, PROMOTING HLTH INTER; Patel KK, 2006, ETHNIC DIS, V16, P35; Rieselbach RE, 2010, ANN INTERN MED, V152, P118, DOI 10.7326/0003-4819-152-2-201001190-00186; Rubenstein LV, 1999, HEALTH AFFAIR, V18, P89, DOI 10.1377/hlthaff.18.5.89; SAMSHA-HRSA Center for Integrated Health Solutions, 2012, BEH HLTH HOM PEOPL M; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smedley B.D, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Thomas SB, 2011, ANNU REV PUBL HEALTH, V32, P399, DOI 10.1146/annurev-publhealth-031210-101136; U.S. Department of Health and Human Services, 2010, HHS POV GUID REM 201; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Wang JL, 2014, DEPRESS ANXIETY, V31, P451, DOI 10.1002/da.22215; Wang PS, 2000, J GEN INTERN MED, V15, P284, DOI 10.1046/j.1525-1497.2000.9908044.x; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wells K, 2004, ARCH GEN PSYCHIAT, V61, P378, DOI 10.1001/archpsyc.61.4.378; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Wells K, 2009, JAMA-J AM MED ASSOC, V302, P320, DOI 10.1001/jama.2009.1033; Wells KB, 2008, HEALTH SERV RES, V43, P1952, DOI 10.1111/j.1475-6773.2008.00871.x; Wells KB, 2013, J GEN INTERN MED, V28, P1268, DOI 10.1007/s11606-013-2484-3; Wennerstrom Ashley, 2011, Ethn Dis, V21, pS1; Williams DR, 2007, ARCH GEN PSYCHIAT, V64, P305, DOI 10.1001/archpsyc.64.3.305	66	42	42	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S23	S34		10.7326/M13-3011	http://dx.doi.org/10.7326/M13-3011			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402400	Green Published, Green Accepted			2022-12-28	WOS:000364909900005
J	Horwitz, LI; Partovian, C; Lin, ZQ; Grady, JN; Herrin, J; Conover, M; Montague, J; Dillaway, C; Bartczak, K; Suter, LG; Ross, JS; Bernheim, SM; Krumholz, HM; Drye, EE				Horwitz, Leora I.; Partovian, Chohreh; Lin, Zhenqiu; Grady, Jacqueline N.; Herrin, Jeph; Conover, Mitchell; Montague, Julia; Dillaway, Chloe; Bartczak, Kathleen; Suter, Lisa G.; Ross, Joseph S.; Bernheim, Susannah M.; Krumholz, Harlan M.; Drye, Elizabeth E.			Development and Use of an Administrative Claims Measure for Profiling Hospital-wide Performance on 30-Day Unplanned Readmission	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; STATISTICAL-METHODS; RATES; RISK; ADJUSTMENT; OUTCOMES; MODEL	Background: Existing publicly reported readmission measures are condition-specific, representing less than 20% of adult hospitalizations. An all-condition measure may better measure quality and promote innovation. Objective: To develop an all-condition, hospital-wide readmission measure. Design: Measure development study. Setting: 4821 U.S. hospitals. Patients: Medicare fee-for-service beneficiaries aged 65 years or older. Measurements: Hospital-level, risk-standardized unplanned readmissions within 30 days of discharge. The measure uses Medicare fee-for-service claims and is a composite of 5 specialty-based, risk-standardized rates for medicine, surgery/gynecology, cardiorespiratory, cardiovascular, and neurology cohorts. The 2007-2008 admissions were randomly split for development and validation. Models were adjusted for age, principal diagnosis, and comorbid conditions. Calibration in Medicare and all-payer data was examined, and hospital rankings in the development and validation samples were compared. Results: The development data set contained 8 018 949 admissions associated with 1 276 165 unplanned readmissions (15.9%). The median hospital risk-standardized unplanned readmission rate was 15.8 (range, 11.6 to 21.9). The 5 specialty cohort models accurately predicted readmission risk in both Medicare and all-payer data sets for average-risk patients but slightly overestimated readmission risk at the extremes. Overall hospital risk-standardized readmission rates did not differ statistically in the split samples (P = 0.71 for difference in rank), and 76% of hospitals' validation-set rankings were within 2 deciles of the development rank (24% were more than 2 deciles). Of hospitals ranking in the top or bottom deciles, 90% remained within 2 deciles (10% were more than 2 deciles) and 82% remained within 1 decile (18% were more than 1 decile). Limitation: Risk adjustment was limited to that available in claims data. Conclusion: A claims-based, hospital-wide unplanned readmission measure for profiling hospitals produced reasonably consistent results in different data sets and was similarly calibrated in both Medicare and all-payer data.	[Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Partovian, Chohreh; Lin, Zhenqiu; Grady, Jacqueline N.; Montague, Julia; Suter, Lisa G.; Bernheim, Susannah M.; Krumholz, Harlan M.; Drye, Elizabeth E.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA; Hlth Res & Educ Trust, Chicago, IL USA	Yale University; Yale University	Horwitz, LI (corresponding author), NYU, Sch Med, Dept Populat Hlth, 550 First Ave,TRB Room 607, New York, NY 10016 USA.	leora.horwitz@nyumc.org	, Harlan/AAI-2875-2020; Horwitz, Leora/ABD-1292-2020; Horwitz, Leora/A-6959-2009	Horwitz, Leora/0000-0003-1800-6040; Ross, Joseph/0000-0002-9218-3320; Conover, Mitchell/0000-0001-5682-3688	Centers for Medicare & Medicaid Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886, P30AG021342, K08AG038336] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Centers for Medicare & Medicaid Services.	Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Anderson GM, 2014, HOSP ESCORECARD REPO; Appleby J, 2010, KAISER HLTH NEW 0707; Ash AS, 2012, STAT ISSUES ASSESSIN; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bradley EH, 2012, J AM COLL CARDIOL, V60, P607, DOI 10.1016/j.jacc.2012.03.067; Canadian Broadcasting Corporation, 2013, RAT MY HOSP; Centers for Medicare & Medicaid Services, 2014, HOSP WID READM VERB; CHAMBERS M, 1990, BRIT MED J, V301, P1134, DOI 10.1136/bmj.301.6761.1134; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; DESHARNAIS S, 1991, EVAL HEALTH PROF, V14, P228, DOI 10.1177/016327879101400206; DESHARNAIS S, 1991, HEALTH SERV RES, V26, P425; FLEMING PJ, 1986, COMMUN ACM, V29, P218, DOI 10.1145/5666.5673; Food and Drug Administration, 2012, FED REGISTER, V77, P2012; Goldfield NI, 2008, HEALTH CARE FINANC R, V30, P75; Grosso LM, 2014, HOSP LEVEL 30 DAY AL; Halfon P, 2006, MED CARE, V44, P972, DOI 10.1097/01.mlr.0000228002.43688.c2; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; He YL, 2014, STAT MED, V33, P1081, DOI 10.1002/sim.6012; Healthcare Cost and Utilization Project (HCUP), 2006, HCUP CLIN CLASS SOFT; Horwitz L., HOSP WIDE ALL CAUSE; Horwitz LI, 2013, JAMA INTERN MED, V173, P1715, DOI 10.1001/jamainternmed.2013.9318; Horwitz LI, 2013, J HOSP MED, V8, P436, DOI 10.1002/jhm.2021; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz H, 2014, HOSP 30 DAY HEART FA; Krumholz H, 2014, HOSP 30 DAY PNEUMONI; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Krumholz HM., HOSP 30 DAY AMI READ; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002; National Committee for Quality Assurance, 2013, PLAN ALL CAUS READM; National Quality Forum, NAT VOL CONS STAND P; National Quality Forum, MEAS EV CRIT; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Normand SLT, 2007, HEALTH SERV OUTCOME, V7, P79, DOI 10.1007/s10742-006-0018-8; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; UnitedHealthcare, 2013, RISK ADJ 30 DAY ALL; van Walraven C, 2012, J EVAL CLIN PRACT, V18, P1211, DOI 10.1111/j.1365-2753.2011.01773.x; Wal-Mart, 2010, KAISER HLTH NEW 1012; Wennberg JE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f549; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Wray NP, 1997, MED CARE, V35, P768, DOI 10.1097/00005650-199708000-00003; Ziaeian B, 2012, J GEN INTERN MED, V27, P1513, DOI 10.1007/s11606-012-2168-4	48	64	67	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S66	S75		10.7326/M13-3000	http://dx.doi.org/10.7326/M13-3000			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402406	Green Accepted			2022-12-28	WOS:000364909900010
J	Aujayeb, A; Weatherhead, M				Aujayeb, Avinash; Weatherhead, Mark			PICTURE QUIZ An abnormal chest radiograph	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aujayeb, Avinash; Weatherhead, Mark] Wansbeck Gen Hosp, Dept Resp Med, Ashington NE63 9JJ, England		Aujayeb, A (corresponding author), Wansbeck Gen Hosp, Dept Resp Med, Ashington NE63 9JJ, England.	aujayeb@doctors.net.uk	Aujayeb, Avinash/ABD-1705-2020	Aujayeb, Avinash/0000-0002-0859-5550				Nishimoto K, 2008, J ADV MECH DES SYST, V2, P197, DOI [10.1299/jamdsm.2.197, 10.1186/1752-1947-2-197]	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2014	349								g6592	10.1136/bmj.g6592	http://dx.doi.org/10.1136/bmj.g6592			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JS	25395482				2022-12-28	WOS:000345445100001
J	Campbell, N; Grayson, M				Campbell, Nick; Grayson, Michelle			nature INDEX 2014 GLOBAL	NATURE			English	Editorial Material																			0	6	6	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S49	S108		10.1038/515S49a	http://dx.doi.org/10.1038/515S49a			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT0MZ	25390141	Bronze			2022-12-28	WOS:000344631400011
J	Pleasants, S				Pleasants, Simon			A moving target	NATURE			English	Editorial Material							SICKLE HEMOGLOBIN											ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Makani J, 2013, SCI WORLD J, DOI 10.1155/2013/193252; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X	7	29	30	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S2	S2		10.1038/515S2a	http://dx.doi.org/10.1038/515S2a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390139				2022-12-28	WOS:000344631400002
J	Simon, J				Simon, Jonathan			Magnetic fields without magnetic fields	NATURE			English	Editorial Material							TOPOLOGICAL INSULATOR		Univ Chicago, Dept Phys, Chicago, IL 60637 USA	University of Chicago	Simon, J (corresponding author), Univ Chicago, Dept Phys, Chicago, IL 60637 USA.	simonjon@uchicago.edu		Simon, Jonathan/0000-0001-7854-4647				BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Gritsev V, 2012, P NATL ACAD SCI USA, V109, P6457, DOI 10.1073/pnas.1116693109; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kitagawa T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.235114; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Lindner NH, 2011, NAT PHYS, V7, P490, DOI 10.1038/NPHYS1926; Roushan P, 2014, NATURE, V515, P241, DOI 10.1038/nature13891; Simon S. H., 2014, PREPRINT; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871; Wang YH, 2013, SCIENCE, V342, P453, DOI 10.1126/science.1239834	11	2	2	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					202	203		10.1038/515202a	http://dx.doi.org/10.1038/515202a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391956				2022-12-28	WOS:000344631400033
J	Barkeshli, M; Berg, E; Kivelson, S				Barkeshli, Maissam; Berg, Erez; Kivelson, Steven			Coherent transmutation of electrons into fractionalized anyons	SCIENCE			English	Article							TUNNELING CHARACTERISTICS; KAGOME-LATTICE; SPIN LIQUIDS; STATE; SUPERCONDUCTIVITY; ANTIFERROMAGNET; EXCITATIONS	Electrons have three quantized properties-charge, spin, and Fermi statistics-that are directly responsible for a vast array of phenomena. Here we show how these properties can be coherently and dynamically stripped from the electron as it enters a certain exotic state of matter known as a quantum spin liquid (QSL). In a QSL, electron spins collectively form a highly entangled quantum state that gives rise to the fractionalization of spin, charge, and statistics. We show that certain QSLs host distinct, topologically robust boundary types, some of which allow the electron to coherently enter the QSL as a fractionalized quasi-particle, leaving its spin, charge, or statistics behind. We use these ideas to propose a number of universal, conclusive experimental signatures that would establish fractionalization in QSLs.	[Barkeshli, Maissam] Microsoft Res, Stn Q, Santa Barbara, CA 93106 USA; [Berg, Erez] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel; [Kivelson, Steven] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Microsoft; Weizmann Institute of Science; Stanford University	Berg, E (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.	erez.berg@gmail.com	Berg, Erez/AAS-9365-2020	Kivelson, Steven/0000-0001-9149-9502	NSF-DMR [1265593]; Israel Science Foundation; Israel-U.S. Binational Foundation; Minerva Foundation; German-Israeli Foundation	NSF-DMR(National Science Foundation (NSF)); Israel Science Foundation(Israel Science Foundation); Israel-U.S. Binational Foundation; Minerva Foundation; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by NSF-DMR grant 1265593 (S. K.), the Israel Science Foundation, the Israel-U.S. Binational Foundation, the Minerva Foundation, and the German-Israeli Foundation (E. B.). M. B. thanks X.-L. Qi for recent collaborations on related topics. We thank E. Altman, C. Nayak, M. Freedman, Z. Wang, K. Walker, M. Hastings, M. P. A. Fisher, B. Bauer, and T. Grover for discussions.	Balents L, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.224412; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Barkeshli M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.241103; Barkeshli M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.140402; Barkeshli M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045130; Barkeshli M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031013; Beigi S, 2011, COMMUN MATH PHYS, V306, P663, DOI 10.1007/s00220-011-1294-x; Cheng M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195126; Clarke DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2340; Depenbrock S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.067201; Freedman M, 2004, ANN PHYS-NEW YORK, V310, P428, DOI 10.1016/j.aop.2004.01.006; Han TH, 2012, NATURE, V492, P406, DOI 10.1038/nature11659; Jiang HC, 2012, NAT PHYS, V8, P902, DOI [10.1038/nphys2465, 10.1038/NPHYS2465]; Jiang HC, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.024424; Kapustin A, 2011, NUCL PHYS B, V845, P393, DOI 10.1016/j.nuclphysb.2010.12.017; Kitaev A, 2012, COMMUN MATH PHYS, V313, P351, DOI 10.1007/s00220-012-1500-5; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; KIVELSON SA, 1990, PHYS REV B, V41, P11693, DOI 10.1103/PhysRevB.41.11693; KIVELSON SA, 1987, PHYS REV B, V35, P8865, DOI 10.1103/PhysRevB.35.8865; Levin M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021009; Lindner NH, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041002; MCMILLAN WL, 1966, PHYS REV LETT, V16, P85, DOI 10.1103/PhysRevLett.16.85; Moessner R, 2001, PHYS REV LETT, V86, P1881, DOI 10.1103/PhysRevLett.86.1881; Punk M, 2014, NAT PHYS, V10, P289, DOI [10.1038/nphys2887, 10.1038/NPHYS2887]; Qi Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176401; READ N, 1991, PHYS REV LETT, V66, P1773, DOI 10.1103/PhysRevLett.66.1773; ROKHSAR DS, 1988, PHYS REV LETT, V61, P2376, DOI 10.1103/PhysRevLett.61.2376; Seidel A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165131; Senthil T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.205104; Senthil T, 2000, PHYS REV B, V62, P7850, DOI 10.1103/PhysRevB.62.7850; TOMASCH WJ, 1965, PHYS REV LETT, V15, P672, DOI 10.1103/PhysRevLett.15.672; Wen X.G., 2004, QUANTUM FIELD THEORY; WEN XG, 1991, PHYS REV B, V44, P2664, DOI 10.1103/PhysRevB.44.2664; Yan SM, 2011, SCIENCE, V332, P1173, DOI 10.1126/science.1201080	35	33	33	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					722	725		10.1126/science.1253251	http://dx.doi.org/10.1126/science.1253251			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378617	Green Submitted			2022-12-28	WOS:000344690100033
J	Jan, CH; Williams, CC; Weissman, JS				Jan, Calvin H.; Williams, Christopher C.; Weissman, Jonathan S.			Principles of ER cotranslational translocation revealed by proximity-specific ribosome profiling	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN-TRANSPORT; SIGNAL SEQUENCES; IN-VITRO; COMPLEX; TRANSLATION; MEMBRANE; INSERTION; PEPTIDES; TOPOLOGY	Localized protein synthesis is a fundamental mechanism for creating distinct subcellular environments. Here we developed a generalizable proximity-specific ribosome profiling strategy that enables global analysis of translation in defined subcellular locations. We applied this approach to the endoplasmic reticulum (ER) in yeast and mammals. We observed the large majority of secretory proteins to be cotranslationally translocated, including substrates capable of posttranslational insertion in vitro. Distinct translocon complexes engaged nascent chains at different points during synthesis. Whereas most proteins engaged the ER immediately after or even before signal sequence (SS) emergence, a class of Sec66-dependent proteins entered with a looped SS conformation. Finally, we observed rapid ribosome exchange into the cytosol after translation termination. These data provide insights into how distinct translocation mechanisms act in concert to promote efficient cotranslational recruitment.	[Jan, Calvin H.; Williams, Christopher C.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA.	jonathan.weissman@ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	Center for RNA Systems Biology; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER	Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Weissman and P. Walter labs, as well as A. Ting, for discussion; and E. Costa, M. Kampmann, P. Kimmig, K. Kostova, and M. Smith for critical reading of the manuscript. Technical assistance was provided by the University of California, San Francisco, Center for Advanced Technology, Nikon Imaging Center, and the Consortium for Frontotemporal Dementia Research. This research was supported by the Center for RNA Systems Biology and the Howard Hughes Medical Institute. C.H.J. is the Rebecca Ridley Kry Fellow of the Damon Runyon Cancer Research Foundation (DRG-2085-11). C. C. W. is an NSF Graduate Research Fellow. Data are deposited in Gene Expression Omnibus under accession nos. GSE61011 and GSE61012.	Ast T, 2013, CRIT REV BIOCHEM MOL, V48, P273, DOI 10.3109/10409238.2013.782999; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BONVEN B, 1979, MOL GEN GENET, V170, P225, DOI 10.1007/BF00337800; BORGESE D, 1973, J MOL BIOL, V74, P415, DOI 10.1016/0022-2836(73)90037-5; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; CHRISTENSEN AK, 1987, AM J ANAT, V178, P1, DOI 10.1002/aja.1001780102; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stephens S, 2007, THEATER HEUTE, P47; van der Zand A, 2010, MOL BIOL CELL, V21, P2057, DOI 10.1091/mbc.E10-02-0082; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	42	219	221	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					716	+	1257521	10.1126/science.1257521	http://dx.doi.org/10.1126/science.1257521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378630	Green Accepted			2022-12-28	WOS:000344690100030
J	Dai, XL; Zhang, ZX; Jin, YZ; Niu, Y; Cao, HJ; Liang, XY; Chen, LW; Wang, JP; Peng, XG				Dai, Xingliang; Zhang, Zhenxing; Jin, Yizheng; Niu, Yuan; Cao, Hujia; Liang, Xiaoyong; Chen, Liwei; Wang, Jianpu; Peng, Xiaogang			Solution-processed, high-performance light-emitting diodes based on quantum dots	NATURE			English	Article							COLLOIDAL NANOCRYSTALS; EFFICIENCY; POLYMER; ELECTROLUMINESCENCE; DEVICES; DEPENDENCE; ELECTRON; STATE	Solution-processed optoelectronic and electronic devices are attractive owing to the potential for low-cost fabrication of large-area devices and the compatibility with lightweight, flexible plastic substrates. Solution-processed light-emitting diodes (LEDs) using conjugated polymers or quantum dots as emitters have attracted great interest over the past two decades(1,2). However, the overall performance of solution-processed LEDs(2-5)-including their efficiency, efficiency roll-off at high current densities, turn-on voltage and lifetime under operational conditions-remains inferior to that of the best vacuum deposited organic LEDs(6-8). Here we report a solution-processed, multilayer quantum-dot-based LED with excellent performance and reproducibility. It exhibits colour-saturated deep-redemission, subband gap turn-on at 1.7 volts, high external quantum efficiencies of up to 20.5 per cent, low efficiency roll-off (up to 15.1 per cent of the external quantum efficiency at 100 mA cm(-2)), anda long operational lifetime of more than 100,000 hours at 100 cd m(-2), making this device the best-performing solution-processed red LED so far, comparable to state-of-the-art vacuum-deposited organic LEDs(2-8). This optoelectronic performance is achieved by inserting an insulating layer between the quantum dot layer and the oxide electron-transport layer to optimize charge balance in the device and preserve the superior emissive properties of the quantum dots. We anticipate that our results will be a starting point for further research, leading to high-performance, all-solution-processed quantum-dot-based LEDs ideal for next-generation display and solid-state lighting technologies.	[Dai, Xingliang; Jin, Yizheng; Liang, Xiaoyong] Zhejiang Univ, Sch Mat Sci & Engn, Ctr Chem High Performance & Novel Mat, State Key Lab Silicon Mat,Cyrus Tang Ctr Sensor M, Hangzhou 310027, Zhejiang, Peoples R China; [Zhang, Zhenxing; Niu, Yuan; Cao, Hujia; Peng, Xiaogang] Zhejiang Univ, Dept Chem, Ctr Chem High Performance & Novel Mat, Hangzhou 310027, Zhejiang, Peoples R China; [Chen, Liwei] Chinese Acad Sci, I Lab, Suzhou Inst Nanotech & Nanobion, Suzhou 215123, Peoples R China; [Wang, Jianpu] Nanjing Tech Univ NanjingTech, Key Lab Flexible Elect KLOFE, Nanjing 211816, Peoples R China; [Wang, Jianpu] Nanjing Tech Univ NanjingTech, Natl Jiangsu Synergist Innovat Ctr Adv Mat SICAM, Inst Adv Mat IAM, Nanjing 211816, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Nanjing Tech University; Nanjing Tech University	Jin, YZ (corresponding author), Zhejiang Univ, Sch Mat Sci & Engn, Ctr Chem High Performance & Novel Mat, State Key Lab Silicon Mat,Cyrus Tang Ctr Sensor M, Hangzhou 310027, Zhejiang, Peoples R China.	yizhengjin@zju.edu.cn; xpeng@zju.edu.cn	peng, xiaogang/R-6184-2016; Wang, Jianpu/HCH-4587-2022	peng, xiaogang/0000-0002-5606-8472; Jin, Yizheng/0000-0002-2485-0064	National High Technology Research and Development Program of China [2011AA050520]; National Natural Science Foundation of China [21233005, 51172203]; Natural Science Funds for Distinguished Young Scholar of Zhejiang Province [R4110189]; Public Welfare Project of Zhejiang Province [2013C31057]; Jiangsu Natural Science Foundation [BK20130006, BK20131413]; National Basic Research Program of China [2015CB932200]; Jiangsu Specially-Appointed Professor programme	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Funds for Distinguished Young Scholar of Zhejiang Province; Public Welfare Project of Zhejiang Province; Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); National Basic Research Program of China(National Basic Research Program of China); Jiangsu Specially-Appointed Professor programme	This work is financially supported by the National High Technology Research and Development Program of China (2011AA050520), the National Natural Science Foundation of China (21233005 and 51172203), the Natural Science Funds for Distinguished Young Scholar of Zhejiang Province (R4110189), the Public Welfare Project of Zhejiang Province (2013C31057), the Jiangsu Natural Science Foundation (BK20130006 and BK20131413), the National Basic Research Program of China (2015CB932200) and the Jiangsu Specially-Appointed Professor programme. We thank L. Liao and L. Zhang for assistance in cross-measuring the QLED and OLED devices. We thank Q. Chen for assistance with atomic force microscopy and scanning Kelvin probe microscopy measurements. We thank Z. Zhang and C. Jin for assistance with cross-sectional transmission electron microscopy experiments. We also thank J. Yu and G. Qian for assistance in obtaining the confocal images.	Andrade B. D., 2007, P SOC PHOTO-OPT INS, V6655; Bae WK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3661; BRUS LE, 1984, J CHEM PHYS, V80, P4403, DOI 10.1063/1.447218; Caruge JM, 2008, NAT PHOTONICS, V2, P247, DOI 10.1038/nphoton.2008.34; Chien CH, 2008, ADV FUNCT MATER, V18, P1430, DOI 10.1002/adfm.200701137; Cho KS, 2009, NAT PHOTONICS, V3, P341, DOI 10.1038/NPHOTON.2009.92; Coe S, 2002, NATURE, V420, P800, DOI 10.1038/nature01217; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Forrest SR, 2003, ADV MATER, V15, P1043, DOI 10.1002/adma.200302151; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Giridhar T, 2014, CHEM COMMUN, V50, P4000, DOI 10.1039/c3cc49796h; GREENHAM NC, 1994, ADV MATER, V6, P491, DOI 10.1002/adma.19940060612; Humphries MJ, 2011, J PHOTON ENERGY, V1, DOI 10.1117/1.3569108; Javaux C, 2013, NAT NANOTECHNOL, V8, P206, DOI [10.1038/nnano.2012.260, 10.1038/NNANO.2012.260]; Kwak J, 2012, NANO LETT, V12, P2362, DOI 10.1021/nl3003254; Lee DH, 2010, ORG ELECTRON, V11, P427, DOI 10.1016/j.orgel.2009.11.022; Lee KH, 2014, ACS NANO, V8, P4893, DOI 10.1021/nn500852g; Mashford BS, 2013, NAT PHOTONICS, V7, P407, DOI [10.1038/NPHOTON.2013.70, 10.1038/nphoton.2013.70]; Meerheim R, 2008, J APPL PHYS, V104, DOI 10.1063/1.2951960; Murawski C, 2013, ADV MATER, V25, P6801, DOI 10.1002/adma.201301603; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Nakanotani H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5016; Nan WN, 2012, J AM CHEM SOC, V134, P19685, DOI 10.1021/ja306651x; Peng XG, 2009, NANO RES, V2, P425, DOI 10.1007/s12274-009-9047-2; Qian L, 2011, NAT PHOTONICS, V5, P543, DOI [10.1038/nphoton.2011.171, 10.1038/NPHOTON.2011.171]; Qian L, 2010, NANO TODAY, V5, P384, DOI 10.1016/j.nantod.2010.08.010; Qin HY, 2014, J AM CHEM SOC, V136, P179, DOI 10.1021/ja4078528; Sayyah S. M., 2005, INT J POLYM MATER, V54, P505; Supran GJ, 2013, MRS BULL, V38, P703, DOI 10.1557/mrs.2013.181; Thesen MW, 2010, J POLYM SCI POL CHEM, V48, P3417, DOI 10.1002/pola.24127; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Wellmann P, 2005, J SOC INF DISPLAY, V13, P393, DOI 10.1889/1.1927730; Yook KS, 2014, ADV MATER, V26, P4218, DOI 10.1002/adma.201306266; Zhao JL, 2006, NANO LETT, V6, P463, DOI 10.1021/nl052417e	34	1661	1722	127	2257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					96	99		10.1038/nature13829	http://dx.doi.org/10.1038/nature13829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25363773				2022-12-28	WOS:000344187500036
J	Price, C; Ashbaugh, C; Miller, AL; Loscalzo, J				Price, Christin; Ashbaugh, Cameron; Miller, Amy Leigh; Loscalzo, Joseph			A Chilly Fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALARIA CHEMOPROPHYLAXIS; PLASMODIUM-VIVAX	A 30-year-old graduate student presented to the emergency department in March reporting fevers associated with shaking chills and severe headaches. He had been well until 1 week before presentation, when he began to have daily fevers, with temperatures as high as 103.0 degrees F (39.4 degrees C) and with associated chills, nausea, and headaches. The fevers were most notable in the evening; by morning, the patient was afebrile and felt well enough to attend class. He had been taking acetaminophen, without symptom relief.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021					Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Chen LH, 2007, JAMA-J AM MED ASSOC, V297, P2251, DOI 10.1001/jama.297.20.2251; Dhorda M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019801; Freedman DO, 2008, NEW ENGL J MED, V359, P603, DOI 10.1056/NEJMcp0803572; Griffith KS, 2007, JAMA-J AM MED ASSOC, V297, P2264, DOI 10.1001/jama.297.20.2264; Long SS, 2005, PEDIATR CLIN N AM, V52, P811, DOI 10.1016/j.pcl.2005.02.007; Maguire JD, 2010, ANN TROP MED PARASIT, V104, P283, DOI 10.1179/136485910X12743554760027; Mali Sonja, 2012, Morbidity and Mortality Weekly Report, V61, P1; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Steinhardt LC, 2011, AM J TROP MED HYG, V85, P1015, DOI 10.4269/ajtmh.2011.11-0464; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297	11	0	0	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1833	1837		10.1056/NEJMcps1313772	http://dx.doi.org/10.1056/NEJMcps1313772			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372092				2022-12-28	WOS:000344170300013
J	Anderson, DC				Anderson, David C.			Review: Screening and treating asymptomatic adults with carotid artery stenosis lead to no net benefit Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Minnesota, Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA	Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Anderson, DC (corresponding author), Univ Minnesota, Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA.			Anderson, David/0000-0001-9874-5649				LeFevre ML, 2014, ANN INTERN MED, V161, P356, DOI 10.7326/M14-1333; Naylor AR, 2011, STROKE, V42, P2080, DOI 10.1161/STROKEAHA.110.597708	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC6	10.7326/0003-4819-161-10-201411180-02006	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402539				2022-12-28	WOS:000347245600010
J	Fernandez, F; Lu, D; Ha, P; Costacurta, P; Chavez, R; Heller, HC; Ruby, NF				Fernandez, Fabian; Lu, Derek; Ha, Phong; Costacurta, Patricia; Chavez, Renee; Heller, H. Craig; Ruby, Norman F.			Dysrhythmia in the suprachiasmatic nucleus inhibits memory processing	SCIENCE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CIRCADIAN SYSTEM; DEMENTIA; RHYTHMS; DISTURBANCES; PERFORMANCE; DEPENDS; GENES; RATS	Chronic circadian dysfunction impairs declarative memory in humans but has little effect in common rodent models of arrhythmia caused by clock gene knockouts or surgical ablation of the suprachiasmatic nucleus (SCN). An important problem overlooked in these translational models is that human dysrhythmia occurs while SCN circuitry is genetically and neurologically intact. Siberian hamsters (Phodopus sungorus) are particularly well suited for translational studies because they can be made arrhythmic by a one-time photic treatment that severely impairs spatial and recognition memory. We found that once animals are made arrhythmic, subsequent SCN ablation completely rescues memory processing. These data suggest that the inhibitory effects of a malfunctioning SCN on cognition require preservation of circuitry between the SCN and downstream targets that are lost when these connections are severed.	[Lu, Derek; Ha, Phong; Costacurta, Patricia; Chavez, Renee; Heller, H. Craig; Ruby, Norman F.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fernandez, Fabian] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Ruby, NF (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ruby@stanford.edu		Fernandez, Fabian-Xose/0000-0002-4288-5383; Heller, H Craig/0000-0003-4479-5880	National Institute of Mental Health [MH095837]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095837] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant from the National Institute of Mental Health (#MH095837).	Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Coogan AN, 2013, BIOL PSYCHIAT, V74, P333, DOI 10.1016/j.biopsych.2012.11.021; Covell GES, 2012, NEUROLOGIST, V18, P426, DOI 10.1097/NRL.0b013e318272f7ef; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Deboer T, 2004, AM J PHYSIOL-REG I, V287, pR8, DOI 10.1152/ajpregu.00125.2004; Grone BP, 2011, J BIOL RHYTHM, V26, P78, DOI 10.1177/0748730410388404; Harper DG, 2008, BRAIN, V131, P1609, DOI 10.1093/brain/awn049; Ko CH, 2003, BIOL RHYTHM RES, V34, P177, DOI 10.1076/brhm.34.2.177.14493; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; Mulder C, 2013, J BIOL RHYTHM, V28, P367, DOI 10.1177/0748730413512958; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; Rouch I, 2005, ERGONOMICS, V48, P1282, DOI 10.1080/00140130500241670; Ruby NF, 2002, J NEUROSCI, V22, P357, DOI 10.1523/JNEUROSCI.22-01-00357.2002; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Ruby NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072433; Smarr BL, 2014, BEHAV NEUROSCI, V128, P283, DOI 10.1037/a0035963; Steinlechner S, 2002, J BIOL RHYTHM, V17, P248, DOI 10.1177/07430402017003008; STEPHAN FK, 1978, BEHAV BIOL, V22, P456, DOI 10.1016/S0091-6773(78)92565-8; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; Turek FW, 2008, AM J PHYSIOL-REG I, V294, pR1672, DOI 10.1152/ajpregu.00160.2008; Van der Zee EA, 2008, CURR BIOL, V18, P844, DOI 10.1016/j.cub.2008.04.077; vanSomeren EJW, 1996, BIOL PSYCHIAT, V40, P259, DOI 10.1016/0006-3223(95)00370-3; Wardlaw SM, 2014, LEARN MEMORY, V21, P417, DOI 10.1101/lm.035451.114; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Wu YH, 2007, SLEEP MED, V8, P623, DOI 10.1016/j.sleep.2006.11.010; Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323	26	63	66	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					854	857		10.1126/science.1259652	http://dx.doi.org/10.1126/science.1259652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395537	Green Accepted			2022-12-28	WOS:000344659900046
J	Rahimi, A; Ulbrich, A; Coon, JJ; Stahl, SS				Rahimi, Alireza; Ulbrich, Arne; Coon, Joshua J.; Stahl, Shannon S.			Formic-acid-induced depolymerization of oxidized lignin to aromatics	NATURE			English	Article							PINE WOOD; OXIDATION; VALORIZATION; BIOMASS; PHOTODEGRADATION; DEGRADATION; STRATEGY	Lignin is a heterogeneous aromatic biopolymer that accounts for nearly 30% of the organic carbon on Earth(1) and is one of the few renewable sources of aromatic chemicals(2). As the most recalcitrant of the three components of lignocellulosic biomass (cellulose, hemicellulose and lignin)(3), lignin has been treated as a waste product in the pulp and paper industry, where it is burned to supply energy and recover pulping chemicals in the operation of paper mills(4). Extraction of higher value from lignin is increasingly recognized as being crucial to the economic viability of integrated biorefineries(5,6). Depolymerization is an important starting point for many lignin valorization strategies, because it could generate valuable aromatic chemicals and/or provide a source of low-molecular-mass feedstocks suitable for downstream processing(7). Commercial precedents show that certain types of lignin(lignosulphonates) may be converted into vanillin and other marketable products(8,9), but new technologies are needed to enhance the lignin value chain. The complex, irregular structure of lignin complicates chemical conversion efforts, and known depolymerization methods typically afford ill-defined products in low yields (that is, less than 10-20wt%)(2,10,11). Here we describe a method for the depolymerization of oxidized lignin under mild conditions in aqueous formic acid that results in more than 60wt% yield of low-molecular-mass aromatics. We present the discovery of this facile C-O cleavage method, its application to aspen lignin depolymerization, and mechanistic insights into the reaction. The broader implications of these results for lignin conversion and biomass refining are also considered.	[Rahimi, Alireza; Ulbrich, Arne; Coon, Joshua J.; Stahl, Shannon S.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Stahl, SS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	stahl@chem.wisc.edu	Ulbrich, Arne/ABG-8048-2021		Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]	Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science)(United States Department of Energy (DOE))	We thank J. Ralph for numerous helpful discussions, H. Kim and A. Azarpira for assistance with the purification and NMR characterization of aspen lignin, and S. Chakraborty for assistance with gel-permeation chromatographic analysis of lignin samples. Financial support for this project was provided by the Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science DE-FC02-07ER64494). The NMR facility was partly supported by the National Science Foundation (CHE-9208463) and the National Institutes of Health (S10 RR08389).	Argyropoulos DS, 1996, PHOTOCHEM PHOTOBIOL, V64, P510, DOI 10.1111/j.1751-1097.1996.tb03098.x; Bauer K., 1985, ULLMANNS ENCY IND CH, VA11, P199; Bjorsvik HR, 2002, ORG PROCESS RES DEV, V6, P279, DOI 10.1021/op010087o; Business Areas, 2014, BORREGAARD      0620; CHANG HM, 1975, HOLZFORSCHUNG, V29, P153, DOI 10.1515/hfsg.1975.29.5.153; Chatel G, 2014, ACS SUSTAIN CHEM ENG, V2, P322, DOI 10.1021/sc4004086; Collinson SR, 2010, COORDIN CHEM REV, V254, P1854, DOI 10.1016/j.ccr.2010.04.007; Crestini C, 1997, TETRAHEDRON, V53, P7877, DOI 10.1016/S0040-4020(97)00460-2; FOUAD FM, 1978, TETRAHEDRON LETT, P4735; FUKAGAWA N, 1991, J WOOD CHEM TECHNOL, V11, P263, DOI 10.1080/02773819108050275; GIERER J, 1982, HOLZFORSCHUNG, V36, P123, DOI 10.1515/hfsg.1982.36.3.123; Hocking MB, 1997, J CHEM EDUC, V74, P1055, DOI 10.1021/ed074p1055; Holladay J.E., 2007, TOP VALUE ADDED CHEM, DOI 10.2172/921839; Lin S. Y., 1985, ULLMANNS ENCY IND CH, VA15, P305; LJUNGGREN S, 1984, HOLZFORSCHUNG, V38, P91, DOI 10.1515/hfsg.1984.38.2.91; Luterbacher JS, 2014, SCIENCE, V343, P277, DOI 10.1126/science.1246748; Martinez AT, 2008, PHYTOCHEMISTRY, V69, P2831, DOI 10.1016/j.phytochem.2008.09.005; Nguyen JD, 2014, J AM CHEM SOC, V136, P1218, DOI 10.1021/ja4113462; Pandey MP, 2011, CHEM ENG TECHNOL, V34, P29, DOI 10.1002/ceat.201000270; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rahimi A, 2013, J AM CHEM SOC, V135, P6415, DOI 10.1021/ja401793n; Ralph J., 2007, ELS; Ralph J., 2010, LIGNIN LIGNANS ADV C, P137, DOI DOI 10.1201/EBK1574444865-C5; Sanderson K, 2011, NATURE, V474, pS12, DOI 10.1038/474S012a; Toledano A, 2013, CHEMSUSCHEM, V6, P529, DOI 10.1002/cssc.201200755; Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930; VANUCCI C, 1988, J PHOTOCH PHOTOBIO A, V41, P251, DOI 10.1016/1010-6030(88)80042-X; Wang H., 2013, J APPL CHEM, V2013, DOI [DOI 10.1155/2013/838645, 10.1155/2013/838645]; Xu WY, 2012, CHEMSUSCHEM, V5, P667, DOI 10.1002/cssc.201100695; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u	30	766	793	51	1060	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					249	252		10.1038/nature13867	http://dx.doi.org/10.1038/nature13867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25363781				2022-12-28	WOS:000344631400046
J	Schaefer, GH; ten Brummelaar, T; Gies, DR; Farrington, CD; Kloppenborg, B; Chesneau, O; Monnier, JD; Ridgway, ST; Scott, N; Tallon-Bosc, I; McAlister, HA; Boyajian, T; Maestro, V; Mourard, D; Meilland, A; Nardetto, N; Stee, P; Sturmann, J; Vargas, N; Baron, F; Ireland, M; Baines, EK; Che, X; Jones, J; Richardson, ND; Roettenbacher, RM; Sturmann, L; Turner, NH; Tuthill, P; van Belle, G; von Braun, K; Zavala, RT; Banerjee, DPK; Ashok, NM; Joshi, V; Becker, J; Muirhead, PS				Schaefer, G. H.; ten Brummelaar, T.; Gies, D. R.; Farrington, C. D.; Kloppenborg, B.; Chesneau, O.; Monnier, J. D.; Ridgway, S. T.; Scott, N.; Tallon-Bosc, I.; McAlister, H. A.; Boyajian, T.; Maestro, V.; Mourard, D.; Meilland, A.; Nardetto, N.; Stee, P.; Sturmann, J.; Vargas, N.; Baron, F.; Ireland, M.; Baines, E. K.; Che, X.; Jones, J.; Richardson, N. D.; Roettenbacher, R. M.; Sturmann, L.; Turner, N. H.; Tuthill, P.; van Belle, G.; von Braun, K.; Zavala, R. T.; Banerjee, D. P. K.; Ashok, N. M.; Joshi, V.; Becker, J.; Muirhead, P. S.			The expanding fireball of Nova Delphini 2013	NATURE			English	Article							CLASSICAL NOVAE; INTERFEROMETRIC OBSERVATIONS; SPECTROSCOPIC EVOLUTION; RECURRENT NOVAE; T PYXIDIS; OUTBURST; SHELLS; SPECTROGRAPH; REMNANTS; PHASE	A classical nova occurs when material accreting onto the surface of a white dwarf in a close binary system ignites in a thermonuclear runaway(1,2). Complex structures observed in the ejecta at late stages(3-5) could result from interactions with the companion during the common-envelope phase(6,7). Alternatively, the explosion could be intrinsically bipolar, resulting from a localized ignition on the surface of the white dwarf(8) or as a consequence of rotational distortion(9,10). Studying the structure of novae during the earliest phases is challenging because of the high spatial resolution needed to measure their small sizes(11). Here we report near-infrared interferometric measurements of the angular size of Nova Delphini 2013, starting one day after the explosion and continuing with extensive time coverage during the first 43 days. Changes in the apparent expansion rate can be explained by an explosion model consisting of an optically thick core surrounded by a diffuse envelope. The optical depth of the ejected material changes as it expands. We detect an ellipticity in the light distribution, suggesting a prolate or bipolar structure that develops as early as the second day. Combining the angular expansion rate with radial velocity measurements, we derive a geometric distance to the nova of 4.54 +/- 60.59 kiloparsecs from the Sun.	[Schaefer, G. H.; ten Brummelaar, T.; Farrington, C. D.; Scott, N.; Sturmann, J.; Vargas, N.; Sturmann, L.; Turner, N. H.] Georgia State Univ, CHARA Array, Mt Wilson Observ, Mt Wilson, CA 91023 USA; [Gies, D. R.; Kloppenborg, B.; McAlister, H. A.; Baron, F.; Jones, J.] Georgia State Univ, Ctr High Angular Resolut Astron, Atlanta, GA 30302 USA; [Gies, D. R.; Kloppenborg, B.; McAlister, H. A.; Baron, F.; Jones, J.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30302 USA; [Chesneau, O.; Mourard, D.; Meilland, A.; Nardetto, N.; Stee, P.] Univ Sophia Antipolis UNS, CNRS, Observ Cote Azur, Lab Lagrange,UMR 7293, F-06304 Nice 4, France; [Monnier, J. D.; Che, X.; Roettenbacher, R. M.; Becker, J.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Ridgway, S. T.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Tallon-Bosc, I.] Univ Lyon 1, Observ Lyon, F-69230 St Genis Laval, France; [Tallon-Bosc, I.] Ecole Normale Super Lyon, Ctr Rech Astrophys Lyon, CNRS, UMR 5574, F-69007 Lyon, France; [Boyajian, T.] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Maestro, V.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Ireland, M.] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT 2611, Australia; [Baines, E. K.] Naval Res Lab, Remote Sensing Div, Washington, DC 20375 USA; [Richardson, N. D.] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Richardson, N. D.] Univ Montreal, CRAQ, Montreal, PQ H3C 3J7, Canada; [van Belle, G.] Lowell Observ, Flagstaff, AZ 86001 USA; [von Braun, K.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Zavala, R. T.] US Naval Observ, Flagstaff Stn, Flagstaff, AZ 86001 USA; [Banerjee, D. P. K.; Ashok, N. M.; Joshi, V.] Phys Res Lab, Astron & Astrophys Div, Ahmadabad 380009, Gujarat, India; [Becker, J.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91106 USA; [Muirhead, P. S.] Boston Univ, Dept Astron, Boston, MA 02215 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Michigan System; University of Michigan; National Optical Astronomy Observatory; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); Yale University; University of Sydney; Australian National University; United States Department of Defense; United States Navy; Naval Research Laboratory; Universite de Montreal; Universite de Montreal; Max Planck Society; Department of Space (DoS), Government of India; Physical Research Laboratory - India; California Institute of Technology; Boston University	Schaefer, GH (corresponding author), Georgia State Univ, CHARA Array, Mt Wilson Observ, Mt Wilson, CA 91023 USA.	schaefer@chara-array.org	van Belle, Gerard/ABE-1321-2021; Zavala, Robert/D-7821-2011; Muirhead, Philip Steven/H-2273-2014; Nardetto, Nicolas/GSE-2085-2022	van Belle, Gerard/0000-0002-8552-158X; Zavala, Robert/0000-0002-9402-2870; Muirhead, Philip Steven/0000-0002-0638-8822; Ireland, Michael/0000-0002-6194-043X; Tuthill, Peter/0000-0001-7026-6291; Richardson, Noel/0000-0002-2806-9339; STEE, Philippe/0000-0001-8220-0636; Monnier, John D/0000-0002-3380-3307; Becker, Juliette/0000-0002-7733-4522; Jones, Jeremy/0000-0003-3045-5148; Boyajian, Tabetha/0000-0001-9879-9313; Roettenbacher, Rachael M/0000-0002-9288-3482	National Science Foundation [AST-1009080]; National Science Foundation through NSF grants [AST 0908253, AST 1211129]; Georgia State University through the College of Arts and Sciences; National Aeronautics and Space Administration; National Science Foundation; Direct For Mathematical & Physical Scien [1009080, 1411654, 1445935, 1211929] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Science Foundation through NSF grants; Georgia State University through the College of Arts and Sciences; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge the variable star observations from the AAVSO International Database contributed by observers worldwide and used in this research. We thank O. Garde and other members of the Astronomical Ring for Access to Spectroscopy for use of their archive of Nova Del 2013 spectra. We thank G. J. Schwarz, S. N. Shore, and F. M. Walter for discussions that helped us to interpret the nova observations. This material is based upon work supported by the National Science Foundation under grant number AST-1009080. The CHARA Array is funded by the National Science Foundation through NSF grants AST 0908253 and AST 1211129, and by Georgia State University through the College of Arts and Sciences. This publication made use of data products from the Two Micron All Sky Survey, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by the National Aeronautics and Space Administration and the National Science Foundation.	Banerjee D. P. K., 2013, ASTRON TELEGR, V5404, P1; Bode MF, 2008, CAM ASTROPH, P1; Bonneau D, 2006, ASTRON ASTROPHYS, V456, P789, DOI 10.1051/0004-6361:20054469; Boyajian TS, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/40; Chesneau O, 2007, ASTRON ASTROPHYS, V464, P119, DOI 10.1051/0004-6361:20066609; Chesneau O, 2012, B ASTRON SOC INDIA, V40, P267; Chesneau O, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219825; Chesneau O, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117792; Crepp JR, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/97; Cushing MC, 2004, PUBL ASTRON SOC PAC, V116, P362, DOI 10.1086/382907; Das RK, 2008, MON NOT R ASTRON SOC, V391, P1874, DOI 10.1111/j.1365-2966.2008.13998.x; Deacon NR, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201423665; Downes RA, 2000, ASTRON J, V120, P2007, DOI 10.1086/301551; GEHRZ RD, 1988, ANNU REV ASTRON ASTR, V26, P377; Gill CD, 1999, MON NOT R ASTRON SOC, V307, P677, DOI 10.1046/j.1365-8711.1999.02681.x; Henden A, 2013, AAVSO INT DATABASE; Herter TL, 2008, PROC SPIE, V7014, DOI 10.1117/12.789660; HJELLMING RM, 1979, ASTRON J, V84, P1619, DOI 10.1086/112585; Ireland MJ, 2006, PROC SPIE, V6268, DOI 10.1117/12.670940; Lane BF, 2007, ASTROPHYS J, V669, P1150, DOI 10.1086/521700; LIVIO M, 1990, ASTROPHYS J, V356, P250, DOI 10.1086/168836; Lloyd HM, 1997, MON NOT R ASTRON SOC, V284, P137, DOI 10.1093/mnras/284.1.137; Markwardt CB, 2009, ASTR SOC P, V411, P251; Monnier J. D., 2006, P SPIE, V6268; Muirhead PS, 2011, PUBL ASTRON SOC PAC, V123, P709, DOI 10.1086/660802; Munari U., 2013, INFORM B VARIABLE ST, V6080, P1; Nakano S., 2013, CENTRAL BUREAU ELECT, V3628, P1; ORIO M, 1993, ASTROPHYS SPACE SCI, V202, P273, DOI 10.1007/BF00626882; Porter JM, 1998, MON NOT R ASTRON SOC, V296, P943, DOI 10.1046/j.1365-8711.1998.01470.x; PRESS WH, 1992, NUMERICAL RECIPES; Scott AD, 2000, MON NOT R ASTRON SOC, V313, P775, DOI 10.1046/j.1365-8711.2000.03300.x; Shore SN, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220337; Shore SN, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117721; Shore S. N., 2013, ASTRONOMERS TELEGRAM, V5410, P1; Shore S. N., 2013, ASTRON TELEGR, V5410, P1; Shore S. N., 2013, ASTRON TELEGR, V5312, P1; Shore SN, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322470; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; SLAVIN AJ, 1995, MON NOT R ASTRON SOC, V276, P353, DOI 10.1093/mnras/276.2.353; Taranova OG, 2014, ASTRON LETT+, V40, P120, DOI 10.1134/S1063773714030086; Ten Brummelaar TA, 2013, J ASTRON INSTRUM, V2, DOI 10.1142/S2251171713400047; ten Brummelaar TA, 2005, ASTROPHYS J, V628, P453, DOI 10.1086/430729; Tuthill P, 2006, PROC SPIE, V6268, DOI 10.1117/12.672277; Vacca WD, 2003, PUBL ASTRON SOC PAC, V115, P389, DOI 10.1086/346193; Wade RA, 2000, PUBL ASTRON SOC PAC, V112, P614, DOI 10.1086/316566; Wilson JC, 2004, P SOC PHOTO-OPT INS, V5492, P1295, DOI 10.1117/12.550925; Woudt PA, 2009, ASTROPHYS J, V706, P738, DOI 10.1088/0004-637X/706/1/738; Wren J., 2013, ASTRON TELEGR, V5316, P1; [No title captured]	49	54	54	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					234	U182		10.1038/nature13834	http://dx.doi.org/10.1038/nature13834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25363778	Green Submitted			2022-12-28	WOS:000344631400042
J	Harcourt, J; Barraclough, K; Bronstein, AM				Harcourt, Jonny; Barraclough, Kevin; Bronstein, Adolfo M.			Meniere's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOUBLE-BLIND; DEXAMETHASONE; INJECTION; SURGERY; VERTIGO		[Harcourt, Jonny] Charing Cross Hosp, London, England; [Barraclough, Kevin] Hoyland House, Painswick, Glos, England; [Bronstein, Adolfo M.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London; Imperial College London	Harcourt, J (corresponding author), Charing Cross Hosp, London, England.	jonnyharcourt@btinternet.com			MRC [G0600183, MC_U950770497, MR/J004685/1] Funding Source: UKRI; Medical Research Council [MC_U950770497, G0600183, MR/J004685/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARRACLOUGH K, 2009, BMJ-BRIT MED J, V339, P749; Boleas-Aguirre MS, 2008, OTOL NEUROTOL, V29, P33, DOI 10.1097/mao.0b013e31815dbafc; Bronstein A, 2007, PRACTICAL APPROACH D; Burgess A, 2006, COCHRANE DB SYST REV; Chia SH, 2004, OTOL NEUROTOL, V25, P544, DOI 10.1097/00129492-200407000-00023; Drachman DA, 1972, NEUROLOGY, V22, P223; EVANS JG, 1990, AGE AGEING, V19, P43, DOI 10.1093/ageing/19.1.43; Fiorino F, 2011, EUR ARCH OTO-RHINO-L, V268, P181, DOI 10.1007/s00405-010-1353-5; Garduno-Anaya MA, 2005, OTOLARYNG HEAD NECK, V133, P285, DOI 10.1016/j.otohns.2005.05.010; Harris JP, 2010, AUDIOL NEURO-OTOL, V15, P318, DOI 10.1159/000286213; Huon LK, 2012, OTOL NEUROTOL, V33, P706, DOI 10.1097/MAO.0b013e318259b3b1; James AL, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001873; Kentala E, 1996, AM J OTOL, V17, P883; McCormick A, 1995, MORBIDITY STATISTICS; Naftalin L, 1963, J LARYNGOL OTOL, V77, P827; ODKVIST LM, 1988, ACTA OTO-LARYNGOL, P82; SILVERSTEIN H, 1989, OTOLARYNG HEAD NECK, V100, P6, DOI 10.1177/019459988910000102; THOMAS K, 1971, P ROY SOC MED, V64, P853, DOI 10.1177/003591577106400823; THOMSEN J, 1981, ARCH OTOLARYNGOL, V107, P271; van Cruijsen N, 2006, INT J AUDIOL, V45, P496, DOI 10.1080/14992020600753239	20	44	49	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2014	349								g6544	10.1136/bmj.g6544	http://dx.doi.org/10.1136/bmj.g6544			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JR	25391837				2022-12-28	WOS:000345445000001
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING How will we know if Obamacare has "worked"?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA		Kamerow, D (corresponding author), Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Abelson R, 2014, NY TIMES, pA17; Quealy Kevin, 2014, NY TIMES; Sanger-Katz M, 2014, NEW YORK TIMES  1027, pA16; Tavernise S, 2014, NY TIMES, pA16	4	2	2	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2014	349								g6725	10.1136/bmj.g6725	http://dx.doi.org/10.1136/bmj.g6725			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JP	25384389				2022-12-28	WOS:000345444800013
J	Litos, M; Adli, E; An, W; Clarke, CI; Clayton, CE; Corde, S; Delahaye, JP; England, RJ; Fisher, AS; Frederico, J; Gessner, S; Green, SZ; Hogan, MJ; Joshi, C; Lu, W; Marsh, KA; Mori, WB; Muggli, P; Vafaei-Najafabadi, N; Walz, D; White, G; Wu, Z; Yakimenko, V; Yocky, G				Litos, M.; Adli, E.; An, W.; Clarke, C. I.; Clayton, C. E.; Corde, S.; Delahaye, J. P.; England, R. J.; Fisher, A. S.; Frederico, J.; Gessner, S.; Green, S. Z.; Hogan, M. J.; Joshi, C.; Lu, W.; Marsh, K. A.; Mori, W. B.; Muggli, P.; Vafaei-Najafabadi, N.; Walz, D.; White, G.; Wu, Z.; Yakimenko, V.; Yocky, G.			High-efficiency acceleration of an electron beam in a plasma wakefield accelerator	NATURE			English	Article								High-efficiency acceleration of charged particle beams at high gradients of energy gain per unit length is necessary to achieve an affordable and compact high-energy collider. The plasma wakefield accelerator is one concept(1-3) being developed for this purpose. In plasma wakefield acceleration, a charge-density wake with high accelerating fields is driven by the passage of an ultra-relativistic bunch of charged particles (the drive bunch) through a plasma(4-6). If a second bunch of relativistic electrons (the trailing bunch) with sufficient charge follows in the wake of the drive bunch at an appropriate distance, it can be efficiently accelerated to high energy. Previous experiments using just a single 42-gigaelectronvolt drive bunch have accelerated electrons with a continuous energy spectrum and a maximum energy of upto 85 gigaelectronvolts from the tail of the same bunch in less than a metre of plasma(7). However, the total charge of these accelerated electrons was insufficient to extract a substantial amount of energy from the wake. Here we report high-efficiency acceleration of a discrete trailing bunch of electrons that contains sufficient charge to extract a substantial amount of energy from the high-gradient, non-linear plasma wakefield accelerator. Specifically, we show the acceleration of about 74 picocoulombs of charge contained in the core of the trailing bunch in an accelerating gradient of about 4.4 gigavolts per metre. These core particles gain about 1.6 gigaelectronvolts of energy per particle, with a final energy spread as low as 0.7 per cent (2.0 per cent on average), and an energy-transfer efficiency from the wake to the bunch that can exceed 30 per cent (17.7 per cent on average). This acceleration of a distinct bunch of electrons containing a substantial charge and having a small energy spread with both a high accelerating gradient and a high energy-transfer efficiency represents a milestone in the development of plasma wakefield acceleration into a compact and affordable accelerator technology.	[Litos, M.; Adli, E.; Clarke, C. I.; Corde, S.; Delahaye, J. P.; England, R. J.; Fisher, A. S.; Frederico, J.; Gessner, S.; Green, S. Z.; Hogan, M. J.; Walz, D.; White, G.; Wu, Z.; Yakimenko, V.; Yocky, G.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Adli, E.] Univ Oslo, Dept Phys, N-0316 Oslo, Norway; [An, W.; Mori, W. B.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Clayton, C. E.; Joshi, C.; Marsh, K. A.; Vafaei-Najafabadi, N.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; [Lu, W.] Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China; [Muggli, P.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Oslo; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Tsinghua University; Max Planck Society	Litos, M (corresponding author), SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.	litos@slac.stanford.edu	England, Robert Joel/ABF-3894-2020; Lu, Wei/F-2504-2016	Gessner, Spencer/0000-0002-9713-1116; White, Glen/0000-0002-4469-7757; Litos, Michael/0000-0003-2434-8207	United States Department of Energy; DOE [DE-AC02-76SF00515, DE-FG02-92-ER40727, DE-SC0010064, DE-SC0008491, DE-SC0008316]; Research Council of Norway; NSF [ACI-1339893, PHY-0960344]; NSFC [11175102]; Thousand Young Talents Program; Tsinghua University Initiative Scientific Research Program; Direct For Computer & Info Scie & Enginr [1339893] Funding Source: National Science Foundation	United States Department of Energy(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Research Council of Norway(Research Council of Norway); NSF(National Science Foundation (NSF)); NSFC(National Natural Science Foundation of China (NSFC)); Thousand Young Talents Program(Chinese Academy of Sciences); Tsinghua University Initiative Scientific Research Program; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The FACET E200 plasma wakefield acceleration experiment was built and has been operated with funding from the United States Department of Energy. Work at SLAC was supported by DOE contract DE-AC02-76SF00515 and also through the Research Council of Norway. Work at UCLA was supported by DOE contracts DE-FG02-92-ER40727 and DE-SC0010064. Simulations were performed on the UCLA Hoffman2 and Dawson2 computers and on Blue Waters through NSF OCI-1036224. Simulation work at UCLA was supported by DOE contracts DE-SC0008491 and DE-SC0008316, and NSF contracts ACI-1339893 and PHY-0960344. The work of W. L. was partially supported by NSFC 11175102, the Thousand Young Talents Program and the Tsinghua University Initiative Scientific Research Program.	Adli E., 2013, EL P SNOWM 2013 COMM; An WM, 2013, J COMPUT PHYS, V250, P165, DOI 10.1016/j.jcp.2013.05.020; Barov N., 2001, IEEE P 2001 PART ACC, V1, P126; Bingham R, 2004, PLASMA PHYS CONTR F, V46, pR1, DOI 10.1088/0741-3335/46/1/R01; Blumenfeld I, 2007, NATURE, V445, P741, DOI 10.1038/nature05538; Caldwell A, 2009, NAT PHYS, V5, P363, DOI 10.1038/NPHYS1248; CHEN P, 1985, PHYS REV LETT, V54, P693, DOI 10.1103/PhysRevLett.54.693; Esarey E, 2009, REV MOD PHYS, V81, P1229, DOI 10.1103/RevModPhys.81.1229; Green SZ, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/8/084011; Hogan MJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.054802; Huang C, 2006, J PHYS CONF SER, V46, P190, DOI 10.1088/1742-6596/46/1/026; Joshi C, 2003, PHYS TODAY, V56, P47, DOI 10.1063/1.1595054; KATSOULEAS T, 1986, PHYS REV A, V33, P2056, DOI 10.1103/PhysRevA.33.2056; Lu W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.165002; Muggli P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.014802; Muggli P, 1999, IEEE T PLASMA SCI, V27, P791, DOI 10.1109/27.774685; ROSENZWEIG JB, 1988, PHYS REV LETT, V61, P98, DOI 10.1103/PhysRevLett.61.98; Ruth R. D., 1985, Particle Accelerators, V17, P171; Tzoufras M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.145002	19	343	346	10	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					92	+		10.1038/nature13882	http://dx.doi.org/10.1038/nature13882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373678	Green Submitted			2022-12-28	WOS:000344187500035
J	Moritz, MA; Batllori, E; Bradstock, RA; Gill, AM; Handmer, J; Hessburg, PF; Leonard, J; McCaffrey, S; Odion, DC; Schoennagel, T; Syphard, AD				Moritz, Max A.; Batllori, Enric; Bradstock, Ross A.; Gill, A. Malcolm; Handmer, John; Hessburg, Paul F.; Leonard, Justin; McCaffrey, Sarah; Odion, Dennis C.; Schoennagel, Tania; Syphard, Alexandra D.			Learning to coexist with wildfire	NATURE			English	Review							WILDLAND-URBAN INTERFACE; FIRE REGIMES; CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; MEDITERRANEAN BASIN; RISK-MANAGEMENT; WESTERN US; FOREST; FUEL; FUTURE	The impacts of escalating wildfire in many regions - the lives and homes lost, the expense of suppression and the damage to ecosystem services - necessitate a more sustainable coexistence with wildfire. Climate change and continued development on fire-prone landscapes will only compound current problems. Emerging strategies for managing ecosystems and mitigating risks to human communities provide some hope, although greater recognition of their inherent variation and links is crucial. Without a more integrated framework, fire will never operate as a natural ecosystem process, and the impact on society will continue to grow. A more coordinated approach to risk management and land-use planning in these coupled systems is needed.	[Moritz, Max A.; Batllori, Enric] Univ Calif Berkeley, Div Ecosyst Sci, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Bradstock, Ross A.] Univ Wollongong, Wollongong, NSW 2522, Australia; [Gill, A. Malcolm] Australian Natl Univ, Canberra, ACT 0200, Australia; [Handmer, John] RMIT Univ, Melbourne, Vic 3000, Australia; [Hessburg, Paul F.; McCaffrey, Sarah] US Forest Serv, Washington, DC 20250 USA; [Leonard, Justin] CSIRO, Clayton, Vic 3169, Australia; [Odion, Dennis C.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Schoennagel, Tania] Univ Colorado, Boulder, CO 80309 USA; [Syphard, Alexandra D.] Conservat Biol Inst, Corvallis, OR 97333 USA	University of California System; University of California Berkeley; University of Wollongong; Australian National University; Royal Melbourne Institute of Technology (RMIT); United States Department of Agriculture (USDA); United States Forest Service; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Santa Barbara; University of Colorado System; University of Colorado Boulder	Moritz, MA (corresponding author), Univ Calif Berkeley, Div Ecosyst Sci, Dept Environm Sci Policy & Management, 130 Mulford Hall, Berkeley, CA 94720 USA.	mmoritz@berkeley.edu	Batllori, Enric/A-5695-2018; leonard, justin/T-1057-2019	Batllori, Enric/0000-0002-2130-0489; Syphard, Alexandra/0000-0003-3070-0596	NSF [EF-0553768]; University of California, Santa Barbara; State of California	NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	We would like to thank V. Butsic, S. Cole Moritz, C. English and K. McLeod for comments on drafts of the manuscript, as well as P. Morgan for suggestions that greatly improved the final version. Some of this work was conducted while M. A. M. was a Center Fellow at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant # EF-0553768), the University of California, Santa Barbara, and the State of California.	Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Allen CD, 2002, ECOL APPL, V12, P1418; [Anonymous], ECOSPHERE; Attiwill PM, 2014, CONSERV LETT, V7, P341, DOI 10.1111/conl.12062; Baker W. L., 2008, Open Forest Science Journal, V1, P1, DOI 10.2174/1874398600801010001; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Bar-Massada A, 2014, BIOSCIENCE, V64, P429, DOI 10.1093/biosci/biu039; Berkes Fikret, 1998, LINKING SOCIAL ECOLO; Blanchi R., 2008, Community bushfire safety, P77; Bovio G, 1997, INT J WILDLAND FIRE, V7, P249, DOI 10.1071/WF9970249; Bradstock RA, 2010, GLOBAL ECOL BIOGEOGR, V19, P145, DOI 10.1111/j.1466-8238.2009.00512.x; Bradstock RA, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P307; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Burby RJ, 2006, ANN AM ACAD POLIT SS, V604, P171, DOI 10.1177/0002716205284676; Buxton M, 2011, GEOGR RES-AUST, V49, P1, DOI 10.1111/j.1745-5871.2010.00670.x; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; Castellnou M., 2010, BEST PRACTICES FIRE, P3; Chapin FS, 2008, BIOSCIENCE, V58, P531, DOI 10.1641/B580609; Chapin FS, 2006, P NATL ACAD SCI USA, V103, P16637, DOI 10.1073/pnas.0606955103; Cohen JD, 2004, CAN J FOREST RES, V34, P1616, DOI 10.1139/X04-049; Cohen JD, 2000, J FOREST, V98, P15; Cook GD, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P293; Cova TJ, 2013, GEOJOURNAL, V78, P273, DOI 10.1007/s10708-011-9419-5; Cruz MG, 2010, INT J WILDLAND FIRE, V19, P377, DOI 10.1071/WF08132; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dillon GK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00271.1; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Dunlop M., 2012, IMPLICATIONS CLIMATE; FAO, 2006, FIR MAN VOL GUID PRI; Fernandes PM, 2013, LANDSCAPE URBAN PLAN, V110, P175, DOI 10.1016/j.landurbplan.2012.10.014; Foote E. I. D., 1991, P 11 C FIR FOR MET, P16; Forest Fire Management Group, 2012, NAT BUSHF MAN POL ST; Forests and Rangelands, 2014, NAT STRAT FIN PHAS D; Franklin S. E., 1996, AM FIRE J, V40, P20; Fuhlendorf SD, 2002, LANDSCAPE ECOL, V17, P617, DOI 10.1023/A:1021592817039; Galiana-Martin L, 2011, LANDSCAPE RES, V36, P151, DOI 10.1080/01426397.2010.549218; Gibbons P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029212; Gill A. M., 2005, Environmental Hazards, V6, P65, DOI 10.1016/j.hazards.2005.10.005; Gill AM, 2013, ECOL APPL, V23, P438, DOI 10.1890/10-2213.1; GrissinoMayer HD, 1997, HOLOCENE, V7, P235, DOI 10.1177/095968369700700212; Gude P, 2008, J FOREST, V106, P198; Handmer J., 2005, Environmental Hazards, V6, P65, DOI 10.1016/j.hazards.2005.10.006; Hannah L, 2014, TRENDS ECOL EVOL, V29, P390, DOI 10.1016/j.tree.2014.04.006; Hessburg PF, 2007, LANDSCAPE ECOL, V22, P5, DOI 10.1007/s10980-007-9098-2; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Jakes PJ, 2012, INT J WILDLAND FIRE, V21, P764, DOI 10.1071/WF11086; Keeley J.E., 2009, ECOLOGICAL FDN FIRE; Koutsias N, 2012, AGR FOREST METEOROL, V156, P41, DOI 10.1016/j.agrformet.2011.12.006; Krawchuk MA, 2011, ECOLOGY, V92, P121, DOI 10.1890/09-1843.1; Lampin-Maillet C, 2010, J ENVIRON MANAGE, V91, P732, DOI 10.1016/j.jenvman.2009.10.001; Leonard J., 2009, BUILDING LAND USE PL; Lowell K, 2009, INT J WILDLAND FIRE, V18, P1010, DOI 10.1071/WF08077; Manzello SL, 2009, FIRE SAFETY J, V44, P894, DOI 10.1016/j.firesaf.2009.05.001; Mazzoleni S., 2004, RECENT DYNAMICS MEDI; McCaffrey S, 2004, SOC NATUR RESOUR, V17, P509, DOI 10.1080/08941920490452445; McCaffrey S.M., 2012, NRS104 USDA FOR SERV; McCaffrey S, 2013, INT J WILDLAND FIRE, V22, P15, DOI 10.1071/WF11115; Mcdonald RI, 2009, LANDSCAPE URBAN PLAN, V93, P63, DOI 10.1016/j.landurbplan.2009.06.002; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mooney S. D., 2012, FLAMMABLE AUSTR FIRE, P293; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Moritz MA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041735; Moritz MA, 2004, FRONT ECOL ENVIRON, V2, P67, DOI 10.1890/1540-9295(2004)002[0067:TABAOS]2.0.CO;2; Moritz MA, 2013, ANN NY ACAD SCI, V1286, P92, DOI 10.1111/nyas.12104; Moritz MA, 2011, ECOL STUD-ANAL SYNTH, V213, P51, DOI 10.1007/978-94-007-0301-8_3; Murphy BP, 2013, J BIOGEOGR, V40, P1048, DOI 10.1111/jbi.12065; Myers R. L., 2006, LIVING FIRE SUSTANIN; NAVEH Z, 1994, ROLE FIRE MEDITERRAN, P163, DOI DOI 10.1007/978-1-4613-8395-6_9; Nimmo DG, 2014, ECOGRAPHY, V37, P805, DOI 10.1111/ecog.00684; Noss RF, 2006, FRONT ECOL ENVIRON, V4, P481, DOI 10.1890/1540-9295(2006)4[481:MFFITW]2.0.CO;2; Odion DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087852; Olsen CS, 2013, INT J WILDLAND FIRE, V22, P822, DOI 10.1071/WF12086; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Pausas JG, 2007, GLOBAL ECOL BIOGEOGR, V16, P330, DOI 10.1111/j.1466-8238.2006.00283.x; Pausas JG, 2012, CLIMATIC CHANGE, V110, P215, DOI 10.1007/s10584-011-0060-6; Paveglio TB, 2009, ENVIRON MANAGE, V43, P1085, DOI 10.1007/s00267-009-9282-z; Penman TD, 2013, INT J DISAST RISK RE, V6, P67, DOI 10.1016/j.ijdrr.2013.09.001; Penman TD, 2011, INT J WILDLAND FIRE, V20, P721, DOI 10.1071/WF09131; Perry DA, 2011, FOREST ECOL MANAG, V262, P703, DOI 10.1016/j.foreco.2011.05.004; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Russell-Smith J, 2007, INT J WILDLAND FIRE, V16, P361, DOI 10.1071/WF07018; San-Miguel-Ayanz J, 2013, FOREST ECOL MANAG, V294, P11, DOI 10.1016/j.foreco.2012.10.050; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Schoennagel T, 2011, FRONT ECOL ENVIRON, V9, P271, DOI 10.1890/090199; Schoennagel T, 2009, P NATL ACAD SCI USA, V106, P10706, DOI 10.1073/pnas.0900991106; Silva J.S., 2010, INTEGRATED FIRE MANA; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Stockmann K, 2010, FOREST POLICY ECON, V12, P147, DOI 10.1016/j.forpol.2009.09.009; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Syphard A. D., 2012, PLOS ONE, V7; Syphard AD, 2014, INT J WILDLAND FIRE, V23, P1165, DOI 10.1071/WF13158; Syphard AD, 2011, FOREST ECOL MANAG, V261, P2038, DOI 10.1016/j.foreco.2011.02.030; Theobald DM, 2007, LANDSCAPE URBAN PLAN, V83, P340, DOI 10.1016/j.landurbplan.2007.06.002; Toman E, 2013, SOCIAL SCI WILDLAND; Trabaud L.V., 1993, FIRE ENV ITS ECOLOGI, P277; TURNER MG, 1994, LANDSCAPE ECOL, V9, P59, DOI 10.1007/BF00135079; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; vanWilgen BW, 1996, BIOSCIENCE, V46, P184, DOI 10.2307/1312739; Viegas DX, 2009, EARTH OBSERVATION OF WILDLAND FIRES IN MEDITERRANEAN ECOSYSTEMS, P97, DOI 10.1007/978-3-642-01754-4_8; Whittaker J, 2013, INT J WILDLAND FIRE, V22, P841, DOI 10.1071/WF12010; Whittaker J, 2010, AUST J EMERG MANAG, V25, P7; ZEDLER PH, 1983, ECOLOGY, V64, P809, DOI 10.2307/1937204	103	538	544	26	427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					58	66		10.1038/nature13946	http://dx.doi.org/10.1038/nature13946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373675				2022-12-28	WOS:000344187500029
J	Hodi, FS; Lee, S; McDermott, DF; Rao, UN; Butterfield, LH; Tarhini, AA; Leming, P; Puzanov, I; Shin, D; Kirkwood, JM				Hodi, F. Stephen; Lee, Sandra; McDermott, David F.; Rao, Uma N.; Butterfield, Lisa H.; Tarhini, Ahmad A.; Leming, Philip; Puzanov, Igor; Shin, Donghoon; Kirkwood, John M.			Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLONY-STIMULATING FACTOR; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; BONE-MARROW CULTURES; REGULATORY T-CELLS; GM-CSF; COMBINATION IMMUNOTHERAPY; PROSTATE-CANCER; ANTIBODY BLOCKADE; CTLA4 BLOCKADE; IMMUNE	IMPORTANCE Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blockade with ipilimumab prolongs survival in patients with metastatic melanoma. CTLA-4 blockade and granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting tumor vaccine combinations demonstrate therapeutic synergy in preclinical models. A key unanswered question is whether systemic GM-CSF (sargramostim) enhances CTLA-4 blockade. OBJECTIVE To compare the effect of ipilimumab plus sargramostim vs ipilimumab alone on overall survival (OS) in patients with metastatic melanoma. DESIGN, SETTING, AND PARTICIPANTS The Eastern Cooperative Oncology Group (ECOG) conducted a US-based phase 2 randomized clinical trial from December 28, 2010, until July 28, 2011, of patients (N = 245) with unresectable stage III or IV melanoma, at least 1 prior therapy, no central nervous system metastases, and ECOG performance status of 0 or 1. INTERVENTIONS Patients were randomized to receive ipilimumab, 10mg/kg, intravenously on day 1 plus sargramostim, 250 mu g subcutaneously, on days 1 to 14 of a 21-day cycle (n = 123) vs ipilimumab alone (n = 122). Ipilimumab treatment included induction for 4 cycles followed by maintenance every fourth cycle. MAIN OUTCOMES AND MEASURES Primary end point: comparison of length of OS. Secondary end point: progression-free survival (PFS), response rate, safety, and tolerability. RESULTS Median follow-up was 13.3 months (range, 0.03-19.9). As of December 2012, median OS and 1-year survival for the ipilimumab plus sargramostim group vs ipilimumab alone were significantly different. [GRAPHICS] A planned interim analysis was conducted at 69.8% of expected events (104 observed of 149 expected deaths) and the O'Brien-Fleming boundary was crossed for improvement in OS. There was no difference in PFS. Adverse events were more common in the ipilimumab-only group. CONCLUSION AND RELEVANCE Among patients with unresectable stage III or IV melanoma, treatment with ipilimumab plus sargramostim vs ipilimumab alone resulted in longer OS and lower toxicity, but no difference in PFS. These findings require confirmation in larger studies with longer follow-up. Copyright 2014 American Medical Association. All rights reserved.	[Hodi, F. Stephen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lee, Sandra; Shin, Donghoon] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Lee, Sandra; McDermott, David F.; Shin, Donghoon] Harvard Univ, Sch Med, Boston, MA USA; [McDermott, David F.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Rao, Uma N.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Butterfield, Lisa H.; Tarhini, Ahmad A.; Kirkwood, John M.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Leming, Philip] Christ Hosp Canc Ctr, Cincinnati, OH USA; [Leming, Philip] Univ Cincinnati, Dept Med, Cincinnati, OH USA; [Puzanov, Igor] Vanderbilt Univ, Dept Med, Div Hematol & Oncol, Nashville, TN USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Christ Hospital - Ohio; University System of Ohio; University of Cincinnati; Vanderbilt University	Hodi, FS (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	stephen_hodi@dfci.harvard.edu	Butterfield, Lisa H./W-1564-2019; PUZANOV, IGOR/AAP-2966-2020	Butterfield, Lisa H./0000-0002-3439-9844; PUZANOV, IGOR/0000-0002-9803-3497; Shin, Donghoon/0000-0003-1582-6190	Public Health Service [CA23318, CA66636, CA21115, CA80775, CA39229, CA49957, CA32291]; NCI; NATIONAL CANCER INSTITUTE [U10CA066636, U10CA180794, U10CA080775, U10CA023318, P50CA121973, U10CA180867, U10CA180820, U10CA039229, U24CA114737, U10CA032291, U10CA021115, U10CA049957] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: This study was coordinated by ECOG (Robert L. Comis, MD, Chair); supported in part by Public Health Service grants CA23318, CA66636, CA21115, CA80775, CA39229, CA49957, CA32291; and the NCI; NIH; the US Department of Health and Human Services; Bristol-Myers Squibb; and Genzyme.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; COX DR, 1972, J R STAT SOC B, V34, P187; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Dranoff G, 2011, GASTROENTEROLOGY, V141, P28, DOI 10.1053/j.gastro.2011.05.023; Egea L, 2010, EXPERT REV GASTROENT, V4, P723, DOI [10.1586/egh.10.73, 10.1586/EGH.10.73]; Everly JJ, 2005, EXPERT OPIN BIOL TH, V5, P293, DOI 10.1517/14712598.5.3.293; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; FISCHER HG, 1988, J IMMUNOL, V141, P3882; Fong L, 2009, CANCER RES, V69, P609, DOI 10.1158/0008-5472.CAN-08-3529; Fu TH, 2011, CANCER RES, V71, P5445, DOI 10.1158/0008-5472.CAN-11-1138; Fukuzawa H, 2003, BIOCHEM BIOPH RES CO, V312, P897, DOI 10.1016/j.bbrc.2003.11.009; Goldstein JI, 2011, GASTROENTEROLOGY, V141, P208, DOI 10.1053/j.gastro.2011.03.060; Han XN, 2009, GASTROENTEROLOGY, V136, P1261, DOI 10.1053/j.gastro.2008.12.046; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jennison C, 1997, J AM STAT ASSOC, V92, P1330; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Tang DN, 2014, CANCER IMMUNOL RES, V2, P501, DOI 10.1158/2326-6066.CIR-14-0056; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Parmiani G, 2007, ANN ONCOL, V18, P226, DOI 10.1093/annonc/mdl158; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Slingluff CL, 2009, CLIN CANCER RES, V15, P7036, DOI 10.1158/1078-0432.CCR-09-1544; Small EJ, 1999, CLIN CANCER RES, V5, P1738; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; SOTOMAYOR EM, 1991, J IMMUNOL, V147, P2816; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van den Eertwegh AJM, 2012, LANCET ONCOL, V13, P509, DOI 10.1016/S1470-2045(12)70007-4; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; WEISBART RH, 1985, NATURE, V314, P361, DOI 10.1038/314361a0; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310	40	80	80	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1744	1753		10.1001/jama.2014.13943	http://dx.doi.org/10.1001/jama.2014.13943			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25369488	Bronze, Green Accepted			2022-12-28	WOS:000344194500012
J	Cheng, CJ; Bahal, R; Babar, IA; Pincus, Z; Barrera, F; Liu, C; Svoronos, A; Braddock, DT; Glazer, PM; Engelman, DM; Saltzman, WM; Slack, FJ				Cheng, Christopher J.; Bahal, Raman; Babar, Imran A.; Pincus, Zachary; Barrera, Francisco; Liu, Connie; Svoronos, Alexander; Braddock, Demetrios T.; Glazer, Peter M.; Engelman, Donald M.; Saltzman, W. Mark; Slack, Frank J.			MicroRNA silencing for cancer therapy targeted to the tumour microenvironment	NATURE			English	Article							PEPTIDE-NUCLEIC-ACIDS; IN-VIVO; CELL PROLIFERATION; ONCOMIR ADDICTION; TRANSLOCATION; TRANSCRIPTOME; MOLECULES; BARRIERS; DELIVERY; MODEL	MicroRNAs are short non-codingRNAs expressed in different tissue and cell types that suppress the expression of target genes. As such, microRNAs are critical cogs innumerous biological processes(1,2), and dysregulated microRNA expression is correlated with many human diseases. Certain microRNAs, called oncomiRs, play a causal role in the onset and maintenance of cancer when overexpressed. Tumours that depend on these microRNAs are said to display oncomiR addiction(3-5). Some of the most effective anticancer therapies target oncogenes such as EGFR and HER2; similarly, inhibition of oncomiRs using antisense oligomers (that is, antimiRs) is an evolving therapeutic strategy(6,7). However, the in vivo efficacy of current antimiR technologies is hindered by physiological and cellular barriers to delivery into targeted cells(8). Here we introduce a novel antimiR delivery platform that targets the acidic tumour microenvironment, evades systemic clearance by the liver, and facilitates cell entry via a non-endocytic pathway. We find that the attachment of peptide nucleic acid antimiRs to a peptide with a low pH-induced transmembrane structure (pHLIP) produces a novel construct that could target the tumour microenvironment, transport antimiRs across plasma membranes under acidic conditions such as those found in solid tumours (pH approximately 6), and effectively inhibit the miR-155 oncomiR in a mouse model of lymphoma. This study introduces a new model for using antimiRs as anti-cancer drugs, which can have broad impacts on the field of targeted drug delivery.	[Cheng, Christopher J.; Babar, Imran A.; Pincus, Zachary; Liu, Connie; Slack, Frank J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Cheng, Christopher J.; Saltzman, W. Mark] Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA; [Cheng, Christopher J.; Barrera, Francisco; Svoronos, Alexander; Engelman, Donald M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Bahal, Raman; Glazer, Peter M.] Yale Univ, Dept Therapeut Radiol, New Haven, CT 06511 USA; [Braddock, Demetrios T.] Yale Univ, Dept Pathol, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Slack, FJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	fslack@bidmc.harvard.edu	Glazer, Peter/S-7651-2019	Glazer, Peter/0000-0003-4525-5560; Bahal, Raman/0000-0002-4514-8004; Pincus, Zachary/0000-0001-9785-5977; Barrera, Francisco N./0000-0002-5200-7891; Slack, Frank/0000-0001-8263-0409	Ruth L. Kirschstein Postdoctoral Fellowship from the National Cancer Institute/National Institutes of Health (NCI/NIH) [F32CA174247]; NCI/NIH [R01CA131301, R01CA148996]; National Heart, Lung, and Blood Institute (NHLBI)/NIH [R01HL085416]; National Institute of General Medical Sciences (NIGMS)/NIH [R01GM073857]; National Institute of Environmental Health Sciences (NIEHS)/NIH [R01ES005775]; National Institute of Biomedical Imaging and Bioengineering (NIBIB)/NIH [R01EB000487]; NHLBI/NIH [2T32HL007974]; Yale Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [F32CA174247, P30CA016359, R01CA149128, R01CA148996, R01CA131301] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974, R01HL085416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, R01GM073857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG042487] Funding Source: NIH RePORTER	Ruth L. Kirschstein Postdoctoral Fellowship from the National Cancer Institute/National Institutes of Health (NCI/NIH); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute (NHLBI)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences (NIGMS)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Environmental Health Sciences (NIEHS)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Yale Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Bosenberg, Y. Dang, A. Karabadzhak, and J. Zhou for discussions and suggestions; R. Ardito, M. Bonk, K. Card, D. Caruso, D. Jenci, D. Laliberte, W. Nazzaro, N. Santiago, and S. Wilson for rodent services; A. Brooks for tissue pathology services; Antech Diagnostics for complete blood count analysis; E. Aronesty, B. Cooper, and E. Norris at Expression Analysis for RNA-seq services; and J. Deacon, A. Kasinski, J. Sawyer, and C. Stahlhut for reading the manuscript. C. J. C. is the recipient of a Ruth L. Kirschstein Postdoctoral Fellowship from the National Cancer Institute/National Institutes of Health (NCI/NIH) (F32CA174247). Our work has been supported by grants from the NCI/NIH (R01CA131301), the National Heart, Lung, and Blood Institute (NHLBI)/NIH (R01HL085416), the National Institute of General Medical Sciences (NIGMS)/NIH (R01GM073857), the National Institute of Environmental Health Sciences (NIEHS)/NIH (R01ES005775), the NCI/NIH (R01CA148996), the National Institute of Biomedical Imaging and Bioengineering (NIBIB)/NIH (R01EB000487), the NHLBI/NIH (2T32HL007974), and pilot grants from the Yale Comprehensive Cancer Center.	Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; Brognara E, 2014, J NEURO-ONCOL, V118, P19, DOI 10.1007/s11060-014-1405-6; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng CJ, 2013, CURR MED CHEM, V20, P3582; Cheng CJ, 2012, CANCER J, V18, P232, DOI 10.1097/PPO.0b013e318258b75b; Christensen L, 1995, J Pept Sci, V1, P175; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eifel PJ., 2011, DEVITA HELLMAN ROSEN; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabani MM, 2010, NUCLEIC ACIDS RES, V38, P4466, DOI 10.1093/nar/gkq160; Fabbri E, 2011, EPIGENOMICS-UK, V3, P733, DOI [10.2217/EPI.11.90, 10.2217/epi.11.90]; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; HE L, 2004, NAT REV GENET, V5, P522; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li SC, 2012, MOL MED REP, V5, P949, DOI 10.3892/mmr.2012.779; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; NIELSEN PE, 1994, BIOCONJUGATE CHEM, V5, P3, DOI 10.1021/bc00025a001; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rather MI, 2013, J BIOL CHEM, V288, P608, DOI 10.1074/jbc.M112.425736; Reshetnyak YK, 2011, MOL IMAGING BIOL, V13, P1146, DOI 10.1007/s11307-010-0457-z; Reshetnyak YK, 2006, P NATL ACAD SCI USA, V103, P6460, DOI 10.1073/pnas.0601463103; Sahu B, 2011, J ORG CHEM, V76, P5614, DOI 10.1021/jo200482d; Sandhu Sukhinder K, 2011, Adv Hematol, V2011, P347137, DOI 10.1155/2011/347137; Shiraishi Takehiko, 2011, Artif DNA PNA XNA, V2, P90; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Thevenin D, 2009, CHEM BIOL, V16, P754, DOI 10.1016/j.chembiol.2009.06.006; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang YZ, 2014, CLIN EXP IMMUNOL, V176, P207, DOI 10.1111/cei.12265; White PJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001021; Xu GR, 2010, RNA, V16, P1610, DOI 10.1261/rna.2194910; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647	37	577	604	16	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					107	+		10.1038/nature13905	http://dx.doi.org/10.1038/nature13905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25409146	Green Accepted			2022-12-28	WOS:000349098000041
J	Schur, FKM; Hagen, WJH; Rumlova, M; Ruml, T; Muller, B; Krausslich, HG; Briggs, JAG				Schur, Florian K. M.; Hagen, Wim J. H.; Rumlova, Michaela; Ruml, Tomas; Mueller, Barbara; Kraeusslich, Hans-Georg; Briggs, John A. G.			Structure of the immature HIV-1 capsid in intact virus particles at 8.8 angstrom resolution	NATURE			English	Article							MAJOR HOMOLOGY REGION; TYPE-1 GAG PRECURSOR; N-TERMINAL DOMAIN; CRYOELECTRON MICROSCOPY; MOLECULAR-DYNAMICS; HELICAL STRUCTURE; IN-SITU; PROTEIN; TOMOGRAPHY; VISUALIZATION	Human immunodeficiency virus type 1 (HIV-1) assembly proceeds in two stages. First, the 55 kilodalton viral Gag polyprotein assembles into a hexameric protein lattice at the plasma membrane of the infected cell, inducing budding and release of an immature particle. Second, Gag is cleaved by the viral protease, leading to internal rearrangement of the virus into the mature, infectious form(1). Immature and mature HIV-1 particles are heterogeneous in size and morphology, preventing high-resolution analysis of their protein arrangement in situ by conventional structural biology methods. Here we apply cryo-electron tomography and sub -tomogram averaging methods to resolve the structure of the capsid lattice within intact immature HIV-1 particles at subnanometre resolution, allowing unambiguous positioning of all alpha-helices. The resulting model reveals tertiary and quaternary structural interactions that mediate HIV-1 assembly. Strikingly, these interactions differ from those predicted by the current model based on in vitro-assembled arrays of Gag-derived proteins from Mason-Pfizer monkey virus(2). To validate this difference, we solve the structure of the capsid lattice within intact immature Mason-Pfizer monkey virus particles. Comparison with the immature HIV-1 structure reveals that retroviral capsid proteins, while having conserved tertiary structures, adopt different quaternary arrangements during virus assembly. The approach demonstrated here should be applicable to determine structures of other proteins at subnanometre resolution within heterogeneous environments.	[Schur, Florian K. M.; Hagen, Wim J. H.; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Schur, Florian K. M.; Mueller, Barbara; Kraeusslich, Hans-Georg; Briggs, John A. G.] Univ Klinikum Heidelberg, European Mol Biol Lab, Mol Med Partnership Unit, Heidelberg, Germany; [Rumlova, Michaela] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague, Czech Republic; [Rumlova, Michaela] Gilead Res Ctr, Prague 16610, Czech Republic; [Rumlova, Michaela] Inst Chem Technol, Dept Biotechnol, CR-16628 Prague, Czech Republic; [Ruml, Tomas] Inst Chem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic; [Mueller, Barbara; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Infect Dis, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Chemistry & Technology, Prague; University of Chemistry & Technology, Prague; Ruprecht Karls University Heidelberg	Briggs, JAG (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	john.briggs@embl.de	Ruml, Tomas/R-2543-2017; Muller, Barbara/AAC-4483-2020; Rumlova, Michaela/G-9142-2018	Ruml, Tomas/0000-0002-5698-4366; Rumlova, Michaela/0000-0002-5645-8227; Briggs, John/0000-0003-3990-6910; Krausslich, Hans-Georg/0000-0002-8756-329X; /0000-0003-4790-8078; Hagen, Wim/0000-0001-6229-2692; Muller, Barbara/0000-0001-5726-5585	Deutsche Forschungsgemeinschaft [BR 3635/2-1, KR 906/7-1]; Grant Agency of the Czech Republic [14-15326S]; European Molecular Biology Laboratory; Chica und Heinz Schaller Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Molecular Biology Laboratory; Chica und Heinz Schaller Stiftung	This study was supported by Deutsche Forschungsgemeinschaft grants BR 3635/2-1 to J.A.G.B., KR 906/7-1 to H.-G.K. and by Grant Agency of the Czech Republic 14-15326S to M.R. The Briggs laboratory acknowledges financial support from the European Molecular Biology Laboratory and from the Chica und Heinz Schaller Stiftung. We thank B. Glass, M. Anders and S. Mattei for preparation of samples, and R. Hadravova, K. H. Bui, F. Thommen, M. Schorb, S. Dodonova, S. Glatt, P. Ulbrich and T. Bharat for technical support and/or discussion. This study was technically supported by the European Molecular Biology Laboratory IT services unit.	Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Bharat TAM, 2014, P NATL ACAD SCI USA, V111, P8233, DOI 10.1073/pnas.1401455111; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Bohne J, 2004, FEBS LETT, V563, P113, DOI 10.1016/S0014-5793(04)00277-7; Borsetti A, 1998, J VIROL, V72, P9313, DOI 10.1128/JVI.72.11.9313-9317.1998; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017; CHOPRA HC, 1970, CANCER RES, V30, P2081; Chu HH, 2006, J BIOMED SCI, V13, P645, DOI 10.1007/s11373-006-9094-6; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; de Marco A, 2012, J VIROL, V86, P13708, DOI 10.1128/JVI.01704-12; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Fuller SD, 1997, CURR BIOL, V7, P729, DOI 10.1016/S0960-9822(06)00331-9; Fung HB, 2000, CLIN THER, V22, P549, DOI 10.1016/S0149-2918(00)80044-2; Khorasanizadeh S, 1999, J BIOMOL NMR, V14, P199, DOI 10.1023/A:1008307507462; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Macek P, 2009, J MOL BIOL, V392, P100, DOI 10.1016/j.jmb.2009.06.029; MAMMANO F, 1994, J VIROL, V68, P4927, DOI 10.1128/JVI.68.8.4927-4936.1994; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Monroe EB, 2010, STRUCTURE, V18, P1483, DOI 10.1016/j.str.2010.08.016; Morellet N, 2005, PROTEIN SCI, V14, P375, DOI 10.1110/ps.041087605; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Pruggnaller S, 2008, J STRUCT BIOL, V164, P161, DOI 10.1016/j.jsb.2008.05.003; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schur FKM, 2013, J STRUCT BIOL, V184, P394, DOI 10.1016/j.jsb.2013.10.015; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Xiong QR, 2009, J STRUCT BIOL, V168, P378, DOI 10.1016/j.jsb.2009.08.016; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	46	213	216	4	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					505	508		10.1038/nature13838	http://dx.doi.org/10.1038/nature13838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25363765				2022-12-28	WOS:000348196500039
J	Rosenbaum, L				Rosenbaum, Lisa			Communicating Uncertainty - Ebola, Public Health, and the Scientific Process	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2014, CBS NEWS; [Anonymous], 2014, CDCS SURG RESP W AFR; Silver Nate, 2012, SIGNAL NOISE WHY SO; Slovic P., 2014, WASH POST; Sunstein C., 2001, 138 U CHIC LAW SCH O	5	32	32	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					7	9		10.1056/NEJMp1413816	http://dx.doi.org/10.1056/NEJMp1413816			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX7MU	25394322	Bronze			2022-12-28	WOS:000347100800004
J	Whorton, M				Whorton, Matt			STRUCTURAL BIOLOGY Calcium-activated proteins visualized	NATURE			English	Editorial Material							TMEM16A		Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Whorton, M (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	whorton@ohsu.edu						Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang TT, 2014, SCIENCE, V346, P355, DOI 10.1126/science.1259723; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440	12	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					176	178		10.1038/nature13944	http://dx.doi.org/10.1038/nature13944			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25383534				2022-12-28	WOS:000346383500030
J	Dias, C; Feng, J; Sun, HS; Shao, NY; Mazei-Robison, MS; Damez-Werno, D; Scobie, K; Bagot, R; LaBonte, B; Ribeiro, E; Liu, XC; Kennedy, P; Vialou, V; Ferguson, D; Pena, C; Calipari, ES; Koo, JW; Mouzon, E; Ghose, S; Tamminga, C; Neve, R; Shen, L; Nestler, EJ				Dias, Caroline; Feng, Jian; Sun, Haosheng; Shao, Ning yi; Mazei-Robison, Michelle S.; Damez-Werno, Diane; Scobie, Kimberly; Bagot, Rosemary; LaBonte, Benoit; Ribeiro, Efrain; Liu, XiaoChuan; Kennedy, Pamela; Vialou, Vincent; Ferguson, Deveroux; Pena, Catherine; Calipari, Erin S.; Koo, Ja Wook; Mouzon, Ezekiell; Ghose, Subroto; Tamminga, Carol; Neve, Rachael; Shen, Li; Nestler, Eric J.			beta-catenin mediates stress resilience through Dicer1/microRNA regulation	NATURE			English	Article							NUCLEUS-ACCUMBENS; DISTINCT ROLES; SOCIAL DEFEAT; SYNTHASE KINASE-3; STRIATAL NEURONS; TRANSCRIPTION; PATHWAY; REWARD; BDNF; IDENTIFICATION	beta-catenin is a multi-functional protein that has an important role in the mature central nervous system; its dysfunction has been implicated in several neuropsychiatric disorders, including depression. Here we show that in mice beta-catenin mediates pro-resilient and anxiolytic effects in the nucleus accumbens, a key brain reward region, an effect mediated by D2-type medium spiny neurons. Using genome-wide beta-catenin enrichment mapping, we identify Dicer1-important in small RNA (for example, microRNA) biogenesis-as a beta-catenin target gene that mediates resilience. Small RNA profiling after excising beta-catenin fromnucleus accumbens in the context of chronic stress reveals beta-catenin-dependent microRNA regulation associated with resilience. Together, these findings establish beta-catenin as a critical regulator in the development of behavioural resilience, activating a network that includes Dicer1 and downstream microRNAs. Wethus present a foundation for the development of novel therapeutic targets to promote stress resilience.	[Dias, Caroline; Feng, Jian; Sun, Haosheng; Shao, Ning yi; Mazei-Robison, Michelle S.; Damez-Werno, Diane; Scobie, Kimberly; Bagot, Rosemary; LaBonte, Benoit; Ribeiro, Efrain; Liu, XiaoChuan; Kennedy, Pamela; Vialou, Vincent; Ferguson, Deveroux; Pena, Catherine; Calipari, Erin S.; Koo, Ja Wook; Mouzon, Ezekiell; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Dias, Caroline; Feng, Jian; Sun, Haosheng; Shao, Ning yi; Mazei-Robison, Michelle S.; Damez-Werno, Diane; Scobie, Kimberly; Bagot, Rosemary; LaBonte, Benoit; Ribeiro, Efrain; Liu, XiaoChuan; Kennedy, Pamela; Vialou, Vincent; Ferguson, Deveroux; Pena, Catherine; Calipari, Erin S.; Koo, Ja Wook; Mouzon, Ezekiell; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Ghose, Subroto; Tamminga, Carol] Univ Texas Southwestern, Dept Psychiat, Dallas, TX 75390 USA; [Neve, Rachael] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT)	Shen, L (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	li.shen@mssm.edu; eric.nestler@mssm.edu	Bagot, Rosemary/V-4325-2019; Ghose, Subroto/J-6732-2016; Mazei-Robison, Michelle/I-4304-2017; vialou, vincent/F-2968-2013; Labonte, Benoit/GPF-5629-2022; SHAO, Ning-Yi/N-4947-2015; Pena, Catherine Jensen/AAU-3014-2021	Mazei-Robison, Michelle/0000-0002-2372-1420; vialou, vincent/0000-0002-8212-751X; Labonte, Benoit/0000-0002-1251-5605; SHAO, Ning-Yi/0000-0003-4231-828X; Pena, Catherine Jensen/0000-0002-2884-5035; Calipari, Erin/0000-0003-4723-0623	National Institute of Mental Health; Hope for Depression Research Foundation (HDRF); NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R00MH094405] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hope for Depression Research Foundation (HDRF); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank O. Jabado and M. Mahajan for support and S. Borkan for providing beta-catenin constructs. This work was supported by grants from the National Institute of Mental Health and the Hope for Depression Research Foundation (HDRF).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Darvas M, 2011, BIOL PSYCHIAT, V69, P704, DOI 10.1016/j.biopsych.2010.09.033; Feng J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r65; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Goodstadt L, 2010, BIOINFORMATICS, V26, P2778, DOI 10.1093/bioinformatics/btq524; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P2173, DOI 10.1038/sj.npp.1301338; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hodar C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-348; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Issler O, 2014, NEURON, V83, P344, DOI 10.1016/j.neuron.2014.05.042; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Koo JW, 2012, SCIENCE, V338, P124, DOI 10.1126/science.1222265; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Rada P, 2003, NEUROSCIENCE, V119, P557, DOI 10.1016/S0306-4522(03)00162-3; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Robison AJ, 2014, NEUROPSYCHOPHARMACOL, V39, P1178, DOI 10.1038/npp.2013.319; Sadot E, 2002, J CELL SCI, V115, P2771; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Veronese A, 2011, P NATL ACAD SCI USA, V108, P4840, DOI 10.1073/pnas.1101734108; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Wexler EM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002282; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Yawata S, 2012, P NATL ACAD SCI USA, V109, P12764, DOI 10.1073/pnas.1210797109	51	159	162	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					51	U86		10.1038/nature13976	http://dx.doi.org/10.1038/nature13976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25383518	Green Accepted			2022-12-28	WOS:000346310800036
J	FitzGerald, GA				FitzGerald, Garret A.			CIRCADIAN RHYTHMS Temporal targets of drug action	SCIENCE			English	Editorial Material							CLOCK; MICE		Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.	garret@upenn.edu						Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Carrara S, 2012, SENSORS-BASEL, V12, P11013, DOI 10.3390/s120811013; Gerber A, 2013, CELL, V152, P492, DOI 10.1016/j.cell.2012.12.027; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kondratov R, 2014, ANN MED, V46, P189, DOI 10.3109/07853890.2014.920213; Liang X, 2013, J BIOL RHYTHM, V28, P208, DOI 10.1177/0748730413486873; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Paschos GK, 2010, ANNU REV PHARMACOL, V50, P187, DOI 10.1146/annurev.pharmtox.010909.105621; Sinues PML, 2013, ANAL CHEM, V85, P369, DOI 10.1021/ac3029097; Yang GR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007225; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	13	4	4	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					921	922		10.1126/science.aaa2285	http://dx.doi.org/10.1126/science.aaa2285			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414292				2022-12-28	WOS:000345696000020
J	Skinner, LB; Benmore, CJ; Weber, JKR; Williamson, MA; Tamalonis, A; Hebden, A; Wiencek, T; Alderman, OLG; Guthrie, M; Leibowitz, L; Parise, JB				Skinner, L. B.; Benmore, C. J.; Weber, J. K. R.; Williamson, M. A.; Tamalonis, A.; Hebden, A.; Wiencek, T.; Alderman, O. L. G.; Guthrie, M.; Leibowitz, L.; Parise, J. B.			Molten uranium dioxide structure and dynamics	SCIENCE			English	Article							X-RAY-DIFFRACTION; THERMOPHYSICAL PROPERTIES; UO2; VISCOSITY; LIQUIDS	Uranium dioxide (UO2) is the major nuclear fuel component of fission power reactors. A key concern during severe accidents is the melting and leakage of radioactive UO2 as it corrodes through its zirconium cladding and steel containment. Yet, the very high temperatures (>3140 kelvin) and chemical reactivity of molten UO2 have prevented structural studies. In this work, we combine laser heating, sample levitation, and synchrotron x-rays to obtain pair distribution function measurements of hot solid and molten UO2. The hot solid shows a substantial increase in oxygen disorder around the lambda transition (2670 K) but negligible U-O coordination change. On melting, the average U-O coordination drops from 8 to 6.7 +/- 0.5. Molecular dynamics models refined to this structure predict higher U-U mobility than 8-coordinated melts.	[Skinner, L. B.; Benmore, C. J.; Weber, J. K. R.; Tamalonis, A.; Alderman, O. L. G.] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Skinner, L. B.; Parise, J. B.] SUNY Stony Brook, Inst Mineral Phys, Stony Brook, NY 11794 USA; [Skinner, L. B.; Weber, J. K. R.; Alderman, O. L. G.] Mat Dev Inc, Arlington Hts, IL 60004 USA; [Williamson, M. A.; Hebden, A.; Wiencek, T.; Leibowitz, L.] Argonne Natl Lab, Argonne, IL 60439 USA; [Guthrie, M.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Parise, J. B.] Brookhaven Natl Lab, Upton, NY 11973 USA	United States Department of Energy (DOE); Argonne National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Argonne National Laboratory; Carnegie Institution for Science; United States Department of Energy (DOE); Brookhaven National Laboratory	Skinner, LB (corresponding author), Argonne Natl Lab, Xray Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	lawrie.skinner@gmail.com	Skinner, Lawrie/I-2603-2012; Alderman, Oliver/AAK-2212-2020; Guthrie, Malcolm/AAZ-5995-2021	Skinner, Lawrie/0000-0001-7317-1642; Alderman, Oliver/0000-0002-2342-811X; Guthrie, Malcolm/0000-0002-9888-7468; Benmore, Chris/0000-0001-7007-7749	U.S. Department of Energy (DOE), Office of Basic Energy Sciences (BES) [BES DE-FG02-09ER46650]; DOE Small Business Innovation Research grant [DE SC0007564]; Argonne Laboratory Directed Research and Development program; EFree, an Energy Frontier Research Center - DOE, BES [DE-SC0001057]; U.S. DOE, BES [DE-AC02-06CH11357]	U.S. Department of Energy (DOE), Office of Basic Energy Sciences (BES)(United States Department of Energy (DOE)); DOE Small Business Innovation Research grant; Argonne Laboratory Directed Research and Development program; EFree, an Energy Frontier Research Center - DOE, BES; U.S. DOE, BES(United States Department of Energy (DOE))	X-ray diffraction data are available for download in the supplementary materials. We thank R. Spence, D. Robinson, and A. Hasozbek for technical support and useful discussions. This work was supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences (BES), grant BES DE-FG02-09ER46650 (MD simulations, analysis, and manuscript preparation, L.B.S. and J.B.P.); DOE Small Business Innovation Research grant DE SC0007564 (x-ray experiment, J.K.R.W., A.T., and O.L.G.A.), and the Argonne Laboratory Directed Research and Development program (sample preparation and handling). M.G. (data analysis) was supported by EFree, an Energy Frontier Research Center funded by the DOE, BES, under award DE-SC0001057. The Advanced Photon Source, Argonne National Laboratory, is funded under U.S. DOE, BES, contract number DE-AC02-06CH11357.	Andrade END, 1934, PHILOS MAG, V17, P497; Arima T, 2005, J ALLOY COMPD, V400, P43, DOI 10.1016/j.jallcom.2005.04.003; Basak CB, 2003, J ALLOY COMPD, V360, P210, DOI 10.1016/S0925-8388(03)00350-5; Fink JK, 2000, J NUCL MATER, V279, P1, DOI 10.1016/S0022-3115(99)00273-1; Fischer HE, 2006, REP PROG PHYS, V69, P233, DOI 10.1088/0034-4885/69/1/R05; Gunay SD, 2012, J MOL LIQ, V173, P124, DOI 10.1016/j.molliq.2012.06.028; Hennet L, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2646812; Kharecha PA, 2013, ENVIRON SCI TECHNOL, V47, P4889, DOI 10.1021/es3051197; Krishnan S, 2005, CHEM MATER, V17, P2662, DOI 10.1021/cm050254p; LEWIS GV, 1985, J PHYS C SOLID STATE, V18, P1149, DOI 10.1088/0022-3719/18/6/010; Lou HB, 2013, P NATL ACAD SCI USA, V110, P10068, DOI 10.1073/pnas.1307967110; Manara D, 2005, J NUCL MATER, V342, P148, DOI 10.1016/j.jnucmat.2005.04.002; Manara D, 2002, INT J THERMOPHYS, V23, P1147, DOI 10.1023/A:1019879917797; Morelon ND, 2003, PHILOS MAG, V83, P1533, DOI 10.1080/1478643031000091454; Skinner LB, 2013, PHYS CHEM CHEM PHYS, V15, P8566, DOI [10.1039/c3cp44347g, 10.1039/c3cp44347]; Sudreau F, 1997, NUCL ENG DES, V178, P269, DOI 10.1016/S0029-5493(97)00137-4; Yakub E, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2764484	17	54	55	4	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					984	987		10.1126/science.1259709	http://dx.doi.org/10.1126/science.1259709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414311	Green Submitted			2022-12-28	WOS:000345696000041
J	Wang, P; Scherler, D; Jing, LZ; Mey, J; Avouac, JP; Zhang, YD; Shi, DG				Wang, Ping; Scherler, Dirk; Jing Liu-Zeng; Mey, Juergen; Avouac, Jean-Philippe; Zhang, Yunda; Shi, Dingguo			Tectonic control of Yarlung Tsangpo Gorge revealed by a buried canyon in Southern Tibet	SCIENCE			English	Article							NAMCHE-BARWA SYNTAXIS; EASTERN HIMALAYA; RIVER INCISION; BRAHMAPUTRA RIVER; BEDROCK INCISION; ROCK UPLIFT; EVOLUTION; PLATEAU; GROWTH; ARC	The Himalayan mountains are dissected by some of the deepest and most impressive gorges on Earth. Constraining the interplay between river incision and rock uplift is important for understanding tectonic deformation in this region. We report here the discovery of a deeply incised canyon of the Yarlung Tsangpo River, at the eastern end of the Himalaya, which is now buried under more than 500 meters of sediments. By reconstructing the former valley bottom and dating sediments at the base of the valley fill, we show that steepening of the Tsangpo Gorge started at about 2 million to 2.5 million years ago as a consequence of an increase in rock uplift rates. The high erosion rates within the gorge are therefore a direct consequence of rapid rock uplift.	[Wang, Ping; Jing Liu-Zeng] China Earthquake Adm, Inst Geol, State Key Lab Earthquake Dynam, Beijing 100029, Peoples R China; [Scherler, Dirk; Avouac, Jean-Philippe] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Mey, Juergen] Univ Potsdam, Inst Earth & Environm Sci, D-14476 Potsdam, Germany; [Zhang, Yunda; Shi, Dingguo] Chengdu Engn Corp, Chengdu 610072, Peoples R China	China Earthquake Administration; California Institute of Technology; University of Potsdam	Scherler, D (corresponding author), GFZ German Res Ctr Geosci, Sect 3-4, D-14473 Potsdam, Germany.	scherler@caltech.edu	Scherler, Dirk/G-2066-2016; Liu-Zeng, Jing/F-8582-2011; Avouac, Jean-Philippe/B-5699-2015; Liu-Zeng, jing/R-2522-2019	Scherler, Dirk/0000-0003-3911-2803; Avouac, Jean-Philippe/0000-0002-3060-8442; Liu-Zeng, jing/0000-0001-7108-6452; Mey, Jurgen/0000-0002-3171-460X	National Natural Science Foundation of China [41372211, 41172179]; State Key Laboratory for Earthquake Dynamics [LED2013A07]; Alexander von Humboldt Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Earthquake Dynamics; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the National Natural Science Foundation of China (41372211 and 41172179) and the State Key Laboratory for Earthquake Dynamics (Project LED2013A07). D.S. was supported by the Alexander von Humboldt Foundation. Data presented here are archived with the of supplementary materials. We thank four anonymous reviewers whose comments improved this paper and B. Hallet for insightful discussions.	[Anonymous], 2001, GSA TODAY, DOI [10.1130/1052-5173(2001)0112.0.CO;2, DOI 10.1130/1052-5173(2001)011<0004:EHGATG>2.0.C0;2]; Avouac JP, 1996, J GEOPHYS RES-SOL EA, V101, P17747, DOI 10.1029/96JB01344; Brookfield ME, 1998, GEOMORPHOLOGY, V22, P285, DOI 10.1016/S0169-555X(97)00082-2; Burbank DW, 1996, NATURE, V379, P505, DOI 10.1038/379505a0; Burg JP, 1998, J ASIAN EARTH SCI, V16, P239, DOI 10.1016/S0743-9547(98)00002-6; Chirouze F, 2013, GEOL SOC AM BULL, V125, P523, DOI 10.1130/B30697.1; Cina SE, 2009, EARTH PLANET SC LETT, V285, P150, DOI 10.1016/j.epsl.2009.06.005; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Cronin V. S., 1989, TECTONICS GEOPHYSICS, P295; Crowley JL, 2009, EARTH PLANET SC LETT, V288, P408, DOI 10.1016/j.epsl.2009.09.044; Duvall AR, 2012, TECTONICS, V31, DOI 10.1029/2011TC002969; Enkelmann E, 2011, EARTH PLANET SC LETT, V307, P323, DOI 10.1016/j.epsl.2011.05.004; Finnegan NJ, 2008, GEOL SOC AM BULL, V120, P142, DOI 10.1130/B26224.1; Hodges KV, 2001, TECTONICS, V20, P799, DOI 10.1029/2001TC001281; Koons P.O., 2013, TREATISE GEOMORPHOLO, V5, P318; Korup O, 2008, NATURE, V455, P786, DOI 10.1038/nature07322; Lang KA, 2014, EARTH PLANET SC LETT, V397, P145, DOI 10.1016/j.epsl.2014.04.026; Larsen IJ, 2012, NAT GEOSCI, V5, P468, DOI 10.1038/ngeo1479; Lave J, 2001, J GEOPHYS RES-SOL EA, V106, P26561, DOI 10.1029/2001JB000359; Liu-Zeng J, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000897; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Molnar P, 2010, ANNU REV EARTH PL SC, V38, P77, DOI 10.1146/annurev-earth-040809-152456; Montgomery DR, 2004, QUATERNARY RES, V62, P201, DOI 10.1016/j.yqres.2004.06.008; SEEBER L, 1983, TECTONOPHYSICS, V92, P335, DOI 10.1016/0040-1951(83)90201-9; Seeber L, 1998, GEOLOGY, V26, P791, DOI 10.1130/0091-7613(1998)026<0791:SPATHA>2.3.CO;2; Seong Yeong Bae, 2007, [Journal of the Korean Geographical Society, 대한지리학회지], V42, P165; Seward D, 2008, TECTONOPHYSICS, V451, P282, DOI 10.1016/j.tecto.2007.11.057; Sobel ER, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001883; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978	29	126	153	11	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					978	981		10.1126/science.1259041	http://dx.doi.org/10.1126/science.1259041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414309				2022-12-28	WOS:000345696000039
J	Liu, YJ; Xu, H; Kong, WJ; Shang, M; Dai, HX; Yu, JQ				Liu, Yue-Jin; Xu, Hui; Kong, Wei-Jun; Shang, Ming; Dai, Hui-Xiong; Yu, Jin-Quan			Overcoming the limitations of directed C-H functionalizations of heterocycles	NATURE			English	Article							CARBON-HYDROGEN BONDS; ORTHO-METALATION; ACTIVATION; ARYLATION; ISOCYANIDES; BORYLATION; CHEMISTRY; AROMATICS; PYRIDINE	In directed C-H activation reactions, any nitrogen or sulphur atoms present in heterocyclic substrates will coordinate strongly with metal catalysts. This coordination, which can lead to catalyst poisoning or C-H functionalization at an undesired position, limits the application of C-H activation reactions in heterocycle-based drug discovery(1-5), in which regard they have attracted much interest from pharmaceutical companies(3-5). Here we report a robust and synthetically useful method that overcomes the complications associated with performing C-H functionalization reactions on heterocycles. Our approach employs a simple N-methoxy amide group, which serves as both a directing group and an anionic ligand that promotes the in situ generation of the reactive PdX2 (X = ArCONOMe) species from a Pd(0) source using air as the sole oxidant. In this way, the PdX2 species is localized near the target C-H bond, avoiding interference from any nitrogen or sulphur atoms present in the heterocyclic substrates. This reaction overrides the conventional positional selectivity patterns observed with substrates containing strongly coordinating heteroatoms, including nitrogen, sulphur and phosphorus. Thus, this operationally simple aerobic reaction demonstrates that it is possible to bypass a fundamental limitation that has long plagued applications of directed C-H activation in medicinal chemistry.	[Liu, Yue-Jin; Xu, Hui; Kong, Wei-Jun; Shang, Ming; Dai, Hui-Xiong; Yu, Jin-Quan] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Organometall Chem, Shanghai 200032, Peoples R China; [Yu, Jin-Quan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Scripps Research Institute	Dai, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Organometall Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	hxdai@sioc.ac.cn; yu200@scripps.edu	Kong, Wei-Jun/F-9551-2018	Kong, Wei-Jun/0000-0001-6996-3444	Shanghai Institute of Organic Chemistry; Chinese Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams; National Natural Science Foundation of China [NSFC-21121062]; Recruitment Program of Global Experts; Scripps Research Institute; NIH (NIGMS) [1R01 GM102265]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102265] Funding Source: NIH RePORTER	Shanghai Institute of Organic Chemistry; Chinese Academy of Sciences(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Recruitment Program of Global Experts; Scripps Research Institute; NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following for financial support: the Shanghai Institute of Organic Chemistry, the Chinese Academy of Sciences, the CAS/SAFEA International Partnership Program for Creative Research Teams, the National Natural Science Foundation of China (grant NSFC-21121062), the Recruitment Program of Global Experts, the Scripps Research Institute and the NIH (NIGMS,1R01 GM102265).	Ackermann L, 2011, ORG LETT, V13, P3332, DOI 10.1021/ol2010648; Bryan MC, 2013, J MED CHEM, V56, P6007, DOI 10.1021/jm400250p; Campbell AN, 2012, ACCOUNTS CHEM RES, V45, P851, DOI 10.1021/ar2002045; Cho JY, 2000, J AM CHEM SOC, V122, P12868, DOI 10.1021/ja0013069; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Davies IW, 2009, SCIENCE, V325, P701, DOI 10.1126/science.1174501; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Fu HY, 2012, J ORG CHEM, V77, P4473, DOI 10.1021/jo300528b; Hurst TE, 2010, CHEM-EUR J, V16, P8155, DOI 10.1002/chem.201000401; ITO Y, 1991, J AM CHEM SOC, V113, P8899, DOI 10.1021/ja00023a043; Jun CH, 1999, SYNLETT, P1; KAKIUCHI F, 1995, B CHEM SOC JPN, V68, P62, DOI 10.1246/bcsj.68.62; Kuznetsov A, 2013, ORG LETT, V15, P2498, DOI 10.1021/ol400977r; Kwak J, 2011, J AM CHEM SOC, V133, P3780, DOI 10.1021/ja111670s; Lang S, 2013, CHEM SOC REV, V42, P4867, DOI 10.1039/c3cs60022j; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Malik HA, 2014, CHEM SCI, V5, P2352, DOI 10.1039/c3sc53414f; Meanwell NA, 2011, CHEM RES TOXICOL, V24, P1420, DOI 10.1021/tx200211v; Nakao Y, 2010, J AM CHEM SOC, V132, P13666, DOI 10.1021/ja106514b; Ritchie TJ, 2011, DRUG DISCOV TODAY, V16, P164, DOI 10.1016/j.drudis.2010.11.014; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; Takagi J, 2002, TETRAHEDRON LETT, V43, P5649, DOI 10.1016/S0040-4039(02)01135-8; Tsai CC, 2010, J AM CHEM SOC, V132, P11887, DOI 10.1021/ja1061246; Wang DH, 2008, J AM CHEM SOC, V130, P7190, DOI 10.1021/ja801355s; Wasa M, 2010, ANGEW CHEM INT EDIT, V49, P1275, DOI 10.1002/anie.200906104; Wencel-Delord J, 2012, ANGEW CHEM INT EDIT, V51, P13001, DOI 10.1002/anie.201205734; Yeung CS, 2011, CHEM REV, V111, P1215, DOI 10.1021/cr100280d	30	245	249	7	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					389	393		10.1038/nature13885	http://dx.doi.org/10.1038/nature13885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25383516	Green Accepted			2022-12-28	WOS:000345770600040
J	Meitinger, F; Khmelinskii, A; Morlot, S; Kurtulmus, B; Palani, S; Andres-Pons, A; Hub, B; Knop, M; Charvin, G; Pereira, G				Meitinger, Franz; Khmelinskii, Anton; Morlot, Sandrine; Kurtulmus, Bahtiyar; Palani, Saravanan; Andres-Pons, Amparo; Hub, Birgit; Knop, Michael; Charvin, Gilles; Pereira, Gislene			A Memory System of Negative Polarity Cues Prevents Replicative Aging	CELL			English	Article							BUD-SITE SELECTION; CELL POLARITY; CAENORHABDITIS-ELEGANS; SYMMETRY-BREAKING; SMALL GTPASES; YEAST GENES; RHO FAMILY; PROTEIN; CDC42; PHOSPHORYLATION	Cdc42 is a highly conserved master regulator of cell polarity. Here, we investigated the mechanism by which yeast cells never re-establish polarity at cortical sites (cytokinesis remnants [CRMs]) that have previously supported Cdc42-mediated growth as a paradigm to mechanistically understand how Cdc42-inhibitory polarity cues are established. We revealed a two-step mechanism of loading the Cdc42 antagonist Nba1 into CRMs to mark these compartments as refractory for a second round of Cdc42 activation. Our data indicate that Nba1 together with a cortically tethered adaptor protein confers memory of previous polarization events to translate this spatial legacy into a biochemical signal that ensures the local singularity of Cdc42 activation. "Memory loss'' mutants that repeatedly use the same polarity site over multiple generations display nuclear segregation defects and a shorter lifespan. Our work thus established CRMs as negative polarity cues that prevent Cdc42 reactivation to sustain the fitness of replicating cells.	[Meitinger, Franz; Kurtulmus, Bahtiyar; Palani, Saravanan; Andres-Pons, Amparo; Pereira, Gislene] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany; [Khmelinskii, Anton; Knop, Michael] Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, D-69120 Heidelberg, Germany; [Morlot, Sandrine; Charvin, Gilles] Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France; [Hub, Birgit] German Canc Res Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; German Cancer Research Center (DKFZ)	Pereira, G (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	g.pereira@dkfz.de	Khmelinskii, Anton/B-2830-2008; Palani, Sarvanan/AAA-1260-2020; Pereira, Gislene/D-4024-2014	Morlot, Sandrine/0000-0002-0326-6694; charvin, gilles/0000-0002-6852-6952; Meitinger, Franz/0000-0002-8635-9078; Palani, Saravanan/0000-0002-1893-6777; Khmelinskii, Anton/0000-0002-0256-5190; Andres-Pons, Amparo/0000-0001-5801-4024; Kurtulmus, Bahtiyar/0000-0001-5796-0887	Atip Avenir program; IDEX program from the University of Strasbourg; French Ligue Nationale contre le Cancer; DFG [Sonderforschungsbereich 1036 (SFB1036), TP10]; Marie Curie Grant [MEXT-CT-042544]; graduate school LGFG "Regulation of Cell Division''; DKFZ	Atip Avenir program; IDEX program from the University of Strasbourg; French Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); DFG(German Research Foundation (DFG)); Marie Curie Grant(European Commission); graduate school LGFG "Regulation of Cell Division''; DKFZ(Helmholtz Association)	We thank Daniel Lew for reagents; Karsten Richter and DKFZ electron microscopy facility for support with electron microscopy; Daniela T. Bertazzi Lazzarini for working with Nba1 and Nis1 at the initial phase of this project; Elmar Schiebel, Iain Hagan, and members of G. P.'s lab for comments on the manuscript. G. C. was supported by the Atip Avenir program and the IDEX program from the University of Strasbourg. S. M. acknowledges a fellowship from the French Ligue Nationale contre le Cancer. M. K. and A. K. were supported by the Sonderforschungsbereich 1036 (SFB1036, TP10) from the DFG. The work of F. M., S. P., and A. A.-P. was supported by the Marie Curie Grant MEXT-CT-042544 granted to G. P. S. P. acknowledges funding from the graduate school LGFG "Regulation of Cell Division''. S. P. and B. K. are members of the international graduate school HBIGS. This project was funded by the Marie Curie Grant MEXT-CT-042544 and DKFZ core funding.	Atkins BD, 2013, J CELL BIOL, V202, P231, DOI 10.1083/jcb.201301090; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Bloch D, 2013, CURR OPIN PLANT BIOL, V16, P734, DOI 10.1016/j.pbi.2013.10.009; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Cabib E, 1993, Arch Med Res, V24, P301; Calvert MEK, 2008, MOL CELL BIOL, V28, P1313, DOI 10.1128/MCB.01035-07; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen CT, 2013, TRENDS CELL BIOL, V23, P118, DOI 10.1016/j.tcb.2012.10.012; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; Dworkin J, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003368; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Fehrmann S, 2013, CELL REP, V5, P1589, DOI 10.1016/j.celrep.2013.11.013; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; HYMAN AA, 1989, J CELL BIOL, V109, P1185, DOI 10.1083/jcb.109.3.1185; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; Iwase M, 2001, GENES GENET SYST, V76, P335, DOI 10.1266/ggs.76.335; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Kang PJ, 2004, MOL BIOL CELL, V15, P5145, DOI 10.1091/mbc.E04-07-0600; Keating HH, 1998, J CELL SCI, V111, P3027; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Li R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003475; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; Meitinger F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001495; Meitinger F, 2011, GENE DEV, V25, P875, DOI 10.1101/gad.622411; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Noatynska A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130083; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Pollarolo G, 2011, NAT NEUROSCI, V14, P1525, DOI 10.1038/nn.2976; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Smith ST, 2013, P I CIVIL ENG-STR B, V166, P1, DOI 10.1680/stbu.2012.166.1.1; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; WADDLE JA, 1994, DEVELOPMENT, V120, P2317; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Wloka C, 2012, CYTOSKELETON, V69, P710, DOI 10.1002/cm.21046	48	27	27	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1056	1069		10.1016/j.cell.2014.10.014	http://dx.doi.org/10.1016/j.cell.2014.10.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416945	Bronze			2022-12-28	WOS:000345506300018
J	Pomeranz, JL; Brownell, KD				Pomeranz, Jennifer L.; Brownell, Kelly D.			Can Government Regulate Portion Sizes?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pomeranz, Jennifer L.] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA; [Pomeranz, Jennifer L.] Temple Univ, Ctr Obes Res & Educ, Philadelphia, PA 19122 USA; [Brownell, Kelly D.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Duke University	Pomeranz, JL (corresponding author), Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA.							Cohen DA, 2014, AM J PUBLIC HEALTH, V104, P586, DOI 10.2105/AJPH.2013.301692	1	8	8	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					1956	1958		10.1056/NEJMp1410076	http://dx.doi.org/10.1056/NEJMp1410076			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT5ST	25409367				2022-12-28	WOS:000345002900002
J	Koretz, RL				Koretz, Ronald L.			Review: Telaprevir, boceprevir, simeprevir, or sofosbuvir improves response in HCV type 1 Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SUSTAINED VIROLOGICAL RESPONSE; HEPATITIS-C VIRUS; INFECTION		Olive View UCLA Med Ctr, Sylmar, CA 91342 USA	University of California System; University of California Los Angeles	Koretz, RL (corresponding author), Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA.							Hara K, 2014, J INFECT DIS, V209, P38, DOI 10.1093/infdis/jit541; Koretz R, 2013, COCHRANE DB SYST REV, V1; van der Meer AJ, 2013, HEPATOLOGY, V58, p280A; Wiese M, 2014, HEPATOLOGY, V59, P49, DOI 10.1002/hep.26644	4	9	9	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10							JC11	10.7326/0003-4819-161-10-201411180-02011	http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402532				2022-12-28	WOS:000347245600020
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Do patients know that their records aren't private?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				BMA, 2014, ETHICS REQUESTS FOR; Care Quality Commission, 2014, BEHIND THE HEADLINES; Care Quality Commission, 2014, GUIDANCE ON ACCESSIN; General Medical Council, 2009, CONFIDENTIALITY REPO	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2014	349								g6763	10.1136/bmj.g6763	http://dx.doi.org/10.1136/bmj.g6763			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JX	25404124	hybrid, Green Published			2022-12-28	WOS:000345445500006
J	Swift, J				Swift, Joseph			The point of it all	SCIENCE			English	Editorial Material									NYU, New York, NY 10003 USA	New York University	Swift, J (corresponding author), NYU, New York, NY 10003 USA.								0	0	0	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					882	882		10.1126/science.346.6211.882	http://dx.doi.org/10.1126/science.346.6211.882			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT0YL	25395540				2022-12-28	WOS:000344659900050
J	McBride, CS; Baier, F; Omondi, AB; Spitzer, SA; Lutomiah, J; Sang, R; Ignell, R; Vosshall, LB				McBride, Carolyn S.; Baier, Felix; Omondi, Aman B.; Spitzer, Sarabeth A.; Lutomiah, Joel; Sang, Rosemary; Ignell, Rickard; Vosshall, Leslie B.			Evolution of mosquito preference for humans linked to an odorant receptor	NATURE			English	Article							AEGYPTI L DIPTERA; AEDES-AEGYPTI; VOLATILE COMPOUNDS; GENOME ANNOTATION; MALARIA MOSQUITO; HOST LOCATION; ALTERS ODOR; IDENTIFICATION; ALIGNMENT; BEHAVIOR	Female mosquitoes are major vectors of human disease and the most dangerous are those that preferentially bite humans. A 'domestic' form of the mosquito Aedes aegypti has evolved to specialize in biting humans and is the main worldwide vector of dengue, yellow fever, and chikungunya viruses. The domestic form coexists with an ancestral, 'forest' form that prefers to bite non-human animals and is found along the coast of Kenya. We collected the two forms, established laboratory colonies, and document striking divergence in preference for human versus non-human animal odour. We further show that the evolution of preference for human odour in domestic mosquitoes is tightly linked to increases in the expression and ligand-sensitivity of the odorant receptor AaegOr4, which we found recognizes a compound present at high levels inhuman odour. Our results provide a rare example of a gene contributing to behavioural evolution and provide insight into how disease-vectoring mosquitoes came to specialize on humans.	[McBride, Carolyn S.; Baier, Felix; Spitzer, Sarabeth A.; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [McBride, Carolyn S.; Vosshall, Leslie B.] Howard Hughes Med Inst, New York, NY 10065 USA; [Omondi, Aman B.; Ignell, Rickard] Swedish Univ Agr Sci, Dept Plant Protect Biol, Unit Chem Ecol, S-23053 Alnarp, Sweden; [Lutomiah, Joel; Sang, Rosemary] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya	Rockefeller University; Howard Hughes Medical Institute; Swedish University of Agricultural Sciences; Kenya Medical Research Institute	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.	Leslie.Vosshall@rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099; Baier, Felix/0000-0003-4056-1729	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health grants: K99 award from NIDCD [DC012069]; NIAID Vectorbase DBP [HHSN272200900039C]; CTSA award from NCATS [5UL1TR000043]; Swedish Research Council and SLU: Insect Chemical Ecology and Evolution (IC-E3); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC012069, R00DC012069] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health grants: K99 award from NIDCD; NIAID Vectorbase DBP; CTSA award from NCATS; Swedish Research Council and SLU: Insect Chemical Ecology and Evolution (IC-E3); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. K. N. Lawniczak, K. J. Lee, M. N. Nitabach, and the Vosshall laboratory for discussion and comments on the manuscript; J. E. Brown and J. R. Powell for discussion and coordination of field collections; W. Takken for advice regarding many aspects of this work; J.-P. Mutebi, B. Miller, and A. Ponlawat for live specimens from Uganda and Thailand; D. Beck, K. Nygaard, K. Prakash, and L. Seeholzer for expert technical assistance. We also thank X. Chen for pre-publication access to a draft Ae. albopictus genome assembly, and J. Liesch for access to Orlando strain RNA-seq data. We received valuable advice on collecting and working with forest and domestic forms of Ae. aegypti from M. Trpis, J. L. Peterson, and P. Lounibos, and on the design and use of two-port olfactometers from U. Bernier and V. Sherman. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative. This work was supported in part by the following National Institutes of Health grants: K99 award from NIDCD to C.S.M. (DC012069), an NIAID Vectorbase DBP subcontract to L. B. V. (HHSN272200900039C), and a CTSA award from NCATS (5UL1TR000043). R. I. received support from the Swedish Research Council and SLU: Insect Chemical Ecology and Evolution (IC-E3). L.B.V. is an investigator of the Howard Hughes Medical Institute.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Birkett MA, 2004, MED VET ENTOMOL, V18, P313, DOI 10.1111/j.0269-283X.2004.00528.x; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Christophers S. R., 1960, AEDES AEGYPTI YELLOW; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Coyne J. A., 2004, SPECIATION; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2; GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680; Greenwood AK, 2013, CURR BIOL, V23, P1884, DOI 10.1016/j.cub.2013.07.058; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Harraca V, 2012, J EXP BIOL, V215, P623, DOI 10.1242/jeb.065748; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johns S. J., TOPO2 TRANSM PROT DI; Jumean Z, 2005, J CHEM ECOL, V31, P911, DOI 10.1007/s10886-005-3552-x; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; LABOWS J, 1979, J CHROMATOGR, V163, P294, DOI 10.1016/S0378-4347(00)81417-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Linz J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0626; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Martin A, 2013, EVOLUTION, V67, P1235, DOI 10.1111/evo.12081; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392; MCCLELLAND G. A. H., 1960, ANN TROP MED AND PARASITOL, V54, P305; MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x; McKenna R. J., 1973, THESIS U CALIFORNIA; Menger D. J., 2014, MED VET ENTOMOL; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MUKWAYA L G, 1974, Acta Tropica, V31, P165; MUKWAYA LG, 1977, PHYSIOL ENTOMOL, V2, P133, DOI 10.1111/j.1365-3032.1977.tb00091.x; Nielsen BL, 2013, PHYSIOL BEHAV, V120, P150, DOI 10.1016/j.physbeh.2013.07.012; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Petersen, 1977, THESIS U NOTRE DAME; RINES HW, 1974, J AGR FOOD CHEM, V22, P96, DOI 10.1021/jf60191a004; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; SAUL SH, 1980, AM MIDL NAT, V104, P118, DOI 10.2307/2424965; Socaci SA, 2014, PHYTOCHEM ANALYSIS, V25, P161, DOI 10.1002/pca.2483; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stoeffler M, 2007, J CHEM ECOL, V33, P1382, DOI 10.1007/s10886-007-9315-0; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; TRPIS M, 1978, B ENTOMOL RES, V68, P521, DOI 10.1017/S0007485300009494; TRPIS M, 1975, B ENTOMOL RES, V65, P199, DOI 10.1017/S0007485300005903; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Wada-Katsumata A, 2013, SCIENCE, V340, P972, DOI 10.1126/science.1234854; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x	69	251	257	6	241	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					222	U151		10.1038/nature13964	http://dx.doi.org/10.1038/nature13964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391959	Green Accepted			2022-12-28	WOS:000344631400040
J	Sedgwick, P				Sedgwick, Philip			Explanatory trials versus pragmatic trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2013, BMJ-BRIT MED J, V347, pf5819; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1742; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3662; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4176; Watson JM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1092	5	45	46	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2014	349								g6694	10.1136/bmj.g6694	http://dx.doi.org/10.1136/bmj.g6694			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JS	25395503				2022-12-28	WOS:000345445100002
J	Jonasch, E; Gao, JJ; Rathmell, WK				Jonasch, Eric; Gao, Jianjun; Rathmell, W. Kimryn			Renal cell carcinoma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LYMPH-NODE DISSECTION; NEPHRON-SPARING SURGERY; RADICAL NEPHRECTOMY; INTERFERON-ALPHA; EUROPEAN ORGANIZATION; PHASE-3 TRIAL; DOUBLE-BLIND; IMPROVED PROGNOSTICATION; DOSE INTERLEUKIN-2; TARGETED THERAPY	The treatment of renal cell carcinoma (RCC) has changed greatly over the past 15 years. Progress in the surgical management of the primary tumor and increased understanding of the molecular biology and genomics of the disease have led to the development of new therapeutic agents. The management of the primary tumor has changed owing to the realization that clean margins around the primary lesion are sufficient to prevent local recurrence, as well as the development of more sophisticated tools and techniques that increase the safety of partial nephrectomy. The management of advanced disease has altered even more dramatically as a result of new agents that target the tumor vasculature or that attenuate the activation of intracellular oncogenic pathways. This review summarizes data from prospective randomized phase III studies on the surgical management and systemic treatment of RCC, and provides an up to date summary of the histology, genomics, staging, and prognosis of RCC. It describes the management of the primary tumor and offers an overview of systemic agents that form the mainstay of treatment for advanced disease. The review concludes with an introduction to the exciting new class of immunomodulatory agents that are currently in clinical trials and may form the basis of a new therapeutic approach for patients with advanced RCC.	[Jonasch, Eric; Gao, Jianjun] Univ Texas MD Anderson Canc Ctr, Dept GU Med Oncol, Houston, TX 77230 USA; [Rathmell, W. Kimryn] Ctr Comprehens Canc, Chapel Hill, NC USA	University of Texas System; UTMD Anderson Cancer Center	Jonasch, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept GU Med Oncol, Houston, TX 77230 USA.	ejonasch@mdanderson.org			Novartis pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Novartis pharmaceuticals(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We have read and understood BMJ policy on declaration of interests and declare the following interests. EJ: consultant for Aveo, Bayer, GSK, Novartis, and Pfizer; clinical research support from BMS, GSK, Novartis, Pfizer, and Onyx; laboratory research support from Exelixis. WKR: consultant for Aveo (uncompensated), clinical research support from GSK and Seattle Genetics.); WKR's husband was funded for a research sabbatical by Novartis pharmaceuticals. JJG: none.	Aitchison M, 2014, EUR J CANCER, V50, P70, DOI 10.1016/j.ejca.2013.08.019; Algaba F, 2011, EUR UROL, V60, P634, DOI 10.1016/j.eururo.2011.06.047; American Cancer Society, 2013, CANC FACTS FIG; Asahina H, 2013, INVEST NEW DRUG, V31, P677, DOI 10.1007/s10637-012-9860-4; Atkinson BJ, 2014, J UROLOGY, V191, P611, DOI 10.1016/j.juro.2013.08.090; Blom JHM, 2009, EUR UROL, V55, P28, DOI 10.1016/j.eururo.2008.09.052; Blom JHM, 1999, EUR UROL, V36, P570, DOI 10.1159/000020050; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Choueiri TK, 2012, J CLIN ONCOL S, V30; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Clark JI, 2003, J CLIN ONCOL, V21, P3133, DOI 10.1200/JCO.2003.02.014; Conti SL, 2014, INT J CANCER, V134, P2245, DOI 10.1002/ijc.28553; Cowey CL, 2010, J CLIN ONCOL, V28, P1502, DOI 10.1200/JCO.2009.24.7759; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Edge S, 2010, AJCC CANC STAGING MA, V7th; El Dib R, 2009, CUAJ-CAN UROL ASSOC, V3, P143; Elmore JM, 2003, CANCER-AM CANCER SOC, V98, P2329, DOI 10.1002/cncr.11806; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Ficarra V, 2006, J UROLOGY, V175, P1235, DOI 10.1016/S0022-5347(05)00684-1; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1016/S0022-5347(05)64153-5; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gore ME, 2011, BRIT J CANCER, V104, P399, DOI 10.1038/sj.bjc.6606084; Gossage L, 2014, GENE CHROMOSOME CANC, V53, P38, DOI 10.1002/gcc.22116; Haddad RL, 2012, UROL J, V9, P629; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Han KR, 2003, J UROLOGY, V170, P2221, DOI 10.1097/01.ju.0000096049.64863.a1; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hines-Peralta A, 2004, CLIN CANC RES 2, V10, p6328S; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hutson TE, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.6_suppl.lba348; Hutson TE, 2013, LANCET ONCOL, V14, P1287, DOI 10.1016/S1470-2045(13)70465-0; International Agency for Research on Cancer, 2012, GLOBOCAN KIDN EST IN; Johnson DB, 2004, J UROLOGY, V172, P874, DOI 10.1097/01.ju.0000135833.67906.ec; Jonasch E, 2012, MOL CANCER RES, V10, P859, DOI 10.1158/1541-7786.MCR-12-0117; Jonasch E, 2009, J CLIN ONCOL, V27, P4076, DOI 10.1200/JCO.2008.21.3660; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Klatte T, 2009, CLIN CANCER RES, V15, P1162, DOI 10.1158/1078-0432.CCR-08-1229; Lane BR, 2008, UROL CLIN N AM, V35, P613, DOI 10.1016/j.ucl.2008.07.003; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Leibovich BC, 2003, CANCER-AM CANCER SOC, V97, P1663, DOI 10.1002/cncr.11234; Leveridge MJ, 2011, EUR UROL, V60, P578, DOI 10.1016/j.eururo.2011.06.021; Linehan WM, 2013, SEMIN ONCOL, V40, P511, DOI 10.1053/j.seminoncol.2013.05.009; Liu QY, 2013, AM J SURG PATHOL, V37, P368, DOI 10.1097/PAS.0b013e3182770406; Ljungberg B, 2009, EUR UROL, V55, P1486, DOI 10.1016/j.eururo.2009.03.037; Long JA, 2012, EUR UROL, V61, P1257, DOI 10.1016/j.eururo.2012.03.012; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; McTigue M, 2012, P NATL ACAD SCI USA, V109, P18281, DOI 10.1073/pnas.1207759109; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Mir SA, 2011, J ENDOUROL, V25, P447, DOI 10.1089/end.2010.0510; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Murphy D P, 2001, Semin Urol Oncol, V19, P133; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; O'Connor SD, 2011, AM J ROENTGENOL, V197, P139, DOI 10.2214/AJR.10.5920; Peggs KS, 2009, CLIN EXP IMMUNOL, V157, P9, DOI 10.1111/j.1365-2249.2009.03912.x; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Perdeaux E, 2013, JAMA-J AM MED ASSOC, V309, P1460, DOI 10.1001/jama.2013.2243; Pyrhonen S, 1999, J CLIN ONCOL, V17, P2859, DOI 10.1200/JCO.1999.17.9.2859; Raj GV, 2008, J UROLOGY, V179, P2146, DOI 10.1016/j.juro.2008.01.101; Rehman J, 2004, J ENDOUROL, V18, P83, DOI 10.1089/089277904322836749; Rini BI, 2013, LANCET ONCOL, V14, P1233, DOI 10.1016/S1470-2045(13)70464-9; Rini BI, 2012, J UROLOGY, V187, P1548, DOI 10.1016/j.juro.2011.12.075; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Rini BI, 2011, JNCI-J NATL CANCER I, V103, P763, DOI 10.1093/jnci/djr128; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Ritchie A, 1999, LANCET, V353, P14; Scherr AJO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-115; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Scosyrev E, 2014, EUR UROL, V65, P372, DOI 10.1016/j.eururo.2013.06.044; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siva S, 2012, BJU INT, V110, pE737, DOI 10.1111/j.1464-410X.2012.11550.x; Sorbellini M, 2005, J UROLOGY, V173, P48, DOI 10.1097/01.ju.0000148261.19532.2c; SPEICHER MR, 1994, AM J PATHOL, V145, P356; Stakhovskyi O, 2011, AM J ROENTGENOL, V196, P1267, DOI 10.2214/AJR.10.6336; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Thomas AA, 2009, J UROLOGY, V181, P518, DOI 10.1016/j.juro.2008.10.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Toro JR, 2003, AM J HUM GENET, V73, P95, DOI 10.1086/376435; Van Poppel H, 2007, EUR UROL, V51, P1606, DOI 10.1016/j.eururo.2006.11.013; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verhoest G, 2009, J UROLOGY, V182, P854, DOI 10.1016/j.juro.2009.05.017; Volpe A, 2011, EUR UROL, V60, P501, DOI 10.1016/j.eururo.2011.05.044; Yamazaki K, 2003, ONCOGENE, V22, P847, DOI 10.1038/sj.onc.1206153; Yang JC, 2007, J IMMUNOTHER, V30, P825, DOI 10.1097/CJI.0b013e318156e47e; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649	113	359	366	3	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2014	349								g4797	10.1136/bmj.g4797	http://dx.doi.org/10.1136/bmj.g4797			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JP	25385470	Green Published			2022-12-28	WOS:000345444800001
J	Misof, B; Liu, SL; Meusemann, K; Peters, RS; Donath, A; Mayer, C; Frandsen, PB; Ware, J; Flouri, T; Beutel, RG; Niehuis, O; Petersen, M; Izquierdo-Carrasco, F; Wappler, T; Rust, J; Aberer, AJ; Aspock, U; Aspock, H; Bartel, D; Blanke, A; Berger, S; Bohm, A; Buckley, TR; Calcott, B; Chen, JQ; Friedrich, F; Fukui, M; Fujita, M; Greve, C; Grobe, P; Gu, SC; Huang, Y; Jermiin, LS; Kawahara, AY; Krogmann, L; Kubiak, M; Lanfear, R; Letsch, H; Li, YY; Li, ZY; Li, JG; Lu, HR; Machida, R; Mashimo, Y; Kapli, P; McKenna, DD; Meng, GL; Nakagaki, Y; Navarrete-Heredia, JL; Ott, M; Ou, YX; Pass, G; Podsiadlowski, L; Pohl, H; von Reumont, BM; Schutte, K; Sekiya, K; Shimizu, S; Slipinski, A; Stamatakis, A; Song, WH; Su, X; Szucsich, NU; Tan, MH; Tan, XM; Tang, M; Tang, JB; Timelthaler, G; Tomizuka, S; Trautwein, M; Tong, XL; Uchifune, T; Walzl, MG; Wiegmann, BM; Wilbrandt, J; Wipfler, B; Wong, TKF; Wu, Q; Wu, GX; Xie, YL; Yang, SZ; Yang, Q; Yeates, DK; Yoshizawa, K; Zhang, Q; Zhang, R; Zhang, WW; Zhang, YH; Zhao, J; Zhou, CR; Zhou, LL; Ziesmann, T; Zou, SJ; Li, YR; Xu, X; Zhang, Y; Yang, HM; Wang, J; Wang, J; Kjer, KM; Zhou, X				Misof, Bernhard; Liu, Shanlin; Meusemann, Karen; Peters, Ralph S.; Donath, Alexander; Mayer, Christoph; Frandsen, Paul B.; Ware, Jessica; Flouri, Tomas; Beutel, Rolf G.; Niehuis, Oliver; Petersen, Malte; Izquierdo-Carrasco, Fernando; Wappler, Torsten; Rust, Jes; Aberer, Andre J.; Aspoeck, Ulrike; Aspoeck, Horst; Bartel, Daniela; Blanke, Alexander; Berger, Simon; Boehm, Alexander; Buckley, Thomas R.; Calcott, Brett; Chen, Junqing; Friedrich, Frank; Fukui, Makiko; Fujita, Mari; Greve, Carola; Grobe, Peter; Gu, Shengchang; Huang, Ying; Jermiin, Lars S.; Kawahara, Akito Y.; Krogmann, Lars; Kubiak, Martin; Lanfear, Robert; Letsch, Harald; Li, Yiyuan; Li, Zhenyu; Li, Jiguang; Lu, Haorong; Machida, Ryuichiro; Mashimo, Yuta; Kapli, Pashalia; McKenna, Duane D.; Meng, Guanliang; Nakagaki, Yasutaka; Luis Navarrete-Heredia, Jose; Ott, Michael; Ou, Yanxiang; Pass, Guenther; Podsiadlowski, Lars; Pohl, Hans; von Reumont, Bjoern M.; Schuette, Kai; Sekiya, Kaoru; Shimizu, Shota; Slipinski, Adam; Stamatakis, Alexandros; Song, Wenhui; Su, Xu; Szucsich, Nikolaus U.; Tan, Meihua; Tan, Xuemei; Tang, Min; Tang, Jingbo; Timelthaler, Gerald; Tomizuka, Shigekazu; Trautwein, Michelle; Tong, Xiaoli; Uchifune, Toshiki; Walzl, Manfred G.; Wiegmann, Brian M.; Wilbrandt, Jeanne; Wipfler, Benjamin; Wong, Thomas K. F.; Wu, Qiong; Wu, Gengxiong; Xie, Yinlong; Yang, Shenzhou; Yang, Qing; Yeates, David K.; Yoshizawa, Kazunori; Zhang, Qing; Zhang, Rui; Zhang, Wenwei; Zhang, Yunhui; Zhao, Jing; Zhou, Chengran; Zhou, Lili; Ziesmann, Tanja; Zou, Shijie; Li, Yingrui; Xu, Xun; Zhang, Yong; Yang, Huanming; Wang, Jian; Wang, Jun; Kjer, Karl M.; Zhou, Xin			Phylogenomics resolves the timing and pattern of insect evolution	SCIENCE			English	Article							HOLOMETABOLOUS INSECTS; EVIDENCE CONVERGE; LIGHT	Insects are the most speciose group of animals, but the phylogenetic relationships of many major lineages remain unresolved. We inferred the phylogeny of insects from 1478 protein-coding genes. Phylogenomic analyses of nucleotide and amino acid sequences, with site-specific nucleotide or domain-specific amino acid substitution models, produced statistically robust and congruent results resolving previously controversial phylogenetic relationships. We dated the origin of insects to the Early Ordovician [similar to 479 million years ago (Ma)], of insect flight to the Early Devonian (similar to 406 Ma), of major extant lineages to the Mississippian (similar to 345 Ma), and the major diversification of holometabolous insects to the Early Cretaceous. Our phylogenomic study provides a comprehensive reliable scaffold for future comparative analyses of evolutionary innovations among insects.	[Misof, Bernhard; Meusemann, Karen; Donath, Alexander; Mayer, Christoph; Niehuis, Oliver; Petersen, Malte; Blanke, Alexander; Greve, Carola; Grobe, Peter; Wilbrandt, Jeanne; Ziesmann, Tanja] ZMB, Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany; [Liu, Shanlin; Huang, Ying; Li, Yiyuan; Meng, Guanliang; Song, Wenhui; Su, Xu; Tan, Meihua; Tang, Min; Wu, Qiong; Yang, Shenzhou; Yang, Qing; Zhang, Qing; Zhang, Rui; Zhao, Jing; Zhou, Chengran; Zhou, Lili; Zhang, Yong; Zhou, Xin] BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China; [Liu, Shanlin; Chen, Junqing; Gu, Shengchang; Huang, Ying; Li, Yiyuan; Li, Zhenyu; Li, Jiguang; Lu, Haorong; Meng, Guanliang; Ou, Yanxiang; Song, Wenhui; Su, Xu; Tan, Meihua; Tan, Xuemei; Tang, Min; Tang, Jingbo; Wu, Qiong; Wu, Gengxiong; Xie, Yinlong; Yang, Shenzhou; Yang, Qing; Zhang, Qing; Zhang, Rui; Zhang, Wenwei; Zhang, Yunhui; Zhao, Jing; Zhou, Chengran; Zhou, Lili; Zou, Shijie; Li, Yingrui; Xu, Xun; Zhang, Yong; Yang, Huanming; Wang, Jian; Wang, Jun; Zhou, Xin] BGI Shenzhen, Shenzhen, Peoples R China; [Meusemann, Karen; Slipinski, Adam; Yeates, David K.] Commonwealth Sci & Ind Res Org Australia CSIRO, Australian Natl Insect Collect, Natl Res Collect Australia, Canberra, ACT, Australia; [Peters, Ralph S.] Zool Forsch Museum Alexander Koenig ZFMK, Abt Arthropoda, Bonn, Germany; [Frandsen, Paul B.] Rutgers State Univ, Dept Entomol, Piscataway, NJ 08854 USA; [Ware, Jessica] Rutgers State Univ, Dept Biol Sci, Piscataway, NJ 08854 USA; [Flouri, Tomas; Izquierdo-Carrasco, Fernando; Aberer, Andre J.; Berger, Simon; Kapli, Pashalia; Stamatakis, Alexandros] HITS, Heidelberg, Germany; [Beutel, Rolf G.; Pohl, Hans; Wipfler, Benjamin] FSU Jena, Inst Spezielle Zool & Evolut Biol, Phyletischem Museum Jena, Jena, Germany; [Wappler, Torsten; Rust, Jes] Univ Bonn, Steinmann Inst, Bereich Palaontol, Bonn, Germany; [Aspoeck, Ulrike] Nat Hist Museum Wien, Zool Abt Insekten 2, Vienna, Austria; [Aspoeck, Ulrike; Bartel, Daniela; Boehm, Alexander; Pass, Guenther; Szucsich, Nikolaus U.; Timelthaler, Gerald; Walzl, Manfred G.] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Aspoeck, Horst] MUW, Inst Spezif Prophylaxe & Tropenmed, Vienna, Austria; [Buckley, Thomas R.] Manaaki Whenua Landcare Res, Auckland, New Zealand; [Calcott, Brett] Johns Hopkins Univ, Dept Emergency Med, Ctr Adv Modeling, Baltimore, MD 21209 USA; [Friedrich, Frank; Kubiak, Martin] Univ Hamburg, Biozentrum Grindel, Hamburg, Germany; [Friedrich, Frank; Kubiak, Martin] Univ Hamburg, Zool Museum, Hamburg, Germany; [Fukui, Makiko] Ehime Univ, Grad Sch Sci & Engn, Evolutionary Morphol Lab, Matsuyama, Ehime 790, Japan; [Blanke, Alexander; Fujita, Mari; Machida, Ryuichiro; Mashimo, Yuta; Nakagaki, Yasutaka; Sekiya, Kaoru; Shimizu, Shota; Tomizuka, Shigekazu; Uchifune, Toshiki] Univ Tsukuba, Sugadaira Montane Res Ctr, Hexapod Comparat Embryol Lab, Tsukuba, Ibaraki 305, Japan; [Jermiin, Lars S.; Wong, Thomas K. F.] CSIRO, Land & Water Flagship, Canberra, ACT, Australia; [Kawahara, Akito Y.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Krogmann, Lars] SMNS, Stuttgart, Germany; [Lanfear, Robert] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Lanfear, Robert] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA; [Lanfear, Robert] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Letsch, Harald] Univ Vienna, Dept Bot & Biodiversitatsforsch, Vienna, Austria; [Kapli, Pashalia] Univ Crete, Nat Hist Museum Crete, GR-71409 Iraklion, Greece; [Kapli, Pashalia] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [McKenna, Duane D.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [McKenna, Duane D.] Univ Memphis, Feinstone Ctr Genom Res, Memphis, TN 38152 USA; [Luis Navarrete-Heredia, Jose] Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Ctr Estudios Zool, Zapopan, Jalisco, Mexico; [Ott, Michael] Bavarian Acad Sci & Humanities, Leibniz Supercomp Ctr, Garching, Germany; [Podsiadlowski, Lars] Univ Bonn, Inst Evolutionary Biol & Ecol Zool & Evolutionary, Bonn, Germany; [von Reumont, Bjoern M.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Schuette, Kai] Univ Hamburg, Abt Entomol, Biozentrum Grindel, Hamburg, Germany; [Schuette, Kai] Univ Hamburg, Zool Museum, Hamburg, Germany; [Stamatakis, Alexandros] Karlsruher Inst Technol, Fak Informat, Karlsruhe, Germany; [Trautwein, Michelle] Calif Acad Sci, San Francisco, CA 94118 USA; [Tong, Xiaoli] South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Uchifune, Toshiki] Yokosuka City Museum, Yokosuka, Kanagawa, Japan; [Wiegmann, Brian M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Yoshizawa, Kazunori] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21413, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Kjer, Karl M.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, Piscataway, NJ 08854 USA	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Rutgers State University New Brunswick; Rutgers State University New Brunswick; Friedrich Schiller University of Jena; University of Bonn; University of Vienna; Landcare Research - New Zealand; Johns Hopkins University; University of Hamburg; University of Hamburg; Ehime University; University of Tsukuba; Commonwealth Scientific & Industrial Research Organisation (CSIRO); State University System of Florida; University of Florida; Australian National University; The National Evolutionary Synthesis Center; Macquarie University; University of Vienna; University of Crete; University of Crete; University of Memphis; University of Memphis; Universidad de Guadalajara; University of Bonn; Natural History Museum London; University of Hamburg; University of Hamburg; Helmholtz Association; Karlsruhe Institute of Technology; California Academy of Sciences; South China Agricultural University; University of North Carolina; North Carolina State University; Hokkaido University; University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; Rutgers State University New Brunswick	Misof, B (corresponding author), ZMB, Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany.	b.misof.zfmk@uni-bonn.de; wangj@genomics.cn; kjer@aesop.rutgers.edu; xinzhou@genomics.cn	Meusemann, Karen/J-4027-2013; Kapli, Paschalia/AAL-3890-2021; Ho, Igor Osorio/AAG-8616-2020; Liu, Shanlin/HGA-2841-2022; Zhou, Xin/D-4025-2009; Friedrich, Frank/A-8309-2015; Navarrete-Heredia, José/T-8250-2019; Buckley, Thomas/H-1284-2012; Lanfear, Robert/A-2022-2010; Wong, Thomas/J-7623-2013; Liu, Shanlin/GNH-3256-2022; Wappler, Torsten/D-4287-2011; Szucsich, Nikolaus/O-1776-2017; Mayer, Christoph/AAD-6696-2019; Wappler, Torsten/P-6831-2019; Buckley, Thomas/HGD-4732-2022; Navarrete-Heredia, José L/R-3624-2019; Li, Yiyuan/I-8414-2019; Donath, Alexander/F-2636-2015; Yoshizawa, Kazunori/A-4268-2012; von Reumont, Bjoern M/Q-7065-2018; Blanke, Alexander/H-9858-2013; Aspöck, Horst/O-1990-2017; Podsiadlowski, Lars/B-2796-2008; Xu, Xun/AAI-6763-2020; Zhou, Xin/AAI-9326-2021; Jermiin, Lars Sommer/AAQ-7033-2020; Pohl, Hans/M-6873-2019; Slipinski, Adam/AAZ-2485-2020; Slipinski, Stanislaw Adam/B-4293-2009; Jermiin, Lars Sommer/C-2458-2009; Stamatakis, Alexandros/B-8740-2009; Wipfler, Benjamin/M-2926-2015; Li, Yingrui/K-1064-2015; Yoshizawa, Kazunori/Q-9390-2019; Yeates, David K/A-9917-2008; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Liu, Shanlin/0000-0001-8118-8313; Zhou, Xin/0000-0002-1407-7952; Buckley, Thomas/0000-0002-3076-4234; Lanfear, Robert/0000-0002-1140-2596; Wong, Thomas/0000-0002-0580-6324; Liu, Shanlin/0000-0001-8118-8313; Wappler, Torsten/0000-0003-1592-0988; Szucsich, Nikolaus/0000-0002-8945-5153; Mayer, Christoph/0000-0001-5104-6621; Wappler, Torsten/0000-0003-1592-0988; Li, Yiyuan/0000-0003-1426-0033; Donath, Alexander/0000-0001-5618-0547; von Reumont, Bjoern M/0000-0002-7462-8226; Aspöck, Horst/0000-0001-9407-3566; Podsiadlowski, Lars/0000-0001-7786-8930; Xu, Xun/0000-0002-5338-5173; Zhou, Xin/0000-0002-1407-7952; Jermiin, Lars Sommer/0000-0002-9619-3809; Slipinski, Adam/0000-0002-1216-8068; Jermiin, Lars Sommer/0000-0002-9619-3809; Stamatakis, Alexandros/0000-0003-0353-0691; Yoshizawa, Kazunori/0000-0001-6170-4296; Yeates, David K/0000-0001-7729-6143; Timelthaler, Gerald/0000-0002-0260-089X; MENG, GUANLIANG/0000-0002-6488-1527; Letsch, Harald/0000-0001-9854-4855; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Tang, Min/0000-0002-6021-7282; Ware, Jessica/0000-0002-4066-7681; Mashimo, Yuta/0000-0001-6866-1778; Pohl, Hans/0000-0002-7090-6612; FUKUI, Makiko/0000-0002-0525-1621; Blanke, Alexander/0000-0003-4385-6039; Frandsen, Paul/0000-0002-4801-7579; Petersen, Malte/0000-0001-7601-9873; Trautwein, Michelle/0000-0003-4469-5839	Umbrella BioProject [PRJNA183205]; China National GeneBank; BGI-Shenzhen, China; German Research Foundation [NI 1387/1-1, MI 649/6, MI 649/10, RE 345/1-2, BE1789/8-1, BE 1789/10-1, STA 860/4, WA 1496/8-1]; Austria Science Fund FWF; NSF [DEB 0816865]; Ministry of Education, Culture, Sports, Science and Technology of Japan [B 22770090]; Japan Society for the Promotion of Science [P14071]; Deutsches Elektronen-Synchrotron [I-20120065]; Paul Scherrer Institute [20110069]; Schlinger Endowment to CSIRO Ecosystem Sciences; Heidelberg Institute for Theoretical Studies; University of Memphis-FedEx Institute of Technology; Rutgers University; Austrian Science Fund (FWF) [P 23251] Funding Source: researchfish; Division Of Environmental Biology [1257960] Funding Source: National Science Foundation	Umbrella BioProject; China National GeneBank; BGI-Shenzhen, China; German Research Foundation(German Research Foundation (DFG)); Austria Science Fund FWF(Austrian Science Fund (FWF)); NSF(National Science Foundation (NSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsches Elektronen-Synchrotron; Paul Scherrer Institute; Schlinger Endowment to CSIRO Ecosystem Sciences; Heidelberg Institute for Theoretical Studies; University of Memphis-FedEx Institute of Technology; Rutgers University; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The data reported in this paper are tabulated in the supplementary materials and archived at National Center for Biotechnology Information, NIH, under the Umbrella BioProject ID PRJNA183205 ("The 1KITE project: evolution of insects"). Supplementary files are archived at the Dryad Digital Repository http://dx.doi.org/10.5061/dryad.3c0f1. Funding support: China National GeneBank and BGI-Shenzhen, China; German Research Foundation (NI 1387/1-1; MI 649/6, MI 649/10, RE 345/1-2, BE1789/8-1, BE 1789/10-1, STA 860/4, Heisenberg grant WA 1496/8-1); Austria Science Fund FWF; NSF (DEB 0816865); Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-Aid for Young Scientists (B 22770090); Japan Society for the Promotion of Science (P14071); Deutsches Elektronen-Synchrotron (I-20120065); Paul Scherrer Institute (20110069); Schlinger Endowment to CSIRO Ecosystem Sciences; Heidelberg Institute for Theoretical Studies; University of Memphis-FedEx Institute of Technology; and Rutgers University. The authors declare no conflicts of interest.	Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Blanke A, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-16; Dell'Ampio E, 2014, MOL BIOL EVOL, V31, P239, DOI 10.1093/molbev/mst196; Doyle JA, 2012, ANNU REV EARTH PL SC, V40, P301, DOI 10.1146/annurev-earth-042711-105313; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Hennig W., 1969, STAMMESGESCHICHTE IN; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; Labandeira Conrad, 2006, Arthropod Systematics & Phylogeny, V64, P53; Labandeira CC, 2014, NEW PHYTOL, V202, P247, DOI 10.1111/nph.12643; Letsch H, 2013, SYST ENTOMOL, V38, P783, DOI 10.1111/syen.12028; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Nel A, 2013, NATURE, V503, P257, DOI 10.1038/nature12629; Niehuis O, 2012, CURR BIOL, V22, P1309, DOI 10.1016/j.cub.2012.05.018; Prokop J, 2005, GEOBIOS-LYON, V38, P383, DOI 10.1016/j.geobios.2003.11.006; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; Smith VS, 2011, BIOL LETTERS, V7, P782, DOI 10.1098/rsbl.2011.0105; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x	21	1526	1583	57	1087	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					763	767		10.1126/science.1257570	http://dx.doi.org/10.1126/science.1257570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378627				2022-12-28	WOS:000344690100045
J	Black, WC; Gareen, IF; Soneji, SS; Sicks, JD; Keeler, EB; Aberle, DR; Naeim, A; Church, TR; Silvestri, GA; Gorelick, J; Gatsonis, C				Black, William C.; Gareen, Ilana F.; Soneji, Samir S.; Sicks, JoRean D.; Keeler, Emmett B.; Aberle, Denise R.; Naeim, Arash; Church, Timothy R.; Silvestri, Gerard A.; Gorelick, Jeremy; Gatsonis, Constantine		Natl Lung Screening Trial Res Team	Cost-Effectiveness of CT Screening in the National Lung Screening Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPUTED-TOMOGRAPHY; CANCER MORTALITY; OVERDIAGNOSIS; BENEFITS; HEALTH; HARMS; RISK	BACKGROUND The National Lung Screening Trial (NLST) showed that screening with low-dose computed tomography (CT) as compared with chest radiography reduced lung-cancer mortality. We examined the cost-effectiveness of screening with low-dose CT in the NLST. METHODS We estimated mean life-years, quality-adjusted life-years (QALYs), costs per person, and incremental cost-effectiveness ratios (ICERs) for three alternative strategies: screening with low-dose CT, screening with radiography, and no screening. Estimations of life-years were based on the number of observed deaths that occurred during the trial and the projected survival of persons who were alive at the end of the trial. Quality adjustments were derived from a subgroup of participants who were selected to complete quality-of-life surveys. Costs were based on utilization rates and Medicare reimbursements. We also performed analyses of subgroups defined according to age, sex, smoking history, and risk of lung cancer and performed sensitivity analyses based on several assumptions. RESULTS As compared with no screening, screening with low-dose CT cost an additional $1,631 per person (95% confidence interval [CI], 1,557 to 1,709) and provided an additional 0.0316 life-years per person (95% CI, 0.0154 to 0.0478) and 0.0201 QALYs per person (95% CI, 0.0088 to 0.0314). The corresponding ICERs were $52,000 per life-year gained (95% CI, 34,000 to 106,000) and $81,000 per QALY gained (95% CI, 52,000 to 186,000). However, the ICERs varied widely in subgroup and sensitivity analyses. CONCLUSIONS We estimated that screening for lung cancer with low-dose CT would cost $81,000 per QALY gained, but we also determined that modest changes in our assumptions would greatly alter this figure. The determination of whether screening outside the trial will be cost-effective will depend on how screening is implemented.	[Black, William C.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Radiol, Lebanon, NH 03755 USA; [Soneji, Samir S.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03755 USA; [Soneji, Samir S.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03755 USA; [Gareen, Ilana F.; Sicks, JoRean D.; Gorelick, Jeremy; Gatsonis, Constantine] Brown Univ, Sch Publ Hlth, Ctr Stat Sci, Providence, RI 02912 USA; [Gareen, Ilana F.] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Gatsonis, Constantine] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Keeler, Emmett B.] Pardee RAND Grad Sch, Santa Monica, CA USA; [Aberle, Denise R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Naeim, Arash] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Naeim, Arash] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr Med, Dept Med, Los Angeles, CA 90095 USA; [Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; [Silvestri, Gerard A.] Med Univ S Carolina, Div Pulm & Crit Care Med, Charleston, SC USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Brown University; Brown University; Brown University; RAND Corporation; Pardee RAND Graduate School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Minnesota System; University of Minnesota Twin Cities; Medical University of South Carolina	Black, WC (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Radiol, Lebanon, NH 03755 USA.	william.c.black@hitchcock.org	Aberle, Denise R./D-5699-2014; Church, Timothy/AAH-7017-2020; Gareen, Ilana/I-2816-2014	Aberle, Denise R./0000-0002-8858-3401; Church, Timothy/0000-0003-3292-5035; Gareen, Ilana/0000-0002-0457-5595; fishman, elliot/0000-0002-2567-1658	National Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA023108, UG1CA189828, U10CA079778, U10CA180794, U01CA080098, U10CA180820] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001088, UL1TR001086] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by the National Cancer Institute; NLST ClinicalTrials.gov number, NCT00047385.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American College of Radiology, 2014, LUNG IM REP DAT SYST; Arias Elizabeth, 2014, Natl Vital Stat Rep, V62, P1; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Centers for Medicare and Medicaid Services, 2011, PHYS FEE SCHED LOOK; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Department of Labor, 2010, EMPL COSTS EMP COMP; Gareen IF, 2014, CANCER-AM CANCER SOC, V120, P3401, DOI 10.1002/cncr.28833; Gareen IF, 2013, CONTEMP CLIN TRIALS, V34, P36, DOI 10.1016/j.cct.2012.09.002; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; General Services Administration, 2012, PRIV OWN VEH POV MIL; Gold MR, 1996, COST EFFECTIVENESS H; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Mahadevia PJ, 2003, JAMA-J AM MED ASSOC, V289, P313, DOI 10.1001/jama.289.3.313; Manser R, 2005, LUNG CANCER, V48, P171, DOI 10.1016/j.lungcan.2004.11.001; Marshall D, 2001, LUNG CANCER, V32, P227, DOI 10.1016/S0169-5002(00)00239-7; McMahon PM, 2011, J THORAC ONCOL, V6, P1841, DOI 10.1097/JTO.0b013e31822e59b3; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Pyenson BS, 2012, HEALTH AFFAIR, V31, P770, DOI 10.1377/hlthaff.2011.0814; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sox HC, 2011, NEW ENGL J MED, V365, P455, DOI 10.1056/NEJMe1103776; Stinnett AA, 1996, HEALTH ECON, V5, P470, DOI 10.1002/(SICI)1099-1050(199609)5:5<470::AID-HEC224>3.0.CO;2-5; Surveillance E and End Results (SEER) Program, 2013, SEER STAT DAT INC SE; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tosteson ANA, 2014, JAMA INTERN MED, V174, P954, DOI 10.1001/jamainternmed.2014.981; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; van der Aalst CM, 2011, EUR RESPIR J, V37, P1466, DOI 10.1183/09031936.00035410; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Wisnivesky JP, 2003, CHEST, V124, P614, DOI 10.1378/chest.124.2.614	39	353	375	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1793	1802		10.1056/NEJMoa1312547	http://dx.doi.org/10.1056/NEJMoa1312547			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS3IH	25372087	Green Published, Green Accepted			2022-12-28	WOS:000344170300008
J	Kalantarian, S; Ay, H; Gollub, RL; Lee, H; Retzepi, K; Mansour, M; Ruskin, JN				Kalantarian, Shadi; Ay, Hakan; Gollub, Randy L.; Lee, Hang; Retzepi, Kallirroi; Mansour, Moussa; Ruskin, Jeremy N.			Association Between Atrial Fibrillation and Silent Cerebral Infarctions A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							BRAIN INFARCTS; COMPUTED-TOMOGRAPHY; RISK-FACTOR; STROKE; DISEASE; PREVALENCE; DEMENTIA; PATTERNS; TRENDS	Background: Atrial fibrillation (AF) is a common cause of stroke. Silent cerebral infarctions (SCIs) are known to occur in the presence and absence of AF, but the association between these disorders has not been well-defined. Purpose: To estimate the association between AF and SCIs and the prevalence of SCIs in stroke-free patients with AF. Data Sources: Searches of MEDLINE, PsycINFO, Cochrane Library, CINAHL, and EMBASE from inception to 8 May 2014 without language restrictions and manual screening of article references. Study Selection: Observational studies involving adults with AF and no clinical history of stroke or prosthetic valves who reported SCIs. Data Extraction: Study characteristics and study quality were assessed in duplicate. Data Synthesis: Eleven studies including 5317 patients with mean ages from 50.0 to 83.6 years reported on the association between AF and SCIs. Autopsy studies were heterogeneous and low-quality; therefore, they were excluded from the meta-analysis of the risk estimates. When computed tomography (CT) and magnetic resonance imaging (MRI) studies were combined, AF was associated with SCIs in patients with no history of symptomatic stroke (odds ratio, 2.62 [95% CI, 1.81 to 3.80]; I-2 = 32.12%; P for heterogeneity = 0.118). This association was independent of AF type (paroxysmal vs. persistent). The results were not altered significantly when the analysis was restricted to studies that met at least 70% of the maximum possible quality score (odds ratio, 3.06 [CI, 2.24 to 4.19]). Seventeen studies reported the prevalence of SCIs. The overall prevalence of SCI lesions on MRI and CT among patients with AF was 40% and 22%, respectively. Limitation: Most studies were cross-sectional, and autopsy studies were heterogeneous and not sufficiently sensitive to detect small lesions. Conclusion: Atrial fibrillation is associated with more than a 2-fold increase in the odds for SCI.	Inst Heart Vasc & Stroke Care, Boston, MA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Ruskin, JN (corresponding author), Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, 55 Fruit St, Boston, MA 02114 USA.	jruskin@partners.org		Gollub, Randy L./0000-0002-9434-4044	Deane Institute for Integrative Research in Atrial Fibrillation and Stroke, Massachusetts General Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Deane Institute for Integrative Research in Atrial Fibrillation and Stroke, Massachusetts General Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Deane Institute for Integrative Research in Atrial Fibrillation and Stroke, Massachusetts General Hospital.	Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; BOGOUSSLAVSKY J, 1991, CEREBROVASC DIS, V1, P61, DOI 10.1159/000108899; BOGOUSSLAVSKY J, 1986, NEUROLOGY, V36, P373, DOI 10.1212/WNL.36.3.373; Bokura Hirokazu, 2006, J Stroke Cerebrovasc Dis, V15, P57, DOI 10.1016/j.jstrokecerebrovasdis.2005.11.001; Bunch TJ, 2010, HEART RHYTHM, V7, P433, DOI 10.1016/j.hrthm.2009.12.004; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Das RR, 2008, STROKE, V39, P2929, DOI 10.1161/STROKEAHA.108.516575; de Falco F A, 1991, Acta Neurol (Napoli), V13, P249; Dublin S, 2011, J AM GERIATR SOC, V59, P1369, DOI 10.1111/j.1532-5415.2011.03508.x; EZEKOWITZ MD, 1995, CIRCULATION, V92, P2178, DOI 10.1161/01.CIR.92.8.2178; FEINBERG WM, 1990, ARCH INTERN MED, V150, P2340, DOI 10.1001/archinte.150.11.2340; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GUIDOTTI M, 1990, IRISH J MED SCI, V159, P96, DOI 10.1007/BF02937438; HARA M, 1995, CLIN CARDIOL, V18, P573, DOI 10.1002/clc.4960181008; HARRISON MJG, 1984, STROKE, V15, P441, DOI 10.1161/01.STR.15.3.441; Kaarisalo MM, 1997, J AM GERIATR SOC, V45, P1297, DOI 10.1111/j.1532-5415.1997.tb02927.x; Kalantarian S, 2013, ANN INTERN MED, V158, P338, DOI 10.7326/0003-4819-158-5-201303050-00007; Kim MH, 2011, EUR NEUROL, V65, P250, DOI 10.1159/000324335; Kobayashi A, 2012, J STROKE CEREBROVASC, V21, P310, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.004; Longstreth WT, 2002, STROKE, V33, P2376, DOI 10.1161/01.STR.0000032241.58727.49; Lucas C, 1998, STROKE, V29, P2646, DOI 10.1161/01.STR.29.12.2646; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; Marfella R, 2013, J AM COLL CARDIOL, V62, P525, DOI 10.1016/j.jacc.2013.02.091; Miwa K, 2010, INTERNAL MED, V49, P817, DOI 10.2169/internalmedicine.49.3211; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; PETERSEN P, 1989, EUR HEART J, V10, P1101, DOI 10.1093/oxfordjournals.eurheartj.a059432; PETERSEN P, 1989, ACTA NEUROL SCAND, V79, P482, DOI 10.1111/j.1600-0404.1989.tb03818.x; Saito T, 2014, J STROKE CEREBROVASC, V23, P1616, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.005; Sawai N, 1997, Nihon Ronen Igakkai Zasshi, V34, P389; SHINKAWA A, 1995, STROKE, V26, P380, DOI 10.1161/01.STR.26.3.380; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Strach K, 2005, ROFO-FORTSCHR RONTG, V177, P1706, DOI 10.1055/s-2005-858787; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thompson S, 2011, INT J EPIDEMIOL, V40, P765, DOI 10.1093/ije/dyq248; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Une F, 1993, Nihon Rinsho, V51 Suppl, P874; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yamanouchi H, 1997, NEUROLOGY, V48, P1593, DOI 10.1212/WNL.48.6.1593; Zhu YC, 2011, STROKE, V42, P1140, DOI 10.1161/STROKEAHA.110.600114; Zito M, 1996, AGING-CLIN EXP RES, V8, P341, DOI 10.1007/BF03339591	44	99	103	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					650	U158		10.7326/M14-0538	http://dx.doi.org/10.7326/M14-0538			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364886	Green Accepted			2022-12-28	WOS:000347244100006
J	Rieselbach, RE; Rockey, PH; Phillips, RL; Klink, K; Cox, M				Rieselbach, Richard E.; Rockey, Paul H.; Phillips, Robert L., Jr.; Klink, Kathleen; Cox, Malcolm			Aligning Expansion of Graduate Medical Education With Recent Recommendations for Reform	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TEACHING HEALTH CENTERS; PRIMARY-CARE		Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; Accreditat Council Grad Med Educ, Chicago, IL USA; So Illinois Univ, Sch Med, Springfield, IL USA; Amer Board Family Med, Lexington, KY USA; Georgetown Univ, Washington, DC USA; Robert Graham Ctr Policy Studies Family Med & Pri, Washington, DC USA; Virginia Commonwealth Univ, Richmond, VA USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Wisconsin System; University of Wisconsin Madison; Southern Illinois University System; Southern Illinois University; Georgetown University; Virginia Commonwealth University; University of Pennsylvania; Pennsylvania Medicine	Rieselbach, RE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, 7974 UW Hlth Court, Middleton, WI 53562 USA.	rer@medicine.wisc.edu						Chandra A, 2014, NEW ENGL J MED, V370, P2357, DOI 10.1056/NEJMp1402468; Chen C, 2012, ACAD MED, V87, P1752, DOI 10.1097/ACM.0b013e3182720f4d; Eden J., 2014, GRADUATE MED ED MEET; Gilman SC, 2014, ACAD MED, V89, P1113, DOI 10.1097/ACM.0000000000000312; Phillips RL, 2013, ACAD MED, V88, P1934, DOI 10.1097/ACM.0000000000000025; Rieselbach Richard E, 2013, J Grad Med Educ, V5, P556, DOI 10.4300/JGME-05-04-39; Rieselbach RE, 2013, ACAD MED, V88, P1835, DOI 10.1097/ACM.0000000000000035; Rieselbach RE, 2010, ANN INTERN MED, V152, P118, DOI 10.7326/0003-4819-152-2-201001190-00186; Voorhees KI, 2013, FAM MED, V45, P164	9	3	3	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					668	U88		10.7326/M14-1838	http://dx.doi.org/10.7326/M14-1838			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364888				2022-12-28	WOS:000347244100008
J	Cheung, F				Cheung, Felix			The search for the rice of the future	NATURE			English	Editorial Material							GENE											[Anonymous], 2014, GIGASCIENCE, V3, P7; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; LI JW, 2014, CHINA RICE, V20, P7; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yuan LP, 2014, RICE SCI, V21, P1, DOI 10.1016/S1672-6308(13)60167-5	8	10	12	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S60	S61		10.1038/514S60a	http://dx.doi.org/10.1038/514S60a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368890				2022-12-28	WOS:000343801500006
J	Eisenstein, M				Eisenstein, Michael			Against the grain	NATURE			English	Editorial Material							GOLDEN-RICE; BETA-CAROTENE; VITAMIN-A											Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Stein AJ, 2008, WORLD DEV, V36, P144, DOI 10.1016/j.worlddev.2007.02.013; Tang GW, 2012, AM J CLIN NUTR, V96, P658, DOI 10.3945/ajcn.111.030775; Wang M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00156; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303	6	15	16	0	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S55	S57		10.1038/514S55a	http://dx.doi.org/10.1038/514S55a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368888	Bronze			2022-12-28	WOS:000343801500004
J	Zeigler, R				Zeigler, Robert			Time to unleash rice	NATURE			English	Editorial Material									Int Rice Res Inst, Los Banos, Philippines	CGIAR; International Rice Research Institute (IRRI)	Zeigler, R (corresponding author), Int Rice Res Inst, Los Banos, Philippines.	r.zeigler@irri.org							0	4	5	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S66	S66		10.1038/514S66a	http://dx.doi.org/10.1038/514S66a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BW	25368893	Bronze			2022-12-28	WOS:000343801500009
J	Williams, B; Morrissey, B; Goenka, A; Magnus, D; Allen, S				Williams, Bhanu; Morrissey, Benita; Goenka, Anu; Magnus, Dan; Allen, Stephen			Global child health competencies for paediatricians	LANCET			English	Editorial Material							NEWBORN; PROFESSIONALS		[Williams, Bhanu] North West London Hosp NHS Trust, Harrow HA1 3UJ, Middx, England; [Morrissey, Benita] Whittington Hosp NHS Trust, London, England; [Morrissey, Benita] UCL Inst Child Hlth, London, England; [Goenka, Anu] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester, Lancs, England; [Magnus, Dan] Bristol Royal Hosp Children, Bristol, Avon, England; [Allen, Stephen] Royal Coll Paediat & Child Hlth, London, England	University of London; University College London; University of Manchester; Bristol Royal Hospital For Children	Williams, B (corresponding author), North West London Hosp NHS Trust, Harrow HA1 3UJ, Middx, England.	bhanu.williams@nhs.net	Goenka, Anu/M-6700-2019	Goenka, Anu/0000-0002-8152-2155				Audcent T, 2007, CLIN INVEST MED S, V30, pS63; Bhutta ZA, 2013, NEW ENGL J MED, V369, P2226, DOI 10.1056/NEJMra1111853; Foundation for Women's Health Research and Development, FEM GEN MUT; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Johnson O, 2012, LANCET, V379, P2033, DOI 10.1016/S0140-6736(11)61582-1; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Molyneux E, 2013, ARCH DIS CHILD, V98, P840, DOI 10.1136/archdischild-2013-304815; Pedrazzoli D., 2013, TUBERCULOSIS UK 2013; Royal College of Paediatrics and Child Health, 2014, MISS VIS VAL; Streetly A, 2010, J CLIN PATHOL, V63, P626, DOI 10.1136/jcp.2010.077560; Suchdev PS, 2012, ACAD PEDIATR, V12, P229, DOI 10.1016/j.acap.2012.02.003; UK Government Home Office, 2013, IMM STAT; UK Government Office for National Statistics, 2012, 2011 CENS SHOWS NONU; UNICEF, CONV RIGHTS CHILD; Viner RM, 2014, LANCET; Wang H, 2014, LANCET	16	10	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1403	1405		10.1016/S0140-6736(14)61128-4	http://dx.doi.org/10.1016/S0140-6736(14)61128-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ8TV	25390308				2022-12-28	WOS:000343107000004
J	Freudenthal, BD; Beard, WA; Perera, L; Shock, DD; Kim, T; Schlick, T; Wilson, SH				Freudenthal, Bret D.; Beard, William A.; Perera, Lalith; Shock, David D.; Kim, Taejin; Schlick, Tamar; Wilson, Samuel H.			Uncovering the polymerase-induced cytotoxicity of an oxidized nucleotide	NATURE			English	Article							EMPIRICAL FORCE-FIELD; BASE EXCISION-REPAIR; MOLECULAR-DYNAMICS; OXIDATIVE STRESS; KINETIC-ANALYSIS; STRUCTURAL BASIS; NUCLEIC-ACIDS; DNA; BETA; TARGET	Oxidative stress promotes genomic instability and humandiseases(1). A common oxidized nucleoside is 8-oxo-7,8-dihydro-2'-deoxyguanosine, which is found both in DNA (8-oxo-G) and as a free nucleotide (8-oxo- dGTP)(2,3). Nucleotide pools are especially vulnerable to oxidative damage(4). Therefore cells encodeanenzyme(MutT/MTH1) that removes free oxidized nucleotides. This cleansing function is required for cancer cell survival(5,6) and to modulate Escherichia coli antibiotic sensitivity in a DNA polymerase (pol)-dependent manner(7). How polymerases discriminate between damaged and non-damaged nucleotides is not well understood. This analysis is essential given the role of oxidized nucleotides in mutagenesis, cancer therapeutics, and bacterial antibiotics(8). Even with cellular sanitizing activities, nucleotide pools contain enough 8-oxo-dGTP to promote mutagenesis(9,10). This arises from the dual coding potential where 8-oxo-dGTP(anti) base pairs with cytosine and 8-oxo-dGTP(syn) uses its Hoogsteen edge to base pair with adenine(11). Here we use time-lapse crystallography to follow 8-oxo-dGTP insertion opposite adenine or cytosine with human pol beta, to reveal that insertion is accommodated in either the syn-oranti-conformation, respectively. For 8-oxo-dGTP(anti) insertion, a novel divalent metal relieves repulsive interactions between the adducted guanine base and the triphosphate of the oxidized nucleotide. With either templating base, hydrogen-bonding interactions between the bases are lost as the enzyme reopens after catalysis, leading to a cytotoxic nicked DNA repair intermediate. Combining structural snapshots with kinetic and computational analysis reveals how 8-oxo-dGTP uses charge modulation during insertion that can lead to a blocked DNA repair intermediate.	[Freudenthal, Bret D.; Beard, William A.; Perera, Lalith; Shock, David D.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Kim, Taejin; Schlick, Tamar] NYU, Dept Chem, New York, NY 10003 USA; [Kim, Taejin; Schlick, Tamar] NYU Shanghai, NYU ECNU Ctr Computat Chem, New York, NY 10003 USA; [Kim, Taejin; Schlick, Tamar] NYU, Courant Inst Math Sci, New York, NY 10012 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); New York University; New York University	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019; perera, Lalith/B-6879-2012; Perera, Lalith/ABB-9995-2021	Wilson, Samuel H/0000-0002-1702-5293; perera, Lalith/0000-0003-0823-1631; Schlick, Tamar/0000-0002-2392-2062	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01-E5050158, Z01-ES050161, ZIC-ES043010]; National Institutes of Health [1U19CA105010]; Philip Morris USA Inc.; Philip Morris International; NATIONAL CANCER INSTITUTE [U19CA105010, U19CA177547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES043010, Z01ES050161, Z01ES050158, ZIAES050158] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA Inc.; Philip Morris International; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the Collaborative Crystallography group at the National Institute of Environmental Health Sciences for help with data collection and analysis. We thank L. Pedersen for discussions. Use of the advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (project numbers Z01-E5050158 (to SW.), Z01-ES050161 (to S.W.), and ZIC-ES043010 (to L.P.)) and in association with National Institutes of Health grant 1U19CA105010. We are grateful for computational support for the molecular dynamics simulations from the HPC clusters at NYU as well as the Blue Gene at CCNI. Support from Philip Morris USA Inc. and Philip Morris International to T.S. is gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amouroux R, 2010, NUCLEIC ACIDS RES, V38, P2878, DOI 10.1093/nar/gkp1247; [Anonymous], 2010, AXPYMOL MOL GRAPH PL, V1.0; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 2014, BIOCHEMISTRY-US, V53, P2768, DOI 10.1021/bi500139h; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown JA, 2007, J MOL BIOL, V367, P1258, DOI 10.1016/j.jmb.2007.01.069; Cabelof DC, 2002, CARCINOGENESIS, V23, P1419, DOI 10.1093/carcin/23.9.1419; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Eckenroth BE, 2014, BIOCHEMISTRY-US, V53, P2075, DOI 10.1021/bi500270e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Freudenthal BD, 2013, NUCLEIC ACIDS RES, V41, P1848, DOI 10.1093/nar/gks1276; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Koag MC, 2014, J BIOL CHEM, V289, P6289, DOI 10.1074/jbc.M113.537803; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Miller H, 2000, BIOCHEMISTRY-US, V39, P1029, DOI 10.1021/bi991789x; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavelites JJ, 1997, J COMPUT CHEM, V18, P221, DOI 10.1002/(SICI)1096-987X(19970130)18:2<221::AID-JCC7>3.0.CO;2-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sucato CA, 2008, BIOCHEMISTRY-US, V47, P870, DOI 10.1021/bi7014162; TOPAL MD, 1982, P NATL ACAD SCI-BIOL, V79, P2211, DOI 10.1073/pnas.79.7.2211; Wang YL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-7; Wang YL, 2006, PROTEIN SCI, V15, P135, DOI 10.1110/ps.051726906	48	112	112	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					635	U261		10.1038/nature13886	http://dx.doi.org/10.1038/nature13886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25409153	Green Accepted, Green Submitted			2022-12-28	WOS:000348775000048
J	Cohn, A; Fehr, E; Marechal, MA				Cohn, Alain; Fehr, Ernst; Marechal, Michel Andre			Business culture and dishonesty in the banking industry	NATURE			English	Article							IDENTITY; HONESTY; TRUST	Trust in others' honesty is a key component of the long-term performance of firms, industries, and even whole countries(1-4). However, in recent years, numerous scandals involving fraud have undermined confidence in the financial industry(5-7). Contemporary commentators have attributed these scandals to the financial sector's business culture(8-9), but no scientific evidence supports this claim. Here we show that employees of a large, international bank behave, on average, honestly in a control condition. However, when their professional identity as bank employees is rendered salient, a significant proportion of them become dishonest. This effect is specific to bank employees because control experiments with employees from other industries and with students show that they do not become more dishonest when their professional identity or bank-related items are rendered salient. Our results thus suggest that the prevailing business culture in the banking industry weakens and undermines the honesty norm, implying that measures to re-establish an honest culture are very important.	[Cohn, Alain; Fehr, Ernst; Marechal, Michel Andre] Univ Zurich, Dept Econ, CH-8006 Zurich, Switzerland	University of Zurich	Fehr, E (corresponding author), Univ Zurich, Dept Econ, CH-8006 Zurich, Switzerland.	ernst.fehr@econ.uzh.ch; michel.marechal@econ.uzh.ch		Marechal, Michel/0000-0002-6627-0252	European Research Council Grant "Foundations of Economic Preferences"; Gottlieb Duttweiler Institute	European Research Council Grant "Foundations of Economic Preferences"(European Research Council (ERC)); Gottlieb Duttweiler Institute	We thank the participating bank, the alumni network organizations of three education programmes, and the municipal office for enabling the research; G. Akerlof and D. Ariely for critical discussions; C. Efferson, T. Herz and S. Gschwend for reading of the manuscript; and D. Bigliel and M. Brunner for research assistance. Financial support from the European Research Council Grant "Foundations of Economic Preferences" and the Gottlieb Duttweiler Institute is gratefully acknowledged.	Abrantes-Metz RM, 2012, J BANK FINANC, V36, P136, DOI 10.1016/j.jbankfin.2011.06.014; Akerlof GA, 2010, IDENTITY ECONOMICS: HOW OUR IDENTITIES SHAPE OUR WORK, WAGES, AND WELL-BEING, P1; Algan Y, 2013, ANNU REV ECON, V5, P521, DOI 10.1146/annurev-economics-081412-102108; Ariely D., 2012, HONEST TRUTH DISHONE; Benjamin DJ, 2010, AM ECON REV, V100, P1913, DOI 10.1257/aer.100.4.1913; Bicchieri C., 2006, GRAMMAR SOC; Boatright JR, 2013, REV SOC ECON, V71, P140, DOI 10.1080/00346764.2013.800305; Bucciol A, 2011, J ECON PSYCHOL, V32, P73, DOI 10.1016/j.joep.2010.12.001; Cohn A., 2013, BAD BOYS CRIMINAL ID; Coricelli G, 2010, EXP ECON, V13, P226, DOI 10.1007/s10683-010-9237-5; Das S., 2010, TRADERS GUNS MONEY K; Fischbacher U, 2013, J EUR ECON ASSOC, V11, P525, DOI 10.1111/jeea.12014; Hill C. A., 2012, PERSONAL PROFESSIONA; Hill C. A., 2012, REV BANK FINANC LAW, V31, P675; Houser D, 2012, EUR ECON REV, V56, P1645, DOI 10.1016/j.euroecorev.2012.08.001; Kantsukov M, 2013, ADV SER MANAG, P147, DOI 10.1108/S1877-6361(2013)0000010011; LeBoeuf RA, 2010, ORGAN BEHAV HUM DEC, V111, P48, DOI 10.1016/j.obhdp.2009.08.004; Levine R, 1997, J ECON LIT, V35, P688; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Moshinsky B., 2012, BLOOMBERG; Ohtsubo Y, 2010, EVOL HUM BEHAV, V31, P259, DOI 10.1016/j.evolhumbehav.2009.12.007; Pruckner GJ, 2013, J EUR ECON ASSOC, V11, P661, DOI 10.1111/jeea.12016; Quinn J., 2012, HSBC CHAIRMAN URGES; Salz A., 2013, SALZ REV INDEPENDENT; Sapienza P, 2012, INT REV FINANC, V12, P123, DOI 10.1111/j.1468-2443.2012.01152.x; Shalvi S, 2012, PSYCHOL SCI, V23, P1264, DOI 10.1177/0956797612443835; Shih M, 1999, PSYCHOL SCI, V10, P80, DOI 10.1111/1467-9280.00111; Shu LL, 2012, P NATL ACAD SCI USA, V109, P15197, DOI 10.1073/pnas.1209746109; Smith Greg, 2012, WHY I LEFT GOLDMAN S; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491	30	306	310	8	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					86	U190		10.1038/nature13977	http://dx.doi.org/10.1038/nature13977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW5JD	25409154				2022-12-28	WOS:000346310800044
J	Fonville, JM; Wilks, SH; James, SL; Fox, A; Ventresca, M; Aban, M; Xue, L; Jones, TC; Le, NMH; Pham, QT; Tran, ND; Wong, Y; Mosterin, A; Katzelnick, LC; Labonte, D; Le, TT; van der Net, G; Skepner, E; Russell, CA; Kaplan, TD; Rimmelzwaan, GF; Masurel, N; de Jong, JC; Palache, A; Beyer, WEP; Le, QM; Nguyen, TH; Wertheim, HFL; Hurt, AC; Osterhaus, ADME; Barr, IG; Fouchier, RAM; Horby, PW; Smith, DJ				Fonville, J. M.; Wilks, S. H.; James, S. L.; Fox, A.; Ventresca, M.; Aban, M.; Xue, L.; Jones, T. C.; Le, N. M. H.; Pham, Q. T.; Tran, N. D.; Wong, Y.; Mosterin, A.; Katzelnick, L. C.; Labonte, D.; Le, T. T.; van der Net, G.; Skepner, E.; Russell, C. A.; Kaplan, T. D.; Rimmelzwaan, G. F.; Masurel, N.; de Jong, J. C.; Palache, A.; Beyer, W. E. P.; Le, Q. M.; Nguyen, T. H.; Wertheim, H. F. L.; Hurt, A. C.; Osterhaus, A. D. M. E.; Barr, I. G.; Fouchier, R. A. M.; Horby, P. W.; Smith, D. J.			Antibody landscapes after influenza virus infection or vaccination	SCIENCE			English	Article							ORIGINAL ANTIGENIC SIN	We introduce the antibody landscape, a method for the quantitative analysis of antibody-mediated immunity to antigenically variable pathogens, achieved by accounting for antigenic variation among pathogen strains. We generated antibody landscapes to study immune profiles covering 43 years of influenza A/H3N2 virus evolution for 69 individuals monitored for infection over 6 years and for 225 individuals pre- and postvaccination. Upon infection and vaccination, titers increased broadly, including previously encountered viruses far beyond the extent of cross-reactivity observed after a primary infection. We explored implications for vaccination and found that the use of an antigenically advanced virus had the dual benefit of inducing antibodies against both advanced and previous antigenic clusters. These results indicate that preemptive vaccine updates may improve influenza vaccine efficacy in previously exposed individuals.	[Fonville, J. M.; Wilks, S. H.; James, S. L.; Ventresca, M.; Jones, T. C.; Mosterin, A.; Katzelnick, L. C.; Skepner, E.; Smith, D. J.] Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Cambridge CB2 3EJ, England; [Fonville, J. M.; Wilks, S. H.; James, S. L.; Jones, T. C.; Mosterin, A.; Katzelnick, L. C.; Skepner, E.; Russell, C. A.; Smith, D. J.] World Hlth Org WHO Collaborating Ctr Modeling Evo, Cambridge CB2 3EJ, England; [Fonville, J. M.; van der Net, G.; Rimmelzwaan, G. F.; Masurel, N.; de Jong, J. C.; Beyer, W. E. P.; Osterhaus, A. D. M. E.; Fouchier, R. A. M.; Smith, D. J.] Erasmus MC, Dept Virosci, NL-3015 CE Rotterdam, Netherlands; [Fox, A.; Le, N. M. H.; Wertheim, H. F. L.; Horby, P. W.] Oxford Univ Clin Res Unit, Hanoi, Vietnam; [Fox, A.; Le, N. M. H.; Wertheim, H. F. L.; Horby, P. W.] Wellcome Trust Major Overseas Programme, Hanoi, Vietnam; [Aban, M.; Xue, L.; Hurt, A. C.; Barr, I. G.] Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3000, Australia; [Pham, Q. T.; Tran, N. D.; Le, T. T.; Le, Q. M.; Nguyen, T. H.] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Wong, Y.] Univ Oxford, Museum Nat Hist, Oxford OX1 3PW, England; [Labonte, D.] Univ Cambridge, Dept Zool, Insect Biomech Grp, Cambridge CB2 3EJ, England; [Russell, C. A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Kaplan, T. D.] Bobblewire Com, St Louis, MO 63112 USA; [Palache, A.] Abbott Labs, NL-1380 DA Weesp, Netherlands; [Wertheim, H. F. L.; Horby, P. W.] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Hurt, A. C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3010, Australia	University of Cambridge; World Health Organization; Erasmus University Rotterdam; Erasmus MC; Victorian Infectious Diseases Reference Laboratory; World Health Organization; National Institute of Hygiene & Epidemiology (NIHE); University of Oxford; University of Cambridge; University of Cambridge; University of Oxford; University of Melbourne	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Downing St, Cambridge CB2 3EJ, England.	dsmith@zoo.cam.ac.uk	Russell, Colin/ABE-7106-2020; Wertheim, Heiman FL/F-3338-2016; Smith, Derek/Z-3075-2019; Fouchier, Ron A/A-1911-2014	Wertheim, Heiman FL/0000-0002-5003-5565; Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; Horby, Peter/0000-0002-9822-1586; Fox, Annette/0000-0002-0565-7146; Hurt, Aeron/0000-0003-1826-4314; James, Sarah/0000-0002-6969-1167; Russell, Colin/0000-0002-2113-162X; Barr, Ian/0000-0002-7351-418X; Labonte, David/0000-0002-1952-8732; Wong, Yan/0000-0002-3536-6411	Medical Research Council Fellowship [MR/K021885/1]; Homerton College; Gates-Cambridge Scholarship; NIH Oxford-Cambridge Scholars program; Royal Society University Research Fellowship [RG55423]; National Institute of Allergy and Infectious Diseases-NIH Centers of Excellence for Influenza Research and Surveillance contracts [HHSN266200700010C, HHSN272201400008C]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant [91896613]; European Union [223498, 278976]; Human Frontier Science Program grant [P0050/2008]; Wellcome Trust [WT087982MA]; NIH Director's Pioneer Award [DP1-OD000490-01]; Australian government Department of Health; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER; MRC [MR/K021885/1] Funding Source: UKRI; Medical Research Council [MR/K021885/1] Funding Source: researchfish	Medical Research Council Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Homerton College; Gates-Cambridge Scholarship; NIH Oxford-Cambridge Scholars program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society University Research Fellowship(Royal Society of London); National Institute of Allergy and Infectious Diseases-NIH Centers of Excellence for Influenza Research and Surveillance contracts; Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant; European Union(European Commission); Human Frontier Science Program grant(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian government Department of Health(Australian GovernmentDepartment of Health & Ageing); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Bodewes, J. Bryant, D. Burke, N. Lewis, E. Selkov, B. Muhlemann, G. de Mutsert, and F. Pistoor. We also thank the staff of the Ha Nam Provincial Preventive Medicine Centre, the Hamlet health workers, and the National Institute for Hygiene and Epidemiology, Vietnam, for their support in conducting the fieldwork. We are indebted to the cooperation of the Ha Nam cohort and vaccine study participants. J.M.F. is supported by a Medical Research Council Fellowship (MR/K021885/1) and a Junior Research Fellowship from Homerton College, L. C. K. by the Gates-Cambridge Scholarship and the NIH Oxford-Cambridge Scholars program, and C. A. R. by a Royal Society University Research Fellowship (RG55423). We acknowledge the National Institute of Allergy and Infectious Diseases-NIH Centers of Excellence for Influenza Research and Surveillance contracts HHSN266200700010C and HHSN272201400008C, Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant 91896613, the European Union FP7 programs EMPERIE (223498) and ANTIGONE (278976), Human Frontier Science Program grant P0050/2008, the Wellcome Trust (WT087982MA), and NIH Director's Pioneer Award DP1-OD000490-01. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian government Department of Health. A.D.M.E.O. (as Chief Scientific Officer of Viroclinics Biosciences BV) has advisory affiliations with GlaxoSmithKline, Novartis, and Roche. Sequences of the influenza viruses used in this study are available in GenBank with accession numbers: KM821278 to KM821358. Erasmus Medical Center (Rotterdam, the Netherlands) requires a materials transfer agreement for sharing viruses and antisera.	Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; DAVENPORT FM, 1955, LANCET, V2, P469; DAVENPORT FM, 1956, J EXP MED, V104, P85, DOI 10.1084/jem.104.1.85; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; FRANCIS T, 1947, AM J PUBLIC HEALTH, V37, P1013, DOI 10.2105/AJPH.37.8.1013; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; HENNESSY AV, 1955, J IMMUNOL, V75, P401; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Horby P, 2012, AM J EPIDEMIOL, V175, P1062, DOI 10.1093/aje/kws121; Horsfall FL, 1941, J EXP MED, V74, P433, DOI 10.1084/jem.74.5.433; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; O'Donnell CD, 2014, CLIN VACCINE IMMUNOL, V21, P737, DOI 10.1128/CVI.00790-13; Pan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023910; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	25	243	245	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					996	1000		10.1126/science.1256427	http://dx.doi.org/10.1126/science.1256427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414313	Green Accepted, Green Submitted			2022-12-28	WOS:000345696000044
J	Kislyakova, KG; Holmstrom, M; Lammer, H; Odert, P; Khodachenko, ML				Kislyakova, Kristina G.; Holmstrom, Mats; Lammer, Helmut; Odert, Petra; Khodachenko, Maxim L.			Magnetic moment and plasma environment of HD 209458b as determined from Ly alpha observations	SCIENCE			English	Article							ENERGETIC NEUTRAL ATOMS; MASS-LOSS; TRANSIT SPECTROSCOPY; UPPER-ATMOSPHERE; HYDROGEN; FIELD; HELIOSPHERE; EVOLUTION; PLANETS; ESCAPE	Transit observations of HD 209458b in the stellar Lyman-alpha(Ly alpha) line revealed strong absorption in both blue and red wings of the line interpreted as hydrogen atoms escaping from the planet's exosphere at high velocities. The following sources for the absorption were suggested: acceleration by the stellar radiation pressure, natural spectral line broadening, or charge exchange with the stellar wind. We reproduced the observation by means of modeling that includes all aforementioned processes. Our results support a stellar wind with a velocity of approximate to 400 kilometers per second at the time of the observation and a planetary magnetic moment of approximate to 1.6 x 10(26) amperes per square meter.	[Kislyakova, Kristina G.; Lammer, Helmut; Khodachenko, Maxim L.] Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; [Holmstrom, Mats] Swedish Inst Space Phys, SE-98128 Kiruna, Sweden; [Odert, Petra] Graz Univ, Inst Phys, A-8010 Graz, Austria; [Khodachenko, Maxim L.] Moscow MV Lomonosov State Univ, Skobeltsyn Inst Nucl Phys, Moscow 119992, Russia	Austrian Academy of Sciences; University of Graz; Lomonosov Moscow State University	Kislyakova, KG (corresponding author), Austrian Acad Sci, Space Res Inst, Schmiedlstr 6, A-8042 Graz, Austria.	kristina.kislyakova@oeaw.ac.at	Khodachenko, Maxim/ABE-9806-2020	Khodachenko, Maxim/0000-0001-7954-5131; Kislyakova, Kristina/0000-0003-4680-6774	Austrian Science Fund (FWF) [S116601-N16, S116 606-N16, S116 607-N16]; FWF [P22950-N16]; Austrian Science Fund (FWF) [P 22950] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was carried out with support by the Austrian Science Fund (FWF) Nationale Forschungsnetzwerke (NFN) project S116601-N16 "Pathways to Habitability: From Disk to Active Stars, Planets and Life" and the related FWF NFN subprojects S116 606-N16 and S116 607-N16. P.O. thanks FWF for grant P22950-N16. The research was conducted using computer resources provided by the Swedish National Infrastructure for Computing (SNUG) at the High Performance Computing Center North (HPC2N). The software was in part developed by the Flash Corer at the University of Chicago. The authors thank L. Ben-Jaffel for providing the reprocessed Hubble Space Telescope observations, B. Wood for providing the processed Ly alpha profile, the team "Characterizing stellar and exoplanetary environments" for useful discussions, and C.P. Johnstone for his valuable comments on the stellar wind issue. The data are available in the supplementary materials.	Baumjohann W., 1996, BASIC SPACE PLASMA P; Ben-Jaffel L, 2007, ASTROPHYS J LETT, V671, pL61, DOI 10.1086/524706; Ben-Jaffel L, 2010, ASTROPHYS J, V709, P1284, DOI 10.1088/0004-637X/709/2/1284; Bird G A, 1976, MOL GAS DYNAMICS DIR; Bourrier V, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321551; CANDY J, 1991, J COMPUT PHYS, V92, P230, DOI 10.1016/0021-9991(91)90299-Z; CHANDRASEKHAR S, 1963, ASTROPHYS J, V138, P1182, DOI 10.1086/147716; Christensen UR, 2009, NATURE, V457, P167, DOI 10.1038/nature07626; Durand-Manterola HJ, 2009, PLANET SPACE SCI, V57, P1405, DOI 10.1016/j.pss.2009.06.024; Ekenback A, 2010, ASTROPHYS J, V709, P670, DOI 10.1088/0004-637X/709/2/670; Etangs ALD, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117330; Fahr HJ, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000214; Fryxell B, 2000, ASTROPHYS J SUPPL S, V131, P273, DOI 10.1086/317361; Garcia A.L., 2000, NUMERICAL METHODS PH; Griessmeier JM, 2004, ASTRON ASTROPHYS, V425, P753, DOI 10.1051/0004-6361:20035684; HODGES RR, 1994, J GEOPHYS RES-SPACE, V99, P23229, DOI 10.1029/94JA02183; Holmstrom M, 2008, NATURE, V451, P970, DOI 10.1038/nature06600; HOLZER TE, 1977, REV GEOPHYS, V15, P467, DOI 10.1029/RG015i004p00467; Izmodenov VV, 2000, ASTROPHYS SPACE SCI, V274, P71, DOI 10.1023/A:1026531519864; Khodachenko ML, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/70; Kislyakova KG, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322933; Kislyakova Kristina G, 2013, Astrobiology, V13, P1030, DOI 10.1089/ast.2012.0958; Koskinen TT, 2013, ICARUS, V226, P1695, DOI 10.1016/j.icarus.2012.09.026; Koskinen TT, 2010, ASTROPHYS J, V723, P116, DOI 10.1088/0004-637X/723/1/116; Kulow JR, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/132; Lindsay BG, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011298; Linsky JL, 2010, ASTROPHYS J, V717, P1291, DOI 10.1088/0004-637X/717/2/1291; Lovis C., 2011, ARXIV11075325V1; MacNeice P, 2000, COMPUT PHYS COMMUN, V126, P330, DOI 10.1016/S0010-4655(99)00501-9; Peebles P.J.E., 1993, PRINCIPLES PHYS COSM, DOI 10.1515/9780691206721; Priest E. R, 1982, SOLAR MAGNETOHYDRODY; Reiners A, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014251; Sanchez-Lavega A, 2004, ASTROPHYS J, V609, pL87, DOI 10.1086/422840; Semelin B, 2007, ASTRON ASTROPHYS, V474, P365, DOI 10.1051/0004-6361:20077965; Shematovich VI, 2010, SOLAR SYST RES+, V44, P96, DOI 10.1134/S0038094610020024; Southworth J, 2010, MON NOT R ASTRON SOC, V408, P1689, DOI 10.1111/j.1365-2966.2010.17231.x; Tremblin P, 2013, MON NOT R ASTRON SOC, V428, P2565, DOI 10.1093/mnras/sts212; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; D'Angelo CV, 2014, MON NOT R ASTRON SOC, V438, P1654, DOI 10.1093/mnras/stt2303; Wood BE, 2005, ASTROPHYS J SUPPL S, V159, P118, DOI 10.1086/430523; Wood BE, 2005, ASTROPHYS J, V628, pL143, DOI 10.1086/432716	41	87	88	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					981	984		10.1126/science.1257829	http://dx.doi.org/10.1126/science.1257829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414310	Green Submitted			2022-12-28	WOS:000345696000040
J	Saini, P; Loke, YK; Gamble, C; Altman, DG; Williamson, PR; Kirkham, JJ				Saini, Pooja; Loke, Yoon K.; Gamble, Carrol; Altman, Douglas G.; Williamson, Paula R.; Kirkham, Jamie J.			Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIALS; IMPACT	Objective To determine the extent and nature of selective non-reporting of harm outcomes in clinical studies that were eligible for inclusion in a cohort of systematic reviews. Design Cohort study of systematic reviews from two databases. Setting Outcome reporting bias in trials for harm outcomes (ORBIT II) in systematic reviews from the Cochrane Library and a separate cohort of systematic reviews of adverse events. Participants 92 systematic reviews of randomised controlled trials and non-randomised studies published in the Cochrane Library between issue 9, 2012 and issue 2, 2013 (Cochrane cohort) and 230 systematic reviews published between 1 January 2007 and 31 December 2011 in other publications, synthesising data on harm outcomes (adverse event cohort). Methods A 13 point classification system for missing outcome data on harm was developed and applied to the studies. Results 86% (79/92) of reviews in the Cochrane cohort did not include full data from the main harm outcome of interest of each review for all of the eligible studies included within that review; 76% (173/230) for the adverse event cohort. Overall, the single primary harm outcome was inadequately reported in 76% (705/931) of the studies included in the 92 reviews from the Cochrane cohort and not reported in 47% (4159/8837) of the 230 reviews in the adverse event cohort. In a sample of primary studies not reporting on the single primary harm outcome in the review, scrutiny of the study publication revealed that outcome reporting bias was suspected in nearly two thirds (63%, 248/393). Conclusions The number of reviews suspected of outcome reporting bias as a result of missing or partially reported harm related outcomes from at least one eligible study is high. The declaration of important harms and the quality of the reporting of harm outcomes must be improved in both primary studies and systematic reviews.	[Saini, Pooja] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3GA, Merseyside, England; [Loke, Yoon K.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Gamble, Carrol; Williamson, Paula R.; Kirkham, Jamie J.] Univ Liverpool, Dept Biostat, Liverpool L69 3GA, Merseyside, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of Liverpool; University of East Anglia; University of Liverpool; University of Oxford	Kirkham, JJ (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3GA, Merseyside, England.	jjk@liv.ac.uk	Kirkham, Jamie/AAD-4490-2019; Gamble, Carrol/AAE-9895-2019; Williamson, Paula R/B-6425-2016	Kirkham, Jamie/0000-0003-2579-9325; Gamble, Carrol/0000-0002-3021-1955; Williamson, Paula R/0000-0001-9802-6636; Saini, Pooja/0000-0002-4981-7914	Medical Research Council [MR/J004855/1]; Cancer Research UL programme [C5529]; Cancer Research UK [16895] Funding Source: researchfish; MRC [MR/J004855/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UL programme; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Outcome Reporting Bias In Trials (ORBIT II) project was funded by the Medical Research Council (grant No MR/J004855/1). DGA is supported by a Cancer Research UL programme grant (C5529). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Golder S, 2014, HEALTH INFO LIBR J, V31, P92, DOI 10.1111/hir.12041; Golder S, 2013, J CLIN EPIDEMIOL, V66, P253, DOI 10.1016/j.jclinepi.2012.09.013; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hodkinson A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003436; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jonsson U, 2014, CONTEMP CLIN TRIALS, V38, P1, DOI 10.1016/j.cct.2014.02.005; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Zorzela L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7668	16	122	124	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 21	2014	349								g6501	10.1136/bmj.g6501	http://dx.doi.org/10.1136/bmj.g6501			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2KB	25416499	Green Published, hybrid			2022-12-28	WOS:000345446000001
J	Holmes, D				Holmes, David			THE CANCER THAT RISES WITH THE SUN	NATURE			English	Editorial Material																			0	30	31	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S110	S111		10.1038/515S110a	http://dx.doi.org/10.1038/515S110a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407705	Bronze			2022-12-28	WOS:000345770600001
J	Olson, KR; Freitag, SK; Johnson, JM; Branda, JA				Olson, Kristian R.; Freitag, Suzanne K.; Johnson, Jason M.; Branda, John A.			Case 36-2014: An 18-Year-Old Woman with Fever, Pharyngitis, and Double Vision	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTION		[Olson, Kristian R.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Olson, Kristian R.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Johnson, Jason M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Olson, Kristian R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Olson, Kristian R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Olson, Kristian R.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Johnson, Jason M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Freitag, Suzanne K.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Olson, KR (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020	johnson, jason/0000-0001-7724-5784	Vodafone Foundation; Omidyar Network	Vodafone Foundation; Omidyar Network	Dr. Olson reports receiving grant support through his institution from Vodafone Foundation and the Omidyar Network. No other potential conflict of interest relevant to this article was reported.	Alcaide ML, 2007, INFECT DIS CLIN N AM, V21, P449, DOI 10.1016/j.idc.2007.03.001; High P., 2010, Morbidity and Mortality Weekly Report, V59, P125; Hunt DP, 2010, NEW ENGL J MED, V363, P1266, DOI 10.1056/NEJMcpc1007084; Hurt C, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.12.011; Jensen A, 2007, CLIN MICROBIOL INFEC, V13, P695, DOI 10.1111/j.1469-0691.2007.01719.x; Kuppalli K, 2012, LANCET INFECT DIS, V12, P808, DOI 10.1016/S1473-3099(12)70089-0; Luzuriaga K, 2010, NEW ENGL J MED, V362, P1993, DOI 10.1056/NEJMcp1001116; Ramirez S, 2003, PEDIATRICS, V112, pE380, DOI 10.1542/peds.112.5.e380; Riordan T, 2007, CLIN MICROBIOL REV, V20, P622, DOI 10.1128/CMR.00011-07; Scott A B, 1981, Trans Am Ophthalmol Soc, V79, P734; Shah M, 2007, J GEN INTERN MED, V22, P272, DOI 10.1007/s11606-006-0049-4; SMITH GR, 1990, EPIDEMIOL INFECT, V104, P73, DOI 10.1017/S0950268800054546; Wilson-Pauwels LAE., 1988, CRANIAL NERVES ANATO; Winston AP, 2012, ANN CLIN BIOCHEM, V49, P132, DOI 10.1258/acb.2011.011185	14	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					2018	2027		10.1056/NEJMcpc1310001	http://dx.doi.org/10.1056/NEJMcpc1310001			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT5ST	25409375				2022-12-28	WOS:000345002900013
J	Sczepanski, JT; Joyce, GF				Sczepanski, Jonathan T.; Joyce, Gerald F.			A cross-chiral RNA polymerase ribozyme	NATURE			English	Article							TEMPLATE; LIGATION; OLIGONUCLEOTIDES; POLYMERIZATION; EXTENSION; SELECTION; MODEL; ACID	Thirty years ago it was shown that the non-enzymatic, template-directed polymerization of activated mononudeotides proceeds readily in a homochiral system, but is severely inhibited by the presence of the opposing enantiomerl. This finding poses a severe challenge for the spontaneous emergence of RNA-based life, and has led to the suggestion that either RNA was preceded by some other genetic polymer that is not subject to chiral inhibition(2) or chiral symmetry was broken through chemical processes before the origin of RNA-based life(3,4). Once an RNA enzyme arose that could catalyse the polymerization of RNA, it would have been possible to distinguish among the two enantiomers, enabling RNA replication and RNA-based evolution to occur. It is commonly thought that the earliest RNA polymerase and its substrates would have been of the same handedness, but this is not necessarily the case. Replicating D- and L-RNA molecules may have emerged together, based on the ability of structured RNAs of one handedness to catalyse the templated polymerization of activated mononudeotides of the opposite handedness. Here we develop such a cross-chiral RNA polymerase, using in vitro evolution starting from a population of random-sequence RNAs. The El-RNA enzyme, consisting of 83 nucleotides, catalyses the joining of L-mono- or oligonudeotide substrates on a complementary L-RNA template, and similar behaviour occurs for the L-enzyme with El-substrates and a El-template. Chiral inhibition is avoided because the 10(6)-fold rate acceleration of the enzyme only pertains to cross-chiral substrates. The enzyme's activity is sufficient to generate full-length copies of its enantiomer through the templated joining of 11 component oligonudeotides.	[Sczepanski, Jonathan T.; Joyce, Gerald F.] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	gjoyce@scripps.edu	Sczepanski, Jonathan/AAC-8094-2021; Sczepanski, Jonathan T/N-8719-2015	Sczepanski, Jonathan/0000-0002-9275-2597; Sczepanski, Jonathan T/0000-0002-9275-2597	NASA [NNX10AQ91G]; Simons Foundation [287624]; National Institutes of Health [F32 GM101741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM101741] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); Simons Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant NNX10AQ91G from NASA and by grant 287624 from the Simons Foundation. J.T.S. was supported by Ruth L. Kirschstein National Research Service Award No. F32 GM101741 from the National Institutes of Health.	Adamala K, 2013, SCIENCE, V342, P1098, DOI 10.1126/science.1241888; ASHLEY GW, 1992, J AM CHEM SOC, V114, P9731, DOI 10.1021/ja00051a001; BOHLER C, 1995, NATURE, V376, P578, DOI 10.1038/376578a0; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Caton-Williams J., 2013, CURR PROTOC NUCL ACI, V52; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; GARBESI A, 1993, NUCLEIC ACIDS RES, V21, P4159, DOI 10.1093/nar/21.18.4159; Hein JE, 2011, NAT CHEM, V3, P704, DOI [10.1038/nchem.1108, 10.1038/NCHEM.1108]; INOUE T, 1983, SCIENCE, V219, P859, DOI 10.1126/science.6186026; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; Klussmann M, 2006, NATURE, V441, P621, DOI 10.1038/nature04780; McGinness KE, 2002, CHEM BIOL, V9, P297, DOI 10.1016/S1074-5521(02)00110-2; Paul N, 2006, CHEM BIOL, V13, P329, DOI 10.1016/j.chembiol.2006.01.007; PLUTHERO FG, 1993, NUCLEIC ACIDS RES, V21, P4850, DOI 10.1093/nar/21.20.4850; Rohatgi R, 1996, J AM CHEM SOC, V118, P3332, DOI 10.1021/ja953712b; Sczepanski JT, 2013, J AM CHEM SOC, V135, P13290, DOI 10.1021/ja406634g; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	21	109	114	0	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					440	+		10.1038/nature13900	http://dx.doi.org/10.1038/nature13900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25363769	Green Accepted			2022-12-28	WOS:000345770600052
J	Lund, LH; Benson, L; Dahlstrom, U; Edner, M; Friberg, L				Lund, Lars H.; Benson, Lina; Dahlstrom, Ulf; Edner, Magnus; Friberg, Leif			Association Between Use of beta-Blockers and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; SYSTOLIC FUNCTION; PROPENSITY SCORE; CLINICAL EFFECTIVENESS; MORTALITY-RATES; OLDER PATIENTS; TASK-FORCE; HOSPITALIZATION; METAANALYSIS; CARVEDILOL	IMPORTANCE Heart failure with preserved ejection fraction (HFPEF) may be as common and may have similar mortality as heart failure with reduced ejection fraction (HFREF). beta-Blockers reduce mortality in HFREF but are inadequately studied in HFPEF. OBJECTIVE To test the hypothesis that beta-blockers are associated with reduced all-cause mortality in HFPEF. DESIGN Propensity score-matched cohort study using the Swedish Heart Failure Registry. Propensity scores for beta-blacker use were derived from 52 baseline clinical and socioeconomic variables. SETTING Nationwide registry of 67 hospitals with inpatient and outpatient units and 95 outpatient primary care clinics in Sweden with patients entered into the registry between July 1, 2005, and December 30, 2012, and followed up until December 31, 2012. PARTICIPANTS From a consecutive sample of 41 976 patients, 19 083 patients with HFPEF (mean [SD] age, 76 [12] years; 46% women). Of these, 8244 were matched 2:1 based on age and propensity score for beta-blocker use, yielding 5496 treated and 2748 untreated patients with HFPEF. Also we conducted a positive-control consistency analysis involving 22 893 patients with HFREF, of whom 6081 were matched yielding 4054 treated and 2027 untreated patients. EXPOSURES beta-Blockers prescribed at discharge from the hospital or during an outpatient visit, analyzed 2 ways: without consideration of crossover and per-protocol analysis with censoring at crossover, if applicable. MAIN OUTCOMES AND MEASURES The prespecified primary outcome was all-cause mortality and the secondary outcome was combined all-cause mortality or heart failure hospitalization. RESULTS Median follow-up in HFPEF was 755 days, overall; 709 days in the matched cohort; no patients were lost to follow-up. In the matched HFPEF cohort, 1-year survival was 80% vs 79% for treated vs untreated patients, and 5-year survival was 45% vs 42%, with 2279(41%) vs 1244(45%) total deaths and 177 vs 191 deaths per 1000 patient-years (hazard ratio [HR], 0.93; 95% Cl, 0.86-0.996; P =.04). beta-Blockers were not associated with reduced combined mortality or heart failure hospitalizations: 3368(61%) vs 1753(64%) total for first events, with 371 vs 378 first events per 1000 patient-years (HR, 0.98; 95% Cl, 0.92-1.04; P = .46). In the matched HFREF cohort, beta-blockers were associated with reduced mortality (HR, 0.89; 95% Cl, 0.82-0.97, P=.005) and also with reduced combined mortality or heart failure hospitalization (HR, 0.89; 95% Cl, 0.84-0.95; P =.001). CONCLUSIONS AND RELEVANCE In patients with HFPEF, use of beta-blockers was associated with lower all-cause mortality but not with combined all-cause mortality or heart failure hospitalization. beta-Blockers in HFPEF should be examined in a large randomized clinical trial.	[Lund, Lars H.; Edner, Magnus] Karolinska Inst, Dept Med, Unit Cardiol, Stockholm, Sweden; [Lund, Lars H.] Karolinska Univ Hosp, Dept Cardiol, S-17176 Stockholm, Sweden; [Benson, Lina] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Dept Cardiol, Linkoping, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Friberg, Leif] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Friberg, Leif] Danderyd Hosp, Dept Cardiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Linkoping University; Linkoping University; Danderyds Hospital; Karolinska Institutet; Danderyds Hospital	Lund, LH (corresponding author), Karolinska Univ Hosp, Sect Heart Failure, Dept Cardiol, N305, S-17176 Stockholm, Sweden.	Lars.Lund@alumni.duke.edu	Friberg, Leif/E-7941-2013	Friberg, Leif/0000-0002-7453-0157; Benson, Lina/0000-0002-5393-0055	Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation; Swedish Research Council [2013-23897-104604-23]; Swedish Heart Lung Foundation [20080409, 20100419]; Sockholm County Council [20090556, 20110120]	Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Sockholm County Council	The Swedish Heart Failure Registry is funded by the Swedish National Board of Health and Welfare, the Swedish Association of Local Authorities and Regions, the Swedish Society of Cardiology, and the Swedish Heart-Lung Foundation. This study was supported in part by grants 2013-23897-104604-23 from the Swedish Research Council, 20080409 and 20100419 from the Swedish Heart Lung Foundation, and 20090556 and 20110120 from the Sockholm County Council to Dr Lund's institution.	Aurigemma GP, 2004, NEW ENGL J MED, V351, P1097, DOI 10.1056/NEJMcp022709; Bergstrom A, 2004, EUR J HEART FAIL, V6, P453, DOI 10.1016/j.ejheart.2004.02.003; Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Chun S, 2012, CIRC-HEART FAIL, V5, P414, DOI 10.1161/CIRCHEARTFAILURE.111.964791; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dharmarajan K, 2013, JAMA INTERN MED, V173, P1547, DOI 10.1001/jamainternmed.2013.7717; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; El-Refai M, 2013, J CARD FAIL, V19, P73, DOI 10.1016/j.cardfail.2012.11.011; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Hernandez AF, 2009, J AM COLL CARDIOL, V53, P184, DOI 10.1016/j.jacc.2008.09.031; Hogg K, 2005, PROG CARDIOVASC DIS, V47, P357, DOI 10.1016/j.pcad.2005.02.001; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Klingbeil AU, 2003, AM J MED, V115, P41, DOI 10.1016/S0002-9343(03)00158-X; Krum H, 2003, JAMA-J AM MED ASSOC, V289, P712, DOI 10.1001/jama.289.6.712; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Lam CSP, 2011, CIRCULATION, V124, P24, DOI 10.1161/CIRCULATIONAHA.110.979203; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Liu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090555; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lund LH, 2014, EUR J HEART FAIL, V16, P992, DOI 10.1002/ejhf.137; Lund LH, 2012, JAMA-J AM MED ASSOC, V308, P2108, DOI 10.1001/jama.2012.14785; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nevzorov R, 2012, EUR J INTERN MED, V23, P374, DOI 10.1016/j.ejim.2012.01.011; Patel K, 2014, INT J CARDIOL, V173, P393, DOI 10.1016/j.ijcard.2014.03.005; Patel K, 2012, EUR J HEART FAIL, V14, P1179, DOI 10.1093/eurjhf/hfs101; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770; Tavazzi L, 2013, CIRC-HEART FAIL, V6, P473, DOI 10.1161/CIRCHEARTFAILURE.112.000161; van Veldhuisen DJ, 2009, J AM COLL CARDIOL, V53, P2150, DOI 10.1016/j.jacc.2009.02.046; Yamamoto K, 2013, EUR J HEART FAIL, V15, P110, DOI 10.1093/eurjhf/hfs141; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	37	107	109	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2008	2018		10.1001/jama.2014.15241	http://dx.doi.org/10.1001/jama.2014.15241			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399276				2022-12-28	WOS:000345450500015
J	Sherwood, MW; Peterson, ED				Sherwood, Matthew W.; Peterson, Eric D.			Revsculariza don in Stable Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CLINICAL-TRIALS; METAANALYSIS; INTERVENTION	IMPORTANCE Recent trials of percutaneous coronary intervention (PCI) vs coronary artery bypass grafting (CABG) for multivessel disease were not designed to detect a difference in mortality and therefore were underpowered for this outcome. Consequently, the comparative effects of these 2 revascularization methods on long-term mortality are still unclear. In the absence of solid evidence for mortality difference, PCI is oftentimes preferred over CABG in these patients, given its less invasive nature. OBJECTIVES To determine the comparative effects of CABG vs PLI iong-term mortality and morbidity by performing a meta-analysis of all randomized clinical trials of the current era that compared the 2 treatment techniques in patients with multivessel disease. DATA SOURCES A systematic literature search was conducted for all randomized clinical trials directly comparing CABG with PCI. 90%, and 1 or more stents used in at least 70% of the cases that reported outcomes in patients with multivessel disease. DATA SOURCES Numbers of events at the longest possible I A and sample sizes were extracted. DATA SYNTHESIS total of 6 randomized trials enrolling a total of 6055 patients were included, with a weighted average follow-up of 4.1 years. There was a significant reduction in total mortality with CABG compared with PCI (I-2 = 0%; risk ratio [RR], 0.73 [95% CI, 0.62-0.86]) (P <.001). There were alsosignificant reductions in myocardial infarction (I-2 = 8.02%; RR, 0.58 [95% CI, 0.48-0.72]) (P <.001) and repeat revascularization (12 = 75.6%; RR, 0.29 [95% CI, 0.21-0.41]) (P <.001) with CABG. There was a trend toward excess strokes with CABG (12 = 24.9%; RR, 1.36 [95% CI, 0.99-1.86]), but this was not statistically significant (P =.06). For reduction in total mortality, there was no heterogeneity between trials that were limited to and not limited to patients with diabetes or whether stents were drug eluting or not. Owingto lack of individual patient-level data, additional subgroup analyses could not be performed. CONCLUSIONS AND RELEVANCE In patients with multivessel cororiaiy disease, compared with PCI, CABG leads to an unequivocal reduction in long-term mortality and myocardial infarctions and to reductions in repeat revascularizations, regardless of whether patients are diabetic or not. These findings have implications for management of such patients.	[Sherwood, Matthew W.; Peterson, Eric D.] Duke Univ, Med Ctr, Div Cardiovasc Med, Duke Clin Res Inst, Durham, NC USA	Duke University	Sherwood, MW (corresponding author), Duke Clin Res Inst, 2400 Pratt St,POB 17969, Durham, NC 27715 USA.	matthew.sherwood@dm.duke.edu	Peterson, Eric David/ABF-5033-2021; Sherwood, Matthew/AAW-5115-2020	Sherwood, Matthew/0000-0002-4305-5883				De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Murad MH, 2014, JAMA-J AM MED ASSOC, V312, P171, DOI 10.1001/jama.2014.5559; Sipahi I, 2014, JAMA INTERN MED, V174, P223, DOI 10.1001/jamainternmed.2013.12844; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P232, DOI 10.1001/jamainternmed.2013.12855	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2028	+		10.1001/jama.2014.9314	http://dx.doi.org/10.1001/jama.2014.9314			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399278				2022-12-28	WOS:000345450500017
J	Lee, JJ; Schmitt, FT; Moore, RG; Johnston, S; Cui, YT; Li, W; Yi, M; Liu, ZK; Hashimoto, M; Zhang, Y; Lu, DH; Devereaux, TP; Lee, DH; Shen, ZX				Lee, J. J.; Schmitt, F. T.; Moore, R. G.; Johnston, S.; Cui, Y. -T.; Li, W.; Yi, M.; Liu, Z. K.; Hashimoto, M.; Zhang, Y.; Lu, D. H.; Devereaux, T. P.; Lee, D. -H.; Shen, Z. -X.			Interfacial mode coupling as the origin of the enhancement of T-c in FeSe films on SrTiO3	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTIVITY; PHOTOEMISSION	Films of iron selenide (FeSe) one unit cell thick grown on strontium titanate (SrTiO3 or STO) substrates have recently shown(1-4) superconducting energy gaps opening at temperatures close to the boiling point of liquid nitrogen (77 kelvin), which is a record for the iron-based superconductors. The gap opening temperature usually sets the superconducting transition temperature T-c, as the gap signals the formation of Cooper pairs, the bound electron states responsible for superconductivity. To understand why Cooper pairs form at such high temperatures, we examine the role of the SrTiO3 substrate. Here we report high-resolution angle-resolved photoemission spectroscopy results that reveal an unexpected characteristic of the single-unit-cell FeSe/SrTiO3 system: shake-off bands suggesting the presence of bosonic modes, most probably oxygen optical phonons in SrTiO3 (refs 5-7), which couple to the FeSe electrons with only a small momentum transfer. Such interfacial coupling assists superconductivity in most channels, including those mediated by spin fluctuations(8-14). Our calculations suggest that this coupling is responsible for raising the superconducting gap opening temperature in single-unit-cell FeSe/SrTiO3.	[Lee, J. J.; Schmitt, F. T.; Moore, R. G.; Cui, Y. -T.; Li, W.; Yi, M.; Liu, Z. K.; Zhang, Y.; Devereaux, T. P.; Shen, Z. -X.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Lee, J. J.; Yi, M.; Liu, Z. K.; Shen, Z. -X.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Lee, J. J.; Yi, M.; Liu, Z. K.; Shen, Z. -X.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Lee, J. J.; Yi, M.; Liu, Z. K.; Shen, Z. -X.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Johnston, S.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Johnston, S.] Univ British Columbia, Quantum Matter Inst, Vancouver, BC V6T 1Z4, Canada; [Johnston, S.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Hashimoto, M.; Lu, D. H.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Zhang, Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Lee, D. -H.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Lee, D. -H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; Stanford University; University of British Columbia; University of British Columbia; University of Tennessee System; University of Tennessee Knoxville; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Shen, ZX (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.	zxshen@stanford.edu	Moore, Rob/CAG-8039-2022; Johnston, Steven/J-7777-2016; Cui, Yong-Tao/G-8505-2015; Ryan, Sheena/R-2234-2018	Moore, Rob/0000-0002-1608-5411; Cui, Yong-Tao/0000-0002-8015-1049; Johnston, Steve/0000-0002-2343-0113; Hashimoto, Makoto/0000-0003-1689-8997	US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division; Department of Energy, Office of Basic Energy Sciences, Division of Materials Science, under the Quantum Material programme [DE-AC02-05CH11231]	US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Department of Energy, Office of Basic Energy Sciences, Division of Materials Science, under the Quantum Material programme	This work was supported by the US Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division. D.-H.L. is supported by the Department of Energy, Office of Basic Energy Sciences, Division of Materials Science, under the Quantum Material programme DE-AC02-05CH11231. Measurements were performed at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences.	Aperis A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.092505; Bulut N, 1996, PHYS REV B, V54, P14971, DOI 10.1103/PhysRevB.54.14971; Chang YJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235109; Choudhury N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.134111; Davis JCS, 2013, P NATL ACAD SCI USA, V110, P17623, DOI 10.1073/pnas.1316512110; He SL, 2013, NAT MATER, V12, P605, DOI [10.1038/nmat3648, 10.1038/NMAT3648]; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Johnston S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.134507; Johnston S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064513; Lasota C, 1997, FERROELECTRICS, V194, P109, DOI 10.1080/00150199708016086; Liu DF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1946; Maletz J, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.220506; Norman MR, 1998, PHYS REV B, V57, pR11093, DOI 10.1103/PhysRevB.57.R11093; Paggel JJ, 2000, PHYS REV B, V61, P1804, DOI 10.1103/PhysRevB.61.1804; Sandvik AW, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.094523; Santi G, 1996, PHYSICA C, V259, P253, DOI 10.1016/0921-4534(96)00052-4; STIRLING WG, 1972, J PHYS PART C SOLID, V5, P2711, DOI 10.1088/0022-3719/5/19/005; Tan SY, 2013, NAT MATER, V12, P634, DOI [10.1038/nmat3654, 10.1038/NMAT3654]; Tang SJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.216803; Turner D. W., 1970, MOL PHOTOELECTRON SP; Varelogiannis G, 1996, PHYS REV B, V54, pR6877, DOI 10.1103/PhysRevB.54.R6877; Wang M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3874; Wang QY, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/037402; Xiang YY, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.134508; Yang F, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.100504; Yu R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3783; Zhang Y, 2011, NAT MATER, V10, P273, DOI 10.1038/NMAT2981	27	483	490	19	461	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					245	U207		10.1038/nature13894	http://dx.doi.org/10.1038/nature13894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391962	Green Submitted			2022-12-28	WOS:000344631400045
J	Lui, JH; Nowakowski, TJ; Pollen, AA; Javaherian, A; Kriegstein, AR; Oldham, MC				Lui, Jan H.; Nowakowski, Tomasz J.; Pollen, Alex A.; Javaherian, Ashkan; Kriegstein, Arnold R.; Oldham, Michael C.			Radial glia require PDGFD-PDGFR beta signalling in human but not mouse neocortex	NATURE			English	Article							RECEPTOR-BETA; EVOLUTION; TRANSCRIPTOME; GENE; BRAIN; ZONES	Evolutionary expansion of the human neocortex underlies many of our unique mental abilities. This expansion has been attributed to the increased proliferative potential(1,2) of radial glia (RG; neural stem cells) and their subventricular dispersion from the periventricular niche(3-5) during neocortical development. Such adaptations may have evolved through gene expression changes in RG. However, whether or how RG gene expression varies between humans and other species is unknown. Here we show that the transcriptional profiles of human and mouse neocortical RG are broadly conserved during neurogenesis, yet diverge for specific signalling pathways. By analysing differential gene co-expression relationships between the species, we demonstrate that the growth factor PDGFD is specifically expressed by RG inhuman, but not mouse, corticogenesis. We also show that the expression domain of PDGFR beta, the cognate receptor(6,7) for PDGFD, is evolutionarily divergent, with high expression in the germinal region of dorsal human neocortex but not in the mouse. Pharmacological inhibition of PDGFD-PDGFR beta signalling in slice culture prevents normal cell cycle progression of neocortical RG in human, but not mouse. Conversely, injection of recombinant PDGFD or ectopic expression of constitutively active PDGFR beta in developing mouse neocortex increases the proportion of RG and their subventricular dispersion. These findings highlight the requirement of PDGFD-PDGFR beta signalling for human neocortical development and suggest that local production of growth factors by RG supports the expanded germinal region and progenitor heterogeneity of species with large brains.	[Lui, Jan H.; Nowakowski, Tomasz J.; Pollen, Alex A.; Javaherian, Ashkan; Kriegstein, Arnold R.; Oldham, Michael C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Lui, Jan H.; Nowakowski, Tomasz J.; Pollen, Alex A.; Javaherian, Ashkan; Kriegstein, Arnold R.; Oldham, Michael C.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Oldham, MC (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	kriegsteina@stemcell.ucsf.edu; oldhamm@stemcell.ucsf.edu	Nowakowski, Tomasz/P-7731-2014	Nowakowski, Tomasz/0000-0003-2345-4964	NIH, NINDS; Bernard Osher Foundation, a California Institute for Regenerative Medicine Predoctoral Fellowship [TG2-01153]; Damon Runyon Foundation Postdoctoral Fellowship [DRG-2013]; University of California San Francisco Program for Breakthrough Biomedical Research - Sandler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075998, R01NS072630, R01NS021223] Funding Source: NIH RePORTER	NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bernard Osher Foundation, a California Institute for Regenerative Medicine Predoctoral Fellowship; Damon Runyon Foundation Postdoctoral Fellowship; University of California San Francisco Program for Breakthrough Biomedical Research - Sandler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the staff at San Francisco General Hospital Women's Options Center for their consideration in allowing access to donated human prenatal tissue. We thank J. DeYoung and the staff at the Southern California Genotyping Consortium at the University of California Los Angeles for microarray data generation. We are grateful to A. Holloway for her critical reading of the manuscript, and also thank W. Walantus, S. Wang, Y. Wang and other University of California San Francisco personnel for technical and administrative support. We thank C. Stiles and D. Rowitch for the TEL-PDGFR beta construct. This work was supported by grants from the NIH, NINDS (A.R.K.), the Bernard Osher Foundation, a California Institute for Regenerative Medicine Predoctoral Fellowship for J.H.L. (TG2-01153), a Damon Runyon Foundation Postdoctoral Fellowship for A.A.P. (DRG-2013), and the University of California San Francisco Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation (M.C.O.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the California Institute for Regenerative Medicine or any other agency of the State of California.	Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Magnusson PU, 2007, ARTERIOSCL THROM VAS, V27, P2142, DOI 10.1161/01.ATV.0000282198.60701.94; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Oldham MC, 2014, OMICS APPL NEUROSCIE, P85; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Roberts WG, 2005, CANCER RES, V65, P957; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Wang Z, 2010, BBA-REV CANCER, V1806, P122, DOI 10.1016/j.bbcan.2010.04.003; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	29	109	111	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					264	U258		10.1038/nature13973	http://dx.doi.org/10.1038/nature13973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391964	Green Submitted, Green Accepted			2022-12-28	WOS:000344631400050
J	Hawkes, N; Arie, S				Hawkes, Nigel; Arie, Sophie			EBOLA Is the United Nations catching up with Ebola at last?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						[Anonymous], 2014, BBC; Chan M, 2014, COMMUNICATION   0808; Clarke Toni, 2014, REUTERS; Fink S., 2014, NY TIMES; Fortner R, 2014, WHAT OTHER GLOBAL HL; Masters S, 2014, INDEPENDENT SUN 1019; UN, 2014, TRUST FUND FACTSH; UN Office for the Coordination of Humanitarian Affairs, 2014, EB VIR DIS OUTBR OV; United Nations Mission for Ebola Emergency Response [UNMEER], 2014, EXT SIT REP; WHO, 2014, EB RESP ROAD MAP SIT; World Health Organization, 2014, WHO STAT M INT HLTH	11	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2014	349								g6576	10.1136/bmj.g6576	http://dx.doi.org/10.1136/bmj.g6576			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CD	25378433	Green Published, Bronze			2022-12-28	WOS:000344603700004
J	Lee, N				Lee, Naomi			The Lancet Technology: October, 2014 Robotic surgery: where are we now?	LANCET			English	Editorial Material												naomi.lee@lancet.com							0	11	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1417	1417		10.1016/S0140-6736(14)61851-1	http://dx.doi.org/10.1016/S0140-6736(14)61851-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25390313				2022-12-28	WOS:000343107000012
